data_2mlz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mlz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.475 ' HE3' HG11 ' A' ' 3' ' ' VAL . 15.8 ptm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' THR . 7.8 tt0 -87.04 97.52 10.77 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.328 -0.989 . . . . 15.0 108.328 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.475 HG11 ' HE3' ' A' ' 1' ' ' MET . 30.4 m -133.02 157.58 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.844 0.458 . . . . 15.0 111.305 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -131.04 86.43 2.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 15' ' ' VAL . 4.8 p -73.77 87.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 122.658 1.218 . . . . 15.0 110.508 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.96 178.2 5.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.97 -1.468 . . . . 15.0 109.546 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 58.1 m -136.63 125.96 24.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -66.24 -58.75 4.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.538 0.735 . . . . 15.0 109.842 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -167.46 120.62 0.94 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.02 0.528 . . . . 15.0 109.998 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.82 -100.67 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 O-C-N 124.423 1.077 . . . . 15.0 114.398 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.36 -43.39 27.79 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.203 1.001 . . . . 15.0 110.076 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.2 88.88 0.08 OUTLIER Glycine 0 C--N 1.344 1.024 0 O-C-N 124.065 0.853 . . . . 15.0 112.5 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.9 ttm180 -95.78 129.11 43.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 15.0 110.326 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -106.04 90.75 3.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.283 1.033 . . . . 15.0 110.416 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 5' ' ' VAL . 46.1 t -81.68 87.02 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.906 -1.146 . . . . 15.0 107.906 173.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 82.0 m -71.67 87.55 0.94 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.281 0.633 . . . . 15.0 110.189 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 74' ' ' ASN . 48.8 mt -80.07 128.22 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.56 -0.745 . . . . 15.0 109.135 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 56.7 m -118.23 104.08 10.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.713 -1.218 . . . . 15.0 107.713 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.532 HG13 ' HE1' ' A' ' 105' ' ' TYR . 24.7 mt -66.39 129.91 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.98 137.54 57.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.189 0.931 . . . . 15.0 111.038 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.08 61.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.032 1.333 . . . . 15.0 112.789 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.68 -40.88 92.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.849 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.7 m -70.08 -34.63 73.41 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.278 -0.874 . . . . 15.0 111.079 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -68.75 -50.98 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.859 0.464 . . . . 15.0 109.85 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -59.2 -33.73 71.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.265 0.626 . . . . 15.0 111.271 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.1 m -76.72 -43.17 38.5 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.367 0.667 . . . . 15.0 111.283 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -42.2 78.87 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.032 0.533 . . . . 15.0 112.249 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.5 t -60.91 -47.77 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.683 0.793 . . . . 15.0 109.838 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 4.8 ttmp? -58.04 -40.06 79.94 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.083 0.953 . . . . 15.0 111.731 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.4 m -70.56 -28.96 65.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.827 0.851 . . . . 15.0 110.822 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.4 tp10 -80.35 -29.07 37.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.021 0.528 . . . . 15.0 110.725 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -70.69 -35.7 72.91 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.702 0.801 . . . . 15.0 111.534 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.0 p -71.18 -29.71 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.764 -0.458 . . . . 15.0 109.764 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -67.16 -36.67 82.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.934 0.494 . . . . 15.0 110.517 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' GLU . 57.8 t -63.4 -43.1 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.31 73.88 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.45 -0.796 . . . . 15.0 111.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 97.8 mttt -75.12 -33.98 61.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.218 0.607 . . . . 15.0 111.098 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -65.27 -36.52 84.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.688 0.795 . . . . 15.0 110.617 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 35' ' ' VAL . 3.8 t -96.13 -1.51 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.163 0.585 . . . . 15.0 110.562 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 66.95 10.42 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.506 1.522 . . . . 15.0 113.792 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -79.29 -11.24 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.896 0.878 . . . . 15.0 111.388 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -57.13 -38.51 73.59 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.818 0.847 . . . . 15.0 111.907 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.97 -19.81 64.47 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.742 -0.663 . . . . 15.0 112.529 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.02 -20.75 34.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.197 0.599 . . . . 15.0 110.57 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.36 107.81 3.95 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.24 6.56 13.68 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.832 0.853 . . . . 15.0 111.777 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 10.5 74.05 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.964 -0.354 . . . . 15.0 113.035 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -65.38 -35.09 79.89 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.759 0.824 . . . . 15.0 109.86 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.37 122.47 59.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 159.05 47.74 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.899 2.4 . . . . 15.0 112.016 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 tpt -72.51 -20.26 61.39 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.908 -0.587 . . . . 15.0 112.09 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -65.44 -43.04 91.65 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.268 -0.271 . . . . 15.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.407 HG21 ' HD2' ' A' ' 57' ' ' ARG . 62.7 mt -66.19 -44.97 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.87 0.868 . . . . 15.0 111.288 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -71.05 -21.7 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 116.582 -0.281 . . . . 15.0 111.471 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.09 -42.13 14.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.892 0.477 . . . . 15.0 112.041 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.511 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 2.4 pt20 -82.6 -42.63 18.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.09 0.556 . . . . 15.0 111.253 -171.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 98.3 mtt180 -91.63 -60.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.111 0.564 . . . . 15.0 110.435 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.53 -46.51 63.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.607 -0.724 . . . . 15.0 110.471 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.51 12.16 35.11 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.015 -0.881 . . . . 15.0 114.083 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.86 -32.86 72.83 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 117.875 0.837 . . . . 15.0 110.613 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -74.37 -52.0 13.42 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.2 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.0 78.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 15.0 109.629 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -132.14 -63.73 0.8 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.466 1.107 . . . . 15.0 109.114 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -60.67 -29.33 69.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 123.794 0.684 . . . . 15.0 110.404 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.39 -49.44 69.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.824 1.25 . . . . 15.0 110.758 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG13 ' HA ' ' A' ' 28' ' ' VAL . 21.2 t -75.35 -38.65 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.056 -0.975 . . . . 15.0 110.075 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 70' ' ' LEU . 96.3 mt -59.17 -33.1 70.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.729 0.812 . . . . 15.0 111.692 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.496 ' HA2' ' HE2' ' A' ' 71' ' ' MET . . . -56.87 -39.73 88.74 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.433 0.458 . . . . 15.0 112.932 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.91 -46.84 22.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.878 0.871 . . . . 15.0 110.334 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 67' ' ' LEU . 80.0 mt -56.91 -37.19 71.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.852 0.861 . . . . 15.0 112.236 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.496 ' HE2' ' HA2' ' A' ' 68' ' ' GLY . 72.5 mtm -59.4 -39.24 82.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.362 0.665 . . . . 15.0 111.169 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -75.14 -30.37 60.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.155 -0.929 . . . . 15.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -71.78 -42.31 67.3 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.511 -0.551 . . . . 15.0 109.511 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' HB3' HG23 ' A' ' 17' ' ' ILE . 53.2 m-80 -71.83 -27.47 62.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.786 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -66.62 -56.57 10.1 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.341 0.4 . . . . 15.0 110.557 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.79 -30.56 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 O-C-N 123.875 0.735 . . . . 15.0 110.456 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.37 -49.05 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.638 0.775 . . . . 15.0 110.077 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.51 -57.3 11.69 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.376 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.1 pt -61.2 -29.14 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 112.83 0.678 . . . . 15.0 112.83 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.74 -49.06 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.263 0.625 . . . . 15.0 110.968 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.449 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -74.62 -25.85 59.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.541 0.21 . . . . 15.0 111.312 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -83.34 -16.71 45.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.727 0.811 . . . . 15.0 111.14 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 64.15 25.75 13.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.763 1.225 . . . . 15.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.487 HG21 ' HE2' ' A' ' 109' ' ' PHE . 51.8 mt -91.01 127.01 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.406 0.682 . . . . 15.0 109.718 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.55 117.22 61.76 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 164.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.35 97.17 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.375 2.05 . . . . 15.0 113.382 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.53 -171.12 3.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.081 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.551 ' H ' ' HB3' ' A' ' 305' ' ' ALA . . . 58.71 -145.03 43.4 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.293 -0.323 . . . . 15.0 112.293 -168.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.28 122.5 17.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.404 -1.702 . . . . 15.0 106.404 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.92 106.51 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.513 2.142 . . . . 15.0 111.7 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -102.16 98.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.672 0.789 . . . . 15.0 109.468 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -84.54 94.35 8.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.33 98.48 0.92 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.928 -0.768 . . . . 15.0 108.928 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 112.23 3.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.857 2.371 . . . . 15.0 111.352 -173.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.5 -62.61 5.95 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.298 -0.721 . . . . 15.0 111.298 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.32 168.41 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.048 0.939 . . . . 15.0 110.629 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -138.75 121.81 16.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.236 1.014 . . . . 15.0 108.864 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 60.6 mttp -94.63 170.46 9.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.36 97.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.655 0.782 . . . . 15.0 111.469 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.45 80.24 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.447 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.7 mt-10 -98.67 -176.8 3.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.722 0.809 . . . . 15.0 110.805 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.29 137.9 57.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.716 0.806 . . . . 15.0 111.588 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -108.87 99.54 8.87 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.936 0.894 . . . . 15.0 109.546 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -79.72 131.28 35.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.731 0.813 . . . . 15.0 110.084 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.532 ' HE1' HG13 ' A' ' 19' ' ' ILE . 28.8 p90 -152.18 125.25 8.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.609 0.764 . . . . 15.0 109.869 173.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.9 m -82.8 100.55 10.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.445 1.098 . . . . 15.0 110.259 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.67 97.9 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.578 -0.527 . . . . 15.0 109.578 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.46 116.65 30.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.605 0.762 . . . . 15.0 110.494 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HE2' HG21 ' A' ' 84' ' ' ILE . 43.2 p90 -145.3 170.18 16.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.758 1.223 . . . . 15.0 107.73 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -94.71 156.58 16.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.392 0.615 . . . . 15.0 111.312 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.63 162.82 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.462 1.105 . . . . 15.0 108.272 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.05 119.87 70.53 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.86 -175.48 2.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.111 2.541 . . . . 15.0 112.46 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.71 128.39 35.36 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -102.48 129.76 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.816 0.846 . . . . 15.0 109.278 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -118.37 113.14 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 15.0 110.751 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.1 mt -82.0 130.69 35.15 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 123.648 0.593 . . . . 15.0 109.611 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.39 154.92 14.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.679 0.792 . . . . 15.0 109.87 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 64.55 20.73 66.15 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.681 0.613 . . . . 15.0 113.481 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 117' ' ' LEU . 68.0 mt -65.04 -42.64 94.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.886 0.874 . . . . 15.0 110.505 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -78.16 -18.65 55.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.636 -1.166 . . . . 15.0 110.646 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.95 47.47 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.234 0.613 . . . . 15.0 111.34 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.517 HG22 ' HA3' ' A' ' 293' ' ' GLY . 61.1 mt -58.35 124.33 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.245 0.966 . . . . 15.0 110.666 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.0 103.92 14.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.421 0.688 . . . . 15.0 109.296 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.665 ' HB ' HG23 ' A' ' 417' ' ' VAL . 41.5 t -107.32 161.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.46 1.104 . . . . 15.0 108.417 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -123.1 138.13 54.74 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.533 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.1 tttt -114.7 88.67 16.82 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.336 -0.987 . . . . 15.0 108.336 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.11 100.81 0.95 Allowed 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.049 1.833 . . . . 15.0 111.298 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.533 HD11 ' HE2' ' A' ' 127' ' ' LYS . 42.1 mm -67.87 84.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 168.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 HG22 ' A' ' 422' ' ' THR . 21.3 t -98.38 136.73 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.22 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -132.66 162.52 31.15 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 167.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.16 79.83 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.2 p -61.93 170.06 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.761 0.824 . . . . 15.0 110.448 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.27 -31.43 65.58 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.955 0.502 . . . . 15.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.96 92.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.782 0.833 . . . . 15.0 110.895 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -73.16 -40.55 64.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.314 0.646 . . . . 15.0 111.113 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.06 -61.87 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.211 1.004 . . . . 15.0 109.514 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.48 -34.49 65.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.574 -0.739 . . . . 15.0 110.934 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.22 -45.67 92.97 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.639 0.587 . . . . 15.0 113.14 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -75.29 -41.82 56.2 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.058 0.543 . . . . 15.0 111.033 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.539 HD21 HG12 ' A' ' 270' ' ' VAL . 32.2 mt -52.23 -40.01 61.05 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.095 0.558 . . . . 15.0 111.841 167.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.54 -41.37 84.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.409 0.684 . . . . 15.0 110.605 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 m -60.41 -39.3 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.836 0.71 . . . . 15.0 110.339 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -40.33 96.07 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 15.0 111.014 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 47.7 mtm180 -62.33 -40.7 97.2 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.621 0.575 . . . . 15.0 110.558 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 87.5 mttt -80.29 -16.4 54.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.324 0.65 . . . . 15.0 112.386 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -82.48 -40.8 20.6 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.883 0.473 . . . . 15.0 109.748 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -100.0 35.81 1.97 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.788 0.835 . . . . 15.0 109.889 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.498 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -79.19 143.97 34.88 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.011 0.925 . . . . 15.0 112.562 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.4 m -74.19 129.4 37.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 15.0 109.643 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -79.18 129.99 35.02 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.21 163.36 36.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 45.7 mt-10 -118.12 157.15 27.42 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.145 0.498 . . . . 15.0 109.839 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.793 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 23.4 pttt -136.63 155.09 50.38 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.34 -0.846 . . . . 15.0 109.982 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.77 96.57 7.0 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.613 -0.721 . . . . 15.0 110.242 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 240' ' ' VAL . . . 60.07 62.36 6.15 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 113.965 -1.47 . . . . 15.0 116.392 165.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.624 ' H ' HG12 ' A' ' 240' ' ' VAL . . . -155.02 107.66 2.75 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 117.344 0.572 . . . . 15.0 110.291 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 203' ' ' LYS . 41.6 t -109.22 137.54 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.488 0.586 . . . . 15.0 109.66 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.61 -176.99 4.22 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.788 1.235 . . . . 15.0 109.315 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.22 67.6 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.892 1.441 . . . . 15.0 114.892 -167.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.9 17.68 9.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.971 0.509 . . . . 15.0 111.305 -170.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.51 -159.57 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.929 0.491 . . . . 15.0 111.815 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 32.3 ttp180 -137.17 153.87 50.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 44.5 t -144.12 155.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 15.0 108.768 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 23.5 m -122.74 124.39 43.26 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 164.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.09 161.34 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.778 0.831 . . . . 15.0 111.012 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.78 121.12 33.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.466 -2.05 . . . . 15.0 105.466 159.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -112.39 163.08 14.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.746 -0.596 . . . . 15.0 110.3 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.5 t -139.78 93.31 2.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -98.12 162.74 21.01 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.205 -1.361 . . . . 15.0 113.295 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 m -149.98 127.45 11.51 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.025 -1.102 . . . . 15.0 108.025 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 71.2 t -97.35 115.97 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.803 0.841 . . . . 15.0 109.422 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 36.6 t70 69.62 3.47 4.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.652 0.781 . . . . 15.0 111.486 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 115.32 -11.9 19.36 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.587 -0.563 . . . . 15.0 113.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 10.3 pt-20 -92.37 131.79 37.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.4 94.58 1.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.217 -1.772 . . . . 15.0 106.217 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.425 ' HD1' ' H ' ' A' ' 177' ' ' PHE . 3.0 p90 -71.78 -160.78 0.06 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.509 -1.678 . . . . 15.0 112.419 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -51.66 103.96 0.07 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.155 0.982 . . . . 15.0 110.571 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' B' ' 386' ' ' VAL . . . 91.56 -62.72 2.69 Favored Glycine 0 C--O 1.239 0.435 0 O-C-N 124.366 1.041 . . . . 15.0 113.195 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.27 -59.42 4.91 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.2 158.03 16.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.566 0.58 . . . . 15.0 112.566 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.16 93.51 2.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.5 m -79.58 130.71 35.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.196 -0.911 . . . . 15.0 112.193 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 58.17 31.12 20.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.749 1.22 . . . . 15.0 113.309 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -71.4 133.96 46.31 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.133 0.492 . . . . 15.0 109.86 173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.7 100.69 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 124.26 1.024 . . . . 15.0 108.912 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.17 98.66 11.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.146 0.979 . . . . 15.0 111.406 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.03 101.65 3.3 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.672 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER -60.08 116.61 4.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.306 0.643 . . . . 15.0 109.641 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.9 -6.61 7.82 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.816 -0.629 . . . . 15.0 112.148 -166.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -81.52 -179.83 7.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.509 0.724 . . . . 15.0 111.097 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.97 52.73 0.68 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.877 -0.602 . . . . 15.0 112.226 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.7 13.52 21.15 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.94 0.876 . . . . 15.0 109.169 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -152.2 154.62 36.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.407 1.083 . . . . 15.0 109.169 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 pt -86.3 164.57 37.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.442 0.697 . . . . 15.0 111.342 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.13 153.57 68.56 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.241 1.961 . . . . 15.0 111.373 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.73 -50.59 1.77 Allowed Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.872 -0.891 . . . . 15.0 110.872 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.441 ' HA ' HD11 ' A' ' 213' ' ' ILE . 65.6 t80 -68.66 -59.98 2.74 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.197 0.599 . . . . 15.0 109.547 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.18 -32.71 73.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.313 1.008 . . . . 15.0 111.623 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.572 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 4.8 m-20 -69.53 -23.43 63.59 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.849 0.86 . . . . 15.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.49 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -83.77 -9.99 81.99 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.461 0.476 . . . . 15.0 113.182 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.1 -46.86 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.677 0.791 . . . . 15.0 110.061 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.672 ' HB3' ' SD ' ' A' ' 189' ' ' MET . 62.3 pttt -84.7 30.88 0.54 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.13 1.159 . . . . 15.0 114.13 -161.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -155.89 35.91 0.62 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.785 -0.526 . . . . 15.0 111.785 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.62 -170.95 3.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.352 0.661 . . . . 15.0 111.29 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -139.42 155.89 47.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.577 1.151 . . . . 15.0 111.226 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.1 147.09 51.96 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 15.0 111.084 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.6 -40.98 2.26 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.229 -0.749 . . . . 15.0 111.229 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.8 pt-20 -78.8 126.79 31.18 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.613 0.72 . . . . 15.0 109.434 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.36 106.4 13.6 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.302 -1.369 . . . . 15.0 107.302 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -126.29 -177.43 3.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.344 1.058 . . . . 15.0 109.877 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.8 t -117.25 158.15 24.82 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.49 HG22 ' HA3' ' A' ' 201' ' ' GLY . 38.0 pt -128.01 150.2 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 173.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.12 117.58 34.43 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 163.92 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 15.0 107.332 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 59.1 m -141.92 134.47 28.23 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.29 128.93 76.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.111 -0.471 . . . . 15.0 109.767 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.06 163.51 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.713 2.942 . . . . 15.0 115.146 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.61 -24.44 53.42 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.397 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.36 -18.63 48.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.363 1.065 . . . . 15.0 110.628 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.43 ' HE2' HD13 ' A' ' 226' ' ' LEU . 30.7 t80 -61.11 111.62 1.78 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 15.0 109.923 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -66.71 -14.39 62.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.163 1.172 . . . . 15.0 114.163 -168.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.16 101.04 10.18 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.74 -31.39 72.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 15.0 111.727 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.512 HD22 HG12 ' B' ' 388' ' ' VAL . 7.0 p30 -70.41 -11.68 61.08 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.862 0.465 . . . . 15.0 111.596 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' H ' ' B' ' 388' ' ' VAL . 57.5 mt -112.61 -30.84 6.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.932 0.893 . . . . 15.0 110.765 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.17 121.48 6.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.583 1.153 . . . . 15.0 112.497 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.69 -22.98 25.19 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.903 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 96.1 mttt -75.99 143.02 41.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.232 0.613 . . . . 15.0 110.964 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.22 115.01 27.71 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.879 0.871 . . . . 15.0 109.825 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.38 118.47 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.553 0.741 . . . . 15.0 111.594 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -92.34 124.16 36.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.113 0.965 . . . . 15.0 108.726 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.2 113.83 19.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.067 0.547 . . . . 15.0 109.79 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 93.62 4.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.63 -0.507 . . . . 15.0 109.63 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.8 mm -82.82 122.55 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.352 1.061 . . . . 15.0 110.324 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -107.67 99.75 9.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 109.569 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.29 111.95 11.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.913 -0.403 . . . . 15.0 109.913 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 239' ' ' LYS . 17.7 ptpt -109.7 -35.46 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 116.461 -0.336 . . . . 15.0 110.597 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 238' ' ' LYS . 74.6 mmtt -129.29 133.0 47.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.241 0.616 . . . . 15.0 110.327 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 157' ' ' ALA . 77.7 t -106.92 123.62 62.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 26.1 mt-10 -124.55 169.98 11.36 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.557 0.743 . . . . 15.0 109.457 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.793 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.2 tt0 -139.21 130.48 26.81 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.896 0.878 . . . . 15.0 109.411 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -83.65 84.68 7.46 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.575 -1.268 . . . . 15.0 107.575 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.95 141.2 53.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.844 -1.526 . . . . 15.0 111.239 -173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.402 HD22 ' HE3' ' A' ' 146' ' ' LYS . 96.7 mt -58.26 126.29 77.78 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.343 0.657 . . . . 15.0 110.714 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -77.78 173.22 14.41 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.892 2.395 . . . . 15.0 111.249 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -79.82 127.06 31.76 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.722 -0.672 . . . . 15.0 110.069 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 17.0 tp -86.87 52.96 2.66 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.558 -0.904 . . . . 15.0 108.558 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 253' ' ' ILE . 59.9 m -55.0 143.54 26.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.825 1.65 . . . . 15.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.81 -45.37 59.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.748 0.819 . . . . 15.0 112.346 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.62 -14.97 63.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.132 0.973 . . . . 15.0 113.446 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.55 -51.32 4.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.76 0.824 . . . . 15.0 110.305 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.703 HG13 HD22 ' A' ' 266' ' ' LEU . 7.3 tt -63.63 -33.08 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.147 0.979 . . . . 15.0 111.893 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.557 ' HZ3' ' HB2' ' A' ' 254' ' ' LYS . 0.1 OUTLIER -59.32 -29.63 67.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 120.757 0.313 . . . . 15.0 111.353 175.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -72.69 -13.56 61.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.588 0.755 . . . . 15.0 111.031 -172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.57 6.76 22.51 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.394 0.678 . . . . 15.0 111.929 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.63 8.91 Favored Glycine 0 N--CA 1.476 1.361 0 CA-C-N 117.554 0.161 . . . . 15.0 113.17 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.82 132.88 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.2 -62.89 1.2 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.87 0.367 . . . . 15.0 110.588 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -83.8 -22.31 31.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.65 0.78 . . . . 15.0 111.383 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 90.7 26.93 21.27 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.631 -0.539 . . . . 15.0 113.449 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 55.3 p -72.22 136.23 46.3 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 117.607 0.703 . . . . 15.0 110.535 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.48 ' HA ' HD13 ' A' ' 253' ' ' ILE . 61.0 t -55.62 -46.97 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.896 0.878 . . . . 15.0 110.468 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.5 -26.69 68.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.701 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.54 -26.28 61.43 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 111.464 -0.654 . . . . 15.0 111.464 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.703 HD22 HG13 ' A' ' 253' ' ' ILE . 53.9 tp -77.27 -41.79 39.56 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.86 -0.422 . . . . 15.0 109.86 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -60.77 -39.7 89.77 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 124.026 0.829 . . . . 15.0 110.026 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.83 -42.24 77.44 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.398 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -64.6 -44.64 89.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.473 0.709 . . . . 15.0 111.107 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.589 ' HB ' ' HE1' ' A' ' 274' ' ' MET . 28.3 m -76.93 -25.21 15.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 119.282 -0.39 . . . . 15.0 110.89 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -55.34 -59.64 4.52 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.8 -36.35 82.19 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.03 0.752 . . . . 15.0 113.03 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -70.42 -52.48 21.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.214 0.461 . . . . 15.0 111.168 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.589 ' HE1' ' HB ' ' A' ' 270' ' ' VAL . 65.8 mtt -65.51 -33.47 75.99 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 118.391 -0.814 . . . . 15.0 110.206 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 45.5 mt-10 -72.21 -30.58 65.07 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -69.59 -38.83 77.48 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -65.12 -46.7 79.92 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.867 -1.06 . . . . 15.0 110.232 169.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 428' ' ' MET . 42.9 tp -63.6 -59.4 4.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.397 -1.274 . . . . 15.0 112.788 -168.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.87 -30.2 70.76 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.718 0.636 . . . . 15.0 111.745 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 m -70.24 -37.6 75.0 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.214 0.53 . . . . 15.0 110.019 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.98 61.05 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 115.74 -0.664 . . . . 15.0 111.873 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 89.4 mt -69.32 -40.08 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.941 -1.133 . . . . 15.0 107.941 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -59.83 -50.5 73.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.602 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.44 -39.09 86.24 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.911 0.757 . . . . 15.0 111.765 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -56.44 -66.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.133 0.973 . . . . 15.0 110.8 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.79 -40.34 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.835 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.59 -46.53 79.01 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 115.6 -0.727 . . . . 15.0 110.724 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.0 p -69.13 -31.85 70.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.226 0.329 . . . . 15.0 111.712 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.461 ' HB2' HG12 ' A' ' 125' ' ' VAL . 54.7 mt-30 -64.56 -47.19 79.66 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.403 0.281 . . . . 15.0 110.779 173.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 412' ' ' LEU . . . -62.07 -44.37 96.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.227 0.611 . . . . 15.0 111.26 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.527 HD11 HD11 ' A' ' 351' ' ' LEU . 1.2 mp -64.44 -45.91 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.684 1.594 . . . . 15.0 111.445 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -67.59 -43.13 81.29 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.766 -0.457 . . . . 15.0 109.766 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.517 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -56.9 -41.43 91.66 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 124.151 0.907 . . . . 15.0 112.186 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.5 -59.62 5.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 15.0 111.292 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.62 -51.47 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 120.936 0.398 . . . . 15.0 110.302 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -62.93 -35.07 78.87 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.985 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.62 -24.64 49.51 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.669 0.618 . . . . 15.0 112.669 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 14.2 m-80 -118.26 152.67 35.28 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.991 0.424 . . . . 15.0 111.887 -162.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -121.61 135.46 54.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.081 0.952 . . . . 15.0 109.713 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.624 HD12 HD13 ' A' ' 349' ' ' LEU . 12.0 tt -168.67 144.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.392 1.077 . . . . 15.0 109.447 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.93 120.74 26.07 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.589 -1.263 . . . . 15.0 107.589 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.15 120.29 65.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.783 0.833 . . . . 15.0 111.219 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.8 126.73 17.19 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.142 2.561 . . . . 15.0 112.776 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.6 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -57.82 -23.18 51.44 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.836 1.254 . . . . 15.0 112.341 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 88' ' ' GLY . . . -56.04 -56.05 25.51 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.385 1.074 . . . . 15.0 111.529 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 37.1 mt -71.8 -33.2 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.622 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 304' ' ' ALA . 69.2 mt -60.82 -44.57 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.549 0.74 . . . . 15.0 110.054 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.59 91.77 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.675 0.79 . . . . 15.0 110.821 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 56.6 m -62.64 -49.9 73.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.669 0.605 . . . . 15.0 112.171 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.473 ' HB2' ' HB1' ' A' ' 341' ' ' ALA . 4.8 mm-40 -68.65 -40.69 80.11 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.304 0.378 . . . . 15.0 110.542 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 334' ' ' ARG . 60.6 mt -56.81 -45.26 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.898 0.879 . . . . 15.0 109.736 173.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.47 -46.75 88.96 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.325 1.016 . . . . 15.0 111.583 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.8 -40.72 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 123.722 0.639 . . . . 15.0 110.424 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.23 -26.71 63.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.307 0.643 . . . . 15.0 112.039 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.0 mtm180 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.877 0.325 . . . . 15.0 111.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.17 -16.82 56.03 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.407 1.083 . . . . 15.0 112.861 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 57.4 mt -54.97 137.99 65.29 Favored Pre-proline 0 N--CA 1.5 2.036 0 CA-C-N 118.477 0.581 . . . . 15.0 111.937 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.13 107.9 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.796 2.997 . . . . 15.0 114.088 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 311' ' ' ILE . 25.7 ttt85 -53.53 -39.25 64.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.208 1.403 . . . . 15.0 112.412 -174.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.31 -26.04 60.27 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 15.0 113.226 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.5 -31.96 71.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.245 0.545 . . . . 15.0 110.533 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -105.53 -19.83 13.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.005 0.922 . . . . 15.0 111.341 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -49.21 -61.15 2.23 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.879 1.272 . . . . 15.0 113.28 -169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.15 -52.16 50.95 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.432 0.693 . . . . 15.0 111.666 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -63.38 -34.46 77.78 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.757 0.66 . . . . 15.0 111.903 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -68.97 -49.34 58.73 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.445 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.2 tttt -55.55 -39.4 70.56 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.138 0.899 . . . . 15.0 110.636 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.453 ' O ' HG21 ' A' ' 347' ' ' VAL . 12.4 mmt180 -59.09 -44.8 91.95 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.419 171.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -68.87 -24.19 64.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.491 0.716 . . . . 15.0 110.718 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.0 t -71.53 -50.9 36.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 123.181 0.592 . . . . 15.0 110.176 173.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 342' ' ' LYS . 39.7 t -56.33 -37.4 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 123.846 0.716 . . . . 15.0 109.887 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 343' ' ' ARG . 60.4 t -54.31 -53.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 15.0 110.972 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.22 -32.76 85.27 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.619 0.575 . . . . 15.0 114.049 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.624 HD13 HD12 ' A' ' 300' ' ' ILE . 89.7 mt -73.28 -50.48 22.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.605 0.762 . . . . 15.0 110.159 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 354' ' ' VAL . 89.6 mt -70.37 -46.82 63.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.631 -0.713 . . . . 15.0 110.825 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.527 HD11 HD11 ' A' ' 291' ' ' ILE . 52.9 mt -64.16 -37.13 86.35 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.439 0.462 . . . . 15.0 111.388 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.76 -40.2 98.91 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.593 0.558 . . . . 15.0 111.918 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.23 -29.27 67.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.107 -0.547 . . . . 15.0 111.304 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.1 t -74.33 -32.3 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.811 0.444 . . . . 15.0 110.357 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 351' ' ' LEU . 95.7 mt -63.45 -42.77 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.26 -0.645 . . . . 15.0 109.26 172.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -65.0 -55.45 18.93 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.2 m -60.31 -44.9 95.02 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.426 1.09 . . . . 15.0 111.535 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -88.26 4.27 46.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.125 0.57 . . . . 15.0 111.696 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 39.08 65.03 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.87 1.668 . . . . 15.0 113.886 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 154.12 18.34 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.5 -1.227 . . . . 15.0 111.204 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.36 144.05 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.538 -1.282 . . . . 15.0 107.538 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 403' ' ' LEU . . . -66.14 132.59 48.83 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.63 0.372 . . . . 15.0 111.781 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.72 123.79 37.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.728 0.811 . . . . 15.0 110.265 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.44 -40.29 82.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.273 0.629 . . . . 15.0 112.383 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.86 -27.59 66.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.655 0.382 . . . . 15.0 111.751 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -74.57 -43.32 56.23 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 371' ' ' ILE . 46.5 t -59.58 -42.0 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.697 -1.138 . . . . 15.0 109.719 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -58.14 -50.17 74.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.651 0.78 . . . . 15.0 110.865 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.76 -46.46 82.75 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 124.193 0.933 . . . . 15.0 112.664 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -55.47 -48.84 73.89 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.416 0.686 . . . . 15.0 111.11 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.544 HD12 ' HG2' ' A' ' 398' ' ' MET . 35.6 mm -58.32 -58.94 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.534 0.733 . . . . 15.0 111.705 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.64 -36.21 83.51 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 124.329 1.018 . . . . 15.0 111.491 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -78.36 -39.06 40.48 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.46 0.541 . . . . 15.0 112.46 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.15 -36.12 82.55 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.343 0.592 . . . . 15.0 109.96 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -81.62 -28.16 33.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.173 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 35.4 t -64.65 -15.42 61.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.792 0.837 . . . . 15.0 111.669 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.09 -5.26 34.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.352 0.661 . . . . 15.0 111.945 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.79 165.58 20.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.327 1.051 . . . . 15.0 110.004 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.18 17.78 7.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.558 0.743 . . . . 15.0 110.354 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 381' ' ' PRO . 1.6 p30 -133.45 41.7 0.73 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.149 0.98 . . . . 15.0 112.626 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.722 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 44.1 Cg_exo -58.06 -43.48 47.79 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 122.128 1.886 . . . . 15.0 113.98 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.47 -50.1 63.36 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.897 0.879 . . . . 15.0 112.711 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.7 -22.04 64.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.594 0.559 . . . . 15.0 111.752 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.06 -45.71 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.191 0.597 . . . . 15.0 109.446 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.98 -39.28 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.04 -0.982 . . . . 15.0 109.776 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.67 -42.12 71.17 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.121 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -60.66 -35.91 77.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.295 0.638 . . . . 15.0 111.701 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.401 ' CD2' ' HG ' ' A' ' 394' ' ' LEU . 51.7 m-85 -88.38 -61.11 1.79 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.636 0.374 . . . . 15.0 111.745 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' SER . . . . . 0.486 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 38.9 m -70.54 -21.33 62.73 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.616 0.969 . . . . 15.0 113.616 -167.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -96.01 11.49 33.85 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.417 0.287 . . . . 15.0 111.055 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -136.8 103.54 5.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.84 -31.61 71.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.065 0.546 . . . . 15.0 111.512 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.08 -47.74 84.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.387 0.675 . . . . 15.0 110.87 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.401 ' HG ' ' CD2' ' A' ' 388' ' ' TYR . 41.8 tp -83.51 -24.71 31.58 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.896 -0.593 . . . . 15.0 111.209 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -71.08 -37.61 72.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.43 -36.19 82.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.761 1.224 . . . . 15.0 110.569 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 400' ' ' ASN . 51.9 t-20 -62.37 -42.48 99.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.742 0.782 . . . . 15.0 109.854 173.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.544 ' HG2' HD12 ' A' ' 371' ' ' ILE . 3.8 tpt -79.23 -17.26 55.14 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.564 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.11 -35.97 64.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 168.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 397' ' ' ASN . 6.8 t30 -59.22 -53.61 56.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.374 0.669 . . . . 15.0 110.421 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.2 p -65.47 -37.11 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 O-C-N 123.577 0.548 . . . . 15.0 111.354 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -62.01 -44.87 95.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.902 0.481 . . . . 15.0 110.96 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 362' ' ' ALA . 23.5 tp -72.04 -30.46 65.2 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.846 -1.07 . . . . 15.0 111.03 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 408' ' ' VAL . 33.7 tt0 -67.56 -39.35 84.95 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.949 0.9 . . . . 15.0 109.492 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 33.1 mm-40 -69.49 -36.2 76.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.551 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -62.25 -39.15 91.92 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.387 0.675 . . . . 15.0 110.098 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.43 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -64.85 -41.77 95.43 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 124.07 0.857 . . . . 15.0 111.534 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 404' ' ' GLU . 96.2 t -57.94 -55.47 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 123.474 0.484 . . . . 15.0 110.031 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.443 ' HG2' HD13 ' A' ' 412' ' ' LEU . 43.5 mt-10 -67.29 -22.89 65.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.553 0.575 . . . . 15.0 112.553 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 414' ' ' LYS . . . -66.13 -37.66 86.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.57 0.544 . . . . 15.0 110.621 169.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 407' ' ' ALA . 45.8 t -74.61 -33.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.443 HD13 ' HG2' ' A' ' 409' ' ' GLU . 96.9 mt -64.33 -40.1 95.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.076 0.55 . . . . 15.0 110.935 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.21 -15.56 57.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.35 0.66 . . . . 15.0 112.492 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 410' ' ' ALA . 24.1 mtpp -101.12 -33.77 9.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.178 0.991 . . . . 15.0 110.672 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.3 160.66 20.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.284 1.033 . . . . 15.0 112.402 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.6 80.29 1.99 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.163 0.985 . . . . 15.0 109.816 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.665 HG23 ' HB ' ' A' ' 125' ' ' VAL . 49.1 t -97.73 109.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.605 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.0 t -87.95 103.4 15.65 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.277 0.631 . . . . 15.0 110.134 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -85.37 129.39 34.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.661 0.785 . . . . 15.0 110.068 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -139.33 153.93 47.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.361 0.664 . . . . 15.0 109.588 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.56 133.3 52.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.592 -0.892 . . . . 15.0 108.592 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 130' ' ' VAL . 7.9 t -159.64 172.12 18.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.763 0.425 . . . . 15.0 111.521 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 77.9 p -91.78 168.28 11.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.22 1.008 . . . . 15.0 111.396 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -54.17 -26.66 29.2 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.459 1.503 . . . . 15.0 112.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.93 -20.62 16.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.06 0.944 . . . . 15.0 113.338 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.466 0.706 . . . . 15.0 112.256 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 22.4 tp -70.48 -78.79 0.07 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.514 0.931 . . . . 15.0 113.514 -153.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 278' ' ' LEU . 1.0 OUTLIER -87.19 -22.79 25.07 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.608 0.363 . . . . 15.0 110.39 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 8.6 t30 . . . . . 0 CA--C 1.564 1.505 0 C-N-CA 123.964 0.906 . . . . 15.0 111.904 -172.362 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . 0.502 HG13 ' HA3' ' A' ' 179' ' ' GLY . 27.2 m -69.4 98.72 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 121.834 0.826 . . . . 0.0 113.086 -166.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.401 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 20.9 pt -144.02 157.54 15.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.763 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 158.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.547 ' H ' HD11 ' A' ' 226' ' ' LEU . 30.2 t . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.482 1.133 0 C-N-CA 123.907 0.883 . . . . 0.0 111.047 178.625 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.907 0.384 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.64 -1.29 38.4 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.612 0.765 . . . . 0.0 111.418 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -164.6 135.86 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 89.3 m -63.3 99.37 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.5 ttt -78.43 120.17 22.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.674 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . 0.463 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.1 OUTLIER -125.62 75.82 1.52 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 122.482 1.134 . . . . 0.0 109.18 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.15 -40.8 36.83 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.58 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 113.845 -1.525 . . . . 0.0 108.776 -172.416 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.779 0.323 . . . . 15.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -126.96 142.67 51.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.883 -1.154 . . . . 15.0 107.883 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.535 HG11 HG12 ' A' ' 17' ' ' ILE . 28.0 m -126.78 152.22 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.505 0.722 . . . . 15.0 110.051 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 48.7 m -146.9 100.63 3.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.349 0.66 . . . . 15.0 110.052 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.26 128.23 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.967 -0.561 . . . . 15.0 109.855 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.03 97.38 3.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 15.0 108.921 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -76.87 93.88 3.82 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.704 -0.85 . . . . 15.0 108.704 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.2 p -66.12 -39.94 90.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.139 0.976 . . . . 15.0 111.858 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -170.13 104.1 0.3 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.393 0.677 . . . . 15.0 109.979 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.67 -100.93 0.47 Allowed Glycine 0 C--N 1.354 1.529 0 O-C-N 124.083 0.864 . . . . 15.0 113.275 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HA ' HG23 ' A' ' 111' ' ' VAL . 9.2 mp -76.99 -39.42 50.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 15.0 110.152 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.7 104.05 0.34 Allowed Glycine 0 C--N 1.353 1.477 0 O-C-N 124.603 1.19 . . . . 15.0 111.634 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.438 ' NH1' HG11 ' A' ' 111' ' ' VAL . 33.8 ttm180 -134.82 120.87 19.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.38 1.072 . . . . 15.0 109.972 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.46 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 43.3 ttm180 -93.76 146.38 23.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.46 -1.245 . . . . 15.0 109.468 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.47 93.69 2.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 107.332 -1.359 . . . . 15.0 107.332 165.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 33.3 m -73.19 108.55 6.13 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.137 -0.938 . . . . 15.0 108.953 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.535 HG12 HG11 ' A' ' 3' ' ' VAL . 47.8 mt -107.92 123.95 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.025 0.53 . . . . 15.0 109.617 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 m -99.93 104.83 16.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.518 0.727 . . . . 15.0 109.156 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 70' ' ' LEU . 56.5 mt -80.52 112.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 160.07 24.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.206 0.603 . . . . 15.0 111.997 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.96 79.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.324 1.049 . . . . 15.0 112.056 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -65.09 -36.2 83.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.741 0.816 . . . . 15.0 111.121 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -70.14 -37.0 75.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.528 0.731 . . . . 15.0 110.459 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 28' ' ' VAL . 73.8 mt -70.67 -44.05 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 114.905 -1.043 . . . . 15.0 109.943 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.26 -41.72 99.08 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.065 0.546 . . . . 15.0 111.799 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 m -56.11 -45.87 79.34 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.81 88.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.462 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 24' ' ' ILE . 71.3 t -60.99 -55.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.284 0.634 . . . . 15.0 110.658 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 5.1 ttmp? -61.75 -41.5 97.76 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.481 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.27 -11.5 59.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.418 0.687 . . . . 15.0 111.767 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -88.64 -43.03 11.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.721 0.408 . . . . 15.0 110.383 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.629 HD11 ' HA3' ' A' ' 59' ' ' GLY . 92.4 mt -70.27 -23.97 62.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.564 0.746 . . . . 15.0 112.386 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.2 p -69.98 -32.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 123.339 0.4 . . . . 15.0 110.054 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -69.36 -43.53 73.4 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.588 0.755 . . . . 15.0 109.613 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG21 ' A' ' 39' ' ' VAL . 46.9 t -63.36 -38.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.885 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.524 0.73 . . . . 15.0 110.926 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 95.6 mttt -67.29 -31.49 71.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.169 0.587 . . . . 15.0 111.392 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.28 -46.05 29.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.694 0.798 . . . . 15.0 110.951 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.422 ' HB ' HG13 ' A' ' 41' ' ' ILE . 3.7 t -82.85 -5.93 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 122.924 0.49 . . . . 15.0 110.005 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 74.45 8.79 4.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.85 1.66 . . . . 15.0 112.15 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' HB ' ' A' ' 39' ' ' VAL . 56.8 mt -63.89 -22.9 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 15.0 110.931 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.99 -33.97 74.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.424 0.69 . . . . 15.0 111.148 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -39.05 15.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.749 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -71.03 -16.97 62.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.157 0.583 . . . . 15.0 111.162 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.0 ttt-85 -76.63 105.93 7.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -85.79 13.22 7.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.406 0.683 . . . . 15.0 112.153 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -34.29 4.66 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.85 -0.417 . . . . 15.0 112.354 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -52.03 -36.14 49.24 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.998 1.319 . . . . 15.0 112.384 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.31 108.92 32.23 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.564 -0.902 . . . . 15.0 108.564 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' HD13 ' A' ' 53' ' ' ILE . 38.8 Cg_exo -64.02 138.94 64.86 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 15.0 111.681 173.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.6 tpp -67.92 -25.74 65.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.196 0.598 . . . . 15.0 111.12 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.13 -33.89 77.1 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.326 0.25 . . . . 15.0 111.13 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.491 HD13 ' HD2' ' A' ' 50' ' ' PRO . 32.1 mt -67.55 -46.15 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.018 0.527 . . . . 15.0 110.234 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -74.14 -21.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 111.567 0.21 . . . . 15.0 111.567 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.23 -45.58 39.3 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.201 0.6 . . . . 15.0 111.4 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.57 -26.56 58.05 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.502 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -92.01 -72.52 0.59 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.839 0.455 . . . . 15.0 110.9 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -84.33 -34.44 23.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.077 0.551 . . . . 15.0 111.466 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.629 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -74.97 -13.23 82.8 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.156 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.68 59.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 15.0 112.163 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.9 p -81.89 -42.75 19.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.293 0.637 . . . . 15.0 109.346 171.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -70.86 88.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.793 0.837 . . . . 15.0 109.152 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.46 -38.28 6.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.625 0.77 . . . . 15.0 110.129 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.14 -46.01 90.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.765 0.826 . . . . 15.0 112.271 -171.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.98 -49.24 71.02 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.301 0.641 . . . . 15.0 110.376 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.6 -63.78 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.543 -1.208 . . . . 15.0 110.76 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 71' ' ' MET . 84.1 mt -64.74 -38.21 90.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.781 0.832 . . . . 15.0 111.511 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.474 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -61.27 -40.72 98.99 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.812 0.695 . . . . 15.0 113.15 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.87 -37.57 39.93 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.004 0.522 . . . . 15.0 110.076 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 19' ' ' ILE . 21.0 mt -54.87 -42.4 72.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.005 0.922 . . . . 15.0 111.29 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 48.2 mtm -58.6 -42.75 88.85 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.675 0.609 . . . . 15.0 110.76 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.9 t -70.28 -43.78 69.75 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.907 -1.042 . . . . 15.0 111.008 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -69.17 -36.05 76.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.698 0.399 . . . . 15.0 111.502 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -36.67 68.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.968 0.507 . . . . 15.0 110.274 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -70.01 -50.25 43.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.886 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.41 -33.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.646 0.591 . . . . 15.0 111.012 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.23 -51.73 62.24 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.254 0.621 . . . . 15.0 110.707 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.79 85.49 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.99 -1.004 . . . . 15.0 112.438 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 pt -75.33 -32.01 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 112.383 0.512 . . . . 15.0 112.383 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.44 -50.62 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 120.841 0.353 . . . . 15.0 110.558 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 17.1 ptpt -73.66 -50.63 19.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.949 -0.569 . . . . 15.0 111.449 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 50.6 mm-40 -84.81 -1.99 57.12 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.133 0.573 . . . . 15.0 111.941 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 63.25 28.26 15.73 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.53 1.144 . . . . 15.0 111.091 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.19 90.37 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 108.399 -0.963 . . . . 15.0 108.399 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.697 HD22 ' HB2' ' A' ' 112' ' ' TYR . 45.9 t30 -70.91 107.5 2.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.381 1.073 . . . . 15.0 110.425 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.37 141.78 12.87 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.345 2.03 . . . . 15.0 112.737 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.16 -177.3 6.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.578 0.751 . . . . 15.0 110.683 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.66 11.85 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.4 -0.818 . . . . 15.0 111.473 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.99 100.64 4.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.732 -1.211 . . . . 15.0 107.732 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.619 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 51.9 Cg_exo -57.78 107.9 0.34 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.972 2.448 . . . . 15.0 112.622 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.0 m -88.86 100.14 12.94 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.679 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -76.85 75.61 3.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.663 -0.866 . . . . 15.0 108.663 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.17 112.57 4.79 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 123.532 0.733 . . . . 15.0 109.361 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -69.43 92.3 0.48 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.407 2.072 . . . . 15.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.61 -63.5 5.05 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.964 0.79 . . . . 15.0 112.004 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -167.87 155.75 8.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.983 0.913 . . . . 15.0 109.792 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.437 ' HE1' HD11 ' A' ' 24' ' ' ILE . 47.0 t80 -135.94 147.27 48.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.12 0.568 . . . . 15.0 109.551 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -124.87 125.22 43.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.748 -1.205 . . . . 15.0 107.748 175.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.39 107.59 0.95 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.675 0.79 . . . . 15.0 111.453 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.76 59.26 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.591 -0.731 . . . . 15.0 113.287 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -106.14 -165.95 1.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.318 1.047 . . . . 15.0 109.379 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -62.93 155.87 26.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.331 1.052 . . . . 15.0 113.287 -171.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.1 t80 -123.66 142.92 50.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 15.0 108.304 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.2 m -137.06 137.59 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.273 0.629 . . . . 15.0 109.371 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.35 156.46 36.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.984 0.914 . . . . 15.0 109.086 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.46 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 47.7 m -125.13 98.28 5.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.844 0.858 . . . . 15.0 109.648 -170.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.26 97.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.852 -0.796 . . . . 15.0 108.852 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.9 119.05 33.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.799 0.44 . . . . 15.0 110.253 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.619 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 22.4 p90 -146.61 -166.78 2.58 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.527 1.131 . . . . 15.0 108.941 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.67 177.17 5.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.63 0.772 . . . . 15.0 110.356 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 11' ' ' LEU . 27.0 m -119.72 154.46 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 122.992 0.517 . . . . 15.0 109.626 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.697 ' HB2' HD22 ' A' ' 85' ' ' ASN . 48.6 m-85 -82.75 105.89 5.81 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 108.334 -0.987 . . . . 15.0 108.334 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.03 149.45 5.69 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.629 2.219 . . . . 15.0 113.704 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.58 132.14 33.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.202 1.001 . . . . 15.0 108.882 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.647 HG13 ' HA ' ' A' ' 350' ' ' LEU . 7.3 p -86.3 151.57 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.256 0.551 . . . . 15.0 111.937 -170.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.34 94.03 8.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.476 -0.784 . . . . 15.0 108.914 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.3 139.08 58.73 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.47 0.481 . . . . 15.0 110.555 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -163.06 155.12 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.915 0.886 . . . . 15.0 109.545 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.98 74.76 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.124 0.89 . . . . 15.0 114.049 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.45 -28.73 67.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.227 0.611 . . . . 15.0 110.935 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 18.3 mp0 -75.65 -34.08 60.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.657 -1.156 . . . . 15.0 109.852 174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HA ' ' HE3' ' A' ' 416' ' ' LYS . . . -78.93 -7.15 57.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.61 0.764 . . . . 15.0 112.255 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.632 HG22 ' HA3' ' A' ' 293' ' ' GLY . 77.6 mt -70.83 120.89 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.439 0.695 . . . . 15.0 109.467 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.08 104.11 15.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.376 0.67 . . . . 15.0 109.685 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 417' ' ' VAL . 45.6 t -106.05 159.55 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.934 -1.135 . . . . 15.0 107.934 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.47 126.37 46.62 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.724 -0.843 . . . . 15.0 108.724 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -107.43 99.21 26.97 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.529 0.732 . . . . 15.0 109.197 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.02 97.85 0.84 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.468 2.112 . . . . 15.0 111.502 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.52 93.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 166.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.466 ' HB ' HD13 ' A' ' 282' ' ' ILE . 12.4 t -122.51 140.48 46.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.535 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.68 154.37 48.6 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.984 -1.117 . . . . 15.0 107.984 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.82 83.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.3 p -68.39 176.9 2.59 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.489 1.116 . . . . 15.0 110.368 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.99 -45.6 64.57 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.429 0.692 . . . . 15.0 111.771 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.19 97.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.92 -1.036 . . . . 15.0 111.338 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.4 -44.15 68.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.173 0.589 . . . . 15.0 111.298 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.9 t -55.51 -62.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.348 1.059 . . . . 15.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -75.45 -31.31 60.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.676 -0.693 . . . . 15.0 111.307 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.86 -43.8 81.98 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.887 0.742 . . . . 15.0 112.713 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -78.16 -37.5 45.76 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.091 0.556 . . . . 15.0 110.878 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.518 HD22 HG12 ' A' ' 270' ' ' VAL . 18.5 mt -54.83 -42.39 71.86 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.253 0.621 . . . . 15.0 111.574 165.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.38 -40.1 95.15 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.375 -0.83 . . . . 15.0 109.997 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.9 m -61.67 -46.27 90.42 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.721 0.638 . . . . 15.0 110.953 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -45.95 91.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.651 0.78 . . . . 15.0 110.66 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -58.27 -37.66 75.4 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.808 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.611 ' HD3' HH12 ' A' ' 243' ' ' ARG . 83.3 mttt -85.41 -12.23 52.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.34 0.656 . . . . 15.0 112.533 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.82 -22.79 34.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.81 0.444 . . . . 15.0 110.005 167.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -97.06 8.4 44.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.262 0.625 . . . . 15.0 111.324 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -74.71 159.53 31.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 15.0 112.312 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.6 m -123.93 155.93 37.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.091 0.956 . . . . 15.0 108.917 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.614 ' HZ3' ' HB3' ' A' ' 243' ' ' ARG . 3.5 m95 -78.91 153.17 30.69 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.817 0.341 . . . . 15.0 111.151 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -151.65 104.77 3.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.043 -0.981 . . . . 15.0 109.368 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.35 98.45 0.11 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.02 170.73 16.23 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.477 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.95 97.24 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.838 0.455 . . . . 15.0 110.729 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.534 ' HA2' ' HB1' ' A' ' 207' ' ' ALA . . . 55.22 53.26 41.77 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 124.589 1.181 . . . . 15.0 115.5 161.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 240' ' ' VAL . . . -153.91 140.86 19.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.334 0.654 . . . . 15.0 109.315 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.4 HG11 HG23 ' A' ' 202' ' ' ILE . 17.0 t -119.32 131.33 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.177 -0.675 . . . . 15.0 109.177 172.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.85 -176.16 3.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.283 . . . . 15.0 109.423 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.82 -27.49 64.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.28 13.88 16.75 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.435 0.532 . . . . 15.0 112.435 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -79.03 136.16 37.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.971 0.415 . . . . 15.0 111.602 -173.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -84.94 90.91 7.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.823 -1.547 . . . . 15.0 106.823 173.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.404 HG22 HG13 ' A' ' 240' ' ' VAL . 44.0 t -90.58 150.79 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.002 0.921 . . . . 15.0 109.847 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 32.9 m -130.09 126.75 38.36 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 165.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.83 163.71 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.341 1.057 . . . . 15.0 110.314 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -116.69 122.21 43.89 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.294 -1.743 . . . . 15.0 106.294 167.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -129.14 160.69 32.06 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.724 0.773 . . . . 15.0 111.235 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.0 t -140.85 111.87 7.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.262 -1.385 . . . . 15.0 107.262 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -80.02 160.34 44.47 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.596 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.0 m -149.53 111.15 4.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.543 0.737 . . . . 15.0 109.194 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 177' ' ' PHE . 59.7 t -93.85 134.87 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.297 -1.001 . . . . 15.0 108.297 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.0 p30 51.39 18.98 0.71 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.138 1.775 . . . . 15.0 113.472 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.36 -11.57 12.71 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-O 118.665 -1.075 . . . . 15.0 115.545 172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.82 147.73 50.82 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.214 1.507 . . . . 15.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.69 112.66 2.61 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.836 0.71 . . . . 15.0 109.217 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 172' ' ' VAL . 37.3 p90 -72.32 156.22 39.33 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.596 0.56 . . . . 15.0 110.829 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.38 126.63 28.09 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.763 0.664 . . . . 15.0 111.124 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.77 77.55 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.051 -0.977 . . . . 15.0 112.175 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.69 47.81 1.39 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 114.672 0.629 . . . . 15.0 114.672 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -136.03 150.72 49.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.018 0.527 . . . . 15.0 110.625 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.12 92.27 0.83 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.154 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.2 p -76.57 127.81 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.357 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 71.6 36.15 1.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 15.0 112.731 174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -66.05 138.85 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 15.0 109.909 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -104.35 110.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.977 0.911 . . . . 15.0 109.719 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -101.93 89.96 3.82 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.675 0.79 . . . . 15.0 111.22 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -78.45 90.3 4.45 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.387 -0.968 . . . . 15.0 108.387 171.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.607 ' HE1' ' HB3' ' A' ' 203' ' ' LYS . 76.7 mtp -71.76 169.68 15.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.43 -0.805 . . . . 15.0 113.024 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.646 ' HA3' HH21 ' A' ' 243' ' ' ARG . . . 91.53 10.66 61.67 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.99 -1.004 . . . . 15.0 113.523 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.427 ' HG3' ' HG2' ' A' ' 193' ' ' ARG . 8.8 pt20 -137.75 160.55 38.94 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.169 0.588 . . . . 15.0 110.077 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.91 89.83 0.06 OUTLIER Glycine 0 C--N 1.353 1.484 0 O-C-N 123.715 0.635 . . . . 15.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.427 ' HG2' ' HG3' ' A' ' 191' ' ' GLN . 29.7 mmt180 -121.03 -60.78 1.62 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.67 0.788 . . . . 15.0 111.227 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 198' ' ' PHE . 63.4 mmm -98.17 148.89 23.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.679 0.622 . . . . 15.0 112.679 -165.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.8 pt -61.27 145.27 90.54 Favored Pre-proline 0 CA--C 1.556 1.207 0 O-C-N 124.74 1.275 . . . . 15.0 109.904 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.62 114.76 1.91 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.472 2.781 . . . . 15.0 111.811 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 128.4 -37.31 2.29 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.71 -0.677 . . . . 15.0 112.385 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 194' ' ' MET . 37.6 t80 -69.64 -67.78 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.423 0.289 . . . . 15.0 110.386 -175.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.41 -18.84 65.08 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.382 0.426 . . . . 15.0 111.859 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.494 ' HA ' ' HZ3' ' A' ' 203' ' ' LYS . 6.7 m-20 -72.28 -41.13 67.01 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.965 0.906 . . . . 15.0 110.2 172.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.22 -24.44 77.0 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.176 -0.92 . . . . 15.0 112.484 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 198' ' ' PHE . 44.9 mm -73.2 -51.85 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.239 0.616 . . . . 15.0 110.134 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.607 ' HB3' ' HE1' ' A' ' 189' ' ' MET . 21.3 pttm -79.01 12.78 2.04 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.508 0.929 . . . . 15.0 113.508 -172.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.55 20.4 15.59 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -144.18 -176.05 4.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.484 1.114 . . . . 15.0 109.991 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.5 OUTLIER -147.37 143.42 27.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.436 0.694 . . . . 15.0 110.101 -176.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.534 ' HB1' ' HA2' ' A' ' 156' ' ' GLY . . . -59.66 145.67 43.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.414 0.894 . . . . 15.0 113.414 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.09 -34.16 4.84 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.478 -0.783 . . . . 15.0 111.553 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.6 pt-20 -87.19 140.74 29.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.588 0.709 . . . . 15.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.14 125.37 52.23 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.67 1.188 . . . . 15.0 107.969 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -148.92 -167.05 2.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.425 1.09 . . . . 15.0 109.633 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.4 t -133.17 150.37 52.01 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.199 -1.037 . . . . 15.0 108.199 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 38.5 pt -113.57 147.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 172.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.04 113.7 26.95 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.93 167.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.302 -1.37 . . . . 15.0 107.302 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.9 m -135.03 137.73 43.24 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -72.58 125.5 91.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 123.873 0.733 . . . . 15.0 109.621 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.48 168.15 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.785 2.99 . . . . 15.0 115.21 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.88 -19.97 53.83 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.937 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -80.3 -22.49 41.52 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.325 1.05 . . . . 15.0 110.75 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.59 116.23 4.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.84 . . . . 15.0 110.46 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -68.14 -32.19 72.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -162.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.42 92.57 1.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.039 -1.467 . . . . 15.0 107.039 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 33.0 tt0 -73.53 -18.11 61.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.744 0.817 . . . . 15.0 111.391 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -65.32 -13.23 58.02 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.365 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -119.26 -29.89 5.07 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.949 1.3 . . . . 15.0 111.773 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 36.8 ttmt -51.61 121.36 6.33 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.998 1.319 . . . . 15.0 111.645 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.63 -25.33 25.32 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.409 -0.359 . . . . 15.0 113.591 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.15 150.44 31.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.524 0.73 . . . . 15.0 111.328 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.8 122.79 37.79 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.646 0.778 . . . . 15.0 109.927 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.43 122.37 47.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.667 0.787 . . . . 15.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 63.9 mttm -93.73 118.4 31.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.193 0.997 . . . . 15.0 109.571 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.446 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 89.5 m-85 -108.4 118.44 36.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.01 89.16 2.98 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.507 0.504 . . . . 15.0 110.323 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 40.9 mm -83.24 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.537 0.735 . . . . 15.0 110.209 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -120.59 99.33 6.49 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.43 99.3 4.83 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.53 0.732 . . . . 15.0 111.005 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -104.12 -43.65 5.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.52 0.728 . . . . 15.0 110.145 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.662 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.3 mmtt -124.51 125.87 44.92 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.561 1.144 . . . . 15.0 108.22 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 157' ' ' ALA . 18.6 t -128.5 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.74 -1.578 . . . . 15.0 106.74 165.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -86.53 163.99 17.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.542 -1.208 . . . . 15.0 108.23 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -130.2 129.46 43.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.453 -0.943 . . . . 15.0 108.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.646 HH21 ' HA3' ' A' ' 190' ' ' GLY . 27.8 ptt85 -74.41 84.4 1.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.366 -0.976 . . . . 15.0 108.366 167.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.36 145.92 37.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.783 -1.553 . . . . 15.0 110.689 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 55.1 mt -57.47 120.73 42.84 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.984 0.914 . . . . 15.0 110.133 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.25 -165.57 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.903 3.736 . . . . 15.0 113.613 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -46.77 136.51 7.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.773 -1.103 . . . . 15.0 110.461 165.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.0 tp -140.66 37.37 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.137 -1.06 . . . . 15.0 108.137 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.6 m -66.03 161.04 22.43 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.47 1.108 . . . . 15.0 109.922 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.83 -44.88 14.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.88 1.272 . . . . 15.0 112.929 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.82 -27.28 64.74 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.981 -0.554 . . . . 15.0 112.173 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -77.58 -49.18 15.15 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.467 HG13 HD22 ' A' ' 266' ' ' LEU . 12.1 tt -64.52 -32.78 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.381 0.672 . . . . 15.0 110.981 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 258' ' ' VAL . 21.1 ptmt -79.23 -18.47 52.82 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 112.147 0.425 . . . . 15.0 112.147 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -65.58 -24.12 67.0 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 15.0 111.672 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -64.23 -22.77 67.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.283 0.633 . . . . 15.0 111.551 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.5 -1.45 0.73 Allowed Glycine 0 C--N 1.356 1.691 0 CA-C-O 119.845 -0.42 . . . . 15.0 113.853 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 2.9 t -80.82 134.94 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.192 0.597 . . . . 15.0 109.403 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -76.51 -47.68 21.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.7 0.4 . . . . 15.0 111.039 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.69 -36.04 16.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.704 0.288 . . . . 15.0 111.116 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 94.14 22.68 24.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.994 -0.548 . . . . 15.0 113.902 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 29.1 p -70.07 142.56 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 117.532 0.666 . . . . 15.0 110.154 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.404 ' HA ' HD11 ' A' ' 253' ' ' ILE . 49.0 t -54.44 -50.91 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.746 0.654 . . . . 15.0 109.283 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.72 -27.45 67.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.034 -0.985 . . . . 15.0 111.44 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.91 -21.1 63.98 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.659 0.599 . . . . 15.0 111.634 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.467 HD22 HG13 ' A' ' 253' ' ' ILE . 55.7 tp -78.35 -42.29 30.96 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -62.15 -39.44 92.61 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.821 -1.081 . . . . 15.0 110.195 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.54 -43.51 80.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.071 0.948 . . . . 15.0 111.045 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -56.59 -56.98 14.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.518 HG12 HD22 ' A' ' 141' ' ' LEU . 17.4 m -76.52 -20.22 14.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.363 -0.835 . . . . 15.0 111.534 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -57.41 -63.13 1.33 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.15 -36.77 82.56 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.0 0.37 . . . . 15.0 112.0 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -72.88 -50.02 26.34 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.383 0.673 . . . . 15.0 111.502 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 66.7 mtt -72.04 -28.19 63.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.394 -0.812 . . . . 15.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 47.1 mt-10 -71.09 -26.12 62.91 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 118.881 0.764 . . . . 15.0 111.539 170.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -70.71 -44.63 66.53 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.492 -0.559 . . . . 15.0 109.492 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -62.39 -45.35 93.53 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.572 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 64.9 tp -61.89 -50.88 70.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.025 -1.443 . . . . 15.0 112.175 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.49 -30.86 71.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.52 0.728 . . . . 15.0 110.688 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.5 t -66.12 -45.92 79.4 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.044 -0.725 . . . . 15.0 109.044 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.01 79.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.368 0.667 . . . . 15.0 112.078 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.466 HD13 ' HB ' ' A' ' 130' ' ' VAL . 90.5 mt -67.03 -45.18 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.775 0.83 . . . . 15.0 109.092 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 23.2 tpt180 -62.05 -46.87 87.22 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.604 -0.725 . . . . 15.0 110.535 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -62.99 -38.5 91.42 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.033 -0.531 . . . . 15.0 110.961 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -56.63 -63.84 1.07 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.66 0.784 . . . . 15.0 110.658 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.05 -46.04 92.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.042 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.55 -45.53 86.74 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.844 -0.617 . . . . 15.0 111.105 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.4 p -68.02 -31.9 71.89 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.44 0.296 . . . . 15.0 111.359 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.43 ' HB2' HG12 ' A' ' 125' ' ' VAL . 55.9 mt-30 -73.31 -34.0 65.48 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.354 0.409 . . . . 15.0 111.719 176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.93 62.83 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 110.05 -0.352 . . . . 15.0 110.05 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.95 -42.87 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.358 1.463 . . . . 15.0 110.958 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.91 -59.43 4.9 Favored 'General case' 0 C--O 1.246 0.897 0 C-N-CA 124.227 1.011 . . . . 15.0 110.231 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.632 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -67.52 -32.77 79.66 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.918 -1.037 . . . . 15.0 113.295 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.672 ' HB3' HD13 ' A' ' 350' ' ' LEU . 9.9 mt -59.85 -53.97 51.74 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 15.0 111.0 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.3 -44.73 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.83 -0.433 . . . . 15.0 109.83 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.18 -32.78 66.78 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.853 0.861 . . . . 15.0 111.746 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.4 -29.95 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.462 0.705 . . . . 15.0 111.611 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -131.92 123.44 27.44 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.096 0.474 . . . . 15.0 111.903 -162.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.58 148.95 26.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.324 1.05 . . . . 15.0 109.363 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.616 HD13 HD13 ' A' ' 349' ' ' LEU . 14.2 tt -162.87 148.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.514 0.726 . . . . 15.0 110.106 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.85 131.94 42.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 345' ' ' VAL . 71.2 t -119.88 126.06 27.07 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.259 0.624 . . . . 15.0 111.153 -165.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.86 136.82 17.11 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.692 2.261 . . . . 15.0 112.475 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.668 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.55 -15.18 57.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.624 1.17 . . . . 15.0 113.337 -174.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.13 64.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.756 0.822 . . . . 15.0 110.703 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' ' 467' ' ' ALA . 71.7 mt -71.45 -38.43 71.32 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 114.121 -1.4 . . . . 15.0 110.442 -175.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 304' ' ' ALA . 55.2 mt -57.28 -50.5 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.233 -1.349 . . . . 15.0 108.516 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.36 -32.35 73.92 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.216 0.948 . . . . 15.0 111.451 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 73.4 m -62.33 -52.88 61.89 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.671 0.389 . . . . 15.0 111.882 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.4 -35.44 79.31 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.561 -0.29 . . . . 15.0 111.124 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.591 HD11 ' HG3' ' A' ' 334' ' ' ARG . 71.0 mt -61.65 -38.35 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.416 -0.587 . . . . 15.0 109.416 173.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.437 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 9.1 t70 -64.44 -46.42 83.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.752 0.821 . . . . 15.0 109.423 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.02 -40.77 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 124.155 0.91 . . . . 15.0 110.259 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.55 -19.26 60.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.377 0.671 . . . . 15.0 112.32 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.437 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 21.7 mtm180 . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 123.795 0.838 . . . . 15.0 109.811 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 CA--C 1.554 1.131 0 N-CA-C 111.811 0.3 . . . . 15.0 111.811 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.75 -16.17 45.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.678 0.791 . . . . 15.0 112.001 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 67.2 mt -53.06 125.89 42.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.812 0.445 . . . . 15.0 111.973 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.491 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 84.0 Cg_exo -46.48 120.24 3.73 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.659 3.572 . . . . 15.0 115.453 -166.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.591 ' HG3' HD11 ' A' ' 311' ' ' ILE . 68.6 ttt180 -55.93 -37.04 68.41 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.922 0.889 . . . . 15.0 112.061 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -63.38 -17.31 62.48 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.319 0.648 . . . . 15.0 112.465 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 89.1 mt -73.51 -32.27 64.17 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.368 0.604 . . . . 15.0 110.34 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.466 ' HA ' HE21 ' A' ' 340' ' ' GLN . 22.7 m-85 -115.62 -6.07 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.971 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -47.19 -71.79 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.222 1.409 . . . . 15.0 113.166 -173.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.54 -51.74 68.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.625 0.77 . . . . 15.0 111.686 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.466 HE21 ' HA ' ' A' ' 337' ' ' PHE . 20.9 pt20 -61.72 -45.93 91.81 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.774 0.671 . . . . 15.0 112.043 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.97 56.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.484 . . . . 15.0 110.346 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.19 -34.88 64.26 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.572 0.749 . . . . 15.0 111.027 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -70.95 -35.29 72.13 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.239 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -66.93 -28.65 68.47 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.158 0.286 . . . . 15.0 110.266 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 302' ' ' VAL . 46.2 t -69.6 -47.55 70.81 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.228 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 67.4 t -51.81 -48.44 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.613 -0.884 . . . . 15.0 108.613 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.73 -43.14 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.201 1.001 . . . . 15.0 111.741 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.91 -34.77 90.82 Favored Glycine 0 N--CA 1.472 1.083 0 O-C-N 123.233 0.333 . . . . 15.0 112.851 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.616 HD13 HD13 ' A' ' 300' ' ' ILE . 65.8 mt -76.46 -38.77 54.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.657 0.783 . . . . 15.0 109.764 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 294' ' ' LEU . 81.3 mt -62.14 -62.05 2.04 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.451 1.101 . . . . 15.0 110.555 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.96 -30.77 71.83 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.26 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.63 95.74 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.866 0.729 . . . . 15.0 111.996 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.13 -34.17 77.44 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.109 -0.545 . . . . 15.0 110.766 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.0 t -67.06 -40.86 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.632 0.373 . . . . 15.0 110.484 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.21 -38.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.599 0.759 . . . . 15.0 110.055 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -70.28 -53.94 14.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.16 0.288 . . . . 15.0 111.518 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -61.45 -35.08 76.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.042 0.937 . . . . 15.0 111.836 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -102.13 10.52 39.38 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 118.962 -0.542 . . . . 15.0 111.348 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 36.83 40.17 0.13 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 126.489 1.916 . . . . 15.0 114.495 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.84 133.36 50.78 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.316 1.046 . . . . 15.0 112.24 -170.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -109.28 142.21 40.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.751 0.82 . . . . 15.0 109.785 176.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.55 115.36 8.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.752 0.421 . . . . 15.0 110.35 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.23 127.94 34.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 15.0 111.408 -171.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.45 -34.38 76.69 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.306 1.042 . . . . 15.0 113.481 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -71.77 -26.64 62.52 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.108 0.255 . . . . 15.0 110.641 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -76.16 -44.95 35.84 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.017 -0.734 . . . . 15.0 109.017 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 398' ' ' MET . 60.9 t -52.28 -56.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.407 1.083 . . . . 15.0 110.341 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.7 -40.37 92.2 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.122 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.17 -40.78 97.7 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.621 0.575 . . . . 15.0 113.336 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 73.6 mt -61.73 -51.7 67.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.686 0.794 . . . . 15.0 109.549 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.489 ' HA ' ' HE3' ' A' ' 374' ' ' MET . 34.5 mm -47.54 -56.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.589 1.181 . . . . 15.0 111.216 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.21 -61.32 2.55 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.459 -0.791 . . . . 15.0 111.637 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.12 -24.5 61.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.151 0.797 . . . . 15.0 113.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.489 ' HE3' ' HA ' ' A' ' 371' ' ' ILE . 23.9 ptt? -78.03 -46.96 19.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.639 0.654 . . . . 15.0 109.304 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -69.48 -32.35 71.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.828 0.451 . . . . 15.0 111.292 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.8 t -63.88 -18.26 64.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.561 0.745 . . . . 15.0 112.214 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.91 66.74 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.289 0.636 . . . . 15.0 111.3 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -97.9 -175.02 3.03 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.696 -0.684 . . . . 15.0 111.01 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.94 -56.19 24.04 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.974 0.91 . . . . 15.0 111.517 -168.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -131.15 116.09 16.59 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.442 -0.799 . . . . 15.0 109.494 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.481 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 22.2 Cg_exo -68.23 -37.81 13.4 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.649 2.232 . . . . 15.0 113.227 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -54.82 -48.04 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.301 1.041 . . . . 15.0 111.873 -164.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.23 -28.2 68.55 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.57 -1.195 . . . . 15.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.33 -41.4 30.07 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 C-N-CA 123.573 0.749 . . . . 15.0 109.541 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.67 -48.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.28 -33.39 65.2 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.302 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -70.4 -24.32 62.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.3 0.64 . . . . 15.0 111.068 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.418 ' HB3' ' HE1' ' A' ' 395' ' ' MET . 23.7 m-85 -92.68 -56.14 3.12 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.053 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' SER . . . . . 0.653 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -58.66 -43.64 89.93 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 112.526 0.565 . . . . 15.0 112.526 -170.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -87.22 3.83 44.97 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.348 0.659 . . . . 15.0 111.963 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -129.44 90.75 3.05 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.547 -0.908 . . . . 15.0 108.547 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -54.22 -34.57 60.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.388 1.075 . . . . 15.0 112.16 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.2 -43.58 82.86 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.806 0.842 . . . . 15.0 110.841 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.81 -24.34 17.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 15.0 111.291 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.653 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.9 OUTLIER -62.94 -37.25 86.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.79 0.836 . . . . 15.0 109.741 176.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.63 -44.4 94.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.496 -1.229 . . . . 15.0 109.843 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.95 -32.05 69.27 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.212 0.605 . . . . 15.0 111.427 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.673 ' HG3' HG11 ' A' ' 367' ' ' VAL . 31.5 tpp -69.7 -31.24 69.15 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.441 0.463 . . . . 15.0 111.774 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -67.66 -38.76 84.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 110.135 -0.32 . . . . 15.0 110.135 168.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 400' ' ' ASN . 0.8 OUTLIER -65.52 -48.1 73.67 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.562 0.745 . . . . 15.0 111.408 -176.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 8.3 p -67.49 -37.86 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 123.634 0.584 . . . . 15.0 110.174 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.01 85.34 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.69 0.757 . . . . 15.0 110.502 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.57 -32.76 72.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.076 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.2 -38.1 84.75 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.867 0.467 . . . . 15.0 110.028 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 60.9 mm-40 -62.7 -41.51 99.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.845 0.458 . . . . 15.0 110.019 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -66.74 -39.0 87.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.051 -0.977 . . . . 15.0 111.734 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.02 -42.23 99.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.849 0.718 . . . . 15.0 110.327 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.36 -54.04 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.548 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.406 ' HA ' HD13 ' A' ' 412' ' ' LEU . 80.0 mt-10 -62.01 -28.07 69.32 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.459 0.704 . . . . 15.0 112.88 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.44 71.87 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.793 0.437 . . . . 15.0 110.297 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.85 -32.54 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.223 -0.658 . . . . 15.0 109.223 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 409' ' ' GLU . 93.4 mt -63.28 -43.77 96.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.33 0.652 . . . . 15.0 110.65 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.88 -25.63 65.24 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.599 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 26.1 mtpp -94.85 -22.4 18.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.408 1.083 . . . . 15.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.47 13.18 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.075 0.95 . . . . 15.0 113.211 -171.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 85.7 mttt -77.74 77.3 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.402 1.081 . . . . 15.0 109.459 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 125' ' ' VAL . 38.1 t -91.62 91.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.3 t -71.01 95.37 1.18 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 122.298 1.047 . . . . 15.0 110.448 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.87 117.32 19.86 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.245 -1.343 . . . . 15.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -122.58 157.52 31.95 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.942 0.897 . . . . 15.0 109.064 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.39 117.57 32.13 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -143.95 176.36 9.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.523 0.329 . . . . 15.0 110.611 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.8 p -101.03 159.83 14.89 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.268 1.027 . . . . 15.0 111.128 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.76 -31.57 69.77 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.979 1.311 . . . . 15.0 110.976 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.526 ' HA ' HD21 ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.96 -9.2 27.76 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.363 -0.835 . . . . 15.0 112.299 178.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.91 -73.34 0.57 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 170.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 35.3 tp -36.99 -59.15 0.73 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 125.323 1.449 . . . . 15.0 114.871 -158.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.414 ' HE1' HD11 ' A' ' 278' ' ' LEU . 0.4 OUTLIER -92.17 -35.18 13.99 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.07 0.548 . . . . 15.0 110.819 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . 0.526 HD21 ' HA ' ' A' ' 425' ' ' ASN . 73.0 m-20 . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 123.474 0.71 . . . . 15.0 111.85 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.409 0.623 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.32 130.56 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.124 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -140.5 162.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.222 1.409 . . . . 0.0 109.077 169.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 177' ' ' PHE . 97.3 t . . . . . 0 N--CA 1.495 1.8 0 C-N-CA 124.081 0.952 . . . . 0.0 112.405 -163.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.209 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 18.5 p90 . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 123.36 0.664 . . . . 0.0 110.412 -175.021 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 35.9 t80 58.57 103.31 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.583 1.553 . . . . 0.0 109.435 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 35.9 t80 65.22 -172.44 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.2 m -141.15 104.47 4.64 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.94 21.34 4.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.922 0.889 . . . . 0.0 111.368 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 70.4 -175.54 0.19 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.974 1.31 . . . . 0.0 111.168 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 68.87 -61.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.074 1.35 . . . . 0.0 110.107 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . 0.478 ' HA ' HD12 ' A' ' 306' ' ' LEU . . . . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 124.29 1.036 . . . . 0.0 108.505 163.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.025 0.44 . . . . 15.0 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -146.68 146.99 30.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.588 -0.893 . . . . 15.0 108.588 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.445 HG13 HG12 ' A' ' 17' ' ' ILE . 24.9 m -137.55 148.72 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.942 0.897 . . . . 15.0 109.467 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 55.6 p -126.2 101.16 6.63 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.96 77.21 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.682 1.229 . . . . 15.0 110.569 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 46.3 mt-10 -75.77 173.45 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.662 -1.154 . . . . 15.0 109.758 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 77.6 m -143.49 112.8 6.82 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.392 -0.966 . . . . 15.0 108.392 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -78.39 -41.3 33.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.431 0.693 . . . . 15.0 110.562 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -164.04 84.46 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.822 0.849 . . . . 15.0 109.512 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.77 -94.76 0.07 OUTLIER Glycine 0 C--N 1.354 1.531 0 O-C-N 123.825 0.703 . . . . 15.0 113.671 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.655 ' HA ' HG23 ' A' ' 111' ' ' VAL . 7.6 mp -62.07 -50.21 72.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.526 1.13 . . . . 15.0 110.602 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.8 86.5 0.21 Allowed Glycine 0 C--N 1.346 1.113 0 O-C-N 124.195 0.934 . . . . 15.0 112.11 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 98.7 mtt180 -99.78 134.04 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.293 1.037 . . . . 15.0 110.378 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.5 ttm180 -103.01 88.27 3.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.282 1.033 . . . . 15.0 110.737 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -81.57 91.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.3 m -75.98 100.41 4.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.853 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 3' ' ' VAL . 51.6 mt -87.98 109.38 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.97 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -84.95 94.24 8.74 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.995 -0.743 . . . . 15.0 108.995 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 70' ' ' LEU . 43.4 mt -73.32 106.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.963 -1.125 . . . . 15.0 107.963 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 150.79 44.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 122.556 0.342 . . . . 15.0 111.315 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.51 -16.88 58.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.603 1.161 . . . . 15.0 114.096 -169.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -64.71 -44.84 88.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.225 0.61 . . . . 15.0 110.429 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.4 m -75.13 -36.79 61.57 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 115.44 -0.8 . . . . 15.0 110.776 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.424 HD11 ' H ' ' A' ' 103' ' ' PHE . 57.9 mt -62.39 -50.58 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.702 0.626 . . . . 15.0 109.881 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -57.53 -50.49 72.92 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.067 0.947 . . . . 15.0 111.098 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.5 m -65.4 -37.77 87.97 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.218 -0.901 . . . . 15.0 111.742 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.28 63.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.123 0.569 . . . . 15.0 112.128 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.739 HG21 ' HD3' ' A' ' 63' ' ' ARG . 93.7 t -65.32 -41.63 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -65.52 -34.99 79.54 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.509 1.124 . . . . 15.0 110.759 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -39.08 91.1 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.55 0.74 . . . . 15.0 110.05 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -74.82 -25.77 59.26 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.524 0.515 . . . . 15.0 111.387 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 94.0 mt -73.09 -38.76 66.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.808 0.443 . . . . 15.0 110.983 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.45 -19.6 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 O-C-N 123.158 0.286 . . . . 15.0 110.329 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.18 -57.7 8.74 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.11 -38.53 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.198 0.999 . . . . 15.0 111.365 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.191 0.596 . . . . 15.0 110.559 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.17 -26.68 35.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.814 0.446 . . . . 15.0 112.095 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -77.32 -35.17 55.06 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.711 1.204 . . . . 15.0 110.935 -173.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.64 5.44 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.788 0.835 . . . . 15.0 109.531 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 65.66 22.39 11.64 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.838 1.655 . . . . 15.0 112.601 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 54.0 mt -78.24 -19.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.448 1.099 . . . . 15.0 111.261 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.26 -30.2 71.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.682 0.793 . . . . 15.0 112.061 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.19 -23.76 73.21 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.59 0.556 . . . . 15.0 112.844 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.433 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 88.9 m-85 -83.68 -24.0 31.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.462 0.705 . . . . 15.0 110.78 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -79.53 88.47 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -92.14 50.06 1.6 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.589 0.755 . . . . 15.0 110.384 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.3 67.68 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.633 -0.712 . . . . 15.0 113.129 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -73.25 -58.79 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.633 0.773 . . . . 15.0 110.147 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.4 t -101.11 122.11 49.7 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.846 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' HD12 ' A' ' 53' ' ' ILE . 73.6 Cg_exo -53.54 138.92 66.74 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.063 2.509 . . . . 15.0 112.409 167.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.8 tpt -70.48 -25.26 63.08 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.817 0.847 . . . . 15.0 112.078 -171.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -70.63 -28.79 65.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.549 0.34 . . . . 15.0 111.163 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.481 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.9 mt -65.44 -53.02 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.817 . . . . 15.0 110.241 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.654 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 30.1 m -69.1 -16.98 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 111.92 0.341 . . . . 15.0 111.92 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -73.65 -65.58 0.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.513 0.725 . . . . 15.0 112.0 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -73.97 -33.79 64.0 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.672 -0.695 . . . . 15.0 111.93 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.49 -73.97 0.46 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.798 0.439 . . . . 15.0 110.618 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 96.5 m-85 -72.52 -28.1 62.65 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.044 0.537 . . . . 15.0 111.814 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.17 10.2 67.0 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.733 -0.481 . . . . 15.0 113.607 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.47 66.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 15.0 111.896 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 p -84.04 -36.37 23.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.185 0.994 . . . . 15.0 111.059 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.84 -18.78 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.306 1.042 . . . . 15.0 111.218 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.739 ' HD3' HG21 ' A' ' 28' ' ' VAL . 20.9 mmt180 -49.88 -42.67 48.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.42 1.088 . . . . 15.0 111.917 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -49.32 -57.58 6.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.882 1.273 . . . . 15.0 112.317 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.72 -33.39 53.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.638 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 28' ' ' VAL . 66.6 t -68.07 -28.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.2 mt -56.49 -41.95 77.5 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.56 0.344 . . . . 15.0 110.75 173.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 71' ' ' MET . . . -61.18 -46.74 93.87 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.793 0.683 . . . . 15.0 112.72 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.55 -38.94 89.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.306 1.042 . . . . 15.0 111.583 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 19' ' ' ILE . 57.3 mt -65.46 -41.58 93.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.93 0.892 . . . . 15.0 110.651 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 64.5 mtm -64.0 -38.38 90.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.083 0.553 . . . . 15.0 110.682 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -64.76 -52.7 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.408 -0.815 . . . . 15.0 110.976 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 mtm105 -74.91 -30.69 61.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.639 -0.71 . . . . 15.0 112.575 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.49 -32.88 54.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.605 0.362 . . . . 15.0 110.513 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.78 -51.39 27.3 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.282 0.364 . . . . 15.0 110.95 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.6 tt -64.45 -33.34 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 123.272 0.357 . . . . 15.0 110.261 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.06 -44.84 96.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.579 0.751 . . . . 15.0 110.428 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.18 -53.03 55.71 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.698 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 76' ' ' ILE . 32.3 pt -65.4 -22.19 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -74.94 -51.83 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 15.0 110.196 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -75.4 -25.32 57.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.695 0.398 . . . . 15.0 111.881 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -89.45 -21.57 22.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.29 0.636 . . . . 15.0 110.544 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 62.96 19.74 11.8 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.707 1.203 . . . . 15.0 112.01 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -104.49 85.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.74 141.66 41.64 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.015 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.78 128.35 18.76 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.682 2.255 . . . . 15.0 112.211 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.63 72.83 4.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.414 0.686 . . . . 15.0 109.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.6 -98.67 0.69 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.534 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.46 138.18 31.86 Favored Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 123.289 0.636 . . . . 15.0 112.248 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -95.09 132.03 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.784 2.989 . . . . 15.0 113.27 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -96.38 105.73 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.403 ' HD2' ' HE2' ' A' ' 105' ' ' TYR . 68.1 m-85 -83.45 118.19 23.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.49 90.8 4.32 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.017 0.927 . . . . 15.0 108.594 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.5 119.8 5.65 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.77 2.314 . . . . 15.0 112.44 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.38 -80.21 0.31 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.636 -0.585 . . . . 15.0 111.636 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.42 170.43 8.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.695 0.798 . . . . 15.0 110.332 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -136.35 136.12 39.41 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.273 1.029 . . . . 15.0 109.255 174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -115.5 137.17 52.34 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.437 -1.32 . . . . 15.0 107.437 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.5 tp -57.22 113.63 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.759 0.824 . . . . 15.0 111.132 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.38 18.53 60.34 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.788 0.68 . . . . 15.0 113.184 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 102' ' ' ASP . 28.1 tt0 -126.58 166.77 16.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.59 0.756 . . . . 15.0 109.382 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 2.9 m-20 -73.02 133.04 44.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.212 1.005 . . . . 15.0 110.703 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' H ' HD11 ' A' ' 24' ' ' ILE . 39.5 t80 -83.52 143.6 30.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.431 0.693 . . . . 15.0 109.398 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.5 m -140.45 135.76 32.32 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.132 0.573 . . . . 15.0 109.645 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' A' ' 92' ' ' TYR . 8.2 p90 -157.04 156.57 33.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.013 0.925 . . . . 15.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.1 m -111.37 108.93 18.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.473 1.109 . . . . 15.0 111.192 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.28 97.88 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.41 99.84 12.72 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.648 0.779 . . . . 15.0 109.46 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.55 149.19 45.56 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 15.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.92 140.58 30.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.711 0.804 . . . . 15.0 109.302 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 11' ' ' LEU . 15.5 m -109.72 179.42 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.236 0.614 . . . . 15.0 110.728 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.84 113.28 31.29 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.86 0.864 . . . . 15.0 110.034 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.659 ' HB2' HD11 ' A' ' 300' ' ' ILE . 84.2 Cg_endo -82.68 115.62 2.48 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.345 2.03 . . . . 15.0 112.887 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -71.32 89.1 0.88 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.216 1.006 . . . . 15.0 109.064 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.2 131.0 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.219 -168.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -80.12 109.75 14.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.869 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.19 147.9 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.996 0.81 . . . . 15.0 110.465 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.54 158.69 21.07 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.965 0.906 . . . . 15.0 109.739 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 68.28 22.6 74.67 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.629 -0.714 . . . . 15.0 113.843 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.3 mt -68.06 -45.49 73.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.58 1.152 . . . . 15.0 110.673 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.07 -27.87 63.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.647 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.09 -17.55 60.93 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.879 0.472 . . . . 15.0 111.803 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' GLY . 57.4 mt -64.78 120.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.638 0.375 . . . . 15.0 110.332 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.22 109.18 21.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.604 -0.887 . . . . 15.0 108.604 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.0 t -110.7 150.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.415 ' HE2' HD13 ' A' ' 129' ' ' ILE . 83.4 tttt -87.31 109.44 25.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.205 1.002 . . . . 15.0 109.729 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.487 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 68.6 Cg_endo -92.44 104.62 0.2 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.492 2.128 . . . . 15.0 112.282 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.415 HD13 ' HE2' ' A' ' 127' ' ' LYS . 50.2 mm -70.44 89.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 422' ' ' THR . 41.4 t -108.81 135.28 48.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.677 -1.147 . . . . 15.0 109.467 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -122.9 154.54 38.2 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.409 -1.33 . . . . 15.0 107.409 160.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 278' ' ' LEU . 34.9 t -81.42 84.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 107.591 -1.263 . . . . 15.0 107.591 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.6 p -63.25 176.39 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.139 0.976 . . . . 15.0 110.744 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.18 -40.21 76.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.065 0.459 . . . . 15.0 111.086 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.98 98.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.178 -0.919 . . . . 15.0 110.975 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -74.0 -39.83 63.35 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.009 0.524 . . . . 15.0 111.721 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 t -60.29 -62.54 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.103 0 C-N-CA 124.546 1.138 . . . . 15.0 108.734 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.99 -27.28 43.35 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 114.13 -1.396 . . . . 15.0 110.693 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.96 -36.13 47.83 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.749 0.656 . . . . 15.0 113.414 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -71.74 -47.42 53.88 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.008 -0.367 . . . . 15.0 110.008 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.582 HD21 HG12 ' A' ' 270' ' ' VAL . 57.1 mt -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.944 0.498 . . . . 15.0 111.915 167.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.38 -45.32 93.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.152 0.981 . . . . 15.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -63.5 -40.17 96.36 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.029 0.83 . . . . 15.0 110.917 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.23 -42.84 99.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.39 0.676 . . . . 15.0 110.938 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.649 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.2 mtp180 -68.62 -29.31 67.79 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.453 -0.794 . . . . 15.0 110.607 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 92.1 mttt -80.94 -15.61 55.78 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.103 0.561 . . . . 15.0 111.937 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -83.34 -31.12 26.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.69 0.396 . . . . 15.0 110.219 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -104.35 34.58 3.03 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.723 0.809 . . . . 15.0 110.616 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -78.1 156.34 30.02 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.734 1.383 . . . . 15.0 114.734 -166.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.8 m -92.39 128.69 38.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.292 -1.322 . . . . 15.0 108.784 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -84.71 108.32 17.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -123.75 126.49 46.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.277 1.031 . . . . 15.0 110.047 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 74.4 mt-10 -75.72 117.67 17.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.455 -0.572 . . . . 15.0 109.455 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.664 ' HG3' HG11 ' A' ' 240' ' ' VAL . 36.8 pttt -104.61 178.86 4.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.494 0.718 . . . . 15.0 110.735 173.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.65 141.74 43.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.685 0.794 . . . . 15.0 109.335 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.17 -51.06 0.8 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.483 -0.621 . . . . 15.0 113.845 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 146.91 24.1 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.82 0.81 . . . . 15.0 112.479 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.29 155.49 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.668 1.187 . . . . 15.0 108.408 168.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.51 ' HG2' ' H ' ' A' ' 160' ' ' ALA . 16.8 tt0 -148.5 -175.15 4.81 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.855 0.862 . . . . 15.0 109.043 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.51 ' H ' ' HG2' ' A' ' 159' ' ' GLU . . . -73.19 -25.54 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.809 1.411 . . . . 15.0 114.809 -164.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -111.22 26.01 11.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.206 0.602 . . . . 15.0 110.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 163' ' ' ARG . 51.9 m-20 -99.5 -165.52 1.24 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.664 0.745 . . . . 15.0 112.753 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.415 ' HG2' ' HA ' ' A' ' 188' ' ' ALA . 0.3 OUTLIER -139.23 135.18 33.65 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.796 -1.927 . . . . 15.0 105.796 -176.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.28 156.23 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.6 m -129.14 126.51 39.45 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.593 -1.262 . . . . 15.0 107.593 161.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.617 HG23 HD22 ' A' ' 237' ' ' LEU . 28.3 pt -125.05 176.33 6.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.342 1.057 . . . . 15.0 110.791 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.68 122.65 12.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.373 -1.714 . . . . 15.0 106.373 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.484 ' HE2' HD13 ' B' ' 385' ' ' LEU . 29.3 p90 -140.6 160.81 39.21 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.68 0.752 . . . . 15.0 112.667 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.6 t -141.28 115.73 9.5 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.853 -1.521 . . . . 15.0 108.435 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -89.17 161.93 30.61 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.015 -0.539 . . . . 15.0 113.425 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 m -151.28 127.97 10.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.066 0.947 . . . . 15.0 108.593 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.623 HG23 ' HB1' ' A' ' 231' ' ' ALA . 58.0 t -107.81 134.31 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.618 0.767 . . . . 15.0 109.207 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 t70 70.53 3.81 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.202 1.001 . . . . 15.0 112.569 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.27 -3.0 16.27 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.522 -0.599 . . . . 15.0 114.002 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.13 166.59 24.95 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.43 0.692 . . . . 15.0 109.665 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -62.33 175.26 0.77 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 121.704 0.764 . . . . 15.0 111.477 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.671 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 1.7 p90 -149.82 170.35 18.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.103 0.961 . . . . 15.0 109.142 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.72 116.62 4.19 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.929 0.768 . . . . 15.0 109.42 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.89 80.59 0.68 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.354 -1.498 . . . . 15.0 109.354 -163.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -102.81 -15.75 23.59 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.166 -0.797 . . . . 15.0 113.492 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -140.65 146.81 38.39 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 117.925 0.862 . . . . 15.0 112.335 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.15 93.35 2.43 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.448 -1.316 . . . . 15.0 107.448 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.8 m -81.98 138.85 34.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.825 -1.079 . . . . 15.0 110.944 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 62.64 22.55 13.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.07 0.948 . . . . 15.0 113.061 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' B' ' 385' ' ' LEU . 83.6 t80 -66.22 138.99 58.07 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.588 0.232 . . . . 15.0 110.863 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.35 109.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.952 0.901 . . . . 15.0 109.754 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.448 HD23 HG21 ' A' ' 202' ' ' ILE . 26.4 tp -93.58 90.33 6.61 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.404 0.682 . . . . 15.0 111.347 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.415 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -83.57 92.87 7.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.577 ' HE2' ' HD3' ' A' ' 203' ' ' LYS . 17.7 mtp -54.57 128.62 33.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.591 0.756 . . . . 15.0 112.311 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.63 -26.94 5.33 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 -165.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.73 129.13 37.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.487 0.715 . . . . 15.0 109.744 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.2 72.47 0.23 Allowed Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.483 0.489 . . . . 15.0 112.571 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -125.99 22.22 7.38 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.266 0.627 . . . . 15.0 111.279 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.532 ' HB3' HD22 ' B' ' 385' ' ' LEU . 1.6 pmm? -140.77 171.35 14.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.467 0.707 . . . . 15.0 109.973 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.3 pt -100.69 157.28 34.01 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.784 0.834 . . . . 15.0 110.239 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.33 147.1 86.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.676 2.25 . . . . 15.0 112.229 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.78 -46.87 1.45 Allowed Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.4 -0.68 . . . . 15.0 111.4 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -63.63 -51.82 63.52 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.18 -41.97 80.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.618 -1.173 . . . . 15.0 111.662 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.32 -33.08 75.12 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.307 1.043 . . . . 15.0 110.873 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.73 82.95 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.268 -0.878 . . . . 15.0 113.286 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.448 HG21 HD23 ' A' ' 187' ' ' LEU . 34.3 mm -90.39 -51.59 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.282 -0.636 . . . . 15.0 109.282 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.577 ' HD3' ' HE2' ' A' ' 189' ' ' MET . 63.8 pttt -84.52 21.48 1.47 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.774 -166.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.44 32.34 2.07 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.24 -0.744 . . . . 15.0 111.24 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -147.12 -174.24 4.45 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.2 1.0 . . . . 15.0 110.329 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 21.5 pttp -146.69 159.85 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.726 0.81 . . . . 15.0 110.349 -174.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -67.54 152.51 45.53 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.452 0.569 . . . . 15.0 112.287 -171.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.65 -41.29 2.17 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.56 -0.745 . . . . 15.0 111.766 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.2 pt-20 -76.61 114.18 15.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.797 0.808 . . . . 15.0 108.937 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.96 104.2 16.21 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.004 -1.48 . . . . 15.0 107.004 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.02 -169.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.42 1.088 . . . . 15.0 109.295 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.6 t -133.28 141.46 48.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.23 -1.026 . . . . 15.0 108.23 168.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 47.0 pt -104.71 139.36 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -102.0 104.01 14.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.707 -0.849 . . . . 15.0 108.707 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.1 t -97.56 158.36 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.547 -1.279 . . . . 15.0 107.547 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -131.81 129.38 40.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.078 -1.082 . . . . 15.0 108.078 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -78.55 124.46 85.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.564 0.745 . . . . 15.0 110.008 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -51.04 165.99 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.928 3.086 . . . . 15.0 115.403 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -27.76 62.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.61 -0.723 . . . . 15.0 109.724 168.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.86 -17.14 59.16 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.952 1.301 . . . . 15.0 111.451 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.477 ' HE2' ' HB1' ' A' ' 223' ' ' ALA . 64.9 t80 -63.04 133.58 54.77 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.914 0.886 . . . . 15.0 110.327 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -76.97 -42.6 38.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.346 1.239 . . . . 15.0 114.346 -166.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' HE2' ' A' ' 221' ' ' TYR . . . -70.72 100.21 1.84 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.33 -23.41 60.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.676 0.79 . . . . 15.0 112.835 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.48 -24.89 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.654 0.382 . . . . 15.0 110.906 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 388' ' ' VAL . 40.7 mt -93.7 -33.68 13.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.945 0.898 . . . . 15.0 111.643 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.33 116.41 1.87 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.59 1.156 . . . . 15.0 111.542 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.56 -34.83 4.87 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.45 171.51 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.668 0.787 . . . . 15.0 111.936 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -123.94 138.67 54.44 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.9 -1.045 . . . . 15.0 109.833 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.623 ' HB1' HG23 ' A' ' 172' ' ' VAL . . . -117.44 131.55 56.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.218 0.607 . . . . 15.0 110.127 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 65.7 mttm -98.12 116.22 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.744 -1.206 . . . . 15.0 107.744 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.45 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 99.3 m-85 -108.81 114.24 27.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -75.92 89.66 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 15.0 110.231 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 mm -82.01 115.85 25.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.425 0.69 . . . . 15.0 109.669 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -103.73 101.17 11.0 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.526 -1.287 . . . . 15.0 107.526 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 166' ' ' ILE . 88.2 mt -76.9 93.21 3.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -85.34 -31.81 22.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.301 -0.863 . . . . 15.0 110.531 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -132.66 123.43 26.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.174 0.59 . . . . 15.0 110.907 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 207' ' ' ALA . 88.9 t -101.29 105.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.675 -1.972 . . . . 15.0 105.675 160.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 31.9 mt-10 -113.23 -174.94 2.56 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.5 tt0 -155.88 126.67 6.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -73.8 83.12 1.64 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 163.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.49 148.16 39.22 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 113.494 -1.685 . . . . 15.0 110.813 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.93 121.57 59.44 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.544 0.738 . . . . 15.0 110.42 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 91.0 Cg_endo -75.54 -167.95 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.538 2.826 . . . . 15.0 111.965 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.78 147.15 19.53 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.323 0.649 . . . . 15.0 111.22 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.4 tp -147.33 25.94 1.08 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.699 1.2 . . . . 15.0 108.047 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.3 m -73.76 164.83 26.12 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.682 -1.145 . . . . 15.0 109.192 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -36.83 -51.88 0.91 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.801 1.64 . . . . 15.0 114.492 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -67.62 -30.13 69.63 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -80.23 -55.61 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.895 0.478 . . . . 15.0 109.976 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.683 HG13 HD22 ' A' ' 266' ' ' LEU . 12.9 tt -63.87 -28.94 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.829 0.852 . . . . 15.0 112.494 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -66.1 -27.52 68.12 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 112.005 0.372 . . . . 15.0 112.005 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.59 -19.64 65.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.59 0.756 . . . . 15.0 111.976 -172.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -68.66 -23.98 64.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.831 0.453 . . . . 15.0 111.835 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.94 -22.48 1.44 Allowed Glycine 0 C--N 1.351 1.415 0 O-C-N 122.944 0.152 . . . . 15.0 112.771 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.433 HG11 ' H ' ' A' ' 261' ' ' GLY . 21.5 t -68.14 133.15 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 15.0 110.071 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.64 -60.98 2.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.78 0.432 . . . . 15.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.75 -36.1 32.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.072 0.549 . . . . 15.0 111.074 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.433 ' H ' HG11 ' A' ' 258' ' ' VAL . . . 98.88 36.09 4.62 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.476 -0.784 . . . . 15.0 112.755 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 p -78.44 139.45 38.72 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.645 0.723 . . . . 15.0 110.362 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 62.3 t -57.16 -58.77 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.189 0.996 . . . . 15.0 110.789 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.33 -15.4 47.85 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.729 0.812 . . . . 15.0 112.108 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.14 -32.84 37.97 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.683 HD22 HG13 ' A' ' 253' ' ' ILE . 56.3 tp -75.84 -38.51 57.97 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.787 -0.449 . . . . 15.0 109.787 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 39.2 mtp-105 -62.9 -39.58 94.94 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.539 0.524 . . . . 15.0 109.639 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.93 73.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 110.992 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.37 -50.35 73.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.022 0.929 . . . . 15.0 111.196 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.582 HG12 HD21 ' A' ' 141' ' ' LEU . 21.6 m -75.97 -25.13 16.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.235 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -57.79 -60.89 3.01 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.106 -0.701 . . . . 15.0 109.106 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -64.61 -37.56 88.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.916 0.71 . . . . 15.0 112.916 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.92 -51.81 23.79 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 117.966 0.348 . . . . 15.0 111.274 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.501 ' HE1' ' HB ' ' A' ' 270' ' ' VAL . 65.8 mtt -65.21 -30.13 70.99 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 118.582 -0.723 . . . . 15.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.62 -30.06 59.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.443 0.534 . . . . 15.0 112.443 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -64.4 -44.2 92.02 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.272 -0.64 . . . . 15.0 109.272 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.92 -38.17 79.37 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.593 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.569 HD11 ' HE3' ' A' ' 428' ' ' MET . 22.5 tp -60.65 -47.04 88.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.647 1.179 . . . . 15.0 111.638 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -59.85 -40.22 87.8 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.798 0.687 . . . . 15.0 111.053 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.1 t -68.11 -33.9 75.37 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.867 0.729 . . . . 15.0 110.401 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -80.36 -32.0 37.82 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 88.2 mt -68.31 -43.08 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -64.04 -40.12 95.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.108 -0.951 . . . . 15.0 109.691 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.78 -46.78 88.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.525 0.73 . . . . 15.0 110.047 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 8.5 tpt180 -57.05 -63.27 1.27 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.681 1.192 . . . . 15.0 111.128 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.5 -47.47 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.359 1.064 . . . . 15.0 111.5 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.403 ' HE3' HG21 ' A' ' 408' ' ' VAL . 86.4 tttt -71.5 -36.76 71.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.745 -0.662 . . . . 15.0 111.437 -175.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -68.55 -37.99 80.4 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 119.357 -0.354 . . . . 15.0 110.39 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -69.85 -35.97 75.16 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.56 0.537 . . . . 15.0 111.673 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.46 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -63.2 -52.9 60.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.114 0.483 . . . . 15.0 110.712 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.37 -35.02 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.345 1.458 . . . . 15.0 111.248 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.553 ' HA ' HH21 ' A' ' 343' ' ' ARG . 14.0 tp10 -64.04 -53.85 43.43 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.407 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -60.12 -39.43 95.83 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 124.598 1.186 . . . . 15.0 112.579 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 -63.5 1.17 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.321 1.048 . . . . 15.0 111.66 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.57 HG11 ' HG2' ' A' ' 343' ' ' ARG . 91.7 t -63.14 -44.07 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 122.481 0.312 . . . . 15.0 110.232 -176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -55.57 -37.33 67.89 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.287 1.035 . . . . 15.0 111.213 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.49 -28.46 37.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.872 0.869 . . . . 15.0 112.344 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -123.18 113.61 19.18 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.802 0.441 . . . . 15.0 111.278 -167.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.59 148.11 26.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.102 -1.073 . . . . 15.0 108.102 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 113' ' ' PRO . 7.4 tt -163.91 153.77 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.622 0.769 . . . . 15.0 109.814 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.45 112.45 7.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.494 -1.299 . . . . 15.0 107.494 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 300' ' ' ILE . 21.8 t -103.97 132.27 21.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.71 0.804 . . . . 15.0 109.46 -172.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.494 ' HG3' HD23 ' A' ' 11' ' ' LEU . 23.6 Cg_exo -62.94 110.59 1.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.699 2.266 . . . . 15.0 112.117 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 307' ' ' ILE . . . -54.74 -21.48 11.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.861 1.665 . . . . 15.0 113.104 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.25 29.34 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.232 1.013 . . . . 15.0 111.196 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' B' ' 467' ' ' ALA . 75.9 mt -63.01 -38.73 92.35 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.59 0.71 . . . . 15.0 110.011 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 304' ' ' ALA . 77.4 mt -58.62 -48.13 86.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 CA-C-N 114.239 -1.346 . . . . 15.0 109.712 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.503 ' HA ' HD12 ' A' ' 311' ' ' ILE . 22.9 t70 -63.1 -29.92 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.062 0.851 . . . . 15.0 111.309 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -69.61 -44.79 70.0 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.562 0.345 . . . . 15.0 111.545 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.3 -28.75 66.55 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.481 0.658 . . . . 15.0 111.571 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 337' ' ' PHE . 78.0 mt -64.66 -42.04 93.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 N-CA-C 108.195 -1.039 . . . . 15.0 108.195 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.89 -41.14 90.98 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.37 1.044 . . . . 15.0 110.481 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.28 -50.62 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 123.802 0.689 . . . . 15.0 109.909 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.62 -17.92 62.88 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.127 0.788 . . . . 15.0 113.127 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 123.577 0.751 . . . . 15.0 109.234 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.9 tp . . . . . 0 CA--C 1.561 1.373 0 N-CA-C 112.263 0.468 . . . . 15.0 112.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.17 -22.38 39.0 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.1 0.96 . . . . 15.0 112.174 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.5 mt -52.9 119.6 16.68 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-O 118.091 -0.957 . . . . 15.0 110.317 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.71 107.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 124.588 3.525 . . . . 15.0 113.55 -169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.531 ' HB2' HD11 ' A' ' 311' ' ' ILE . 9.0 ptm180 -61.21 -31.32 71.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.782 -1.099 . . . . 15.0 112.572 -170.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.65 -18.11 64.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.222 1.009 . . . . 15.0 112.822 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.49 -37.86 88.04 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.689 0.757 . . . . 15.0 109.73 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.554 ' HB2' HG23 ' A' ' 311' ' ' ILE . 33.2 m-85 -103.38 -20.51 14.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.388 -1.278 . . . . 15.0 111.097 -168.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -54.83 -36.5 65.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.304 1.041 . . . . 15.0 112.976 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.06 -48.06 83.45 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.661 0.384 . . . . 15.0 111.713 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.04 -38.59 44.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.941 0.496 . . . . 15.0 111.358 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.33 -55.17 26.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.393 0.677 . . . . 15.0 110.937 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.538 ' HA ' HG12 ' A' ' 307' ' ' ILE . 86.3 tttt -48.74 -44.34 38.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.692 1.197 . . . . 15.0 111.146 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.57 ' HG2' HG11 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -60.32 -39.26 86.38 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.603 1.19 . . . . 15.0 110.207 178.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -73.18 -28.11 62.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.817 0.281 . . . . 15.0 111.463 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 20.4 t -71.7 -38.24 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.495 -0.558 . . . . 15.0 109.495 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.3 t -59.39 -44.98 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 343' ' ' ARG . 61.1 t -54.22 -46.7 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.82 0.848 . . . . 15.0 110.818 172.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.42 -30.51 75.28 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.433 0.458 . . . . 15.0 113.789 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.46 HD12 HD12 ' A' ' 300' ' ' ILE . 95.7 mt -74.6 -49.35 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.453 0.701 . . . . 15.0 109.955 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.6 mt -64.06 -54.77 28.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.939 0.896 . . . . 15.0 110.548 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 355' ' ' ILE . 78.0 mt -63.6 -34.94 78.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.035 0.834 . . . . 15.0 111.098 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.465 ' HA2' HD11 ' A' ' 355' ' ' ILE . . . -62.88 -38.61 96.84 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 123.49 0.493 . . . . 15.0 112.611 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.17 -35.12 73.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.371 0.669 . . . . 15.0 110.862 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 350' ' ' LEU . 96.4 t -66.6 -37.33 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.927 0.491 . . . . 15.0 110.218 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.465 HD11 ' HA2' ' A' ' 352' ' ' GLY . 76.7 mt -64.26 -42.16 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.352 0.661 . . . . 15.0 110.074 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -60.65 -62.57 1.76 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.827 -0.624 . . . . 15.0 110.096 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.1 m -66.26 -33.8 76.57 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.149 0.98 . . . . 15.0 112.482 -173.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -94.35 11.01 31.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.924 0.49 . . . . 15.0 111.322 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.82 38.58 4.48 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 125.766 1.627 . . . . 15.0 113.888 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.68 147.89 43.25 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.632 0.773 . . . . 15.0 111.85 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 148.51 39.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.229 1.012 . . . . 15.0 108.615 172.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.17 137.39 57.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 122.07 37.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.042 0.937 . . . . 15.0 109.77 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.65 -46.82 83.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.263 1.025 . . . . 15.0 111.829 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.69 -21.06 61.12 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.082 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 -72.62 -46.66 53.01 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.553 -0.906 . . . . 15.0 108.553 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.627 HG22 ' HG2' ' A' ' 399' ' ' ARG . 31.7 t -55.41 -47.52 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 124.55 1.156 . . . . 15.0 109.591 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -51.89 -54.99 22.94 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.237 0.961 . . . . 15.0 111.718 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.73 92.77 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.98 0.8 . . . . 15.0 113.428 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.93 -51.45 69.21 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.515 0.726 . . . . 15.0 110.34 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 367' ' ' VAL . 38.6 mm -54.94 -56.38 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.434 0.694 . . . . 15.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.69 -49.21 78.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.927 -1.488 . . . . 15.0 111.967 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.74 -39.57 64.17 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.615 0.598 . . . . 15.0 112.615 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 56.7 ttp -56.06 -47.49 77.82 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.296 0.639 . . . . 15.0 109.597 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -73.31 -36.42 66.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.8 -1.091 . . . . 15.0 112.183 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 33.5 t -70.55 -12.04 61.32 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.394 0.677 . . . . 15.0 111.811 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.16 -7.95 56.69 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.204 0.601 . . . . 15.0 111.422 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.35 179.53 4.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.225 1.01 . . . . 15.0 110.403 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.01 0.924 . . . . 15.0 110.512 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -114.9 109.89 46.82 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.833 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.666 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 89.3 Cg_endo -80.56 -29.66 2.24 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 121.995 1.796 . . . . 15.0 112.648 168.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.07 -48.54 75.87 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.933 0.893 . . . . 15.0 112.383 -161.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.78 -37.74 85.44 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.992 0.808 . . . . 15.0 110.402 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.46 -46.66 69.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 123.744 0.653 . . . . 15.0 110.087 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -49.3 82.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.06 -12.18 60.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.253 0.621 . . . . 15.0 112.431 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -88.2 -39.66 14.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.212 0.605 . . . . 15.0 111.382 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -86.5 -48.3 8.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.744 0.417 . . . . 15.0 112.083 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.6 p -49.73 -48.04 50.29 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.535 1.134 . . . . 15.0 113.731 -165.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -109.58 14.95 23.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.335 0.654 . . . . 15.0 111.52 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -110.69 88.97 2.9 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.272 -1.381 . . . . 15.0 107.272 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt -66.47 -23.18 66.23 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.413 -0.812 . . . . 15.0 111.691 -170.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.73 -56.88 12.28 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.697 0.799 . . . . 15.0 110.047 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.68 -24.39 58.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.036 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 46.1 tpp -59.52 -46.06 89.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.457 -0.572 . . . . 15.0 109.457 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -54.39 -49.83 68.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.893 0.877 . . . . 15.0 111.462 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.18 -33.83 74.08 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 124.023 0.827 . . . . 15.0 110.976 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.558 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -84.69 -11.97 54.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.392 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.627 ' HG2' HG22 ' A' ' 367' ' ' VAL . 50.0 mtp180 -85.87 -24.89 26.51 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -71.16 -40.27 71.42 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.235 0.614 . . . . 15.0 110.066 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.3 p -71.57 -28.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 117.748 0.249 . . . . 15.0 111.254 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -68.57 -37.5 79.93 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.419 0.628 . . . . 15.0 110.553 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.74 -31.38 57.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.284 -0.871 . . . . 15.0 110.493 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 408' ' ' VAL . 29.2 tt0 -59.89 -46.3 89.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.383 1.073 . . . . 15.0 109.596 169.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 9.1 mm-40 -53.49 -55.09 28.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.524 1.129 . . . . 15.0 111.487 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -58.76 -37.48 76.33 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.483 -0.78 . . . . 15.0 111.953 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -64.09 -41.68 97.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 15.0 111.278 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 404' ' ' GLU . 85.9 t -58.16 -48.39 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 123.757 0.661 . . . . 15.0 109.534 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 57.1 mt-10 -61.87 -36.86 82.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.896 0.748 . . . . 15.0 111.99 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.11 64.73 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.704 -0.68 . . . . 15.0 111.705 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 407' ' ' ALA . 54.7 t -88.05 -29.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 290' ' ' ALA . 97.0 mt -72.04 -27.36 62.65 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.417 0.687 . . . . 15.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.97 70.17 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 15.0 110.873 170.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -95.91 -28.3 14.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.373 1.069 . . . . 15.0 111.368 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.85 154.95 21.18 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.955 0.902 . . . . 15.0 110.924 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.88 84.18 5.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.786 0.834 . . . . 15.0 109.645 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.0 t -95.57 89.3 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.262 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -72.51 112.01 8.19 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.216 0.606 . . . . 15.0 110.295 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.24 132.55 36.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.261 0.625 . . . . 15.0 110.153 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -140.83 141.55 34.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.36 0.664 . . . . 15.0 110.212 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.92 125.13 36.51 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 130' ' ' VAL . 9.8 t -157.31 173.72 16.52 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.947 0.499 . . . . 15.0 111.345 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 64.9 p -96.47 174.62 6.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.656 0.783 . . . . 15.0 112.145 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.99 -25.23 57.99 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.47 1.908 . . . . 15.0 111.702 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 429' ' ' ASN . 33.6 m-80 -65.53 -34.24 77.79 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.865 1.266 . . . . 15.0 112.21 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -66.68 -37.4 84.69 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.321 0.581 . . . . 15.0 111.739 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 278' ' ' LEU . 15.6 tp -85.24 -77.5 0.28 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.377 -0.829 . . . . 15.0 111.124 -165.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.569 ' HE3' HD11 ' A' ' 278' ' ' LEU . 1.3 pmm? -106.01 -30.51 9.26 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.214 -0.304 . . . . 15.0 111.425 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 425' ' ' ASN . 65.1 t30 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 122.308 1.051 . . . . 15.0 110.5 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 194' ' ' MET . 1.5 mm? . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 13.5 m -64.37 98.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 125.168 1.542 . . . . 0.0 112.311 -164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.671 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 5.8 pt -125.08 160.64 30.29 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.035 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.497 ' H ' HD12 ' A' ' 226' ' ' LEU . 54.5 t . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 122.755 0.422 . . . . 0.0 110.414 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 0.0 110.489 177.591 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -67.27 -33.56 75.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.23 109.12 4.75 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 61.2 p -77.43 164.66 25.26 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.667 0.787 . . . . 0.0 111.066 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 35.4 mtm -125.15 -178.16 4.11 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.558 0.694 . . . . 0.0 111.696 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -91.46 -175.25 4.16 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.019 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 65.68 -72.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.877 1.271 . . . . 0.0 109.217 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . 0.691 ' HA ' HD12 ' A' ' 306' ' ' LEU . . . . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.522 0.201 . . . . 15.0 110.689 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.1 tt0 -142.71 118.41 10.46 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.909 -0.775 . . . . 15.0 108.909 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.586 HG13 HG12 ' A' ' 17' ' ' ILE . 26.7 m -106.25 131.96 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.82 -0.437 . . . . 15.0 109.82 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -142.55 94.65 2.67 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.611 0.765 . . . . 15.0 109.217 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -77.2 95.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.184 0.992 . . . . 15.0 110.696 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 48.5 mt-10 -76.21 100.11 4.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.709 -1.132 . . . . 15.0 109.468 173.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -78.43 85.91 4.51 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 107.967 -1.123 . . . . 15.0 107.967 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -61.94 -44.43 96.79 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.685 -1.143 . . . . 15.0 110.749 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -169.36 97.41 0.33 Allowed 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.632 0.582 . . . . 15.0 109.925 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -98.44 0.35 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.747 0.654 . . . . 15.0 113.645 172.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.628 HD22 ' HG3' ' A' ' 113' ' ' PRO . 8.1 mp -69.83 -25.13 63.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.653 0.781 . . . . 15.0 111.311 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.63 79.53 0.69 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.573 0.546 . . . . 15.0 112.832 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HD2' HG11 ' A' ' 111' ' ' VAL . 92.8 mtt180 -99.81 89.99 4.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.6 ttm180 -75.89 95.77 3.59 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.004 -0.998 . . . . 15.0 109.677 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.57 87.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.9 m -82.62 109.74 17.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.813 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.586 HG12 HG13 ' A' ' 3' ' ' VAL . 53.6 mt -110.58 116.56 52.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.912 -0.586 . . . . 15.0 109.729 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 67.6 m -87.39 105.25 17.14 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.866 -0.79 . . . . 15.0 108.866 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 70' ' ' LEU . 62.4 mt -74.37 126.2 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 147.77 51.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.911 0.485 . . . . 15.0 111.26 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.67 94.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 15.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.71 -30.21 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.116 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -69.13 -38.5 78.89 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.841 0.456 . . . . 15.0 110.369 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.23 -42.41 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -61.55 -42.82 99.4 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.914 0.886 . . . . 15.0 111.101 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -75.48 -35.39 60.84 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.71 62.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.891 0.477 . . . . 15.0 111.889 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.788 HG21 ' HD3' ' A' ' 63' ' ' ARG . 86.8 t -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.625 0.77 . . . . 15.0 109.916 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.621 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -65.0 -42.62 94.32 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.384 0.674 . . . . 15.0 111.304 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 65.7 m -69.34 -18.58 63.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.865 0.866 . . . . 15.0 110.638 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.9 tp10 -86.83 -33.05 19.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.071 0.548 . . . . 15.0 110.689 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.5 mt -74.68 -27.34 60.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.335 0.494 . . . . 15.0 112.335 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.51 -29.63 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -68.85 -48.98 62.11 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.0 t -60.74 -35.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.343 1.057 . . . . 15.0 111.294 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.49 -49.0 73.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.092 0.557 . . . . 15.0 110.609 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.57 -29.13 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.34 0.656 . . . . 15.0 112.171 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -80.35 -32.44 37.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.534 1.134 . . . . 15.0 111.15 -171.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.9 t -96.33 1.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.515 0.726 . . . . 15.0 109.621 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 70.06 12.61 7.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.609 1.564 . . . . 15.0 112.635 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 39' ' ' VAL . 69.8 mt -61.59 -24.11 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.154 0.982 . . . . 15.0 110.917 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 11.7 p-10 -65.39 -34.02 77.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.998 0.919 . . . . 15.0 111.614 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.03 -23.9 77.64 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.678 0.611 . . . . 15.0 112.207 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -93.82 -21.7 19.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.722 0.809 . . . . 15.0 110.68 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 48.1 ttt85 -75.89 130.67 38.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.36 1.064 . . . . 15.0 109.084 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.0 16.78 21.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.521 0.728 . . . . 15.0 111.53 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.02 27.0 69.52 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 115.433 -0.803 . . . . 15.0 113.83 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -100.35 -38.89 8.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.355 0.662 . . . . 15.0 111.315 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.26 118.61 67.5 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-O 118.894 -0.574 . . . . 15.0 109.944 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.7 Cg_exo -64.24 147.78 91.12 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.068 2.512 . . . . 15.0 112.257 175.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.2 tpp -74.78 -29.37 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.361 0.664 . . . . 15.0 111.632 -172.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 29.9 p-10 -65.47 -36.72 84.72 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.833 0.453 . . . . 15.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' HD2' ' A' ' 50' ' ' PRO . 38.7 mt -61.49 -52.18 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.641 0.776 . . . . 15.0 110.519 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 58' ' ' TYR . 28.8 m -72.38 -26.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -63.71 -53.83 45.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.216 0.606 . . . . 15.0 111.273 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 2.7 pt20 -83.66 -45.59 13.27 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.546 -0.752 . . . . 15.0 112.127 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -79.9 -63.04 1.5 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.489 0.316 . . . . 15.0 110.513 -171.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 3.6 m-85 -68.97 -38.8 79.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.542 0.737 . . . . 15.0 110.157 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.15 -2.04 86.56 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.576 -1.193 . . . . 15.0 113.965 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.19 -29.92 69.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.413 0.685 . . . . 15.0 111.573 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.0 p -80.13 -39.73 28.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.517 0.727 . . . . 15.0 110.65 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.07 -17.26 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 124.369 1.068 . . . . 15.0 111.711 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.788 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -48.14 -46.72 34.68 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.342 1.057 . . . . 15.0 111.467 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.64 -53.85 49.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.557 1.543 . . . . 15.0 112.26 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.84 -29.97 66.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.241 -0.89 . . . . 15.0 111.728 -171.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -74.2 -27.87 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.947 -0.57 . . . . 15.0 110.594 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.1 mt -57.77 -39.21 76.92 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.828 0.451 . . . . 15.0 111.151 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.85 -42.88 98.33 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.211 0.319 . . . . 15.0 112.794 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.15 -41.69 94.52 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.231 1.012 . . . . 15.0 111.056 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.581 ' HB3' HD12 ' A' ' 19' ' ' ILE . 86.3 mt -69.49 -40.19 77.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.694 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 75.2 mtm -67.18 -36.86 82.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.917 0.487 . . . . 15.0 111.033 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -63.38 -47.42 82.12 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.025 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.2 mtm105 -83.08 -51.11 7.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.983 -0.553 . . . . 15.0 112.204 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -23.52 44.21 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 122.858 0.463 . . . . 15.0 111.655 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -72.12 -52.2 17.84 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.568 0.543 . . . . 15.0 111.229 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.509 ' HA ' HG12 ' A' ' 79' ' ' ILE . 12.2 tt -67.28 -39.34 82.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.141 0 CA-C-N 117.899 0.318 . . . . 15.0 110.956 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -59.21 -34.68 72.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.467 0.707 . . . . 15.0 111.181 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.94 -54.88 7.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.528 0.731 . . . . 15.0 111.146 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' A' ' 76' ' ' ILE . 21.8 pt -68.32 -22.23 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.145 0.794 . . . . 15.0 113.145 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.38 -49.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.536 0.335 . . . . 15.0 110.454 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -72.14 -36.83 69.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.332 0.253 . . . . 15.0 111.293 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -76.72 -12.74 60.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.959 0.504 . . . . 15.0 111.542 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 61.13 29.78 19.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.766 1.226 . . . . 15.0 112.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -82.29 125.0 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.47 104.03 31.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.61 147.28 24.86 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.464 2.109 . . . . 15.0 112.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.18 178.44 10.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.74 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.81 -124.95 18.76 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.117 -0.947 . . . . 15.0 112.054 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.18 99.76 28.96 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.565 0.746 . . . . 15.0 110.188 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.5 Cg_endo -76.57 108.09 2.59 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.119 1.879 . . . . 15.0 110.528 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -102.75 100.64 10.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.634 -0.712 . . . . 15.0 109.963 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -85.95 80.87 8.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.453 0.701 . . . . 15.0 109.383 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.76 113.69 34.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.332 -0.849 . . . . 15.0 108.988 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.81 96.23 0.67 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.381 2.054 . . . . 15.0 110.459 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -51.28 -51.07 37.99 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.818 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -174.65 137.73 0.48 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.914 0.886 . . . . 15.0 110.668 172.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -106.34 135.46 47.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 38.3 mtpt -129.71 114.24 15.74 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.158 -1.423 . . . . 15.0 107.158 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.27 118.37 9.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.891 0.477 . . . . 15.0 109.716 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.25 39.08 Favored Glycine 0 N--CA 1.47 0.94 0 CA-C-N 115.985 -0.552 . . . . 15.0 112.659 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.3 mt-10 -112.34 -178.81 3.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.117 0.967 . . . . 15.0 109.652 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.28 151.22 46.51 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.706 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HD2' HD13 ' A' ' 19' ' ' ILE . 48.7 t80 -95.16 146.45 24.3 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.4 m -134.46 133.31 40.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.333 0.653 . . . . 15.0 109.574 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.52 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 13.7 p90 -138.34 171.15 14.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.925 0.89 . . . . 15.0 109.051 172.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.3 m -140.77 124.37 16.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.888 0.875 . . . . 15.0 109.349 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.19 104.3 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -102.04 114.93 29.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.949 0.9 . . . . 15.0 109.417 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 33.6 p90 -139.64 164.04 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.604 0.761 . . . . 15.0 110.619 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.86 113.72 20.67 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.364 -0.835 . . . . 15.0 109.705 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.6 HG11 ' HD2' ' A' ' 13' ' ' ARG . 12.1 m -89.43 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.671 -0.492 . . . . 15.0 109.671 171.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -89.33 126.37 58.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.674 . . . . 15.0 110.224 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.628 ' HG3' HD22 ' A' ' 11' ' ' LEU . 14.5 Cg_exo -69.39 145.29 58.86 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.441 2.094 . . . . 15.0 110.868 170.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.45 100.15 1.05 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.301 0.64 . . . . 15.0 109.351 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.37 123.8 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.724 0.773 . . . . 15.0 112.057 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.96 107.82 15.03 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.537 1.135 . . . . 15.0 108.705 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.95 131.5 45.19 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.645 0.591 . . . . 15.0 109.995 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -136.6 155.9 49.3 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.169 0.988 . . . . 15.0 109.586 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 60.65 20.77 56.94 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 124.442 1.089 . . . . 15.0 114.823 171.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.03 -39.46 94.81 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.368 0.667 . . . . 15.0 111.029 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.05 -20.31 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.239 0.615 . . . . 15.0 111.305 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.89 -15.92 42.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.63 0.772 . . . . 15.0 111.652 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.516 HG23 HG23 ' A' ' 125' ' ' VAL . 58.5 mt -65.11 124.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.158 0.583 . . . . 15.0 109.758 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.623 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.7 mt-10 -116.2 85.91 2.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.925 0.869 . . . . 15.0 109.948 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 289' ' ' GLN . 67.8 t -83.03 164.78 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.51 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.7 141.23 49.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.744 0.817 . . . . 15.0 109.45 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -114.38 94.75 37.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.872 -1.159 . . . . 15.0 107.872 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.635 ' HG3' ' HD2' ' A' ' 285' ' ' ARG . 85.0 Cg_endo -78.16 103.49 1.7 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.984 1.789 . . . . 15.0 111.38 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -69.12 92.73 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 427' ' ' LEU . 25.5 t -118.29 134.06 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.219 -0.901 . . . . 15.0 110.196 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.44 154.73 48.38 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 106.664 -1.606 . . . . 15.0 106.664 167.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 274' ' ' MET . 3.4 t -83.29 89.66 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.814 -1.18 . . . . 15.0 107.814 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.9 p -69.52 173.96 5.44 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.257 0.623 . . . . 15.0 109.79 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -55.26 -43.72 74.93 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.561 0.344 . . . . 15.0 111.474 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.41 -25.65 64.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.557 0.743 . . . . 15.0 111.929 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -78.81 -45.11 21.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.754 0.422 . . . . 15.0 110.675 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -56.06 -58.09 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.938 0.895 . . . . 15.0 109.129 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -61.69 -47.01 87.23 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.844 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.17 72.16 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.13 0.894 . . . . 15.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.661 ' SD ' ' HE1' ' A' ' 274' ' ' MET . 27.8 ttt -69.54 -50.71 42.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.771 0.428 . . . . 15.0 111.151 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.18 -37.51 69.68 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.143 0.577 . . . . 15.0 112.067 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.75 -41.75 82.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.107 0.963 . . . . 15.0 109.929 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.479 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 82.7 m -58.95 -43.2 91.21 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.188 0.93 . . . . 15.0 110.574 173.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 140' ' ' MET . 81.0 mt -61.3 -42.94 99.5 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.425 0.69 . . . . 15.0 111.076 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 69.3 mtm180 -63.57 -35.89 81.99 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.297 -0.865 . . . . 15.0 110.676 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.607 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 85.6 mttt -85.06 -5.33 59.35 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.37 0.668 . . . . 15.0 112.537 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 143' ' ' THR . 96.8 mt-30 -79.74 -44.62 20.39 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.914 -0.772 . . . . 15.0 108.914 163.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -97.59 37.94 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.367 0.667 . . . . 15.0 110.864 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -71.51 141.13 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.458 0.703 . . . . 15.0 112.092 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.1 m -82.18 127.02 32.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.379 1.072 . . . . 15.0 109.353 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -86.95 126.61 34.82 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.02 0.528 . . . . 15.0 110.269 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -148.52 122.58 9.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 15.0 110.032 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.538 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.5 mt-10 -75.57 143.78 42.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.01 0.524 . . . . 15.0 110.263 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.685 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 36.6 pttt -137.05 -179.3 5.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.706 0.802 . . . . 15.0 111.031 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -147.14 153.74 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.06 -51.81 0.79 Allowed Glycine 0 N--CA 1.467 0.707 0 CA-C-O 119.548 -0.584 . . . . 15.0 112.757 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -155.53 148.07 23.99 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 117.415 0.608 . . . . 15.0 111.158 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.83 153.01 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 107.902 -1.147 . . . . 15.0 107.902 165.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.07 -169.88 2.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.457 1.103 . . . . 15.0 109.711 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.51 96.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.397 1.079 . . . . 15.0 113.245 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.65 33.25 5.14 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.889 0.7 . . . . 15.0 112.889 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -87.84 -164.26 1.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 120.934 0.397 . . . . 15.0 111.795 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 18.7 mtm180 -122.88 160.44 26.1 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.027 -1.101 . . . . 15.0 108.027 161.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.62 116.92 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.677 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 15.2 m -95.63 116.46 28.88 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 237' ' ' LEU . 40.1 pt -130.13 168.77 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.752 0.821 . . . . 15.0 110.346 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.45 ' HB2' ' HZ2' ' A' ' 181' ' ' LYS . 7.7 p-10 -127.64 161.2 29.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.424 -1.325 . . . . 15.0 107.424 161.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.63 174.92 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.333 0.587 . . . . 15.0 111.385 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.653 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 6.6 t -158.62 131.64 7.24 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.658 -1.608 . . . . 15.0 106.658 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.48 -177.13 26.67 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.602 -0.808 . . . . 15.0 113.407 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 p -148.2 131.67 16.7 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.754 0.822 . . . . 15.0 109.306 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 226' ' ' LEU . 45.7 t -93.08 102.81 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 27.7 t70 77.7 -0.65 2.73 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 125.296 1.439 . . . . 15.0 111.047 -170.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.45 37.35 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 121.868 -0.52 . . . . 15.0 113.092 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.2 pt-20 -105.77 137.41 43.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.267 0.627 . . . . 15.0 109.353 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.18 95.16 5.54 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.659 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.474 ' CD1' HG23 ' A' ' 172' ' ' VAL . 39.7 p90 -59.48 158.77 9.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.659 -1.155 . . . . 15.0 110.655 174.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -54.14 135.45 43.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 15.0 111.195 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.633 ' HA3' HG23 ' B' ' 386' ' ' VAL . . . 78.99 -70.49 2.75 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 123.985 0.803 . . . . 15.0 111.675 -170.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.61 -69.77 2.78 Favored Glycine 0 C--N 1.348 1.201 0 C-N-CA 123.212 0.434 . . . . 15.0 112.605 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.653 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 6.5 tmtt? -86.29 137.37 32.66 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.252 1.021 . . . . 15.0 110.185 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.523 ' HB3' HG13 ' B' ' 386' ' ' VAL . . . -127.89 155.52 44.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.887 0.875 . . . . 15.0 108.816 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 m -139.35 128.51 23.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 15.0 110.663 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 63.09 37.81 11.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.603 1.161 . . . . 15.0 112.255 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 44.6 t80 -71.22 136.06 47.84 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.39 -0.823 . . . . 15.0 108.915 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.5 t -107.16 119.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.008 0.923 . . . . 15.0 109.573 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 24.6 tp -112.66 93.64 4.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.986 0.914 . . . . 15.0 110.867 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.19 105.01 3.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 189' ' ' MET . 1.3 mmt -77.25 165.07 24.98 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 114.872 -1.058 . . . . 15.0 111.063 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.42 11.69 56.87 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.056 -0.974 . . . . 15.0 112.029 -170.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.14 143.84 22.73 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 125.125 1.37 . . . . 15.0 107.767 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -79.15 82.84 1.33 Allowed Glycine 0 C--N 1.344 0.978 0 O-C-N 123.148 0.28 . . . . 15.0 112.692 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.03 -19.95 26.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.966 0.506 . . . . 15.0 111.374 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.86 156.91 43.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.606 0.362 . . . . 15.0 110.69 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.04 140.85 98.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.761 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.89 105.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.217 2.612 . . . . 15.0 112.665 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.55 -49.44 0.66 Allowed Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.153 -0.931 . . . . 15.0 111.102 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -69.04 -64.65 0.83 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.488 0.315 . . . . 15.0 110.291 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 203' ' ' LYS . 8.4 pt-20 -62.58 -27.6 69.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.108 0.88 . . . . 15.0 112.429 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.23 -30.58 67.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.957 0.903 . . . . 15.0 110.527 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.43 -5.66 85.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.167 -0.924 . . . . 15.0 112.98 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.4 HG21 HD22 ' A' ' 187' ' ' LEU . 33.6 mm -103.74 -47.97 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 123.429 0.692 . . . . 15.0 110.47 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 199' ' ' GLU . 22.6 pttm -85.4 16.5 3.7 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.782 1.03 . . . . 15.0 113.782 -169.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -127.91 32.28 3.5 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.744 -0.942 . . . . 15.0 110.744 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -146.52 -167.83 2.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 15.0 110.473 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -151.86 161.67 42.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.598 0.759 . . . . 15.0 110.01 177.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.96 139.09 52.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.139 0.576 . . . . 15.0 111.892 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.54 8.63 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.501 -0.772 . . . . 15.0 112.429 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.8 pt-20 -92.45 137.63 32.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.496 0.719 . . . . 15.0 109.485 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.18 112.11 18.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.929 -1.137 . . . . 15.0 107.929 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -131.89 -178.31 4.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.788 1.235 . . . . 15.0 109.878 -171.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 43.3 m -131.11 120.35 23.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.775 0.83 . . . . 15.0 108.98 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.04 156.35 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.274 0.63 . . . . 15.0 110.514 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -116.18 105.28 12.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.095 0.958 . . . . 15.0 108.996 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.1 167.1 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 91.3 m -141.09 133.61 28.47 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.355 -0.98 . . . . 15.0 108.355 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.449 ' HZ ' HD13 ' B' ' 387' ' ' ILE . 49.0 m-85 -76.42 138.64 67.46 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 123.432 0.457 . . . . 15.0 111.837 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.8 158.35 11.03 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.695 2.93 . . . . 15.0 113.61 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.35 -31.01 63.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.67 -23.97 67.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.346 1.058 . . . . 15.0 111.657 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.5 ' O ' ' HB2' ' A' ' 227' ' ' LYS . 1.9 t80 -74.35 74.69 1.87 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.076 0.95 . . . . 15.0 109.052 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -67.8 4.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.049 1.5 . . . . 15.0 115.049 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.21 93.1 0.8 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.183 -1.414 . . . . 15.0 107.183 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.1 tt0 -64.08 -29.0 70.17 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.761 0.652 . . . . 15.0 112.761 -166.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -61.2 -22.57 64.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.835 0.854 . . . . 15.0 110.961 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.629 ' HA ' HG13 ' A' ' 172' ' ' VAL . 76.4 mt -102.55 -43.37 5.65 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.72 1.208 . . . . 15.0 110.82 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 221' ' ' TYR . 0.7 OUTLIER -54.82 130.62 41.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.889 1.675 . . . . 15.0 112.759 -165.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.48 -18.91 7.69 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.832 0.708 . . . . 15.0 114.398 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 93.0 mttt -89.85 143.25 26.96 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.874 0.87 . . . . 15.0 110.562 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.0 106.88 11.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.552 0.741 . . . . 15.0 110.174 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.81 115.97 27.54 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.896 -1.047 . . . . 15.0 110.759 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -106.13 107.64 18.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.411 -0.588 . . . . 15.0 109.411 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -104.9 119.71 39.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.038 0.935 . . . . 15.0 109.121 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.51 93.74 4.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.326 0.65 . . . . 15.0 109.405 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.96 125.89 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 15.0 110.421 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -109.34 98.52 7.91 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.336 -1.357 . . . . 15.0 107.336 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.5 ' HA ' HG23 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.59 99.52 6.57 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 -175.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -93.43 -40.92 10.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.229 -0.442 . . . . 15.0 110.985 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.677 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 35.3 mmtp -131.89 139.36 48.75 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.051 0.54 . . . . 15.0 110.687 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 207' ' ' ALA . 86.0 t -104.03 141.93 18.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.112 -1.811 . . . . 15.0 106.112 159.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.749 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.2 mt-10 -133.1 -176.26 4.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.685 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 41.4 tt0 -154.36 130.64 10.43 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.551 0.741 . . . . 15.0 109.358 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.402 ' NH1' ' HB3' ' A' ' 146' ' ' LYS . 23.4 ptt180 -86.24 86.03 7.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.19 0.995 . . . . 15.0 108.356 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.89 141.78 58.13 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.116 -1.402 . . . . 15.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.61 132.76 94.61 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.1 -0.704 . . . . 15.0 109.1 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 59.9 Cg_endo -67.83 176.52 5.12 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.468 2.112 . . . . 15.0 112.002 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.97 88.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.19 69.92 4.47 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.934 0.873 . . . . 15.0 109.006 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.9 p -101.83 163.89 12.02 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.591 1.156 . . . . 15.0 109.282 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.11 -41.27 48.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.98 0.912 . . . . 15.0 111.195 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.2 -39.46 86.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.179 1.392 . . . . 15.0 111.312 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.14 -59.9 2.59 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.897 . . . . 15.0 109.146 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 258' ' ' VAL . 9.5 tt -57.78 -42.0 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.954 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -67.71 -26.68 66.29 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.687 0.254 . . . . 15.0 111.687 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -72.79 -19.06 61.42 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.622 0.769 . . . . 15.0 110.949 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -87.63 -6.58 58.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.452 0.701 . . . . 15.0 111.322 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.5 5.1 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 119.428 -0.651 . . . . 15.0 114.721 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.514 HG11 ' H ' ' A' ' 261' ' ' GLY . 44.2 t -62.72 111.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 117.483 0.642 . . . . 15.0 110.902 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -58.78 -48.57 80.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.599 1.16 . . . . 15.0 112.001 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.634 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 5.3 t70 -76.69 -43.49 37.46 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.458 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.514 ' H ' HG11 ' A' ' 258' ' ' VAL . . . 82.96 18.97 64.02 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 115.866 -0.606 . . . . 15.0 114.337 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -148.78 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.902 0.881 . . . . 15.0 109.602 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 95.7 t -50.4 -52.97 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 124.364 1.066 . . . . 15.0 113.457 -165.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -31.04 68.53 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.979 0.512 . . . . 15.0 111.549 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' A' ' 260' ' ' ASP . . . -80.28 -24.08 59.84 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.145 -0.382 . . . . 15.0 112.145 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 270' ' ' VAL . 38.5 tp -77.67 -28.16 51.06 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.503 ' HA ' HG21 ' A' ' 270' ' ' VAL . 77.3 mtp180 -72.45 -37.6 68.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.956 0.902 . . . . 15.0 109.666 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.65 88.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.751 -0.659 . . . . 15.0 110.411 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.37 -48.7 55.11 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.328 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 267' ' ' ARG . 19.2 m -67.4 -25.58 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-O 120.64 0.257 . . . . 15.0 110.634 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -60.01 -66.1 0.57 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.76 0.424 . . . . 15.0 110.48 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.28 -7.84 53.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.233 0.613 . . . . 15.0 112.61 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -101.22 -68.91 0.8 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.424 0.69 . . . . 15.0 109.965 170.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.661 ' HE1' ' SD ' ' A' ' 140' ' ' MET . 1.6 mpt? -66.84 -43.79 82.77 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 117.698 -1.144 . . . . 15.0 111.694 -170.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.12 -49.63 71.44 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.441 1.473 . . . . 15.0 109.95 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -51.81 -49.16 63.32 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 113.509 -1.678 . . . . 15.0 111.989 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -84.35 -37.77 21.15 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.558 0.536 . . . . 15.0 111.348 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.535 ' HA ' ' HE1' ' A' ' 428' ' ' MET . 61.6 tp -67.16 -56.92 7.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.737 0.415 . . . . 15.0 111.894 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.78 -31.65 72.97 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.481 0.488 . . . . 15.0 110.194 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.9 t -64.86 -45.57 85.51 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.954 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.43 65.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 15.0 112.26 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.51 HD12 ' HB ' ' A' ' 130' ' ' VAL . 98.6 mt -66.28 -51.43 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.788 HH21 ' HB3' ' A' ' 405' ' ' GLU . 28.8 tpt180 -62.14 -37.5 85.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.65 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.67 -23.77 45.5 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.388 0.675 . . . . 15.0 111.05 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.635 ' HD2' ' HG3' ' A' ' 128' ' ' PRO . 25.1 ttm180 -70.33 -49.31 50.71 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.577 0.626 . . . . 15.0 109.452 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 98.6 t -57.56 -48.25 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.761 0.791 . . . . 15.0 110.008 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.419 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -64.21 -46.44 83.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.58 -1.191 . . . . 15.0 111.463 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -65.89 -39.21 90.44 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 119.256 -0.402 . . . . 15.0 110.935 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.542 ' HB2' HG11 ' A' ' 125' ' ' VAL . 56.8 mt-30 -69.95 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.553 0.533 . . . . 15.0 111.172 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.21 -50.84 66.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.625 0.37 . . . . 15.0 110.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.9 mm -67.76 -41.17 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.796 0.839 . . . . 15.0 111.01 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -64.43 -36.19 83.35 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.732 0.813 . . . . 15.0 109.474 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.443 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -65.54 -43.87 93.86 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.926 -1.034 . . . . 15.0 112.005 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.59 -45.49 81.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.108 0.963 . . . . 15.0 110.841 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.37 -58.67 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.051 0.94 . . . . 15.0 110.26 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.86 -23.47 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.641 0.776 . . . . 15.0 112.348 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -79.52 -33.65 41.86 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.547 0.739 . . . . 15.0 111.508 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.52 138.22 7.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 112.719 0.637 . . . . 15.0 112.719 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.08 144.48 29.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.167 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.46 HG12 HD23 ' A' ' 349' ' ' LEU . 6.5 tp -138.89 123.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . 7.6 m-20 -79.0 137.43 37.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.24 130.98 21.44 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.192 0.597 . . . . 15.0 109.449 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.88 130.03 32.74 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.029 2.486 . . . . 15.0 112.501 168.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.58 -9.67 20.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.759 1.022 . . . . 15.0 113.759 -173.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.22 91.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.244 0.618 . . . . 15.0 110.925 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.31 -38.66 68.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 15.0 111.122 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.61 -52.13 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -38.57 89.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.832 0.853 . . . . 15.0 111.453 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.9 t -59.07 -50.57 73.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 15.0 111.226 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.91 -26.33 43.78 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.381 -0.372 . . . . 15.0 111.42 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.29 -35.52 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 166.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.534 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.0 t70 -70.88 -39.36 72.89 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.97 0.508 . . . . 15.0 111.01 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.08 -48.07 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 123.792 0.683 . . . . 15.0 109.27 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 341' ' ' ALA . 83.2 mt -73.68 -21.3 60.3 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.117 -0.947 . . . . 15.0 113.237 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 72.1 mtm180 . . . . . 0 N--CA 1.483 1.223 0 C-N-CA 123.055 0.542 . . . . 15.0 109.806 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.0 tp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.944 0.402 . . . . 15.0 111.358 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -113.68 21.96 14.52 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.065 0.946 . . . . 15.0 111.055 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 24.2 mt -64.65 128.79 93.88 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.611 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 87.9 Cg_exo -47.7 118.29 2.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.664 2.909 . . . . 15.0 114.328 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -56.02 -36.55 68.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.091 0.957 . . . . 15.0 111.235 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.31 -12.05 47.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.468 0.914 . . . . 15.0 113.468 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 96.9 mt -71.76 -40.15 69.52 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.368 -0.604 . . . . 15.0 109.368 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -107.01 -10.77 15.83 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.271 -168.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -48.66 -57.75 5.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.147 1.379 . . . . 15.0 113.021 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.1 -59.21 4.95 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 111.397 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.01 -36.55 69.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.617 -0.72 . . . . 15.0 112.416 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.468 ' HB3' HD13 ' A' ' 314' ' ' LEU . . . -70.7 -50.79 32.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.547 . . . . 15.0 110.04 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.11 -34.94 74.19 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.03 0.832 . . . . 15.0 110.328 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 347' ' ' VAL . 9.6 mmt85 -62.89 -38.1 89.56 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.003 -0.522 . . . . 15.0 111.26 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.73 -28.8 66.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 123.286 0.366 . . . . 15.0 110.853 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.633 ' HA ' ' HB2' ' B' ' 466' ' ' ALA . 24.9 t -75.48 -36.01 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.98 -0.378 . . . . 15.0 109.98 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.8 -35.03 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.561 0.744 . . . . 15.0 109.863 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.52 HG11 HD12 ' A' ' 351' ' ' LEU . 55.4 t -60.47 -54.64 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.809 -0.811 . . . . 15.0 108.809 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.56 ' HA2' ' HE2' ' B' ' 464' ' ' MET . . . -61.2 -39.66 97.48 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.388 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.46 HD23 HG12 ' A' ' 300' ' ' ILE . 6.5 tt -78.15 -55.32 5.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.046 0.538 . . . . 15.0 110.234 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.412 ' O ' HG23 ' A' ' 354' ' ' VAL . 72.3 mt -67.1 -49.27 65.53 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.039 0.212 . . . . 15.0 110.694 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 347' ' ' VAL . 64.9 mt -69.2 -28.26 66.22 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 119.334 -0.365 . . . . 15.0 111.055 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.559 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -62.2 -42.36 99.72 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.923 -0.471 . . . . 15.0 111.923 172.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.21 -39.14 93.35 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.238 -0.481 . . . . 15.0 110.58 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -59.57 -37.04 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 122.888 0.475 . . . . 15.0 111.041 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.559 HD13 ' HA2' ' A' ' 352' ' ' GLY . 75.9 mt -65.2 -46.85 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.744 0.818 . . . . 15.0 110.543 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.95 -53.25 41.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.525 0.203 . . . . 15.0 110.908 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.0 m -60.27 -40.72 91.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.588 1.155 . . . . 15.0 112.053 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.39 17.98 18.86 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.174 0.589 . . . . 15.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 46.33 30.02 0.96 Allowed 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 125.703 1.601 . . . . 15.0 114.626 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.557 ' HB3' HE21 ' A' ' 406' ' ' GLN . 83.1 mt -65.72 148.28 52.02 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.072 0.949 . . . . 15.0 112.811 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -129.31 158.09 40.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.522 1.129 . . . . 15.0 108.83 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.67 90.33 2.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 367' ' ' VAL . 5.2 t70 -67.73 120.93 14.88 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.11 0.964 . . . . 15.0 110.758 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.26 -23.67 67.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.826 0.85 . . . . 15.0 113.0 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.61 -34.11 73.62 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 30.9 tpt85 -77.82 -36.81 49.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.725 0.81 . . . . 15.0 109.951 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 399' ' ' ARG . 41.3 t -63.99 -55.01 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.617 0.767 . . . . 15.0 109.746 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -36.18 81.59 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.813 -1.085 . . . . 15.0 109.778 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.95 96.75 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.787 0.679 . . . . 15.0 112.711 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 367' ' ' VAL . 69.3 mt -57.44 -48.15 79.9 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.636 0.774 . . . . 15.0 111.07 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.628 HG21 ' HA ' ' A' ' 385' ' ' ILE . 17.8 mm -56.35 -44.69 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 124.183 0.927 . . . . 15.0 110.81 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -61.57 -54.46 42.77 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 15.0 110.782 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -61.6 -37.7 84.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.499 0.72 . . . . 15.0 112.769 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -74.76 -45.76 41.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.423 0.689 . . . . 15.0 109.931 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.476 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -73.28 -16.83 61.38 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.184 0.594 . . . . 15.0 111.959 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -73.1 -0.18 13.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.991 0.917 . . . . 15.0 111.692 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -98.54 -10.11 23.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.583 0.753 . . . . 15.0 111.268 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.476 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 79.1 m-85 -111.31 157.56 20.03 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.108 0.963 . . . . 15.0 109.604 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.0 -45.06 71.51 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.211 0.604 . . . . 15.0 110.834 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.88 100.71 17.5 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 124.596 1.158 . . . . 15.0 110.26 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.9 -41.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.605 2.204 . . . . 15.0 115.794 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -68.92 -28.97 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -163.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.32 -28.69 67.38 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.344 0.403 . . . . 15.0 110.095 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.74 -38.81 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.556 0.742 . . . . 15.0 109.261 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.628 ' HA ' HG21 ' A' ' 371' ' ' ILE . 1.8 mp -55.55 -48.56 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.493 -0.558 . . . . 15.0 109.493 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.74 -34.01 76.0 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.591 0.756 . . . . 15.0 111.668 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -64.35 -40.04 95.08 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.794 0.838 . . . . 15.0 110.961 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.421 ' HB3' ' HE2' ' A' ' 395' ' ' MET . 29.9 m-85 -79.0 -50.51 10.98 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.916 0.135 . . . . 15.0 111.014 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' SER . . . . . 0.576 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -169.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.02 0.07 54.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.184 0.594 . . . . 15.0 112.052 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -113.52 118.84 35.58 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -63.84 -61.47 2.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.434 0.693 . . . . 15.0 112.164 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.98 -30.66 69.26 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.426 0.69 . . . . 15.0 112.173 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.16 -38.9 20.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.984 0.513 . . . . 15.0 111.441 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -62.13 -48.26 80.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 175.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.564 ' HA ' ' HD2' ' A' ' 399' ' ' ARG . 13.2 t70 -62.95 -39.7 95.44 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.575 1.172 . . . . 15.0 110.826 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.427 ' O ' HG22 ' A' ' 401' ' ' VAL . 9.5 t30 -59.8 -40.64 89.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.245 0.545 . . . . 15.0 110.391 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 -16.75 56.96 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.301 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 396' ' ' ASP . 97.9 mtt180 -71.81 -36.25 70.19 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 15.0 109.429 167.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -64.2 -42.27 96.7 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.525 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 397' ' ' ASN . 24.9 t -62.48 -42.36 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 123.851 0.719 . . . . 15.0 110.867 175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.51 85.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.491 0.716 . . . . 15.0 111.188 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.33 -35.17 71.12 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.465 -1.243 . . . . 15.0 111.001 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.04 -54.49 45.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.292 1.037 . . . . 15.0 110.327 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.788 ' HB3' HH21 ' A' ' 283' ' ' ARG . 47.8 mt-10 -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.384 -0.826 . . . . 15.0 111.92 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.557 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.5 tt0 -67.47 -37.58 83.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.21 0.604 . . . . 15.0 109.857 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.6 78.58 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.474 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.22 -56.13 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.86 -25.52 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.429 1.092 . . . . 15.0 112.409 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.13 66.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.038 0.535 . . . . 15.0 111.233 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.49 -34.81 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.911 -0.774 . . . . 15.0 108.911 172.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.532 ' HA ' ' HB1' ' A' ' 415' ' ' ALA . 80.9 mt -70.06 -31.08 68.52 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.458 0.703 . . . . 15.0 111.502 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.7 0.8 . . . . 15.0 110.812 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -86.41 -34.17 20.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.739 0.816 . . . . 15.0 109.881 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 412' ' ' LEU . . . -86.34 -171.81 3.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.73 1.212 . . . . 15.0 112.126 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.623 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 79.0 mttt -114.9 117.47 30.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.911 -1.041 . . . . 15.0 108.696 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.53 101.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 109.19 -0.67 . . . . 15.0 109.19 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 t -71.32 89.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.132 0.968 . . . . 15.0 109.466 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.52 110.02 8.48 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.286 -1.325 . . . . 15.0 109.566 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -133.99 137.88 45.06 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 15.0 110.157 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.05 131.41 39.47 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.384 0.674 . . . . 15.0 109.233 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.2 t -158.76 170.66 21.64 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.214 0.605 . . . . 15.0 110.372 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.6 p -90.68 176.98 6.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.471 0.709 . . . . 15.0 112.313 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -63.7 -23.91 67.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.777 1.231 . . . . 15.0 110.935 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -66.93 -17.78 65.07 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.64 1.176 . . . . 15.0 112.301 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.501 ' HB3' HD13 ' A' ' 427' ' ' LEU . 13.2 tp10 -63.83 -36.15 82.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.029 0.932 . . . . 15.0 111.38 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.61 HD11 HG21 ' A' ' 130' ' ' VAL . 3.1 mp -104.16 -69.58 0.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.87 0.468 . . . . 15.0 111.476 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.535 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.6 mpt? -92.54 -50.19 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.054 0.39 . . . . 15.0 112.054 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 59.4 t30 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.842 0.829 . . . . 15.0 110.997 -165.404 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 C--O 1.246 0.913 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . 0.633 HG23 ' HA3' ' A' ' 179' ' ' GLY . 7.5 p -77.88 91.74 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.69 1.233 . . . . 0.0 110.995 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.449 HD13 ' HZ ' ' A' ' 217' ' ' PHE . 8.3 mm -150.98 141.71 16.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 127.805 2.442 . . . . 0.0 104.484 162.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.557 1.224 0 CA-C-N 119.099 0.863 . . . . 0.0 110.266 -164.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 N--CA 1.487 1.387 0 C-N-CA 123.646 0.778 . . . . 0.0 110.993 -174.634 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -45.89 -53.1 10.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.564 1.146 . . . . 0.0 113.142 -169.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -131.87 115.07 15.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 88.3 m -68.83 104.99 2.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 124.163 0.914 . . . . 0.0 109.759 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 464' ' ' MET . . . . . 0.56 ' HE2' ' HA2' ' A' ' 348' ' ' GLY . 26.4 ptt? -83.08 177.44 8.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.813 0.445 . . . . 0.0 110.062 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.69 150.08 37.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.127 0.571 . . . . 0.0 109.507 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' A' ' 345' ' ' VAL . . . 68.02 8.01 6.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.05 1.34 . . . . 0.0 112.565 -171.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 123.969 0.908 . . . . 0.0 110.667 -177.111 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.665 0.269 . . . . 15.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.598 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -158.31 149.61 21.01 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.753 1.221 . . . . 15.0 109.054 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 17' ' ' ILE . 13.5 m -133.68 77.96 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.838 0.855 . . . . 15.0 110.537 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -78.95 91.01 4.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 15.0 110.497 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 2.6 p -80.51 93.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 122.2 1.0 . . . . 15.0 111.433 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.94 98.2 7.79 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.501 1.12 . . . . 15.0 109.989 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -64.55 112.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.102 0.561 . . . . 15.0 109.962 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -76.32 -54.74 6.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -167.43 120.16 0.93 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 15.0 109.671 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.55 -101.6 0.47 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 124.157 0.91 . . . . 15.0 113.551 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 113' ' ' PRO . 1.8 mm? -90.54 -22.08 21.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.175 0.59 . . . . 15.0 110.884 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.46 122.8 30.31 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.359 1.037 . . . . 15.0 112.223 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.472 HH12 ' HA ' ' A' ' 11' ' ' LEU . 68.7 mtt85 -140.86 108.16 5.52 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.751 1.22 . . . . 15.0 109.892 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.441 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 31.0 ttm180 -83.94 82.95 8.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.564 1.146 . . . . 15.0 109.131 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 t -76.49 88.46 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 61.6 m -75.94 96.62 3.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.273 -0.876 . . . . 15.0 109.633 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.546 HG12 HG13 ' A' ' 3' ' ' VAL . 54.1 mt -84.21 106.07 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.555 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 35.9 m -83.72 100.6 10.99 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 70' ' ' LEU . 39.0 mt -77.01 130.85 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 140.54 58.88 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 123.92 0.763 . . . . 15.0 110.517 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.12 63.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.979 1.312 . . . . 15.0 112.208 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -38.65 78.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.114 -0.948 . . . . 15.0 111.285 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.4 m -68.62 -30.92 69.76 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.406 0.682 . . . . 15.0 111.158 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 103' ' ' PHE . 78.8 mt -65.25 -54.08 33.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 CA-C-N 115.496 -0.774 . . . . 15.0 109.087 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -59.22 -29.45 67.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.192 0.997 . . . . 15.0 111.841 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.7 m -74.8 -52.76 10.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.768 0.827 . . . . 15.0 110.317 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.06 85.04 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.395 0.678 . . . . 15.0 112.287 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.473 HG21 ' HD3' ' A' ' 63' ' ' ARG . 58.6 t -67.59 -45.36 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.09 0.556 . . . . 15.0 109.868 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -65.9 -31.45 72.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.178 0.591 . . . . 15.0 111.32 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -63.35 -44.51 94.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.437 0.695 . . . . 15.0 109.78 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 35' ' ' VAL . 14.4 tp10 -63.81 -42.36 97.71 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.434 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 55' ' ' ALA . 79.6 mt -66.77 -39.23 87.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.909 0.884 . . . . 15.0 112.891 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.44 -28.07 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -71.72 -34.16 69.35 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 118.994 -0.527 . . . . 15.0 111.074 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 31' ' ' GLU . 77.2 t -60.68 -35.46 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.259 0.624 . . . . 15.0 110.163 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.05 -49.08 78.14 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.449 -0.796 . . . . 15.0 110.721 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -69.56 -42.95 73.88 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.895 0.878 . . . . 15.0 110.779 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.81 -34.43 66.87 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.743 1.617 . . . . 15.0 111.286 -169.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.54 10.87 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-O 121.338 0.59 . . . . 15.0 109.794 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 59.26 23.37 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.821 1.248 . . . . 15.0 112.796 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 60.0 mt -72.99 -22.92 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.416 1.086 . . . . 15.0 109.862 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 8.2 p-10 -58.08 -29.56 65.52 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.556 1.142 . . . . 15.0 112.758 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.49 -41.37 94.28 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.588 -0.605 . . . . 15.0 111.588 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -79.13 -24.29 43.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.964 0.906 . . . . 15.0 110.169 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 28.3 tpt180 -79.97 90.13 5.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.232 1.013 . . . . 15.0 109.335 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -92.62 -7.44 46.98 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.832 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 49.44 3.29 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.6 0.563 . . . . 15.0 112.503 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -77.27 -58.56 3.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.197 0.599 . . . . 15.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.61 122.66 70.36 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.712 -0.847 . . . . 15.0 108.712 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.1 148.28 7.14 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.844 3.029 . . . . 15.0 114.488 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.41 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.7 tpp -64.52 -34.51 78.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.369 1.068 . . . . 15.0 112.118 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.35 -37.36 86.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.715 0.406 . . . . 15.0 111.1 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.25 -42.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.985 0.914 . . . . 15.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 19.5 m -71.61 -21.18 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 122.342 -0.224 . . . . 15.0 110.871 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -76.9 -46.65 23.66 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.187 0.595 . . . . 15.0 111.801 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.72 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.5 pt20 -81.63 -30.1 32.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.517 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.72 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 75.2 mtt180 -103.1 -60.78 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.062 0.545 . . . . 15.0 110.9 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 68.5 m-85 -76.95 -19.43 57.36 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 15.0 111.142 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.89 9.18 58.18 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.247 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.02 -30.07 69.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.542 0.737 . . . . 15.0 111.088 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.9 p -81.39 -33.19 32.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.76 0.824 . . . . 15.0 110.866 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.06 -16.26 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.068 0.947 . . . . 15.0 111.279 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.473 ' HD3' HG21 ' A' ' 28' ' ' VAL . 19.8 mmt180 -48.2 -42.33 29.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.277 1.031 . . . . 15.0 111.442 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -52.03 -54.23 32.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.975 1.31 . . . . 15.0 112.185 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.04 -24.61 58.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.86 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 28' ' ' VAL . 44.0 t -79.23 -23.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 122.546 0.338 . . . . 15.0 110.234 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.527 HD23 HD11 ' A' ' 70' ' ' LEU . 66.1 mt -57.69 -29.59 64.79 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.35 -0.357 . . . . 15.0 111.66 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.82 -38.66 95.65 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 117.844 0.293 . . . . 15.0 112.935 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.49 -36.44 63.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.771 0.828 . . . . 15.0 109.972 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.527 HD11 HD23 ' A' ' 67' ' ' LEU . 96.4 mt -73.24 -19.28 61.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.003 -0.999 . . . . 15.0 111.917 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 76.7 mtm -104.81 -66.35 0.97 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.762 0.425 . . . . 15.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.3 t -70.83 -35.56 72.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.48 0.712 . . . . 15.0 112.503 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' HG21 ' A' ' 76' ' ' ILE . 4.9 tmm_? -87.76 -43.67 11.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -58.99 -25.55 63.72 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.467 0.576 . . . . 15.0 111.606 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -54.81 -50.73 67.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.098 0.959 . . . . 15.0 111.73 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.443 HG21 ' O ' ' A' ' 73' ' ' ARG . 13.2 tt -69.32 -37.34 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 110.11 -0.33 . . . . 15.0 110.11 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 -23.38 67.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.321 0.649 . . . . 15.0 111.729 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -83.52 -42.19 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.873 0.869 . . . . 15.0 111.677 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.54 HD12 ' HD3' ' A' ' 86' ' ' PRO . 28.2 pt -85.28 -30.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.203 0.816 . . . . 15.0 113.203 -169.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.26 -50.17 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.4 0.68 . . . . 15.0 111.042 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.9 ptpt -60.79 -39.65 89.66 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.705 0.628 . . . . 15.0 111.486 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 24.5 mm-40 -87.85 5.63 39.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.384 0.673 . . . . 15.0 111.706 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.62 17.81 11.09 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.068 1.347 . . . . 15.0 112.281 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.63 112.87 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.192 0.997 . . . . 15.0 109.939 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -101.2 114.75 65.75 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.361 -0.977 . . . . 15.0 108.361 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.54 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.1 Cg_endo -74.11 153.07 46.31 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.838 2.359 . . . . 15.0 112.989 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.72 18.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.804 1.242 . . . . 15.0 108.318 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.503 ' H ' ' HB3' ' A' ' 305' ' ' ALA . . . 94.48 -151.71 20.28 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.731 -0.548 . . . . 15.0 111.731 -174.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.99 128.66 27.23 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.552 0.741 . . . . 15.0 110.678 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.0 Cg_endo -81.83 107.3 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.383 2.055 . . . . 15.0 111.626 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.5 m -76.96 96.09 4.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.607 0.763 . . . . 15.0 110.824 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -74.1 94.49 2.42 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.081 -0.711 . . . . 15.0 109.081 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.8 t -90.96 102.15 4.95 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.949 -0.76 . . . . 15.0 108.949 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.52 95.74 0.86 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.648 2.232 . . . . 15.0 109.995 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -46.45 93.49 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.172 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.49 146.14 4.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.557 0.743 . . . . 15.0 110.745 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -128.49 142.7 51.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.548 1.139 . . . . 15.0 108.41 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.721 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 95.0 mttt -129.83 158.61 38.97 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.235 1.014 . . . . 15.0 108.619 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.07 98.44 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.591 0.756 . . . . 15.0 110.235 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.51 19.02 74.22 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.599 -0.728 . . . . 15.0 114.39 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.1 mt-10 -110.67 158.86 18.14 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.467 0.707 . . . . 15.0 110.421 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.25 107.13 0.13 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.171 1.544 . . . . 15.0 112.896 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.452 ' HD2' HD13 ' A' ' 19' ' ' ILE . 13.3 t80 -80.42 96.28 6.67 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.488 -0.778 . . . . 15.0 109.539 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.0 m -95.14 105.54 17.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.106 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -129.92 143.75 50.97 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.341 0.657 . . . . 15.0 109.905 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.1 m -99.47 105.59 17.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.7 1.2 . . . . 15.0 111.672 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 t -86.01 99.93 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.927 0.491 . . . . 15.0 109.724 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.65 106.02 18.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.419 0.688 . . . . 15.0 110.26 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.692 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.7 p90 -142.06 174.21 10.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.962 0.905 . . . . 15.0 109.233 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -116.61 164.82 14.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.779 0.831 . . . . 15.0 109.934 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.66 -177.52 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.988 0.915 . . . . 15.0 109.152 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -72.83 143.79 84.83 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.029 0.532 . . . . 15.0 110.211 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 11' ' ' LEU . 23.9 Cg_endo -89.4 -167.95 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.426 2.751 . . . . 15.0 114.946 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -88.66 155.37 19.64 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.581 -1.19 . . . . 15.0 109.433 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 123.02 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.16 0.584 . . . . 15.0 110.096 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -119.94 119.36 33.23 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.66 146.77 28.9 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.79 -0.818 . . . . 15.0 108.79 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -88.67 -171.24 3.24 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.377 0.271 . . . . 15.0 110.495 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.9 102.43 0.28 Allowed Glycine 0 C--N 1.351 1.405 0 O-C-N 123.962 0.789 . . . . 15.0 111.726 173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.38 -23.91 67.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.963 0.905 . . . . 15.0 110.386 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.97 -24.52 66.06 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.86 1.264 . . . . 15.0 111.256 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.58 61.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.348 0.659 . . . . 15.0 110.929 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.6 mt -65.48 120.28 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.065 0.853 . . . . 15.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.29 102.89 13.32 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.606 0.762 . . . . 15.0 109.245 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.44 162.65 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.908 1.283 . . . . 15.0 107.802 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -113.69 148.69 35.92 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HE2' HD12 ' A' ' 129' ' ' ILE . 84.0 tttt -127.65 89.8 49.97 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.904 0.882 . . . . 15.0 108.753 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.36 102.66 1.63 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.218 1.945 . . . . 15.0 111.738 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.517 HD12 ' HE2' ' A' ' 127' ' ' LYS . 47.3 mm -73.02 106.35 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 169.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.584 HG21 HD11 ' A' ' 427' ' ' LEU . 15.3 t -132.24 147.27 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.779 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.47 157.37 46.32 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.777 1.231 . . . . 15.0 107.894 166.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.46 87.75 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 107.454 -1.313 . . . . 15.0 107.454 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 175.51 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.72 0.808 . . . . 15.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.93 -36.97 78.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.042 0.448 . . . . 15.0 110.863 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.51 91.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.831 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 71.7 m-20 -74.98 -42.61 57.22 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.451 0.701 . . . . 15.0 111.717 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.62 -57.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.29 -31.12 62.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.206 -0.907 . . . . 15.0 111.058 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.79 -36.38 57.93 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.518 0.511 . . . . 15.0 113.033 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -71.5 -45.1 63.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.935 0.494 . . . . 15.0 109.683 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.83 -36.12 67.13 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.477 0.711 . . . . 15.0 111.676 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.95 -45.17 86.85 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.325 1.05 . . . . 15.0 110.144 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.1 m -58.92 -46.85 86.95 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.254 0.971 . . . . 15.0 110.094 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.97 -40.21 94.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.975 0.91 . . . . 15.0 111.562 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -66.88 -36.8 83.13 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.533 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.569 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 83.4 mttt -83.63 -16.82 43.73 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -80.92 -40.62 24.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -96.6 25.34 5.21 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.656 0.783 . . . . 15.0 110.535 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -74.15 149.37 41.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.522 0.729 . . . . 15.0 112.336 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.5 m -70.32 120.41 15.94 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.064 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -79.43 105.71 10.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -118.69 160.25 22.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.308 1.043 . . . . 15.0 108.698 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 51.6 mt-10 -107.64 147.13 31.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.283 0.633 . . . . 15.0 110.215 173.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -145.22 -178.92 6.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.109 0.964 . . . . 15.0 111.001 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -155.01 161.68 41.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.525 1.13 . . . . 15.0 108.001 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 -50.81 0.82 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.225 -0.75 . . . . 15.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.04 134.8 13.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.929 0.491 . . . . 15.0 110.72 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.0 137.12 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.61 170.25 8.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.67 -0.863 . . . . 15.0 108.67 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.25 61.24 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.83 1.048 . . . . 15.0 113.83 -169.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.89 16.99 18.25 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.94 -176.02 4.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.946 0.879 . . . . 15.0 112.539 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 11.5 mtm180 -106.52 150.4 26.15 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.305 -1.316 . . . . 15.0 108.533 166.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.09 114.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.724 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 20.5 m -94.06 117.08 29.6 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.792 -1.188 . . . . 15.0 107.792 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.45 163.98 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.807 0.813 . . . . 15.0 111.495 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 15.7 t70 -106.58 155.14 19.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 105.703 -1.962 . . . . 15.0 105.703 159.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -154.41 169.31 24.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.348 0.594 . . . . 15.0 110.34 168.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 t -157.92 124.32 4.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.041 -1.436 . . . . 15.0 107.975 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -127.81 177.71 17.43 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 122.04 -0.412 . . . . 15.0 113.822 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.3 p -150.71 130.89 13.56 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.127 0.971 . . . . 15.0 109.715 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.53 HG13 HD22 ' A' ' 226' ' ' LEU . 47.0 t -94.7 117.72 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.5 t70 73.83 -5.36 2.04 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.768 1.227 . . . . 15.0 112.11 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.39 -0.13 23.61 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.731 -0.483 . . . . 15.0 112.471 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 15.0 pt-20 -113.04 139.46 48.66 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.63 0.715 . . . . 15.0 109.408 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.44 149.59 45.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.738 0.415 . . . . 15.0 110.728 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.507 ' HD2' HG22 ' A' ' 172' ' ' VAL . 4.5 p90 -106.84 -175.71 2.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.92 0.888 . . . . 15.0 111.794 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.531 ' HG3' HG12 ' B' ' 388' ' ' VAL . 55.7 mt-10 -53.73 116.32 2.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.1 0.96 . . . . 15.0 110.134 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 -63.67 4.38 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.037 0.836 . . . . 15.0 112.341 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.18 -62.22 4.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.471 -0.252 . . . . 15.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -88.2 150.35 23.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.086 0.954 . . . . 15.0 111.931 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 167' ' ' ASP . . . -145.37 94.02 2.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.775 -1.102 . . . . 15.0 109.576 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.6 m -78.91 121.2 24.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.935 0.494 . . . . 15.0 110.494 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.5 42.2 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.447 1.099 . . . . 15.0 112.248 171.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -71.03 129.17 38.3 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.47 -0.567 . . . . 15.0 109.47 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.72 105.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.057 0.943 . . . . 15.0 109.258 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 202' ' ' ILE . 30.8 tp -91.68 89.95 7.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.868 0.867 . . . . 15.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.3 87.18 5.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.582 -0.896 . . . . 15.0 108.582 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.574 ' HE2' ' HD3' ' A' ' 203' ' ' LYS . 58.6 mtp -62.19 139.17 58.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.119 0.967 . . . . 15.0 111.596 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.66 -26.86 5.6 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.81 0.694 . . . . 15.0 112.235 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -92.02 147.81 22.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.343 0.657 . . . . 15.0 110.206 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.75 65.28 3.94 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 123.021 0.343 . . . . 15.0 113.766 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -105.77 -36.0 7.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.027 0.931 . . . . 15.0 110.221 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.459 ' HE2' HD13 ' B' ' 385' ' ' LEU . 23.4 mmt -99.36 150.87 21.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.254 0.621 . . . . 15.0 111.266 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.1 pt -99.07 153.92 37.56 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 114.937 -1.029 . . . . 15.0 109.619 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.22 116.82 3.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.952 2.435 . . . . 15.0 112.281 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.9 -41.8 1.39 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.38 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.38 -59.75 2.61 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.945 0.498 . . . . 15.0 110.426 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.516 ' HB2' ' HE3' ' A' ' 189' ' ' MET . 9.8 pt-20 -64.81 -23.14 67.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.902 -1.044 . . . . 15.0 112.278 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.04 -36.43 83.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.186 0.994 . . . . 15.0 110.927 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.566 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -72.55 -17.22 77.79 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.248 -0.887 . . . . 15.0 113.097 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.451 HG21 HD22 ' A' ' 187' ' ' LEU . 31.7 mm -92.59 -48.32 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.56 0.744 . . . . 15.0 110.459 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.574 ' HD3' ' HE2' ' A' ' 189' ' ' MET . 58.4 pttt -85.1 19.94 2.05 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.144 1.165 . . . . 15.0 114.144 -166.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -137.33 24.15 3.1 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.865 -0.494 . . . . 15.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -144.07 -171.33 3.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.19 0.996 . . . . 15.0 110.232 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -151.19 156.79 41.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 15.0 110.101 -178.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.578 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.46 142.67 58.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.735 0.814 . . . . 15.0 111.521 -171.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.04 -32.96 4.39 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.455 -0.793 . . . . 15.0 111.516 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.3 pt-20 -93.2 138.12 31.89 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.563 0.697 . . . . 15.0 110.572 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -121.22 105.74 10.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.653 1.181 . . . . 15.0 108.28 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -121.7 177.45 5.25 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.52 1.128 . . . . 15.0 109.568 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 57.0 m -121.04 128.32 52.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.566 HG22 ' HA3' ' A' ' 201' ' ' GLY . 43.2 pt -101.78 160.91 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.557 0.743 . . . . 15.0 109.83 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -113.46 111.07 21.31 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.739 0.815 . . . . 15.0 109.396 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.22 160.86 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.478 -1.304 . . . . 15.0 107.478 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.1 m -143.48 132.89 23.39 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.8 -1.185 . . . . 15.0 107.8 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 90.1 m-85 -85.81 139.66 35.24 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -47.68 157.93 0.83 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.283 3.322 . . . . 15.0 116.016 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -23.84 63.64 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.88 167.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.96 -18.92 55.46 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.387 1.075 . . . . 15.0 111.16 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.62 141.26 56.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.02 0.528 . . . . 15.0 112.299 -170.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -78.03 17.83 0.56 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 125.163 1.385 . . . . 15.0 114.626 -168.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.47 119.47 15.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.5 -40.66 97.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 123.928 0.768 . . . . 15.0 111.972 -175.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -63.1 -19.61 64.58 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.142 0.577 . . . . 15.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.53 HD22 HG13 ' A' ' 172' ' ' VAL . 39.9 mt -99.42 -29.85 12.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.195 0.998 . . . . 15.0 111.691 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -57.83 105.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.77 1.228 . . . . 15.0 111.117 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.74 -19.49 28.91 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.57 -0.741 . . . . 15.0 113.408 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.94 145.48 31.24 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.64 0.776 . . . . 15.0 111.468 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -88.34 126.13 35.04 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.897 -1.047 . . . . 15.0 110.185 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.93 113.94 27.85 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.944 0.898 . . . . 15.0 109.238 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -103.78 101.69 11.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.723 0.809 . . . . 15.0 110.145 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -95.68 117.52 30.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.255 1.022 . . . . 15.0 109.998 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.55 96.76 4.84 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.16 116.39 26.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.036 0.934 . . . . 15.0 110.084 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 9.8 m120 -99.3 91.92 5.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.097 -1.075 . . . . 15.0 108.097 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 74.8 mt -68.47 109.25 3.61 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.099 -0.704 . . . . 15.0 109.099 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.84 -37.58 5.83 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.724 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 73.1 mmtt -133.99 122.58 23.24 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.844 0.858 . . . . 15.0 110.017 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 207' ' ' ALA . 89.0 t -95.58 132.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 105.55 -2.019 . . . . 15.0 105.55 161.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 37.6 mt-10 -120.01 179.35 4.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.96 117.5 5.73 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.871 0.868 . . . . 15.0 109.171 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -84.75 86.6 7.32 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.244 1.021 . . . . 15.0 108.348 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.04 146.7 28.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.682 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 75.1 mt -54.32 122.7 38.83 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 123.836 0.854 . . . . 15.0 110.592 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.14 -169.95 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.371 2.714 . . . . 15.0 112.944 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.58 106.53 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.216 -0.661 . . . . 15.0 109.216 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 252' ' ' PHE . 33.3 tp -82.99 14.95 2.99 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.343 1.057 . . . . 15.0 110.299 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.2 p -60.19 174.96 0.46 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.103 1.361 . . . . 15.0 112.321 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.49 -54.78 3.04 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.807 1.643 . . . . 15.0 113.86 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.45 -22.78 67.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.404 ' HD2' HD12 ' A' ' 248' ' ' LEU . 71.2 t80 -90.37 -52.26 5.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.37 0.668 . . . . 15.0 110.254 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.447 HG13 HD22 ' A' ' 266' ' ' LEU . 15.8 tt -66.4 -26.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.691 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.671 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 20.8 ptmt -82.6 -16.36 48.73 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 111.932 0.345 . . . . 15.0 111.932 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -58.83 -34.53 71.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.047 0.939 . . . . 15.0 110.95 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -62.76 -28.18 69.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.763 -1.108 . . . . 15.0 111.96 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.82 1.6 0.82 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.583 -0.565 . . . . 15.0 113.461 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.671 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 21.3 t -72.83 151.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.272 0.629 . . . . 15.0 110.06 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -67.57 -64.06 0.93 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.527 1.131 . . . . 15.0 110.483 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -102.64 -40.53 6.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.338 -1.301 . . . . 15.0 109.836 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 128.34 12.8 2.73 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.558 -0.746 . . . . 15.0 113.21 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 p -64.97 138.24 58.24 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.579 0.689 . . . . 15.0 110.375 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.89 -38.14 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.245 1.018 . . . . 15.0 111.711 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -55.48 -34.7 64.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.498 0.719 . . . . 15.0 111.388 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.21 -28.08 62.78 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.598 -0.601 . . . . 15.0 111.598 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 253' ' ' ILE . 58.9 tp -73.39 -32.72 64.61 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.37 -42.04 93.14 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.34 0.656 . . . . 15.0 109.699 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.03 90.61 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.928 -1.033 . . . . 15.0 110.39 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 15.6 tp10 -67.15 -39.99 86.61 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.729 -1.123 . . . . 15.0 111.465 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 266' ' ' LEU . 24.6 m -75.57 -24.42 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.044 -0.41 . . . . 15.0 110.253 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -69.03 -60.56 2.27 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 121.947 -0.471 . . . . 15.0 110.856 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.7 ptmt -61.9 -23.26 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 15.0 112.32 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -88.65 -69.48 0.7 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.403 0.281 . . . . 15.0 110.406 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 53.6 mtt -71.83 -45.33 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.895 -0.574 . . . . 15.0 112.361 -166.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.14 -42.16 72.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.625 0.648 . . . . 15.0 110.383 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 44.9 ttp85 -58.7 -53.55 57.14 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.167 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.26 -27.68 64.62 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.98 0.8 . . . . 15.0 111.084 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.429 HD12 HG13 ' A' ' 130' ' ' VAL . 59.9 tp -67.5 -54.96 15.64 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.557 0.743 . . . . 15.0 110.562 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.02 -31.36 72.48 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.583 0.753 . . . . 15.0 110.316 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.2 t -68.89 -43.18 75.78 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 123.801 0.84 . . . . 15.0 110.0 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.86 98.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.146 0.578 . . . . 15.0 110.386 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' A' ' 130' ' ' VAL . 73.4 mt -63.08 -49.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.011 0.924 . . . . 15.0 109.17 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.98 -54.96 38.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.648 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.22 -35.1 80.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.16 0.984 . . . . 15.0 111.019 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -65.57 -55.0 20.11 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.577 0.626 . . . . 15.0 110.996 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.66 -42.57 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.303 0.641 . . . . 15.0 110.366 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.5 tttt -58.36 -51.31 70.35 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.567 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -69.11 -31.68 70.56 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.531 0.519 . . . . 15.0 111.292 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -69.1 -39.44 78.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.907 0.483 . . . . 15.0 110.093 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.27 75.82 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 295' ' ' VAL . 33.4 mm -67.12 -36.89 78.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 123.803 0.689 . . . . 15.0 110.709 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.88 -47.76 81.95 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.271 -0.64 . . . . 15.0 109.271 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.28 94.05 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 124.698 1.249 . . . . 15.0 112.531 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.403 ' HB3' HD13 ' A' ' 350' ' ' LEU . 28.3 mt -59.96 -57.86 11.02 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 123.439 0.696 . . . . 15.0 110.39 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.4 t -56.09 -46.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.528 0.731 . . . . 15.0 110.159 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.84 -35.29 74.43 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.892 0.877 . . . . 15.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.15 -4.61 42.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.125 0.57 . . . . 15.0 112.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -133.9 115.12 14.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.972 0.805 . . . . 15.0 111.05 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.42 130.57 47.66 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.479 HD12 HD11 ' A' ' 349' ' ' LEU . 3.3 tt -149.13 146.11 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.344 1.058 . . . . 15.0 109.051 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.05 140.67 49.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 307' ' ' ILE . 40.4 t -117.73 105.29 48.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.57 130.36 29.62 Favored 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 123.217 2.611 . . . . 15.0 112.563 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -59.21 -29.93 67.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.872 1.269 . . . . 15.0 112.554 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 88' ' ' GLY . . . -54.1 -39.14 66.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.127 0.971 . . . . 15.0 111.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.78 -30.54 56.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.467 -0.788 . . . . 15.0 111.222 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 304' ' ' ALA . 2.0 mp -62.58 -49.96 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.841 -0.8 . . . . 15.0 108.841 173.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.33 -42.02 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.238 -0.892 . . . . 15.0 110.58 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.444 ' O ' HG21 ' A' ' 313' ' ' VAL . 36.5 t -57.44 -60.91 2.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.169 0.918 . . . . 15.0 111.219 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -69.8 -39.47 76.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.386 0.513 . . . . 15.0 112.386 -171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 14.9 mt -61.38 -43.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 119.035 -0.507 . . . . 15.0 109.694 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.26 -43.57 87.96 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.851 0.461 . . . . 15.0 111.208 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 309' ' ' SER . 81.2 t -54.74 -51.08 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.73 0.812 . . . . 15.0 110.339 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 341' ' ' ALA . 72.6 mt -71.4 -27.5 63.36 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.075 -0.966 . . . . 15.0 112.459 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 29.1 mtm180 . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 109.563 -0.532 . . . . 15.0 109.563 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.105 0.478 . . . . 15.0 112.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.01 72.66 1.42 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.966 0.889 . . . . 15.0 110.089 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 73.1 mt -81.05 153.71 72.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 153.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.29 108.73 0.21 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.959 2.439 . . . . 15.0 113.369 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -55.95 -29.09 59.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.254 1.022 . . . . 15.0 110.859 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.08 -21.42 31.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.572 1.149 . . . . 15.0 111.878 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.06 -35.31 20.37 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.542 0.737 . . . . 15.0 111.118 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.499 ' HA ' HE21 ' A' ' 340' ' ' GLN . 23.5 m-85 -107.34 -14.38 14.89 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.879 0.696 . . . . 15.0 112.879 -167.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.96 -62.55 1.58 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.851 1.26 . . . . 15.0 112.029 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.45 -46.29 73.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.728 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 337' ' ' PHE . 25.4 pt20 -67.99 -37.24 81.25 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.624 0.578 . . . . 15.0 111.623 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 314' ' ' LEU . . . -64.94 -52.71 54.87 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.57 -40.67 60.21 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 124.642 1.214 . . . . 15.0 110.83 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.422 ' O ' HG21 ' A' ' 347' ' ' VAL . 15.6 mmt180 -60.26 -46.87 88.32 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 123.418 0.687 . . . . 15.0 110.402 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -63.63 -34.21 77.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.473 0.483 . . . . 15.0 111.219 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.81 -53.89 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 15.0 110.148 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.43 -31.06 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.313 0.645 . . . . 15.0 110.957 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 343' ' ' ARG . 40.3 t -60.46 -50.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.522 0.729 . . . . 15.0 109.095 170.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.76 -33.74 88.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.636 -0.711 . . . . 15.0 113.759 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 300' ' ' ILE . 96.0 mt -73.82 -54.7 7.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.929 0.491 . . . . 15.0 110.574 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 354' ' ' VAL . 75.6 mt -68.87 -52.67 27.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.891 0.476 . . . . 15.0 110.812 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.14 -38.11 89.55 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 119.275 -0.393 . . . . 15.0 110.834 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.98 -38.41 88.98 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.753 0.658 . . . . 15.0 112.544 176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -69.25 -40.6 77.77 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 119.295 -0.383 . . . . 15.0 111.316 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 350' ' ' LEU . 81.2 t -57.39 -39.94 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.211 0.529 . . . . 15.0 110.575 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.401 HG23 HD21 ' A' ' 403' ' ' LEU . 64.1 mt -67.84 -45.46 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.756 1.222 . . . . 15.0 110.755 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.484 ' HA ' ' HE2' ' B' ' 461' ' ' PHE . 20.2 ttp180 -61.28 -53.14 60.56 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.021 0.529 . . . . 15.0 110.785 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 33.0 m -57.13 -50.37 73.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.62 1.168 . . . . 15.0 111.433 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -90.66 14.8 12.39 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.638 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 43.04 36.2 0.89 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 125.375 1.47 . . . . 15.0 114.136 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.487 ' HB3' HE21 ' A' ' 406' ' ' GLN . 99.0 mt -67.26 149.17 50.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.047 0.939 . . . . 15.0 112.159 -176.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.61 150.91 52.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.333 1.053 . . . . 15.0 109.699 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.77 104.49 3.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.38 -0.6 . . . . 15.0 109.38 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.78 132.64 42.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.149 0.58 . . . . 15.0 110.395 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -63.94 -30.85 71.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.88 0.872 . . . . 15.0 112.48 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -86.04 -10.64 54.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.961 0.504 . . . . 15.0 111.436 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.5 tpt85 -81.33 -38.13 27.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 371' ' ' ILE . 89.7 t -58.16 -58.29 7.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.837 1.255 . . . . 15.0 109.18 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 372' ' ' GLU . 24.0 mmmt -59.49 -39.62 84.35 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 115.628 -0.715 . . . . 15.0 111.589 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.33 67.06 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.934 0.772 . . . . 15.0 112.436 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.08 -42.49 84.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.31 0.644 . . . . 15.0 111.96 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 367' ' ' VAL . 50.5 mm -52.77 -44.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 123.992 0.807 . . . . 15.0 110.686 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 368' ' ' LYS . 14.7 mm-40 -70.06 -54.71 11.9 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.46 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -52.43 -36.97 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.837 0.855 . . . . 15.0 112.463 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 60.4 ttp -80.09 -69.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.774 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.87 79.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.858 0.863 . . . . 15.0 113.297 -164.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -21.44 64.92 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.037 0.535 . . . . 15.0 112.166 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -66.79 -20.32 65.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.739 0.816 . . . . 15.0 112.591 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.49 167.83 9.89 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.383 0.673 . . . . 15.0 110.646 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -80.01 -9.73 59.71 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.851 . . . . 15.0 110.809 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.42 59.78 46.08 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.991 1.317 . . . . 15.0 110.545 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.75 -27.95 4.51 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 121.931 1.754 . . . . 15.0 112.301 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -54.79 -45.78 74.37 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.254 1.022 . . . . 15.0 111.042 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 12.7 pt-20 -65.57 -31.46 72.51 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.84 -1.073 . . . . 15.0 111.242 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.96 -37.84 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.277 0.631 . . . . 15.0 109.912 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.95 -54.21 37.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 108.607 -0.886 . . . . 15.0 108.607 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.35 -27.52 67.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.525 0.73 . . . . 15.0 111.527 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 383' ' ' GLU . 24.0 t80 -62.19 -44.01 97.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.99 0.916 . . . . 15.0 109.877 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -82.71 -66.27 0.91 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.638 0.607 . . . . 15.0 112.638 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' SER . . . . . 0.573 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 84.4 p -56.45 -27.23 56.27 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.474 1.287 . . . . 15.0 114.474 -169.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -103.36 27.72 7.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.079 0.551 . . . . 15.0 110.396 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -149.8 105.35 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.296 -1.002 . . . . 15.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -55.6 -38.73 69.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.264 1.026 . . . . 15.0 111.726 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.34 -36.61 66.2 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 123.782 0.676 . . . . 15.0 111.625 -174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.98 -32.98 61.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.763 0.425 . . . . 15.0 111.117 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.573 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 90.0 mmm -62.83 -38.88 92.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 171.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.27 -38.21 78.27 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 123.719 0.637 . . . . 15.0 109.983 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.1 -39.66 93.25 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 123.559 0.744 . . . . 15.0 110.54 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.455 ' HA ' HG12 ' A' ' 401' ' ' VAL . 43.1 tpp -77.34 -23.78 50.86 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.543 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.46 ' HB3' ' OG1' ' B' ' 463' ' ' THR . 43.2 mtm-85 -74.95 -31.83 61.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.143 0.577 . . . . 15.0 110.318 169.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -55.87 22.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.478 0.711 . . . . 15.0 109.398 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.5 p -69.43 -29.97 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 123.788 0.68 . . . . 15.0 111.745 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.66 -53.62 55.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.861 -0.422 . . . . 15.0 109.861 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.624 HD23 HG22 ' B' ' 463' ' ' THR . 48.1 tp -71.3 -30.11 65.86 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.903 -1.044 . . . . 15.0 111.687 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.25 -57.07 10.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.723 1.209 . . . . 15.0 109.953 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -67.12 -32.43 73.56 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.27 -0.877 . . . . 15.0 110.633 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.487 HE21 ' HB3' ' A' ' 360' ' ' LEU . 25.0 tt0 -63.91 -37.77 88.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.042 0.537 . . . . 15.0 110.388 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.49 85.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.748 0.819 . . . . 15.0 110.891 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 74.8 t -55.81 -53.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 123.955 0.784 . . . . 15.0 109.306 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -30.35 70.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.104 0.962 . . . . 15.0 112.023 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.4 -30.86 68.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.929 0.491 . . . . 15.0 110.895 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.01 -39.51 57.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 77.0 mt -72.84 -26.37 61.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.436 1.094 . . . . 15.0 112.007 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.72 73.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.96 0.904 . . . . 15.0 110.054 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.3 -34.94 13.32 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.593 -1.185 . . . . 15.0 110.094 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 412' ' ' LEU . . . -81.93 154.61 25.69 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.316 1.046 . . . . 15.0 111.465 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.5 86.73 3.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.952 -1.022 . . . . 15.0 110.147 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -84.61 94.12 3.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.57 0.7 . . . . 15.0 109.712 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -70.48 95.19 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.115 -0.948 . . . . 15.0 108.647 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.33 138.87 37.87 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 114.991 -1.004 . . . . 15.0 110.131 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.411 ' HE3' HG21 ' A' ' 422' ' ' THR . 62.1 pttt -144.42 137.35 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 173.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.89 122.4 30.7 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.128 -1.064 . . . . 15.0 108.128 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.411 HG21 ' HE3' ' A' ' 420' ' ' LYS . 8.8 t -149.78 175.52 11.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.008 0.523 . . . . 15.0 110.69 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -89.92 161.07 16.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.71 1.204 . . . . 15.0 112.119 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.439 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 26.5 t80 -52.68 -48.59 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.234 1.414 . . . . 15.0 111.253 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -58.79 -19.4 40.56 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.161 0.913 . . . . 15.0 112.886 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 427' ' ' LEU . 7.7 tp10 -54.06 -49.95 67.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.382 1.073 . . . . 15.0 112.127 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.584 HD11 HG21 ' A' ' 130' ' ' VAL . 5.5 mp -75.37 -29.18 59.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.788 0.835 . . . . 15.0 111.507 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -77.14 -41.97 39.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 174.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 N--CA 1.482 1.131 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.16 179.504 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . 0.459 HD13 ' HE2' ' A' ' 194' ' ' MET . 18.9 tp . . . . . 0 C--O 1.248 0.986 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.39 97.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 122.895 1.331 . . . . 0.0 109.279 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 2.9 tp -149.78 156.24 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 113.954 -1.476 . . . . 0.0 107.043 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.531 HG12 ' HG3' ' A' ' 178' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 0.0 110.254 171.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.618 0.247 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . 0.484 ' HE2' ' HA ' ' A' ' 356' ' ' ARG . 97.4 m-85 -77.22 24.4 0.18 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.576 1.15 . . . . 0.0 113.751 -174.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 19.5 t80 76.92 -49.49 0.55 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.723 1.209 . . . . 0.0 113.412 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 463' ' ' THR . . . . . 0.624 HG22 HD23 ' A' ' 403' ' ' LEU . 11.8 t -84.16 20.54 1.57 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.533 1.133 . . . . 0.0 113.668 -156.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 464' ' ' MET . . . . . 0.457 ' HE2' ' HB3' ' B' ' 467' ' ' ALA . 25.0 ptm -141.03 129.81 22.95 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.58 -62.12 1.74 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.514 0.725 . . . . 0.0 109.685 -173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.38 0.39 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.077 0.951 . . . . 0.0 110.522 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . 0.457 ' HB3' ' HE2' ' B' ' 464' ' ' MET . . . . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 125.615 1.566 . . . . 0.0 108.254 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.65 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -78.11 97.08 5.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.162 0.585 . . . . 15.0 109.817 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 17' ' ' ILE . 24.9 m -111.1 128.49 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.348 0.659 . . . . 15.0 109.479 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.3 p -129.63 110.7 12.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.094 0.558 . . . . 15.0 109.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.26 126.59 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.601 0.76 . . . . 15.0 110.417 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 32.5 mt-10 -125.55 133.22 52.4 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.8 1.24 . . . . 15.0 108.5 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 m -94.0 98.22 10.87 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.493 -0.929 . . . . 15.0 108.493 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -84.29 -51.23 7.16 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.291 0.636 . . . . 15.0 111.937 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -151.2 90.95 1.64 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.16 -100.74 0.43 Allowed Glycine 0 C--N 1.35 1.338 0 O-C-N 123.867 0.73 . . . . 15.0 113.363 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 5.2 mp -77.85 -33.14 52.34 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 15.0 109.56 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 122.72 30.63 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.363 1.039 . . . . 15.0 112.867 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -135.46 129.03 32.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.572 1.149 . . . . 15.0 110.259 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 43.4 ttm180 -96.64 101.82 13.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.431 1.092 . . . . 15.0 110.022 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.03 94.41 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 169.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 85.8 m -78.32 102.74 7.84 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.482 -0.781 . . . . 15.0 109.467 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.575 HG12 HG13 ' A' ' 3' ' ' VAL . 54.0 mt -95.74 131.92 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.737 0.815 . . . . 15.0 109.315 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 33.9 m -116.07 118.81 33.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 70' ' ' LEU . 58.6 mt -93.03 120.12 41.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.77 154.11 42.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.173 0.589 . . . . 15.0 111.166 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.65 -39.99 62.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.238 1.415 . . . . 15.0 113.183 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.65 -38.64 77.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.407 0.683 . . . . 15.0 110.984 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -70.22 -32.31 70.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.61 0.764 . . . . 15.0 110.824 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 28' ' ' VAL . 76.4 mt -66.79 -54.14 27.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.962 0.905 . . . . 15.0 109.384 173.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -59.94 -38.79 83.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.421 1.076 . . . . 15.0 111.761 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -63.75 -45.18 91.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.779 0.674 . . . . 15.0 110.27 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -33.64 73.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.543 0.737 . . . . 15.0 112.277 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' HG23 ' A' ' 66' ' ' VAL . 68.0 t -69.54 -42.47 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.261 0.624 . . . . 15.0 109.423 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.734 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -68.02 -31.03 70.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.263 -0.88 . . . . 15.0 111.079 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 m -69.1 -37.39 78.37 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.474 -0.785 . . . . 15.0 109.702 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.6 tp10 -69.37 -39.53 78.01 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.826 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 91.6 mt -67.24 -34.69 77.99 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.316 0.646 . . . . 15.0 111.725 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 p -80.97 -17.63 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 O-C-N 123.317 0.386 . . . . 15.0 110.604 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.44 -46.64 66.29 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.452 -0.574 . . . . 15.0 109.452 168.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 40.0 t -65.09 -39.11 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 123.876 0.735 . . . . 15.0 109.891 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.55 -55.38 31.55 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 115.198 -0.91 . . . . 15.0 110.671 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 97.2 mttt -66.18 -30.03 70.42 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.423 0.452 . . . . 15.0 111.98 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 36.5 ttpt -64.29 -46.71 82.44 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.491 0.717 . . . . 15.0 111.118 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.1 t -94.03 3.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.348 0.659 . . . . 15.0 110.154 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 24.8 mmt180 65.17 16.8 10.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.866 1.666 . . . . 15.0 112.43 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.548 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.1 mt -54.08 -31.04 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.562 1.545 . . . . 15.0 111.784 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.756 0.822 . . . . 15.0 111.037 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -39.13 79.26 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.08 -0.509 . . . . 15.0 112.03 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.99 -22.17 59.71 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.142 0.577 . . . . 15.0 111.003 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -65.93 116.55 7.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.386 1.074 . . . . 15.0 110.145 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.82 1.99 48.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.064 0.945 . . . . 15.0 111.329 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.91 69.85 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.28 0.362 . . . . 15.0 112.706 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -77.15 -49.4 15.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.636 0.774 . . . . 15.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.88 117.36 61.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 108.486 -0.931 . . . . 15.0 108.486 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD2' HD12 ' A' ' 53' ' ' ILE . 87.5 Cg_exo -48.75 142.39 18.93 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.417 2.745 . . . . 15.0 113.484 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.408 ' HA ' HG21 ' A' ' 54' ' ' VAL . 56.4 tpp -64.01 -26.57 68.63 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 15.0 111.298 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.27 -35.18 77.49 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.592 0.357 . . . . 15.0 111.64 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.436 HD12 ' HD2' ' A' ' 50' ' ' PRO . 43.1 mt -72.68 -46.93 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.685 0.794 . . . . 15.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 51' ' ' MET . 31.1 m -68.66 -21.14 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 122.429 -0.169 . . . . 15.0 111.291 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.21 -47.77 60.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.059 0.544 . . . . 15.0 111.862 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.59 -19.79 48.51 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.755 -0.657 . . . . 15.0 111.627 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -94.45 -70.15 0.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.551 0.34 . . . . 15.0 111.252 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.61 -22.8 59.91 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.287 0.635 . . . . 15.0 111.613 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.84 14.56 59.94 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.305 -0.72 . . . . 15.0 114.041 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 -42.61 66.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.497 0.719 . . . . 15.0 111.574 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 p -77.11 -32.76 56.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.291 0.636 . . . . 15.0 110.298 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.7 t -67.17 -18.79 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.616 1.166 . . . . 15.0 111.321 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.438 ' HD3' HG21 ' A' ' 28' ' ' VAL . 17.1 mmt180 -51.05 -44.8 61.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.283 0.633 . . . . 15.0 110.599 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -51.85 -55.48 19.74 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.429 1.092 . . . . 15.0 111.456 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.76 -48.96 79.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.625 -1.17 . . . . 15.0 111.095 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' A' ' 28' ' ' VAL . 79.6 t -64.24 -49.17 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.367 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.7 mt -56.84 -43.44 81.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 123.837 0.711 . . . . 15.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.526 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -59.7 -47.57 90.27 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.294 0.996 . . . . 15.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.97 -41.39 97.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.649 1.18 . . . . 15.0 111.454 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 19' ' ' ILE . 59.2 mt -64.59 -27.2 68.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.262 -0.881 . . . . 15.0 111.235 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE1' ' HA2' ' A' ' 68' ' ' GLY . 68.4 mtm -59.21 -40.93 87.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.361 0.413 . . . . 15.0 111.049 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -81.59 -50.01 9.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.779 0.432 . . . . 15.0 111.105 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -75.19 -24.14 57.77 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.31 -25.85 36.14 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.927 0.33 . . . . 15.0 110.288 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -77.96 -42.23 33.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.686 0.394 . . . . 15.0 111.171 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.0 -27.4 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.26 0.552 . . . . 15.0 110.081 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.57 -41.49 54.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.429 0.692 . . . . 15.0 109.981 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.09 84.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 15.0 111.869 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -60.13 -27.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 112.79 0.663 . . . . 15.0 112.79 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.9 mt -71.81 -47.33 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.942 0.897 . . . . 15.0 110.568 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -75.96 -29.97 58.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.622 0.369 . . . . 15.0 110.785 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.87 -22.28 53.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.757 . . . . 15.0 111.132 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 62.85 23.86 14.23 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.482 1.113 . . . . 15.0 111.428 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.6 mt -105.35 97.9 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.314 -0.995 . . . . 15.0 108.314 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -72.53 116.92 54.44 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.528 -0.916 . . . . 15.0 108.528 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.7 158.65 35.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.521 2.147 . . . . 15.0 113.127 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.59 167.88 21.98 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.81 -1.086 . . . . 15.0 108.956 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 -136.15 15.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.697 -0.683 . . . . 15.0 111.458 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.14 97.65 45.35 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 108.263 -1.014 . . . . 15.0 108.263 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.4 106.36 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.018 1.812 . . . . 15.0 110.792 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.6 m -92.25 98.3 11.43 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.277 0.631 . . . . 15.0 109.58 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -76.45 83.42 3.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.158 0.983 . . . . 15.0 109.316 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.51 106.33 10.09 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 118.536 -0.745 . . . . 15.0 109.147 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HG3' ' SD ' ' A' ' 71' ' ' MET . 16.3 Cg_exo -68.79 110.42 2.35 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.4 2.067 . . . . 15.0 111.33 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -59.12 11.36 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.773 0.671 . . . . 15.0 111.99 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.27 168.05 13.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 15.0 111.483 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.425 ' HB2' ' HD1' ' A' ' 103' ' ' PHE . 76.1 t80 -147.29 143.57 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.571 1.149 . . . . 15.0 109.17 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 49.1 mtmt -122.52 144.4 49.1 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 170.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.58 108.41 0.82 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.943 0.897 . . . . 15.0 111.86 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.58 62.29 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.578 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.9 mt-10 -99.23 -173.17 2.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.482 1.113 . . . . 15.0 109.392 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.1 154.12 42.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.647 0.736 . . . . 15.0 112.897 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 97' ' ' TYR . 56.2 t80 -119.01 141.61 48.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.153 1.381 . . . . 15.0 108.392 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -132.57 140.31 48.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -147.35 136.23 22.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.789 0.836 . . . . 15.0 109.535 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 70.8 m -103.5 123.77 47.52 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.324 1.05 . . . . 15.0 109.589 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.88 110.3 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.101 0.56 . . . . 15.0 110.253 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -101.1 130.41 47.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.68 0.392 . . . . 15.0 110.298 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.6 157.05 37.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 15.0 109.544 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.85 164.66 23.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.284 0.634 . . . . 15.0 109.632 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.526 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.5 m -123.23 178.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.239 0.615 . . . . 15.0 109.442 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -86.3 108.01 15.74 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 15.0 108.489 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.54 163.64 26.73 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.451 2.101 . . . . 15.0 113.018 -170.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.92 89.22 5.87 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.67 111.48 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.514 -1.221 . . . . 15.0 110.017 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -96.14 98.49 10.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.892 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.628 HD13 HD11 ' A' ' 120' ' ' LEU . 85.7 mt -73.03 129.01 37.13 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -136.98 111.14 8.36 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.32 75.89 0.21 Allowed Glycine 0 C--N 1.353 1.504 0 O-C-N 124.324 1.015 . . . . 15.0 113.519 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.628 HD11 HD13 ' A' ' 117' ' ' LEU . 17.8 mt -75.59 -11.64 60.05 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.055 0.428 . . . . 15.0 110.874 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 13.2 mp0 -74.53 -28.08 60.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.303 1.041 . . . . 15.0 110.146 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.76 62.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.044 0.937 . . . . 15.0 112.078 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.453 HG22 ' HA3' ' A' ' 293' ' ' GLY . 65.2 mt -68.88 134.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.717 0.807 . . . . 15.0 109.731 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.441 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.1 mt-10 -118.29 110.87 18.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.458 0.703 . . . . 15.0 109.263 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.679 ' HB ' HG22 ' A' ' 417' ' ' VAL . 47.1 t -115.97 156.19 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.529 1.132 . . . . 15.0 109.68 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.53 141.04 39.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.993 0.917 . . . . 15.0 108.692 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 83.1 tttt -112.43 89.9 13.43 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 107.344 -1.354 . . . . 15.0 107.344 170.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.54 95.41 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.403 2.068 . . . . 15.0 111.087 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.15 87.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.202 -1.407 . . . . 15.0 107.202 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.544 ' HB ' HD12 ' A' ' 282' ' ' ILE . 3.2 t -122.38 141.24 43.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.576 -1.193 . . . . 15.0 109.56 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.94 165.5 24.86 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.813 -1.551 . . . . 15.0 106.813 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.53 85.9 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.683 -1.599 . . . . 15.0 106.683 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 137' ' ' VAL . 26.6 p -69.12 175.78 3.61 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.554 0.742 . . . . 15.0 110.238 -175.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.21 -43.38 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.022 0.374 . . . . 15.0 110.296 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.34 80.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.875 0.87 . . . . 15.0 111.298 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.44 -39.03 54.59 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.743 0.417 . . . . 15.0 111.662 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 133' ' ' THR . 91.5 t -65.09 -53.71 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 108.933 -0.766 . . . . 15.0 108.933 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -63.5 -48.63 76.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.148 0.905 . . . . 15.0 110.385 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.01 93.85 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 123.877 0.735 . . . . 15.0 114.195 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -80.51 -45.44 17.49 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.978 0.511 . . . . 15.0 111.111 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 270' ' ' VAL . 48.1 mt -54.52 -34.56 61.93 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.457 0.572 . . . . 15.0 112.025 167.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.74 -45.8 84.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.403 1.081 . . . . 15.0 109.623 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -60.78 -36.84 80.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.624 0.77 . . . . 15.0 111.628 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.431 HD11 HD22 ' A' ' 141' ' ' LEU . 96.1 mt -70.31 -40.33 74.28 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.254 0.621 . . . . 15.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.64 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 68.0 mtm180 -74.44 -18.78 60.59 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.743 -0.662 . . . . 15.0 111.619 174.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 97.0 mttt -85.36 -22.56 28.39 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.077 0.399 . . . . 15.0 111.233 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.426 ' HG2' HE21 ' A' ' 148' ' ' GLN . 46.4 tt0 -72.13 -42.17 66.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 15.0 109.362 171.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.426 HE21 ' HG2' ' A' ' 147' ' ' GLN . 30.8 mm-40 -104.87 41.32 1.35 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.003 . . . . 15.0 110.1 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -76.12 139.06 41.14 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.6 m -81.36 126.77 32.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.132 0.973 . . . . 15.0 109.398 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -80.97 111.01 17.05 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -120.66 114.87 22.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.909 0.883 . . . . 15.0 109.79 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 52.7 mt-10 -73.19 119.57 17.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.847 0.459 . . . . 15.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 28.6 pttt -106.02 176.8 5.05 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.39 0.676 . . . . 15.0 110.32 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -115.55 99.4 7.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.133 0.573 . . . . 15.0 111.487 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.429 ' HA2' ' H ' ' A' ' 207' ' ' ALA . . . 58.66 58.76 12.85 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.589 168.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 98.89 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.298 0.549 . . . . 15.0 109.688 172.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 203' ' ' LYS . 14.2 t -96.98 130.2 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 120.914 0.388 . . . . 15.0 110.953 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 -168.4 2.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.749 1.62 . . . . 15.0 109.18 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.76 -2.64 54.96 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.031 0.932 . . . . 15.0 112.585 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -97.49 8.4 44.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.22 0.608 . . . . 15.0 111.829 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 1.1 m-20 -92.41 176.41 6.48 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.388 1.089 . . . . 15.0 113.873 -166.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 3.1 tmt_? -143.42 90.21 2.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.519 -2.4 . . . . 15.0 104.519 167.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.36 152.28 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.766 0.826 . . . . 15.0 110.561 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.736 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 11.4 m -126.1 117.68 23.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.773 -1.195 . . . . 15.0 107.773 173.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.489 HG23 HD22 ' A' ' 237' ' ' LEU . 38.6 pt -128.24 173.4 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.982 0.913 . . . . 15.0 111.963 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.35 134.1 50.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.766 -1.198 . . . . 15.0 107.766 163.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -127.72 149.85 50.04 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.709 0.231 . . . . 15.0 110.483 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.588 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 9.0 t -131.81 113.32 13.36 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 165.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.44 148.81 18.78 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.9 -0.591 . . . . 15.0 113.725 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.3 m -146.07 118.08 8.26 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.312 -1.366 . . . . 15.0 107.312 167.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 98.9 t -88.69 114.97 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.967 0.907 . . . . 15.0 109.334 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 67.91 7.8 6.02 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.405 1.082 . . . . 15.0 111.325 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.92 26.14 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 121.769 -0.582 . . . . 15.0 113.507 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.6 pt-20 -98.64 134.89 40.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.552 0.676 . . . . 15.0 109.196 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.81 85.59 3.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.048 0.451 . . . . 15.0 110.069 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.51 ' HD2' HG22 ' B' ' 388' ' ' VAL . 0.1 OUTLIER -43.44 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.755 1.622 . . . . 15.0 111.85 172.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.24 172.69 7.01 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.961 1.304 . . . . 15.0 109.313 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.6 71.52 0.67 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.22 -1.552 . . . . 15.0 109.22 155.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . -78.79 57.48 4.25 Favored Glycine 0 C--N 1.356 1.684 0 C-N-CA 123.915 0.769 . . . . 15.0 114.401 -171.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.588 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 24.6 mmtt -107.15 149.87 27.21 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.617 1.167 . . . . 15.0 110.163 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.19 93.36 0.69 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.988 0.805 . . . . 15.0 109.204 173.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 129.6 36.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.2 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 66.23 32.64 7.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.312 1.045 . . . . 15.0 111.483 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.16 130.27 43.87 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.76 102.7 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.549 0.74 . . . . 15.0 109.536 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.0 tp -93.95 91.85 7.09 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -70.15 92.7 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 173.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER -66.5 154.57 39.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.789 0.836 . . . . 15.0 111.241 -175.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.45 -19.03 13.16 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.173 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -102.69 122.82 45.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.495 0.718 . . . . 15.0 109.38 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.23 61.34 4.78 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.239 -0.744 . . . . 15.0 111.239 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -31.23 11.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.884 0.874 . . . . 15.0 109.174 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 25.9 mmt -75.07 160.78 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.973 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.2 pt -59.72 130.96 88.55 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 115.057 -0.974 . . . . 15.0 110.426 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.64 115.85 2.69 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.25 2.633 . . . . 15.0 112.215 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.53 -42.1 1.53 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.475 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.05 -65.0 0.73 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 122.687 0.395 . . . . 15.0 110.109 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.522 ' HB2' ' HE1' ' A' ' 189' ' ' MET . 10.8 pt-20 -66.59 -26.43 67.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.019 0.825 . . . . 15.0 111.42 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.0 m-20 -68.31 -32.28 72.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.98 0.912 . . . . 15.0 110.62 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.45 -11.08 85.83 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.39 -0.823 . . . . 15.0 112.837 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.11 -53.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.962 -0.755 . . . . 15.0 108.962 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.567 ' HA ' HG13 ' A' ' 158' ' ' VAL . 57.9 pttt -83.12 31.79 0.44 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.63 1.172 . . . . 15.0 112.577 -170.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.59 25.99 2.42 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.896 -0.882 . . . . 15.0 110.896 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -145.91 -166.04 2.35 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.271 1.028 . . . . 15.0 110.41 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 8.8 ptpp? -146.44 159.16 43.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.14 0.976 . . . . 15.0 110.425 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 240' ' ' VAL . . . -65.67 145.59 55.84 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 120.733 0.302 . . . . 15.0 111.517 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.82 -44.03 1.51 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.984 -0.846 . . . . 15.0 110.984 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.6 pt-20 -77.6 129.95 36.27 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.921 -0.639 . . . . 15.0 109.695 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.94 109.8 18.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.693 -1.225 . . . . 15.0 107.693 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -128.45 -171.05 2.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.011 1.324 . . . . 15.0 110.133 -169.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 72.9 m -132.02 129.09 39.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.917 0.887 . . . . 15.0 108.867 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.9 pt -98.55 150.24 5.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.032 0.533 . . . . 15.0 110.396 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.26 112.3 24.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.84 -1.073 . . . . 15.0 108.973 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.6 166.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 67.6 m -141.44 129.19 21.64 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.22 133.41 81.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.733 -0.651 . . . . 15.0 109.584 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 221' ' ' TYR . 35.8 Cg_exo -44.45 161.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 124.234 3.289 . . . . 15.0 115.412 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -75.92 -30.08 58.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.652 -0.704 . . . . 15.0 110.349 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.38 -31.39 68.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.17 0.588 . . . . 15.0 110.525 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 218' ' ' PRO . 25.8 t80 -48.59 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.821 1.648 . . . . 15.0 110.554 -172.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.999 1.111 . . . . 15.0 113.999 -160.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.99 92.91 0.54 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 165.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.33 -41.87 85.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.952 0.901 . . . . 15.0 111.289 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.59 -15.92 43.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.082 0.953 . . . . 15.0 112.825 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 172' ' ' VAL . 64.7 mt -107.46 -30.9 8.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.915 0.886 . . . . 15.0 111.197 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -51.78 121.31 6.36 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.336 1.455 . . . . 15.0 112.036 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.06 -22.84 12.68 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.772 0.67 . . . . 15.0 113.942 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.1 147.16 40.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.304 0.552 . . . . 15.0 111.037 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.21 111.92 23.82 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.499 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.92 133.43 34.78 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.574 0.749 . . . . 15.0 111.874 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -90.0 107.68 19.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.198 0.999 . . . . 15.0 108.574 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.26 108.64 19.31 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.397 -0.964 . . . . 15.0 108.397 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.38 96.36 4.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.765 0.426 . . . . 15.0 109.993 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 mm -87.47 128.6 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.179 0.992 . . . . 15.0 110.651 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.9 100.93 8.8 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.313 1.045 . . . . 15.0 108.216 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 166' ' ' ILE . 87.5 mt -78.6 94.61 5.05 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.036 0.446 . . . . 15.0 109.816 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.19 -44.63 7.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.123 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.736 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.7 mmtt -127.31 135.84 51.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.239 0.616 . . . . 15.0 110.036 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 207' ' ' ALA . 98.6 t -127.6 103.68 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.573 1.149 . . . . 15.0 108.623 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 29.2 mt-10 -104.03 -175.26 2.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.637 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.0 tt0 -142.89 129.64 20.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.21 -0.663 . . . . 15.0 109.21 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 -78.55 84.39 4.68 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.37 144.14 30.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.984 -1.462 . . . . 15.0 110.79 -174.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.61 119.76 53.53 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.838 0.855 . . . . 15.0 109.636 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 69.4 Cg_endo -68.2 -169.58 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.418 2.745 . . . . 15.0 112.558 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.4 148.0 46.76 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.209 -0.905 . . . . 15.0 110.759 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 25.6 tp -121.65 15.8 11.1 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.9 p -66.66 179.55 1.04 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.627 1.171 . . . . 15.0 112.135 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.13 -61.85 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.689 1.595 . . . . 15.0 114.635 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.91 -1.76 27.03 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.48 0.712 . . . . 15.0 112.806 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -99.22 -50.57 4.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.357 0.663 . . . . 15.0 109.563 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.56 HG13 HD22 ' A' ' 266' ' ' LEU . 18.0 tt -64.56 -29.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.961 0.504 . . . . 15.0 111.357 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . 18.7 ptmt -76.99 -18.04 58.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.385 0.513 . . . . 15.0 112.385 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -69.11 -18.85 64.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.388 0.675 . . . . 15.0 110.909 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -74.16 -22.3 59.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.788 0.835 . . . . 15.0 111.495 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 139.74 -28.97 2.5 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 112.569 -0.212 . . . . 15.0 112.569 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.17 84.58 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.68 0.792 . . . . 15.0 109.671 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -63.69 -27.63 69.35 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.044 1.127 . . . . 15.0 114.044 -167.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -31.12 47.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.43 20.36 27.47 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.409 -0.662 . . . . 15.0 113.799 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 54.3 p -62.28 123.59 18.63 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.456 0.702 . . . . 15.0 111.091 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.81 -54.66 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.454 1.102 . . . . 15.0 111.242 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.62 -24.78 64.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.754 0.821 . . . . 15.0 111.991 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.7 -27.2 54.74 Favored Glycine 0 C--N 1.36 1.869 0 N-CA-C 110.609 -0.996 . . . . 15.0 110.609 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 253' ' ' ILE . 41.3 tp -75.1 -35.11 61.78 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -61.86 -41.79 98.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.576 0.548 . . . . 15.0 109.646 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.92 63.57 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.133 0.973 . . . . 15.0 111.065 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.05 -54.63 44.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.772 -1.104 . . . . 15.0 111.327 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.702 ' HB ' ' HE2' ' A' ' 274' ' ' MET . 30.8 m -69.07 -37.85 77.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.989 -1.005 . . . . 15.0 110.867 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -65.84 -42.98 89.84 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 119.104 0.865 . . . . 15.0 110.049 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -73.38 -26.08 60.85 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 118.364 0.529 . . . . 15.0 111.592 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -65.48 -52.8 50.32 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.659 0.742 . . . . 15.0 109.697 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.702 ' HE2' ' HB ' ' A' ' 270' ' ' VAL . 57.6 mtt -72.7 -14.97 61.69 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-N 114.59 -1.186 . . . . 15.0 111.415 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.23 -38.66 15.08 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.661 0.664 . . . . 15.0 109.922 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.45 -25.4 67.21 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.183 0.593 . . . . 15.0 110.235 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -84.5 -71.81 0.5 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.445 0.698 . . . . 15.0 110.77 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 130' ' ' VAL . 43.3 tp -62.7 -54.23 42.46 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.042 1.337 . . . . 15.0 113.453 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.408 ' HA ' HD11 ' A' ' 282' ' ' ILE . 38.2 ttpt -70.93 -28.57 64.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 123.454 0.471 . . . . 15.0 110.79 -172.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -64.79 -46.9 80.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.779 -0.823 . . . . 15.0 108.779 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.0 71.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.572 0.749 . . . . 15.0 111.622 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 130' ' ' VAL . 96.0 mt -66.87 -55.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 N-CA-C 108.77 -0.826 . . . . 15.0 108.77 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.42 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 16.9 tpt180 -58.03 -41.53 83.39 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.087 0.867 . . . . 15.0 110.705 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.67 -32.75 70.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.154 0.582 . . . . 15.0 111.09 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -65.62 -51.94 55.75 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.1 0.409 . . . . 15.0 110.423 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 282' ' ' ILE . 21.8 t -62.03 -45.75 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.957 0.786 . . . . 15.0 109.778 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.7 tttt -64.95 -41.36 95.56 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.117 -0.947 . . . . 15.0 111.624 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.581 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 77.6 p -65.61 -42.61 91.41 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.726 0.239 . . . . 15.0 110.92 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.58 ' HB2' HG12 ' A' ' 125' ' ' VAL . 54.0 mt-30 -66.86 -34.81 78.61 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.324 0.39 . . . . 15.0 111.005 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.4 -50.31 68.11 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.807 0.443 . . . . 15.0 111.537 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 287' ' ' LYS . 31.4 mm -73.29 -55.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.408 0.683 . . . . 15.0 111.322 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.94 -27.03 68.57 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.728 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.54 -41.57 94.07 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 119.432 -0.649 . . . . 15.0 112.524 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.529 ' HB3' HD13 ' A' ' 350' ' ' LEU . 23.0 mt -56.91 -47.43 80.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.772 0.829 . . . . 15.0 110.552 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 22.9 t -58.28 -53.89 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.689 0.757 . . . . 15.0 109.593 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.24 -18.78 65.37 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.568 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.02 -25.69 22.98 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.9 155.03 28.85 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.887 1.069 . . . . 15.0 113.887 -168.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.82 145.31 55.63 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.108 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 5.9 tp -143.38 117.19 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.687 -0.688 . . . . 15.0 109.594 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -81.19 118.37 22.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.262 -1.014 . . . . 15.0 108.262 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.582 HG11 HD13 ' A' ' 307' ' ' ILE . 47.0 t -110.88 100.33 45.88 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.38 1.072 . . . . 15.0 109.289 -168.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 349' ' ' LEU . 58.8 Cg_endo -73.59 132.07 16.92 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.573 2.182 . . . . 15.0 112.255 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.21 -18.02 45.54 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.874 1.27 . . . . 15.0 112.201 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -45.86 -56.21 5.69 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.399 1.479 . . . . 15.0 111.578 171.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.44 -27.73 41.68 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.242 -1.344 . . . . 15.0 110.815 -172.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.582 HD13 HG11 ' A' ' 302' ' ' VAL . 2.0 mp -61.21 -54.25 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.347 -0.983 . . . . 15.0 108.347 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.83 -31.47 70.46 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.81 0.694 . . . . 15.0 110.429 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG21 ' A' ' 313' ' ' VAL . 41.3 t -61.8 -53.43 56.05 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 123.837 0.71 . . . . 15.0 111.231 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -80.23 -31.0 38.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.581 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 27.1 mt -59.04 -46.57 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 166.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.31 -41.63 80.26 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.888 0.875 . . . . 15.0 112.055 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.516 HG13 HH12 ' A' ' 344' ' ' ARG . 94.5 t -51.23 -58.35 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 124.291 0.994 . . . . 15.0 109.591 171.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.77 -17.0 62.21 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 113.806 -1.543 . . . . 15.0 112.436 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.5 mtm180 . . . . . 0 N--CA 1.483 1.184 0 C-N-CA 123.333 0.653 . . . . 15.0 109.75 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.179 0.514 . . . . 15.0 112.193 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -114.15 31.45 6.57 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.509 1.124 . . . . 15.0 110.828 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.32 134.03 95.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-O 118.84 -0.6 . . . . 15.0 109.82 172.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -42.64 123.6 3.0 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 124.266 3.311 . . . . 15.0 113.479 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -52.73 -47.32 67.45 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 124.149 0.905 . . . . 15.0 111.498 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.78 -7.04 2.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.12 -43.95 63.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.397 0.544 . . . . 15.0 110.076 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.99 2.13 8.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.526 0.73 . . . . 15.0 112.614 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -58.57 -55.33 36.48 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.735 0.814 . . . . 15.0 111.007 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 40.6 tt0 -56.14 -60.9 2.83 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.796 1.31 . . . . 15.0 111.215 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -64.68 -38.16 90.03 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.85 -52.89 17.54 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 110.429 -0.212 . . . . 15.0 110.429 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.36 -28.1 64.81 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.908 0.755 . . . . 15.0 110.685 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.581 ' NH2' ' HA ' ' A' ' 288' ' ' SER . 0.2 OUTLIER -72.5 -36.9 68.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.887 0.875 . . . . 15.0 109.563 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.516 HH12 HG13 ' A' ' 313' ' ' VAL . 75.4 mtt180 -64.36 -35.09 79.76 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.886 0.312 . . . . 15.0 110.206 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.58 -53.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.883 0.873 . . . . 15.0 110.227 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.78 -47.28 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 114.304 -1.316 . . . . 15.0 111.239 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.585 HG11 HD13 ' A' ' 351' ' ' LEU . 53.9 t -61.8 -48.25 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 15.0 110.722 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.58 95.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.695 0.622 . . . . 15.0 113.575 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 303' ' ' PRO . 94.7 mt -79.74 -58.01 3.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.536 0.735 . . . . 15.0 110.96 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 294' ' ' LEU . 91.1 mt -65.31 -51.81 58.18 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.673 0.608 . . . . 15.0 111.044 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.585 HD13 HG11 ' A' ' 347' ' ' VAL . 39.8 mt -71.17 -33.68 70.23 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 118.843 -0.599 . . . . 15.0 111.222 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.66 92.05 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.78 -0.528 . . . . 15.0 111.78 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.59 -42.83 91.25 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.742 -0.729 . . . . 15.0 111.041 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 350' ' ' LEU . 89.7 t -58.99 -39.95 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 122.976 0.511 . . . . 15.0 111.3 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 360' ' ' LEU . 73.0 mt -68.83 -41.25 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.572 0.749 . . . . 15.0 110.198 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -60.23 -54.75 42.13 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.528 0.517 . . . . 15.0 110.631 174.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.3 m -60.64 -40.0 90.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.256 1.022 . . . . 15.0 111.945 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.6 8.62 43.74 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.511 0.725 . . . . 15.0 111.763 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 40.56 51.99 2.99 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.823 1.649 . . . . 15.0 113.648 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.609 ' HB2' HG21 ' A' ' 355' ' ' ILE . 78.5 mt -84.1 142.19 30.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.844 -1.071 . . . . 15.0 111.505 -176.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.62 151.67 49.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 167.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.24 94.87 0.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.036 0.535 . . . . 15.0 110.258 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.8 135.29 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.613 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -58.97 -35.87 73.91 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.12 0.888 . . . . 15.0 111.693 -170.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.49 -33.79 76.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.852 0.461 . . . . 15.0 110.755 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -80.89 -35.8 32.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.112 -0.495 . . . . 15.0 110.424 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.461 HG13 ' HG3' ' A' ' 398' ' ' MET . 86.4 t -56.99 -57.57 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.441 0.697 . . . . 15.0 109.544 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -62.89 -33.11 74.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.654 0.781 . . . . 15.0 111.413 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -54.97 -55.21 29.1 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.067 0.855 . . . . 15.0 111.627 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.52 -46.02 80.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.542 0.737 . . . . 15.0 111.26 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 398' ' ' MET . 47.0 mm -48.85 -61.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 124.539 1.149 . . . . 15.0 110.729 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.68 -37.69 73.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.775 0.658 . . . . 15.0 112.775 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.54 -46.84 77.98 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.043 0.449 . . . . 15.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.2 ttp -69.93 -35.98 74.98 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.432 1.093 . . . . 15.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.72 60.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.138 0.575 . . . . 15.0 112.038 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.4 t -65.83 -17.23 64.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.792 0.837 . . . . 15.0 111.501 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.03 -7.25 50.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.18 0.592 . . . . 15.0 111.664 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -103.31 166.23 10.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.238 1.015 . . . . 15.0 110.874 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.21 -29.2 63.74 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.278 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -155.12 112.71 2.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 15.0 107.7 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.46 -3.94 3.64 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.032 2.488 . . . . 15.0 115.469 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -60.69 -36.93 80.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.668 0.618 . . . . 15.0 112.668 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.1 -36.22 82.85 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.625 0.578 . . . . 15.0 109.897 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.33 -49.14 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.52 0.728 . . . . 15.0 110.121 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.93 -52.24 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 123.831 0.707 . . . . 15.0 109.9 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.33 -54.75 39.68 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.228 0.955 . . . . 15.0 110.674 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -51.09 -57.78 7.8 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.744 1.278 . . . . 15.0 111.566 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -58.37 -53.4 58.76 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.82 0.7 . . . . 15.0 110.662 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.1 p -62.71 -19.05 63.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.69 -7.01 21.01 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.448 0.699 . . . . 15.0 111.861 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 395' ' ' MET . 51.0 t-20 -121.69 86.26 2.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.959 -0.756 . . . . 15.0 108.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -58.62 -32.09 68.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.159 1.384 . . . . 15.0 111.41 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.6 -32.47 73.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.675 0.61 . . . . 15.0 110.754 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 22.3 tp -94.42 -20.18 19.94 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-O 119.464 -0.303 . . . . 15.0 111.112 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.515 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 77.2 mmm -59.38 -38.03 79.46 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.196 -0.668 . . . . 15.0 109.196 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.4 -60.24 1.57 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.869 1.268 . . . . 15.0 112.072 168.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -66.34 -34.93 79.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.178 0.991 . . . . 15.0 110.808 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.542 ' HG2' HD12 ' A' ' 371' ' ' ILE . 26.3 tpp -70.27 -27.32 64.33 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.851 0.861 . . . . 15.0 111.226 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 395' ' ' MET . 64.0 mtp85 -79.14 -35.18 42.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.48 -44.91 93.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.611 0.569 . . . . 15.0 110.244 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.0 p -75.7 -28.47 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 123.118 0.261 . . . . 15.0 111.33 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.71 -40.23 96.5 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.275 0.489 . . . . 15.0 110.278 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.532 ' HG ' HD13 ' A' ' 355' ' ' ILE . 27.8 tp -73.38 -36.4 66.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.521 -1.218 . . . . 15.0 110.238 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.79 -51.98 67.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.26 1.024 . . . . 15.0 111.187 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 75.3 mm-40 -67.08 -40.77 87.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.401 0.68 . . . . 15.0 110.865 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.501 HE21 ' HB3' ' A' ' 360' ' ' LEU . 23.9 tt0 -63.2 -34.3 77.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.794 0.838 . . . . 15.0 110.56 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.71 85.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.538 0.735 . . . . 15.0 111.505 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 94.4 t -52.98 -54.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 O-C-N 123.982 0.801 . . . . 15.0 108.914 171.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.47 ' HA ' HD13 ' A' ' 412' ' ' LEU . 31.2 mt-10 -62.47 -26.61 68.61 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.799 -1.091 . . . . 15.0 112.744 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.56 74.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.036 0.534 . . . . 15.0 110.882 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 294' ' ' LEU . 57.8 t -72.63 -35.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.847 -0.798 . . . . 15.0 108.847 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 409' ' ' GLU . 81.6 mt -65.77 -37.35 86.1 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.978 0.798 . . . . 15.0 110.89 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.28 64.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.365 -0.834 . . . . 15.0 112.125 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -106.71 -27.27 10.91 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.959 0.904 . . . . 15.0 111.867 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.21 158.94 16.97 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.743 0.817 . . . . 15.0 111.93 -171.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.441 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 88.4 mttt -69.04 78.77 0.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.454 1.101 . . . . 15.0 110.351 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 125' ' ' VAL . 25.5 t -97.9 103.11 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -78.41 119.9 22.38 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.368 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 32.2 tt0 -78.61 87.23 4.56 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.733 0.778 . . . . 15.0 109.263 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -95.66 100.74 12.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.859 -1.064 . . . . 15.0 110.704 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.03 128.54 35.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 15.0 109.279 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.441 HG22 HG22 ' A' ' 130' ' ' VAL . 7.7 t -161.93 176.88 10.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.725 0.41 . . . . 15.0 111.126 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 40.6 p -106.41 171.02 7.58 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.213 1.005 . . . . 15.0 111.669 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -43.57 -60.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.042 1.737 . . . . 15.0 113.593 -168.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.36 -23.02 65.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.732 1.012 . . . . 15.0 113.732 -167.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.4 ' HG2' HG21 ' A' ' 422' ' ' THR . 15.4 tp10 -45.21 -46.78 12.48 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.895 1.278 . . . . 15.0 112.966 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.66 -31.06 41.42 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.799 0.84 . . . . 15.0 110.943 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -71.74 -31.83 67.08 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.448 0.699 . . . . 15.0 110.04 175.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 124.27 1.028 . . . . 15.0 113.627 -173.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.38 91.32 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 118.999 0.818 . . . . 0.0 109.173 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.413 HG13 ' OH ' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -145.14 162.6 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 126.107 1.763 . . . . 0.0 108.088 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.51 HG22 ' HD2' ' A' ' 177' ' ' PHE . 28.8 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 125.215 1.406 . . . . 0.0 112.929 -177.721 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' B' ' 463' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.551 1.007 0 CA-C-O 120.48 0.181 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . 0.304 19.3 p90 67.76 -39.91 0.4 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 128.256 2.622 . . . . 0.0 116.656 169.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -177.83 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.274 1.03 . . . . 0.0 109.652 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 463' ' ' THR . . . . . 0.579 ' HB ' HD11 ' B' ' 460' ' ' LEU . 72.4 m -34.95 118.2 0.42 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.719 1.607 . . . . 0.0 114.612 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 464' ' ' MET . . . . . 0.557 ' HB2' ' HB1' ' B' ' 467' ' ' ALA . 24.5 mmt 64.71 119.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.161 1.384 . . . . 0.0 112.302 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.25 -25.01 66.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.085 0.554 . . . . 0.0 110.521 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -96.03 17.99 14.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.528 1.131 . . . . 0.0 111.454 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' B' ' 464' ' ' MET . . . . . . . . 0 N--CA 1.479 0.98 0 C-N-CA 123.121 0.569 . . . . 0.0 109.675 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 23.3 ptm . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.5 -0.185 . . . . 15.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -150.91 113.29 4.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 17' ' ' ILE . 28.9 m -123.67 146.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.695 0.798 . . . . 15.0 110.29 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 p -137.36 115.47 11.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.377 0.671 . . . . 15.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.33 131.99 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.096 0.559 . . . . 15.0 111.094 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -135.34 148.71 49.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.841 1.256 . . . . 15.0 108.443 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 m -93.46 112.06 23.87 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.538 -0.541 . . . . 15.0 109.538 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -80.52 -44.33 19.3 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.974 0.51 . . . . 15.0 111.284 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -167.42 94.52 0.44 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.344 0.657 . . . . 15.0 109.786 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.36 -102.86 0.41 Allowed Glycine 0 C--N 1.352 1.461 0 O-C-N 123.958 0.786 . . . . 15.0 113.765 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 113' ' ' PRO . 50.9 tp -68.49 -35.25 77.25 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.879 0.872 . . . . 15.0 110.733 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.43 135.26 22.03 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.138 -0.937 . . . . 15.0 112.079 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.6 -177.31 4.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.921 1.288 . . . . 15.0 109.757 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -150.15 110.52 4.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.89 0.876 . . . . 15.0 109.709 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.3 t -98.56 92.03 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.709 -0.848 . . . . 15.0 108.709 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 44.8 m -75.11 105.03 5.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.554 0.742 . . . . 15.0 109.87 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 3' ' ' VAL . 35.8 mt -93.31 115.77 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.857 -0.611 . . . . 15.0 109.6 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -92.71 96.41 10.15 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.433 -0.951 . . . . 15.0 108.433 166.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 70' ' ' LEU . 74.3 mt -73.27 98.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 171.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.93 162.64 23.84 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.232 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.6 -22.35 55.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.572 1.149 . . . . 15.0 113.955 -170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.84 -42.89 89.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.884 0.474 . . . . 15.0 110.508 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -73.68 -36.57 65.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.493 -0.776 . . . . 15.0 110.923 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.07 -59.05 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.933 0.493 . . . . 15.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.37 -41.84 97.74 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.217 1.007 . . . . 15.0 112.291 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 m -64.99 -42.11 94.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.647 0.592 . . . . 15.0 110.979 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.31 71.41 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 15.0 112.007 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' HA ' HG23 ' A' ' 66' ' ' VAL . 79.5 t -62.82 -45.43 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 15.0 110.31 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.694 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 3.8 ttmp? -66.27 -39.27 89.33 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.249 -1.341 . . . . 15.0 110.367 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 m -72.27 -21.91 61.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.12 0.968 . . . . 15.0 111.01 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.8 tp10 -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.658 0.383 . . . . 15.0 111.221 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.53 -26.54 65.48 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.382 0.273 . . . . 15.0 111.7 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 p -76.54 -29.2 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 123.245 0.34 . . . . 15.0 110.097 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -66.29 -46.33 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.967 0.507 . . . . 15.0 109.934 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' GLU . 61.0 t -65.54 -37.54 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.983 0.913 . . . . 15.0 110.167 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.24 92.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.32 0.648 . . . . 15.0 111.182 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.58 -23.87 39.59 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.923 0.489 . . . . 15.0 111.513 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.98 -49.3 38.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.613 0.765 . . . . 15.0 110.188 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.38 -5.91 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.944 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 69.47 21.1 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.097 1.359 . . . . 15.0 111.95 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -64.37 -26.28 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 124.331 1.052 . . . . 15.0 111.126 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -59.38 -36.69 76.25 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.112 0.965 . . . . 15.0 111.627 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.54 -10.92 80.08 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.359 -0.382 . . . . 15.0 113.598 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -119.23 2.23 11.36 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.037 0.935 . . . . 15.0 110.774 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.5 ttt85 -76.86 94.86 3.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.288 0.635 . . . . 15.0 110.027 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -80.3 86.5 5.67 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.397 -0.82 . . . . 15.0 110.835 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 37.26 -56.57 0.0 OUTLIER Glycine 0 CA--C 1.55 2.266 0 N-CA-C 120.142 2.817 . . . . 15.0 120.142 160.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -43.09 -47.9 6.13 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.205 1.802 . . . . 15.0 114.228 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.44 106.37 16.31 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.75 0.42 . . . . 15.0 110.192 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 3.5 Cg_exo -78.84 156.63 27.31 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.514 2.809 . . . . 15.0 112.299 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.423 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 58.9 tpp -70.58 -27.18 63.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.863 0.865 . . . . 15.0 111.752 -172.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.688 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 34.0 p-10 -69.84 -28.97 66.13 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.849 0.46 . . . . 15.0 111.924 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.502 HG21 ' HD2' ' A' ' 57' ' ' ARG . 12.3 mt -72.36 -51.89 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.665 0.786 . . . . 15.0 110.14 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 33.8 m -68.61 -25.6 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.47 0.545 . . . . 15.0 112.47 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.12 92.96 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.393 0.677 . . . . 15.0 112.59 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -117.25 -3.56 11.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 -170.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.502 ' HD2' HG21 ' A' ' 53' ' ' ILE . 75.9 mtt180 -115.64 -45.84 2.88 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.135 0.425 . . . . 15.0 111.623 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.454 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 94.9 m-85 -104.69 -39.01 6.5 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.202 0.816 . . . . 15.0 113.202 -168.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.84 39.5 2.78 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 112.492 -0.243 . . . . 15.0 112.492 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.58 61.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.906 0.882 . . . . 15.0 112.098 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p -73.71 -35.58 65.13 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.062 0.945 . . . . 15.0 111.088 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -69.13 -25.22 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.724 0.81 . . . . 15.0 110.622 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 25.3 mtp180 -61.1 -22.1 64.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.643 0.777 . . . . 15.0 111.951 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.73 -54.23 49.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.136 0.975 . . . . 15.0 111.232 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 -27.46 66.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 28' ' ' VAL . 94.7 t -64.85 -43.28 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 123.61 0.568 . . . . 15.0 109.76 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 91.5 mt -62.37 -41.65 98.8 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.997 0.519 . . . . 15.0 111.162 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.62 99.13 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.644 0.59 . . . . 15.0 112.282 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.66 -41.17 96.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.384 1.074 . . . . 15.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 19' ' ' ILE . 71.2 mt -67.84 -34.53 76.89 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.661 -0.7 . . . . 15.0 111.01 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.2 mtm -67.8 -20.69 65.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.566 0.346 . . . . 15.0 111.255 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -87.2 -55.7 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 15.0 110.203 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -72.76 -39.09 67.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.463 0.705 . . . . 15.0 112.544 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -73.22 -27.07 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 117.875 0.307 . . . . 15.0 110.704 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.87 -54.12 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.222 -0.288 . . . . 15.0 110.222 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.442 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.3 tt -65.04 -37.32 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 123.423 0.452 . . . . 15.0 110.896 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.665 0.786 . . . . 15.0 110.653 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.03 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.48 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 76' ' ' ILE . 33.3 pt -67.06 -23.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 112.717 0.636 . . . . 15.0 112.717 -172.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.39 -53.4 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.452 0.701 . . . . 15.0 110.652 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.478 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -75.1 -29.5 60.62 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.607 0.363 . . . . 15.0 111.455 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -84.31 -16.35 43.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.278 0.631 . . . . 15.0 111.454 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 66.77 14.06 9.64 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.64 1.176 . . . . 15.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.442 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 74.7 mt -77.24 105.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -81.0 110.03 15.98 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.45 148.53 38.14 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.585 2.19 . . . . 15.0 112.957 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.65 -177.74 6.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.505 0.722 . . . . 15.0 109.856 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' HB3' ' A' ' 305' ' ' ALA . . . 64.1 -102.13 0.56 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.86 116.34 2.43 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 107.826 -1.175 . . . . 15.0 107.826 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 43.5 Cg_exo -59.59 105.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 121.687 1.591 . . . . 15.0 110.249 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 m -101.71 99.26 9.5 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.247 -0.649 . . . . 15.0 109.247 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.39 78.19 3.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.636 0.774 . . . . 15.0 109.134 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.05 109.47 3.29 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.46 106.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.118 2.545 . . . . 15.0 111.961 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.85 -79.32 0.57 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.243 -0.743 . . . . 15.0 111.243 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -168.16 151.2 5.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.4 0.68 . . . . 15.0 111.533 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.79 142.21 44.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.601 1.16 . . . . 15.0 109.398 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.2 mttt -133.54 142.83 48.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.259 1.024 . . . . 15.0 108.773 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -61.61 106.18 0.63 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 15.0 110.251 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.64 -17.52 58.79 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 116.038 -0.528 . . . . 15.0 113.477 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 43.4 mt-10 -97.94 -173.52 2.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.563 0.745 . . . . 15.0 110.095 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -72.78 160.09 32.74 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.909 0.883 . . . . 15.0 112.492 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -121.55 106.12 11.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.73 1.212 . . . . 15.0 108.56 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 m -105.07 139.52 39.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.624 0.77 . . . . 15.0 109.93 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -159.96 143.58 14.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.027 0.931 . . . . 15.0 108.818 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.8 m -100.64 107.99 19.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.72 0.808 . . . . 15.0 110.565 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.15 97.69 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.98 -0.748 . . . . 15.0 108.98 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.3 123.05 35.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.229 0.612 . . . . 15.0 109.882 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.548 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 47.1 p90 -159.52 157.85 30.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.772 0.829 . . . . 15.0 110.276 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.3 176.63 7.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 15.0 109.994 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.36 175.96 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -89.76 118.08 68.67 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' HD12 ' A' ' 300' ' ' ILE . 58.6 Cg_endo -88.53 173.03 4.63 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.606 2.204 . . . . 15.0 114.427 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.65 134.68 33.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.123 -1.399 . . . . 15.0 109.059 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.49 126.98 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.417 -0.586 . . . . 15.0 109.417 172.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -84.3 94.13 8.38 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.4 145.25 54.5 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.141 -0.936 . . . . 15.0 108.763 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -79.15 173.83 12.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.58 109.86 2.43 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.548 -1.021 . . . . 15.0 110.548 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 HG23 ' A' ' 411' ' ' VAL . 47.1 mt -66.8 -14.12 62.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.609 0.763 . . . . 15.0 111.246 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.96 -22.61 63.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.289 . . . . 15.0 111.289 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.74 62.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.773 0.829 . . . . 15.0 110.947 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.04 131.34 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.619 0.768 . . . . 15.0 109.657 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.25 123.84 49.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.911 0.884 . . . . 15.0 109.618 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.534 ' HB ' HG22 ' A' ' 417' ' ' VAL . 61.4 t -125.27 163.66 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.838 1.255 . . . . 15.0 107.917 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.34 143.97 48.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.532 0.733 . . . . 15.0 109.262 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HE2' HD13 ' A' ' 129' ' ' ILE . 80.6 tttt -114.87 93.52 34.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.133 -1.062 . . . . 15.0 108.133 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.79 98.61 1.22 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.17 1.914 . . . . 15.0 112.289 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.446 HD13 ' HE2' ' A' ' 127' ' ' LYS . 48.5 mm -72.52 96.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.563 HG21 HD13 ' A' ' 427' ' ' LEU . 21.0 t -122.74 142.82 37.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.526 -0.761 . . . . 15.0 109.997 -173.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.47 146.25 39.81 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.817 0.847 . . . . 15.0 108.932 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.54 88.81 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.5 p -76.24 -179.85 5.31 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.894 0.878 . . . . 15.0 110.339 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.92 -37.59 74.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.444 0.698 . . . . 15.0 111.689 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.8 96.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 15.0 111.492 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.45 -42.94 52.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.808 0.843 . . . . 15.0 111.556 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.79 -56.44 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.902 0.881 . . . . 15.0 109.489 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.37 -45.89 92.49 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.175 0.99 . . . . 15.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.33 -46.91 89.35 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.919 0.762 . . . . 15.0 113.333 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.24 -51.68 50.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.143 0.577 . . . . 15.0 110.896 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.2 mt -53.91 -39.39 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.569 0.748 . . . . 15.0 111.86 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.43 -40.9 85.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.925 0.49 . . . . 15.0 111.027 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 m -67.89 -26.74 66.16 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.752 0.421 . . . . 15.0 110.756 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.86 -37.73 76.19 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.852 0.461 . . . . 15.0 110.333 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -64.68 -35.06 79.82 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.707 0.289 . . . . 15.0 110.424 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -69.3 -34.6 74.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.306 0.642 . . . . 15.0 111.099 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.66 -41.26 79.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 15.0 109.98 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -95.1 29.66 2.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.027 0.931 . . . . 15.0 111.184 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.525 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.09 135.48 46.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.106 0.562 . . . . 15.0 112.434 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.1 m -83.54 138.85 33.22 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.625 1.17 . . . . 15.0 110.25 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -80.16 139.17 36.91 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.829 0.452 . . . . 15.0 110.236 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 33.1 ttpt -156.98 172.99 17.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.09 -1.078 . . . . 15.0 108.09 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 41.6 mt-10 -121.64 165.72 15.33 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.97 0.908 . . . . 15.0 110.035 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.538 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 41.6 pttt -156.78 -179.92 8.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.031 0.933 . . . . 15.0 110.87 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.03 146.95 28.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.977 0.511 . . . . 15.0 109.655 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.19 -50.21 0.88 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.0 -0.889 . . . . 15.0 113.533 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.57 153.89 33.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.465 1.132 . . . . 15.0 112.234 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.84 157.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.47 1.108 . . . . 15.0 109.517 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -138.51 -174.88 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.485 1.914 . . . . 15.0 108.252 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.08 -8.73 59.03 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.459 0.911 . . . . 15.0 113.459 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.52 -6.5 20.55 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.143 0.429 . . . . 15.0 112.021 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -81.61 178.4 8.36 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.054 1.131 . . . . 15.0 114.054 -165.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.706 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 16.0 mtm180 -116.27 98.77 6.78 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.833 -1.076 . . . . 15.0 108.503 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.01 97.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 -169.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 9.0 m -73.32 111.73 8.72 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.851 -1.166 . . . . 15.0 107.851 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.8 pt -132.95 179.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.422 1.089 . . . . 15.0 110.924 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.8 t70 -130.04 157.53 42.1 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.179 1.391 . . . . 15.0 107.713 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.493 ' HE2' HD12 ' B' ' 385' ' ' LEU . 24.4 p90 -144.61 150.59 37.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.636 0.731 . . . . 15.0 111.074 164.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.545 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 1.8 t -125.99 95.12 4.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 106.467 -1.679 . . . . 15.0 106.467 166.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.96 166.77 31.34 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 114.93 -1.032 . . . . 15.0 115.067 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -151.19 141.97 22.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.964 1.306 . . . . 15.0 108.283 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 177' ' ' PHE . 98.3 t -118.55 137.52 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.584 0.754 . . . . 15.0 109.141 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.54 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 35.3 t70 70.48 5.83 5.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.721 1.208 . . . . 15.0 111.875 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.31 -1.0 46.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.722 -0.488 . . . . 15.0 113.37 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.01 145.41 49.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.627 0.771 . . . . 15.0 110.576 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -76.01 110.48 10.52 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.149 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 172' ' ' VAL . 32.7 p90 -70.84 170.38 12.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.219 0.608 . . . . 15.0 111.259 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -69.68 134.56 48.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.63 -1.168 . . . . 15.0 111.057 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.579 ' HA3' HG12 ' B' ' 386' ' ' VAL . . . 88.25 -78.64 1.75 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 -52.4 4.17 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.412 0.925 . . . . 15.0 115.412 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.545 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 40.6 mmtt -85.9 145.97 26.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.913 1.079 . . . . 15.0 113.913 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.05 92.48 1.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.658 -1.61 . . . . 15.0 106.933 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -96.32 143.78 27.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.308 -0.86 . . . . 15.0 110.967 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.5 t70 65.75 21.92 11.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.338 1.055 . . . . 15.0 111.373 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 165' ' ' THR . 46.7 t80 -71.59 134.23 46.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.225 0.61 . . . . 15.0 110.579 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.35 103.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.794 -0.817 . . . . 15.0 108.794 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.44 ' HG ' ' HG2' ' A' ' 189' ' ' MET . 27.0 tp -82.8 80.1 8.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 15.0 110.047 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.54 92.44 0.31 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.691 -1.226 . . . . 15.0 107.691 167.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.668 ' HE2' ' HB2' ' A' ' 199' ' ' GLU . 62.5 mtp -66.98 144.64 56.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.394 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.12 14.57 Favored Glycine 0 N--CA 1.471 0.978 0 O-C-N 123.496 0.498 . . . . 15.0 112.494 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.44 -178.96 3.65 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.27 1.028 . . . . 15.0 110.339 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.17 6.93 56.5 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 115.912 -0.586 . . . . 15.0 113.518 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -77.84 2.09 18.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.098 0.559 . . . . 15.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.7 mmt -134.74 154.53 51.54 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.911 0.884 . . . . 15.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.57 152.84 37.94 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 114.757 -1.11 . . . . 15.0 109.374 170.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.93 143.97 46.95 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.03 2.487 . . . . 15.0 112.928 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.24 -40.29 2.47 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 115.803 -0.635 . . . . 15.0 112.164 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -67.85 -63.81 0.99 Allowed 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.668 ' HB2' ' HE2' ' A' ' 189' ' ' MET . 5.4 pt-20 -62.28 -24.57 67.36 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.437 -0.801 . . . . 15.0 112.077 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.91 -37.59 81.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.083 0.953 . . . . 15.0 110.682 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.78 -10.95 80.79 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.468 -0.787 . . . . 15.0 113.075 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 187' ' ' LEU . 42.9 mm -94.84 -47.12 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.763 0.825 . . . . 15.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.514 ' HB3' ' HE1' ' A' ' 189' ' ' MET . 19.6 pttm -82.41 19.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.325 1.232 . . . . 15.0 114.325 -167.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.78 25.39 5.31 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.99 -1.244 . . . . 15.0 109.99 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -140.71 -169.96 2.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.729 1.211 . . . . 15.0 110.213 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -153.52 163.56 39.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.996 0.918 . . . . 15.0 110.675 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -68.07 132.2 46.81 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.38 0.672 . . . . 15.0 112.06 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 126.77 -28.24 4.71 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.761 -1.109 . . . . 15.0 111.799 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.8 pt-20 -96.14 139.32 32.48 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.727 0.775 . . . . 15.0 111.455 -174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.27 125.8 51.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.981 1.313 . . . . 15.0 108.948 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -144.38 169.67 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.073 0.949 . . . . 15.0 109.769 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 70.2 m -124.34 120.45 32.17 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -95.64 160.48 2.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.497 0.719 . . . . 15.0 111.207 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -104.92 118.42 36.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.99 -1.005 . . . . 15.0 109.903 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.6 163.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 87.3 m -146.26 131.9 18.86 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.971 -1.122 . . . . 15.0 107.971 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' HZ ' ' HB ' ' B' ' 387' ' ' ILE . 73.0 m-85 -68.23 135.47 91.32 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 110.128 -0.323 . . . . 15.0 110.128 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.21 156.68 19.91 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.161 2.574 . . . . 15.0 113.515 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -75.22 -20.71 59.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.917 169.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.22 -16.7 57.59 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.914 0.886 . . . . 15.0 111.21 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.417 ' HE2' ' HB1' ' A' ' 223' ' ' ALA . 69.5 t80 -60.66 142.09 56.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.069 0.948 . . . . 15.0 111.616 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -65.03 -44.95 87.45 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.027 0.931 . . . . 15.0 112.76 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 221' ' ' TYR . . . -88.2 104.11 16.4 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.791 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.8 tt0 -63.3 -21.08 66.03 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.672 1.189 . . . . 15.0 112.428 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.44 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 29.6 p30 -68.14 -10.56 55.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.809 0.843 . . . . 15.0 112.518 174.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' B' ' 388' ' ' VAL . 79.1 mt -121.39 -36.91 2.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.235 1.014 . . . . 15.0 110.05 175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.791 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 9.3 tttm -53.48 128.89 30.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.779 1.632 . . . . 15.0 111.991 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.02 16.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.998 -0.547 . . . . 15.0 113.22 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.54 ' HD3' ' HB2' ' A' ' 173' ' ' ASP . 93.3 mttt -86.24 147.44 26.1 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.379 0.672 . . . . 15.0 110.343 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.25 166.63 22.48 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.728 0.643 . . . . 15.0 110.416 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.02 119.62 5.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.39 0.676 . . . . 15.0 109.816 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -98.86 134.45 41.72 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -128.54 110.73 12.54 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.87 0.468 . . . . 15.0 110.273 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.466 ' HB2' HG23 ' A' ' 169' ' ' THR . . . -77.8 91.73 4.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.405 0.622 . . . . 15.0 109.342 176.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.6 mm -81.16 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.926 1.29 . . . . 15.0 110.636 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -111.3 97.25 6.64 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.463 -1.31 . . . . 15.0 107.463 176.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -81.41 118.55 22.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -115.46 -37.49 4.0 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.588 0.355 . . . . 15.0 111.618 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.734 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.0 mmtt -135.87 142.97 44.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.999 0.52 . . . . 15.0 110.235 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 207' ' ' ALA . 41.8 t -118.45 94.49 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.644 -1.243 . . . . 15.0 107.644 169.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.7 mt-10 -88.28 167.01 13.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.538 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.8 tt0 -138.9 130.54 27.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.949 0.499 . . . . 15.0 109.823 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -86.14 85.8 7.35 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.673 -1.232 . . . . 15.0 107.673 166.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.76 134.7 53.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.856 -1.065 . . . . 15.0 109.837 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.41 126.59 87.46 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.788 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 63.9 Cg_endo -68.93 157.95 59.84 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.958 2.439 . . . . 15.0 111.917 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -70.9 160.13 33.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.938 -1.028 . . . . 15.0 110.415 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.4 tp -88.3 30.01 0.92 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.622 0.769 . . . . 15.0 109.83 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.6 p -70.14 169.57 13.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.518 1.127 . . . . 15.0 111.623 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -37.97 -65.86 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.082 1.753 . . . . 15.0 114.72 -166.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.01 -22.57 66.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.678 0.791 . . . . 15.0 112.611 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -86.74 -49.87 7.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.061 0.544 . . . . 15.0 110.465 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.41 -31.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.758 0.423 . . . . 15.0 110.78 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.3 ptmt -98.97 5.14 47.33 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -61.27 -31.11 70.93 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.377 0.671 . . . . 15.0 110.777 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.12 -18.72 64.71 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.087 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.67 45.45 1.79 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.703 -0.559 . . . . 15.0 111.703 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 260' ' ' ASP . 65.8 t -71.91 149.28 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.717 0.807 . . . . 15.0 111.431 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -55.97 -41.51 74.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.478 1.111 . . . . 15.0 111.601 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.467 ' H ' HG11 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -128.36 -47.97 1.31 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.581 -175.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 114.73 -12.62 20.57 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.634 -0.536 . . . . 15.0 113.373 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 94.2 p -73.47 167.64 20.88 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.558 0.679 . . . . 15.0 110.955 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.85 -49.41 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.124 0.97 . . . . 15.0 111.257 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.32 -28.8 68.42 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.314 0.646 . . . . 15.0 111.715 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.67 -26.13 57.11 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.129 -0.788 . . . . 15.0 111.129 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 270' ' ' VAL . 63.9 tp -74.71 -33.7 62.46 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -61.57 -40.08 93.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.396 0.679 . . . . 15.0 109.919 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.6 86.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.698 0.799 . . . . 15.0 111.317 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.549 ' HA ' ' HZ1' ' A' ' 272' ' ' LYS . 23.7 tp10 -67.3 -49.49 64.01 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.661 0.784 . . . . 15.0 110.516 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.478 ' HA ' ' SD ' ' A' ' 274' ' ' MET . 70.2 t -61.67 -33.67 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.736 1.214 . . . . 15.0 109.75 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -62.85 -61.65 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.493 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.549 ' HZ1' ' HA ' ' A' ' 269' ' ' GLU . 24.4 pttm -71.71 -15.73 62.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.774 0.657 . . . . 15.0 112.774 -174.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -89.27 -78.78 0.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 270' ' ' VAL . 1.7 mpt? -62.85 -50.58 70.37 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.656 -0.687 . . . . 15.0 111.553 -169.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.15 -34.32 56.49 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.586 0.63 . . . . 15.0 111.656 -170.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -73.57 -44.08 58.21 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.942 -0.392 . . . . 15.0 109.942 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.03 -37.87 88.92 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.609 0.568 . . . . 15.0 109.783 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.13 -60.87 2.85 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.405 0.682 . . . . 15.0 111.354 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.83 -29.47 69.94 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.726 0.641 . . . . 15.0 111.281 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -65.34 -46.11 81.55 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.68 -30.72 68.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.772 0.829 . . . . 15.0 111.761 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.507 HD12 ' HB ' ' A' ' 130' ' ' VAL . 90.1 mt -67.88 -51.42 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.558 HH21 ' HB3' ' A' ' 405' ' ' GLU . 22.9 tpt180 -61.05 -41.84 97.36 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.351 -0.84 . . . . 15.0 110.429 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -72.09 -30.27 64.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.799 -0.619 . . . . 15.0 110.851 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -64.24 -57.89 8.15 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.985 0.514 . . . . 15.0 109.672 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 282' ' ' ILE . 42.1 t -57.33 -46.17 85.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 124.263 0.977 . . . . 15.0 110.216 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -59.45 -55.75 30.67 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.749 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -65.15 -28.86 69.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.311 0.644 . . . . 15.0 111.995 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.474 ' HB2' HG12 ' A' ' 125' ' ' VAL . 58.6 mt-30 -68.29 -44.32 75.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.563 0.345 . . . . 15.0 110.506 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.34 -42.32 96.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.578 0.351 . . . . 15.0 111.202 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -60.35 -53.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 15.0 111.01 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.78 -41.23 99.16 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.985 0.803 . . . . 15.0 110.271 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.19 91.88 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.939 0.775 . . . . 15.0 112.095 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.6 HD13 HG21 ' A' ' 411' ' ' VAL . 35.1 mt -59.03 -56.73 18.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.96 0.904 . . . . 15.0 111.846 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.31 -53.73 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.581 0.551 . . . . 15.0 110.3 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.88 -40.3 75.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.499 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.58 -33.93 67.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.022 -0.536 . . . . 15.0 112.224 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -116.76 103.85 10.76 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.038 0.381 . . . . 15.0 111.433 -163.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -74.11 144.52 44.9 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.589 HD12 ' HG2' ' A' ' 113' ' ' PRO . 5.3 tp -165.08 130.39 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.408 0.683 . . . . 15.0 110.214 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.58 95.88 4.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.536 HG12 HG12 ' A' ' 345' ' ' VAL . 22.7 t -89.04 128.02 53.43 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 109.264 -0.643 . . . . 15.0 109.264 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.2 135.12 33.44 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.466 2.111 . . . . 15.0 111.858 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -64.5 -4.77 4.33 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.095 1.146 . . . . 15.0 114.095 -171.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.428 ' HB3' ' N ' ' A' ' 88' ' ' GLY . . . -56.83 -55.14 38.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.989 0.915 . . . . 15.0 110.803 174.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.57 -35.63 77.64 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.654 1.221 . . . . 15.0 110.89 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.642 ' HA ' HG22 ' A' ' 345' ' ' VAL . 2.1 mp -60.33 -56.68 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.964 -0.754 . . . . 15.0 108.964 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.16 -28.43 68.11 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.789 0.681 . . . . 15.0 111.135 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.0 t -60.67 -53.54 56.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.028 0.931 . . . . 15.0 111.222 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -76.73 -30.14 56.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.329 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.592 HD11 ' HG3' ' A' ' 334' ' ' ARG . 71.3 mt -60.99 -39.18 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 168.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.473 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.5 t70 -66.41 -40.22 89.46 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-O 118.398 -0.811 . . . . 15.0 110.607 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.67 -47.74 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.164 0.507 . . . . 15.0 110.281 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.43 -27.01 63.93 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.202 -0.908 . . . . 15.0 112.047 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 84.1 mtm180 . . . . . 0 N--CA 1.48 1.059 0 C-N-CA 123.584 0.753 . . . . 15.0 110.54 172.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.9 tp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 112.178 0.436 . . . . 15.0 112.178 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.53 -27.97 60.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.092 0.557 . . . . 15.0 111.496 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.84 128.23 63.05 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 123.455 0.472 . . . . 15.0 110.363 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.562 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.6 Cg_exo -47.96 118.23 2.99 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.56 2.84 . . . . 15.0 113.649 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.592 ' HG3' HD11 ' A' ' 311' ' ' ILE . 66.3 ttt180 -52.79 -37.5 59.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.075 0.95 . . . . 15.0 112.028 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -10.22 48.84 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.572 0.749 . . . . 15.0 112.964 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.562 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.9 mt -71.27 -30.0 65.76 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.16 0.436 . . . . 15.0 110.653 171.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 311' ' ' ILE . 32.6 m-85 -122.9 -4.63 8.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.524 0.73 . . . . 15.0 111.541 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -45.96 -68.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.565 1.146 . . . . 15.0 112.836 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.76 -48.84 80.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.702 0.626 . . . . 15.0 112.042 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.76 -45.95 73.44 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 123.575 0.547 . . . . 15.0 111.362 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -66.26 -56.34 11.74 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.231 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -53.53 -35.61 60.88 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.316 1.01 . . . . 15.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -61.5 -51.15 69.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.966 -0.561 . . . . 15.0 109.677 171.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -68.38 -18.77 64.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.119 0.568 . . . . 15.0 111.906 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 307' ' ' ILE . 69.5 t -77.57 -45.3 29.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.12 0.968 . . . . 15.0 110.167 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 77.6 t -58.9 -44.71 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 343' ' ' ARG . 77.7 t -56.06 -46.47 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.338 1.055 . . . . 15.0 110.878 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.51 72.64 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.763 -0.653 . . . . 15.0 113.258 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.67 -44.34 56.96 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.2 mt -70.72 -46.42 63.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.216 0.607 . . . . 15.0 110.65 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.18 -38.74 92.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.136 0.574 . . . . 15.0 110.417 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.23 94.09 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.783 0.677 . . . . 15.0 112.512 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.82 -36.64 78.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.088 0.555 . . . . 15.0 110.945 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -64.97 -40.8 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.91 0.484 . . . . 15.0 110.201 174.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.467 ' HA ' HD11 ' A' ' 360' ' ' LEU . 96.1 mt -63.56 -41.79 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.984 0.913 . . . . 15.0 110.428 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.64 ' HA ' HD11 ' B' ' 460' ' ' LEU . 35.9 ttp180 -69.92 -58.94 3.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.775 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 51.9 m -61.25 -37.3 82.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.189 0.996 . . . . 15.0 112.059 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.73 8.23 41.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.138 0.421 . . . . 15.0 112.138 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 41.4 48.54 3.32 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.233 1.413 . . . . 15.0 113.383 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.57 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.0 mt -70.79 148.39 47.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.847 -1.07 . . . . 15.0 111.709 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.55 143.78 41.76 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.681 0.792 . . . . 15.0 110.053 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -78.28 111.68 14.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.05 0.94 . . . . 15.0 110.12 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.81 140.47 29.63 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.744 0.818 . . . . 15.0 110.719 -172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -60.23 -40.33 89.83 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.785 0.834 . . . . 15.0 112.366 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.33 -25.85 64.41 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.248 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -74.79 -40.97 60.83 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 371' ' ' ILE . 61.0 t -58.83 -47.24 89.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.004 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -51.96 -47.73 64.66 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.156 0.91 . . . . 15.0 111.684 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.89 -51.02 48.08 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.277 0.986 . . . . 15.0 112.771 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 402' ' ' ALA . 90.7 mt -62.62 -46.69 87.11 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.662 0.785 . . . . 15.0 112.378 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.552 ' HA ' ' HE1' ' A' ' 374' ' ' MET . 48.4 mm -54.68 -53.35 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.041 0.937 . . . . 15.0 110.164 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.84 -35.26 74.6 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.37 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.0 -50.17 75.11 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.618 0.767 . . . . 15.0 112.031 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.552 ' HE1' ' HA ' ' A' ' 371' ' ' ILE . 26.6 ptt? -74.06 -43.66 57.0 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.277 -0.419 . . . . 15.0 110.703 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -43.05 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.345 0.658 . . . . 15.0 112.241 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.3 t -60.19 -25.8 65.87 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 124.024 0.828 . . . . 15.0 111.699 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.8 58.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.73 0.812 . . . . 15.0 112.25 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -92.41 169.53 10.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.317 0.647 . . . . 15.0 111.151 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.8 -36.57 82.69 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.442 -1.254 . . . . 15.0 110.365 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -131.86 100.97 15.63 Favored Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.987 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.7 -24.53 18.25 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.389 2.06 . . . . 15.0 112.703 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -54.46 -48.53 71.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.349 1.06 . . . . 15.0 111.544 -168.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -65.85 -30.45 71.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.26 0.975 . . . . 15.0 111.177 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.16 -45.27 54.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.64 -55.06 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.681 0.613 . . . . 15.0 109.397 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.92 -34.84 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.546 0.738 . . . . 15.0 112.493 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.99 -54.54 6.72 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.738 0.304 . . . . 15.0 111.139 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -47.71 33.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.248 0.619 . . . . 15.0 111.409 -166.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.7 p -58.83 -30.07 67.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.704 0.802 . . . . 15.0 112.534 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -86.12 -26.33 25.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.511 -0.768 . . . . 15.0 111.681 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.43 95.54 6.56 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 2.9 ttmt -71.31 -18.93 62.38 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.262 1.025 . . . . 15.0 111.6 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -66.76 -41.53 87.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.564 0.746 . . . . 15.0 110.489 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.24 -31.46 19.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.555 0.742 . . . . 15.0 109.846 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.666 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 55.4 ttm -61.92 -26.64 68.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.74 0.416 . . . . 15.0 110.835 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -48.17 81.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.073 0.549 . . . . 15.0 110.125 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.47 -26.87 66.58 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.563 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.551 ' HA ' HG12 ' A' ' 401' ' ' VAL . 10.5 tpt -74.55 -27.39 60.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.975 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 395' ' ' MET . 82.2 mtp180 -72.06 -34.62 68.87 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 170.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -42.95 94.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.918 0.487 . . . . 15.0 111.235 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.9 p -73.97 -27.79 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 121.215 -0.194 . . . . 15.0 111.243 174.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -61.36 -44.04 97.85 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.36 0.6 . . . . 15.0 109.449 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 21.1 tp -73.41 -32.52 64.48 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.183 -1.371 . . . . 15.0 110.672 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -66.22 -51.91 53.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 15.0 110.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.558 ' HB3' HH21 ' A' ' 283' ' ' ARG . 77.9 mm-40 -61.92 -35.38 78.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.464 0.706 . . . . 15.0 110.833 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.57 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.8 tt0 -74.2 -32.74 63.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.433 0.693 . . . . 15.0 110.791 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.75 99.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.193 0.597 . . . . 15.0 110.244 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.78 -53.96 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.693 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.69 -21.57 66.55 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.754 0.822 . . . . 15.0 113.193 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.13 -31.69 64.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.023 0.529 . . . . 15.0 110.523 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.6 HG21 HD13 ' A' ' 294' ' ' LEU . 75.4 t -77.38 -36.35 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.88 -37.83 82.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.939 0.896 . . . . 15.0 111.246 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.24 68.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.616 0.767 . . . . 15.0 111.038 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -95.96 -29.73 14.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.028 0.931 . . . . 15.0 111.555 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.39 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.63 0.772 . . . . 15.0 112.29 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -79.02 78.93 5.44 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.248 -0.887 . . . . 15.0 109.709 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 125' ' ' VAL . 48.5 t -90.17 92.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.456 0.702 . . . . 15.0 109.567 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 39.8 p -74.07 94.66 2.42 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.779 0.832 . . . . 15.0 110.859 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.28 119.9 17.13 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.2 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.437 ' HE3' HG21 ' A' ' 422' ' ' THR . 0.0 OUTLIER -135.35 145.74 47.71 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.438 -0.578 . . . . 15.0 109.438 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.94 136.91 39.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 15.0 109.675 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.437 HG21 ' HE3' ' A' ' 420' ' ' LYS . 11.9 t -163.41 176.66 9.6 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.822 0.449 . . . . 15.0 111.382 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.3 p -93.55 173.4 7.71 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.142 0.977 . . . . 15.0 111.389 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.24 -19.05 42.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.303 1.441 . . . . 15.0 112.05 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -66.43 -5.41 10.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.939 1.296 . . . . 15.0 113.526 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.574 ' HB3' HD12 ' A' ' 427' ' ' LEU . 14.4 tp10 -74.95 -55.41 5.8 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.529 0.732 . . . . 15.0 112.472 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.4 mp -90.35 -71.84 0.6 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.332 0.493 . . . . 15.0 112.332 -163.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -107.15 33.54 3.93 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.358 0.663 . . . . 15.0 111.873 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.8 t30 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 122.091 0.948 . . . . 15.0 111.867 -174.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . 0.493 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.8 mm? . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . 0.579 HG12 ' HA3' ' A' ' 179' ' ' GLY . 11.4 t -75.32 98.21 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.451 ' HB ' ' HZ ' ' A' ' 217' ' ' PHE . 22.5 pt -136.66 84.58 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 159.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.777 ' HA ' HD12 ' A' ' 226' ' ' LEU . 5.4 p . . . . . 0 CA--C 1.544 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.845 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.474 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 111.274 -174.79 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.64 HD11 ' HA ' ' A' ' 356' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -48.23 -33.72 9.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.099 1.76 . . . . 0.0 114.65 -166.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -136.86 -70.21 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 110.839 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 70.35 136.29 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.451 1.5 . . . . 0.0 111.587 -172.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 464' ' ' MET . . . . . 0.41 ' HE1' ' HB1' ' B' ' 466' ' ' ALA . 0.0 OUTLIER -76.12 166.02 24.08 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.028 0.531 . . . . 0.0 110.233 174.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.26 90.92 2.12 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.107 0.48 . . . . 0.0 109.816 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . 0.41 ' HB1' ' HE1' ' B' ' 464' ' ' MET . . . -173.15 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.219 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.804 172.679 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 18.7 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.326 -0.25 . . . . 15.0 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -168.01 97.36 0.44 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.84 -1.17 . . . . 15.0 107.84 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.599 HG13 HG12 ' A' ' 17' ' ' ILE . 22.9 m -111.62 152.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.709 0.804 . . . . 15.0 111.873 -169.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -137.64 92.04 2.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 15.0 109.018 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.46 89.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 122.559 1.171 . . . . 15.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -94.08 92.6 7.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.67 -1.15 . . . . 15.0 109.494 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 32.4 m -67.41 94.18 0.38 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.388 -0.824 . . . . 15.0 109.896 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 p -75.18 -66.96 0.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.137 0.975 . . . . 15.0 111.343 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -151.23 121.6 7.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.927 0.491 . . . . 15.0 110.368 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -103.96 0.64 Allowed Glycine 0 C--N 1.35 1.325 0 O-C-N 124.38 1.05 . . . . 15.0 114.239 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 2.5 mm? -77.33 -34.29 55.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.508 0.723 . . . . 15.0 110.083 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.37 97.4 0.11 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 124.622 1.201 . . . . 15.0 114.06 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HD2' HG11 ' A' ' 111' ' ' VAL . 50.9 mtt85 -112.59 86.81 2.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.354 -1.35 . . . . 15.0 107.354 168.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -72.53 91.53 1.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.47 -1.241 . . . . 15.0 110.376 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.7 t -79.27 87.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.774 -0.824 . . . . 15.0 108.774 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 88.8 m -74.77 105.36 5.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.321 -0.854 . . . . 15.0 109.779 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.599 HG12 HG13 ' A' ' 3' ' ' VAL . 33.6 mt -101.28 118.49 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.679 0.791 . . . . 15.0 110.301 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.1 m -88.75 104.87 17.3 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.366 0.666 . . . . 15.0 109.214 165.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -81.29 108.16 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.939 -1.134 . . . . 15.0 107.939 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.95 160.12 33.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.929 0.491 . . . . 15.0 111.869 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.27 -22.5 66.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.363 1.065 . . . . 15.0 113.419 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.35 -42.03 88.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.836 0.455 . . . . 15.0 109.963 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 m -70.95 -40.16 72.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.161 -0.927 . . . . 15.0 110.278 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 28' ' ' VAL . 67.0 mt -69.85 -51.97 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.656 0.782 . . . . 15.0 111.087 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.86 -39.83 90.63 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.758 0.823 . . . . 15.0 111.077 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.7 m -66.24 -44.7 83.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.609 -0.723 . . . . 15.0 110.952 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.23 -39.86 78.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.217 0.607 . . . . 15.0 112.522 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 24' ' ' ILE . 66.7 t -61.18 -44.95 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.131 0.572 . . . . 15.0 109.728 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 3.9 ttmp? -67.82 -39.49 83.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.241 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -73.41 -16.93 61.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.414 1.085 . . . . 15.0 111.424 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -88.6 -39.98 13.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.937 0.495 . . . . 15.0 110.439 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.23 -20.79 60.05 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.89 0.7 . . . . 15.0 112.89 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 37' ' ' LYS . 14.2 p -66.39 -32.19 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 109.854 -0.424 . . . . 15.0 109.854 174.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -67.97 -45.3 74.54 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.901 0.88 . . . . 15.0 109.917 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.5 -40.08 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 114.923 -1.035 . . . . 15.0 110.506 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.65 85.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.889 0.876 . . . . 15.0 110.85 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 33' ' ' VAL . 95.2 mttt -66.82 -44.19 81.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.652 -0.704 . . . . 15.0 111.462 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.08 -51.24 68.76 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.731 0.644 . . . . 15.0 110.752 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.43 -5.35 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 115.544 -0.753 . . . . 15.0 110.904 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 76.05 10.77 3.09 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.598 1.559 . . . . 15.0 112.39 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.11 -33.5 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.264 1.026 . . . . 15.0 110.607 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.76 -41.47 77.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 15.0 110.276 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.11 -36.23 92.03 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 124.204 0.94 . . . . 15.0 112.947 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -77.81 -31.96 52.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.167 0.587 . . . . 15.0 110.794 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -75.57 117.3 17.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.937 0.495 . . . . 15.0 110.989 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.95 21.36 17.67 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.776 0.83 . . . . 15.0 110.205 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.67 48.41 50.05 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.465 -0.789 . . . . 15.0 112.426 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.26 -60.71 3.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.115 0.566 . . . . 15.0 110.713 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 t -103.86 128.73 26.66 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.4 148.74 4.86 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 124.045 3.163 . . . . 15.0 114.917 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG21 ' A' ' 54' ' ' VAL . 53.6 tpp -65.18 -36.56 84.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.338 1.055 . . . . 15.0 111.984 -172.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -58.59 -37.68 76.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.501 0.721 . . . . 15.0 111.964 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.77 -54.25 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.153 0.981 . . . . 15.0 110.557 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 51' ' ' MET . 35.6 m -68.56 -34.24 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.488 0.551 . . . . 15.0 112.488 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.11 63.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.89 0.476 . . . . 15.0 112.058 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -70.04 -19.94 63.27 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.125 0.417 . . . . 15.0 112.125 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.34 -58.92 2.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.1 0.56 . . . . 15.0 111.142 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.65 -23.27 66.13 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.993 0.517 . . . . 15.0 111.98 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.4 21.55 40.01 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.715 -0.491 . . . . 15.0 113.935 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.82 73.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.501 0.721 . . . . 15.0 110.865 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 p -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.48 0.712 . . . . 15.0 111.096 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.17 -6.99 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 124.306 1.043 . . . . 15.0 112.05 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -55.07 -38.42 68.02 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.849 0.46 . . . . 15.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -58.2 -47.4 83.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.682 0.793 . . . . 15.0 111.469 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.17 -43.76 98.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.559 0.744 . . . . 15.0 110.551 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.38 -44.33 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.414 -1.266 . . . . 15.0 110.946 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' HG3' ' A' ' 71' ' ' MET . 91.2 mt -66.95 -36.75 82.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.939 0.495 . . . . 15.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.583 ' HA2' ' HE2' ' A' ' 71' ' ' MET . . . -58.24 -43.72 95.33 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.734 0.646 . . . . 15.0 111.873 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 27.4 t70 -64.08 -48.38 76.43 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.48 0.712 . . . . 15.0 110.512 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.576 ' HB3' HD11 ' A' ' 19' ' ' ILE . 80.5 mt -63.38 -32.46 73.89 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.191 0.996 . . . . 15.0 112.556 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.583 ' HE2' ' HA2' ' A' ' 68' ' ' GLY . 58.8 mtm -61.62 -41.52 97.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.613 0.365 . . . . 15.0 110.561 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -72.85 -36.86 67.52 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.597 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 29.4 mmt180 -60.63 -52.32 65.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.411 0.684 . . . . 15.0 110.65 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 17' ' ' ILE . 33.7 m-80 -75.65 -26.06 57.39 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.188 -0.914 . . . . 15.0 111.756 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -68.7 -58.07 4.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.577 0.351 . . . . 15.0 110.925 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.39 -40.44 87.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 123.721 0.638 . . . . 15.0 110.288 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.92 -40.37 96.33 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.219 1.008 . . . . 15.0 110.85 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.26 -61.77 2.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.595 -0.729 . . . . 15.0 111.446 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 pt -60.73 -24.45 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.63 0.772 . . . . 15.0 112.975 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.6 -58.08 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.543 0.737 . . . . 15.0 110.532 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.4 ptpt -77.57 -23.41 50.0 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.055 0.391 . . . . 15.0 112.055 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -86.89 -17.24 33.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.21 0.604 . . . . 15.0 110.749 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 62.0 33.47 17.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.417 1.087 . . . . 15.0 111.416 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.9 mt -77.96 106.5 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.96 -1.126 . . . . 15.0 107.96 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.486 HD22 ' HB2' ' A' ' 112' ' ' TYR . 8.0 t30 -78.07 102.4 0.94 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.8 0.84 . . . . 15.0 109.047 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -94.5 -177.0 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.237 2.625 . . . . 15.0 112.662 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.89 166.17 11.39 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.447 1.099 . . . . 15.0 109.635 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.43 -156.43 51.1 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.472 -0.786 . . . . 15.0 113.675 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.29 67.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.661 0.785 . . . . 15.0 109.665 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.26 107.35 0.56 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.416 2.077 . . . . 15.0 111.041 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -87.13 94.88 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.482 0.713 . . . . 15.0 109.912 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.99 91.53 4.86 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.21 109.37 6.21 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.596 -0.89 . . . . 15.0 108.596 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.07 98.63 0.73 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.363 2.042 . . . . 15.0 110.861 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.82 -71.23 0.88 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.187 -0.915 . . . . 15.0 112.329 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -169.89 133.42 1.21 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.919 0.887 . . . . 15.0 110.238 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -107.96 123.57 48.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.097 0.559 . . . . 15.0 109.642 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 93.3 mttt -97.41 129.59 44.62 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 171.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.2 101.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.279 1.031 . . . . 15.0 112.16 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.51 79.21 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.68 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.2 mt-10 -116.43 -163.92 0.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 15.0 108.383 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -73.54 116.01 13.61 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.095 0.558 . . . . 15.0 111.06 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -79.37 138.57 37.72 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.201 1.0 . . . . 15.0 109.3 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.2 m -133.83 132.83 40.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.109 -0.7 . . . . 15.0 109.109 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.58 169.42 21.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.064 0.946 . . . . 15.0 108.866 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 52.1 m -125.71 119.56 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.324 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -98.33 106.42 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.84 133.58 45.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -154.27 167.11 31.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.498 0.719 . . . . 15.0 109.536 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.701 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 31.8 mt-10 -84.71 170.38 13.33 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 15.0 110.238 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.454 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.0 m -136.83 155.12 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.85 0.86 . . . . 15.0 108.941 174.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HB2' HD22 ' A' ' 85' ' ' ASN . 68.3 m-85 -78.91 109.82 12.28 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 169.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.34 -173.62 1.78 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.035 2.49 . . . . 15.0 112.771 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -78.15 104.34 8.67 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.744 -175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.56 103.0 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.943 0.877 . . . . 15.0 108.671 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -102.59 101.04 11.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.598 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.69 140.34 32.21 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.281 -0.637 . . . . 15.0 109.281 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.95 -166.83 1.31 Allowed 'General case' 0 C--O 1.246 0.896 0 N-CA-C 108.747 -0.834 . . . . 15.0 108.747 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.67 109.35 2.31 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.247 -0.741 . . . . 15.0 111.247 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 414' ' ' LYS . 69.0 mt -66.16 -14.61 62.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.33 0.652 . . . . 15.0 111.063 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.68 -32.89 69.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.371 1.469 . . . . 15.0 111.698 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.33 75.43 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.873 0.869 . . . . 15.0 112.145 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -65.15 130.98 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.276 1.03 . . . . 15.0 110.397 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.52 115.39 29.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.636 0.774 . . . . 15.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 289' ' ' GLN . 38.3 t -120.13 159.14 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 125.241 1.416 . . . . 15.0 108.47 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.55 149.46 34.41 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.533 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.0 tttt -124.11 105.56 31.57 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 107.86 -1.163 . . . . 15.0 107.86 168.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.73 99.12 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 121.77 1.646 . . . . 15.0 110.54 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 41.4 mm -66.42 97.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.552 -1.277 . . . . 15.0 107.552 169.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.47 HG23 HD11 ' A' ' 427' ' ' LEU . 40.3 t -132.42 145.74 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.475 0.655 . . . . 15.0 111.362 -172.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -142.94 150.96 40.43 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.513 1.525 . . . . 15.0 107.553 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.561 HG13 ' SD ' ' A' ' 274' ' ' MET . 6.6 t -80.89 87.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.672 -1.233 . . . . 15.0 107.672 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.1 p -69.85 171.87 8.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.416 0.686 . . . . 15.0 110.117 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -58.1 -33.33 69.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.81 0.444 . . . . 15.0 111.285 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.54 82.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 15.0 110.512 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.16 -42.57 72.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.206 -0.906 . . . . 15.0 111.811 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.05 -54.6 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.85 0.86 . . . . 15.0 109.827 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.56 -44.8 93.07 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.124 0.89 . . . . 15.0 110.549 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.5 -40.92 99.29 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.845 0.716 . . . . 15.0 113.475 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.542 ' HG2' ' HE1' ' A' ' 274' ' ' MET . 13.6 tpt -67.42 -57.48 6.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.554 0.742 . . . . 15.0 110.476 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.61 HD22 HD11 ' A' ' 144' ' ' LEU . 90.7 mt -55.24 -32.92 62.7 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.631 0.772 . . . . 15.0 112.583 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.63 -51.91 63.14 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.329 1.052 . . . . 15.0 109.961 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.9 m -67.18 -24.37 65.86 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.5 0.72 . . . . 15.0 111.533 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.61 HD11 HD22 ' A' ' 141' ' ' LEU . 74.9 mt -71.94 -47.29 53.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.83 0.452 . . . . 15.0 110.326 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.596 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 47.2 mtm180 -74.82 -19.36 60.22 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 111.696 0.258 . . . . 15.0 111.696 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -79.52 -23.41 42.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.827 -0.546 . . . . 15.0 110.461 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.09 -35.24 69.17 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.476 -0.565 . . . . 15.0 109.476 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -87.74 42.39 1.05 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.997 0.919 . . . . 15.0 109.656 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.32 118.18 4.51 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.167 1.387 . . . . 15.0 114.245 -168.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 244' ' ' GLU . 17.4 m -79.33 114.68 18.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.69 -0.855 . . . . 15.0 108.69 169.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.414 ' HZ3' ' HG3' ' A' ' 163' ' ' ARG . 36.3 m95 -79.88 110.9 15.68 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.414 -0.587 . . . . 15.0 109.414 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -141.59 115.18 9.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.36 0.664 . . . . 15.0 110.397 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.82 131.6 50.35 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.145 0.578 . . . . 15.0 110.527 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.569 ' HE3' ' HB2' ' A' ' 242' ' ' GLU . 18.1 ptpt -108.37 172.02 7.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.528 0.731 . . . . 15.0 110.801 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.4 91.82 8.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.718 -0.674 . . . . 15.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.55 -56.48 1.25 Allowed Glycine 0 CA--C 1.544 1.902 0 N-CA-C 118.277 2.071 . . . . 15.0 118.277 159.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.15 132.46 47.86 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.67 1.235 . . . . 15.0 111.631 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.506 HG11 HG23 ' A' ' 202' ' ' ILE . 20.0 t -95.54 136.52 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 122.9 0.48 . . . . 15.0 110.079 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.85 171.87 8.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.943 1.297 . . . . 15.0 108.823 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.77 65.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.793 0.837 . . . . 15.0 112.021 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -95.34 13.54 25.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.326 0.65 . . . . 15.0 111.713 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -84.33 178.65 7.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.868 0.842 . . . . 15.0 113.068 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.414 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 1.7 tmm_? -131.94 92.52 3.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 106.687 -1.597 . . . . 15.0 106.687 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.7 t -89.42 157.22 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.461 1.105 . . . . 15.0 110.378 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.698 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 61.5 m -132.77 134.84 45.24 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.867 -1.16 . . . . 15.0 107.867 166.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 237' ' ' LEU . 27.8 pt -148.33 169.68 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.652 1.181 . . . . 15.0 110.303 -171.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -104.6 155.57 18.72 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 106.269 -1.752 . . . . 15.0 106.269 156.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 24.4 p90 -151.2 165.08 35.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.019 0.438 . . . . 15.0 111.131 167.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.1 t -142.75 103.15 4.16 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.006 -0.997 . . . . 15.0 108.626 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.84 140.33 15.81 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 114.914 -1.039 . . . . 15.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.3 p -150.13 116.59 5.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.974 0.91 . . . . 15.0 108.741 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 25.6 t -86.57 115.48 27.65 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 C-N-CA 123.498 0.719 . . . . 15.0 110.066 -168.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.1 t70 71.16 -1.26 2.78 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.063 1.345 . . . . 15.0 111.092 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.76 31.66 6.59 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.315 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 19.9 pt-20 -131.29 150.47 52.14 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 123.485 0.714 . . . . 15.0 110.542 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -90.86 81.63 5.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.756 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.648 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 0.0 OUTLIER -52.28 -70.12 0.1 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.4 1.48 . . . . 15.0 110.839 165.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.715 ' HB2' HG11 ' B' ' 386' ' ' VAL . 65.4 mm-40 -99.39 176.35 5.54 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.021 1.328 . . . . 15.0 109.487 168.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.97 5.72 0.12 Allowed Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.346 1.698 . . . . 15.0 117.346 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.43 -60.87 3.26 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 117.754 0.777 . . . . 15.0 113.493 168.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.67 160.74 14.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.627 0.973 . . . . 15.0 113.627 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.85 94.19 1.84 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.452 -1.249 . . . . 15.0 109.025 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.3 m -69.53 125.1 25.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.233 1.013 . . . . 15.0 112.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.03 41.8 10.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.64 1.176 . . . . 15.0 112.393 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.433 ' CZ ' HD22 ' B' ' 385' ' ' LEU . 18.7 t80 -67.92 131.85 46.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.345 -0.843 . . . . 15.0 109.365 170.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.78 104.15 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.019 1.328 . . . . 15.0 108.357 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.4 tp -90.95 98.44 11.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 15.0 111.542 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.46 83.55 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.556 ' HE1' ' HB3' ' A' ' 203' ' ' LYS . 50.8 mtp -57.02 134.03 55.45 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.547 0.739 . . . . 15.0 110.941 -174.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.91 -28.68 4.84 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 -168.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.38 114.62 9.65 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.008 0.523 . . . . 15.0 109.899 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.53 3.15 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.22 -0.446 . . . . 15.0 112.647 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.522 ' NH2' HD21 ' B' ' 385' ' ' LEU . 2.9 tmm_? -87.12 -33.88 19.3 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.485 -0.931 . . . . 15.0 108.485 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.1 mmt -84.37 154.14 23.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.196 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.5 pt -86.75 163.7 40.07 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.244 0.618 . . . . 15.0 110.824 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.17 144.75 46.28 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.72 2.28 . . . . 15.0 112.276 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.88 -52.93 0.61 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.839 -0.904 . . . . 15.0 110.839 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -66.47 -54.4 24.52 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.454 -0.573 . . . . 15.0 109.454 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.66 -40.77 69.36 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.79 -32.54 71.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.02 0.928 . . . . 15.0 110.465 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -71.15 -16.85 75.35 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.105 -0.952 . . . . 15.0 113.293 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.506 HG23 HG11 ' A' ' 158' ' ' VAL . 36.1 mm -93.68 -54.51 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.771 0.828 . . . . 15.0 109.553 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HB3' ' HE1' ' A' ' 189' ' ' MET . 60.0 pttt -79.55 14.02 1.8 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.676 0.991 . . . . 15.0 113.676 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -122.06 20.21 8.11 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.099 -0.801 . . . . 15.0 111.099 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -142.37 -171.11 3.33 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.968 0.907 . . . . 15.0 111.175 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -149.89 154.03 37.66 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.279 1.032 . . . . 15.0 109.797 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.593 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -60.57 148.26 38.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.095 0.958 . . . . 15.0 112.598 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.72 -48.41 0.94 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.175 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.7 pt-20 -74.08 133.46 42.87 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.519 0.676 . . . . 15.0 110.419 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.53 105.56 10.58 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.147 0.979 . . . . 15.0 108.539 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -124.02 -169.16 1.91 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.944 1.298 . . . . 15.0 110.278 -168.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 44.8 m -136.3 125.69 24.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.897 0.879 . . . . 15.0 109.402 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.447 HG22 ' HA3' ' A' ' 201' ' ' GLY . 46.6 pt -102.6 154.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.633 0.773 . . . . 15.0 109.435 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -116.45 104.6 11.6 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.264 1.025 . . . . 15.0 108.395 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.2 t -92.35 154.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 107.087 -1.449 . . . . 15.0 107.087 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 m -137.5 121.33 17.56 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.087 0.858 . . . . 15.0 109.3 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 51.1 m-85 -92.21 136.47 25.73 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 119.539 -0.267 . . . . 15.0 111.373 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 81.1 Cg_exo -54.57 170.9 0.49 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.977 3.784 . . . . 15.0 117.3 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 22.6 mm-40 -79.74 -26.36 40.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.147 -1.388 . . . . 15.0 110.473 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -25.28 63.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.873 0.869 . . . . 15.0 110.383 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 226' ' ' LEU . 6.9 t80 -68.15 106.56 2.45 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.612 -0.885 . . . . 15.0 108.612 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.68 -19.29 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.882 0.873 . . . . 15.0 113.208 -167.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.88 101.85 3.9 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 41.3 tt0 -67.38 -24.99 65.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 15.0 112.287 -173.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -63.92 -17.85 63.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.686 0.794 . . . . 15.0 112.222 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.46 ' HG ' HG11 ' B' ' 388' ' ' VAL . 16.7 mt -114.35 -30.61 6.53 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.27 0.628 . . . . 15.0 111.316 173.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.644 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 55.2 tttm -55.68 116.67 3.05 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.227 1.411 . . . . 15.0 111.809 -172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.58 -19.94 8.26 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.834 0.709 . . . . 15.0 113.885 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -87.29 156.99 19.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.806 0.842 . . . . 15.0 110.847 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -109.28 112.96 25.4 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -80.71 113.36 18.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 15.0 111.35 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -83.67 97.32 9.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.638 -0.71 . . . . 15.0 109.966 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.485 ' HZ ' HD11 ' B' ' 387' ' ' ILE . 95.9 m-85 -93.83 109.02 20.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.92 92.24 4.26 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.63 126.09 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.56 0.744 . . . . 15.0 110.46 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.16 91.07 3.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.204 1.002 . . . . 15.0 109.198 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 84.5 mt -68.41 108.0 3.09 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 110.152 -0.314 . . . . 15.0 110.152 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -110.87 -40.43 4.53 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.391 0.676 . . . . 15.0 110.103 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.698 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.5 mmtt -131.44 136.61 48.11 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.185 0.994 . . . . 15.0 109.594 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 207' ' ' ALA . 25.6 t -130.74 115.01 29.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.768 -1.567 . . . . 15.0 106.768 168.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -112.31 -175.37 2.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.569 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 35.4 tt0 -133.58 130.85 38.96 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 175.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -79.18 82.79 5.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.1 -1.445 . . . . 15.0 107.1 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 42.0 tt0 -73.89 147.62 43.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.72 -1.582 . . . . 15.0 111.353 -171.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.21 114.64 19.6 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.728 0.811 . . . . 15.0 109.173 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 30.2 Cg_endo -59.74 150.55 76.37 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.257 2.638 . . . . 15.0 111.291 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -53.54 106.82 0.2 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.422 1.076 . . . . 15.0 110.033 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.519 HD12 ' HD2' ' A' ' 252' ' ' PHE . 31.8 tp -77.06 73.54 3.64 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 253' ' ' ILE . 67.5 p -91.55 168.68 11.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.014 -0.994 . . . . 15.0 108.805 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.97 -45.55 42.28 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.751 1.22 . . . . 15.0 111.979 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.36 -21.1 60.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.911 0.884 . . . . 15.0 112.886 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.519 ' HD2' HD12 ' A' ' 248' ' ' LEU . 59.6 t80 -85.69 -49.99 7.54 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.508 -0.553 . . . . 15.0 109.508 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.469 HG21 ' O ' ' A' ' 249' ' ' THR . 6.2 tt -67.29 -28.34 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.044 0.538 . . . . 15.0 111.564 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.64 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.4 ptmt -79.61 -12.43 59.84 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.826 0.676 . . . . 15.0 112.826 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.92 -25.7 65.35 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.093 0.557 . . . . 15.0 111.51 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -68.15 -33.83 75.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.089 0.956 . . . . 15.0 111.932 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.68 7.22 0.46 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 116.664 -0.244 . . . . 15.0 113.271 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 20.5 t -79.26 157.75 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.652 0.781 . . . . 15.0 110.119 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -59.82 -72.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.832 1.253 . . . . 15.0 111.92 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -121.86 6.61 9.87 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.554 0.742 . . . . 15.0 110.456 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.95 4.93 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.953 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 7.1 m -64.21 132.02 49.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.136 0.975 . . . . 15.0 110.561 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.42 -47.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 124.049 0.843 . . . . 15.0 110.241 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.6 -32.87 63.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.729 0.812 . . . . 15.0 111.609 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.55 ' HA3' HG13 ' A' ' 258' ' ' VAL . . . -79.28 -25.06 60.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 111.276 -0.73 . . . . 15.0 111.276 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.24 -33.62 56.02 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.404 ' HA ' HG22 ' A' ' 270' ' ' VAL . 18.4 mtp180 -67.75 -38.72 83.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.418 0.687 . . . . 15.0 109.641 175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.02 82.5 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.198 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.19 -48.18 76.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.127 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.437 ' HB ' ' HE3' ' A' ' 274' ' ' MET . 24.3 m -69.37 -27.88 36.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.318 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -65.05 -52.45 55.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.218 0.463 . . . . 15.0 110.296 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 377' ' ' ALA . 13.2 ptmm? -73.79 -16.7 61.15 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.983 0.734 . . . . 15.0 112.983 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -95.1 -47.39 6.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 118.167 0.439 . . . . 15.0 111.796 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.561 ' SD ' HG13 ' A' ' 132' ' ' VAL . 66.4 mtt -73.83 -26.23 60.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 118.653 -0.689 . . . . 15.0 111.459 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.6 -32.88 41.93 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 119.062 0.846 . . . . 15.0 110.443 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.428 ' NH2' ' HB2' ' A' ' 377' ' ' ALA . 24.2 tpp180 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.923 0.489 . . . . 15.0 110.186 174.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -76.96 -60.29 2.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.309 -0.86 . . . . 15.0 109.881 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.414 HD12 HG11 ' A' ' 130' ' ' VAL . 58.8 tp -70.69 -59.73 2.65 Favored 'General case' 0 C--O 1.211 -0.947 0 C-N-CA 124.022 0.929 . . . . 15.0 112.933 -168.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.76 -32.61 73.79 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.797 0.439 . . . . 15.0 110.713 -171.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -68.92 -46.56 67.97 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.08 -0.964 . . . . 15.0 109.658 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.38 72.53 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.336 0.655 . . . . 15.0 111.949 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 286' ' ' VAL . 79.8 mt -70.94 -51.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -58.34 -42.15 86.23 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.992 0.808 . . . . 15.0 110.338 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.13 61.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 15.0 110.947 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -63.94 -59.44 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 282' ' ' ILE . 40.2 t -58.53 -44.3 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 114.95 -1.023 . . . . 15.0 110.457 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -68.78 -41.15 79.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.668 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.4 p -65.25 -40.35 93.9 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.991 0.359 . . . . 15.0 110.489 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.438 ' HB2' HG12 ' A' ' 125' ' ' VAL . 51.5 mt-30 -68.68 -34.93 76.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.53 0.519 . . . . 15.0 111.245 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.8 -50.22 67.59 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.132 0.573 . . . . 15.0 110.519 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 295' ' ' VAL . 27.0 mm -65.07 -54.62 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.676 0.791 . . . . 15.0 110.907 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.64 -38.54 90.66 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.761 0.663 . . . . 15.0 110.383 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.96 -35.3 89.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.581 -0.736 . . . . 15.0 112.758 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.5 OUTLIER -66.32 -42.59 88.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.97 0.908 . . . . 15.0 110.299 177.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 291' ' ' ILE . 47.6 t -62.13 -53.43 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.799 -0.815 . . . . 15.0 108.799 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.26 -27.64 69.15 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.593 -1.185 . . . . 15.0 111.613 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.17 59.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 15.0 113.171 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.79 150.63 15.64 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.204 0.816 . . . . 15.0 113.204 -169.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.06 143.27 58.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.774 0.829 . . . . 15.0 111.113 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.456 HG12 HG11 ' A' ' 346' ' ' VAL . 6.1 tp -147.62 115.04 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.0 130.77 54.59 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.217 1.007 . . . . 15.0 108.57 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.579 HG21 HD21 ' A' ' 349' ' ' LEU . 45.6 t -131.95 131.26 22.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.935 0.894 . . . . 15.0 110.097 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.426 ' HB2' ' HG ' ' A' ' 306' ' ' LEU . 53.0 Cg_exo -55.06 130.14 39.11 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.144 2.562 . . . . 15.0 112.468 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.61 -24.83 67.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.506 1.122 . . . . 15.0 112.902 -173.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.12 73.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.201 0.6 . . . . 15.0 111.536 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 303' ' ' PRO . 19.5 mt -69.86 -43.39 71.97 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.379 -0.6 . . . . 15.0 109.379 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 304' ' ' ALA . 3.2 mp -59.09 -50.21 80.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.013 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.17 -35.74 81.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.783 0.833 . . . . 15.0 111.738 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -44.03 94.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.376 0.671 . . . . 15.0 110.339 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -79.13 -27.4 42.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.647 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.43 HG22 ' HB2' ' A' ' 337' ' ' PHE . 34.0 mt -65.76 -35.88 76.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 108.585 -0.895 . . . . 15.0 108.585 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.557 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 14.9 t70 -63.67 -44.07 94.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.653 0.781 . . . . 15.0 110.575 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.67 -52.12 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 123.72 0.637 . . . . 15.0 110.114 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.27 -21.41 62.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.897 -1.047 . . . . 15.0 112.426 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 58.9 mtm180 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 123.908 0.883 . . . . 15.0 109.871 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 50.0 tp . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 111.926 0.343 . . . . 15.0 111.926 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.06 -8.58 53.66 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.489 0.716 . . . . 15.0 112.388 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 69.0 mt -54.03 130.31 58.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 118.587 0.63 . . . . 15.0 110.248 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.526 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 86.2 Cg_exo -48.35 116.04 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.634 2.889 . . . . 15.0 113.759 -170.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -51.7 -37.78 52.27 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.925 0.89 . . . . 15.0 111.519 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -54.5 -33.13 59.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.174 0.989 . . . . 15.0 112.851 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 95.3 mt -62.7 -30.16 71.2 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.274 0.559 . . . . 15.0 110.891 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.499 ' HA ' HE21 ' A' ' 340' ' ' GLN . 28.2 m-85 -116.47 -3.04 11.9 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.246 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.83 -63.05 1.3 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.304 1.042 . . . . 15.0 111.965 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.05 -47.18 85.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.15 0.906 . . . . 15.0 111.589 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 337' ' ' PHE . 16.8 pt20 -67.72 -51.93 43.54 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.683 0.614 . . . . 15.0 111.558 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.3 -43.21 98.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.776 0.43 . . . . 15.0 110.627 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.38 -43.24 88.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 123.883 0.739 . . . . 15.0 110.164 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.47 ' O ' HG21 ' A' ' 347' ' ' VAL . 45.3 mmt-85 -61.31 -35.75 78.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.655 -0.688 . . . . 15.0 111.268 172.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.5 mtt-85 -69.33 -34.01 73.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.807 0.443 . . . . 15.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.684 ' HA ' ' HB2' ' B' ' 467' ' ' ALA . 9.9 t -77.69 -41.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.856 0.36 . . . . 15.0 110.069 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.456 HG11 HG12 ' A' ' 300' ' ' ILE . 53.6 t -58.88 -35.05 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.455 -0.793 . . . . 15.0 110.449 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 343' ' ' ARG . 11.8 t -51.28 -54.55 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.675 0.79 . . . . 15.0 109.316 169.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.99 -37.85 93.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.404 -0.816 . . . . 15.0 114.334 -174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.579 HD21 HG21 ' A' ' 302' ' ' VAL . 10.3 mp -72.02 -50.11 31.26 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.858 0.829 . . . . 15.0 111.124 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 354' ' ' VAL . 87.6 mt -63.05 -52.85 61.16 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.271 0.357 . . . . 15.0 110.337 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 347' ' ' VAL . 81.5 mt -69.85 -31.19 68.91 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.904 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -62.42 -39.22 97.51 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 111.779 -0.528 . . . . 15.0 111.779 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.67 -38.63 84.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.096 -0.552 . . . . 15.0 110.429 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -60.6 -36.43 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 122.746 0.418 . . . . 15.0 111.07 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.538 HD13 ' HA2' ' A' ' 352' ' ' GLY . 85.3 mt -62.96 -52.58 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.876 0.87 . . . . 15.0 109.902 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -62.14 -56.42 18.93 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.52 0.513 . . . . 15.0 110.912 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.1 m -54.67 -48.25 72.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 15.0 112.192 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.2 16.34 11.69 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 119.323 -0.37 . . . . 15.0 111.919 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 44.46 41.34 4.55 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 125.746 1.618 . . . . 15.0 113.776 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.467 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.8 mt -74.7 150.51 39.46 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.021 -0.99 . . . . 15.0 112.184 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 147.29 52.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.456 1.102 . . . . 15.0 109.555 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.23 92.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.117 0.567 . . . . 15.0 110.438 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 367' ' ' VAL . 13.9 t70 -70.54 127.01 31.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.834 0.854 . . . . 15.0 110.44 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.47 -32.96 74.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.631 1.172 . . . . 15.0 112.783 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.15 -23.76 60.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.461 0.304 . . . . 15.0 110.336 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.452 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 40.6 tpt85 -80.51 -33.58 36.35 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.129 0.572 . . . . 15.0 109.585 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 363' ' ' ASP . 44.6 t -61.68 -54.46 34.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -65.69 -28.7 69.27 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.859 0.724 . . . . 15.0 110.868 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.55 -54.01 37.48 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 111.66 -0.576 . . . . 15.0 111.66 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.34 -56.52 20.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.592 0.757 . . . . 15.0 110.698 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.604 HD13 ' HG2' ' A' ' 398' ' ' MET . 44.9 mm -50.75 -53.4 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 124.771 1.294 . . . . 15.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.04 -41.51 61.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.004 0.521 . . . . 15.0 111.133 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.59 -23.28 62.55 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.64 0.607 . . . . 15.0 112.64 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 -33.3 12.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 119.159 -0.448 . . . . 15.0 111.57 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -93.24 -40.64 10.33 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 112.671 0.619 . . . . 15.0 112.671 -171.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 381' ' ' PRO . 22.1 t -70.06 -13.29 62.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.01 0.374 . . . . 15.0 112.01 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 272' ' ' LYS . . . -86.92 -0.56 56.74 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.136 0.574 . . . . 15.0 111.664 174.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -94.69 -175.31 3.55 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.426 0.69 . . . . 15.0 110.367 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.85 -51.67 17.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.437 1.095 . . . . 15.0 110.305 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -123.33 106.92 32.71 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 174.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 376' ' ' SER . 97.1 Cg_endo -84.93 -23.56 2.47 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.599 2.199 . . . . 15.0 113.61 170.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -57.23 -49.54 75.7 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.453 0.701 . . . . 15.0 112.288 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.61 -16.06 60.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.267 -0.879 . . . . 15.0 111.383 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.417 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 88.7 t -76.58 -50.26 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.604 -0.888 . . . . 15.0 108.604 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.22 -49.53 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.635 0.774 . . . . 15.0 109.078 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.94 -36.14 80.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.237 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.05 -57.99 10.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.754 0.422 . . . . 15.0 110.451 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.448 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 87.0 m-85 -64.09 -53.05 55.87 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.892 0.745 . . . . 15.0 111.352 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.0 p -56.05 -33.94 65.45 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -98.13 -4.61 35.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.075 0.55 . . . . 15.0 112.461 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -119.49 90.18 3.28 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -56.09 -29.28 60.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.765 1.226 . . . . 15.0 113.031 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.85 -57.88 10.99 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.407 0.683 . . . . 15.0 111.056 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.66 -18.9 28.54 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.243 -0.89 . . . . 15.0 109.775 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 7.4 tpt -67.13 -43.32 82.69 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -40.03 95.77 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.065 0.946 . . . . 15.0 110.403 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.86 -44.1 90.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.258 0.623 . . . . 15.0 110.378 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.604 ' HG2' HD13 ' A' ' 371' ' ' ILE . 37.7 tpp -72.72 -23.52 60.86 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.488 -0.778 . . . . 15.0 111.671 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -76.53 -35.32 58.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.599 0.76 . . . . 15.0 109.85 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' B' ' 464' ' ' MET . 0.9 OUTLIER -69.19 -38.4 78.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.139 0.576 . . . . 15.0 110.269 178.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.1 p -79.09 -22.86 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 119.49 -0.291 . . . . 15.0 111.11 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.41 96.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.866 0.757 . . . . 15.0 109.468 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.96 -34.92 64.45 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.844 -1.525 . . . . 15.0 111.77 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 401' ' ' VAL . 0.6 OUTLIER -67.93 -48.01 67.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.376 1.07 . . . . 15.0 109.965 177.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.452 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 6.1 mm-40 -56.49 -46.99 80.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.024 1.329 . . . . 15.0 111.199 171.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 360' ' ' LEU . 27.4 tt0 -62.32 -35.11 78.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.803 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.07 82.88 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.244 0.618 . . . . 15.0 110.997 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 59.5 t -56.1 -53.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.969 -0.752 . . . . 15.0 108.969 170.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -63.08 -26.45 68.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.163 0.985 . . . . 15.0 112.959 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -74.71 -27.36 60.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.06 0.544 . . . . 15.0 111.148 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.79 -38.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.521 -0.918 . . . . 15.0 108.521 171.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.8 mt -67.56 -35.16 78.51 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.78 0.832 . . . . 15.0 111.32 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.57 -20.83 65.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.648 0.779 . . . . 15.0 111.592 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.515 ' HD3' HD11 ' A' ' 120' ' ' LEU . 27.8 mtpp -105.67 -30.15 9.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.059 0.944 . . . . 15.0 111.556 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.82 159.25 22.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.071 0.948 . . . . 15.0 111.741 -172.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -75.61 82.63 2.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.972 0.909 . . . . 15.0 109.464 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 42.5 t -90.15 92.15 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -70.67 96.03 1.17 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.402 1.096 . . . . 15.0 110.493 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.533 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 37.1 mt-10 -75.2 105.01 6.0 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.253 -1.34 . . . . 15.0 109.562 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -114.41 138.29 50.75 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.279 0.562 . . . . 15.0 109.951 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 28.4 mt-10 -81.44 130.89 35.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.959 0.904 . . . . 15.0 109.193 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.417 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -163.64 169.55 18.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.285 0.634 . . . . 15.0 110.446 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.2 p -93.22 171.83 8.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.243 1.017 . . . . 15.0 111.487 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 428' ' ' MET . 57.0 t80 -52.54 -47.27 66.82 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.888 1.275 . . . . 15.0 110.828 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -54.93 -22.94 16.62 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.945 1.091 . . . . 15.0 113.945 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.495 ' HB3' HD13 ' A' ' 427' ' ' LEU . 10.0 tp10 -54.34 -55.7 25.82 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.647 0.779 . . . . 15.0 112.068 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.495 HD13 ' HB3' ' A' ' 426' ' ' GLU . 5.4 mp -74.87 -29.5 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.42 -0.809 . . . . 15.0 111.709 -167.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.1 OUTLIER -80.69 -42.87 21.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.992 0.517 . . . . 15.0 109.832 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 123.002 0.521 . . . . 15.0 111.109 -178.108 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . 0.522 HD21 ' NH2' ' A' ' 193' ' ' ARG . 5.6 mp . . . . . 0 C--O 1.243 0.758 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 178' ' ' GLU . 50.9 t -81.93 90.06 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 123.771 1.748 . . . . 0.0 109.265 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.648 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 7.6 tp -153.17 173.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 110.983 -2.826 . . . . 0.0 105.329 170.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.499 ' H ' HG13 ' B' ' 387' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -150.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.629 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.7 t80 . . . . . 0 N--CA 1.483 1.176 0 C-N-CA 125.258 1.423 . . . . 0.0 113.075 168.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . 0.503 HD13 ' H ' ' B' ' 460' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.142 0 CA-C-O 120.741 0.305 . . . . 0.0 110.798 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 66.82 -84.52 0.03 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.737 1.615 . . . . 0.0 111.644 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -91.33 135.31 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 59.6 m -58.16 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 O-C-N 124.243 0.964 . . . . 0.0 110.815 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 464' ' ' MET . . . . . 0.459 ' HA ' ' OD1' ' A' ' 400' ' ' ASN . 1.3 tmt? -129.48 110.17 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 108.576 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . 0.571 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.0 OUTLIER -80.86 121.16 25.63 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -51.38 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.942 1.401 . . . . 0.0 112.318 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 345' ' ' VAL . . . . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -82.2 108.33 15.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.42 -0.585 . . . . 15.0 109.42 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 17' ' ' ILE . 33.0 m -121.25 141.18 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 15.0 109.552 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 9.2 m -140.33 92.64 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.332 0.653 . . . . 15.0 109.405 -174.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.03 102.14 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-O 121.91 0.862 . . . . 15.0 110.492 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 38.6 mt-10 -92.41 107.2 19.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.781 0.832 . . . . 15.0 109.595 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -72.4 90.96 1.32 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.5 m -64.13 -51.67 62.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.69 1.196 . . . . 15.0 111.031 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -155.7 84.9 1.03 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.23 -0.441 . . . . 15.0 109.934 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.42 0.23 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 123.558 0.536 . . . . 15.0 113.063 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' HA ' HH12 ' A' ' 13' ' ' ARG . 10.0 mp -66.91 -37.74 84.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.655 0.782 . . . . 15.0 110.982 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.26 97.41 0.17 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 124.362 1.039 . . . . 15.0 112.311 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.507 HH12 ' HA ' ' A' ' 11' ' ' LEU . 66.9 mtt85 -108.75 143.14 38.28 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.799 1.24 . . . . 15.0 109.684 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 42.2 ttm180 -119.9 88.95 3.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.845 1.258 . . . . 15.0 107.868 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.75 91.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.581 0.705 . . . . 15.0 109.179 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 91.0 m -81.28 105.2 12.29 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.418 -1.265 . . . . 15.0 109.905 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 HG13 ' A' ' 3' ' ' VAL . 52.8 mt -107.29 127.73 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.167 0.587 . . . . 15.0 110.211 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 85.5 m -100.61 111.86 24.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.188 0.995 . . . . 15.0 108.649 171.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.7 mt -88.91 130.99 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.45 138.24 58.31 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.587 0.755 . . . . 15.0 110.815 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.53 -39.9 74.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.941 1.297 . . . . 15.0 112.598 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.29 -40.24 93.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.267 -0.879 . . . . 15.0 110.324 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -71.65 -26.18 62.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.524 0.729 . . . . 15.0 111.549 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -70.81 -51.12 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.638 0.775 . . . . 15.0 109.685 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.25 -24.15 59.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.463 -0.335 . . . . 15.0 111.587 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -68.35 -39.64 81.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.459 0.704 . . . . 15.0 109.776 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.15 -42.14 94.07 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.148 0.579 . . . . 15.0 111.011 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 66' ' ' VAL . 95.9 t -59.68 -44.78 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 121.625 0.726 . . . . 15.0 109.974 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.516 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -63.7 -36.11 82.78 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.592 -1.186 . . . . 15.0 111.089 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -92.67 -1.99 56.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.605 1.162 . . . . 15.0 111.245 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -99.71 -39.9 8.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.376 0.67 . . . . 15.0 109.782 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 55' ' ' ALA . 52.8 mt -82.12 -8.64 59.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.412 -0.813 . . . . 15.0 112.225 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.9 -31.62 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 109.241 -0.651 . . . . 15.0 109.241 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -71.98 -43.76 64.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.04 0.936 . . . . 15.0 109.334 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.91 -37.95 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.4 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -46.1 90.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.656 . . . . 15.0 110.853 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -69.58 -34.97 74.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.616 0.366 . . . . 15.0 111.698 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.28 -53.01 59.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.893 0.877 . . . . 15.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.85 2.19 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.718 0.807 . . . . 15.0 110.645 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 74.26 9.44 4.49 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.764 1.625 . . . . 15.0 112.695 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mt -58.31 -27.73 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.155 1.382 . . . . 15.0 111.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.58 -32.54 74.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.564 0.746 . . . . 15.0 111.122 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.32 -33.68 64.39 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.668 0.605 . . . . 15.0 111.852 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.5 -18.18 42.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.368 0.667 . . . . 15.0 110.766 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -70.58 108.34 4.3 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.518 0.727 . . . . 15.0 109.059 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -91.0 -2.81 57.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.278 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -7.87 79.39 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-O 119.548 -0.585 . . . . 15.0 113.859 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -65.82 -48.66 70.92 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.289 0.636 . . . . 15.0 110.768 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.08 121.79 80.98 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.474 -0.935 . . . . 15.0 108.474 174.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.68 131.68 45.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.882 2.388 . . . . 15.0 112.25 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.7 tpt -63.23 -32.6 74.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.308 1.043 . . . . 15.0 111.602 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.3 p30 -57.97 -38.8 76.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.587 0.755 . . . . 15.0 112.765 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.44 -51.93 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.085 0.954 . . . . 15.0 110.429 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.498 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 29.6 m -72.39 -19.34 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.754 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -74.18 -58.42 3.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.043 0.537 . . . . 15.0 110.983 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.535 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.7 pt20 -73.31 -34.71 65.86 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.878 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.1 mtt180 -96.51 -70.38 0.72 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.072 0.549 . . . . 15.0 111.091 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.498 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 91.8 m-85 -72.29 -18.89 61.76 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.473 0.709 . . . . 15.0 112.177 -169.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.27 23.4 15.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.526 -0.597 . . . . 15.0 112.704 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -21.82 66.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.088 0.955 . . . . 15.0 111.882 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.8 p -62.56 -32.44 73.41 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.563 0.745 . . . . 15.0 111.32 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 78.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.173 0.989 . . . . 15.0 109.692 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -108.07 -48.18 3.42 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.184 -0.673 . . . . 15.0 109.184 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -56.72 -45.34 81.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.677 1.191 . . . . 15.0 111.576 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.53 -34.1 77.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.85 -1.068 . . . . 15.0 111.206 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 28' ' ' VAL . 42.5 t -80.18 -63.64 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.24 -44.58 83.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.962 0.905 . . . . 15.0 112.773 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -63.48 -37.4 94.73 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.542 0.526 . . . . 15.0 112.606 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.35 -33.5 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.984 0.914 . . . . 15.0 111.122 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 70.4 mt -70.06 -32.5 70.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.955 0.502 . . . . 15.0 110.432 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.497 ' HE1' ' HA2' ' A' ' 68' ' ' GLY . 68.5 mtm -63.14 -37.64 88.01 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 123.413 0.445 . . . . 15.0 110.455 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 -55.6 5.81 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.488 0.715 . . . . 15.0 110.799 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -67.92 -37.15 81.3 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.117 0.567 . . . . 15.0 112.425 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -75.47 -30.02 59.78 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 117.875 0.307 . . . . 15.0 111.026 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -64.31 -54.54 31.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.073 0.549 . . . . 15.0 110.666 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.6 -35.13 71.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 123.74 0.65 . . . . 15.0 110.618 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.71 -47.66 82.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.63 0.772 . . . . 15.0 110.611 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -56.46 20.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.929 -1.032 . . . . 15.0 111.325 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.532 HD13 ' HD3' ' A' ' 86' ' ' PRO . 21.4 pt -64.88 -31.86 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.914 0.709 . . . . 15.0 112.914 -170.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.87 -49.23 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.798 0.439 . . . . 15.0 110.519 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -72.12 -29.71 64.34 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.641 -0.254 . . . . 15.0 111.053 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -87.3 1.34 53.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.514 0.726 . . . . 15.0 111.57 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 66.96 12.99 9.29 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.86 1.264 . . . . 15.0 112.942 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 70.4 mt -87.06 122.1 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.919 0.888 . . . . 15.0 108.727 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.9 117.27 35.66 Favored Pre-proline 0 N--CA 1.481 1.075 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.532 ' HD3' HD13 ' A' ' 79' ' ' ILE . 72.9 Cg_endo -71.6 152.71 59.76 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 15.0 113.383 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.67 52.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.099 -1.41 . . . . 15.0 107.218 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 304' ' ' ALA . . . -162.23 146.2 11.69 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.031 -1.44 . . . . 15.0 110.002 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -58.57 108.26 1.25 Allowed Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.415 0.607 . . . . 15.0 109.859 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 11.3 Cg_exo -69.16 109.8 2.28 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.439 2.093 . . . . 15.0 111.802 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 47.4 m -69.89 92.39 0.7 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.775 0.83 . . . . 15.0 109.971 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.43 104.71 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.92 103.56 3.45 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.021 -1.103 . . . . 15.0 108.021 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 104.24 1.32 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.076 1.851 . . . . 15.0 109.848 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.59 176.75 38.42 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.764 -0.653 . . . . 15.0 113.166 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.8 116.81 20.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.212 0.53 . . . . 15.0 110.07 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -102.01 98.78 8.94 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.783 -1.191 . . . . 15.0 107.783 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.7 mttt -77.84 136.47 38.09 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.769 -1.197 . . . . 15.0 107.769 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.01 106.94 2.51 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.394 -0.595 . . . . 15.0 109.394 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.64 10.46 40.78 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 116.238 -0.437 . . . . 15.0 112.693 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.3 mt-10 -134.71 -179.75 5.79 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.996 1.318 . . . . 15.0 109.221 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -81.04 173.71 12.32 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.597 0.759 . . . . 15.0 111.76 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -115.27 92.34 3.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 15.0 108.723 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -92.55 96.08 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.847 0.859 . . . . 15.0 109.228 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -108.98 178.23 4.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.43 0.692 . . . . 15.0 109.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.6 m -139.49 150.12 44.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.86 0.864 . . . . 15.0 109.284 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.97 117.22 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -98.07 136.91 37.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.401 1.08 . . . . 15.0 109.366 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -167.58 165.74 14.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.509 0.723 . . . . 15.0 109.823 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.89 174.67 5.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.306 0.643 . . . . 15.0 109.379 170.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.16 -166.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.161 0.984 . . . . 15.0 109.174 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 114.4 58.5 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 122.853 0.461 . . . . 15.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.03 112.47 3.26 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.681 2.254 . . . . 15.0 111.787 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.39 96.42 0.88 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.611 0.764 . . . . 15.0 109.421 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.97 134.38 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.054 0.941 . . . . 15.0 110.992 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.8 110.53 22.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.48 0.712 . . . . 15.0 109.379 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.623 ' HB3' HD22 ' A' ' 120' ' ' LEU . 94.1 mt -75.08 128.85 36.49 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -124.6 112.47 16.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.627 0.771 . . . . 15.0 109.784 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.0 67.1 2.28 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 124.469 1.106 . . . . 15.0 113.536 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 117' ' ' LEU . 38.5 mt -66.33 -25.15 66.69 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.59 0.356 . . . . 15.0 110.547 175.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -71.82 -35.99 70.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.084 0.953 . . . . 15.0 110.75 175.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.29 -22.09 63.83 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.538 0.735 . . . . 15.0 111.548 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.34 127.43 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.951 0.9 . . . . 15.0 109.991 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 38.2 mt-10 -108.47 110.14 21.58 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.835 0.854 . . . . 15.0 109.778 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.416 ' HB ' HG11 ' A' ' 417' ' ' VAL . 37.9 t -119.82 165.06 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.789 1.236 . . . . 15.0 107.853 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.04 149.01 32.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.625 -0.88 . . . . 15.0 108.625 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HE2' HD13 ' A' ' 129' ' ' ILE . 83.4 tttt -116.64 85.51 16.97 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.42 102.01 1.38 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.2 1.933 . . . . 15.0 111.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.478 HD13 ' HE2' ' A' ' 127' ' ' LYS . 41.1 mm -73.95 86.98 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.852 -1.166 . . . . 15.0 107.852 171.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.703 HG23 HG22 ' A' ' 422' ' ' THR . 28.7 t -107.27 148.37 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.08 -0.964 . . . . 15.0 110.502 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.12 165.17 37.06 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.246 1.018 . . . . 15.0 109.696 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.477 HG13 ' SD ' ' A' ' 274' ' ' MET . 2.8 t -96.77 88.54 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.8 p -77.21 -175.94 3.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.032 0.933 . . . . 15.0 110.352 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.99 -55.12 34.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.53 0.732 . . . . 15.0 111.366 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.05 66.97 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.977 0.798 . . . . 15.0 111.799 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -79.03 -45.33 20.39 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.362 0.665 . . . . 15.0 110.889 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.64 -54.94 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.204 0.602 . . . . 15.0 109.434 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.77 -48.04 82.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.96 99.09 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.91 0.757 . . . . 15.0 113.379 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.425 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.2 tpt -68.51 -50.86 48.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.599 0.759 . . . . 15.0 111.038 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.26 -38.33 68.4 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.024 0.53 . . . . 15.0 111.817 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 t70 -68.05 -39.17 83.09 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.45 -0.796 . . . . 15.0 110.571 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 71.1 m -61.97 -39.82 93.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.186 0.594 . . . . 15.0 110.128 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 140' ' ' MET . 83.4 mt -63.48 -38.26 90.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.166 0.587 . . . . 15.0 110.06 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 63.7 mtm180 -64.59 -34.41 78.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.223 173.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 142' ' ' ASP . 87.1 mttt -67.85 -35.94 79.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.513 0.325 . . . . 15.0 110.885 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 143' ' ' THR . 92.8 mt-30 -70.47 -33.32 71.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.859 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -103.59 29.47 5.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.848 . . . . 15.0 111.241 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.88 24.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.276 0.843 . . . . 15.0 113.276 -171.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -96.05 136.24 36.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.46 1.104 . . . . 15.0 110.306 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -81.78 111.82 18.36 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.225 0.61 . . . . 15.0 110.238 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -125.81 113.04 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 15.0 110.406 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.7 mt-10 -65.04 119.37 10.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.385 0.674 . . . . 15.0 111.063 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.537 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 47.0 pttt -123.78 -179.57 4.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.385 1.074 . . . . 15.0 110.009 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -165.58 154.12 11.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.916 0.887 . . . . 15.0 108.827 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.27 -38.75 2.39 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.436 -0.666 . . . . 15.0 111.436 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.02 123.68 7.28 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.608 0.363 . . . . 15.0 110.786 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' A' ' 206' ' ' LYS . 40.5 t -85.43 131.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 171.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -121.85 -177.63 3.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.149 0.979 . . . . 15.0 109.72 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -81.43 -9.23 59.77 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.505 0.722 . . . . 15.0 111.893 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -97.62 19.33 13.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.958 0.903 . . . . 15.0 111.718 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.8 m-20 -94.11 158.78 15.45 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.102 0.953 . . . . 15.0 112.301 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 6.5 tmm_? -120.85 91.53 3.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.068 -2.197 . . . . 15.0 105.068 165.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -90.22 148.75 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.392 1.077 . . . . 15.0 110.791 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.702 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 41.0 m -126.19 121.63 33.33 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.759 -1.2 . . . . 15.0 107.759 171.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.577 HG22 HD23 ' A' ' 237' ' ' LEU . 36.3 pt -128.95 174.08 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.577 0.751 . . . . 15.0 111.914 -172.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -118.49 116.57 26.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.163 -1.792 . . . . 15.0 106.163 158.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.559 ' HE1' HG22 ' B' ' 387' ' ' ILE . 11.6 p90 -107.88 140.99 40.16 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 234' ' ' ALA . 1.5 t -137.28 113.65 10.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.923 -1.14 . . . . 15.0 107.923 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -101.25 154.79 19.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 116.131 -0.486 . . . . 15.0 113.072 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 p -136.88 104.17 5.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.741 0.816 . . . . 15.0 109.206 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.598 HG23 ' HB1' ' A' ' 231' ' ' ALA . 52.9 t -77.39 112.95 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.141 -0.936 . . . . 15.0 109.271 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.9 t70 64.44 25.34 13.32 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 124.703 1.252 . . . . 15.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.47 21.15 52.56 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.04 -0.982 . . . . 15.0 114.524 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.12 150.43 49.98 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.02 0.91 . . . . 15.0 110.911 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.97 81.44 5.24 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.996 -1.113 . . . . 15.0 107.996 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 1.1 p90 -59.48 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 112.712 -2.04 . . . . 15.0 112.387 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 177' ' ' PHE . 12.0 mm-40 -101.0 176.52 5.23 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.574 1.55 . . . . 15.0 109.231 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.61 60.68 2.45 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 165.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -99.97 83.42 0.56 Allowed Glycine 0 C--N 1.344 0.985 0 C-N-CA 123.335 0.493 . . . . 15.0 111.985 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -148.39 165.22 31.75 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.909 0.883 . . . . 15.0 109.399 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.52 94.94 1.52 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.855 -0.611 . . . . 15.0 109.855 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 128.69 37.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.631 -1.168 . . . . 15.0 109.335 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 65.25 33.28 9.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.073 0.949 . . . . 15.0 111.145 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.01 127.65 32.38 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 122.784 0.434 . . . . 15.0 109.945 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.83 95.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.624 0.77 . . . . 15.0 110.263 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.616 HD23 ' HE3' ' A' ' 194' ' ' MET . 36.7 tp -86.79 90.08 8.18 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.433 0.635 . . . . 15.0 110.285 170.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.444 ' HB2' ' NE2' ' A' ' 191' ' ' GLN . . . -83.27 89.72 7.03 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.811 -1.181 . . . . 15.0 107.811 169.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.409 ' HE1' ' HB3' ' A' ' 189' ' ' MET . 46.7 mtp -57.07 137.48 55.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.321 0.648 . . . . 15.0 111.83 -173.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.87 5.18 Favored Glycine 0 N--CA 1.47 0.95 0 N-CA-C 112.077 -0.409 . . . . 15.0 112.077 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.444 ' NE2' ' HB2' ' A' ' 188' ' ' ALA . 10.4 pt20 -98.98 158.72 15.46 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.296 0.639 . . . . 15.0 110.553 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.98 66.32 2.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.986 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -107.7 10.63 28.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.54 0.736 . . . . 15.0 110.859 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.616 ' HE3' HD23 ' A' ' 187' ' ' LEU . 24.6 mmt -129.7 149.13 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.944 0.898 . . . . 15.0 110.583 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.8 pt -95.34 141.31 23.04 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.946 -1.025 . . . . 15.0 108.711 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.43 120.99 7.68 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.383 2.722 . . . . 15.0 112.918 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.89 -34.03 3.38 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.107 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -78.07 -57.05 4.0 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.097 0.559 . . . . 15.0 110.233 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -19.93 65.47 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.953 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.639 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 21.2 m-20 -58.16 -41.15 83.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.426 0.69 . . . . 15.0 110.815 170.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -67.71 -30.51 74.7 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.92 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.498 HG21 HD22 ' A' ' 187' ' ' LEU . 39.1 mm -75.99 -52.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.982 0.513 . . . . 15.0 110.346 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 55.8 pttt -80.16 20.19 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.053 0.941 . . . . 15.0 113.365 -167.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.48 31.22 2.15 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.367 -0.693 . . . . 15.0 111.367 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -146.99 -161.73 1.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.342 1.057 . . . . 15.0 109.695 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.427 ' HA ' HG21 ' A' ' 158' ' ' VAL . 9.9 ptpp? -148.89 168.75 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.189 0.596 . . . . 15.0 109.671 172.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 240' ' ' VAL . . . -65.4 148.64 51.37 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 117.987 0.358 . . . . 15.0 110.626 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.75 -45.63 1.28 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.804 -0.634 . . . . 15.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.92 122.95 28.93 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.471 0.653 . . . . 15.0 110.375 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.43 135.95 40.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.19 0.996 . . . . 15.0 110.11 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -144.46 173.03 12.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.033 0.933 . . . . 15.0 109.172 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.7 m -129.79 116.81 19.28 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.89 -0.781 . . . . 15.0 108.89 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.618 HG22 ' HA3' ' A' ' 201' ' ' GLY . 23.1 pt -92.32 170.58 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.029 0.932 . . . . 15.0 110.071 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.93 124.6 33.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.379 0.672 . . . . 15.0 109.441 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.01 163.64 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.586 -1.264 . . . . 15.0 107.586 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.3 m -129.83 140.13 51.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.723 0.809 . . . . 15.0 109.38 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.84 143.11 45.92 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 122.977 0.511 . . . . 15.0 110.549 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.63 155.51 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 124.295 3.33 . . . . 15.0 115.587 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.29 -25.79 63.5 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.176 -0.92 . . . . 15.0 110.406 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.29 -13.13 35.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.277 1.031 . . . . 15.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -55.67 140.98 39.64 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 123.259 0.623 . . . . 15.0 111.275 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -46.84 -67.61 0.27 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 125.178 1.549 . . . . 15.0 112.806 -171.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.69 125.57 28.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 15.0 110.45 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.18 -31.94 62.88 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.6 0.76 . . . . 15.0 111.587 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.421 ' O ' ' HD2' ' A' ' 229' ' ' LYS . 27.8 p-10 -64.23 -17.2 63.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.447 0.699 . . . . 15.0 111.416 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.813 HD11 ' HA ' ' B' ' 388' ' ' VAL . 28.8 mt -100.01 -39.31 8.2 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.172 0.989 . . . . 15.0 110.601 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -46.63 113.58 0.67 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.136 1.774 . . . . 15.0 112.813 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.65 -18.93 27.32 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.608 0.567 . . . . 15.0 114.253 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 98.4 mttt -84.17 154.28 23.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.619 0.768 . . . . 15.0 112.453 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.44 23.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.363 1.065 . . . . 15.0 110.638 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 172' ' ' VAL . . . -90.23 135.67 33.53 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.215 1.006 . . . . 15.0 111.067 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.74 100.85 11.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.475 ' HE1' HG21 ' B' ' 387' ' ' ILE . 90.6 m-85 -96.53 107.74 20.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.555 0.342 . . . . 15.0 110.563 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.572 ' HB2' HG23 ' A' ' 169' ' ' THR . . . -77.23 102.68 6.77 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.078 -0.712 . . . . 15.0 109.078 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.52 134.38 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.865 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -115.99 100.44 7.97 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 166' ' ' ILE . 95.0 mt -74.08 110.15 8.14 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.874 -0.787 . . . . 15.0 108.874 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -108.96 -33.37 6.94 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.096 0.474 . . . . 15.0 110.142 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.702 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.4 mmtt -133.28 122.99 24.69 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.108 0.963 . . . . 15.0 109.498 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 207' ' ' ALA . 97.5 t -114.97 87.44 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 106.872 -1.529 . . . . 15.0 106.872 169.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 163' ' ' ARG . 44.7 mt-10 -93.77 169.18 10.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.62 -0.881 . . . . 15.0 108.62 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 32.2 tt0 -134.42 122.84 23.1 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -74.1 83.99 1.81 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.132 -1.432 . . . . 15.0 107.132 167.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 127.17 31.6 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.752 -1.567 . . . . 15.0 110.746 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.38 115.0 9.36 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.389 1.076 . . . . 15.0 109.247 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 78.7 Cg_endo -75.52 -176.56 3.02 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.047 2.498 . . . . 15.0 112.407 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.96 142.53 56.42 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.964 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 24.4 tp -107.1 23.04 15.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 p -71.56 176.7 4.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.509 1.124 . . . . 15.0 111.216 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -38.05 -59.49 0.84 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.944 1.698 . . . . 15.0 114.573 -166.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.28 -22.82 65.63 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.31 -50.21 6.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.095 0.558 . . . . 15.0 109.786 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.618 HG13 HD22 ' A' ' 266' ' ' LEU . 15.6 tt -65.36 -27.29 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.012 0.525 . . . . 15.0 111.841 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -22.65 42.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.022 0.378 . . . . 15.0 112.022 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -62.81 -22.15 66.42 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.052 0.941 . . . . 15.0 111.568 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -39.95 90.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 15.0 110.857 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 150.1 26.5 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 O-C-N 123.416 0.447 . . . . 15.0 113.452 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.11 143.56 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 117.558 0.679 . . . . 15.0 109.185 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -69.65 -57.2 5.45 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.386 0.674 . . . . 15.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -91.54 -38.3 12.59 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.745 0.418 . . . . 15.0 110.51 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.17 32.43 5.27 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.147 -0.479 . . . . 15.0 112.645 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.7 p -78.65 145.64 34.51 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.392 0.596 . . . . 15.0 109.738 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.16 -41.59 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.127 0.971 . . . . 15.0 111.126 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.22 -34.66 61.16 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.853 0.861 . . . . 15.0 111.858 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.88 -25.36 58.2 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 111.366 -0.694 . . . . 15.0 111.366 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.618 HD22 HG13 ' A' ' 253' ' ' ILE . 54.7 tp -75.97 -28.46 57.9 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.44 -45.88 78.33 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.071 -0.714 . . . . 15.0 109.071 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.99 82.05 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.307 -1.315 . . . . 15.0 110.419 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -68.13 -45.55 73.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.222 0.951 . . . . 15.0 111.855 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.04 -22.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 122.506 0.322 . . . . 15.0 110.649 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -68.47 -53.14 25.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.948 -0.39 . . . . 15.0 109.948 169.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -77.43 -2.18 33.98 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 112.537 0.569 . . . . 15.0 112.537 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.85 -59.37 1.75 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.271 0.628 . . . . 15.0 110.39 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.477 ' SD ' HG13 ' A' ' 132' ' ' VAL . 64.2 mtt -74.23 -38.0 63.65 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-O 118.045 -0.979 . . . . 15.0 112.055 -169.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -71.2 -37.81 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 120.044 1.293 . . . . 15.0 109.804 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.468 ' NH2' ' HA ' ' A' ' 378' ' ' TYR . 5.8 tpp180 -56.58 -40.36 75.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.714 0.805 . . . . 15.0 110.939 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.12 -60.38 2.36 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.891 -0.595 . . . . 15.0 110.581 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.597 HD22 HG13 ' A' ' 130' ' ' VAL . 39.8 tp -64.24 -60.47 3.16 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 125.174 1.39 . . . . 15.0 112.775 -171.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.06 -32.53 73.92 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.03 0.443 . . . . 15.0 110.756 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.1 t -69.82 -38.53 76.6 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.075 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.65 98.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 15.0 110.734 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.45 -51.52 71.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 O-C-N 123.593 0.558 . . . . 15.0 109.558 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -57.5 -52.23 66.24 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.639 0.587 . . . . 15.0 111.35 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -69.24 -28.7 66.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.922 0.889 . . . . 15.0 111.456 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -64.22 -57.62 8.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.814 0.445 . . . . 15.0 110.084 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.51 -35.84 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.677 0.791 . . . . 15.0 110.534 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.511 ' HG3' HG23 ' A' ' 408' ' ' VAL . 86.6 tttt -64.05 -48.74 75.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.931 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.9 p -67.69 -31.1 70.83 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.182 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.25 -35.98 74.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.09 0.556 . . . . 15.0 110.701 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -52.43 57.76 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 123.446 0.467 . . . . 15.0 109.929 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 347' ' ' VAL . 34.0 mm -61.78 -50.25 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.847 0.717 . . . . 15.0 111.486 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.45 -35.34 80.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.802 -0.635 . . . . 15.0 109.707 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.41 -40.57 96.43 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.009 0.818 . . . . 15.0 112.474 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 350' ' ' LEU . 45.7 mt -60.76 -46.33 90.89 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.18 0.992 . . . . 15.0 111.109 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.2 -48.23 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.696 0.76 . . . . 15.0 109.784 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -66.37 -24.07 66.43 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.028 -0.987 . . . . 15.0 110.685 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.09 53.25 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.863 . . . . 15.0 112.473 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.38 149.39 10.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 -169.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.41 136.37 47.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.776 -0.647 . . . . 15.0 110.314 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.403 HG21 HG11 ' A' ' 346' ' ' VAL . 4.8 tp -117.8 115.91 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.001 0.92 . . . . 15.0 109.228 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.82 141.76 35.93 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 342' ' ' LYS . 24.7 t -126.93 115.33 22.14 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.747 0.819 . . . . 15.0 109.633 -165.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.02 141.13 16.37 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.275 2.65 . . . . 15.0 112.974 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.497 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -64.55 -33.65 76.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.267 1.21 . . . . 15.0 114.267 -166.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.63 65.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.753 0.421 . . . . 15.0 111.552 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.419 HD13 HG11 ' A' ' 345' ' ' VAL . 14.5 mt -88.16 -29.83 20.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.417 -0.811 . . . . 15.0 110.271 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.39 -51.63 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.82 -57.21 11.75 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 114.438 -1.255 . . . . 15.0 110.342 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 313' ' ' VAL . 32.3 t -60.77 -56.32 22.63 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.401 1.063 . . . . 15.0 111.848 -173.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.78 -45.47 78.35 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 111.744 0.275 . . . . 15.0 111.744 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 46.7 mt -64.83 -37.02 79.12 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 N-CA-C 109.803 -0.443 . . . . 15.0 109.803 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.59 -46.68 83.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.694 0.797 . . . . 15.0 110.934 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 309' ' ' SER . 96.3 t -55.55 -52.0 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 123.837 0.711 . . . . 15.0 110.573 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 341' ' ' ALA . 84.1 mt -70.57 -21.96 62.63 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.803 -1.09 . . . . 15.0 112.3 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 . . . . . 0 N--CA 1.484 1.232 0 C-N-CA 123.125 0.57 . . . . 15.0 110.783 175.611 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.45 0.643 . . . . 15.0 111.601 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.7 -29.3 68.52 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.937 1.695 . . . . 15.0 113.04 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 337' ' ' PHE . 53.1 mt -43.76 123.26 3.84 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 123.853 0.861 . . . . 15.0 112.556 -171.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.47 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 53.5 Cg_exo -43.03 127.8 5.15 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 124.995 3.797 . . . . 15.0 115.189 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -52.91 -48.42 67.26 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.655 1.182 . . . . 15.0 112.076 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.52 -18.79 4.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.332 1.053 . . . . 15.0 113.447 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.47 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.1 mt -74.8 -38.02 62.22 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.224 0.465 . . . . 15.0 110.878 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 332' ' ' LEU . 41.9 m-85 -120.03 -51.94 2.21 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.095 0.558 . . . . 15.0 112.241 -168.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -47.53 -40.21 18.24 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.987 1.315 . . . . 15.0 113.301 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.56 -34.9 59.92 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.279 1.032 . . . . 15.0 112.469 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -104.22 -30.78 9.95 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.154 0.982 . . . . 15.0 111.126 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 314' ' ' LEU . . . -76.49 -60.63 2.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.249 1.02 . . . . 15.0 110.971 -173.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 302' ' ' VAL . 88.3 tttt -62.32 -25.03 67.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.428 -0.805 . . . . 15.0 109.792 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -71.69 -35.09 70.14 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 118.421 -0.8 . . . . 15.0 110.719 171.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -57.36 -43.16 83.3 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 119.243 0.929 . . . . 15.0 109.306 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG11 HD13 ' A' ' 306' ' ' LEU . 41.3 t -60.73 -49.8 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.265 -1.334 . . . . 15.0 110.704 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 342' ' ' LYS . 68.2 t -59.59 -48.95 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.611 0.764 . . . . 15.0 111.058 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 291' ' ' ILE . 71.6 t -52.64 -43.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.138 0.975 . . . . 15.0 110.267 173.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -70.36 -37.87 70.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 15.0 113.854 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.88 -47.2 54.45 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.267 0.627 . . . . 15.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 294' ' ' LEU . 76.9 mt -62.38 -57.88 9.7 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.998 0.811 . . . . 15.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 355' ' ' ILE . 53.2 mt -65.65 -34.45 78.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.125 0.57 . . . . 15.0 112.216 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.5 99.0 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.696 -0.562 . . . . 15.0 111.696 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.25 -37.42 85.46 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.072 -0.564 . . . . 15.0 110.687 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 350' ' ' LEU . 62.5 t -63.49 -36.28 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 117.956 0.343 . . . . 15.0 110.786 176.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 360' ' ' LEU . 97.1 mt -64.0 -44.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.367 0.667 . . . . 15.0 109.807 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.23 -56.4 11.46 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.488 -0.324 . . . . 15.0 111.361 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 77.0 m -54.48 -42.65 70.96 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.982 1.313 . . . . 15.0 111.985 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -101.19 14.65 31.31 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.155 0.582 . . . . 15.0 111.547 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 48.65 33.56 4.32 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 125.729 1.612 . . . . 15.0 114.205 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 355' ' ' ILE . 65.9 mt -72.42 157.04 38.38 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.087 0.955 . . . . 15.0 113.055 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 152.68 40.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.967 0.907 . . . . 15.0 110.415 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.69 111.62 17.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.477 0.711 . . . . 15.0 109.556 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 15.2 t70 -107.55 137.39 45.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.327 0.651 . . . . 15.0 110.884 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -64.48 -31.76 73.1 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.739 0.815 . . . . 15.0 113.03 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -66.08 -32.74 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 10.7 tpp180 -71.75 -44.99 63.13 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 371' ' ' ILE . 94.1 t -55.56 -60.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.111 0.882 . . . . 15.0 109.819 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -59.48 -35.83 74.85 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.161 0.913 . . . . 15.0 111.897 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.62 -55.7 27.41 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.902 0.751 . . . . 15.0 111.816 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.04 -42.97 81.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.641 0.776 . . . . 15.0 111.014 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 398' ' ' MET . 51.2 mm -51.22 -60.22 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.467 1.104 . . . . 15.0 110.461 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.54 -42.87 95.45 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.755 0.659 . . . . 15.0 112.14 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.59 -44.89 93.21 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 124.017 0.823 . . . . 15.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -77.09 -35.45 56.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 119.658 -0.211 . . . . 15.0 110.668 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.19 -27.09 65.2 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.482 0.713 . . . . 15.0 111.798 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.6 t -65.78 -19.64 65.96 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 123.916 0.76 . . . . 15.0 110.908 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -95.75 3.03 54.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.972 0.909 . . . . 15.0 111.933 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.468 ' HA ' ' NH2' ' A' ' 276' ' ' ARG . 2.8 m-85 -88.74 177.57 6.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.065 0.546 . . . . 15.0 109.686 172.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.29 -47.22 62.15 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.173 -0.921 . . . . 15.0 109.359 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.37 122.31 13.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.379 1.072 . . . . 15.0 109.233 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -70.69 -40.28 4.0 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.708 2.272 . . . . 15.0 114.178 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -54.32 -47.79 72.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.359 0.874 . . . . 15.0 113.359 -167.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.93 -24.68 66.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.236 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.07 -45.79 29.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 123.859 0.864 . . . . 15.0 109.164 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.04 -47.04 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.053 0.541 . . . . 15.0 109.57 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.66 -39.93 80.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.142 0.577 . . . . 15.0 112.36 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.4 -36.65 84.44 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.527 0.731 . . . . 15.0 111.08 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.437 ' HA ' HD21 ' A' ' 394' ' ' LEU . 34.8 m-85 -73.84 -62.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.922 -0.581 . . . . 15.0 110.599 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.2 p -57.6 -32.17 66.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.32 17.42 11.29 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 15.0 111.98 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -139.84 106.14 5.27 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.35 -0.982 . . . . 15.0 108.35 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -65.83 -41.2 92.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.998 0.519 . . . . 15.0 111.345 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.67 -41.97 96.13 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.932 0.77 . . . . 15.0 110.517 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 388' ' ' TYR . 22.5 tp -72.14 -38.92 69.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.691 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 93.0 mmm -66.26 -30.76 71.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.92 0.488 . . . . 15.0 110.69 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.9 -39.96 69.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.285 1.034 . . . . 15.0 109.852 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 400' ' ' ASN . 67.1 m-80 -75.43 -21.58 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.916 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.569 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -87.69 -20.07 26.79 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.586 0.217 . . . . 15.0 111.586 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.57 -36.89 57.33 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 167.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 397' ' ' ASN . 4.1 t30 -52.02 -61.59 2.17 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.736 -1.12 . . . . 15.0 110.343 168.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.8 p -66.32 -27.47 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 118.154 0.434 . . . . 15.0 111.685 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.73 -58.01 10.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.033 0.533 . . . . 15.0 110.355 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 24.3 tp -77.76 -23.32 49.27 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.76 -1.109 . . . . 15.0 111.582 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.52 -51.66 33.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.99 0.516 . . . . 15.0 109.625 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.28 -35.8 82.03 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.8 -0.636 . . . . 15.0 111.176 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -69.85 -33.55 72.42 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.012 0.525 . . . . 15.0 111.205 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.97 93.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.84 0.456 . . . . 15.0 110.303 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.511 HG23 ' HG3' ' A' ' 287' ' ' LYS . 84.5 t -58.12 -53.6 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.815 -0.63 . . . . 15.0 109.752 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.38 -25.6 66.01 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.987 0.915 . . . . 15.0 112.908 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.94 -30.59 62.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.783 0.433 . . . . 15.0 111.317 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.5 t -70.67 -43.27 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.077 -1.082 . . . . 15.0 108.077 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 83.4 mt -65.23 -40.7 94.42 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.362 1.039 . . . . 15.0 111.57 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.35 -23.16 67.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.836 0.854 . . . . 15.0 111.564 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -98.96 -27.42 13.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 15.0 111.116 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.966 0.907 . . . . 15.0 111.348 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.8 mttt -69.93 83.51 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.692 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.416 HG11 ' HB ' ' A' ' 125' ' ' VAL . 5.0 m -93.8 91.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.033 0.921 . . . . 15.0 109.487 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.7 t -70.72 95.2 1.09 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.513 -1.221 . . . . 15.0 109.188 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 131.81 40.59 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 115.055 -0.975 . . . . 15.0 110.505 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -146.86 145.43 29.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.27 135.12 33.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.703 HG22 HG23 ' A' ' 130' ' ' VAL . 4.5 t -159.86 174.03 15.06 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.495 0.497 . . . . 15.0 110.657 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.5 p -100.61 175.34 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.475 1.11 . . . . 15.0 111.948 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.445 ' HD2' HD21 ' A' ' 278' ' ' LEU . 38.4 t80 -52.71 -28.06 20.33 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.578 1.551 . . . . 15.0 111.691 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.654 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 23.2 m-80 -65.12 -15.61 62.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.775 1.23 . . . . 15.0 112.945 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' HD13 ' A' ' 427' ' ' LEU . 23.4 tp10 -60.7 -37.21 80.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.582 1.153 . . . . 15.0 111.414 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 426' ' ' GLU . 4.8 mp -109.23 -77.85 0.59 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.435 -0.165 . . . . 15.0 111.192 -174.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.5 mpt? -68.35 -50.54 52.56 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.838 0.455 . . . . 15.0 112.1 -171.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 15.9 m120 . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . 0.519 HD11 ' SD ' ' A' ' 194' ' ' MET . 2.3 pt? . . . . . 0 C--O 1.244 0.774 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.6 91.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -164.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.559 HG22 ' HE1' ' A' ' 168' ' ' PHE . 0.1 OUTLIER -146.37 87.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 156.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . 0.813 ' HA ' HD11 ' A' ' 226' ' ' LEU . 9.8 p . . . . . 0 C--O 1.24 0.602 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.406 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . 0.46 ' HE2' ' HB ' ' A' ' 401' ' ' VAL . 97.3 m-85 . . . . . 0 C--O 1.242 0.661 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.306 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -66.28 -72.45 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.23 0.612 . . . . 0.0 109.561 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -166.69 -128.96 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.342 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 463' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' B' ' 464' ' ' MET . 53.3 m 79.62 152.33 0.12 Allowed 'General case' 0 C--N 1.366 1.326 0 C-N-CA 124.597 1.159 . . . . 0.0 110.413 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 464' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 463' ' ' THR . 2.7 ptp 75.35 -47.95 0.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.248 2.619 . . . . 0.0 111.242 -173.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 70.72 -30.38 0.2 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.908 1.683 . . . . 0.0 112.943 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.36 -11.51 4.39 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 124.491 1.116 . . . . 0.0 112.649 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.437 1.095 . . . . 0.0 112.37 172.471 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.37 116.09 16.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.763 . . . . 15.0 109.039 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.68 161.57 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.053 0.454 . . . . 15.0 111.224 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.406 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 9.4 p -152.92 103.45 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.111 -0.95 . . . . 15.0 109.137 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.79 107.3 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.646 0.736 . . . . 15.0 110.233 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.2 100.54 10.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.323 1.049 . . . . 15.0 109.375 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 m -69.19 97.66 0.94 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.676 -0.861 . . . . 15.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.7 p -75.6 -61.35 1.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.912 0.885 . . . . 15.0 111.402 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -149.46 103.99 3.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.663 -0.495 . . . . 15.0 109.663 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.02 -108.02 1.95 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 124.018 0.824 . . . . 15.0 113.644 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.26 -29.64 61.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 15.0 110.682 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 119.35 12.41 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 124.164 0.915 . . . . 15.0 112.968 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HD2' HG11 ' A' ' 111' ' ' VAL . 64.6 mtt85 -133.39 118.95 19.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.527 1.131 . . . . 15.0 109.515 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.541 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 37.5 ttm180 -89.94 96.74 10.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.001 1.32 . . . . 15.0 110.248 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG11 ' HB1' ' A' ' 78' ' ' ALA . 41.0 t -89.11 88.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.558 -0.905 . . . . 15.0 108.558 173.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 31.5 m -77.65 114.26 16.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.087 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -105.08 112.95 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.752 0.821 . . . . 15.0 109.19 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 87.3 m -94.62 105.07 17.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.547 0.739 . . . . 15.0 109.885 174.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.8 mt -91.47 101.25 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.9 0.88 . . . . 15.0 109.53 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.8 173.6 9.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.151 0.58 . . . . 15.0 111.365 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.12 59.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.385 1.474 . . . . 15.0 113.798 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.11 -32.34 73.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.64 0.776 . . . . 15.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -92.03 -29.62 16.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.991 0.516 . . . . 15.0 111.473 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.49 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.72 78.88 5.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.947 0.879 . . . . 15.0 109.374 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.4 m -158.72 -55.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.612 -1.995 . . . . 15.0 105.612 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.97 70.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.331 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG23 HG23 ' A' ' 66' ' ' VAL . 89.1 t -58.29 -62.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 123.945 0.778 . . . . 15.0 110.125 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.692 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.8 ttmp? -63.51 -39.83 95.46 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.736 -1.12 . . . . 15.0 111.86 -175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.3 m -68.66 -25.34 64.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.622 -0.717 . . . . 15.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -80.57 -43.25 20.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.7 0.286 . . . . 15.0 110.239 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.716 HD21 HG12 ' A' ' 62' ' ' VAL . 68.4 mt -74.15 -18.74 60.74 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.928 0.714 . . . . 15.0 112.928 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 p -76.71 -31.98 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 171.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -67.89 -49.03 64.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.342 0.657 . . . . 15.0 109.517 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.5 -33.64 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.288 1.035 . . . . 15.0 110.538 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.562 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.5 -54.12 50.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.994 0.518 . . . . 15.0 110.908 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.65 -42.54 86.49 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.291 0.636 . . . . 15.0 111.641 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -66.88 -51.84 50.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.643 1.177 . . . . 15.0 111.52 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.84 2.71 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.515 0.726 . . . . 15.0 110.407 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 71.11 17.28 6.14 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.265 1.426 . . . . 15.0 112.736 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 48.3 mt -66.57 -25.09 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.55 1.14 . . . . 15.0 110.771 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 -33.47 73.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.945 0.898 . . . . 15.0 111.201 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.91 -30.55 74.33 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.861 0.725 . . . . 15.0 112.855 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.414 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.5 m-85 -80.51 -24.79 39.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.358 0.663 . . . . 15.0 110.444 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -71.31 105.38 3.47 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.983 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.77 6.54 45.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.151 0.981 . . . . 15.0 110.774 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.79 68.56 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.211 0.319 . . . . 15.0 112.588 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -69.02 -49.06 61.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.087 0.955 . . . . 15.0 110.092 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.01 127.84 30.02 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.0 -1.0 . . . . 15.0 108.644 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.67 144.91 51.23 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.202 2.601 . . . . 15.0 113.337 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.58 -29.02 68.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.865 0.866 . . . . 15.0 112.351 -170.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HA ' ' HZ1' ' A' ' 29' ' ' LYS . 21.5 p-10 -67.35 -38.94 85.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.648 0.379 . . . . 15.0 110.85 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.739 HG23 ' HD2' ' A' ' 57' ' ' ARG . 61.4 mt -73.28 -32.61 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.959 0.904 . . . . 15.0 111.202 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 15.8 m -75.3 -20.1 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.922 -0.486 . . . . 15.0 111.358 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -86.9 -62.97 1.39 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.255 0.622 . . . . 15.0 111.438 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.82 -41.49 26.3 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.739 ' HD2' HG23 ' A' ' 53' ' ' ILE . 95.2 mtt180 -86.78 -63.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.814 0.446 . . . . 15.0 110.648 -173.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 40.3 m-85 -75.73 -21.57 57.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 111.803 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.38 25.51 12.61 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.432 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.41 69.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.354 0.662 . . . . 15.0 112.581 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 m -77.45 -8.13 57.27 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.617 0.767 . . . . 15.0 112.61 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.716 HG12 HD21 ' A' ' 32' ' ' LEU . 2.7 p -119.36 86.58 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 122.537 1.16 . . . . 15.0 109.814 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.402 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 4.5 mmp_? -115.66 -47.98 2.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.567 -1.197 . . . . 15.0 108.959 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.88 -50.0 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.996 1.318 . . . . 15.0 111.993 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.03 -35.61 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.991 0.916 . . . . 15.0 111.151 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG23 HG23 ' A' ' 28' ' ' VAL . 96.3 t -66.79 -38.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 114.813 -1.085 . . . . 15.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.8 mt -62.0 -27.56 68.95 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.595 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.01 86.74 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.567 0.542 . . . . 15.0 112.507 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.68 -47.54 83.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.733 0.813 . . . . 15.0 110.943 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.94 -57.38 13.04 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.377 -1.283 . . . . 15.0 111.547 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 71.6 mtm -69.98 -30.49 67.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.5 0.72 . . . . 15.0 112.288 -174.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 t -68.62 -51.31 43.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.002 0.521 . . . . 15.0 111.06 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.692 -0.686 . . . . 15.0 110.456 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.03 -26.45 64.04 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.538 0.524 . . . . 15.0 112.153 -171.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -63.05 -59.31 4.97 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.469 0.308 . . . . 15.0 110.517 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.86 -25.61 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.936 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -58.32 7.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.289 0.636 . . . . 15.0 109.384 171.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' HB1' HG11 ' A' ' 15' ' ' VAL . . . -59.74 -53.87 52.98 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.052 -0.976 . . . . 15.0 112.077 -171.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 86' ' ' PRO . 30.1 pt -58.79 -35.11 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.792 0.664 . . . . 15.0 112.792 -172.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.6 -42.35 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.086 0.554 . . . . 15.0 111.028 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -73.74 -31.9 63.59 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.242 0.217 . . . . 15.0 111.226 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.09 -0.96 33.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.683 0.793 . . . . 15.0 110.951 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 67.58 12.34 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.134 1.373 . . . . 15.0 112.432 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -78.26 118.69 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.653 0.781 . . . . 15.0 109.349 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -87.86 96.67 0.64 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 79' ' ' ILE . 55.2 Cg_endo -87.3 145.79 7.26 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.086 2.524 . . . . 15.0 114.164 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.3 46.98 0.82 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.945 0.898 . . . . 15.0 109.079 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.523 ' HA3' ' H ' ' A' ' 110' ' ' GLU . . . -144.24 153.68 25.22 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.443 -0.798 . . . . 15.0 112.088 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 113.0 12.65 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 15.0 109.785 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.26 106.97 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.953 1.769 . . . . 15.0 111.334 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -88.27 92.8 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.934 -0.765 . . . . 15.0 108.934 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -74.76 111.73 10.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.18 0.592 . . . . 15.0 109.508 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.38 93.62 27.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.173 0.989 . . . . 15.0 108.797 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.69 91.65 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.911 2.407 . . . . 15.0 111.951 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.24 -27.15 70.16 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.456 -0.793 . . . . 15.0 113.121 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 14.7 pt-20 -165.47 161.58 18.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.503 0.721 . . . . 15.0 110.456 172.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.402 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 13.8 t80 -157.22 108.35 2.33 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.685 -1.228 . . . . 15.0 107.685 168.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -125.7 130.01 50.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.163 0.985 . . . . 15.0 108.423 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 tp -67.16 104.8 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.693 0.621 . . . . 15.0 109.484 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.74 12.24 44.47 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.602 -0.554 . . . . 15.0 113.467 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.0 mt-10 -130.09 -97.43 0.35 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 118.738 -0.649 . . . . 15.0 109.841 172.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -140.93 160.05 40.9 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.274 0.943 . . . . 15.0 112.105 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -131.8 74.5 1.59 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.437 1.495 . . . . 15.0 107.058 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.491 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 43.1 m -80.66 124.54 29.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.8 -1.091 . . . . 15.0 109.319 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -143.82 129.54 19.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.921 0.488 . . . . 15.0 109.871 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.541 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 70.2 m -84.89 120.02 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.172 0.989 . . . . 15.0 110.423 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.7 94.3 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -99.27 113.37 25.61 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.41 0.684 . . . . 15.0 110.505 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -142.66 162.74 34.69 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.205 0.602 . . . . 15.0 110.504 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.523 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 36.1 mt-10 -85.41 167.33 15.62 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.192 -0.913 . . . . 15.0 110.116 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.5 m -127.67 170.09 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.484 0.714 . . . . 15.0 110.726 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -75.22 113.49 25.99 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.532 -0.914 . . . . 15.0 108.532 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.35 161.84 19.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.064 1.843 . . . . 15.0 110.848 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.27 111.51 5.93 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' ' 300' ' ' ILE . 4.8 p -71.1 124.83 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.862 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.33 122.8 43.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.48 -0.782 . . . . 15.0 110.79 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 120' ' ' LEU . 91.3 mt -93.71 133.77 36.73 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 163.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -137.82 112.53 8.9 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.552 0.741 . . . . 15.0 109.063 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.96 63.79 4.32 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.747 0.654 . . . . 15.0 114.239 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 117' ' ' LEU . 29.2 mt -70.79 -30.6 67.1 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.144 0.497 . . . . 15.0 110.346 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -72.3 -23.04 61.11 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.654 1.182 . . . . 15.0 111.212 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.8 43.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.232 0.613 . . . . 15.0 111.503 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.79 123.59 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.717 0.807 . . . . 15.0 109.982 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -105.89 109.57 21.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 15.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 289' ' ' GLN . 59.1 t -109.02 154.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.866 1.266 . . . . 15.0 107.714 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 286' ' ' VAL . 42.7 tt0 -103.36 142.66 33.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 119.24 0.927 . . . . 15.0 109.973 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HE2' HD13 ' A' ' 129' ' ' ILE . 82.5 tttt -123.56 87.36 52.23 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.941 0.897 . . . . 15.0 109.083 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 282' ' ' ILE . 6.7 Cg_exo -72.66 97.5 0.89 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.884 1.723 . . . . 15.0 111.554 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.518 HD13 ' HE2' ' A' ' 127' ' ' LYS . 40.2 mm -69.25 92.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.768 -1.197 . . . . 15.0 107.768 166.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.583 HG21 HD12 ' A' ' 427' ' ' LEU . 37.5 t -116.04 142.55 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.487 -0.779 . . . . 15.0 110.128 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.39 159.23 32.36 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.242 -1.345 . . . . 15.0 108.578 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.93 86.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 137' ' ' VAL . 43.6 p -64.4 174.89 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.701 0.8 . . . . 15.0 110.317 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.73 -33.02 72.28 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 120.95 0.405 . . . . 15.0 110.853 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.41 83.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.979 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 69.2 m-20 -74.59 -41.64 60.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.884 0.474 . . . . 15.0 111.195 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 133' ' ' THR . 82.4 t -61.79 -61.03 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.65 -33.84 73.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.856 0.722 . . . . 15.0 111.359 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.53 Favored Glycine 0 N--CA 1.478 1.476 0 O-C-N 123.62 0.575 . . . . 15.0 113.676 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.1 tpt -68.57 -46.36 69.6 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.069 0.548 . . . . 15.0 110.082 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 78.4 mt -58.07 -31.96 67.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.14 0.576 . . . . 15.0 111.748 172.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.56 -41.48 72.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.34 1.056 . . . . 15.0 110.216 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 86.0 m -58.2 -44.09 87.91 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.07 0.856 . . . . 15.0 109.71 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD12 HD22 ' A' ' 141' ' ' LEU . 89.9 mt -63.65 -40.93 98.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.918 0.887 . . . . 15.0 111.208 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 39.0 mtm-85 -64.51 -31.5 72.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.325 0.65 . . . . 15.0 110.157 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 92.2 mttt -87.32 -15.9 36.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.235 0.614 . . . . 15.0 112.443 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 143' ' ' THR . 97.5 mt-30 -78.17 -30.42 49.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.642 -0.503 . . . . 15.0 109.642 167.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.45 36.54 2.78 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.102 0.961 . . . . 15.0 110.538 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -76.19 152.82 36.52 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.629 0.974 . . . . 15.0 113.629 -172.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -81.75 122.18 27.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.616 -1.175 . . . . 15.0 110.027 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -80.8 125.28 29.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 28.9 ttpt -158.83 128.32 5.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.914 -0.773 . . . . 15.0 108.914 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.622 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.4 mt-10 -77.26 134.39 38.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.885 0.374 . . . . 15.0 111.184 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 34.0 pttt -120.74 179.99 4.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.574 1.15 . . . . 15.0 109.816 169.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -142.92 152.91 42.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.566 0.746 . . . . 15.0 109.296 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -49.77 0.88 Allowed Glycine 0 N--CA 1.465 0.581 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.339 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.71 43.17 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.356 0.578 . . . . 15.0 111.417 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 t -116.79 134.39 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.347 1.059 . . . . 15.0 108.821 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -107.21 -179.58 3.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.31 1.044 . . . . 15.0 109.878 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.67 28.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.407 0.891 . . . . 15.0 113.407 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.27 40.83 3.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.227 0.537 . . . . 15.0 110.349 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -122.27 -170.52 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.045 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.744 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 15.2 mtm180 -119.94 124.07 45.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 171.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.61 100.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.773 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 12.5 m -83.31 110.02 17.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.13 -1.063 . . . . 15.0 108.13 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.557 HG23 ' HA ' ' A' ' 237' ' ' LEU . 33.6 pt -132.79 164.48 35.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.288 1.035 . . . . 15.0 110.4 -172.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -111.47 126.69 55.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.526 -1.657 . . . . 15.0 106.526 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.85 150.01 49.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.52 0.676 . . . . 15.0 111.281 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.417 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 10.1 t -139.16 123.78 18.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.147 -1.427 . . . . 15.0 107.147 165.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -113.53 166.66 12.17 Favored Glycine 0 C--O 1.241 0.585 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.065 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -145.1 134.93 23.6 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.308 0.643 . . . . 15.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.546 HG13 ' HA ' ' A' ' 226' ' ' LEU . 61.6 t -118.54 137.89 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 171.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.66 16.35 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.982 0.896 . . . . 15.0 110.889 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.77 1.98 76.21 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 115.781 -0.645 . . . . 15.0 113.946 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -136.98 163.12 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.509 0.724 . . . . 15.0 110.654 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.24 165.5 22.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.23 0.612 . . . . 15.0 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.83 -159.78 0.97 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.405 1.082 . . . . 15.0 110.186 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.72 118.28 5.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.459 0.703 . . . . 15.0 111.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.471 ' HA3' ' HB ' ' B' ' 386' ' ' VAL . . . 85.15 -57.12 4.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.941 -1.027 . . . . 15.0 111.827 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.12 -60.37 4.78 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.384 -0.286 . . . . 15.0 112.384 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.417 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 86.2 mttt -116.36 150.92 36.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.611 0.764 . . . . 15.0 111.801 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -153.91 93.1 1.61 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.801 -1.09 . . . . 15.0 108.87 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.2 m -73.69 137.94 44.39 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.682 -1.144 . . . . 15.0 110.172 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.67 29.21 18.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.703 0.801 . . . . 15.0 113.018 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 165' ' ' THR . 40.0 t80 -65.84 132.77 49.48 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.144 0.577 . . . . 15.0 110.292 174.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.8 t -97.96 113.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 202' ' ' ILE . 12.5 tp -97.54 89.0 4.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.692 0.397 . . . . 15.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.22 86.36 1.08 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 15.0 109.543 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.8 OUTLIER -51.78 132.09 31.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.012 0.925 . . . . 15.0 110.878 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.0 49.78 1.86 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.213 -0.755 . . . . 15.0 111.213 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.7 150.43 48.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.628 0.771 . . . . 15.0 111.082 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.36 56.32 3.91 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.589 -0.732 . . . . 15.0 113.046 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -136.7 1.89 2.6 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.95 0.9 . . . . 15.0 109.672 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 187' ' ' LEU . 33.1 mmt -94.09 154.25 17.71 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.87 0.868 . . . . 15.0 111.107 -173.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.76 143.3 46.1 Favored Pre-proline 0 C--O 1.248 0.991 0 CA-C-N 114.887 -1.051 . . . . 15.0 108.438 172.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.65 109.79 0.47 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.796 2.331 . . . . 15.0 111.226 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.01 -44.26 1.2 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.798 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 202' ' ' ILE . 86.4 t80 -73.09 -62.25 1.53 Allowed 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -32.93 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.259 -1.337 . . . . 15.0 111.984 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.54 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 14.8 t70 -71.02 -31.94 68.57 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.665 0.786 . . . . 15.0 110.835 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -5.53 89.21 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.836 0.71 . . . . 15.0 113.134 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.639 HG21 HD23 ' A' ' 187' ' ' LEU . 31.6 mm -104.54 -51.07 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.399 0.68 . . . . 15.0 110.947 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 58.5 pttt -76.88 6.35 6.34 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.475 1.11 . . . . 15.0 113.817 -163.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -131.87 27.32 3.69 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.507 -1.037 . . . . 15.0 110.507 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -125.08 -161.6 1.04 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.357 1.063 . . . . 15.0 110.361 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -154.85 153.28 30.9 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.516 0.727 . . . . 15.0 110.894 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.556 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.81 120.25 15.27 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.886 0.474 . . . . 15.0 111.392 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.69 -35.04 2.2 Favored Glycine 0 C--N 1.334 0.455 0 O-C-N 124.237 0.961 . . . . 15.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.72 126.21 32.66 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.442 -0.577 . . . . 15.0 109.442 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.0 123.82 48.73 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.08 -1.082 . . . . 15.0 108.08 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -145.08 178.04 8.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.333 1.053 . . . . 15.0 110.612 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.2 m -130.93 130.97 44.15 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.529 -1.286 . . . . 15.0 107.529 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.1 pt -104.06 160.48 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.378 0.671 . . . . 15.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.11 106.05 13.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 15.0 109.549 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.41 166.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.416 -1.327 . . . . 15.0 107.416 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 65.9 m -147.02 135.33 21.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.522 ' HZ ' HD12 ' B' ' 387' ' ' ILE . 95.5 m-85 -86.23 142.39 35.73 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 109.874 -0.417 . . . . 15.0 109.874 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.3 154.49 46.37 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.493 2.129 . . . . 15.0 111.834 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.14 -17.64 60.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.061 167.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.56 -24.5 61.93 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.294 1.438 . . . . 15.0 111.235 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.448 ' HE2' ' HB1' ' A' ' 223' ' ' ALA . 79.7 t80 -61.96 147.0 48.36 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.029 0.931 . . . . 15.0 111.238 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -71.12 -61.74 1.65 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.769 0.828 . . . . 15.0 113.109 -166.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' A' ' 221' ' ' TYR . . . -63.98 113.94 3.8 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.011 0.524 . . . . 15.0 110.356 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -65.02 -36.66 85.11 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.819 0.848 . . . . 15.0 112.652 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.46 -27.89 69.3 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.079 0.551 . . . . 15.0 111.429 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.546 ' HA ' HG13 ' A' ' 172' ' ' VAL . 81.7 mt -90.33 -40.51 12.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.848 0.859 . . . . 15.0 110.315 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -47.89 128.62 13.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.631 1.972 . . . . 15.0 113.001 -171.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.9 -31.44 3.66 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.379 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -98.04 163.73 12.64 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.636 0.774 . . . . 15.0 112.123 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -88.75 144.58 26.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.522 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.433 ' HB3' ' HE1' ' A' ' 217' ' ' PHE . . . -117.98 108.38 15.2 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.178 0.991 . . . . 15.0 109.837 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.12 101.04 12.52 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.24 0.616 . . . . 15.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -96.18 120.47 36.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.878 0.871 . . . . 15.0 109.752 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.24 98.55 9.45 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.96 -0.756 . . . . 15.0 108.96 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.1 mm -88.26 133.6 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.081 0.952 . . . . 15.0 110.611 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.81 95.15 4.71 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.456 -1.313 . . . . 15.0 107.456 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.557 ' HA ' HG23 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.06 97.36 5.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 -173.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -96.58 -38.63 9.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.633 0.373 . . . . 15.0 111.475 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.773 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.4 mmtt -131.63 148.73 52.63 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.095 0.558 . . . . 15.0 110.775 -176.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 207' ' ' ALA . 21.2 t -121.44 99.0 6.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 34.1 mt-10 -83.14 169.23 16.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.277 -1.009 . . . . 15.0 108.277 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 38.9 tt0 -140.24 139.76 35.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.725 0.41 . . . . 15.0 110.278 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.459 HH12 ' HD3' ' A' ' 146' ' ' LYS . 26.3 ptt85 -98.97 83.89 2.98 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 164.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.1 154.36 31.37 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.829 -1.078 . . . . 15.0 109.681 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.12 133.25 87.57 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 122.715 0.406 . . . . 15.0 110.022 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 95.5 Cg_endo -77.71 -179.23 5.24 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.642 2.228 . . . . 15.0 111.351 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 249' ' ' THR . 47.1 mt-10 -70.56 116.73 11.22 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.516 -0.765 . . . . 15.0 108.964 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.82 43.81 1.07 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.046 0.927 . . . . 15.0 108.992 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.456 HG21 ' HB3' ' A' ' 247' ' ' GLU . 25.5 p -76.23 166.65 23.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.054 1.342 . . . . 15.0 110.174 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.6 -45.74 13.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.701 1.2 . . . . 15.0 113.063 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.01 -31.85 71.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.545 0.738 . . . . 15.0 112.592 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -81.57 -49.77 10.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.048 0.539 . . . . 15.0 110.379 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.676 HG13 HD22 ' A' ' 266' ' ' LEU . 12.8 tt -65.16 -29.54 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 122.974 0.51 . . . . 15.0 111.249 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.58 -17.12 56.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 111.944 0.35 . . . . 15.0 111.944 174.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -70.14 -19.32 63.22 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.113 0.565 . . . . 15.0 110.675 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -71.43 -17.86 62.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.251 0.62 . . . . 15.0 111.152 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 146.05 -24.44 1.76 Allowed Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.417 -0.657 . . . . 15.0 113.184 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 10.8 t -54.91 144.46 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.185 0.994 . . . . 15.0 111.394 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.79 -46.96 50.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.563 0.745 . . . . 15.0 111.001 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -106.22 -43.82 4.71 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.545 0.738 . . . . 15.0 110.587 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 112.35 24.85 4.9 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.892 -0.393 . . . . 15.0 113.1 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.1 p -71.96 144.3 48.94 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 117.471 0.635 . . . . 15.0 109.776 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 253' ' ' ILE . 60.9 t -59.37 -48.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.219 0.608 . . . . 15.0 110.165 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -58.71 -25.11 62.57 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.506 1.123 . . . . 15.0 112.237 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.29 -27.68 54.8 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.077 -0.809 . . . . 15.0 111.077 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.676 HD22 HG13 ' A' ' 253' ' ' ILE . 60.6 tp -76.28 -30.09 57.66 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.009 -0.737 . . . . 15.0 109.009 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.45 ' HA ' HG21 ' A' ' 270' ' ' VAL . 73.5 mtp180 -67.48 -37.41 82.83 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.61 93.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.76 . . . . 15.0 110.892 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -66.72 -40.83 88.55 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.349 -0.841 . . . . 15.0 111.314 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 267' ' ' ARG . 19.3 m -81.56 -19.62 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.592 0.357 . . . . 15.0 110.512 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt85 -59.79 -66.16 0.56 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -59.28 -44.17 92.49 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.483 0.49 . . . . 15.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -74.06 -42.06 60.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.26 -13.28 55.58 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.532 0.605 . . . . 15.0 111.432 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.89 -47.01 49.59 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.096 0.862 . . . . 15.0 108.707 162.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.582 ' HB2' ' HB1' ' A' ' 377' ' ' ALA . 74.8 ttt180 -60.41 -27.51 67.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.489 1.516 . . . . 15.0 111.904 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.516 ' HG3' ' HE2' ' A' ' 428' ' ' MET . 10.0 tp10 -91.78 -59.72 2.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.826 0.45 . . . . 15.0 110.199 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.448 ' HA ' ' HE3' ' A' ' 428' ' ' MET . 62.7 tp -67.85 -57.58 6.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.358 0.503 . . . . 15.0 112.358 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.74 -27.66 67.79 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.196 0.31 . . . . 15.0 110.185 -172.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.3 t -66.63 -50.1 64.11 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.82 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.41 88.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.786 0.834 . . . . 15.0 111.94 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.7 mt -64.14 -50.32 77.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 C-N-CA 123.947 0.899 . . . . 15.0 108.823 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.369 0.668 . . . . 15.0 110.776 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -68.52 -45.53 71.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.992 -0.744 . . . . 15.0 108.992 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -57.69 -54.85 42.18 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.04 0.838 . . . . 15.0 110.599 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 282' ' ' ILE . 59.1 t -60.63 -52.96 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.113 -0.949 . . . . 15.0 110.725 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.29 -39.84 93.07 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.539 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.6 p -64.3 -43.83 93.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 119.47 -0.3 . . . . 15.0 110.588 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' A' ' 125' ' ' VAL . 57.0 mt-30 -68.01 -33.88 75.44 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.96 0.788 . . . . 15.0 111.832 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.4 -55.1 27.11 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 123.511 0.507 . . . . 15.0 109.865 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.452 ' O ' HG22 ' A' ' 295' ' ' VAL . 25.7 mm -61.65 -44.03 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.067 0.947 . . . . 15.0 111.774 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.24 -48.0 80.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.382 0.61 . . . . 15.0 109.491 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.85 99.74 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 114.038 -1.437 . . . . 15.0 112.246 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.489 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.8 mt -55.7 -60.14 3.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.237 1.015 . . . . 15.0 110.987 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 291' ' ' ILE . 40.6 t -56.07 -51.45 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 124.039 0.837 . . . . 15.0 109.638 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -64.27 -26.84 68.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.638 0.775 . . . . 15.0 112.138 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.67 -24.77 53.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.564 0.579 . . . . 15.0 112.564 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 164.62 29.77 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.516 0.932 . . . . 15.0 113.516 -168.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.6 133.66 49.98 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.036 -0.984 . . . . 15.0 109.835 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 115' ' ' VAL . 5.1 tp -155.77 116.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.695 0.798 . . . . 15.0 108.96 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.36 94.76 9.87 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.614 -0.884 . . . . 15.0 108.614 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 346' ' ' VAL . 19.0 t -79.93 127.33 77.64 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 114.466 -1.243 . . . . 15.0 110.513 -168.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.77 124.11 12.29 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.138 2.559 . . . . 15.0 112.896 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.492 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.75 -20.05 54.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.142 1.377 . . . . 15.0 114.196 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.17 94.7 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.947 0.499 . . . . 15.0 111.588 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.74 -35.39 80.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.635 0.774 . . . . 15.0 110.86 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 304' ' ' ALA . 2.7 mp -65.78 -53.28 40.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.501 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.22 -33.52 74.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.461 0.704 . . . . 15.0 111.14 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.6 t -58.07 -58.39 8.62 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 124.027 0.829 . . . . 15.0 110.607 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.02 -18.96 57.81 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.403 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 30.1 mt -67.1 -42.84 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 167.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.738 ' HA ' ' HD2' ' A' ' 315' ' ' ARG . 15.1 t70 -59.04 -39.25 81.41 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 123.958 0.786 . . . . 15.0 111.349 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 23.4 t -58.33 -51.85 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.19 0.519 . . . . 15.0 110.819 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.71 -21.39 64.41 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.46 -0.791 . . . . 15.0 112.093 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.738 ' HD2' ' HA ' ' A' ' 312' ' ' ASP . 77.0 mtt180 . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 124.168 0.987 . . . . 15.0 108.86 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.567 1.616 0 N-CA-C 112.895 0.702 . . . . 15.0 112.895 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -98.55 -11.43 22.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.623 0.769 . . . . 15.0 112.174 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 92.8 mt -55.59 131.78 71.45 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 123.244 0.618 . . . . 15.0 111.024 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 77.6 Cg_exo -52.24 125.26 16.96 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.142 3.228 . . . . 15.0 114.501 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -51.82 -44.23 63.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.703 1.201 . . . . 15.0 112.416 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -60.35 -18.91 53.26 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 15.0 113.114 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 84.8 mt -69.5 -32.68 71.7 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.997 0.427 . . . . 15.0 110.468 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.89 -17.3 12.05 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.237 1.015 . . . . 15.0 111.238 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -49.95 -46.8 52.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.435 1.894 . . . . 15.0 113.213 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.46 -60.74 2.7 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.794 1.309 . . . . 15.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.7 pt20 -80.87 -32.4 34.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 15.0 111.387 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.85 2.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 15.0 110.844 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -55.4 -41.41 72.65 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.113 0.883 . . . . 15.0 109.869 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG21 ' A' ' 347' ' ' VAL . 38.3 ttt-85 -59.42 -36.1 75.25 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.113 0.883 . . . . 15.0 110.909 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 70.3 mtt-85 -76.22 -29.4 57.57 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.807 0.443 . . . . 15.0 110.34 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.53 -37.95 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 302' ' ' VAL . 43.1 t -67.59 -34.42 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 351' ' ' LEU . 41.2 t -56.97 -50.22 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.553 0.741 . . . . 15.0 109.216 167.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.13 80.27 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.255 -0.884 . . . . 15.0 113.912 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.401 HD11 HG13 ' A' ' 302' ' ' VAL . 97.0 mt -80.47 -58.61 3.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.124 0.57 . . . . 15.0 111.528 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 294' ' ' LEU . 89.9 mt -60.29 -53.52 56.63 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.919 0.888 . . . . 15.0 110.872 -176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.497 HD11 HG11 ' A' ' 347' ' ' VAL . 44.8 mt -68.38 -30.72 69.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -59.47 -38.62 93.8 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.504 0.502 . . . . 15.0 112.478 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.43 -42.34 83.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.956 -0.622 . . . . 15.0 110.387 174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.7 -34.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.115 0.566 . . . . 15.0 111.146 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.0 mt -66.73 -49.68 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.819 0.848 . . . . 15.0 110.057 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -60.15 -54.36 46.81 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 116.064 -0.517 . . . . 15.0 110.988 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.4 m -61.22 -43.99 97.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.196 0.999 . . . . 15.0 111.72 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -91.9 12.61 21.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.066 0.546 . . . . 15.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 47.38 30.9 1.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.312 1.845 . . . . 15.0 114.181 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.467 HD22 HE21 ' A' ' 406' ' ' GLN . 73.7 mt -66.72 158.1 31.06 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.339 1.056 . . . . 15.0 113.032 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.9 167.27 27.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.856 -1.52 . . . . 15.0 107.799 170.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.0 90.99 0.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.701 -0.481 . . . . 15.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.74 131.29 45.97 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.254 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -51.71 -41.98 61.91 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.699 1.249 . . . . 15.0 112.12 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.5 -19.69 49.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.582 -0.735 . . . . 15.0 111.643 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -86.23 -35.0 20.28 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 110.025 -0.361 . . . . 15.0 110.025 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.78 -52.47 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -51.06 -45.24 61.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.66 1.184 . . . . 15.0 111.381 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.75 5.88 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.851 1.344 . . . . 15.0 112.155 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 402' ' ' ALA . 66.6 mt -55.73 -52.27 64.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.394 0.678 . . . . 15.0 111.675 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.469 HD12 ' HG2' ' A' ' 398' ' ' MET . 39.9 mm -50.55 -57.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 124.387 1.054 . . . . 15.0 111.417 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.36 -36.57 60.95 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.467 0.48 . . . . 15.0 111.781 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -51.04 71.08 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.279 0.561 . . . . 15.0 110.266 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -67.18 -44.08 80.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.224 1.409 . . . . 15.0 111.016 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -70.56 -44.78 66.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.68 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.4 m -69.5 -16.97 63.56 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.801 0.334 . . . . 15.0 111.458 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 276' ' ' ARG . . . -74.2 -29.33 61.69 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.513 0.725 . . . . 15.0 110.31 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -87.61 -168.6 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.773 0.829 . . . . 15.0 111.178 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -70.87 -66.22 0.64 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.122 0.969 . . . . 15.0 110.822 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.16 108.29 48.33 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.557 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 24.6 Cg_endo -63.08 -40.29 34.58 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.553 2.169 . . . . 15.0 113.953 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -57.39 -51.71 68.33 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.907 0.883 . . . . 15.0 113.041 -161.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.11 -20.07 63.2 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.131 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 68.4 t -76.44 -45.29 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.51 -52.58 19.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.04 -32.07 73.33 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.188 -0.915 . . . . 15.0 112.647 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -64.78 -50.66 65.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.088 0.555 . . . . 15.0 109.771 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -72.41 -50.92 22.9 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.518 0.511 . . . . 15.0 111.437 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.5 p -62.07 -28.05 69.33 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.695 0.628 . . . . 15.0 112.695 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.46 17.08 23.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.589 0.755 . . . . 15.0 111.034 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 395' ' ' MET . 50.5 t-20 -137.26 93.58 2.84 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.776 -1.194 . . . . 15.0 107.776 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.57 -33.81 70.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.258 1.023 . . . . 15.0 112.204 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.82 -63.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.269 0.98 . . . . 15.0 110.243 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.87 -18.33 58.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.307 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER -67.03 -48.85 67.07 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.544 -0.91 . . . . 15.0 108.544 177.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.62 -34.32 73.9 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 114.962 -1.017 . . . . 15.0 110.695 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.54 -45.12 95.03 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.463 0.649 . . . . 15.0 110.201 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.469 ' HG2' HD12 ' A' ' 371' ' ' ILE . 32.6 tpp -66.92 -30.99 71.29 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.111 -0.95 . . . . 15.0 110.855 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -71.95 -32.72 67.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.154 0.582 . . . . 15.0 111.205 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -51.49 61.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.0 p -72.63 -20.35 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.377 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -70.12 -43.62 70.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.899 0.479 . . . . 15.0 110.412 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.97 -26.59 59.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.228 -0.896 . . . . 15.0 110.721 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.429 ' O ' HG22 ' A' ' 408' ' ' VAL . 73.2 tt0 -60.63 -51.29 70.03 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 109.69 -0.485 . . . . 15.0 109.69 170.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -56.35 -49.2 75.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.074 0.949 . . . . 15.0 111.017 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.467 HE21 HD22 ' A' ' 360' ' ' LEU . 53.4 tt0 -64.8 -36.36 84.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.752 1.221 . . . . 15.0 111.614 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.39 66.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.02 -0.536 . . . . 15.0 111.063 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 404' ' ' GLU . 68.8 t -55.18 -54.18 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.925 -0.768 . . . . 15.0 108.925 168.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.482 ' HA ' HD13 ' A' ' 412' ' ' LEU . 44.6 mt-10 -61.21 -30.7 70.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.635 1.174 . . . . 15.0 112.425 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.55 73.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.992 0.517 . . . . 15.0 111.342 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.27 -31.56 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.061 -0.718 . . . . 15.0 109.061 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 409' ' ' GLU . 91.6 mt -67.45 -35.3 78.94 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 15.0 110.864 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.13 -17.43 63.46 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.298 0.639 . . . . 15.0 111.978 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -109.58 -26.26 10.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.575 1.15 . . . . 15.0 112.076 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.94 158.38 16.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.919 0.888 . . . . 15.0 110.875 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -73.41 84.78 1.47 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.306 0.642 . . . . 15.0 109.751 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 127' ' ' LYS . 21.2 t -86.8 94.78 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.59 -0.892 . . . . 15.0 108.59 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.9 t -68.92 94.5 0.63 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 122.429 1.109 . . . . 15.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -76.25 130.82 38.75 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.027 -1.442 . . . . 15.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -133.69 136.87 44.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.759 0.824 . . . . 15.0 108.905 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -98.72 127.82 44.78 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.287 -0.635 . . . . 15.0 109.287 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.455 HG21 ' HG2' ' A' ' 426' ' ' GLU . 9.7 t -160.89 176.61 11.25 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 122.78 0.432 . . . . 15.0 111.724 -173.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 33.6 p -92.96 165.92 12.63 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 111.488 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 56.7 t80 -58.6 -28.96 66.09 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.715 1.206 . . . . 15.0 111.228 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.24 -6.84 10.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.03 0.932 . . . . 15.0 113.387 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.483 ' HB3' HD11 ' A' ' 427' ' ' LEU . 12.6 tp10 -74.22 -41.49 61.29 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.033 0.933 . . . . 15.0 112.106 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.583 HD12 HG21 ' A' ' 130' ' ' VAL . 5.3 mp -89.54 -68.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.035 0.534 . . . . 15.0 111.031 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.516 ' HE2' ' HG3' ' A' ' 277' ' ' GLU . 1.2 mpt? -74.36 -49.62 21.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.847 0.459 . . . . 15.0 110.668 -175.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 1.7 m-20 . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 386' ' ' VAL . . . . . 0.471 ' HB ' ' HA3' ' A' ' 179' ' ' GLY . 24.0 m -71.91 95.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.668 0.747 . . . . 0.0 111.051 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.522 HD12 ' HZ ' ' A' ' 217' ' ' PHE . 13.5 tt -155.82 162.64 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.62 0.768 . . . . 0.0 108.97 165.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.425 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 443' ' ' ALA . . . . . 0.421 ' HB3' ' HE2' ' A' ' 398' ' ' MET . . . . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 121.364 0.602 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.24 0.567 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.155 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.712 0.291 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 64.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.144 1.378 . . . . 0.0 111.681 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -89.78 116.28 27.76 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 27.9 m -68.62 106.49 2.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.406 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -89.34 131.62 35.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -86.48 25.96 1.15 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.633 0.773 . . . . 0.0 112.285 -165.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.09 -41.79 90.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.425 0.69 . . . . 0.0 109.271 166.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.523 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.033 168.331 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' HE3' HG11 ' A' ' 3' ' ' VAL . 15.8 ptm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' THR . 7.8 tt0 -87.04 97.52 10.77 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.328 -0.989 . . . . 15.0 108.328 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.475 HG11 ' HE3' ' A' ' 1' ' ' MET . 30.4 m -133.02 157.58 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.844 0.458 . . . . 15.0 111.305 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -131.04 86.43 2.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 15' ' ' VAL . 4.8 p -73.77 87.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 122.658 1.218 . . . . 15.0 110.508 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.96 178.2 5.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.97 -1.468 . . . . 15.0 109.546 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 58.1 m -136.63 125.96 24.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -66.24 -58.75 4.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.538 0.735 . . . . 15.0 109.842 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -167.46 120.62 0.94 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.02 0.528 . . . . 15.0 109.998 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.82 -100.67 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 O-C-N 124.423 1.077 . . . . 15.0 114.398 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.36 -43.39 27.79 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.203 1.001 . . . . 15.0 110.076 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.2 88.88 0.08 OUTLIER Glycine 0 C--N 1.344 1.024 0 O-C-N 124.065 0.853 . . . . 15.0 112.5 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.9 ttm180 -95.78 129.11 43.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 15.0 110.326 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -106.04 90.75 3.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.283 1.033 . . . . 15.0 110.416 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 5' ' ' VAL . 46.1 t -81.68 87.02 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.906 -1.146 . . . . 15.0 107.906 173.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 82.0 m -71.67 87.55 0.94 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.281 0.633 . . . . 15.0 110.189 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 74' ' ' ASN . 48.8 mt -80.07 128.22 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.56 -0.745 . . . . 15.0 109.135 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 56.7 m -118.23 104.08 10.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.713 -1.218 . . . . 15.0 107.713 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.532 HG13 ' HE1' ' A' ' 105' ' ' TYR . 24.7 mt -66.39 129.91 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.98 137.54 57.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.189 0.931 . . . . 15.0 111.038 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.08 61.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.032 1.333 . . . . 15.0 112.789 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.68 -40.88 92.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.849 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.7 m -70.08 -34.63 73.41 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.278 -0.874 . . . . 15.0 111.079 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -68.75 -50.98 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.859 0.464 . . . . 15.0 109.85 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -59.2 -33.73 71.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.265 0.626 . . . . 15.0 111.271 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.1 m -76.72 -43.17 38.5 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.367 0.667 . . . . 15.0 111.283 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -42.2 78.87 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.032 0.533 . . . . 15.0 112.249 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.5 t -60.91 -47.77 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.683 0.793 . . . . 15.0 109.838 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 4.8 ttmp? -58.04 -40.06 79.94 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.083 0.953 . . . . 15.0 111.731 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.4 m -70.56 -28.96 65.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.827 0.851 . . . . 15.0 110.822 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.4 tp10 -80.35 -29.07 37.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.021 0.528 . . . . 15.0 110.725 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -70.69 -35.7 72.91 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.702 0.801 . . . . 15.0 111.534 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.0 p -71.18 -29.71 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.764 -0.458 . . . . 15.0 109.764 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -67.16 -36.67 82.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.934 0.494 . . . . 15.0 110.517 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' GLU . 57.8 t -63.4 -43.1 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.31 73.88 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.45 -0.796 . . . . 15.0 111.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 97.8 mttt -75.12 -33.98 61.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.218 0.607 . . . . 15.0 111.098 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -65.27 -36.52 84.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.688 0.795 . . . . 15.0 110.617 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 35' ' ' VAL . 3.8 t -96.13 -1.51 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.163 0.585 . . . . 15.0 110.562 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 66.95 10.42 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.506 1.522 . . . . 15.0 113.792 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -79.29 -11.24 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.896 0.878 . . . . 15.0 111.388 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -57.13 -38.51 73.59 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.818 0.847 . . . . 15.0 111.907 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.97 -19.81 64.47 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.742 -0.663 . . . . 15.0 112.529 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.02 -20.75 34.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.197 0.599 . . . . 15.0 110.57 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.36 107.81 3.95 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.24 6.56 13.68 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.832 0.853 . . . . 15.0 111.777 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 10.5 74.05 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.964 -0.354 . . . . 15.0 113.035 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -65.38 -35.09 79.89 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.759 0.824 . . . . 15.0 109.86 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.37 122.47 59.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 159.05 47.74 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.899 2.4 . . . . 15.0 112.016 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 tpt -72.51 -20.26 61.39 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.908 -0.587 . . . . 15.0 112.09 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -65.44 -43.04 91.65 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.268 -0.271 . . . . 15.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.407 HG21 ' HD2' ' A' ' 57' ' ' ARG . 62.7 mt -66.19 -44.97 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.87 0.868 . . . . 15.0 111.288 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -71.05 -21.7 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 116.582 -0.281 . . . . 15.0 111.471 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.09 -42.13 14.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.892 0.477 . . . . 15.0 112.041 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.511 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 2.4 pt20 -82.6 -42.63 18.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.09 0.556 . . . . 15.0 111.253 -171.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 98.3 mtt180 -91.63 -60.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.111 0.564 . . . . 15.0 110.435 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.53 -46.51 63.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.607 -0.724 . . . . 15.0 110.471 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.51 12.16 35.11 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.015 -0.881 . . . . 15.0 114.083 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.86 -32.86 72.83 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 117.875 0.837 . . . . 15.0 110.613 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -74.37 -52.0 13.42 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.2 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.0 78.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 15.0 109.629 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -132.14 -63.73 0.8 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.466 1.107 . . . . 15.0 109.114 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -60.67 -29.33 69.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 123.794 0.684 . . . . 15.0 110.404 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.39 -49.44 69.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.824 1.25 . . . . 15.0 110.758 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG13 ' HA ' ' A' ' 28' ' ' VAL . 21.2 t -75.35 -38.65 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.056 -0.975 . . . . 15.0 110.075 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 70' ' ' LEU . 96.3 mt -59.17 -33.1 70.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.729 0.812 . . . . 15.0 111.692 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.496 ' HA2' ' HE2' ' A' ' 71' ' ' MET . . . -56.87 -39.73 88.74 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.433 0.458 . . . . 15.0 112.932 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.91 -46.84 22.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.878 0.871 . . . . 15.0 110.334 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 67' ' ' LEU . 80.0 mt -56.91 -37.19 71.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.852 0.861 . . . . 15.0 112.236 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.496 ' HE2' ' HA2' ' A' ' 68' ' ' GLY . 72.5 mtm -59.4 -39.24 82.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.362 0.665 . . . . 15.0 111.169 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -75.14 -30.37 60.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.155 -0.929 . . . . 15.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -71.78 -42.31 67.3 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.511 -0.551 . . . . 15.0 109.511 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' HB3' HG23 ' A' ' 17' ' ' ILE . 53.2 m-80 -71.83 -27.47 62.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.786 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -66.62 -56.57 10.1 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.341 0.4 . . . . 15.0 110.557 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.79 -30.56 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 O-C-N 123.875 0.735 . . . . 15.0 110.456 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.37 -49.05 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.638 0.775 . . . . 15.0 110.077 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.51 -57.3 11.69 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.376 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.1 pt -61.2 -29.14 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 112.83 0.678 . . . . 15.0 112.83 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.74 -49.06 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.263 0.625 . . . . 15.0 110.968 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.449 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -74.62 -25.85 59.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.541 0.21 . . . . 15.0 111.312 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -83.34 -16.71 45.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.727 0.811 . . . . 15.0 111.14 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 64.15 25.75 13.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.763 1.225 . . . . 15.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.487 HG21 ' HE2' ' A' ' 109' ' ' PHE . 51.8 mt -91.01 127.01 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.406 0.682 . . . . 15.0 109.718 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.55 117.22 61.76 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 164.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.35 97.17 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.375 2.05 . . . . 15.0 113.382 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.53 -171.12 3.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.081 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.551 ' H ' ' HB3' ' A' ' 305' ' ' ALA . . . 58.71 -145.03 43.4 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.293 -0.323 . . . . 15.0 112.293 -168.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.28 122.5 17.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.404 -1.702 . . . . 15.0 106.404 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.92 106.51 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.513 2.142 . . . . 15.0 111.7 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -102.16 98.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.672 0.789 . . . . 15.0 109.468 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -84.54 94.35 8.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.33 98.48 0.92 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.928 -0.768 . . . . 15.0 108.928 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 112.23 3.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.857 2.371 . . . . 15.0 111.352 -173.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.5 -62.61 5.95 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.298 -0.721 . . . . 15.0 111.298 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.32 168.41 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.048 0.939 . . . . 15.0 110.629 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -138.75 121.81 16.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.236 1.014 . . . . 15.0 108.864 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 60.6 mttp -94.63 170.46 9.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.36 97.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.655 0.782 . . . . 15.0 111.469 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.45 80.24 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.447 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.7 mt-10 -98.67 -176.8 3.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.722 0.809 . . . . 15.0 110.805 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.29 137.9 57.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.716 0.806 . . . . 15.0 111.588 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -108.87 99.54 8.87 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.936 0.894 . . . . 15.0 109.546 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -79.72 131.28 35.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.731 0.813 . . . . 15.0 110.084 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.532 ' HE1' HG13 ' A' ' 19' ' ' ILE . 28.8 p90 -152.18 125.25 8.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.609 0.764 . . . . 15.0 109.869 173.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.9 m -82.8 100.55 10.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.445 1.098 . . . . 15.0 110.259 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.67 97.9 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.578 -0.527 . . . . 15.0 109.578 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.46 116.65 30.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.605 0.762 . . . . 15.0 110.494 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HE2' HG21 ' A' ' 84' ' ' ILE . 43.2 p90 -145.3 170.18 16.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.758 1.223 . . . . 15.0 107.73 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -94.71 156.58 16.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.392 0.615 . . . . 15.0 111.312 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.63 162.82 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.462 1.105 . . . . 15.0 108.272 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.05 119.87 70.53 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.86 -175.48 2.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.111 2.541 . . . . 15.0 112.46 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.71 128.39 35.36 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -102.48 129.76 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.816 0.846 . . . . 15.0 109.278 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -118.37 113.14 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 15.0 110.751 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.1 mt -82.0 130.69 35.15 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 123.648 0.593 . . . . 15.0 109.611 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.39 154.92 14.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.679 0.792 . . . . 15.0 109.87 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 64.55 20.73 66.15 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.681 0.613 . . . . 15.0 113.481 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 117' ' ' LEU . 68.0 mt -65.04 -42.64 94.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.886 0.874 . . . . 15.0 110.505 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -78.16 -18.65 55.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.636 -1.166 . . . . 15.0 110.646 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.95 47.47 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.234 0.613 . . . . 15.0 111.34 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.517 HG22 ' HA3' ' A' ' 293' ' ' GLY . 61.1 mt -58.35 124.33 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.245 0.966 . . . . 15.0 110.666 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.0 103.92 14.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.421 0.688 . . . . 15.0 109.296 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.665 ' HB ' HG23 ' A' ' 417' ' ' VAL . 41.5 t -107.32 161.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.46 1.104 . . . . 15.0 108.417 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -123.1 138.13 54.74 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.533 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.1 tttt -114.7 88.67 16.82 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.336 -0.987 . . . . 15.0 108.336 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.11 100.81 0.95 Allowed 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.049 1.833 . . . . 15.0 111.298 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.533 HD11 ' HE2' ' A' ' 127' ' ' LYS . 42.1 mm -67.87 84.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 168.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG23 HG22 ' A' ' 422' ' ' THR . 21.3 t -98.38 136.73 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.22 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -132.66 162.52 31.15 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 167.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.16 79.83 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.2 p -61.93 170.06 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.761 0.824 . . . . 15.0 110.448 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.27 -31.43 65.58 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.955 0.502 . . . . 15.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.96 92.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.782 0.833 . . . . 15.0 110.895 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -73.16 -40.55 64.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.314 0.646 . . . . 15.0 111.113 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.06 -61.87 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.211 1.004 . . . . 15.0 109.514 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.48 -34.49 65.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.574 -0.739 . . . . 15.0 110.934 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.22 -45.67 92.97 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.639 0.587 . . . . 15.0 113.14 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -75.29 -41.82 56.2 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.058 0.543 . . . . 15.0 111.033 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.539 HD21 HG12 ' A' ' 270' ' ' VAL . 32.2 mt -52.23 -40.01 61.05 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.095 0.558 . . . . 15.0 111.841 167.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.54 -41.37 84.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.409 0.684 . . . . 15.0 110.605 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 m -60.41 -39.3 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.836 0.71 . . . . 15.0 110.339 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -40.33 96.07 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 15.0 111.014 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 47.7 mtm180 -62.33 -40.7 97.2 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.621 0.575 . . . . 15.0 110.558 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 87.5 mttt -80.29 -16.4 54.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.324 0.65 . . . . 15.0 112.386 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -82.48 -40.8 20.6 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.883 0.473 . . . . 15.0 109.748 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -100.0 35.81 1.97 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.788 0.835 . . . . 15.0 109.889 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.498 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -79.19 143.97 34.88 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.011 0.925 . . . . 15.0 112.562 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.4 m -74.19 129.4 37.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 15.0 109.643 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -79.18 129.99 35.02 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.21 163.36 36.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 45.7 mt-10 -118.12 157.15 27.42 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.145 0.498 . . . . 15.0 109.839 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.793 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 23.4 pttt -136.63 155.09 50.38 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.34 -0.846 . . . . 15.0 109.982 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.77 96.57 7.0 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.613 -0.721 . . . . 15.0 110.242 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 240' ' ' VAL . . . 60.07 62.36 6.15 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 113.965 -1.47 . . . . 15.0 116.392 165.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.624 ' H ' HG12 ' A' ' 240' ' ' VAL . . . -155.02 107.66 2.75 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 117.344 0.572 . . . . 15.0 110.291 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 203' ' ' LYS . 41.6 t -109.22 137.54 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.488 0.586 . . . . 15.0 109.66 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.61 -176.99 4.22 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.788 1.235 . . . . 15.0 109.315 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.22 67.6 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.892 1.441 . . . . 15.0 114.892 -167.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.9 17.68 9.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.971 0.509 . . . . 15.0 111.305 -170.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.51 -159.57 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.929 0.491 . . . . 15.0 111.815 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 32.3 ttp180 -137.17 153.87 50.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 44.5 t -144.12 155.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 15.0 108.768 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 23.5 m -122.74 124.39 43.26 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 164.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.09 161.34 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.778 0.831 . . . . 15.0 111.012 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.78 121.12 33.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.466 -2.05 . . . . 15.0 105.466 159.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -112.39 163.08 14.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.746 -0.596 . . . . 15.0 110.3 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.5 t -139.78 93.31 2.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -98.12 162.74 21.01 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.205 -1.361 . . . . 15.0 113.295 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 m -149.98 127.45 11.51 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.025 -1.102 . . . . 15.0 108.025 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 71.2 t -97.35 115.97 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.803 0.841 . . . . 15.0 109.422 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 36.6 t70 69.62 3.47 4.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.652 0.781 . . . . 15.0 111.486 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 115.32 -11.9 19.36 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.587 -0.563 . . . . 15.0 113.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 10.3 pt-20 -92.37 131.79 37.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.4 94.58 1.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.217 -1.772 . . . . 15.0 106.217 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.425 ' HD1' ' H ' ' A' ' 177' ' ' PHE . 3.0 p90 -71.78 -160.78 0.06 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.509 -1.678 . . . . 15.0 112.419 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -51.66 103.96 0.07 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.155 0.982 . . . . 15.0 110.571 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' B' ' 386' ' ' VAL . . . 91.56 -62.72 2.69 Favored Glycine 0 C--O 1.239 0.435 0 O-C-N 124.366 1.041 . . . . 15.0 113.195 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.27 -59.42 4.91 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.2 158.03 16.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.566 0.58 . . . . 15.0 112.566 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.16 93.51 2.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.5 m -79.58 130.71 35.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.196 -0.911 . . . . 15.0 112.193 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 58.17 31.12 20.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.749 1.22 . . . . 15.0 113.309 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -71.4 133.96 46.31 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.133 0.492 . . . . 15.0 109.86 173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.7 100.69 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 124.26 1.024 . . . . 15.0 108.912 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.17 98.66 11.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.146 0.979 . . . . 15.0 111.406 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.03 101.65 3.3 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.672 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER -60.08 116.61 4.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.306 0.643 . . . . 15.0 109.641 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.9 -6.61 7.82 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.816 -0.629 . . . . 15.0 112.148 -166.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -81.52 -179.83 7.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.509 0.724 . . . . 15.0 111.097 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.97 52.73 0.68 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.877 -0.602 . . . . 15.0 112.226 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.7 13.52 21.15 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.94 0.876 . . . . 15.0 109.169 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -152.2 154.62 36.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.407 1.083 . . . . 15.0 109.169 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 pt -86.3 164.57 37.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.442 0.697 . . . . 15.0 111.342 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.13 153.57 68.56 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.241 1.961 . . . . 15.0 111.373 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.73 -50.59 1.77 Allowed Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.872 -0.891 . . . . 15.0 110.872 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.441 ' HA ' HD11 ' A' ' 213' ' ' ILE . 65.6 t80 -68.66 -59.98 2.74 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.197 0.599 . . . . 15.0 109.547 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.18 -32.71 73.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.313 1.008 . . . . 15.0 111.623 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.572 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 4.8 m-20 -69.53 -23.43 63.59 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.849 0.86 . . . . 15.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.49 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -83.77 -9.99 81.99 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.461 0.476 . . . . 15.0 113.182 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.1 -46.86 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.677 0.791 . . . . 15.0 110.061 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.672 ' HB3' ' SD ' ' A' ' 189' ' ' MET . 62.3 pttt -84.7 30.88 0.54 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.13 1.159 . . . . 15.0 114.13 -161.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -155.89 35.91 0.62 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.785 -0.526 . . . . 15.0 111.785 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.62 -170.95 3.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.352 0.661 . . . . 15.0 111.29 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -139.42 155.89 47.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.577 1.151 . . . . 15.0 111.226 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.1 147.09 51.96 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 15.0 111.084 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.6 -40.98 2.26 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.229 -0.749 . . . . 15.0 111.229 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.8 pt-20 -78.8 126.79 31.18 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.613 0.72 . . . . 15.0 109.434 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.36 106.4 13.6 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.302 -1.369 . . . . 15.0 107.302 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -126.29 -177.43 3.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.344 1.058 . . . . 15.0 109.877 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.8 t -117.25 158.15 24.82 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.49 HG22 ' HA3' ' A' ' 201' ' ' GLY . 38.0 pt -128.01 150.2 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 173.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.12 117.58 34.43 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 163.92 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 15.0 107.332 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 59.1 m -141.92 134.47 28.23 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.29 128.93 76.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.111 -0.471 . . . . 15.0 109.767 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.06 163.51 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.713 2.942 . . . . 15.0 115.146 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.61 -24.44 53.42 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.397 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.36 -18.63 48.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.363 1.065 . . . . 15.0 110.628 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.43 ' HE2' HD13 ' A' ' 226' ' ' LEU . 30.7 t80 -61.11 111.62 1.78 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 15.0 109.923 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -66.71 -14.39 62.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.163 1.172 . . . . 15.0 114.163 -168.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.16 101.04 10.18 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.74 -31.39 72.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 15.0 111.727 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.512 HD22 HG12 ' B' ' 388' ' ' VAL . 7.0 p30 -70.41 -11.68 61.08 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.862 0.465 . . . . 15.0 111.596 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' H ' ' B' ' 388' ' ' VAL . 57.5 mt -112.61 -30.84 6.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.932 0.893 . . . . 15.0 110.765 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.17 121.48 6.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.583 1.153 . . . . 15.0 112.497 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.69 -22.98 25.19 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.903 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 96.1 mttt -75.99 143.02 41.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.232 0.613 . . . . 15.0 110.964 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.22 115.01 27.71 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.879 0.871 . . . . 15.0 109.825 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.38 118.47 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.553 0.741 . . . . 15.0 111.594 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -92.34 124.16 36.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.113 0.965 . . . . 15.0 108.726 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.2 113.83 19.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.067 0.547 . . . . 15.0 109.79 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 93.62 4.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.63 -0.507 . . . . 15.0 109.63 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.8 mm -82.82 122.55 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.352 1.061 . . . . 15.0 110.324 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -107.67 99.75 9.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 109.569 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.29 111.95 11.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.913 -0.403 . . . . 15.0 109.913 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 239' ' ' LYS . 17.7 ptpt -109.7 -35.46 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 116.461 -0.336 . . . . 15.0 110.597 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 238' ' ' LYS . 74.6 mmtt -129.29 133.0 47.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.241 0.616 . . . . 15.0 110.327 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 157' ' ' ALA . 77.7 t -106.92 123.62 62.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 26.1 mt-10 -124.55 169.98 11.36 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.557 0.743 . . . . 15.0 109.457 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.793 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.2 tt0 -139.21 130.48 26.81 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.896 0.878 . . . . 15.0 109.411 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -83.65 84.68 7.46 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.575 -1.268 . . . . 15.0 107.575 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.95 141.2 53.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.844 -1.526 . . . . 15.0 111.239 -173.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.402 HD22 ' HE3' ' A' ' 146' ' ' LYS . 96.7 mt -58.26 126.29 77.78 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.343 0.657 . . . . 15.0 110.714 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -77.78 173.22 14.41 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.892 2.395 . . . . 15.0 111.249 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -79.82 127.06 31.76 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.722 -0.672 . . . . 15.0 110.069 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 17.0 tp -86.87 52.96 2.66 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.558 -0.904 . . . . 15.0 108.558 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 253' ' ' ILE . 59.9 m -55.0 143.54 26.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.825 1.65 . . . . 15.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.81 -45.37 59.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.748 0.819 . . . . 15.0 112.346 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.62 -14.97 63.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.132 0.973 . . . . 15.0 113.446 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.55 -51.32 4.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.76 0.824 . . . . 15.0 110.305 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.703 HG13 HD22 ' A' ' 266' ' ' LEU . 7.3 tt -63.63 -33.08 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.147 0.979 . . . . 15.0 111.893 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.557 ' HZ3' ' HB2' ' A' ' 254' ' ' LYS . 0.1 OUTLIER -59.32 -29.63 67.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 120.757 0.313 . . . . 15.0 111.353 175.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -72.69 -13.56 61.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.588 0.755 . . . . 15.0 111.031 -172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.57 6.76 22.51 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.394 0.678 . . . . 15.0 111.929 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.63 8.91 Favored Glycine 0 N--CA 1.476 1.361 0 CA-C-N 117.554 0.161 . . . . 15.0 113.17 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.82 132.88 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.2 -62.89 1.2 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.87 0.367 . . . . 15.0 110.588 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -83.8 -22.31 31.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.65 0.78 . . . . 15.0 111.383 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 90.7 26.93 21.27 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.631 -0.539 . . . . 15.0 113.449 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 55.3 p -72.22 136.23 46.3 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 117.607 0.703 . . . . 15.0 110.535 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.48 ' HA ' HD13 ' A' ' 253' ' ' ILE . 61.0 t -55.62 -46.97 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.896 0.878 . . . . 15.0 110.468 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.5 -26.69 68.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.701 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.54 -26.28 61.43 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 111.464 -0.654 . . . . 15.0 111.464 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.703 HD22 HG13 ' A' ' 253' ' ' ILE . 53.9 tp -77.27 -41.79 39.56 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.86 -0.422 . . . . 15.0 109.86 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -60.77 -39.7 89.77 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 124.026 0.829 . . . . 15.0 110.026 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.83 -42.24 77.44 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.398 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -64.6 -44.64 89.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.473 0.709 . . . . 15.0 111.107 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.589 ' HB ' ' HE1' ' A' ' 274' ' ' MET . 28.3 m -76.93 -25.21 15.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 119.282 -0.39 . . . . 15.0 110.89 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -55.34 -59.64 4.52 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.8 -36.35 82.19 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.03 0.752 . . . . 15.0 113.03 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -70.42 -52.48 21.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.214 0.461 . . . . 15.0 111.168 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.589 ' HE1' ' HB ' ' A' ' 270' ' ' VAL . 65.8 mtt -65.51 -33.47 75.99 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 118.391 -0.814 . . . . 15.0 110.206 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 45.5 mt-10 -72.21 -30.58 65.07 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -69.59 -38.83 77.48 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -65.12 -46.7 79.92 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.867 -1.06 . . . . 15.0 110.232 169.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 428' ' ' MET . 42.9 tp -63.6 -59.4 4.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.397 -1.274 . . . . 15.0 112.788 -168.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.87 -30.2 70.76 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.718 0.636 . . . . 15.0 111.745 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 m -70.24 -37.6 75.0 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.214 0.53 . . . . 15.0 110.019 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.98 61.05 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 115.74 -0.664 . . . . 15.0 111.873 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 89.4 mt -69.32 -40.08 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.941 -1.133 . . . . 15.0 107.941 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -59.83 -50.5 73.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.602 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.44 -39.09 86.24 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.911 0.757 . . . . 15.0 111.765 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -56.44 -66.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.133 0.973 . . . . 15.0 110.8 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.79 -40.34 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.835 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.59 -46.53 79.01 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 115.6 -0.727 . . . . 15.0 110.724 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.0 p -69.13 -31.85 70.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.226 0.329 . . . . 15.0 111.712 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.461 ' HB2' HG12 ' A' ' 125' ' ' VAL . 54.7 mt-30 -64.56 -47.19 79.66 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.403 0.281 . . . . 15.0 110.779 173.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 412' ' ' LEU . . . -62.07 -44.37 96.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.227 0.611 . . . . 15.0 111.26 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.527 HD11 HD11 ' A' ' 351' ' ' LEU . 1.2 mp -64.44 -45.91 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.684 1.594 . . . . 15.0 111.445 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.431 ' HG2' ' HA ' ' B' ' 400' ' ' ALA . 15.4 tp10 -67.59 -43.13 81.29 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.766 -0.457 . . . . 15.0 109.766 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.517 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -56.9 -41.43 91.66 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 124.151 0.907 . . . . 15.0 112.186 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.5 -59.62 5.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 15.0 111.292 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.62 -51.47 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 120.936 0.398 . . . . 15.0 110.302 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -62.93 -35.07 78.87 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.985 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.62 -24.64 49.51 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.669 0.618 . . . . 15.0 112.669 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 14.2 m-80 -118.26 152.67 35.28 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.991 0.424 . . . . 15.0 111.887 -162.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -121.61 135.46 54.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.081 0.952 . . . . 15.0 109.713 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.624 HD12 HD13 ' A' ' 349' ' ' LEU . 12.0 tt -168.67 144.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.392 1.077 . . . . 15.0 109.447 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.93 120.74 26.07 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.589 -1.263 . . . . 15.0 107.589 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.15 120.29 65.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.783 0.833 . . . . 15.0 111.219 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.8 126.73 17.19 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.142 2.561 . . . . 15.0 112.776 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.6 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -57.82 -23.18 51.44 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.836 1.254 . . . . 15.0 112.341 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 88' ' ' GLY . . . -56.04 -56.05 25.51 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.385 1.074 . . . . 15.0 111.529 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 37.1 mt -71.8 -33.2 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.622 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 304' ' ' ALA . 69.2 mt -60.82 -44.57 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.549 0.74 . . . . 15.0 110.054 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.59 91.77 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.675 0.79 . . . . 15.0 110.821 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 56.6 m -62.64 -49.9 73.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.669 0.605 . . . . 15.0 112.171 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.473 ' HB2' ' HB1' ' A' ' 341' ' ' ALA . 4.8 mm-40 -68.65 -40.69 80.11 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.304 0.378 . . . . 15.0 110.542 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 334' ' ' ARG . 60.6 mt -56.81 -45.26 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.898 0.879 . . . . 15.0 109.736 173.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 23.8 t70 -60.47 -46.75 88.96 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.325 1.016 . . . . 15.0 111.583 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.8 -40.72 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 123.722 0.639 . . . . 15.0 110.424 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.23 -26.71 63.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.307 0.643 . . . . 15.0 112.039 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.0 mtm180 -73.79 -41.63 62.11 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 320' ' ' GLN . 57.9 mtt180 -64.06 -44.62 91.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.852 -0.613 . . . . 15.0 109.698 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.439 ' HG3' HD11 ' B' ' 439' ' ' LEU . 35.0 tt0 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.699 1.199 . . . . 15.0 111.65 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.6 -58.75 4.13 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.316 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 332' ' ' LEU . . . -53.6 -38.6 64.13 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.463 1.102 . . . . 15.0 111.77 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.584 HE22 HG23 ' B' ' 421' ' ' VAL . 0.8 OUTLIER -49.45 -43.3 44.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.6 1.56 . . . . 15.0 110.825 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -104.12 -9.21 18.89 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.342 0.657 . . . . 15.0 111.831 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -93.87 44.63 1.13 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.481 1.113 . . . . 15.0 109.343 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.25 79.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.069 -0.514 . . . . 15.0 113.4 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 83.1 35.97 16.5 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.436 -0.647 . . . . 15.0 113.456 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 5.1 m-20 -51.82 108.39 0.27 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.79 1.236 . . . . 15.0 111.451 -175.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.28 91.05 0.71 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.615 1.166 . . . . 15.0 110.634 -165.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm 59.19 15.55 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.28 1.432 . . . . 15.0 113.085 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 23.2 tm0? -76.52 -13.19 60.11 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.92 0.888 . . . . 15.0 108.758 169.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.21 -41.97 1.98 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.206 1.803 . . . . 15.0 113.669 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.92 -38.73 62.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.446 1.098 . . . . 15.0 111.877 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.17 -16.82 56.03 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.407 1.083 . . . . 15.0 112.861 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' A' ' 319' ' ' ALA . 57.4 mt -54.97 137.99 65.29 Favored Pre-proline 0 N--CA 1.5 2.036 0 CA-C-N 118.477 0.581 . . . . 15.0 111.937 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.13 107.9 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.796 2.997 . . . . 15.0 114.088 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 311' ' ' ILE . 25.7 ttt85 -53.53 -39.25 64.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.208 1.403 . . . . 15.0 112.412 -174.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.31 -26.04 60.27 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 15.0 113.226 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.5 -31.96 71.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.245 0.545 . . . . 15.0 110.533 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -105.53 -19.83 13.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.005 0.922 . . . . 15.0 111.341 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -49.21 -61.15 2.23 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.879 1.272 . . . . 15.0 113.28 -169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.15 -52.16 50.95 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.432 0.693 . . . . 15.0 111.666 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -63.38 -34.46 77.78 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.757 0.66 . . . . 15.0 111.903 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -68.97 -49.34 58.73 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.445 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.2 tttt -55.55 -39.4 70.56 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.138 0.899 . . . . 15.0 110.636 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.453 ' O ' HG21 ' A' ' 347' ' ' VAL . 12.4 mmt180 -59.09 -44.8 91.95 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.419 171.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -68.87 -24.19 64.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.491 0.716 . . . . 15.0 110.718 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.0 t -71.53 -50.9 36.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 123.181 0.592 . . . . 15.0 110.176 173.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 342' ' ' LYS . 39.7 t -56.33 -37.4 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 123.846 0.716 . . . . 15.0 109.887 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 343' ' ' ARG . 60.4 t -54.31 -53.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 15.0 110.972 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.22 -32.76 85.27 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.619 0.575 . . . . 15.0 114.049 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.624 HD13 HD12 ' A' ' 300' ' ' ILE . 89.7 mt -73.28 -50.48 22.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.605 0.762 . . . . 15.0 110.159 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 354' ' ' VAL . 89.6 mt -70.37 -46.82 63.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.631 -0.713 . . . . 15.0 110.825 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.527 HD11 HD11 ' A' ' 291' ' ' ILE . 52.9 mt -64.16 -37.13 86.35 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.439 0.462 . . . . 15.0 111.388 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.76 -40.2 98.91 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.593 0.558 . . . . 15.0 111.918 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.23 -29.27 67.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.107 -0.547 . . . . 15.0 111.304 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.1 t -74.33 -32.3 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.811 0.444 . . . . 15.0 110.357 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 351' ' ' LEU . 95.7 mt -63.45 -42.77 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.26 -0.645 . . . . 15.0 109.26 172.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -65.0 -55.45 18.93 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.2 m -60.31 -44.9 95.02 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.426 1.09 . . . . 15.0 111.535 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -88.26 4.27 46.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.125 0.57 . . . . 15.0 111.696 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 39.08 65.03 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.87 1.668 . . . . 15.0 113.886 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 154.12 18.34 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.5 -1.227 . . . . 15.0 111.204 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.36 144.05 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.538 -1.282 . . . . 15.0 107.538 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 403' ' ' LEU . . . -66.14 132.59 48.83 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.63 0.372 . . . . 15.0 111.781 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.72 123.79 37.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.728 0.811 . . . . 15.0 110.265 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.44 -40.29 82.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.273 0.629 . . . . 15.0 112.383 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.86 -27.59 66.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.655 0.382 . . . . 15.0 111.751 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -74.57 -43.32 56.23 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 371' ' ' ILE . 46.5 t -59.58 -42.0 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.697 -1.138 . . . . 15.0 109.719 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -58.14 -50.17 74.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.651 0.78 . . . . 15.0 110.865 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.76 -46.46 82.75 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 124.193 0.933 . . . . 15.0 112.664 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -55.47 -48.84 73.89 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.416 0.686 . . . . 15.0 111.11 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.544 HD12 ' HG2' ' A' ' 398' ' ' MET . 35.6 mm -58.32 -58.94 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.534 0.733 . . . . 15.0 111.705 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.64 -36.21 83.51 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 124.329 1.018 . . . . 15.0 111.491 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -78.36 -39.06 40.48 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.46 0.541 . . . . 15.0 112.46 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.443 ' HG2' HG23 ' B' ' 441' ' ' ILE . 53.2 ttp -63.15 -36.12 82.55 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.343 0.592 . . . . 15.0 109.96 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -81.62 -28.16 33.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.173 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 35.4 t -64.65 -15.42 61.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.792 0.837 . . . . 15.0 111.669 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.09 -5.26 34.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.352 0.661 . . . . 15.0 111.945 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.79 165.58 20.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.327 1.051 . . . . 15.0 110.004 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.18 17.78 7.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.558 0.743 . . . . 15.0 110.354 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 381' ' ' PRO . 1.6 p30 -133.45 41.7 0.73 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.149 0.98 . . . . 15.0 112.626 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.722 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 44.1 Cg_exo -58.06 -43.48 47.79 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 122.128 1.886 . . . . 15.0 113.98 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.47 -50.1 63.36 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.897 0.879 . . . . 15.0 112.711 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.7 -22.04 64.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.594 0.559 . . . . 15.0 111.752 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.45 HG11 HG21 ' B' ' 441' ' ' ILE . 99.6 t -77.06 -45.71 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.191 0.597 . . . . 15.0 109.446 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.98 -39.28 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.04 -0.982 . . . . 15.0 109.776 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.67 -42.12 71.17 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.121 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -60.66 -35.91 77.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.295 0.638 . . . . 15.0 111.701 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.413 ' HE1' HD11 ' B' ' 441' ' ' ILE . 51.7 m-85 -88.38 -61.11 1.79 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.636 0.374 . . . . 15.0 111.745 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . 0.486 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 38.9 m -70.54 -21.33 62.73 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.616 0.969 . . . . 15.0 113.616 -167.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -96.01 11.49 33.85 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.417 0.287 . . . . 15.0 111.055 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -136.8 103.54 5.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.84 -31.61 71.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.065 0.546 . . . . 15.0 111.512 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.08 -47.74 84.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.387 0.675 . . . . 15.0 110.87 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.401 ' HG ' ' CD2' ' A' ' 388' ' ' TYR . 41.8 tp -83.51 -24.71 31.58 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.896 -0.593 . . . . 15.0 111.209 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -71.08 -37.61 72.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.43 -36.19 82.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.761 1.224 . . . . 15.0 110.569 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 400' ' ' ASN . 51.9 t-20 -62.37 -42.48 99.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.742 0.782 . . . . 15.0 109.854 173.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.544 ' HG2' HD12 ' A' ' 371' ' ' ILE . 3.8 tpt -79.23 -17.26 55.14 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.564 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.11 -35.97 64.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 168.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 397' ' ' ASN . 6.8 t30 -59.22 -53.61 56.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.374 0.669 . . . . 15.0 110.421 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.2 p -65.47 -37.11 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 O-C-N 123.577 0.548 . . . . 15.0 111.354 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -62.01 -44.87 95.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.902 0.481 . . . . 15.0 110.96 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 362' ' ' ALA . 23.5 tp -72.04 -30.46 65.2 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.846 -1.07 . . . . 15.0 111.03 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 408' ' ' VAL . 33.7 tt0 -67.56 -39.35 84.95 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.949 0.9 . . . . 15.0 109.492 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 33.1 mm-40 -69.49 -36.2 76.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.551 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -62.25 -39.15 91.92 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.387 0.675 . . . . 15.0 110.098 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.43 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -64.85 -41.77 95.43 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 124.07 0.857 . . . . 15.0 111.534 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 404' ' ' GLU . 96.2 t -57.94 -55.47 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 123.474 0.484 . . . . 15.0 110.031 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.443 ' HG2' HD13 ' A' ' 412' ' ' LEU . 43.5 mt-10 -67.29 -22.89 65.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.553 0.575 . . . . 15.0 112.553 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 414' ' ' LYS . . . -66.13 -37.66 86.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.57 0.544 . . . . 15.0 110.621 169.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 407' ' ' ALA . 45.8 t -74.61 -33.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.443 HD13 ' HG2' ' A' ' 409' ' ' GLU . 96.9 mt -64.33 -40.1 95.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.076 0.55 . . . . 15.0 110.935 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.21 -15.56 57.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.35 0.66 . . . . 15.0 112.492 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 410' ' ' ALA . 24.1 mtpp -101.12 -33.77 9.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.178 0.991 . . . . 15.0 110.672 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.3 160.66 20.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.284 1.033 . . . . 15.0 112.402 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.6 80.29 1.99 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.163 0.985 . . . . 15.0 109.816 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.665 HG23 ' HB ' ' A' ' 125' ' ' VAL . 49.1 t -97.73 109.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.605 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.0 t -87.95 103.4 15.65 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.277 0.631 . . . . 15.0 110.134 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -85.37 129.39 34.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.661 0.785 . . . . 15.0 110.068 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -139.33 153.93 47.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.361 0.664 . . . . 15.0 109.588 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.56 133.3 52.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.592 -0.892 . . . . 15.0 108.592 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 130' ' ' VAL . 7.9 t -159.64 172.12 18.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.763 0.425 . . . . 15.0 111.521 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 77.9 p -91.78 168.28 11.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.22 1.008 . . . . 15.0 111.396 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -54.17 -26.66 29.2 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.459 1.503 . . . . 15.0 112.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.93 -20.62 16.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.06 0.944 . . . . 15.0 113.338 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.466 0.706 . . . . 15.0 112.256 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 22.4 tp -70.48 -78.79 0.07 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.514 0.931 . . . . 15.0 113.514 -153.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 278' ' ' LEU . 1.0 OUTLIER -87.19 -22.79 25.07 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.608 0.363 . . . . 15.0 110.39 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.93 21.41 0.16 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.964 0.906 . . . . 15.0 111.904 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.31 81.21 4.68 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.334 -1.358 . . . . 15.0 107.334 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -95.04 40.3 1.1 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 15.0 109.563 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.329 1.051 . . . . 15.0 108.413 -175.225 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 36.9 t . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.65 55.96 1.78 Allowed 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.77 -28.47 58.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.474 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.19 -16.92 61.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.09 1.356 . . . . 0.0 112.497 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -83.26 -42.1 17.58 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.337 0.655 . . . . 0.0 110.302 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.7 67.41 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.622 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 19.4 m -103.33 1.16 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.212 1.005 . . . . 0.0 111.605 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -28.36 -67.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 126.735 2.014 . . . . 0.0 115.177 -164.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -101.32 -79.05 0.52 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' B' ' 378' ' ' ALA . . . -106.24 -73.43 0.68 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 160.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.39 -71.84 0.74 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 166.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 379' ' ' LYS . 23.0 mt-10 -103.55 -75.58 0.61 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.86 -80.13 0.52 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 165.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . 0.467 ' HA ' ' HB1' ' B' ' 374' ' ' ALA . . . -100.35 -80.32 0.48 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 154.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' B' ' 376' ' ' GLU . 28.4 mmtp -106.93 -85.79 0.5 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 155.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -151.91 127.72 10.25 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.121 0.568 . . . . 0.0 110.082 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 56.53 -171.5 0.08 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 113.562 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -139.6 -158.33 7.59 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.63 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -172.2 165.46 6.02 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.416 1.087 . . . . 0.0 109.254 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -55.15 -51.13 67.44 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.497 1.119 . . . . 0.0 111.727 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -136.46 97.74 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.502 HG13 ' HA3' ' A' ' 179' ' ' GLY . 27.2 m -69.4 98.72 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 121.834 0.826 . . . . 0.0 113.086 -166.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.401 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 20.9 pt -144.02 157.54 15.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.763 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 158.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.547 ' H ' HD11 ' A' ' 226' ' ' LEU . 30.2 t -79.27 109.57 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 31.8 m -64.95 100.29 0.41 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 124.153 0.908 . . . . 0.0 111.357 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -89.24 148.12 23.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -79.16 164.33 24.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.289 0.566 . . . . 0.0 109.806 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -139.46 72.28 1.4 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -74.9 75.16 2.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.997 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -120.63 -72.43 0.69 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 165.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 57.75 -157.86 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.371 1.069 . . . . 0.0 111.22 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 21.4 t -77.05 -0.94 26.49 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.917 0.487 . . . . 0.0 111.043 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -73.09 98.67 2.61 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.881 0.872 . . . . 0.0 108.708 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 27.6 pt -67.18 157.06 6.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 110.734 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.94 93.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 109.669 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.431 ' HA ' ' HG2' ' A' ' 292' ' ' GLU . . . -145.52 -56.21 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.988 0.915 . . . . 0.0 110.676 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.89 178.74 6.92 Favored 'Trans proline' 0 C--N 1.39 2.723 0 CA-C-N 121.666 1.631 . . . . 0.0 111.526 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.79 -82.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.422 HG22 ' HB3' ' B' ' 406' ' ' PRO . 2.8 m 47.48 45.11 17.27 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 125.138 1.375 . . . . 0.0 112.433 172.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -66.41 -26.64 67.33 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.006 0.522 . . . . 0.0 112.106 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -126.54 87.53 56.21 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 123.695 0.798 . . . . 0.0 109.211 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' B' ' 403' ' ' THR . 94.4 Cg_endo -76.51 -31.27 4.49 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.954 2.436 . . . . 0.0 112.987 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.45 -101.37 0.62 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -167.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 42.3 tp 60.72 107.33 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.025 1.33 . . . . 0.0 112.093 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 22.8 m -77.07 82.18 3.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.118 0.567 . . . . 0.0 110.528 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 74.27 -62.38 0.46 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.959 1.703 . . . . 0.0 112.734 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 67.63 -169.22 0.19 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.637 1.175 . . . . 0.0 111.258 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.7 87.78 2.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.59 -84.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.581 1.552 . . . . 0.0 112.447 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 414' ' ' THR . . . . . 0.424 HG23 ' H ' ' B' ' 415' ' ' LYS . 3.6 t -163.16 -63.63 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.631 0.772 . . . . 0.0 109.508 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' B' ' 418' ' ' ALA . 21.9 tptm -96.59 126.18 41.58 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -142.42 -60.6 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.733 0.813 . . . . 0.0 109.492 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -68.35 112.66 4.82 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.545 0.528 . . . . 0.0 112.406 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . 0.457 ' HB3' ' HE2' ' B' ' 415' ' ' LYS . . . -157.42 -62.69 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.177 0.591 . . . . 0.0 110.32 -172.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 21.2 m -83.82 -10.06 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.105 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.43 ' HE2' ' HG2' ' B' ' 422' ' ' MET . 24.3 ptm -134.4 142.88 47.31 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.716 0.807 . . . . 0.0 109.103 172.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.584 HG23 HE22 ' A' ' 320' ' ' GLN . 12.9 p -95.41 -15.09 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.483 0.713 . . . . 0.0 110.999 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.43 ' HG2' ' HE2' ' B' ' 420' ' ' MET . 83.7 mtp 67.12 29.71 7.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.92 1.288 . . . . 0.0 111.295 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 41.8 t -154.68 164.19 39.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.358 0.663 . . . . 0.0 111.209 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 53.75 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.673 1.589 . . . . 0.0 112.604 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.61 27.99 0.02 OUTLIER Glycine 0 C--O 1.223 -0.556 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' B' ' 432' ' ' GLN . 25.5 t-20 -99.21 98.53 9.5 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.912 0.885 . . . . 0.0 110.74 -167.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 50.8 m -148.96 -78.14 0.15 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.978 0.911 . . . . 0.0 109.293 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -70.08 142.35 52.66 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' B' ' 432' ' ' GLN . 60.9 mm-40 -53.7 -25.11 16.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.125 0.97 . . . . 0.0 113.137 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -53.27 -55.19 26.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.253 1.021 . . . . 0.0 110.638 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 22.9 t -107.52 2.74 24.33 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.58 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.499 ' HG2' ' ND2' ' B' ' 426' ' ' ASN . 1.3 tm0? -73.87 -35.29 64.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.337 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 161.01 26.82 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 22.7 m80 63.59 -72.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.993 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 37.9 p -82.75 56.5 3.41 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.376 0.67 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . 0.443 ' HA2' ' ND2' ' B' ' 426' ' ' ASN . . . -82.73 61.81 4.7 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 18.0 t -118.01 97.9 6.05 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . 0.402 ' NE2' HD22 ' B' ' 426' ' ' ASN . 1.1 pm0 -153.51 18.99 0.54 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.775 1.23 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.439 HD11 ' HG3' ' A' ' 317' ' ' GLN . 75.1 mt 65.06 33.3 9.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.748 1.219 . . . . 0.0 111.192 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.69 121.49 12.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.597 0.759 . . . . 0.0 109.763 172.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.45 HG21 HG11 ' A' ' 384' ' ' VAL 0.292 2.8 pp 46.62 102.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 C-N-CA 126.407 1.883 . . . . 0.0 112.951 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -87.07 160.01 18.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -164.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -154.93 147.65 24.36 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -79.02 139.28 38.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.907 0.883 . . . . 0.0 111.047 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -117.91 78.43 0.3 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.42 -11.15 24.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.08 2.52 . . . . 0.0 114.261 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 m80 85.43 143.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.613 1.965 . . . . 0.0 110.78 -167.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 66.37 -173.28 0.19 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.065 1.346 . . . . 0.0 112.782 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -85.93 49.22 1.73 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.002 0.921 . . . . 0.0 112.294 -174.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 60.87 -80.7 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.516 1.527 . . . . 0.0 111.91 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.48 -36.64 75.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.9 0.88 . . . . 0.0 109.804 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 47.8 t 76.16 -55.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.864 1.666 . . . . 0.0 110.376 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 160.48 -53.59 0.34 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 4.6 tt -89.9 104.01 16.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 6.2 t -118.86 -29.24 5.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.095 0.958 . . . . 0.0 108.531 164.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.71 -83.51 0.02 OUTLIER 'General case' 0 C--N 1.364 1.222 0 C-N-CA 125.564 1.546 . . . . 0.0 111.585 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -157.82 85.83 0.9 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 14.8 m -71.98 -11.87 60.97 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 168.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 18.4 t70 79.05 11.52 1.45 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.513 1.925 . . . . 0.0 111.212 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.25 165.2 15.2 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.866 . . . . 0.0 110.508 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.64 -1.29 38.4 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.612 0.765 . . . . 0.0 111.418 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -164.6 135.86 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 89.3 m -63.3 99.37 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.5 ttt -78.43 120.17 22.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.674 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.463 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.1 OUTLIER -125.62 75.82 1.52 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 122.482 1.134 . . . . 0.0 109.18 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.15 -40.8 36.83 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.58 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -152.6 144.6 23.74 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 113.845 -1.525 . . . . 0.0 108.776 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -157.46 135.12 10.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . 0.536 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . -88.57 -135.54 5.25 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.449 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 469' ' ' GLY 0.287 4.0 pp 64.88 -30.61 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 128.031 2.532 . . . . 0.0 115.793 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 CA--C 1.555 1.14 0 N-CA-C 109.029 -0.73 . . . . 12.06 109.029 -178.105 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.779 0.323 . . . . 15.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -126.96 142.67 51.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.883 -1.154 . . . . 15.0 107.883 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.535 HG11 HG12 ' A' ' 17' ' ' ILE . 28.0 m -126.78 152.22 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.505 0.722 . . . . 15.0 110.051 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 48.7 m -146.9 100.63 3.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.349 0.66 . . . . 15.0 110.052 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.26 128.23 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.967 -0.561 . . . . 15.0 109.855 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.03 97.38 3.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 15.0 108.921 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -76.87 93.88 3.82 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.704 -0.85 . . . . 15.0 108.704 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.2 p -66.12 -39.94 90.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.139 0.976 . . . . 15.0 111.858 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -170.13 104.1 0.3 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.393 0.677 . . . . 15.0 109.979 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.67 -100.93 0.47 Allowed Glycine 0 C--N 1.354 1.529 0 O-C-N 124.083 0.864 . . . . 15.0 113.275 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HA ' HG23 ' A' ' 111' ' ' VAL . 9.2 mp -76.99 -39.42 50.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 15.0 110.152 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.7 104.05 0.34 Allowed Glycine 0 C--N 1.353 1.477 0 O-C-N 124.603 1.19 . . . . 15.0 111.634 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.438 ' NH1' HG11 ' A' ' 111' ' ' VAL . 33.8 ttm180 -134.82 120.87 19.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.38 1.072 . . . . 15.0 109.972 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.46 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 43.3 ttm180 -93.76 146.38 23.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.46 -1.245 . . . . 15.0 109.468 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.47 93.69 2.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 107.332 -1.359 . . . . 15.0 107.332 165.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 33.3 m -73.19 108.55 6.13 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.137 -0.938 . . . . 15.0 108.953 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.535 HG12 HG11 ' A' ' 3' ' ' VAL . 47.8 mt -107.92 123.95 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.025 0.53 . . . . 15.0 109.617 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 m -99.93 104.83 16.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.518 0.727 . . . . 15.0 109.156 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 70' ' ' LEU . 56.5 mt -80.52 112.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 160.07 24.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.206 0.603 . . . . 15.0 111.997 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.96 79.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.324 1.049 . . . . 15.0 112.056 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -65.09 -36.2 83.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.741 0.816 . . . . 15.0 111.121 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -70.14 -37.0 75.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.528 0.731 . . . . 15.0 110.459 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 28' ' ' VAL . 73.8 mt -70.67 -44.05 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 114.905 -1.043 . . . . 15.0 109.943 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.26 -41.72 99.08 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.065 0.546 . . . . 15.0 111.799 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 m -56.11 -45.87 79.34 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.81 88.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.462 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 24' ' ' ILE . 71.3 t -60.99 -55.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.284 0.634 . . . . 15.0 110.658 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 5.1 ttmp? -61.75 -41.5 97.76 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.481 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.27 -11.5 59.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.418 0.687 . . . . 15.0 111.767 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -88.64 -43.03 11.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.721 0.408 . . . . 15.0 110.383 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.629 HD11 ' HA3' ' A' ' 59' ' ' GLY . 92.4 mt -70.27 -23.97 62.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.564 0.746 . . . . 15.0 112.386 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.2 p -69.98 -32.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 123.339 0.4 . . . . 15.0 110.054 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -69.36 -43.53 73.4 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.588 0.755 . . . . 15.0 109.613 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG21 ' A' ' 39' ' ' VAL . 46.9 t -63.36 -38.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.885 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.524 0.73 . . . . 15.0 110.926 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 95.6 mttt -67.29 -31.49 71.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.169 0.587 . . . . 15.0 111.392 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.28 -46.05 29.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.694 0.798 . . . . 15.0 110.951 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.422 ' HB ' HG13 ' A' ' 41' ' ' ILE . 3.7 t -82.85 -5.93 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 122.924 0.49 . . . . 15.0 110.005 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 74.45 8.79 4.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.85 1.66 . . . . 15.0 112.15 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' HB ' ' A' ' 39' ' ' VAL . 56.8 mt -63.89 -22.9 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 15.0 110.931 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.99 -33.97 74.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.424 0.69 . . . . 15.0 111.148 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -39.05 15.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.749 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -71.03 -16.97 62.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.157 0.583 . . . . 15.0 111.162 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.0 ttt-85 -76.63 105.93 7.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 172.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -85.79 13.22 7.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.406 0.683 . . . . 15.0 112.153 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -34.29 4.66 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.85 -0.417 . . . . 15.0 112.354 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -52.03 -36.14 49.24 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.998 1.319 . . . . 15.0 112.384 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.31 108.92 32.23 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.564 -0.902 . . . . 15.0 108.564 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' HD13 ' A' ' 53' ' ' ILE . 38.8 Cg_exo -64.02 138.94 64.86 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 15.0 111.681 173.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.6 tpp -67.92 -25.74 65.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.196 0.598 . . . . 15.0 111.12 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.13 -33.89 77.1 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.326 0.25 . . . . 15.0 111.13 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.491 HD13 ' HD2' ' A' ' 50' ' ' PRO . 32.1 mt -67.55 -46.15 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.018 0.527 . . . . 15.0 110.234 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -74.14 -21.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 111.567 0.21 . . . . 15.0 111.567 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.23 -45.58 39.3 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.201 0.6 . . . . 15.0 111.4 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.57 -26.56 58.05 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.502 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -92.01 -72.52 0.59 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.839 0.455 . . . . 15.0 110.9 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -84.33 -34.44 23.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.077 0.551 . . . . 15.0 111.466 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.629 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -74.97 -13.23 82.8 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.156 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.68 59.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 15.0 112.163 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.9 p -81.89 -42.75 19.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.293 0.637 . . . . 15.0 109.346 171.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -70.86 88.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.793 0.837 . . . . 15.0 109.152 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.46 -38.28 6.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.625 0.77 . . . . 15.0 110.129 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.14 -46.01 90.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.765 0.826 . . . . 15.0 112.271 -171.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.98 -49.24 71.02 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.301 0.641 . . . . 15.0 110.376 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.6 -63.78 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.543 -1.208 . . . . 15.0 110.76 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 71' ' ' MET . 84.1 mt -64.74 -38.21 90.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.781 0.832 . . . . 15.0 111.511 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -61.27 -40.72 98.99 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.812 0.695 . . . . 15.0 113.15 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.87 -37.57 39.93 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.004 0.522 . . . . 15.0 110.076 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 19' ' ' ILE . 21.0 mt -54.87 -42.4 72.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.005 0.922 . . . . 15.0 111.29 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 48.2 mtm -58.6 -42.75 88.85 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.675 0.609 . . . . 15.0 110.76 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.9 t -70.28 -43.78 69.75 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.907 -1.042 . . . . 15.0 111.008 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -69.17 -36.05 76.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.698 0.399 . . . . 15.0 111.502 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -36.67 68.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.968 0.507 . . . . 15.0 110.274 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -70.01 -50.25 43.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.886 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.41 -33.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.646 0.591 . . . . 15.0 111.012 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.23 -51.73 62.24 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.254 0.621 . . . . 15.0 110.707 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.79 85.49 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.99 -1.004 . . . . 15.0 112.438 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 pt -75.33 -32.01 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 112.383 0.512 . . . . 15.0 112.383 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.44 -50.62 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 120.841 0.353 . . . . 15.0 110.558 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 17.1 ptpt -73.66 -50.63 19.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.949 -0.569 . . . . 15.0 111.449 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 50.6 mm-40 -84.81 -1.99 57.12 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.133 0.573 . . . . 15.0 111.941 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 63.25 28.26 15.73 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.53 1.144 . . . . 15.0 111.091 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.19 90.37 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 108.399 -0.963 . . . . 15.0 108.399 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.697 HD22 ' HB2' ' A' ' 112' ' ' TYR . 45.9 t30 -70.91 107.5 2.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.381 1.073 . . . . 15.0 110.425 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.37 141.78 12.87 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.345 2.03 . . . . 15.0 112.737 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.16 -177.3 6.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.578 0.751 . . . . 15.0 110.683 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.66 11.85 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.4 -0.818 . . . . 15.0 111.473 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.99 100.64 4.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.732 -1.211 . . . . 15.0 107.732 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.619 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 51.9 Cg_exo -57.78 107.9 0.34 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.972 2.448 . . . . 15.0 112.622 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.0 m -88.86 100.14 12.94 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.679 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -76.85 75.61 3.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.663 -0.866 . . . . 15.0 108.663 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.17 112.57 4.79 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 123.532 0.733 . . . . 15.0 109.361 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -69.43 92.3 0.48 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.407 2.072 . . . . 15.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.61 -63.5 5.05 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.964 0.79 . . . . 15.0 112.004 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -167.87 155.75 8.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.983 0.913 . . . . 15.0 109.792 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.437 ' HE1' HD11 ' A' ' 24' ' ' ILE . 47.0 t80 -135.94 147.27 48.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.12 0.568 . . . . 15.0 109.551 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -124.87 125.22 43.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.748 -1.205 . . . . 15.0 107.748 175.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.39 107.59 0.95 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.675 0.79 . . . . 15.0 111.453 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.76 59.26 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.591 -0.731 . . . . 15.0 113.287 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -106.14 -165.95 1.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.318 1.047 . . . . 15.0 109.379 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -62.93 155.87 26.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.331 1.052 . . . . 15.0 113.287 -171.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.1 t80 -123.66 142.92 50.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 15.0 108.304 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.2 m -137.06 137.59 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.273 0.629 . . . . 15.0 109.371 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.35 156.46 36.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.984 0.914 . . . . 15.0 109.086 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.46 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 47.7 m -125.13 98.28 5.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.844 0.858 . . . . 15.0 109.648 -170.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.26 97.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.852 -0.796 . . . . 15.0 108.852 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.9 119.05 33.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.799 0.44 . . . . 15.0 110.253 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.619 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 22.4 p90 -146.61 -166.78 2.58 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.527 1.131 . . . . 15.0 108.941 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.67 177.17 5.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.63 0.772 . . . . 15.0 110.356 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 11' ' ' LEU . 27.0 m -119.72 154.46 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 122.992 0.517 . . . . 15.0 109.626 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.697 ' HB2' HD22 ' A' ' 85' ' ' ASN . 48.6 m-85 -82.75 105.89 5.81 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 108.334 -0.987 . . . . 15.0 108.334 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.03 149.45 5.69 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.629 2.219 . . . . 15.0 113.704 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.58 132.14 33.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.202 1.001 . . . . 15.0 108.882 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.647 HG13 ' HA ' ' A' ' 350' ' ' LEU . 7.3 p -86.3 151.57 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.256 0.551 . . . . 15.0 111.937 -170.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.34 94.03 8.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.476 -0.784 . . . . 15.0 108.914 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.3 139.08 58.73 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.47 0.481 . . . . 15.0 110.555 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -163.06 155.12 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.915 0.886 . . . . 15.0 109.545 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.98 74.76 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.124 0.89 . . . . 15.0 114.049 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.45 -28.73 67.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.227 0.611 . . . . 15.0 110.935 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 18.3 mp0 -75.65 -34.08 60.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.657 -1.156 . . . . 15.0 109.852 174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HA ' ' HE3' ' A' ' 416' ' ' LYS . . . -78.93 -7.15 57.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.61 0.764 . . . . 15.0 112.255 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.632 HG22 ' HA3' ' A' ' 293' ' ' GLY . 77.6 mt -70.83 120.89 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.439 0.695 . . . . 15.0 109.467 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.08 104.11 15.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.376 0.67 . . . . 15.0 109.685 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 417' ' ' VAL . 45.6 t -106.05 159.55 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.934 -1.135 . . . . 15.0 107.934 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.47 126.37 46.62 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.724 -0.843 . . . . 15.0 108.724 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -107.43 99.21 26.97 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.529 0.732 . . . . 15.0 109.197 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.02 97.85 0.84 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.468 2.112 . . . . 15.0 111.502 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.52 93.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 166.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.466 ' HB ' HD13 ' A' ' 282' ' ' ILE . 12.4 t -122.51 140.48 46.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.535 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.68 154.37 48.6 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.984 -1.117 . . . . 15.0 107.984 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.82 83.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.3 p -68.39 176.9 2.59 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.489 1.116 . . . . 15.0 110.368 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.99 -45.6 64.57 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.429 0.692 . . . . 15.0 111.771 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.19 97.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.92 -1.036 . . . . 15.0 111.338 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.4 -44.15 68.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.173 0.589 . . . . 15.0 111.298 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.9 t -55.51 -62.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.348 1.059 . . . . 15.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -75.45 -31.31 60.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.676 -0.693 . . . . 15.0 111.307 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.86 -43.8 81.98 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.887 0.742 . . . . 15.0 112.713 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -78.16 -37.5 45.76 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.091 0.556 . . . . 15.0 110.878 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.518 HD22 HG12 ' A' ' 270' ' ' VAL . 18.5 mt -54.83 -42.39 71.86 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.253 0.621 . . . . 15.0 111.574 165.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.38 -40.1 95.15 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.375 -0.83 . . . . 15.0 109.997 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.9 m -61.67 -46.27 90.42 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.721 0.638 . . . . 15.0 110.953 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -45.95 91.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.651 0.78 . . . . 15.0 110.66 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -58.27 -37.66 75.4 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.808 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.611 ' HD3' HH12 ' A' ' 243' ' ' ARG . 83.3 mttt -85.41 -12.23 52.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.34 0.656 . . . . 15.0 112.533 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.82 -22.79 34.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.81 0.444 . . . . 15.0 110.005 167.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -97.06 8.4 44.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.262 0.625 . . . . 15.0 111.324 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -74.71 159.53 31.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 15.0 112.312 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.6 m -123.93 155.93 37.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.091 0.956 . . . . 15.0 108.917 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.614 ' HZ3' ' HB3' ' A' ' 243' ' ' ARG . 3.5 m95 -78.91 153.17 30.69 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.817 0.341 . . . . 15.0 111.151 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -151.65 104.77 3.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.043 -0.981 . . . . 15.0 109.368 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.35 98.45 0.11 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.02 170.73 16.23 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.477 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.95 97.24 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.838 0.455 . . . . 15.0 110.729 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.534 ' HA2' ' HB1' ' A' ' 207' ' ' ALA . . . 55.22 53.26 41.77 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 124.589 1.181 . . . . 15.0 115.5 161.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 240' ' ' VAL . . . -153.91 140.86 19.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.334 0.654 . . . . 15.0 109.315 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.4 HG11 HG23 ' A' ' 202' ' ' ILE . 17.0 t -119.32 131.33 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.177 -0.675 . . . . 15.0 109.177 172.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.85 -176.16 3.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.283 . . . . 15.0 109.423 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.82 -27.49 64.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.28 13.88 16.75 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.435 0.532 . . . . 15.0 112.435 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -79.03 136.16 37.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.971 0.415 . . . . 15.0 111.602 -173.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -84.94 90.91 7.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.823 -1.547 . . . . 15.0 106.823 173.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.404 HG22 HG13 ' A' ' 240' ' ' VAL . 44.0 t -90.58 150.79 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.002 0.921 . . . . 15.0 109.847 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 32.9 m -130.09 126.75 38.36 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 165.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.83 163.71 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.341 1.057 . . . . 15.0 110.314 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -116.69 122.21 43.89 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.294 -1.743 . . . . 15.0 106.294 167.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -129.14 160.69 32.06 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.724 0.773 . . . . 15.0 111.235 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.0 t -140.85 111.87 7.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.262 -1.385 . . . . 15.0 107.262 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -80.02 160.34 44.47 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.596 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.0 m -149.53 111.15 4.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.543 0.737 . . . . 15.0 109.194 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 177' ' ' PHE . 59.7 t -93.85 134.87 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.297 -1.001 . . . . 15.0 108.297 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.0 p30 51.39 18.98 0.71 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.138 1.775 . . . . 15.0 113.472 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.36 -11.57 12.71 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-O 118.665 -1.075 . . . . 15.0 115.545 172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.82 147.73 50.82 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.214 1.507 . . . . 15.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.69 112.66 2.61 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.836 0.71 . . . . 15.0 109.217 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 172' ' ' VAL . 37.3 p90 -72.32 156.22 39.33 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.596 0.56 . . . . 15.0 110.829 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.38 126.63 28.09 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.763 0.664 . . . . 15.0 111.124 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.77 77.55 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.051 -0.977 . . . . 15.0 112.175 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.69 47.81 1.39 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 114.672 0.629 . . . . 15.0 114.672 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -136.03 150.72 49.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.018 0.527 . . . . 15.0 110.625 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.12 92.27 0.83 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.154 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.2 p -76.57 127.81 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.357 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.49 ' HB3' HG11 ' B' ' 421' ' ' VAL . 15.3 m-20 71.6 36.15 1.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 15.0 112.731 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -66.05 138.85 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 15.0 109.909 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -104.35 110.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.977 0.911 . . . . 15.0 109.719 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -101.93 89.96 3.82 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.675 0.79 . . . . 15.0 111.22 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -78.45 90.3 4.45 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.387 -0.968 . . . . 15.0 108.387 171.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.607 ' HE1' ' HB3' ' A' ' 203' ' ' LYS . 76.7 mtp -71.76 169.68 15.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.43 -0.805 . . . . 15.0 113.024 -174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.646 ' HA3' HH21 ' A' ' 243' ' ' ARG . . . 91.53 10.66 61.67 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.99 -1.004 . . . . 15.0 113.523 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.427 ' HG3' ' HG2' ' A' ' 193' ' ' ARG . 8.8 pt20 -137.75 160.55 38.94 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.169 0.588 . . . . 15.0 110.077 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.91 89.83 0.06 OUTLIER Glycine 0 C--N 1.353 1.484 0 O-C-N 123.715 0.635 . . . . 15.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.427 ' HG2' ' HG3' ' A' ' 191' ' ' GLN . 29.7 mmt180 -121.03 -60.78 1.62 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.67 0.788 . . . . 15.0 111.227 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 198' ' ' PHE . 63.4 mmm -98.17 148.89 23.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.679 0.622 . . . . 15.0 112.679 -165.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.8 pt -61.27 145.27 90.54 Favored Pre-proline 0 CA--C 1.556 1.207 0 O-C-N 124.74 1.275 . . . . 15.0 109.904 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.62 114.76 1.91 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.472 2.781 . . . . 15.0 111.811 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 128.4 -37.31 2.29 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.71 -0.677 . . . . 15.0 112.385 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 194' ' ' MET . 37.6 t80 -69.64 -67.78 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.423 0.289 . . . . 15.0 110.386 -175.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.41 -18.84 65.08 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.382 0.426 . . . . 15.0 111.859 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.494 ' HA ' ' HZ3' ' A' ' 203' ' ' LYS . 6.7 m-20 -72.28 -41.13 67.01 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.965 0.906 . . . . 15.0 110.2 172.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.22 -24.44 77.0 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.176 -0.92 . . . . 15.0 112.484 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 198' ' ' PHE . 44.9 mm -73.2 -51.85 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.239 0.616 . . . . 15.0 110.134 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.607 ' HB3' ' HE1' ' A' ' 189' ' ' MET . 21.3 pttm -79.01 12.78 2.04 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.508 0.929 . . . . 15.0 113.508 -172.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.55 20.4 15.59 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -144.18 -176.05 4.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.484 1.114 . . . . 15.0 109.991 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.5 OUTLIER -147.37 143.42 27.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.436 0.694 . . . . 15.0 110.101 -176.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.534 ' HB1' ' HA2' ' A' ' 156' ' ' GLY . . . -59.66 145.67 43.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.414 0.894 . . . . 15.0 113.414 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.09 -34.16 4.84 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.478 -0.783 . . . . 15.0 111.553 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.6 pt-20 -87.19 140.74 29.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.588 0.709 . . . . 15.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.14 125.37 52.23 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.67 1.188 . . . . 15.0 107.969 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -148.92 -167.05 2.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.425 1.09 . . . . 15.0 109.633 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.4 t -133.17 150.37 52.01 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.199 -1.037 . . . . 15.0 108.199 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 38.5 pt -113.57 147.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 172.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.04 113.7 26.95 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.93 167.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.302 -1.37 . . . . 15.0 107.302 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.9 m -135.03 137.73 43.24 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -72.58 125.5 91.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 123.873 0.733 . . . . 15.0 109.621 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.48 168.15 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.785 2.99 . . . . 15.0 115.21 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.88 -19.97 53.83 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.937 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -80.3 -22.49 41.52 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.325 1.05 . . . . 15.0 110.75 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.59 116.23 4.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.84 . . . . 15.0 110.46 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -68.14 -32.19 72.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -162.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.42 92.57 1.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.039 -1.467 . . . . 15.0 107.039 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 33.0 tt0 -73.53 -18.11 61.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.744 0.817 . . . . 15.0 111.391 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -65.32 -13.23 58.02 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.365 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -119.26 -29.89 5.07 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.949 1.3 . . . . 15.0 111.773 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 36.8 ttmt -51.61 121.36 6.33 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.998 1.319 . . . . 15.0 111.645 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.63 -25.33 25.32 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.409 -0.359 . . . . 15.0 113.591 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.15 150.44 31.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.524 0.73 . . . . 15.0 111.328 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.8 122.79 37.79 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.646 0.778 . . . . 15.0 109.927 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.43 122.37 47.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.667 0.787 . . . . 15.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 63.9 mttm -93.73 118.4 31.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.193 0.997 . . . . 15.0 109.571 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.446 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 89.5 m-85 -108.4 118.44 36.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.01 89.16 2.98 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.507 0.504 . . . . 15.0 110.323 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 40.9 mm -83.24 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.537 0.735 . . . . 15.0 110.209 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -120.59 99.33 6.49 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.43 99.3 4.83 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.53 0.732 . . . . 15.0 111.005 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -104.12 -43.65 5.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.52 0.728 . . . . 15.0 110.145 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.662 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.3 mmtt -124.51 125.87 44.92 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.561 1.144 . . . . 15.0 108.22 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 157' ' ' ALA . 18.6 t -128.5 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.74 -1.578 . . . . 15.0 106.74 165.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -86.53 163.99 17.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.542 -1.208 . . . . 15.0 108.23 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -130.2 129.46 43.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.453 -0.943 . . . . 15.0 108.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.646 HH21 ' HA3' ' A' ' 190' ' ' GLY . 27.8 ptt85 -74.41 84.4 1.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.366 -0.976 . . . . 15.0 108.366 167.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.36 145.92 37.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.783 -1.553 . . . . 15.0 110.689 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 55.1 mt -57.47 120.73 42.84 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.984 0.914 . . . . 15.0 110.133 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.25 -165.57 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.903 3.736 . . . . 15.0 113.613 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -46.77 136.51 7.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.773 -1.103 . . . . 15.0 110.461 165.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.0 tp -140.66 37.37 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.137 -1.06 . . . . 15.0 108.137 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.6 m -66.03 161.04 22.43 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.47 1.108 . . . . 15.0 109.922 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.83 -44.88 14.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.88 1.272 . . . . 15.0 112.929 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.82 -27.28 64.74 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.981 -0.554 . . . . 15.0 112.173 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -77.58 -49.18 15.15 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.467 HG13 HD22 ' A' ' 266' ' ' LEU . 12.1 tt -64.52 -32.78 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.381 0.672 . . . . 15.0 110.981 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 258' ' ' VAL . 21.1 ptmt -79.23 -18.47 52.82 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 112.147 0.425 . . . . 15.0 112.147 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -65.58 -24.12 67.0 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 15.0 111.672 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -64.23 -22.77 67.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.283 0.633 . . . . 15.0 111.551 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.5 -1.45 0.73 Allowed Glycine 0 C--N 1.356 1.691 0 CA-C-O 119.845 -0.42 . . . . 15.0 113.853 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 2.9 t -80.82 134.94 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.192 0.597 . . . . 15.0 109.403 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -76.51 -47.68 21.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.7 0.4 . . . . 15.0 111.039 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.69 -36.04 16.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.704 0.288 . . . . 15.0 111.116 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 94.14 22.68 24.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.994 -0.548 . . . . 15.0 113.902 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 29.1 p -70.07 142.56 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 117.532 0.666 . . . . 15.0 110.154 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.404 ' HA ' HD11 ' A' ' 253' ' ' ILE . 49.0 t -54.44 -50.91 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.746 0.654 . . . . 15.0 109.283 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.72 -27.45 67.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.034 -0.985 . . . . 15.0 111.44 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.91 -21.1 63.98 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.659 0.599 . . . . 15.0 111.634 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.467 HD22 HG13 ' A' ' 253' ' ' ILE . 55.7 tp -78.35 -42.29 30.96 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -62.15 -39.44 92.61 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.821 -1.081 . . . . 15.0 110.195 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.54 -43.51 80.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.071 0.948 . . . . 15.0 111.045 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -56.59 -56.98 14.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.518 HG12 HD22 ' A' ' 141' ' ' LEU . 17.4 m -76.52 -20.22 14.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.363 -0.835 . . . . 15.0 111.534 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -57.41 -63.13 1.33 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.15 -36.77 82.56 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.0 0.37 . . . . 15.0 112.0 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -72.88 -50.02 26.34 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.383 0.673 . . . . 15.0 111.502 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 66.7 mtt -72.04 -28.19 63.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.394 -0.812 . . . . 15.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 47.1 mt-10 -71.09 -26.12 62.91 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 118.881 0.764 . . . . 15.0 111.539 170.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -70.71 -44.63 66.53 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.492 -0.559 . . . . 15.0 109.492 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -62.39 -45.35 93.53 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.572 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 64.9 tp -61.89 -50.88 70.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.025 -1.443 . . . . 15.0 112.175 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.49 -30.86 71.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.52 0.728 . . . . 15.0 110.688 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.5 t -66.12 -45.92 79.4 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.044 -0.725 . . . . 15.0 109.044 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.01 79.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.368 0.667 . . . . 15.0 112.078 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.466 HD13 ' HB ' ' A' ' 130' ' ' VAL . 90.5 mt -67.03 -45.18 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.775 0.83 . . . . 15.0 109.092 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 23.2 tpt180 -62.05 -46.87 87.22 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.604 -0.725 . . . . 15.0 110.535 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -62.99 -38.5 91.42 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.033 -0.531 . . . . 15.0 110.961 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -56.63 -63.84 1.07 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.66 0.784 . . . . 15.0 110.658 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.05 -46.04 92.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.042 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.55 -45.53 86.74 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.844 -0.617 . . . . 15.0 111.105 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.4 p -68.02 -31.9 71.89 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.44 0.296 . . . . 15.0 111.359 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.43 ' HB2' HG12 ' A' ' 125' ' ' VAL . 55.9 mt-30 -73.31 -34.0 65.48 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.354 0.409 . . . . 15.0 111.719 176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.93 62.83 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 110.05 -0.352 . . . . 15.0 110.05 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.95 -42.87 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.358 1.463 . . . . 15.0 110.958 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.91 -59.43 4.9 Favored 'General case' 0 C--O 1.246 0.897 0 C-N-CA 124.227 1.011 . . . . 15.0 110.231 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.632 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -67.52 -32.77 79.66 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.918 -1.037 . . . . 15.0 113.295 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.672 ' HB3' HD13 ' A' ' 350' ' ' LEU . 9.9 mt -59.85 -53.97 51.74 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 15.0 111.0 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.3 -44.73 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.83 -0.433 . . . . 15.0 109.83 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.18 -32.78 66.78 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.853 0.861 . . . . 15.0 111.746 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.4 -29.95 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.462 0.705 . . . . 15.0 111.611 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -131.92 123.44 27.44 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.096 0.474 . . . . 15.0 111.903 -162.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.58 148.95 26.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.324 1.05 . . . . 15.0 109.363 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.616 HD13 HD13 ' A' ' 349' ' ' LEU . 14.2 tt -162.87 148.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.514 0.726 . . . . 15.0 110.106 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.85 131.94 42.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 345' ' ' VAL . 71.2 t -119.88 126.06 27.07 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.259 0.624 . . . . 15.0 111.153 -165.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.86 136.82 17.11 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.692 2.261 . . . . 15.0 112.475 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.668 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.55 -15.18 57.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.624 1.17 . . . . 15.0 113.337 -174.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.13 64.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.756 0.822 . . . . 15.0 110.703 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' B' ' 467' ' ' ALA . 71.7 mt -71.45 -38.43 71.32 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 114.121 -1.4 . . . . 15.0 110.442 -175.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 304' ' ' ALA . 55.2 mt -57.28 -50.5 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.233 -1.349 . . . . 15.0 108.516 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.36 -32.35 73.92 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.216 0.948 . . . . 15.0 111.451 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 73.4 m -62.33 -52.88 61.89 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.671 0.389 . . . . 15.0 111.882 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.4 -35.44 79.31 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.561 -0.29 . . . . 15.0 111.124 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.591 HD11 ' HG3' ' A' ' 334' ' ' ARG . 71.0 mt -61.65 -38.35 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.416 -0.587 . . . . 15.0 109.416 173.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 9.1 t70 -64.44 -46.42 83.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.752 0.821 . . . . 15.0 109.423 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.02 -40.77 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 124.155 0.91 . . . . 15.0 110.259 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.55 -19.26 60.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.377 0.671 . . . . 15.0 112.32 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.437 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 21.7 mtm180 -81.06 -34.16 32.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.795 0.838 . . . . 15.0 109.811 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 81.4 mtt180 -66.98 -46.79 73.54 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 171.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.476 ' HG3' HD21 ' B' ' 439' ' ' LEU . 34.1 tt0 -56.05 -47.43 77.9 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.27 72.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.157 0.583 . . . . 15.0 110.591 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -59.5 -30.01 68.26 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.831 0.707 . . . . 15.0 111.741 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.14 -37.72 80.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.418 0.687 . . . . 15.0 109.802 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -23.64 24.34 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.69 0.796 . . . . 15.0 110.356 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 12.5 t80 -100.05 31.84 3.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 15.0 111.462 -170.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.89 65.56 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 115.153 0.821 . . . . 15.0 115.153 168.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 65.26 69.11 1.42 Allowed Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.14 0.4 . . . . 15.0 112.918 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 9.6 m120 -72.22 112.01 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.486 0.714 . . . . 15.0 110.592 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.99 90.05 0.08 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.376 1.07 . . . . 15.0 110.466 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 70.29 -10.21 0.69 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.183 1.393 . . . . 15.0 113.001 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.4 tm0? -72.2 -15.9 61.95 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 124.151 0.98 . . . . 15.0 109.545 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.03 -39.2 26.23 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 124.173 0.989 . . . . 15.0 111.432 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.67 -28.1 68.34 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.08 0.952 . . . . 15.0 111.811 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.75 -16.17 45.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.678 0.791 . . . . 15.0 112.001 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 67.2 mt -53.06 125.89 42.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.812 0.445 . . . . 15.0 111.973 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.491 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 84.0 Cg_exo -46.48 120.24 3.73 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.659 3.572 . . . . 15.0 115.453 -166.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.591 ' HG3' HD11 ' A' ' 311' ' ' ILE . 68.6 ttt180 -55.93 -37.04 68.41 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.922 0.889 . . . . 15.0 112.061 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -63.38 -17.31 62.48 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.319 0.648 . . . . 15.0 112.465 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 89.1 mt -73.51 -32.27 64.17 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.368 0.604 . . . . 15.0 110.34 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.466 ' HA ' HE21 ' A' ' 340' ' ' GLN . 22.7 m-85 -115.62 -6.07 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.971 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -47.19 -71.79 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.222 1.409 . . . . 15.0 113.166 -173.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.54 -51.74 68.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.625 0.77 . . . . 15.0 111.686 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.466 HE21 ' HA ' ' A' ' 337' ' ' PHE . 20.9 pt20 -61.72 -45.93 91.81 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.774 0.671 . . . . 15.0 112.043 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.97 56.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.484 . . . . 15.0 110.346 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.19 -34.88 64.26 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.572 0.749 . . . . 15.0 111.027 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -70.95 -35.29 72.13 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.239 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -66.93 -28.65 68.47 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.158 0.286 . . . . 15.0 110.266 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 302' ' ' VAL . 46.2 t -69.6 -47.55 70.81 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.228 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 67.4 t -51.81 -48.44 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.613 -0.884 . . . . 15.0 108.613 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.73 -43.14 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.201 1.001 . . . . 15.0 111.741 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.91 -34.77 90.82 Favored Glycine 0 N--CA 1.472 1.083 0 O-C-N 123.233 0.333 . . . . 15.0 112.851 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.616 HD13 HD13 ' A' ' 300' ' ' ILE . 65.8 mt -76.46 -38.77 54.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.657 0.783 . . . . 15.0 109.764 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 294' ' ' LEU . 81.3 mt -62.14 -62.05 2.04 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.451 1.101 . . . . 15.0 110.555 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.96 -30.77 71.83 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.26 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.63 95.74 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.866 0.729 . . . . 15.0 111.996 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.13 -34.17 77.44 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.109 -0.545 . . . . 15.0 110.766 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.0 t -67.06 -40.86 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.632 0.373 . . . . 15.0 110.484 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.21 -38.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.599 0.759 . . . . 15.0 110.055 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -70.28 -53.94 14.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.16 0.288 . . . . 15.0 111.518 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -61.45 -35.08 76.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.042 0.937 . . . . 15.0 111.836 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -102.13 10.52 39.38 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 118.962 -0.542 . . . . 15.0 111.348 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 36.83 40.17 0.13 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 126.489 1.916 . . . . 15.0 114.495 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.84 133.36 50.78 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.316 1.046 . . . . 15.0 112.24 -170.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -109.28 142.21 40.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.751 0.82 . . . . 15.0 109.785 176.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.55 115.36 8.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.752 0.421 . . . . 15.0 110.35 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.23 127.94 34.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 15.0 111.408 -171.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.45 -34.38 76.69 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.306 1.042 . . . . 15.0 113.481 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -71.77 -26.64 62.52 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.108 0.255 . . . . 15.0 110.641 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -76.16 -44.95 35.84 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.017 -0.734 . . . . 15.0 109.017 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 398' ' ' MET . 60.9 t -52.28 -56.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.407 1.083 . . . . 15.0 110.341 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.7 -40.37 92.2 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.122 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.17 -40.78 97.7 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.621 0.575 . . . . 15.0 113.336 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 73.6 mt -61.73 -51.7 67.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.686 0.794 . . . . 15.0 109.549 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.489 ' HA ' ' HE3' ' A' ' 374' ' ' MET . 34.5 mm -47.54 -56.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.589 1.181 . . . . 15.0 111.216 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.21 -61.32 2.55 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.459 -0.791 . . . . 15.0 111.637 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.12 -24.5 61.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.151 0.797 . . . . 15.0 113.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.489 ' HE3' ' HA ' ' A' ' 371' ' ' ILE . 23.9 ptt? -78.03 -46.96 19.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.639 0.654 . . . . 15.0 109.304 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -69.48 -32.35 71.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.828 0.451 . . . . 15.0 111.292 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.8 t -63.88 -18.26 64.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.561 0.745 . . . . 15.0 112.214 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.91 66.74 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.289 0.636 . . . . 15.0 111.3 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -97.9 -175.02 3.03 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.696 -0.684 . . . . 15.0 111.01 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.94 -56.19 24.04 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.974 0.91 . . . . 15.0 111.517 -168.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -131.15 116.09 16.59 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.442 -0.799 . . . . 15.0 109.494 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.481 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 22.2 Cg_exo -68.23 -37.81 13.4 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.649 2.232 . . . . 15.0 113.227 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -54.82 -48.04 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.301 1.041 . . . . 15.0 111.873 -164.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.23 -28.2 68.55 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.57 -1.195 . . . . 15.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.33 -41.4 30.07 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 C-N-CA 123.573 0.749 . . . . 15.0 109.541 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.67 -48.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.28 -33.39 65.2 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.302 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -70.4 -24.32 62.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.3 0.64 . . . . 15.0 111.068 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.418 ' HB3' ' HE1' ' A' ' 395' ' ' MET . 23.7 m-85 -92.68 -56.14 3.12 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.053 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . 0.653 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -58.66 -43.64 89.93 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 112.526 0.565 . . . . 15.0 112.526 -170.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -87.22 3.83 44.97 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.348 0.659 . . . . 15.0 111.963 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -129.44 90.75 3.05 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.547 -0.908 . . . . 15.0 108.547 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -54.22 -34.57 60.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.388 1.075 . . . . 15.0 112.16 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.2 -43.58 82.86 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.806 0.842 . . . . 15.0 110.841 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.81 -24.34 17.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 15.0 111.291 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.653 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.9 OUTLIER -62.94 -37.25 86.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.79 0.836 . . . . 15.0 109.741 176.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.63 -44.4 94.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.496 -1.229 . . . . 15.0 109.843 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.95 -32.05 69.27 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.212 0.605 . . . . 15.0 111.427 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.673 ' HG3' HG11 ' A' ' 367' ' ' VAL . 31.5 tpp -69.7 -31.24 69.15 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.441 0.463 . . . . 15.0 111.774 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -67.66 -38.76 84.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 110.135 -0.32 . . . . 15.0 110.135 168.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 400' ' ' ASN . 0.8 OUTLIER -65.52 -48.1 73.67 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.562 0.745 . . . . 15.0 111.408 -176.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 8.3 p -67.49 -37.86 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 123.634 0.584 . . . . 15.0 110.174 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.01 85.34 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.69 0.757 . . . . 15.0 110.502 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 16.7 tp -68.57 -32.76 72.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.076 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.2 -38.1 84.75 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.867 0.467 . . . . 15.0 110.028 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 60.9 mm-40 -62.7 -41.51 99.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.845 0.458 . . . . 15.0 110.019 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -66.74 -39.0 87.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.051 -0.977 . . . . 15.0 111.734 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.02 -42.23 99.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.849 0.718 . . . . 15.0 110.327 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.36 -54.04 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.548 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.406 ' HA ' HD13 ' A' ' 412' ' ' LEU . 80.0 mt-10 -62.01 -28.07 69.32 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.459 0.704 . . . . 15.0 112.88 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.44 71.87 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.793 0.437 . . . . 15.0 110.297 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.85 -32.54 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.223 -0.658 . . . . 15.0 109.223 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 409' ' ' GLU . 93.4 mt -63.28 -43.77 96.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.33 0.652 . . . . 15.0 110.65 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.88 -25.63 65.24 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.599 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 26.1 mtpp -94.85 -22.4 18.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.408 1.083 . . . . 15.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.47 13.18 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.075 0.95 . . . . 15.0 113.211 -171.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 85.7 mttt -77.74 77.3 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.402 1.081 . . . . 15.0 109.459 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 125' ' ' VAL . 38.1 t -91.62 91.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.3 t -71.01 95.37 1.18 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 122.298 1.047 . . . . 15.0 110.448 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.87 117.32 19.86 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.245 -1.343 . . . . 15.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -122.58 157.52 31.95 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.942 0.897 . . . . 15.0 109.064 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.39 117.57 32.13 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -143.95 176.36 9.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.523 0.329 . . . . 15.0 110.611 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.8 p -101.03 159.83 14.89 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.268 1.027 . . . . 15.0 111.128 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.76 -31.57 69.77 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.979 1.311 . . . . 15.0 110.976 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.526 ' HA ' HD21 ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.96 -9.2 27.76 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.363 -0.835 . . . . 15.0 112.299 178.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.91 -73.34 0.57 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 170.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 35.3 tp -36.99 -59.15 0.73 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 125.323 1.449 . . . . 15.0 114.871 -158.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.414 ' HE1' HD11 ' A' ' 278' ' ' LEU . 0.4 OUTLIER -92.17 -35.18 13.99 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.07 0.548 . . . . 15.0 110.819 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.526 HD21 ' HA ' ' A' ' 425' ' ' ASN . 73.0 m-20 -85.36 39.26 0.77 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.474 0.71 . . . . 15.0 111.85 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -80.54 18.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.521 0.729 . . . . 15.0 112.441 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.56 -40.43 94.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.844 0.858 . . . . 15.0 110.795 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.018 0 N-CA-C 108.372 -0.973 . . . . 15.0 108.372 175.322 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.07 -161.57 0.86 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -32.43 -63.03 0.21 Allowed 'General case' 0 C--N 1.369 1.449 0 C-N-CA 126.238 1.815 . . . . 0.0 112.587 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' B' ' 373' ' ' ARG . 10.3 t70 -106.08 -82.55 0.53 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.644 -0.217 . . . . 0.0 110.44 170.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.09 -79.78 0.55 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.891 0.476 . . . . 0.0 111.544 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -107.46 -61.29 1.58 Allowed 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.461 -165.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.13 -84.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 122.309 -0.244 . . . . 0.0 110.699 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -97.91 -73.86 0.6 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' B' ' 368' ' ' ASP . 36.4 mmt180 -101.63 -82.56 0.47 Allowed 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -99.11 -72.29 0.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 167.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 53.4 tp -97.86 -78.51 0.48 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -105.1 -70.13 0.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -100.87 -80.97 0.48 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.5 -77.83 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -107.42 -85.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 175.44 132.17 0.04 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.486 1.515 . . . . 0.0 107.702 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 73.46 143.17 0.07 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.233 1.413 . . . . 0.0 112.488 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -158.34 -16.37 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.786 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.36 -31.47 37.88 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.694 0.798 . . . . 0.0 110.084 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 16.5 m -109.31 154.14 22.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.252 1.021 . . . . 0.0 109.074 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.7 mp -86.91 163.39 17.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.554 0.741 . . . . 0.0 111.014 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.32 130.56 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.124 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -140.5 162.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.222 1.409 . . . . 0.0 109.077 169.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 177' ' ' PHE . 97.3 t -53.84 114.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.081 0.952 . . . . 0.0 112.405 -163.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 56.9 m -145.01 144.77 31.19 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.784 1.234 . . . . 0.0 108.434 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.77 55.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.216 0.606 . . . . 0.0 110.098 172.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.44 86.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.58 0.705 . . . . 0.0 110.929 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 48.27 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.008 1.723 . . . . 0.0 111.67 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -164.54 89.06 0.51 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -60.05 -44.01 94.98 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.024 0.93 . . . . 0.0 110.771 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 62.84 -72.26 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.81 1.644 . . . . 0.0 113.014 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 24.5 m -62.41 97.45 0.09 Allowed 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.713 1.205 . . . . 0.0 110.288 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -163.86 150.19 11.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 108.194 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 77.9 mt 65.52 119.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.48 1.112 . . . . 0.0 110.791 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 96.8 t 73.84 -53.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 125.304 1.441 . . . . 0.0 110.066 -172.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -84.73 110.2 25.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 165.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.48 -29.59 61.96 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.871 2.381 . . . . 0.0 113.091 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 31.6 t70 62.69 97.99 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.048 1.339 . . . . 0.0 110.064 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 24.2 m -124.83 106.62 10.17 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -149.55 162.96 39.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -94.52 121.49 63.17 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.151 0.98 . . . . 0.0 109.112 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.85 -21.32 71.98 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.36 2.707 . . . . 0.0 113.39 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.72 -134.03 1.66 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.562 HD22 HD22 ' B' ' 413' ' ' ASN . 4.2 tt -74.4 -67.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 27.9 m -147.7 100.59 3.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 65.87 -87.26 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.803 1.241 . . . . 0.0 110.868 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -172.48 127.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.127 0.971 . . . . 0.0 109.613 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 69.8 mt 52.31 38.2 24.29 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.057 1.343 . . . . 0.0 112.476 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . 0.562 HD22 HD22 ' B' ' 408' ' ' LEU . 19.6 p-10 -66.37 -39.17 88.96 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.296 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 34.0 p -81.88 64.67 6.68 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.153 0.981 . . . . 0.0 109.176 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.533 ' HZ1' ' HB2' ' B' ' 415' ' ' LYS . 5.0 ttmp? -83.32 98.79 9.63 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.851 -173.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.32 -44.77 92.55 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.541 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 178.71 -147.7 7.97 Favored Glycine 0 C--O 1.241 0.573 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.883 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.47 77.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 88.9 t 71.32 -65.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.927 1.691 . . . . 0.0 111.388 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 15.3 ptp 58.04 -177.18 0.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.636 1.974 . . . . 0.0 113.256 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 184' ' ' ASP . 31.1 m -63.77 151.96 8.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-O 121.251 0.548 . . . . 0.0 110.277 172.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 45.0 ttm -88.17 24.5 1.84 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 14.3 m 61.42 -162.01 0.28 Allowed 'General case' 0 C--N 1.367 1.335 0 C-N-CA 124.979 1.312 . . . . 0.0 109.952 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 64.56 -153.28 0.29 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.554 0.742 . . . . 0.0 109.96 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 84.9 65.35 1.49 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.03 90.46 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.493 1.117 . . . . 0.0 112.232 -173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.554 ' H ' ' HZ2' ' A' ' 151' ' ' TRP . 31.8 p -78.17 86.19 4.32 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.236 1.014 . . . . 0.0 110.549 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 22.91 12.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.489 1.116 . . . . 0.0 109.633 172.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.1 -29.39 70.25 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.948 0.899 . . . . 0.0 111.563 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -75.28 -16.12 60.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.201 0.6 . . . . 0.0 111.941 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 34.5 m -71.28 -28.48 64.17 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.804 0.442 . . . . 0.0 110.689 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.82 -47.01 70.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.747 0.819 . . . . 0.0 110.126 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 60.32 -100.64 0.1 Allowed 'General case' 0 CA--C 1.562 1.43 0 O-C-N 124.725 1.266 . . . . 0.0 108.332 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 24.2 p80 178.4 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.704 1.602 . . . . 0.0 108.423 169.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 1.7 t 52.45 -179.66 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 127.267 2.227 . . . . 0.0 113.639 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -112.94 106.03 1.77 Allowed Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 19.0 m -62.25 137.8 58.32 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.458 0.703 . . . . 0.0 111.484 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.76 166.45 20.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.624 0.769 . . . . 0.0 109.998 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 317' ' ' GLN . 3.3 mm? -95.45 18.61 12.32 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.727 0.811 . . . . 0.0 109.589 172.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 78.3 -33.67 0.17 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 126.489 1.915 . . . . 0.0 111.912 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 2.8 pt -148.38 172.18 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.163 1.385 . . . . 0.0 108.501 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.83 -70.24 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 57.04 11.93 1.11 Allowed 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.26 151.1 45.7 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.36 0.664 . . . . 0.0 110.412 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 127.81 -36.72 2.47 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-O 117.3 -1.833 . . . . 0.0 117.266 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.09 82.1 2.27 Favored 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.693 3.247 . . . . 0.0 112.12 -166.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -101.26 100.0 10.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 81.69 -46.16 0.2 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 126.015 1.726 . . . . 0.0 111.854 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -162.2 -172.02 3.05 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.34 1.056 . . . . 0.0 110.482 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.36 1.01 20.2 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.629 0.372 . . . . 0.0 111.56 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.3 t 68.75 83.79 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 124.693 1.197 . . . . 0.0 109.913 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 11.0 m -90.76 84.23 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.4 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -156.22 65.59 0.31 Allowed Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' B' ' 462' ' ' TYR . 55.6 tp -65.06 91.07 0.09 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.428 1.091 . . . . 0.0 109.345 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.1 p 53.81 60.98 3.31 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.175 1.39 . . . . 0.0 111.099 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.52 -75.16 0.44 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.118 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -94.97 -7.04 41.02 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.989 0.516 . . . . 0.0 111.993 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 8.9 t -164.3 155.98 16.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.016 0.927 . . . . 0.0 109.242 168.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -106.47 136.58 45.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.379 0.671 . . . . 0.0 110.836 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 21.21 0.99 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.471 1.108 . . . . 0.0 109.996 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 35.9 t80 58.57 103.31 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.583 1.553 . . . . 0.0 109.435 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . 0.464 ' HA ' HD12 ' B' ' 454' ' ' LEU . 35.9 t80 65.22 -172.44 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.2 m -141.15 104.47 4.64 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.94 21.34 4.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.922 0.889 . . . . 0.0 111.368 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 70.4 -175.54 0.19 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.974 1.31 . . . . 0.0 111.168 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 68.87 -61.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.074 1.35 . . . . 0.0 110.107 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.478 ' HA ' HD12 ' A' ' 306' ' ' LEU . . . -95.53 123.98 39.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.29 1.036 . . . . 0.0 108.505 163.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.6 155.1 16.89 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.308 0.643 . . . . 0.0 109.74 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -137.96 39.76 1.56 Allowed Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.256 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.74 166.09 32.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.041 0.448 . . . . 0.0 111.639 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 17.8 pttm . . . . . 0 C--O 1.252 1.216 0 CA-C-N 114.879 -1.055 . . . . 12.06 109.018 168.398 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.025 0.44 . . . . 15.0 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -146.68 146.99 30.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.588 -0.893 . . . . 15.0 108.588 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.445 HG13 HG12 ' A' ' 17' ' ' ILE . 24.9 m -137.55 148.72 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.942 0.897 . . . . 15.0 109.467 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 55.6 p -126.2 101.16 6.63 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.96 77.21 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.682 1.229 . . . . 15.0 110.569 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 46.3 mt-10 -75.77 173.45 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.662 -1.154 . . . . 15.0 109.758 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 77.6 m -143.49 112.8 6.82 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.392 -0.966 . . . . 15.0 108.392 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -78.39 -41.3 33.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.431 0.693 . . . . 15.0 110.562 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -164.04 84.46 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.822 0.849 . . . . 15.0 109.512 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.77 -94.76 0.07 OUTLIER Glycine 0 C--N 1.354 1.531 0 O-C-N 123.825 0.703 . . . . 15.0 113.671 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.655 ' HA ' HG23 ' A' ' 111' ' ' VAL . 7.6 mp -62.07 -50.21 72.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.526 1.13 . . . . 15.0 110.602 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.8 86.5 0.21 Allowed Glycine 0 C--N 1.346 1.113 0 O-C-N 124.195 0.934 . . . . 15.0 112.11 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 98.7 mtt180 -99.78 134.04 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.293 1.037 . . . . 15.0 110.378 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.5 ttm180 -103.01 88.27 3.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.282 1.033 . . . . 15.0 110.737 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -81.57 91.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.3 m -75.98 100.41 4.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.853 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 3' ' ' VAL . 51.6 mt -87.98 109.38 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.97 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -84.95 94.24 8.74 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.995 -0.743 . . . . 15.0 108.995 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 70' ' ' LEU . 43.4 mt -73.32 106.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.963 -1.125 . . . . 15.0 107.963 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 150.79 44.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 122.556 0.342 . . . . 15.0 111.315 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.51 -16.88 58.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.603 1.161 . . . . 15.0 114.096 -169.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -64.71 -44.84 88.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.225 0.61 . . . . 15.0 110.429 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.4 m -75.13 -36.79 61.57 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 115.44 -0.8 . . . . 15.0 110.776 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.424 HD11 ' H ' ' A' ' 103' ' ' PHE . 57.9 mt -62.39 -50.58 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.702 0.626 . . . . 15.0 109.881 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -57.53 -50.49 72.92 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.067 0.947 . . . . 15.0 111.098 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.5 m -65.4 -37.77 87.97 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.218 -0.901 . . . . 15.0 111.742 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.28 63.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.123 0.569 . . . . 15.0 112.128 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.739 HG21 ' HD3' ' A' ' 63' ' ' ARG . 93.7 t -65.32 -41.63 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -65.52 -34.99 79.54 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.509 1.124 . . . . 15.0 110.759 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -39.08 91.1 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.55 0.74 . . . . 15.0 110.05 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -74.82 -25.77 59.26 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.524 0.515 . . . . 15.0 111.387 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 94.0 mt -73.09 -38.76 66.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.808 0.443 . . . . 15.0 110.983 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.45 -19.6 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 O-C-N 123.158 0.286 . . . . 15.0 110.329 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.18 -57.7 8.74 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.11 -38.53 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.198 0.999 . . . . 15.0 111.365 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.191 0.596 . . . . 15.0 110.559 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.17 -26.68 35.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.814 0.446 . . . . 15.0 112.095 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -77.32 -35.17 55.06 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.711 1.204 . . . . 15.0 110.935 -173.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.64 5.44 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.788 0.835 . . . . 15.0 109.531 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 65.66 22.39 11.64 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.838 1.655 . . . . 15.0 112.601 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 54.0 mt -78.24 -19.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.448 1.099 . . . . 15.0 111.261 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.26 -30.2 71.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.682 0.793 . . . . 15.0 112.061 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.19 -23.76 73.21 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.59 0.556 . . . . 15.0 112.844 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.433 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 88.9 m-85 -83.68 -24.0 31.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.462 0.705 . . . . 15.0 110.78 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -79.53 88.47 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -92.14 50.06 1.6 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.589 0.755 . . . . 15.0 110.384 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.3 67.68 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.633 -0.712 . . . . 15.0 113.129 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -73.25 -58.79 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.633 0.773 . . . . 15.0 110.147 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.4 t -101.11 122.11 49.7 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.846 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' HD12 ' A' ' 53' ' ' ILE . 73.6 Cg_exo -53.54 138.92 66.74 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.063 2.509 . . . . 15.0 112.409 167.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.8 tpt -70.48 -25.26 63.08 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.817 0.847 . . . . 15.0 112.078 -171.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -70.63 -28.79 65.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.549 0.34 . . . . 15.0 111.163 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.481 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.9 mt -65.44 -53.02 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.817 . . . . 15.0 110.241 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.654 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 30.1 m -69.1 -16.98 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 111.92 0.341 . . . . 15.0 111.92 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -73.65 -65.58 0.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.513 0.725 . . . . 15.0 112.0 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -73.97 -33.79 64.0 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.672 -0.695 . . . . 15.0 111.93 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.49 -73.97 0.46 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.798 0.439 . . . . 15.0 110.618 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 96.5 m-85 -72.52 -28.1 62.65 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.044 0.537 . . . . 15.0 111.814 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.17 10.2 67.0 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.733 -0.481 . . . . 15.0 113.607 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.47 66.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 15.0 111.896 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 p -84.04 -36.37 23.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.185 0.994 . . . . 15.0 111.059 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.84 -18.78 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.306 1.042 . . . . 15.0 111.218 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.739 ' HD3' HG21 ' A' ' 28' ' ' VAL . 20.9 mmt180 -49.88 -42.67 48.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.42 1.088 . . . . 15.0 111.917 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -49.32 -57.58 6.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.882 1.273 . . . . 15.0 112.317 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.72 -33.39 53.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.638 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 28' ' ' VAL . 66.6 t -68.07 -28.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.2 mt -56.49 -41.95 77.5 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.56 0.344 . . . . 15.0 110.75 173.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 71' ' ' MET . . . -61.18 -46.74 93.87 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.793 0.683 . . . . 15.0 112.72 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.55 -38.94 89.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.306 1.042 . . . . 15.0 111.583 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 19' ' ' ILE . 57.3 mt -65.46 -41.58 93.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.93 0.892 . . . . 15.0 110.651 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 64.5 mtm -64.0 -38.38 90.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.083 0.553 . . . . 15.0 110.682 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -64.76 -52.7 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.408 -0.815 . . . . 15.0 110.976 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 mtm105 -74.91 -30.69 61.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.639 -0.71 . . . . 15.0 112.575 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.49 -32.88 54.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.605 0.362 . . . . 15.0 110.513 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.78 -51.39 27.3 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.282 0.364 . . . . 15.0 110.95 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HA ' HG12 ' A' ' 79' ' ' ILE . 14.6 tt -64.45 -33.34 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 123.272 0.357 . . . . 15.0 110.261 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.06 -44.84 96.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.579 0.751 . . . . 15.0 110.428 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.18 -53.03 55.71 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.698 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 76' ' ' ILE . 32.3 pt -65.4 -22.19 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -74.94 -51.83 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 15.0 110.196 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -75.4 -25.32 57.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.695 0.398 . . . . 15.0 111.881 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -89.45 -21.57 22.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.29 0.636 . . . . 15.0 110.544 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 62.96 19.74 11.8 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.707 1.203 . . . . 15.0 112.01 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -104.49 85.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.74 141.66 41.64 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.015 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.78 128.35 18.76 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.682 2.255 . . . . 15.0 112.211 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.63 72.83 4.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.414 0.686 . . . . 15.0 109.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.6 -98.67 0.69 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.534 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.46 138.18 31.86 Favored Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 123.289 0.636 . . . . 15.0 112.248 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -95.09 132.03 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.784 2.989 . . . . 15.0 113.27 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -96.38 105.73 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.403 ' HD2' ' HE2' ' A' ' 105' ' ' TYR . 68.1 m-85 -83.45 118.19 23.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.49 90.8 4.32 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.017 0.927 . . . . 15.0 108.594 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.5 119.8 5.65 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.77 2.314 . . . . 15.0 112.44 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.38 -80.21 0.31 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.636 -0.585 . . . . 15.0 111.636 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.42 170.43 8.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.695 0.798 . . . . 15.0 110.332 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -136.35 136.12 39.41 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.273 1.029 . . . . 15.0 109.255 174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -115.5 137.17 52.34 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.437 -1.32 . . . . 15.0 107.437 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.5 tp -57.22 113.63 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.759 0.824 . . . . 15.0 111.132 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.38 18.53 60.34 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.788 0.68 . . . . 15.0 113.184 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 102' ' ' ASP . 28.1 tt0 -126.58 166.77 16.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.59 0.756 . . . . 15.0 109.382 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 2.9 m-20 -73.02 133.04 44.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.212 1.005 . . . . 15.0 110.703 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' H ' HD11 ' A' ' 24' ' ' ILE . 39.5 t80 -83.52 143.6 30.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.431 0.693 . . . . 15.0 109.398 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.5 m -140.45 135.76 32.32 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.132 0.573 . . . . 15.0 109.645 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' A' ' 92' ' ' TYR . 8.2 p90 -157.04 156.57 33.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.013 0.925 . . . . 15.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.1 m -111.37 108.93 18.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.473 1.109 . . . . 15.0 111.192 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.28 97.88 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.41 99.84 12.72 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.648 0.779 . . . . 15.0 109.46 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.55 149.19 45.56 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 15.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.92 140.58 30.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.711 0.804 . . . . 15.0 109.302 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 11' ' ' LEU . 15.5 m -109.72 179.42 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.236 0.614 . . . . 15.0 110.728 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.84 113.28 31.29 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.86 0.864 . . . . 15.0 110.034 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.659 ' HB2' HD11 ' A' ' 300' ' ' ILE . 84.2 Cg_endo -82.68 115.62 2.48 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.345 2.03 . . . . 15.0 112.887 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -71.32 89.1 0.88 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.216 1.006 . . . . 15.0 109.064 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.2 131.0 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.219 -168.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -80.12 109.75 14.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.869 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.19 147.9 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.996 0.81 . . . . 15.0 110.465 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.54 158.69 21.07 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.965 0.906 . . . . 15.0 109.739 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 68.28 22.6 74.67 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.629 -0.714 . . . . 15.0 113.843 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.3 mt -68.06 -45.49 73.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.58 1.152 . . . . 15.0 110.673 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.07 -27.87 63.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.647 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.09 -17.55 60.93 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.879 0.472 . . . . 15.0 111.803 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' GLY . 57.4 mt -64.78 120.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.638 0.375 . . . . 15.0 110.332 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.22 109.18 21.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.604 -0.887 . . . . 15.0 108.604 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.0 t -110.7 150.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.415 ' HE2' HD13 ' A' ' 129' ' ' ILE . 83.4 tttt -87.31 109.44 25.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.205 1.002 . . . . 15.0 109.729 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.487 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 68.6 Cg_endo -92.44 104.62 0.2 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.492 2.128 . . . . 15.0 112.282 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.415 HD13 ' HE2' ' A' ' 127' ' ' LYS . 50.2 mm -70.44 89.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 422' ' ' THR . 41.4 t -108.81 135.28 48.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.677 -1.147 . . . . 15.0 109.467 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -122.9 154.54 38.2 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.409 -1.33 . . . . 15.0 107.409 160.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 278' ' ' LEU . 34.9 t -81.42 84.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 107.591 -1.263 . . . . 15.0 107.591 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.6 p -63.25 176.39 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.139 0.976 . . . . 15.0 110.744 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.18 -40.21 76.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.065 0.459 . . . . 15.0 111.086 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.98 98.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.178 -0.919 . . . . 15.0 110.975 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -74.0 -39.83 63.35 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.009 0.524 . . . . 15.0 111.721 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 t -60.29 -62.54 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.103 0 C-N-CA 124.546 1.138 . . . . 15.0 108.734 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.99 -27.28 43.35 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 114.13 -1.396 . . . . 15.0 110.693 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.96 -36.13 47.83 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.749 0.656 . . . . 15.0 113.414 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -71.74 -47.42 53.88 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.008 -0.367 . . . . 15.0 110.008 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.582 HD21 HG12 ' A' ' 270' ' ' VAL . 57.1 mt -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.944 0.498 . . . . 15.0 111.915 167.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.38 -45.32 93.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.152 0.981 . . . . 15.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -63.5 -40.17 96.36 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.029 0.83 . . . . 15.0 110.917 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.23 -42.84 99.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.39 0.676 . . . . 15.0 110.938 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.649 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.2 mtp180 -68.62 -29.31 67.79 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.453 -0.794 . . . . 15.0 110.607 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 92.1 mttt -80.94 -15.61 55.78 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.103 0.561 . . . . 15.0 111.937 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -83.34 -31.12 26.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.69 0.396 . . . . 15.0 110.219 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -104.35 34.58 3.03 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.723 0.809 . . . . 15.0 110.616 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -78.1 156.34 30.02 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.734 1.383 . . . . 15.0 114.734 -166.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.8 m -92.39 128.69 38.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.292 -1.322 . . . . 15.0 108.784 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -84.71 108.32 17.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -123.75 126.49 46.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.277 1.031 . . . . 15.0 110.047 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 74.4 mt-10 -75.72 117.67 17.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.455 -0.572 . . . . 15.0 109.455 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.664 ' HG3' HG11 ' A' ' 240' ' ' VAL . 36.8 pttt -104.61 178.86 4.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.494 0.718 . . . . 15.0 110.735 173.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.65 141.74 43.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.685 0.794 . . . . 15.0 109.335 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.17 -51.06 0.8 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.483 -0.621 . . . . 15.0 113.845 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 146.91 24.1 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.82 0.81 . . . . 15.0 112.479 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.29 155.49 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.668 1.187 . . . . 15.0 108.408 168.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.51 ' HG2' ' H ' ' A' ' 160' ' ' ALA . 16.8 tt0 -148.5 -175.15 4.81 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.855 0.862 . . . . 15.0 109.043 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.51 ' H ' ' HG2' ' A' ' 159' ' ' GLU . . . -73.19 -25.54 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.809 1.411 . . . . 15.0 114.809 -164.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -111.22 26.01 11.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.206 0.602 . . . . 15.0 110.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 163' ' ' ARG . 51.9 m-20 -99.5 -165.52 1.24 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.664 0.745 . . . . 15.0 112.753 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.415 ' HG2' ' HA ' ' A' ' 188' ' ' ALA . 0.3 OUTLIER -139.23 135.18 33.65 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.796 -1.927 . . . . 15.0 105.796 -176.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.28 156.23 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.6 m -129.14 126.51 39.45 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.593 -1.262 . . . . 15.0 107.593 161.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.617 HG23 HD22 ' A' ' 237' ' ' LEU . 28.3 pt -125.05 176.33 6.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.342 1.057 . . . . 15.0 110.791 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.68 122.65 12.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.373 -1.714 . . . . 15.0 106.373 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.484 ' HE2' HD13 ' B' ' 385' ' ' LEU . 29.3 p90 -140.6 160.81 39.21 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.68 0.752 . . . . 15.0 112.667 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.6 t -141.28 115.73 9.5 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.853 -1.521 . . . . 15.0 108.435 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -89.17 161.93 30.61 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.015 -0.539 . . . . 15.0 113.425 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 m -151.28 127.97 10.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.066 0.947 . . . . 15.0 108.593 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.623 HG23 ' HB1' ' A' ' 231' ' ' ALA . 58.0 t -107.81 134.31 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.618 0.767 . . . . 15.0 109.207 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 t70 70.53 3.81 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.202 1.001 . . . . 15.0 112.569 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.27 -3.0 16.27 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.522 -0.599 . . . . 15.0 114.002 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.13 166.59 24.95 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.43 0.692 . . . . 15.0 109.665 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -62.33 175.26 0.77 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 121.704 0.764 . . . . 15.0 111.477 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.671 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 1.7 p90 -149.82 170.35 18.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.103 0.961 . . . . 15.0 109.142 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -59.72 116.62 4.19 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.929 0.768 . . . . 15.0 109.42 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.89 80.59 0.68 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.354 -1.498 . . . . 15.0 109.354 -163.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -102.81 -15.75 23.59 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.166 -0.797 . . . . 15.0 113.492 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -140.65 146.81 38.39 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 117.925 0.862 . . . . 15.0 112.335 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.15 93.35 2.43 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.448 -1.316 . . . . 15.0 107.448 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.8 m -81.98 138.85 34.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.825 -1.079 . . . . 15.0 110.944 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 62.64 22.55 13.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.07 0.948 . . . . 15.0 113.061 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' B' ' 385' ' ' LEU . 83.6 t80 -66.22 138.99 58.07 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.588 0.232 . . . . 15.0 110.863 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.35 109.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.952 0.901 . . . . 15.0 109.754 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.448 HD23 HG21 ' A' ' 202' ' ' ILE . 26.4 tp -93.58 90.33 6.61 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.404 0.682 . . . . 15.0 111.347 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.415 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -83.57 92.87 7.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.577 ' HE2' ' HD3' ' A' ' 203' ' ' LYS . 17.7 mtp -54.57 128.62 33.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.591 0.756 . . . . 15.0 112.311 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.63 -26.94 5.33 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 -165.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.73 129.13 37.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.487 0.715 . . . . 15.0 109.744 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.2 72.47 0.23 Allowed Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.483 0.489 . . . . 15.0 112.571 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.521 ' HB3' HG21 ' B' ' 384' ' ' THR . 23.6 mtm180 -125.99 22.22 7.38 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.266 0.627 . . . . 15.0 111.279 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.532 ' HB3' HD22 ' B' ' 385' ' ' LEU . 1.6 pmm? -140.77 171.35 14.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.467 0.707 . . . . 15.0 109.973 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.3 pt -100.69 157.28 34.01 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.784 0.834 . . . . 15.0 110.239 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.33 147.1 86.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.676 2.25 . . . . 15.0 112.229 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.78 -46.87 1.45 Allowed Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.4 -0.68 . . . . 15.0 111.4 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -63.63 -51.82 63.52 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.18 -41.97 80.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.618 -1.173 . . . . 15.0 111.662 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.32 -33.08 75.12 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.307 1.043 . . . . 15.0 110.873 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.35 -13.73 82.95 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.268 -0.878 . . . . 15.0 113.286 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.448 HG21 HD23 ' A' ' 187' ' ' LEU . 34.3 mm -90.39 -51.59 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.282 -0.636 . . . . 15.0 109.282 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.577 ' HD3' ' HE2' ' A' ' 189' ' ' MET . 63.8 pttt -84.52 21.48 1.47 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.774 -166.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.44 32.34 2.07 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.24 -0.744 . . . . 15.0 111.24 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -147.12 -174.24 4.45 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.2 1.0 . . . . 15.0 110.329 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 21.5 pttp -146.69 159.85 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.726 0.81 . . . . 15.0 110.349 -174.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -67.54 152.51 45.53 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.452 0.569 . . . . 15.0 112.287 -171.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.65 -41.29 2.17 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.56 -0.745 . . . . 15.0 111.766 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.2 pt-20 -76.61 114.18 15.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.797 0.808 . . . . 15.0 108.937 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.96 104.2 16.21 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.004 -1.48 . . . . 15.0 107.004 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.02 -169.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.42 1.088 . . . . 15.0 109.295 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.6 t -133.28 141.46 48.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.23 -1.026 . . . . 15.0 108.23 168.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 47.0 pt -104.71 139.36 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -102.0 104.01 14.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.707 -0.849 . . . . 15.0 108.707 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.1 t -97.56 158.36 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.547 -1.279 . . . . 15.0 107.547 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -131.81 129.38 40.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.078 -1.082 . . . . 15.0 108.078 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -78.55 124.46 85.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.564 0.745 . . . . 15.0 110.008 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -51.04 165.99 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.928 3.086 . . . . 15.0 115.403 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -27.76 62.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.61 -0.723 . . . . 15.0 109.724 168.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.86 -17.14 59.16 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.952 1.301 . . . . 15.0 111.451 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.477 ' HE2' ' HB1' ' A' ' 223' ' ' ALA . 64.9 t80 -63.04 133.58 54.77 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.914 0.886 . . . . 15.0 110.327 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -76.97 -42.6 38.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.346 1.239 . . . . 15.0 114.346 -166.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' HE2' ' A' ' 221' ' ' TYR . . . -70.72 100.21 1.84 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.33 -23.41 60.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.676 0.79 . . . . 15.0 112.835 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.48 -24.89 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.654 0.382 . . . . 15.0 110.906 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 388' ' ' VAL . 40.7 mt -93.7 -33.68 13.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.945 0.898 . . . . 15.0 111.643 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.33 116.41 1.87 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.59 1.156 . . . . 15.0 111.542 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.56 -34.83 4.87 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.45 171.51 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.668 0.787 . . . . 15.0 111.936 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -123.94 138.67 54.44 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.9 -1.045 . . . . 15.0 109.833 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.623 ' HB1' HG23 ' A' ' 172' ' ' VAL . . . -117.44 131.55 56.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.218 0.607 . . . . 15.0 110.127 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 65.7 mttm -98.12 116.22 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.744 -1.206 . . . . 15.0 107.744 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.45 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 99.3 m-85 -108.81 114.24 27.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -75.92 89.66 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 15.0 110.231 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 mm -82.01 115.85 25.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.425 0.69 . . . . 15.0 109.669 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -103.73 101.17 11.0 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.526 -1.287 . . . . 15.0 107.526 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 166' ' ' ILE . 88.2 mt -76.9 93.21 3.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -85.34 -31.81 22.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.301 -0.863 . . . . 15.0 110.531 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -132.66 123.43 26.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.174 0.59 . . . . 15.0 110.907 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 207' ' ' ALA . 88.9 t -101.29 105.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.675 -1.972 . . . . 15.0 105.675 160.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 31.9 mt-10 -113.23 -174.94 2.56 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.5 tt0 -155.88 126.67 6.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -73.8 83.12 1.64 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 163.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.49 148.16 39.22 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 113.494 -1.685 . . . . 15.0 110.813 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.93 121.57 59.44 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.544 0.738 . . . . 15.0 110.42 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 91.0 Cg_endo -75.54 -167.95 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.538 2.826 . . . . 15.0 111.965 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -55.78 147.15 19.53 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.323 0.649 . . . . 15.0 111.22 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.4 tp -147.33 25.94 1.08 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.699 1.2 . . . . 15.0 108.047 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.3 m -73.76 164.83 26.12 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.682 -1.145 . . . . 15.0 109.192 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -36.83 -51.88 0.91 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.801 1.64 . . . . 15.0 114.492 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -67.62 -30.13 69.63 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -80.23 -55.61 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.895 0.478 . . . . 15.0 109.976 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.683 HG13 HD22 ' A' ' 266' ' ' LEU . 12.9 tt -63.87 -28.94 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.829 0.852 . . . . 15.0 112.494 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -66.1 -27.52 68.12 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 112.005 0.372 . . . . 15.0 112.005 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.59 -19.64 65.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.59 0.756 . . . . 15.0 111.976 -172.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -68.66 -23.98 64.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.831 0.453 . . . . 15.0 111.835 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.94 -22.48 1.44 Allowed Glycine 0 C--N 1.351 1.415 0 O-C-N 122.944 0.152 . . . . 15.0 112.771 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.433 HG11 ' H ' ' A' ' 261' ' ' GLY . 21.5 t -68.14 133.15 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 15.0 110.071 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.64 -60.98 2.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.78 0.432 . . . . 15.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.75 -36.1 32.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.072 0.549 . . . . 15.0 111.074 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.433 ' H ' HG11 ' A' ' 258' ' ' VAL . . . 98.88 36.09 4.62 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.476 -0.784 . . . . 15.0 112.755 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 p -78.44 139.45 38.72 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.645 0.723 . . . . 15.0 110.362 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 62.3 t -57.16 -58.77 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.189 0.996 . . . . 15.0 110.789 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.33 -15.4 47.85 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.729 0.812 . . . . 15.0 112.108 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.14 -32.84 37.97 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.683 HD22 HG13 ' A' ' 253' ' ' ILE . 56.3 tp -75.84 -38.51 57.97 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.787 -0.449 . . . . 15.0 109.787 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 39.2 mtp-105 -62.9 -39.58 94.94 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.539 0.524 . . . . 15.0 109.639 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.93 73.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 110.992 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.37 -50.35 73.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.022 0.929 . . . . 15.0 111.196 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.582 HG12 HD21 ' A' ' 141' ' ' LEU . 21.6 m -75.97 -25.13 16.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.235 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -57.79 -60.89 3.01 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.106 -0.701 . . . . 15.0 109.106 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -64.61 -37.56 88.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.916 0.71 . . . . 15.0 112.916 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.92 -51.81 23.79 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 117.966 0.348 . . . . 15.0 111.274 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.501 ' HE1' ' HB ' ' A' ' 270' ' ' VAL . 65.8 mtt -65.21 -30.13 70.99 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 118.582 -0.723 . . . . 15.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.62 -30.06 59.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.443 0.534 . . . . 15.0 112.443 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -64.4 -44.2 92.02 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.272 -0.64 . . . . 15.0 109.272 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.92 -38.17 79.37 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.593 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.569 HD11 ' HE3' ' A' ' 428' ' ' MET . 22.5 tp -60.65 -47.04 88.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.647 1.179 . . . . 15.0 111.638 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -59.85 -40.22 87.8 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.798 0.687 . . . . 15.0 111.053 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.1 t -68.11 -33.9 75.37 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.867 0.729 . . . . 15.0 110.401 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -80.36 -32.0 37.82 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 88.2 mt -68.31 -43.08 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -64.04 -40.12 95.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.108 -0.951 . . . . 15.0 109.691 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.78 -46.78 88.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.525 0.73 . . . . 15.0 110.047 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 8.5 tpt180 -57.05 -63.27 1.27 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.681 1.192 . . . . 15.0 111.128 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.5 -47.47 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.359 1.064 . . . . 15.0 111.5 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.403 ' HE3' HG21 ' A' ' 408' ' ' VAL . 86.4 tttt -71.5 -36.76 71.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.745 -0.662 . . . . 15.0 111.437 -175.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -68.55 -37.99 80.4 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 119.357 -0.354 . . . . 15.0 110.39 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -69.85 -35.97 75.16 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.56 0.537 . . . . 15.0 111.673 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.46 ' HB3' HD23 ' A' ' 412' ' ' LEU . . . -63.2 -52.9 60.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.114 0.483 . . . . 15.0 110.712 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.37 -35.02 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.345 1.458 . . . . 15.0 111.248 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.553 ' HA ' HH21 ' A' ' 343' ' ' ARG . 14.0 tp10 -64.04 -53.85 43.43 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.407 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -60.12 -39.43 95.83 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 124.598 1.186 . . . . 15.0 112.579 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 -63.5 1.17 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.321 1.048 . . . . 15.0 111.66 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.57 HG11 ' HG2' ' A' ' 343' ' ' ARG . 91.7 t -63.14 -44.07 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 122.481 0.312 . . . . 15.0 110.232 -176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -55.57 -37.33 67.89 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.287 1.035 . . . . 15.0 111.213 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.49 -28.46 37.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.872 0.869 . . . . 15.0 112.344 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -123.18 113.61 19.18 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.802 0.441 . . . . 15.0 111.278 -167.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.59 148.11 26.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.102 -1.073 . . . . 15.0 108.102 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 113' ' ' PRO . 7.4 tt -163.91 153.77 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.622 0.769 . . . . 15.0 109.814 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.45 112.45 7.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.494 -1.299 . . . . 15.0 107.494 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 300' ' ' ILE . 21.8 t -103.97 132.27 21.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.71 0.804 . . . . 15.0 109.46 -172.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.494 ' HG3' HD23 ' A' ' 11' ' ' LEU . 23.6 Cg_exo -62.94 110.59 1.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.699 2.266 . . . . 15.0 112.117 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 307' ' ' ILE . . . -54.74 -21.48 11.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.861 1.665 . . . . 15.0 113.104 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.25 29.34 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.232 1.013 . . . . 15.0 111.196 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' B' ' 467' ' ' ALA . 75.9 mt -63.01 -38.73 92.35 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.59 0.71 . . . . 15.0 110.011 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 304' ' ' ALA . 77.4 mt -58.62 -48.13 86.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 CA-C-N 114.239 -1.346 . . . . 15.0 109.712 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.503 ' HA ' HD12 ' A' ' 311' ' ' ILE . 22.9 t70 -63.1 -29.92 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.062 0.851 . . . . 15.0 111.309 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -69.61 -44.79 70.0 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.562 0.345 . . . . 15.0 111.545 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.3 -28.75 66.55 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.481 0.658 . . . . 15.0 111.571 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 337' ' ' PHE . 78.0 mt -64.66 -42.04 93.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 N-CA-C 108.195 -1.039 . . . . 15.0 108.195 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.89 -41.14 90.98 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.37 1.044 . . . . 15.0 110.481 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.28 -50.62 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 123.802 0.689 . . . . 15.0 109.909 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.62 -17.92 62.88 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.127 0.788 . . . . 15.0 113.127 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 329' ' ' ALA . 20.9 mtm180 -81.6 -32.7 31.93 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.577 0.751 . . . . 15.0 109.234 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -71.11 -39.45 72.07 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.405 0.682 . . . . 15.0 110.326 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -58.75 -50.45 73.87 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.588 -0.733 . . . . 15.0 110.324 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.07 90.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.475 0.71 . . . . 15.0 110.752 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . . . -53.81 -37.39 63.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.477 1.111 . . . . 15.0 111.671 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -66.12 -39.21 89.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.822 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.401 ' HG3' ' HB ' ' B' ' 435' ' ' THR . 10.8 mpt_? -81.85 -11.7 58.83 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.982 0.513 . . . . 15.0 109.967 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.456 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 66.6 t80 -92.5 13.18 20.48 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.139 1.376 . . . . 15.0 109.784 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.01 21.25 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 116.118 -0.492 . . . . 15.0 113.358 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 71.96 62.69 3.26 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 112.134 -0.386 . . . . 15.0 112.134 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.669 ' HB3' ' HB3' ' A' ' 319' ' ' ALA . 23.9 t-20 -63.11 147.46 50.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.784 0.834 . . . . 15.0 110.292 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.58 88.85 2.84 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.986 1.315 . . . . 15.0 110.018 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm 67.45 -5.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.401 1.481 . . . . 15.0 114.551 170.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -84.24 -10.32 57.78 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.119 0.967 . . . . 15.0 108.989 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -51.96 -33.12 36.28 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.2 1.4 . . . . 15.0 112.347 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.9 tp -51.18 -32.32 23.03 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.808 1.243 . . . . 15.0 112.263 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.17 -22.38 39.0 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.1 0.96 . . . . 15.0 112.174 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.5 mt -52.9 119.6 16.68 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-O 118.091 -0.957 . . . . 15.0 110.317 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.71 107.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 124.588 3.525 . . . . 15.0 113.55 -169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.531 ' HB2' HD11 ' A' ' 311' ' ' ILE . 9.0 ptm180 -61.21 -31.32 71.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.782 -1.099 . . . . 15.0 112.572 -170.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.65 -18.11 64.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.222 1.009 . . . . 15.0 112.822 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.49 -37.86 88.04 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.689 0.757 . . . . 15.0 109.73 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.554 ' HB2' HG23 ' A' ' 311' ' ' ILE . 33.2 m-85 -103.38 -20.51 14.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.388 -1.278 . . . . 15.0 111.097 -168.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -54.83 -36.5 65.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.304 1.041 . . . . 15.0 112.976 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.06 -48.06 83.45 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.661 0.384 . . . . 15.0 111.713 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.04 -38.59 44.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.941 0.496 . . . . 15.0 111.358 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.33 -55.17 26.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.393 0.677 . . . . 15.0 110.937 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.538 ' HA ' HG12 ' A' ' 307' ' ' ILE . 86.3 tttt -48.74 -44.34 38.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.692 1.197 . . . . 15.0 111.146 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.57 ' HG2' HG11 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -60.32 -39.26 86.38 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.603 1.19 . . . . 15.0 110.207 178.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -73.18 -28.11 62.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.817 0.281 . . . . 15.0 111.463 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 20.4 t -71.7 -38.24 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.495 -0.558 . . . . 15.0 109.495 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.3 t -59.39 -44.98 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 343' ' ' ARG . 61.1 t -54.22 -46.7 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.82 0.848 . . . . 15.0 110.818 172.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.42 -30.51 75.28 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.433 0.458 . . . . 15.0 113.789 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.46 HD12 HD12 ' A' ' 300' ' ' ILE . 95.7 mt -74.6 -49.35 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.453 0.701 . . . . 15.0 109.955 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.6 mt -64.06 -54.77 28.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.939 0.896 . . . . 15.0 110.548 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 355' ' ' ILE . 78.0 mt -63.6 -34.94 78.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.035 0.834 . . . . 15.0 111.098 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.465 ' HA2' HD11 ' A' ' 355' ' ' ILE . . . -62.88 -38.61 96.84 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 123.49 0.493 . . . . 15.0 112.611 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.17 -35.12 73.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.371 0.669 . . . . 15.0 110.862 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 350' ' ' LEU . 96.4 t -66.6 -37.33 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.927 0.491 . . . . 15.0 110.218 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.465 HD11 ' HA2' ' A' ' 352' ' ' GLY . 76.7 mt -64.26 -42.16 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.352 0.661 . . . . 15.0 110.074 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -60.65 -62.57 1.76 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.827 -0.624 . . . . 15.0 110.096 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.1 m -66.26 -33.8 76.57 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.149 0.98 . . . . 15.0 112.482 -173.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -94.35 11.01 31.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.924 0.49 . . . . 15.0 111.322 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.82 38.58 4.48 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 125.766 1.627 . . . . 15.0 113.888 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.68 147.89 43.25 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.632 0.773 . . . . 15.0 111.85 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 148.51 39.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.229 1.012 . . . . 15.0 108.615 172.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.17 137.39 57.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 122.07 37.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.042 0.937 . . . . 15.0 109.77 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.65 -46.82 83.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.263 1.025 . . . . 15.0 111.829 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.69 -21.06 61.12 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.082 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 -72.62 -46.66 53.01 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.553 -0.906 . . . . 15.0 108.553 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.627 HG22 ' HG2' ' A' ' 399' ' ' ARG . 31.7 t -55.41 -47.52 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 124.55 1.156 . . . . 15.0 109.591 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -51.89 -54.99 22.94 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.237 0.961 . . . . 15.0 111.718 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.73 92.77 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.98 0.8 . . . . 15.0 113.428 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.93 -51.45 69.21 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.515 0.726 . . . . 15.0 110.34 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 367' ' ' VAL . 38.6 mm -54.94 -56.38 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.434 0.694 . . . . 15.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.69 -49.21 78.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.927 -1.488 . . . . 15.0 111.967 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.74 -39.57 64.17 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.615 0.598 . . . . 15.0 112.615 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 56.7 ttp -56.06 -47.49 77.82 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.296 0.639 . . . . 15.0 109.597 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -73.31 -36.42 66.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.8 -1.091 . . . . 15.0 112.183 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 33.5 t -70.55 -12.04 61.32 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.394 0.677 . . . . 15.0 111.811 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.16 -7.95 56.69 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.204 0.601 . . . . 15.0 111.422 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.35 179.53 4.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.225 1.01 . . . . 15.0 110.403 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.01 0.924 . . . . 15.0 110.512 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -114.9 109.89 46.82 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.833 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.666 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 89.3 Cg_endo -80.56 -29.66 2.24 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 121.995 1.796 . . . . 15.0 112.648 168.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.07 -48.54 75.87 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.933 0.893 . . . . 15.0 112.383 -161.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.78 -37.74 85.44 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.992 0.808 . . . . 15.0 110.402 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.46 -46.66 69.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 123.744 0.653 . . . . 15.0 110.087 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -49.3 82.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.06 -12.18 60.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.253 0.621 . . . . 15.0 112.431 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -88.2 -39.66 14.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.212 0.605 . . . . 15.0 111.382 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -86.5 -48.3 8.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.744 0.417 . . . . 15.0 112.083 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.6 p -49.73 -48.04 50.29 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.535 1.134 . . . . 15.0 113.731 -165.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -109.58 14.95 23.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.335 0.654 . . . . 15.0 111.52 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -110.69 88.97 2.9 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.272 -1.381 . . . . 15.0 107.272 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' B' ' 452' ' ' VAL . 38.6 ttmt -66.47 -23.18 66.23 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.413 -0.812 . . . . 15.0 111.691 -170.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.73 -56.88 12.28 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.697 0.799 . . . . 15.0 110.047 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.68 -24.39 58.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.036 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 46.1 tpp -59.52 -46.06 89.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.457 -0.572 . . . . 15.0 109.457 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.411 ' HB2' HG21 ' B' ' 452' ' ' VAL . 6.3 t70 -54.39 -49.83 68.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.893 0.877 . . . . 15.0 111.462 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.18 -33.83 74.08 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 124.023 0.827 . . . . 15.0 110.976 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.558 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -84.69 -11.97 54.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.392 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.627 ' HG2' HG22 ' A' ' 367' ' ' VAL . 50.0 mtp180 -85.87 -24.89 26.51 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -71.16 -40.27 71.42 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.235 0.614 . . . . 15.0 110.066 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.3 p -71.57 -28.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 117.748 0.249 . . . . 15.0 111.254 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -68.57 -37.5 79.93 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.419 0.628 . . . . 15.0 110.553 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.74 -31.38 57.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.284 -0.871 . . . . 15.0 110.493 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 408' ' ' VAL . 29.2 tt0 -59.89 -46.3 89.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.383 1.073 . . . . 15.0 109.596 169.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 9.1 mm-40 -53.49 -55.09 28.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.524 1.129 . . . . 15.0 111.487 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -58.76 -37.48 76.33 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.483 -0.78 . . . . 15.0 111.953 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -64.09 -41.68 97.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 15.0 111.278 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 404' ' ' GLU . 85.9 t -58.16 -48.39 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 123.757 0.661 . . . . 15.0 109.534 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 57.1 mt-10 -61.87 -36.86 82.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.896 0.748 . . . . 15.0 111.99 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.11 64.73 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.704 -0.68 . . . . 15.0 111.705 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 407' ' ' ALA . 54.7 t -88.05 -29.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 290' ' ' ALA . 97.0 mt -72.04 -27.36 62.65 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.417 0.687 . . . . 15.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.97 70.17 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 15.0 110.873 170.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -95.91 -28.3 14.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.373 1.069 . . . . 15.0 111.368 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.85 154.95 21.18 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.955 0.902 . . . . 15.0 110.924 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.88 84.18 5.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.786 0.834 . . . . 15.0 109.645 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.0 t -95.57 89.3 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.262 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -72.51 112.01 8.19 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.216 0.606 . . . . 15.0 110.295 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.24 132.55 36.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.261 0.625 . . . . 15.0 110.153 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -140.83 141.55 34.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.36 0.664 . . . . 15.0 110.212 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.92 125.13 36.51 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.498 HG22 HG23 ' A' ' 130' ' ' VAL . 9.8 t -157.31 173.72 16.52 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.947 0.499 . . . . 15.0 111.345 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 64.9 p -96.47 174.62 6.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.656 0.783 . . . . 15.0 112.145 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.99 -25.23 57.99 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.47 1.908 . . . . 15.0 111.702 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.615 ' HA ' ' HB3' ' A' ' 429' ' ' ASN . 33.6 m-80 -65.53 -34.24 77.79 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.865 1.266 . . . . 15.0 112.21 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -66.68 -37.4 84.69 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.321 0.581 . . . . 15.0 111.739 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 278' ' ' LEU . 15.6 tp -85.24 -77.5 0.28 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.377 -0.829 . . . . 15.0 111.124 -165.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.569 ' HE3' HD11 ' A' ' 278' ' ' LEU . 1.3 pmm? -106.01 -30.51 9.26 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.214 -0.304 . . . . 15.0 111.425 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 425' ' ' ASN . 65.1 t30 -86.85 46.89 1.42 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.308 1.051 . . . . 15.0 110.5 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -77.38 -7.92 56.87 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.833 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -63.4 -20.72 65.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.604 1.162 . . . . 15.0 111.503 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.411 0.684 . . . . 15.0 109.302 171.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -125.35 121.46 34.01 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.622 HD21 ' H ' ' B' ' 368' ' ' ASP . 0.0 OUTLIER -55.71 -61.6 2.25 Favored 'General case' 0 CA--C 1.558 1.275 0 O-C-N 124.041 0.838 . . . . 0.0 111.886 -176.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.622 ' H ' HD21 ' B' ' 367' ' ' LEU . 13.1 t70 -108.54 -88.21 0.48 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 164.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -112.73 -77.22 0.58 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 156.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -107.49 -75.25 0.64 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.92 -72.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 162.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -103.81 -76.64 0.59 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 164.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' B' ' 377' ' ' PHE . 20.8 tpt180 -98.74 -75.53 0.56 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -102.58 -72.74 0.68 Allowed 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 165.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.493 ' H ' HD22 ' B' ' 375' ' ' LEU . 0.0 OUTLIER -107.06 -77.99 0.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.0 -83.39 0.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 164.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' B' ' 373' ' ' ARG . 36.1 t80 -109.2 -88.13 0.49 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 118.81 0.732 . . . . 0.0 110.403 160.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.58 -67.9 0.87 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.658 0.783 . . . . 0.0 110.416 -172.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -110.81 -84.31 0.56 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.179 0.591 . . . . 0.0 109.77 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? 167.62 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.39 126.67 19.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.471 0.709 . . . . 0.0 109.976 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.07 51.12 0.26 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.797 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -129.81 150.13 51.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 193' ' ' ARG . 6.4 m 68.94 -179.09 0.23 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.197 0.999 . . . . 0.0 108.89 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 194' ' ' MET . 1.5 mm? -73.37 120.83 19.52 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.11 -0.994 . . . . 0.0 108.617 168.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 13.5 m -64.37 98.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 125.168 1.542 . . . . 0.0 112.311 -164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.671 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 5.8 pt -125.08 160.64 30.29 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.035 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.497 ' H ' HD12 ' A' ' 226' ' ' LEU . 54.5 t -55.44 150.54 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.755 0.422 . . . . 0.0 110.414 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 12.2 t -46.79 173.94 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 126.358 1.863 . . . . 0.0 113.709 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -51.89 175.6 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.747 1.219 . . . . 0.0 113.78 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -49.36 159.44 0.32 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.801 1.241 . . . . 0.0 112.639 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -51.2 -33.42 27.48 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.634 0.774 . . . . 0.0 110.837 175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -87.28 92.85 9.21 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 161.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -64.99 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.914 0.886 . . . . 0.0 113.034 -166.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -163.08 116.74 1.63 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.369 0.668 . . . . 0.0 110.382 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 60.0 m -68.84 150.45 47.8 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.519 0.728 . . . . 0.0 110.339 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 137.11 57.03 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.132 0.491 . . . . 0.0 111.32 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 12.3 tt -169.76 170.58 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 C-N-CA 125.257 1.423 . . . . 0.0 107.72 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.0 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.398 1.094 . . . . 0.0 109.152 167.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.628 ' H ' ' HD2' ' B' ' 401' ' ' PRO . . . -135.46 -47.9 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.368 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.628 ' HD2' ' H ' ' B' ' 400' ' ' ALA . 1.8 Cg_endo -44.35 -62.08 0.49 Allowed 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.229 2.619 . . . . 0.0 113.52 175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.78 -98.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.35 0.66 . . . . 0.0 109.703 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 14.5 t -164.56 -163.69 0.76 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 72.8 -70.0 0.17 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -133.71 71.01 75.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.764 0.826 . . . . 0.0 110.907 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -103.31 9.47 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.23 2.62 . . . . 0.0 112.835 169.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 81.47 171.25 45.14 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.514 0.509 . . . . 0.0 112.532 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.21 10.23 34.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.243 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 61.9 m -65.38 91.63 0.12 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.736 0.814 . . . . 0.0 109.71 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 64.82 175.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.227 1.411 . . . . 0.0 111.759 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -164.33 114.99 1.25 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' B' ' 415' ' ' LYS . 2.3 pt? -61.69 106.24 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -61.69 -57.73 10.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.779 0.832 . . . . 0.0 110.265 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 34.7 m -96.08 -69.32 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.242 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' B' ' 412' ' ' LEU . 60.1 tttm -172.27 135.79 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.552 0.741 . . . . 0.0 109.21 -176.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.04 -62.83 1.57 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.242 0.617 . . . . 0.0 110.624 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -82.29 71.51 2.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.972 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -79.21 76.63 5.74 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.0 110.262 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 47.2 t 60.1 -82.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.735 1.614 . . . . 0.0 111.211 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 50.3 ttm -160.19 -25.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.841 0.856 . . . . 0.0 109.982 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 41.2 t 59.62 74.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.157 1.383 . . . . 0.0 110.094 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 25.5 ptm -71.59 107.23 4.36 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.343 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 33.9 p -156.74 167.7 29.67 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.019 0.927 . . . . 0.0 109.445 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -77.68 90.76 3.99 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -80.82 64.37 4.11 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.872 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -99.89 -11.16 20.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.915 0.886 . . . . 0.0 109.793 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 26.7 m -139.57 178.47 7.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.235 1.014 . . . . 0.0 109.787 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.56 -163.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.133 0.973 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.76 -65.24 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.155 0.582 . . . . 0.0 110.164 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.44 -80.48 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.3 m -108.71 -61.21 1.64 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.506 ' HG3' ' HG3' ' B' ' 433' ' ' GLU . 20.6 tp60 -112.63 -61.54 1.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.124 0.97 . . . . 0.0 108.473 168.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' B' ' 432' ' ' GLN . 41.6 mt-10 -116.29 -161.28 0.79 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.727 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.19 130.48 42.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.108 0.563 . . . . 0.0 110.083 174.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 321' ' ' ARG . 26.4 m 61.32 87.98 0.09 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.645 1.178 . . . . 0.0 110.972 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -116.83 -55.02 0.31 Allowed Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.348 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 41.6 m -78.93 69.31 5.07 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.781 0.833 . . . . 0.0 109.935 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -147.57 74.17 1.31 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.98 88.93 0.77 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.481 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -74.36 -45.16 48.78 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 -171.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 15.9 pt -137.37 174.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.306 0.642 . . . . 0.0 110.936 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -131.15 147.06 52.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.996 0.518 . . . . 0.0 111.831 -171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -165.63 126.53 1.88 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.613 0.765 . . . . 0.0 110.455 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -95.36 168.46 10.7 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 0.0 110.489 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 56.18 71.88 0.66 Allowed Glycine 0 C--N 1.35 1.343 0 O-C-N 124.263 0.977 . . . . 0.0 114.562 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.02 -27.43 8.43 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.831 2.354 . . . . 0.0 112.083 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -89.71 49.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.81 0.844 . . . . 0.0 109.571 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -130.92 135.57 47.79 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.567 0.747 . . . . 0.0 110.022 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.29 61.93 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.849 0.718 . . . . 0.0 110.325 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 1.3 t30 67.6 -89.45 0.03 OUTLIER 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.718 1.607 . . . . 0.0 109.315 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 59.2 t 53.3 91.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.567 1.147 . . . . 0.0 111.579 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 392' ' ' LYS . 42.4 t -58.85 104.99 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.333 1.053 . . . . 0.0 111.247 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -169.39 -143.87 4.04 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.337 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 470' ' ' LEU . 80.4 mt 61.5 81.9 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.359 1.463 . . . . 0.0 112.196 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 4.7 t -100.3 70.05 1.5 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.834 0.854 . . . . 0.0 109.423 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -82.16 139.95 34.04 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.893 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -110.52 -25.27 10.11 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.237 1.015 . . . . 0.0 109.995 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 6.8 m -73.88 -55.79 5.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.424 0.69 . . . . 0.0 111.584 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -119.38 -88.39 0.62 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.767 -167.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 41.6 tp -108.38 111.01 22.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -67.27 -33.56 75.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.23 109.12 4.75 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 61.2 p -77.43 164.66 25.26 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.667 0.787 . . . . 0.0 111.066 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 35.4 mtm -125.15 -178.16 4.11 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.558 0.694 . . . . 0.0 111.696 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.459 ' HA ' HD23 ' B' ' 468' ' ' LEU . 49.6 mmtm -91.46 -175.25 4.16 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.019 171.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 65.68 -72.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.877 1.271 . . . . 0.0 109.217 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.691 ' HA ' HD12 ' A' ' 306' ' ' LEU . . . -79.73 79.79 6.19 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' B' ' 465' ' ' LYS . 78.8 mt -65.39 90.54 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.367 1.067 . . . . 0.0 111.051 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -86.42 58.83 4.68 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.529 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.549 ' HB2' HD11 ' B' ' 454' ' ' LEU . 75.9 mt 75.57 -43.29 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.813 1.645 . . . . 0.0 112.55 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp . . . . . 0 CA--C 1.554 1.122 0 C-N-CA 124.401 1.081 . . . . 12.06 109.21 -179.374 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.522 0.201 . . . . 15.0 110.689 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.1 tt0 -142.71 118.41 10.46 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.909 -0.775 . . . . 15.0 108.909 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.586 HG13 HG12 ' A' ' 17' ' ' ILE . 26.7 m -106.25 131.96 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.82 -0.437 . . . . 15.0 109.82 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -142.55 94.65 2.67 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.611 0.765 . . . . 15.0 109.217 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -77.2 95.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.184 0.992 . . . . 15.0 110.696 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 48.5 mt-10 -76.21 100.11 4.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.709 -1.132 . . . . 15.0 109.468 173.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -78.43 85.91 4.51 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 107.967 -1.123 . . . . 15.0 107.967 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -61.94 -44.43 96.79 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.685 -1.143 . . . . 15.0 110.749 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -169.36 97.41 0.33 Allowed 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.632 0.582 . . . . 15.0 109.925 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -98.44 0.35 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.747 0.654 . . . . 15.0 113.645 172.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.628 HD22 ' HG3' ' A' ' 113' ' ' PRO . 8.1 mp -69.83 -25.13 63.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.653 0.781 . . . . 15.0 111.311 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.63 79.53 0.69 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.573 0.546 . . . . 15.0 112.832 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.6 ' HD2' HG11 ' A' ' 111' ' ' VAL . 92.8 mtt180 -99.81 89.99 4.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.6 ttm180 -75.89 95.77 3.59 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.004 -0.998 . . . . 15.0 109.677 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.57 87.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.9 m -82.62 109.74 17.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.813 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.586 HG12 HG13 ' A' ' 3' ' ' VAL . 53.6 mt -110.58 116.56 52.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.912 -0.586 . . . . 15.0 109.729 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 67.6 m -87.39 105.25 17.14 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.866 -0.79 . . . . 15.0 108.866 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 70' ' ' LEU . 62.4 mt -74.37 126.2 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 147.77 51.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.911 0.485 . . . . 15.0 111.26 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.67 94.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 15.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.71 -30.21 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.116 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -69.13 -38.5 78.89 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.841 0.456 . . . . 15.0 110.369 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.23 -42.41 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -61.55 -42.82 99.4 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.914 0.886 . . . . 15.0 111.101 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -75.48 -35.39 60.84 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.71 62.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.891 0.477 . . . . 15.0 111.889 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.788 HG21 ' HD3' ' A' ' 63' ' ' ARG . 86.8 t -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.625 0.77 . . . . 15.0 109.916 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.621 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -65.0 -42.62 94.32 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.384 0.674 . . . . 15.0 111.304 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 65.7 m -69.34 -18.58 63.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.865 0.866 . . . . 15.0 110.638 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.9 tp10 -86.83 -33.05 19.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.071 0.548 . . . . 15.0 110.689 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.5 mt -74.68 -27.34 60.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.335 0.494 . . . . 15.0 112.335 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.51 -29.63 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -68.85 -48.98 62.11 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.0 t -60.74 -35.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.343 1.057 . . . . 15.0 111.294 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.49 -49.0 73.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.092 0.557 . . . . 15.0 110.609 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.57 -29.13 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.34 0.656 . . . . 15.0 112.171 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -80.35 -32.44 37.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.534 1.134 . . . . 15.0 111.15 -171.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.9 t -96.33 1.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.515 0.726 . . . . 15.0 109.621 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 70.06 12.61 7.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.609 1.564 . . . . 15.0 112.635 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 39' ' ' VAL . 69.8 mt -61.59 -24.11 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.154 0.982 . . . . 15.0 110.917 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 11.7 p-10 -65.39 -34.02 77.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.998 0.919 . . . . 15.0 111.614 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.03 -23.9 77.64 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.678 0.611 . . . . 15.0 112.207 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -93.82 -21.7 19.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.722 0.809 . . . . 15.0 110.68 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 48.1 ttt85 -75.89 130.67 38.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.36 1.064 . . . . 15.0 109.084 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.0 16.78 21.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.521 0.728 . . . . 15.0 111.53 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.02 27.0 69.52 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 115.433 -0.803 . . . . 15.0 113.83 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -100.35 -38.89 8.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.355 0.662 . . . . 15.0 111.315 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.26 118.61 67.5 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-O 118.894 -0.574 . . . . 15.0 109.944 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.7 Cg_exo -64.24 147.78 91.12 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.068 2.512 . . . . 15.0 112.257 175.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.2 tpp -74.78 -29.37 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.361 0.664 . . . . 15.0 111.632 -172.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 29.9 p-10 -65.47 -36.72 84.72 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.833 0.453 . . . . 15.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' HD2' ' A' ' 50' ' ' PRO . 38.7 mt -61.49 -52.18 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.641 0.776 . . . . 15.0 110.519 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 58' ' ' TYR . 28.8 m -72.38 -26.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -63.71 -53.83 45.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.216 0.606 . . . . 15.0 111.273 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 2.7 pt20 -83.66 -45.59 13.27 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.546 -0.752 . . . . 15.0 112.127 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -79.9 -63.04 1.5 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.489 0.316 . . . . 15.0 110.513 -171.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 3.6 m-85 -68.97 -38.8 79.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.542 0.737 . . . . 15.0 110.157 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.15 -2.04 86.56 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.576 -1.193 . . . . 15.0 113.965 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.19 -29.92 69.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.413 0.685 . . . . 15.0 111.573 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.0 p -80.13 -39.73 28.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.517 0.727 . . . . 15.0 110.65 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.07 -17.26 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 124.369 1.068 . . . . 15.0 111.711 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.788 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -48.14 -46.72 34.68 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.342 1.057 . . . . 15.0 111.467 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.64 -53.85 49.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.557 1.543 . . . . 15.0 112.26 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.84 -29.97 66.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.241 -0.89 . . . . 15.0 111.728 -171.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -74.2 -27.87 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.947 -0.57 . . . . 15.0 110.594 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.1 mt -57.77 -39.21 76.92 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.828 0.451 . . . . 15.0 111.151 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.85 -42.88 98.33 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.211 0.319 . . . . 15.0 112.794 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.15 -41.69 94.52 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.231 1.012 . . . . 15.0 111.056 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.581 ' HB3' HD12 ' A' ' 19' ' ' ILE . 86.3 mt -69.49 -40.19 77.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.694 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 75.2 mtm -67.18 -36.86 82.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.917 0.487 . . . . 15.0 111.033 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -63.38 -47.42 82.12 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.025 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.2 mtm105 -83.08 -51.11 7.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.983 -0.553 . . . . 15.0 112.204 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -23.52 44.21 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 122.858 0.463 . . . . 15.0 111.655 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -72.12 -52.2 17.84 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.568 0.543 . . . . 15.0 111.229 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.509 ' HA ' HG12 ' A' ' 79' ' ' ILE . 12.2 tt -67.28 -39.34 82.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.141 0 CA-C-N 117.899 0.318 . . . . 15.0 110.956 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -59.21 -34.68 72.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.467 0.707 . . . . 15.0 111.181 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.94 -54.88 7.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.528 0.731 . . . . 15.0 111.146 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' A' ' 76' ' ' ILE . 21.8 pt -68.32 -22.23 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.145 0.794 . . . . 15.0 113.145 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.38 -49.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.536 0.335 . . . . 15.0 110.454 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -72.14 -36.83 69.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.332 0.253 . . . . 15.0 111.293 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -76.72 -12.74 60.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.959 0.504 . . . . 15.0 111.542 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 61.13 29.78 19.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.766 1.226 . . . . 15.0 112.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -82.29 125.0 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.47 104.03 31.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.61 147.28 24.86 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.464 2.109 . . . . 15.0 112.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.18 178.44 10.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.74 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.81 -124.95 18.76 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.117 -0.947 . . . . 15.0 112.054 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.18 99.76 28.96 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.565 0.746 . . . . 15.0 110.188 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.5 Cg_endo -76.57 108.09 2.59 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.119 1.879 . . . . 15.0 110.528 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -102.75 100.64 10.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.634 -0.712 . . . . 15.0 109.963 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -85.95 80.87 8.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.453 0.701 . . . . 15.0 109.383 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.76 113.69 34.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.332 -0.849 . . . . 15.0 108.988 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.81 96.23 0.67 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.381 2.054 . . . . 15.0 110.459 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -51.28 -51.07 37.99 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.818 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -174.65 137.73 0.48 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.914 0.886 . . . . 15.0 110.668 172.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -106.34 135.46 47.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 38.3 mtpt -129.71 114.24 15.74 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.158 -1.423 . . . . 15.0 107.158 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.27 118.37 9.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.891 0.477 . . . . 15.0 109.716 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.25 39.08 Favored Glycine 0 N--CA 1.47 0.94 0 CA-C-N 115.985 -0.552 . . . . 15.0 112.659 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.3 mt-10 -112.34 -178.81 3.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.117 0.967 . . . . 15.0 109.652 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.28 151.22 46.51 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.706 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HD2' HD13 ' A' ' 19' ' ' ILE . 48.7 t80 -95.16 146.45 24.3 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.4 m -134.46 133.31 40.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.333 0.653 . . . . 15.0 109.574 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.52 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 13.7 p90 -138.34 171.15 14.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.925 0.89 . . . . 15.0 109.051 172.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.3 m -140.77 124.37 16.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.888 0.875 . . . . 15.0 109.349 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.19 104.3 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -102.04 114.93 29.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.949 0.9 . . . . 15.0 109.417 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 33.6 p90 -139.64 164.04 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.604 0.761 . . . . 15.0 110.619 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.86 113.72 20.67 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.364 -0.835 . . . . 15.0 109.705 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.6 HG11 ' HD2' ' A' ' 13' ' ' ARG . 12.1 m -89.43 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.671 -0.492 . . . . 15.0 109.671 171.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -89.33 126.37 58.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.674 . . . . 15.0 110.224 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.628 ' HG3' HD22 ' A' ' 11' ' ' LEU . 14.5 Cg_exo -69.39 145.29 58.86 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.441 2.094 . . . . 15.0 110.868 170.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.45 100.15 1.05 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.301 0.64 . . . . 15.0 109.351 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.37 123.8 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.724 0.773 . . . . 15.0 112.057 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.96 107.82 15.03 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.537 1.135 . . . . 15.0 108.705 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.95 131.5 45.19 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.645 0.591 . . . . 15.0 109.995 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -136.6 155.9 49.3 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.169 0.988 . . . . 15.0 109.586 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 60.65 20.77 56.94 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 124.442 1.089 . . . . 15.0 114.823 171.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.03 -39.46 94.81 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.368 0.667 . . . . 15.0 111.029 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.05 -20.31 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.239 0.615 . . . . 15.0 111.305 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.89 -15.92 42.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.63 0.772 . . . . 15.0 111.652 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.516 HG23 HG23 ' A' ' 125' ' ' VAL . 58.5 mt -65.11 124.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.158 0.583 . . . . 15.0 109.758 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.623 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.7 mt-10 -116.2 85.91 2.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.925 0.869 . . . . 15.0 109.948 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 289' ' ' GLN . 67.8 t -83.03 164.78 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.51 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.7 141.23 49.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.744 0.817 . . . . 15.0 109.45 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -114.38 94.75 37.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.872 -1.159 . . . . 15.0 107.872 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.635 ' HG3' ' HD2' ' A' ' 285' ' ' ARG . 85.0 Cg_endo -78.16 103.49 1.7 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.984 1.789 . . . . 15.0 111.38 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -69.12 92.73 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 427' ' ' LEU . 25.5 t -118.29 134.06 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.219 -0.901 . . . . 15.0 110.196 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.44 154.73 48.38 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 106.664 -1.606 . . . . 15.0 106.664 167.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 274' ' ' MET . 3.4 t -83.29 89.66 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.814 -1.18 . . . . 15.0 107.814 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.9 p -69.52 173.96 5.44 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.257 0.623 . . . . 15.0 109.79 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -55.26 -43.72 74.93 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.561 0.344 . . . . 15.0 111.474 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.41 -25.65 64.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.557 0.743 . . . . 15.0 111.929 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -78.81 -45.11 21.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.754 0.422 . . . . 15.0 110.675 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -56.06 -58.09 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.938 0.895 . . . . 15.0 109.129 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -61.69 -47.01 87.23 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.844 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.17 72.16 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.13 0.894 . . . . 15.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.661 ' SD ' ' HE1' ' A' ' 274' ' ' MET . 27.8 ttt -69.54 -50.71 42.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.771 0.428 . . . . 15.0 111.151 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.18 -37.51 69.68 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.143 0.577 . . . . 15.0 112.067 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.75 -41.75 82.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.107 0.963 . . . . 15.0 109.929 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.479 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 82.7 m -58.95 -43.2 91.21 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.188 0.93 . . . . 15.0 110.574 173.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 140' ' ' MET . 81.0 mt -61.3 -42.94 99.5 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.425 0.69 . . . . 15.0 111.076 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 69.3 mtm180 -63.57 -35.89 81.99 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.297 -0.865 . . . . 15.0 110.676 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.607 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 85.6 mttt -85.06 -5.33 59.35 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.37 0.668 . . . . 15.0 112.537 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 143' ' ' THR . 96.8 mt-30 -79.74 -44.62 20.39 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.914 -0.772 . . . . 15.0 108.914 163.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -97.59 37.94 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.367 0.667 . . . . 15.0 110.864 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -71.51 141.13 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.458 0.703 . . . . 15.0 112.092 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.1 m -82.18 127.02 32.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.379 1.072 . . . . 15.0 109.353 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -86.95 126.61 34.82 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.02 0.528 . . . . 15.0 110.269 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -148.52 122.58 9.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 15.0 110.032 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.538 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.5 mt-10 -75.57 143.78 42.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.01 0.524 . . . . 15.0 110.263 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.685 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 36.6 pttt -137.05 -179.3 5.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.706 0.802 . . . . 15.0 111.031 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -147.14 153.74 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.06 -51.81 0.79 Allowed Glycine 0 N--CA 1.467 0.707 0 CA-C-O 119.548 -0.584 . . . . 15.0 112.757 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -155.53 148.07 23.99 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 117.415 0.608 . . . . 15.0 111.158 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.83 153.01 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 107.902 -1.147 . . . . 15.0 107.902 165.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.07 -169.88 2.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.457 1.103 . . . . 15.0 109.711 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.51 96.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.397 1.079 . . . . 15.0 113.245 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.65 33.25 5.14 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.889 0.7 . . . . 15.0 112.889 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -87.84 -164.26 1.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 120.934 0.397 . . . . 15.0 111.795 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 18.7 mtm180 -122.88 160.44 26.1 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.027 -1.101 . . . . 15.0 108.027 161.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.62 116.92 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.677 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 15.2 m -95.63 116.46 28.88 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.5 HG23 ' HA ' ' A' ' 237' ' ' LEU . 40.1 pt -130.13 168.77 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.752 0.821 . . . . 15.0 110.346 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.45 ' HB2' ' HZ2' ' A' ' 181' ' ' LYS . 7.7 p-10 -127.64 161.2 29.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.424 -1.325 . . . . 15.0 107.424 161.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.63 174.92 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.333 0.587 . . . . 15.0 111.385 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.653 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 6.6 t -158.62 131.64 7.24 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.658 -1.608 . . . . 15.0 106.658 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.48 -177.13 26.67 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.602 -0.808 . . . . 15.0 113.407 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 p -148.2 131.67 16.7 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.754 0.822 . . . . 15.0 109.306 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.629 HG13 ' HA ' ' A' ' 226' ' ' LEU . 45.7 t -93.08 102.81 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 27.7 t70 77.7 -0.65 2.73 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 125.296 1.439 . . . . 15.0 111.047 -170.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.45 37.35 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 121.868 -0.52 . . . . 15.0 113.092 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.2 pt-20 -105.77 137.41 43.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.267 0.627 . . . . 15.0 109.353 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.18 95.16 5.54 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.659 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.474 ' CD1' HG23 ' A' ' 172' ' ' VAL . 39.7 p90 -59.48 158.77 9.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.659 -1.155 . . . . 15.0 110.655 174.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -54.14 135.45 43.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 15.0 111.195 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.633 ' HA3' HG23 ' B' ' 386' ' ' VAL . . . 78.99 -70.49 2.75 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 123.985 0.803 . . . . 15.0 111.675 -170.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.61 -69.77 2.78 Favored Glycine 0 C--N 1.348 1.201 0 C-N-CA 123.212 0.434 . . . . 15.0 112.605 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.653 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 6.5 tmtt? -86.29 137.37 32.66 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.252 1.021 . . . . 15.0 110.185 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.523 ' HB3' HG13 ' B' ' 386' ' ' VAL . . . -127.89 155.52 44.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.887 0.875 . . . . 15.0 108.816 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 m -139.35 128.51 23.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 15.0 110.663 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 63.09 37.81 11.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.603 1.161 . . . . 15.0 112.255 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 44.6 t80 -71.22 136.06 47.84 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.39 -0.823 . . . . 15.0 108.915 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.5 t -107.16 119.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.008 0.923 . . . . 15.0 109.573 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 24.6 tp -112.66 93.64 4.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.986 0.914 . . . . 15.0 110.867 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.19 105.01 3.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 189' ' ' MET . 1.3 mmt -77.25 165.07 24.98 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 114.872 -1.058 . . . . 15.0 111.063 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.42 11.69 56.87 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.056 -0.974 . . . . 15.0 112.029 -170.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.14 143.84 22.73 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 125.125 1.37 . . . . 15.0 107.767 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -79.15 82.84 1.33 Allowed Glycine 0 C--N 1.344 0.978 0 O-C-N 123.148 0.28 . . . . 15.0 112.692 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.03 -19.95 26.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.966 0.506 . . . . 15.0 111.374 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.86 156.91 43.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.606 0.362 . . . . 15.0 110.69 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.04 140.85 98.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.761 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.89 105.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.217 2.612 . . . . 15.0 112.665 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.55 -49.44 0.66 Allowed Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.153 -0.931 . . . . 15.0 111.102 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -69.04 -64.65 0.83 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.488 0.315 . . . . 15.0 110.291 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 203' ' ' LYS . 8.4 pt-20 -62.58 -27.6 69.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.108 0.88 . . . . 15.0 112.429 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.23 -30.58 67.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.957 0.903 . . . . 15.0 110.527 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.43 -5.66 85.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.167 -0.924 . . . . 15.0 112.98 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.4 HG21 HD22 ' A' ' 187' ' ' LEU . 33.6 mm -103.74 -47.97 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 123.429 0.692 . . . . 15.0 110.47 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 199' ' ' GLU . 22.6 pttm -85.4 16.5 3.7 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.782 1.03 . . . . 15.0 113.782 -169.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -127.91 32.28 3.5 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.744 -0.942 . . . . 15.0 110.744 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -146.52 -167.83 2.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 15.0 110.473 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -151.86 161.67 42.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.598 0.759 . . . . 15.0 110.01 177.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.96 139.09 52.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.139 0.576 . . . . 15.0 111.892 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.54 8.63 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.501 -0.772 . . . . 15.0 112.429 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.8 pt-20 -92.45 137.63 32.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.496 0.719 . . . . 15.0 109.485 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.18 112.11 18.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.929 -1.137 . . . . 15.0 107.929 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -131.89 -178.31 4.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.788 1.235 . . . . 15.0 109.878 -171.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 43.3 m -131.11 120.35 23.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.775 0.83 . . . . 15.0 108.98 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.04 156.35 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.274 0.63 . . . . 15.0 110.514 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -116.18 105.28 12.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.095 0.958 . . . . 15.0 108.996 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.1 167.1 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 91.3 m -141.09 133.61 28.47 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.355 -0.98 . . . . 15.0 108.355 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.449 ' HZ ' HD13 ' B' ' 387' ' ' ILE . 49.0 m-85 -76.42 138.64 67.46 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 123.432 0.457 . . . . 15.0 111.837 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.8 158.35 11.03 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.695 2.93 . . . . 15.0 113.61 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.35 -31.01 63.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.67 -23.97 67.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.346 1.058 . . . . 15.0 111.657 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.5 ' O ' ' HB2' ' A' ' 227' ' ' LYS . 1.9 t80 -74.35 74.69 1.87 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.076 0.95 . . . . 15.0 109.052 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -67.8 4.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.049 1.5 . . . . 15.0 115.049 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.21 93.1 0.8 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.183 -1.414 . . . . 15.0 107.183 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.1 tt0 -64.08 -29.0 70.17 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.761 0.652 . . . . 15.0 112.761 -166.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -61.2 -22.57 64.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.835 0.854 . . . . 15.0 110.961 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.629 ' HA ' HG13 ' A' ' 172' ' ' VAL . 76.4 mt -102.55 -43.37 5.65 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.72 1.208 . . . . 15.0 110.82 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 221' ' ' TYR . 0.7 OUTLIER -54.82 130.62 41.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.889 1.675 . . . . 15.0 112.759 -165.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.48 -18.91 7.69 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.832 0.708 . . . . 15.0 114.398 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 93.0 mttt -89.85 143.25 26.96 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.874 0.87 . . . . 15.0 110.562 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.0 106.88 11.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.552 0.741 . . . . 15.0 110.174 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.81 115.97 27.54 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.896 -1.047 . . . . 15.0 110.759 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -106.13 107.64 18.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.411 -0.588 . . . . 15.0 109.411 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -104.9 119.71 39.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.038 0.935 . . . . 15.0 109.121 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.51 93.74 4.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.326 0.65 . . . . 15.0 109.405 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.96 125.89 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 15.0 110.421 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -109.34 98.52 7.91 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.336 -1.357 . . . . 15.0 107.336 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.5 ' HA ' HG23 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.59 99.52 6.57 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 -175.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -93.43 -40.92 10.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.229 -0.442 . . . . 15.0 110.985 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.677 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 35.3 mmtp -131.89 139.36 48.75 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.051 0.54 . . . . 15.0 110.687 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 207' ' ' ALA . 86.0 t -104.03 141.93 18.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.112 -1.811 . . . . 15.0 106.112 159.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.749 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.2 mt-10 -133.1 -176.26 4.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.685 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 41.4 tt0 -154.36 130.64 10.43 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.551 0.741 . . . . 15.0 109.358 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.402 ' NH1' ' HB3' ' A' ' 146' ' ' LYS . 23.4 ptt180 -86.24 86.03 7.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.19 0.995 . . . . 15.0 108.356 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.89 141.78 58.13 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.116 -1.402 . . . . 15.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.61 132.76 94.61 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.1 -0.704 . . . . 15.0 109.1 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 59.9 Cg_endo -67.83 176.52 5.12 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.468 2.112 . . . . 15.0 112.002 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.97 88.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.19 69.92 4.47 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.934 0.873 . . . . 15.0 109.006 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.9 p -101.83 163.89 12.02 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.591 1.156 . . . . 15.0 109.282 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.11 -41.27 48.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.98 0.912 . . . . 15.0 111.195 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.2 -39.46 86.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.179 1.392 . . . . 15.0 111.312 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.14 -59.9 2.59 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.897 . . . . 15.0 109.146 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 258' ' ' VAL . 9.5 tt -57.78 -42.0 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.954 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -67.71 -26.68 66.29 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.687 0.254 . . . . 15.0 111.687 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -72.79 -19.06 61.42 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.622 0.769 . . . . 15.0 110.949 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -87.63 -6.58 58.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.452 0.701 . . . . 15.0 111.322 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.5 5.1 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 119.428 -0.651 . . . . 15.0 114.721 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.514 HG11 ' H ' ' A' ' 261' ' ' GLY . 44.2 t -62.72 111.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 117.483 0.642 . . . . 15.0 110.902 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -58.78 -48.57 80.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.599 1.16 . . . . 15.0 112.001 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.634 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 5.3 t70 -76.69 -43.49 37.46 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.458 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.514 ' H ' HG11 ' A' ' 258' ' ' VAL . . . 82.96 18.97 64.02 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 115.866 -0.606 . . . . 15.0 114.337 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -148.78 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.902 0.881 . . . . 15.0 109.602 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 95.7 t -50.4 -52.97 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 124.364 1.066 . . . . 15.0 113.457 -165.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -31.04 68.53 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.979 0.512 . . . . 15.0 111.549 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' A' ' 260' ' ' ASP . . . -80.28 -24.08 59.84 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.145 -0.382 . . . . 15.0 112.145 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 270' ' ' VAL . 38.5 tp -77.67 -28.16 51.06 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.503 ' HA ' HG21 ' A' ' 270' ' ' VAL . 77.3 mtp180 -72.45 -37.6 68.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.956 0.902 . . . . 15.0 109.666 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.65 88.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.751 -0.659 . . . . 15.0 110.411 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.37 -48.7 55.11 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.328 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 267' ' ' ARG . 19.2 m -67.4 -25.58 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-O 120.64 0.257 . . . . 15.0 110.634 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -60.01 -66.1 0.57 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.76 0.424 . . . . 15.0 110.48 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.28 -7.84 53.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.233 0.613 . . . . 15.0 112.61 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -101.22 -68.91 0.8 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.424 0.69 . . . . 15.0 109.965 170.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.661 ' HE1' ' SD ' ' A' ' 140' ' ' MET . 1.6 mpt? -66.84 -43.79 82.77 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 117.698 -1.144 . . . . 15.0 111.694 -170.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.12 -49.63 71.44 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.441 1.473 . . . . 15.0 109.95 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -51.81 -49.16 63.32 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 113.509 -1.678 . . . . 15.0 111.989 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -84.35 -37.77 21.15 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.558 0.536 . . . . 15.0 111.348 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.535 ' HA ' ' HE1' ' A' ' 428' ' ' MET . 61.6 tp -67.16 -56.92 7.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.737 0.415 . . . . 15.0 111.894 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.78 -31.65 72.97 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.481 0.488 . . . . 15.0 110.194 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.9 t -64.86 -45.57 85.51 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.954 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.43 65.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 15.0 112.26 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.51 HD12 ' HB ' ' A' ' 130' ' ' VAL . 98.6 mt -66.28 -51.43 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.788 HH21 ' HB3' ' A' ' 405' ' ' GLU . 28.8 tpt180 -62.14 -37.5 85.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.65 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.67 -23.77 45.5 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.388 0.675 . . . . 15.0 111.05 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.635 ' HD2' ' HG3' ' A' ' 128' ' ' PRO . 25.1 ttm180 -70.33 -49.31 50.71 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.577 0.626 . . . . 15.0 109.452 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 98.6 t -57.56 -48.25 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.761 0.791 . . . . 15.0 110.008 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.419 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -64.21 -46.44 83.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.58 -1.191 . . . . 15.0 111.463 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -65.89 -39.21 90.44 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 119.256 -0.402 . . . . 15.0 110.935 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.542 ' HB2' HG11 ' A' ' 125' ' ' VAL . 56.8 mt-30 -69.95 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.553 0.533 . . . . 15.0 111.172 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.21 -50.84 66.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.625 0.37 . . . . 15.0 110.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.9 mm -67.76 -41.17 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.796 0.839 . . . . 15.0 111.01 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -64.43 -36.19 83.35 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.732 0.813 . . . . 15.0 109.474 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.443 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -65.54 -43.87 93.86 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.926 -1.034 . . . . 15.0 112.005 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.59 -45.49 81.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.108 0.963 . . . . 15.0 110.841 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.37 -58.67 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.051 0.94 . . . . 15.0 110.26 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.86 -23.47 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.641 0.776 . . . . 15.0 112.348 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -79.52 -33.65 41.86 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.547 0.739 . . . . 15.0 111.508 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.52 138.22 7.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 112.719 0.637 . . . . 15.0 112.719 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.08 144.48 29.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.167 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.46 HG12 HD23 ' A' ' 349' ' ' LEU . 6.5 tp -138.89 123.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . 7.6 m-20 -79.0 137.43 37.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.24 130.98 21.44 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.192 0.597 . . . . 15.0 109.449 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.88 130.03 32.74 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.029 2.486 . . . . 15.0 112.501 168.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.58 -9.67 20.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.759 1.022 . . . . 15.0 113.759 -173.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.22 91.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.244 0.618 . . . . 15.0 110.925 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.447 HD11 HD12 ' B' ' 468' ' ' LEU . 90.4 mt -72.31 -38.66 68.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 15.0 111.122 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.61 -52.13 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -38.57 89.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.832 0.853 . . . . 15.0 111.453 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.9 t -59.07 -50.57 73.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 15.0 111.226 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.91 -26.33 43.78 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.381 -0.372 . . . . 15.0 111.42 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 62.9 mt -62.29 -35.52 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 166.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.534 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.0 t70 -70.88 -39.36 72.89 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.97 0.508 . . . . 15.0 111.01 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.08 -48.07 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 123.792 0.683 . . . . 15.0 109.27 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 341' ' ' ALA . 83.2 mt -73.68 -21.3 60.3 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.117 -0.947 . . . . 15.0 113.237 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 72.1 mtm180 -75.23 -39.78 59.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.055 0.542 . . . . 15.0 109.806 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -70.38 -41.17 73.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.079 0.552 . . . . 15.0 110.499 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -69.31 -31.09 69.33 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.89 -51.45 55.26 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.161 -0.681 . . . . 15.0 109.161 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -56.12 -30.65 62.4 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.41 1.069 . . . . 15.0 112.27 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -60.37 -38.75 84.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.791 0.836 . . . . 15.0 111.502 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -95.44 -15.41 23.0 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.797 0.439 . . . . 15.0 111.525 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.505 ' HE2' ' HG2' ' A' ' 326' ' ' GLU . 42.1 t80 -80.17 -12.75 59.62 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.764 0.826 . . . . 15.0 109.489 173.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.1 33.45 8.17 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.385 -0.825 . . . . 15.0 114.431 166.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 327' ' ' LYS . . . 66.15 3.47 17.97 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 120.134 -0.259 . . . . 15.0 113.44 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -69.23 148.76 49.36 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 109.004 -0.739 . . . . 15.0 109.004 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 322' ' ' PHE . 21.8 mm-40 75.48 -67.24 0.25 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.429 1.492 . . . . 15.0 110.566 -170.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 324' ' ' GLY . 27.3 mtmm 62.47 18.87 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.414 1.086 . . . . 15.0 110.639 -164.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -100.83 15.1 29.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.508 1.923 . . . . 15.0 108.954 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.594 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -52.73 -22.9 5.76 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 126.211 1.804 . . . . 15.0 114.271 -172.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.56 -26.62 55.62 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.275 0.63 . . . . 15.0 111.358 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -113.68 21.96 14.52 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.065 0.946 . . . . 15.0 111.055 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 24.2 mt -64.65 128.79 93.88 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.611 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 87.9 Cg_exo -47.7 118.29 2.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.664 2.909 . . . . 15.0 114.328 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -56.02 -36.55 68.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.091 0.957 . . . . 15.0 111.235 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.31 -12.05 47.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.468 0.914 . . . . 15.0 113.468 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 96.9 mt -71.76 -40.15 69.52 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.368 -0.604 . . . . 15.0 109.368 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -107.01 -10.77 15.83 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.271 -168.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -48.66 -57.75 5.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.147 1.379 . . . . 15.0 113.021 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.1 -59.21 4.95 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 111.397 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.01 -36.55 69.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.617 -0.72 . . . . 15.0 112.416 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.468 ' HB3' HD13 ' A' ' 314' ' ' LEU . . . -70.7 -50.79 32.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.547 . . . . 15.0 110.04 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -60.11 -34.94 74.19 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.03 0.832 . . . . 15.0 110.328 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 347' ' ' VAL . 9.6 mmt85 -62.89 -38.1 89.56 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.003 -0.522 . . . . 15.0 111.26 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.73 -28.8 66.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 123.286 0.366 . . . . 15.0 110.853 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.633 ' HA ' ' HB2' ' B' ' 466' ' ' ALA . 24.9 t -75.48 -36.01 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.98 -0.378 . . . . 15.0 109.98 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.8 -35.03 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.561 0.744 . . . . 15.0 109.863 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.52 HG11 HD12 ' A' ' 351' ' ' LEU . 55.4 t -60.47 -54.64 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.809 -0.811 . . . . 15.0 108.809 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.56 ' HA2' ' HE2' ' B' ' 464' ' ' MET . . . -61.2 -39.66 97.48 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.388 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.46 HD23 HG12 ' A' ' 300' ' ' ILE . 6.5 tt -78.15 -55.32 5.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.046 0.538 . . . . 15.0 110.234 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.412 ' O ' HG23 ' A' ' 354' ' ' VAL . 72.3 mt -67.1 -49.27 65.53 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.039 0.212 . . . . 15.0 110.694 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 347' ' ' VAL . 64.9 mt -69.2 -28.26 66.22 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 119.334 -0.365 . . . . 15.0 111.055 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.559 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -62.2 -42.36 99.72 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.923 -0.471 . . . . 15.0 111.923 172.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.21 -39.14 93.35 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.238 -0.481 . . . . 15.0 110.58 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -59.57 -37.04 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 122.888 0.475 . . . . 15.0 111.041 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.559 HD13 ' HA2' ' A' ' 352' ' ' GLY . 75.9 mt -65.2 -46.85 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.744 0.818 . . . . 15.0 110.543 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.95 -53.25 41.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.525 0.203 . . . . 15.0 110.908 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.0 m -60.27 -40.72 91.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.588 1.155 . . . . 15.0 112.053 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.39 17.98 18.86 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.174 0.589 . . . . 15.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 46.33 30.02 0.96 Allowed 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 125.703 1.601 . . . . 15.0 114.626 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.557 ' HB3' HE21 ' A' ' 406' ' ' GLN . 83.1 mt -65.72 148.28 52.02 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.072 0.949 . . . . 15.0 112.811 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -129.31 158.09 40.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.522 1.129 . . . . 15.0 108.83 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.67 90.33 2.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 367' ' ' VAL . 5.2 t70 -67.73 120.93 14.88 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.11 0.964 . . . . 15.0 110.758 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.26 -23.67 67.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.826 0.85 . . . . 15.0 113.0 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.61 -34.11 73.62 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 30.9 tpt85 -77.82 -36.81 49.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.725 0.81 . . . . 15.0 109.951 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 399' ' ' ARG . 41.3 t -63.99 -55.01 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.617 0.767 . . . . 15.0 109.746 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -36.18 81.59 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.813 -1.085 . . . . 15.0 109.778 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.95 96.75 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.787 0.679 . . . . 15.0 112.711 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 367' ' ' VAL . 69.3 mt -57.44 -48.15 79.9 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.636 0.774 . . . . 15.0 111.07 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.628 HG21 ' HA ' ' A' ' 385' ' ' ILE . 17.8 mm -56.35 -44.69 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 124.183 0.927 . . . . 15.0 110.81 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -61.57 -54.46 42.77 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 15.0 110.782 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -61.6 -37.7 84.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.499 0.72 . . . . 15.0 112.769 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.486 ' SD ' HD12 ' B' ' 441' ' ' ILE . 18.2 tmm? -74.76 -45.76 41.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.423 0.689 . . . . 15.0 109.931 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.476 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -73.28 -16.83 61.38 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.184 0.594 . . . . 15.0 111.959 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -73.1 -0.18 13.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.991 0.917 . . . . 15.0 111.692 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -98.54 -10.11 23.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.583 0.753 . . . . 15.0 111.268 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.476 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 79.1 m-85 -111.31 157.56 20.03 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.108 0.963 . . . . 15.0 109.604 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.0 -45.06 71.51 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.211 0.604 . . . . 15.0 110.834 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.88 100.71 17.5 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 124.596 1.158 . . . . 15.0 110.26 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.9 -41.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.605 2.204 . . . . 15.0 115.794 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -68.92 -28.97 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -163.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.32 -28.69 67.38 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.344 0.403 . . . . 15.0 110.095 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.74 -38.81 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.556 0.742 . . . . 15.0 109.261 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.628 ' HA ' HG21 ' A' ' 371' ' ' ILE . 1.8 mp -55.55 -48.56 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.493 -0.558 . . . . 15.0 109.493 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.74 -34.01 76.0 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.591 0.756 . . . . 15.0 111.668 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -64.35 -40.04 95.08 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.794 0.838 . . . . 15.0 110.961 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.421 ' HB3' ' HE2' ' A' ' 395' ' ' MET . 29.9 m-85 -79.0 -50.51 10.98 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.916 0.135 . . . . 15.0 111.014 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . 0.576 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -169.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.02 0.07 54.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.184 0.594 . . . . 15.0 112.052 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -113.52 118.84 35.58 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -63.84 -61.47 2.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.434 0.693 . . . . 15.0 112.164 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.526 ' HA ' HD21 ' B' ' 450' ' ' ASN . 5.0 mp0 -59.98 -30.66 69.26 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.426 0.69 . . . . 15.0 112.173 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.16 -38.9 20.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.984 0.513 . . . . 15.0 111.441 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -62.13 -48.26 80.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 175.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.564 ' HA ' ' HD2' ' A' ' 399' ' ' ARG . 13.2 t70 -62.95 -39.7 95.44 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.575 1.172 . . . . 15.0 110.826 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.427 ' O ' HG22 ' A' ' 401' ' ' VAL . 9.5 t30 -59.8 -40.64 89.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.245 0.545 . . . . 15.0 110.391 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 -16.75 56.96 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.301 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 396' ' ' ASP . 97.9 mtt180 -71.81 -36.25 70.19 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 15.0 109.429 167.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -64.2 -42.27 96.7 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.525 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 397' ' ' ASN . 24.9 t -62.48 -42.36 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 123.851 0.719 . . . . 15.0 110.867 175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.51 85.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.491 0.716 . . . . 15.0 111.188 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.33 -35.17 71.12 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.465 -1.243 . . . . 15.0 111.001 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.04 -54.49 45.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.292 1.037 . . . . 15.0 110.327 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.788 ' HB3' HH21 ' A' ' 283' ' ' ARG . 47.8 mt-10 -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.384 -0.826 . . . . 15.0 111.92 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.557 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.5 tt0 -67.47 -37.58 83.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.21 0.604 . . . . 15.0 109.857 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.6 78.58 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.474 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.22 -56.13 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.86 -25.52 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.429 1.092 . . . . 15.0 112.409 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.13 66.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.038 0.535 . . . . 15.0 111.233 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.49 -34.81 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.911 -0.774 . . . . 15.0 108.911 172.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.532 ' HA ' ' HB1' ' A' ' 415' ' ' ALA . 80.9 mt -70.06 -31.08 68.52 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.458 0.703 . . . . 15.0 111.502 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.7 0.8 . . . . 15.0 110.812 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -86.41 -34.17 20.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.739 0.816 . . . . 15.0 109.881 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 412' ' ' LEU . . . -86.34 -171.81 3.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.73 1.212 . . . . 15.0 112.126 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.623 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 79.0 mttt -114.9 117.47 30.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.911 -1.041 . . . . 15.0 108.696 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.53 101.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 109.19 -0.67 . . . . 15.0 109.19 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 t -71.32 89.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.132 0.968 . . . . 15.0 109.466 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.52 110.02 8.48 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.286 -1.325 . . . . 15.0 109.566 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -133.99 137.88 45.06 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 15.0 110.157 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.05 131.41 39.47 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.384 0.674 . . . . 15.0 109.233 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.2 t -158.76 170.66 21.64 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.214 0.605 . . . . 15.0 110.372 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.6 p -90.68 176.98 6.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.471 0.709 . . . . 15.0 112.313 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -63.7 -23.91 67.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.777 1.231 . . . . 15.0 110.935 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -66.93 -17.78 65.07 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.64 1.176 . . . . 15.0 112.301 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.501 ' HB3' HD13 ' A' ' 427' ' ' LEU . 13.2 tp10 -63.83 -36.15 82.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.029 0.932 . . . . 15.0 111.38 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.61 HD11 HG21 ' A' ' 130' ' ' VAL . 3.1 mp -104.16 -69.58 0.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.87 0.468 . . . . 15.0 111.476 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.535 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.6 mpt? -92.54 -50.19 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.054 0.39 . . . . 15.0 112.054 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -88.71 49.69 1.83 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.842 0.829 . . . . 15.0 110.997 -165.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -71.35 168.28 17.73 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.61 1.164 . . . . 15.0 111.405 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -79.57 -13.43 59.53 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.653 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 C-N-CA 124.742 1.217 . . . . 15.0 108.681 175.692 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -118.26 -168.8 1.59 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.93 0.892 . . . . 0.0 109.585 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.16 -73.4 0.59 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.053 0.541 . . . . 0.0 110.086 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -103.95 -82.87 0.5 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 120.964 0.411 . . . . 0.0 111.75 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -109.33 -69.67 0.85 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.888 0.875 . . . . 0.0 112.522 -168.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.53 -79.59 0.42 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.458 HG11 ' H ' ' B' ' 372' ' ' GLN . 1.2 p -113.02 -82.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.458 ' H ' HG11 ' B' ' 371' ' ' VAL . 6.6 tp60 -100.17 -82.51 0.45 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -105.25 -82.88 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.861 0.464 . . . . 0.0 109.756 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -101.37 -71.93 0.7 Allowed 'General case' 0 C--N 1.351 0.632 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 6.6 tt -107.27 -75.92 0.62 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' B' ' 377' ' ' PHE . 0.0 OUTLIER -103.64 -89.27 0.4 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.15 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.402 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 89.0 t80 -102.37 -62.88 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.377 1.071 . . . . 0.0 109.851 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.13 -83.57 0.48 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.54 ' HG2' ' H ' ' B' ' 380' ' ' LYS . 0.0 OUTLIER -110.76 -66.81 1.04 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.916 0.487 . . . . 0.0 111.327 -172.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.54 ' H ' ' HG2' ' B' ' 379' ' ' LYS . 2.0 ptpp? -160.11 132.23 6.26 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.676 1.19 . . . . 0.0 109.127 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . 0.48 ' HB2' ' ND2' ' B' ' 383' ' ' ASN . 36.1 mt-10 67.88 156.43 0.12 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.817 1.247 . . . . 0.0 113.515 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -75.51 69.48 2.03 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.821 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' B' ' 381' ' ' GLU . 44.2 m-80 -86.14 -157.58 0.35 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.797 0.839 . . . . 0.0 111.041 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 11.4 m 72.1 60.27 0.14 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.75 1.22 . . . . 0.0 109.169 -172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.38 131.32 45.48 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.005 169.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.633 HG23 ' HA3' ' A' ' 179' ' ' GLY . 7.5 p -77.88 91.74 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.69 1.233 . . . . 0.0 110.995 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.449 HD13 ' HZ ' ' A' ' 217' ' ' PHE . 8.3 mm -150.98 141.71 16.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 127.805 2.442 . . . . 0.0 104.484 162.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.26 93.99 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 119.099 0.863 . . . . 0.0 110.266 -164.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 42.0 m -177.91 95.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.415 2.686 . . . . 0.0 105.399 166.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -91.24 84.38 5.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.784 0.72 . . . . 0.0 111.033 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 25.5 t70 169.22 110.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 126.447 1.899 . . . . 0.0 108.404 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -154.01 82.36 1.14 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.42 0.688 . . . . 0.0 110.264 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.1 116.72 1.0 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.742 0.817 . . . . 0.0 110.04 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -115.31 -82.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.616 0.767 . . . . 0.0 109.407 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 178.38 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.556 1.143 . . . . 0.0 109.049 -173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 25.6 m -141.53 116.7 10.01 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -126.32 166.08 17.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.539 1.136 . . . . 0.0 108.736 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 21.4 mt 62.63 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.167 0.984 . . . . 0.0 110.694 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.28 -30.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.395 0.678 . . . . 0.0 110.284 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -137.72 137.44 21.74 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 166.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.35 158.87 38.19 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.881 2.387 . . . . 0.0 113.191 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.38 150.69 45.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.165 0.986 . . . . 0.0 110.566 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 2.8 m -130.82 17.26 5.2 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.399 0.679 . . . . 0.0 110.99 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.613 ' HD3' ' HA3' ' B' ' 407' ' ' GLY . 64.1 tttp -155.05 -59.85 0.11 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.865 -0.522 . . . . 0.0 111.675 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . 0.31 . . 100.69 -66.4 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.206 0 C-N-CA 127.965 2.506 . . . . 0.0 113.489 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.99 38.93 0.69 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 CA-C-N 122.646 1.981 . . . . 0.0 111.989 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . 0.613 ' HA3' ' HD3' ' B' ' 404' ' ' LYS . . . -118.21 32.45 5.26 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.883 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.91 112.34 11.04 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.6 m -65.14 86.83 0.06 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.909 0.884 . . . . 0.0 110.065 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 64.0 -174.32 0.16 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.942 -176.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -145.78 -40.75 0.22 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.443 0.697 . . . . 0.0 110.16 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 54.8 tp 70.93 -75.35 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.203 1.401 . . . . 0.0 111.2 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -163.06 -167.57 1.52 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.153 0.981 . . . . 0.0 109.922 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 59.7 m -133.31 102.89 5.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -157.36 137.95 13.05 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.06 -37.64 84.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.444 0.698 . . . . 0.0 111.285 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -87.48 -11.55 68.67 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.212 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 66.27 -70.45 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.449 1.5 . . . . 0.0 111.737 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.8 98.94 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.237 1.015 . . . . 0.0 108.728 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.429 ' HG3' HG13 ' B' ' 421' ' ' VAL . 50.7 tpp 65.25 -85.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' B' ' 420' ' ' MET . 10.4 p -168.75 140.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.12 0.968 . . . . 0.0 108.914 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 13.3 tpt -159.43 75.99 0.67 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 35.0 t -88.22 -51.27 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.844 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.07 155.12 46.2 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.533 1.133 . . . . 0.0 109.635 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -164.27 58.49 0.27 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -93.52 167.01 11.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.577 0.751 . . . . 0.0 110.652 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 63.3 m -73.87 108.62 6.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 110.323 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.42 -59.25 2.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.249 0.619 . . . . 0.0 111.034 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.695 ' HG2' ' H ' ' B' ' 430' ' ' ASP . 0.7 OUTLIER -107.43 -79.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.913 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . 0.695 ' H ' ' HG2' ' B' ' 429' ' ' GLU . 21.0 t70 -88.1 -82.37 0.23 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 170.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 9.6 t -112.08 -82.41 0.59 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 154.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -114.82 -40.29 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.704 0.802 . . . . 0.0 109.211 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.88 -35.36 0.22 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.177 0.991 . . . . 0.0 109.589 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -141.92 162.62 35.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 24.6 p -54.79 -44.2 73.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.538 0.735 . . . . 0.0 112.082 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 148.49 -136.43 5.9 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 19.5 m -84.45 22.06 1.34 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.737 0.815 . . . . 0.0 111.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? 82.36 -53.97 0.22 Allowed 'General case' 0 C--N 1.367 1.334 0 C-N-CA 126.504 1.922 . . . . 0.0 111.257 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.44 135.19 55.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.892 0.477 . . . . 0.0 111.339 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -60.0 -63.03 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.574 1.15 . . . . 0.0 111.881 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.486 HD12 ' SD ' ' A' ' 374' ' ' MET . 0.0 OUTLIER -145.42 137.08 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -172.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . 0.416 ' HA ' ' HH ' ' A' ' 388' ' ' TYR . . . -169.34 177.77 4.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.539 1.136 . . . . 0.0 110.702 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -92.26 -66.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.045 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -110.83 -177.56 3.25 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.646 0.778 . . . . 0.0 110.993 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.31 128.43 3.68 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.59 -1.116 . . . . 0.0 110.475 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.8 123.59 13.29 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.009 2.472 . . . . 0.0 112.246 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -74.3 -15.91 60.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.219 0.608 . . . . 0.0 111.319 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.24 51.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 0.0 108.983 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -65.42 125.27 24.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . 0.526 HD21 ' HA ' ' A' ' 393' ' ' GLU . 74.5 m-20 -72.36 -44.1 63.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.322 0.649 . . . . 0.0 110.578 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 75.9 t 66.22 -71.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 124.735 1.214 . . . . 0.0 111.981 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.48 126.5 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -70.75 76.63 0.53 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 48.9 tp -70.36 92.5 0.8 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.661 1.184 . . . . 0.0 110.111 -170.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.0 m -84.82 84.97 7.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.784 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.96 -74.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 54.67 22.8 4.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.614 1.566 . . . . 0.0 113.058 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.8 m 70.08 -65.2 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.683 1.593 . . . . 0.0 110.366 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.05 156.55 46.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.767 1.227 . . . . 0.0 108.124 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 3.5 tt 66.53 99.38 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -170.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -45.89 -53.1 10.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.564 1.146 . . . . 0.0 113.142 -169.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -131.87 115.07 15.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 88.3 m -68.83 104.99 2.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 124.163 0.914 . . . . 0.0 109.759 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.56 ' HE2' ' HA2' ' A' ' 348' ' ' GLY . 26.4 ptt? -83.08 177.44 8.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.813 0.445 . . . . 0.0 110.062 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.69 150.08 37.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.127 0.571 . . . . 0.0 109.507 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' A' ' 345' ' ' VAL . . . 68.02 8.01 6.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.05 1.34 . . . . 0.0 112.565 -171.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -122.78 168.51 12.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.969 0.908 . . . . 0.0 110.667 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.447 HD12 HD11 ' A' ' 306' ' ' LEU . 2.6 mm? -111.34 163.41 14.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.687 0.795 . . . . 0.0 110.974 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.24 -134.93 4.39 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.262 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 41.5 tp 52.38 -98.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.217 1.007 . . . . 0.0 109.49 -170.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.687 1.195 . . . . 12.06 108.079 176.067 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.665 0.269 . . . . 15.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.598 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -158.31 149.61 21.01 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.753 1.221 . . . . 15.0 109.054 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 17' ' ' ILE . 13.5 m -133.68 77.96 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.838 0.855 . . . . 15.0 110.537 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -78.95 91.01 4.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 15.0 110.497 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 2.6 p -80.51 93.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 122.2 1.0 . . . . 15.0 111.433 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.94 98.2 7.79 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.501 1.12 . . . . 15.0 109.989 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -64.55 112.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.102 0.561 . . . . 15.0 109.962 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -76.32 -54.74 6.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -167.43 120.16 0.93 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 15.0 109.671 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.55 -101.6 0.47 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 124.157 0.91 . . . . 15.0 113.551 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 113' ' ' PRO . 1.8 mm? -90.54 -22.08 21.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.175 0.59 . . . . 15.0 110.884 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.46 122.8 30.31 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.359 1.037 . . . . 15.0 112.223 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.472 HH12 ' HA ' ' A' ' 11' ' ' LEU . 68.7 mtt85 -140.86 108.16 5.52 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.751 1.22 . . . . 15.0 109.892 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.441 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 31.0 ttm180 -83.94 82.95 8.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.564 1.146 . . . . 15.0 109.131 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 t -76.49 88.46 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 61.6 m -75.94 96.62 3.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.273 -0.876 . . . . 15.0 109.633 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.546 HG12 HG13 ' A' ' 3' ' ' VAL . 54.1 mt -84.21 106.07 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.555 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 35.9 m -83.72 100.6 10.99 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 70' ' ' LEU . 39.0 mt -77.01 130.85 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 140.54 58.88 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 123.92 0.763 . . . . 15.0 110.517 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.12 63.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.979 1.312 . . . . 15.0 112.208 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -38.65 78.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.114 -0.948 . . . . 15.0 111.285 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.4 m -68.62 -30.92 69.76 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.406 0.682 . . . . 15.0 111.158 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 103' ' ' PHE . 78.8 mt -65.25 -54.08 33.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 CA-C-N 115.496 -0.774 . . . . 15.0 109.087 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -59.22 -29.45 67.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.192 0.997 . . . . 15.0 111.841 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.7 m -74.8 -52.76 10.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.768 0.827 . . . . 15.0 110.317 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.06 85.04 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.395 0.678 . . . . 15.0 112.287 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.473 HG21 ' HD3' ' A' ' 63' ' ' ARG . 58.6 t -67.59 -45.36 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.09 0.556 . . . . 15.0 109.868 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -65.9 -31.45 72.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.178 0.591 . . . . 15.0 111.32 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -63.35 -44.51 94.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.437 0.695 . . . . 15.0 109.78 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 35' ' ' VAL . 14.4 tp10 -63.81 -42.36 97.71 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.434 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 55' ' ' ALA . 79.6 mt -66.77 -39.23 87.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.909 0.884 . . . . 15.0 112.891 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.44 -28.07 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -71.72 -34.16 69.35 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 118.994 -0.527 . . . . 15.0 111.074 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 31' ' ' GLU . 77.2 t -60.68 -35.46 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.259 0.624 . . . . 15.0 110.163 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.05 -49.08 78.14 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.449 -0.796 . . . . 15.0 110.721 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -69.56 -42.95 73.88 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.895 0.878 . . . . 15.0 110.779 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.81 -34.43 66.87 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.743 1.617 . . . . 15.0 111.286 -169.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.54 10.87 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-O 121.338 0.59 . . . . 15.0 109.794 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 59.26 23.37 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.821 1.248 . . . . 15.0 112.796 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 60.0 mt -72.99 -22.92 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.416 1.086 . . . . 15.0 109.862 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 8.2 p-10 -58.08 -29.56 65.52 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.556 1.142 . . . . 15.0 112.758 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.49 -41.37 94.28 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.588 -0.605 . . . . 15.0 111.588 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -79.13 -24.29 43.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.964 0.906 . . . . 15.0 110.169 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 28.3 tpt180 -79.97 90.13 5.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.232 1.013 . . . . 15.0 109.335 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -92.62 -7.44 46.98 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.832 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 49.44 3.29 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.6 0.563 . . . . 15.0 112.503 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -77.27 -58.56 3.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.197 0.599 . . . . 15.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.61 122.66 70.36 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.712 -0.847 . . . . 15.0 108.712 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.1 148.28 7.14 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.844 3.029 . . . . 15.0 114.488 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.41 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.7 tpp -64.52 -34.51 78.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.369 1.068 . . . . 15.0 112.118 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.35 -37.36 86.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.715 0.406 . . . . 15.0 111.1 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.25 -42.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.985 0.914 . . . . 15.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 19.5 m -71.61 -21.18 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 122.342 -0.224 . . . . 15.0 110.871 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -76.9 -46.65 23.66 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.187 0.595 . . . . 15.0 111.801 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.72 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.5 pt20 -81.63 -30.1 32.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.517 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.72 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 75.2 mtt180 -103.1 -60.78 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.062 0.545 . . . . 15.0 110.9 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 68.5 m-85 -76.95 -19.43 57.36 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 15.0 111.142 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.89 9.18 58.18 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.247 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.02 -30.07 69.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.542 0.737 . . . . 15.0 111.088 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.9 p -81.39 -33.19 32.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.76 0.824 . . . . 15.0 110.866 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.06 -16.26 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.068 0.947 . . . . 15.0 111.279 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.473 ' HD3' HG21 ' A' ' 28' ' ' VAL . 19.8 mmt180 -48.2 -42.33 29.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.277 1.031 . . . . 15.0 111.442 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -52.03 -54.23 32.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.975 1.31 . . . . 15.0 112.185 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.04 -24.61 58.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.86 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 28' ' ' VAL . 44.0 t -79.23 -23.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 122.546 0.338 . . . . 15.0 110.234 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.527 HD23 HD11 ' A' ' 70' ' ' LEU . 66.1 mt -57.69 -29.59 64.79 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.35 -0.357 . . . . 15.0 111.66 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.82 -38.66 95.65 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 117.844 0.293 . . . . 15.0 112.935 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.49 -36.44 63.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.771 0.828 . . . . 15.0 109.972 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.527 HD11 HD23 ' A' ' 67' ' ' LEU . 96.4 mt -73.24 -19.28 61.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.003 -0.999 . . . . 15.0 111.917 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 76.7 mtm -104.81 -66.35 0.97 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.762 0.425 . . . . 15.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.3 t -70.83 -35.56 72.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.48 0.712 . . . . 15.0 112.503 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' HG21 ' A' ' 76' ' ' ILE . 4.9 tmm_? -87.76 -43.67 11.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -58.99 -25.55 63.72 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.467 0.576 . . . . 15.0 111.606 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -54.81 -50.73 67.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.098 0.959 . . . . 15.0 111.73 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.443 HG21 ' O ' ' A' ' 73' ' ' ARG . 13.2 tt -69.32 -37.34 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 110.11 -0.33 . . . . 15.0 110.11 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 -23.38 67.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.321 0.649 . . . . 15.0 111.729 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -83.52 -42.19 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.873 0.869 . . . . 15.0 111.677 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.54 HD12 ' HD3' ' A' ' 86' ' ' PRO . 28.2 pt -85.28 -30.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.203 0.816 . . . . 15.0 113.203 -169.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.26 -50.17 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.4 0.68 . . . . 15.0 111.042 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.9 ptpt -60.79 -39.65 89.66 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.705 0.628 . . . . 15.0 111.486 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 24.5 mm-40 -87.85 5.63 39.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.384 0.673 . . . . 15.0 111.706 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.62 17.81 11.09 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.068 1.347 . . . . 15.0 112.281 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.63 112.87 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.192 0.997 . . . . 15.0 109.939 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -101.2 114.75 65.75 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.361 -0.977 . . . . 15.0 108.361 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.54 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.1 Cg_endo -74.11 153.07 46.31 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.838 2.359 . . . . 15.0 112.989 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.72 18.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.804 1.242 . . . . 15.0 108.318 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.503 ' H ' ' HB3' ' A' ' 305' ' ' ALA . . . 94.48 -151.71 20.28 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.731 -0.548 . . . . 15.0 111.731 -174.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.99 128.66 27.23 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.552 0.741 . . . . 15.0 110.678 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.0 Cg_endo -81.83 107.3 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.383 2.055 . . . . 15.0 111.626 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.5 m -76.96 96.09 4.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.607 0.763 . . . . 15.0 110.824 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -74.1 94.49 2.42 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.081 -0.711 . . . . 15.0 109.081 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.8 t -90.96 102.15 4.95 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.949 -0.76 . . . . 15.0 108.949 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.52 95.74 0.86 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.648 2.232 . . . . 15.0 109.995 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -46.45 93.49 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.172 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.49 146.14 4.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.557 0.743 . . . . 15.0 110.745 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -128.49 142.7 51.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.548 1.139 . . . . 15.0 108.41 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.721 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 95.0 mttt -129.83 158.61 38.97 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.235 1.014 . . . . 15.0 108.619 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.07 98.44 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.591 0.756 . . . . 15.0 110.235 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.51 19.02 74.22 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.599 -0.728 . . . . 15.0 114.39 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.1 mt-10 -110.67 158.86 18.14 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.467 0.707 . . . . 15.0 110.421 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.25 107.13 0.13 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.171 1.544 . . . . 15.0 112.896 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.452 ' HD2' HD13 ' A' ' 19' ' ' ILE . 13.3 t80 -80.42 96.28 6.67 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.488 -0.778 . . . . 15.0 109.539 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.0 m -95.14 105.54 17.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.106 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -129.92 143.75 50.97 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.341 0.657 . . . . 15.0 109.905 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.1 m -99.47 105.59 17.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.7 1.2 . . . . 15.0 111.672 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 t -86.01 99.93 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.927 0.491 . . . . 15.0 109.724 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.65 106.02 18.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.419 0.688 . . . . 15.0 110.26 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.692 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.7 p90 -142.06 174.21 10.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.962 0.905 . . . . 15.0 109.233 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -116.61 164.82 14.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.779 0.831 . . . . 15.0 109.934 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.66 -177.52 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.988 0.915 . . . . 15.0 109.152 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -72.83 143.79 84.83 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.029 0.532 . . . . 15.0 110.211 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HA ' HD12 ' A' ' 11' ' ' LEU . 23.9 Cg_endo -89.4 -167.95 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.426 2.751 . . . . 15.0 114.946 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -88.66 155.37 19.64 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.581 -1.19 . . . . 15.0 109.433 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 123.02 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.16 0.584 . . . . 15.0 110.096 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -119.94 119.36 33.23 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.66 146.77 28.9 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.79 -0.818 . . . . 15.0 108.79 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -88.67 -171.24 3.24 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.377 0.271 . . . . 15.0 110.495 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.9 102.43 0.28 Allowed Glycine 0 C--N 1.351 1.405 0 O-C-N 123.962 0.789 . . . . 15.0 111.726 173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.38 -23.91 67.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.963 0.905 . . . . 15.0 110.386 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.97 -24.52 66.06 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.86 1.264 . . . . 15.0 111.256 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.58 61.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.348 0.659 . . . . 15.0 110.929 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.6 mt -65.48 120.28 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.065 0.853 . . . . 15.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.29 102.89 13.32 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.606 0.762 . . . . 15.0 109.245 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.44 162.65 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.908 1.283 . . . . 15.0 107.802 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -113.69 148.69 35.92 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HE2' HD12 ' A' ' 129' ' ' ILE . 84.0 tttt -127.65 89.8 49.97 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.904 0.882 . . . . 15.0 108.753 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.36 102.66 1.63 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.218 1.945 . . . . 15.0 111.738 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.517 HD12 ' HE2' ' A' ' 127' ' ' LYS . 47.3 mm -73.02 106.35 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 169.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.584 HG21 HD11 ' A' ' 427' ' ' LEU . 15.3 t -132.24 147.27 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.779 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.47 157.37 46.32 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.777 1.231 . . . . 15.0 107.894 166.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.46 87.75 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 107.454 -1.313 . . . . 15.0 107.454 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 175.51 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.72 0.808 . . . . 15.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.93 -36.97 78.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.042 0.448 . . . . 15.0 110.863 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.51 91.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.831 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 71.7 m-20 -74.98 -42.61 57.22 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.451 0.701 . . . . 15.0 111.717 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.62 -57.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.29 -31.12 62.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.206 -0.907 . . . . 15.0 111.058 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.79 -36.38 57.93 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.518 0.511 . . . . 15.0 113.033 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -71.5 -45.1 63.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.935 0.494 . . . . 15.0 109.683 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.83 -36.12 67.13 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.477 0.711 . . . . 15.0 111.676 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.95 -45.17 86.85 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.325 1.05 . . . . 15.0 110.144 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.1 m -58.92 -46.85 86.95 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.254 0.971 . . . . 15.0 110.094 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.97 -40.21 94.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.975 0.91 . . . . 15.0 111.562 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -66.88 -36.8 83.13 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.533 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.569 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 83.4 mttt -83.63 -16.82 43.73 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -80.92 -40.62 24.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -96.6 25.34 5.21 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.656 0.783 . . . . 15.0 110.535 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -74.15 149.37 41.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.522 0.729 . . . . 15.0 112.336 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.5 m -70.32 120.41 15.94 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.064 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -79.43 105.71 10.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -118.69 160.25 22.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.308 1.043 . . . . 15.0 108.698 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 51.6 mt-10 -107.64 147.13 31.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.283 0.633 . . . . 15.0 110.215 173.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -145.22 -178.92 6.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.109 0.964 . . . . 15.0 111.001 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -155.01 161.68 41.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.525 1.13 . . . . 15.0 108.001 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 -50.81 0.82 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.225 -0.75 . . . . 15.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.04 134.8 13.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.929 0.491 . . . . 15.0 110.72 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.0 137.12 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.61 170.25 8.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.67 -0.863 . . . . 15.0 108.67 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.25 61.24 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.83 1.048 . . . . 15.0 113.83 -169.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.89 16.99 18.25 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.94 -176.02 4.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.946 0.879 . . . . 15.0 112.539 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 11.5 mtm180 -106.52 150.4 26.15 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.305 -1.316 . . . . 15.0 108.533 166.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.09 114.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.724 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 20.5 m -94.06 117.08 29.6 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.792 -1.188 . . . . 15.0 107.792 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.45 163.98 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.807 0.813 . . . . 15.0 111.495 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 15.7 t70 -106.58 155.14 19.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 105.703 -1.962 . . . . 15.0 105.703 159.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -154.41 169.31 24.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.348 0.594 . . . . 15.0 110.34 168.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 t -157.92 124.32 4.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.041 -1.436 . . . . 15.0 107.975 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -127.81 177.71 17.43 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 122.04 -0.412 . . . . 15.0 113.822 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.3 p -150.71 130.89 13.56 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.127 0.971 . . . . 15.0 109.715 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.53 HG13 HD22 ' A' ' 226' ' ' LEU . 47.0 t -94.7 117.72 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.5 t70 73.83 -5.36 2.04 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.768 1.227 . . . . 15.0 112.11 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.39 -0.13 23.61 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.731 -0.483 . . . . 15.0 112.471 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 15.0 pt-20 -113.04 139.46 48.66 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.63 0.715 . . . . 15.0 109.408 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.44 149.59 45.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.738 0.415 . . . . 15.0 110.728 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.507 ' HD2' HG22 ' A' ' 172' ' ' VAL . 4.5 p90 -106.84 -175.71 2.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.92 0.888 . . . . 15.0 111.794 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.531 ' HG3' HG12 ' B' ' 388' ' ' VAL . 55.7 mt-10 -53.73 116.32 2.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.1 0.96 . . . . 15.0 110.134 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 -63.67 4.38 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.037 0.836 . . . . 15.0 112.341 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.18 -62.22 4.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.471 -0.252 . . . . 15.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -88.2 150.35 23.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.086 0.954 . . . . 15.0 111.931 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 167' ' ' ASP . . . -145.37 94.02 2.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.775 -1.102 . . . . 15.0 109.576 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.6 m -78.91 121.2 24.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.935 0.494 . . . . 15.0 110.494 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.5 42.2 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.447 1.099 . . . . 15.0 112.248 171.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -71.03 129.17 38.3 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.47 -0.567 . . . . 15.0 109.47 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.72 105.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.057 0.943 . . . . 15.0 109.258 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 202' ' ' ILE . 30.8 tp -91.68 89.95 7.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.868 0.867 . . . . 15.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.3 87.18 5.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.582 -0.896 . . . . 15.0 108.582 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.574 ' HE2' ' HD3' ' A' ' 203' ' ' LYS . 58.6 mtp -62.19 139.17 58.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.119 0.967 . . . . 15.0 111.596 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.66 -26.86 5.6 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.81 0.694 . . . . 15.0 112.235 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -92.02 147.81 22.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.343 0.657 . . . . 15.0 110.206 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.75 65.28 3.94 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 123.021 0.343 . . . . 15.0 113.766 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -105.77 -36.0 7.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.027 0.931 . . . . 15.0 110.221 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.459 ' HE2' HD13 ' B' ' 385' ' ' LEU . 23.4 mmt -99.36 150.87 21.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.254 0.621 . . . . 15.0 111.266 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.1 pt -99.07 153.92 37.56 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 114.937 -1.029 . . . . 15.0 109.619 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.22 116.82 3.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.952 2.435 . . . . 15.0 112.281 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.9 -41.8 1.39 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.38 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.38 -59.75 2.61 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.945 0.498 . . . . 15.0 110.426 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.516 ' HB2' ' HE3' ' A' ' 189' ' ' MET . 9.8 pt-20 -64.81 -23.14 67.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.902 -1.044 . . . . 15.0 112.278 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.04 -36.43 83.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.186 0.994 . . . . 15.0 110.927 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.566 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -72.55 -17.22 77.79 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.248 -0.887 . . . . 15.0 113.097 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.451 HG21 HD22 ' A' ' 187' ' ' LEU . 31.7 mm -92.59 -48.32 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.56 0.744 . . . . 15.0 110.459 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.574 ' HD3' ' HE2' ' A' ' 189' ' ' MET . 58.4 pttt -85.1 19.94 2.05 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.144 1.165 . . . . 15.0 114.144 -166.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -137.33 24.15 3.1 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.865 -0.494 . . . . 15.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -144.07 -171.33 3.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.19 0.996 . . . . 15.0 110.232 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -151.19 156.79 41.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 15.0 110.101 -178.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.578 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.46 142.67 58.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.735 0.814 . . . . 15.0 111.521 -171.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.04 -32.96 4.39 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.455 -0.793 . . . . 15.0 111.516 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.3 pt-20 -93.2 138.12 31.89 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.563 0.697 . . . . 15.0 110.572 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -121.22 105.74 10.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.653 1.181 . . . . 15.0 108.28 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -121.7 177.45 5.25 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.52 1.128 . . . . 15.0 109.568 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 57.0 m -121.04 128.32 52.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.566 HG22 ' HA3' ' A' ' 201' ' ' GLY . 43.2 pt -101.78 160.91 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.557 0.743 . . . . 15.0 109.83 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -113.46 111.07 21.31 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.739 0.815 . . . . 15.0 109.396 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.22 160.86 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.478 -1.304 . . . . 15.0 107.478 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.1 m -143.48 132.89 23.39 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.8 -1.185 . . . . 15.0 107.8 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 90.1 m-85 -85.81 139.66 35.24 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -47.68 157.93 0.83 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.283 3.322 . . . . 15.0 116.016 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -23.84 63.64 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.88 167.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.96 -18.92 55.46 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.387 1.075 . . . . 15.0 111.16 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.62 141.26 56.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.02 0.528 . . . . 15.0 112.299 -170.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.616 ' HB2' ' H ' ' B' ' 392' ' ' HIS . 6.8 p-80 -78.03 17.83 0.56 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 125.163 1.385 . . . . 15.0 114.626 -168.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.47 119.47 15.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' B' ' 394' ' ' HIS . 42.0 tt0 -63.5 -40.66 97.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 123.928 0.768 . . . . 15.0 111.972 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -63.1 -19.61 64.58 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.142 0.577 . . . . 15.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.53 HD22 HG13 ' A' ' 172' ' ' VAL . 39.9 mt -99.42 -29.85 12.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.195 0.998 . . . . 15.0 111.691 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -57.83 105.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.77 1.228 . . . . 15.0 111.117 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.74 -19.49 28.91 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.57 -0.741 . . . . 15.0 113.408 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.94 145.48 31.24 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.64 0.776 . . . . 15.0 111.468 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -88.34 126.13 35.04 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.897 -1.047 . . . . 15.0 110.185 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.93 113.94 27.85 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.944 0.898 . . . . 15.0 109.238 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -103.78 101.69 11.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.723 0.809 . . . . 15.0 110.145 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -95.68 117.52 30.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.255 1.022 . . . . 15.0 109.998 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.55 96.76 4.84 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.16 116.39 26.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.036 0.934 . . . . 15.0 110.084 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 9.8 m120 -99.3 91.92 5.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.097 -1.075 . . . . 15.0 108.097 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 74.8 mt -68.47 109.25 3.61 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.099 -0.704 . . . . 15.0 109.099 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.84 -37.58 5.83 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.724 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 73.1 mmtt -133.99 122.58 23.24 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.844 0.858 . . . . 15.0 110.017 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 207' ' ' ALA . 89.0 t -95.58 132.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 105.55 -2.019 . . . . 15.0 105.55 161.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 37.6 mt-10 -120.01 179.35 4.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.96 117.5 5.73 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.871 0.868 . . . . 15.0 109.171 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -84.75 86.6 7.32 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.244 1.021 . . . . 15.0 108.348 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.04 146.7 28.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.682 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 75.1 mt -54.32 122.7 38.83 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 123.836 0.854 . . . . 15.0 110.592 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.14 -169.95 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.371 2.714 . . . . 15.0 112.944 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.58 106.53 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.216 -0.661 . . . . 15.0 109.216 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 252' ' ' PHE . 33.3 tp -82.99 14.95 2.99 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.343 1.057 . . . . 15.0 110.299 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.2 p -60.19 174.96 0.46 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.103 1.361 . . . . 15.0 112.321 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.49 -54.78 3.04 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.807 1.643 . . . . 15.0 113.86 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.45 -22.78 67.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.404 ' HD2' HD12 ' A' ' 248' ' ' LEU . 71.2 t80 -90.37 -52.26 5.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.37 0.668 . . . . 15.0 110.254 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.447 HG13 HD22 ' A' ' 266' ' ' LEU . 15.8 tt -66.4 -26.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.691 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.671 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 20.8 ptmt -82.6 -16.36 48.73 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 111.932 0.345 . . . . 15.0 111.932 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -58.83 -34.53 71.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.047 0.939 . . . . 15.0 110.95 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -62.76 -28.18 69.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.763 -1.108 . . . . 15.0 111.96 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.82 1.6 0.82 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.583 -0.565 . . . . 15.0 113.461 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.671 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 21.3 t -72.83 151.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.272 0.629 . . . . 15.0 110.06 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -67.57 -64.06 0.93 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.527 1.131 . . . . 15.0 110.483 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -102.64 -40.53 6.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.338 -1.301 . . . . 15.0 109.836 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 128.34 12.8 2.73 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.558 -0.746 . . . . 15.0 113.21 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 p -64.97 138.24 58.24 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.579 0.689 . . . . 15.0 110.375 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.89 -38.14 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.245 1.018 . . . . 15.0 111.711 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -55.48 -34.7 64.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.498 0.719 . . . . 15.0 111.388 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.21 -28.08 62.78 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.598 -0.601 . . . . 15.0 111.598 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 253' ' ' ILE . 58.9 tp -73.39 -32.72 64.61 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.37 -42.04 93.14 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.34 0.656 . . . . 15.0 109.699 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.03 90.61 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.928 -1.033 . . . . 15.0 110.39 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 15.6 tp10 -67.15 -39.99 86.61 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.729 -1.123 . . . . 15.0 111.465 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 266' ' ' LEU . 24.6 m -75.57 -24.42 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.044 -0.41 . . . . 15.0 110.253 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -69.03 -60.56 2.27 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 121.947 -0.471 . . . . 15.0 110.856 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.7 ptmt -61.9 -23.26 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 15.0 112.32 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -88.65 -69.48 0.7 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.403 0.281 . . . . 15.0 110.406 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 53.6 mtt -71.83 -45.33 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.895 -0.574 . . . . 15.0 112.361 -166.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.14 -42.16 72.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.625 0.648 . . . . 15.0 110.383 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 44.9 ttp85 -58.7 -53.55 57.14 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.167 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.26 -27.68 64.62 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.98 0.8 . . . . 15.0 111.084 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.429 HD12 HG13 ' A' ' 130' ' ' VAL . 59.9 tp -67.5 -54.96 15.64 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.557 0.743 . . . . 15.0 110.562 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.02 -31.36 72.48 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.583 0.753 . . . . 15.0 110.316 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.2 t -68.89 -43.18 75.78 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 123.801 0.84 . . . . 15.0 110.0 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.86 98.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.146 0.578 . . . . 15.0 110.386 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' A' ' 130' ' ' VAL . 73.4 mt -63.08 -49.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.011 0.924 . . . . 15.0 109.17 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.98 -54.96 38.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.648 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.22 -35.1 80.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.16 0.984 . . . . 15.0 111.019 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -65.57 -55.0 20.11 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.577 0.626 . . . . 15.0 110.996 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.66 -42.57 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.303 0.641 . . . . 15.0 110.366 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.5 tttt -58.36 -51.31 70.35 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.567 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -69.11 -31.68 70.56 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.531 0.519 . . . . 15.0 111.292 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -69.1 -39.44 78.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.907 0.483 . . . . 15.0 110.093 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.27 75.82 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 295' ' ' VAL . 33.4 mm -67.12 -36.89 78.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 123.803 0.689 . . . . 15.0 110.709 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.88 -47.76 81.95 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.271 -0.64 . . . . 15.0 109.271 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.28 94.05 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 124.698 1.249 . . . . 15.0 112.531 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.403 ' HB3' HD13 ' A' ' 350' ' ' LEU . 28.3 mt -59.96 -57.86 11.02 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 123.439 0.696 . . . . 15.0 110.39 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.4 t -56.09 -46.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.528 0.731 . . . . 15.0 110.159 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.84 -35.29 74.43 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.892 0.877 . . . . 15.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.15 -4.61 42.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.125 0.57 . . . . 15.0 112.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -133.9 115.12 14.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.972 0.805 . . . . 15.0 111.05 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.42 130.57 47.66 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.479 HD12 HD11 ' A' ' 349' ' ' LEU . 3.3 tt -149.13 146.11 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.344 1.058 . . . . 15.0 109.051 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.05 140.67 49.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 307' ' ' ILE . 40.4 t -117.73 105.29 48.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.57 130.36 29.62 Favored 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 123.217 2.611 . . . . 15.0 112.563 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -59.21 -29.93 67.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.872 1.269 . . . . 15.0 112.554 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 88' ' ' GLY . . . -54.1 -39.14 66.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.127 0.971 . . . . 15.0 111.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.78 -30.54 56.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.467 -0.788 . . . . 15.0 111.222 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 304' ' ' ALA . 2.0 mp -62.58 -49.96 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.841 -0.8 . . . . 15.0 108.841 173.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.33 -42.02 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.238 -0.892 . . . . 15.0 110.58 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.444 ' O ' HG21 ' A' ' 313' ' ' VAL . 36.5 t -57.44 -60.91 2.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.169 0.918 . . . . 15.0 111.219 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -69.8 -39.47 76.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.386 0.513 . . . . 15.0 112.386 -171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 14.9 mt -61.38 -43.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 119.035 -0.507 . . . . 15.0 109.694 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.26 -43.57 87.96 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.851 0.461 . . . . 15.0 111.208 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 309' ' ' SER . 81.2 t -54.74 -51.08 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.73 0.812 . . . . 15.0 110.339 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 341' ' ' ALA . 72.6 mt -71.4 -27.5 63.36 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.075 -0.966 . . . . 15.0 112.459 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 29.1 mtm180 -72.85 -38.41 67.08 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.563 -0.532 . . . . 15.0 109.563 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.5 -31.59 67.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.148 0.579 . . . . 15.0 110.978 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.21 -43.9 90.07 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.009 0.924 . . . . 15.0 110.432 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.38 -46.0 64.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.58 -0.736 . . . . 15.0 110.131 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -29.2 67.88 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.773 0.829 . . . . 15.0 111.594 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -62.72 -39.67 94.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.737 0.815 . . . . 15.0 109.652 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -81.8 -21.95 37.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.019 -0.537 . . . . 15.0 110.368 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -80.71 0.3 35.07 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.519 1.128 . . . . 15.0 110.16 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.89 82.73 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 123.16 0.41 . . . . 15.0 113.651 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 73.56 15.06 79.29 Favored Glycine 0 C--N 1.344 0.996 0 C-N-CA 123.313 0.483 . . . . 15.0 112.816 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.36 142.31 48.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.949 0.9 . . . . 15.0 110.434 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.82 -42.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.377 1.871 . . . . 15.0 112.942 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm 58.73 26.77 15.05 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.197 1.399 . . . . 15.0 111.571 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -91.9 13.8 17.46 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.723 1.209 . . . . 15.0 110.736 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.589 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -53.26 -25.16 13.44 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.089 1.356 . . . . 15.0 113.025 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp -43.8 -35.84 2.07 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.723 1.209 . . . . 15.0 112.166 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.01 72.66 1.42 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.966 0.889 . . . . 15.0 110.089 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 73.1 mt -81.05 153.71 72.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 153.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.29 108.73 0.21 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.959 2.439 . . . . 15.0 113.369 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -55.95 -29.09 59.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.254 1.022 . . . . 15.0 110.859 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.08 -21.42 31.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.572 1.149 . . . . 15.0 111.878 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.06 -35.31 20.37 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.542 0.737 . . . . 15.0 111.118 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.499 ' HA ' HE21 ' A' ' 340' ' ' GLN . 23.5 m-85 -107.34 -14.38 14.89 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.879 0.696 . . . . 15.0 112.879 -167.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.96 -62.55 1.58 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.851 1.26 . . . . 15.0 112.029 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.45 -46.29 73.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.728 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 337' ' ' PHE . 25.4 pt20 -67.99 -37.24 81.25 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.624 0.578 . . . . 15.0 111.623 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 314' ' ' LEU . . . -64.94 -52.71 54.87 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -51.57 -40.67 60.21 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 124.642 1.214 . . . . 15.0 110.83 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.422 ' O ' HG21 ' A' ' 347' ' ' VAL . 15.6 mmt180 -60.26 -46.87 88.32 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 123.418 0.687 . . . . 15.0 110.402 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -63.63 -34.21 77.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.473 0.483 . . . . 15.0 111.219 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.81 -53.89 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 15.0 110.148 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.43 -31.06 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.313 0.645 . . . . 15.0 110.957 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 343' ' ' ARG . 40.3 t -60.46 -50.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.522 0.729 . . . . 15.0 109.095 170.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.76 -33.74 88.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.636 -0.711 . . . . 15.0 113.759 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 300' ' ' ILE . 96.0 mt -73.82 -54.7 7.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.929 0.491 . . . . 15.0 110.574 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 354' ' ' VAL . 75.6 mt -68.87 -52.67 27.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.891 0.476 . . . . 15.0 110.812 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.14 -38.11 89.55 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 119.275 -0.393 . . . . 15.0 110.834 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.98 -38.41 88.98 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.753 0.658 . . . . 15.0 112.544 176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -69.25 -40.6 77.77 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 119.295 -0.383 . . . . 15.0 111.316 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 350' ' ' LEU . 81.2 t -57.39 -39.94 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.211 0.529 . . . . 15.0 110.575 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.401 HG23 HD21 ' A' ' 403' ' ' LEU . 64.1 mt -67.84 -45.46 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.756 1.222 . . . . 15.0 110.755 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.484 ' HA ' ' HE2' ' B' ' 461' ' ' PHE . 20.2 ttp180 -61.28 -53.14 60.56 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.021 0.529 . . . . 15.0 110.785 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 33.0 m -57.13 -50.37 73.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.62 1.168 . . . . 15.0 111.433 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -90.66 14.8 12.39 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.638 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 43.04 36.2 0.89 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 125.375 1.47 . . . . 15.0 114.136 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.487 ' HB3' HE21 ' A' ' 406' ' ' GLN . 99.0 mt -67.26 149.17 50.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.047 0.939 . . . . 15.0 112.159 -176.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.61 150.91 52.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.333 1.053 . . . . 15.0 109.699 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.77 104.49 3.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.38 -0.6 . . . . 15.0 109.38 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.78 132.64 42.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.149 0.58 . . . . 15.0 110.395 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -63.94 -30.85 71.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.88 0.872 . . . . 15.0 112.48 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -86.04 -10.64 54.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.961 0.504 . . . . 15.0 111.436 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.5 tpt85 -81.33 -38.13 27.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 371' ' ' ILE . 89.7 t -58.16 -58.29 7.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.837 1.255 . . . . 15.0 109.18 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 372' ' ' GLU . 24.0 mmmt -59.49 -39.62 84.35 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 115.628 -0.715 . . . . 15.0 111.589 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.33 67.06 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.934 0.772 . . . . 15.0 112.436 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.08 -42.49 84.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.31 0.644 . . . . 15.0 111.96 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 367' ' ' VAL . 50.5 mm -52.77 -44.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 123.992 0.807 . . . . 15.0 110.686 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 368' ' ' LYS . 14.7 mm-40 -70.06 -54.71 11.9 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.46 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -52.43 -36.97 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.837 0.855 . . . . 15.0 112.463 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 60.4 ttp -80.09 -69.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.774 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.87 79.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.858 0.863 . . . . 15.0 113.297 -164.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -21.44 64.92 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.037 0.535 . . . . 15.0 112.166 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -66.79 -20.32 65.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.739 0.816 . . . . 15.0 112.591 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.49 167.83 9.89 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.383 0.673 . . . . 15.0 110.646 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -80.01 -9.73 59.71 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.851 . . . . 15.0 110.809 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.42 59.78 46.08 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.991 1.317 . . . . 15.0 110.545 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.75 -27.95 4.51 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 121.931 1.754 . . . . 15.0 112.301 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -54.79 -45.78 74.37 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.254 1.022 . . . . 15.0 111.042 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 12.7 pt-20 -65.57 -31.46 72.51 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.84 -1.073 . . . . 15.0 111.242 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.96 -37.84 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.277 0.631 . . . . 15.0 109.912 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.95 -54.21 37.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 108.607 -0.886 . . . . 15.0 108.607 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.35 -27.52 67.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.525 0.73 . . . . 15.0 111.527 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 383' ' ' GLU . 24.0 t80 -62.19 -44.01 97.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.99 0.916 . . . . 15.0 109.877 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -82.71 -66.27 0.91 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.638 0.607 . . . . 15.0 112.638 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . 0.573 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 84.4 p -56.45 -27.23 56.27 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.474 1.287 . . . . 15.0 114.474 -169.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -103.36 27.72 7.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.079 0.551 . . . . 15.0 110.396 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -149.8 105.35 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.296 -1.002 . . . . 15.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -55.6 -38.73 69.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.264 1.026 . . . . 15.0 111.726 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.34 -36.61 66.2 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 123.782 0.676 . . . . 15.0 111.625 -174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.98 -32.98 61.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.763 0.425 . . . . 15.0 111.117 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.573 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 90.0 mmm -62.83 -38.88 92.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 171.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.27 -38.21 78.27 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 123.719 0.637 . . . . 15.0 109.983 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.1 -39.66 93.25 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 123.559 0.744 . . . . 15.0 110.54 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.455 ' HA ' HG12 ' A' ' 401' ' ' VAL . 43.1 tpp -77.34 -23.78 50.86 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.543 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.46 ' HB3' ' OG1' ' B' ' 463' ' ' THR . 43.2 mtm-85 -74.95 -31.83 61.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.143 0.577 . . . . 15.0 110.318 169.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -55.87 22.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.478 0.711 . . . . 15.0 109.398 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.5 p -69.43 -29.97 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 123.788 0.68 . . . . 15.0 111.745 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.66 -53.62 55.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.861 -0.422 . . . . 15.0 109.861 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.624 HD23 HG22 ' B' ' 463' ' ' THR . 48.1 tp -71.3 -30.11 65.86 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.903 -1.044 . . . . 15.0 111.687 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.25 -57.07 10.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.723 1.209 . . . . 15.0 109.953 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -67.12 -32.43 73.56 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.27 -0.877 . . . . 15.0 110.633 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.487 HE21 ' HB3' ' A' ' 360' ' ' LEU . 25.0 tt0 -63.91 -37.77 88.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.042 0.537 . . . . 15.0 110.388 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.49 85.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.748 0.819 . . . . 15.0 110.891 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 74.8 t -55.81 -53.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 123.955 0.784 . . . . 15.0 109.306 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -30.35 70.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.104 0.962 . . . . 15.0 112.023 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.4 -30.86 68.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.929 0.491 . . . . 15.0 110.895 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.01 -39.51 57.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 77.0 mt -72.84 -26.37 61.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.436 1.094 . . . . 15.0 112.007 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.72 73.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.96 0.904 . . . . 15.0 110.054 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.3 -34.94 13.32 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.593 -1.185 . . . . 15.0 110.094 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 412' ' ' LEU . . . -81.93 154.61 25.69 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.316 1.046 . . . . 15.0 111.465 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.5 86.73 3.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.952 -1.022 . . . . 15.0 110.147 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -84.61 94.12 3.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.57 0.7 . . . . 15.0 109.712 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -70.48 95.19 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.115 -0.948 . . . . 15.0 108.647 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.33 138.87 37.87 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 114.991 -1.004 . . . . 15.0 110.131 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.411 ' HE3' HG21 ' A' ' 422' ' ' THR . 62.1 pttt -144.42 137.35 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 173.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.89 122.4 30.7 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.128 -1.064 . . . . 15.0 108.128 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.411 HG21 ' HE3' ' A' ' 420' ' ' LYS . 8.8 t -149.78 175.52 11.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.008 0.523 . . . . 15.0 110.69 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -89.92 161.07 16.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.71 1.204 . . . . 15.0 112.119 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.439 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 26.5 t80 -52.68 -48.59 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.234 1.414 . . . . 15.0 111.253 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -58.79 -19.4 40.56 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.161 0.913 . . . . 15.0 112.886 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 427' ' ' LEU . 7.7 tp10 -54.06 -49.95 67.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.382 1.073 . . . . 15.0 112.127 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.584 HD11 HG21 ' A' ' 130' ' ' VAL . 5.5 mp -75.37 -29.18 59.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.788 0.835 . . . . 15.0 111.507 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -77.14 -41.97 39.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 174.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -80.72 33.46 0.32 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.16 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 75.69 10.02 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.843 -1.169 . . . . 15.0 107.843 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -87.74 -11.61 47.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.618 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.481 0.712 . . . . 15.0 109.559 174.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 121.996 0.903 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -151.67 95.45 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 66.2 mt -77.77 -77.05 0.16 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.536 0.334 . . . . 0.0 110.85 -172.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' B' ' 411' ' ' ALA . 7.0 t0 -102.98 -82.58 0.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 373' ' ' ARG . 43.8 mt-10 -90.08 -75.51 0.45 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.017 -0.427 . . . . 0.0 110.018 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -103.4 -79.72 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.559 HG12 ' H ' ' B' ' 372' ' ' GLN . 2.6 p -108.85 -81.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.611 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.559 ' H ' HG12 ' B' ' 371' ' ' VAL . 2.2 mp0 -85.06 -80.1 0.22 Allowed 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 120.159 1.345 . . . . 0.0 108.44 170.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' B' ' 369' ' ' GLU . 15.6 mmm180 -102.52 -83.66 0.47 Allowed 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 163.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -102.54 -73.91 0.65 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.65 -78.05 0.59 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.736 0.414 . . . . 0.0 110.932 173.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.78 -80.93 0.52 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.666 -0.646 . . . . 0.0 111.598 -171.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.455 ' HD2' ' HA ' ' B' ' 380' ' ' LYS . 91.2 m-85 -95.63 -85.18 0.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.82 -68.92 0.79 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 158.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -101.22 -79.13 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 163.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' B' ' 381' ' ' GLU . 47.6 pttt -161.18 -74.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.01 0.924 . . . . 0.0 109.26 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . 0.56 ' H ' ' HG3' ' B' ' 380' ' ' LYS . 32.9 tt0 -172.65 152.35 2.53 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.662 0.785 . . . . 0.0 109.327 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -171.81 98.61 0.13 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.01 142.39 21.65 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.397 0.679 . . . . 0.0 110.616 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 4.1 t -173.35 -55.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.564 1.146 . . . . 0.0 109.69 171.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.459 HD13 ' HE2' ' A' ' 194' ' ' MET . 18.9 tp -145.56 159.21 43.45 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 124.846 1.258 . . . . 0.0 107.68 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.39 97.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 122.895 1.331 . . . . 0.0 109.279 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.469 HG22 HG21 ' B' ' 389' ' ' THR . 2.9 tp -149.78 156.24 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 113.954 -1.476 . . . . 0.0 107.043 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.531 HG12 ' HG3' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -58.11 106.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 389' ' ' THR . . . . . 0.469 HG21 HG22 ' B' ' 387' ' ' ILE . 9.3 p -125.7 93.79 3.94 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.451 0.643 . . . . 0.0 110.4 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' B' ' 393' ' ' ALA . . . -94.16 176.14 6.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 161.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -133.76 131.39 39.3 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . 0.616 ' H ' ' HB2' ' A' ' 222' ' ' HIS . 19.8 p-80 47.06 18.14 0.07 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.019 2.128 . . . . 0.0 113.293 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' B' ' 390' ' ' ALA . . . -117.4 162.96 17.09 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.157 0.983 . . . . 0.0 110.119 -169.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 224' ' ' GLU . 32.5 m-70 -96.01 -57.65 2.29 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.898 -170.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -85.12 167.29 15.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.567 0.747 . . . . 0.0 111.145 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 24.3 m -128.34 170.18 13.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.263 1.025 . . . . 0.0 109.499 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.523 ' HA ' HE21 ' B' ' 397' ' ' GLN . 0.0 OUTLIER 58.97 -80.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.919 1.288 . . . . 0.0 111.052 -170.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.441 ' H ' HD13 ' B' ' 398' ' ' ILE . 0.2 OUTLIER -121.04 90.44 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 122.246 1.022 . . . . 0.0 109.973 -177.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.14 -46.84 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -165.66 163.45 12.69 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.994 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.24 72.38 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.448 2.099 . . . . 0.0 111.495 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.46 157.91 22.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.931 0.892 . . . . 0.0 108.785 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 50.7 p 52.14 27.65 4.79 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.393 1.477 . . . . 0.0 112.493 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -147.1 11.45 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.017 1.327 . . . . 0.0 109.505 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.524 ' H ' ' HD2' ' B' ' 406' ' ' PRO . . . -164.32 -45.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 116.265 -1.826 . . . . 0.0 114.139 -164.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.524 ' HD2' ' H ' ' B' ' 405' ' ' ALA . 4.5 Cg_exo -33.03 96.95 0.02 OUTLIER 'Trans proline' 1 C--N 1.416 4.111 0 C-N-CA 124.609 3.539 . . . . 0.0 114.407 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 79.39 -96.62 1.51 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -170.1 146.05 2.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.089 0.956 . . . . 0.0 109.214 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 31.9 p -70.95 91.37 0.86 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.734 0.814 . . . . 0.0 110.256 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.43 -56.73 4.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.935 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . 0.419 ' H ' ' HA ' ' B' ' 368' ' ' ASP . . . -90.46 -168.46 2.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.5 -173.87 2.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.62 1.168 . . . . 0.0 110.032 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -51.06 -46.27 61.65 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.934 0.894 . . . . 0.0 112.068 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 17.2 m 59.55 85.15 0.1 Allowed 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.486 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -67.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.019 0.927 . . . . 0.0 112.8 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -62.84 -49.02 76.54 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.786 0.834 . . . . 0.0 110.968 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 67.24 71.54 0.91 Allowed Glycine 0 C--N 1.352 1.461 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.14 56.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.756 0.822 . . . . 0.0 112.169 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 48.7 t 64.95 97.7 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 125.497 1.519 . . . . 0.0 112.132 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 27.0 ttt -111.49 118.65 36.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.95 148.2 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 110.524 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 96.0 mmm -89.13 121.06 31.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 53.1 p -141.15 139.64 33.94 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.651 0.78 . . . . 0.0 109.732 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 44.3 p90 50.89 -168.82 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.381 1.872 . . . . 0.0 114.129 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 81.59 -173.42 53.93 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.871 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 66.84 3.57 3.1 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.863 1.265 . . . . 0.0 113.486 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.6 m 56.92 23.44 8.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.424 1.09 . . . . 0.0 111.94 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -138.4 -67.9 0.46 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.64 -4.62 28.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.169 0.988 . . . . 0.0 111.235 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -53.68 -61.28 2.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.554 1.542 . . . . 0.0 112.624 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 38.5 t -69.95 -31.36 69.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.424 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.604 ' HB3' ' HB ' ' B' ' 435' ' ' THR . 1.3 mp0 -78.35 -24.36 46.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.319 0.648 . . . . 0.0 111.622 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 59.51 -85.5 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.492 1.517 . . . . 0.0 112.684 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -93.58 28.82 2.17 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.719 0.808 . . . . 0.0 111.166 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' B' ' 432' ' ' GLN . 19.0 m -128.87 141.47 51.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.387 0.675 . . . . 0.0 109.549 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -63.6 -29.09 73.62 Favored Glycine 0 C--N 1.357 1.749 0 O-C-N 124.054 0.846 . . . . 0.0 113.853 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 13.3 m 57.26 76.07 0.34 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.066 1.347 . . . . 0.0 111.53 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -160.48 23.96 0.15 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.206 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 39.5 tp -86.48 76.45 9.6 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.742 0.782 . . . . 0.0 110.53 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -109.61 -39.67 5.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.441 166.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 35.1 mt -124.44 138.01 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.151 0.98 . . . . 0.0 109.683 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.98 31.67 0.96 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.768 1.227 . . . . 0.0 111.496 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.65 96.37 0.71 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.502 0.721 . . . . 0.0 110.528 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -65.39 145.07 56.63 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 0.0 110.254 171.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -67.74 109.02 2.68 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.31 -33.62 5.45 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.586 2.19 . . . . 0.0 113.944 -167.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.429 ' HB2' HG22 ' A' ' 313' ' ' VAL . 11.0 t-160 65.35 5.44 3.13 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.874 1.269 . . . . 0.0 112.426 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' B' ' 451' ' ' VAL . . . 58.18 27.27 14.85 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.89 1.276 . . . . 0.0 112.76 -177.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -60.53 -24.84 65.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -106.6 -15.34 14.8 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.938 0.895 . . . . 0.0 111.117 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . 0.407 ' HB ' ' HB1' ' B' ' 448' ' ' ALA . 86.6 t -84.07 -59.37 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 0.0 110.177 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.42 -36.51 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -70.06 156.87 53.5 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.69 81.38 0.85 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.401 0.68 . . . . 0.0 110.027 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.43 HG23 ' H ' ' B' ' 456' ' ' ASP 0.251 5.5 t 36.31 -76.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 127.448 2.299 . . . . 0.0 115.041 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . 0.528 ' HA ' ' HD1' ' B' ' 462' ' ' TYR . 16.0 m-20 -74.64 169.02 18.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.575 0.75 . . . . 0.0 111.264 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -91.02 159.9 15.9 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.058 0.943 . . . . 0.0 109.676 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.4 t -67.22 -24.92 65.88 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.793 0.837 . . . . 0.0 113.112 -167.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . 0.404 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 32.7 t70 -163.05 69.49 0.23 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.118 0.567 . . . . 0.0 110.036 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.0 tp -172.25 174.22 4.01 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . 0.484 ' HE2' ' HA ' ' A' ' 356' ' ' ARG . 97.4 m-85 -77.22 24.4 0.18 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.576 1.15 . . . . 0.0 113.751 -174.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . 0.528 ' HD1' ' HA ' ' B' ' 456' ' ' ASP . 19.5 t80 76.92 -49.49 0.55 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.723 1.209 . . . . 0.0 113.412 173.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 463' ' ' THR . . . . . 0.624 HG22 HD23 ' A' ' 403' ' ' LEU . 11.8 t -84.16 20.54 1.57 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.533 1.133 . . . . 0.0 113.668 -156.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.457 ' HE2' ' HB3' ' B' ' 467' ' ' ALA . 25.0 ptm -141.03 129.81 22.95 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.58 -62.12 1.74 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.514 0.725 . . . . 0.0 109.685 -173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.38 0.39 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.077 0.951 . . . . 0.0 110.522 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.457 ' HB3' ' HE2' ' B' ' 464' ' ' MET . . . 176.23 -53.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.615 1.566 . . . . 0.0 108.254 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 10.1 mp 67.69 -70.01 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 O-C-N 125.099 1.5 . . . . 0.0 111.59 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' B' ' 459' ' ' ASP . . . 171.26 -175.26 44.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.839 -0.22 . . . . 0.0 113.11 176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.66 -19.07 25.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.086 0.554 . . . . 0.0 110.624 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.887 0.875 . . . . 12.06 109.107 173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.65 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -78.11 97.08 5.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.162 0.585 . . . . 15.0 109.817 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 17' ' ' ILE . 24.9 m -111.1 128.49 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.348 0.659 . . . . 15.0 109.479 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.3 p -129.63 110.7 12.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.094 0.558 . . . . 15.0 109.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.26 126.59 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.601 0.76 . . . . 15.0 110.417 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 32.5 mt-10 -125.55 133.22 52.4 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.8 1.24 . . . . 15.0 108.5 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 m -94.0 98.22 10.87 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.493 -0.929 . . . . 15.0 108.493 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -84.29 -51.23 7.16 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.291 0.636 . . . . 15.0 111.937 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -151.2 90.95 1.64 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.16 -100.74 0.43 Allowed Glycine 0 C--N 1.35 1.338 0 O-C-N 123.867 0.73 . . . . 15.0 113.363 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 5.2 mp -77.85 -33.14 52.34 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 15.0 109.56 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 122.72 30.63 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.363 1.039 . . . . 15.0 112.867 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -135.46 129.03 32.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.572 1.149 . . . . 15.0 110.259 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 43.4 ttm180 -96.64 101.82 13.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.431 1.092 . . . . 15.0 110.022 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.03 94.41 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 169.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 85.8 m -78.32 102.74 7.84 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.482 -0.781 . . . . 15.0 109.467 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.575 HG12 HG13 ' A' ' 3' ' ' VAL . 54.0 mt -95.74 131.92 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.737 0.815 . . . . 15.0 109.315 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 33.9 m -116.07 118.81 33.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 70' ' ' LEU . 58.6 mt -93.03 120.12 41.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.77 154.11 42.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.173 0.589 . . . . 15.0 111.166 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.65 -39.99 62.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.238 1.415 . . . . 15.0 113.183 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.65 -38.64 77.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.407 0.683 . . . . 15.0 110.984 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -70.22 -32.31 70.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.61 0.764 . . . . 15.0 110.824 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 28' ' ' VAL . 76.4 mt -66.79 -54.14 27.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.962 0.905 . . . . 15.0 109.384 173.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -59.94 -38.79 83.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.421 1.076 . . . . 15.0 111.761 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -63.75 -45.18 91.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.779 0.674 . . . . 15.0 110.27 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -33.64 73.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.543 0.737 . . . . 15.0 112.277 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' HG23 ' A' ' 66' ' ' VAL . 68.0 t -69.54 -42.47 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.261 0.624 . . . . 15.0 109.423 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.734 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -68.02 -31.03 70.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.263 -0.88 . . . . 15.0 111.079 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 m -69.1 -37.39 78.37 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.474 -0.785 . . . . 15.0 109.702 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.6 tp10 -69.37 -39.53 78.01 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.826 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 91.6 mt -67.24 -34.69 77.99 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.316 0.646 . . . . 15.0 111.725 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 p -80.97 -17.63 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 O-C-N 123.317 0.386 . . . . 15.0 110.604 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.44 -46.64 66.29 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.452 -0.574 . . . . 15.0 109.452 168.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 40.0 t -65.09 -39.11 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 123.876 0.735 . . . . 15.0 109.891 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.55 -55.38 31.55 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 115.198 -0.91 . . . . 15.0 110.671 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 97.2 mttt -66.18 -30.03 70.42 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.423 0.452 . . . . 15.0 111.98 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 36.5 ttpt -64.29 -46.71 82.44 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.491 0.717 . . . . 15.0 111.118 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.1 t -94.03 3.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.348 0.659 . . . . 15.0 110.154 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 24.8 mmt180 65.17 16.8 10.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.866 1.666 . . . . 15.0 112.43 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.548 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.1 mt -54.08 -31.04 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.562 1.545 . . . . 15.0 111.784 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.756 0.822 . . . . 15.0 111.037 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -39.13 79.26 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.08 -0.509 . . . . 15.0 112.03 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.99 -22.17 59.71 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.142 0.577 . . . . 15.0 111.003 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -65.93 116.55 7.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.386 1.074 . . . . 15.0 110.145 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.82 1.99 48.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.064 0.945 . . . . 15.0 111.329 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.91 69.85 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.28 0.362 . . . . 15.0 112.706 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -77.15 -49.4 15.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.636 0.774 . . . . 15.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.88 117.36 61.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 108.486 -0.931 . . . . 15.0 108.486 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD2' HD12 ' A' ' 53' ' ' ILE . 87.5 Cg_exo -48.75 142.39 18.93 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.417 2.745 . . . . 15.0 113.484 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.408 ' HA ' HG21 ' A' ' 54' ' ' VAL . 56.4 tpp -64.01 -26.57 68.63 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 15.0 111.298 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.27 -35.18 77.49 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.592 0.357 . . . . 15.0 111.64 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.436 HD12 ' HD2' ' A' ' 50' ' ' PRO . 43.1 mt -72.68 -46.93 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.685 0.794 . . . . 15.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 51' ' ' MET . 31.1 m -68.66 -21.14 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 122.429 -0.169 . . . . 15.0 111.291 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.21 -47.77 60.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.059 0.544 . . . . 15.0 111.862 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.59 -19.79 48.51 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.755 -0.657 . . . . 15.0 111.627 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -94.45 -70.15 0.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.551 0.34 . . . . 15.0 111.252 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.61 -22.8 59.91 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.287 0.635 . . . . 15.0 111.613 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.84 14.56 59.94 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.305 -0.72 . . . . 15.0 114.041 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 -42.61 66.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.497 0.719 . . . . 15.0 111.574 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 p -77.11 -32.76 56.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.291 0.636 . . . . 15.0 110.298 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.7 t -67.17 -18.79 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.616 1.166 . . . . 15.0 111.321 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.438 ' HD3' HG21 ' A' ' 28' ' ' VAL . 17.1 mmt180 -51.05 -44.8 61.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.283 0.633 . . . . 15.0 110.599 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -51.85 -55.48 19.74 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.429 1.092 . . . . 15.0 111.456 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.76 -48.96 79.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.625 -1.17 . . . . 15.0 111.095 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' A' ' 28' ' ' VAL . 79.6 t -64.24 -49.17 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.367 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.7 mt -56.84 -43.44 81.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 123.837 0.711 . . . . 15.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.526 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -59.7 -47.57 90.27 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.294 0.996 . . . . 15.0 112.002 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.97 -41.39 97.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.649 1.18 . . . . 15.0 111.454 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 19' ' ' ILE . 59.2 mt -64.59 -27.2 68.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.262 -0.881 . . . . 15.0 111.235 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE1' ' HA2' ' A' ' 68' ' ' GLY . 68.4 mtm -59.21 -40.93 87.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.361 0.413 . . . . 15.0 111.049 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -81.59 -50.01 9.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.779 0.432 . . . . 15.0 111.105 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -75.19 -24.14 57.77 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -81.31 -25.85 36.14 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.927 0.33 . . . . 15.0 110.288 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -77.96 -42.23 33.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.686 0.394 . . . . 15.0 111.171 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.0 -27.4 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.26 0.552 . . . . 15.0 110.081 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.57 -41.49 54.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.429 0.692 . . . . 15.0 109.981 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -47.09 84.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 15.0 111.869 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -60.13 -27.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 112.79 0.663 . . . . 15.0 112.79 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.9 mt -71.81 -47.33 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.942 0.897 . . . . 15.0 110.568 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -75.96 -29.97 58.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.622 0.369 . . . . 15.0 110.785 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.87 -22.28 53.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.757 . . . . 15.0 111.132 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.706 ' HB3' ' HG3' ' B' ' 471' ' ' LYS . 46.3 mmtm 62.85 23.86 14.23 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.482 1.113 . . . . 15.0 111.428 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.6 mt -105.35 97.9 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.314 -0.995 . . . . 15.0 108.314 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -72.53 116.92 54.44 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.528 -0.916 . . . . 15.0 108.528 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.7 158.65 35.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.521 2.147 . . . . 15.0 113.127 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.59 167.88 21.98 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.81 -1.086 . . . . 15.0 108.956 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 -136.15 15.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.697 -0.683 . . . . 15.0 111.458 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.14 97.65 45.35 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 108.263 -1.014 . . . . 15.0 108.263 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.4 106.36 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.018 1.812 . . . . 15.0 110.792 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.6 m -92.25 98.3 11.43 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.277 0.631 . . . . 15.0 109.58 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -76.45 83.42 3.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.158 0.983 . . . . 15.0 109.316 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.51 106.33 10.09 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 118.536 -0.745 . . . . 15.0 109.147 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HG3' ' SD ' ' A' ' 71' ' ' MET . 16.3 Cg_exo -68.79 110.42 2.35 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.4 2.067 . . . . 15.0 111.33 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -59.12 11.36 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.773 0.671 . . . . 15.0 111.99 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.27 168.05 13.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 15.0 111.483 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.425 ' HB2' ' HD1' ' A' ' 103' ' ' PHE . 76.1 t80 -147.29 143.57 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.571 1.149 . . . . 15.0 109.17 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 49.1 mtmt -122.52 144.4 49.1 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 170.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.58 108.41 0.82 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.943 0.897 . . . . 15.0 111.86 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.58 62.29 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.578 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.9 mt-10 -99.23 -173.17 2.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.482 1.113 . . . . 15.0 109.392 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.1 154.12 42.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.647 0.736 . . . . 15.0 112.897 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 97' ' ' TYR . 56.2 t80 -119.01 141.61 48.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.153 1.381 . . . . 15.0 108.392 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -132.57 140.31 48.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -147.35 136.23 22.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.789 0.836 . . . . 15.0 109.535 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 70.8 m -103.5 123.77 47.52 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.324 1.05 . . . . 15.0 109.589 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.88 110.3 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.101 0.56 . . . . 15.0 110.253 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -101.1 130.41 47.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.68 0.392 . . . . 15.0 110.298 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.6 157.05 37.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 15.0 109.544 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.85 164.66 23.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.284 0.634 . . . . 15.0 109.632 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.526 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.5 m -123.23 178.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.239 0.615 . . . . 15.0 109.442 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -86.3 108.01 15.74 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 15.0 108.489 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.54 163.64 26.73 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.451 2.101 . . . . 15.0 113.018 -170.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.92 89.22 5.87 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.67 111.48 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.514 -1.221 . . . . 15.0 110.017 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -96.14 98.49 10.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.892 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.628 HD13 HD11 ' A' ' 120' ' ' LEU . 85.7 mt -73.03 129.01 37.13 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -136.98 111.14 8.36 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.32 75.89 0.21 Allowed Glycine 0 C--N 1.353 1.504 0 O-C-N 124.324 1.015 . . . . 15.0 113.519 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.628 HD11 HD13 ' A' ' 117' ' ' LEU . 17.8 mt -75.59 -11.64 60.05 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.055 0.428 . . . . 15.0 110.874 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 13.2 mp0 -74.53 -28.08 60.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.303 1.041 . . . . 15.0 110.146 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.76 62.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.044 0.937 . . . . 15.0 112.078 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.453 HG22 ' HA3' ' A' ' 293' ' ' GLY . 65.2 mt -68.88 134.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.717 0.807 . . . . 15.0 109.731 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.441 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.1 mt-10 -118.29 110.87 18.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.458 0.703 . . . . 15.0 109.263 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.679 ' HB ' HG22 ' A' ' 417' ' ' VAL . 47.1 t -115.97 156.19 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.529 1.132 . . . . 15.0 109.68 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.53 141.04 39.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.993 0.917 . . . . 15.0 108.692 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 83.1 tttt -112.43 89.9 13.43 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 107.344 -1.354 . . . . 15.0 107.344 170.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.54 95.41 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.403 2.068 . . . . 15.0 111.087 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.15 87.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.202 -1.407 . . . . 15.0 107.202 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.544 ' HB ' HD12 ' A' ' 282' ' ' ILE . 3.2 t -122.38 141.24 43.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.576 -1.193 . . . . 15.0 109.56 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.94 165.5 24.86 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.813 -1.551 . . . . 15.0 106.813 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.53 85.9 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.683 -1.599 . . . . 15.0 106.683 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 137' ' ' VAL . 26.6 p -69.12 175.78 3.61 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.554 0.742 . . . . 15.0 110.238 -175.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.21 -43.38 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.022 0.374 . . . . 15.0 110.296 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.34 80.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.875 0.87 . . . . 15.0 111.298 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.44 -39.03 54.59 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.743 0.417 . . . . 15.0 111.662 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 133' ' ' THR . 91.5 t -65.09 -53.71 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 108.933 -0.766 . . . . 15.0 108.933 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -63.5 -48.63 76.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.148 0.905 . . . . 15.0 110.385 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.01 93.85 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 123.877 0.735 . . . . 15.0 114.195 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -80.51 -45.44 17.49 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.978 0.511 . . . . 15.0 111.111 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 270' ' ' VAL . 48.1 mt -54.52 -34.56 61.93 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.457 0.572 . . . . 15.0 112.025 167.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.74 -45.8 84.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.403 1.081 . . . . 15.0 109.623 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -60.78 -36.84 80.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.624 0.77 . . . . 15.0 111.628 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.431 HD11 HD22 ' A' ' 141' ' ' LEU . 96.1 mt -70.31 -40.33 74.28 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.254 0.621 . . . . 15.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.64 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 68.0 mtm180 -74.44 -18.78 60.59 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.743 -0.662 . . . . 15.0 111.619 174.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 97.0 mttt -85.36 -22.56 28.39 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.077 0.399 . . . . 15.0 111.233 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.426 ' HG2' HE21 ' A' ' 148' ' ' GLN . 46.4 tt0 -72.13 -42.17 66.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 15.0 109.362 171.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.426 HE21 ' HG2' ' A' ' 147' ' ' GLN . 30.8 mm-40 -104.87 41.32 1.35 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.003 . . . . 15.0 110.1 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -76.12 139.06 41.14 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.6 m -81.36 126.77 32.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.132 0.973 . . . . 15.0 109.398 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -80.97 111.01 17.05 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -120.66 114.87 22.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.909 0.883 . . . . 15.0 109.79 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 52.7 mt-10 -73.19 119.57 17.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.847 0.459 . . . . 15.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 28.6 pttt -106.02 176.8 5.05 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.39 0.676 . . . . 15.0 110.32 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -115.55 99.4 7.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.133 0.573 . . . . 15.0 111.487 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.429 ' HA2' ' H ' ' A' ' 207' ' ' ALA . . . 58.66 58.76 12.85 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.589 168.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 98.89 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.298 0.549 . . . . 15.0 109.688 172.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 203' ' ' LYS . 14.2 t -96.98 130.2 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 120.914 0.388 . . . . 15.0 110.953 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 -168.4 2.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.749 1.62 . . . . 15.0 109.18 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.76 -2.64 54.96 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.031 0.932 . . . . 15.0 112.585 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -97.49 8.4 44.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.22 0.608 . . . . 15.0 111.829 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 1.1 m-20 -92.41 176.41 6.48 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.388 1.089 . . . . 15.0 113.873 -166.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 3.1 tmt_? -143.42 90.21 2.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.519 -2.4 . . . . 15.0 104.519 167.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.36 152.28 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.766 0.826 . . . . 15.0 110.561 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.736 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 11.4 m -126.1 117.68 23.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.773 -1.195 . . . . 15.0 107.773 173.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.489 HG23 HD22 ' A' ' 237' ' ' LEU . 38.6 pt -128.24 173.4 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.982 0.913 . . . . 15.0 111.963 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.35 134.1 50.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.766 -1.198 . . . . 15.0 107.766 163.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -127.72 149.85 50.04 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.709 0.231 . . . . 15.0 110.483 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.588 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 9.0 t -131.81 113.32 13.36 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 165.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.44 148.81 18.78 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.9 -0.591 . . . . 15.0 113.725 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.3 m -146.07 118.08 8.26 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.312 -1.366 . . . . 15.0 107.312 167.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 98.9 t -88.69 114.97 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.967 0.907 . . . . 15.0 109.334 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 67.91 7.8 6.02 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.405 1.082 . . . . 15.0 111.325 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.92 26.14 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 121.769 -0.582 . . . . 15.0 113.507 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.6 pt-20 -98.64 134.89 40.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.552 0.676 . . . . 15.0 109.196 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.81 85.59 3.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.048 0.451 . . . . 15.0 110.069 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.51 ' HD2' HG22 ' B' ' 388' ' ' VAL . 0.1 OUTLIER -43.44 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.755 1.622 . . . . 15.0 111.85 172.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.24 172.69 7.01 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.961 1.304 . . . . 15.0 109.313 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.6 71.52 0.67 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.22 -1.552 . . . . 15.0 109.22 155.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . -78.79 57.48 4.25 Favored Glycine 0 C--N 1.356 1.684 0 C-N-CA 123.915 0.769 . . . . 15.0 114.401 -171.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.588 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 24.6 mmtt -107.15 149.87 27.21 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.617 1.167 . . . . 15.0 110.163 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.19 93.36 0.69 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.988 0.805 . . . . 15.0 109.204 173.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 129.6 36.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.2 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 66.23 32.64 7.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.312 1.045 . . . . 15.0 111.483 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.16 130.27 43.87 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.76 102.7 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.549 0.74 . . . . 15.0 109.536 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.0 tp -93.95 91.85 7.09 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -70.15 92.7 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 173.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER -66.5 154.57 39.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.789 0.836 . . . . 15.0 111.241 -175.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.45 -19.03 13.16 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.173 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -102.69 122.82 45.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.495 0.718 . . . . 15.0 109.38 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.23 61.34 4.78 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.239 -0.744 . . . . 15.0 111.239 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -31.23 11.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.884 0.874 . . . . 15.0 109.174 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 25.9 mmt -75.07 160.78 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.973 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.2 pt -59.72 130.96 88.55 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 115.057 -0.974 . . . . 15.0 110.426 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.64 115.85 2.69 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.25 2.633 . . . . 15.0 112.215 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.53 -42.1 1.53 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.475 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.05 -65.0 0.73 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 122.687 0.395 . . . . 15.0 110.109 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.522 ' HB2' ' HE1' ' A' ' 189' ' ' MET . 10.8 pt-20 -66.59 -26.43 67.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.019 0.825 . . . . 15.0 111.42 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.441 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.0 m-20 -68.31 -32.28 72.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.98 0.912 . . . . 15.0 110.62 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.45 -11.08 85.83 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.39 -0.823 . . . . 15.0 112.837 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.11 -53.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.962 -0.755 . . . . 15.0 108.962 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.567 ' HA ' HG13 ' A' ' 158' ' ' VAL . 57.9 pttt -83.12 31.79 0.44 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.63 1.172 . . . . 15.0 112.577 -170.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.59 25.99 2.42 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.896 -0.882 . . . . 15.0 110.896 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -145.91 -166.04 2.35 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.271 1.028 . . . . 15.0 110.41 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 8.8 ptpp? -146.44 159.16 43.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.14 0.976 . . . . 15.0 110.425 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 240' ' ' VAL . . . -65.67 145.59 55.84 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 120.733 0.302 . . . . 15.0 111.517 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.82 -44.03 1.51 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.984 -0.846 . . . . 15.0 110.984 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.6 pt-20 -77.6 129.95 36.27 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.921 -0.639 . . . . 15.0 109.695 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.94 109.8 18.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.693 -1.225 . . . . 15.0 107.693 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -128.45 -171.05 2.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.011 1.324 . . . . 15.0 110.133 -169.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 72.9 m -132.02 129.09 39.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.917 0.887 . . . . 15.0 108.867 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.9 pt -98.55 150.24 5.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.032 0.533 . . . . 15.0 110.396 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.26 112.3 24.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.84 -1.073 . . . . 15.0 108.973 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.6 166.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 67.6 m -141.44 129.19 21.64 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.22 133.41 81.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.733 -0.651 . . . . 15.0 109.584 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 221' ' ' TYR . 35.8 Cg_exo -44.45 161.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 124.234 3.289 . . . . 15.0 115.412 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -75.92 -30.08 58.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.652 -0.704 . . . . 15.0 110.349 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.38 -31.39 68.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.17 0.588 . . . . 15.0 110.525 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 218' ' ' PRO . 25.8 t80 -48.59 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.821 1.648 . . . . 15.0 110.554 -172.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.999 1.111 . . . . 15.0 113.999 -160.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.99 92.91 0.54 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 165.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.33 -41.87 85.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.952 0.901 . . . . 15.0 111.289 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.59 -15.92 43.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.082 0.953 . . . . 15.0 112.825 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 172' ' ' VAL . 64.7 mt -107.46 -30.9 8.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.915 0.886 . . . . 15.0 111.197 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -51.78 121.31 6.36 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.336 1.455 . . . . 15.0 112.036 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.06 -22.84 12.68 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.772 0.67 . . . . 15.0 113.942 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.1 147.16 40.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.304 0.552 . . . . 15.0 111.037 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.21 111.92 23.82 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.499 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.92 133.43 34.78 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.574 0.749 . . . . 15.0 111.874 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -90.0 107.68 19.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.198 0.999 . . . . 15.0 108.574 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.26 108.64 19.31 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.397 -0.964 . . . . 15.0 108.397 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.38 96.36 4.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.765 0.426 . . . . 15.0 109.993 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 mm -87.47 128.6 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.179 0.992 . . . . 15.0 110.651 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.9 100.93 8.8 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.313 1.045 . . . . 15.0 108.216 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 166' ' ' ILE . 87.5 mt -78.6 94.61 5.05 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.036 0.446 . . . . 15.0 109.816 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.19 -44.63 7.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.123 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.736 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.7 mmtt -127.31 135.84 51.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.239 0.616 . . . . 15.0 110.036 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 207' ' ' ALA . 98.6 t -127.6 103.68 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.573 1.149 . . . . 15.0 108.623 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 29.2 mt-10 -104.03 -175.26 2.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.637 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.0 tt0 -142.89 129.64 20.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.21 -0.663 . . . . 15.0 109.21 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 -78.55 84.39 4.68 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.37 144.14 30.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.984 -1.462 . . . . 15.0 110.79 -174.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.61 119.76 53.53 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.838 0.855 . . . . 15.0 109.636 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 69.4 Cg_endo -68.2 -169.58 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.418 2.745 . . . . 15.0 112.558 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.4 148.0 46.76 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.209 -0.905 . . . . 15.0 110.759 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 25.6 tp -121.65 15.8 11.1 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.9 p -66.66 179.55 1.04 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.627 1.171 . . . . 15.0 112.135 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.13 -61.85 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.689 1.595 . . . . 15.0 114.635 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.91 -1.76 27.03 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.48 0.712 . . . . 15.0 112.806 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -99.22 -50.57 4.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.357 0.663 . . . . 15.0 109.563 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.56 HG13 HD22 ' A' ' 266' ' ' LEU . 18.0 tt -64.56 -29.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.961 0.504 . . . . 15.0 111.357 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . 18.7 ptmt -76.99 -18.04 58.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.385 0.513 . . . . 15.0 112.385 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -69.11 -18.85 64.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.388 0.675 . . . . 15.0 110.909 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -74.16 -22.3 59.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.788 0.835 . . . . 15.0 111.495 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 139.74 -28.97 2.5 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 112.569 -0.212 . . . . 15.0 112.569 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.17 84.58 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.68 0.792 . . . . 15.0 109.671 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -63.69 -27.63 69.35 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.044 1.127 . . . . 15.0 114.044 -167.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -31.12 47.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.43 20.36 27.47 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.409 -0.662 . . . . 15.0 113.799 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 54.3 p -62.28 123.59 18.63 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.456 0.702 . . . . 15.0 111.091 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.81 -54.66 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.454 1.102 . . . . 15.0 111.242 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.62 -24.78 64.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.754 0.821 . . . . 15.0 111.991 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.7 -27.2 54.74 Favored Glycine 0 C--N 1.36 1.869 0 N-CA-C 110.609 -0.996 . . . . 15.0 110.609 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 253' ' ' ILE . 41.3 tp -75.1 -35.11 61.78 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -61.86 -41.79 98.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.576 0.548 . . . . 15.0 109.646 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.92 63.57 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.133 0.973 . . . . 15.0 111.065 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.05 -54.63 44.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.772 -1.104 . . . . 15.0 111.327 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.702 ' HB ' ' HE2' ' A' ' 274' ' ' MET . 30.8 m -69.07 -37.85 77.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.989 -1.005 . . . . 15.0 110.867 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -65.84 -42.98 89.84 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 119.104 0.865 . . . . 15.0 110.049 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -73.38 -26.08 60.85 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 118.364 0.529 . . . . 15.0 111.592 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -65.48 -52.8 50.32 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.659 0.742 . . . . 15.0 109.697 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.702 ' HE2' ' HB ' ' A' ' 270' ' ' VAL . 57.6 mtt -72.7 -14.97 61.69 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-N 114.59 -1.186 . . . . 15.0 111.415 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.23 -38.66 15.08 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.661 0.664 . . . . 15.0 109.922 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.45 -25.4 67.21 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.183 0.593 . . . . 15.0 110.235 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -84.5 -71.81 0.5 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.445 0.698 . . . . 15.0 110.77 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.459 HD22 HG13 ' A' ' 130' ' ' VAL . 43.3 tp -62.7 -54.23 42.46 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.042 1.337 . . . . 15.0 113.453 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.408 ' HA ' HD11 ' A' ' 282' ' ' ILE . 38.2 ttpt -70.93 -28.57 64.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 123.454 0.471 . . . . 15.0 110.79 -172.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -64.79 -46.9 80.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.779 -0.823 . . . . 15.0 108.779 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.0 71.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.572 0.749 . . . . 15.0 111.622 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 130' ' ' VAL . 96.0 mt -66.87 -55.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 N-CA-C 108.77 -0.826 . . . . 15.0 108.77 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.42 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 16.9 tpt180 -58.03 -41.53 83.39 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.087 0.867 . . . . 15.0 110.705 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.67 -32.75 70.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.154 0.582 . . . . 15.0 111.09 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -65.62 -51.94 55.75 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.1 0.409 . . . . 15.0 110.423 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 282' ' ' ILE . 21.8 t -62.03 -45.75 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.957 0.786 . . . . 15.0 109.778 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.7 tttt -64.95 -41.36 95.56 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.117 -0.947 . . . . 15.0 111.624 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.581 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 77.6 p -65.61 -42.61 91.41 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.726 0.239 . . . . 15.0 110.92 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.58 ' HB2' HG12 ' A' ' 125' ' ' VAL . 54.0 mt-30 -66.86 -34.81 78.61 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.324 0.39 . . . . 15.0 111.005 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.4 -50.31 68.11 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.807 0.443 . . . . 15.0 111.537 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 287' ' ' LYS . 31.4 mm -73.29 -55.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.408 0.683 . . . . 15.0 111.322 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.94 -27.03 68.57 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.728 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -66.54 -41.57 94.07 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 119.432 -0.649 . . . . 15.0 112.524 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.529 ' HB3' HD13 ' A' ' 350' ' ' LEU . 23.0 mt -56.91 -47.43 80.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.772 0.829 . . . . 15.0 110.552 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 22.9 t -58.28 -53.89 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.689 0.757 . . . . 15.0 109.593 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.24 -18.78 65.37 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.568 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.02 -25.69 22.98 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.9 155.03 28.85 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.887 1.069 . . . . 15.0 113.887 -168.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.82 145.31 55.63 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.108 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 5.9 tp -143.38 117.19 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.687 -0.688 . . . . 15.0 109.594 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -81.19 118.37 22.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.262 -1.014 . . . . 15.0 108.262 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.582 HG11 HD13 ' A' ' 307' ' ' ILE . 47.0 t -110.88 100.33 45.88 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.38 1.072 . . . . 15.0 109.289 -168.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 349' ' ' LEU . 58.8 Cg_endo -73.59 132.07 16.92 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.573 2.182 . . . . 15.0 112.255 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.21 -18.02 45.54 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.874 1.27 . . . . 15.0 112.201 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -45.86 -56.21 5.69 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.399 1.479 . . . . 15.0 111.578 171.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.44 -27.73 41.68 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.242 -1.344 . . . . 15.0 110.815 -172.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.582 HD13 HG11 ' A' ' 302' ' ' VAL . 2.0 mp -61.21 -54.25 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.347 -0.983 . . . . 15.0 108.347 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.83 -31.47 70.46 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.81 0.694 . . . . 15.0 110.429 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG21 ' A' ' 313' ' ' VAL . 41.3 t -61.8 -53.43 56.05 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 123.837 0.71 . . . . 15.0 111.231 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -80.23 -31.0 38.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.581 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 27.1 mt -59.04 -46.57 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 166.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.31 -41.63 80.26 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.888 0.875 . . . . 15.0 112.055 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.645 HG22 ' HA ' ' B' ' 447' ' ' HIS . 94.5 t -51.23 -58.35 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 124.291 0.994 . . . . 15.0 109.591 171.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.77 -17.0 62.21 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 113.806 -1.543 . . . . 15.0 112.436 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.5 mtm180 -76.47 -48.96 17.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.333 0.653 . . . . 15.0 109.75 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -65.32 -42.25 93.16 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.253 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.07 -38.01 89.5 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 114.915 -1.038 . . . . 15.0 110.809 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.18 -59.61 4.8 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 123.456 0.473 . . . . 15.0 109.957 175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 329' ' ' ALA . . . -56.26 -33.28 65.3 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.021 0.826 . . . . 15.0 112.405 -176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.86 -40.87 95.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.904 0.881 . . . . 15.0 110.47 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -93.31 -3.25 53.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.512 0.725 . . . . 15.0 110.955 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -95.72 9.52 40.11 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.642 1.177 . . . . 15.0 109.835 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.43 83.73 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.134 -0.484 . . . . 15.0 113.622 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.68 15.38 81.62 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 122.772 0.225 . . . . 15.0 113.017 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -74.86 152.54 38.91 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.549 0.739 . . . . 15.0 109.626 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 72.41 -70.1 0.17 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.526 1.53 . . . . 15.0 111.801 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 65.03 9.22 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.618 1.167 . . . . 15.0 112.371 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -89.3 15.56 8.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.888 1.275 . . . . 15.0 109.29 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.725 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -48.62 -33.2 9.44 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 125.754 1.622 . . . . 15.0 113.588 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.88 -29.08 26.13 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.045 0.938 . . . . 15.0 112.193 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -114.15 31.45 6.57 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.509 1.124 . . . . 15.0 110.828 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.725 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 19.6 mt -63.32 134.03 95.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-O 118.84 -0.6 . . . . 15.0 109.82 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -42.64 123.6 3.0 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 124.266 3.311 . . . . 15.0 113.479 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -52.73 -47.32 67.45 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 124.149 0.905 . . . . 15.0 111.498 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.78 -7.04 2.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.12 -43.95 63.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.397 0.544 . . . . 15.0 110.076 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.99 2.13 8.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.526 0.73 . . . . 15.0 112.614 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -58.57 -55.33 36.48 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.735 0.814 . . . . 15.0 111.007 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 40.6 tt0 -56.14 -60.9 2.83 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.796 1.31 . . . . 15.0 111.215 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -64.68 -38.16 90.03 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.85 -52.89 17.54 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 110.429 -0.212 . . . . 15.0 110.429 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.36 -28.1 64.81 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.908 0.755 . . . . 15.0 110.685 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.581 ' NH2' ' HA ' ' A' ' 288' ' ' SER . 0.2 OUTLIER -72.5 -36.9 68.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.887 0.875 . . . . 15.0 109.563 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.516 HH12 HG13 ' A' ' 313' ' ' VAL . 75.4 mtt180 -64.36 -35.09 79.76 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.886 0.312 . . . . 15.0 110.206 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.58 -53.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.883 0.873 . . . . 15.0 110.227 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.78 -47.28 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 114.304 -1.316 . . . . 15.0 111.239 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.585 HG11 HD13 ' A' ' 351' ' ' LEU . 53.9 t -61.8 -48.25 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 15.0 110.722 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.58 95.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.695 0.622 . . . . 15.0 113.575 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 303' ' ' PRO . 94.7 mt -79.74 -58.01 3.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.536 0.735 . . . . 15.0 110.96 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 294' ' ' LEU . 91.1 mt -65.31 -51.81 58.18 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.673 0.608 . . . . 15.0 111.044 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.585 HD13 HG11 ' A' ' 347' ' ' VAL . 39.8 mt -71.17 -33.68 70.23 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 118.843 -0.599 . . . . 15.0 111.222 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.66 92.05 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.78 -0.528 . . . . 15.0 111.78 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.59 -42.83 91.25 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.742 -0.729 . . . . 15.0 111.041 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 350' ' ' LEU . 89.7 t -58.99 -39.95 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 122.976 0.511 . . . . 15.0 111.3 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 360' ' ' LEU . 73.0 mt -68.83 -41.25 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.572 0.749 . . . . 15.0 110.198 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -60.23 -54.75 42.13 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.528 0.517 . . . . 15.0 110.631 174.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.3 m -60.64 -40.0 90.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.256 1.022 . . . . 15.0 111.945 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.6 8.62 43.74 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.511 0.725 . . . . 15.0 111.763 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 40.56 51.99 2.99 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.823 1.649 . . . . 15.0 113.648 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.609 ' HB2' HG21 ' A' ' 355' ' ' ILE . 78.5 mt -84.1 142.19 30.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.844 -1.071 . . . . 15.0 111.505 -176.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.62 151.67 49.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 167.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.24 94.87 0.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.036 0.535 . . . . 15.0 110.258 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.8 135.29 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.613 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -58.97 -35.87 73.91 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.12 0.888 . . . . 15.0 111.693 -170.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.49 -33.79 76.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.852 0.461 . . . . 15.0 110.755 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -80.89 -35.8 32.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.112 -0.495 . . . . 15.0 110.424 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.461 HG13 ' HG3' ' A' ' 398' ' ' MET . 86.4 t -56.99 -57.57 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.441 0.697 . . . . 15.0 109.544 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -62.89 -33.11 74.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.654 0.781 . . . . 15.0 111.413 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -54.97 -55.21 29.1 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.067 0.855 . . . . 15.0 111.627 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.52 -46.02 80.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.542 0.737 . . . . 15.0 111.26 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 398' ' ' MET . 47.0 mm -48.85 -61.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 124.539 1.149 . . . . 15.0 110.729 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.68 -37.69 73.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.775 0.658 . . . . 15.0 112.775 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.54 -46.84 77.98 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.043 0.449 . . . . 15.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.2 ttp -69.93 -35.98 74.98 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.432 1.093 . . . . 15.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.72 60.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.138 0.575 . . . . 15.0 112.038 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.4 t -65.83 -17.23 64.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.792 0.837 . . . . 15.0 111.501 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.03 -7.25 50.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.18 0.592 . . . . 15.0 111.664 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -103.31 166.23 10.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.238 1.015 . . . . 15.0 110.874 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.21 -29.2 63.74 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.278 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -155.12 112.71 2.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 15.0 107.7 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.46 -3.94 3.64 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.032 2.488 . . . . 15.0 115.469 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -60.69 -36.93 80.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.668 0.618 . . . . 15.0 112.668 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.1 -36.22 82.85 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.625 0.578 . . . . 15.0 109.897 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.33 -49.14 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.52 0.728 . . . . 15.0 110.121 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.93 -52.24 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 123.831 0.707 . . . . 15.0 109.9 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.33 -54.75 39.68 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.228 0.955 . . . . 15.0 110.674 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -51.09 -57.78 7.8 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.744 1.278 . . . . 15.0 111.566 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -58.37 -53.4 58.76 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.82 0.7 . . . . 15.0 110.662 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.1 p -62.71 -19.05 63.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.69 -7.01 21.01 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.448 0.699 . . . . 15.0 111.861 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 395' ' ' MET . 51.0 t-20 -121.69 86.26 2.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.959 -0.756 . . . . 15.0 108.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -58.62 -32.09 68.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.159 1.384 . . . . 15.0 111.41 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.6 -32.47 73.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.675 0.61 . . . . 15.0 110.754 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.552 HD13 HD22 ' B' ' 450' ' ' ASN . 22.3 tp -94.42 -20.18 19.94 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-O 119.464 -0.303 . . . . 15.0 111.112 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.515 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 77.2 mmm -59.38 -38.03 79.46 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.196 -0.668 . . . . 15.0 109.196 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.4 -60.24 1.57 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.869 1.268 . . . . 15.0 112.072 168.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -66.34 -34.93 79.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.178 0.991 . . . . 15.0 110.808 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.542 ' HG2' HD12 ' A' ' 371' ' ' ILE . 26.3 tpp -70.27 -27.32 64.33 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.851 0.861 . . . . 15.0 111.226 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 395' ' ' MET . 64.0 mtp85 -79.14 -35.18 42.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.48 -44.91 93.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.611 0.569 . . . . 15.0 110.244 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.0 p -75.7 -28.47 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 123.118 0.261 . . . . 15.0 111.33 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.71 -40.23 96.5 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.275 0.489 . . . . 15.0 110.278 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.532 ' HG ' HD13 ' A' ' 355' ' ' ILE . 27.8 tp -73.38 -36.4 66.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.521 -1.218 . . . . 15.0 110.238 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.79 -51.98 67.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.26 1.024 . . . . 15.0 111.187 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 75.3 mm-40 -67.08 -40.77 87.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.401 0.68 . . . . 15.0 110.865 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.501 HE21 ' HB3' ' A' ' 360' ' ' LEU . 23.9 tt0 -63.2 -34.3 77.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.794 0.838 . . . . 15.0 110.56 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.71 85.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.538 0.735 . . . . 15.0 111.505 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 94.4 t -52.98 -54.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 O-C-N 123.982 0.801 . . . . 15.0 108.914 171.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.47 ' HA ' HD13 ' A' ' 412' ' ' LEU . 31.2 mt-10 -62.47 -26.61 68.61 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.799 -1.091 . . . . 15.0 112.744 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.56 74.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.036 0.534 . . . . 15.0 110.882 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 294' ' ' LEU . 57.8 t -72.63 -35.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.847 -0.798 . . . . 15.0 108.847 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 409' ' ' GLU . 81.6 mt -65.77 -37.35 86.1 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.978 0.798 . . . . 15.0 110.89 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.28 64.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.365 -0.834 . . . . 15.0 112.125 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -106.71 -27.27 10.91 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.959 0.904 . . . . 15.0 111.867 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.21 158.94 16.97 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.743 0.817 . . . . 15.0 111.93 -171.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.441 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 88.4 mttt -69.04 78.77 0.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.454 1.101 . . . . 15.0 110.351 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 125' ' ' VAL . 25.5 t -97.9 103.11 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -78.41 119.9 22.38 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.368 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 32.2 tt0 -78.61 87.23 4.56 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.733 0.778 . . . . 15.0 109.263 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -95.66 100.74 12.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.859 -1.064 . . . . 15.0 110.704 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.03 128.54 35.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 15.0 109.279 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.441 HG22 HG22 ' A' ' 130' ' ' VAL . 7.7 t -161.93 176.88 10.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.725 0.41 . . . . 15.0 111.126 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 40.6 p -106.41 171.02 7.58 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.213 1.005 . . . . 15.0 111.669 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -43.57 -60.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.042 1.737 . . . . 15.0 113.593 -168.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.36 -23.02 65.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.732 1.012 . . . . 15.0 113.732 -167.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.4 ' HG2' HG21 ' A' ' 422' ' ' THR . 15.4 tp10 -45.21 -46.78 12.48 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.895 1.278 . . . . 15.0 112.966 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.66 -31.06 41.42 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.799 0.84 . . . . 15.0 110.943 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -71.74 -31.83 67.08 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.448 0.699 . . . . 15.0 110.04 175.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -75.72 20.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.27 1.028 . . . . 15.0 113.627 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.79 64.41 5.57 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.515 0.674 . . . . 15.0 109.831 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.01 102.18 14.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.23 1.012 . . . . 15.0 110.408 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . 0.448 ' HB3' ' HD1' ' B' ' 377' ' ' PHE . . . . . . . . 0 CA--C 1.552 1.028 0 C-N-CA 124.518 1.127 . . . . 15.0 109.683 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.443 0.639 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.83 136.09 5.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.395 1.078 . . . . 0.0 108.84 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.87 -81.94 0.48 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' B' ' 372' ' ' GLN . 12.4 t70 -91.45 -75.71 0.47 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' B' ' 373' ' ' ARG . 39.7 tt0 -104.02 -78.68 0.55 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.661 0.384 . . . . 0.0 110.428 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -104.38 -77.63 0.57 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.102 0.561 . . . . 0.0 110.258 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.402 HG21 ' NE2' ' B' ' 372' ' ' GLN . 0.6 OUTLIER -98.62 -82.96 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.503 ' HG2' ' H ' ' B' ' 373' ' ' ARG . 0.5 OUTLIER -101.69 -79.54 0.51 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 161.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' B' ' 372' ' ' GLN . 35.8 tpt85 -100.07 -85.18 0.41 Allowed 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.737 1.153 . . . . 0.0 111.653 -176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -106.67 -80.8 0.56 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -168.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.37 -79.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.797 0.439 . . . . 0.0 111.921 -169.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.22 -75.79 0.5 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.448 ' HD1' ' HB3' ' A' ' 432' ' ' ALA . 90.1 m-85 -105.31 -87.63 0.45 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.712 0.405 . . . . 0.0 110.546 167.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -106.35 -81.13 0.55 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.561 0.744 . . . . 0.0 111.902 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.425 ' HB2' ' HZ1' ' B' ' 379' ' ' LYS . 0.0 OUTLIER -108.85 -56.27 2.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.855 0.862 . . . . 0.0 113.237 -165.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? 75.02 149.04 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.368 1.467 . . . . 0.0 109.852 -158.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.83 166.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' B' ' 391' ' ' ASP . . . -148.75 84.17 0.17 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.189 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -61.41 97.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.791 0.836 . . . . 0.0 111.419 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 3.3 t -85.61 85.31 7.42 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 122.088 0.947 . . . . 0.0 110.347 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 19.6 tp -146.11 167.58 23.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.776 1.23 . . . . 0.0 107.745 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.38 91.32 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 118.999 0.818 . . . . 0.0 109.173 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.413 HG13 ' OH ' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -145.14 162.6 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 126.107 1.763 . . . . 0.0 108.088 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.51 HG22 ' HD2' ' A' ' 177' ' ' PHE . 28.8 t -55.78 138.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 8.7 t -57.4 96.13 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.934 1.35 . . . . 0.0 112.277 -170.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -92.8 -169.39 2.17 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.738 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.491 ' O ' ' HA2' ' B' ' 382' ' ' GLY . 5.6 m-20 -40.86 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.393 1.477 . . . . 0.0 111.497 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -120.92 60.06 0.92 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -79.07 75.73 5.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.149 0.976 . . . . 0.0 110.248 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -100.94 -23.45 14.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.898 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 66.09 -72.97 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.505 1.522 . . . . 0.0 111.963 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t 69.0 13.94 8.82 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.797 1.239 . . . . 0.0 111.819 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 62.0 -74.57 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.349 1.46 . . . . 0.0 110.624 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.26 125.84 43.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.26 94.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -166.94 145.01 4.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.281 1.032 . . . . 0.0 108.817 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.25 109.93 1.67 Allowed 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.392 2.061 . . . . 0.0 110.77 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.14 170.79 14.2 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.105 0.562 . . . . 0.0 110.581 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 14.8 t -143.22 155.56 44.55 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.616 0.366 . . . . 0.0 110.731 -171.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.456 ' HB2' ' HZ3' ' B' ' 404' ' ' LYS . 0.2 OUTLIER 70.28 7.27 6.15 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.765 1.626 . . . . 0.0 112.625 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.456 ' N ' ' HD2' ' B' ' 406' ' ' PRO . . . -70.75 -37.21 6.15 Favored Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.721 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' B' ' 405' ' ' ALA . 30.7 Cg_endo -61.68 -10.68 17.57 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 122.037 1.825 . . . . 0.0 113.324 172.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -78.75 78.91 1.61 Allowed Glycine 0 C--N 1.353 1.479 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.45 81.27 2.5 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.329 0.652 . . . . 0.0 110.506 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 36.1 p -79.14 99.91 7.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 171.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -79.11 70.87 5.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.377 0.608 . . . . 0.0 109.809 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.43 -23.24 61.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.903 0.881 . . . . 0.0 111.227 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.81 -11.39 55.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.463 0.705 . . . . 0.0 111.149 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -105.46 -82.62 0.52 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 15.0 t -172.57 167.25 5.51 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.142 0.977 . . . . 0.0 110.192 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -158.4 149.57 20.81 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 108.943 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -67.31 -49.1 65.55 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.326 0.65 . . . . 0.0 110.413 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 53.75 -97.83 0.03 OUTLIER Glycine 0 C--N 1.362 1.992 0 O-C-N 124.11 0.881 . . . . 0.0 113.534 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.48 145.69 47.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 46.2 t -70.87 82.75 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 122.187 0.994 . . . . 0.0 109.471 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 52.0 tpp -98.41 -76.51 0.53 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.857 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 44.6 t 50.77 -79.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.96 1.704 . . . . 0.0 112.69 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 22.2 mmt 66.56 175.5 0.24 Allowed 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.702 1.601 . . . . 0.0 111.778 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 50.9 p -73.37 -40.92 64.0 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 2.5 t80 65.64 -69.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.923 1.689 . . . . 0.0 111.035 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.08 -95.13 0.1 OUTLIER Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -177.83 -54.92 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.098 0.959 . . . . 0.0 109.291 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 34.2 t -148.42 77.19 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.11 -21.11 3.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.521 1.128 . . . . 0.0 111.328 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.54 -36.62 84.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.38 1.072 . . . . 0.0 110.045 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' B' ' 440' ' ' ARG . 8.6 p-10 -84.22 -23.52 30.44 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.593 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 32.9 t -67.28 -21.22 65.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.65 0.78 . . . . 0.0 111.018 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.98 -24.46 67.52 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.026 0.931 . . . . 0.0 110.852 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.25 -78.2 0.09 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 162.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -164.34 177.37 8.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.297 1.439 . . . . 0.0 108.964 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 30.7 m -69.42 100.57 1.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.691 0.796 . . . . 0.0 109.718 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 83.32 163.81 35.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.004 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 124.4 20.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.439 0.696 . . . . 0.0 111.063 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -116.53 -30.07 5.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.293 1.037 . . . . 0.0 110.213 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.03 -83.31 0.42 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.535 ' HG2' ' H ' ' B' ' 441' ' ' ILE . 23.8 ttm180 53.46 -161.23 0.12 Allowed 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 124.475 1.11 . . . . 0.0 111.9 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.535 ' H ' ' HG2' ' B' ' 440' ' ' ARG 0.306 0.0 OUTLIER 58.09 -78.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 C-N-CA 126.508 1.923 . . . . 0.0 113.353 163.428 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -155.41 -84.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 59.43 13.03 2.99 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 124.501 1.121 . . . . 0.0 113.457 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 59.45 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.215 1.406 . . . . 0.0 112.929 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.19 88.33 0.35 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.655 -2.578 . . . . 0.0 106.655 -165.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -88.82 176.7 3.27 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.441 2.761 . . . . 0.0 111.89 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.645 ' HA ' HG22 ' A' ' 313' ' ' VAL . 3.1 t60 -71.5 93.62 1.21 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.887 0.475 . . . . 0.0 110.54 -173.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 66.4 -72.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.546 1.538 . . . . 0.0 110.512 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -111.23 176.53 4.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.105 0.962 . . . . 0.0 109.189 171.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . 0.552 HD22 HD13 ' A' ' 394' ' ' LEU . 6.3 m-20 -59.6 -63.47 1.29 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.791 . . . . 0.0 111.129 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.1 -47.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 165.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.1 t 53.32 74.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 124.932 1.293 . . . . 0.0 110.034 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 83.88 119.54 0.75 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.964 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.38 -48.04 74.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.807 0.843 . . . . 0.0 110.207 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 65.9 p 48.35 31.04 2.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.117 1.767 . . . . 0.0 113.664 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -149.86 138.59 20.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -65.0 -33.29 75.69 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.823 0.702 . . . . 0.0 111.911 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 8.0 t 32.48 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.95 2.1 . . . . 0.0 114.971 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -56.22 -31.32 63.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.132 -168.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' B' ' 463' ' ' THR . 0.3 OUTLIER -101.38 36.47 2.01 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.182 -177.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . 0.304 19.3 p90 67.76 -39.91 0.4 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 128.256 2.622 . . . . 0.0 116.656 169.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -177.83 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.274 1.03 . . . . 0.0 109.652 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 463' ' ' THR . . . . . 0.579 ' HB ' HD11 ' B' ' 460' ' ' LEU . 72.4 m -34.95 118.2 0.42 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.719 1.607 . . . . 0.0 114.612 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.557 ' HB2' ' HB1' ' B' ' 467' ' ' ALA . 24.5 mmt 64.71 119.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.161 1.384 . . . . 0.0 112.302 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.25 -25.01 66.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.085 0.554 . . . . 0.0 110.521 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -96.03 17.99 14.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.528 1.131 . . . . 0.0 111.454 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' B' ' 464' ' ' MET . . . -146.22 94.53 2.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.121 0.569 . . . . 0.0 109.675 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.78 -166.36 1.45 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.722 0.809 . . . . 0.0 109.889 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.75 -169.26 22.94 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.567 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -155.55 -36.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.412 0.685 . . . . 0.0 110.408 -174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.706 ' HG3' ' HB3' ' A' ' 83' ' ' LYS . 4.2 ttmp? . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.304 1.042 . . . . 12.06 108.293 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 23.3 ptm . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.5 -0.185 . . . . 15.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -150.91 113.29 4.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 17' ' ' ILE . 28.9 m -123.67 146.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.695 0.798 . . . . 15.0 110.29 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 p -137.36 115.47 11.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.377 0.671 . . . . 15.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.33 131.99 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.096 0.559 . . . . 15.0 111.094 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -135.34 148.71 49.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.841 1.256 . . . . 15.0 108.443 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 m -93.46 112.06 23.87 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.538 -0.541 . . . . 15.0 109.538 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -80.52 -44.33 19.3 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.974 0.51 . . . . 15.0 111.284 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -167.42 94.52 0.44 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.344 0.657 . . . . 15.0 109.786 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.36 -102.86 0.41 Allowed Glycine 0 C--N 1.352 1.461 0 O-C-N 123.958 0.786 . . . . 15.0 113.765 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 113' ' ' PRO . 50.9 tp -68.49 -35.25 77.25 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.879 0.872 . . . . 15.0 110.733 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.43 135.26 22.03 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.138 -0.937 . . . . 15.0 112.079 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.6 -177.31 4.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.921 1.288 . . . . 15.0 109.757 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -150.15 110.52 4.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.89 0.876 . . . . 15.0 109.709 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.3 t -98.56 92.03 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.709 -0.848 . . . . 15.0 108.709 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 44.8 m -75.11 105.03 5.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.554 0.742 . . . . 15.0 109.87 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 3' ' ' VAL . 35.8 mt -93.31 115.77 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.857 -0.611 . . . . 15.0 109.6 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -92.71 96.41 10.15 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.433 -0.951 . . . . 15.0 108.433 166.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 70' ' ' LEU . 74.3 mt -73.27 98.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 171.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.93 162.64 23.84 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.232 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.6 -22.35 55.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.572 1.149 . . . . 15.0 113.955 -170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.84 -42.89 89.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.884 0.474 . . . . 15.0 110.508 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -73.68 -36.57 65.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.493 -0.776 . . . . 15.0 110.923 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -68.07 -59.05 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.933 0.493 . . . . 15.0 110.204 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.37 -41.84 97.74 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.217 1.007 . . . . 15.0 112.291 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 m -64.99 -42.11 94.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.647 0.592 . . . . 15.0 110.979 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.31 71.41 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 15.0 112.007 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' HA ' HG23 ' A' ' 66' ' ' VAL . 79.5 t -62.82 -45.43 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 15.0 110.31 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.694 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 3.8 ttmp? -66.27 -39.27 89.33 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.249 -1.341 . . . . 15.0 110.367 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 m -72.27 -21.91 61.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.12 0.968 . . . . 15.0 111.01 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.8 tp10 -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.658 0.383 . . . . 15.0 111.221 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.53 -26.54 65.48 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.382 0.273 . . . . 15.0 111.7 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 p -76.54 -29.2 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 123.245 0.34 . . . . 15.0 110.097 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -66.29 -46.33 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.967 0.507 . . . . 15.0 109.934 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' GLU . 61.0 t -65.54 -37.54 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.983 0.913 . . . . 15.0 110.167 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.24 92.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.32 0.648 . . . . 15.0 111.182 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.58 -23.87 39.59 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.923 0.489 . . . . 15.0 111.513 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.98 -49.3 38.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.613 0.765 . . . . 15.0 110.188 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.38 -5.91 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.944 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 69.47 21.1 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.097 1.359 . . . . 15.0 111.95 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -64.37 -26.28 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 124.331 1.052 . . . . 15.0 111.126 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -59.38 -36.69 76.25 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.112 0.965 . . . . 15.0 111.627 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.54 -10.92 80.08 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.359 -0.382 . . . . 15.0 113.598 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -119.23 2.23 11.36 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.037 0.935 . . . . 15.0 110.774 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.5 ttt85 -76.86 94.86 3.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.288 0.635 . . . . 15.0 110.027 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -80.3 86.5 5.67 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.397 -0.82 . . . . 15.0 110.835 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 37.26 -56.57 0.0 OUTLIER Glycine 0 CA--C 1.55 2.266 0 N-CA-C 120.142 2.817 . . . . 15.0 120.142 160.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -43.09 -47.9 6.13 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.205 1.802 . . . . 15.0 114.228 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.44 106.37 16.31 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.75 0.42 . . . . 15.0 110.192 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 3.5 Cg_exo -78.84 156.63 27.31 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.514 2.809 . . . . 15.0 112.299 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.423 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 58.9 tpp -70.58 -27.18 63.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.863 0.865 . . . . 15.0 111.752 -172.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.688 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 34.0 p-10 -69.84 -28.97 66.13 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.849 0.46 . . . . 15.0 111.924 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.502 HG21 ' HD2' ' A' ' 57' ' ' ARG . 12.3 mt -72.36 -51.89 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.665 0.786 . . . . 15.0 110.14 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 33.8 m -68.61 -25.6 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.47 0.545 . . . . 15.0 112.47 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.12 92.96 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.393 0.677 . . . . 15.0 112.59 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -117.25 -3.56 11.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 -170.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.502 ' HD2' HG21 ' A' ' 53' ' ' ILE . 75.9 mtt180 -115.64 -45.84 2.88 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.135 0.425 . . . . 15.0 111.623 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.454 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 94.9 m-85 -104.69 -39.01 6.5 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.202 0.816 . . . . 15.0 113.202 -168.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.84 39.5 2.78 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 112.492 -0.243 . . . . 15.0 112.492 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.58 61.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.906 0.882 . . . . 15.0 112.098 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p -73.71 -35.58 65.13 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.062 0.945 . . . . 15.0 111.088 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -69.13 -25.22 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.724 0.81 . . . . 15.0 110.622 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 25.3 mtp180 -61.1 -22.1 64.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.643 0.777 . . . . 15.0 111.951 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.73 -54.23 49.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.136 0.975 . . . . 15.0 111.232 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 -27.46 66.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 28' ' ' VAL . 94.7 t -64.85 -43.28 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 123.61 0.568 . . . . 15.0 109.76 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 91.5 mt -62.37 -41.65 98.8 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.997 0.519 . . . . 15.0 111.162 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.62 99.13 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.644 0.59 . . . . 15.0 112.282 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.66 -41.17 96.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.384 1.074 . . . . 15.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 19' ' ' ILE . 71.2 mt -67.84 -34.53 76.89 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.661 -0.7 . . . . 15.0 111.01 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.2 mtm -67.8 -20.69 65.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.566 0.346 . . . . 15.0 111.255 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -87.2 -55.7 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 15.0 110.203 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -72.76 -39.09 67.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.463 0.705 . . . . 15.0 112.544 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -73.22 -27.07 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 117.875 0.307 . . . . 15.0 110.704 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.87 -54.12 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.222 -0.288 . . . . 15.0 110.222 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.3 tt -65.04 -37.32 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 123.423 0.452 . . . . 15.0 110.896 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.665 0.786 . . . . 15.0 110.653 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.03 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.48 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 76' ' ' ILE . 33.3 pt -67.06 -23.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 112.717 0.636 . . . . 15.0 112.717 -172.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.39 -53.4 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.452 0.701 . . . . 15.0 110.652 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.478 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -75.1 -29.5 60.62 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.607 0.363 . . . . 15.0 111.455 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -84.31 -16.35 43.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.278 0.631 . . . . 15.0 111.454 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 66.77 14.06 9.64 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.64 1.176 . . . . 15.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.442 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 74.7 mt -77.24 105.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' ND2' ' HG ' ' B' ' 470' ' ' LEU . 43.7 t30 -81.0 110.03 15.98 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.45 148.53 38.14 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.585 2.19 . . . . 15.0 112.957 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.65 -177.74 6.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.505 0.722 . . . . 15.0 109.856 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' HB3' ' A' ' 305' ' ' ALA . . . 64.1 -102.13 0.56 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.86 116.34 2.43 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 107.826 -1.175 . . . . 15.0 107.826 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 43.5 Cg_exo -59.59 105.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 121.687 1.591 . . . . 15.0 110.249 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 m -101.71 99.26 9.5 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.247 -0.649 . . . . 15.0 109.247 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.39 78.19 3.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.636 0.774 . . . . 15.0 109.134 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.05 109.47 3.29 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.46 106.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.118 2.545 . . . . 15.0 111.961 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.85 -79.32 0.57 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.243 -0.743 . . . . 15.0 111.243 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -168.16 151.2 5.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.4 0.68 . . . . 15.0 111.533 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.79 142.21 44.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.601 1.16 . . . . 15.0 109.398 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.2 mttt -133.54 142.83 48.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.259 1.024 . . . . 15.0 108.773 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -61.61 106.18 0.63 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 15.0 110.251 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.64 -17.52 58.79 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 116.038 -0.528 . . . . 15.0 113.477 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 43.4 mt-10 -97.94 -173.52 2.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.563 0.745 . . . . 15.0 110.095 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -72.78 160.09 32.74 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.909 0.883 . . . . 15.0 112.492 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -121.55 106.12 11.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.73 1.212 . . . . 15.0 108.56 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 m -105.07 139.52 39.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.624 0.77 . . . . 15.0 109.93 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -159.96 143.58 14.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.027 0.931 . . . . 15.0 108.818 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.8 m -100.64 107.99 19.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.72 0.808 . . . . 15.0 110.565 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.15 97.69 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.98 -0.748 . . . . 15.0 108.98 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.3 123.05 35.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.229 0.612 . . . . 15.0 109.882 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.548 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 47.1 p90 -159.52 157.85 30.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.772 0.829 . . . . 15.0 110.276 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.3 176.63 7.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 15.0 109.994 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.36 175.96 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.435 ' HB2' ' HA ' ' B' ' 471' ' ' LYS . 94.4 m-85 -89.76 118.08 68.67 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' HD12 ' A' ' 300' ' ' ILE . 58.6 Cg_endo -88.53 173.03 4.63 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.606 2.204 . . . . 15.0 114.427 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.65 134.68 33.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.123 -1.399 . . . . 15.0 109.059 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.49 126.98 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.417 -0.586 . . . . 15.0 109.417 172.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -84.3 94.13 8.38 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.4 145.25 54.5 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.141 -0.936 . . . . 15.0 108.763 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -79.15 173.83 12.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.58 109.86 2.43 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.548 -1.021 . . . . 15.0 110.548 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.447 HD12 HG23 ' A' ' 411' ' ' VAL . 47.1 mt -66.8 -14.12 62.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.609 0.763 . . . . 15.0 111.246 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.96 -22.61 63.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.289 . . . . 15.0 111.289 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.74 62.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.773 0.829 . . . . 15.0 110.947 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.04 131.34 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.619 0.768 . . . . 15.0 109.657 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.25 123.84 49.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.911 0.884 . . . . 15.0 109.618 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.534 ' HB ' HG22 ' A' ' 417' ' ' VAL . 61.4 t -125.27 163.66 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.838 1.255 . . . . 15.0 107.917 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.34 143.97 48.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.532 0.733 . . . . 15.0 109.262 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HE2' HD13 ' A' ' 129' ' ' ILE . 80.6 tttt -114.87 93.52 34.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.133 -1.062 . . . . 15.0 108.133 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.79 98.61 1.22 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.17 1.914 . . . . 15.0 112.289 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.446 HD13 ' HE2' ' A' ' 127' ' ' LYS . 48.5 mm -72.52 96.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.563 HG21 HD13 ' A' ' 427' ' ' LEU . 21.0 t -122.74 142.82 37.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.526 -0.761 . . . . 15.0 109.997 -173.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.47 146.25 39.81 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.817 0.847 . . . . 15.0 108.932 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.54 88.81 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.5 p -76.24 -179.85 5.31 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.894 0.878 . . . . 15.0 110.339 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.92 -37.59 74.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.444 0.698 . . . . 15.0 111.689 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.8 96.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 15.0 111.492 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.45 -42.94 52.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.808 0.843 . . . . 15.0 111.556 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.79 -56.44 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.902 0.881 . . . . 15.0 109.489 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.37 -45.89 92.49 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.175 0.99 . . . . 15.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.33 -46.91 89.35 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.919 0.762 . . . . 15.0 113.333 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.24 -51.68 50.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.143 0.577 . . . . 15.0 110.896 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.2 mt -53.91 -39.39 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.569 0.748 . . . . 15.0 111.86 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.43 -40.9 85.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.925 0.49 . . . . 15.0 111.027 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 m -67.89 -26.74 66.16 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.752 0.421 . . . . 15.0 110.756 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.86 -37.73 76.19 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.852 0.461 . . . . 15.0 110.333 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -64.68 -35.06 79.82 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.707 0.289 . . . . 15.0 110.424 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -69.3 -34.6 74.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.306 0.642 . . . . 15.0 111.099 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.66 -41.26 79.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 15.0 109.98 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -95.1 29.66 2.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.027 0.931 . . . . 15.0 111.184 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.525 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.09 135.48 46.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.106 0.562 . . . . 15.0 112.434 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.1 m -83.54 138.85 33.22 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.625 1.17 . . . . 15.0 110.25 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -80.16 139.17 36.91 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.829 0.452 . . . . 15.0 110.236 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 33.1 ttpt -156.98 172.99 17.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.09 -1.078 . . . . 15.0 108.09 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 41.6 mt-10 -121.64 165.72 15.33 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.97 0.908 . . . . 15.0 110.035 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.538 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 41.6 pttt -156.78 -179.92 8.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.031 0.933 . . . . 15.0 110.87 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.03 146.95 28.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.977 0.511 . . . . 15.0 109.655 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.19 -50.21 0.88 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.0 -0.889 . . . . 15.0 113.533 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.57 153.89 33.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.465 1.132 . . . . 15.0 112.234 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.84 157.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.47 1.108 . . . . 15.0 109.517 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -138.51 -174.88 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.485 1.914 . . . . 15.0 108.252 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.08 -8.73 59.03 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.459 0.911 . . . . 15.0 113.459 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.52 -6.5 20.55 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.143 0.429 . . . . 15.0 112.021 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -81.61 178.4 8.36 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.054 1.131 . . . . 15.0 114.054 -165.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.706 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 16.0 mtm180 -116.27 98.77 6.78 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.833 -1.076 . . . . 15.0 108.503 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.01 97.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 -169.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 9.0 m -73.32 111.73 8.72 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.851 -1.166 . . . . 15.0 107.851 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.8 pt -132.95 179.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.422 1.089 . . . . 15.0 110.924 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.8 t70 -130.04 157.53 42.1 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.179 1.391 . . . . 15.0 107.713 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.493 ' HE2' HD12 ' B' ' 385' ' ' LEU . 24.4 p90 -144.61 150.59 37.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.636 0.731 . . . . 15.0 111.074 164.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.545 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 1.8 t -125.99 95.12 4.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 106.467 -1.679 . . . . 15.0 106.467 166.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.96 166.77 31.34 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 114.93 -1.032 . . . . 15.0 115.067 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -151.19 141.97 22.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.964 1.306 . . . . 15.0 108.283 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 177' ' ' PHE . 98.3 t -118.55 137.52 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.584 0.754 . . . . 15.0 109.141 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.54 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 35.3 t70 70.48 5.83 5.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.721 1.208 . . . . 15.0 111.875 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.31 -1.0 46.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.722 -0.488 . . . . 15.0 113.37 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.01 145.41 49.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.627 0.771 . . . . 15.0 110.576 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -76.01 110.48 10.52 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.149 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 172' ' ' VAL . 32.7 p90 -70.84 170.38 12.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.219 0.608 . . . . 15.0 111.259 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -69.68 134.56 48.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.63 -1.168 . . . . 15.0 111.057 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.579 ' HA3' HG12 ' B' ' 386' ' ' VAL . . . 88.25 -78.64 1.75 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 -52.4 4.17 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.412 0.925 . . . . 15.0 115.412 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.545 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 40.6 mmtt -85.9 145.97 26.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.913 1.079 . . . . 15.0 113.913 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.05 92.48 1.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.658 -1.61 . . . . 15.0 106.933 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -96.32 143.78 27.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.308 -0.86 . . . . 15.0 110.967 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' B' ' 379' ' ' LYS . 7.5 t70 65.75 21.92 11.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.338 1.055 . . . . 15.0 111.373 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 165' ' ' THR . 46.7 t80 -71.59 134.23 46.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.225 0.61 . . . . 15.0 110.579 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.35 103.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.794 -0.817 . . . . 15.0 108.794 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.44 ' HG ' ' HG2' ' A' ' 189' ' ' MET . 27.0 tp -82.8 80.1 8.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 15.0 110.047 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.54 92.44 0.31 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.691 -1.226 . . . . 15.0 107.691 167.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.668 ' HE2' ' HB2' ' A' ' 199' ' ' GLU . 62.5 mtp -66.98 144.64 56.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.394 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.12 14.57 Favored Glycine 0 N--CA 1.471 0.978 0 O-C-N 123.496 0.498 . . . . 15.0 112.494 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.44 -178.96 3.65 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.27 1.028 . . . . 15.0 110.339 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.17 6.93 56.5 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 115.912 -0.586 . . . . 15.0 113.518 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -77.84 2.09 18.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.098 0.559 . . . . 15.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.7 mmt -134.74 154.53 51.54 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.911 0.884 . . . . 15.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.57 152.84 37.94 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 114.757 -1.11 . . . . 15.0 109.374 170.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.93 143.97 46.95 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.03 2.487 . . . . 15.0 112.928 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.24 -40.29 2.47 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 115.803 -0.635 . . . . 15.0 112.164 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -67.85 -63.81 0.99 Allowed 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.668 ' HB2' ' HE2' ' A' ' 189' ' ' MET . 5.4 pt-20 -62.28 -24.57 67.36 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.437 -0.801 . . . . 15.0 112.077 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.91 -37.59 81.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.083 0.953 . . . . 15.0 110.682 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.78 -10.95 80.79 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.468 -0.787 . . . . 15.0 113.075 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 187' ' ' LEU . 42.9 mm -94.84 -47.12 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.763 0.825 . . . . 15.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.514 ' HB3' ' HE1' ' A' ' 189' ' ' MET . 19.6 pttm -82.41 19.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.325 1.232 . . . . 15.0 114.325 -167.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.78 25.39 5.31 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.99 -1.244 . . . . 15.0 109.99 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -140.71 -169.96 2.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.729 1.211 . . . . 15.0 110.213 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -153.52 163.56 39.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.996 0.918 . . . . 15.0 110.675 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -68.07 132.2 46.81 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.38 0.672 . . . . 15.0 112.06 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 126.77 -28.24 4.71 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.761 -1.109 . . . . 15.0 111.799 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.8 pt-20 -96.14 139.32 32.48 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.727 0.775 . . . . 15.0 111.455 -174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.27 125.8 51.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.981 1.313 . . . . 15.0 108.948 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -144.38 169.67 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.073 0.949 . . . . 15.0 109.769 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 70.2 m -124.34 120.45 32.17 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -95.64 160.48 2.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.497 0.719 . . . . 15.0 111.207 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -104.92 118.42 36.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.99 -1.005 . . . . 15.0 109.903 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.6 163.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 87.3 m -146.26 131.9 18.86 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.971 -1.122 . . . . 15.0 107.971 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' HZ ' ' HB ' ' B' ' 387' ' ' ILE . 73.0 m-85 -68.23 135.47 91.32 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 110.128 -0.323 . . . . 15.0 110.128 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.21 156.68 19.91 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.161 2.574 . . . . 15.0 113.515 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -75.22 -20.71 59.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.917 169.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.22 -16.7 57.59 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.914 0.886 . . . . 15.0 111.21 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.417 ' HE2' ' HB1' ' A' ' 223' ' ' ALA . 69.5 t80 -60.66 142.09 56.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.069 0.948 . . . . 15.0 111.616 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -65.03 -44.95 87.45 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.027 0.931 . . . . 15.0 112.76 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 221' ' ' TYR . . . -88.2 104.11 16.4 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.791 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.8 tt0 -63.3 -21.08 66.03 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.672 1.189 . . . . 15.0 112.428 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.44 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 29.6 p30 -68.14 -10.56 55.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.809 0.843 . . . . 15.0 112.518 174.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' B' ' 388' ' ' VAL . 79.1 mt -121.39 -36.91 2.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.235 1.014 . . . . 15.0 110.05 175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.791 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 9.3 tttm -53.48 128.89 30.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.779 1.632 . . . . 15.0 111.991 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.02 16.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.998 -0.547 . . . . 15.0 113.22 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.54 ' HD3' ' HB2' ' A' ' 173' ' ' ASP . 93.3 mttt -86.24 147.44 26.1 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.379 0.672 . . . . 15.0 110.343 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.25 166.63 22.48 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.728 0.643 . . . . 15.0 110.416 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.02 119.62 5.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.39 0.676 . . . . 15.0 109.816 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -98.86 134.45 41.72 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -128.54 110.73 12.54 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.87 0.468 . . . . 15.0 110.273 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.466 ' HB2' HG23 ' A' ' 169' ' ' THR . . . -77.8 91.73 4.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.405 0.622 . . . . 15.0 109.342 176.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.6 mm -81.16 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.926 1.29 . . . . 15.0 110.636 -176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.581 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -111.3 97.25 6.64 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.463 -1.31 . . . . 15.0 107.463 176.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -81.41 118.55 22.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -115.46 -37.49 4.0 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.588 0.355 . . . . 15.0 111.618 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.734 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.0 mmtt -135.87 142.97 44.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.999 0.52 . . . . 15.0 110.235 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 207' ' ' ALA . 41.8 t -118.45 94.49 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.644 -1.243 . . . . 15.0 107.644 169.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.706 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.7 mt-10 -88.28 167.01 13.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.538 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.8 tt0 -138.9 130.54 27.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.949 0.499 . . . . 15.0 109.823 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -86.14 85.8 7.35 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.673 -1.232 . . . . 15.0 107.673 166.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.76 134.7 53.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.856 -1.065 . . . . 15.0 109.837 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.41 126.59 87.46 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.788 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 63.9 Cg_endo -68.93 157.95 59.84 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.958 2.439 . . . . 15.0 111.917 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -70.9 160.13 33.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.938 -1.028 . . . . 15.0 110.415 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.4 tp -88.3 30.01 0.92 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.622 0.769 . . . . 15.0 109.83 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.6 p -70.14 169.57 13.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.518 1.127 . . . . 15.0 111.623 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -37.97 -65.86 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.082 1.753 . . . . 15.0 114.72 -166.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.01 -22.57 66.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.678 0.791 . . . . 15.0 112.611 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -86.74 -49.87 7.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.061 0.544 . . . . 15.0 110.465 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.41 -31.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.758 0.423 . . . . 15.0 110.78 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.3 ptmt -98.97 5.14 47.33 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -61.27 -31.11 70.93 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.377 0.671 . . . . 15.0 110.777 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.12 -18.72 64.71 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.087 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.67 45.45 1.79 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.703 -0.559 . . . . 15.0 111.703 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 260' ' ' ASP . 65.8 t -71.91 149.28 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.717 0.807 . . . . 15.0 111.431 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -55.97 -41.51 74.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.478 1.111 . . . . 15.0 111.601 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.467 ' H ' HG11 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -128.36 -47.97 1.31 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.581 -175.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 114.73 -12.62 20.57 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.634 -0.536 . . . . 15.0 113.373 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 94.2 p -73.47 167.64 20.88 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.558 0.679 . . . . 15.0 110.955 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.85 -49.41 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.124 0.97 . . . . 15.0 111.257 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.32 -28.8 68.42 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.314 0.646 . . . . 15.0 111.715 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.67 -26.13 57.11 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.129 -0.788 . . . . 15.0 111.129 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 270' ' ' VAL . 63.9 tp -74.71 -33.7 62.46 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -61.57 -40.08 93.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.396 0.679 . . . . 15.0 109.919 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.6 86.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.698 0.799 . . . . 15.0 111.317 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.549 ' HA ' ' HZ1' ' A' ' 272' ' ' LYS . 23.7 tp10 -67.3 -49.49 64.01 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.661 0.784 . . . . 15.0 110.516 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.478 ' HA ' ' SD ' ' A' ' 274' ' ' MET . 70.2 t -61.67 -33.67 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.736 1.214 . . . . 15.0 109.75 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -62.85 -61.65 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.493 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.549 ' HZ1' ' HA ' ' A' ' 269' ' ' GLU . 24.4 pttm -71.71 -15.73 62.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.774 0.657 . . . . 15.0 112.774 -174.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -89.27 -78.78 0.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 270' ' ' VAL . 1.7 mpt? -62.85 -50.58 70.37 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.656 -0.687 . . . . 15.0 111.553 -169.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.15 -34.32 56.49 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.586 0.63 . . . . 15.0 111.656 -170.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -73.57 -44.08 58.21 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.942 -0.392 . . . . 15.0 109.942 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.03 -37.87 88.92 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.609 0.568 . . . . 15.0 109.783 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.13 -60.87 2.85 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.405 0.682 . . . . 15.0 111.354 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.83 -29.47 69.94 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.726 0.641 . . . . 15.0 111.281 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -65.34 -46.11 81.55 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.68 -30.72 68.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.772 0.829 . . . . 15.0 111.761 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.507 HD12 ' HB ' ' A' ' 130' ' ' VAL . 90.1 mt -67.88 -51.42 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.558 HH21 ' HB3' ' A' ' 405' ' ' GLU . 22.9 tpt180 -61.05 -41.84 97.36 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.351 -0.84 . . . . 15.0 110.429 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -72.09 -30.27 64.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.799 -0.619 . . . . 15.0 110.851 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -64.24 -57.89 8.15 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.985 0.514 . . . . 15.0 109.672 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 282' ' ' ILE . 42.1 t -57.33 -46.17 85.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 124.263 0.977 . . . . 15.0 110.216 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -59.45 -55.75 30.67 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.749 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -65.15 -28.86 69.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.311 0.644 . . . . 15.0 111.995 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.474 ' HB2' HG12 ' A' ' 125' ' ' VAL . 58.6 mt-30 -68.29 -44.32 75.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.563 0.345 . . . . 15.0 110.506 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.34 -42.32 96.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.578 0.351 . . . . 15.0 111.202 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -60.35 -53.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 15.0 111.01 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.78 -41.23 99.16 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.985 0.803 . . . . 15.0 110.271 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.19 91.88 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.939 0.775 . . . . 15.0 112.095 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.6 HD13 HG21 ' A' ' 411' ' ' VAL . 35.1 mt -59.03 -56.73 18.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.96 0.904 . . . . 15.0 111.846 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.31 -53.73 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.581 0.551 . . . . 15.0 110.3 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.88 -40.3 75.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.499 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.58 -33.93 67.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.022 -0.536 . . . . 15.0 112.224 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -116.76 103.85 10.76 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.038 0.381 . . . . 15.0 111.433 -163.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -74.11 144.52 44.9 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.589 HD12 ' HG2' ' A' ' 113' ' ' PRO . 5.3 tp -165.08 130.39 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.408 0.683 . . . . 15.0 110.214 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.58 95.88 4.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.536 HG12 HG12 ' A' ' 345' ' ' VAL . 22.7 t -89.04 128.02 53.43 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 109.264 -0.643 . . . . 15.0 109.264 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.2 135.12 33.44 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.466 2.111 . . . . 15.0 111.858 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -64.5 -4.77 4.33 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.095 1.146 . . . . 15.0 114.095 -171.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.428 ' HB3' ' N ' ' A' ' 88' ' ' GLY . . . -56.83 -55.14 38.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.989 0.915 . . . . 15.0 110.803 174.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.57 -35.63 77.64 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.654 1.221 . . . . 15.0 110.89 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.642 ' HA ' HG22 ' A' ' 345' ' ' VAL . 2.1 mp -60.33 -56.68 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.964 -0.754 . . . . 15.0 108.964 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.16 -28.43 68.11 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.789 0.681 . . . . 15.0 111.135 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.0 t -60.67 -53.54 56.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.028 0.931 . . . . 15.0 111.222 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -76.73 -30.14 56.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.329 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.592 HD11 ' HG3' ' A' ' 334' ' ' ARG . 71.3 mt -60.99 -39.18 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 168.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 27.5 t70 -66.41 -40.22 89.46 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-O 118.398 -0.811 . . . . 15.0 110.607 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.67 -47.74 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.164 0.507 . . . . 15.0 110.281 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.43 -27.01 63.93 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.202 -0.908 . . . . 15.0 112.047 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 84.1 mtm180 -71.85 -39.25 69.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.584 0.753 . . . . 15.0 110.54 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 22.0 mmt180 -65.21 -42.76 93.19 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.222 -0.658 . . . . 15.0 109.222 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -56.63 -50.34 72.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.651 1.181 . . . . 15.0 111.176 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.86 -59.31 5.63 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.278 0.631 . . . . 15.0 110.797 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.48 66.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.607 0.763 . . . . 15.0 112.366 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -65.44 -40.92 93.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.391 1.076 . . . . 15.0 110.552 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.431 ' NH2' ' HB2' ' B' ' 437' ' ' SER . 56.1 mtp180 -87.66 -8.35 56.27 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.062 0.458 . . . . 15.0 110.268 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -90.46 17.48 7.31 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 124.27 1.028 . . . . 15.0 109.753 167.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' B' ' 432' ' ' GLN . . . 92.6 17.61 44.62 Favored Glycine 0 C--N 1.356 1.694 0 CA-C-O 119.543 -0.587 . . . . 15.0 113.799 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 66.07 43.71 92.81 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 117.131 0.465 . . . . 15.0 112.075 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -63.55 92.11 0.06 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.834 0.854 . . . . 15.0 112.75 -170.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 52.3 20.43 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.457 1.651 . . . . 15.0 115.457 164.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 58.65 30.11 19.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.364 1.066 . . . . 15.0 111.594 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.19 10.71 3.34 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.645 1.178 . . . . 15.0 112.359 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.03 -46.77 33.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.255 1.422 . . . . 15.0 112.537 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.41 -32.66 65.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.515 0.726 . . . . 15.0 112.178 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.53 -27.97 60.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.092 0.557 . . . . 15.0 111.496 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.84 128.23 63.05 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 123.455 0.472 . . . . 15.0 110.363 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.562 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.6 Cg_exo -47.96 118.23 2.99 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.56 2.84 . . . . 15.0 113.649 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.592 ' HG3' HD11 ' A' ' 311' ' ' ILE . 66.3 ttt180 -52.79 -37.5 59.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.075 0.95 . . . . 15.0 112.028 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -10.22 48.84 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.572 0.749 . . . . 15.0 112.964 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.562 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.9 mt -71.27 -30.0 65.76 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.16 0.436 . . . . 15.0 110.653 171.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 311' ' ' ILE . 32.6 m-85 -122.9 -4.63 8.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.524 0.73 . . . . 15.0 111.541 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -45.96 -68.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.565 1.146 . . . . 15.0 112.836 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.76 -48.84 80.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.702 0.626 . . . . 15.0 112.042 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.76 -45.95 73.44 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 123.575 0.547 . . . . 15.0 111.362 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -66.26 -56.34 11.74 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.231 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -53.53 -35.61 60.88 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.316 1.01 . . . . 15.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.499 ' O ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -61.5 -51.15 69.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.966 -0.561 . . . . 15.0 109.677 171.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -68.38 -18.77 64.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.119 0.568 . . . . 15.0 111.906 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 307' ' ' ILE . 69.5 t -77.57 -45.3 29.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.12 0.968 . . . . 15.0 110.167 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 77.6 t -58.9 -44.71 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 343' ' ' ARG . 77.7 t -56.06 -46.47 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.338 1.055 . . . . 15.0 110.878 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.51 72.64 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.763 -0.653 . . . . 15.0 113.258 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.67 -44.34 56.96 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.2 mt -70.72 -46.42 63.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.216 0.607 . . . . 15.0 110.65 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.18 -38.74 92.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.136 0.574 . . . . 15.0 110.417 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.23 94.09 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.783 0.677 . . . . 15.0 112.512 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.82 -36.64 78.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.088 0.555 . . . . 15.0 110.945 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -64.97 -40.8 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.91 0.484 . . . . 15.0 110.201 174.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.467 ' HA ' HD11 ' A' ' 360' ' ' LEU . 96.1 mt -63.56 -41.79 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.984 0.913 . . . . 15.0 110.428 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.64 ' HA ' HD11 ' B' ' 460' ' ' LEU . 35.9 ttp180 -69.92 -58.94 3.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.775 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 51.9 m -61.25 -37.3 82.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.189 0.996 . . . . 15.0 112.059 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.73 8.23 41.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.138 0.421 . . . . 15.0 112.138 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 41.4 48.54 3.32 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.233 1.413 . . . . 15.0 113.383 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.57 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.0 mt -70.79 148.39 47.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.847 -1.07 . . . . 15.0 111.709 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.55 143.78 41.76 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.681 0.792 . . . . 15.0 110.053 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -78.28 111.68 14.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.05 0.94 . . . . 15.0 110.12 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.81 140.47 29.63 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.744 0.818 . . . . 15.0 110.719 -172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -60.23 -40.33 89.83 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.785 0.834 . . . . 15.0 112.366 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.33 -25.85 64.41 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.248 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -74.79 -40.97 60.83 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 371' ' ' ILE . 61.0 t -58.83 -47.24 89.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.004 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -51.96 -47.73 64.66 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.156 0.91 . . . . 15.0 111.684 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.89 -51.02 48.08 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.277 0.986 . . . . 15.0 112.771 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 402' ' ' ALA . 90.7 mt -62.62 -46.69 87.11 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.662 0.785 . . . . 15.0 112.378 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.552 ' HA ' ' HE1' ' A' ' 374' ' ' MET . 48.4 mm -54.68 -53.35 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.041 0.937 . . . . 15.0 110.164 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.84 -35.26 74.6 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.37 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.0 -50.17 75.11 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.618 0.767 . . . . 15.0 112.031 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.552 ' HE1' ' HA ' ' A' ' 371' ' ' ILE . 26.6 ptt? -74.06 -43.66 57.0 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.277 -0.419 . . . . 15.0 110.703 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -43.05 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.345 0.658 . . . . 15.0 112.241 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.3 t -60.19 -25.8 65.87 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 124.024 0.828 . . . . 15.0 111.699 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.8 58.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.73 0.812 . . . . 15.0 112.25 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -92.41 169.53 10.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.317 0.647 . . . . 15.0 111.151 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.8 -36.57 82.69 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.442 -1.254 . . . . 15.0 110.365 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -131.86 100.97 15.63 Favored Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.987 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.7 -24.53 18.25 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.389 2.06 . . . . 15.0 112.703 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -54.46 -48.53 71.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.349 1.06 . . . . 15.0 111.544 -168.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -65.85 -30.45 71.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.26 0.975 . . . . 15.0 111.177 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.16 -45.27 54.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.64 -55.06 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.681 0.613 . . . . 15.0 109.397 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.92 -34.84 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.546 0.738 . . . . 15.0 112.493 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.99 -54.54 6.72 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.738 0.304 . . . . 15.0 111.139 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -47.71 33.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.248 0.619 . . . . 15.0 111.409 -166.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.7 p -58.83 -30.07 67.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.704 0.802 . . . . 15.0 112.534 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -86.12 -26.33 25.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.511 -0.768 . . . . 15.0 111.681 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.43 95.54 6.56 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 2.9 ttmt -71.31 -18.93 62.38 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.262 1.025 . . . . 15.0 111.6 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -66.76 -41.53 87.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.564 0.746 . . . . 15.0 110.489 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.24 -31.46 19.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.555 0.742 . . . . 15.0 109.846 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.666 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 55.4 ttm -61.92 -26.64 68.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.74 0.416 . . . . 15.0 110.835 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -48.17 81.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.073 0.549 . . . . 15.0 110.125 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.47 -26.87 66.58 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.563 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.602 ' HE1' ' HB2' ' B' ' 442' ' ' ALA . 10.5 tpt -74.55 -27.39 60.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.975 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 395' ' ' MET . 82.2 mtp180 -72.06 -34.62 68.87 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 170.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -42.95 94.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.918 0.487 . . . . 15.0 111.235 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.9 p -73.97 -27.79 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 121.215 -0.194 . . . . 15.0 111.243 174.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.428 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -61.36 -44.04 97.85 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.36 0.6 . . . . 15.0 109.449 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 21.1 tp -73.41 -32.52 64.48 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.183 -1.371 . . . . 15.0 110.672 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -66.22 -51.91 53.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 15.0 110.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.558 ' HB3' HH21 ' A' ' 283' ' ' ARG . 77.9 mm-40 -61.92 -35.38 78.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.464 0.706 . . . . 15.0 110.833 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.57 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.8 tt0 -74.2 -32.74 63.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.433 0.693 . . . . 15.0 110.791 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.75 99.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.193 0.597 . . . . 15.0 110.244 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.78 -53.96 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.693 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.69 -21.57 66.55 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.754 0.822 . . . . 15.0 113.193 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.13 -31.69 64.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.023 0.529 . . . . 15.0 110.523 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.6 HG21 HD13 ' A' ' 294' ' ' LEU . 75.4 t -77.38 -36.35 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.88 -37.83 82.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.939 0.896 . . . . 15.0 111.246 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.24 68.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.616 0.767 . . . . 15.0 111.038 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -95.96 -29.73 14.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.028 0.931 . . . . 15.0 111.555 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.39 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.63 0.772 . . . . 15.0 112.29 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -79.02 78.93 5.44 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.248 -0.887 . . . . 15.0 109.709 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 125' ' ' VAL . 48.5 t -90.17 92.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.456 0.702 . . . . 15.0 109.567 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 39.8 p -74.07 94.66 2.42 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.779 0.832 . . . . 15.0 110.859 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.28 119.9 17.13 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.2 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.437 ' HE3' HG21 ' A' ' 422' ' ' THR . 0.0 OUTLIER -135.35 145.74 47.71 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.438 -0.578 . . . . 15.0 109.438 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.94 136.91 39.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 15.0 109.675 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.437 HG21 ' HE3' ' A' ' 420' ' ' LYS . 11.9 t -163.41 176.66 9.6 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.822 0.449 . . . . 15.0 111.382 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.3 p -93.55 173.4 7.71 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.142 0.977 . . . . 15.0 111.389 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.24 -19.05 42.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.303 1.441 . . . . 15.0 112.05 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -66.43 -5.41 10.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.939 1.296 . . . . 15.0 113.526 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.574 ' HB3' HD12 ' A' ' 427' ' ' LEU . 14.4 tp10 -74.95 -55.41 5.8 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.529 0.732 . . . . 15.0 112.472 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.4 mp -90.35 -71.84 0.6 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.332 0.493 . . . . 15.0 112.332 -163.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -107.15 33.54 3.93 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.358 0.663 . . . . 15.0 111.873 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -82.78 45.41 0.99 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.091 0.948 . . . . 15.0 111.867 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -133.24 85.38 2.21 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -67.65 -33.05 74.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.499 0.72 . . . . 15.0 109.979 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 108.043 -1.095 . . . . 15.0 108.043 167.139 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.79 -166.84 1.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.451 0.7 . . . . 0.0 111.692 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.98 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 123.614 0.766 . . . . 0.0 110.074 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -104.47 -90.3 0.39 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -114.71 -83.13 0.61 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.412 0.685 . . . . 0.0 109.331 160.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . 0.493 ' HB2' HH21 ' B' ' 373' ' ' ARG . . . -113.53 5.48 16.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.337 1.055 . . . . 0.0 111.98 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 7.2 p -28.39 -44.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -97.63 3.33 50.41 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.493 HH21 ' HB2' ' B' ' 370' ' ' ALA . 0.8 OUTLIER -42.88 -72.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -154.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.437 ' N ' ' HG2' ' B' ' 373' ' ' ARG . . . -108.41 -76.96 0.6 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.233 0.924 . . . . 0.0 112.812 -170.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' B' ' 379' ' ' LYS . 2.4 pt? -111.68 2.16 17.1 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -159.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -54.62 -33.82 61.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -164.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -103.21 -68.84 0.82 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.074 0.464 . . . . 0.0 111.511 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -82.22 -1.74 50.15 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -158.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' B' ' 375' ' ' LEU . 0.0 OUTLIER -69.5 -27.59 65.33 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 117.984 0.356 . . . . 0.0 111.758 -173.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -100.04 150.34 22.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 112.143 -169.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -162.25 -71.11 0.05 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.504 1.122 . . . . 0.0 108.328 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 136.76 -143.23 14.51 Favored Glycine 0 C--N 1.355 1.586 0 O-C-N 123.182 0.301 . . . . 0.0 112.942 176.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.12 -169.14 1.26 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 125.11 1.364 . . . . 0.0 110.373 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 42.8 p 70.72 87.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.725 2.01 . . . . 0.0 110.92 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.493 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.8 mm? -77.17 108.83 10.55 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.519 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.579 HG12 ' HA3' ' A' ' 179' ' ' GLY . 11.4 t -75.32 98.21 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.451 ' HB ' ' HZ ' ' A' ' 217' ' ' PHE . 22.5 pt -136.66 84.58 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 159.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.777 ' HA ' HD12 ' A' ' 226' ' ' LEU . 5.4 p -154.67 165.93 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.845 171.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 41.8 m -79.74 96.34 6.23 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 160.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -94.29 105.41 17.39 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.413 0.685 . . . . 0.0 112.739 -162.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -155.68 97.48 1.85 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 63.43 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.15 1.38 . . . . 0.0 110.83 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -157.61 166.11 33.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 107.441 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -66.75 -28.33 68.33 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.937 0.335 . . . . 0.0 110.468 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.11 70.16 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.337 0.655 . . . . 0.0 111.011 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 42.6 t 70.54 -72.58 0.11 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.562 1.545 . . . . 0.0 112.028 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -71.37 -39.55 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.892 0.877 . . . . 0.0 111.432 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.521 HG21 HG12 ' B' ' 399' ' ' VAL . 0.7 OUTLIER 78.08 -46.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 125.231 1.412 . . . . 0.0 111.932 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.564 HG11 ' H ' ' B' ' 400' ' ' ALA . 2.4 p -150.55 -68.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.482 0.713 . . . . 0.0 109.722 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.564 ' H ' HG11 ' B' ' 399' ' ' VAL . . . 177.06 -56.67 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 125.549 1.54 . . . . 0.0 109.474 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 400' ' ' ALA . 1.1 Cg_endo -85.64 130.37 3.75 Favored 'Trans proline' 0 C--N 1.393 2.897 0 C-N-CA 122.023 1.815 . . . . 0.0 111.831 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.6 177.7 6.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.491 0.716 . . . . 0.0 109.243 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 50.8 p -77.42 73.53 3.99 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.471 0.653 . . . . 0.0 110.112 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -70.64 -36.79 73.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.267 1.027 . . . . 0.0 109.771 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -81.96 140.77 46.72 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.859 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.76 82.75 1.18 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.84 2.36 . . . . 0.0 111.774 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -164.78 45.82 0.3 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.62 105.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 2.0 t 53.79 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.362 1.865 . . . . 0.0 113.072 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 75.9 -60.01 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.367 1.467 . . . . 0.0 110.46 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 66.49 37.12 4.72 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.34 1.056 . . . . 0.0 111.499 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 4.1 pp 50.0 25.02 1.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.659 1.584 . . . . 0.0 113.618 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 8.3 t30 59.34 80.33 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.355 1.062 . . . . 0.0 109.409 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 97.4 m -71.9 101.98 2.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.47 0.708 . . . . 0.0 111.468 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.28 -76.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.39 1.876 . . . . 0.0 113.662 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -53.04 61.64 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.253 1.421 . . . . 0.0 110.603 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 80.44 -56.18 4.68 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.508 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.9 129.77 13.36 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 108.934 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.27 93.05 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 74.62 131.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 110.777 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.19 -36.7 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.881 0.472 . . . . 0.0 111.318 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -165.14 -42.58 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.089 0.555 . . . . 0.0 111.142 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.2 m 59.6 -177.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.49 1.116 . . . . 0.0 110.7 -170.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 50.0 t80 68.6 -65.73 0.26 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.351 1.061 . . . . 0.0 113.805 166.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -51.59 125.03 25.06 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.745 0.688 . . . . 0.0 113.26 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 78.03 -24.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.648 1.979 . . . . 0.0 112.62 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.524 ' HA ' ' HB2' ' B' ' 431' ' ' SER . 48.0 t -68.94 -53.45 20.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.183 0.593 . . . . 0.0 109.444 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.19 -37.64 78.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.514 0.725 . . . . 0.0 111.815 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.5 -46.64 21.8 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.024 -0.422 . . . . 0.0 110.282 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -113.34 -67.16 1.02 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -169.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' B' ' 427' ' ' SER . 19.7 m -72.77 -28.19 62.46 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -154.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 323' ' ' GLY . 0.6 OUTLIER -83.98 -22.14 31.51 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.665 0.666 . . . . 0.0 110.492 -174.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 75.17 -57.14 0.61 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.183 1.793 . . . . 0.0 111.899 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -76.82 97.35 4.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.39 0.676 . . . . 0.0 109.723 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 41.3 p -53.5 109.69 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.455 1.102 . . . . 0.0 111.841 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -85.08 -26.7 36.18 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.053 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 437' ' ' SER . . . . . 0.431 ' HB2' ' NH2' ' A' ' 321' ' ' ARG . 17.7 t -90.83 73.0 6.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.959 0.904 . . . . 0.0 108.964 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -95.26 53.66 1.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.49 75.74 7.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -173.47 148.17 1.55 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.567 -1.652 . . . . 0.0 107.535 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 6.7 pt 55.93 175.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 126.64 1.976 . . . . 0.0 112.974 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . 0.602 ' HB2' ' HE1' ' A' ' 398' ' ' MET . . . -107.51 111.9 24.4 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -150.5 98.77 2.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -80.55 131.78 35.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 111.274 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -101.27 93.54 1.15 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.67 175.5 7.84 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.607 2.204 . . . . 0.0 113.289 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -83.04 82.64 8.16 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 60.92 -144.76 0.47 Allowed 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.308 1.005 . . . . 0.0 109.834 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' B' ' 452' ' ' VAL . . . 66.56 -166.02 0.22 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.189 0.996 . . . . 0.0 111.302 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 69.8 -68.82 0.18 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.393 1.077 . . . . 0.0 110.211 -172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 42.6 t -62.93 -36.72 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.665 0.786 . . . . 0.0 110.001 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 3.7 p -123.14 119.09 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.787 0.835 . . . . 0.0 109.324 174.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -157.49 -60.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.623 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 65.64 -83.92 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.431 1.492 . . . . 0.0 110.251 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 m 60.36 71.27 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.822 1.249 . . . . 0.0 111.32 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.21 -37.15 66.54 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.558 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.42 138.9 55.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.332 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 33.8 m -86.76 96.01 10.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 109.811 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' B' ' 469' ' ' GLY . 26.4 t70 -138.2 -62.1 0.59 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.64 HD11 ' HA ' ' A' ' 356' ' ' ARG . 23.5 tp -140.0 119.04 12.63 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 166.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -48.23 -33.72 9.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.099 1.76 . . . . 0.0 114.65 -166.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -136.86 -70.21 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 110.839 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 70.35 136.29 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.451 1.5 . . . . 0.0 111.587 -172.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.41 ' HE1' ' HB1' ' B' ' 466' ' ' ALA . 0.0 OUTLIER -76.12 166.02 24.08 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.028 0.531 . . . . 0.0 110.233 174.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.26 90.92 2.12 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.107 0.48 . . . . 0.0 109.816 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . 0.41 ' HB1' ' HE1' ' B' ' 464' ' ' MET . . . -173.15 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.219 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.98 9.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.804 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.408 ' HB3' HD22 ' B' ' 470' ' ' LEU . 11.1 mp -101.77 163.17 12.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.35 0.66 . . . . 0.0 110.852 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' B' ' 459' ' ' ASP . . . -82.71 22.18 6.85 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.742 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.42 ' HG ' ' ND2' ' A' ' 85' ' ' ASN . 2.5 pt? -161.68 154.89 20.96 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.096 1.358 . . . . 0.0 109.604 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 34.4 mmtp . . . . . 0 C--O 1.255 1.367 0 C-N-CA 123.751 0.82 . . . . 12.06 109.844 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 18.7 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.326 -0.25 . . . . 15.0 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -168.01 97.36 0.44 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.84 -1.17 . . . . 15.0 107.84 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.599 HG13 HG12 ' A' ' 17' ' ' ILE . 22.9 m -111.62 152.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.709 0.804 . . . . 15.0 111.873 -169.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -137.64 92.04 2.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 15.0 109.018 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.46 89.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 122.559 1.171 . . . . 15.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -94.08 92.6 7.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.67 -1.15 . . . . 15.0 109.494 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 32.4 m -67.41 94.18 0.38 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.388 -0.824 . . . . 15.0 109.896 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 p -75.18 -66.96 0.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.137 0.975 . . . . 15.0 111.343 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -151.23 121.6 7.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.927 0.491 . . . . 15.0 110.368 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -103.96 0.64 Allowed Glycine 0 C--N 1.35 1.325 0 O-C-N 124.38 1.05 . . . . 15.0 114.239 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 2.5 mm? -77.33 -34.29 55.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.508 0.723 . . . . 15.0 110.083 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.37 97.4 0.11 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 124.622 1.201 . . . . 15.0 114.06 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HD2' HG11 ' A' ' 111' ' ' VAL . 50.9 mtt85 -112.59 86.81 2.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.354 -1.35 . . . . 15.0 107.354 168.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -72.53 91.53 1.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.47 -1.241 . . . . 15.0 110.376 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.7 t -79.27 87.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.774 -0.824 . . . . 15.0 108.774 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 88.8 m -74.77 105.36 5.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.321 -0.854 . . . . 15.0 109.779 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.599 HG12 HG13 ' A' ' 3' ' ' VAL . 33.6 mt -101.28 118.49 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.679 0.791 . . . . 15.0 110.301 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.1 m -88.75 104.87 17.3 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.366 0.666 . . . . 15.0 109.214 165.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -81.29 108.16 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.939 -1.134 . . . . 15.0 107.939 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.95 160.12 33.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.929 0.491 . . . . 15.0 111.869 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.27 -22.5 66.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.363 1.065 . . . . 15.0 113.419 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.35 -42.03 88.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.836 0.455 . . . . 15.0 109.963 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 m -70.95 -40.16 72.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.161 -0.927 . . . . 15.0 110.278 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 28' ' ' VAL . 67.0 mt -69.85 -51.97 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.656 0.782 . . . . 15.0 111.087 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.86 -39.83 90.63 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.758 0.823 . . . . 15.0 111.077 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.7 m -66.24 -44.7 83.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.609 -0.723 . . . . 15.0 110.952 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.23 -39.86 78.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.217 0.607 . . . . 15.0 112.522 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 24' ' ' ILE . 66.7 t -61.18 -44.95 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.131 0.572 . . . . 15.0 109.728 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 29' ' ' LYS . 3.9 ttmp? -67.82 -39.49 83.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.241 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -73.41 -16.93 61.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.414 1.085 . . . . 15.0 111.424 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -88.6 -39.98 13.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.937 0.495 . . . . 15.0 110.439 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.23 -20.79 60.05 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.89 0.7 . . . . 15.0 112.89 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 37' ' ' LYS . 14.2 p -66.39 -32.19 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 109.854 -0.424 . . . . 15.0 109.854 174.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -67.97 -45.3 74.54 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.901 0.88 . . . . 15.0 109.917 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.5 -40.08 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 114.923 -1.035 . . . . 15.0 110.506 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.65 85.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.889 0.876 . . . . 15.0 110.85 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 33' ' ' VAL . 95.2 mttt -66.82 -44.19 81.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.652 -0.704 . . . . 15.0 111.462 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.08 -51.24 68.76 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.731 0.644 . . . . 15.0 110.752 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.43 -5.35 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 115.544 -0.753 . . . . 15.0 110.904 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 76.05 10.77 3.09 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.598 1.559 . . . . 15.0 112.39 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.11 -33.5 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.264 1.026 . . . . 15.0 110.607 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.76 -41.47 77.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 15.0 110.276 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.11 -36.23 92.03 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 124.204 0.94 . . . . 15.0 112.947 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -77.81 -31.96 52.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.167 0.587 . . . . 15.0 110.794 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -75.57 117.3 17.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.937 0.495 . . . . 15.0 110.989 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.95 21.36 17.67 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.776 0.83 . . . . 15.0 110.205 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.67 48.41 50.05 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.465 -0.789 . . . . 15.0 112.426 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.26 -60.71 3.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.115 0.566 . . . . 15.0 110.713 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 t -103.86 128.73 26.66 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.4 148.74 4.86 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 124.045 3.163 . . . . 15.0 114.917 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG21 ' A' ' 54' ' ' VAL . 53.6 tpp -65.18 -36.56 84.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.338 1.055 . . . . 15.0 111.984 -172.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -58.59 -37.68 76.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.501 0.721 . . . . 15.0 111.964 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.77 -54.25 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.153 0.981 . . . . 15.0 110.557 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 51' ' ' MET . 35.6 m -68.56 -34.24 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.488 0.551 . . . . 15.0 112.488 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.11 63.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.89 0.476 . . . . 15.0 112.058 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -70.04 -19.94 63.27 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.125 0.417 . . . . 15.0 112.125 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.34 -58.92 2.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.1 0.56 . . . . 15.0 111.142 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.65 -23.27 66.13 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.993 0.517 . . . . 15.0 111.98 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.4 21.55 40.01 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.715 -0.491 . . . . 15.0 113.935 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.82 73.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.501 0.721 . . . . 15.0 110.865 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 p -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.48 0.712 . . . . 15.0 111.096 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.17 -6.99 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 124.306 1.043 . . . . 15.0 112.05 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -55.07 -38.42 68.02 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.849 0.46 . . . . 15.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -58.2 -47.4 83.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.682 0.793 . . . . 15.0 111.469 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.17 -43.76 98.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.559 0.744 . . . . 15.0 110.551 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.38 -44.33 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.414 -1.266 . . . . 15.0 110.946 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' HG3' ' A' ' 71' ' ' MET . 91.2 mt -66.95 -36.75 82.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.939 0.495 . . . . 15.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.583 ' HA2' ' HE2' ' A' ' 71' ' ' MET . . . -58.24 -43.72 95.33 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.734 0.646 . . . . 15.0 111.873 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 27.4 t70 -64.08 -48.38 76.43 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.48 0.712 . . . . 15.0 110.512 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.576 ' HB3' HD11 ' A' ' 19' ' ' ILE . 80.5 mt -63.38 -32.46 73.89 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.191 0.996 . . . . 15.0 112.556 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.583 ' HE2' ' HA2' ' A' ' 68' ' ' GLY . 58.8 mtm -61.62 -41.52 97.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.613 0.365 . . . . 15.0 110.561 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -72.85 -36.86 67.52 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.597 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 29.4 mmt180 -60.63 -52.32 65.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.411 0.684 . . . . 15.0 110.65 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 17' ' ' ILE . 33.7 m-80 -75.65 -26.06 57.39 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.188 -0.914 . . . . 15.0 111.756 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -68.7 -58.07 4.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.577 0.351 . . . . 15.0 110.925 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.39 -40.44 87.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 123.721 0.638 . . . . 15.0 110.288 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.92 -40.37 96.33 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.219 1.008 . . . . 15.0 110.85 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.26 -61.77 2.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.595 -0.729 . . . . 15.0 111.446 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 pt -60.73 -24.45 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.63 0.772 . . . . 15.0 112.975 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.6 -58.08 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.543 0.737 . . . . 15.0 110.532 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.4 ptpt -77.57 -23.41 50.0 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.055 0.391 . . . . 15.0 112.055 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -86.89 -17.24 33.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.21 0.604 . . . . 15.0 110.749 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 62.0 33.47 17.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.417 1.087 . . . . 15.0 111.416 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.9 mt -77.96 106.5 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.96 -1.126 . . . . 15.0 107.96 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.486 HD22 ' HB2' ' A' ' 112' ' ' TYR . 8.0 t30 -78.07 102.4 0.94 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.8 0.84 . . . . 15.0 109.047 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -94.5 -177.0 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.237 2.625 . . . . 15.0 112.662 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.89 166.17 11.39 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.447 1.099 . . . . 15.0 109.635 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.43 -156.43 51.1 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.472 -0.786 . . . . 15.0 113.675 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.29 67.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.661 0.785 . . . . 15.0 109.665 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.26 107.35 0.56 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.416 2.077 . . . . 15.0 111.041 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -87.13 94.88 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.482 0.713 . . . . 15.0 109.912 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.99 91.53 4.86 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.21 109.37 6.21 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.596 -0.89 . . . . 15.0 108.596 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.07 98.63 0.73 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.363 2.042 . . . . 15.0 110.861 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.82 -71.23 0.88 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.187 -0.915 . . . . 15.0 112.329 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -169.89 133.42 1.21 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.919 0.887 . . . . 15.0 110.238 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -107.96 123.57 48.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.097 0.559 . . . . 15.0 109.642 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 93.3 mttt -97.41 129.59 44.62 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 171.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.2 101.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.279 1.031 . . . . 15.0 112.16 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.51 79.21 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.68 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.2 mt-10 -116.43 -163.92 0.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 15.0 108.383 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -73.54 116.01 13.61 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.095 0.558 . . . . 15.0 111.06 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -79.37 138.57 37.72 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.201 1.0 . . . . 15.0 109.3 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.2 m -133.83 132.83 40.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.109 -0.7 . . . . 15.0 109.109 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.58 169.42 21.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.064 0.946 . . . . 15.0 108.866 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 52.1 m -125.71 119.56 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.324 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -98.33 106.42 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.84 133.58 45.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -154.27 167.11 31.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.498 0.719 . . . . 15.0 109.536 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.701 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 31.8 mt-10 -84.71 170.38 13.33 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 15.0 110.238 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.454 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.0 m -136.83 155.12 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.85 0.86 . . . . 15.0 108.941 174.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HB2' HD22 ' A' ' 85' ' ' ASN . 68.3 m-85 -78.91 109.82 12.28 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 169.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.34 -173.62 1.78 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.035 2.49 . . . . 15.0 112.771 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -78.15 104.34 8.67 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.744 -175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.56 103.0 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.943 0.877 . . . . 15.0 108.671 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -102.59 101.04 11.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.598 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.69 140.34 32.21 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.281 -0.637 . . . . 15.0 109.281 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.95 -166.83 1.31 Allowed 'General case' 0 C--O 1.246 0.896 0 N-CA-C 108.747 -0.834 . . . . 15.0 108.747 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.67 109.35 2.31 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.247 -0.741 . . . . 15.0 111.247 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 414' ' ' LYS . 69.0 mt -66.16 -14.61 62.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.33 0.652 . . . . 15.0 111.063 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.68 -32.89 69.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.371 1.469 . . . . 15.0 111.698 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.33 75.43 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.873 0.869 . . . . 15.0 112.145 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -65.15 130.98 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.276 1.03 . . . . 15.0 110.397 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.52 115.39 29.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.636 0.774 . . . . 15.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 289' ' ' GLN . 38.3 t -120.13 159.14 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 125.241 1.416 . . . . 15.0 108.47 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.55 149.46 34.41 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.533 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.0 tttt -124.11 105.56 31.57 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 107.86 -1.163 . . . . 15.0 107.86 168.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.73 99.12 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 121.77 1.646 . . . . 15.0 110.54 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 41.4 mm -66.42 97.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.552 -1.277 . . . . 15.0 107.552 169.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.47 HG23 HD11 ' A' ' 427' ' ' LEU . 40.3 t -132.42 145.74 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.475 0.655 . . . . 15.0 111.362 -172.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -142.94 150.96 40.43 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.513 1.525 . . . . 15.0 107.553 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.561 HG13 ' SD ' ' A' ' 274' ' ' MET . 6.6 t -80.89 87.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.672 -1.233 . . . . 15.0 107.672 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.1 p -69.85 171.87 8.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.416 0.686 . . . . 15.0 110.117 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -58.1 -33.33 69.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.81 0.444 . . . . 15.0 111.285 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.54 82.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 15.0 110.512 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.16 -42.57 72.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.206 -0.906 . . . . 15.0 111.811 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.05 -54.6 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.85 0.86 . . . . 15.0 109.827 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.56 -44.8 93.07 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.124 0.89 . . . . 15.0 110.549 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.5 -40.92 99.29 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.845 0.716 . . . . 15.0 113.475 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.542 ' HG2' ' HE1' ' A' ' 274' ' ' MET . 13.6 tpt -67.42 -57.48 6.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.554 0.742 . . . . 15.0 110.476 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.61 HD22 HD11 ' A' ' 144' ' ' LEU . 90.7 mt -55.24 -32.92 62.7 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.631 0.772 . . . . 15.0 112.583 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.63 -51.91 63.14 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.329 1.052 . . . . 15.0 109.961 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.9 m -67.18 -24.37 65.86 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.5 0.72 . . . . 15.0 111.533 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.61 HD11 HD22 ' A' ' 141' ' ' LEU . 74.9 mt -71.94 -47.29 53.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.83 0.452 . . . . 15.0 110.326 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.596 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 47.2 mtm180 -74.82 -19.36 60.22 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 111.696 0.258 . . . . 15.0 111.696 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -79.52 -23.41 42.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.827 -0.546 . . . . 15.0 110.461 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.09 -35.24 69.17 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.476 -0.565 . . . . 15.0 109.476 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -87.74 42.39 1.05 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.997 0.919 . . . . 15.0 109.656 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.32 118.18 4.51 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.167 1.387 . . . . 15.0 114.245 -168.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 244' ' ' GLU . 17.4 m -79.33 114.68 18.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.69 -0.855 . . . . 15.0 108.69 169.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.414 ' HZ3' ' HG3' ' A' ' 163' ' ' ARG . 36.3 m95 -79.88 110.9 15.68 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.414 -0.587 . . . . 15.0 109.414 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -141.59 115.18 9.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.36 0.664 . . . . 15.0 110.397 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.82 131.6 50.35 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.145 0.578 . . . . 15.0 110.527 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.569 ' HE3' ' HB2' ' A' ' 242' ' ' GLU . 18.1 ptpt -108.37 172.02 7.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.528 0.731 . . . . 15.0 110.801 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.4 91.82 8.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.718 -0.674 . . . . 15.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.55 -56.48 1.25 Allowed Glycine 0 CA--C 1.544 1.902 0 N-CA-C 118.277 2.071 . . . . 15.0 118.277 159.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.15 132.46 47.86 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.67 1.235 . . . . 15.0 111.631 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.506 HG11 HG23 ' A' ' 202' ' ' ILE . 20.0 t -95.54 136.52 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 122.9 0.48 . . . . 15.0 110.079 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.85 171.87 8.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.943 1.297 . . . . 15.0 108.823 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.77 65.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.793 0.837 . . . . 15.0 112.021 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -95.34 13.54 25.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.326 0.65 . . . . 15.0 111.713 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -84.33 178.65 7.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.868 0.842 . . . . 15.0 113.068 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.414 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 1.7 tmm_? -131.94 92.52 3.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 106.687 -1.597 . . . . 15.0 106.687 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.7 t -89.42 157.22 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.461 1.105 . . . . 15.0 110.378 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.698 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 61.5 m -132.77 134.84 45.24 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.867 -1.16 . . . . 15.0 107.867 166.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 237' ' ' LEU . 27.8 pt -148.33 169.68 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.652 1.181 . . . . 15.0 110.303 -171.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -104.6 155.57 18.72 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 106.269 -1.752 . . . . 15.0 106.269 156.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 24.4 p90 -151.2 165.08 35.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.019 0.438 . . . . 15.0 111.131 167.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.1 t -142.75 103.15 4.16 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.006 -0.997 . . . . 15.0 108.626 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.84 140.33 15.81 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 114.914 -1.039 . . . . 15.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.3 p -150.13 116.59 5.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.974 0.91 . . . . 15.0 108.741 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 25.6 t -86.57 115.48 27.65 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 C-N-CA 123.498 0.719 . . . . 15.0 110.066 -168.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.1 t70 71.16 -1.26 2.78 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.063 1.345 . . . . 15.0 111.092 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.76 31.66 6.59 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.315 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 19.9 pt-20 -131.29 150.47 52.14 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 123.485 0.714 . . . . 15.0 110.542 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -90.86 81.63 5.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.756 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.648 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 0.0 OUTLIER -52.28 -70.12 0.1 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.4 1.48 . . . . 15.0 110.839 165.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.715 ' HB2' HG11 ' B' ' 386' ' ' VAL . 65.4 mm-40 -99.39 176.35 5.54 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.021 1.328 . . . . 15.0 109.487 168.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.97 5.72 0.12 Allowed Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.346 1.698 . . . . 15.0 117.346 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.43 -60.87 3.26 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 117.754 0.777 . . . . 15.0 113.493 168.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.67 160.74 14.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.627 0.973 . . . . 15.0 113.627 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.85 94.19 1.84 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.452 -1.249 . . . . 15.0 109.025 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.3 m -69.53 125.1 25.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.233 1.013 . . . . 15.0 112.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.03 41.8 10.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.64 1.176 . . . . 15.0 112.393 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.433 ' CZ ' HD22 ' B' ' 385' ' ' LEU . 18.7 t80 -67.92 131.85 46.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.345 -0.843 . . . . 15.0 109.365 170.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.78 104.15 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.019 1.328 . . . . 15.0 108.357 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.4 tp -90.95 98.44 11.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 15.0 111.542 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.46 83.55 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.556 ' HE1' ' HB3' ' A' ' 203' ' ' LYS . 50.8 mtp -57.02 134.03 55.45 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.547 0.739 . . . . 15.0 110.941 -174.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.91 -28.68 4.84 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 -168.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.38 114.62 9.65 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.008 0.523 . . . . 15.0 109.899 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.53 3.15 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.22 -0.446 . . . . 15.0 112.647 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.522 ' NH2' HD21 ' B' ' 385' ' ' LEU . 2.9 tmm_? -87.12 -33.88 19.3 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.485 -0.931 . . . . 15.0 108.485 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.1 mmt -84.37 154.14 23.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.196 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.5 pt -86.75 163.7 40.07 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.244 0.618 . . . . 15.0 110.824 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.17 144.75 46.28 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.72 2.28 . . . . 15.0 112.276 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.88 -52.93 0.61 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.839 -0.904 . . . . 15.0 110.839 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -66.47 -54.4 24.52 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.454 -0.573 . . . . 15.0 109.454 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.66 -40.77 69.36 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.79 -32.54 71.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.02 0.928 . . . . 15.0 110.465 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -71.15 -16.85 75.35 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.105 -0.952 . . . . 15.0 113.293 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.506 HG23 HG11 ' A' ' 158' ' ' VAL . 36.1 mm -93.68 -54.51 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.771 0.828 . . . . 15.0 109.553 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HB3' ' HE1' ' A' ' 189' ' ' MET . 60.0 pttt -79.55 14.02 1.8 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.676 0.991 . . . . 15.0 113.676 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -122.06 20.21 8.11 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.099 -0.801 . . . . 15.0 111.099 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -142.37 -171.11 3.33 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.968 0.907 . . . . 15.0 111.175 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -149.89 154.03 37.66 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.279 1.032 . . . . 15.0 109.797 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.593 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -60.57 148.26 38.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.095 0.958 . . . . 15.0 112.598 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.72 -48.41 0.94 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.175 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.7 pt-20 -74.08 133.46 42.87 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.519 0.676 . . . . 15.0 110.419 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.53 105.56 10.58 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.147 0.979 . . . . 15.0 108.539 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -124.02 -169.16 1.91 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.944 1.298 . . . . 15.0 110.278 -168.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 44.8 m -136.3 125.69 24.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.897 0.879 . . . . 15.0 109.402 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.447 HG22 ' HA3' ' A' ' 201' ' ' GLY . 46.6 pt -102.6 154.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.633 0.773 . . . . 15.0 109.435 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -116.45 104.6 11.6 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.264 1.025 . . . . 15.0 108.395 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.2 t -92.35 154.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 107.087 -1.449 . . . . 15.0 107.087 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 m -137.5 121.33 17.56 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.087 0.858 . . . . 15.0 109.3 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 51.1 m-85 -92.21 136.47 25.73 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 119.539 -0.267 . . . . 15.0 111.373 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 81.1 Cg_exo -54.57 170.9 0.49 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.977 3.784 . . . . 15.0 117.3 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 22.6 mm-40 -79.74 -26.36 40.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.147 -1.388 . . . . 15.0 110.473 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -25.28 63.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.873 0.869 . . . . 15.0 110.383 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 226' ' ' LEU . 6.9 t80 -68.15 106.56 2.45 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.612 -0.885 . . . . 15.0 108.612 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.68 -19.29 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.882 0.873 . . . . 15.0 113.208 -167.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.88 101.85 3.9 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 41.3 tt0 -67.38 -24.99 65.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 15.0 112.287 -173.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -63.92 -17.85 63.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.686 0.794 . . . . 15.0 112.222 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.46 ' HG ' HG11 ' B' ' 388' ' ' VAL . 16.7 mt -114.35 -30.61 6.53 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.27 0.628 . . . . 15.0 111.316 173.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.644 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 55.2 tttm -55.68 116.67 3.05 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.227 1.411 . . . . 15.0 111.809 -172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.58 -19.94 8.26 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.834 0.709 . . . . 15.0 113.885 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -87.29 156.99 19.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.806 0.842 . . . . 15.0 110.847 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -109.28 112.96 25.4 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -80.71 113.36 18.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 15.0 111.35 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -83.67 97.32 9.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.638 -0.71 . . . . 15.0 109.966 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.485 ' HZ ' HD11 ' B' ' 387' ' ' ILE . 95.9 m-85 -93.83 109.02 20.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.92 92.24 4.26 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.63 126.09 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.56 0.744 . . . . 15.0 110.46 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.16 91.07 3.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.204 1.002 . . . . 15.0 109.198 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 84.5 mt -68.41 108.0 3.09 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 110.152 -0.314 . . . . 15.0 110.152 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -110.87 -40.43 4.53 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.391 0.676 . . . . 15.0 110.103 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.698 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.5 mmtt -131.44 136.61 48.11 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.185 0.994 . . . . 15.0 109.594 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 207' ' ' ALA . 25.6 t -130.74 115.01 29.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.768 -1.567 . . . . 15.0 106.768 168.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -112.31 -175.37 2.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.569 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 35.4 tt0 -133.58 130.85 38.96 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 175.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -79.18 82.79 5.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.1 -1.445 . . . . 15.0 107.1 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 42.0 tt0 -73.89 147.62 43.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.72 -1.582 . . . . 15.0 111.353 -171.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.21 114.64 19.6 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.728 0.811 . . . . 15.0 109.173 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 30.2 Cg_endo -59.74 150.55 76.37 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.257 2.638 . . . . 15.0 111.291 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -53.54 106.82 0.2 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.422 1.076 . . . . 15.0 110.033 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.519 HD12 ' HD2' ' A' ' 252' ' ' PHE . 31.8 tp -77.06 73.54 3.64 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 253' ' ' ILE . 67.5 p -91.55 168.68 11.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.014 -0.994 . . . . 15.0 108.805 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.97 -45.55 42.28 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.751 1.22 . . . . 15.0 111.979 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.36 -21.1 60.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.911 0.884 . . . . 15.0 112.886 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.519 ' HD2' HD12 ' A' ' 248' ' ' LEU . 59.6 t80 -85.69 -49.99 7.54 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.508 -0.553 . . . . 15.0 109.508 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.469 HG21 ' O ' ' A' ' 249' ' ' THR . 6.2 tt -67.29 -28.34 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.044 0.538 . . . . 15.0 111.564 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.64 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.4 ptmt -79.61 -12.43 59.84 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.826 0.676 . . . . 15.0 112.826 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.92 -25.7 65.35 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.093 0.557 . . . . 15.0 111.51 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -68.15 -33.83 75.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.089 0.956 . . . . 15.0 111.932 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.68 7.22 0.46 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 116.664 -0.244 . . . . 15.0 113.271 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 20.5 t -79.26 157.75 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.652 0.781 . . . . 15.0 110.119 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -59.82 -72.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.832 1.253 . . . . 15.0 111.92 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -121.86 6.61 9.87 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.554 0.742 . . . . 15.0 110.456 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.95 4.93 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.953 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 7.1 m -64.21 132.02 49.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.136 0.975 . . . . 15.0 110.561 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.42 -47.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 124.049 0.843 . . . . 15.0 110.241 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.6 -32.87 63.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.729 0.812 . . . . 15.0 111.609 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.55 ' HA3' HG13 ' A' ' 258' ' ' VAL . . . -79.28 -25.06 60.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 111.276 -0.73 . . . . 15.0 111.276 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.24 -33.62 56.02 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.404 ' HA ' HG22 ' A' ' 270' ' ' VAL . 18.4 mtp180 -67.75 -38.72 83.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.418 0.687 . . . . 15.0 109.641 175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.02 82.5 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.198 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.19 -48.18 76.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.127 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.437 ' HB ' ' HE3' ' A' ' 274' ' ' MET . 24.3 m -69.37 -27.88 36.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.318 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -65.05 -52.45 55.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.218 0.463 . . . . 15.0 110.296 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 377' ' ' ALA . 13.2 ptmm? -73.79 -16.7 61.15 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.983 0.734 . . . . 15.0 112.983 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -95.1 -47.39 6.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 118.167 0.439 . . . . 15.0 111.796 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.561 ' SD ' HG13 ' A' ' 132' ' ' VAL . 66.4 mtt -73.83 -26.23 60.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 118.653 -0.689 . . . . 15.0 111.459 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.6 -32.88 41.93 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 119.062 0.846 . . . . 15.0 110.443 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.428 ' NH2' ' HB2' ' A' ' 377' ' ' ALA . 24.2 tpp180 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.923 0.489 . . . . 15.0 110.186 174.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -76.96 -60.29 2.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.309 -0.86 . . . . 15.0 109.881 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.414 HD12 HG11 ' A' ' 130' ' ' VAL . 58.8 tp -70.69 -59.73 2.65 Favored 'General case' 0 C--O 1.211 -0.947 0 C-N-CA 124.022 0.929 . . . . 15.0 112.933 -168.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.76 -32.61 73.79 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.797 0.439 . . . . 15.0 110.713 -171.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -68.92 -46.56 67.97 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.08 -0.964 . . . . 15.0 109.658 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.38 72.53 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.336 0.655 . . . . 15.0 111.949 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 286' ' ' VAL . 79.8 mt -70.94 -51.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -58.34 -42.15 86.23 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.992 0.808 . . . . 15.0 110.338 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.13 61.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 15.0 110.947 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -63.94 -59.44 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 282' ' ' ILE . 40.2 t -58.53 -44.3 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 114.95 -1.023 . . . . 15.0 110.457 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -68.78 -41.15 79.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.668 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.4 p -65.25 -40.35 93.9 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.991 0.359 . . . . 15.0 110.489 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.438 ' HB2' HG12 ' A' ' 125' ' ' VAL . 51.5 mt-30 -68.68 -34.93 76.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.53 0.519 . . . . 15.0 111.245 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.8 -50.22 67.59 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.132 0.573 . . . . 15.0 110.519 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 295' ' ' VAL . 27.0 mm -65.07 -54.62 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.676 0.791 . . . . 15.0 110.907 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.64 -38.54 90.66 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.761 0.663 . . . . 15.0 110.383 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.96 -35.3 89.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.581 -0.736 . . . . 15.0 112.758 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.5 OUTLIER -66.32 -42.59 88.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.97 0.908 . . . . 15.0 110.299 177.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 291' ' ' ILE . 47.6 t -62.13 -53.43 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.799 -0.815 . . . . 15.0 108.799 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.26 -27.64 69.15 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.593 -1.185 . . . . 15.0 111.613 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.17 59.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 15.0 113.171 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.79 150.63 15.64 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.204 0.816 . . . . 15.0 113.204 -169.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.06 143.27 58.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.774 0.829 . . . . 15.0 111.113 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.456 HG12 HG11 ' A' ' 346' ' ' VAL . 6.1 tp -147.62 115.04 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.0 130.77 54.59 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.217 1.007 . . . . 15.0 108.57 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.579 HG21 HD21 ' A' ' 349' ' ' LEU . 45.6 t -131.95 131.26 22.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.935 0.894 . . . . 15.0 110.097 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.426 ' HB2' ' HG ' ' A' ' 306' ' ' LEU . 53.0 Cg_exo -55.06 130.14 39.11 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.144 2.562 . . . . 15.0 112.468 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.61 -24.83 67.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.506 1.122 . . . . 15.0 112.902 -173.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.12 73.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.201 0.6 . . . . 15.0 111.536 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 303' ' ' PRO . 19.5 mt -69.86 -43.39 71.97 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.379 -0.6 . . . . 15.0 109.379 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 304' ' ' ALA . 3.2 mp -59.09 -50.21 80.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.013 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.17 -35.74 81.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.783 0.833 . . . . 15.0 111.738 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -44.03 94.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.376 0.671 . . . . 15.0 110.339 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -79.13 -27.4 42.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.647 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.43 HG22 ' HB2' ' A' ' 337' ' ' PHE . 34.0 mt -65.76 -35.88 76.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 108.585 -0.895 . . . . 15.0 108.585 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.557 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 14.9 t70 -63.67 -44.07 94.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.653 0.781 . . . . 15.0 110.575 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.67 -52.12 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 123.72 0.637 . . . . 15.0 110.114 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.27 -21.41 62.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.897 -1.047 . . . . 15.0 112.426 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 58.9 mtm180 -76.62 -42.51 42.04 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.908 0.883 . . . . 15.0 109.871 176.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -66.36 -40.18 89.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.907 0.483 . . . . 15.0 110.417 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -67.92 -38.02 82.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.348 -0.842 . . . . 15.0 110.622 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.75 70.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.911 0.484 . . . . 15.0 109.946 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.22 -34.79 66.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.171 -0.922 . . . . 15.0 111.525 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -66.34 -37.3 85.02 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.865 0.866 . . . . 15.0 110.689 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -79.87 -15.14 57.97 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.655 0.782 . . . . 15.0 110.007 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.505 ' HE2' ' HG2' ' A' ' 326' ' ' GLU . 18.5 t80 -91.33 10.28 28.05 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.967 1.307 . . . . 15.0 110.469 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 85.47 8.06 81.35 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.126 0.393 . . . . 15.0 114.031 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 83.52 13.28 76.41 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.297 0.475 . . . . 15.0 113.028 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -78.62 156.9 28.86 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.732 0.813 . . . . 15.0 111.367 -173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 322' ' ' PHE . 16.5 mm-40 79.34 -54.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.976 2.111 . . . . 15.0 112.618 176.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 63.39 24.7 14.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.293 1.037 . . . . 15.0 110.388 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -101.34 16.58 25.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.257 1.423 . . . . 15.0 110.006 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.47 -42.76 15.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.559 1.544 . . . . 15.0 113.736 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 50.0 tp -59.17 -27.9 66.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.299 0.64 . . . . 15.0 111.926 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.06 -8.58 53.66 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.489 0.716 . . . . 15.0 112.388 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 69.0 mt -54.03 130.31 58.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 118.587 0.63 . . . . 15.0 110.248 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.526 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 86.2 Cg_exo -48.35 116.04 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.634 2.889 . . . . 15.0 113.759 -170.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -51.7 -37.78 52.27 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.925 0.89 . . . . 15.0 111.519 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -54.5 -33.13 59.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.174 0.989 . . . . 15.0 112.851 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 95.3 mt -62.7 -30.16 71.2 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.274 0.559 . . . . 15.0 110.891 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.499 ' HA ' HE21 ' A' ' 340' ' ' GLN . 28.2 m-85 -116.47 -3.04 11.9 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.246 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.83 -63.05 1.3 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.304 1.042 . . . . 15.0 111.965 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.05 -47.18 85.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.15 0.906 . . . . 15.0 111.589 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 337' ' ' PHE . 16.8 pt20 -67.72 -51.93 43.54 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.683 0.614 . . . . 15.0 111.558 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.3 -43.21 98.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.776 0.43 . . . . 15.0 110.627 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.38 -43.24 88.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 123.883 0.739 . . . . 15.0 110.164 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.47 ' O ' HG21 ' A' ' 347' ' ' VAL . 45.3 mmt-85 -61.31 -35.75 78.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.655 -0.688 . . . . 15.0 111.268 172.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.5 mtt-85 -69.33 -34.01 73.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.807 0.443 . . . . 15.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.684 ' HA ' ' HB2' ' B' ' 467' ' ' ALA . 9.9 t -77.69 -41.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.856 0.36 . . . . 15.0 110.069 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.456 HG11 HG12 ' A' ' 300' ' ' ILE . 53.6 t -58.88 -35.05 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.455 -0.793 . . . . 15.0 110.449 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 343' ' ' ARG . 11.8 t -51.28 -54.55 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.675 0.79 . . . . 15.0 109.316 169.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.99 -37.85 93.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.404 -0.816 . . . . 15.0 114.334 -174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.579 HD21 HG21 ' A' ' 302' ' ' VAL . 10.3 mp -72.02 -50.11 31.26 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.858 0.829 . . . . 15.0 111.124 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 354' ' ' VAL . 87.6 mt -63.05 -52.85 61.16 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.271 0.357 . . . . 15.0 110.337 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.423 HD12 HG11 ' A' ' 347' ' ' VAL . 81.5 mt -69.85 -31.19 68.91 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.904 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -62.42 -39.22 97.51 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 111.779 -0.528 . . . . 15.0 111.779 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.67 -38.63 84.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.096 -0.552 . . . . 15.0 110.429 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -60.6 -36.43 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 122.746 0.418 . . . . 15.0 111.07 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.538 HD13 ' HA2' ' A' ' 352' ' ' GLY . 85.3 mt -62.96 -52.58 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.876 0.87 . . . . 15.0 109.902 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -62.14 -56.42 18.93 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.52 0.513 . . . . 15.0 110.912 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.1 m -54.67 -48.25 72.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 15.0 112.192 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.2 16.34 11.69 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 119.323 -0.37 . . . . 15.0 111.919 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 44.46 41.34 4.55 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 125.746 1.618 . . . . 15.0 113.776 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.467 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.8 mt -74.7 150.51 39.46 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.021 -0.99 . . . . 15.0 112.184 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 147.29 52.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.456 1.102 . . . . 15.0 109.555 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.23 92.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.117 0.567 . . . . 15.0 110.438 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 367' ' ' VAL . 13.9 t70 -70.54 127.01 31.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.834 0.854 . . . . 15.0 110.44 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.47 -32.96 74.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.631 1.172 . . . . 15.0 112.783 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.15 -23.76 60.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.461 0.304 . . . . 15.0 110.336 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.452 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 40.6 tpt85 -80.51 -33.58 36.35 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.129 0.572 . . . . 15.0 109.585 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 363' ' ' ASP . 44.6 t -61.68 -54.46 34.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -65.69 -28.7 69.27 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.859 0.724 . . . . 15.0 110.868 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.55 -54.01 37.48 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 111.66 -0.576 . . . . 15.0 111.66 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.34 -56.52 20.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.592 0.757 . . . . 15.0 110.698 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.604 HD13 ' HG2' ' A' ' 398' ' ' MET . 44.9 mm -50.75 -53.4 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 124.771 1.294 . . . . 15.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.04 -41.51 61.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.004 0.521 . . . . 15.0 111.133 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.59 -23.28 62.55 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.64 0.607 . . . . 15.0 112.64 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 -33.3 12.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 119.159 -0.448 . . . . 15.0 111.57 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -93.24 -40.64 10.33 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 112.671 0.619 . . . . 15.0 112.671 -171.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 381' ' ' PRO . 22.1 t -70.06 -13.29 62.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.01 0.374 . . . . 15.0 112.01 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 272' ' ' LYS . . . -86.92 -0.56 56.74 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.136 0.574 . . . . 15.0 111.664 174.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -94.69 -175.31 3.55 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.426 0.69 . . . . 15.0 110.367 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.85 -51.67 17.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.437 1.095 . . . . 15.0 110.305 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.411 ' HB3' ' NH1' ' B' ' 440' ' ' ARG . 11.6 t70 -123.33 106.92 32.71 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 376' ' ' SER . 97.1 Cg_endo -84.93 -23.56 2.47 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.599 2.199 . . . . 15.0 113.61 170.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -57.23 -49.54 75.7 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.453 0.701 . . . . 15.0 112.288 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.61 -16.06 60.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.267 -0.879 . . . . 15.0 111.383 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.618 HG13 HD13 ' B' ' 441' ' ' ILE . 88.7 t -76.58 -50.26 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.604 -0.888 . . . . 15.0 108.604 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.22 -49.53 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.635 0.774 . . . . 15.0 109.078 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.94 -36.14 80.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.237 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.05 -57.99 10.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.754 0.422 . . . . 15.0 110.451 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.448 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 87.0 m-85 -64.09 -53.05 55.87 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.892 0.745 . . . . 15.0 111.352 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.0 p -56.05 -33.94 65.45 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -98.13 -4.61 35.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.075 0.55 . . . . 15.0 112.461 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -119.49 90.18 3.28 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -56.09 -29.28 60.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.765 1.226 . . . . 15.0 113.031 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.85 -57.88 10.99 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.407 0.683 . . . . 15.0 111.056 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.66 -18.9 28.54 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.243 -0.89 . . . . 15.0 109.775 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 7.4 tpt -67.13 -43.32 82.69 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -40.03 95.77 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.065 0.946 . . . . 15.0 110.403 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.86 -44.1 90.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.258 0.623 . . . . 15.0 110.378 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.604 ' HG2' HD13 ' A' ' 371' ' ' ILE . 37.7 tpp -72.72 -23.52 60.86 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.488 -0.778 . . . . 15.0 111.671 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -76.53 -35.32 58.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.599 0.76 . . . . 15.0 109.85 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' B' ' 464' ' ' MET . 0.9 OUTLIER -69.19 -38.4 78.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.139 0.576 . . . . 15.0 110.269 178.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.1 p -79.09 -22.86 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 119.49 -0.291 . . . . 15.0 111.11 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.41 96.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.866 0.757 . . . . 15.0 109.468 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.96 -34.92 64.45 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.844 -1.525 . . . . 15.0 111.77 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 401' ' ' VAL . 0.6 OUTLIER -67.93 -48.01 67.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.376 1.07 . . . . 15.0 109.965 177.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.452 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 6.1 mm-40 -56.49 -46.99 80.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.024 1.329 . . . . 15.0 111.199 171.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 360' ' ' LEU . 27.4 tt0 -62.32 -35.11 78.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.803 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.07 82.88 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.244 0.618 . . . . 15.0 110.997 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 59.5 t -56.1 -53.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.969 -0.752 . . . . 15.0 108.969 170.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -63.08 -26.45 68.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.163 0.985 . . . . 15.0 112.959 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -74.71 -27.36 60.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.06 0.544 . . . . 15.0 111.148 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.79 -38.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.521 -0.918 . . . . 15.0 108.521 171.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.8 mt -67.56 -35.16 78.51 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.78 0.832 . . . . 15.0 111.32 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.57 -20.83 65.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.648 0.779 . . . . 15.0 111.592 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.515 ' HD3' HD11 ' A' ' 120' ' ' LEU . 27.8 mtpp -105.67 -30.15 9.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.059 0.944 . . . . 15.0 111.556 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.82 159.25 22.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.071 0.948 . . . . 15.0 111.741 -172.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -75.61 82.63 2.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.972 0.909 . . . . 15.0 109.464 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 42.5 t -90.15 92.15 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -70.67 96.03 1.17 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.402 1.096 . . . . 15.0 110.493 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.533 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 37.1 mt-10 -75.2 105.01 6.0 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.253 -1.34 . . . . 15.0 109.562 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -114.41 138.29 50.75 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.279 0.562 . . . . 15.0 109.951 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 28.4 mt-10 -81.44 130.89 35.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.959 0.904 . . . . 15.0 109.193 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.417 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -163.64 169.55 18.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.285 0.634 . . . . 15.0 110.446 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.2 p -93.22 171.83 8.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.243 1.017 . . . . 15.0 111.487 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 428' ' ' MET . 57.0 t80 -52.54 -47.27 66.82 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.888 1.275 . . . . 15.0 110.828 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -54.93 -22.94 16.62 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.945 1.091 . . . . 15.0 113.945 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.495 ' HB3' HD13 ' A' ' 427' ' ' LEU . 10.0 tp10 -54.34 -55.7 25.82 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.647 0.779 . . . . 15.0 112.068 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.495 HD13 ' HB3' ' A' ' 426' ' ' GLU . 5.4 mp -74.87 -29.5 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.42 -0.809 . . . . 15.0 111.709 -167.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.1 OUTLIER -80.69 -42.87 21.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.992 0.517 . . . . 15.0 109.832 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 41.02 0.85 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.002 0.521 . . . . 15.0 111.109 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -91.18 71.27 6.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -79.81 -54.32 5.95 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.993 0.917 . . . . 15.0 108.664 176.322 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -139.89 107.44 5.59 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.4 tt -74.16 -81.97 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' B' ' 372' ' ' GLN . 11.7 t70 -104.83 -86.02 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.335 0.516 . . . . 0.0 110.777 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' B' ' 370' ' ' ALA . 5.8 pt-20 -105.35 -67.92 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.954 0.502 . . . . 0.0 111.835 -169.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . 0.456 ' H ' ' HG3' ' B' ' 369' ' ' GLU . . . -96.2 -77.42 0.48 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.84 -80.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.677 ' HB3' ' HA ' ' B' ' 377' ' ' PHE . 24.0 tm0? -100.7 -78.2 0.52 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 167.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 377' ' ' PHE . 10.2 mmm180 -102.09 -84.65 0.45 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.578 0.626 . . . . 0.0 110.754 168.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -104.48 -75.47 0.62 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -165.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 81.9 mt -88.8 -78.62 0.34 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.4 -70.81 0.76 Allowed 'General case' 0 C--N 1.345 0.402 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 165.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.677 ' HA ' ' HB3' ' B' ' 372' ' ' GLN . 82.1 m-85 -99.86 -92.11 0.29 Allowed 'General case' 0 C--N 1.351 0.65 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.777 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -104.21 -82.64 0.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.205 0.911 . . . . 0.0 110.616 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -107.02 -32.15 7.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.849 0.86 . . . . 0.0 110.626 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm 72.08 83.47 0.13 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.528 1.531 . . . . 0.0 111.112 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -170.77 139.66 1.54 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.317 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 160.41 164.6 15.7 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.005 0.19 . . . . 0.0 112.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.66 154.08 27.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.668 0.787 . . . . 0.0 111.256 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 48.3 p -80.77 -16.19 54.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.944 0.898 . . . . 0.0 111.479 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.522 HD21 ' NH2' ' A' ' 193' ' ' ARG . 5.6 mp -70.6 134.52 47.68 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 178' ' ' GLU . 50.9 t -81.93 90.06 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 123.771 1.748 . . . . 0.0 109.265 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.648 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 7.6 tp -153.17 173.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 110.983 -2.826 . . . . 0.0 105.329 170.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.499 ' H ' HG13 ' B' ' 387' ' ' ILE . 0.1 OUTLIER -39.94 167.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -150.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 389' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' B' ' 394' ' ' HIS . 61.0 p -36.75 99.01 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 110.02 -3.263 . . . . 0.0 115.327 -157.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -85.79 -177.76 6.44 Favored 'General case' 0 C--O 1.251 1.177 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 153.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' B' ' 377' ' ' PHE . 1.6 m-20 -75.61 88.89 2.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 112.461 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.93 -49.01 0.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.363 1.865 . . . . 0.0 107.149 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.38 114.34 4.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.246 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . 0.479 ' HA ' ' HB ' ' B' ' 389' ' ' THR . 67.1 m-70 -99.47 -82.23 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.294 0.497 . . . . 0.0 112.027 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 52.86 -93.61 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.728 0.811 . . . . 0.0 110.417 -162.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 50.3 m 54.97 21.62 3.84 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.852 1.261 . . . . 0.0 113.997 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 66.62 -72.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.146 1.379 . . . . 0.0 110.316 -172.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.94 -175.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.68 1.192 . . . . 0.0 110.241 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.98 42.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.336 1.065 . . . . 0.0 111.704 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -162.04 156.07 18.49 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 0.0 109.785 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.78 -16.57 33.27 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.445 2.097 . . . . 0.0 112.382 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.75 153.54 10.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.467 1.107 . . . . 0.0 109.269 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 15.1 t -144.41 44.88 1.41 Allowed 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 121.586 0.708 . . . . 0.0 111.649 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.99 -42.14 98.81 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.267 0.556 . . . . 0.0 110.152 170.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -112.61 104.19 55.83 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.5 -7.28 20.59 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.792 2.328 . . . . 0.0 113.006 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 86.03 -81.93 1.69 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.3 tt 61.73 -82.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.256 1.422 . . . . 0.0 110.013 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 91.8 m -74.16 -40.63 62.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.905 1.282 . . . . 0.0 110.392 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.83 102.74 4.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.528 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -88.04 113.42 23.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.621 0.768 . . . . 0.0 108.994 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.0 -37.4 47.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.371 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -68.18 92.75 0.41 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 123.44 0.696 . . . . 0.0 110.138 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 37.3 m -77.5 83.29 3.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.013 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -156.15 -63.0 0.11 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.01 -42.87 6.57 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.829 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -97.82 60.83 0.99 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -60.83 110.63 1.38 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.764 0.826 . . . . 0.0 110.81 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.16 92.81 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.244 1.018 . . . . 0.0 110.187 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 55.5 ttp 58.37 -83.68 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.254 1.422 . . . . 0.0 111.415 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.529 HG13 ' H ' ' B' ' 422' ' ' MET 0.282 3.2 p 33.99 -93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.369 1.419 0 C-N-CA 126.911 2.084 . . . . 0.0 113.651 -175.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.529 ' H ' HG13 ' B' ' 421' ' ' VAL . 8.3 ptm 65.33 -34.98 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.061 2.145 . . . . 0.0 114.985 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' B' ' 438' ' ' GLN . 21.7 t 60.89 -161.65 0.28 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -117.27 149.59 40.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.663 0.785 . . . . 0.0 109.511 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 161.86 -147.11 13.05 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.672 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -149.48 -108.85 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 117.475 -1.25 . . . . 0.0 108.385 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 70.0 p 41.52 -72.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 126.862 2.065 . . . . 0.0 114.332 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.49 -28.51 67.1 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.372 1.069 . . . . 0.0 111.313 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.44 -24.81 61.23 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.048 1.339 . . . . 0.0 111.339 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -50.42 -21.39 1.44 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 124.195 0.998 . . . . 0.0 113.193 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 67.8 p -59.42 -48.57 81.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.607 0.763 . . . . 0.0 111.273 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -90.94 -13.15 34.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 79.02 -30.75 0.14 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.154 1.781 . . . . 0.0 115.227 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -165.8 29.17 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.076 0.853 . . . . 0.0 112.681 -169.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 10.9 m -134.68 95.22 3.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.32 0.648 . . . . 0.0 109.352 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -81.95 41.8 2.78 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.222 -0.21 . . . . 0.0 113.418 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 25.6 p -74.15 90.45 2.05 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.756 0.822 . . . . 0.0 109.878 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' B' ' 423' ' ' SER . 50.3 mt-30 -134.21 116.32 15.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.34 1.056 . . . . 0.0 108.807 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 94.5 mt 61.79 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.985 1.314 . . . . 0.0 110.953 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 380' ' ' ASP . 24.3 ptt180 -69.76 159.67 33.11 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 170.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.618 HD13 HG13 ' A' ' 384' ' ' VAL . 32.3 mm 62.85 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -162.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.28 89.59 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 68.06 -77.39 0.05 OUTLIER 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.105 1.503 . . . . 0.0 110.327 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.7 t80 52.4 94.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.258 1.423 . . . . 0.0 113.075 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.48 -172.93 26.23 Favored Glycine 0 C--O 1.244 0.769 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.709 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' B' ' 467' ' ' ALA . 89.1 Cg_endo -76.02 -168.88 0.6 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.806 2.337 . . . . 0.0 112.769 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.462 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 19.4 t-160 -61.42 122.46 15.23 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 69.81 8.31 6.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 72.19 -49.19 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.704 1.602 . . . . 0.0 113.029 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . 0.594 ' HA ' ' HE3' ' B' ' 465' ' ' LYS . 14.7 t-20 -132.98 164.17 27.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.051 0.941 . . . . 0.0 109.447 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.71 149.64 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 125.236 1.414 . . . . 0.0 109.963 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.15 -37.76 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.214 0.606 . . . . 0.0 111.442 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -117.89 137.29 13.04 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.43 42.47 0.51 Allowed 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.179 0.991 . . . . 0.0 112.275 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 10.1 m 72.09 -0.84 3.09 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.463 1.505 . . . . 0.0 112.136 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.7 t70 63.93 -75.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.274 1.43 . . . . 0.0 110.017 -172.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -96.85 100.02 11.57 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 108.446 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 4.8 t -80.03 71.64 6.77 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.368 1.08 . . . . 0.0 109.065 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.41 -16.4 64.21 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.533 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.503 HD13 ' H ' ' B' ' 460' ' ' LEU . 0.0 OUTLIER -91.42 34.0 0.97 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.953 0.901 . . . . 0.0 110.798 175.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 66.82 -84.52 0.03 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.737 1.615 . . . . 0.0 111.644 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -91.33 135.31 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 59.6 m -58.16 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 O-C-N 124.243 0.964 . . . . 0.0 110.815 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.459 ' HA ' ' OD1' ' A' ' 400' ' ' ASN . 1.3 tmt? -129.48 110.17 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 108.576 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' B' ' 450' ' ' ASN . 0.0 OUTLIER -80.86 121.16 25.63 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -51.38 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.942 1.401 . . . . 0.0 112.318 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 345' ' ' VAL . . . -169.77 80.87 0.11 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -161.61 163.39 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.759 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' B' ' 447' ' ' HIS . . . -166.08 60.49 0.23 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.91 -47.23 87.38 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.829 0.851 . . . . 0.0 108.934 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 85.8 tttt . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.252 1.021 . . . . 12.06 108.525 178.814 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -82.2 108.33 15.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.42 -0.585 . . . . 15.0 109.42 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 17' ' ' ILE . 33.0 m -121.25 141.18 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 15.0 109.552 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 9.2 m -140.33 92.64 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.332 0.653 . . . . 15.0 109.405 -174.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.03 102.14 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-O 121.91 0.862 . . . . 15.0 110.492 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 38.6 mt-10 -92.41 107.2 19.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.781 0.832 . . . . 15.0 109.595 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -72.4 90.96 1.32 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.5 m -64.13 -51.67 62.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.69 1.196 . . . . 15.0 111.031 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -155.7 84.9 1.03 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.23 -0.441 . . . . 15.0 109.934 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.42 0.23 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 123.558 0.536 . . . . 15.0 113.063 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' HA ' HH12 ' A' ' 13' ' ' ARG . 10.0 mp -66.91 -37.74 84.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.655 0.782 . . . . 15.0 110.982 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.26 97.41 0.17 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 124.362 1.039 . . . . 15.0 112.311 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.507 HH12 ' HA ' ' A' ' 11' ' ' LEU . 66.9 mtt85 -108.75 143.14 38.28 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.799 1.24 . . . . 15.0 109.684 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 42.2 ttm180 -119.9 88.95 3.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.845 1.258 . . . . 15.0 107.868 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.75 91.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.581 0.705 . . . . 15.0 109.179 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 91.0 m -81.28 105.2 12.29 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.418 -1.265 . . . . 15.0 109.905 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 HG13 ' A' ' 3' ' ' VAL . 52.8 mt -107.29 127.73 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.167 0.587 . . . . 15.0 110.211 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 85.5 m -100.61 111.86 24.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.188 0.995 . . . . 15.0 108.649 171.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.7 mt -88.91 130.99 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.45 138.24 58.31 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.587 0.755 . . . . 15.0 110.815 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.53 -39.9 74.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.941 1.297 . . . . 15.0 112.598 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.29 -40.24 93.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.267 -0.879 . . . . 15.0 110.324 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -71.65 -26.18 62.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.524 0.729 . . . . 15.0 111.549 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -70.81 -51.12 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.638 0.775 . . . . 15.0 109.685 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.25 -24.15 59.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.463 -0.335 . . . . 15.0 111.587 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -68.35 -39.64 81.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.459 0.704 . . . . 15.0 109.776 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.15 -42.14 94.07 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.148 0.579 . . . . 15.0 111.011 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 66' ' ' VAL . 95.9 t -59.68 -44.78 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 121.625 0.726 . . . . 15.0 109.974 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.1 ttmp? -63.7 -36.11 82.78 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.592 -1.186 . . . . 15.0 111.089 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -92.67 -1.99 56.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.605 1.162 . . . . 15.0 111.245 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -99.71 -39.9 8.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.376 0.67 . . . . 15.0 109.782 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 55' ' ' ALA . 52.8 mt -82.12 -8.64 59.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.412 -0.813 . . . . 15.0 112.225 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.9 -31.62 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 109.241 -0.651 . . . . 15.0 109.241 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -71.98 -43.76 64.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.04 0.936 . . . . 15.0 109.334 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.91 -37.95 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.4 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -46.1 90.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.656 . . . . 15.0 110.853 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -69.58 -34.97 74.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.616 0.366 . . . . 15.0 111.698 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.28 -53.01 59.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.893 0.877 . . . . 15.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.85 2.19 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.718 0.807 . . . . 15.0 110.645 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 74.26 9.44 4.49 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.764 1.625 . . . . 15.0 112.695 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mt -58.31 -27.73 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.155 1.382 . . . . 15.0 111.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.58 -32.54 74.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.564 0.746 . . . . 15.0 111.122 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.32 -33.68 64.39 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.668 0.605 . . . . 15.0 111.852 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.5 -18.18 42.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.368 0.667 . . . . 15.0 110.766 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -70.58 108.34 4.3 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.518 0.727 . . . . 15.0 109.059 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -91.0 -2.81 57.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.278 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -7.87 79.39 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-O 119.548 -0.585 . . . . 15.0 113.859 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -65.82 -48.66 70.92 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.289 0.636 . . . . 15.0 110.768 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.08 121.79 80.98 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.474 -0.935 . . . . 15.0 108.474 174.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.68 131.68 45.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.882 2.388 . . . . 15.0 112.25 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.7 tpt -63.23 -32.6 74.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.308 1.043 . . . . 15.0 111.602 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.3 p30 -57.97 -38.8 76.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.587 0.755 . . . . 15.0 112.765 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.44 -51.93 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.085 0.954 . . . . 15.0 110.429 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.498 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 29.6 m -72.39 -19.34 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.754 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -74.18 -58.42 3.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.043 0.537 . . . . 15.0 110.983 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.535 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.7 pt20 -73.31 -34.71 65.86 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.878 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.1 mtt180 -96.51 -70.38 0.72 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.072 0.549 . . . . 15.0 111.091 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.498 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 91.8 m-85 -72.29 -18.89 61.76 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.473 0.709 . . . . 15.0 112.177 -169.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.27 23.4 15.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.526 -0.597 . . . . 15.0 112.704 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -21.82 66.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.088 0.955 . . . . 15.0 111.882 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.8 p -62.56 -32.44 73.41 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.563 0.745 . . . . 15.0 111.32 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 78.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.173 0.989 . . . . 15.0 109.692 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -108.07 -48.18 3.42 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.184 -0.673 . . . . 15.0 109.184 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -56.72 -45.34 81.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.677 1.191 . . . . 15.0 111.576 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.53 -34.1 77.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.85 -1.068 . . . . 15.0 111.206 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 28' ' ' VAL . 42.5 t -80.18 -63.64 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.24 -44.58 83.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.962 0.905 . . . . 15.0 112.773 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' HA2' ' HE1' ' A' ' 71' ' ' MET . . . -63.48 -37.4 94.73 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.542 0.526 . . . . 15.0 112.606 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.35 -33.5 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.984 0.914 . . . . 15.0 111.122 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 70.4 mt -70.06 -32.5 70.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.955 0.502 . . . . 15.0 110.432 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.497 ' HE1' ' HA2' ' A' ' 68' ' ' GLY . 68.5 mtm -63.14 -37.64 88.01 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 123.413 0.445 . . . . 15.0 110.455 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 -55.6 5.81 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.488 0.715 . . . . 15.0 110.799 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -67.92 -37.15 81.3 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.117 0.567 . . . . 15.0 112.425 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -75.47 -30.02 59.78 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 117.875 0.307 . . . . 15.0 111.026 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -64.31 -54.54 31.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.073 0.549 . . . . 15.0 110.666 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.6 -35.13 71.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 123.74 0.65 . . . . 15.0 110.618 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.71 -47.66 82.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.63 0.772 . . . . 15.0 110.611 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -56.46 20.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.929 -1.032 . . . . 15.0 111.325 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.532 HD13 ' HD3' ' A' ' 86' ' ' PRO . 21.4 pt -64.88 -31.86 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.914 0.709 . . . . 15.0 112.914 -170.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.87 -49.23 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.798 0.439 . . . . 15.0 110.519 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -72.12 -29.71 64.34 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.641 -0.254 . . . . 15.0 111.053 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -87.3 1.34 53.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.514 0.726 . . . . 15.0 111.57 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 66.96 12.99 9.29 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.86 1.264 . . . . 15.0 112.942 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 70.4 mt -87.06 122.1 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.919 0.888 . . . . 15.0 108.727 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.9 117.27 35.66 Favored Pre-proline 0 N--CA 1.481 1.075 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.532 ' HD3' HD13 ' A' ' 79' ' ' ILE . 72.9 Cg_endo -71.6 152.71 59.76 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 15.0 113.383 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.67 52.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.099 -1.41 . . . . 15.0 107.218 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 304' ' ' ALA . . . -162.23 146.2 11.69 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.031 -1.44 . . . . 15.0 110.002 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -58.57 108.26 1.25 Allowed Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.415 0.607 . . . . 15.0 109.859 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 11.3 Cg_exo -69.16 109.8 2.28 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.439 2.093 . . . . 15.0 111.802 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 47.4 m -69.89 92.39 0.7 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.775 0.83 . . . . 15.0 109.971 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.43 104.71 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.92 103.56 3.45 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.021 -1.103 . . . . 15.0 108.021 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 104.24 1.32 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.076 1.851 . . . . 15.0 109.848 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.59 176.75 38.42 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.764 -0.653 . . . . 15.0 113.166 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.8 116.81 20.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.212 0.53 . . . . 15.0 110.07 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -102.01 98.78 8.94 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.783 -1.191 . . . . 15.0 107.783 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.7 mttt -77.84 136.47 38.09 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.769 -1.197 . . . . 15.0 107.769 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.01 106.94 2.51 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.394 -0.595 . . . . 15.0 109.394 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.64 10.46 40.78 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 116.238 -0.437 . . . . 15.0 112.693 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.3 mt-10 -134.71 -179.75 5.79 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.996 1.318 . . . . 15.0 109.221 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -81.04 173.71 12.32 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.597 0.759 . . . . 15.0 111.76 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -115.27 92.34 3.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 15.0 108.723 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -92.55 96.08 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.847 0.859 . . . . 15.0 109.228 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -108.98 178.23 4.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.43 0.692 . . . . 15.0 109.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.6 m -139.49 150.12 44.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.86 0.864 . . . . 15.0 109.284 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.97 117.22 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -98.07 136.91 37.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.401 1.08 . . . . 15.0 109.366 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -167.58 165.74 14.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.509 0.723 . . . . 15.0 109.823 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.89 174.67 5.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.306 0.643 . . . . 15.0 109.379 170.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.16 -166.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.161 0.984 . . . . 15.0 109.174 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 114.4 58.5 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 122.853 0.461 . . . . 15.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.03 112.47 3.26 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.681 2.254 . . . . 15.0 111.787 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.39 96.42 0.88 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.611 0.764 . . . . 15.0 109.421 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.97 134.38 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.054 0.941 . . . . 15.0 110.992 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.8 110.53 22.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.48 0.712 . . . . 15.0 109.379 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.623 ' HB3' HD22 ' A' ' 120' ' ' LEU . 94.1 mt -75.08 128.85 36.49 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -124.6 112.47 16.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.627 0.771 . . . . 15.0 109.784 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.0 67.1 2.28 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 124.469 1.106 . . . . 15.0 113.536 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 117' ' ' LEU . 38.5 mt -66.33 -25.15 66.69 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.59 0.356 . . . . 15.0 110.547 175.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -71.82 -35.99 70.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.084 0.953 . . . . 15.0 110.75 175.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.29 -22.09 63.83 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.538 0.735 . . . . 15.0 111.548 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.34 127.43 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.951 0.9 . . . . 15.0 109.991 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 38.2 mt-10 -108.47 110.14 21.58 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.835 0.854 . . . . 15.0 109.778 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.416 ' HB ' HG11 ' A' ' 417' ' ' VAL . 37.9 t -119.82 165.06 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.789 1.236 . . . . 15.0 107.853 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.04 149.01 32.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.625 -0.88 . . . . 15.0 108.625 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HE2' HD13 ' A' ' 129' ' ' ILE . 83.4 tttt -116.64 85.51 16.97 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.42 102.01 1.38 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.2 1.933 . . . . 15.0 111.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.478 HD13 ' HE2' ' A' ' 127' ' ' LYS . 41.1 mm -73.95 86.98 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.852 -1.166 . . . . 15.0 107.852 171.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.703 HG23 HG22 ' A' ' 422' ' ' THR . 28.7 t -107.27 148.37 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.08 -0.964 . . . . 15.0 110.502 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.12 165.17 37.06 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.246 1.018 . . . . 15.0 109.696 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.477 HG13 ' SD ' ' A' ' 274' ' ' MET . 2.8 t -96.77 88.54 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.8 p -77.21 -175.94 3.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.032 0.933 . . . . 15.0 110.352 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.99 -55.12 34.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.53 0.732 . . . . 15.0 111.366 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.05 66.97 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.977 0.798 . . . . 15.0 111.799 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -79.03 -45.33 20.39 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.362 0.665 . . . . 15.0 110.889 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.64 -54.94 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.204 0.602 . . . . 15.0 109.434 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.77 -48.04 82.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.96 99.09 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.91 0.757 . . . . 15.0 113.379 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.425 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.2 tpt -68.51 -50.86 48.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.599 0.759 . . . . 15.0 111.038 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.26 -38.33 68.4 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.024 0.53 . . . . 15.0 111.817 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 t70 -68.05 -39.17 83.09 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.45 -0.796 . . . . 15.0 110.571 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 71.1 m -61.97 -39.82 93.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.186 0.594 . . . . 15.0 110.128 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 140' ' ' MET . 83.4 mt -63.48 -38.26 90.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.166 0.587 . . . . 15.0 110.06 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 63.7 mtm180 -64.59 -34.41 78.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.223 173.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 142' ' ' ASP . 87.1 mttt -67.85 -35.94 79.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.513 0.325 . . . . 15.0 110.885 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 143' ' ' THR . 92.8 mt-30 -70.47 -33.32 71.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.859 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -103.59 29.47 5.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.848 . . . . 15.0 111.241 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.88 24.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.276 0.843 . . . . 15.0 113.276 -171.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -96.05 136.24 36.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.46 1.104 . . . . 15.0 110.306 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -81.78 111.82 18.36 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.225 0.61 . . . . 15.0 110.238 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -125.81 113.04 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 15.0 110.406 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.7 mt-10 -65.04 119.37 10.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.385 0.674 . . . . 15.0 111.063 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.537 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 47.0 pttt -123.78 -179.57 4.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.385 1.074 . . . . 15.0 110.009 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -165.58 154.12 11.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.916 0.887 . . . . 15.0 108.827 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.27 -38.75 2.39 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.436 -0.666 . . . . 15.0 111.436 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.02 123.68 7.28 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.608 0.363 . . . . 15.0 110.786 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' A' ' 206' ' ' LYS . 40.5 t -85.43 131.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 171.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -121.85 -177.63 3.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.149 0.979 . . . . 15.0 109.72 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -81.43 -9.23 59.77 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.505 0.722 . . . . 15.0 111.893 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -97.62 19.33 13.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.958 0.903 . . . . 15.0 111.718 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.8 m-20 -94.11 158.78 15.45 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.102 0.953 . . . . 15.0 112.301 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 6.5 tmm_? -120.85 91.53 3.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.068 -2.197 . . . . 15.0 105.068 165.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.4 t -90.22 148.75 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.392 1.077 . . . . 15.0 110.791 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.702 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 41.0 m -126.19 121.63 33.33 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.759 -1.2 . . . . 15.0 107.759 171.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.577 HG22 HD23 ' A' ' 237' ' ' LEU . 36.3 pt -128.95 174.08 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.577 0.751 . . . . 15.0 111.914 -172.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -118.49 116.57 26.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.163 -1.792 . . . . 15.0 106.163 158.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.559 ' HE1' HG22 ' B' ' 387' ' ' ILE . 11.6 p90 -107.88 140.99 40.16 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 234' ' ' ALA . 1.5 t -137.28 113.65 10.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.923 -1.14 . . . . 15.0 107.923 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -101.25 154.79 19.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 116.131 -0.486 . . . . 15.0 113.072 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 p -136.88 104.17 5.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.741 0.816 . . . . 15.0 109.206 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.598 HG23 ' HB1' ' A' ' 231' ' ' ALA . 52.9 t -77.39 112.95 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.141 -0.936 . . . . 15.0 109.271 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.9 t70 64.44 25.34 13.32 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 124.703 1.252 . . . . 15.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.47 21.15 52.56 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.04 -0.982 . . . . 15.0 114.524 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.12 150.43 49.98 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.02 0.91 . . . . 15.0 110.911 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.97 81.44 5.24 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.996 -1.113 . . . . 15.0 107.996 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 1.1 p90 -59.48 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 112.712 -2.04 . . . . 15.0 112.387 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 177' ' ' PHE . 12.0 mm-40 -101.0 176.52 5.23 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.574 1.55 . . . . 15.0 109.231 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.61 60.68 2.45 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 165.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -99.97 83.42 0.56 Allowed Glycine 0 C--N 1.344 0.985 0 C-N-CA 123.335 0.493 . . . . 15.0 111.985 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -148.39 165.22 31.75 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.909 0.883 . . . . 15.0 109.399 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.52 94.94 1.52 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.855 -0.611 . . . . 15.0 109.855 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 128.69 37.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.631 -1.168 . . . . 15.0 109.335 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 65.25 33.28 9.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.073 0.949 . . . . 15.0 111.145 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.01 127.65 32.38 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 122.784 0.434 . . . . 15.0 109.945 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.83 95.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.624 0.77 . . . . 15.0 110.263 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.616 HD23 ' HE3' ' A' ' 194' ' ' MET . 36.7 tp -86.79 90.08 8.18 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.433 0.635 . . . . 15.0 110.285 170.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.444 ' HB2' ' NE2' ' A' ' 191' ' ' GLN . . . -83.27 89.72 7.03 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.811 -1.181 . . . . 15.0 107.811 169.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.409 ' HE1' ' HB3' ' A' ' 189' ' ' MET . 46.7 mtp -57.07 137.48 55.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.321 0.648 . . . . 15.0 111.83 -173.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.87 5.18 Favored Glycine 0 N--CA 1.47 0.95 0 N-CA-C 112.077 -0.409 . . . . 15.0 112.077 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.444 ' NE2' ' HB2' ' A' ' 188' ' ' ALA . 10.4 pt20 -98.98 158.72 15.46 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.296 0.639 . . . . 15.0 110.553 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.98 66.32 2.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.986 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -107.7 10.63 28.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.54 0.736 . . . . 15.0 110.859 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.616 ' HE3' HD23 ' A' ' 187' ' ' LEU . 24.6 mmt -129.7 149.13 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.944 0.898 . . . . 15.0 110.583 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.8 pt -95.34 141.31 23.04 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.946 -1.025 . . . . 15.0 108.711 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.43 120.99 7.68 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.383 2.722 . . . . 15.0 112.918 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.89 -34.03 3.38 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.107 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -78.07 -57.05 4.0 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.097 0.559 . . . . 15.0 110.233 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -19.93 65.47 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.953 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.639 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 21.2 m-20 -58.16 -41.15 83.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.426 0.69 . . . . 15.0 110.815 170.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -67.71 -30.51 74.7 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.92 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.498 HG21 HD22 ' A' ' 187' ' ' LEU . 39.1 mm -75.99 -52.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.982 0.513 . . . . 15.0 110.346 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 55.8 pttt -80.16 20.19 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.053 0.941 . . . . 15.0 113.365 -167.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.48 31.22 2.15 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.367 -0.693 . . . . 15.0 111.367 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -146.99 -161.73 1.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.342 1.057 . . . . 15.0 109.695 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.427 ' HA ' HG21 ' A' ' 158' ' ' VAL . 9.9 ptpp? -148.89 168.75 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.189 0.596 . . . . 15.0 109.671 172.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 240' ' ' VAL . . . -65.4 148.64 51.37 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 117.987 0.358 . . . . 15.0 110.626 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.75 -45.63 1.28 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.804 -0.634 . . . . 15.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.92 122.95 28.93 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.471 0.653 . . . . 15.0 110.375 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.43 135.95 40.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.19 0.996 . . . . 15.0 110.11 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -144.46 173.03 12.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.033 0.933 . . . . 15.0 109.172 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.7 m -129.79 116.81 19.28 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.89 -0.781 . . . . 15.0 108.89 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.618 HG22 ' HA3' ' A' ' 201' ' ' GLY . 23.1 pt -92.32 170.58 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.029 0.932 . . . . 15.0 110.071 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.93 124.6 33.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.379 0.672 . . . . 15.0 109.441 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.01 163.64 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.586 -1.264 . . . . 15.0 107.586 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.3 m -129.83 140.13 51.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.723 0.809 . . . . 15.0 109.38 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.84 143.11 45.92 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 122.977 0.511 . . . . 15.0 110.549 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.63 155.51 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 124.295 3.33 . . . . 15.0 115.587 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.29 -25.79 63.5 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.176 -0.92 . . . . 15.0 110.406 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.29 -13.13 35.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.277 1.031 . . . . 15.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -55.67 140.98 39.64 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 123.259 0.623 . . . . 15.0 111.275 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -46.84 -67.61 0.27 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 125.178 1.549 . . . . 15.0 112.806 -171.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.69 125.57 28.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 15.0 110.45 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.18 -31.94 62.88 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.6 0.76 . . . . 15.0 111.587 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.421 ' O ' ' HD2' ' A' ' 229' ' ' LYS . 27.8 p-10 -64.23 -17.2 63.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.447 0.699 . . . . 15.0 111.416 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.813 HD11 ' HA ' ' B' ' 388' ' ' VAL . 28.8 mt -100.01 -39.31 8.2 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.172 0.989 . . . . 15.0 110.601 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -46.63 113.58 0.67 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.136 1.774 . . . . 15.0 112.813 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.65 -18.93 27.32 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.608 0.567 . . . . 15.0 114.253 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 98.4 mttt -84.17 154.28 23.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.619 0.768 . . . . 15.0 112.453 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.44 23.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.363 1.065 . . . . 15.0 110.638 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 172' ' ' VAL . . . -90.23 135.67 33.53 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.215 1.006 . . . . 15.0 111.067 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.74 100.85 11.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.475 ' HE1' HG21 ' B' ' 387' ' ' ILE . 90.6 m-85 -96.53 107.74 20.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.555 0.342 . . . . 15.0 110.563 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.572 ' HB2' HG23 ' A' ' 169' ' ' THR . . . -77.23 102.68 6.77 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.078 -0.712 . . . . 15.0 109.078 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.52 134.38 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.865 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -115.99 100.44 7.97 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 166' ' ' ILE . 95.0 mt -74.08 110.15 8.14 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.874 -0.787 . . . . 15.0 108.874 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -108.96 -33.37 6.94 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.096 0.474 . . . . 15.0 110.142 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.702 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.4 mmtt -133.28 122.99 24.69 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.108 0.963 . . . . 15.0 109.498 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 207' ' ' ALA . 97.5 t -114.97 87.44 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 106.872 -1.529 . . . . 15.0 106.872 169.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 163' ' ' ARG . 44.7 mt-10 -93.77 169.18 10.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.62 -0.881 . . . . 15.0 108.62 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 32.2 tt0 -134.42 122.84 23.1 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -74.1 83.99 1.81 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.132 -1.432 . . . . 15.0 107.132 167.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 127.17 31.6 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.752 -1.567 . . . . 15.0 110.746 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.38 115.0 9.36 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.389 1.076 . . . . 15.0 109.247 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 78.7 Cg_endo -75.52 -176.56 3.02 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.047 2.498 . . . . 15.0 112.407 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.96 142.53 56.42 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.964 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 24.4 tp -107.1 23.04 15.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 p -71.56 176.7 4.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.509 1.124 . . . . 15.0 111.216 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -38.05 -59.49 0.84 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.944 1.698 . . . . 15.0 114.573 -166.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.28 -22.82 65.63 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.31 -50.21 6.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.095 0.558 . . . . 15.0 109.786 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.618 HG13 HD22 ' A' ' 266' ' ' LEU . 15.6 tt -65.36 -27.29 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.012 0.525 . . . . 15.0 111.841 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -22.65 42.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.022 0.378 . . . . 15.0 112.022 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -62.81 -22.15 66.42 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.052 0.941 . . . . 15.0 111.568 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -39.95 90.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 15.0 110.857 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 150.1 26.5 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 O-C-N 123.416 0.447 . . . . 15.0 113.452 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.11 143.56 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 117.558 0.679 . . . . 15.0 109.185 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -69.65 -57.2 5.45 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.386 0.674 . . . . 15.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -91.54 -38.3 12.59 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.745 0.418 . . . . 15.0 110.51 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.17 32.43 5.27 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.147 -0.479 . . . . 15.0 112.645 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.7 p -78.65 145.64 34.51 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.392 0.596 . . . . 15.0 109.738 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.16 -41.59 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.127 0.971 . . . . 15.0 111.126 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.22 -34.66 61.16 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.853 0.861 . . . . 15.0 111.858 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.88 -25.36 58.2 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 111.366 -0.694 . . . . 15.0 111.366 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.618 HD22 HG13 ' A' ' 253' ' ' ILE . 54.7 tp -75.97 -28.46 57.9 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.44 -45.88 78.33 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.071 -0.714 . . . . 15.0 109.071 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.99 82.05 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.307 -1.315 . . . . 15.0 110.419 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -68.13 -45.55 73.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.222 0.951 . . . . 15.0 111.855 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.04 -22.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 122.506 0.322 . . . . 15.0 110.649 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -68.47 -53.14 25.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.948 -0.39 . . . . 15.0 109.948 169.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -77.43 -2.18 33.98 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 112.537 0.569 . . . . 15.0 112.537 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.85 -59.37 1.75 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.271 0.628 . . . . 15.0 110.39 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.477 ' SD ' HG13 ' A' ' 132' ' ' VAL . 64.2 mtt -74.23 -38.0 63.65 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-O 118.045 -0.979 . . . . 15.0 112.055 -169.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -71.2 -37.81 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 120.044 1.293 . . . . 15.0 109.804 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.468 ' NH2' ' HA ' ' A' ' 378' ' ' TYR . 5.8 tpp180 -56.58 -40.36 75.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.714 0.805 . . . . 15.0 110.939 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.12 -60.38 2.36 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.891 -0.595 . . . . 15.0 110.581 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.597 HD22 HG13 ' A' ' 130' ' ' VAL . 39.8 tp -64.24 -60.47 3.16 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 125.174 1.39 . . . . 15.0 112.775 -171.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.06 -32.53 73.92 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.03 0.443 . . . . 15.0 110.756 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.1 t -69.82 -38.53 76.6 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.075 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.65 98.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 15.0 110.734 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.45 -51.52 71.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 O-C-N 123.593 0.558 . . . . 15.0 109.558 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -57.5 -52.23 66.24 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.639 0.587 . . . . 15.0 111.35 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -69.24 -28.7 66.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.922 0.889 . . . . 15.0 111.456 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -64.22 -57.62 8.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.814 0.445 . . . . 15.0 110.084 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.51 -35.84 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.677 0.791 . . . . 15.0 110.534 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.511 ' HG3' HG23 ' A' ' 408' ' ' VAL . 86.6 tttt -64.05 -48.74 75.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.931 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.9 p -67.69 -31.1 70.83 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.182 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.25 -35.98 74.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.09 0.556 . . . . 15.0 110.701 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -52.43 57.76 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 123.446 0.467 . . . . 15.0 109.929 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 347' ' ' VAL . 34.0 mm -61.78 -50.25 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.847 0.717 . . . . 15.0 111.486 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.45 -35.34 80.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.802 -0.635 . . . . 15.0 109.707 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.41 -40.57 96.43 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.009 0.818 . . . . 15.0 112.474 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 350' ' ' LEU . 45.7 mt -60.76 -46.33 90.89 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.18 0.992 . . . . 15.0 111.109 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.2 -48.23 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.696 0.76 . . . . 15.0 109.784 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -66.37 -24.07 66.43 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.028 -0.987 . . . . 15.0 110.685 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.09 53.25 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.863 . . . . 15.0 112.473 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.38 149.39 10.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 -169.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.41 136.37 47.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.776 -0.647 . . . . 15.0 110.314 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.403 HG21 HG11 ' A' ' 346' ' ' VAL . 4.8 tp -117.8 115.91 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.001 0.92 . . . . 15.0 109.228 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.82 141.76 35.93 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 342' ' ' LYS . 24.7 t -126.93 115.33 22.14 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.747 0.819 . . . . 15.0 109.633 -165.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.02 141.13 16.37 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.275 2.65 . . . . 15.0 112.974 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.497 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -64.55 -33.65 76.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.267 1.21 . . . . 15.0 114.267 -166.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.63 65.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.753 0.421 . . . . 15.0 111.552 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.419 HD13 HG11 ' A' ' 345' ' ' VAL . 14.5 mt -88.16 -29.83 20.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.417 -0.811 . . . . 15.0 110.271 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.39 -51.63 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.82 -57.21 11.75 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 114.438 -1.255 . . . . 15.0 110.342 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 313' ' ' VAL . 32.3 t -60.77 -56.32 22.63 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.401 1.063 . . . . 15.0 111.848 -173.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.78 -45.47 78.35 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 111.744 0.275 . . . . 15.0 111.744 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 46.7 mt -64.83 -37.02 79.12 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 N-CA-C 109.803 -0.443 . . . . 15.0 109.803 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 8.2 t70 -57.59 -46.68 83.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.694 0.797 . . . . 15.0 110.934 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' B' ' 471' ' ' LYS . 96.3 t -55.55 -52.0 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 123.837 0.711 . . . . 15.0 110.573 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 341' ' ' ALA . 84.1 mt -70.57 -21.96 62.63 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.803 -1.09 . . . . 15.0 112.3 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 329' ' ' ALA . 49.8 mtm180 -83.4 -27.89 29.28 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.125 0.57 . . . . 15.0 110.783 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 64.5 mtt180 -70.46 -42.66 71.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 172.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.18 -51.55 69.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.088 0.955 . . . . 15.0 110.502 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.46 31.11 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.499 -0.773 . . . . 15.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.29 74.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 123.965 0.791 . . . . 15.0 111.476 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -59.48 -36.04 75.26 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.2 0.6 . . . . 15.0 110.789 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -87.51 -19.76 27.47 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.52 0.728 . . . . 15.0 110.45 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -86.81 -5.84 58.99 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.826 1.25 . . . . 15.0 110.508 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.83 61.65 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.035 -0.53 . . . . 15.0 113.308 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.95 17.36 74.95 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 122.613 -0.345 . . . . 15.0 113.246 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.4 HD21 HD13 ' B' ' 408' ' ' LEU . 53.9 t30 -70.55 159.56 34.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 122.887 0.475 . . . . 15.0 109.771 174.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 76.82 -55.5 0.56 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.236 1.815 . . . . 15.0 111.354 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.474 ' HE3' ' HA2' ' B' ' 417' ' ' GLY . 48.6 mttm 65.39 21.03 11.88 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.128 1.371 . . . . 15.0 110.937 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -97.79 15.25 24.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.781 1.632 . . . . 15.0 110.083 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -50.72 -19.87 1.08 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 126.013 1.725 . . . . 15.0 114.692 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 59.1 tp -49.77 -34.96 20.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.931 0.893 . . . . 15.0 111.601 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.7 -29.3 68.52 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.937 1.695 . . . . 15.0 113.04 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 337' ' ' PHE . 53.1 mt -43.76 123.26 3.84 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 123.853 0.861 . . . . 15.0 112.556 -171.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.47 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 53.5 Cg_exo -43.03 127.8 5.15 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 124.995 3.797 . . . . 15.0 115.189 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -52.91 -48.42 67.26 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.655 1.182 . . . . 15.0 112.076 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.52 -18.79 4.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.332 1.053 . . . . 15.0 113.447 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.47 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.1 mt -74.8 -38.02 62.22 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.224 0.465 . . . . 15.0 110.878 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 332' ' ' LEU . 41.9 m-85 -120.03 -51.94 2.21 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.095 0.558 . . . . 15.0 112.241 -168.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -47.53 -40.21 18.24 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.987 1.315 . . . . 15.0 113.301 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.56 -34.9 59.92 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.279 1.032 . . . . 15.0 112.469 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -104.22 -30.78 9.95 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.154 0.982 . . . . 15.0 111.126 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 314' ' ' LEU . . . -76.49 -60.63 2.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.249 1.02 . . . . 15.0 110.971 -173.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 302' ' ' VAL . 88.3 tttt -62.32 -25.03 67.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.428 -0.805 . . . . 15.0 109.792 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -71.69 -35.09 70.14 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 118.421 -0.8 . . . . 15.0 110.719 171.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -57.36 -43.16 83.3 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 119.243 0.929 . . . . 15.0 109.306 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG11 HD13 ' A' ' 306' ' ' LEU . 41.3 t -60.73 -49.8 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.265 -1.334 . . . . 15.0 110.704 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 342' ' ' LYS . 68.2 t -59.59 -48.95 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.611 0.764 . . . . 15.0 111.058 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 291' ' ' ILE . 71.6 t -52.64 -43.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.138 0.975 . . . . 15.0 110.267 173.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -70.36 -37.87 70.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 15.0 113.854 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.88 -47.2 54.45 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.267 0.627 . . . . 15.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 294' ' ' LEU . 76.9 mt -62.38 -57.88 9.7 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.998 0.811 . . . . 15.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 355' ' ' ILE . 53.2 mt -65.65 -34.45 78.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.125 0.57 . . . . 15.0 112.216 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.5 99.0 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.696 -0.562 . . . . 15.0 111.696 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.25 -37.42 85.46 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.072 -0.564 . . . . 15.0 110.687 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 350' ' ' LEU . 62.5 t -63.49 -36.28 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 117.956 0.343 . . . . 15.0 110.786 176.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 360' ' ' LEU . 97.1 mt -64.0 -44.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.367 0.667 . . . . 15.0 109.807 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.23 -56.4 11.46 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.488 -0.324 . . . . 15.0 111.361 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 77.0 m -54.48 -42.65 70.96 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.982 1.313 . . . . 15.0 111.985 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -101.19 14.65 31.31 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.155 0.582 . . . . 15.0 111.547 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 48.65 33.56 4.32 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 125.729 1.612 . . . . 15.0 114.205 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 355' ' ' ILE . 65.9 mt -72.42 157.04 38.38 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.087 0.955 . . . . 15.0 113.055 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 152.68 40.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.967 0.907 . . . . 15.0 110.415 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.69 111.62 17.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.477 0.711 . . . . 15.0 109.556 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 15.2 t70 -107.55 137.39 45.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.327 0.651 . . . . 15.0 110.884 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -64.48 -31.76 73.1 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.739 0.815 . . . . 15.0 113.03 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -66.08 -32.74 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 10.7 tpp180 -71.75 -44.99 63.13 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 371' ' ' ILE . 94.1 t -55.56 -60.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.111 0.882 . . . . 15.0 109.819 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -59.48 -35.83 74.85 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.161 0.913 . . . . 15.0 111.897 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.62 -55.7 27.41 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.902 0.751 . . . . 15.0 111.816 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.04 -42.97 81.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.641 0.776 . . . . 15.0 111.014 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 398' ' ' MET . 51.2 mm -51.22 -60.22 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.467 1.104 . . . . 15.0 110.461 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.54 -42.87 95.45 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.755 0.659 . . . . 15.0 112.14 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.59 -44.89 93.21 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 124.017 0.823 . . . . 15.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -77.09 -35.45 56.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 119.658 -0.211 . . . . 15.0 110.668 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.19 -27.09 65.2 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.482 0.713 . . . . 15.0 111.798 -172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.6 t -65.78 -19.64 65.96 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 123.916 0.76 . . . . 15.0 110.908 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -95.75 3.03 54.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.972 0.909 . . . . 15.0 111.933 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.468 ' HA ' ' NH2' ' A' ' 276' ' ' ARG . 2.8 m-85 -88.74 177.57 6.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.065 0.546 . . . . 15.0 109.686 172.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.29 -47.22 62.15 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.173 -0.921 . . . . 15.0 109.359 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.37 122.31 13.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.379 1.072 . . . . 15.0 109.233 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -70.69 -40.28 4.0 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.708 2.272 . . . . 15.0 114.178 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -54.32 -47.79 72.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.359 0.874 . . . . 15.0 113.359 -167.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.93 -24.68 66.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.236 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.07 -45.79 29.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 123.859 0.864 . . . . 15.0 109.164 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.04 -47.04 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.053 0.541 . . . . 15.0 109.57 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.66 -39.93 80.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.142 0.577 . . . . 15.0 112.36 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.4 -36.65 84.44 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.527 0.731 . . . . 15.0 111.08 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.437 ' HA ' HD21 ' A' ' 394' ' ' LEU . 34.8 m-85 -73.84 -62.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.922 -0.581 . . . . 15.0 110.599 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.2 p -57.6 -32.17 66.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.32 17.42 11.29 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 15.0 111.98 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.627 HD22 HG22 ' B' ' 435' ' ' THR . 56.7 t-20 -139.84 106.14 5.27 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.35 -0.982 . . . . 15.0 108.35 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -65.83 -41.2 92.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.998 0.519 . . . . 15.0 111.345 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.67 -41.97 96.13 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.932 0.77 . . . . 15.0 110.517 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 388' ' ' TYR . 22.5 tp -72.14 -38.92 69.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.691 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 93.0 mmm -66.26 -30.76 71.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.92 0.488 . . . . 15.0 110.69 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.9 -39.96 69.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.285 1.034 . . . . 15.0 109.852 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 400' ' ' ASN . 67.1 m-80 -75.43 -21.58 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.916 172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.569 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -87.69 -20.07 26.79 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.586 0.217 . . . . 15.0 111.586 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.57 -36.89 57.33 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 167.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 397' ' ' ASN . 4.1 t30 -52.02 -61.59 2.17 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.736 -1.12 . . . . 15.0 110.343 168.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.8 p -66.32 -27.47 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 118.154 0.434 . . . . 15.0 111.685 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.73 -58.01 10.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.033 0.533 . . . . 15.0 110.355 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 24.3 tp -77.76 -23.32 49.27 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.76 -1.109 . . . . 15.0 111.582 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.52 -51.66 33.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.99 0.516 . . . . 15.0 109.625 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.28 -35.8 82.03 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.8 -0.636 . . . . 15.0 111.176 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -69.85 -33.55 72.42 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.012 0.525 . . . . 15.0 111.205 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.97 93.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.84 0.456 . . . . 15.0 110.303 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.511 HG23 ' HG3' ' A' ' 287' ' ' LYS . 84.5 t -58.12 -53.6 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.815 -0.63 . . . . 15.0 109.752 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.38 -25.6 66.01 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.987 0.915 . . . . 15.0 112.908 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.94 -30.59 62.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.783 0.433 . . . . 15.0 111.317 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.5 t -70.67 -43.27 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.077 -1.082 . . . . 15.0 108.077 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 83.4 mt -65.23 -40.7 94.42 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.362 1.039 . . . . 15.0 111.57 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.35 -23.16 67.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.836 0.854 . . . . 15.0 111.564 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -98.96 -27.42 13.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 15.0 111.116 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.966 0.907 . . . . 15.0 111.348 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.8 mttt -69.93 83.51 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.692 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.416 HG11 ' HB ' ' A' ' 125' ' ' VAL . 5.0 m -93.8 91.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.033 0.921 . . . . 15.0 109.487 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.7 t -70.72 95.2 1.09 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.513 -1.221 . . . . 15.0 109.188 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 131.81 40.59 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 115.055 -0.975 . . . . 15.0 110.505 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -146.86 145.43 29.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.27 135.12 33.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.703 HG22 HG23 ' A' ' 130' ' ' VAL . 4.5 t -159.86 174.03 15.06 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.495 0.497 . . . . 15.0 110.657 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.5 p -100.61 175.34 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.475 1.11 . . . . 15.0 111.948 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.445 ' HD2' HD21 ' A' ' 278' ' ' LEU . 38.4 t80 -52.71 -28.06 20.33 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.578 1.551 . . . . 15.0 111.691 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.654 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 23.2 m-80 -65.12 -15.61 62.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.775 1.23 . . . . 15.0 112.945 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.466 ' HB3' HD13 ' A' ' 427' ' ' LEU . 23.4 tp10 -60.7 -37.21 80.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.582 1.153 . . . . 15.0 111.414 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 426' ' ' GLU . 4.8 mp -109.23 -77.85 0.59 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.435 -0.165 . . . . 15.0 111.192 -174.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.5 mpt? -68.35 -50.54 52.56 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.838 0.455 . . . . 15.0 112.1 -171.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 15.9 m120 -82.84 47.88 1.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -174.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -102.09 76.02 1.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.18 -38.71 11.42 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.574 0.75 . . . . 15.0 109.437 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.017 0.927 . . . . 15.0 109.482 -176.241 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.35 120.5 13.95 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.52 HD22 ' H ' ' B' ' 367' ' ' LEU . 1.1 pt? -94.46 -70.42 0.71 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -161.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.447 ' H ' ' HG ' ' B' ' 367' ' ' LEU . 7.2 t70 -79.93 -81.22 0.12 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.014 0.825 . . . . 0.0 109.243 -169.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' B' ' 370' ' ' ALA . 1.7 pm0 -104.26 -73.19 0.68 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 160.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . 0.474 ' H ' ' HG2' ' B' ' 369' ' ' GLU . . . -107.25 -85.19 0.51 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.197 0.908 . . . . 0.0 110.426 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.546 HG11 ' H ' ' B' ' 372' ' ' GLN . 1.7 p -110.71 -78.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.546 ' H ' HG11 ' B' ' 371' ' ' VAL . 8.4 tt0 -95.13 -78.89 0.44 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' B' ' 377' ' ' PHE . 26.1 tpt180 -104.83 -84.0 0.5 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 163.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' B' ' 378' ' ' ALA . . . -105.67 -78.73 0.57 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.952 0.797 . . . . 0.0 111.834 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.434 HD21 ' H ' ' B' ' 376' ' ' GLU 0.292 0.0 OUTLIER -111.65 -58.28 2.14 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.212 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.434 ' H ' HD21 ' B' ' 375' ' ' LEU . 4.8 tm-20 -102.43 -82.58 0.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.553 ' O ' ' HB3' ' B' ' 373' ' ' ARG . 3.0 m-85 -98.73 -87.91 0.33 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 161.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' B' ' 374' ' ' ALA . . . -91.56 -84.92 0.25 Allowed 'General case' 0 C--N 1.358 0.946 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -107.48 -85.66 0.51 Allowed 'General case' 0 C--O 1.242 0.71 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 166.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.491 ' HG3' ' HA ' ' B' ' 393' ' ' ALA . 40.2 tptt 176.0 80.55 0.0 OUTLIER 'General case' 0 C--N 1.35 0.595 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.27 -69.52 0.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.72 -167.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 74.73 -87.98 0.74 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.367 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.82 134.93 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.387 0.675 . . . . 0.0 111.233 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 55.1 m -144.99 -73.74 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 166.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.519 HD11 ' SD ' ' A' ' 194' ' ' MET . 2.3 pt? -142.88 147.8 35.95 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 157.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.6 91.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -164.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.559 HG22 ' HE1' ' A' ' 168' ' ' PHE . 0.1 OUTLIER -146.37 87.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 156.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.813 ' HA ' HD11 ' A' ' 226' ' ' LEU . 9.8 p -152.5 154.69 7.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.406 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 97.8 m -64.08 128.12 34.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 160.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -41.5 112.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.17 1.388 . . . . 0.0 112.82 -167.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -149.02 146.14 27.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.358 0.663 . . . . 0.0 110.137 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -152.21 137.94 17.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.272 1.029 . . . . 0.0 109.782 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' B' ' 380' ' ' LYS . . . -77.61 148.41 35.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.113 0.965 . . . . 0.0 111.733 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -91.05 4.06 53.12 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.859 0.864 . . . . 0.0 111.101 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -54.46 107.86 0.32 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.145 0.978 . . . . 0.0 111.264 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 39.3 m 70.44 178.61 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.126 1.516 . . . . 0.0 112.373 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 64.34 -87.44 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.06 1.344 . . . . 0.0 110.516 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.524 HG13 ' H ' ' B' ' 399' ' ' VAL . 11.4 pt 32.71 -83.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 126.136 1.774 . . . . 0.0 114.128 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.524 ' H ' HG13 ' B' ' 398' ' ' ILE . 2.6 p -60.87 108.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.456 0.702 . . . . 0.0 109.234 171.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 63.23 91.39 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -164.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.57 -25.68 26.47 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.538 2.825 . . . . 0.0 113.961 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.04 -78.17 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 54.6 m -157.23 -42.27 0.07 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 63.93 -168.44 0.2 Allowed 'General case' 0 C--N 1.36 1.035 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.045 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -74.59 113.64 26.15 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.791 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.13 149.01 74.71 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.927 2.418 . . . . 0.0 112.703 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -66.48 -20.69 70.0 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.717 0.635 . . . . 0.0 113.574 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 325' ' ' ASN . 98.3 mt -99.3 27.39 5.21 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 54.2 p 65.72 -60.36 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 126.759 2.024 . . . . 0.0 112.152 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.52 -167.07 1.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.496 1.119 . . . . 0.0 109.571 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.39 -17.53 60.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.539 0.735 . . . . 0.0 111.321 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 25.9 tp 72.53 159.18 0.21 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.732 1.613 . . . . 0.0 111.521 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.26 -74.94 0.09 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.348 0.659 . . . . 0.0 110.321 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 48.3 m -162.19 -60.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.951 0.9 . . . . 0.0 109.054 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.05 94.1 0.07 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.947 1.299 . . . . 0.0 110.591 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -54.19 -57.96 9.18 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.189 1.796 . . . . 0.0 113.355 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . 0.474 ' HA2' ' HE3' ' A' ' 327' ' ' LYS . . . -168.1 -64.98 0.03 OUTLIER Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.044 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 59.04 -150.22 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.934 0.894 . . . . 0.0 111.147 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.466 HG13 ' H ' ' B' ' 420' ' ' MET 0.281 7.2 p 47.58 -78.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 126.762 2.025 . . . . 0.0 114.948 177.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.466 ' H ' HG13 ' B' ' 419' ' ' VAL . 12.5 tmm? -156.38 106.82 2.38 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 59.91 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.38 1.872 . . . . 0.0 112.948 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 13.5 ttt 63.69 33.48 13.0 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.999 1.32 . . . . 0.0 111.286 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -4.43 41.85 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.511 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -104.8 120.16 40.72 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.42 58.86 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.536 0.522 . . . . 0.0 112.823 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 65.7 t30 59.7 20.73 9.43 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.889 1.276 . . . . 0.0 111.31 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 65.5 p -78.42 173.35 12.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.64 0.776 . . . . 0.0 111.335 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 63.94 8.0 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.925 1.29 . . . . 0.0 112.379 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' B' ' 432' ' ' GLN . 3.5 tm-20 -70.0 -32.14 70.17 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.47 1.108 . . . . 0.0 110.027 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -55.5 -40.14 71.37 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.453 1.101 . . . . 0.0 110.905 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 22.7 t -101.13 -7.5 23.11 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.204 -169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' B' ' 429' ' ' GLU . 29.4 mm-40 -56.92 -56.01 27.16 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.2 0.455 . . . . 0.0 110.995 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.31 111.85 20.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -88.14 48.95 1.71 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.742 0.817 . . . . 0.0 111.414 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.627 HG22 HD22 ' A' ' 391' ' ' ASN . 19.8 m -66.71 -24.72 66.28 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.15 0.98 . . . . 0.0 110.998 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -137.44 -179.19 16.63 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 38.6 t 62.1 -90.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.863 1.265 . . . . 0.0 111.915 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 61.21 36.48 17.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.152 0.981 . . . . 0.0 110.022 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 99.0 mt 64.2 18.33 11.21 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.179 1.392 . . . . 0.0 112.337 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.655 ' HG3' HG12 ' B' ' 441' ' ' ILE . 35.3 ptt180 -151.9 -159.81 1.07 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.665 1.186 . . . . 0.0 108.175 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.655 HG12 ' HG3' ' B' ' 440' ' ' ARG . 34.0 mm 68.55 110.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.78 0.832 . . . . 0.0 112.066 168.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.73 92.47 1.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -142.93 167.3 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.183 -169.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' B' ' 470' ' ' LEU . 97.3 m-85 -121.3 169.77 10.26 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.306 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -125.46 156.2 19.16 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -89.52 156.08 5.33 Favored 'Trans proline' 0 CA--C 1.555 1.57 0 C-N-CA 122.569 2.179 . . . . 0.0 113.109 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -137.58 75.88 1.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 62.86 21.27 12.73 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.997 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -83.88 -34.65 24.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.89 4.17 2.78 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.683 0.793 . . . . 0.0 112.21 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.15 -19.73 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 123.485 0.714 . . . . 0.0 110.759 168.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 14.0 p -62.46 -35.83 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.562 1.145 . . . . 0.0 110.928 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.4 -73.63 2.01 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.004 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -168.86 -34.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.461 1.504 . . . . 0.0 107.237 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 72.4 p 57.83 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.946 2.098 . . . . 0.0 112.219 -172.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.6 138.28 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.336 1.454 . . . . 0.0 111.953 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 73.25 -19.15 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.635 1.174 . . . . 0.0 113.038 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 35.2 p -65.84 -59.28 4.03 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.511 1.124 . . . . 0.0 111.802 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -173.52 -63.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.764 1.226 . . . . 0.0 107.752 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.76 126.35 47.31 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -66.28 -72.45 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.23 0.612 . . . . 0.0 109.561 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -166.69 -128.96 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.342 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 463' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' B' ' 464' ' ' MET . 53.3 m 79.62 152.33 0.12 Allowed 'General case' 0 C--N 1.366 1.326 0 C-N-CA 124.597 1.159 . . . . 0.0 110.413 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 463' ' ' THR . 2.7 ptp 75.35 -47.95 0.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.248 2.619 . . . . 0.0 111.242 -173.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.4 ' HB2' HD12 ' B' ' 470' ' ' LEU . 91.5 mttt 70.72 -30.38 0.2 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.908 1.683 . . . . 0.0 112.943 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.36 -11.51 4.39 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 124.491 1.116 . . . . 0.0 112.649 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.37 -19.56 56.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.437 1.095 . . . . 0.0 112.37 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 16.3 mt -152.96 -2.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.017 0.927 . . . . 0.0 112.662 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.95 97.67 0.14 Allowed Glycine 0 C--N 1.355 1.609 0 N-CA-C 115.115 0.806 . . . . 0.0 115.115 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' B' ' 444' ' ' TYR . 51.7 tp -106.96 152.33 24.1 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.589 ' HA ' HG13 ' A' ' 313' ' ' VAL . 3.5 tmmm? . . . . . 0 C--O 1.249 1.031 0 N-CA-C 107.711 -1.218 . . . . 12.06 107.711 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.37 116.09 16.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.763 . . . . 15.0 109.039 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.68 161.57 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.053 0.454 . . . . 15.0 111.224 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.406 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 9.4 p -152.92 103.45 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.111 -0.95 . . . . 15.0 109.137 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.79 107.3 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.646 0.736 . . . . 15.0 110.233 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.2 100.54 10.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.323 1.049 . . . . 15.0 109.375 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 m -69.19 97.66 0.94 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.676 -0.861 . . . . 15.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.7 p -75.6 -61.35 1.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.912 0.885 . . . . 15.0 111.402 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -149.46 103.99 3.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.663 -0.495 . . . . 15.0 109.663 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.02 -108.02 1.95 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 124.018 0.824 . . . . 15.0 113.644 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.26 -29.64 61.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 15.0 110.682 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 119.35 12.41 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 124.164 0.915 . . . . 15.0 112.968 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HD2' HG11 ' A' ' 111' ' ' VAL . 64.6 mtt85 -133.39 118.95 19.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.527 1.131 . . . . 15.0 109.515 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.541 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 37.5 ttm180 -89.94 96.74 10.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.001 1.32 . . . . 15.0 110.248 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG11 ' HB1' ' A' ' 78' ' ' ALA . 41.0 t -89.11 88.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.558 -0.905 . . . . 15.0 108.558 173.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 31.5 m -77.65 114.26 16.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.087 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -105.08 112.95 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.752 0.821 . . . . 15.0 109.19 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 87.3 m -94.62 105.07 17.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.547 0.739 . . . . 15.0 109.885 174.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 60.8 mt -91.47 101.25 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.9 0.88 . . . . 15.0 109.53 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.8 173.6 9.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.151 0.58 . . . . 15.0 111.365 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.12 59.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.385 1.474 . . . . 15.0 113.798 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.11 -32.34 73.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.64 0.776 . . . . 15.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -92.03 -29.62 16.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.991 0.516 . . . . 15.0 111.473 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.49 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.72 78.88 5.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.947 0.879 . . . . 15.0 109.374 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.4 m -158.72 -55.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.612 -1.995 . . . . 15.0 105.612 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.97 70.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.331 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG23 HG23 ' A' ' 66' ' ' VAL . 89.1 t -58.29 -62.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 123.945 0.778 . . . . 15.0 110.125 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.692 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.8 ttmp? -63.51 -39.83 95.46 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.736 -1.12 . . . . 15.0 111.86 -175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.3 m -68.66 -25.34 64.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.622 -0.717 . . . . 15.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -80.57 -43.25 20.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.7 0.286 . . . . 15.0 110.239 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.716 HD21 HG12 ' A' ' 62' ' ' VAL . 68.4 mt -74.15 -18.74 60.74 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.928 0.714 . . . . 15.0 112.928 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 p -76.71 -31.98 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 171.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -67.89 -49.03 64.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.342 0.657 . . . . 15.0 109.517 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.5 -33.64 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.288 1.035 . . . . 15.0 110.538 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.5 -54.12 50.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.994 0.518 . . . . 15.0 110.908 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.65 -42.54 86.49 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.291 0.636 . . . . 15.0 111.641 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -66.88 -51.84 50.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.643 1.177 . . . . 15.0 111.52 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.84 2.71 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.515 0.726 . . . . 15.0 110.407 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 71.11 17.28 6.14 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.265 1.426 . . . . 15.0 112.736 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 48.3 mt -66.57 -25.09 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.55 1.14 . . . . 15.0 110.771 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 -33.47 73.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.945 0.898 . . . . 15.0 111.201 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.91 -30.55 74.33 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.861 0.725 . . . . 15.0 112.855 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.414 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.5 m-85 -80.51 -24.79 39.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.358 0.663 . . . . 15.0 110.444 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -71.31 105.38 3.47 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.983 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.77 6.54 45.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.151 0.981 . . . . 15.0 110.774 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.79 68.56 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.211 0.319 . . . . 15.0 112.588 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -69.02 -49.06 61.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.087 0.955 . . . . 15.0 110.092 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.01 127.84 30.02 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.0 -1.0 . . . . 15.0 108.644 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.67 144.91 51.23 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.202 2.601 . . . . 15.0 113.337 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.58 -29.02 68.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.865 0.866 . . . . 15.0 112.351 -170.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HA ' ' HZ1' ' A' ' 29' ' ' LYS . 21.5 p-10 -67.35 -38.94 85.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.648 0.379 . . . . 15.0 110.85 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.739 HG23 ' HD2' ' A' ' 57' ' ' ARG . 61.4 mt -73.28 -32.61 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.959 0.904 . . . . 15.0 111.202 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 15.8 m -75.3 -20.1 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.922 -0.486 . . . . 15.0 111.358 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -86.9 -62.97 1.39 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.255 0.622 . . . . 15.0 111.438 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.82 -41.49 26.3 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.739 ' HD2' HG23 ' A' ' 53' ' ' ILE . 95.2 mtt180 -86.78 -63.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.814 0.446 . . . . 15.0 110.648 -173.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 40.3 m-85 -75.73 -21.57 57.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 111.803 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.38 25.51 12.61 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.432 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.41 69.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.354 0.662 . . . . 15.0 112.581 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 m -77.45 -8.13 57.27 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.617 0.767 . . . . 15.0 112.61 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.716 HG12 HD21 ' A' ' 32' ' ' LEU . 2.7 p -119.36 86.58 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 122.537 1.16 . . . . 15.0 109.814 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.402 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 4.5 mmp_? -115.66 -47.98 2.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.567 -1.197 . . . . 15.0 108.959 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.88 -50.0 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.996 1.318 . . . . 15.0 111.993 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.03 -35.61 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.991 0.916 . . . . 15.0 111.151 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG23 HG23 ' A' ' 28' ' ' VAL . 96.3 t -66.79 -38.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 114.813 -1.085 . . . . 15.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.8 mt -62.0 -27.56 68.95 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.595 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.01 86.74 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.567 0.542 . . . . 15.0 112.507 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.68 -47.54 83.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.733 0.813 . . . . 15.0 110.943 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.94 -57.38 13.04 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.377 -1.283 . . . . 15.0 111.547 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 71.6 mtm -69.98 -30.49 67.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.5 0.72 . . . . 15.0 112.288 -174.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 t -68.62 -51.31 43.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.002 0.521 . . . . 15.0 111.06 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.692 -0.686 . . . . 15.0 110.456 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.03 -26.45 64.04 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.538 0.524 . . . . 15.0 112.153 -171.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -63.05 -59.31 4.97 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.469 0.308 . . . . 15.0 110.517 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.86 -25.61 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.936 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -58.32 7.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.289 0.636 . . . . 15.0 109.384 171.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' HB1' HG11 ' A' ' 15' ' ' VAL . . . -59.74 -53.87 52.98 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.052 -0.976 . . . . 15.0 112.077 -171.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 86' ' ' PRO . 30.1 pt -58.79 -35.11 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.792 0.664 . . . . 15.0 112.792 -172.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.6 -42.35 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.086 0.554 . . . . 15.0 111.028 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -73.74 -31.9 63.59 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.242 0.217 . . . . 15.0 111.226 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.09 -0.96 33.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.683 0.793 . . . . 15.0 110.951 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 67.58 12.34 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.134 1.373 . . . . 15.0 112.432 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -78.26 118.69 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.653 0.781 . . . . 15.0 109.349 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -87.86 96.67 0.64 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 79' ' ' ILE . 55.2 Cg_endo -87.3 145.79 7.26 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.086 2.524 . . . . 15.0 114.164 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.3 46.98 0.82 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.945 0.898 . . . . 15.0 109.079 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.523 ' HA3' ' H ' ' A' ' 110' ' ' GLU . . . -144.24 153.68 25.22 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.443 -0.798 . . . . 15.0 112.088 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 113.0 12.65 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 15.0 109.785 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.26 106.97 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.953 1.769 . . . . 15.0 111.334 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -88.27 92.8 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.934 -0.765 . . . . 15.0 108.934 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -74.76 111.73 10.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.18 0.592 . . . . 15.0 109.508 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.38 93.62 27.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.173 0.989 . . . . 15.0 108.797 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.69 91.65 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.911 2.407 . . . . 15.0 111.951 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.24 -27.15 70.16 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.456 -0.793 . . . . 15.0 113.121 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 14.7 pt-20 -165.47 161.58 18.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.503 0.721 . . . . 15.0 110.456 172.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.402 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 13.8 t80 -157.22 108.35 2.33 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.685 -1.228 . . . . 15.0 107.685 168.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -125.7 130.01 50.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.163 0.985 . . . . 15.0 108.423 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 tp -67.16 104.8 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.693 0.621 . . . . 15.0 109.484 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.74 12.24 44.47 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.602 -0.554 . . . . 15.0 113.467 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.0 mt-10 -130.09 -97.43 0.35 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 118.738 -0.649 . . . . 15.0 109.841 172.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -140.93 160.05 40.9 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.274 0.943 . . . . 15.0 112.105 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -131.8 74.5 1.59 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.437 1.495 . . . . 15.0 107.058 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.491 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 43.1 m -80.66 124.54 29.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.8 -1.091 . . . . 15.0 109.319 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -143.82 129.54 19.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.921 0.488 . . . . 15.0 109.871 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.541 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 70.2 m -84.89 120.02 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.172 0.989 . . . . 15.0 110.423 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.7 94.3 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -99.27 113.37 25.61 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.41 0.684 . . . . 15.0 110.505 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -142.66 162.74 34.69 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.205 0.602 . . . . 15.0 110.504 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.523 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 36.1 mt-10 -85.41 167.33 15.62 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.192 -0.913 . . . . 15.0 110.116 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.5 m -127.67 170.09 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.484 0.714 . . . . 15.0 110.726 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -75.22 113.49 25.99 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.532 -0.914 . . . . 15.0 108.532 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.35 161.84 19.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.064 1.843 . . . . 15.0 110.848 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.27 111.51 5.93 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' ' 300' ' ' ILE . 4.8 p -71.1 124.83 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.862 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.33 122.8 43.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.48 -0.782 . . . . 15.0 110.79 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.528 HD12 HD11 ' A' ' 120' ' ' LEU . 91.3 mt -93.71 133.77 36.73 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 163.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -137.82 112.53 8.9 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.552 0.741 . . . . 15.0 109.063 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.96 63.79 4.32 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.747 0.654 . . . . 15.0 114.239 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 117' ' ' LEU . 29.2 mt -70.79 -30.6 67.1 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.144 0.497 . . . . 15.0 110.346 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -72.3 -23.04 61.11 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.654 1.182 . . . . 15.0 111.212 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.8 43.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.232 0.613 . . . . 15.0 111.503 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.79 123.59 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.717 0.807 . . . . 15.0 109.982 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -105.89 109.57 21.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 15.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 289' ' ' GLN . 59.1 t -109.02 154.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.866 1.266 . . . . 15.0 107.714 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 286' ' ' VAL . 42.7 tt0 -103.36 142.66 33.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 119.24 0.927 . . . . 15.0 109.973 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.518 ' HE2' HD13 ' A' ' 129' ' ' ILE . 82.5 tttt -123.56 87.36 52.23 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.941 0.897 . . . . 15.0 109.083 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 282' ' ' ILE . 6.7 Cg_exo -72.66 97.5 0.89 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.884 1.723 . . . . 15.0 111.554 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.518 HD13 ' HE2' ' A' ' 127' ' ' LYS . 40.2 mm -69.25 92.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.768 -1.197 . . . . 15.0 107.768 166.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.583 HG21 HD12 ' A' ' 427' ' ' LEU . 37.5 t -116.04 142.55 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.487 -0.779 . . . . 15.0 110.128 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.39 159.23 32.36 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.242 -1.345 . . . . 15.0 108.578 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.93 86.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 137' ' ' VAL . 43.6 p -64.4 174.89 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.701 0.8 . . . . 15.0 110.317 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.73 -33.02 72.28 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 120.95 0.405 . . . . 15.0 110.853 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.41 83.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.979 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 69.2 m-20 -74.59 -41.64 60.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.884 0.474 . . . . 15.0 111.195 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 133' ' ' THR . 82.4 t -61.79 -61.03 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.65 -33.84 73.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.856 0.722 . . . . 15.0 111.359 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.53 Favored Glycine 0 N--CA 1.478 1.476 0 O-C-N 123.62 0.575 . . . . 15.0 113.676 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.1 tpt -68.57 -46.36 69.6 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.069 0.548 . . . . 15.0 110.082 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 78.4 mt -58.07 -31.96 67.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.14 0.576 . . . . 15.0 111.748 172.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.56 -41.48 72.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.34 1.056 . . . . 15.0 110.216 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 86.0 m -58.2 -44.09 87.91 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.07 0.856 . . . . 15.0 109.71 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD12 HD22 ' A' ' 141' ' ' LEU . 89.9 mt -63.65 -40.93 98.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.918 0.887 . . . . 15.0 111.208 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 39.0 mtm-85 -64.51 -31.5 72.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.325 0.65 . . . . 15.0 110.157 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . 92.2 mttt -87.32 -15.9 36.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.235 0.614 . . . . 15.0 112.443 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 143' ' ' THR . 97.5 mt-30 -78.17 -30.42 49.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.642 -0.503 . . . . 15.0 109.642 167.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.45 36.54 2.78 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.102 0.961 . . . . 15.0 110.538 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' A' ' 146' ' ' LYS . . . -76.19 152.82 36.52 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.629 0.974 . . . . 15.0 113.629 -172.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -81.75 122.18 27.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.616 -1.175 . . . . 15.0 110.027 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -80.8 125.28 29.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 28.9 ttpt -158.83 128.32 5.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.914 -0.773 . . . . 15.0 108.914 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.622 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.4 mt-10 -77.26 134.39 38.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.885 0.374 . . . . 15.0 111.184 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 34.0 pttt -120.74 179.99 4.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.574 1.15 . . . . 15.0 109.816 169.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -142.92 152.91 42.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.566 0.746 . . . . 15.0 109.296 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -49.77 0.88 Allowed Glycine 0 N--CA 1.465 0.581 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.339 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.71 43.17 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.356 0.578 . . . . 15.0 111.417 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 t -116.79 134.39 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.347 1.059 . . . . 15.0 108.821 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -107.21 -179.58 3.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.31 1.044 . . . . 15.0 109.878 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.67 28.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.407 0.891 . . . . 15.0 113.407 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.27 40.83 3.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.227 0.537 . . . . 15.0 110.349 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -122.27 -170.52 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.045 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.744 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 15.2 mtm180 -119.94 124.07 45.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 171.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.61 100.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.773 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 12.5 m -83.31 110.02 17.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.13 -1.063 . . . . 15.0 108.13 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.557 HG23 ' HA ' ' A' ' 237' ' ' LEU . 33.6 pt -132.79 164.48 35.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.288 1.035 . . . . 15.0 110.4 -172.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -111.47 126.69 55.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.526 -1.657 . . . . 15.0 106.526 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.85 150.01 49.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.52 0.676 . . . . 15.0 111.281 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.417 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 10.1 t -139.16 123.78 18.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.147 -1.427 . . . . 15.0 107.147 165.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -113.53 166.66 12.17 Favored Glycine 0 C--O 1.241 0.585 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.065 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -145.1 134.93 23.6 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.308 0.643 . . . . 15.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.546 HG13 ' HA ' ' A' ' 226' ' ' LEU . 61.6 t -118.54 137.89 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 171.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.66 16.35 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.982 0.896 . . . . 15.0 110.889 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.77 1.98 76.21 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 115.781 -0.645 . . . . 15.0 113.946 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -136.98 163.12 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.509 0.724 . . . . 15.0 110.654 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.24 165.5 22.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.23 0.612 . . . . 15.0 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.83 -159.78 0.97 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.405 1.082 . . . . 15.0 110.186 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.72 118.28 5.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.459 0.703 . . . . 15.0 111.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.471 ' HA3' ' HB ' ' B' ' 386' ' ' VAL . . . 85.15 -57.12 4.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.941 -1.027 . . . . 15.0 111.827 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.12 -60.37 4.78 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.384 -0.286 . . . . 15.0 112.384 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.417 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 86.2 mttt -116.36 150.92 36.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.611 0.764 . . . . 15.0 111.801 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -153.91 93.1 1.61 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.801 -1.09 . . . . 15.0 108.87 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.2 m -73.69 137.94 44.39 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.682 -1.144 . . . . 15.0 110.172 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' B' ' 380' ' ' LYS . 2.9 m-20 60.67 29.21 18.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.703 0.801 . . . . 15.0 113.018 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 165' ' ' THR . 40.0 t80 -65.84 132.77 49.48 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.144 0.577 . . . . 15.0 110.292 174.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.8 t -97.96 113.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 202' ' ' ILE . 12.5 tp -97.54 89.0 4.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.692 0.397 . . . . 15.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.22 86.36 1.08 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 15.0 109.543 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.8 OUTLIER -51.78 132.09 31.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.012 0.925 . . . . 15.0 110.878 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.0 49.78 1.86 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.213 -0.755 . . . . 15.0 111.213 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.7 150.43 48.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.628 0.771 . . . . 15.0 111.082 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.36 56.32 3.91 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.589 -0.732 . . . . 15.0 113.046 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -136.7 1.89 2.6 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.95 0.9 . . . . 15.0 109.672 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 187' ' ' LEU . 33.1 mmt -94.09 154.25 17.71 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.87 0.868 . . . . 15.0 111.107 -173.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.76 143.3 46.1 Favored Pre-proline 0 C--O 1.248 0.991 0 CA-C-N 114.887 -1.051 . . . . 15.0 108.438 172.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.65 109.79 0.47 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.796 2.331 . . . . 15.0 111.226 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.01 -44.26 1.2 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.798 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 202' ' ' ILE . 86.4 t80 -73.09 -62.25 1.53 Allowed 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -32.93 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.259 -1.337 . . . . 15.0 111.984 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.54 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 14.8 t70 -71.02 -31.94 68.57 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.665 0.786 . . . . 15.0 110.835 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -5.53 89.21 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.836 0.71 . . . . 15.0 113.134 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.639 HG21 HD23 ' A' ' 187' ' ' LEU . 31.6 mm -104.54 -51.07 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.399 0.68 . . . . 15.0 110.947 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 58.5 pttt -76.88 6.35 6.34 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.475 1.11 . . . . 15.0 113.817 -163.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -131.87 27.32 3.69 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.507 -1.037 . . . . 15.0 110.507 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -125.08 -161.6 1.04 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.357 1.063 . . . . 15.0 110.361 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -154.85 153.28 30.9 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.516 0.727 . . . . 15.0 110.894 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.556 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.81 120.25 15.27 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.886 0.474 . . . . 15.0 111.392 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.69 -35.04 2.2 Favored Glycine 0 C--N 1.334 0.455 0 O-C-N 124.237 0.961 . . . . 15.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.72 126.21 32.66 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.442 -0.577 . . . . 15.0 109.442 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.0 123.82 48.73 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.08 -1.082 . . . . 15.0 108.08 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -145.08 178.04 8.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.333 1.053 . . . . 15.0 110.612 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.2 m -130.93 130.97 44.15 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.529 -1.286 . . . . 15.0 107.529 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.1 pt -104.06 160.48 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.378 0.671 . . . . 15.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.11 106.05 13.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 15.0 109.549 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.41 166.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.416 -1.327 . . . . 15.0 107.416 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 65.9 m -147.02 135.33 21.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.522 ' HZ ' HD12 ' B' ' 387' ' ' ILE . 95.5 m-85 -86.23 142.39 35.73 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 109.874 -0.417 . . . . 15.0 109.874 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.3 154.49 46.37 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.493 2.129 . . . . 15.0 111.834 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.14 -17.64 60.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.061 167.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.56 -24.5 61.93 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.294 1.438 . . . . 15.0 111.235 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.448 ' HE2' ' HB1' ' A' ' 223' ' ' ALA . 79.7 t80 -61.96 147.0 48.36 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.029 0.931 . . . . 15.0 111.238 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -71.12 -61.74 1.65 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.769 0.828 . . . . 15.0 113.109 -166.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' A' ' 221' ' ' TYR . . . -63.98 113.94 3.8 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.011 0.524 . . . . 15.0 110.356 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -65.02 -36.66 85.11 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.819 0.848 . . . . 15.0 112.652 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.46 -27.89 69.3 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.079 0.551 . . . . 15.0 111.429 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.546 ' HA ' HG13 ' A' ' 172' ' ' VAL . 81.7 mt -90.33 -40.51 12.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.848 0.859 . . . . 15.0 110.315 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -47.89 128.62 13.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.631 1.972 . . . . 15.0 113.001 -171.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.9 -31.44 3.66 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.379 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -98.04 163.73 12.64 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.636 0.774 . . . . 15.0 112.123 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -88.75 144.58 26.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.522 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.433 ' HB3' ' HE1' ' A' ' 217' ' ' PHE . . . -117.98 108.38 15.2 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.178 0.991 . . . . 15.0 109.837 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.12 101.04 12.52 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.24 0.616 . . . . 15.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -96.18 120.47 36.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.878 0.871 . . . . 15.0 109.752 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.24 98.55 9.45 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.96 -0.756 . . . . 15.0 108.96 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.1 mm -88.26 133.6 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.081 0.952 . . . . 15.0 110.611 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.81 95.15 4.71 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.456 -1.313 . . . . 15.0 107.456 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.557 ' HA ' HG23 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.06 97.36 5.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 -173.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -96.58 -38.63 9.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.633 0.373 . . . . 15.0 111.475 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.773 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.4 mmtt -131.63 148.73 52.63 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.095 0.558 . . . . 15.0 110.775 -176.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' A' ' 207' ' ' ALA . 21.2 t -121.44 99.0 6.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 34.1 mt-10 -83.14 169.23 16.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.277 -1.009 . . . . 15.0 108.277 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.437 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 38.9 tt0 -140.24 139.76 35.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.725 0.41 . . . . 15.0 110.278 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.459 HH12 ' HD3' ' A' ' 146' ' ' LYS . 26.3 ptt85 -98.97 83.89 2.98 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 164.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.1 154.36 31.37 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.829 -1.078 . . . . 15.0 109.681 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.12 133.25 87.57 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 122.715 0.406 . . . . 15.0 110.022 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 95.5 Cg_endo -77.71 -179.23 5.24 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.642 2.228 . . . . 15.0 111.351 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 249' ' ' THR . 47.1 mt-10 -70.56 116.73 11.22 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.516 -0.765 . . . . 15.0 108.964 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.82 43.81 1.07 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.046 0.927 . . . . 15.0 108.992 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.456 HG21 ' HB3' ' A' ' 247' ' ' GLU . 25.5 p -76.23 166.65 23.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.054 1.342 . . . . 15.0 110.174 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.6 -45.74 13.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.701 1.2 . . . . 15.0 113.063 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.01 -31.85 71.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.545 0.738 . . . . 15.0 112.592 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -81.57 -49.77 10.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.048 0.539 . . . . 15.0 110.379 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.676 HG13 HD22 ' A' ' 266' ' ' LEU . 12.8 tt -65.16 -29.54 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 122.974 0.51 . . . . 15.0 111.249 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.58 -17.12 56.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 111.944 0.35 . . . . 15.0 111.944 174.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -70.14 -19.32 63.22 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.113 0.565 . . . . 15.0 110.675 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -71.43 -17.86 62.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.251 0.62 . . . . 15.0 111.152 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 146.05 -24.44 1.76 Allowed Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.417 -0.657 . . . . 15.0 113.184 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 10.8 t -54.91 144.46 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.185 0.994 . . . . 15.0 111.394 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.79 -46.96 50.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.563 0.745 . . . . 15.0 111.001 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -106.22 -43.82 4.71 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.545 0.738 . . . . 15.0 110.587 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 112.35 24.85 4.9 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.892 -0.393 . . . . 15.0 113.1 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.1 p -71.96 144.3 48.94 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 117.471 0.635 . . . . 15.0 109.776 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 253' ' ' ILE . 60.9 t -59.37 -48.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.219 0.608 . . . . 15.0 110.165 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -58.71 -25.11 62.57 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.506 1.123 . . . . 15.0 112.237 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.29 -27.68 54.8 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.077 -0.809 . . . . 15.0 111.077 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.676 HD22 HG13 ' A' ' 253' ' ' ILE . 60.6 tp -76.28 -30.09 57.66 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.009 -0.737 . . . . 15.0 109.009 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.45 ' HA ' HG21 ' A' ' 270' ' ' VAL . 73.5 mtp180 -67.48 -37.41 82.83 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.61 93.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.76 . . . . 15.0 110.892 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -66.72 -40.83 88.55 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.349 -0.841 . . . . 15.0 111.314 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 267' ' ' ARG . 19.3 m -81.56 -19.62 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.592 0.357 . . . . 15.0 110.512 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt85 -59.79 -66.16 0.56 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -59.28 -44.17 92.49 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.483 0.49 . . . . 15.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -74.06 -42.06 60.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.26 -13.28 55.58 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.532 0.605 . . . . 15.0 111.432 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.89 -47.01 49.59 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.096 0.862 . . . . 15.0 108.707 162.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.582 ' HB2' ' HB1' ' A' ' 377' ' ' ALA . 74.8 ttt180 -60.41 -27.51 67.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.489 1.516 . . . . 15.0 111.904 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.516 ' HG3' ' HE2' ' A' ' 428' ' ' MET . 10.0 tp10 -91.78 -59.72 2.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.826 0.45 . . . . 15.0 110.199 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.448 ' HA ' ' HE3' ' A' ' 428' ' ' MET . 62.7 tp -67.85 -57.58 6.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.358 0.503 . . . . 15.0 112.358 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.74 -27.66 67.79 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.196 0.31 . . . . 15.0 110.185 -172.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.3 t -66.63 -50.1 64.11 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.82 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.41 88.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.786 0.834 . . . . 15.0 111.94 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.7 mt -64.14 -50.32 77.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 C-N-CA 123.947 0.899 . . . . 15.0 108.823 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.369 0.668 . . . . 15.0 110.776 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -68.52 -45.53 71.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.992 -0.744 . . . . 15.0 108.992 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -57.69 -54.85 42.18 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.04 0.838 . . . . 15.0 110.599 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 282' ' ' ILE . 59.1 t -60.63 -52.96 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.113 -0.949 . . . . 15.0 110.725 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.29 -39.84 93.07 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.539 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.6 p -64.3 -43.83 93.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 119.47 -0.3 . . . . 15.0 110.588 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' A' ' 125' ' ' VAL . 57.0 mt-30 -68.01 -33.88 75.44 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.96 0.788 . . . . 15.0 111.832 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.4 -55.1 27.11 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 123.511 0.507 . . . . 15.0 109.865 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.452 ' O ' HG22 ' A' ' 295' ' ' VAL . 25.7 mm -61.65 -44.03 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.067 0.947 . . . . 15.0 111.774 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.24 -48.0 80.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.382 0.61 . . . . 15.0 109.491 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.8 -40.85 99.74 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 114.038 -1.437 . . . . 15.0 112.246 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.489 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.8 mt -55.7 -60.14 3.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.237 1.015 . . . . 15.0 110.987 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 291' ' ' ILE . 40.6 t -56.07 -51.45 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 124.039 0.837 . . . . 15.0 109.638 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -64.27 -26.84 68.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.638 0.775 . . . . 15.0 112.138 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.67 -24.77 53.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.564 0.579 . . . . 15.0 112.564 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 164.62 29.77 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.516 0.932 . . . . 15.0 113.516 -168.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.6 133.66 49.98 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.036 -0.984 . . . . 15.0 109.835 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 115' ' ' VAL . 5.1 tp -155.77 116.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.695 0.798 . . . . 15.0 108.96 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.36 94.76 9.87 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.614 -0.884 . . . . 15.0 108.614 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 346' ' ' VAL . 19.0 t -79.93 127.33 77.64 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 114.466 -1.243 . . . . 15.0 110.513 -168.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.77 124.11 12.29 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.138 2.559 . . . . 15.0 112.896 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.492 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.75 -20.05 54.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.142 1.377 . . . . 15.0 114.196 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.17 94.7 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.947 0.499 . . . . 15.0 111.588 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.74 -35.39 80.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.635 0.774 . . . . 15.0 110.86 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 304' ' ' ALA . 2.7 mp -65.78 -53.28 40.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.501 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.22 -33.52 74.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.461 0.704 . . . . 15.0 111.14 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.6 t -58.07 -58.39 8.62 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 124.027 0.829 . . . . 15.0 110.607 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.02 -18.96 57.81 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.403 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 30.1 mt -67.1 -42.84 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 167.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.738 ' HA ' ' HD2' ' A' ' 315' ' ' ARG . 15.1 t70 -59.04 -39.25 81.41 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 123.958 0.786 . . . . 15.0 111.349 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.495 HG22 ' HA ' ' B' ' 447' ' ' HIS . 23.4 t -58.33 -51.85 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.19 0.519 . . . . 15.0 110.819 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 76.0 mt -68.71 -21.39 64.41 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.46 -0.791 . . . . 15.0 112.093 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.738 ' HD2' ' HA ' ' A' ' 312' ' ' ASP . 77.0 mtt180 -69.97 -44.82 68.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.168 0.987 . . . . 15.0 108.86 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -66.8 -35.62 80.48 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.815 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.13 -41.2 98.03 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.436 0.695 . . . . 15.0 110.996 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.26 -46.87 78.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.083 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.86 70.82 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.148 0.979 . . . . 15.0 111.839 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -59.86 -43.41 94.69 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.968 0.907 . . . . 15.0 109.882 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -83.81 -16.69 43.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.569 0.748 . . . . 15.0 110.099 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -82.06 10.24 7.0 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.706 1.202 . . . . 15.0 110.353 171.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.22 46.25 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.061 -0.518 . . . . 15.0 113.85 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.57 17.45 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 114.107 0.403 . . . . 15.0 114.107 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.05 158.57 19.19 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 124.437 1.095 . . . . 15.0 109.79 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.597 ' HB3' ' HG2' ' A' ' 328' ' ' GLN . 34.6 mm-40 80.8 -53.06 0.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.789 1.636 . . . . 15.0 112.547 173.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm 58.4 28.52 16.93 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.469 1.107 . . . . 15.0 110.764 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.597 ' HG2' ' HB3' ' A' ' 326' ' ' GLU . 81.2 mm-40 -87.3 11.77 13.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.573 1.149 . . . . 15.0 109.968 174.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 315' ' ' ARG . . . -40.17 -45.95 2.12 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 126.823 2.049 . . . . 15.0 113.498 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.54 -18.06 26.52 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.871 0.869 . . . . 15.0 112.895 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -98.55 -11.43 22.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.623 0.769 . . . . 15.0 112.174 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 92.8 mt -55.59 131.78 71.45 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 123.244 0.618 . . . . 15.0 111.024 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 77.6 Cg_exo -52.24 125.26 16.96 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.142 3.228 . . . . 15.0 114.501 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -51.82 -44.23 63.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.703 1.201 . . . . 15.0 112.416 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -60.35 -18.91 53.26 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 15.0 113.114 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 84.8 mt -69.5 -32.68 71.7 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.997 0.427 . . . . 15.0 110.468 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.89 -17.3 12.05 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.237 1.015 . . . . 15.0 111.238 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -49.95 -46.8 52.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.435 1.894 . . . . 15.0 113.213 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.46 -60.74 2.7 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.794 1.309 . . . . 15.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.7 pt20 -80.87 -32.4 34.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 15.0 111.387 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.85 2.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 15.0 110.844 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -55.4 -41.41 72.65 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.113 0.883 . . . . 15.0 109.869 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.461 ' O ' HG21 ' A' ' 347' ' ' VAL . 38.3 ttt-85 -59.42 -36.1 75.25 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.113 0.883 . . . . 15.0 110.909 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 70.3 mtt-85 -76.22 -29.4 57.57 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.807 0.443 . . . . 15.0 110.34 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.53 -37.95 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 302' ' ' VAL . 43.1 t -67.59 -34.42 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 351' ' ' LEU . 41.2 t -56.97 -50.22 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.553 0.741 . . . . 15.0 109.216 167.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.13 80.27 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.255 -0.884 . . . . 15.0 113.912 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.401 HD11 HG13 ' A' ' 302' ' ' VAL . 97.0 mt -80.47 -58.61 3.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.124 0.57 . . . . 15.0 111.528 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 294' ' ' LEU . 89.9 mt -60.29 -53.52 56.63 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.919 0.888 . . . . 15.0 110.872 -176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.497 HD11 HG11 ' A' ' 347' ' ' VAL . 44.8 mt -68.38 -30.72 69.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -59.47 -38.62 93.8 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.504 0.502 . . . . 15.0 112.478 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.43 -42.34 83.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.956 -0.622 . . . . 15.0 110.387 174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.7 -34.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.115 0.566 . . . . 15.0 111.146 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.0 mt -66.73 -49.68 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.819 0.848 . . . . 15.0 110.057 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -60.15 -54.36 46.81 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 116.064 -0.517 . . . . 15.0 110.988 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.4 m -61.22 -43.99 97.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.196 0.999 . . . . 15.0 111.72 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -91.9 12.61 21.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.066 0.546 . . . . 15.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 47.38 30.9 1.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.312 1.845 . . . . 15.0 114.181 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.467 HD22 HE21 ' A' ' 406' ' ' GLN . 73.7 mt -66.72 158.1 31.06 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.339 1.056 . . . . 15.0 113.032 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.9 167.27 27.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.856 -1.52 . . . . 15.0 107.799 170.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.0 90.99 0.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.701 -0.481 . . . . 15.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.74 131.29 45.97 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.254 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -51.71 -41.98 61.91 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.699 1.249 . . . . 15.0 112.12 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.5 -19.69 49.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.582 -0.735 . . . . 15.0 111.643 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -86.23 -35.0 20.28 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 110.025 -0.361 . . . . 15.0 110.025 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.78 -52.47 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -51.06 -45.24 61.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.66 1.184 . . . . 15.0 111.381 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.75 5.88 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.851 1.344 . . . . 15.0 112.155 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 402' ' ' ALA . 66.6 mt -55.73 -52.27 64.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.394 0.678 . . . . 15.0 111.675 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.469 HD12 ' HG2' ' A' ' 398' ' ' MET . 39.9 mm -50.55 -57.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 124.387 1.054 . . . . 15.0 111.417 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.36 -36.57 60.95 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.467 0.48 . . . . 15.0 111.781 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -51.04 71.08 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.279 0.561 . . . . 15.0 110.266 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.633 ' SD ' ' HB1' ' B' ' 442' ' ' ALA . 54.6 ttp -67.18 -44.08 80.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.224 1.409 . . . . 15.0 111.016 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -70.56 -44.78 66.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.68 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.4 m -69.5 -16.97 63.56 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.801 0.334 . . . . 15.0 111.458 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 276' ' ' ARG . . . -74.2 -29.33 61.69 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.513 0.725 . . . . 15.0 110.31 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.42 ' HB3' ' HG3' ' B' ' 440' ' ' ARG . 20.8 m-85 -87.61 -168.6 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.773 0.829 . . . . 15.0 111.178 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -70.87 -66.22 0.64 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.122 0.969 . . . . 15.0 110.822 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.16 108.29 48.33 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.557 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 24.6 Cg_endo -63.08 -40.29 34.58 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.553 2.169 . . . . 15.0 113.953 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -57.39 -51.71 68.33 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.907 0.883 . . . . 15.0 113.041 -161.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.734 ' HB3' HH12 ' B' ' 440' ' ' ARG . 31.3 tt0 -70.11 -20.07 63.2 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 68.4 t -76.44 -45.29 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.51 -52.58 19.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.04 -32.07 73.33 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.188 -0.915 . . . . 15.0 112.647 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -64.78 -50.66 65.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.088 0.555 . . . . 15.0 109.771 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -72.41 -50.92 22.9 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.518 0.511 . . . . 15.0 111.437 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.5 p -62.07 -28.05 69.33 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.695 0.628 . . . . 15.0 112.695 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.46 17.08 23.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.589 0.755 . . . . 15.0 111.034 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 395' ' ' MET . 50.5 t-20 -137.26 93.58 2.84 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.776 -1.194 . . . . 15.0 107.776 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.57 -33.81 70.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.258 1.023 . . . . 15.0 112.204 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.82 -63.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.269 0.98 . . . . 15.0 110.243 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.87 -18.33 58.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.307 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER -67.03 -48.85 67.07 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.544 -0.91 . . . . 15.0 108.544 177.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.62 -34.32 73.9 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 114.962 -1.017 . . . . 15.0 110.695 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.54 -45.12 95.03 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.463 0.649 . . . . 15.0 110.201 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.469 ' HG2' HD12 ' A' ' 371' ' ' ILE . 32.6 tpp -66.92 -30.99 71.29 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.111 -0.95 . . . . 15.0 110.855 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -71.95 -32.72 67.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.154 0.582 . . . . 15.0 111.205 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -51.49 61.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.0 p -72.63 -20.35 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.377 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -70.12 -43.62 70.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.899 0.479 . . . . 15.0 110.412 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.97 -26.59 59.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.228 -0.896 . . . . 15.0 110.721 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.429 ' O ' HG22 ' A' ' 408' ' ' VAL . 73.2 tt0 -60.63 -51.29 70.03 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 109.69 -0.485 . . . . 15.0 109.69 170.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -56.35 -49.2 75.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.074 0.949 . . . . 15.0 111.017 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.467 HE21 HD22 ' A' ' 360' ' ' LEU . 53.4 tt0 -64.8 -36.36 84.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.752 1.221 . . . . 15.0 111.614 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.39 66.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.02 -0.536 . . . . 15.0 111.063 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 404' ' ' GLU . 68.8 t -55.18 -54.18 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.925 -0.768 . . . . 15.0 108.925 168.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.482 ' HA ' HD13 ' A' ' 412' ' ' LEU . 44.6 mt-10 -61.21 -30.7 70.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.635 1.174 . . . . 15.0 112.425 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.55 73.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.992 0.517 . . . . 15.0 111.342 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.27 -31.56 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.061 -0.718 . . . . 15.0 109.061 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 409' ' ' GLU . 91.6 mt -67.45 -35.3 78.94 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 15.0 110.864 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.13 -17.43 63.46 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.298 0.639 . . . . 15.0 111.978 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -109.58 -26.26 10.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.575 1.15 . . . . 15.0 112.076 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.94 158.38 16.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.919 0.888 . . . . 15.0 110.875 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -73.41 84.78 1.47 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.306 0.642 . . . . 15.0 109.751 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 127' ' ' LYS . 21.2 t -86.8 94.78 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.59 -0.892 . . . . 15.0 108.59 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.9 t -68.92 94.5 0.63 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 122.429 1.109 . . . . 15.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -76.25 130.82 38.75 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.027 -1.442 . . . . 15.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -133.69 136.87 44.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.759 0.824 . . . . 15.0 108.905 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -98.72 127.82 44.78 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.287 -0.635 . . . . 15.0 109.287 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.455 HG21 ' HG2' ' A' ' 426' ' ' GLU . 9.7 t -160.89 176.61 11.25 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 122.78 0.432 . . . . 15.0 111.724 -173.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 33.6 p -92.96 165.92 12.63 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 111.488 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 56.7 t80 -58.6 -28.96 66.09 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.715 1.206 . . . . 15.0 111.228 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.24 -6.84 10.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.03 0.932 . . . . 15.0 113.387 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.483 ' HB3' HD11 ' A' ' 427' ' ' LEU . 12.6 tp10 -74.22 -41.49 61.29 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.033 0.933 . . . . 15.0 112.106 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.583 HD12 HG21 ' A' ' 130' ' ' VAL . 5.3 mp -89.54 -68.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.035 0.534 . . . . 15.0 111.031 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.516 ' HE2' ' HG3' ' A' ' 277' ' ' GLU . 1.2 mpt? -74.36 -49.62 21.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.847 0.459 . . . . 15.0 110.668 -175.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 1.7 m-20 -79.38 31.57 0.23 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -170.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -43.19 99.29 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.297 0.57 . . . . 15.0 109.754 172.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -98.99 40.49 1.2 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.12 0.968 . . . . 15.0 110.796 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.744 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.65 61.54 1.51 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.698 1.237 . . . . 0.0 109.103 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.11 14.77 30.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.725 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -46.22 -49.09 17.55 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.383 1.873 . . . . 0.0 114.131 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -88.82 0.24 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -167.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -114.48 -75.21 0.59 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 109.694 169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.24 -84.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.962 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -104.55 -78.45 0.56 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -102.62 -69.98 0.77 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -103.99 -73.61 0.67 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.067 0.547 . . . . 0.0 109.672 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.61 -75.96 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.693 ' HB3' ' HG2' ' B' ' 381' ' ' GLU . 32.5 tt0 -103.07 -75.79 0.6 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.541 0.736 . . . . 0.0 109.483 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -102.58 -85.09 0.45 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.15 0.58 . . . . 0.0 112.264 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.29 -84.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -166.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 -69.24 0.86 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.665 0.386 . . . . 0.0 111.446 -164.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -141.49 111.58 6.77 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.696 0.76 . . . . 0.0 109.518 177.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . 0.693 ' HG2' ' HB3' ' B' ' 376' ' ' GLU . 6.4 mp0 -105.73 147.99 27.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.271 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.64 -138.71 25.34 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.047 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -165.62 -87.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 117.186 0.493 . . . . 0.0 110.504 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 23.7 m 53.41 98.29 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 125.559 1.544 . . . . 0.0 114.524 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.63 108.78 19.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 165.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.471 ' HB ' ' HA3' ' A' ' 179' ' ' GLY . 24.0 m -71.91 95.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.668 0.747 . . . . 0.0 111.051 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.522 HD12 ' HZ ' ' A' ' 217' ' ' PHE . 13.5 tt -155.82 162.64 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.62 0.768 . . . . 0.0 108.97 165.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 10.6 t -56.81 109.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 22.6 m -74.09 99.11 3.26 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.346 0.658 . . . . 0.0 110.91 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -89.45 170.25 10.69 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.481 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.5 170.81 14.97 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.633 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -151.82 -154.08 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.592 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.87 177.77 0.53 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.015 0.926 . . . . 0.0 113.194 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -55.74 -39.88 71.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.748 1.219 . . . . 0.0 112.351 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.65 -71.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.208 1.403 . . . . 0.0 111.67 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 48.8 m 66.86 -178.1 0.2 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.069 1.348 . . . . 0.0 111.686 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.629 HE22 HG11 ' B' ' 399' ' ' VAL . 0.9 OUTLIER 47.89 -172.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.124 1.769 . . . . 0.0 113.162 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 29.1 pt -133.94 118.38 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 110.91 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.629 HG11 HE22 ' B' ' 397' ' ' GLN . 9.4 p -157.54 116.85 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.137 0.975 . . . . 0.0 108.692 170.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -167.18 101.55 0.63 Allowed Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 124.288 1.035 . . . . 0.0 108.302 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.98 -67.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.509 2.139 . . . . 0.0 111.631 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -173.95 -69.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 23.2 m 68.49 -75.81 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.474 1.51 . . . . 0.0 112.92 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.07 115.16 19.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 0.0 110.309 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . 55.95 82.4 0.24 Allowed Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.605 1.162 . . . . 0.0 110.746 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -52.72 94.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.754 2.969 . . . . 0.0 114.02 -170.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -86.33 -83.43 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.391 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 4.8 tt 60.42 -83.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.359 1.464 . . . . 0.0 110.514 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 23.7 p 40.46 83.62 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 125.974 1.71 . . . . 0.0 112.997 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.62 147.8 52.78 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -103.57 138.03 40.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.85 -33.9 57.86 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 109.934 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 31.7 t30 66.65 103.54 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.902 1.376 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 11.3 t -73.16 -24.8 60.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.358 0.663 . . . . 0.0 111.731 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -87.32 150.05 24.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.0 -21.57 61.54 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.629 0.372 . . . . 0.0 110.614 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -75.57 -154.23 4.57 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.392 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 69.29 -67.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 125.236 1.414 . . . . 0.0 110.721 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.15 157.1 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 C-N-CA 124.384 1.073 . . . . 0.0 109.97 168.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 42.7 mtm 81.35 -32.92 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.122 1.769 . . . . 0.0 112.308 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 59.6 t 64.12 -81.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 111.082 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.63 138.99 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 66.5 p -158.18 -171.52 3.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.756 0.823 . . . . 0.0 110.212 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 65.6 t80 66.32 93.5 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.809 1.244 . . . . 0.0 110.263 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.32 130.52 6.23 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.549 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -94.0 -86.0 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.567 0.747 . . . . 0.0 109.792 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.1 t -116.4 -86.49 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.868 0.467 . . . . 0.0 111.667 -168.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 66.62 9.06 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.241 1.02 . . . . 0.0 110.785 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -93.27 -61.34 1.59 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.738 -173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.57 -83.09 0.16 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.882 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 9.0 p -111.61 -78.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.46 0.704 . . . . 0.0 109.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -104.58 -46.37 4.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.281 0.633 . . . . 0.0 111.926 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.13 169.09 19.42 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.247 0.619 . . . . 0.0 109.838 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -143.29 -61.16 0.42 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.146 0.978 . . . . 0.0 108.676 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 6.6 t -164.77 4.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.527 0.731 . . . . 0.0 110.677 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.62 48.22 Favored Glycine 0 C--N 1.359 1.853 0 C-N-CA 123.751 0.691 . . . . 0.0 114.805 -168.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 437' ' ' SER . . . . . 0.486 ' HA ' ' HB ' ' B' ' 441' ' ' ILE . 10.7 p -53.22 -58.96 5.26 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.746 0.818 . . . . 0.0 110.564 166.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 44.57 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.934 1.694 . . . . 0.0 113.729 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.4 -57.41 0.95 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.472 1.109 . . . . 0.0 109.553 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.734 HH12 ' HB3' ' A' ' 383' ' ' GLU . 28.0 ttp85 -86.76 -8.43 57.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.428 0.691 . . . . 0.0 112.469 -165.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' B' ' 437' ' ' SER . 31.1 mm -117.03 125.21 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . 0.633 ' HB1' ' SD ' ' A' ' 374' ' ' MET . . . -105.95 -147.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . 0.421 ' HB3' ' HE2' ' A' ' 398' ' ' MET . . . 70.75 165.98 0.29 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.345 1.058 . . . . 0.0 111.609 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.06 136.4 10.98 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.155 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -75.91 140.97 26.6 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.148 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.28 94.94 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.437 2.092 . . . . 0.0 109.437 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.495 ' HA ' HG22 ' A' ' 313' ' ' VAL . 3.6 t60 72.34 -71.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.921 1.688 . . . . 0.0 112.402 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -139.89 -151.96 0.39 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.782 0.833 . . . . 0.0 109.29 -171.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -56.23 114.49 1.99 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.499 0.72 . . . . 0.0 110.797 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.88 142.28 56.14 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 0.0 110.608 -174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 48.1 t -75.57 -26.28 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.011 0.924 . . . . 0.0 110.411 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 73.2 t 67.63 -72.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.546 1.538 . . . . 0.0 112.131 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -89.08 119.17 5.37 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 120.026 -0.319 . . . . 0.0 112.585 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.542 HD21 HG21 ' B' ' 463' ' ' THR . 43.9 tp -148.92 128.81 13.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 5.6 t -138.79 161.55 36.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.196 0.998 . . . . 0.0 109.454 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.54 135.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.956 1.302 . . . . 0.0 112.189 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 60.74 17.87 8.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.891 1.277 . . . . 0.0 111.987 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 14.2 m -138.71 85.03 2.05 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -94.4 24.83 4.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.099 1.36 . . . . 0.0 113.188 -162.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.19 30.49 5.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.58 0.752 . . . . 0.0 110.271 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 64.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.144 1.378 . . . . 0.0 111.681 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -89.78 116.28 27.76 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 463' ' ' THR . . . . . 0.542 HG21 HD21 ' B' ' 454' ' ' LEU . 27.9 m -68.62 106.49 2.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.406 175.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -89.34 131.62 35.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -86.48 25.96 1.15 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.633 0.773 . . . . 0.0 112.285 -165.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.09 -41.79 90.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.425 0.69 . . . . 0.0 109.271 166.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.42 32.82 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.033 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.23 -86.38 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.629 0.772 . . . . 0.0 111.0 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 71.43 -84.32 0.44 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.901 -172.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.73 79.23 0.22 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.021 1.328 . . . . 0.0 111.463 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.064 -1.087 . . . . 12.06 108.064 177.062 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 15.8 ptm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' THR . 7.8 tt0 -87.04 97.52 10.77 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.328 -0.989 . . . . 15.0 108.328 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.02 157.58 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.844 0.458 . . . . 15.0 111.305 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 25.4 m -131.04 86.43 2.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 15' ' ' VAL . 4.8 p -73.77 87.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 122.658 1.218 . . . . 15.0 110.508 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.96 178.2 5.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.97 -1.468 . . . . 15.0 109.546 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 58.1 m -136.63 125.96 24.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -66.24 -58.75 4.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.538 0.735 . . . . 15.0 109.842 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -167.46 120.62 0.94 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.02 0.528 . . . . 15.0 109.998 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.82 -100.67 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 O-C-N 124.423 1.077 . . . . 15.0 114.398 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.36 -43.39 27.79 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.203 1.001 . . . . 15.0 110.076 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.2 88.88 0.08 OUTLIER Glycine 0 C--N 1.344 1.024 0 O-C-N 124.065 0.853 . . . . 15.0 112.5 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.9 ttm180 -95.78 129.11 43.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 15.0 110.326 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -106.04 90.75 3.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.283 1.033 . . . . 15.0 110.416 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 5' ' ' VAL . 46.1 t -81.68 87.02 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.906 -1.146 . . . . 15.0 107.906 173.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 82.0 m -71.67 87.55 0.94 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.281 0.633 . . . . 15.0 110.189 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 74' ' ' ASN . 48.8 mt -80.07 128.22 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.56 -0.745 . . . . 15.0 109.135 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 56.7 m -118.23 104.08 10.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.713 -1.218 . . . . 15.0 107.713 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' HE1' ' A' ' 105' ' ' TYR . 24.7 mt -66.39 129.91 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.98 137.54 57.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.189 0.931 . . . . 15.0 111.038 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.08 61.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.032 1.333 . . . . 15.0 112.789 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.68 -40.88 92.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.849 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.7 m -70.08 -34.63 73.41 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.278 -0.874 . . . . 15.0 111.079 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -68.75 -50.98 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.859 0.464 . . . . 15.0 109.85 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -59.2 -33.73 71.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.265 0.626 . . . . 15.0 111.271 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.1 m -76.72 -43.17 38.5 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.367 0.667 . . . . 15.0 111.283 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -42.2 78.87 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.032 0.533 . . . . 15.0 112.249 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' HG11 ' A' ' 66' ' ' VAL . 69.5 t -60.91 -47.77 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.683 0.793 . . . . 15.0 109.838 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -58.04 -40.06 79.94 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.083 0.953 . . . . 15.0 111.731 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.4 m -70.56 -28.96 65.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.827 0.851 . . . . 15.0 110.822 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.4 tp10 -80.35 -29.07 37.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.021 0.528 . . . . 15.0 110.725 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -70.69 -35.7 72.91 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.702 0.801 . . . . 15.0 111.534 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.0 p -71.18 -29.71 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.764 -0.458 . . . . 15.0 109.764 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -67.16 -36.67 82.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.934 0.494 . . . . 15.0 110.517 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 57.8 t -63.4 -43.1 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.31 73.88 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.45 -0.796 . . . . 15.0 111.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 97.8 mttt -75.12 -33.98 61.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.218 0.607 . . . . 15.0 111.098 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -65.27 -36.52 84.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.688 0.795 . . . . 15.0 110.617 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.8 t -96.13 -1.51 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.163 0.585 . . . . 15.0 110.562 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 66.95 10.42 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.506 1.522 . . . . 15.0 113.792 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -79.29 -11.24 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.896 0.878 . . . . 15.0 111.388 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -57.13 -38.51 73.59 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.818 0.847 . . . . 15.0 111.907 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.97 -19.81 64.47 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.742 -0.663 . . . . 15.0 112.529 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.02 -20.75 34.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.197 0.599 . . . . 15.0 110.57 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.36 107.81 3.95 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.24 6.56 13.68 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.832 0.853 . . . . 15.0 111.777 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 10.5 74.05 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.964 -0.354 . . . . 15.0 113.035 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -65.38 -35.09 79.89 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.759 0.824 . . . . 15.0 109.86 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.37 122.47 59.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 159.05 47.74 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.899 2.4 . . . . 15.0 112.016 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 tpt -72.51 -20.26 61.39 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.908 -0.587 . . . . 15.0 112.09 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -65.44 -43.04 91.65 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.268 -0.271 . . . . 15.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' A' ' 57' ' ' ARG . 62.7 mt -66.19 -44.97 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.87 0.868 . . . . 15.0 111.288 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -71.05 -21.7 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 116.582 -0.281 . . . . 15.0 111.471 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.09 -42.13 14.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.892 0.477 . . . . 15.0 112.041 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 2.4 pt20 -82.6 -42.63 18.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.09 0.556 . . . . 15.0 111.253 -171.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 98.3 mtt180 -91.63 -60.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.111 0.564 . . . . 15.0 110.435 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.53 -46.51 63.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.607 -0.724 . . . . 15.0 110.471 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.51 12.16 35.11 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.015 -0.881 . . . . 15.0 114.083 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.86 -32.86 72.83 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 117.875 0.837 . . . . 15.0 110.613 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -74.37 -52.0 13.42 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.2 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.0 78.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 15.0 109.629 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -132.14 -63.73 0.8 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.466 1.107 . . . . 15.0 109.114 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -60.67 -29.33 69.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 123.794 0.684 . . . . 15.0 110.404 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.39 -49.44 69.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.824 1.25 . . . . 15.0 110.758 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 28' ' ' VAL . 21.2 t -75.35 -38.65 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.056 -0.975 . . . . 15.0 110.075 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.472 HD23 HD12 ' A' ' 70' ' ' LEU . 96.3 mt -59.17 -33.1 70.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.729 0.812 . . . . 15.0 111.692 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.87 -39.73 88.74 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.433 0.458 . . . . 15.0 112.932 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.91 -46.84 22.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.878 0.871 . . . . 15.0 110.334 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 67' ' ' LEU . 80.0 mt -56.91 -37.19 71.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.852 0.861 . . . . 15.0 112.236 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 72.5 mtm -59.4 -39.24 82.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.362 0.665 . . . . 15.0 111.169 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -75.14 -30.37 60.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.155 -0.929 . . . . 15.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 70' ' ' LEU . 6.9 mmm180 -71.78 -42.31 67.3 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.511 -0.551 . . . . 15.0 109.511 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.427 ' HB3' HG21 ' A' ' 17' ' ' ILE . 53.2 m-80 -71.83 -27.47 62.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.786 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -66.62 -56.57 10.1 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.341 0.4 . . . . 15.0 110.557 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.79 -30.56 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 O-C-N 123.875 0.735 . . . . 15.0 110.456 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.37 -49.05 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.638 0.775 . . . . 15.0 110.077 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.51 -57.3 11.69 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.376 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.1 pt -61.2 -29.14 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 112.83 0.678 . . . . 15.0 112.83 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.74 -49.06 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.263 0.625 . . . . 15.0 110.968 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -74.62 -25.85 59.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.541 0.21 . . . . 15.0 111.312 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -83.34 -16.71 45.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.727 0.811 . . . . 15.0 111.14 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 64.15 25.75 13.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.763 1.225 . . . . 15.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' A' ' 109' ' ' PHE . 51.8 mt -91.01 127.01 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.406 0.682 . . . . 15.0 109.718 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.55 117.22 61.76 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 164.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.35 97.17 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.375 2.05 . . . . 15.0 113.382 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.53 -171.12 3.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.081 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 58.71 -145.03 43.4 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.293 -0.323 . . . . 15.0 112.293 -168.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.28 122.5 17.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.404 -1.702 . . . . 15.0 106.404 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.92 106.51 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.513 2.142 . . . . 15.0 111.7 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -102.16 98.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.672 0.789 . . . . 15.0 109.468 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -84.54 94.35 8.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.33 98.48 0.92 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.928 -0.768 . . . . 15.0 108.928 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 112.23 3.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.857 2.371 . . . . 15.0 111.352 -173.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.5 -62.61 5.95 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.298 -0.721 . . . . 15.0 111.298 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.32 168.41 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.048 0.939 . . . . 15.0 110.629 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -138.75 121.81 16.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.236 1.014 . . . . 15.0 108.864 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 60.6 mttp -94.63 170.46 9.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.36 97.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.655 0.782 . . . . 15.0 111.469 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.45 80.24 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.447 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.7 mt-10 -98.67 -176.8 3.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.722 0.809 . . . . 15.0 110.805 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.29 137.9 57.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.716 0.806 . . . . 15.0 111.588 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -108.87 99.54 8.87 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.936 0.894 . . . . 15.0 109.546 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -79.72 131.28 35.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.731 0.813 . . . . 15.0 110.084 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.525 ' HE1' HG13 ' A' ' 19' ' ' ILE . 28.8 p90 -152.18 125.25 8.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.609 0.764 . . . . 15.0 109.869 173.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.9 m -82.8 100.55 10.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.445 1.098 . . . . 15.0 110.259 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.67 97.9 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.578 -0.527 . . . . 15.0 109.578 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.46 116.65 30.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.605 0.762 . . . . 15.0 110.494 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HE2' HG21 ' A' ' 84' ' ' ILE . 43.2 p90 -145.3 170.18 16.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.758 1.223 . . . . 15.0 107.73 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -94.71 156.58 16.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.392 0.615 . . . . 15.0 111.312 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 ' NH1' ' A' ' 13' ' ' ARG . 32.9 m -115.63 162.82 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.462 1.105 . . . . 15.0 108.272 170.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.05 119.87 70.53 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.86 -175.48 2.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.111 2.541 . . . . 15.0 112.46 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.71 128.39 35.36 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -102.48 129.76 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.816 0.846 . . . . 15.0 109.278 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -118.37 113.14 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 15.0 110.751 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.1 mt -82.0 130.69 35.15 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 123.648 0.593 . . . . 15.0 109.611 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.39 154.92 14.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.679 0.792 . . . . 15.0 109.87 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 64.55 20.73 66.15 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.681 0.613 . . . . 15.0 113.481 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 117' ' ' LEU . 68.0 mt -65.04 -42.64 94.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.886 0.874 . . . . 15.0 110.505 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -78.16 -18.65 55.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.636 -1.166 . . . . 15.0 110.646 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.95 47.47 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.234 0.613 . . . . 15.0 111.34 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.519 HG23 ' HA3' ' A' ' 293' ' ' GLY . 61.1 mt -58.35 124.33 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.245 0.966 . . . . 15.0 110.666 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.0 103.92 14.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.421 0.688 . . . . 15.0 109.296 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 417' ' ' VAL . 41.5 t -107.32 161.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.46 1.104 . . . . 15.0 108.417 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -123.1 138.13 54.74 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.561 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.1 tttt -114.7 88.67 16.82 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.336 -0.987 . . . . 15.0 108.336 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.11 100.81 0.95 Allowed 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.049 1.833 . . . . 15.0 111.298 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.561 HD11 ' HE2' ' A' ' 127' ' ' LYS . 42.1 mm -67.87 84.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 168.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 278' ' ' LEU . 21.3 t -98.38 136.73 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.22 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -132.66 162.52 31.15 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 167.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.16 79.83 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.2 p -61.93 170.06 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.761 0.824 . . . . 15.0 110.448 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.27 -31.43 65.58 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.955 0.502 . . . . 15.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.96 92.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.782 0.833 . . . . 15.0 110.895 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -73.16 -40.55 64.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.314 0.646 . . . . 15.0 111.113 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.06 -61.87 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.211 1.004 . . . . 15.0 109.514 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.48 -34.49 65.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.574 -0.739 . . . . 15.0 110.934 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.22 -45.67 92.97 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.639 0.587 . . . . 15.0 113.14 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -75.29 -41.82 56.2 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.058 0.543 . . . . 15.0 111.033 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 270' ' ' VAL . 32.2 mt -52.23 -40.01 61.05 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.095 0.558 . . . . 15.0 111.841 167.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.54 -41.37 84.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.409 0.684 . . . . 15.0 110.605 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 m -60.41 -39.3 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.836 0.71 . . . . 15.0 110.339 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -40.33 96.07 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 15.0 111.014 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 47.7 mtm180 -62.33 -40.7 97.2 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.621 0.575 . . . . 15.0 110.558 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 87.5 mttt -80.29 -16.4 54.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.324 0.65 . . . . 15.0 112.386 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -82.48 -40.8 20.6 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.883 0.473 . . . . 15.0 109.748 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -100.0 35.81 1.97 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.788 0.835 . . . . 15.0 109.889 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.19 143.97 34.88 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.011 0.925 . . . . 15.0 112.562 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.4 m -74.19 129.4 37.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 15.0 109.643 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -79.18 129.99 35.02 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.21 163.36 36.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 45.7 mt-10 -118.12 157.15 27.42 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.145 0.498 . . . . 15.0 109.839 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 23.4 pttt -136.63 155.09 50.38 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.34 -0.846 . . . . 15.0 109.982 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.77 96.57 7.0 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.613 -0.721 . . . . 15.0 110.242 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 240' ' ' VAL . . . 60.07 62.36 6.15 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 113.965 -1.47 . . . . 15.0 116.392 165.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.683 ' H ' HG11 ' A' ' 240' ' ' VAL . . . -155.02 107.66 2.75 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 117.344 0.572 . . . . 15.0 110.291 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 203' ' ' LYS . 41.6 t -109.22 137.54 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.488 0.586 . . . . 15.0 109.66 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.61 -176.99 4.22 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.788 1.235 . . . . 15.0 109.315 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.22 67.6 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.892 1.441 . . . . 15.0 114.892 -167.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.9 17.68 9.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.971 0.509 . . . . 15.0 111.305 -170.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.51 -159.57 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.929 0.491 . . . . 15.0 111.815 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 32.3 ttp180 -137.17 153.87 50.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 44.5 t -144.12 155.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 15.0 108.768 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 23.5 m -122.74 124.39 43.26 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 164.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.09 161.34 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.778 0.831 . . . . 15.0 111.012 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.78 121.12 33.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.466 -2.05 . . . . 15.0 105.466 159.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -112.39 163.08 14.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.746 -0.596 . . . . 15.0 110.3 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.5 t -139.78 93.31 2.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -98.12 162.74 21.01 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.205 -1.361 . . . . 15.0 113.295 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 m -149.98 127.45 11.51 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.025 -1.102 . . . . 15.0 108.025 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 71.2 t -97.35 115.97 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.803 0.841 . . . . 15.0 109.422 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 36.6 t70 69.62 3.47 4.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.652 0.781 . . . . 15.0 111.486 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 115.32 -11.9 19.36 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.587 -0.563 . . . . 15.0 113.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 10.3 pt-20 -92.37 131.79 37.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.4 94.58 1.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.217 -1.772 . . . . 15.0 106.217 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.499 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 3.0 p90 -71.78 -160.78 0.06 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.509 -1.678 . . . . 15.0 112.419 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -51.66 103.96 0.07 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.155 0.982 . . . . 15.0 110.571 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.51 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 91.56 -62.72 2.69 Favored Glycine 0 C--O 1.239 0.435 0 O-C-N 124.366 1.041 . . . . 15.0 113.195 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.27 -59.42 4.91 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.2 158.03 16.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.566 0.58 . . . . 15.0 112.566 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.16 93.51 2.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.5 m -79.58 130.71 35.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.196 -0.911 . . . . 15.0 112.193 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 58.17 31.12 20.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.749 1.22 . . . . 15.0 113.309 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.414 ' CD2' HD23 ' B' ' 385' ' ' LEU . 72.6 t80 -71.4 133.96 46.31 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.133 0.492 . . . . 15.0 109.86 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.7 100.69 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 124.26 1.024 . . . . 15.0 108.912 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.17 98.66 11.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.146 0.979 . . . . 15.0 111.406 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.03 101.65 3.3 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.679 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER -60.08 116.61 4.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.306 0.643 . . . . 15.0 109.641 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.9 -6.61 7.82 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.816 -0.629 . . . . 15.0 112.148 -166.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -81.52 -179.83 7.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.509 0.724 . . . . 15.0 111.097 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.97 52.73 0.68 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.877 -0.602 . . . . 15.0 112.226 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.7 13.52 21.15 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.94 0.876 . . . . 15.0 109.169 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -152.2 154.62 36.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.407 1.083 . . . . 15.0 109.169 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 pt -86.3 164.57 37.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.442 0.697 . . . . 15.0 111.342 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.13 153.57 68.56 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.241 1.961 . . . . 15.0 111.373 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.73 -50.59 1.77 Allowed Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.872 -0.891 . . . . 15.0 110.872 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 213' ' ' ILE . 65.6 t80 -68.66 -59.98 2.74 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.197 0.599 . . . . 15.0 109.547 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.18 -32.71 73.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.313 1.008 . . . . 15.0 111.623 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 4.8 m-20 -69.53 -23.43 63.59 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.849 0.86 . . . . 15.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -83.77 -9.99 81.99 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.461 0.476 . . . . 15.0 113.182 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.1 -46.86 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.677 0.791 . . . . 15.0 110.061 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HB3' ' SD ' ' A' ' 189' ' ' MET . 62.3 pttt -84.7 30.88 0.54 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.13 1.159 . . . . 15.0 114.13 -161.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -155.89 35.91 0.62 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.785 -0.526 . . . . 15.0 111.785 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.62 -170.95 3.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.352 0.661 . . . . 15.0 111.29 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -139.42 155.89 47.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.577 1.151 . . . . 15.0 111.226 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.1 147.09 51.96 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 15.0 111.084 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.6 -40.98 2.26 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.229 -0.749 . . . . 15.0 111.229 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.8 pt-20 -78.8 126.79 31.18 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.613 0.72 . . . . 15.0 109.434 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.36 106.4 13.6 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.302 -1.369 . . . . 15.0 107.302 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -126.29 -177.43 3.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.344 1.058 . . . . 15.0 109.877 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.8 t -117.25 158.15 24.82 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.504 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.0 pt -128.01 150.2 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 173.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.12 117.58 34.43 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 163.92 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 15.0 107.332 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 59.1 m -141.92 134.47 28.23 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.29 128.93 76.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.111 -0.471 . . . . 15.0 109.767 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.06 163.51 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.713 2.942 . . . . 15.0 115.146 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.61 -24.44 53.42 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.397 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.36 -18.63 48.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.363 1.065 . . . . 15.0 110.628 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.434 ' HE2' HD12 ' A' ' 226' ' ' LEU . 30.7 t80 -61.11 111.62 1.78 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 15.0 109.923 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -66.71 -14.39 62.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.163 1.172 . . . . 15.0 114.163 -168.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.16 101.04 10.18 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.74 -31.39 72.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 15.0 111.727 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.575 HD21 HG11 ' B' ' 388' ' ' VAL . 7.0 p30 -70.41 -11.68 61.08 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.862 0.465 . . . . 15.0 111.596 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.616 HD11 ' H ' ' B' ' 388' ' ' VAL . 57.5 mt -112.61 -30.84 6.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.932 0.893 . . . . 15.0 110.765 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.17 121.48 6.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.583 1.153 . . . . 15.0 112.497 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.69 -22.98 25.19 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.903 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 96.1 mttt -75.99 143.02 41.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.232 0.613 . . . . 15.0 110.964 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.22 115.01 27.71 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.879 0.871 . . . . 15.0 109.825 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.38 118.47 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.553 0.741 . . . . 15.0 111.594 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -92.34 124.16 36.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.113 0.965 . . . . 15.0 108.726 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.2 113.83 19.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.067 0.547 . . . . 15.0 109.79 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 93.62 4.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.63 -0.507 . . . . 15.0 109.63 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.8 mm -82.82 122.55 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.352 1.061 . . . . 15.0 110.324 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -107.67 99.75 9.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 109.569 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.29 111.95 11.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.913 -0.403 . . . . 15.0 109.913 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 239' ' ' LYS . 17.7 ptpt -109.7 -35.46 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 116.461 -0.336 . . . . 15.0 110.597 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 238' ' ' LYS . 74.6 mmtt -129.29 133.0 47.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.241 0.616 . . . . 15.0 110.327 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.683 HG11 ' H ' ' A' ' 157' ' ' ALA . 77.7 t -106.92 123.62 62.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 26.1 mt-10 -124.55 169.98 11.36 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.557 0.743 . . . . 15.0 109.457 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.797 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.2 tt0 -139.21 130.48 26.81 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.896 0.878 . . . . 15.0 109.411 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -83.65 84.68 7.46 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.575 -1.268 . . . . 15.0 107.575 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.95 141.2 53.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.844 -1.526 . . . . 15.0 111.239 -173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' A' ' 146' ' ' LYS . 96.7 mt -58.26 126.29 77.78 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.343 0.657 . . . . 15.0 110.714 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -77.78 173.22 14.41 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.892 2.395 . . . . 15.0 111.249 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -79.82 127.06 31.76 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.722 -0.672 . . . . 15.0 110.069 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 17.0 tp -86.87 52.96 2.66 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.558 -0.904 . . . . 15.0 108.558 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 253' ' ' ILE . 59.9 m -55.0 143.54 26.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.825 1.65 . . . . 15.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.81 -45.37 59.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.748 0.819 . . . . 15.0 112.346 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.62 -14.97 63.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.132 0.973 . . . . 15.0 113.446 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.55 -51.32 4.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.76 0.824 . . . . 15.0 110.305 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.727 HG13 HD22 ' A' ' 266' ' ' LEU . 7.3 tt -63.63 -33.08 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.147 0.979 . . . . 15.0 111.893 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.32 -29.63 67.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 120.757 0.313 . . . . 15.0 111.353 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -72.69 -13.56 61.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.588 0.755 . . . . 15.0 111.031 -172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.57 6.76 22.51 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.394 0.678 . . . . 15.0 111.929 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.63 8.91 Favored Glycine 0 N--CA 1.476 1.361 0 CA-C-N 117.554 0.161 . . . . 15.0 113.17 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 261' ' ' GLY . 14.4 t -102.82 132.88 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.2 -62.89 1.2 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.87 0.367 . . . . 15.0 110.588 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -83.8 -22.31 31.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.65 0.78 . . . . 15.0 111.383 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 90.7 26.93 21.27 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.631 -0.539 . . . . 15.0 113.449 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 55.3 p -72.22 136.23 46.3 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 117.607 0.703 . . . . 15.0 110.535 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.495 ' HA ' HD11 ' A' ' 253' ' ' ILE . 61.0 t -55.62 -46.97 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.896 0.878 . . . . 15.0 110.468 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.5 -26.69 68.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.701 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.54 -26.28 61.43 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 111.464 -0.654 . . . . 15.0 111.464 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.727 HD22 HG13 ' A' ' 253' ' ' ILE . 53.9 tp -77.27 -41.79 39.56 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.86 -0.422 . . . . 15.0 109.86 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -60.77 -39.7 89.77 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 124.026 0.829 . . . . 15.0 110.026 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.83 -42.24 77.44 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.398 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -64.6 -44.64 89.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.473 0.709 . . . . 15.0 111.107 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 141' ' ' LEU . 28.3 m -76.93 -25.21 15.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 119.282 -0.39 . . . . 15.0 110.89 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -55.34 -59.64 4.52 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.8 -36.35 82.19 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.03 0.752 . . . . 15.0 113.03 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -70.42 -52.48 21.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.214 0.461 . . . . 15.0 111.168 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.51 -33.47 75.99 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 118.391 -0.814 . . . . 15.0 110.206 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 45.5 mt-10 -72.21 -30.58 65.07 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -69.59 -38.83 77.48 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -65.12 -46.7 79.92 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.867 -1.06 . . . . 15.0 110.232 169.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.49 ' HA ' ' HE1' ' A' ' 428' ' ' MET . 42.9 tp -63.6 -59.4 4.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.397 -1.274 . . . . 15.0 112.788 -168.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.87 -30.2 70.76 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.718 0.636 . . . . 15.0 111.745 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 m -70.24 -37.6 75.0 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.214 0.53 . . . . 15.0 110.019 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.98 61.05 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 115.74 -0.664 . . . . 15.0 111.873 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.4 mt -69.32 -40.08 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.941 -1.133 . . . . 15.0 107.941 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 15.9 tpt180 -59.83 -50.5 73.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.602 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.44 -39.09 86.24 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.911 0.757 . . . . 15.0 111.765 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -56.44 -66.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.133 0.973 . . . . 15.0 110.8 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.79 -40.34 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.835 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.59 -46.53 79.01 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 115.6 -0.727 . . . . 15.0 110.724 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.0 p -69.13 -31.85 70.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.226 0.329 . . . . 15.0 111.712 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.7 mt-30 -64.56 -47.19 79.66 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.403 0.281 . . . . 15.0 110.779 173.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.07 -44.37 96.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.227 0.611 . . . . 15.0 111.26 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 351' ' ' LEU . 1.2 mp -64.44 -45.91 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.684 1.594 . . . . 15.0 111.445 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -67.59 -43.13 81.29 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.766 -0.457 . . . . 15.0 109.766 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -56.9 -41.43 91.66 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 124.151 0.907 . . . . 15.0 112.186 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.5 -59.62 5.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 15.0 111.292 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.62 -51.47 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 120.936 0.398 . . . . 15.0 110.302 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -62.93 -35.07 78.87 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.985 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.62 -24.64 49.51 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.669 0.618 . . . . 15.0 112.669 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 14.2 m-80 -118.26 152.67 35.28 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.991 0.424 . . . . 15.0 111.887 -162.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -121.61 135.46 54.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.081 0.952 . . . . 15.0 109.713 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 349' ' ' LEU . 12.0 tt -168.67 144.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.392 1.077 . . . . 15.0 109.447 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.93 120.74 26.07 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.589 -1.263 . . . . 15.0 107.589 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.15 120.29 65.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.783 0.833 . . . . 15.0 111.219 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.8 126.73 17.19 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.142 2.561 . . . . 15.0 112.776 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -57.82 -23.18 51.44 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.836 1.254 . . . . 15.0 112.341 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.612 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -56.04 -56.05 25.51 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.385 1.074 . . . . 15.0 111.529 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 37.1 mt -71.8 -33.2 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.622 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 304' ' ' ALA . 69.2 mt -60.82 -44.57 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.549 0.74 . . . . 15.0 110.054 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.59 91.77 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.675 0.79 . . . . 15.0 110.821 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 56.6 m -62.64 -49.9 73.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.669 0.605 . . . . 15.0 112.171 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 341' ' ' ALA . 4.8 mm-40 -68.65 -40.69 80.11 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.304 0.378 . . . . 15.0 110.542 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.511 HD13 ' HG3' ' A' ' 334' ' ' ARG . 60.6 mt -56.81 -45.26 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.898 0.879 . . . . 15.0 109.736 173.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.47 -46.75 88.96 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.325 1.016 . . . . 15.0 111.583 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.8 -40.72 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 123.722 0.639 . . . . 15.0 110.424 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.23 -26.71 63.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.307 0.643 . . . . 15.0 112.039 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.0 mtm180 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.877 0.325 . . . . 15.0 111.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.17 -16.82 56.03 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.407 1.083 . . . . 15.0 112.861 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 57.4 mt -54.97 137.99 65.29 Favored Pre-proline 0 N--CA 1.5 2.036 0 CA-C-N 118.477 0.581 . . . . 15.0 111.937 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.13 107.9 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.796 2.997 . . . . 15.0 114.088 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HG3' HD13 ' A' ' 311' ' ' ILE . 25.7 ttt85 -53.53 -39.25 64.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.208 1.403 . . . . 15.0 112.412 -174.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.31 -26.04 60.27 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 15.0 113.226 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.5 -31.96 71.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.245 0.545 . . . . 15.0 110.533 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.414 ' HA ' HE21 ' A' ' 340' ' ' GLN . 26.4 m-85 -105.53 -19.83 13.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.005 0.922 . . . . 15.0 111.341 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.413 ' HA ' HD11 ' A' ' 311' ' ' ILE . 5.9 tp10 -49.21 -61.15 2.23 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.879 1.272 . . . . 15.0 113.28 -169.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.15 -52.16 50.95 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.432 0.693 . . . . 15.0 111.666 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.3 pt20 -63.38 -34.46 77.78 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.757 0.66 . . . . 15.0 111.903 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -68.97 -49.34 58.73 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.445 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.2 tttt -55.55 -39.4 70.56 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.138 0.899 . . . . 15.0 110.636 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.4 mmt180 -59.09 -44.8 91.95 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.419 171.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -68.87 -24.19 64.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.491 0.716 . . . . 15.0 110.718 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.0 t -71.53 -50.9 36.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 123.181 0.592 . . . . 15.0 110.176 173.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 342' ' ' LYS . 39.7 t -56.33 -37.4 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 123.846 0.716 . . . . 15.0 109.887 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 343' ' ' ARG . 60.4 t -54.31 -53.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 15.0 110.972 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.22 -32.76 85.27 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.619 0.575 . . . . 15.0 114.049 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 300' ' ' ILE . 89.7 mt -73.28 -50.48 22.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.605 0.762 . . . . 15.0 110.159 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 354' ' ' VAL . 89.6 mt -70.37 -46.82 63.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.631 -0.713 . . . . 15.0 110.825 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 291' ' ' ILE . 52.9 mt -64.16 -37.13 86.35 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.439 0.462 . . . . 15.0 111.388 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.76 -40.2 98.91 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.593 0.558 . . . . 15.0 111.918 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.23 -29.27 67.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.107 -0.547 . . . . 15.0 111.304 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.1 t -74.33 -32.3 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.811 0.444 . . . . 15.0 110.357 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 351' ' ' LEU . 95.7 mt -63.45 -42.77 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.26 -0.645 . . . . 15.0 109.26 172.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -65.0 -55.45 18.93 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.2 m -60.31 -44.9 95.02 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.426 1.09 . . . . 15.0 111.535 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -88.26 4.27 46.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.125 0.57 . . . . 15.0 111.696 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 39.08 65.03 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.87 1.668 . . . . 15.0 113.886 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 154.12 18.34 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.5 -1.227 . . . . 15.0 111.204 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.36 144.05 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.538 -1.282 . . . . 15.0 107.538 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -66.14 132.59 48.83 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.63 0.372 . . . . 15.0 111.781 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.72 123.79 37.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.728 0.811 . . . . 15.0 110.265 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.44 -40.29 82.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.273 0.629 . . . . 15.0 112.383 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.86 -27.59 66.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.655 0.382 . . . . 15.0 111.751 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 406' ' ' GLN . 27.6 ttt180 -74.57 -43.32 56.23 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 371' ' ' ILE . 46.5 t -59.58 -42.0 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.697 -1.138 . . . . 15.0 109.719 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -58.14 -50.17 74.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.651 0.78 . . . . 15.0 110.865 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.76 -46.46 82.75 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 124.193 0.933 . . . . 15.0 112.664 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 96.5 mt -55.47 -48.84 73.89 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.416 0.686 . . . . 15.0 111.11 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.645 HD11 ' HG2' ' A' ' 398' ' ' MET . 35.6 mm -58.32 -58.94 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.534 0.733 . . . . 15.0 111.705 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.64 -36.21 83.51 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 124.329 1.018 . . . . 15.0 111.491 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -78.36 -39.06 40.48 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.46 0.541 . . . . 15.0 112.46 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.15 -36.12 82.55 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.343 0.592 . . . . 15.0 109.96 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.711 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -81.62 -28.16 33.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.173 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 35.4 t -64.65 -15.42 61.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.792 0.837 . . . . 15.0 111.669 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.09 -5.26 34.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.352 0.661 . . . . 15.0 111.945 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.79 165.58 20.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.327 1.051 . . . . 15.0 110.004 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.18 17.78 7.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.558 0.743 . . . . 15.0 110.354 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 381' ' ' PRO . 1.6 p30 -133.45 41.7 0.73 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.149 0.98 . . . . 15.0 112.626 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.711 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 44.1 Cg_exo -58.06 -43.48 47.79 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 122.128 1.886 . . . . 15.0 113.98 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.47 -50.1 63.36 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.897 0.879 . . . . 15.0 112.711 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.7 -22.04 64.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.594 0.559 . . . . 15.0 111.752 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.06 -45.71 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.191 0.597 . . . . 15.0 109.446 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.98 -39.28 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.04 -0.982 . . . . 15.0 109.776 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.67 -42.12 71.17 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.121 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -60.66 -35.91 77.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.295 0.638 . . . . 15.0 111.701 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 51.7 m-85 -88.38 -61.11 1.79 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.636 0.374 . . . . 15.0 111.745 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' SER . . . . . 0.473 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 38.9 m -70.54 -21.33 62.73 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.616 0.969 . . . . 15.0 113.616 -167.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -96.01 11.49 33.85 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.417 0.287 . . . . 15.0 111.055 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -136.8 103.54 5.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.84 -31.61 71.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.065 0.546 . . . . 15.0 111.512 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.08 -47.74 84.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.387 0.675 . . . . 15.0 110.87 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 41.8 tp -83.51 -24.71 31.58 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.896 -0.593 . . . . 15.0 111.209 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.51 ' HE3' ' HB3' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -71.08 -37.61 72.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.43 -36.19 82.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.761 1.224 . . . . 15.0 110.569 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 400' ' ' ASN . 51.9 t-20 -62.37 -42.48 99.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.742 0.782 . . . . 15.0 109.854 173.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.645 ' HG2' HD11 ' A' ' 371' ' ' ILE . 3.8 tpt -79.23 -17.26 55.14 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.564 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.11 -35.97 64.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 168.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 397' ' ' ASN . 6.8 t30 -59.22 -53.61 56.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.374 0.669 . . . . 15.0 110.421 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.2 p -65.47 -37.11 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 O-C-N 123.577 0.548 . . . . 15.0 111.354 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -62.01 -44.87 95.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.902 0.481 . . . . 15.0 110.96 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 23.5 tp -72.04 -30.46 65.2 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.846 -1.07 . . . . 15.0 111.03 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 33.7 tt0 -67.56 -39.35 84.95 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.949 0.9 . . . . 15.0 109.492 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 33.1 mm-40 -69.49 -36.2 76.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.551 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -62.25 -39.15 91.92 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.387 0.675 . . . . 15.0 110.098 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.85 -41.77 95.43 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 124.07 0.857 . . . . 15.0 111.534 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 96.2 t -57.94 -55.47 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 123.474 0.484 . . . . 15.0 110.031 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.463 ' HG2' HD12 ' A' ' 412' ' ' LEU . 43.5 mt-10 -67.29 -22.89 65.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.553 0.575 . . . . 15.0 112.553 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 414' ' ' LYS . . . -66.13 -37.66 86.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.57 0.544 . . . . 15.0 110.621 169.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 45.8 t -74.61 -33.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 409' ' ' GLU . 96.9 mt -64.33 -40.1 95.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.076 0.55 . . . . 15.0 110.935 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.21 -15.56 57.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.35 0.66 . . . . 15.0 112.492 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 410' ' ' ALA . 24.1 mtpp -101.12 -33.77 9.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.178 0.991 . . . . 15.0 110.672 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.3 160.66 20.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.284 1.033 . . . . 15.0 112.402 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.6 80.29 1.99 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.163 0.985 . . . . 15.0 109.816 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 125' ' ' VAL . 49.1 t -97.73 109.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.605 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.0 t -87.95 103.4 15.65 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.277 0.631 . . . . 15.0 110.134 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -85.37 129.39 34.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.661 0.785 . . . . 15.0 110.068 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -139.33 153.93 47.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.361 0.664 . . . . 15.0 109.588 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.56 133.3 52.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.592 -0.892 . . . . 15.0 108.592 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.436 HG23 HG22 ' A' ' 130' ' ' VAL . 7.9 t -159.64 172.12 18.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.763 0.425 . . . . 15.0 111.521 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 77.9 p -91.78 168.28 11.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.22 1.008 . . . . 15.0 111.396 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -54.17 -26.66 29.2 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.459 1.503 . . . . 15.0 112.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.93 -20.62 16.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.06 0.944 . . . . 15.0 113.338 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.466 0.706 . . . . 15.0 112.256 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 278' ' ' LEU . 22.4 tp -70.48 -78.79 0.07 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.514 0.931 . . . . 15.0 113.514 -153.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.49 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.0 OUTLIER -87.19 -22.79 25.07 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.608 0.363 . . . . 15.0 110.39 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 8.6 t30 . . . . . 0 CA--C 1.564 1.505 0 C-N-CA 123.964 0.906 . . . . 15.0 111.904 -172.362 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 385' ' ' LEU . . . . . 0.414 HD23 ' CD2' ' A' ' 185' ' ' PHE . 1.9 tm? . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 386' ' ' VAL . . . . . 0.51 HG11 ' HA3' ' A' ' 179' ' ' GLY . 27.2 m -69.4 98.72 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 121.834 0.826 . . . . 0.0 113.086 -166.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.42 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 20.9 pt -144.02 157.54 15.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.763 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 158.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 226' ' ' LEU . 30.2 t . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.482 1.133 0 C-N-CA 123.907 0.883 . . . . 0.0 111.047 178.625 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.907 0.384 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.64 -1.29 38.4 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.612 0.765 . . . . 0.0 111.418 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -164.6 135.86 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 89.3 m -63.3 99.37 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.5 ttt -78.43 120.17 22.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.674 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 465' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.1 OUTLIER -125.62 75.82 1.52 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 122.482 1.134 . . . . 0.0 109.18 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.15 -40.8 36.83 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.58 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 113.845 -1.525 . . . . 0.0 108.776 -172.416 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.779 0.323 . . . . 15.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -126.96 142.67 51.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.883 -1.154 . . . . 15.0 107.883 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -126.78 152.22 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.505 0.722 . . . . 15.0 110.051 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.529 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 48.7 m -146.9 100.63 3.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.349 0.66 . . . . 15.0 110.052 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.26 128.23 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.967 -0.561 . . . . 15.0 109.855 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.03 97.38 3.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 15.0 108.921 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -76.87 93.88 3.82 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.704 -0.85 . . . . 15.0 108.704 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.2 p -66.12 -39.94 90.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.139 0.976 . . . . 15.0 111.858 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -170.13 104.1 0.3 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.393 0.677 . . . . 15.0 109.979 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.67 -100.93 0.47 Allowed Glycine 0 C--N 1.354 1.529 0 O-C-N 124.083 0.864 . . . . 15.0 113.275 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.2 mp -76.99 -39.42 50.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 15.0 110.152 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.7 104.05 0.34 Allowed Glycine 0 C--N 1.353 1.477 0 O-C-N 124.603 1.19 . . . . 15.0 111.634 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' NH1' HG11 ' A' ' 111' ' ' VAL . 33.8 ttm180 -134.82 120.87 19.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.38 1.072 . . . . 15.0 109.972 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 43.3 ttm180 -93.76 146.38 23.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.46 -1.245 . . . . 15.0 109.468 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.47 93.69 2.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 107.332 -1.359 . . . . 15.0 107.332 165.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 33.3 m -73.19 108.55 6.13 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.137 -0.938 . . . . 15.0 108.953 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 3' ' ' VAL . 47.8 mt -107.92 123.95 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.025 0.53 . . . . 15.0 109.617 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 m -99.93 104.83 16.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.518 0.727 . . . . 15.0 109.156 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.5 mt -80.52 112.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 160.07 24.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.206 0.603 . . . . 15.0 111.997 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.96 79.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.324 1.049 . . . . 15.0 112.056 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -65.09 -36.2 83.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.741 0.816 . . . . 15.0 111.121 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -70.14 -37.0 75.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.528 0.731 . . . . 15.0 110.459 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 28' ' ' VAL . 73.8 mt -70.67 -44.05 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 114.905 -1.043 . . . . 15.0 109.943 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.26 -41.72 99.08 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.065 0.546 . . . . 15.0 111.799 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 m -56.11 -45.87 79.34 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -64.85 -44.81 88.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.462 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 24' ' ' ILE . 71.3 t -60.99 -55.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.284 0.634 . . . . 15.0 110.658 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -61.75 -41.5 97.76 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.27 -11.5 59.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.418 0.687 . . . . 15.0 111.767 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 8.8 tp10 -88.64 -43.03 11.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.721 0.408 . . . . 15.0 110.383 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.692 HD11 ' HA3' ' A' ' 59' ' ' GLY . 92.4 mt -70.27 -23.97 62.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.564 0.746 . . . . 15.0 112.386 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.2 p -69.98 -32.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 123.339 0.4 . . . . 15.0 110.054 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -69.36 -43.53 73.4 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.588 0.755 . . . . 15.0 109.613 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' VAL . 46.9 t -63.36 -38.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.885 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.524 0.73 . . . . 15.0 110.926 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 95.6 mttt -67.29 -31.49 71.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.169 0.587 . . . . 15.0 111.392 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.28 -46.05 29.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.694 0.798 . . . . 15.0 110.951 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.7 t -82.85 -5.93 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 122.924 0.49 . . . . 15.0 110.005 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 74.45 8.79 4.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.85 1.66 . . . . 15.0 112.15 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.419 HG13 ' HB ' ' A' ' 39' ' ' VAL . 56.8 mt -63.89 -22.9 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 15.0 110.931 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.99 -33.97 74.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.424 0.69 . . . . 15.0 111.148 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -39.05 15.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.749 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -71.03 -16.97 62.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.157 0.583 . . . . 15.0 111.162 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.412 HH21 ' HA ' ' A' ' 50' ' ' PRO . 49.0 ttt-85 -76.63 105.93 7.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -85.79 13.22 7.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.406 0.683 . . . . 15.0 112.153 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -34.29 4.66 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.85 -0.417 . . . . 15.0 112.354 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -52.03 -36.14 49.24 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.998 1.319 . . . . 15.0 112.384 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.31 108.92 32.23 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.564 -0.902 . . . . 15.0 108.564 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 53' ' ' ILE . 38.8 Cg_exo -64.02 138.94 64.86 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 15.0 111.681 173.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.6 tpp -67.92 -25.74 65.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.196 0.598 . . . . 15.0 111.12 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.13 -33.89 77.1 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.326 0.25 . . . . 15.0 111.13 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 50' ' ' PRO . 32.1 mt -67.55 -46.15 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.018 0.527 . . . . 15.0 110.234 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -74.14 -21.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 111.567 0.21 . . . . 15.0 111.567 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.23 -45.58 39.3 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.201 0.6 . . . . 15.0 111.4 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -75.57 -26.56 58.05 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.502 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -92.01 -72.52 0.59 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.839 0.455 . . . . 15.0 110.9 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -84.33 -34.44 23.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.077 0.551 . . . . 15.0 111.466 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -74.97 -13.23 82.8 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.156 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.68 59.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 15.0 112.163 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.9 p -81.89 -42.75 19.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.293 0.637 . . . . 15.0 109.346 171.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -70.86 88.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.793 0.837 . . . . 15.0 109.152 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.46 -38.28 6.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.625 0.77 . . . . 15.0 110.129 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.14 -46.01 90.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.765 0.826 . . . . 15.0 112.271 -171.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.98 -49.24 71.02 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.301 0.641 . . . . 15.0 110.376 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.6 -63.78 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.543 -1.208 . . . . 15.0 110.76 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 71' ' ' MET . 84.1 mt -64.74 -38.21 90.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.781 0.832 . . . . 15.0 111.511 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.27 -40.72 98.99 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.812 0.695 . . . . 15.0 113.15 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 28.7 t70 -78.87 -37.57 39.93 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.004 0.522 . . . . 15.0 110.076 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.0 mt -54.87 -42.4 72.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.005 0.922 . . . . 15.0 111.29 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 48.2 mtm -58.6 -42.75 88.85 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.675 0.609 . . . . 15.0 110.76 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.9 t -70.28 -43.78 69.75 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.907 -1.042 . . . . 15.0 111.008 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 20.8 mtm180 -69.17 -36.05 76.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.698 0.399 . . . . 15.0 111.502 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -36.67 68.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.968 0.507 . . . . 15.0 110.274 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -70.01 -50.25 43.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.886 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.41 -33.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.646 0.591 . . . . 15.0 111.012 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.23 -51.73 62.24 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.254 0.621 . . . . 15.0 110.707 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.79 85.49 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.99 -1.004 . . . . 15.0 112.438 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 pt -75.33 -32.01 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 112.383 0.512 . . . . 15.0 112.383 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.44 -50.62 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 120.841 0.353 . . . . 15.0 110.558 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 17.1 ptpt -73.66 -50.63 19.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.949 -0.569 . . . . 15.0 111.449 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 50.6 mm-40 -84.81 -1.99 57.12 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.133 0.573 . . . . 15.0 111.941 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 63.25 28.26 15.73 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.53 1.144 . . . . 15.0 111.091 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.19 90.37 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 108.399 -0.963 . . . . 15.0 108.399 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.556 HD22 ' HD2' ' A' ' 112' ' ' TYR . 2.1 t-20 -70.91 107.5 2.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.381 1.073 . . . . 15.0 110.425 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.37 141.78 12.87 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.345 2.03 . . . . 15.0 112.737 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.16 -177.3 6.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.578 0.751 . . . . 15.0 110.683 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.66 11.85 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.4 -0.818 . . . . 15.0 111.473 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.99 100.64 4.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.732 -1.211 . . . . 15.0 107.732 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 51.9 Cg_exo -57.78 107.9 0.34 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.972 2.448 . . . . 15.0 112.622 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.0 m -88.86 100.14 12.94 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.679 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -76.85 75.61 3.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.663 -0.866 . . . . 15.0 108.663 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.17 112.57 4.79 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 123.532 0.733 . . . . 15.0 109.361 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -69.43 92.3 0.48 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.407 2.072 . . . . 15.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -59.61 -63.5 5.05 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.964 0.79 . . . . 15.0 112.004 -176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -167.87 155.75 8.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.983 0.913 . . . . 15.0 109.792 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HE1' HD13 ' A' ' 24' ' ' ILE . 47.0 t80 -135.94 147.27 48.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.12 0.568 . . . . 15.0 109.551 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -124.87 125.22 43.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.748 -1.205 . . . . 15.0 107.748 175.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.39 107.59 0.95 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.675 0.79 . . . . 15.0 111.453 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.76 59.26 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.591 -0.731 . . . . 15.0 113.287 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -106.14 -165.95 1.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.318 1.047 . . . . 15.0 109.379 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -62.93 155.87 26.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.331 1.052 . . . . 15.0 113.287 -171.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.1 t80 -123.66 142.92 50.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 15.0 108.304 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.2 m -137.06 137.59 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.273 0.629 . . . . 15.0 109.371 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.412 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 11.6 p90 -154.35 156.46 36.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.984 0.914 . . . . 15.0 109.086 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 47.7 m -125.13 98.28 5.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.844 0.858 . . . . 15.0 109.648 -170.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.26 97.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.852 -0.796 . . . . 15.0 108.852 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.9 119.05 33.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.799 0.44 . . . . 15.0 110.253 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 22.4 p90 -146.61 -166.78 2.58 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.527 1.131 . . . . 15.0 108.941 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.67 177.17 5.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.63 0.772 . . . . 15.0 110.356 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 11' ' ' LEU . 27.0 m -119.72 154.46 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 122.992 0.517 . . . . 15.0 109.626 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.556 ' HD2' HD22 ' A' ' 85' ' ' ASN . 48.6 m-85 -82.75 105.89 5.81 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 108.334 -0.987 . . . . 15.0 108.334 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' HD11 ' A' ' 300' ' ' ILE . 64.5 Cg_endo -89.03 149.45 5.69 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.629 2.219 . . . . 15.0 113.704 -172.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.58 132.14 33.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.202 1.001 . . . . 15.0 108.882 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 350' ' ' LEU . 7.3 p -86.3 151.57 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.256 0.551 . . . . 15.0 111.937 -170.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.34 94.03 8.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.476 -0.784 . . . . 15.0 108.914 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.3 139.08 58.73 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.47 0.481 . . . . 15.0 110.555 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -163.06 155.12 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.915 0.886 . . . . 15.0 109.545 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.98 74.76 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.124 0.89 . . . . 15.0 114.049 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.45 -28.73 67.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.227 0.611 . . . . 15.0 110.935 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 18.3 mp0 -75.65 -34.08 60.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.657 -1.156 . . . . 15.0 109.852 174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.464 ' HA ' ' HE3' ' A' ' 416' ' ' LYS . . . -78.93 -7.15 57.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.61 0.764 . . . . 15.0 112.255 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.632 HG23 ' HA3' ' A' ' 293' ' ' GLY . 77.6 mt -70.83 120.89 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.439 0.695 . . . . 15.0 109.467 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.08 104.11 15.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.376 0.67 . . . . 15.0 109.685 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 417' ' ' VAL . 45.6 t -106.05 159.55 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.934 -1.135 . . . . 15.0 107.934 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.47 126.37 46.62 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.724 -0.843 . . . . 15.0 108.724 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -107.43 99.21 26.97 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.529 0.732 . . . . 15.0 109.197 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.02 97.85 0.84 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.468 2.112 . . . . 15.0 111.502 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.52 93.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 166.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 12.4 t -122.51 140.48 46.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.535 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.68 154.37 48.6 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.984 -1.117 . . . . 15.0 107.984 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.82 83.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.3 p -68.39 176.9 2.59 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.489 1.116 . . . . 15.0 110.368 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.99 -45.6 64.57 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.429 0.692 . . . . 15.0 111.771 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.19 97.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.92 -1.036 . . . . 15.0 111.338 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.4 -44.15 68.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.173 0.589 . . . . 15.0 111.298 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.9 t -55.51 -62.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.348 1.059 . . . . 15.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -75.45 -31.31 60.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.676 -0.693 . . . . 15.0 111.307 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.86 -43.8 81.98 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.887 0.742 . . . . 15.0 112.713 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -78.16 -37.5 45.76 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.091 0.556 . . . . 15.0 110.878 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.554 HD21 HG11 ' A' ' 270' ' ' VAL . 18.5 mt -54.83 -42.39 71.86 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.253 0.621 . . . . 15.0 111.574 165.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.38 -40.1 95.15 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.375 -0.83 . . . . 15.0 109.997 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.9 m -61.67 -46.27 90.42 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.721 0.638 . . . . 15.0 110.953 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -45.95 91.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.651 0.78 . . . . 15.0 110.66 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -58.27 -37.66 75.4 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.808 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.618 ' HD3' HH12 ' A' ' 243' ' ' ARG . 83.3 mttt -85.41 -12.23 52.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.34 0.656 . . . . 15.0 112.533 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.82 -22.79 34.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.81 0.444 . . . . 15.0 110.005 167.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -97.06 8.4 44.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.262 0.625 . . . . 15.0 111.324 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.71 159.53 31.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 15.0 112.312 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.6 m -123.93 155.93 37.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.091 0.956 . . . . 15.0 108.917 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.627 ' HZ3' ' HB3' ' A' ' 243' ' ' ARG . 3.5 m95 -78.91 153.17 30.69 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.817 0.341 . . . . 15.0 111.151 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -151.65 104.77 3.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.043 -0.981 . . . . 15.0 109.368 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.35 98.45 0.11 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.02 170.73 16.23 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.477 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.95 97.24 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.838 0.455 . . . . 15.0 110.729 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 207' ' ' ALA . . . 55.22 53.26 41.77 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 124.589 1.181 . . . . 15.0 115.5 161.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -153.91 140.86 19.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.334 0.654 . . . . 15.0 109.315 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 202' ' ' ILE . 17.0 t -119.32 131.33 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.177 -0.675 . . . . 15.0 109.177 172.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.85 -176.16 3.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.283 . . . . 15.0 109.423 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.82 -27.49 64.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.28 13.88 16.75 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.435 0.532 . . . . 15.0 112.435 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -79.03 136.16 37.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.971 0.415 . . . . 15.0 111.602 -173.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -84.94 90.91 7.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.823 -1.547 . . . . 15.0 106.823 173.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 44.0 t -90.58 150.79 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.002 0.921 . . . . 15.0 109.847 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.669 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 32.9 m -130.09 126.75 38.36 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 165.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.83 163.71 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.341 1.057 . . . . 15.0 110.314 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -116.69 122.21 43.89 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.294 -1.743 . . . . 15.0 106.294 167.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -129.14 160.69 32.06 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.724 0.773 . . . . 15.0 111.235 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.0 t -140.85 111.87 7.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.262 -1.385 . . . . 15.0 107.262 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -80.02 160.34 44.47 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.596 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.0 m -149.53 111.15 4.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.543 0.737 . . . . 15.0 109.194 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 177' ' ' PHE . 59.7 t -93.85 134.87 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.297 -1.001 . . . . 15.0 108.297 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.0 p30 51.39 18.98 0.71 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.138 1.775 . . . . 15.0 113.472 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.36 -11.57 12.71 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-O 118.665 -1.075 . . . . 15.0 115.545 172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.82 147.73 50.82 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.214 1.507 . . . . 15.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.69 112.66 2.61 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.836 0.71 . . . . 15.0 109.217 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -72.32 156.22 39.33 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.596 0.56 . . . . 15.0 110.829 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.38 126.63 28.09 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.763 0.664 . . . . 15.0 111.124 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.77 77.55 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.051 -0.977 . . . . 15.0 112.175 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.69 47.81 1.39 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 114.672 0.629 . . . . 15.0 114.672 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -136.03 150.72 49.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.018 0.527 . . . . 15.0 110.625 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.12 92.27 0.83 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.154 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.2 p -76.57 127.81 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.357 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 71.6 36.15 1.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 15.0 112.731 174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -66.05 138.85 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 15.0 109.909 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -104.35 110.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.977 0.911 . . . . 15.0 109.719 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -101.93 89.96 3.82 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.675 0.79 . . . . 15.0 111.22 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -78.45 90.3 4.45 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.387 -0.968 . . . . 15.0 108.387 171.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.7 mtp -71.76 169.68 15.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.43 -0.805 . . . . 15.0 113.024 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.67 ' HA3' HH21 ' A' ' 243' ' ' ARG . . . 91.53 10.66 61.67 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.99 -1.004 . . . . 15.0 113.523 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.446 ' HG3' ' HG2' ' A' ' 193' ' ' ARG . 8.8 pt20 -137.75 160.55 38.94 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.169 0.588 . . . . 15.0 110.077 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.91 89.83 0.06 OUTLIER Glycine 0 C--N 1.353 1.484 0 O-C-N 123.715 0.635 . . . . 15.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 191' ' ' GLN . 29.7 mmt180 -121.03 -60.78 1.62 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.67 0.788 . . . . 15.0 111.227 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 198' ' ' PHE . 63.4 mmm -98.17 148.89 23.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.679 0.622 . . . . 15.0 112.679 -165.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.8 pt -61.27 145.27 90.54 Favored Pre-proline 0 CA--C 1.556 1.207 0 O-C-N 124.74 1.275 . . . . 15.0 109.904 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.62 114.76 1.91 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.472 2.781 . . . . 15.0 111.811 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 128.4 -37.31 2.29 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.71 -0.677 . . . . 15.0 112.385 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 194' ' ' MET . 37.6 t80 -69.64 -67.78 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.423 0.289 . . . . 15.0 110.386 -175.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.41 -18.84 65.08 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.382 0.426 . . . . 15.0 111.859 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.28 -41.13 67.01 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.965 0.906 . . . . 15.0 110.2 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.22 -24.44 77.0 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.176 -0.92 . . . . 15.0 112.484 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 198' ' ' PHE . 44.9 mm -73.2 -51.85 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.239 0.616 . . . . 15.0 110.134 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -79.01 12.78 2.04 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.508 0.929 . . . . 15.0 113.508 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.55 20.4 15.59 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -144.18 -176.05 4.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.484 1.114 . . . . 15.0 109.991 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.5 OUTLIER -147.37 143.42 27.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.436 0.694 . . . . 15.0 110.101 -176.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.599 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . . . -59.66 145.67 43.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.414 0.894 . . . . 15.0 113.414 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.09 -34.16 4.84 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.478 -0.783 . . . . 15.0 111.553 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.6 pt-20 -87.19 140.74 29.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.588 0.709 . . . . 15.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.14 125.37 52.23 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.67 1.188 . . . . 15.0 107.969 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -148.92 -167.05 2.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.425 1.09 . . . . 15.0 109.633 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.4 t -133.17 150.37 52.01 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.199 -1.037 . . . . 15.0 108.199 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 38.5 pt -113.57 147.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 172.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.04 113.7 26.95 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.93 167.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.302 -1.37 . . . . 15.0 107.302 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.9 m -135.03 137.73 43.24 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -72.58 125.5 91.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 123.873 0.733 . . . . 15.0 109.621 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.48 168.15 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.785 2.99 . . . . 15.0 115.21 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.88 -19.97 53.83 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.937 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -80.3 -22.49 41.52 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.325 1.05 . . . . 15.0 110.75 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.59 116.23 4.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.84 . . . . 15.0 110.46 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -68.14 -32.19 72.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -162.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.42 92.57 1.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.039 -1.467 . . . . 15.0 107.039 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 33.0 tt0 -73.53 -18.11 61.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.744 0.817 . . . . 15.0 111.391 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -65.32 -13.23 58.02 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.365 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 172' ' ' VAL . 95.4 mt -119.26 -29.89 5.07 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.949 1.3 . . . . 15.0 111.773 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 36.8 ttmt -51.61 121.36 6.33 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.998 1.319 . . . . 15.0 111.645 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.63 -25.33 25.32 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.409 -0.359 . . . . 15.0 113.591 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.15 150.44 31.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.524 0.73 . . . . 15.0 111.328 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.8 122.79 37.79 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.646 0.778 . . . . 15.0 109.927 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.43 122.37 47.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.667 0.787 . . . . 15.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 63.9 mttm -93.73 118.4 31.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.193 0.997 . . . . 15.0 109.571 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 89.5 m-85 -108.4 118.44 36.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.01 89.16 2.98 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.507 0.504 . . . . 15.0 110.323 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 40.9 mm -83.24 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.537 0.735 . . . . 15.0 110.209 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -120.59 99.33 6.49 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.43 99.3 4.83 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.53 0.732 . . . . 15.0 111.005 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -104.12 -43.65 5.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.52 0.728 . . . . 15.0 110.145 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.3 mmtt -124.51 125.87 44.92 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.561 1.144 . . . . 15.0 108.22 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 157' ' ' ALA . 18.6 t -128.5 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.74 -1.578 . . . . 15.0 106.74 165.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -86.53 163.99 17.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.542 -1.208 . . . . 15.0 108.23 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -130.2 129.46 43.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.453 -0.943 . . . . 15.0 108.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.67 HH21 ' HA3' ' A' ' 190' ' ' GLY . 27.8 ptt85 -74.41 84.4 1.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.366 -0.976 . . . . 15.0 108.366 167.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.36 145.92 37.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.783 -1.553 . . . . 15.0 110.689 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 146' ' ' LYS . 55.1 mt -57.47 120.73 42.84 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.984 0.914 . . . . 15.0 110.133 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.25 -165.57 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.903 3.736 . . . . 15.0 113.613 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -46.77 136.51 7.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.773 -1.103 . . . . 15.0 110.461 165.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.0 tp -140.66 37.37 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.137 -1.06 . . . . 15.0 108.137 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.6 m -66.03 161.04 22.43 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.47 1.108 . . . . 15.0 109.922 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.83 -44.88 14.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.88 1.272 . . . . 15.0 112.929 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.82 -27.28 64.74 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.981 -0.554 . . . . 15.0 112.173 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -77.58 -49.18 15.15 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.567 HG13 HD22 ' A' ' 266' ' ' LEU . 12.1 tt -64.52 -32.78 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.381 0.672 . . . . 15.0 110.981 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 258' ' ' VAL . 21.1 ptmt -79.23 -18.47 52.82 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 112.147 0.425 . . . . 15.0 112.147 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -65.58 -24.12 67.0 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 15.0 111.672 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -64.23 -22.77 67.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.283 0.633 . . . . 15.0 111.551 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.5 -1.45 0.73 Allowed Glycine 0 C--N 1.356 1.691 0 CA-C-O 119.845 -0.42 . . . . 15.0 113.853 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 2.9 t -80.82 134.94 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.192 0.597 . . . . 15.0 109.403 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -76.51 -47.68 21.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.7 0.4 . . . . 15.0 111.039 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.69 -36.04 16.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.704 0.288 . . . . 15.0 111.116 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 94.14 22.68 24.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.994 -0.548 . . . . 15.0 113.902 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 29.1 p -70.07 142.56 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 117.532 0.666 . . . . 15.0 110.154 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 253' ' ' ILE . 49.0 t -54.44 -50.91 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.746 0.654 . . . . 15.0 109.283 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.72 -27.45 67.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.034 -0.985 . . . . 15.0 111.44 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.91 -21.1 63.98 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.659 0.599 . . . . 15.0 111.634 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 253' ' ' ILE . 55.7 tp -78.35 -42.29 30.96 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -62.15 -39.44 92.61 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.821 -1.081 . . . . 15.0 110.195 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.54 -43.51 80.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.071 0.948 . . . . 15.0 111.045 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -56.59 -56.98 14.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 141' ' ' LEU . 17.4 m -76.52 -20.22 14.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.363 -0.835 . . . . 15.0 111.534 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -57.41 -63.13 1.33 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.15 -36.77 82.56 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.0 0.37 . . . . 15.0 112.0 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -72.88 -50.02 26.34 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.383 0.673 . . . . 15.0 111.502 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 66.7 mtt -72.04 -28.19 63.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.394 -0.812 . . . . 15.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 47.1 mt-10 -71.09 -26.12 62.91 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 118.881 0.764 . . . . 15.0 111.539 170.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -70.71 -44.63 66.53 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.492 -0.559 . . . . 15.0 109.492 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -62.39 -45.35 93.53 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.572 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 64.9 tp -61.89 -50.88 70.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.025 -1.443 . . . . 15.0 112.175 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.49 -30.86 71.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.52 0.728 . . . . 15.0 110.688 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.5 t -66.12 -45.92 79.4 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.044 -0.725 . . . . 15.0 109.044 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.01 79.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.368 0.667 . . . . 15.0 112.078 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.5 mt -67.03 -45.18 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.775 0.83 . . . . 15.0 109.092 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 23.2 tpt180 -62.05 -46.87 87.22 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.604 -0.725 . . . . 15.0 110.535 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -62.99 -38.5 91.42 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.033 -0.531 . . . . 15.0 110.961 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -56.63 -63.84 1.07 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.66 0.784 . . . . 15.0 110.658 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.05 -46.04 92.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.042 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.1 tttt -64.55 -45.53 86.74 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.844 -0.617 . . . . 15.0 111.105 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.4 p -68.02 -31.9 71.89 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.44 0.296 . . . . 15.0 111.359 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.458 ' HB2' HG13 ' A' ' 125' ' ' VAL . 55.9 mt-30 -73.31 -34.0 65.48 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.354 0.409 . . . . 15.0 111.719 176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.93 62.83 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 110.05 -0.352 . . . . 15.0 110.05 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.95 -42.87 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.358 1.463 . . . . 15.0 110.958 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.91 -59.43 4.9 Favored 'General case' 0 C--O 1.246 0.897 0 C-N-CA 124.227 1.011 . . . . 15.0 110.231 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.632 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.52 -32.77 79.66 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.918 -1.037 . . . . 15.0 113.295 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.703 ' HB3' HD13 ' A' ' 350' ' ' LEU . 9.9 mt -59.85 -53.97 51.74 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 15.0 111.0 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.3 -44.73 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.83 -0.433 . . . . 15.0 109.83 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.18 -32.78 66.78 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.853 0.861 . . . . 15.0 111.746 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.4 -29.95 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.462 0.705 . . . . 15.0 111.611 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -131.92 123.44 27.44 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.096 0.474 . . . . 15.0 111.903 -162.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.58 148.95 26.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.324 1.05 . . . . 15.0 109.363 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.641 HD13 HD13 ' A' ' 349' ' ' LEU . 14.2 tt -162.87 148.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.514 0.726 . . . . 15.0 110.106 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.85 131.94 42.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.472 HG13 HG11 ' A' ' 345' ' ' VAL . 71.2 t -119.88 126.06 27.07 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.259 0.624 . . . . 15.0 111.153 -165.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.86 136.82 17.11 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.692 2.261 . . . . 15.0 112.475 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.55 -15.18 57.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.624 1.17 . . . . 15.0 113.337 -174.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.13 64.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.756 0.822 . . . . 15.0 110.703 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' B' ' 467' ' ' ALA . 71.7 mt -71.45 -38.43 71.32 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 114.121 -1.4 . . . . 15.0 110.442 -175.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 304' ' ' ALA . 55.2 mt -57.28 -50.5 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.233 -1.349 . . . . 15.0 108.516 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.36 -32.35 73.92 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.216 0.948 . . . . 15.0 111.451 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 73.4 m -62.33 -52.88 61.89 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.671 0.389 . . . . 15.0 111.882 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.4 -35.44 79.31 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.561 -0.29 . . . . 15.0 111.124 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.591 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.0 mt -61.65 -38.35 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.416 -0.587 . . . . 15.0 109.416 173.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.469 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 9.1 t70 -64.44 -46.42 83.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.752 0.821 . . . . 15.0 109.423 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.02 -40.77 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 124.155 0.91 . . . . 15.0 110.259 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.55 -19.26 60.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.377 0.671 . . . . 15.0 112.32 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 21.7 mtm180 . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 123.795 0.838 . . . . 15.0 109.811 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 CA--C 1.554 1.131 0 N-CA-C 111.811 0.3 . . . . 15.0 111.811 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.75 -16.17 45.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.678 0.791 . . . . 15.0 112.001 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 67.2 mt -53.06 125.89 42.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.812 0.445 . . . . 15.0 111.973 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.484 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 84.0 Cg_exo -46.48 120.24 3.73 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.659 3.572 . . . . 15.0 115.453 -166.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.591 ' HG3' HD13 ' A' ' 311' ' ' ILE . 68.6 ttt180 -55.93 -37.04 68.41 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.922 0.889 . . . . 15.0 112.061 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -63.38 -17.31 62.48 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.319 0.648 . . . . 15.0 112.465 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 89.1 mt -73.51 -32.27 64.17 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.368 0.604 . . . . 15.0 110.34 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -115.62 -6.07 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.971 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -47.19 -71.79 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.222 1.409 . . . . 15.0 113.166 -173.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.54 -51.74 68.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.625 0.77 . . . . 15.0 111.686 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -61.72 -45.93 91.81 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.774 0.671 . . . . 15.0 112.043 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.97 56.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.484 . . . . 15.0 110.346 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.19 -34.88 64.26 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.572 0.749 . . . . 15.0 111.027 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -70.95 -35.29 72.13 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.239 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -66.93 -28.65 68.47 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.158 0.286 . . . . 15.0 110.266 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 302' ' ' VAL . 46.2 t -69.6 -47.55 70.81 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.228 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 67.4 t -51.81 -48.44 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.613 -0.884 . . . . 15.0 108.613 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.73 -43.14 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.201 1.001 . . . . 15.0 111.741 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.91 -34.77 90.82 Favored Glycine 0 N--CA 1.472 1.083 0 O-C-N 123.233 0.333 . . . . 15.0 112.851 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.641 HD13 HD13 ' A' ' 300' ' ' ILE . 65.8 mt -76.46 -38.77 54.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.657 0.783 . . . . 15.0 109.764 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.703 HD13 ' HB3' ' A' ' 294' ' ' LEU . 81.3 mt -62.14 -62.05 2.04 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.451 1.101 . . . . 15.0 110.555 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.96 -30.77 71.83 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.26 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.63 95.74 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.866 0.729 . . . . 15.0 111.996 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.13 -34.17 77.44 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.109 -0.545 . . . . 15.0 110.766 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.0 t -67.06 -40.86 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.632 0.373 . . . . 15.0 110.484 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.21 -38.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.599 0.759 . . . . 15.0 110.055 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -70.28 -53.94 14.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.16 0.288 . . . . 15.0 111.518 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -61.45 -35.08 76.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.042 0.937 . . . . 15.0 111.836 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -102.13 10.52 39.38 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 118.962 -0.542 . . . . 15.0 111.348 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 36.83 40.17 0.13 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 126.489 1.916 . . . . 15.0 114.495 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.84 133.36 50.78 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.316 1.046 . . . . 15.0 112.24 -170.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -109.28 142.21 40.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.751 0.82 . . . . 15.0 109.785 176.019 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.55 115.36 8.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.752 0.421 . . . . 15.0 110.35 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.23 127.94 34.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 15.0 111.408 -171.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.45 -34.38 76.69 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.306 1.042 . . . . 15.0 113.481 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -71.77 -26.64 62.52 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.108 0.255 . . . . 15.0 110.641 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -76.16 -44.95 35.84 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.017 -0.734 . . . . 15.0 109.017 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 398' ' ' MET . 60.9 t -52.28 -56.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.407 1.083 . . . . 15.0 110.341 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.7 -40.37 92.2 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.122 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.17 -40.78 97.7 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.621 0.575 . . . . 15.0 113.336 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 73.6 mt -61.73 -51.7 67.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.686 0.794 . . . . 15.0 109.549 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' A' ' 398' ' ' MET . 34.5 mm -47.54 -56.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.589 1.181 . . . . 15.0 111.216 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.21 -61.32 2.55 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.459 -0.791 . . . . 15.0 111.637 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.12 -24.5 61.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.151 0.797 . . . . 15.0 113.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -78.03 -46.96 19.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.639 0.654 . . . . 15.0 109.304 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -69.48 -32.35 71.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.828 0.451 . . . . 15.0 111.292 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.8 t -63.88 -18.26 64.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.561 0.745 . . . . 15.0 112.214 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.91 66.74 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.289 0.636 . . . . 15.0 111.3 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -97.9 -175.02 3.03 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.696 -0.684 . . . . 15.0 111.01 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.94 -56.19 24.04 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.974 0.91 . . . . 15.0 111.517 -168.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -131.15 116.09 16.59 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.442 -0.799 . . . . 15.0 109.494 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 22.2 Cg_exo -68.23 -37.81 13.4 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.649 2.232 . . . . 15.0 113.227 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -54.82 -48.04 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.301 1.041 . . . . 15.0 111.873 -164.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.23 -28.2 68.55 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.57 -1.195 . . . . 15.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.33 -41.4 30.07 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 C-N-CA 123.573 0.749 . . . . 15.0 109.541 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.67 -48.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.28 -33.39 65.2 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.302 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -70.4 -24.32 62.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.3 0.64 . . . . 15.0 111.068 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.455 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 23.7 m-85 -92.68 -56.14 3.12 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.053 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' SER . . . . . 0.662 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -58.66 -43.64 89.93 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 112.526 0.565 . . . . 15.0 112.526 -170.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -87.22 3.83 44.97 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.348 0.659 . . . . 15.0 111.963 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -129.44 90.75 3.05 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.547 -0.908 . . . . 15.0 108.547 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -54.22 -34.57 60.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.388 1.075 . . . . 15.0 112.16 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.2 -43.58 82.86 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.806 0.842 . . . . 15.0 110.841 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.81 -24.34 17.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 15.0 111.291 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.9 OUTLIER -62.94 -37.25 86.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.79 0.836 . . . . 15.0 109.741 176.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.63 -44.4 94.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.496 -1.229 . . . . 15.0 109.843 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.95 -32.05 69.27 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.212 0.605 . . . . 15.0 111.427 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 367' ' ' VAL . 31.5 tpp -69.7 -31.24 69.15 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.441 0.463 . . . . 15.0 111.774 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -67.66 -38.76 84.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 110.135 -0.32 . . . . 15.0 110.135 168.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 400' ' ' ASN . 0.8 OUTLIER -65.52 -48.1 73.67 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.562 0.745 . . . . 15.0 111.408 -176.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 8.3 p -67.49 -37.86 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 123.634 0.584 . . . . 15.0 110.174 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.01 85.34 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.69 0.757 . . . . 15.0 110.502 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 16.7 tp -68.57 -32.76 72.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.076 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.9 tt0 -67.2 -38.1 84.75 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.867 0.467 . . . . 15.0 110.028 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 60.9 mm-40 -62.7 -41.51 99.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.845 0.458 . . . . 15.0 110.019 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -66.74 -39.0 87.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.051 -0.977 . . . . 15.0 111.734 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.02 -42.23 99.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.849 0.718 . . . . 15.0 110.327 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 287' ' ' LYS . 64.4 t -59.36 -54.04 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.548 173.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.407 ' HA ' HD12 ' A' ' 412' ' ' LEU . 80.0 mt-10 -62.01 -28.07 69.32 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.459 0.704 . . . . 15.0 112.88 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.44 71.87 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.793 0.437 . . . . 15.0 110.297 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.85 -32.54 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.223 -0.658 . . . . 15.0 109.223 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 409' ' ' GLU . 93.4 mt -63.28 -43.77 96.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.33 0.652 . . . . 15.0 110.65 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.88 -25.63 65.24 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.599 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 26.1 mtpp -94.85 -22.4 18.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.408 1.083 . . . . 15.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.47 13.18 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.075 0.95 . . . . 15.0 113.211 -171.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 85.7 mttt -77.74 77.3 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.402 1.081 . . . . 15.0 109.459 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 125' ' ' VAL . 38.1 t -91.62 91.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.3 t -71.01 95.37 1.18 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 122.298 1.047 . . . . 15.0 110.448 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.87 117.32 19.86 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.245 -1.343 . . . . 15.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -122.58 157.52 31.95 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.942 0.897 . . . . 15.0 109.064 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.39 117.57 32.13 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -143.95 176.36 9.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.523 0.329 . . . . 15.0 110.611 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.8 p -101.03 159.83 14.89 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.268 1.027 . . . . 15.0 111.128 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.76 -31.57 69.77 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.979 1.311 . . . . 15.0 110.976 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -65.96 -9.2 27.76 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.363 -0.835 . . . . 15.0 112.299 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.91 -73.34 0.57 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 170.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 35.3 tp -36.99 -59.15 0.73 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 125.323 1.449 . . . . 15.0 114.871 -158.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -35.18 13.99 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.07 0.548 . . . . 15.0 110.819 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.6 m120 . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 123.474 0.71 . . . . 15.0 111.85 -171.562 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.409 0.623 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.32 130.56 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.124 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -140.5 162.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.222 1.409 . . . . 0.0 109.077 169.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 177' ' ' PHE . 97.3 t . . . . . 0 N--CA 1.495 1.8 0 C-N-CA 124.081 0.952 . . . . 0.0 112.405 -163.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.209 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 18.5 p90 . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 123.36 0.664 . . . . 0.0 110.412 -175.021 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 35.9 t80 58.57 103.31 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.583 1.553 . . . . 0.0 109.435 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 35.9 t80 65.22 -172.44 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.2 m -141.15 104.47 4.64 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.94 21.34 4.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.922 0.889 . . . . 0.0 111.368 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 70.4 -175.54 0.19 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.974 1.31 . . . . 0.0 111.168 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 68.87 -61.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.074 1.35 . . . . 0.0 110.107 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 467' ' ' ALA . . . . . 0.489 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 124.29 1.036 . . . . 0.0 108.505 163.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.025 0.44 . . . . 15.0 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -146.68 146.99 30.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.588 -0.893 . . . . 15.0 108.588 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -137.55 148.72 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.942 0.897 . . . . 15.0 109.467 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.463 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 55.6 p -126.2 101.16 6.63 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.96 77.21 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.682 1.229 . . . . 15.0 110.569 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 46.3 mt-10 -75.77 173.45 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.662 -1.154 . . . . 15.0 109.758 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 77.6 m -143.49 112.8 6.82 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.392 -0.966 . . . . 15.0 108.392 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -78.39 -41.3 33.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.431 0.693 . . . . 15.0 110.562 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -164.04 84.46 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.822 0.849 . . . . 15.0 109.512 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.77 -94.76 0.07 OUTLIER Glycine 0 C--N 1.354 1.531 0 O-C-N 123.825 0.703 . . . . 15.0 113.671 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.6 mp -62.07 -50.21 72.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.526 1.13 . . . . 15.0 110.602 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.8 86.5 0.21 Allowed Glycine 0 C--N 1.346 1.113 0 O-C-N 124.195 0.934 . . . . 15.0 112.11 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 98.7 mtt180 -99.78 134.04 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.293 1.037 . . . . 15.0 110.378 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.5 ttm180 -103.01 88.27 3.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.282 1.033 . . . . 15.0 110.737 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -81.57 91.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.3 m -75.98 100.41 4.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.853 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 51.6 mt -87.98 109.38 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.97 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -84.95 94.24 8.74 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.995 -0.743 . . . . 15.0 108.995 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 70' ' ' LEU . 43.4 mt -73.32 106.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.963 -1.125 . . . . 15.0 107.963 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 150.79 44.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 122.556 0.342 . . . . 15.0 111.315 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.51 -16.88 58.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.603 1.161 . . . . 15.0 114.096 -169.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -64.71 -44.84 88.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.225 0.61 . . . . 15.0 110.429 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.4 m -75.13 -36.79 61.57 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 115.44 -0.8 . . . . 15.0 110.776 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 103' ' ' PHE . 57.9 mt -62.39 -50.58 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.702 0.626 . . . . 15.0 109.881 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -57.53 -50.49 72.92 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.067 0.947 . . . . 15.0 111.098 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.5 m -65.4 -37.77 87.97 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.218 -0.901 . . . . 15.0 111.742 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.28 63.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.123 0.569 . . . . 15.0 112.128 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.794 HG21 ' HD3' ' A' ' 63' ' ' ARG . 93.7 t -65.32 -41.63 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -65.52 -34.99 79.54 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.509 1.124 . . . . 15.0 110.759 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -39.08 91.1 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.55 0.74 . . . . 15.0 110.05 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -74.82 -25.77 59.26 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.524 0.515 . . . . 15.0 111.387 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD11 ' HA3' ' A' ' 59' ' ' GLY . 94.0 mt -73.09 -38.76 66.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.808 0.443 . . . . 15.0 110.983 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.45 -19.6 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 O-C-N 123.158 0.286 . . . . 15.0 110.329 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.18 -57.7 8.74 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.11 -38.53 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.198 0.999 . . . . 15.0 111.365 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.191 0.596 . . . . 15.0 110.559 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.17 -26.68 35.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.814 0.446 . . . . 15.0 112.095 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -77.32 -35.17 55.06 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.711 1.204 . . . . 15.0 110.935 -173.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.64 5.44 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.788 0.835 . . . . 15.0 109.531 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 65.66 22.39 11.64 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.838 1.655 . . . . 15.0 112.601 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 54.0 mt -78.24 -19.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.448 1.099 . . . . 15.0 111.261 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.26 -30.2 71.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.682 0.793 . . . . 15.0 112.061 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.19 -23.76 73.21 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.59 0.556 . . . . 15.0 112.844 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 88.9 m-85 -83.68 -24.0 31.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.462 0.705 . . . . 15.0 110.78 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -79.53 88.47 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -92.14 50.06 1.6 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.589 0.755 . . . . 15.0 110.384 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.3 67.68 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.633 -0.712 . . . . 15.0 113.129 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -73.25 -58.79 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.633 0.773 . . . . 15.0 110.147 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.4 t -101.11 122.11 49.7 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.846 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 53' ' ' ILE . 73.6 Cg_exo -53.54 138.92 66.74 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.063 2.509 . . . . 15.0 112.409 167.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.8 tpt -70.48 -25.26 63.08 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.817 0.847 . . . . 15.0 112.078 -171.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -70.63 -28.79 65.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.549 0.34 . . . . 15.0 111.163 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.491 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.9 mt -65.44 -53.02 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.817 . . . . 15.0 110.241 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 30.1 m -69.1 -16.98 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 111.92 0.341 . . . . 15.0 111.92 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -73.65 -65.58 0.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.513 0.725 . . . . 15.0 112.0 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -73.97 -33.79 64.0 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.672 -0.695 . . . . 15.0 111.93 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -87.49 -73.97 0.46 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.798 0.439 . . . . 15.0 110.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 96.5 m-85 -72.52 -28.1 62.65 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.044 0.537 . . . . 15.0 111.814 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -86.17 10.2 67.0 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.733 -0.481 . . . . 15.0 113.607 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.47 66.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 15.0 111.896 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 p -84.04 -36.37 23.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.185 0.994 . . . . 15.0 111.059 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.84 -18.78 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.306 1.042 . . . . 15.0 111.218 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.794 ' HD3' HG21 ' A' ' 28' ' ' VAL . 20.9 mmt180 -49.88 -42.67 48.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.42 1.088 . . . . 15.0 111.917 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -49.32 -57.58 6.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.882 1.273 . . . . 15.0 112.317 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.72 -33.39 53.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.638 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' A' ' 28' ' ' VAL . 66.6 t -68.07 -28.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.2 mt -56.49 -41.95 77.5 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.56 0.344 . . . . 15.0 110.75 173.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.18 -46.74 93.87 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.793 0.683 . . . . 15.0 112.72 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.55 -38.94 89.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.306 1.042 . . . . 15.0 111.583 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 19' ' ' ILE . 57.3 mt -65.46 -41.58 93.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.93 0.892 . . . . 15.0 110.651 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 64.5 mtm -64.0 -38.38 90.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.083 0.553 . . . . 15.0 110.682 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -64.76 -52.7 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.408 -0.815 . . . . 15.0 110.976 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 mtm105 -74.91 -30.69 61.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.639 -0.71 . . . . 15.0 112.575 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.49 -32.88 54.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.605 0.362 . . . . 15.0 110.513 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.78 -51.39 27.3 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.282 0.364 . . . . 15.0 110.95 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.45 -33.34 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 123.272 0.357 . . . . 15.0 110.261 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.06 -44.84 96.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.579 0.751 . . . . 15.0 110.428 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.18 -53.03 55.71 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.698 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 pt -65.4 -22.19 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -74.94 -51.83 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 15.0 110.196 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -75.4 -25.32 57.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.695 0.398 . . . . 15.0 111.881 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -89.45 -21.57 22.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.29 0.636 . . . . 15.0 110.544 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 62.96 19.74 11.8 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.707 1.203 . . . . 15.0 112.01 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -104.49 85.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.74 141.66 41.64 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.015 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.78 128.35 18.76 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.682 2.255 . . . . 15.0 112.211 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.63 72.83 4.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.414 0.686 . . . . 15.0 109.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.6 -98.67 0.69 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.534 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.46 138.18 31.86 Favored Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 123.289 0.636 . . . . 15.0 112.248 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -95.09 132.03 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.784 2.989 . . . . 15.0 113.27 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -96.38 105.73 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.405 ' HD2' ' HE2' ' A' ' 105' ' ' TYR . 68.1 m-85 -83.45 118.19 23.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.49 90.8 4.32 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.017 0.927 . . . . 15.0 108.594 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.5 119.8 5.65 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.77 2.314 . . . . 15.0 112.44 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.38 -80.21 0.31 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.636 -0.585 . . . . 15.0 111.636 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.42 170.43 8.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.695 0.798 . . . . 15.0 110.332 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -136.35 136.12 39.41 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.273 1.029 . . . . 15.0 109.255 174.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -115.5 137.17 52.34 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.437 -1.32 . . . . 15.0 107.437 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.5 tp -57.22 113.63 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.759 0.824 . . . . 15.0 111.132 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.38 18.53 60.34 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.788 0.68 . . . . 15.0 113.184 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 102' ' ' ASP . 28.1 tt0 -126.58 166.77 16.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.59 0.756 . . . . 15.0 109.382 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 2.9 m-20 -73.02 133.04 44.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.212 1.005 . . . . 15.0 110.703 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.492 ' H ' HD11 ' A' ' 24' ' ' ILE . 39.5 t80 -83.52 143.6 30.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.431 0.693 . . . . 15.0 109.398 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.5 m -140.45 135.76 32.32 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.132 0.573 . . . . 15.0 109.645 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.405 ' HE2' ' HD2' ' A' ' 92' ' ' TYR . 8.2 p90 -157.04 156.57 33.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.013 0.925 . . . . 15.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.1 m -111.37 108.93 18.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.473 1.109 . . . . 15.0 111.192 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.28 97.88 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.41 99.84 12.72 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.648 0.779 . . . . 15.0 109.46 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.55 149.19 45.56 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 15.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.92 140.58 30.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.711 0.804 . . . . 15.0 109.302 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 11' ' ' LEU . 15.5 m -109.72 179.42 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.236 0.614 . . . . 15.0 110.728 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.84 113.28 31.29 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.86 0.864 . . . . 15.0 110.034 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.673 ' HB2' HD11 ' A' ' 300' ' ' ILE . 84.2 Cg_endo -82.68 115.62 2.48 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.345 2.03 . . . . 15.0 112.887 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -71.32 89.1 0.88 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.216 1.006 . . . . 15.0 109.064 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.2 131.0 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.219 -168.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -80.12 109.75 14.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.869 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.19 147.9 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.996 0.81 . . . . 15.0 110.465 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.54 158.69 21.07 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.965 0.906 . . . . 15.0 109.739 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 68.28 22.6 74.67 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.629 -0.714 . . . . 15.0 113.843 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.3 mt -68.06 -45.49 73.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.58 1.152 . . . . 15.0 110.673 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.07 -27.87 63.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.647 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.09 -17.55 60.93 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.879 0.472 . . . . 15.0 111.803 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 119' ' ' GLY . 57.4 mt -64.78 120.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.638 0.375 . . . . 15.0 110.332 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.22 109.18 21.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.604 -0.887 . . . . 15.0 108.604 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.0 t -110.7 150.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -87.31 109.44 25.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.205 1.002 . . . . 15.0 109.729 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 68.6 Cg_endo -92.44 104.62 0.2 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.492 2.128 . . . . 15.0 112.282 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 127' ' ' LYS . 50.2 mm -70.44 89.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 422' ' ' THR . 41.4 t -108.81 135.28 48.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.677 -1.147 . . . . 15.0 109.467 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -122.9 154.54 38.2 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.409 -1.33 . . . . 15.0 107.409 160.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.468 HG23 HD22 ' A' ' 278' ' ' LEU . 34.9 t -81.42 84.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 107.591 -1.263 . . . . 15.0 107.591 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.6 p -63.25 176.39 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.139 0.976 . . . . 15.0 110.744 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.18 -40.21 76.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.065 0.459 . . . . 15.0 111.086 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.98 98.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.178 -0.919 . . . . 15.0 110.975 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -74.0 -39.83 63.35 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.009 0.524 . . . . 15.0 111.721 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 t -60.29 -62.54 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.103 0 C-N-CA 124.546 1.138 . . . . 15.0 108.734 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.99 -27.28 43.35 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 114.13 -1.396 . . . . 15.0 110.693 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.96 -36.13 47.83 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.749 0.656 . . . . 15.0 113.414 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -71.74 -47.42 53.88 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.008 -0.367 . . . . 15.0 110.008 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.605 HD21 HG11 ' A' ' 270' ' ' VAL . 57.1 mt -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.944 0.498 . . . . 15.0 111.915 167.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.38 -45.32 93.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.152 0.981 . . . . 15.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -63.5 -40.17 96.36 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.029 0.83 . . . . 15.0 110.917 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.23 -42.84 99.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.39 0.676 . . . . 15.0 110.938 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.661 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.2 mtp180 -68.62 -29.31 67.79 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.453 -0.794 . . . . 15.0 110.607 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.1 mttt -80.94 -15.61 55.78 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.103 0.561 . . . . 15.0 111.937 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -83.34 -31.12 26.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.69 0.396 . . . . 15.0 110.219 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -104.35 34.58 3.03 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.723 0.809 . . . . 15.0 110.616 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -78.1 156.34 30.02 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.734 1.383 . . . . 15.0 114.734 -166.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.8 m -92.39 128.69 38.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.292 -1.322 . . . . 15.0 108.784 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -84.71 108.32 17.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -123.75 126.49 46.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.277 1.031 . . . . 15.0 110.047 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 74.4 mt-10 -75.72 117.67 17.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.455 -0.572 . . . . 15.0 109.455 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.684 ' HG3' HG12 ' A' ' 240' ' ' VAL . 36.8 pttt -104.61 178.86 4.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.494 0.718 . . . . 15.0 110.735 173.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.65 141.74 43.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.685 0.794 . . . . 15.0 109.335 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.17 -51.06 0.8 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.483 -0.621 . . . . 15.0 113.845 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 146.91 24.1 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.82 0.81 . . . . 15.0 112.479 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 43.0 t -105.29 155.49 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.668 1.187 . . . . 15.0 108.408 168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 160' ' ' ALA . 16.8 tt0 -148.5 -175.15 4.81 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.855 0.862 . . . . 15.0 109.043 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.5 ' H ' ' HG2' ' A' ' 159' ' ' GLU . . . -73.19 -25.54 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.809 1.411 . . . . 15.0 114.809 -164.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -111.22 26.01 11.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.206 0.602 . . . . 15.0 110.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.5 -165.52 1.24 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.664 0.745 . . . . 15.0 112.753 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' A' ' 188' ' ' ALA . 0.3 OUTLIER -139.23 135.18 33.65 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.796 -1.927 . . . . 15.0 105.796 -176.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.28 156.23 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.6 m -129.14 126.51 39.45 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.593 -1.262 . . . . 15.0 107.593 161.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.654 HG22 HD23 ' A' ' 237' ' ' LEU . 28.3 pt -125.05 176.33 6.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.342 1.057 . . . . 15.0 110.791 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.68 122.65 12.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.373 -1.714 . . . . 15.0 106.373 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' B' ' 385' ' ' LEU . 29.3 p90 -140.6 160.81 39.21 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.68 0.752 . . . . 15.0 112.667 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.6 t -141.28 115.73 9.5 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.853 -1.521 . . . . 15.0 108.435 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -89.17 161.93 30.61 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.015 -0.539 . . . . 15.0 113.425 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 m -151.28 127.97 10.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.066 0.947 . . . . 15.0 108.593 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 231' ' ' ALA . 58.0 t -107.81 134.31 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.618 0.767 . . . . 15.0 109.207 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 t70 70.53 3.81 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.202 1.001 . . . . 15.0 112.569 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.27 -3.0 16.27 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.522 -0.599 . . . . 15.0 114.002 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.13 166.59 24.95 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.43 0.692 . . . . 15.0 109.665 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -62.33 175.26 0.77 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 121.704 0.764 . . . . 15.0 111.477 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.632 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 1.7 p90 -149.82 170.35 18.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.103 0.961 . . . . 15.0 109.142 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' B' ' 388' ' ' VAL . 1.9 pm0 -59.72 116.62 4.19 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.929 0.768 . . . . 15.0 109.42 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.89 80.59 0.68 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.354 -1.498 . . . . 15.0 109.354 -163.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -102.81 -15.75 23.59 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.166 -0.797 . . . . 15.0 113.492 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -140.65 146.81 38.39 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 117.925 0.862 . . . . 15.0 112.335 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.15 93.35 2.43 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.448 -1.316 . . . . 15.0 107.448 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.8 m -81.98 138.85 34.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.825 -1.079 . . . . 15.0 110.944 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 62.64 22.55 13.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.07 0.948 . . . . 15.0 113.061 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD2' HD11 ' B' ' 385' ' ' LEU . 83.6 t80 -66.22 138.99 58.07 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.588 0.232 . . . . 15.0 110.863 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.35 109.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.952 0.901 . . . . 15.0 109.754 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 202' ' ' ILE . 26.4 tp -93.58 90.33 6.61 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.404 0.682 . . . . 15.0 111.347 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.428 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -83.57 92.87 7.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.406 ' HG2' ' HG ' ' A' ' 187' ' ' LEU . 17.7 mtp -54.57 128.62 33.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.591 0.756 . . . . 15.0 112.311 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.63 -26.94 5.33 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 -165.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.73 129.13 37.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.487 0.715 . . . . 15.0 109.744 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.2 72.47 0.23 Allowed Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.483 0.489 . . . . 15.0 112.571 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -125.99 22.22 7.38 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.266 0.627 . . . . 15.0 111.279 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.561 ' HB3' HD23 ' B' ' 385' ' ' LEU . 1.6 pmm? -140.77 171.35 14.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.467 0.707 . . . . 15.0 109.973 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.3 pt -100.69 157.28 34.01 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.784 0.834 . . . . 15.0 110.239 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.33 147.1 86.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.676 2.25 . . . . 15.0 112.229 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.78 -46.87 1.45 Allowed Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.4 -0.68 . . . . 15.0 111.4 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -63.63 -51.82 63.52 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.18 -41.97 80.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.618 -1.173 . . . . 15.0 111.662 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.32 -33.08 75.12 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.307 1.043 . . . . 15.0 110.873 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -78.35 -13.73 82.95 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.268 -0.878 . . . . 15.0 113.286 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.461 HG21 HD23 ' A' ' 187' ' ' LEU . 34.3 mm -90.39 -51.59 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.282 -0.636 . . . . 15.0 109.282 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -84.52 21.48 1.47 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.774 -166.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.44 32.34 2.07 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.24 -0.744 . . . . 15.0 111.24 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -147.12 -174.24 4.45 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.2 1.0 . . . . 15.0 110.329 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 21.5 pttp -146.69 159.85 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.726 0.81 . . . . 15.0 110.349 -174.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -67.54 152.51 45.53 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.452 0.569 . . . . 15.0 112.287 -171.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.65 -41.29 2.17 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.56 -0.745 . . . . 15.0 111.766 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.2 pt-20 -76.61 114.18 15.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.797 0.808 . . . . 15.0 108.937 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.96 104.2 16.21 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.004 -1.48 . . . . 15.0 107.004 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.02 -169.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.42 1.088 . . . . 15.0 109.295 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.6 t -133.28 141.46 48.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.23 -1.026 . . . . 15.0 108.23 168.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 47.0 pt -104.71 139.36 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -102.0 104.01 14.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.707 -0.849 . . . . 15.0 108.707 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.1 t -97.56 158.36 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.547 -1.279 . . . . 15.0 107.547 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -131.81 129.38 40.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.078 -1.082 . . . . 15.0 108.078 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -78.55 124.46 85.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.564 0.745 . . . . 15.0 110.008 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -51.04 165.99 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.928 3.086 . . . . 15.0 115.403 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -27.76 62.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.61 -0.723 . . . . 15.0 109.724 168.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.86 -17.14 59.16 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.952 1.301 . . . . 15.0 111.451 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.475 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 64.9 t80 -63.04 133.58 54.77 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.914 0.886 . . . . 15.0 110.327 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -76.97 -42.6 38.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.346 1.239 . . . . 15.0 114.346 -166.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.475 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -70.72 100.21 1.84 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.33 -23.41 60.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.676 0.79 . . . . 15.0 112.835 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.48 -24.89 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.654 0.382 . . . . 15.0 110.906 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.57 HD11 ' H ' ' B' ' 388' ' ' VAL . 40.7 mt -93.7 -33.68 13.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.945 0.898 . . . . 15.0 111.643 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.33 116.41 1.87 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.59 1.156 . . . . 15.0 111.542 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.56 -34.83 4.87 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.45 171.51 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.668 0.787 . . . . 15.0 111.936 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -123.94 138.67 54.44 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.9 -1.045 . . . . 15.0 109.833 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -117.44 131.55 56.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.218 0.607 . . . . 15.0 110.127 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 65.7 mttm -98.12 116.22 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.744 -1.206 . . . . 15.0 107.744 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 99.3 m-85 -108.81 114.24 27.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -75.92 89.66 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 15.0 110.231 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 mm -82.01 115.85 25.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.425 0.69 . . . . 15.0 109.669 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -103.73 101.17 11.0 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.526 -1.287 . . . . 15.0 107.526 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 166' ' ' ILE . 88.2 mt -76.9 93.21 3.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -85.34 -31.81 22.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.301 -0.863 . . . . 15.0 110.531 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -132.66 123.43 26.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.174 0.59 . . . . 15.0 110.907 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 207' ' ' ALA . 88.9 t -101.29 105.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.675 -1.972 . . . . 15.0 105.675 160.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 31.9 mt-10 -113.23 -174.94 2.56 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.5 tt0 -155.88 126.67 6.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -73.8 83.12 1.64 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 163.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.49 148.16 39.22 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 113.494 -1.685 . . . . 15.0 110.813 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.93 121.57 59.44 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.544 0.738 . . . . 15.0 110.42 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 91.0 Cg_endo -75.54 -167.95 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.538 2.826 . . . . 15.0 111.965 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 249' ' ' THR . 39.9 tt0 -55.78 147.15 19.53 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.323 0.649 . . . . 15.0 111.22 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.4 tp -147.33 25.94 1.08 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.699 1.2 . . . . 15.0 108.047 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.451 ' H ' ' HG2' ' A' ' 247' ' ' GLU . 6.3 m -73.76 164.83 26.12 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.682 -1.145 . . . . 15.0 109.192 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -36.83 -51.88 0.91 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.801 1.64 . . . . 15.0 114.492 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -67.62 -30.13 69.63 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -80.23 -55.61 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.895 0.478 . . . . 15.0 109.976 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.721 HG13 HD22 ' A' ' 266' ' ' LEU . 12.9 tt -63.87 -28.94 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.829 0.852 . . . . 15.0 112.494 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -66.1 -27.52 68.12 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 112.005 0.372 . . . . 15.0 112.005 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.59 -19.64 65.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.59 0.756 . . . . 15.0 111.976 -172.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -68.66 -23.98 64.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.831 0.453 . . . . 15.0 111.835 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.94 -22.48 1.44 Allowed Glycine 0 C--N 1.351 1.415 0 O-C-N 122.944 0.152 . . . . 15.0 112.771 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 261' ' ' GLY . 21.5 t -68.14 133.15 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 15.0 110.071 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.64 -60.98 2.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.78 0.432 . . . . 15.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.75 -36.1 32.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.072 0.549 . . . . 15.0 111.074 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 98.88 36.09 4.62 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.476 -0.784 . . . . 15.0 112.755 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 p -78.44 139.45 38.72 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.645 0.723 . . . . 15.0 110.362 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 62.3 t -57.16 -58.77 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.189 0.996 . . . . 15.0 110.789 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.33 -15.4 47.85 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.729 0.812 . . . . 15.0 112.108 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.14 -32.84 37.97 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 253' ' ' ILE . 56.3 tp -75.84 -38.51 57.97 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.787 -0.449 . . . . 15.0 109.787 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 39.2 mtp-105 -62.9 -39.58 94.94 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.539 0.524 . . . . 15.0 109.639 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.93 73.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 110.992 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.37 -50.35 73.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.022 0.929 . . . . 15.0 111.196 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.605 HG11 HD21 ' A' ' 141' ' ' LEU . 21.6 m -75.97 -25.13 16.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.235 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -57.79 -60.89 3.01 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.106 -0.701 . . . . 15.0 109.106 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -64.61 -37.56 88.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.916 0.71 . . . . 15.0 112.916 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.92 -51.81 23.79 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 117.966 0.348 . . . . 15.0 111.274 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.21 -30.13 70.99 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 118.582 -0.723 . . . . 15.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.62 -30.06 59.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.443 0.534 . . . . 15.0 112.443 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -64.4 -44.2 92.02 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.272 -0.64 . . . . 15.0 109.272 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.92 -38.17 79.37 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.593 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.496 HD12 HD23 ' A' ' 427' ' ' LEU . 22.5 tp -60.65 -47.04 88.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.647 1.179 . . . . 15.0 111.638 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -59.85 -40.22 87.8 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.798 0.687 . . . . 15.0 111.053 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.1 t -68.11 -33.9 75.37 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.867 0.729 . . . . 15.0 110.401 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -80.36 -32.0 37.82 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 88.2 mt -68.31 -43.08 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -64.04 -40.12 95.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.108 -0.951 . . . . 15.0 109.691 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.78 -46.78 88.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.525 0.73 . . . . 15.0 110.047 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.493 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 8.5 tpt180 -57.05 -63.27 1.27 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.681 1.192 . . . . 15.0 111.128 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.5 -47.47 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.359 1.064 . . . . 15.0 111.5 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 408' ' ' VAL . 86.4 tttt -71.5 -36.76 71.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.745 -0.662 . . . . 15.0 111.437 -175.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -68.55 -37.99 80.4 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 119.357 -0.354 . . . . 15.0 110.39 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -69.85 -35.97 75.16 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.56 0.537 . . . . 15.0 111.673 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.476 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.2 -52.9 60.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.114 0.483 . . . . 15.0 110.712 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.37 -35.02 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.345 1.458 . . . . 15.0 111.248 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.546 ' HA ' HH21 ' A' ' 343' ' ' ARG . 14.0 tp10 -64.04 -53.85 43.43 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -60.12 -39.43 95.83 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 124.598 1.186 . . . . 15.0 112.579 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 -63.5 1.17 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.321 1.048 . . . . 15.0 111.66 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.594 HG11 ' HG2' ' A' ' 343' ' ' ARG . 91.7 t -63.14 -44.07 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 122.481 0.312 . . . . 15.0 110.232 -176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -55.57 -37.33 67.89 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.287 1.035 . . . . 15.0 111.213 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.49 -28.46 37.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.872 0.869 . . . . 15.0 112.344 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -123.18 113.61 19.18 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.802 0.441 . . . . 15.0 111.278 -167.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.59 148.11 26.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.102 -1.073 . . . . 15.0 108.102 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 113' ' ' PRO . 7.4 tt -163.91 153.77 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.622 0.769 . . . . 15.0 109.814 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.45 112.45 7.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.494 -1.299 . . . . 15.0 107.494 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 300' ' ' ILE . 21.8 t -103.97 132.27 21.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.71 0.804 . . . . 15.0 109.46 -172.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.48 ' HG3' HD23 ' A' ' 11' ' ' LEU . 23.6 Cg_exo -62.94 110.59 1.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.699 2.266 . . . . 15.0 112.117 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -54.74 -21.48 11.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.861 1.665 . . . . 15.0 113.104 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.25 29.34 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.232 1.013 . . . . 15.0 111.196 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.698 HD13 ' HA ' ' B' ' 467' ' ' ALA . 75.9 mt -63.01 -38.73 92.35 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.59 0.71 . . . . 15.0 110.011 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 304' ' ' ALA . 77.4 mt -58.62 -48.13 86.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 CA-C-N 114.239 -1.346 . . . . 15.0 109.712 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HA ' HD12 ' A' ' 311' ' ' ILE . 22.9 t70 -63.1 -29.92 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.062 0.851 . . . . 15.0 111.309 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -69.61 -44.79 70.0 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.562 0.345 . . . . 15.0 111.545 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.3 -28.75 66.55 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.481 0.658 . . . . 15.0 111.571 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 334' ' ' ARG . 78.0 mt -64.66 -42.04 93.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 N-CA-C 108.195 -1.039 . . . . 15.0 108.195 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.89 -41.14 90.98 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.37 1.044 . . . . 15.0 110.481 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.28 -50.62 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 123.802 0.689 . . . . 15.0 109.909 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.62 -17.92 62.88 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.127 0.788 . . . . 15.0 113.127 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 123.577 0.751 . . . . 15.0 109.234 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.9 tp . . . . . 0 CA--C 1.561 1.373 0 N-CA-C 112.263 0.468 . . . . 15.0 112.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.17 -22.38 39.0 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.1 0.96 . . . . 15.0 112.174 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.5 mt -52.9 119.6 16.68 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-O 118.091 -0.957 . . . . 15.0 110.317 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.71 107.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 124.588 3.525 . . . . 15.0 113.55 -169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 311' ' ' ILE . 9.0 ptm180 -61.21 -31.32 71.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.782 -1.099 . . . . 15.0 112.572 -170.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.65 -18.11 64.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.222 1.009 . . . . 15.0 112.822 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.49 -37.86 88.04 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.689 0.757 . . . . 15.0 109.73 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.55 ' HB2' HG23 ' A' ' 311' ' ' ILE . 33.2 m-85 -103.38 -20.51 14.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.388 -1.278 . . . . 15.0 111.097 -168.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -54.83 -36.5 65.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.304 1.041 . . . . 15.0 112.976 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.06 -48.06 83.45 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.661 0.384 . . . . 15.0 111.713 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.04 -38.59 44.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.941 0.496 . . . . 15.0 111.358 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.33 -55.17 26.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.393 0.677 . . . . 15.0 110.937 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.543 ' HA ' HG12 ' A' ' 307' ' ' ILE . 86.3 tttt -48.74 -44.34 38.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.692 1.197 . . . . 15.0 111.146 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.594 ' HG2' HG11 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -60.32 -39.26 86.38 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.603 1.19 . . . . 15.0 110.207 178.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -73.18 -28.11 62.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.817 0.281 . . . . 15.0 111.463 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 20.4 t -71.7 -38.24 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.495 -0.558 . . . . 15.0 109.495 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.3 t -59.39 -44.98 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 343' ' ' ARG . 61.1 t -54.22 -46.7 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.82 0.848 . . . . 15.0 110.818 172.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.42 -30.51 75.28 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.433 0.458 . . . . 15.0 113.789 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 300' ' ' ILE . 95.7 mt -74.6 -49.35 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.453 0.701 . . . . 15.0 109.955 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.6 mt -64.06 -54.77 28.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.939 0.896 . . . . 15.0 110.548 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.6 -34.94 78.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.035 0.834 . . . . 15.0 111.098 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.88 -38.61 96.84 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 123.49 0.493 . . . . 15.0 112.611 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.17 -35.12 73.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.371 0.669 . . . . 15.0 110.862 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 350' ' ' LEU . 96.4 t -66.6 -37.33 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.927 0.491 . . . . 15.0 110.218 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 352' ' ' GLY . 76.7 mt -64.26 -42.16 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.352 0.661 . . . . 15.0 110.074 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -60.65 -62.57 1.76 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.827 -0.624 . . . . 15.0 110.096 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.1 m -66.26 -33.8 76.57 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.149 0.98 . . . . 15.0 112.482 -173.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -94.35 11.01 31.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.924 0.49 . . . . 15.0 111.322 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.82 38.58 4.48 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 125.766 1.627 . . . . 15.0 113.888 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.68 147.89 43.25 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.632 0.773 . . . . 15.0 111.85 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 148.51 39.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.229 1.012 . . . . 15.0 108.615 172.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.17 137.39 57.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -172.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 122.07 37.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.042 0.937 . . . . 15.0 109.77 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.65 -46.82 83.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.263 1.025 . . . . 15.0 111.829 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.69 -21.06 61.12 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.082 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 21.1 ttt85 -72.62 -46.66 53.01 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.553 -0.906 . . . . 15.0 108.553 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 399' ' ' ARG . 31.7 t -55.41 -47.52 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 124.55 1.156 . . . . 15.0 109.591 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -51.89 -54.99 22.94 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.237 0.961 . . . . 15.0 111.718 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.73 92.77 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.98 0.8 . . . . 15.0 113.428 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 94.8 mt -60.93 -51.45 69.21 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.515 0.726 . . . . 15.0 110.34 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 367' ' ' VAL . 38.6 mm -54.94 -56.38 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.434 0.694 . . . . 15.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.69 -49.21 78.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.927 -1.488 . . . . 15.0 111.967 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.74 -39.57 64.17 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.615 0.598 . . . . 15.0 112.615 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 56.7 ttp -56.06 -47.49 77.82 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.296 0.639 . . . . 15.0 109.597 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -73.31 -36.42 66.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.8 -1.091 . . . . 15.0 112.183 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 33.5 t -70.55 -12.04 61.32 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.394 0.677 . . . . 15.0 111.811 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.16 -7.95 56.69 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.204 0.601 . . . . 15.0 111.422 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.35 179.53 4.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.225 1.01 . . . . 15.0 110.403 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.01 0.924 . . . . 15.0 110.512 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -114.9 109.89 46.82 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.833 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.709 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 89.3 Cg_endo -80.56 -29.66 2.24 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 121.995 1.796 . . . . 15.0 112.648 168.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.07 -48.54 75.87 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.933 0.893 . . . . 15.0 112.383 -161.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.78 -37.74 85.44 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.992 0.808 . . . . 15.0 110.402 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.46 -46.66 69.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 123.744 0.653 . . . . 15.0 110.087 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -49.3 82.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.06 -12.18 60.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.253 0.621 . . . . 15.0 112.431 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -88.2 -39.66 14.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.212 0.605 . . . . 15.0 111.382 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -86.5 -48.3 8.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.744 0.417 . . . . 15.0 112.083 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.6 p -49.73 -48.04 50.29 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.535 1.134 . . . . 15.0 113.731 -165.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -109.58 14.95 23.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.335 0.654 . . . . 15.0 111.52 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -110.69 88.97 2.9 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.272 -1.381 . . . . 15.0 107.272 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt -66.47 -23.18 66.23 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.413 -0.812 . . . . 15.0 111.691 -170.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.73 -56.88 12.28 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.697 0.799 . . . . 15.0 110.047 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.68 -24.39 58.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.036 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 46.1 tpp -59.52 -46.06 89.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.457 -0.572 . . . . 15.0 109.457 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -54.39 -49.83 68.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.893 0.877 . . . . 15.0 111.462 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.18 -33.83 74.08 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 124.023 0.827 . . . . 15.0 110.976 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.597 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -84.69 -11.97 54.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.392 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 367' ' ' VAL . 50.0 mtp180 -85.87 -24.89 26.51 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -71.16 -40.27 71.42 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.235 0.614 . . . . 15.0 110.066 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.3 p -71.57 -28.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 117.748 0.249 . . . . 15.0 111.254 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -68.57 -37.5 79.93 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.419 0.628 . . . . 15.0 110.553 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.74 -31.38 57.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.284 -0.871 . . . . 15.0 110.493 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 408' ' ' VAL . 29.2 tt0 -59.89 -46.3 89.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.383 1.073 . . . . 15.0 109.596 169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 9.1 mm-40 -53.49 -55.09 28.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.524 1.129 . . . . 15.0 111.487 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -58.76 -37.48 76.33 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.483 -0.78 . . . . 15.0 111.953 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.09 -41.68 97.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 15.0 111.278 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.9 t -58.16 -48.39 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 123.757 0.661 . . . . 15.0 109.534 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 57.1 mt-10 -61.87 -36.86 82.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.896 0.748 . . . . 15.0 111.99 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.11 64.73 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.704 -0.68 . . . . 15.0 111.705 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 54.7 t -88.05 -29.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 290' ' ' ALA . 97.0 mt -72.04 -27.36 62.65 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.417 0.687 . . . . 15.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.97 70.17 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 15.0 110.873 170.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -95.91 -28.3 14.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.373 1.069 . . . . 15.0 111.368 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.85 154.95 21.18 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.955 0.902 . . . . 15.0 110.924 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.88 84.18 5.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.786 0.834 . . . . 15.0 109.645 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.0 t -95.57 89.3 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.262 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -72.51 112.01 8.19 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.216 0.606 . . . . 15.0 110.295 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.24 132.55 36.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.261 0.625 . . . . 15.0 110.153 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -140.83 141.55 34.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.36 0.664 . . . . 15.0 110.212 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.92 125.13 36.51 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 130' ' ' VAL . 9.8 t -157.31 173.72 16.52 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.947 0.499 . . . . 15.0 111.345 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 64.9 p -96.47 174.62 6.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.656 0.783 . . . . 15.0 112.145 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.99 -25.23 57.99 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.47 1.908 . . . . 15.0 111.702 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 429' ' ' ASN . 33.6 m-80 -65.53 -34.24 77.79 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.865 1.266 . . . . 15.0 112.21 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.403 ' HG2' HG21 ' A' ' 422' ' ' THR . 13.0 tp10 -66.68 -37.4 84.69 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.321 0.581 . . . . 15.0 111.739 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.496 HD23 HD12 ' A' ' 278' ' ' LEU . 15.6 tp -85.24 -77.5 0.28 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.377 -0.829 . . . . 15.0 111.124 -165.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.01 -30.51 9.26 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.214 -0.304 . . . . 15.0 111.425 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 425' ' ' ASN . 65.1 t30 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 122.308 1.051 . . . . 15.0 110.5 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 385' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.5 mm? . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 13.5 m -64.37 98.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 125.168 1.542 . . . . 0.0 112.311 -164.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.632 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 5.8 pt -125.08 160.64 30.29 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.035 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.57 ' H ' HD11 ' A' ' 226' ' ' LEU . 54.5 t . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 122.755 0.422 . . . . 0.0 110.414 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 0.0 110.489 177.591 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -67.27 -33.56 75.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.23 109.12 4.75 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 61.2 p -77.43 164.66 25.26 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.667 0.787 . . . . 0.0 111.066 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 35.4 mtm -125.15 -178.16 4.11 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.558 0.694 . . . . 0.0 111.696 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -91.46 -175.25 4.16 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.019 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 65.68 -72.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.877 1.271 . . . . 0.0 109.217 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 467' ' ' ALA . . . . . 0.698 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.522 0.201 . . . . 15.0 110.689 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.1 tt0 -142.71 118.41 10.46 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.909 -0.775 . . . . 15.0 108.909 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 17' ' ' ILE . 26.7 m -106.25 131.96 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.82 -0.437 . . . . 15.0 109.82 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -142.55 94.65 2.67 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.611 0.765 . . . . 15.0 109.217 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -77.2 95.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.184 0.992 . . . . 15.0 110.696 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 48.5 mt-10 -76.21 100.11 4.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.709 -1.132 . . . . 15.0 109.468 173.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -78.43 85.91 4.51 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 107.967 -1.123 . . . . 15.0 107.967 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -61.94 -44.43 96.79 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.685 -1.143 . . . . 15.0 110.749 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -169.36 97.41 0.33 Allowed 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.632 0.582 . . . . 15.0 109.925 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -98.44 0.35 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.747 0.654 . . . . 15.0 113.645 172.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.634 HD21 ' HG3' ' A' ' 113' ' ' PRO . 8.1 mp -69.83 -25.13 63.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.653 0.781 . . . . 15.0 111.311 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.63 79.53 0.69 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.573 0.546 . . . . 15.0 112.832 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HD2' HG11 ' A' ' 111' ' ' VAL . 92.8 mtt180 -99.81 89.99 4.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.6 ttm180 -75.89 95.77 3.59 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.004 -0.998 . . . . 15.0 109.677 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.57 87.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.9 m -82.62 109.74 17.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.813 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 3' ' ' VAL . 53.6 mt -110.58 116.56 52.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.912 -0.586 . . . . 15.0 109.729 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 67.6 m -87.39 105.25 17.14 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.866 -0.79 . . . . 15.0 108.866 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' LEU . 62.4 mt -74.37 126.2 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 147.77 51.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.911 0.485 . . . . 15.0 111.26 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.67 94.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 15.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.71 -30.21 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.116 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -69.13 -38.5 78.89 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.841 0.456 . . . . 15.0 110.369 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.23 -42.41 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -61.55 -42.82 99.4 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.914 0.886 . . . . 15.0 111.101 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -75.48 -35.39 60.84 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.71 62.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.891 0.477 . . . . 15.0 111.889 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.77 HG21 ' HD3' ' A' ' 63' ' ' ARG . 86.8 t -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.625 0.77 . . . . 15.0 109.916 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.0 -42.62 94.32 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.384 0.674 . . . . 15.0 111.304 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 65.7 m -69.34 -18.58 63.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.865 0.866 . . . . 15.0 110.638 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.9 tp10 -86.83 -33.05 19.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.071 0.548 . . . . 15.0 110.689 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.5 mt -74.68 -27.34 60.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.335 0.494 . . . . 15.0 112.335 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.51 -29.63 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -68.85 -48.98 62.11 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.0 t -60.74 -35.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.343 1.057 . . . . 15.0 111.294 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.49 -49.0 73.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.092 0.557 . . . . 15.0 110.609 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.57 -29.13 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.34 0.656 . . . . 15.0 112.171 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -80.35 -32.44 37.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.534 1.134 . . . . 15.0 111.15 -171.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.9 t -96.33 1.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.515 0.726 . . . . 15.0 109.621 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 70.06 12.61 7.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.609 1.564 . . . . 15.0 112.635 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 39' ' ' VAL . 69.8 mt -61.59 -24.11 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.154 0.982 . . . . 15.0 110.917 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 11.7 p-10 -65.39 -34.02 77.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.998 0.919 . . . . 15.0 111.614 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.03 -23.9 77.64 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.678 0.611 . . . . 15.0 112.207 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -93.82 -21.7 19.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.722 0.809 . . . . 15.0 110.68 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 48.1 ttt85 -75.89 130.67 38.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.36 1.064 . . . . 15.0 109.084 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.0 16.78 21.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.521 0.728 . . . . 15.0 111.53 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 45' ' ' ARG . . . 73.02 27.0 69.52 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 115.433 -0.803 . . . . 15.0 113.83 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -100.35 -38.89 8.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.355 0.662 . . . . 15.0 111.315 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.26 118.61 67.5 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-O 118.894 -0.574 . . . . 15.0 109.944 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.7 Cg_exo -64.24 147.78 91.12 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.068 2.512 . . . . 15.0 112.257 175.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.2 tpp -74.78 -29.37 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.361 0.664 . . . . 15.0 111.632 -172.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 29.9 p-10 -65.47 -36.72 84.72 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.833 0.453 . . . . 15.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.47 HD12 ' HD2' ' A' ' 50' ' ' PRO . 38.7 mt -61.49 -52.18 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.641 0.776 . . . . 15.0 110.519 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' HA ' ' CD1' ' A' ' 58' ' ' TYR . 28.8 m -72.38 -26.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -63.71 -53.83 45.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.216 0.606 . . . . 15.0 111.273 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.7 pt20 -83.66 -45.59 13.27 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.546 -0.752 . . . . 15.0 112.127 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -79.9 -63.04 1.5 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.489 0.316 . . . . 15.0 110.513 -171.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 3.6 m-85 -68.97 -38.8 79.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.542 0.737 . . . . 15.0 110.157 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.15 -2.04 86.56 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.576 -1.193 . . . . 15.0 113.965 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.19 -29.92 69.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.413 0.685 . . . . 15.0 111.573 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.0 p -80.13 -39.73 28.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.517 0.727 . . . . 15.0 110.65 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.07 -17.26 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 124.369 1.068 . . . . 15.0 111.711 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.77 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -48.14 -46.72 34.68 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.342 1.057 . . . . 15.0 111.467 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.64 -53.85 49.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.557 1.543 . . . . 15.0 112.26 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.84 -29.97 66.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.241 -0.89 . . . . 15.0 111.728 -171.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -74.2 -27.87 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.947 -0.57 . . . . 15.0 110.594 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.1 mt -57.77 -39.21 76.92 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.828 0.451 . . . . 15.0 111.151 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.85 -42.88 98.33 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.211 0.319 . . . . 15.0 112.794 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.15 -41.69 94.52 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.231 1.012 . . . . 15.0 111.056 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' HD13 ' A' ' 19' ' ' ILE . 86.3 mt -69.49 -40.19 77.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.694 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 75.2 mtm -67.18 -36.86 82.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.917 0.487 . . . . 15.0 111.033 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -63.38 -47.42 82.12 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.025 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.2 mtm105 -83.08 -51.11 7.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.983 -0.553 . . . . 15.0 112.204 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.81 -23.52 44.21 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 122.858 0.463 . . . . 15.0 111.655 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -72.12 -52.2 17.84 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.568 0.543 . . . . 15.0 111.229 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.469 ' HA ' HG12 ' A' ' 79' ' ' ILE . 12.2 tt -67.28 -39.34 82.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.141 0 CA-C-N 117.899 0.318 . . . . 15.0 110.956 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -59.21 -34.68 72.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.467 0.707 . . . . 15.0 111.181 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.94 -54.88 7.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.528 0.731 . . . . 15.0 111.146 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 76' ' ' ILE . 21.8 pt -68.32 -22.23 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.145 0.794 . . . . 15.0 113.145 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.38 -49.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.536 0.335 . . . . 15.0 110.454 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -72.14 -36.83 69.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.332 0.253 . . . . 15.0 111.293 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -76.72 -12.74 60.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.959 0.504 . . . . 15.0 111.542 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 61.13 29.78 19.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.766 1.226 . . . . 15.0 112.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -82.29 125.0 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.47 104.03 31.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.61 147.28 24.86 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.464 2.109 . . . . 15.0 112.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.18 178.44 10.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.74 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.81 -124.95 18.76 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.117 -0.947 . . . . 15.0 112.054 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.18 99.76 28.96 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.565 0.746 . . . . 15.0 110.188 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.5 Cg_endo -76.57 108.09 2.59 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.119 1.879 . . . . 15.0 110.528 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -102.75 100.64 10.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.634 -0.712 . . . . 15.0 109.963 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -85.95 80.87 8.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.453 0.701 . . . . 15.0 109.383 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.76 113.69 34.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.332 -0.849 . . . . 15.0 108.988 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.81 96.23 0.67 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.381 2.054 . . . . 15.0 110.459 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.542 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -51.28 -51.07 37.99 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.818 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -174.65 137.73 0.48 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.914 0.886 . . . . 15.0 110.668 172.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -106.34 135.46 47.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 38.3 mtpt -129.71 114.24 15.74 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.158 -1.423 . . . . 15.0 107.158 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.27 118.37 9.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.891 0.477 . . . . 15.0 109.716 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.25 39.08 Favored Glycine 0 N--CA 1.47 0.94 0 CA-C-N 115.985 -0.552 . . . . 15.0 112.659 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.3 mt-10 -112.34 -178.81 3.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.117 0.967 . . . . 15.0 109.652 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.28 151.22 46.51 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.706 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 19' ' ' ILE . 48.7 t80 -95.16 146.45 24.3 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.4 m -134.46 133.31 40.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.333 0.653 . . . . 15.0 109.574 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.542 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 13.7 p90 -138.34 171.15 14.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.925 0.89 . . . . 15.0 109.051 172.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.3 m -140.77 124.37 16.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.888 0.875 . . . . 15.0 109.349 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.19 104.3 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -102.04 114.93 29.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.949 0.9 . . . . 15.0 109.417 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 33.6 p90 -139.64 164.04 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.604 0.761 . . . . 15.0 110.619 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.86 113.72 20.67 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.364 -0.835 . . . . 15.0 109.705 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.595 HG11 ' HD2' ' A' ' 13' ' ' ARG . 12.1 m -89.43 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.671 -0.492 . . . . 15.0 109.671 171.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -89.33 126.37 58.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.674 . . . . 15.0 110.224 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.634 ' HG3' HD21 ' A' ' 11' ' ' LEU . 14.5 Cg_exo -69.39 145.29 58.86 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.441 2.094 . . . . 15.0 110.868 170.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.45 100.15 1.05 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.301 0.64 . . . . 15.0 109.351 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.37 123.8 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.724 0.773 . . . . 15.0 112.057 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.96 107.82 15.03 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.537 1.135 . . . . 15.0 108.705 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.95 131.5 45.19 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.645 0.591 . . . . 15.0 109.995 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -136.6 155.9 49.3 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.169 0.988 . . . . 15.0 109.586 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 60.65 20.77 56.94 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 124.442 1.089 . . . . 15.0 114.823 171.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.03 -39.46 94.81 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.368 0.667 . . . . 15.0 111.029 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.05 -20.31 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.239 0.615 . . . . 15.0 111.305 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.89 -15.92 42.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.63 0.772 . . . . 15.0 111.652 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.54 HG22 HG23 ' A' ' 125' ' ' VAL . 58.5 mt -65.11 124.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.158 0.583 . . . . 15.0 109.758 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.629 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.7 mt-10 -116.2 85.91 2.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.925 0.869 . . . . 15.0 109.948 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.8 t -83.03 164.78 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.51 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.7 141.23 49.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.744 0.817 . . . . 15.0 109.45 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -114.38 94.75 37.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.872 -1.159 . . . . 15.0 107.872 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.64 ' HG3' ' HD2' ' A' ' 285' ' ' ARG . 85.0 Cg_endo -78.16 103.49 1.7 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.984 1.789 . . . . 15.0 111.38 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -69.12 92.73 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.619 HG21 HD11 ' A' ' 427' ' ' LEU . 25.5 t -118.29 134.06 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.219 -0.901 . . . . 15.0 110.196 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.44 154.73 48.38 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 106.664 -1.606 . . . . 15.0 106.664 167.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 274' ' ' MET . 3.4 t -83.29 89.66 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.814 -1.18 . . . . 15.0 107.814 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.9 p -69.52 173.96 5.44 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.257 0.623 . . . . 15.0 109.79 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -55.26 -43.72 74.93 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.561 0.344 . . . . 15.0 111.474 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.41 -25.65 64.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.557 0.743 . . . . 15.0 111.929 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -78.81 -45.11 21.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.754 0.422 . . . . 15.0 110.675 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -56.06 -58.09 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.938 0.895 . . . . 15.0 109.129 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -61.69 -47.01 87.23 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.844 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.17 72.16 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.13 0.894 . . . . 15.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.8 ttt -69.54 -50.71 42.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.771 0.428 . . . . 15.0 111.151 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.18 -37.51 69.68 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.143 0.577 . . . . 15.0 112.067 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.413 ' HA ' ' HE ' ' A' ' 145' ' ' ARG . 17.1 t70 -67.75 -41.75 82.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.107 0.963 . . . . 15.0 109.929 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 82.7 m -58.95 -43.2 91.21 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.188 0.93 . . . . 15.0 110.574 173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' MET . 81.0 mt -61.3 -42.94 99.5 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.425 0.69 . . . . 15.0 111.076 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.42 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 69.3 mtm180 -63.57 -35.89 81.99 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.297 -0.865 . . . . 15.0 110.676 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 85.6 mttt -85.06 -5.33 59.35 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.37 0.668 . . . . 15.0 112.537 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 143' ' ' THR . 96.8 mt-30 -79.74 -44.62 20.39 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.914 -0.772 . . . . 15.0 108.914 163.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -97.59 37.94 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.367 0.667 . . . . 15.0 110.864 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -71.51 141.13 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.458 0.703 . . . . 15.0 112.092 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.1 m -82.18 127.02 32.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.379 1.072 . . . . 15.0 109.353 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -86.95 126.61 34.82 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.02 0.528 . . . . 15.0 110.269 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -148.52 122.58 9.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 15.0 110.032 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 43.5 mt-10 -75.57 143.78 42.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.01 0.524 . . . . 15.0 110.263 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.687 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 36.6 pttt -137.05 -179.3 5.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.706 0.802 . . . . 15.0 111.031 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -147.14 153.74 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.06 -51.81 0.79 Allowed Glycine 0 N--CA 1.467 0.707 0 CA-C-O 119.548 -0.584 . . . . 15.0 112.757 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -155.53 148.07 23.99 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 117.415 0.608 . . . . 15.0 111.158 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.405 HG22 HG13 ' A' ' 240' ' ' VAL . 21.9 t -98.83 153.01 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 107.902 -1.147 . . . . 15.0 107.902 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.07 -169.88 2.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.457 1.103 . . . . 15.0 109.711 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.51 96.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.397 1.079 . . . . 15.0 113.245 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.65 33.25 5.14 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.889 0.7 . . . . 15.0 112.889 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -87.84 -164.26 1.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 120.934 0.397 . . . . 15.0 111.795 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.777 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 18.7 mtm180 -122.88 160.44 26.1 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.027 -1.101 . . . . 15.0 108.027 161.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.404 HG12 HG23 ' A' ' 166' ' ' ILE . 2.8 t -144.62 116.92 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.685 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 15.2 m -95.63 116.46 28.88 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' LEU . 40.1 pt -130.13 168.77 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.752 0.821 . . . . 15.0 110.346 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -127.64 161.2 29.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.424 -1.325 . . . . 15.0 107.424 161.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.63 174.92 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.333 0.587 . . . . 15.0 111.385 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.649 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 6.6 t -158.62 131.64 7.24 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.658 -1.608 . . . . 15.0 106.658 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.48 -177.13 26.67 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.602 -0.808 . . . . 15.0 113.407 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 p -148.2 131.67 16.7 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.754 0.822 . . . . 15.0 109.306 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 226' ' ' LEU . 45.7 t -93.08 102.81 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 27.7 t70 77.7 -0.65 2.73 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 125.296 1.439 . . . . 15.0 111.047 -170.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.45 37.35 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 121.868 -0.52 . . . . 15.0 113.092 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.2 pt-20 -105.77 137.41 43.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.267 0.627 . . . . 15.0 109.353 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.18 95.16 5.54 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.659 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 172' ' ' VAL . 39.7 p90 -59.48 158.77 9.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.659 -1.155 . . . . 15.0 110.655 174.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -54.14 135.45 43.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 15.0 111.195 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' ' 386' ' ' VAL . . . 78.99 -70.49 2.75 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 123.985 0.803 . . . . 15.0 111.675 -170.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.61 -69.77 2.78 Favored Glycine 0 C--N 1.348 1.201 0 C-N-CA 123.212 0.434 . . . . 15.0 112.605 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.649 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 6.5 tmtt? -86.29 137.37 32.66 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.252 1.021 . . . . 15.0 110.185 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB2' HG12 ' B' ' 386' ' ' VAL . . . -127.89 155.52 44.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.887 0.875 . . . . 15.0 108.816 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 m -139.35 128.51 23.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 15.0 110.663 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 63.09 37.81 11.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.603 1.161 . . . . 15.0 112.255 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 44.6 t80 -71.22 136.06 47.84 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.39 -0.823 . . . . 15.0 108.915 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.5 t -107.16 119.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.008 0.923 . . . . 15.0 109.573 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 24.6 tp -112.66 93.64 4.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.986 0.914 . . . . 15.0 110.867 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.19 105.01 3.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.3 mmt -77.25 165.07 24.98 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 114.872 -1.058 . . . . 15.0 111.063 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.42 11.69 56.87 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.056 -0.974 . . . . 15.0 112.029 -170.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.14 143.84 22.73 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 125.125 1.37 . . . . 15.0 107.767 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -79.15 82.84 1.33 Allowed Glycine 0 C--N 1.344 0.978 0 O-C-N 123.148 0.28 . . . . 15.0 112.692 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.03 -19.95 26.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.966 0.506 . . . . 15.0 111.374 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.86 156.91 43.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.606 0.362 . . . . 15.0 110.69 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.04 140.85 98.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.761 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.89 105.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.217 2.612 . . . . 15.0 112.665 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.55 -49.44 0.66 Allowed Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.153 -0.931 . . . . 15.0 111.102 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' B' ' 385' ' ' LEU . 43.5 t80 -69.04 -64.65 0.83 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.488 0.315 . . . . 15.0 110.291 -176.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 203' ' ' LYS . 8.4 pt-20 -62.58 -27.6 69.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.108 0.88 . . . . 15.0 112.429 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.23 -30.58 67.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.957 0.903 . . . . 15.0 110.527 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.43 -5.66 85.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.167 -0.924 . . . . 15.0 112.98 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 33.6 mm -103.74 -47.97 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 123.429 0.692 . . . . 15.0 110.47 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 199' ' ' GLU . 22.6 pttm -85.4 16.5 3.7 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.782 1.03 . . . . 15.0 113.782 -169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -127.91 32.28 3.5 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.744 -0.942 . . . . 15.0 110.744 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -146.52 -167.83 2.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 15.0 110.473 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -151.86 161.67 42.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.598 0.759 . . . . 15.0 110.01 177.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.96 139.09 52.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.139 0.576 . . . . 15.0 111.892 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.54 8.63 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.501 -0.772 . . . . 15.0 112.429 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.8 pt-20 -92.45 137.63 32.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.496 0.719 . . . . 15.0 109.485 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.18 112.11 18.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.929 -1.137 . . . . 15.0 107.929 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -131.89 -178.31 4.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.788 1.235 . . . . 15.0 109.878 -171.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 43.3 m -131.11 120.35 23.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.775 0.83 . . . . 15.0 108.98 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.04 156.35 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.274 0.63 . . . . 15.0 110.514 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -116.18 105.28 12.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.095 0.958 . . . . 15.0 108.996 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.1 167.1 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 91.3 m -141.09 133.61 28.47 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.355 -0.98 . . . . 15.0 108.355 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.462 ' HZ ' HD12 ' B' ' 387' ' ' ILE . 49.0 m-85 -76.42 138.64 67.46 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 123.432 0.457 . . . . 15.0 111.837 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.8 158.35 11.03 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.695 2.93 . . . . 15.0 113.61 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.35 -31.01 63.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.67 -23.97 67.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.346 1.058 . . . . 15.0 111.657 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 227' ' ' LYS . 1.9 t80 -74.35 74.69 1.87 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.076 0.95 . . . . 15.0 109.052 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -67.8 4.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.049 1.5 . . . . 15.0 115.049 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.21 93.1 0.8 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.183 -1.414 . . . . 15.0 107.183 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.1 tt0 -64.08 -29.0 70.17 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.761 0.652 . . . . 15.0 112.761 -166.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -61.2 -22.57 64.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.835 0.854 . . . . 15.0 110.961 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 172' ' ' VAL . 76.4 mt -102.55 -43.37 5.65 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.72 1.208 . . . . 15.0 110.82 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 221' ' ' TYR . 0.7 OUTLIER -54.82 130.62 41.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.889 1.675 . . . . 15.0 112.759 -165.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.48 -18.91 7.69 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.832 0.708 . . . . 15.0 114.398 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 93.0 mttt -89.85 143.25 26.96 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.874 0.87 . . . . 15.0 110.562 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.0 106.88 11.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.552 0.741 . . . . 15.0 110.174 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.81 115.97 27.54 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.896 -1.047 . . . . 15.0 110.759 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -106.13 107.64 18.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.411 -0.588 . . . . 15.0 109.411 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -104.9 119.71 39.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.038 0.935 . . . . 15.0 109.121 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.51 93.74 4.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.326 0.65 . . . . 15.0 109.405 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.96 125.89 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 15.0 110.421 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -109.34 98.52 7.91 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.336 -1.357 . . . . 15.0 107.336 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.59 99.52 6.57 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 -175.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -93.43 -40.92 10.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.229 -0.442 . . . . 15.0 110.985 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 35.3 mmtp -131.89 139.36 48.75 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.051 0.54 . . . . 15.0 110.687 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 207' ' ' ALA . 86.0 t -104.03 141.93 18.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.112 -1.811 . . . . 15.0 106.112 159.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.2 mt-10 -133.1 -176.26 4.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.687 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 41.4 tt0 -154.36 130.64 10.43 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.551 0.741 . . . . 15.0 109.358 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 146' ' ' LYS . 23.4 ptt180 -86.24 86.03 7.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.19 0.995 . . . . 15.0 108.356 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.89 141.78 58.13 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.116 -1.402 . . . . 15.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.61 132.76 94.61 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.1 -0.704 . . . . 15.0 109.1 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 59.9 Cg_endo -67.83 176.52 5.12 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.468 2.112 . . . . 15.0 112.002 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.97 88.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.19 69.92 4.47 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.934 0.873 . . . . 15.0 109.006 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.9 p -101.83 163.89 12.02 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.591 1.156 . . . . 15.0 109.282 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.11 -41.27 48.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.98 0.912 . . . . 15.0 111.195 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.2 -39.46 86.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.179 1.392 . . . . 15.0 111.312 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.14 -59.9 2.59 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.897 . . . . 15.0 109.146 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 258' ' ' VAL . 9.5 tt -57.78 -42.0 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.954 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -67.71 -26.68 66.29 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.687 0.254 . . . . 15.0 111.687 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -72.79 -19.06 61.42 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.622 0.769 . . . . 15.0 110.949 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -87.63 -6.58 58.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.452 0.701 . . . . 15.0 111.322 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.5 5.1 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 119.428 -0.651 . . . . 15.0 114.721 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 261' ' ' GLY . 44.2 t -62.72 111.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 117.483 0.642 . . . . 15.0 110.902 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -58.78 -48.57 80.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.599 1.16 . . . . 15.0 112.001 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.663 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 5.3 t70 -76.69 -43.49 37.46 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.458 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 82.96 18.97 64.02 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 115.866 -0.606 . . . . 15.0 114.337 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -148.78 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.902 0.881 . . . . 15.0 109.602 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 95.7 t -50.4 -52.97 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 124.364 1.066 . . . . 15.0 113.457 -165.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -31.04 68.53 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.979 0.512 . . . . 15.0 111.549 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 260' ' ' ASP . . . -80.28 -24.08 59.84 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.145 -0.382 . . . . 15.0 112.145 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 270' ' ' VAL . 38.5 tp -77.67 -28.16 51.06 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.504 ' HA ' HG22 ' A' ' 270' ' ' VAL . 77.3 mtp180 -72.45 -37.6 68.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.956 0.902 . . . . 15.0 109.666 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.65 88.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.751 -0.659 . . . . 15.0 110.411 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.37 -48.7 55.11 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.328 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 274' ' ' MET . 19.2 m -67.4 -25.58 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-O 120.64 0.257 . . . . 15.0 110.634 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -60.01 -66.1 0.57 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.76 0.424 . . . . 15.0 110.48 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.28 -7.84 53.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.233 0.613 . . . . 15.0 112.61 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -101.22 -68.91 0.8 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.424 0.69 . . . . 15.0 109.965 170.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.564 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.6 mpt? -66.84 -43.79 82.77 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 117.698 -1.144 . . . . 15.0 111.694 -170.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.12 -49.63 71.44 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.441 1.473 . . . . 15.0 109.95 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -51.81 -49.16 63.32 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 113.509 -1.678 . . . . 15.0 111.989 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -84.35 -37.77 21.15 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.558 0.536 . . . . 15.0 111.348 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 130' ' ' VAL . 61.6 tp -67.16 -56.92 7.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.737 0.415 . . . . 15.0 111.894 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.78 -31.65 72.97 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.481 0.488 . . . . 15.0 110.194 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.9 t -64.86 -45.57 85.51 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.954 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.43 65.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 15.0 112.26 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 130' ' ' VAL . 98.6 mt -66.28 -51.43 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.802 HH21 ' HB3' ' A' ' 405' ' ' GLU . 28.8 tpt180 -62.14 -37.5 85.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.65 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.67 -23.77 45.5 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.388 0.675 . . . . 15.0 111.05 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.64 ' HD2' ' HG3' ' A' ' 128' ' ' PRO . 25.1 ttm180 -70.33 -49.31 50.71 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.577 0.626 . . . . 15.0 109.452 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 282' ' ' ILE . 98.6 t -57.56 -48.25 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.761 0.791 . . . . 15.0 110.008 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -64.21 -46.44 83.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.58 -1.191 . . . . 15.0 111.463 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -65.89 -39.21 90.44 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 119.256 -0.402 . . . . 15.0 110.935 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 125' ' ' VAL . 56.8 mt-30 -69.95 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.553 0.533 . . . . 15.0 111.172 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.21 -50.84 66.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.625 0.37 . . . . 15.0 110.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.9 mm -67.76 -41.17 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.796 0.839 . . . . 15.0 111.01 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 12.4 tp10 -64.43 -36.19 83.35 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.732 0.813 . . . . 15.0 109.474 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.54 -43.87 93.86 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.926 -1.034 . . . . 15.0 112.005 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.59 -45.49 81.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.108 0.963 . . . . 15.0 110.841 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.37 -58.67 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.051 0.94 . . . . 15.0 110.26 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.4 mttm -60.86 -23.47 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.641 0.776 . . . . 15.0 112.348 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -79.52 -33.65 41.86 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.547 0.739 . . . . 15.0 111.508 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.52 138.22 7.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 112.719 0.637 . . . . 15.0 112.719 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.08 144.48 29.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.167 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.48 HG12 HD22 ' A' ' 349' ' ' LEU . 6.5 tp -138.89 123.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . 7.6 m-20 -79.0 137.43 37.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.24 130.98 21.44 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.192 0.597 . . . . 15.0 109.449 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.88 130.03 32.74 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.029 2.486 . . . . 15.0 112.501 168.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.58 -9.67 20.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.759 1.022 . . . . 15.0 113.759 -173.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.22 91.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.244 0.618 . . . . 15.0 110.925 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.31 -38.66 68.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 15.0 111.122 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.61 -52.13 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -38.57 89.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.832 0.853 . . . . 15.0 111.453 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.9 t -59.07 -50.57 73.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 15.0 111.226 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.91 -26.33 43.78 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.381 -0.372 . . . . 15.0 111.42 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.41 HG22 ' NE ' ' A' ' 315' ' ' ARG . 62.9 mt -62.29 -35.52 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 166.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.573 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.0 t70 -70.88 -39.36 72.89 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.97 0.508 . . . . 15.0 111.01 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.08 -48.07 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 123.792 0.683 . . . . 15.0 109.27 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 341' ' ' ALA . 83.2 mt -73.68 -21.3 60.3 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.117 -0.947 . . . . 15.0 113.237 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.573 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 72.1 mtm180 . . . . . 0 N--CA 1.483 1.223 0 C-N-CA 123.055 0.542 . . . . 15.0 109.806 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.0 tp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.944 0.402 . . . . 15.0 111.358 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -113.68 21.96 14.52 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.065 0.946 . . . . 15.0 111.055 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 24.2 mt -64.65 128.79 93.88 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.603 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 87.9 Cg_exo -47.7 118.29 2.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.664 2.909 . . . . 15.0 114.328 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -56.02 -36.55 68.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.091 0.957 . . . . 15.0 111.235 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.31 -12.05 47.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.468 0.914 . . . . 15.0 113.468 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 96.9 mt -71.76 -40.15 69.52 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.368 -0.604 . . . . 15.0 109.368 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -107.01 -10.77 15.83 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.271 -168.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -48.66 -57.75 5.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.147 1.379 . . . . 15.0 113.021 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.1 -59.21 4.95 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 111.397 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.01 -36.55 69.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.617 -0.72 . . . . 15.0 112.416 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -70.7 -50.79 32.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.547 . . . . 15.0 110.04 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.8 tttt -60.11 -34.94 74.19 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.03 0.832 . . . . 15.0 110.328 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.6 mmt85 -62.89 -38.1 89.56 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.003 -0.522 . . . . 15.0 111.26 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.73 -28.8 66.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 123.286 0.366 . . . . 15.0 110.853 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' B' ' 466' ' ' ALA . 24.9 t -75.48 -36.01 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.98 -0.378 . . . . 15.0 109.98 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -65.8 -35.03 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.561 0.744 . . . . 15.0 109.863 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 351' ' ' LEU . 55.4 t -60.47 -54.64 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.809 -0.811 . . . . 15.0 108.809 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.66 97.48 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.388 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 300' ' ' ILE . 6.5 tt -78.15 -55.32 5.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.046 0.538 . . . . 15.0 110.234 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 354' ' ' VAL . 72.3 mt -67.1 -49.27 65.53 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.039 0.212 . . . . 15.0 110.694 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 347' ' ' VAL . 64.9 mt -69.2 -28.26 66.22 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 119.334 -0.365 . . . . 15.0 111.055 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.2 -42.36 99.72 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.923 -0.471 . . . . 15.0 111.923 172.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.21 -39.14 93.35 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.238 -0.481 . . . . 15.0 110.58 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -59.57 -37.04 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 122.888 0.475 . . . . 15.0 111.041 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.572 HD12 ' HA2' ' A' ' 352' ' ' GLY . 75.9 mt -65.2 -46.85 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.744 0.818 . . . . 15.0 110.543 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.95 -53.25 41.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.525 0.203 . . . . 15.0 110.908 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.0 m -60.27 -40.72 91.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.588 1.155 . . . . 15.0 112.053 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.39 17.98 18.86 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.174 0.589 . . . . 15.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 46.33 30.02 0.96 Allowed 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 125.703 1.601 . . . . 15.0 114.626 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.72 148.28 52.02 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.072 0.949 . . . . 15.0 112.811 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -129.31 158.09 40.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.522 1.129 . . . . 15.0 108.83 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.67 90.33 2.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 367' ' ' VAL . 5.2 t70 -67.73 120.93 14.88 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.11 0.964 . . . . 15.0 110.758 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.26 -23.67 67.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.826 0.85 . . . . 15.0 113.0 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.61 -34.11 73.62 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 30.9 tpt85 -77.82 -36.81 49.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.725 0.81 . . . . 15.0 109.951 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.3 t -63.99 -55.01 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.617 0.767 . . . . 15.0 109.746 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -36.18 81.59 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.813 -1.085 . . . . 15.0 109.778 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.95 96.75 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.787 0.679 . . . . 15.0 112.711 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 367' ' ' VAL . 69.3 mt -57.44 -48.15 79.9 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.636 0.774 . . . . 15.0 111.07 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.632 HG21 ' HA ' ' A' ' 385' ' ' ILE . 17.8 mm -56.35 -44.69 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 124.183 0.927 . . . . 15.0 110.81 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -61.57 -54.46 42.77 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 15.0 110.782 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -61.6 -37.7 84.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.499 0.72 . . . . 15.0 112.769 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -74.76 -45.76 41.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.423 0.689 . . . . 15.0 109.931 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -73.28 -16.83 61.38 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.184 0.594 . . . . 15.0 111.959 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -73.1 -0.18 13.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.991 0.917 . . . . 15.0 111.692 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -98.54 -10.11 23.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.583 0.753 . . . . 15.0 111.268 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.497 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 79.1 m-85 -111.31 157.56 20.03 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.108 0.963 . . . . 15.0 109.604 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.0 -45.06 71.51 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.211 0.604 . . . . 15.0 110.834 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.88 100.71 17.5 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 124.596 1.158 . . . . 15.0 110.26 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.9 -41.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.605 2.204 . . . . 15.0 115.794 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -68.92 -28.97 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -163.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.32 -28.69 67.38 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.344 0.403 . . . . 15.0 110.095 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.74 -38.81 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.556 0.742 . . . . 15.0 109.261 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.632 ' HA ' HG21 ' A' ' 371' ' ' ILE . 1.8 mp -55.55 -48.56 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.493 -0.558 . . . . 15.0 109.493 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.74 -34.01 76.0 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.591 0.756 . . . . 15.0 111.668 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -64.35 -40.04 95.08 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.794 0.838 . . . . 15.0 110.961 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.509 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 29.9 m-85 -79.0 -50.51 10.98 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.916 0.135 . . . . 15.0 111.014 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' SER . . . . . 0.58 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -169.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.02 0.07 54.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.184 0.594 . . . . 15.0 112.052 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -113.52 118.84 35.58 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -63.84 -61.47 2.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.434 0.693 . . . . 15.0 112.164 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.98 -30.66 69.26 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.426 0.69 . . . . 15.0 112.173 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.16 -38.9 20.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.984 0.513 . . . . 15.0 111.441 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -62.13 -48.26 80.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 175.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.56 ' HA ' ' HD2' ' A' ' 399' ' ' ARG . 13.2 t70 -62.95 -39.7 95.44 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.575 1.172 . . . . 15.0 110.826 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 401' ' ' VAL . 9.5 t30 -59.8 -40.64 89.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.245 0.545 . . . . 15.0 110.391 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 -16.75 56.96 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.301 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.56 ' HD2' ' HA ' ' A' ' 396' ' ' ASP . 97.9 mtt180 -71.81 -36.25 70.19 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 15.0 109.429 167.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -64.2 -42.27 96.7 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.525 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 397' ' ' ASN . 24.9 t -62.48 -42.36 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 123.851 0.719 . . . . 15.0 110.867 175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.51 85.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.491 0.716 . . . . 15.0 111.188 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.33 -35.17 71.12 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.465 -1.243 . . . . 15.0 111.001 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.04 -54.49 45.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.292 1.037 . . . . 15.0 110.327 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.802 ' HB3' HH21 ' A' ' 283' ' ' ARG . 47.8 mt-10 -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.384 -0.826 . . . . 15.0 111.92 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.47 -37.58 83.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.21 0.604 . . . . 15.0 109.857 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.6 78.58 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.474 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.22 -56.13 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.86 -25.52 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.429 1.092 . . . . 15.0 112.409 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.13 66.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.038 0.535 . . . . 15.0 111.233 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.49 -34.81 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.911 -0.774 . . . . 15.0 108.911 172.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 80.9 mt -70.06 -31.08 68.52 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.458 0.703 . . . . 15.0 111.502 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.7 0.8 . . . . 15.0 110.812 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -86.41 -34.17 20.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.739 0.816 . . . . 15.0 109.881 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -86.34 -171.81 3.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.73 1.212 . . . . 15.0 112.126 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.629 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 79.0 mttt -114.9 117.47 30.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.911 -1.041 . . . . 15.0 108.696 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.53 101.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 109.19 -0.67 . . . . 15.0 109.19 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 t -71.32 89.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.132 0.968 . . . . 15.0 109.466 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.52 110.02 8.48 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.286 -1.325 . . . . 15.0 109.566 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -133.99 137.88 45.06 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 15.0 110.157 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.05 131.41 39.47 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.384 0.674 . . . . 15.0 109.233 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.2 t -158.76 170.66 21.64 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.214 0.605 . . . . 15.0 110.372 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.6 p -90.68 176.98 6.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.471 0.709 . . . . 15.0 112.313 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -63.7 -23.91 67.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.777 1.231 . . . . 15.0 110.935 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -66.93 -17.78 65.07 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.64 1.176 . . . . 15.0 112.301 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.512 ' HB3' HD12 ' A' ' 427' ' ' LEU . 13.2 tp10 -63.83 -36.15 82.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.029 0.932 . . . . 15.0 111.38 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 130' ' ' VAL . 3.1 mp -104.16 -69.58 0.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.87 0.468 . . . . 15.0 111.476 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.528 ' SD ' ' HB2' ' A' ' 427' ' ' LEU . 1.6 mpt? -92.54 -50.19 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.054 0.39 . . . . 15.0 112.054 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 59.4 t30 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.842 0.829 . . . . 15.0 110.997 -165.404 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 385' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 198' ' ' PHE . 5.4 tt . . . . . 0 C--O 1.246 0.913 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 386' ' ' VAL . . . . . 0.623 HG21 ' HA3' ' A' ' 179' ' ' GLY . 7.5 p -77.88 91.74 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.69 1.233 . . . . 0.0 110.995 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.462 HD12 ' HZ ' ' A' ' 217' ' ' PHE . 8.3 mm -150.98 141.71 16.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 127.805 2.442 . . . . 0.0 104.484 162.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.557 1.224 0 CA-C-N 119.099 0.863 . . . . 0.0 110.266 -164.906 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 N--CA 1.487 1.387 0 C-N-CA 123.646 0.778 . . . . 0.0 110.993 -174.634 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -45.89 -53.1 10.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.564 1.146 . . . . 0.0 113.142 -169.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -131.87 115.07 15.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 88.3 m -68.83 104.99 2.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 124.163 0.914 . . . . 0.0 109.759 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -83.08 177.44 8.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.813 0.445 . . . . 0.0 110.062 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.69 150.08 37.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.127 0.571 . . . . 0.0 109.507 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 466' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 345' ' ' VAL . . . 68.02 8.01 6.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.05 1.34 . . . . 0.0 112.565 -171.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 123.969 0.908 . . . . 0.0 110.667 -177.111 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.665 0.269 . . . . 15.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -158.31 149.61 21.01 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.753 1.221 . . . . 15.0 109.054 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 17' ' ' ILE . 13.5 m -133.68 77.96 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.838 0.855 . . . . 15.0 110.537 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -78.95 91.01 4.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 15.0 110.497 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 2.6 p -80.51 93.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 122.2 1.0 . . . . 15.0 111.433 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.94 98.2 7.79 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.501 1.12 . . . . 15.0 109.989 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -64.55 112.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.102 0.561 . . . . 15.0 109.962 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -76.32 -54.74 6.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -167.43 120.16 0.93 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 15.0 109.671 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.55 -101.6 0.47 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 124.157 0.91 . . . . 15.0 113.551 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' A' ' 113' ' ' PRO . 1.8 mm? -90.54 -22.08 21.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.175 0.59 . . . . 15.0 110.884 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.46 122.8 30.31 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.359 1.037 . . . . 15.0 112.223 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.471 HH12 ' HA ' ' A' ' 11' ' ' LEU . 68.7 mtt85 -140.86 108.16 5.52 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.751 1.22 . . . . 15.0 109.892 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 31.0 ttm180 -83.94 82.95 8.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.564 1.146 . . . . 15.0 109.131 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 t -76.49 88.46 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 61.6 m -75.94 96.62 3.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.273 -0.876 . . . . 15.0 109.633 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 3' ' ' VAL . 54.1 mt -84.21 106.07 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.555 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 35.9 m -83.72 100.6 10.99 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 70' ' ' LEU . 39.0 mt -77.01 130.85 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 140.54 58.88 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 123.92 0.763 . . . . 15.0 110.517 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.12 63.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.979 1.312 . . . . 15.0 112.208 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -38.65 78.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.114 -0.948 . . . . 15.0 111.285 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.4 m -68.62 -30.92 69.76 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.406 0.682 . . . . 15.0 111.158 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 103' ' ' PHE . 78.8 mt -65.25 -54.08 33.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 CA-C-N 115.496 -0.774 . . . . 15.0 109.087 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -59.22 -29.45 67.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.192 0.997 . . . . 15.0 111.841 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.7 m -74.8 -52.76 10.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.768 0.827 . . . . 15.0 110.317 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.06 85.04 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.395 0.678 . . . . 15.0 112.287 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 63' ' ' ARG . 58.6 t -67.59 -45.36 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.09 0.556 . . . . 15.0 109.868 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.9 -31.45 72.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.178 0.591 . . . . 15.0 111.32 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -63.35 -44.51 94.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.437 0.695 . . . . 15.0 109.78 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 35' ' ' VAL . 14.4 tp10 -63.81 -42.36 97.71 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.434 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 55' ' ' ALA . 79.6 mt -66.77 -39.23 87.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.909 0.884 . . . . 15.0 112.891 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.44 -28.07 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -71.72 -34.16 69.35 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 118.994 -0.527 . . . . 15.0 111.074 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 31' ' ' GLU . 77.2 t -60.68 -35.46 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.259 0.624 . . . . 15.0 110.163 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.05 -49.08 78.14 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.449 -0.796 . . . . 15.0 110.721 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -69.56 -42.95 73.88 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.895 0.878 . . . . 15.0 110.779 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.81 -34.43 66.87 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.743 1.617 . . . . 15.0 111.286 -169.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.54 10.87 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-O 121.338 0.59 . . . . 15.0 109.794 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 59.26 23.37 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.821 1.248 . . . . 15.0 112.796 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 60.0 mt -72.99 -22.92 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.416 1.086 . . . . 15.0 109.862 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 8.2 p-10 -58.08 -29.56 65.52 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.556 1.142 . . . . 15.0 112.758 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.49 -41.37 94.28 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.588 -0.605 . . . . 15.0 111.588 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -79.13 -24.29 43.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.964 0.906 . . . . 15.0 110.169 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 28.3 tpt180 -79.97 90.13 5.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.232 1.013 . . . . 15.0 109.335 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -92.62 -7.44 46.98 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.832 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 49.44 3.29 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.6 0.563 . . . . 15.0 112.503 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -77.27 -58.56 3.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.197 0.599 . . . . 15.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.61 122.66 70.36 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.712 -0.847 . . . . 15.0 108.712 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.1 148.28 7.14 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.844 3.029 . . . . 15.0 114.488 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.7 tpp -64.52 -34.51 78.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.369 1.068 . . . . 15.0 112.118 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.35 -37.36 86.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.715 0.406 . . . . 15.0 111.1 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.25 -42.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.985 0.914 . . . . 15.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 19.5 m -71.61 -21.18 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 122.342 -0.224 . . . . 15.0 110.871 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -76.9 -46.65 23.66 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.187 0.595 . . . . 15.0 111.801 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.743 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.5 pt20 -81.63 -30.1 32.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.517 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 75.2 mtt180 -103.1 -60.78 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.062 0.545 . . . . 15.0 110.9 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.556 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 68.5 m-85 -76.95 -19.43 57.36 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 15.0 111.142 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -100.89 9.18 58.18 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.247 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.02 -30.07 69.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.542 0.737 . . . . 15.0 111.088 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.9 p -81.39 -33.19 32.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.76 0.824 . . . . 15.0 110.866 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.06 -16.26 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.068 0.947 . . . . 15.0 111.279 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HD3' HG21 ' A' ' 28' ' ' VAL . 19.8 mmt180 -48.2 -42.33 29.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.277 1.031 . . . . 15.0 111.442 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -52.03 -54.23 32.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.975 1.31 . . . . 15.0 112.185 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.04 -24.61 58.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.86 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 28' ' ' VAL . 44.0 t -79.23 -23.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 122.546 0.338 . . . . 15.0 110.234 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 HD12 ' A' ' 70' ' ' LEU . 66.1 mt -57.69 -29.59 64.79 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.35 -0.357 . . . . 15.0 111.66 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.82 -38.66 95.65 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 117.844 0.293 . . . . 15.0 112.935 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 29.8 t70 -74.49 -36.44 63.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.771 0.828 . . . . 15.0 109.972 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.524 HD12 HD23 ' A' ' 67' ' ' LEU . 96.4 mt -73.24 -19.28 61.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.003 -0.999 . . . . 15.0 111.917 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 76.7 mtm -104.81 -66.35 0.97 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.762 0.425 . . . . 15.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.3 t -70.83 -35.56 72.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.48 0.712 . . . . 15.0 112.503 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 76' ' ' ILE . 4.9 tmm_? -87.76 -43.67 11.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -58.99 -25.55 63.72 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.467 0.576 . . . . 15.0 111.606 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -54.81 -50.73 67.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.098 0.959 . . . . 15.0 111.73 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 73' ' ' ARG . 13.2 tt -69.32 -37.34 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 110.11 -0.33 . . . . 15.0 110.11 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 -23.38 67.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.321 0.649 . . . . 15.0 111.729 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -83.52 -42.19 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.873 0.869 . . . . 15.0 111.677 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.558 HD12 ' HD3' ' A' ' 86' ' ' PRO . 28.2 pt -85.28 -30.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.203 0.816 . . . . 15.0 113.203 -169.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.26 -50.17 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.4 0.68 . . . . 15.0 111.042 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.9 ptpt -60.79 -39.65 89.66 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.705 0.628 . . . . 15.0 111.486 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 24.5 mm-40 -87.85 5.63 39.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.384 0.673 . . . . 15.0 111.706 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.62 17.81 11.09 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.068 1.347 . . . . 15.0 112.281 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.63 112.87 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.192 0.997 . . . . 15.0 109.939 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -101.2 114.75 65.75 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.361 -0.977 . . . . 15.0 108.361 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.558 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.1 Cg_endo -74.11 153.07 46.31 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.838 2.359 . . . . 15.0 112.989 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.72 18.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.804 1.242 . . . . 15.0 108.318 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 94.48 -151.71 20.28 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.731 -0.548 . . . . 15.0 111.731 -174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.99 128.66 27.23 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.552 0.741 . . . . 15.0 110.678 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.0 Cg_endo -81.83 107.3 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.383 2.055 . . . . 15.0 111.626 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.5 m -76.96 96.09 4.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.607 0.763 . . . . 15.0 110.824 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -74.1 94.49 2.42 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.081 -0.711 . . . . 15.0 109.081 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.8 t -90.96 102.15 4.95 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.949 -0.76 . . . . 15.0 108.949 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.52 95.74 0.86 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.648 2.232 . . . . 15.0 109.995 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -46.45 93.49 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.172 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.49 146.14 4.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.557 0.743 . . . . 15.0 110.745 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -128.49 142.7 51.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.548 1.139 . . . . 15.0 108.41 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 95.0 mttt -129.83 158.61 38.97 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.235 1.014 . . . . 15.0 108.619 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.07 98.44 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.591 0.756 . . . . 15.0 110.235 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.51 19.02 74.22 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.599 -0.728 . . . . 15.0 114.39 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.743 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.1 mt-10 -110.67 158.86 18.14 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.467 0.707 . . . . 15.0 110.421 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.25 107.13 0.13 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.171 1.544 . . . . 15.0 112.896 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.482 ' H ' HD11 ' A' ' 24' ' ' ILE . 13.3 t80 -80.42 96.28 6.67 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.488 -0.778 . . . . 15.0 109.539 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.0 m -95.14 105.54 17.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.106 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -129.92 143.75 50.97 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.341 0.657 . . . . 15.0 109.905 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.1 m -99.47 105.59 17.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.7 1.2 . . . . 15.0 111.672 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 t -86.01 99.93 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.927 0.491 . . . . 15.0 109.724 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.65 106.02 18.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.419 0.688 . . . . 15.0 110.26 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.657 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.7 p90 -142.06 174.21 10.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.962 0.905 . . . . 15.0 109.233 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -116.61 164.82 14.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.779 0.831 . . . . 15.0 109.934 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.66 -177.52 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.988 0.915 . . . . 15.0 109.152 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -72.83 143.79 84.83 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.029 0.532 . . . . 15.0 110.211 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 11' ' ' LEU . 23.9 Cg_endo -89.4 -167.95 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.426 2.751 . . . . 15.0 114.946 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -88.66 155.37 19.64 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.581 -1.19 . . . . 15.0 109.433 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 123.02 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.16 0.584 . . . . 15.0 110.096 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -119.94 119.36 33.23 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.66 146.77 28.9 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.79 -0.818 . . . . 15.0 108.79 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -88.67 -171.24 3.24 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.377 0.271 . . . . 15.0 110.495 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.9 102.43 0.28 Allowed Glycine 0 C--N 1.351 1.405 0 O-C-N 123.962 0.789 . . . . 15.0 111.726 173.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.38 -23.91 67.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.963 0.905 . . . . 15.0 110.386 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.97 -24.52 66.06 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.86 1.264 . . . . 15.0 111.256 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.58 61.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.348 0.659 . . . . 15.0 110.929 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.6 mt -65.48 120.28 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.065 0.853 . . . . 15.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.29 102.89 13.32 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.606 0.762 . . . . 15.0 109.245 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.44 162.65 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.908 1.283 . . . . 15.0 107.802 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -113.69 148.69 35.92 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HE2' HD11 ' A' ' 129' ' ' ILE . 84.0 tttt -127.65 89.8 49.97 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.904 0.882 . . . . 15.0 108.753 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.36 102.66 1.63 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.218 1.945 . . . . 15.0 111.738 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.543 HD11 ' HE2' ' A' ' 127' ' ' LYS . 47.3 mm -73.02 106.35 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 169.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 427' ' ' LEU . 15.3 t -132.24 147.27 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.779 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.47 157.37 46.32 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.777 1.231 . . . . 15.0 107.894 166.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.46 87.75 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 107.454 -1.313 . . . . 15.0 107.454 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 137' ' ' VAL . 28.7 p -65.56 175.51 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.72 0.808 . . . . 15.0 110.147 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.93 -36.97 78.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.042 0.448 . . . . 15.0 110.863 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.51 91.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.831 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 71.7 m-20 -74.98 -42.61 57.22 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.451 0.701 . . . . 15.0 111.717 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 133' ' ' THR . 89.6 t -62.62 -57.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.29 -31.12 62.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.206 -0.907 . . . . 15.0 111.058 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.79 -36.38 57.93 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.518 0.511 . . . . 15.0 113.033 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -71.5 -45.1 63.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.935 0.494 . . . . 15.0 109.683 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.83 -36.12 67.13 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.477 0.711 . . . . 15.0 111.676 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.95 -45.17 86.85 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.325 1.05 . . . . 15.0 110.144 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.1 m -58.92 -46.85 86.95 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.254 0.971 . . . . 15.0 110.094 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.97 -40.21 94.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.975 0.91 . . . . 15.0 111.562 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -66.88 -36.8 83.13 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.533 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 83.4 mttt -83.63 -16.82 43.73 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -80.92 -40.62 24.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -96.6 25.34 5.21 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.656 0.783 . . . . 15.0 110.535 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.15 149.37 41.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.522 0.729 . . . . 15.0 112.336 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.5 m -70.32 120.41 15.94 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.064 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -79.43 105.71 10.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -118.69 160.25 22.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.308 1.043 . . . . 15.0 108.698 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 51.6 mt-10 -107.64 147.13 31.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.283 0.633 . . . . 15.0 110.215 173.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 240' ' ' VAL . 49.5 pttt -145.22 -178.92 6.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.109 0.964 . . . . 15.0 111.001 171.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -155.01 161.68 41.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.525 1.13 . . . . 15.0 108.001 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 -50.81 0.82 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.225 -0.75 . . . . 15.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.04 134.8 13.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.929 0.491 . . . . 15.0 110.72 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 240' ' ' VAL . 53.8 t -88.0 137.12 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 167.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.61 170.25 8.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.67 -0.863 . . . . 15.0 108.67 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.25 61.24 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.83 1.048 . . . . 15.0 113.83 -169.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.89 16.99 18.25 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.94 -176.02 4.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.946 0.879 . . . . 15.0 112.539 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 11.5 mtm180 -106.52 150.4 26.15 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.305 -1.316 . . . . 15.0 108.533 166.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.09 114.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 20.5 m -94.06 117.08 29.6 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.792 -1.188 . . . . 15.0 107.792 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.45 163.98 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.807 0.813 . . . . 15.0 111.495 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 15.7 t70 -106.58 155.14 19.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 105.703 -1.962 . . . . 15.0 105.703 159.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -154.41 169.31 24.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.348 0.594 . . . . 15.0 110.34 168.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 t -157.92 124.32 4.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.041 -1.436 . . . . 15.0 107.975 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -127.81 177.71 17.43 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 122.04 -0.412 . . . . 15.0 113.822 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.3 p -150.71 130.89 13.56 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.127 0.971 . . . . 15.0 109.715 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.59 HG11 HD23 ' A' ' 226' ' ' LEU . 47.0 t -94.7 117.72 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.5 t70 73.83 -5.36 2.04 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.768 1.227 . . . . 15.0 112.11 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.39 -0.13 23.61 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.731 -0.483 . . . . 15.0 112.471 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 15.0 pt-20 -113.04 139.46 48.66 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.63 0.715 . . . . 15.0 109.408 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.44 149.59 45.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.738 0.415 . . . . 15.0 110.728 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.517 ' HD2' HG23 ' A' ' 172' ' ' VAL . 4.5 p90 -106.84 -175.71 2.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.92 0.888 . . . . 15.0 111.794 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.556 ' HG3' HG12 ' B' ' 388' ' ' VAL . 55.7 mt-10 -53.73 116.32 2.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.1 0.96 . . . . 15.0 110.134 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 -63.67 4.38 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.037 0.836 . . . . 15.0 112.341 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.18 -62.22 4.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.471 -0.252 . . . . 15.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -88.2 150.35 23.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.086 0.954 . . . . 15.0 111.931 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 167' ' ' ASP . . . -145.37 94.02 2.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.775 -1.102 . . . . 15.0 109.576 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.6 m -78.91 121.2 24.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.935 0.494 . . . . 15.0 110.494 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.5 42.2 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.447 1.099 . . . . 15.0 112.248 171.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -71.03 129.17 38.3 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.47 -0.567 . . . . 15.0 109.47 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.72 105.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.057 0.943 . . . . 15.0 109.258 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 202' ' ' ILE . 30.8 tp -91.68 89.95 7.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.868 0.867 . . . . 15.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.3 87.18 5.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.582 -0.896 . . . . 15.0 108.582 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.6 mtp -62.19 139.17 58.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.119 0.967 . . . . 15.0 111.596 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.66 -26.86 5.6 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.81 0.694 . . . . 15.0 112.235 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -92.02 147.81 22.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.343 0.657 . . . . 15.0 110.206 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.75 65.28 3.94 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 123.021 0.343 . . . . 15.0 113.766 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -105.77 -36.0 7.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.027 0.931 . . . . 15.0 110.221 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.417 ' HE1' HD13 ' B' ' 385' ' ' LEU . 23.4 mmt -99.36 150.87 21.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.254 0.621 . . . . 15.0 111.266 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.1 pt -99.07 153.92 37.56 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 114.937 -1.029 . . . . 15.0 109.619 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.22 116.82 3.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.952 2.435 . . . . 15.0 112.281 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.9 -41.8 1.39 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.38 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.38 -59.75 2.61 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.945 0.498 . . . . 15.0 110.426 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.81 -23.14 67.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.902 -1.044 . . . . 15.0 112.278 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.04 -36.43 83.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.186 0.994 . . . . 15.0 110.927 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.581 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -72.55 -17.22 77.79 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.248 -0.887 . . . . 15.0 113.097 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 187' ' ' LEU . 31.7 mm -92.59 -48.32 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.56 0.744 . . . . 15.0 110.459 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.1 19.94 2.05 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.144 1.165 . . . . 15.0 114.144 -166.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -137.33 24.15 3.1 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.865 -0.494 . . . . 15.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -144.07 -171.33 3.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.19 0.996 . . . . 15.0 110.232 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -151.19 156.79 41.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 15.0 110.101 -178.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.564 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.46 142.67 58.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.735 0.814 . . . . 15.0 111.521 -171.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.04 -32.96 4.39 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.455 -0.793 . . . . 15.0 111.516 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.3 pt-20 -93.2 138.12 31.89 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.563 0.697 . . . . 15.0 110.572 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -121.22 105.74 10.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.653 1.181 . . . . 15.0 108.28 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -121.7 177.45 5.25 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.52 1.128 . . . . 15.0 109.568 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 57.0 m -121.04 128.32 52.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.581 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.2 pt -101.78 160.91 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.557 0.743 . . . . 15.0 109.83 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -113.46 111.07 21.31 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.739 0.815 . . . . 15.0 109.396 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.22 160.86 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.478 -1.304 . . . . 15.0 107.478 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.1 m -143.48 132.89 23.39 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.8 -1.185 . . . . 15.0 107.8 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 90.1 m-85 -85.81 139.66 35.24 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -47.68 157.93 0.83 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.283 3.322 . . . . 15.0 116.016 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -23.84 63.64 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.88 167.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.96 -18.92 55.46 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.387 1.075 . . . . 15.0 111.16 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.62 141.26 56.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.02 0.528 . . . . 15.0 112.299 -170.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -78.03 17.83 0.56 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 125.163 1.385 . . . . 15.0 114.626 -168.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.47 119.47 15.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.5 -40.66 97.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 123.928 0.768 . . . . 15.0 111.972 -175.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -63.1 -19.61 64.58 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.142 0.577 . . . . 15.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.59 HD23 HG11 ' A' ' 172' ' ' VAL . 39.9 mt -99.42 -29.85 12.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.195 0.998 . . . . 15.0 111.691 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -57.83 105.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.77 1.228 . . . . 15.0 111.117 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.74 -19.49 28.91 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.57 -0.741 . . . . 15.0 113.408 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.94 145.48 31.24 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.64 0.776 . . . . 15.0 111.468 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -88.34 126.13 35.04 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.897 -1.047 . . . . 15.0 110.185 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.93 113.94 27.85 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.944 0.898 . . . . 15.0 109.238 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -103.78 101.69 11.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.723 0.809 . . . . 15.0 110.145 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -95.68 117.52 30.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.255 1.022 . . . . 15.0 109.998 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.55 96.76 4.84 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.16 116.39 26.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.036 0.934 . . . . 15.0 110.084 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 9.8 m120 -99.3 91.92 5.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.097 -1.075 . . . . 15.0 108.097 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 74.8 mt -68.47 109.25 3.61 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.099 -0.704 . . . . 15.0 109.099 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.84 -37.58 5.83 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 73.1 mmtt -133.99 122.58 23.24 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.844 0.858 . . . . 15.0 110.017 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 207' ' ' ALA . 89.0 t -95.58 132.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 105.55 -2.019 . . . . 15.0 105.55 161.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 37.6 mt-10 -120.01 179.35 4.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.96 117.5 5.73 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.871 0.868 . . . . 15.0 109.171 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -84.75 86.6 7.32 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.244 1.021 . . . . 15.0 108.348 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.04 146.7 28.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.682 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 75.1 mt -54.32 122.7 38.83 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 123.836 0.854 . . . . 15.0 110.592 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.14 -169.95 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.371 2.714 . . . . 15.0 112.944 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.58 106.53 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.216 -0.661 . . . . 15.0 109.216 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 252' ' ' PHE . 33.3 tp -82.99 14.95 2.99 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.343 1.057 . . . . 15.0 110.299 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.2 p -60.19 174.96 0.46 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.103 1.361 . . . . 15.0 112.321 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.49 -54.78 3.04 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.807 1.643 . . . . 15.0 113.86 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.45 -22.78 67.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 248' ' ' LEU . 71.2 t80 -90.37 -52.26 5.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.37 0.668 . . . . 15.0 110.254 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 266' ' ' LEU . 15.8 tt -66.4 -26.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.691 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.672 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 20.8 ptmt -82.6 -16.36 48.73 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 111.932 0.345 . . . . 15.0 111.932 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -58.83 -34.53 71.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.047 0.939 . . . . 15.0 110.95 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -62.76 -28.18 69.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.763 -1.108 . . . . 15.0 111.96 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.82 1.6 0.82 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.583 -0.565 . . . . 15.0 113.461 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 21.3 t -72.83 151.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.272 0.629 . . . . 15.0 110.06 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -67.57 -64.06 0.93 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.527 1.131 . . . . 15.0 110.483 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -102.64 -40.53 6.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.338 -1.301 . . . . 15.0 109.836 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 128.34 12.8 2.73 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.558 -0.746 . . . . 15.0 113.21 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 p -64.97 138.24 58.24 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.579 0.689 . . . . 15.0 110.375 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.89 -38.14 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.245 1.018 . . . . 15.0 111.711 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -55.48 -34.7 64.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.498 0.719 . . . . 15.0 111.388 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.21 -28.08 62.78 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.598 -0.601 . . . . 15.0 111.598 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 270' ' ' VAL . 58.9 tp -73.39 -32.72 64.61 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.37 -42.04 93.14 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.34 0.656 . . . . 15.0 109.699 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.03 90.61 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.928 -1.033 . . . . 15.0 110.39 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 15.6 tp10 -67.15 -39.99 86.61 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.729 -1.123 . . . . 15.0 111.465 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 266' ' ' LEU . 24.6 m -75.57 -24.42 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.044 -0.41 . . . . 15.0 110.253 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -69.03 -60.56 2.27 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 121.947 -0.471 . . . . 15.0 110.856 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.7 ptmt -61.9 -23.26 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 15.0 112.32 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -88.65 -69.48 0.7 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.403 0.281 . . . . 15.0 110.406 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 53.6 mtt -71.83 -45.33 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.895 -0.574 . . . . 15.0 112.361 -166.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.14 -42.16 72.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.625 0.648 . . . . 15.0 110.383 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 44.9 ttp85 -58.7 -53.55 57.14 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.167 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.26 -27.68 64.62 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.98 0.8 . . . . 15.0 111.084 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' VAL . 59.9 tp -67.5 -54.96 15.64 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.557 0.743 . . . . 15.0 110.562 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.02 -31.36 72.48 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.583 0.753 . . . . 15.0 110.316 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.2 t -68.89 -43.18 75.78 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 123.801 0.84 . . . . 15.0 110.0 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.86 98.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.146 0.578 . . . . 15.0 110.386 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 130' ' ' VAL . 73.4 mt -63.08 -49.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.011 0.924 . . . . 15.0 109.17 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.98 -54.96 38.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.648 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.22 -35.1 80.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.16 0.984 . . . . 15.0 111.019 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -65.57 -55.0 20.11 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.577 0.626 . . . . 15.0 110.996 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.66 -42.57 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.303 0.641 . . . . 15.0 110.366 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.5 tttt -58.36 -51.31 70.35 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.567 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 292' ' ' GLU . 90.2 p -69.11 -31.68 70.56 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.531 0.519 . . . . 15.0 111.292 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -69.1 -39.44 78.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.907 0.483 . . . . 15.0 110.093 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.419 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.5 -48.27 75.82 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.352 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 33.4 mm -67.12 -36.89 78.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 123.803 0.689 . . . . 15.0 110.709 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 288' ' ' SER . 8.4 tp10 -62.88 -47.76 81.95 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.271 -0.64 . . . . 15.0 109.271 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.28 94.05 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 124.698 1.249 . . . . 15.0 112.531 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB3' HD13 ' A' ' 350' ' ' LEU . 28.3 mt -59.96 -57.86 11.02 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 123.439 0.696 . . . . 15.0 110.39 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.4 t -56.09 -46.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.528 0.731 . . . . 15.0 110.159 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.84 -35.29 74.43 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.892 0.877 . . . . 15.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.15 -4.61 42.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.125 0.57 . . . . 15.0 112.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -133.9 115.12 14.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.972 0.805 . . . . 15.0 111.05 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.42 130.57 47.66 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.476 HD13 HD13 ' A' ' 349' ' ' LEU . 3.3 tt -149.13 146.11 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.344 1.058 . . . . 15.0 109.051 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 113' ' ' PRO . 29.3 t70 -72.05 140.67 49.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 307' ' ' ILE . 40.4 t -117.73 105.29 48.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.57 130.36 29.62 Favored 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 123.217 2.611 . . . . 15.0 112.563 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.43 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.21 -29.93 67.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.872 1.269 . . . . 15.0 112.554 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.549 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -54.1 -39.14 66.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.127 0.971 . . . . 15.0 111.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.78 -30.54 56.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.467 -0.788 . . . . 15.0 111.222 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -62.58 -49.96 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.841 -0.8 . . . . 15.0 108.841 173.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.33 -42.02 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.238 -0.892 . . . . 15.0 110.58 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 313' ' ' VAL . 36.5 t -57.44 -60.91 2.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.169 0.918 . . . . 15.0 111.219 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -69.8 -39.47 76.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.386 0.513 . . . . 15.0 112.386 -171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 14.9 mt -61.38 -43.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 119.035 -0.507 . . . . 15.0 109.694 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.26 -43.57 87.96 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.851 0.461 . . . . 15.0 111.208 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 309' ' ' SER . 81.2 t -54.74 -51.08 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.73 0.812 . . . . 15.0 110.339 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 341' ' ' ALA . 72.6 mt -71.4 -27.5 63.36 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.075 -0.966 . . . . 15.0 112.459 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 29.1 mtm180 . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 109.563 -0.532 . . . . 15.0 109.563 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.105 0.478 . . . . 15.0 112.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.01 72.66 1.42 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.966 0.889 . . . . 15.0 110.089 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 73.1 mt -81.05 153.71 72.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 153.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.29 108.73 0.21 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.959 2.439 . . . . 15.0 113.369 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -55.95 -29.09 59.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.254 1.022 . . . . 15.0 110.859 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.08 -21.42 31.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.572 1.149 . . . . 15.0 111.878 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.06 -35.31 20.37 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.542 0.737 . . . . 15.0 111.118 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -107.34 -14.38 14.89 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.879 0.696 . . . . 15.0 112.879 -167.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.96 -62.55 1.58 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.851 1.26 . . . . 15.0 112.029 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.45 -46.29 73.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.728 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -67.99 -37.24 81.25 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.624 0.578 . . . . 15.0 111.623 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -64.94 -52.71 54.87 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -51.57 -40.67 60.21 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 124.642 1.214 . . . . 15.0 110.83 176.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 347' ' ' VAL . 15.6 mmt180 -60.26 -46.87 88.32 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 123.418 0.687 . . . . 15.0 110.402 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -63.63 -34.21 77.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.473 0.483 . . . . 15.0 111.219 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.81 -53.89 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 15.0 110.148 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 62.5 t -65.43 -31.06 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.313 0.645 . . . . 15.0 110.957 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 343' ' ' ARG . 40.3 t -60.46 -50.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.522 0.729 . . . . 15.0 109.095 170.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.76 -33.74 88.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.636 -0.711 . . . . 15.0 113.759 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.476 HD13 HD13 ' A' ' 300' ' ' ILE . 96.0 mt -73.82 -54.7 7.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.929 0.491 . . . . 15.0 110.574 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 294' ' ' LEU . 75.6 mt -68.87 -52.67 27.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.891 0.476 . . . . 15.0 110.812 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.14 -38.11 89.55 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 119.275 -0.393 . . . . 15.0 110.834 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.98 -38.41 88.98 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.753 0.658 . . . . 15.0 112.544 176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -69.25 -40.6 77.77 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 119.295 -0.383 . . . . 15.0 111.316 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 350' ' ' LEU . 81.2 t -57.39 -39.94 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.211 0.529 . . . . 15.0 110.575 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.84 -45.46 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.756 1.222 . . . . 15.0 110.755 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.458 ' HA ' ' HE2' ' B' ' 461' ' ' PHE . 20.2 ttp180 -61.28 -53.14 60.56 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.021 0.529 . . . . 15.0 110.785 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 33.0 m -57.13 -50.37 73.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.62 1.168 . . . . 15.0 111.433 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -90.66 14.8 12.39 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.638 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 43.04 36.2 0.89 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 125.375 1.47 . . . . 15.0 114.136 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.26 149.17 50.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.047 0.939 . . . . 15.0 112.159 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.61 150.91 52.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.333 1.053 . . . . 15.0 109.699 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.77 104.49 3.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.38 -0.6 . . . . 15.0 109.38 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.78 132.64 42.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.149 0.58 . . . . 15.0 110.395 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -63.94 -30.85 71.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.88 0.872 . . . . 15.0 112.48 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -86.04 -10.64 54.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.961 0.504 . . . . 15.0 111.436 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.5 tpt85 -81.33 -38.13 27.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 371' ' ' ILE . 89.7 t -58.16 -58.29 7.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.837 1.255 . . . . 15.0 109.18 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 372' ' ' GLU . 24.0 mmmt -59.49 -39.62 84.35 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 115.628 -0.715 . . . . 15.0 111.589 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.33 67.06 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.934 0.772 . . . . 15.0 112.436 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.08 -42.49 84.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.31 0.644 . . . . 15.0 111.96 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 367' ' ' VAL . 50.5 mm -52.77 -44.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 123.992 0.807 . . . . 15.0 110.686 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 368' ' ' LYS . 14.7 mm-40 -70.06 -54.71 11.9 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.46 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -52.43 -36.97 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.837 0.855 . . . . 15.0 112.463 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 60.4 ttp -80.09 -69.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.774 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.87 79.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.858 0.863 . . . . 15.0 113.297 -164.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -21.44 64.92 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.037 0.535 . . . . 15.0 112.166 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -66.79 -20.32 65.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.739 0.816 . . . . 15.0 112.591 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.49 167.83 9.89 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.383 0.673 . . . . 15.0 110.646 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -80.01 -9.73 59.71 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.851 . . . . 15.0 110.809 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.42 59.78 46.08 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.991 1.317 . . . . 15.0 110.545 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.75 -27.95 4.51 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 121.931 1.754 . . . . 15.0 112.301 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -54.79 -45.78 74.37 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.254 1.022 . . . . 15.0 111.042 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 12.7 pt-20 -65.57 -31.46 72.51 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.84 -1.073 . . . . 15.0 111.242 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.96 -37.84 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.277 0.631 . . . . 15.0 109.912 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.95 -54.21 37.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 108.607 -0.886 . . . . 15.0 108.607 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.35 -27.52 67.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.525 0.73 . . . . 15.0 111.527 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 383' ' ' GLU . 24.0 t80 -62.19 -44.01 97.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.99 0.916 . . . . 15.0 109.877 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -82.71 -66.27 0.91 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.638 0.607 . . . . 15.0 112.638 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' SER . . . . . 0.586 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 84.4 p -56.45 -27.23 56.27 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.474 1.287 . . . . 15.0 114.474 -169.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -103.36 27.72 7.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.079 0.551 . . . . 15.0 110.396 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -149.8 105.35 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.296 -1.002 . . . . 15.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -55.6 -38.73 69.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.264 1.026 . . . . 15.0 111.726 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.34 -36.61 66.2 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 123.782 0.676 . . . . 15.0 111.625 -174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 397' ' ' ASN . 11.3 mt -74.98 -32.98 61.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.763 0.425 . . . . 15.0 111.117 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 90.0 mmm -62.83 -38.88 92.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 171.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.27 -38.21 78.27 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 123.719 0.637 . . . . 15.0 109.983 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.44 HD22 HD23 ' A' ' 394' ' ' LEU . 88.6 m-20 -62.1 -39.66 93.25 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 123.559 0.744 . . . . 15.0 110.54 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.449 ' HA ' HG12 ' A' ' 401' ' ' VAL . 43.1 tpp -77.34 -23.78 50.86 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.543 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' B' ' 463' ' ' THR . 43.2 mtm-85 -74.95 -31.83 61.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.143 0.577 . . . . 15.0 110.318 169.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -55.87 22.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.478 0.711 . . . . 15.0 109.398 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.5 p -69.43 -29.97 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 123.788 0.68 . . . . 15.0 111.745 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.66 -53.62 55.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.861 -0.422 . . . . 15.0 109.861 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.656 HD22 HG23 ' B' ' 463' ' ' THR . 48.1 tp -71.3 -30.11 65.86 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.903 -1.044 . . . . 15.0 111.687 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.25 -57.07 10.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.723 1.209 . . . . 15.0 109.953 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -67.12 -32.43 73.56 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.27 -0.877 . . . . 15.0 110.633 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -63.91 -37.77 88.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.042 0.537 . . . . 15.0 110.388 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.49 85.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.748 0.819 . . . . 15.0 110.891 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 74.8 t -55.81 -53.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 123.955 0.784 . . . . 15.0 109.306 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -30.35 70.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.104 0.962 . . . . 15.0 112.023 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.4 -30.86 68.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.929 0.491 . . . . 15.0 110.895 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.01 -39.51 57.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 77.0 mt -72.84 -26.37 61.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.436 1.094 . . . . 15.0 112.007 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.72 73.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.96 0.904 . . . . 15.0 110.054 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.3 -34.94 13.32 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.593 -1.185 . . . . 15.0 110.094 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -81.93 154.61 25.69 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.316 1.046 . . . . 15.0 111.465 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.5 86.73 3.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.952 -1.022 . . . . 15.0 110.147 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -84.61 94.12 3.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.57 0.7 . . . . 15.0 109.712 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -70.48 95.19 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.115 -0.948 . . . . 15.0 108.647 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.33 138.87 37.87 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 114.991 -1.004 . . . . 15.0 110.131 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.415 ' HE3' HG21 ' A' ' 422' ' ' THR . 62.1 pttt -144.42 137.35 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 173.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.89 122.4 30.7 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.128 -1.064 . . . . 15.0 108.128 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.415 HG21 ' HE3' ' A' ' 420' ' ' LYS . 8.8 t -149.78 175.52 11.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.008 0.523 . . . . 15.0 110.69 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -89.92 161.07 16.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.71 1.204 . . . . 15.0 112.119 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 26.5 t80 -52.68 -48.59 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.234 1.414 . . . . 15.0 111.253 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -58.79 -19.4 40.56 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.161 0.913 . . . . 15.0 112.886 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 427' ' ' LEU . 7.7 tp10 -54.06 -49.95 67.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.382 1.073 . . . . 15.0 112.127 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 130' ' ' VAL . 5.5 mp -75.37 -29.18 59.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.788 0.835 . . . . 15.0 111.507 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -77.14 -41.97 39.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 174.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 . . . . . 0 N--CA 1.482 1.131 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.16 179.504 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 385' ' ' LEU . . . . . 0.417 HD13 ' HE1' ' A' ' 194' ' ' MET . 18.9 tp . . . . . 0 C--O 1.248 0.986 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 386' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 178' ' ' GLU . 8.1 p -77.39 97.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 122.895 1.331 . . . . 0.0 109.279 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 2.9 tp -149.78 156.24 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 113.954 -1.476 . . . . 0.0 107.043 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.556 HG12 ' HG3' ' A' ' 178' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 0.0 110.254 171.82 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.618 0.247 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 461' ' ' PHE . . . . . 0.458 ' HE2' ' HA ' ' A' ' 356' ' ' ARG . 97.4 m-85 -77.22 24.4 0.18 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.576 1.15 . . . . 0.0 113.751 -174.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 19.5 t80 76.92 -49.49 0.55 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.723 1.209 . . . . 0.0 113.412 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 463' ' ' THR . . . . . 0.656 HG23 HD22 ' A' ' 403' ' ' LEU . 11.8 t -84.16 20.54 1.57 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.533 1.133 . . . . 0.0 113.668 -156.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 25.0 ptm -141.03 129.81 22.95 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.58 -62.12 1.74 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.514 0.725 . . . . 0.0 109.685 -173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.38 0.39 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.077 0.951 . . . . 0.0 110.522 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 125.615 1.566 . . . . 0.0 108.254 -178.717 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.654 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -78.11 97.08 5.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.162 0.585 . . . . 15.0 109.817 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -111.1 128.49 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.348 0.659 . . . . 15.0 109.479 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.3 p -129.63 110.7 12.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.094 0.558 . . . . 15.0 109.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.26 126.59 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.601 0.76 . . . . 15.0 110.417 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 32.5 mt-10 -125.55 133.22 52.4 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.8 1.24 . . . . 15.0 108.5 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 m -94.0 98.22 10.87 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.493 -0.929 . . . . 15.0 108.493 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -84.29 -51.23 7.16 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.291 0.636 . . . . 15.0 111.937 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -151.2 90.95 1.64 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.16 -100.74 0.43 Allowed Glycine 0 C--N 1.35 1.338 0 O-C-N 123.867 0.73 . . . . 15.0 113.363 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 5.2 mp -77.85 -33.14 52.34 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 15.0 109.56 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 122.72 30.63 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.363 1.039 . . . . 15.0 112.867 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -135.46 129.03 32.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.572 1.149 . . . . 15.0 110.259 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 43.4 ttm180 -96.64 101.82 13.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.431 1.092 . . . . 15.0 110.022 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.03 94.41 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 169.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 85.8 m -78.32 102.74 7.84 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.482 -0.781 . . . . 15.0 109.467 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -95.74 131.92 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.737 0.815 . . . . 15.0 109.315 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 33.9 m -116.07 118.81 33.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 70' ' ' LEU . 58.6 mt -93.03 120.12 41.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.77 154.11 42.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.173 0.589 . . . . 15.0 111.166 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.65 -39.99 62.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.238 1.415 . . . . 15.0 113.183 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.65 -38.64 77.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.407 0.683 . . . . 15.0 110.984 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -70.22 -32.31 70.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.61 0.764 . . . . 15.0 110.824 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 76.4 mt -66.79 -54.14 27.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.962 0.905 . . . . 15.0 109.384 173.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -59.94 -38.79 83.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.421 1.076 . . . . 15.0 111.761 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -63.75 -45.18 91.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.779 0.674 . . . . 15.0 110.27 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -33.64 73.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.543 0.737 . . . . 15.0 112.277 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.643 ' HA ' HG21 ' A' ' 66' ' ' VAL . 68.0 t -69.54 -42.47 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.261 0.624 . . . . 15.0 109.423 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -68.02 -31.03 70.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.263 -0.88 . . . . 15.0 111.079 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 m -69.1 -37.39 78.37 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.474 -0.785 . . . . 15.0 109.702 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.6 tp10 -69.37 -39.53 78.01 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.826 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 91.6 mt -67.24 -34.69 77.99 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.316 0.646 . . . . 15.0 111.725 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 p -80.97 -17.63 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 O-C-N 123.317 0.386 . . . . 15.0 110.604 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.44 -46.64 66.29 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.452 -0.574 . . . . 15.0 109.452 168.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 40.0 t -65.09 -39.11 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 123.876 0.735 . . . . 15.0 109.891 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.55 -55.38 31.55 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 115.198 -0.91 . . . . 15.0 110.671 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 97.2 mttt -66.18 -30.03 70.42 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.423 0.452 . . . . 15.0 111.98 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 36.5 ttpt -64.29 -46.71 82.44 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.491 0.717 . . . . 15.0 111.118 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.1 t -94.03 3.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.348 0.659 . . . . 15.0 110.154 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 24.8 mmt180 65.17 16.8 10.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.866 1.666 . . . . 15.0 112.43 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.1 mt -54.08 -31.04 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.562 1.545 . . . . 15.0 111.784 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.756 0.822 . . . . 15.0 111.037 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -39.13 79.26 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.08 -0.509 . . . . 15.0 112.03 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.99 -22.17 59.71 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.142 0.577 . . . . 15.0 111.003 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -65.93 116.55 7.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.386 1.074 . . . . 15.0 110.145 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.82 1.99 48.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.064 0.945 . . . . 15.0 111.329 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.91 69.85 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.28 0.362 . . . . 15.0 112.706 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -77.15 -49.4 15.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.636 0.774 . . . . 15.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.88 117.36 61.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 108.486 -0.931 . . . . 15.0 108.486 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD2' HD12 ' A' ' 53' ' ' ILE . 87.5 Cg_exo -48.75 142.39 18.93 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.417 2.745 . . . . 15.0 113.484 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 54' ' ' VAL . 56.4 tpp -64.01 -26.57 68.63 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 15.0 111.298 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.27 -35.18 77.49 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.592 0.357 . . . . 15.0 111.64 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 50' ' ' PRO . 43.1 mt -72.68 -46.93 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.685 0.794 . . . . 15.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 51' ' ' MET . 31.1 m -68.66 -21.14 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 122.429 -0.169 . . . . 15.0 111.291 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.21 -47.77 60.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.059 0.544 . . . . 15.0 111.862 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -79.59 -19.79 48.51 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.755 -0.657 . . . . 15.0 111.627 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -94.45 -70.15 0.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.551 0.34 . . . . 15.0 111.252 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.61 -22.8 59.91 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.287 0.635 . . . . 15.0 111.613 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.84 14.56 59.94 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.305 -0.72 . . . . 15.0 114.041 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 -42.61 66.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.497 0.719 . . . . 15.0 111.574 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 p -77.11 -32.76 56.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.291 0.636 . . . . 15.0 110.298 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.7 t -67.17 -18.79 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.616 1.166 . . . . 15.0 111.321 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HD3' HG21 ' A' ' 28' ' ' VAL . 17.1 mmt180 -51.05 -44.8 61.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.283 0.633 . . . . 15.0 110.599 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -51.85 -55.48 19.74 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.429 1.092 . . . . 15.0 111.456 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.76 -48.96 79.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.625 -1.17 . . . . 15.0 111.095 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 28' ' ' VAL . 79.6 t -64.24 -49.17 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.367 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.7 mt -56.84 -43.44 81.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 123.837 0.711 . . . . 15.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.7 -47.57 90.27 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.294 0.996 . . . . 15.0 112.002 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.97 -41.39 97.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.649 1.18 . . . . 15.0 111.454 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.425 ' HB3' HD13 ' A' ' 19' ' ' ILE . 59.2 mt -64.59 -27.2 68.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.262 -0.881 . . . . 15.0 111.235 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.448 ' SD ' ' HG3' ' A' ' 94' ' ' PRO . 68.4 mtm -59.21 -40.93 87.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.361 0.413 . . . . 15.0 111.049 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -81.59 -50.01 9.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.779 0.432 . . . . 15.0 111.105 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -75.19 -24.14 57.77 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -81.31 -25.85 36.14 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.927 0.33 . . . . 15.0 110.288 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -77.96 -42.23 33.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.686 0.394 . . . . 15.0 111.171 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.0 -27.4 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.26 0.552 . . . . 15.0 110.081 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.57 -41.49 54.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.429 0.692 . . . . 15.0 109.981 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -62.8 -47.09 84.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 15.0 111.869 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -60.13 -27.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 112.79 0.663 . . . . 15.0 112.79 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.9 mt -71.81 -47.33 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.942 0.897 . . . . 15.0 110.568 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.4 ptpt -75.96 -29.97 58.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.622 0.369 . . . . 15.0 110.785 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.87 -22.28 53.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.757 . . . . 15.0 111.132 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 62.85 23.86 14.23 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.482 1.113 . . . . 15.0 111.428 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.6 mt -105.35 97.9 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.314 -0.995 . . . . 15.0 108.314 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -72.53 116.92 54.44 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.528 -0.916 . . . . 15.0 108.528 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.7 158.65 35.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.521 2.147 . . . . 15.0 113.127 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.59 167.88 21.98 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.81 -1.086 . . . . 15.0 108.956 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 82.14 -136.15 15.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.697 -0.683 . . . . 15.0 111.458 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.14 97.65 45.35 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 108.263 -1.014 . . . . 15.0 108.263 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.4 106.36 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.018 1.812 . . . . 15.0 110.792 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.6 m -92.25 98.3 11.43 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.277 0.631 . . . . 15.0 109.58 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -76.45 83.42 3.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.158 0.983 . . . . 15.0 109.316 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.51 106.33 10.09 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 118.536 -0.745 . . . . 15.0 109.147 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HG3' ' SD ' ' A' ' 71' ' ' MET . 16.3 Cg_exo -68.79 110.42 2.35 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.4 2.067 . . . . 15.0 111.33 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -59.12 11.36 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.773 0.671 . . . . 15.0 111.99 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.27 168.05 13.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 15.0 111.483 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HB2' ' HD1' ' A' ' 103' ' ' PHE . 76.1 t80 -147.29 143.57 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.571 1.149 . . . . 15.0 109.17 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 49.1 mtmt -122.52 144.4 49.1 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 170.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.58 108.41 0.82 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.943 0.897 . . . . 15.0 111.86 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.58 62.29 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.578 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.9 mt-10 -99.23 -173.17 2.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.482 1.113 . . . . 15.0 109.392 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.1 154.12 42.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.647 0.736 . . . . 15.0 112.897 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' HD1' ' HB2' ' A' ' 97' ' ' TYR . 56.2 t80 -119.01 141.61 48.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.153 1.381 . . . . 15.0 108.392 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -132.57 140.31 48.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -147.35 136.23 22.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.789 0.836 . . . . 15.0 109.535 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 70.8 m -103.5 123.77 47.52 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.324 1.05 . . . . 15.0 109.589 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.88 110.3 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.101 0.56 . . . . 15.0 110.253 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -101.1 130.41 47.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.68 0.392 . . . . 15.0 110.298 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.6 157.05 37.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 15.0 109.544 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.85 164.66 23.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.284 0.634 . . . . 15.0 109.632 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.5 m -123.23 178.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.239 0.615 . . . . 15.0 109.442 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -86.3 108.01 15.74 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 15.0 108.489 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.54 163.64 26.73 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.451 2.101 . . . . 15.0 113.018 -170.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.92 89.22 5.87 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.67 111.48 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.514 -1.221 . . . . 15.0 110.017 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -96.14 98.49 10.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.892 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 120' ' ' LEU . 85.7 mt -73.03 129.01 37.13 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -136.98 111.14 8.36 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.32 75.89 0.21 Allowed Glycine 0 C--N 1.353 1.504 0 O-C-N 124.324 1.015 . . . . 15.0 113.519 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 117' ' ' LEU . 17.8 mt -75.59 -11.64 60.05 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.055 0.428 . . . . 15.0 110.874 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 13.2 mp0 -74.53 -28.08 60.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.303 1.041 . . . . 15.0 110.146 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.76 62.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.044 0.937 . . . . 15.0 112.078 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.476 HG23 ' HA3' ' A' ' 293' ' ' GLY . 65.2 mt -68.88 134.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.717 0.807 . . . . 15.0 109.731 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.1 mt-10 -118.29 110.87 18.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.458 0.703 . . . . 15.0 109.263 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 417' ' ' VAL . 47.1 t -115.97 156.19 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.529 1.132 . . . . 15.0 109.68 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.53 141.04 39.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.993 0.917 . . . . 15.0 108.692 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 83.1 tttt -112.43 89.9 13.43 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 107.344 -1.354 . . . . 15.0 107.344 170.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.54 95.41 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.403 2.068 . . . . 15.0 111.087 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.15 87.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.202 -1.407 . . . . 15.0 107.202 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 282' ' ' ILE . 3.2 t -122.38 141.24 43.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.576 -1.193 . . . . 15.0 109.56 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.94 165.5 24.86 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.813 -1.551 . . . . 15.0 106.813 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.53 85.9 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.683 -1.599 . . . . 15.0 106.683 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 137' ' ' VAL . 26.6 p -69.12 175.78 3.61 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.554 0.742 . . . . 15.0 110.238 -175.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.21 -43.38 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.022 0.374 . . . . 15.0 110.296 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.34 80.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.875 0.87 . . . . 15.0 111.298 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.44 -39.03 54.59 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.743 0.417 . . . . 15.0 111.662 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 133' ' ' THR . 91.5 t -65.09 -53.71 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 108.933 -0.766 . . . . 15.0 108.933 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -63.5 -48.63 76.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.148 0.905 . . . . 15.0 110.385 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.01 93.85 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 123.877 0.735 . . . . 15.0 114.195 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -80.51 -45.44 17.49 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.978 0.511 . . . . 15.0 111.111 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 270' ' ' VAL . 48.1 mt -54.52 -34.56 61.93 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.457 0.572 . . . . 15.0 112.025 167.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.74 -45.8 84.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.403 1.081 . . . . 15.0 109.623 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -60.78 -36.84 80.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.624 0.77 . . . . 15.0 111.628 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 HD23 ' A' ' 141' ' ' LEU . 96.1 mt -70.31 -40.33 74.28 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.254 0.621 . . . . 15.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.64 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 68.0 mtm180 -74.44 -18.78 60.59 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.743 -0.662 . . . . 15.0 111.619 174.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 97.0 mttt -85.36 -22.56 28.39 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.077 0.399 . . . . 15.0 111.233 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -72.13 -42.17 66.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 15.0 109.362 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -104.87 41.32 1.35 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.003 . . . . 15.0 110.1 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.12 139.06 41.14 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.6 m -81.36 126.77 32.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.132 0.973 . . . . 15.0 109.398 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -80.97 111.01 17.05 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -120.66 114.87 22.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.909 0.883 . . . . 15.0 109.79 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 52.7 mt-10 -73.19 119.57 17.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.847 0.459 . . . . 15.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 28.6 pttt -106.02 176.8 5.05 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.39 0.676 . . . . 15.0 110.32 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -115.55 99.4 7.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.133 0.573 . . . . 15.0 111.487 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.505 ' HA2' ' H ' ' A' ' 207' ' ' ALA . . . 58.66 58.76 12.85 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.589 168.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 98.89 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.298 0.549 . . . . 15.0 109.688 172.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 203' ' ' LYS . 14.2 t -96.98 130.2 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 120.914 0.388 . . . . 15.0 110.953 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 -168.4 2.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.749 1.62 . . . . 15.0 109.18 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.76 -2.64 54.96 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.031 0.932 . . . . 15.0 112.585 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -97.49 8.4 44.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.22 0.608 . . . . 15.0 111.829 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 1.1 m-20 -92.41 176.41 6.48 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.388 1.089 . . . . 15.0 113.873 -166.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 3.1 tmt_? -143.42 90.21 2.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.519 -2.4 . . . . 15.0 104.519 167.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 166' ' ' ILE . 33.2 t -93.36 152.28 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.766 0.826 . . . . 15.0 110.561 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.717 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 11.4 m -126.1 117.68 23.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.773 -1.195 . . . . 15.0 107.773 173.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 237' ' ' LEU . 38.6 pt -128.24 173.4 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.982 0.913 . . . . 15.0 111.963 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.35 134.1 50.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.766 -1.198 . . . . 15.0 107.766 163.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -127.72 149.85 50.04 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.709 0.231 . . . . 15.0 110.483 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.56 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 9.0 t -131.81 113.32 13.36 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 165.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.44 148.81 18.78 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.9 -0.591 . . . . 15.0 113.725 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.3 m -146.07 118.08 8.26 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.312 -1.366 . . . . 15.0 107.312 167.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 98.9 t -88.69 114.97 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.967 0.907 . . . . 15.0 109.334 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 67.91 7.8 6.02 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.405 1.082 . . . . 15.0 111.325 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.92 26.14 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 121.769 -0.582 . . . . 15.0 113.507 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.6 pt-20 -98.64 134.89 40.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.552 0.676 . . . . 15.0 109.196 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.81 85.59 3.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.048 0.451 . . . . 15.0 110.069 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.511 ' HD2' HG23 ' B' ' 388' ' ' VAL . 0.1 OUTLIER -43.44 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.755 1.622 . . . . 15.0 111.85 172.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.24 172.69 7.01 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.961 1.304 . . . . 15.0 109.313 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.6 71.52 0.67 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.22 -1.552 . . . . 15.0 109.22 155.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.79 57.48 4.25 Favored Glycine 0 C--N 1.356 1.684 0 C-N-CA 123.915 0.769 . . . . 15.0 114.401 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 24.6 mmtt -107.15 149.87 27.21 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.617 1.167 . . . . 15.0 110.163 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.19 93.36 0.69 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.988 0.805 . . . . 15.0 109.204 173.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 129.6 36.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.2 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 66.23 32.64 7.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.312 1.045 . . . . 15.0 111.483 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.16 130.27 43.87 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.76 102.7 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.549 0.74 . . . . 15.0 109.536 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 202' ' ' ILE . 27.0 tp -93.95 91.85 7.09 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 170.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -70.15 92.7 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 173.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER -66.5 154.57 39.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.789 0.836 . . . . 15.0 111.241 -175.143 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.45 -19.03 13.16 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.173 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -102.69 122.82 45.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.495 0.718 . . . . 15.0 109.38 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.23 61.34 4.78 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.239 -0.744 . . . . 15.0 111.239 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -31.23 11.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.884 0.874 . . . . 15.0 109.174 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 25.9 mmt -75.07 160.78 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.973 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.2 pt -59.72 130.96 88.55 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 115.057 -0.974 . . . . 15.0 110.426 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.64 115.85 2.69 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.25 2.633 . . . . 15.0 112.215 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.53 -42.1 1.53 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.475 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.05 -65.0 0.73 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 122.687 0.395 . . . . 15.0 110.109 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 189' ' ' MET . 10.8 pt-20 -66.59 -26.43 67.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.019 0.825 . . . . 15.0 111.42 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.0 m-20 -68.31 -32.28 72.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.98 0.912 . . . . 15.0 110.62 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.45 -11.08 85.83 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.39 -0.823 . . . . 15.0 112.837 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.409 HG21 HD23 ' A' ' 187' ' ' LEU . 23.7 mm -92.11 -53.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.962 -0.755 . . . . 15.0 108.962 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.563 ' HA ' HG12 ' A' ' 158' ' ' VAL . 57.9 pttt -83.12 31.79 0.44 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.63 1.172 . . . . 15.0 112.577 -170.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.59 25.99 2.42 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.896 -0.882 . . . . 15.0 110.896 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -145.91 -166.04 2.35 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.271 1.028 . . . . 15.0 110.41 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 8.8 ptpp? -146.44 159.16 43.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.14 0.976 . . . . 15.0 110.425 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.67 145.59 55.84 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 120.733 0.302 . . . . 15.0 111.517 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.82 -44.03 1.51 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.984 -0.846 . . . . 15.0 110.984 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.6 pt-20 -77.6 129.95 36.27 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.921 -0.639 . . . . 15.0 109.695 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.94 109.8 18.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.693 -1.225 . . . . 15.0 107.693 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -128.45 -171.05 2.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.011 1.324 . . . . 15.0 110.133 -169.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 72.9 m -132.02 129.09 39.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.917 0.887 . . . . 15.0 108.867 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.9 pt -98.55 150.24 5.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.032 0.533 . . . . 15.0 110.396 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.26 112.3 24.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.84 -1.073 . . . . 15.0 108.973 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.6 166.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 67.6 m -141.44 129.19 21.64 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.22 133.41 81.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.733 -0.651 . . . . 15.0 109.584 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 221' ' ' TYR . 35.8 Cg_exo -44.45 161.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 124.234 3.289 . . . . 15.0 115.412 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -75.92 -30.08 58.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.652 -0.704 . . . . 15.0 110.349 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.38 -31.39 68.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.17 0.588 . . . . 15.0 110.525 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 218' ' ' PRO . 25.8 t80 -48.59 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.821 1.648 . . . . 15.0 110.554 -172.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.999 1.111 . . . . 15.0 113.999 -160.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.99 92.91 0.54 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 165.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.33 -41.87 85.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.952 0.901 . . . . 15.0 111.289 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.59 -15.92 43.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.082 0.953 . . . . 15.0 112.825 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.499 HD22 HG21 ' A' ' 172' ' ' VAL . 64.7 mt -107.46 -30.9 8.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.915 0.886 . . . . 15.0 111.197 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -51.78 121.31 6.36 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.336 1.455 . . . . 15.0 112.036 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.06 -22.84 12.68 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.772 0.67 . . . . 15.0 113.942 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.1 147.16 40.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.304 0.552 . . . . 15.0 111.037 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.21 111.92 23.82 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.499 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.92 133.43 34.78 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.574 0.749 . . . . 15.0 111.874 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -90.0 107.68 19.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.198 0.999 . . . . 15.0 108.574 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.26 108.64 19.31 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.397 -0.964 . . . . 15.0 108.397 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.38 96.36 4.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.765 0.426 . . . . 15.0 109.993 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 mm -87.47 128.6 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.179 0.992 . . . . 15.0 110.651 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.9 100.93 8.8 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.313 1.045 . . . . 15.0 108.216 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 166' ' ' ILE . 87.5 mt -78.6 94.61 5.05 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.036 0.446 . . . . 15.0 109.816 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.19 -44.63 7.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.123 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.717 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.7 mmtt -127.31 135.84 51.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.239 0.616 . . . . 15.0 110.036 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 207' ' ' ALA . 98.6 t -127.6 103.68 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.573 1.149 . . . . 15.0 108.623 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 29.2 mt-10 -104.03 -175.26 2.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.639 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.0 tt0 -142.89 129.64 20.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.21 -0.663 . . . . 15.0 109.21 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 -78.55 84.39 4.68 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.37 144.14 30.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.984 -1.462 . . . . 15.0 110.79 -174.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.61 119.76 53.53 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.838 0.855 . . . . 15.0 109.636 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 69.4 Cg_endo -68.2 -169.58 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.418 2.745 . . . . 15.0 112.558 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.4 148.0 46.76 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.209 -0.905 . . . . 15.0 110.759 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 25.6 tp -121.65 15.8 11.1 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.9 p -66.66 179.55 1.04 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.627 1.171 . . . . 15.0 112.135 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.13 -61.85 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.689 1.595 . . . . 15.0 114.635 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.91 -1.76 27.03 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.48 0.712 . . . . 15.0 112.806 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -99.22 -50.57 4.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.357 0.663 . . . . 15.0 109.563 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 266' ' ' LEU . 18.0 tt -64.56 -29.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.961 0.504 . . . . 15.0 111.357 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . 18.7 ptmt -76.99 -18.04 58.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.385 0.513 . . . . 15.0 112.385 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -69.11 -18.85 64.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.388 0.675 . . . . 15.0 110.909 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -74.16 -22.3 59.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.788 0.835 . . . . 15.0 111.495 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 139.74 -28.97 2.5 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 112.569 -0.212 . . . . 15.0 112.569 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.17 84.58 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.68 0.792 . . . . 15.0 109.671 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -63.69 -27.63 69.35 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.044 1.127 . . . . 15.0 114.044 -167.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -31.12 47.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.43 20.36 27.47 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.409 -0.662 . . . . 15.0 113.799 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 54.3 p -62.28 123.59 18.63 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.456 0.702 . . . . 15.0 111.091 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.81 -54.66 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.454 1.102 . . . . 15.0 111.242 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.62 -24.78 64.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.754 0.821 . . . . 15.0 111.991 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.7 -27.2 54.74 Favored Glycine 0 C--N 1.36 1.869 0 N-CA-C 110.609 -0.996 . . . . 15.0 110.609 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 253' ' ' ILE . 41.3 tp -75.1 -35.11 61.78 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -61.86 -41.79 98.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.576 0.548 . . . . 15.0 109.646 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.92 63.57 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.133 0.973 . . . . 15.0 111.065 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.05 -54.63 44.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.772 -1.104 . . . . 15.0 111.327 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 141' ' ' LEU . 30.8 m -69.07 -37.85 77.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.989 -1.005 . . . . 15.0 110.867 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -65.84 -42.98 89.84 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 119.104 0.865 . . . . 15.0 110.049 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -73.38 -26.08 60.85 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 118.364 0.529 . . . . 15.0 111.592 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -65.48 -52.8 50.32 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.659 0.742 . . . . 15.0 109.697 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.477 ' HE3' ' HB ' ' A' ' 270' ' ' VAL . 57.6 mtt -72.7 -14.97 61.69 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-N 114.59 -1.186 . . . . 15.0 111.415 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.23 -38.66 15.08 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.661 0.664 . . . . 15.0 109.922 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.45 -25.4 67.21 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.183 0.593 . . . . 15.0 110.235 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -84.5 -71.81 0.5 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.445 0.698 . . . . 15.0 110.77 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.539 HD21 HG12 ' A' ' 130' ' ' VAL . 43.3 tp -62.7 -54.23 42.46 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.042 1.337 . . . . 15.0 113.453 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 282' ' ' ILE . 38.2 ttpt -70.93 -28.57 64.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 123.454 0.471 . . . . 15.0 110.79 -172.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -64.79 -46.9 80.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.779 -0.823 . . . . 15.0 108.779 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.0 71.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.572 0.749 . . . . 15.0 111.622 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.606 HD11 ' HB ' ' A' ' 130' ' ' VAL . 96.0 mt -66.87 -55.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 N-CA-C 108.77 -0.826 . . . . 15.0 108.77 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 16.9 tpt180 -58.03 -41.53 83.39 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.087 0.867 . . . . 15.0 110.705 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.67 -32.75 70.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.154 0.582 . . . . 15.0 111.09 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -65.62 -51.94 55.75 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.1 0.409 . . . . 15.0 110.423 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 282' ' ' ILE . 21.8 t -62.03 -45.75 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.957 0.786 . . . . 15.0 109.778 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.7 tttt -64.95 -41.36 95.56 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.117 -0.947 . . . . 15.0 111.624 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.589 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 77.6 p -65.61 -42.61 91.41 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.726 0.239 . . . . 15.0 110.92 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.6 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.0 mt-30 -66.86 -34.81 78.61 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.324 0.39 . . . . 15.0 111.005 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.4 -50.31 68.11 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.807 0.443 . . . . 15.0 111.537 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 287' ' ' LYS . 31.4 mm -73.29 -55.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.408 0.683 . . . . 15.0 111.322 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.94 -27.03 68.57 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.728 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.476 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.54 -41.57 94.07 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 119.432 -0.649 . . . . 15.0 112.524 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 350' ' ' LEU . 23.0 mt -56.91 -47.43 80.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.772 0.829 . . . . 15.0 110.552 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 22.9 t -58.28 -53.89 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.689 0.757 . . . . 15.0 109.593 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.24 -18.78 65.37 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.568 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.02 -25.69 22.98 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -157.9 155.03 28.85 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.887 1.069 . . . . 15.0 113.887 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.82 145.31 55.63 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.108 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 5.9 tp -143.38 117.19 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.687 -0.688 . . . . 15.0 109.594 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -81.19 118.37 22.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.262 -1.014 . . . . 15.0 108.262 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 307' ' ' ILE . 47.0 t -110.88 100.33 45.88 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.38 1.072 . . . . 15.0 109.289 -168.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.519 ' HD2' HD11 ' A' ' 349' ' ' LEU . 58.8 Cg_endo -73.59 132.07 16.92 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.573 2.182 . . . . 15.0 112.255 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -60.21 -18.02 45.54 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.874 1.27 . . . . 15.0 112.201 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -45.86 -56.21 5.69 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.399 1.479 . . . . 15.0 111.578 171.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.44 -27.73 41.68 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.242 -1.344 . . . . 15.0 110.815 -172.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -61.21 -54.25 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.347 -0.983 . . . . 15.0 108.347 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.83 -31.47 70.46 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.81 0.694 . . . . 15.0 110.429 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 313' ' ' VAL . 41.3 t -61.8 -53.43 56.05 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 123.837 0.71 . . . . 15.0 111.231 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -80.23 -31.0 38.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.581 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 27.1 mt -59.04 -46.57 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 166.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.31 -41.63 80.26 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.888 0.875 . . . . 15.0 112.055 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.525 HG11 HH12 ' A' ' 344' ' ' ARG . 94.5 t -51.23 -58.35 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 124.291 0.994 . . . . 15.0 109.591 171.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.77 -17.0 62.21 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 113.806 -1.543 . . . . 15.0 112.436 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.5 mtm180 . . . . . 0 N--CA 1.483 1.184 0 C-N-CA 123.333 0.653 . . . . 15.0 109.75 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.179 0.514 . . . . 15.0 112.193 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -114.15 31.45 6.57 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.509 1.124 . . . . 15.0 110.828 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.32 134.03 95.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-O 118.84 -0.6 . . . . 15.0 109.82 172.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -42.64 123.6 3.0 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 124.266 3.311 . . . . 15.0 113.479 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -52.73 -47.32 67.45 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 124.149 0.905 . . . . 15.0 111.498 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.78 -7.04 2.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.12 -43.95 63.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.397 0.544 . . . . 15.0 110.076 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.99 2.13 8.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.526 0.73 . . . . 15.0 112.614 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -58.57 -55.33 36.48 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.735 0.814 . . . . 15.0 111.007 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 40.6 tt0 -56.14 -60.9 2.83 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.796 1.31 . . . . 15.0 111.215 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.68 -38.16 90.03 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.85 -52.89 17.54 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 110.429 -0.212 . . . . 15.0 110.429 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.36 -28.1 64.81 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.908 0.755 . . . . 15.0 110.685 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.589 ' NH2' ' HA ' ' A' ' 288' ' ' SER . 0.2 OUTLIER -72.5 -36.9 68.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.887 0.875 . . . . 15.0 109.563 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.525 HH12 HG11 ' A' ' 313' ' ' VAL . 75.4 mtt180 -64.36 -35.09 79.76 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.886 0.312 . . . . 15.0 110.206 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.58 -53.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.883 0.873 . . . . 15.0 110.227 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.78 -47.28 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 114.304 -1.316 . . . . 15.0 111.239 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 351' ' ' LEU . 53.9 t -61.8 -48.25 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 15.0 110.722 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.58 95.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.695 0.622 . . . . 15.0 113.575 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.519 HD11 ' HD2' ' A' ' 303' ' ' PRO . 94.7 mt -79.74 -58.01 3.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.536 0.735 . . . . 15.0 110.96 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 294' ' ' LEU . 91.1 mt -65.31 -51.81 58.18 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.673 0.608 . . . . 15.0 111.044 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.652 HD12 HG13 ' A' ' 347' ' ' VAL . 39.8 mt -71.17 -33.68 70.23 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 118.843 -0.599 . . . . 15.0 111.222 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.66 92.05 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.78 -0.528 . . . . 15.0 111.78 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.59 -42.83 91.25 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.742 -0.729 . . . . 15.0 111.041 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 350' ' ' LEU . 89.7 t -58.99 -39.95 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 122.976 0.511 . . . . 15.0 111.3 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 360' ' ' LEU . 73.0 mt -68.83 -41.25 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.572 0.749 . . . . 15.0 110.198 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -60.23 -54.75 42.13 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.528 0.517 . . . . 15.0 110.631 174.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.3 m -60.64 -40.0 90.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.256 1.022 . . . . 15.0 111.945 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -96.6 8.62 43.74 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.511 0.725 . . . . 15.0 111.763 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 40.56 51.99 2.99 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.823 1.649 . . . . 15.0 113.648 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.618 ' HB2' HG23 ' A' ' 355' ' ' ILE . 78.5 mt -84.1 142.19 30.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.844 -1.071 . . . . 15.0 111.505 -176.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.62 151.67 49.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 167.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.24 94.87 0.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.036 0.535 . . . . 15.0 110.258 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.8 135.29 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.613 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -58.97 -35.87 73.91 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.12 0.888 . . . . 15.0 111.693 -170.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.49 -33.79 76.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.852 0.461 . . . . 15.0 110.755 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -80.89 -35.8 32.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.112 -0.495 . . . . 15.0 110.424 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 398' ' ' MET . 86.4 t -56.99 -57.57 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.441 0.697 . . . . 15.0 109.544 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -62.89 -33.11 74.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.654 0.781 . . . . 15.0 111.413 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -54.97 -55.21 29.1 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.067 0.855 . . . . 15.0 111.627 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.52 -46.02 80.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.542 0.737 . . . . 15.0 111.26 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.611 HD11 ' HG2' ' A' ' 398' ' ' MET . 47.0 mm -48.85 -61.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 124.539 1.149 . . . . 15.0 110.729 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.68 -37.69 73.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.775 0.658 . . . . 15.0 112.775 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.54 -46.84 77.98 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.043 0.449 . . . . 15.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.2 ttp -69.93 -35.98 74.98 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.432 1.093 . . . . 15.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.72 60.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.138 0.575 . . . . 15.0 112.038 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.4 t -65.83 -17.23 64.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.792 0.837 . . . . 15.0 111.501 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.03 -7.25 50.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.18 0.592 . . . . 15.0 111.664 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -103.31 166.23 10.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.238 1.015 . . . . 15.0 110.874 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.21 -29.2 63.74 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.278 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -155.12 112.71 2.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 15.0 107.7 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.46 -3.94 3.64 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.032 2.488 . . . . 15.0 115.469 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -60.69 -36.93 80.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.668 0.618 . . . . 15.0 112.668 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.1 -36.22 82.85 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.625 0.578 . . . . 15.0 109.897 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.33 -49.14 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.52 0.728 . . . . 15.0 110.121 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.93 -52.24 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 123.831 0.707 . . . . 15.0 109.9 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.33 -54.75 39.68 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.228 0.955 . . . . 15.0 110.674 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -51.09 -57.78 7.8 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.744 1.278 . . . . 15.0 111.566 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -58.37 -53.4 58.76 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.82 0.7 . . . . 15.0 110.662 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.1 p -62.71 -19.05 63.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.69 -7.01 21.01 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.448 0.699 . . . . 15.0 111.861 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 395' ' ' MET . 51.0 t-20 -121.69 86.26 2.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.959 -0.756 . . . . 15.0 108.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -58.62 -32.09 68.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.159 1.384 . . . . 15.0 111.41 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.6 -32.47 73.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.675 0.61 . . . . 15.0 110.754 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 22.3 tp -94.42 -20.18 19.94 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-O 119.464 -0.303 . . . . 15.0 111.112 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 77.2 mmm -59.38 -38.03 79.46 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.196 -0.668 . . . . 15.0 109.196 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.4 -60.24 1.57 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.869 1.268 . . . . 15.0 112.072 168.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -66.34 -34.93 79.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.178 0.991 . . . . 15.0 110.808 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.611 ' HG2' HD11 ' A' ' 371' ' ' ILE . 26.3 tpp -70.27 -27.32 64.33 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.851 0.861 . . . . 15.0 111.226 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 395' ' ' MET . 64.0 mtp85 -79.14 -35.18 42.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.48 -44.91 93.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.611 0.569 . . . . 15.0 110.244 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.0 p -75.7 -28.47 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 123.118 0.261 . . . . 15.0 111.33 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.71 -40.23 96.5 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.275 0.489 . . . . 15.0 110.278 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 355' ' ' ILE . 27.8 tp -73.38 -36.4 66.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.521 -1.218 . . . . 15.0 110.238 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.79 -51.98 67.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.26 1.024 . . . . 15.0 111.187 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 75.3 mm-40 -67.08 -40.77 87.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.401 0.68 . . . . 15.0 110.865 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 360' ' ' LEU . 23.9 tt0 -63.2 -34.3 77.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.794 0.838 . . . . 15.0 110.56 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.71 85.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.538 0.735 . . . . 15.0 111.505 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 94.4 t -52.98 -54.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 O-C-N 123.982 0.801 . . . . 15.0 108.914 171.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 412' ' ' LEU . 31.2 mt-10 -62.47 -26.61 68.61 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.799 -1.091 . . . . 15.0 112.744 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.56 74.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.036 0.534 . . . . 15.0 110.882 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 294' ' ' LEU . 57.8 t -72.63 -35.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.847 -0.798 . . . . 15.0 108.847 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 409' ' ' GLU . 81.6 mt -65.77 -37.35 86.1 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.978 0.798 . . . . 15.0 110.89 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.28 64.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.365 -0.834 . . . . 15.0 112.125 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -106.71 -27.27 10.91 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.959 0.904 . . . . 15.0 111.867 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.21 158.94 16.97 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.743 0.817 . . . . 15.0 111.93 -171.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 88.4 mttt -69.04 78.77 0.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.454 1.101 . . . . 15.0 110.351 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 125' ' ' VAL . 25.5 t -97.9 103.11 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -78.41 119.9 22.38 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.368 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 32.2 tt0 -78.61 87.23 4.56 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.733 0.778 . . . . 15.0 109.263 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -95.66 100.74 12.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.859 -1.064 . . . . 15.0 110.704 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.03 128.54 35.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 15.0 109.279 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.484 HG23 HG22 ' A' ' 130' ' ' VAL . 7.7 t -161.93 176.88 10.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.725 0.41 . . . . 15.0 111.126 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 40.6 p -106.41 171.02 7.58 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.213 1.005 . . . . 15.0 111.669 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -43.57 -60.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.042 1.737 . . . . 15.0 113.593 -168.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.36 -23.02 65.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.732 1.012 . . . . 15.0 113.732 -167.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.442 ' HG2' HG21 ' A' ' 422' ' ' THR . 15.4 tp10 -45.21 -46.78 12.48 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.895 1.278 . . . . 15.0 112.966 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.66 -31.06 41.42 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.799 0.84 . . . . 15.0 110.943 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -71.74 -31.83 67.08 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.448 0.699 . . . . 15.0 110.04 175.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 124.27 1.028 . . . . 15.0 113.627 -173.896 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.38 91.32 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 118.999 0.818 . . . . 0.0 109.173 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.426 HG13 ' OH ' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -145.14 162.6 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 126.107 1.763 . . . . 0.0 108.088 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 177' ' ' PHE . 28.8 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 125.215 1.406 . . . . 0.0 112.929 -177.721 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.611 HD13 ' HB ' ' B' ' 463' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.551 1.007 0 CA-C-O 120.48 0.181 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . 0.304 19.3 p90 67.76 -39.91 0.4 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 128.256 2.622 . . . . 0.0 116.656 169.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -177.83 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.274 1.03 . . . . 0.0 109.652 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 463' ' ' THR . . . . . 0.611 ' HB ' HD13 ' B' ' 460' ' ' LEU . 72.4 m -34.95 118.2 0.42 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.719 1.607 . . . . 0.0 114.612 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 464' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' B' ' 467' ' ' ALA . 24.5 mmt 64.71 119.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.161 1.384 . . . . 0.0 112.302 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.25 -25.01 66.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.085 0.554 . . . . 0.0 110.521 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -96.03 17.99 14.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.528 1.131 . . . . 0.0 111.454 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 467' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' B' ' 464' ' ' MET . . . . . . . . 0 N--CA 1.479 0.98 0 C-N-CA 123.121 0.569 . . . . 0.0 109.675 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 23.3 ptm . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.5 -0.185 . . . . 15.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -150.91 113.29 4.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 17' ' ' ILE . 28.9 m -123.67 146.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.695 0.798 . . . . 15.0 110.29 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 p -137.36 115.47 11.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.377 0.671 . . . . 15.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.33 131.99 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.096 0.559 . . . . 15.0 111.094 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -135.34 148.71 49.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.841 1.256 . . . . 15.0 108.443 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 m -93.46 112.06 23.87 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.538 -0.541 . . . . 15.0 109.538 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -80.52 -44.33 19.3 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.974 0.51 . . . . 15.0 111.284 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -167.42 94.52 0.44 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.344 0.657 . . . . 15.0 109.786 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.36 -102.86 0.41 Allowed Glycine 0 C--N 1.352 1.461 0 O-C-N 123.958 0.786 . . . . 15.0 113.765 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD13 ' HB3' ' A' ' 113' ' ' PRO . 50.9 tp -68.49 -35.25 77.25 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.879 0.872 . . . . 15.0 110.733 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.43 135.26 22.03 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.138 -0.937 . . . . 15.0 112.079 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.6 -177.31 4.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.921 1.288 . . . . 15.0 109.757 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -150.15 110.52 4.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.89 0.876 . . . . 15.0 109.709 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.3 t -98.56 92.03 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.709 -0.848 . . . . 15.0 108.709 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 44.8 m -75.11 105.03 5.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.554 0.742 . . . . 15.0 109.87 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 3' ' ' VAL . 35.8 mt -93.31 115.77 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.857 -0.611 . . . . 15.0 109.6 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -92.71 96.41 10.15 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.433 -0.951 . . . . 15.0 108.433 166.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 70' ' ' LEU . 74.3 mt -73.27 98.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 171.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.93 162.64 23.84 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.232 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.6 -22.35 55.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.572 1.149 . . . . 15.0 113.955 -170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.84 -42.89 89.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.884 0.474 . . . . 15.0 110.508 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -73.68 -36.57 65.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.493 -0.776 . . . . 15.0 110.923 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 28' ' ' VAL . 56.5 mt -68.07 -59.05 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.933 0.493 . . . . 15.0 110.204 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.37 -41.84 97.74 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.217 1.007 . . . . 15.0 112.291 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 m -64.99 -42.11 94.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.647 0.592 . . . . 15.0 110.979 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.31 71.41 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 15.0 112.007 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.446 ' HA ' HG21 ' A' ' 66' ' ' VAL . 79.5 t -62.82 -45.43 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 15.0 110.31 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 3.8 ttmp? -66.27 -39.27 89.33 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.249 -1.341 . . . . 15.0 110.367 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 m -72.27 -21.91 61.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.12 0.968 . . . . 15.0 111.01 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.8 tp10 -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.658 0.383 . . . . 15.0 111.221 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 55' ' ' ALA . 36.2 mt -68.53 -26.54 65.48 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.382 0.273 . . . . 15.0 111.7 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 p -76.54 -29.2 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 123.245 0.34 . . . . 15.0 110.097 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -66.29 -46.33 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.967 0.507 . . . . 15.0 109.934 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 61.0 t -65.54 -37.54 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.983 0.913 . . . . 15.0 110.167 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.24 92.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.32 0.648 . . . . 15.0 111.182 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.58 -23.87 39.59 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.923 0.489 . . . . 15.0 111.513 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.98 -49.3 38.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.613 0.765 . . . . 15.0 110.188 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.38 -5.91 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.944 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 69.47 21.1 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.097 1.359 . . . . 15.0 111.95 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -64.37 -26.28 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 124.331 1.052 . . . . 15.0 111.126 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -59.38 -36.69 76.25 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.112 0.965 . . . . 15.0 111.627 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.54 -10.92 80.08 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.359 -0.382 . . . . 15.0 113.598 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -119.23 2.23 11.36 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.037 0.935 . . . . 15.0 110.774 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.5 ttt85 -76.86 94.86 3.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.288 0.635 . . . . 15.0 110.027 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -80.3 86.5 5.67 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.397 -0.82 . . . . 15.0 110.835 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 37.26 -56.57 0.0 OUTLIER Glycine 0 CA--C 1.55 2.266 0 N-CA-C 120.142 2.817 . . . . 15.0 120.142 160.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -43.09 -47.9 6.13 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.205 1.802 . . . . 15.0 114.228 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.44 106.37 16.31 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.75 0.42 . . . . 15.0 110.192 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 53' ' ' ILE . 3.5 Cg_exo -78.84 156.63 27.31 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.514 2.809 . . . . 15.0 112.299 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 54' ' ' VAL . 58.9 tpp -70.58 -27.18 63.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.863 0.865 . . . . 15.0 111.752 -172.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.7 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 34.0 p-10 -69.84 -28.97 66.13 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.849 0.46 . . . . 15.0 111.924 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.524 HG23 ' HD2' ' A' ' 57' ' ' ARG . 12.3 mt -72.36 -51.89 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.665 0.786 . . . . 15.0 110.14 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 33.8 m -68.61 -25.6 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.47 0.545 . . . . 15.0 112.47 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -60.35 -41.12 92.96 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.393 0.677 . . . . 15.0 112.59 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.25 -3.56 11.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 -170.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 53' ' ' ILE . 75.9 mtt180 -115.64 -45.84 2.88 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.135 0.425 . . . . 15.0 111.623 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.46 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 94.9 m-85 -104.69 -39.01 6.5 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.202 0.816 . . . . 15.0 113.202 -168.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.84 39.5 2.78 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 112.492 -0.243 . . . . 15.0 112.492 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.58 61.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.906 0.882 . . . . 15.0 112.098 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p -73.71 -35.58 65.13 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.062 0.945 . . . . 15.0 111.088 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -69.13 -25.22 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.724 0.81 . . . . 15.0 110.622 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.543 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 25.3 mtp180 -61.1 -22.1 64.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.643 0.777 . . . . 15.0 111.951 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.73 -54.23 49.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.136 0.975 . . . . 15.0 111.232 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 -27.46 66.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 28' ' ' VAL . 94.7 t -64.85 -43.28 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 123.61 0.568 . . . . 15.0 109.76 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 91.5 mt -62.37 -41.65 98.8 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.997 0.519 . . . . 15.0 111.162 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.62 99.13 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.644 0.59 . . . . 15.0 112.282 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.66 -41.17 96.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.384 1.074 . . . . 15.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.692 ' HB3' HD13 ' A' ' 19' ' ' ILE . 71.2 mt -67.84 -34.53 76.89 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.661 -0.7 . . . . 15.0 111.01 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.2 mtm -67.8 -20.69 65.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.566 0.346 . . . . 15.0 111.255 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -87.2 -55.7 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 15.0 110.203 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -72.76 -39.09 67.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.463 0.705 . . . . 15.0 112.544 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -73.22 -27.07 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 117.875 0.307 . . . . 15.0 110.704 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.87 -54.12 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.222 -0.288 . . . . 15.0 110.222 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.421 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.3 tt -65.04 -37.32 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 123.423 0.452 . . . . 15.0 110.896 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.665 0.786 . . . . 15.0 110.653 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.03 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.48 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 33.3 pt -67.06 -23.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 112.717 0.636 . . . . 15.0 112.717 -172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.39 -53.4 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.452 0.701 . . . . 15.0 110.652 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -75.1 -29.5 60.62 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.607 0.363 . . . . 15.0 111.455 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -84.31 -16.35 43.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.278 0.631 . . . . 15.0 111.454 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 66.77 14.06 9.64 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.64 1.176 . . . . 15.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.436 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 74.7 mt -77.24 105.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -81.0 110.03 15.98 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.45 148.53 38.14 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.585 2.19 . . . . 15.0 112.957 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 303' ' ' PRO . . . -152.65 -177.74 6.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.505 0.722 . . . . 15.0 109.856 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 305' ' ' ALA . . . 64.1 -102.13 0.56 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.86 116.34 2.43 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 107.826 -1.175 . . . . 15.0 107.826 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 43.5 Cg_exo -59.59 105.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 121.687 1.591 . . . . 15.0 110.249 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 m -101.71 99.26 9.5 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.247 -0.649 . . . . 15.0 109.247 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.39 78.19 3.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.636 0.774 . . . . 15.0 109.134 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.05 109.47 3.29 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.46 106.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.118 2.545 . . . . 15.0 111.961 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.85 -79.32 0.57 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.243 -0.743 . . . . 15.0 111.243 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -168.16 151.2 5.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.4 0.68 . . . . 15.0 111.533 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.79 142.21 44.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.601 1.16 . . . . 15.0 109.398 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.2 mttt -133.54 142.83 48.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.259 1.024 . . . . 15.0 108.773 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -61.61 106.18 0.63 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 15.0 110.251 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.64 -17.52 58.79 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 116.038 -0.528 . . . . 15.0 113.477 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 43.4 mt-10 -97.94 -173.52 2.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.563 0.745 . . . . 15.0 110.095 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -72.78 160.09 32.74 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.909 0.883 . . . . 15.0 112.492 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -121.55 106.12 11.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.73 1.212 . . . . 15.0 108.56 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 m -105.07 139.52 39.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.624 0.77 . . . . 15.0 109.93 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -159.96 143.58 14.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.027 0.931 . . . . 15.0 108.818 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.8 m -100.64 107.99 19.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.72 0.808 . . . . 15.0 110.565 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.15 97.69 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.98 -0.748 . . . . 15.0 108.98 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.3 123.05 35.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.229 0.612 . . . . 15.0 109.882 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 47.1 p90 -159.52 157.85 30.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.772 0.829 . . . . 15.0 110.276 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.3 176.63 7.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 15.0 109.994 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.36 175.96 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -89.76 118.08 68.67 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.63 ' HG2' HD11 ' A' ' 300' ' ' ILE . 58.6 Cg_endo -88.53 173.03 4.63 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.606 2.204 . . . . 15.0 114.427 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.65 134.68 33.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.123 -1.399 . . . . 15.0 109.059 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.49 126.98 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.417 -0.586 . . . . 15.0 109.417 172.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -84.3 94.13 8.38 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.4 145.25 54.5 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.141 -0.936 . . . . 15.0 108.763 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -79.15 173.83 12.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.58 109.86 2.43 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.548 -1.021 . . . . 15.0 110.548 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.433 HD13 HG22 ' A' ' 411' ' ' VAL . 47.1 mt -66.8 -14.12 62.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.609 0.763 . . . . 15.0 111.246 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.96 -22.61 63.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.289 . . . . 15.0 111.289 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.74 62.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.773 0.829 . . . . 15.0 110.947 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.04 131.34 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.619 0.768 . . . . 15.0 109.657 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.25 123.84 49.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.911 0.884 . . . . 15.0 109.618 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 417' ' ' VAL . 61.4 t -125.27 163.66 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.838 1.255 . . . . 15.0 107.917 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.34 143.97 48.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.532 0.733 . . . . 15.0 109.262 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 129' ' ' ILE . 80.6 tttt -114.87 93.52 34.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.133 -1.062 . . . . 15.0 108.133 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.79 98.61 1.22 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.17 1.914 . . . . 15.0 112.289 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 127' ' ' LYS . 48.5 mm -72.52 96.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 427' ' ' LEU . 21.0 t -122.74 142.82 37.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.526 -0.761 . . . . 15.0 109.997 -173.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.47 146.25 39.81 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.817 0.847 . . . . 15.0 108.932 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.54 88.81 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.5 p -76.24 -179.85 5.31 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.894 0.878 . . . . 15.0 110.339 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.92 -37.59 74.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.444 0.698 . . . . 15.0 111.689 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.8 96.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 15.0 111.492 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.45 -42.94 52.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.808 0.843 . . . . 15.0 111.556 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.79 -56.44 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.902 0.881 . . . . 15.0 109.489 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.37 -45.89 92.49 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.175 0.99 . . . . 15.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.33 -46.91 89.35 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.919 0.762 . . . . 15.0 113.333 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.24 -51.68 50.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.143 0.577 . . . . 15.0 110.896 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.2 mt -53.91 -39.39 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.569 0.748 . . . . 15.0 111.86 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.43 -40.9 85.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.925 0.49 . . . . 15.0 111.027 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 m -67.89 -26.74 66.16 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.752 0.421 . . . . 15.0 110.756 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.86 -37.73 76.19 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.852 0.461 . . . . 15.0 110.333 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -64.68 -35.06 79.82 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.707 0.289 . . . . 15.0 110.424 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -69.3 -34.6 74.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.306 0.642 . . . . 15.0 111.099 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.66 -41.26 79.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 15.0 109.98 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -95.1 29.66 2.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.027 0.931 . . . . 15.0 111.184 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.09 135.48 46.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.106 0.562 . . . . 15.0 112.434 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.1 m -83.54 138.85 33.22 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.625 1.17 . . . . 15.0 110.25 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -80.16 139.17 36.91 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.829 0.452 . . . . 15.0 110.236 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 33.1 ttpt -156.98 172.99 17.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.09 -1.078 . . . . 15.0 108.09 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 41.6 mt-10 -121.64 165.72 15.33 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.97 0.908 . . . . 15.0 110.035 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.533 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 41.6 pttt -156.78 -179.92 8.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.031 0.933 . . . . 15.0 110.87 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.03 146.95 28.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.977 0.511 . . . . 15.0 109.655 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.19 -50.21 0.88 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.0 -0.889 . . . . 15.0 113.533 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 206' ' ' LYS . . . -153.57 153.89 33.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.465 1.132 . . . . 15.0 112.234 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.84 157.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.47 1.108 . . . . 15.0 109.517 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -138.51 -174.88 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.485 1.914 . . . . 15.0 108.252 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.531 ' HA ' ' HE1' ' A' ' 189' ' ' MET . . . -84.08 -8.73 59.03 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.459 0.911 . . . . 15.0 113.459 -174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.52 -6.5 20.55 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.143 0.429 . . . . 15.0 112.021 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -81.61 178.4 8.36 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.054 1.131 . . . . 15.0 114.054 -165.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.717 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 16.0 mtm180 -116.27 98.77 6.78 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.833 -1.076 . . . . 15.0 108.503 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.01 97.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 -169.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 9.0 m -73.32 111.73 8.72 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.851 -1.166 . . . . 15.0 107.851 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.8 pt -132.95 179.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.422 1.089 . . . . 15.0 110.924 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.8 t70 -130.04 157.53 42.1 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.179 1.391 . . . . 15.0 107.713 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' B' ' 385' ' ' LEU . 24.4 p90 -144.61 150.59 37.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.636 0.731 . . . . 15.0 111.074 164.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.536 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 1.8 t -125.99 95.12 4.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 106.467 -1.679 . . . . 15.0 106.467 166.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.96 166.77 31.34 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 114.93 -1.032 . . . . 15.0 115.067 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -151.19 141.97 22.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.964 1.306 . . . . 15.0 108.283 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.3 t -118.55 137.52 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.584 0.754 . . . . 15.0 109.141 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.544 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 35.3 t70 70.48 5.83 5.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.721 1.208 . . . . 15.0 111.875 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.31 -1.0 46.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.722 -0.488 . . . . 15.0 113.37 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.01 145.41 49.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.627 0.771 . . . . 15.0 110.576 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -76.01 110.48 10.52 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.149 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 172' ' ' VAL . 32.7 p90 -70.84 170.38 12.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.219 0.608 . . . . 15.0 111.259 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -69.68 134.56 48.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.63 -1.168 . . . . 15.0 111.057 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.587 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 88.25 -78.64 1.75 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 -52.4 4.17 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.412 0.925 . . . . 15.0 115.412 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.536 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 40.6 mmtt -85.9 145.97 26.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.913 1.079 . . . . 15.0 113.913 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.05 92.48 1.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.658 -1.61 . . . . 15.0 106.933 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -96.32 143.78 27.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.308 -0.86 . . . . 15.0 110.967 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.5 t70 65.75 21.92 11.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.338 1.055 . . . . 15.0 111.373 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 165' ' ' THR . 46.7 t80 -71.59 134.23 46.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.225 0.61 . . . . 15.0 110.579 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.35 103.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.794 -0.817 . . . . 15.0 108.794 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HG ' ' HG2' ' A' ' 189' ' ' MET . 27.0 tp -82.8 80.1 8.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 15.0 110.047 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.54 92.44 0.31 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.691 -1.226 . . . . 15.0 107.691 167.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.531 ' HE1' ' HA ' ' A' ' 160' ' ' ALA . 62.5 mtp -66.98 144.64 56.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.394 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.12 14.57 Favored Glycine 0 N--CA 1.471 0.978 0 O-C-N 123.496 0.498 . . . . 15.0 112.494 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.44 -178.96 3.65 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.27 1.028 . . . . 15.0 110.339 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.17 6.93 56.5 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 115.912 -0.586 . . . . 15.0 113.518 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -77.84 2.09 18.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.098 0.559 . . . . 15.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.7 mmt -134.74 154.53 51.54 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.911 0.884 . . . . 15.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.57 152.84 37.94 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 114.757 -1.11 . . . . 15.0 109.374 170.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.93 143.97 46.95 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.03 2.487 . . . . 15.0 112.928 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.24 -40.29 2.47 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 115.803 -0.635 . . . . 15.0 112.164 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -67.85 -63.81 0.99 Allowed 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.28 -24.57 67.36 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.437 -0.801 . . . . 15.0 112.077 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.91 -37.59 81.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.083 0.953 . . . . 15.0 110.682 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.78 -10.95 80.79 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.468 -0.787 . . . . 15.0 113.075 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.448 HG21 HD23 ' A' ' 187' ' ' LEU . 42.9 mm -94.84 -47.12 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.763 0.825 . . . . 15.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -82.41 19.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.325 1.232 . . . . 15.0 114.325 -167.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.78 25.39 5.31 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.99 -1.244 . . . . 15.0 109.99 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -140.71 -169.96 2.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.729 1.211 . . . . 15.0 110.213 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -153.52 163.56 39.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.996 0.918 . . . . 15.0 110.675 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -68.07 132.2 46.81 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.38 0.672 . . . . 15.0 112.06 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 126.77 -28.24 4.71 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.761 -1.109 . . . . 15.0 111.799 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.8 pt-20 -96.14 139.32 32.48 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.727 0.775 . . . . 15.0 111.455 -174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.27 125.8 51.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.981 1.313 . . . . 15.0 108.948 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -144.38 169.67 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.073 0.949 . . . . 15.0 109.769 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 70.2 m -124.34 120.45 32.17 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -95.64 160.48 2.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.497 0.719 . . . . 15.0 111.207 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -104.92 118.42 36.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.99 -1.005 . . . . 15.0 109.903 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.6 163.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 87.3 m -146.26 131.9 18.86 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.971 -1.122 . . . . 15.0 107.971 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.473 ' HZ ' ' HB ' ' B' ' 387' ' ' ILE . 73.0 m-85 -68.23 135.47 91.32 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 110.128 -0.323 . . . . 15.0 110.128 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.21 156.68 19.91 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.161 2.574 . . . . 15.0 113.515 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.609 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -75.22 -20.71 59.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.917 169.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.22 -16.7 57.59 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.914 0.886 . . . . 15.0 111.21 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.443 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 69.5 t80 -60.66 142.09 56.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.069 0.948 . . . . 15.0 111.616 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -65.03 -44.95 87.45 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.027 0.931 . . . . 15.0 112.76 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.443 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -88.2 104.11 16.4 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.8 tt0 -63.3 -21.08 66.03 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.672 1.189 . . . . 15.0 112.428 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.448 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 29.6 p30 -68.14 -10.56 55.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.809 0.843 . . . . 15.0 112.518 174.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 388' ' ' VAL . 79.1 mt -121.39 -36.91 2.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.235 1.014 . . . . 15.0 110.05 175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.799 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 9.3 tttm -53.48 128.89 30.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.779 1.632 . . . . 15.0 111.991 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.02 16.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.998 -0.547 . . . . 15.0 113.22 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 173' ' ' ASP . 93.3 mttt -86.24 147.44 26.1 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.379 0.672 . . . . 15.0 110.343 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.25 166.63 22.48 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.728 0.643 . . . . 15.0 110.416 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.02 119.62 5.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.39 0.676 . . . . 15.0 109.816 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -98.86 134.45 41.72 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -128.54 110.73 12.54 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.87 0.468 . . . . 15.0 110.273 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.8 91.73 4.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.405 0.622 . . . . 15.0 109.342 176.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 168' ' ' PHE . 33.6 mm -81.16 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.926 1.29 . . . . 15.0 110.636 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.3 m120 -111.3 97.25 6.64 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.463 -1.31 . . . . 15.0 107.463 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -81.41 118.55 22.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -115.46 -37.49 4.0 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.588 0.355 . . . . 15.0 111.618 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.723 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.0 mmtt -135.87 142.97 44.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.999 0.52 . . . . 15.0 110.235 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 207' ' ' ALA . 41.8 t -118.45 94.49 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.644 -1.243 . . . . 15.0 107.644 169.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.7 mt-10 -88.28 167.01 13.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.8 tt0 -138.9 130.54 27.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.949 0.499 . . . . 15.0 109.823 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -86.14 85.8 7.35 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.673 -1.232 . . . . 15.0 107.673 166.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.76 134.7 53.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.856 -1.065 . . . . 15.0 109.837 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.41 126.59 87.46 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.788 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 63.9 Cg_endo -68.93 157.95 59.84 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.958 2.439 . . . . 15.0 111.917 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -70.9 160.13 33.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.938 -1.028 . . . . 15.0 110.415 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.4 tp -88.3 30.01 0.92 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.622 0.769 . . . . 15.0 109.83 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.6 p -70.14 169.57 13.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.518 1.127 . . . . 15.0 111.623 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -37.97 -65.86 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.082 1.753 . . . . 15.0 114.72 -166.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.01 -22.57 66.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.678 0.791 . . . . 15.0 112.611 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -86.74 -49.87 7.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.061 0.544 . . . . 15.0 110.465 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.41 -31.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.758 0.423 . . . . 15.0 110.78 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.3 ptmt -98.97 5.14 47.33 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -61.27 -31.11 70.93 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.377 0.671 . . . . 15.0 110.777 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.12 -18.72 64.71 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.087 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.67 45.45 1.79 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.703 -0.559 . . . . 15.0 111.703 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 260' ' ' ASP . 65.8 t -71.91 149.28 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.717 0.807 . . . . 15.0 111.431 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -55.97 -41.51 74.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.478 1.111 . . . . 15.0 111.601 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.518 ' H ' HG12 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -128.36 -47.97 1.31 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.581 -175.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 114.73 -12.62 20.57 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.634 -0.536 . . . . 15.0 113.373 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 94.2 p -73.47 167.64 20.88 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.558 0.679 . . . . 15.0 110.955 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.85 -49.41 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.124 0.97 . . . . 15.0 111.257 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.32 -28.8 68.42 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.314 0.646 . . . . 15.0 111.715 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.67 -26.13 57.11 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.129 -0.788 . . . . 15.0 111.129 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 270' ' ' VAL . 63.9 tp -74.71 -33.7 62.46 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -61.57 -40.08 93.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.396 0.679 . . . . 15.0 109.919 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.6 86.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.698 0.799 . . . . 15.0 111.317 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.3 -49.49 64.01 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.661 0.784 . . . . 15.0 110.516 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.483 ' HA ' ' SD ' ' A' ' 274' ' ' MET . 70.2 t -61.67 -33.67 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.736 1.214 . . . . 15.0 109.75 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -62.85 -61.65 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.493 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -71.71 -15.73 62.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.774 0.657 . . . . 15.0 112.774 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -89.27 -78.78 0.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' A' ' 270' ' ' VAL . 1.7 mpt? -62.85 -50.58 70.37 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.656 -0.687 . . . . 15.0 111.553 -169.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.15 -34.32 56.49 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.586 0.63 . . . . 15.0 111.656 -170.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -73.57 -44.08 58.21 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.942 -0.392 . . . . 15.0 109.942 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.03 -37.87 88.92 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.609 0.568 . . . . 15.0 109.783 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.13 -60.87 2.85 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.405 0.682 . . . . 15.0 111.354 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.83 -29.47 69.94 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.726 0.641 . . . . 15.0 111.281 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -65.34 -46.11 81.55 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.68 -30.72 68.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.772 0.829 . . . . 15.0 111.761 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.1 mt -67.88 -51.42 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.565 HH21 ' HB3' ' A' ' 405' ' ' GLU . 22.9 tpt180 -61.05 -41.84 97.36 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.351 -0.84 . . . . 15.0 110.429 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -72.09 -30.27 64.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.799 -0.619 . . . . 15.0 110.851 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -64.24 -57.89 8.15 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.985 0.514 . . . . 15.0 109.672 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 282' ' ' ILE . 42.1 t -57.33 -46.17 85.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 124.263 0.977 . . . . 15.0 110.216 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -59.45 -55.75 30.67 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.749 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -65.15 -28.86 69.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.311 0.644 . . . . 15.0 111.995 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.496 ' HB2' HG13 ' A' ' 125' ' ' VAL . 58.6 mt-30 -68.29 -44.32 75.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.563 0.345 . . . . 15.0 110.506 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.34 -42.32 96.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.578 0.351 . . . . 15.0 111.202 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -60.35 -53.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 15.0 111.01 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.78 -41.23 99.16 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.985 0.803 . . . . 15.0 110.271 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.19 91.88 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.939 0.775 . . . . 15.0 112.095 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 411' ' ' VAL . 35.1 mt -59.03 -56.73 18.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.96 0.904 . . . . 15.0 111.846 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.31 -53.73 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.581 0.551 . . . . 15.0 110.3 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.88 -40.3 75.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.499 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.58 -33.93 67.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.022 -0.536 . . . . 15.0 112.224 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -116.76 103.85 10.76 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.038 0.381 . . . . 15.0 111.433 -163.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -74.11 144.52 44.9 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.63 HD11 ' HG2' ' A' ' 113' ' ' PRO . 5.3 tp -165.08 130.39 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.408 0.683 . . . . 15.0 110.214 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.58 95.88 4.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.505 HG11 HG12 ' A' ' 345' ' ' VAL . 22.7 t -89.04 128.02 53.43 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 109.264 -0.643 . . . . 15.0 109.264 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 54.3 Cg_endo -68.2 135.12 33.44 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.466 2.111 . . . . 15.0 111.858 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -64.5 -4.77 4.33 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.095 1.146 . . . . 15.0 114.095 -171.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 88' ' ' GLY . . . -56.83 -55.14 38.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.989 0.915 . . . . 15.0 110.803 174.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.57 -35.63 77.64 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.654 1.221 . . . . 15.0 110.89 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.626 ' HA ' HG21 ' A' ' 345' ' ' VAL . 2.1 mp -60.33 -56.68 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.964 -0.754 . . . . 15.0 108.964 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.16 -28.43 68.11 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.789 0.681 . . . . 15.0 111.135 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.0 t -60.67 -53.54 56.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.028 0.931 . . . . 15.0 111.222 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -76.73 -30.14 56.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.329 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.647 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.3 mt -60.99 -39.18 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 168.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.502 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.5 t70 -66.41 -40.22 89.46 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-O 118.398 -0.811 . . . . 15.0 110.607 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.67 -47.74 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.164 0.507 . . . . 15.0 110.281 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.1 mt -70.43 -27.01 63.93 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.202 -0.908 . . . . 15.0 112.047 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 84.1 mtm180 . . . . . 0 N--CA 1.48 1.059 0 C-N-CA 123.584 0.753 . . . . 15.0 110.54 172.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.9 tp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 112.178 0.436 . . . . 15.0 112.178 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.53 -27.97 60.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.092 0.557 . . . . 15.0 111.496 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.84 128.23 63.05 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 123.455 0.472 . . . . 15.0 110.363 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.6 Cg_exo -47.96 118.23 2.99 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.56 2.84 . . . . 15.0 113.649 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.647 ' HG3' HD13 ' A' ' 311' ' ' ILE . 66.3 ttt180 -52.79 -37.5 59.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.075 0.95 . . . . 15.0 112.028 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -10.22 48.84 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.572 0.749 . . . . 15.0 112.964 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.9 mt -71.27 -30.0 65.76 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.16 0.436 . . . . 15.0 110.653 171.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 311' ' ' ILE . 32.6 m-85 -122.9 -4.63 8.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.524 0.73 . . . . 15.0 111.541 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.425 ' HA ' HD11 ' A' ' 311' ' ' ILE . 8.9 tp10 -45.96 -68.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.565 1.146 . . . . 15.0 112.836 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.76 -48.84 80.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.702 0.626 . . . . 15.0 112.042 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.76 -45.95 73.44 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 123.575 0.547 . . . . 15.0 111.362 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.421 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -66.26 -56.34 11.74 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.231 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -53.53 -35.61 60.88 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.316 1.01 . . . . 15.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -61.5 -51.15 69.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.966 -0.561 . . . . 15.0 109.677 171.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -68.38 -18.77 64.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.119 0.568 . . . . 15.0 111.906 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 307' ' ' ILE . 69.5 t -77.57 -45.3 29.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.12 0.968 . . . . 15.0 110.167 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 77.6 t -58.9 -44.71 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.7 t -56.06 -46.47 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.338 1.055 . . . . 15.0 110.878 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.51 72.64 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.763 -0.653 . . . . 15.0 113.258 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.67 -44.34 56.96 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.2 mt -70.72 -46.42 63.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.216 0.607 . . . . 15.0 110.65 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.18 -38.74 92.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.136 0.574 . . . . 15.0 110.417 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.23 94.09 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.783 0.677 . . . . 15.0 112.512 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.82 -36.64 78.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.088 0.555 . . . . 15.0 110.945 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -64.97 -40.8 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.91 0.484 . . . . 15.0 110.201 174.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.481 ' HA ' HD12 ' A' ' 360' ' ' LEU . 96.1 mt -63.56 -41.79 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.984 0.913 . . . . 15.0 110.428 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.668 ' HA ' HD13 ' B' ' 460' ' ' LEU . 35.9 ttp180 -69.92 -58.94 3.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.775 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 51.9 m -61.25 -37.3 82.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.189 0.996 . . . . 15.0 112.059 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.73 8.23 41.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.138 0.421 . . . . 15.0 112.138 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 41.4 48.54 3.32 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.233 1.413 . . . . 15.0 113.383 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 355' ' ' ILE . 96.0 mt -70.79 148.39 47.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.847 -1.07 . . . . 15.0 111.709 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.55 143.78 41.76 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.681 0.792 . . . . 15.0 110.053 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -78.28 111.68 14.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.05 0.94 . . . . 15.0 110.12 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.81 140.47 29.63 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.744 0.818 . . . . 15.0 110.719 -172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -60.23 -40.33 89.83 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.785 0.834 . . . . 15.0 112.366 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.33 -25.85 64.41 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.248 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.423 HH21 ' HB2' ' A' ' 405' ' ' GLU . 58.7 ttt85 -74.79 -40.97 60.83 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 371' ' ' ILE . 61.0 t -58.83 -47.24 89.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.004 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -51.96 -47.73 64.66 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.156 0.91 . . . . 15.0 111.684 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.89 -51.02 48.08 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.277 0.986 . . . . 15.0 112.771 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 402' ' ' ALA . 90.7 mt -62.62 -46.69 87.11 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.662 0.785 . . . . 15.0 112.378 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 367' ' ' VAL . 48.4 mm -54.68 -53.35 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.041 0.937 . . . . 15.0 110.164 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.84 -35.26 74.6 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.37 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.0 -50.17 75.11 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.618 0.767 . . . . 15.0 112.031 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -74.06 -43.66 57.0 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.277 -0.419 . . . . 15.0 110.703 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -43.05 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.345 0.658 . . . . 15.0 112.241 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.3 t -60.19 -25.8 65.87 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 124.024 0.828 . . . . 15.0 111.699 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.8 58.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.73 0.812 . . . . 15.0 112.25 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -92.41 169.53 10.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.317 0.647 . . . . 15.0 111.151 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.8 -36.57 82.69 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.442 -1.254 . . . . 15.0 110.365 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -131.86 100.97 15.63 Favored Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.987 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.7 -24.53 18.25 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.389 2.06 . . . . 15.0 112.703 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -54.46 -48.53 71.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.349 1.06 . . . . 15.0 111.544 -168.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -65.85 -30.45 71.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.26 0.975 . . . . 15.0 111.177 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.16 -45.27 54.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.64 -55.06 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.681 0.613 . . . . 15.0 109.397 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.92 -34.84 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.546 0.738 . . . . 15.0 112.493 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.99 -54.54 6.72 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.738 0.304 . . . . 15.0 111.139 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -47.71 33.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.248 0.619 . . . . 15.0 111.409 -166.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.7 p -58.83 -30.07 67.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.704 0.802 . . . . 15.0 112.534 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -86.12 -26.33 25.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.511 -0.768 . . . . 15.0 111.681 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.43 95.54 6.56 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 2.9 ttmt -71.31 -18.93 62.38 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.262 1.025 . . . . 15.0 111.6 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -66.76 -41.53 87.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.564 0.746 . . . . 15.0 110.489 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.407 HD11 ' HB1' ' B' ' 443' ' ' ALA . 58.6 tp -88.24 -31.46 19.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.555 0.742 . . . . 15.0 109.846 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.682 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 55.4 ttm -61.92 -26.64 68.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.74 0.416 . . . . 15.0 110.835 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -48.17 81.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.073 0.549 . . . . 15.0 110.125 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.47 -26.87 66.58 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.563 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.562 ' HA ' HG12 ' A' ' 401' ' ' VAL . 10.5 tpt -74.55 -27.39 60.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.975 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 395' ' ' MET . 82.2 mtp180 -72.06 -34.62 68.87 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 170.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -42.95 94.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.918 0.487 . . . . 15.0 111.235 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.9 p -73.97 -27.79 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 121.215 -0.194 . . . . 15.0 111.243 174.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -61.36 -44.04 97.85 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.36 0.6 . . . . 15.0 109.449 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 21.1 tp -73.41 -32.52 64.48 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.183 -1.371 . . . . 15.0 110.672 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -66.22 -51.91 53.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 15.0 110.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.565 ' HB3' HH21 ' A' ' 283' ' ' ARG . 77.9 mm-40 -61.92 -35.38 78.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.464 0.706 . . . . 15.0 110.833 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -74.2 -32.74 63.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.433 0.693 . . . . 15.0 110.791 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.75 99.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.193 0.597 . . . . 15.0 110.244 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.78 -53.96 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.693 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.69 -21.57 66.55 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.754 0.822 . . . . 15.0 113.193 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.13 -31.69 64.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.023 0.529 . . . . 15.0 110.523 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 294' ' ' LEU . 75.4 t -77.38 -36.35 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.88 -37.83 82.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.939 0.896 . . . . 15.0 111.246 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.24 68.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.616 0.767 . . . . 15.0 111.038 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -95.96 -29.73 14.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.028 0.931 . . . . 15.0 111.555 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.39 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.63 0.772 . . . . 15.0 112.29 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -79.02 78.93 5.44 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.248 -0.887 . . . . 15.0 109.709 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 125' ' ' VAL . 48.5 t -90.17 92.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.456 0.702 . . . . 15.0 109.567 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 39.8 p -74.07 94.66 2.42 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.779 0.832 . . . . 15.0 110.859 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.28 119.9 17.13 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.2 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 422' ' ' THR . 0.0 OUTLIER -135.35 145.74 47.71 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.438 -0.578 . . . . 15.0 109.438 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.94 136.91 39.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 15.0 109.675 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.424 HG21 ' HE3' ' A' ' 420' ' ' LYS . 11.9 t -163.41 176.66 9.6 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.822 0.449 . . . . 15.0 111.382 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.3 p -93.55 173.4 7.71 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.142 0.977 . . . . 15.0 111.389 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.24 -19.05 42.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.303 1.441 . . . . 15.0 112.05 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -66.43 -5.41 10.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.939 1.296 . . . . 15.0 113.526 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.595 ' HB3' HD12 ' A' ' 427' ' ' LEU . 14.4 tp10 -74.95 -55.41 5.8 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.529 0.732 . . . . 15.0 112.472 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.4 mp -90.35 -71.84 0.6 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.332 0.493 . . . . 15.0 112.332 -163.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -107.15 33.54 3.93 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.358 0.663 . . . . 15.0 111.873 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.8 t30 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 122.091 0.948 . . . . 15.0 111.867 -174.958 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 385' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.8 mm? . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 386' ' ' VAL . . . . . 0.587 HG11 ' HA3' ' A' ' 179' ' ' GLY . 11.4 t -75.32 98.21 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.473 ' HB ' ' HZ ' ' A' ' 217' ' ' PHE . 22.5 pt -136.66 84.58 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 159.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.862 ' HA ' HD11 ' A' ' 226' ' ' LEU . 5.4 p . . . . . 0 CA--C 1.544 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.845 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 443' ' ' ALA . . . . . 0.407 ' HB1' HD11 ' A' ' 394' ' ' LEU . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.474 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 111.274 -174.79 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 460' ' ' LEU . . . . . 0.668 HD13 ' HA ' ' A' ' 356' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -48.23 -33.72 9.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.099 1.76 . . . . 0.0 114.65 -166.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -136.86 -70.21 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 110.839 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 70.35 136.29 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.451 1.5 . . . . 0.0 111.587 -172.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.12 166.02 24.08 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.028 0.531 . . . . 0.0 110.233 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.26 90.92 2.12 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.107 0.48 . . . . 0.0 109.816 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -173.15 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.219 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.804 172.679 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 18.7 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.326 -0.25 . . . . 15.0 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -168.01 97.36 0.44 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.84 -1.17 . . . . 15.0 107.84 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 17' ' ' ILE . 22.9 m -111.62 152.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.709 0.804 . . . . 15.0 111.873 -169.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -137.64 92.04 2.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 15.0 109.018 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.46 89.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 122.559 1.171 . . . . 15.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -94.08 92.6 7.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.67 -1.15 . . . . 15.0 109.494 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 32.4 m -67.41 94.18 0.38 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.388 -0.824 . . . . 15.0 109.896 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 p -75.18 -66.96 0.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.137 0.975 . . . . 15.0 111.343 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -151.23 121.6 7.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.927 0.491 . . . . 15.0 110.368 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -103.96 0.64 Allowed Glycine 0 C--N 1.35 1.325 0 O-C-N 124.38 1.05 . . . . 15.0 114.239 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 2.5 mm? -77.33 -34.29 55.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.508 0.723 . . . . 15.0 110.083 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.37 97.4 0.11 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 124.622 1.201 . . . . 15.0 114.06 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD2' HG11 ' A' ' 111' ' ' VAL . 50.9 mtt85 -112.59 86.81 2.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.354 -1.35 . . . . 15.0 107.354 168.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -72.53 91.53 1.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.47 -1.241 . . . . 15.0 110.376 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.7 t -79.27 87.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.774 -0.824 . . . . 15.0 108.774 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 88.8 m -74.77 105.36 5.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.321 -0.854 . . . . 15.0 109.779 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 HG12 ' A' ' 3' ' ' VAL . 33.6 mt -101.28 118.49 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.679 0.791 . . . . 15.0 110.301 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.1 m -88.75 104.87 17.3 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.366 0.666 . . . . 15.0 109.214 165.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -81.29 108.16 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.939 -1.134 . . . . 15.0 107.939 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.95 160.12 33.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.929 0.491 . . . . 15.0 111.869 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.27 -22.5 66.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.363 1.065 . . . . 15.0 113.419 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.35 -42.03 88.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.836 0.455 . . . . 15.0 109.963 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 m -70.95 -40.16 72.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.161 -0.927 . . . . 15.0 110.278 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.0 mt -69.85 -51.97 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.656 0.782 . . . . 15.0 111.087 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.86 -39.83 90.63 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.758 0.823 . . . . 15.0 111.077 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.7 m -66.24 -44.7 83.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.609 -0.723 . . . . 15.0 110.952 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.23 -39.86 78.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.217 0.607 . . . . 15.0 112.522 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' ILE . 66.7 t -61.18 -44.95 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.131 0.572 . . . . 15.0 109.728 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -67.82 -39.49 83.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -73.41 -16.93 61.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.414 1.085 . . . . 15.0 111.424 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -88.6 -39.98 13.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.937 0.495 . . . . 15.0 110.439 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 59' ' ' GLY . 81.6 mt -74.23 -20.79 60.05 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.89 0.7 . . . . 15.0 112.89 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.2 p -66.39 -32.19 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 109.854 -0.424 . . . . 15.0 109.854 174.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -67.97 -45.3 74.54 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.901 0.88 . . . . 15.0 109.917 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.5 -40.08 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 114.923 -1.035 . . . . 15.0 110.506 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.65 85.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.889 0.876 . . . . 15.0 110.85 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -66.82 -44.19 81.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.652 -0.704 . . . . 15.0 111.462 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.08 -51.24 68.76 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.731 0.644 . . . . 15.0 110.752 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.43 -5.35 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 115.544 -0.753 . . . . 15.0 110.904 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 76.05 10.77 3.09 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.598 1.559 . . . . 15.0 112.39 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.11 -33.5 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.264 1.026 . . . . 15.0 110.607 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.76 -41.47 77.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 15.0 110.276 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.11 -36.23 92.03 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 124.204 0.94 . . . . 15.0 112.947 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -77.81 -31.96 52.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.167 0.587 . . . . 15.0 110.794 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -75.57 117.3 17.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.937 0.495 . . . . 15.0 110.989 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.95 21.36 17.67 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.776 0.83 . . . . 15.0 110.205 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.67 48.41 50.05 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.465 -0.789 . . . . 15.0 112.426 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.26 -60.71 3.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.115 0.566 . . . . 15.0 110.713 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 t -103.86 128.73 26.66 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.4 148.74 4.86 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 124.045 3.163 . . . . 15.0 114.917 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.453 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.6 tpp -65.18 -36.56 84.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.338 1.055 . . . . 15.0 111.984 -172.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -58.59 -37.68 76.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.501 0.721 . . . . 15.0 111.964 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.77 -54.25 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.153 0.981 . . . . 15.0 110.557 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 51' ' ' MET . 35.6 m -68.56 -34.24 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.488 0.551 . . . . 15.0 112.488 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.11 63.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.89 0.476 . . . . 15.0 112.058 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.04 -19.94 63.27 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.125 0.417 . . . . 15.0 112.125 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.34 -58.92 2.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.1 0.56 . . . . 15.0 111.142 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.65 -23.27 66.13 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.993 0.517 . . . . 15.0 111.98 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -93.4 21.55 40.01 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.715 -0.491 . . . . 15.0 113.935 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.82 73.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.501 0.721 . . . . 15.0 110.865 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 p -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.48 0.712 . . . . 15.0 111.096 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.17 -6.99 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 124.306 1.043 . . . . 15.0 112.05 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -55.07 -38.42 68.02 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.849 0.46 . . . . 15.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -58.2 -47.4 83.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.682 0.793 . . . . 15.0 111.469 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.17 -43.76 98.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.559 0.744 . . . . 15.0 110.551 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.38 -44.33 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.414 -1.266 . . . . 15.0 110.946 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 71' ' ' MET . 91.2 mt -66.95 -36.75 82.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.939 0.495 . . . . 15.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.24 -43.72 95.33 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.734 0.646 . . . . 15.0 111.873 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 27.4 t70 -64.08 -48.38 76.43 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.48 0.712 . . . . 15.0 110.512 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 80.5 mt -63.38 -32.46 73.89 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.191 0.996 . . . . 15.0 112.556 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 58.8 mtm -61.62 -41.52 97.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.613 0.365 . . . . 15.0 110.561 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -72.85 -36.86 67.52 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.597 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 29.4 mmt180 -60.63 -52.32 65.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.411 0.684 . . . . 15.0 110.65 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 17' ' ' ILE . 33.7 m-80 -75.65 -26.06 57.39 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.188 -0.914 . . . . 15.0 111.756 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -68.7 -58.07 4.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.577 0.351 . . . . 15.0 110.925 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.39 -40.44 87.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 123.721 0.638 . . . . 15.0 110.288 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.92 -40.37 96.33 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.219 1.008 . . . . 15.0 110.85 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.26 -61.77 2.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.595 -0.729 . . . . 15.0 111.446 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 pt -60.73 -24.45 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.63 0.772 . . . . 15.0 112.975 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.6 -58.08 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.543 0.737 . . . . 15.0 110.532 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.4 ptpt -77.57 -23.41 50.0 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.055 0.391 . . . . 15.0 112.055 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -86.89 -17.24 33.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.21 0.604 . . . . 15.0 110.749 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 62.0 33.47 17.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.417 1.087 . . . . 15.0 111.416 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.9 mt -77.96 106.5 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.96 -1.126 . . . . 15.0 107.96 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -78.07 102.4 0.94 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.8 0.84 . . . . 15.0 109.047 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -94.5 -177.0 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.237 2.625 . . . . 15.0 112.662 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.89 166.17 11.39 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.447 1.099 . . . . 15.0 109.635 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.43 -156.43 51.1 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.472 -0.786 . . . . 15.0 113.675 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.29 67.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.661 0.785 . . . . 15.0 109.665 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.26 107.35 0.56 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.416 2.077 . . . . 15.0 111.041 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -87.13 94.88 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.482 0.713 . . . . 15.0 109.912 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.99 91.53 4.86 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.21 109.37 6.21 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.596 -0.89 . . . . 15.0 108.596 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.07 98.63 0.73 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.363 2.042 . . . . 15.0 110.861 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.82 -71.23 0.88 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.187 -0.915 . . . . 15.0 112.329 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -169.89 133.42 1.21 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.919 0.887 . . . . 15.0 110.238 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -107.96 123.57 48.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.097 0.559 . . . . 15.0 109.642 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 93.3 mttt -97.41 129.59 44.62 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 171.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.2 101.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.279 1.031 . . . . 15.0 112.16 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.51 79.21 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.68 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.2 mt-10 -116.43 -163.92 0.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 15.0 108.383 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -73.54 116.01 13.61 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.095 0.558 . . . . 15.0 111.06 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -79.37 138.57 37.72 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.201 1.0 . . . . 15.0 109.3 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.2 m -133.83 132.83 40.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.109 -0.7 . . . . 15.0 109.109 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.58 169.42 21.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.064 0.946 . . . . 15.0 108.866 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 52.1 m -125.71 119.56 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.324 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -98.33 106.42 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.84 133.58 45.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -154.27 167.11 31.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.498 0.719 . . . . 15.0 109.536 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.715 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 31.8 mt-10 -84.71 170.38 13.33 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 15.0 110.238 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.0 m -136.83 155.12 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.85 0.86 . . . . 15.0 108.941 174.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HE1' HD11 ' A' ' 306' ' ' LEU . 68.3 m-85 -78.91 109.82 12.28 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.34 -173.62 1.78 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.035 2.49 . . . . 15.0 112.771 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -78.15 104.34 8.67 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.744 -175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.56 103.0 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.943 0.877 . . . . 15.0 108.671 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -102.59 101.04 11.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.598 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.69 140.34 32.21 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.281 -0.637 . . . . 15.0 109.281 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.95 -166.83 1.31 Allowed 'General case' 0 C--O 1.246 0.896 0 N-CA-C 108.747 -0.834 . . . . 15.0 108.747 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.67 109.35 2.31 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.247 -0.741 . . . . 15.0 111.247 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 414' ' ' LYS . 69.0 mt -66.16 -14.61 62.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.33 0.652 . . . . 15.0 111.063 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.68 -32.89 69.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.371 1.469 . . . . 15.0 111.698 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.33 75.43 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.873 0.869 . . . . 15.0 112.145 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -65.15 130.98 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.276 1.03 . . . . 15.0 110.397 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.52 115.39 29.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.636 0.774 . . . . 15.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.3 t -120.13 159.14 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 125.241 1.416 . . . . 15.0 108.47 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.55 149.46 34.41 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.0 tttt -124.11 105.56 31.57 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 107.86 -1.163 . . . . 15.0 107.86 168.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.73 99.12 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 121.77 1.646 . . . . 15.0 110.54 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 41.4 mm -66.42 97.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.552 -1.277 . . . . 15.0 107.552 169.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 427' ' ' LEU . 40.3 t -132.42 145.74 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.475 0.655 . . . . 15.0 111.362 -172.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -142.94 150.96 40.43 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.513 1.525 . . . . 15.0 107.553 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.556 HG11 ' SD ' ' A' ' 274' ' ' MET . 6.6 t -80.89 87.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.672 -1.233 . . . . 15.0 107.672 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.1 p -69.85 171.87 8.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.416 0.686 . . . . 15.0 110.117 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -58.1 -33.33 69.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.81 0.444 . . . . 15.0 111.285 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.54 82.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 15.0 110.512 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.16 -42.57 72.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.206 -0.906 . . . . 15.0 111.811 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.05 -54.6 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.85 0.86 . . . . 15.0 109.827 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.56 -44.8 93.07 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.124 0.89 . . . . 15.0 110.549 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.5 -40.92 99.29 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.845 0.716 . . . . 15.0 113.475 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.402 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.6 tpt -67.42 -57.48 6.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.554 0.742 . . . . 15.0 110.476 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 144' ' ' LEU . 90.7 mt -55.24 -32.92 62.7 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.631 0.772 . . . . 15.0 112.583 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.63 -51.91 63.14 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.329 1.052 . . . . 15.0 109.961 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.9 m -67.18 -24.37 65.86 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.5 0.72 . . . . 15.0 111.533 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 141' ' ' LEU . 74.9 mt -71.94 -47.29 53.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.83 0.452 . . . . 15.0 110.326 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 47.2 mtm180 -74.82 -19.36 60.22 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 111.696 0.258 . . . . 15.0 111.696 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.403 ' HB3' HH11 ' A' ' 243' ' ' ARG . 87.5 mttt -79.52 -23.41 42.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.827 -0.546 . . . . 15.0 110.461 169.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.09 -35.24 69.17 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.476 -0.565 . . . . 15.0 109.476 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 22.7 mm-40 -87.74 42.39 1.05 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.997 0.919 . . . . 15.0 109.656 172.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.32 118.18 4.51 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.167 1.387 . . . . 15.0 114.245 -168.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 244' ' ' GLU . 17.4 m -79.33 114.68 18.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.69 -0.855 . . . . 15.0 108.69 169.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.431 ' HZ3' ' HG3' ' A' ' 163' ' ' ARG . 36.3 m95 -79.88 110.9 15.68 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.414 -0.587 . . . . 15.0 109.414 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -141.59 115.18 9.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.36 0.664 . . . . 15.0 110.397 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 45.9 mt-10 -61.82 131.6 50.35 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.145 0.578 . . . . 15.0 110.527 172.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HE3' ' HB2' ' A' ' 242' ' ' GLU . 18.1 ptpt -108.37 172.02 7.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.528 0.731 . . . . 15.0 110.801 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.4 91.82 8.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.718 -0.674 . . . . 15.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.55 -56.48 1.25 Allowed Glycine 0 CA--C 1.544 1.902 0 N-CA-C 118.277 2.071 . . . . 15.0 118.277 159.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.15 132.46 47.86 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.67 1.235 . . . . 15.0 111.631 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 202' ' ' ILE . 20.0 t -95.54 136.52 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 122.9 0.48 . . . . 15.0 110.079 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.85 171.87 8.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.943 1.297 . . . . 15.0 108.823 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.77 65.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.793 0.837 . . . . 15.0 112.021 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -95.34 13.54 25.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.326 0.65 . . . . 15.0 111.713 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -84.33 178.65 7.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.868 0.842 . . . . 15.0 113.068 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.431 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 1.7 tmm_? -131.94 92.52 3.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 106.687 -1.597 . . . . 15.0 106.687 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 HG23 ' A' ' 166' ' ' ILE . 38.7 t -89.42 157.22 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.461 1.105 . . . . 15.0 110.378 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 61.5 m -132.77 134.84 45.24 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.867 -1.16 . . . . 15.0 107.867 166.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.8 pt -148.33 169.68 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.652 1.181 . . . . 15.0 110.303 -171.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -104.6 155.57 18.72 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 106.269 -1.752 . . . . 15.0 106.269 156.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 24.4 p90 -151.2 165.08 35.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.019 0.438 . . . . 15.0 111.131 167.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.1 t -142.75 103.15 4.16 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.006 -0.997 . . . . 15.0 108.626 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.84 140.33 15.81 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 114.914 -1.039 . . . . 15.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.3 p -150.13 116.59 5.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.974 0.91 . . . . 15.0 108.741 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 25.6 t -86.57 115.48 27.65 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 C-N-CA 123.498 0.719 . . . . 15.0 110.066 -168.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.1 t70 71.16 -1.26 2.78 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.063 1.345 . . . . 15.0 111.092 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.76 31.66 6.59 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.315 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 19.9 pt-20 -131.29 150.47 52.14 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 123.485 0.714 . . . . 15.0 110.542 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -90.86 81.63 5.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.756 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.602 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 0.0 OUTLIER -52.28 -70.12 0.1 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.4 1.48 . . . . 15.0 110.839 165.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.727 ' HB2' HG13 ' B' ' 386' ' ' VAL . 65.4 mm-40 -99.39 176.35 5.54 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.021 1.328 . . . . 15.0 109.487 168.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.97 5.72 0.12 Allowed Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.346 1.698 . . . . 15.0 117.346 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.43 -60.87 3.26 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 117.754 0.777 . . . . 15.0 113.493 168.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.67 160.74 14.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.627 0.973 . . . . 15.0 113.627 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.85 94.19 1.84 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.452 -1.249 . . . . 15.0 109.025 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.3 m -69.53 125.1 25.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.233 1.013 . . . . 15.0 112.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.03 41.8 10.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.64 1.176 . . . . 15.0 112.393 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' B' ' 385' ' ' LEU . 18.7 t80 -67.92 131.85 46.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.345 -0.843 . . . . 15.0 109.365 170.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.78 104.15 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.019 1.328 . . . . 15.0 108.357 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.4 tp -90.95 98.44 11.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 15.0 111.542 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -79.46 83.55 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 170.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.8 mtp -57.02 134.03 55.45 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.547 0.739 . . . . 15.0 110.941 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.91 -28.68 4.84 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 -168.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -71.38 114.62 9.65 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.008 0.523 . . . . 15.0 109.899 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.53 3.15 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.22 -0.446 . . . . 15.0 112.647 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.543 ' NH2' HD22 ' B' ' 385' ' ' LEU . 2.9 tmm_? -87.12 -33.88 19.3 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.485 -0.931 . . . . 15.0 108.485 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.1 mmt -84.37 154.14 23.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.196 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.5 pt -86.75 163.7 40.07 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.244 0.618 . . . . 15.0 110.824 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.17 144.75 46.28 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.72 2.28 . . . . 15.0 112.276 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.88 -52.93 0.61 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.839 -0.904 . . . . 15.0 110.839 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -66.47 -54.4 24.52 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.454 -0.573 . . . . 15.0 109.454 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.66 -40.77 69.36 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.79 -32.54 71.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.02 0.928 . . . . 15.0 110.465 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -71.15 -16.85 75.35 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.105 -0.952 . . . . 15.0 113.293 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.509 HG22 HG11 ' A' ' 158' ' ' VAL . 36.1 mm -93.68 -54.51 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.771 0.828 . . . . 15.0 109.553 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -79.55 14.02 1.8 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.676 0.991 . . . . 15.0 113.676 -169.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -122.06 20.21 8.11 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.099 -0.801 . . . . 15.0 111.099 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -142.37 -171.11 3.33 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.968 0.907 . . . . 15.0 111.175 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -149.89 154.03 37.66 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.279 1.032 . . . . 15.0 109.797 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -60.57 148.26 38.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.095 0.958 . . . . 15.0 112.598 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.72 -48.41 0.94 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.175 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.7 pt-20 -74.08 133.46 42.87 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.519 0.676 . . . . 15.0 110.419 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.53 105.56 10.58 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.147 0.979 . . . . 15.0 108.539 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -124.02 -169.16 1.91 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.944 1.298 . . . . 15.0 110.278 -168.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 44.8 m -136.3 125.69 24.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.897 0.879 . . . . 15.0 109.402 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.6 pt -102.6 154.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.633 0.773 . . . . 15.0 109.435 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -116.45 104.6 11.6 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.264 1.025 . . . . 15.0 108.395 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.2 t -92.35 154.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 107.087 -1.449 . . . . 15.0 107.087 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 m -137.5 121.33 17.56 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.087 0.858 . . . . 15.0 109.3 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 51.1 m-85 -92.21 136.47 25.73 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 119.539 -0.267 . . . . 15.0 111.373 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 81.1 Cg_exo -54.57 170.9 0.49 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.977 3.784 . . . . 15.0 117.3 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 22.6 mm-40 -79.74 -26.36 40.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.147 -1.388 . . . . 15.0 110.473 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -25.28 63.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.873 0.869 . . . . 15.0 110.383 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 226' ' ' LEU . 6.9 t80 -68.15 106.56 2.45 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.612 -0.885 . . . . 15.0 108.612 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.68 -19.29 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.882 0.873 . . . . 15.0 113.208 -167.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.88 101.85 3.9 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.672 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 41.3 tt0 -67.38 -24.99 65.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 15.0 112.287 -173.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -63.92 -17.85 63.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.686 0.794 . . . . 15.0 112.222 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 172' ' ' VAL . 16.7 mt -114.35 -30.61 6.53 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.27 0.628 . . . . 15.0 111.316 173.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.672 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 55.2 tttm -55.68 116.67 3.05 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.227 1.411 . . . . 15.0 111.809 -172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.58 -19.94 8.26 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.834 0.709 . . . . 15.0 113.885 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -87.29 156.99 19.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.806 0.842 . . . . 15.0 110.847 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -109.28 112.96 25.4 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -80.71 113.36 18.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 15.0 111.35 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -83.67 97.32 9.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.638 -0.71 . . . . 15.0 109.966 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.499 ' HZ ' HD13 ' B' ' 387' ' ' ILE . 95.9 m-85 -93.83 109.02 20.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.92 92.24 4.26 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.63 126.09 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.56 0.744 . . . . 15.0 110.46 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -113.16 91.07 3.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.204 1.002 . . . . 15.0 109.198 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 84.5 mt -68.41 108.0 3.09 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 110.152 -0.314 . . . . 15.0 110.152 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -110.87 -40.43 4.53 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.391 0.676 . . . . 15.0 110.103 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.5 mmtt -131.44 136.61 48.11 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.185 0.994 . . . . 15.0 109.594 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 207' ' ' ALA . 25.6 t -130.74 115.01 29.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.768 -1.567 . . . . 15.0 106.768 168.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 34.7 mt-10 -112.31 -175.37 2.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.583 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 35.4 tt0 -133.58 130.85 38.96 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 175.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.403 HH11 ' HB3' ' A' ' 146' ' ' LYS . 11.4 ptt180 -79.18 82.79 5.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.1 -1.445 . . . . 15.0 107.1 164.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 42.0 tt0 -73.89 147.62 43.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.72 -1.582 . . . . 15.0 111.353 -171.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.21 114.64 19.6 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.728 0.811 . . . . 15.0 109.173 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 30.2 Cg_endo -59.74 150.55 76.37 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.257 2.638 . . . . 15.0 111.291 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -53.54 106.82 0.2 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.422 1.076 . . . . 15.0 110.033 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 252' ' ' PHE . 31.8 tp -77.06 73.54 3.64 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 253' ' ' ILE . 67.5 p -91.55 168.68 11.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.014 -0.994 . . . . 15.0 108.805 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.97 -45.55 42.28 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.751 1.22 . . . . 15.0 111.979 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 48.0 mt-10 -73.36 -21.1 60.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.911 0.884 . . . . 15.0 112.886 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.526 ' HD2' HD12 ' A' ' 248' ' ' LEU . 59.6 t80 -85.69 -49.99 7.54 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.508 -0.553 . . . . 15.0 109.508 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 249' ' ' THR . 6.2 tt -67.29 -28.34 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.044 0.538 . . . . 15.0 111.564 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.647 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.4 ptmt -79.61 -12.43 59.84 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.826 0.676 . . . . 15.0 112.826 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.92 -25.7 65.35 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.093 0.557 . . . . 15.0 111.51 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -68.15 -33.83 75.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.089 0.956 . . . . 15.0 111.932 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.68 7.22 0.46 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 116.664 -0.244 . . . . 15.0 113.271 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 20.5 t -79.26 157.75 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.652 0.781 . . . . 15.0 110.119 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -59.82 -72.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.832 1.253 . . . . 15.0 111.92 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -121.86 6.61 9.87 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.554 0.742 . . . . 15.0 110.456 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.95 4.93 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.953 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 7.1 m -64.21 132.02 49.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.136 0.975 . . . . 15.0 110.561 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.42 -47.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 124.049 0.843 . . . . 15.0 110.241 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.6 -32.87 63.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.729 0.812 . . . . 15.0 111.609 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.552 ' HA3' HG13 ' A' ' 258' ' ' VAL . . . -79.28 -25.06 60.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 111.276 -0.73 . . . . 15.0 111.276 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.24 -33.62 56.02 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -67.75 -38.72 83.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.418 0.687 . . . . 15.0 109.641 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.02 82.5 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.198 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.19 -48.18 76.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.127 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.37 -27.88 36.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.318 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -65.05 -52.45 55.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.218 0.463 . . . . 15.0 110.296 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 377' ' ' ALA . 13.2 ptmm? -73.79 -16.7 61.15 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.983 0.734 . . . . 15.0 112.983 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -95.1 -47.39 6.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 118.167 0.439 . . . . 15.0 111.796 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.556 ' SD ' HG11 ' A' ' 132' ' ' VAL . 66.4 mtt -73.83 -26.23 60.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 118.653 -0.689 . . . . 15.0 111.459 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.6 -32.88 41.93 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 119.062 0.846 . . . . 15.0 110.443 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' NH2' ' HB3' ' A' ' 377' ' ' ALA . 24.2 tpp180 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.923 0.489 . . . . 15.0 110.186 174.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -76.96 -60.29 2.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.309 -0.86 . . . . 15.0 109.881 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.474 HD11 HG11 ' A' ' 130' ' ' VAL . 58.8 tp -70.69 -59.73 2.65 Favored 'General case' 0 C--O 1.211 -0.947 0 C-N-CA 124.022 0.929 . . . . 15.0 112.933 -168.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.76 -32.61 73.79 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.797 0.439 . . . . 15.0 110.713 -171.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -68.92 -46.56 67.97 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.08 -0.964 . . . . 15.0 109.658 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.38 72.53 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.336 0.655 . . . . 15.0 111.949 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 286' ' ' VAL . 79.8 mt -70.94 -51.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -58.34 -42.15 86.23 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.992 0.808 . . . . 15.0 110.338 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -74.89 -30.13 61.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 15.0 110.947 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -63.94 -59.44 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 282' ' ' ILE . 40.2 t -58.53 -44.3 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 114.95 -1.023 . . . . 15.0 110.457 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -68.78 -41.15 79.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.668 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.4 p -65.25 -40.35 93.9 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.991 0.359 . . . . 15.0 110.489 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.462 ' HB2' HG13 ' A' ' 125' ' ' VAL . 51.5 mt-30 -68.68 -34.93 76.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.53 0.519 . . . . 15.0 111.245 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.8 -50.22 67.59 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.132 0.573 . . . . 15.0 110.519 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 295' ' ' VAL . 27.0 mm -65.07 -54.62 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.676 0.791 . . . . 15.0 110.907 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.64 -38.54 90.66 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.761 0.663 . . . . 15.0 110.383 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.96 -35.3 89.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.581 -0.736 . . . . 15.0 112.758 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.5 OUTLIER -66.32 -42.59 88.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.97 0.908 . . . . 15.0 110.299 177.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 291' ' ' ILE . 47.6 t -62.13 -53.43 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.799 -0.815 . . . . 15.0 108.799 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.26 -27.64 69.15 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.593 -1.185 . . . . 15.0 111.613 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.17 59.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 15.0 113.171 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.79 150.63 15.64 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.204 0.816 . . . . 15.0 113.204 -169.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.06 143.27 58.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.774 0.829 . . . . 15.0 111.113 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 346' ' ' VAL . 6.1 tp -147.62 115.04 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.0 130.77 54.59 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.217 1.007 . . . . 15.0 108.57 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 349' ' ' LEU . 45.6 t -131.95 131.26 22.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.935 0.894 . . . . 15.0 110.097 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.412 ' HB2' ' HG ' ' A' ' 306' ' ' LEU . 53.0 Cg_exo -55.06 130.14 39.11 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.144 2.562 . . . . 15.0 112.468 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -63.61 -24.83 67.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.506 1.122 . . . . 15.0 112.902 -173.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.12 73.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.201 0.6 . . . . 15.0 111.536 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.446 HD11 ' HE1' ' A' ' 112' ' ' TYR . 19.5 mt -69.86 -43.39 71.97 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.379 -0.6 . . . . 15.0 109.379 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 304' ' ' ALA . 3.2 mp -59.09 -50.21 80.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.013 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.17 -35.74 81.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.783 0.833 . . . . 15.0 111.738 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -44.03 94.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.376 0.671 . . . . 15.0 110.339 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -79.13 -27.4 42.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.647 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 337' ' ' PHE . 34.0 mt -65.76 -35.88 76.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 108.585 -0.895 . . . . 15.0 108.585 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.579 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 14.9 t70 -63.67 -44.07 94.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.653 0.781 . . . . 15.0 110.575 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.67 -52.12 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 123.72 0.637 . . . . 15.0 110.114 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.9 mt -70.27 -21.41 62.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.897 -1.047 . . . . 15.0 112.426 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 58.9 mtm180 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 123.908 0.883 . . . . 15.0 109.871 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 50.0 tp . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 111.926 0.343 . . . . 15.0 111.926 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.06 -8.58 53.66 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.489 0.716 . . . . 15.0 112.388 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 69.0 mt -54.03 130.31 58.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 118.587 0.63 . . . . 15.0 110.248 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 86.2 Cg_exo -48.35 116.04 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.634 2.889 . . . . 15.0 113.759 -170.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -51.7 -37.78 52.27 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.925 0.89 . . . . 15.0 111.519 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -54.5 -33.13 59.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.174 0.989 . . . . 15.0 112.851 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.523 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 95.3 mt -62.7 -30.16 71.2 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.274 0.559 . . . . 15.0 110.891 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.511 ' HA ' HE21 ' A' ' 340' ' ' GLN . 28.2 m-85 -116.47 -3.04 11.9 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.246 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.414 ' HA ' HD11 ' A' ' 311' ' ' ILE . 11.3 tp10 -55.83 -63.05 1.3 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.304 1.042 . . . . 15.0 111.965 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.05 -47.18 85.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.15 0.906 . . . . 15.0 111.589 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 337' ' ' PHE . 16.8 pt20 -67.72 -51.93 43.54 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.683 0.614 . . . . 15.0 111.558 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -63.3 -43.21 98.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.776 0.43 . . . . 15.0 110.627 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 346' ' ' VAL . 75.5 tttt -58.38 -43.24 88.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 123.883 0.739 . . . . 15.0 110.164 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 347' ' ' VAL . 45.3 mmt-85 -61.31 -35.75 78.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.655 -0.688 . . . . 15.0 111.268 172.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.5 mtt-85 -69.33 -34.01 73.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.807 0.443 . . . . 15.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.701 ' HA ' ' HB3' ' B' ' 467' ' ' ALA . 9.9 t -77.69 -41.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.856 0.36 . . . . 15.0 110.069 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 300' ' ' ILE . 53.6 t -58.88 -35.05 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.455 -0.793 . . . . 15.0 110.449 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 343' ' ' ARG . 11.8 t -51.28 -54.55 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.675 0.79 . . . . 15.0 109.316 169.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.99 -37.85 93.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.404 -0.816 . . . . 15.0 114.334 -174.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 302' ' ' VAL . 10.3 mp -72.02 -50.11 31.26 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.858 0.829 . . . . 15.0 111.124 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 87.6 mt -63.05 -52.85 61.16 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.271 0.357 . . . . 15.0 110.337 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.471 HD12 HG13 ' A' ' 347' ' ' VAL . 81.5 mt -69.85 -31.19 68.91 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.904 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.548 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.42 -39.22 97.51 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 111.779 -0.528 . . . . 15.0 111.779 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.67 -38.63 84.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.096 -0.552 . . . . 15.0 110.429 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -60.6 -36.43 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 122.746 0.418 . . . . 15.0 111.07 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.548 HD12 ' HA2' ' A' ' 352' ' ' GLY . 85.3 mt -62.96 -52.58 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.876 0.87 . . . . 15.0 109.902 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -62.14 -56.42 18.93 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.52 0.513 . . . . 15.0 110.912 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.1 m -54.67 -48.25 72.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 15.0 112.192 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -92.2 16.34 11.69 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 119.323 -0.37 . . . . 15.0 111.919 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 44.46 41.34 4.55 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 125.746 1.618 . . . . 15.0 113.776 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 355' ' ' ILE . 96.8 mt -74.7 150.51 39.46 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.021 -0.99 . . . . 15.0 112.184 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 147.29 52.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.456 1.102 . . . . 15.0 109.555 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.23 92.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.117 0.567 . . . . 15.0 110.438 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 367' ' ' VAL . 13.9 t70 -70.54 127.01 31.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.834 0.854 . . . . 15.0 110.44 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.47 -32.96 74.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.631 1.172 . . . . 15.0 112.783 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.15 -23.76 60.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.461 0.304 . . . . 15.0 110.336 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.45 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 40.6 tpt85 -80.51 -33.58 36.35 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.129 0.572 . . . . 15.0 109.585 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 363' ' ' ASP . 44.6 t -61.68 -54.46 34.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -65.69 -28.7 69.27 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.859 0.724 . . . . 15.0 110.868 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.55 -54.01 37.48 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 111.66 -0.576 . . . . 15.0 111.66 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.34 -56.52 20.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.592 0.757 . . . . 15.0 110.698 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.669 HD11 ' HG2' ' A' ' 398' ' ' MET . 44.9 mm -50.75 -53.4 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 124.771 1.294 . . . . 15.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.04 -41.51 61.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.004 0.521 . . . . 15.0 111.133 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.59 -23.28 62.55 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.64 0.607 . . . . 15.0 112.64 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 -33.3 12.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 119.159 -0.448 . . . . 15.0 111.57 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -93.24 -40.64 10.33 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 112.671 0.619 . . . . 15.0 112.671 -171.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 381' ' ' PRO . 22.1 t -70.06 -13.29 62.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.01 0.374 . . . . 15.0 112.01 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 272' ' ' LYS . . . -86.92 -0.56 56.74 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.136 0.574 . . . . 15.0 111.664 174.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -94.69 -175.31 3.55 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.426 0.69 . . . . 15.0 110.367 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.85 -51.67 17.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.437 1.095 . . . . 15.0 110.305 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -123.33 106.92 32.71 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 174.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.46 ' HB3' ' HA ' ' A' ' 376' ' ' SER . 97.1 Cg_endo -84.93 -23.56 2.47 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.599 2.199 . . . . 15.0 113.61 170.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -57.23 -49.54 75.7 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.453 0.701 . . . . 15.0 112.288 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.61 -16.06 60.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.267 -0.879 . . . . 15.0 111.383 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.426 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 88.7 t -76.58 -50.26 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.604 -0.888 . . . . 15.0 108.604 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.22 -49.53 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.635 0.774 . . . . 15.0 109.078 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.94 -36.14 80.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.237 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.05 -57.99 10.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.754 0.422 . . . . 15.0 110.451 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.459 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 87.0 m-85 -64.09 -53.05 55.87 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.892 0.745 . . . . 15.0 111.352 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.0 p -56.05 -33.94 65.45 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -98.13 -4.61 35.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.075 0.55 . . . . 15.0 112.461 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -119.49 90.18 3.28 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -56.09 -29.28 60.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.765 1.226 . . . . 15.0 113.031 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.85 -57.88 10.99 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.407 0.683 . . . . 15.0 111.056 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' B' ' 443' ' ' ALA . 2.0 tt -87.66 -18.9 28.54 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.243 -0.89 . . . . 15.0 109.775 -174.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 7.4 tpt -67.13 -43.32 82.69 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -40.03 95.77 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.065 0.946 . . . . 15.0 110.403 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.86 -44.1 90.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.258 0.623 . . . . 15.0 110.378 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.669 ' HG2' HD11 ' A' ' 371' ' ' ILE . 37.7 tpp -72.72 -23.52 60.86 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.488 -0.778 . . . . 15.0 111.671 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HG2' HG21 ' A' ' 367' ' ' VAL . 12.7 mtp180 -76.53 -35.32 58.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.599 0.76 . . . . 15.0 109.85 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' B' ' 464' ' ' MET . 0.9 OUTLIER -69.19 -38.4 78.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.139 0.576 . . . . 15.0 110.269 178.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.1 p -79.09 -22.86 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 119.49 -0.291 . . . . 15.0 111.11 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.41 96.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.866 0.757 . . . . 15.0 109.468 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.96 -34.92 64.45 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.844 -1.525 . . . . 15.0 111.77 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 401' ' ' VAL . 0.6 OUTLIER -67.93 -48.01 67.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.376 1.07 . . . . 15.0 109.965 177.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.45 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 6.1 mm-40 -56.49 -46.99 80.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.024 1.329 . . . . 15.0 111.199 171.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.32 -35.11 78.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.803 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -67.78 -38.07 82.88 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.244 0.618 . . . . 15.0 110.997 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 59.5 t -56.1 -53.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.969 -0.752 . . . . 15.0 108.969 170.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -63.08 -26.45 68.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.163 0.985 . . . . 15.0 112.959 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -74.71 -27.36 60.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.06 0.544 . . . . 15.0 111.148 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 407' ' ' ALA . 89.0 t -75.79 -38.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.521 -0.918 . . . . 15.0 108.521 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 290' ' ' ALA . 92.8 mt -67.56 -35.16 78.51 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.78 0.832 . . . . 15.0 111.32 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.57 -20.83 65.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.648 0.779 . . . . 15.0 111.592 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.522 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.8 mtpp -105.67 -30.15 9.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.059 0.944 . . . . 15.0 111.556 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.82 159.25 22.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.071 0.948 . . . . 15.0 111.741 -172.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -75.61 82.63 2.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.972 0.909 . . . . 15.0 109.464 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 125' ' ' VAL . 42.5 t -90.15 92.15 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -70.67 96.03 1.17 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.402 1.096 . . . . 15.0 110.493 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.54 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 37.1 mt-10 -75.2 105.01 6.0 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.253 -1.34 . . . . 15.0 109.562 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -114.41 138.29 50.75 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.279 0.562 . . . . 15.0 109.951 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 28.4 mt-10 -81.44 130.89 35.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.959 0.904 . . . . 15.0 109.193 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.446 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -163.64 169.55 18.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.285 0.634 . . . . 15.0 110.446 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.2 p -93.22 171.83 8.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.243 1.017 . . . . 15.0 111.487 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 428' ' ' MET . 57.0 t80 -52.54 -47.27 66.82 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.888 1.275 . . . . 15.0 110.828 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -54.93 -22.94 16.62 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.945 1.091 . . . . 15.0 113.945 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 427' ' ' LEU . 10.0 tp10 -54.34 -55.7 25.82 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.647 0.779 . . . . 15.0 112.068 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 426' ' ' GLU . 5.4 mp -74.87 -29.5 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.42 -0.809 . . . . 15.0 111.709 -167.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.1 OUTLIER -80.69 -42.87 21.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.992 0.517 . . . . 15.0 109.832 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 123.002 0.521 . . . . 15.0 111.109 -178.108 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 385' ' ' LEU . . . . . 0.543 HD22 ' NH2' ' A' ' 193' ' ' ARG . 5.6 mp . . . . . 0 C--O 1.243 0.758 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 386' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 178' ' ' GLU . 50.9 t -81.93 90.06 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 123.771 1.748 . . . . 0.0 109.265 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.602 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 7.6 tp -153.17 173.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 110.983 -2.826 . . . . 0.0 105.329 170.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.489 ' H ' HG13 ' B' ' 387' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -150.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 443' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 394' ' ' LEU . . . . . . . . 0 C--O 1.241 0.629 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.7 t80 . . . . . 0 N--CA 1.483 1.176 0 C-N-CA 125.258 1.423 . . . . 0.0 113.075 168.893 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.142 0 CA-C-O 120.741 0.305 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 66.82 -84.52 0.03 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.737 1.615 . . . . 0.0 111.644 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -91.33 135.31 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 59.6 m -58.16 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 O-C-N 124.243 0.964 . . . . 0.0 110.815 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 464' ' ' MET . . . . . 0.451 ' HA ' ' OD1' ' A' ' 400' ' ' ASN . 1.3 tmt? -129.48 110.17 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 108.576 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 465' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.0 OUTLIER -80.86 121.16 25.63 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -51.38 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.942 1.401 . . . . 0.0 112.318 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 467' ' ' ALA . . . . . 0.701 ' HB3' ' HA ' ' A' ' 345' ' ' VAL . . . . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 52.5 tt0 -82.2 108.33 15.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.42 -0.585 . . . . 15.0 109.42 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 HG12 ' A' ' 17' ' ' ILE . 33.0 m -121.25 141.18 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 15.0 109.552 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 9.2 m -140.33 92.64 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.332 0.653 . . . . 15.0 109.405 -174.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.03 102.14 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-O 121.91 0.862 . . . . 15.0 110.492 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 38.6 mt-10 -92.41 107.2 19.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.781 0.832 . . . . 15.0 109.595 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -72.4 90.96 1.32 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.5 m -64.13 -51.67 62.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.69 1.196 . . . . 15.0 111.031 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -155.7 84.9 1.03 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.23 -0.441 . . . . 15.0 109.934 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.42 0.23 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 123.558 0.536 . . . . 15.0 113.063 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.515 ' HA ' HH12 ' A' ' 13' ' ' ARG . 10.0 mp -66.91 -37.74 84.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.655 0.782 . . . . 15.0 110.982 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.26 97.41 0.17 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 124.362 1.039 . . . . 15.0 112.311 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.515 HH12 ' HA ' ' A' ' 11' ' ' LEU . 66.9 mtt85 -108.75 143.14 38.28 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.799 1.24 . . . . 15.0 109.684 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 42.2 ttm180 -119.9 88.95 3.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.845 1.258 . . . . 15.0 107.868 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.75 91.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.581 0.705 . . . . 15.0 109.179 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 91.0 m -81.28 105.2 12.29 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.418 -1.265 . . . . 15.0 109.905 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 3' ' ' VAL . 52.8 mt -107.29 127.73 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.167 0.587 . . . . 15.0 110.211 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 85.5 m -100.61 111.86 24.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.188 0.995 . . . . 15.0 108.649 171.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.7 mt -88.91 130.99 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.45 138.24 58.31 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.587 0.755 . . . . 15.0 110.815 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.53 -39.9 74.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.941 1.297 . . . . 15.0 112.598 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.29 -40.24 93.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.267 -0.879 . . . . 15.0 110.324 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -71.65 -26.18 62.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.524 0.729 . . . . 15.0 111.549 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -70.81 -51.12 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.638 0.775 . . . . 15.0 109.685 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.25 -24.15 59.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.463 -0.335 . . . . 15.0 111.587 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.579 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 87.5 m -68.35 -39.64 81.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.459 0.704 . . . . 15.0 109.776 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.15 -42.14 94.07 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.148 0.579 . . . . 15.0 111.011 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 66' ' ' VAL . 95.9 t -59.68 -44.78 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 121.625 0.726 . . . . 15.0 109.974 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.1 ttmp? -63.7 -36.11 82.78 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.592 -1.186 . . . . 15.0 111.089 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -92.67 -1.99 56.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.605 1.162 . . . . 15.0 111.245 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -99.71 -39.9 8.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.376 0.67 . . . . 15.0 109.782 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 55' ' ' ALA . 52.8 mt -82.12 -8.64 59.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.412 -0.813 . . . . 15.0 112.225 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.9 -31.62 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 109.241 -0.651 . . . . 15.0 109.241 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -71.98 -43.76 64.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.04 0.936 . . . . 15.0 109.334 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.91 -37.95 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.4 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -46.1 90.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.656 . . . . 15.0 110.853 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -69.58 -34.97 74.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.616 0.366 . . . . 15.0 111.698 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.28 -53.01 59.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.893 0.877 . . . . 15.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.85 2.19 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.718 0.807 . . . . 15.0 110.645 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 74.26 9.44 4.49 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.764 1.625 . . . . 15.0 112.695 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mt -58.31 -27.73 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.155 1.382 . . . . 15.0 111.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.58 -32.54 74.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.564 0.746 . . . . 15.0 111.122 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.32 -33.68 64.39 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.668 0.605 . . . . 15.0 111.852 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.5 -18.18 42.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.368 0.667 . . . . 15.0 110.766 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -70.58 108.34 4.3 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.518 0.727 . . . . 15.0 109.059 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -91.0 -2.81 57.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.278 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -7.87 79.39 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-O 119.548 -0.585 . . . . 15.0 113.859 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -65.82 -48.66 70.92 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.289 0.636 . . . . 15.0 110.768 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.08 121.79 80.98 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.474 -0.935 . . . . 15.0 108.474 174.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.68 131.68 45.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.882 2.388 . . . . 15.0 112.25 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.7 tpt -63.23 -32.6 74.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.308 1.043 . . . . 15.0 111.602 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.3 p30 -57.97 -38.8 76.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.587 0.755 . . . . 15.0 112.765 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.44 -51.93 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.085 0.954 . . . . 15.0 110.429 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.495 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 29.6 m -72.39 -19.34 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.754 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -74.18 -58.42 3.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.043 0.537 . . . . 15.0 110.983 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.551 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 14.2 pt20 -73.31 -34.71 65.86 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.878 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.1 mtt180 -96.51 -70.38 0.72 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.072 0.549 . . . . 15.0 111.091 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 91.8 m-85 -72.29 -18.89 61.76 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.473 0.709 . . . . 15.0 112.177 -169.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.27 23.4 15.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.526 -0.597 . . . . 15.0 112.704 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -21.82 66.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.088 0.955 . . . . 15.0 111.882 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.8 p -62.56 -32.44 73.41 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.563 0.745 . . . . 15.0 111.32 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 78.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.173 0.989 . . . . 15.0 109.692 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -108.07 -48.18 3.42 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.184 -0.673 . . . . 15.0 109.184 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -56.72 -45.34 81.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.677 1.191 . . . . 15.0 111.576 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.53 -34.1 77.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.85 -1.068 . . . . 15.0 111.206 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 28' ' ' VAL . 42.5 t -80.18 -63.64 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.24 -44.58 83.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.962 0.905 . . . . 15.0 112.773 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.4 94.73 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.542 0.526 . . . . 15.0 112.606 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.35 -33.5 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.984 0.914 . . . . 15.0 111.122 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 70.4 mt -70.06 -32.5 70.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.955 0.502 . . . . 15.0 110.432 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.5 mtm -63.14 -37.64 88.01 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 123.413 0.445 . . . . 15.0 110.455 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 -55.6 5.81 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.488 0.715 . . . . 15.0 110.799 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -67.92 -37.15 81.3 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.117 0.567 . . . . 15.0 112.425 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -75.47 -30.02 59.78 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 117.875 0.307 . . . . 15.0 111.026 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -64.31 -54.54 31.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.073 0.549 . . . . 15.0 110.666 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.6 -35.13 71.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 123.74 0.65 . . . . 15.0 110.618 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.71 -47.66 82.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.63 0.772 . . . . 15.0 110.611 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -56.46 20.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.929 -1.032 . . . . 15.0 111.325 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.559 HD12 ' HD3' ' A' ' 86' ' ' PRO . 21.4 pt -64.88 -31.86 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.914 0.709 . . . . 15.0 112.914 -170.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.87 -49.23 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.798 0.439 . . . . 15.0 110.519 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -72.12 -29.71 64.34 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.641 -0.254 . . . . 15.0 111.053 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -87.3 1.34 53.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.514 0.726 . . . . 15.0 111.57 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 66.96 12.99 9.29 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.86 1.264 . . . . 15.0 112.942 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 70.4 mt -87.06 122.1 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.919 0.888 . . . . 15.0 108.727 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.9 117.27 35.66 Favored Pre-proline 0 N--CA 1.481 1.075 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.559 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.9 Cg_endo -71.6 152.71 59.76 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 15.0 113.383 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.67 52.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.099 -1.41 . . . . 15.0 107.218 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 304' ' ' ALA . . . -162.23 146.2 11.69 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.031 -1.44 . . . . 15.0 110.002 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -58.57 108.26 1.25 Allowed Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.415 0.607 . . . . 15.0 109.859 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 11.3 Cg_exo -69.16 109.8 2.28 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.439 2.093 . . . . 15.0 111.802 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 47.4 m -69.89 92.39 0.7 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.775 0.83 . . . . 15.0 109.971 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.43 104.71 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.92 103.56 3.45 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.021 -1.103 . . . . 15.0 108.021 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 104.24 1.32 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.076 1.851 . . . . 15.0 109.848 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.59 176.75 38.42 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.764 -0.653 . . . . 15.0 113.166 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.8 116.81 20.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.212 0.53 . . . . 15.0 110.07 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -102.01 98.78 8.94 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.783 -1.191 . . . . 15.0 107.783 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.7 mttt -77.84 136.47 38.09 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.769 -1.197 . . . . 15.0 107.769 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.01 106.94 2.51 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.394 -0.595 . . . . 15.0 109.394 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.64 10.46 40.78 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 116.238 -0.437 . . . . 15.0 112.693 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.3 mt-10 -134.71 -179.75 5.79 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.996 1.318 . . . . 15.0 109.221 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -81.04 173.71 12.32 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.597 0.759 . . . . 15.0 111.76 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -115.27 92.34 3.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 15.0 108.723 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -92.55 96.08 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.847 0.859 . . . . 15.0 109.228 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -108.98 178.23 4.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.43 0.692 . . . . 15.0 109.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.6 m -139.49 150.12 44.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.86 0.864 . . . . 15.0 109.284 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.97 117.22 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -98.07 136.91 37.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.401 1.08 . . . . 15.0 109.366 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -167.58 165.74 14.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.509 0.723 . . . . 15.0 109.823 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.89 174.67 5.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.306 0.643 . . . . 15.0 109.379 170.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.16 -166.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.161 0.984 . . . . 15.0 109.174 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 114.4 58.5 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 122.853 0.461 . . . . 15.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.03 112.47 3.26 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.681 2.254 . . . . 15.0 111.787 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.39 96.42 0.88 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.611 0.764 . . . . 15.0 109.421 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.97 134.38 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.054 0.941 . . . . 15.0 110.992 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.8 110.53 22.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.48 0.712 . . . . 15.0 109.379 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 120' ' ' LEU . 94.1 mt -75.08 128.85 36.49 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -124.6 112.47 16.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.627 0.771 . . . . 15.0 109.784 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.0 67.1 2.28 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 124.469 1.106 . . . . 15.0 113.536 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 117' ' ' LEU . 38.5 mt -66.33 -25.15 66.69 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.59 0.356 . . . . 15.0 110.547 175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 2.8 mp0 -71.82 -35.99 70.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.084 0.953 . . . . 15.0 110.75 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.29 -22.09 63.83 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.538 0.735 . . . . 15.0 111.548 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.34 127.43 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.951 0.9 . . . . 15.0 109.991 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 38.2 mt-10 -108.47 110.14 21.58 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.835 0.854 . . . . 15.0 109.778 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HB ' HG12 ' A' ' 417' ' ' VAL . 37.9 t -119.82 165.06 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.789 1.236 . . . . 15.0 107.853 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.04 149.01 32.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.625 -0.88 . . . . 15.0 108.625 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -116.64 85.51 16.97 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.42 102.01 1.38 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.2 1.933 . . . . 15.0 111.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.496 HD11 ' HE2' ' A' ' 127' ' ' LYS . 41.1 mm -73.95 86.98 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.852 -1.166 . . . . 15.0 107.852 171.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.728 HG22 HG23 ' A' ' 422' ' ' THR . 28.7 t -107.27 148.37 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.08 -0.964 . . . . 15.0 110.502 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.12 165.17 37.06 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.246 1.018 . . . . 15.0 109.696 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 ' SD ' ' A' ' 274' ' ' MET . 2.8 t -96.77 88.54 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.8 p -77.21 -175.94 3.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.032 0.933 . . . . 15.0 110.352 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.99 -55.12 34.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.53 0.732 . . . . 15.0 111.366 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.05 66.97 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.977 0.798 . . . . 15.0 111.799 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -79.03 -45.33 20.39 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.362 0.665 . . . . 15.0 110.889 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.64 -54.94 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.204 0.602 . . . . 15.0 109.434 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.77 -48.04 82.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.96 99.09 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.91 0.757 . . . . 15.0 113.379 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.2 tpt -68.51 -50.86 48.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.599 0.759 . . . . 15.0 111.038 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.26 -38.33 68.4 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.024 0.53 . . . . 15.0 111.817 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 t70 -68.05 -39.17 83.09 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.45 -0.796 . . . . 15.0 110.571 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 71.1 m -61.97 -39.82 93.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.186 0.594 . . . . 15.0 110.128 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 140' ' ' MET . 83.4 mt -63.48 -38.26 90.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.166 0.587 . . . . 15.0 110.06 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 63.7 mtm180 -64.59 -34.41 78.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.223 173.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 142' ' ' ASP . 87.1 mttt -67.85 -35.94 79.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.513 0.325 . . . . 15.0 110.885 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 143' ' ' THR . 92.8 mt-30 -70.47 -33.32 71.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.859 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -103.59 29.47 5.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.848 . . . . 15.0 111.241 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.88 24.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.276 0.843 . . . . 15.0 113.276 -171.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -96.05 136.24 36.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.46 1.104 . . . . 15.0 110.306 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -81.78 111.82 18.36 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.225 0.61 . . . . 15.0 110.238 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -125.81 113.04 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 15.0 110.406 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.7 mt-10 -65.04 119.37 10.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.385 0.674 . . . . 15.0 111.063 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 47.0 pttt -123.78 -179.57 4.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.385 1.074 . . . . 15.0 110.009 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -165.58 154.12 11.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.916 0.887 . . . . 15.0 108.827 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.27 -38.75 2.39 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.436 -0.666 . . . . 15.0 111.436 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.02 123.68 7.28 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.608 0.363 . . . . 15.0 110.786 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 206' ' ' LYS . 40.5 t -85.43 131.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 171.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -121.85 -177.63 3.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.149 0.979 . . . . 15.0 109.72 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -81.43 -9.23 59.77 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.505 0.722 . . . . 15.0 111.893 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -97.62 19.33 13.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.958 0.903 . . . . 15.0 111.718 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.8 m-20 -94.11 158.78 15.45 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.102 0.953 . . . . 15.0 112.301 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 6.5 tmm_? -120.85 91.53 3.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.068 -2.197 . . . . 15.0 105.068 165.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 166' ' ' ILE . 28.4 t -90.22 148.75 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.392 1.077 . . . . 15.0 110.791 -174.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 41.0 m -126.19 121.63 33.33 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.759 -1.2 . . . . 15.0 107.759 171.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.611 HG22 HD23 ' A' ' 237' ' ' LEU . 36.3 pt -128.95 174.08 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.577 0.751 . . . . 15.0 111.914 -172.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -118.49 116.57 26.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.163 -1.792 . . . . 15.0 106.163 158.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.562 ' HE1' HG23 ' B' ' 387' ' ' ILE . 11.6 p90 -107.88 140.99 40.16 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 234' ' ' ALA . 1.5 t -137.28 113.65 10.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.923 -1.14 . . . . 15.0 107.923 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -101.25 154.79 19.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 116.131 -0.486 . . . . 15.0 113.072 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 p -136.88 104.17 5.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.741 0.816 . . . . 15.0 109.206 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 231' ' ' ALA . 52.9 t -77.39 112.95 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.141 -0.936 . . . . 15.0 109.271 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.9 t70 64.44 25.34 13.32 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 124.703 1.252 . . . . 15.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.47 21.15 52.56 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.04 -0.982 . . . . 15.0 114.524 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.12 150.43 49.98 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.02 0.91 . . . . 15.0 110.911 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.97 81.44 5.24 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.996 -1.113 . . . . 15.0 107.996 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.538 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 1.1 p90 -59.48 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 112.712 -2.04 . . . . 15.0 112.387 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.46 ' HG2' ' HD2' ' A' ' 177' ' ' PHE . 12.0 mm-40 -101.0 176.52 5.23 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.574 1.55 . . . . 15.0 109.231 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.61 60.68 2.45 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 165.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -99.97 83.42 0.56 Allowed Glycine 0 C--N 1.344 0.985 0 C-N-CA 123.335 0.493 . . . . 15.0 111.985 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -148.39 165.22 31.75 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.909 0.883 . . . . 15.0 109.399 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.52 94.94 1.52 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.855 -0.611 . . . . 15.0 109.855 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 128.69 37.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.631 -1.168 . . . . 15.0 109.335 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 65.25 33.28 9.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.073 0.949 . . . . 15.0 111.145 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.01 127.65 32.38 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 122.784 0.434 . . . . 15.0 109.945 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.83 95.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.624 0.77 . . . . 15.0 110.263 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.603 HD22 ' HE3' ' A' ' 194' ' ' MET . 36.7 tp -86.79 90.08 8.18 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.433 0.635 . . . . 15.0 110.285 170.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.461 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -83.27 89.72 7.03 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.811 -1.181 . . . . 15.0 107.811 169.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 46.7 mtp -57.07 137.48 55.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.321 0.648 . . . . 15.0 111.83 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.87 5.18 Favored Glycine 0 N--CA 1.47 0.95 0 N-CA-C 112.077 -0.409 . . . . 15.0 112.077 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 10.4 pt20 -98.98 158.72 15.46 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.296 0.639 . . . . 15.0 110.553 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.98 66.32 2.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.986 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -107.7 10.63 28.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.54 0.736 . . . . 15.0 110.859 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.603 ' HE3' HD22 ' A' ' 187' ' ' LEU . 24.6 mmt -129.7 149.13 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.944 0.898 . . . . 15.0 110.583 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.8 pt -95.34 141.31 23.04 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.946 -1.025 . . . . 15.0 108.711 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.43 120.99 7.68 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.383 2.722 . . . . 15.0 112.918 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.89 -34.03 3.38 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.107 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 213' ' ' ILE . 5.4 t80 -78.07 -57.05 4.0 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.097 0.559 . . . . 15.0 110.233 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -19.93 65.47 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.953 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.669 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 21.2 m-20 -58.16 -41.15 83.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.426 0.69 . . . . 15.0 110.815 170.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.628 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -67.71 -30.51 74.7 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.92 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 187' ' ' LEU . 39.1 mm -75.99 -52.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.982 0.513 . . . . 15.0 110.346 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 55.8 pttt -80.16 20.19 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.053 0.941 . . . . 15.0 113.365 -167.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.48 31.22 2.15 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.367 -0.693 . . . . 15.0 111.367 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -146.99 -161.73 1.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.342 1.057 . . . . 15.0 109.695 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 158' ' ' VAL . 9.9 ptpp? -148.89 168.75 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.189 0.596 . . . . 15.0 109.671 172.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.4 148.64 51.37 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 117.987 0.358 . . . . 15.0 110.626 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.75 -45.63 1.28 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.804 -0.634 . . . . 15.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.92 122.95 28.93 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.471 0.653 . . . . 15.0 110.375 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.43 135.95 40.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.19 0.996 . . . . 15.0 110.11 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -144.46 173.03 12.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.033 0.933 . . . . 15.0 109.172 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.7 m -129.79 116.81 19.28 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.89 -0.781 . . . . 15.0 108.89 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.628 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.1 pt -92.32 170.58 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.029 0.932 . . . . 15.0 110.071 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.93 124.6 33.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.379 0.672 . . . . 15.0 109.441 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.01 163.64 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.586 -1.264 . . . . 15.0 107.586 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.3 m -129.83 140.13 51.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.723 0.809 . . . . 15.0 109.38 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.84 143.11 45.92 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 122.977 0.511 . . . . 15.0 110.549 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.63 155.51 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 124.295 3.33 . . . . 15.0 115.587 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.29 -25.79 63.5 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.176 -0.92 . . . . 15.0 110.406 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.29 -13.13 35.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.277 1.031 . . . . 15.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -55.67 140.98 39.64 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 123.259 0.623 . . . . 15.0 111.275 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -46.84 -67.61 0.27 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 125.178 1.549 . . . . 15.0 112.806 -171.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.69 125.57 28.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 15.0 110.45 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.18 -31.94 62.88 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.6 0.76 . . . . 15.0 111.587 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 229' ' ' LYS . 27.8 p-10 -64.23 -17.2 63.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.447 0.699 . . . . 15.0 111.416 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.824 HD11 ' HA ' ' B' ' 388' ' ' VAL . 28.8 mt -100.01 -39.31 8.2 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.172 0.989 . . . . 15.0 110.601 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -46.63 113.58 0.67 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.136 1.774 . . . . 15.0 112.813 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.65 -18.93 27.32 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.608 0.567 . . . . 15.0 114.253 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 98.4 mttt -84.17 154.28 23.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.619 0.768 . . . . 15.0 112.453 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.44 23.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.363 1.065 . . . . 15.0 110.638 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -90.23 135.67 33.53 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.215 1.006 . . . . 15.0 111.067 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.74 100.85 11.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.479 ' HE1' HG21 ' B' ' 387' ' ' ILE . 90.6 m-85 -96.53 107.74 20.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.555 0.342 . . . . 15.0 110.563 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.23 102.68 6.77 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.078 -0.712 . . . . 15.0 109.078 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.52 134.38 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.865 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -115.99 100.44 7.97 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 166' ' ' ILE . 95.0 mt -74.08 110.15 8.14 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.874 -0.787 . . . . 15.0 108.874 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -108.96 -33.37 6.94 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.096 0.474 . . . . 15.0 110.142 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.694 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.4 mmtt -133.28 122.99 24.69 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.108 0.963 . . . . 15.0 109.498 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 207' ' ' ALA . 97.5 t -114.97 87.44 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 106.872 -1.529 . . . . 15.0 106.872 169.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 163' ' ' ARG . 44.7 mt-10 -93.77 169.18 10.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.62 -0.881 . . . . 15.0 108.62 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 32.2 tt0 -134.42 122.84 23.1 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -74.1 83.99 1.81 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.132 -1.432 . . . . 15.0 107.132 167.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 127.17 31.6 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.752 -1.567 . . . . 15.0 110.746 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.38 115.0 9.36 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.389 1.076 . . . . 15.0 109.247 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 78.7 Cg_endo -75.52 -176.56 3.02 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.047 2.498 . . . . 15.0 112.407 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.96 142.53 56.42 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.964 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 24.4 tp -107.1 23.04 15.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 p -71.56 176.7 4.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.509 1.124 . . . . 15.0 111.216 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -38.05 -59.49 0.84 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.944 1.698 . . . . 15.0 114.573 -166.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.28 -22.82 65.63 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.31 -50.21 6.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.095 0.558 . . . . 15.0 109.786 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.609 HG13 HD22 ' A' ' 266' ' ' LEU . 15.6 tt -65.36 -27.29 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.012 0.525 . . . . 15.0 111.841 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -22.65 42.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.022 0.378 . . . . 15.0 112.022 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -62.81 -22.15 66.42 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.052 0.941 . . . . 15.0 111.568 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -39.95 90.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 15.0 110.857 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 150.1 26.5 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 O-C-N 123.416 0.447 . . . . 15.0 113.452 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.11 143.56 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 117.558 0.679 . . . . 15.0 109.185 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -69.65 -57.2 5.45 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.386 0.674 . . . . 15.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -91.54 -38.3 12.59 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.745 0.418 . . . . 15.0 110.51 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.17 32.43 5.27 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.147 -0.479 . . . . 15.0 112.645 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.7 p -78.65 145.64 34.51 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.392 0.596 . . . . 15.0 109.738 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 253' ' ' ILE . 44.7 t -58.16 -41.59 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.127 0.971 . . . . 15.0 111.126 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.22 -34.66 61.16 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.853 0.861 . . . . 15.0 111.858 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.88 -25.36 58.2 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 111.366 -0.694 . . . . 15.0 111.366 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.609 HD22 HG13 ' A' ' 253' ' ' ILE . 54.7 tp -75.97 -28.46 57.9 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.44 -45.88 78.33 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.071 -0.714 . . . . 15.0 109.071 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.99 82.05 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.307 -1.315 . . . . 15.0 110.419 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -68.13 -45.55 73.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.222 0.951 . . . . 15.0 111.855 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.04 -22.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 122.506 0.322 . . . . 15.0 110.649 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -68.47 -53.14 25.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.948 -0.39 . . . . 15.0 109.948 169.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -77.43 -2.18 33.98 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 112.537 0.569 . . . . 15.0 112.537 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -98.85 -59.37 1.75 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.271 0.628 . . . . 15.0 110.39 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.485 ' SD ' HG11 ' A' ' 132' ' ' VAL . 64.2 mtt -74.23 -38.0 63.65 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-O 118.045 -0.979 . . . . 15.0 112.055 -169.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -71.2 -37.81 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 120.044 1.293 . . . . 15.0 109.804 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.486 ' NH2' ' HA ' ' A' ' 378' ' ' TYR . 5.8 tpp180 -56.58 -40.36 75.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.714 0.805 . . . . 15.0 110.939 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.12 -60.38 2.36 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.891 -0.595 . . . . 15.0 110.581 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 130' ' ' VAL . 39.8 tp -64.24 -60.47 3.16 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 125.174 1.39 . . . . 15.0 112.775 -171.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.06 -32.53 73.92 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.03 0.443 . . . . 15.0 110.756 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.1 t -69.82 -38.53 76.6 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.075 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.65 98.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 15.0 110.734 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.45 -51.52 71.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 O-C-N 123.593 0.558 . . . . 15.0 109.558 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.4 HH22 ' HG3' ' A' ' 409' ' ' GLU . 12.5 tpt180 -57.5 -52.23 66.24 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.639 0.587 . . . . 15.0 111.35 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -69.24 -28.7 66.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.922 0.889 . . . . 15.0 111.456 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -64.22 -57.62 8.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.814 0.445 . . . . 15.0 110.084 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.51 -35.84 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.677 0.791 . . . . 15.0 110.534 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.6 tttt -64.05 -48.74 75.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.931 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.9 p -67.69 -31.1 70.83 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.182 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.25 -35.98 74.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.09 0.556 . . . . 15.0 110.701 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -52.43 57.76 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 123.446 0.467 . . . . 15.0 109.929 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 HG22 ' A' ' 347' ' ' VAL . 34.0 mm -61.78 -50.25 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.847 0.717 . . . . 15.0 111.486 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.45 -35.34 80.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.802 -0.635 . . . . 15.0 109.707 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.41 -40.57 96.43 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.009 0.818 . . . . 15.0 112.474 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 350' ' ' LEU . 45.7 mt -60.76 -46.33 90.89 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.18 0.992 . . . . 15.0 111.109 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 291' ' ' ILE . 41.4 t -64.2 -48.23 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.696 0.76 . . . . 15.0 109.784 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -66.37 -24.07 66.43 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.028 -0.987 . . . . 15.0 110.685 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.09 53.25 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.863 . . . . 15.0 112.473 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.38 149.39 10.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 -169.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.41 136.37 47.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.776 -0.647 . . . . 15.0 110.314 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 346' ' ' VAL . 4.8 tp -117.8 115.91 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.001 0.92 . . . . 15.0 109.228 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.82 141.76 35.93 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.469 HG12 HD11 ' A' ' 307' ' ' ILE . 24.7 t -126.93 115.33 22.14 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.747 0.819 . . . . 15.0 109.633 -165.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.02 141.13 16.37 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.275 2.65 . . . . 15.0 112.974 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.497 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -64.55 -33.65 76.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.267 1.21 . . . . 15.0 114.267 -166.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.63 65.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.753 0.421 . . . . 15.0 111.552 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 345' ' ' VAL . 14.5 mt -88.16 -29.83 20.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.417 -0.811 . . . . 15.0 110.271 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 302' ' ' VAL . 2.2 mp -59.39 -51.63 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 167.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.82 -57.21 11.75 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 114.438 -1.255 . . . . 15.0 110.342 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 313' ' ' VAL . 32.3 t -60.77 -56.32 22.63 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.401 1.063 . . . . 15.0 111.848 -173.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.78 -45.47 78.35 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 111.744 0.275 . . . . 15.0 111.744 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 46.7 mt -64.83 -37.02 79.12 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 N-CA-C 109.803 -0.443 . . . . 15.0 109.803 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.59 -46.68 83.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.694 0.797 . . . . 15.0 110.934 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 309' ' ' SER . 96.3 t -55.55 -52.0 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 123.837 0.711 . . . . 15.0 110.573 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 341' ' ' ALA . 84.1 mt -70.57 -21.96 62.63 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.803 -1.09 . . . . 15.0 112.3 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 . . . . . 0 N--CA 1.484 1.232 0 C-N-CA 123.125 0.57 . . . . 15.0 110.783 175.611 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.45 0.643 . . . . 15.0 111.601 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.7 -29.3 68.52 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.937 1.695 . . . . 15.0 113.04 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 337' ' ' PHE . 53.1 mt -43.76 123.26 3.84 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 123.853 0.861 . . . . 15.0 112.556 -171.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 53.5 Cg_exo -43.03 127.8 5.15 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 124.995 3.797 . . . . 15.0 115.189 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -52.91 -48.42 67.26 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.655 1.182 . . . . 15.0 112.076 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.52 -18.79 4.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.332 1.053 . . . . 15.0 113.447 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.1 mt -74.8 -38.02 62.22 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.224 0.465 . . . . 15.0 110.878 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 332' ' ' LEU . 41.9 m-85 -120.03 -51.94 2.21 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.095 0.558 . . . . 15.0 112.241 -168.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -47.53 -40.21 18.24 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.987 1.315 . . . . 15.0 113.301 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.56 -34.9 59.92 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.279 1.032 . . . . 15.0 112.469 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -104.22 -30.78 9.95 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.154 0.982 . . . . 15.0 111.126 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -76.49 -60.63 2.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.249 1.02 . . . . 15.0 110.971 -173.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.439 ' HG3' HG11 ' A' ' 302' ' ' VAL . 88.3 tttt -62.32 -25.03 67.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.428 -0.805 . . . . 15.0 109.792 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 347' ' ' VAL . 29.5 ttt85 -71.69 -35.09 70.14 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 118.421 -0.8 . . . . 15.0 110.719 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -57.36 -43.16 83.3 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 119.243 0.929 . . . . 15.0 109.306 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 306' ' ' LEU . 41.3 t -60.73 -49.8 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.265 -1.334 . . . . 15.0 110.704 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 300' ' ' ILE . 68.2 t -59.59 -48.95 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.611 0.764 . . . . 15.0 111.058 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 291' ' ' ILE . 71.6 t -52.64 -43.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.138 0.975 . . . . 15.0 110.267 173.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -70.36 -37.87 70.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 15.0 113.854 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.88 -47.2 54.45 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.267 0.627 . . . . 15.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HB3' HD13 ' A' ' 294' ' ' LEU . 76.9 mt -62.38 -57.88 9.7 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.998 0.811 . . . . 15.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 355' ' ' ILE . 53.2 mt -65.65 -34.45 78.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.125 0.57 . . . . 15.0 112.216 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.5 99.0 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.696 -0.562 . . . . 15.0 111.696 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.25 -37.42 85.46 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.072 -0.564 . . . . 15.0 110.687 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 350' ' ' LEU . 62.5 t -63.49 -36.28 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 117.956 0.343 . . . . 15.0 110.786 176.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 360' ' ' LEU . 97.1 mt -64.0 -44.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.367 0.667 . . . . 15.0 109.807 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.23 -56.4 11.46 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.488 -0.324 . . . . 15.0 111.361 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 77.0 m -54.48 -42.65 70.96 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.982 1.313 . . . . 15.0 111.985 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -101.19 14.65 31.31 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.155 0.582 . . . . 15.0 111.547 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 48.65 33.56 4.32 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 125.729 1.612 . . . . 15.0 114.205 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 355' ' ' ILE . 65.9 mt -72.42 157.04 38.38 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.087 0.955 . . . . 15.0 113.055 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 152.68 40.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.967 0.907 . . . . 15.0 110.415 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.69 111.62 17.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.477 0.711 . . . . 15.0 109.556 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 15.2 t70 -107.55 137.39 45.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.327 0.651 . . . . 15.0 110.884 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -64.48 -31.76 73.1 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.739 0.815 . . . . 15.0 113.03 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -66.08 -32.74 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 10.7 tpp180 -71.75 -44.99 63.13 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 371' ' ' ILE . 94.1 t -55.56 -60.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.111 0.882 . . . . 15.0 109.819 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -59.48 -35.83 74.85 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.161 0.913 . . . . 15.0 111.897 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.62 -55.7 27.41 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.902 0.751 . . . . 15.0 111.816 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.04 -42.97 81.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.641 0.776 . . . . 15.0 111.014 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 398' ' ' MET . 51.2 mm -51.22 -60.22 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.467 1.104 . . . . 15.0 110.461 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.54 -42.87 95.45 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.755 0.659 . . . . 15.0 112.14 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.59 -44.89 93.21 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 124.017 0.823 . . . . 15.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -77.09 -35.45 56.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 119.658 -0.211 . . . . 15.0 110.668 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 378' ' ' TYR . . . -69.19 -27.09 65.2 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.482 0.713 . . . . 15.0 111.798 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.6 t -65.78 -19.64 65.96 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 123.916 0.76 . . . . 15.0 110.908 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -95.75 3.03 54.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.972 0.909 . . . . 15.0 111.933 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.486 ' HA ' ' NH2' ' A' ' 276' ' ' ARG . 2.8 m-85 -88.74 177.57 6.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.065 0.546 . . . . 15.0 109.686 172.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.29 -47.22 62.15 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.173 -0.921 . . . . 15.0 109.359 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.37 122.31 13.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.379 1.072 . . . . 15.0 109.233 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -70.69 -40.28 4.0 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.708 2.272 . . . . 15.0 114.178 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -54.32 -47.79 72.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.359 0.874 . . . . 15.0 113.359 -167.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.93 -24.68 66.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.236 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.07 -45.79 29.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 123.859 0.864 . . . . 15.0 109.164 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.04 -47.04 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.053 0.541 . . . . 15.0 109.57 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.66 -39.93 80.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.142 0.577 . . . . 15.0 112.36 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.4 -36.65 84.44 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.527 0.731 . . . . 15.0 111.08 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.453 ' HA ' HD23 ' A' ' 394' ' ' LEU . 34.8 m-85 -73.84 -62.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.922 -0.581 . . . . 15.0 110.599 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.2 p -57.6 -32.17 66.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.32 17.42 11.29 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 15.0 111.98 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -139.84 106.14 5.27 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.35 -0.982 . . . . 15.0 108.35 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -65.83 -41.2 92.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.998 0.519 . . . . 15.0 111.345 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.67 -41.97 96.13 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.932 0.77 . . . . 15.0 110.517 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 388' ' ' TYR . 22.5 tp -72.14 -38.92 69.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.691 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 93.0 mmm -66.26 -30.76 71.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.92 0.488 . . . . 15.0 110.69 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.9 -39.96 69.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.285 1.034 . . . . 15.0 109.852 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -75.43 -21.58 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.916 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 371' ' ' ILE . 5.8 tpt -87.69 -20.07 26.79 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.586 0.217 . . . . 15.0 111.586 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.57 -36.89 57.33 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 167.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -52.02 -61.59 2.17 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.736 -1.12 . . . . 15.0 110.343 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.8 p -66.32 -27.47 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 118.154 0.434 . . . . 15.0 111.685 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.73 -58.01 10.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.033 0.533 . . . . 15.0 110.355 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 24.3 tp -77.76 -23.32 49.27 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.76 -1.109 . . . . 15.0 111.582 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.52 -51.66 33.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.99 0.516 . . . . 15.0 109.625 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.28 -35.8 82.03 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.8 -0.636 . . . . 15.0 111.176 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -69.85 -33.55 72.42 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.012 0.525 . . . . 15.0 111.205 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.97 93.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.84 0.456 . . . . 15.0 110.303 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.5 t -58.12 -53.6 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.815 -0.63 . . . . 15.0 109.752 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.4 ' HG3' HH22 ' A' ' 283' ' ' ARG . 43.6 mt-10 -60.38 -25.6 66.01 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.987 0.915 . . . . 15.0 112.908 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.94 -30.59 62.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.783 0.433 . . . . 15.0 111.317 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 294' ' ' LEU . 43.5 t -70.67 -43.27 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.077 -1.082 . . . . 15.0 108.077 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 83.4 mt -65.23 -40.7 94.42 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.362 1.039 . . . . 15.0 111.57 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.35 -23.16 67.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.836 0.854 . . . . 15.0 111.564 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 24.4 mtpp -98.96 -27.42 13.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 15.0 111.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.966 0.907 . . . . 15.0 111.348 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.8 mttt -69.93 83.51 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.692 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 125' ' ' VAL . 5.0 m -93.8 91.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.033 0.921 . . . . 15.0 109.487 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.7 t -70.72 95.2 1.09 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.513 -1.221 . . . . 15.0 109.188 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 131.81 40.59 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 115.055 -0.975 . . . . 15.0 110.505 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -146.86 145.43 29.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.27 135.12 33.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.728 HG23 HG22 ' A' ' 130' ' ' VAL . 4.5 t -159.86 174.03 15.06 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.495 0.497 . . . . 15.0 110.657 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.5 p -100.61 175.34 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.475 1.11 . . . . 15.0 111.948 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.454 ' HD2' HD22 ' A' ' 278' ' ' LEU . 38.4 t80 -52.71 -28.06 20.33 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.578 1.551 . . . . 15.0 111.691 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 23.2 m-80 -65.12 -15.61 62.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.775 1.23 . . . . 15.0 112.945 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' A' ' 427' ' ' LEU . 23.4 tp10 -60.7 -37.21 80.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.582 1.153 . . . . 15.0 111.414 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.8 mp -109.23 -77.85 0.59 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.435 -0.165 . . . . 15.0 111.192 -174.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -68.35 -50.54 52.56 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.838 0.455 . . . . 15.0 112.1 -171.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 15.9 m120 . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 385' ' ' LEU . . . . . 0.515 HD13 ' SD ' ' A' ' 194' ' ' MET . 2.3 pt? . . . . . 0 C--O 1.244 0.774 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.6 91.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -164.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 168' ' ' PHE . 0.1 OUTLIER -146.37 87.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 156.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 388' ' ' VAL . . . . . 0.824 ' HA ' HD11 ' A' ' 226' ' ' LEU . 9.8 p . . . . . 0 C--O 1.24 0.602 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.406 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 444' ' ' TYR . . . . . 0.455 ' HE2' ' HB ' ' A' ' 401' ' ' VAL . 97.3 m-85 . . . . . 0 C--O 1.242 0.661 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.306 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -66.28 -72.45 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.23 0.612 . . . . 0.0 109.561 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -166.69 -128.96 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.342 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 463' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' B' ' 464' ' ' MET . 53.3 m 79.62 152.33 0.12 Allowed 'General case' 0 C--N 1.366 1.326 0 C-N-CA 124.597 1.159 . . . . 0.0 110.413 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 464' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' B' ' 463' ' ' THR . 2.7 ptp 75.35 -47.95 0.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.248 2.619 . . . . 0.0 111.242 -173.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 70.72 -30.38 0.2 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.908 1.683 . . . . 0.0 112.943 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.36 -11.51 4.39 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 124.491 1.116 . . . . 0.0 112.649 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.437 1.095 . . . . 0.0 112.37 172.471 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -76.37 116.09 16.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.763 . . . . 15.0 109.039 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.68 161.57 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.053 0.454 . . . . 15.0 111.224 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 9.4 p -152.92 103.45 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.111 -0.95 . . . . 15.0 109.137 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.79 107.3 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.646 0.736 . . . . 15.0 110.233 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.2 100.54 10.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.323 1.049 . . . . 15.0 109.375 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 m -69.19 97.66 0.94 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.676 -0.861 . . . . 15.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.7 p -75.6 -61.35 1.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.912 0.885 . . . . 15.0 111.402 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -149.46 103.99 3.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.663 -0.495 . . . . 15.0 109.663 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.02 -108.02 1.95 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 124.018 0.824 . . . . 15.0 113.644 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.26 -29.64 61.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 15.0 110.682 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 119.35 12.41 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 124.164 0.915 . . . . 15.0 112.968 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HD2' HG11 ' A' ' 111' ' ' VAL . 64.6 mtt85 -133.39 118.95 19.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.527 1.131 . . . . 15.0 109.515 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 37.5 ttm180 -89.94 96.74 10.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.001 1.32 . . . . 15.0 110.248 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG11 ' HB1' ' A' ' 78' ' ' ALA . 41.0 t -89.11 88.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.558 -0.905 . . . . 15.0 108.558 173.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 31.5 m -77.65 114.26 16.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.087 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -105.08 112.95 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.752 0.821 . . . . 15.0 109.19 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 87.3 m -94.62 105.07 17.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.547 0.739 . . . . 15.0 109.885 174.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 23' ' ' SER . 60.8 mt -91.47 101.25 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.9 0.88 . . . . 15.0 109.53 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.8 173.6 9.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.151 0.58 . . . . 15.0 111.365 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.12 59.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.385 1.474 . . . . 15.0 113.798 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.11 -32.34 73.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.64 0.776 . . . . 15.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 19' ' ' ILE . 50.1 m -92.03 -29.62 16.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.991 0.516 . . . . 15.0 111.473 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.7 mt -59.49 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.72 78.88 5.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.947 0.879 . . . . 15.0 109.374 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.4 m -158.72 -55.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.612 -1.995 . . . . 15.0 105.612 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.97 70.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.331 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 66' ' ' VAL . 89.1 t -58.29 -62.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 123.945 0.778 . . . . 15.0 110.125 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -63.51 -39.83 95.46 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.736 -1.12 . . . . 15.0 111.86 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.3 m -68.66 -25.34 64.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.622 -0.717 . . . . 15.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -80.57 -43.25 20.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.7 0.286 . . . . 15.0 110.239 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.771 HD21 HG11 ' A' ' 62' ' ' VAL . 68.4 mt -74.15 -18.74 60.74 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.928 0.714 . . . . 15.0 112.928 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 p -76.71 -31.98 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 171.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -67.89 -49.03 64.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.342 0.657 . . . . 15.0 109.517 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.5 -33.64 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.288 1.035 . . . . 15.0 110.538 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.5 -54.12 50.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.994 0.518 . . . . 15.0 110.908 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.65 -42.54 86.49 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.291 0.636 . . . . 15.0 111.641 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -66.88 -51.84 50.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.643 1.177 . . . . 15.0 111.52 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.84 2.71 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.515 0.726 . . . . 15.0 110.407 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 71.11 17.28 6.14 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.265 1.426 . . . . 15.0 112.736 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 48.3 mt -66.57 -25.09 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.55 1.14 . . . . 15.0 110.771 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 -33.47 73.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.945 0.898 . . . . 15.0 111.201 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.91 -30.55 74.33 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.861 0.725 . . . . 15.0 112.855 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.5 m-85 -80.51 -24.79 39.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.358 0.663 . . . . 15.0 110.444 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -71.31 105.38 3.47 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.983 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.77 6.54 45.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.151 0.981 . . . . 15.0 110.774 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.79 68.56 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.211 0.319 . . . . 15.0 112.588 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -69.02 -49.06 61.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.087 0.955 . . . . 15.0 110.092 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.01 127.84 30.02 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.0 -1.0 . . . . 15.0 108.644 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.67 144.91 51.23 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.202 2.601 . . . . 15.0 113.337 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.58 -29.02 68.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.865 0.866 . . . . 15.0 112.351 -170.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -67.35 -38.94 85.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.648 0.379 . . . . 15.0 110.85 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.742 HG23 ' HD2' ' A' ' 57' ' ' ARG . 61.4 mt -73.28 -32.61 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.959 0.904 . . . . 15.0 111.202 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 15.8 m -75.3 -20.1 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.922 -0.486 . . . . 15.0 111.358 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -86.9 -62.97 1.39 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.255 0.622 . . . . 15.0 111.438 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -79.82 -41.49 26.3 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.742 ' HD2' HG23 ' A' ' 53' ' ' ILE . 95.2 mtt180 -86.78 -63.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.814 0.446 . . . . 15.0 110.648 -173.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 40.3 m-85 -75.73 -21.57 57.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 111.803 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.38 25.51 12.61 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.432 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.41 69.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.354 0.662 . . . . 15.0 112.581 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 m -77.45 -8.13 57.27 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.617 0.767 . . . . 15.0 112.61 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.771 HG11 HD21 ' A' ' 32' ' ' LEU . 2.7 p -119.36 86.58 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 122.537 1.16 . . . . 15.0 109.814 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 4.5 mmp_? -115.66 -47.98 2.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.567 -1.197 . . . . 15.0 108.959 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.88 -50.0 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.996 1.318 . . . . 15.0 111.993 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.03 -35.61 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.991 0.916 . . . . 15.0 111.151 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 28' ' ' VAL . 96.3 t -66.79 -38.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 114.813 -1.085 . . . . 15.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 HD21 ' CZ ' ' A' ' 97' ' ' TYR . 57.8 mt -62.0 -27.56 68.95 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.595 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.01 86.74 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.567 0.542 . . . . 15.0 112.507 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.68 -47.54 83.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.733 0.813 . . . . 15.0 110.943 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.94 -57.38 13.04 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.377 -1.283 . . . . 15.0 111.547 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 71.6 mtm -69.98 -30.49 67.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.5 0.72 . . . . 15.0 112.288 -174.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 t -68.62 -51.31 43.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.002 0.521 . . . . 15.0 111.06 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.692 -0.686 . . . . 15.0 110.456 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.03 -26.45 64.04 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.538 0.524 . . . . 15.0 112.153 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -63.05 -59.31 4.97 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.469 0.308 . . . . 15.0 110.517 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.86 -25.61 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.936 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -58.32 7.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.289 0.636 . . . . 15.0 109.384 171.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HB1' HG11 ' A' ' 15' ' ' VAL . . . -59.74 -53.87 52.98 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.052 -0.976 . . . . 15.0 112.077 -171.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.451 HD12 ' HG3' ' A' ' 86' ' ' PRO . 30.1 pt -58.79 -35.11 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.792 0.664 . . . . 15.0 112.792 -172.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.6 -42.35 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.086 0.554 . . . . 15.0 111.028 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -73.74 -31.9 63.59 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.242 0.217 . . . . 15.0 111.226 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.09 -0.96 33.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.683 0.793 . . . . 15.0 110.951 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 67.58 12.34 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.134 1.373 . . . . 15.0 112.432 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -78.26 118.69 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.653 0.781 . . . . 15.0 109.349 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -87.86 96.67 0.64 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 79' ' ' ILE . 55.2 Cg_endo -87.3 145.79 7.26 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.086 2.524 . . . . 15.0 114.164 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.3 46.98 0.82 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.945 0.898 . . . . 15.0 109.079 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 110' ' ' GLU . . . -144.24 153.68 25.22 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.443 -0.798 . . . . 15.0 112.088 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 113.0 12.65 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 15.0 109.785 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.26 106.97 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.953 1.769 . . . . 15.0 111.334 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -88.27 92.8 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.934 -0.765 . . . . 15.0 108.934 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -74.76 111.73 10.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.18 0.592 . . . . 15.0 109.508 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.38 93.62 27.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.173 0.989 . . . . 15.0 108.797 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.69 91.65 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.911 2.407 . . . . 15.0 111.951 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.24 -27.15 70.16 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.456 -0.793 . . . . 15.0 113.121 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 98' ' ' LYS . 14.7 pt-20 -165.47 161.58 18.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.503 0.721 . . . . 15.0 110.456 172.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 13.8 t80 -157.22 108.35 2.33 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.685 -1.228 . . . . 15.0 107.685 168.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -125.7 130.01 50.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.163 0.985 . . . . 15.0 108.423 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 tp -67.16 104.8 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.693 0.621 . . . . 15.0 109.484 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.74 12.24 44.47 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.602 -0.554 . . . . 15.0 113.467 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.0 mt-10 -130.09 -97.43 0.35 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 118.738 -0.649 . . . . 15.0 109.841 172.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -140.93 160.05 40.9 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.274 0.943 . . . . 15.0 112.105 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -131.8 74.5 1.59 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.437 1.495 . . . . 15.0 107.058 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.481 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 43.1 m -80.66 124.54 29.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.8 -1.091 . . . . 15.0 109.319 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -143.82 129.54 19.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.921 0.488 . . . . 15.0 109.871 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 70.2 m -84.89 120.02 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.172 0.989 . . . . 15.0 110.423 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.7 94.3 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -99.27 113.37 25.61 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.41 0.684 . . . . 15.0 110.505 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -142.66 162.74 34.69 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.205 0.602 . . . . 15.0 110.504 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.586 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 36.1 mt-10 -85.41 167.33 15.62 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.192 -0.913 . . . . 15.0 110.116 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.5 m -127.67 170.09 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.484 0.714 . . . . 15.0 110.726 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -75.22 113.49 25.99 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.532 -0.914 . . . . 15.0 108.532 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.35 161.84 19.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.064 1.843 . . . . 15.0 110.848 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.27 111.51 5.93 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 300' ' ' ILE . 4.8 p -71.1 124.83 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.862 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.33 122.8 43.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.48 -0.782 . . . . 15.0 110.79 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 91.3 mt -93.71 133.77 36.73 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 163.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -137.82 112.53 8.9 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.552 0.741 . . . . 15.0 109.063 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.96 63.79 4.32 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.747 0.654 . . . . 15.0 114.239 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 29.2 mt -70.79 -30.6 67.1 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.144 0.497 . . . . 15.0 110.346 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -72.3 -23.04 61.11 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.654 1.182 . . . . 15.0 111.212 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.8 43.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.232 0.613 . . . . 15.0 111.503 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.412 HG23 ' HA3' ' A' ' 293' ' ' GLY . 67.6 mt -65.79 123.59 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.717 0.807 . . . . 15.0 109.982 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -105.89 109.57 21.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 15.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 289' ' ' GLN . 59.1 t -109.02 154.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.866 1.266 . . . . 15.0 107.714 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 286' ' ' VAL . 42.7 tt0 -103.36 142.66 33.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 119.24 0.927 . . . . 15.0 109.973 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 417' ' ' VAL . 82.5 tttt -123.56 87.36 52.23 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.941 0.897 . . . . 15.0 109.083 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 282' ' ' ILE . 6.7 Cg_exo -72.66 97.5 0.89 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.884 1.723 . . . . 15.0 111.554 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.549 HD11 ' HE2' ' A' ' 127' ' ' LYS . 40.2 mm -69.25 92.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.768 -1.197 . . . . 15.0 107.768 166.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 427' ' ' LEU . 37.5 t -116.04 142.55 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.487 -0.779 . . . . 15.0 110.128 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.39 159.23 32.36 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.242 -1.345 . . . . 15.0 108.578 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.93 86.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' VAL . 43.6 p -64.4 174.89 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.701 0.8 . . . . 15.0 110.317 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.73 -33.02 72.28 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 120.95 0.405 . . . . 15.0 110.853 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.41 83.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.979 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 69.2 m-20 -74.59 -41.64 60.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.884 0.474 . . . . 15.0 111.195 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 133' ' ' THR . 82.4 t -61.79 -61.03 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.65 -33.84 73.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.856 0.722 . . . . 15.0 111.359 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.53 Favored Glycine 0 N--CA 1.478 1.476 0 O-C-N 123.62 0.575 . . . . 15.0 113.676 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.411 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 12.1 tpt -68.57 -46.36 69.6 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.069 0.548 . . . . 15.0 110.082 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 78.4 mt -58.07 -31.96 67.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.14 0.576 . . . . 15.0 111.748 172.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.56 -41.48 72.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.34 1.056 . . . . 15.0 110.216 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 86.0 m -58.2 -44.09 87.91 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.07 0.856 . . . . 15.0 109.71 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 141' ' ' LEU . 89.9 mt -63.65 -40.93 98.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.918 0.887 . . . . 15.0 111.208 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 39.0 mtm-85 -64.51 -31.5 72.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.325 0.65 . . . . 15.0 110.157 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.2 mttt -87.32 -15.9 36.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.235 0.614 . . . . 15.0 112.443 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 143' ' ' THR . 97.5 mt-30 -78.17 -30.42 49.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.642 -0.503 . . . . 15.0 109.642 167.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.45 36.54 2.78 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.102 0.961 . . . . 15.0 110.538 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.19 152.82 36.52 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.629 0.974 . . . . 15.0 113.629 -172.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -81.75 122.18 27.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.616 -1.175 . . . . 15.0 110.027 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 26.5 m95 -80.8 125.28 29.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 28.9 ttpt -158.83 128.32 5.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.914 -0.773 . . . . 15.0 108.914 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.629 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.4 mt-10 -77.26 134.39 38.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.885 0.374 . . . . 15.0 111.184 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 34.0 pttt -120.74 179.99 4.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.574 1.15 . . . . 15.0 109.816 169.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -142.92 152.91 42.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.566 0.746 . . . . 15.0 109.296 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -49.77 0.88 Allowed Glycine 0 N--CA 1.465 0.581 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.339 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.71 43.17 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.356 0.578 . . . . 15.0 111.417 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 t -116.79 134.39 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.347 1.059 . . . . 15.0 108.821 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -107.21 -179.58 3.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.31 1.044 . . . . 15.0 109.878 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.67 28.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.407 0.891 . . . . 15.0 113.407 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.27 40.83 3.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.227 0.537 . . . . 15.0 110.349 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -122.27 -170.52 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.045 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.771 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 15.2 mtm180 -119.94 124.07 45.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 171.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.61 100.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.784 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 12.5 m -83.31 110.02 17.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.13 -1.063 . . . . 15.0 108.13 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.6 pt -132.79 164.48 35.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.288 1.035 . . . . 15.0 110.4 -172.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -111.47 126.69 55.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.526 -1.657 . . . . 15.0 106.526 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.85 150.01 49.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.52 0.676 . . . . 15.0 111.281 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.1 t -139.16 123.78 18.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.147 -1.427 . . . . 15.0 107.147 165.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -113.53 166.66 12.17 Favored Glycine 0 C--O 1.241 0.585 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.065 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -145.1 134.93 23.6 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.308 0.643 . . . . 15.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 226' ' ' LEU . 61.6 t -118.54 137.89 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 171.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.66 16.35 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.982 0.896 . . . . 15.0 110.889 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.77 1.98 76.21 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 115.781 -0.645 . . . . 15.0 113.946 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -136.98 163.12 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.509 0.724 . . . . 15.0 110.654 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.24 165.5 22.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.23 0.612 . . . . 15.0 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.83 -159.78 0.97 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.405 1.082 . . . . 15.0 110.186 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.72 118.28 5.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.459 0.703 . . . . 15.0 111.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.461 ' HA3' ' HB ' ' B' ' 386' ' ' VAL . . . 85.15 -57.12 4.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.941 -1.027 . . . . 15.0 111.827 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.12 -60.37 4.78 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.384 -0.286 . . . . 15.0 112.384 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -116.36 150.92 36.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.611 0.764 . . . . 15.0 111.801 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -153.91 93.1 1.61 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.801 -1.09 . . . . 15.0 108.87 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.2 m -73.69 137.94 44.39 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.682 -1.144 . . . . 15.0 110.172 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.67 29.21 18.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.703 0.801 . . . . 15.0 113.018 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.84 132.77 49.48 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.144 0.577 . . . . 15.0 110.292 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.8 t -97.96 113.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 202' ' ' ILE . 12.5 tp -97.54 89.0 4.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.692 0.397 . . . . 15.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.22 86.36 1.08 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 15.0 109.543 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.8 OUTLIER -51.78 132.09 31.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.012 0.925 . . . . 15.0 110.878 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.0 49.78 1.86 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.213 -0.755 . . . . 15.0 111.213 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.7 150.43 48.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.628 0.771 . . . . 15.0 111.082 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.36 56.32 3.91 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.589 -0.732 . . . . 15.0 113.046 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -136.7 1.89 2.6 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.95 0.9 . . . . 15.0 109.672 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 187' ' ' LEU . 33.1 mmt -94.09 154.25 17.71 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.87 0.868 . . . . 15.0 111.107 -173.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.76 143.3 46.1 Favored Pre-proline 0 C--O 1.248 0.991 0 CA-C-N 114.887 -1.051 . . . . 15.0 108.438 172.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.65 109.79 0.47 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.796 2.331 . . . . 15.0 111.226 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.01 -44.26 1.2 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.798 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 202' ' ' ILE . 86.4 t80 -73.09 -62.25 1.53 Allowed 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -59.39 -32.93 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.259 -1.337 . . . . 15.0 111.984 -176.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.546 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 14.8 t70 -71.02 -31.94 68.57 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.665 0.786 . . . . 15.0 110.835 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -5.53 89.21 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.836 0.71 . . . . 15.0 113.134 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 187' ' ' LEU . 31.6 mm -104.54 -51.07 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.399 0.68 . . . . 15.0 110.947 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 58.5 pttt -76.88 6.35 6.34 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.475 1.11 . . . . 15.0 113.817 -163.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -131.87 27.32 3.69 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.507 -1.037 . . . . 15.0 110.507 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -125.08 -161.6 1.04 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.357 1.063 . . . . 15.0 110.361 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -154.85 153.28 30.9 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.516 0.727 . . . . 15.0 110.894 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.81 120.25 15.27 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.886 0.474 . . . . 15.0 111.392 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.69 -35.04 2.2 Favored Glycine 0 C--N 1.334 0.455 0 O-C-N 124.237 0.961 . . . . 15.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.72 126.21 32.66 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.442 -0.577 . . . . 15.0 109.442 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.0 123.82 48.73 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.08 -1.082 . . . . 15.0 108.08 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -145.08 178.04 8.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.333 1.053 . . . . 15.0 110.612 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.2 m -130.93 130.97 44.15 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.529 -1.286 . . . . 15.0 107.529 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.1 pt -104.06 160.48 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.378 0.671 . . . . 15.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.11 106.05 13.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 15.0 109.549 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.41 166.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.416 -1.327 . . . . 15.0 107.416 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 65.9 m -147.02 135.33 21.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.536 ' HZ ' HD11 ' B' ' 387' ' ' ILE . 95.5 m-85 -86.23 142.39 35.73 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 109.874 -0.417 . . . . 15.0 109.874 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.3 154.49 46.37 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.493 2.129 . . . . 15.0 111.834 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.14 -17.64 60.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.061 167.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.56 -24.5 61.93 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.294 1.438 . . . . 15.0 111.235 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 79.7 t80 -61.96 147.0 48.36 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.029 0.931 . . . . 15.0 111.238 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -71.12 -61.74 1.65 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.769 0.828 . . . . 15.0 113.109 -166.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.467 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -63.98 113.94 3.8 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.011 0.524 . . . . 15.0 110.356 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 42.7 tt0 -65.02 -36.66 85.11 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.819 0.848 . . . . 15.0 112.652 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.46 -27.89 69.3 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.079 0.551 . . . . 15.0 111.429 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.558 ' HA ' HG11 ' A' ' 172' ' ' VAL . 81.7 mt -90.33 -40.51 12.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.848 0.859 . . . . 15.0 110.315 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 14.6 ttmm -47.89 128.62 13.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.631 1.972 . . . . 15.0 113.001 -171.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.9 -31.44 3.66 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.379 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -98.04 163.73 12.64 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.636 0.774 . . . . 15.0 112.123 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -88.75 144.58 26.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.522 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -117.98 108.38 15.2 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.178 0.991 . . . . 15.0 109.837 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.12 101.04 12.52 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.24 0.616 . . . . 15.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -96.18 120.47 36.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.878 0.871 . . . . 15.0 109.752 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.24 98.55 9.45 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.96 -0.756 . . . . 15.0 108.96 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.1 mm -88.26 133.6 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.081 0.952 . . . . 15.0 110.611 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.81 95.15 4.71 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.456 -1.313 . . . . 15.0 107.456 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.551 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.06 97.36 5.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 -173.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -96.58 -38.63 9.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.633 0.373 . . . . 15.0 111.475 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.784 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.4 mmtt -131.63 148.73 52.63 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.095 0.558 . . . . 15.0 110.775 -176.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 207' ' ' ALA . 21.2 t -121.44 99.0 6.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 34.1 mt-10 -83.14 169.23 16.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.277 -1.009 . . . . 15.0 108.277 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 38.9 tt0 -140.24 139.76 35.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.725 0.41 . . . . 15.0 110.278 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.468 HH12 ' HD3' ' A' ' 146' ' ' LYS . 26.3 ptt85 -98.97 83.89 2.98 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 164.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.1 154.36 31.37 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.829 -1.078 . . . . 15.0 109.681 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.404 HD21 ' HE3' ' A' ' 146' ' ' LYS . 97.5 mt -59.12 133.25 87.57 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 122.715 0.406 . . . . 15.0 110.022 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 95.5 Cg_endo -77.71 -179.23 5.24 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.642 2.228 . . . . 15.0 111.351 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 249' ' ' THR . 47.1 mt-10 -70.56 116.73 11.22 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.516 -0.765 . . . . 15.0 108.964 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.82 43.81 1.07 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.046 0.927 . . . . 15.0 108.992 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.489 HG23 ' HB3' ' A' ' 247' ' ' GLU . 25.5 p -76.23 166.65 23.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.054 1.342 . . . . 15.0 110.174 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.6 -45.74 13.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.701 1.2 . . . . 15.0 113.063 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.01 -31.85 71.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.545 0.738 . . . . 15.0 112.592 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -81.57 -49.77 10.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.048 0.539 . . . . 15.0 110.379 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.689 HG13 HD22 ' A' ' 266' ' ' LEU . 12.8 tt -65.16 -29.54 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 122.974 0.51 . . . . 15.0 111.249 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.58 -17.12 56.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 111.944 0.35 . . . . 15.0 111.944 174.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -70.14 -19.32 63.22 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.113 0.565 . . . . 15.0 110.675 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -71.43 -17.86 62.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.251 0.62 . . . . 15.0 111.152 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 146.05 -24.44 1.76 Allowed Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.417 -0.657 . . . . 15.0 113.184 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 10.8 t -54.91 144.46 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.185 0.994 . . . . 15.0 111.394 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.79 -46.96 50.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.563 0.745 . . . . 15.0 111.001 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -106.22 -43.82 4.71 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.545 0.738 . . . . 15.0 110.587 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 112.35 24.85 4.9 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.892 -0.393 . . . . 15.0 113.1 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.1 p -71.96 144.3 48.94 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 117.471 0.635 . . . . 15.0 109.776 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 253' ' ' ILE . 60.9 t -59.37 -48.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.219 0.608 . . . . 15.0 110.165 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -58.71 -25.11 62.57 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.506 1.123 . . . . 15.0 112.237 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.29 -27.68 54.8 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.077 -0.809 . . . . 15.0 111.077 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.689 HD22 HG13 ' A' ' 253' ' ' ILE . 60.6 tp -76.28 -30.09 57.66 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.009 -0.737 . . . . 15.0 109.009 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.442 ' HA ' HG22 ' A' ' 270' ' ' VAL . 73.5 mtp180 -67.48 -37.41 82.83 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.61 93.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.76 . . . . 15.0 110.892 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -66.72 -40.83 88.55 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.349 -0.841 . . . . 15.0 111.314 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 267' ' ' ARG . 19.3 m -81.56 -19.62 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.592 0.357 . . . . 15.0 110.512 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt85 -59.79 -66.16 0.56 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -59.28 -44.17 92.49 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.483 0.49 . . . . 15.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -74.06 -42.06 60.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.26 -13.28 55.58 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.532 0.605 . . . . 15.0 111.432 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.89 -47.01 49.59 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.096 0.862 . . . . 15.0 108.707 162.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.588 ' HB2' ' HB1' ' A' ' 377' ' ' ALA . 74.8 ttt180 -60.41 -27.51 67.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.489 1.516 . . . . 15.0 111.904 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.78 -59.72 2.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.826 0.45 . . . . 15.0 110.199 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.426 HD11 HG11 ' A' ' 130' ' ' VAL . 62.7 tp -67.85 -57.58 6.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.358 0.503 . . . . 15.0 112.358 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.74 -27.66 67.79 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.196 0.31 . . . . 15.0 110.185 -172.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.3 t -66.63 -50.1 64.11 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.82 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.41 88.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.786 0.834 . . . . 15.0 111.94 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.7 mt -64.14 -50.32 77.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 C-N-CA 123.947 0.899 . . . . 15.0 108.823 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.369 0.668 . . . . 15.0 110.776 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -68.52 -45.53 71.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.992 -0.744 . . . . 15.0 108.992 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -57.69 -54.85 42.18 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.04 0.838 . . . . 15.0 110.599 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 282' ' ' ILE . 59.1 t -60.63 -52.96 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.113 -0.949 . . . . 15.0 110.725 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.29 -39.84 93.07 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.539 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.6 p -64.3 -43.83 93.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 119.47 -0.3 . . . . 15.0 110.588 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.441 ' HB2' HG13 ' A' ' 125' ' ' VAL . 57.0 mt-30 -68.01 -33.88 75.44 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.96 0.788 . . . . 15.0 111.832 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.4 -55.1 27.11 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 123.511 0.507 . . . . 15.0 109.865 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 295' ' ' VAL . 25.7 mm -61.65 -44.03 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.067 0.947 . . . . 15.0 111.774 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.24 -48.0 80.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.382 0.61 . . . . 15.0 109.491 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.8 -40.85 99.74 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 114.038 -1.437 . . . . 15.0 112.246 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.518 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.8 mt -55.7 -60.14 3.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.237 1.015 . . . . 15.0 110.987 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 291' ' ' ILE . 40.6 t -56.07 -51.45 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 124.039 0.837 . . . . 15.0 109.638 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -64.27 -26.84 68.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.638 0.775 . . . . 15.0 112.138 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.67 -24.77 53.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.564 0.579 . . . . 15.0 112.564 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 164.62 29.77 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.516 0.932 . . . . 15.0 113.516 -168.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.6 133.66 49.98 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.036 -0.984 . . . . 15.0 109.835 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.1 tp -155.77 116.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.695 0.798 . . . . 15.0 108.96 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.36 94.76 9.87 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.614 -0.884 . . . . 15.0 108.614 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.694 HG21 HG22 ' A' ' 346' ' ' VAL . 19.0 t -79.93 127.33 77.64 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 114.466 -1.243 . . . . 15.0 110.513 -168.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.77 124.11 12.29 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.138 2.559 . . . . 15.0 112.896 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.75 -20.05 54.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.142 1.377 . . . . 15.0 114.196 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.17 94.7 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.947 0.499 . . . . 15.0 111.588 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.74 -35.39 80.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.635 0.774 . . . . 15.0 110.86 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 304' ' ' ALA . 2.7 mp -65.78 -53.28 40.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.501 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.22 -33.52 74.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.461 0.704 . . . . 15.0 111.14 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.6 t -58.07 -58.39 8.62 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 124.027 0.829 . . . . 15.0 110.607 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.414 ' HA ' HG23 ' A' ' 313' ' ' VAL . 17.4 mm-40 -77.02 -18.96 57.81 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.1 -42.84 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.736 ' HA ' ' HD2' ' A' ' 315' ' ' ARG . 15.1 t70 -59.04 -39.25 81.41 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 123.958 0.786 . . . . 15.0 111.349 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 310' ' ' GLU . 23.4 t -58.33 -51.85 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.19 0.519 . . . . 15.0 110.819 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 341' ' ' ALA . 76.0 mt -68.71 -21.39 64.41 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.46 -0.791 . . . . 15.0 112.093 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.736 ' HD2' ' HA ' ' A' ' 312' ' ' ASP . 77.0 mtt180 . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 124.168 0.987 . . . . 15.0 108.86 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.567 1.616 0 N-CA-C 112.895 0.702 . . . . 15.0 112.895 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -98.55 -11.43 22.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.623 0.769 . . . . 15.0 112.174 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 92.8 mt -55.59 131.78 71.45 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 123.244 0.618 . . . . 15.0 111.024 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.413 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 77.6 Cg_exo -52.24 125.26 16.96 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.142 3.228 . . . . 15.0 114.501 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -51.82 -44.23 63.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.703 1.201 . . . . 15.0 112.416 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -60.35 -18.91 53.26 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 15.0 113.114 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 84.8 mt -69.5 -32.68 71.7 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.997 0.427 . . . . 15.0 110.468 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.89 -17.3 12.05 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.237 1.015 . . . . 15.0 111.238 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -49.95 -46.8 52.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.435 1.894 . . . . 15.0 113.213 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.46 -60.74 2.7 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.794 1.309 . . . . 15.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.7 pt20 -80.87 -32.4 34.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 15.0 111.387 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -60.71 -61.85 2.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 15.0 110.844 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -55.4 -41.41 72.65 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.113 0.883 . . . . 15.0 109.869 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt-85 -59.42 -36.1 75.25 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.113 0.883 . . . . 15.0 110.909 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 70.3 mtt-85 -76.22 -29.4 57.57 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.807 0.443 . . . . 15.0 110.34 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.53 -37.95 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 302' ' ' VAL . 43.1 t -67.59 -34.42 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 351' ' ' LEU . 41.2 t -56.97 -50.22 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.553 0.741 . . . . 15.0 109.216 167.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.13 80.27 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.255 -0.884 . . . . 15.0 113.912 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.47 -58.61 3.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.124 0.57 . . . . 15.0 111.528 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' A' ' 294' ' ' LEU . 89.9 mt -60.29 -53.52 56.63 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.919 0.888 . . . . 15.0 110.872 -176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.564 HD12 HG13 ' A' ' 347' ' ' VAL . 44.8 mt -68.38 -30.72 69.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -59.47 -38.62 93.8 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.504 0.502 . . . . 15.0 112.478 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.43 -42.34 83.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.956 -0.622 . . . . 15.0 110.387 174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.7 -34.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.115 0.566 . . . . 15.0 111.146 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.0 mt -66.73 -49.68 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.819 0.848 . . . . 15.0 110.057 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -60.15 -54.36 46.81 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 116.064 -0.517 . . . . 15.0 110.988 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.4 m -61.22 -43.99 97.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.196 0.999 . . . . 15.0 111.72 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -91.9 12.61 21.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.066 0.546 . . . . 15.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 47.38 30.9 1.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.312 1.845 . . . . 15.0 114.181 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.532 HD22 HE21 ' A' ' 406' ' ' GLN . 73.7 mt -66.72 158.1 31.06 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.339 1.056 . . . . 15.0 113.032 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.9 167.27 27.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.856 -1.52 . . . . 15.0 107.799 170.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.0 90.99 0.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.701 -0.481 . . . . 15.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.74 131.29 45.97 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.254 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -51.71 -41.98 61.91 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.699 1.249 . . . . 15.0 112.12 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.5 -19.69 49.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.582 -0.735 . . . . 15.0 111.643 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -86.23 -35.0 20.28 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 110.025 -0.361 . . . . 15.0 110.025 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.78 -52.47 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -51.06 -45.24 61.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.66 1.184 . . . . 15.0 111.381 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.75 5.88 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.851 1.344 . . . . 15.0 112.155 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 402' ' ' ALA . 66.6 mt -55.73 -52.27 64.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.394 0.678 . . . . 15.0 111.675 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 398' ' ' MET . 39.9 mm -50.55 -57.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 124.387 1.054 . . . . 15.0 111.417 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.36 -36.57 60.95 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.467 0.48 . . . . 15.0 111.781 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -51.04 71.08 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.279 0.561 . . . . 15.0 110.266 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -67.18 -44.08 80.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.224 1.409 . . . . 15.0 111.016 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -70.56 -44.78 66.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.68 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.4 m -69.5 -16.97 63.56 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.801 0.334 . . . . 15.0 111.458 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 276' ' ' ARG . . . -74.2 -29.33 61.69 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.513 0.725 . . . . 15.0 110.31 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -87.61 -168.6 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.773 0.829 . . . . 15.0 111.178 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -70.87 -66.22 0.64 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.122 0.969 . . . . 15.0 110.822 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.16 108.29 48.33 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.599 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 24.6 Cg_endo -63.08 -40.29 34.58 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.553 2.169 . . . . 15.0 113.953 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -57.39 -51.71 68.33 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.907 0.883 . . . . 15.0 113.041 -161.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.11 -20.07 63.2 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.131 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 68.4 t -76.44 -45.29 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.51 -52.58 19.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.04 -32.07 73.33 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.188 -0.915 . . . . 15.0 112.647 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -64.78 -50.66 65.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.088 0.555 . . . . 15.0 109.771 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -72.41 -50.92 22.9 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.518 0.511 . . . . 15.0 111.437 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.5 p -62.07 -28.05 69.33 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.695 0.628 . . . . 15.0 112.695 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.46 17.08 23.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.589 0.755 . . . . 15.0 111.034 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 395' ' ' MET . 50.5 t-20 -137.26 93.58 2.84 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.776 -1.194 . . . . 15.0 107.776 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.57 -33.81 70.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.258 1.023 . . . . 15.0 112.204 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.82 -63.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.269 0.98 . . . . 15.0 110.243 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.87 -18.33 58.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.307 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER -67.03 -48.85 67.07 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.544 -0.91 . . . . 15.0 108.544 177.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.62 -34.32 73.9 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 114.962 -1.017 . . . . 15.0 110.695 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.54 -45.12 95.03 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.463 0.649 . . . . 15.0 110.201 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.533 ' HG2' HD11 ' A' ' 371' ' ' ILE . 32.6 tpp -66.92 -30.99 71.29 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.111 -0.95 . . . . 15.0 110.855 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -71.95 -32.72 67.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.154 0.582 . . . . 15.0 111.205 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -51.49 61.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.0 p -72.63 -20.35 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.377 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -70.12 -43.62 70.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.899 0.479 . . . . 15.0 110.412 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.97 -26.59 59.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.228 -0.896 . . . . 15.0 110.721 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 408' ' ' VAL . 73.2 tt0 -60.63 -51.29 70.03 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 109.69 -0.485 . . . . 15.0 109.69 170.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -56.35 -49.2 75.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.074 0.949 . . . . 15.0 111.017 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.532 HE21 HD22 ' A' ' 360' ' ' LEU . 53.4 tt0 -64.8 -36.36 84.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.752 1.221 . . . . 15.0 111.614 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.39 66.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.02 -0.536 . . . . 15.0 111.063 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 404' ' ' GLU . 68.8 t -55.18 -54.18 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.925 -0.768 . . . . 15.0 108.925 168.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.6 mt-10 -61.21 -30.7 70.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.635 1.174 . . . . 15.0 112.425 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.55 73.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.992 0.517 . . . . 15.0 111.342 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.27 -31.56 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.061 -0.718 . . . . 15.0 109.061 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 409' ' ' GLU . 91.6 mt -67.45 -35.3 78.94 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 15.0 110.864 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.13 -17.43 63.46 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.298 0.639 . . . . 15.0 111.978 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -109.58 -26.26 10.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.575 1.15 . . . . 15.0 112.076 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.94 158.38 16.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.919 0.888 . . . . 15.0 110.875 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -73.41 84.78 1.47 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.306 0.642 . . . . 15.0 109.751 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 127' ' ' LYS . 21.2 t -86.8 94.78 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.59 -0.892 . . . . 15.0 108.59 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.9 t -68.92 94.5 0.63 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 122.429 1.109 . . . . 15.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -76.25 130.82 38.75 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.027 -1.442 . . . . 15.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -133.69 136.87 44.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.759 0.824 . . . . 15.0 108.905 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -98.72 127.82 44.78 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.287 -0.635 . . . . 15.0 109.287 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.469 HG21 ' HG2' ' A' ' 426' ' ' GLU . 9.7 t -160.89 176.61 11.25 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 122.78 0.432 . . . . 15.0 111.724 -173.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 33.6 p -92.96 165.92 12.63 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 111.488 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 56.7 t80 -58.6 -28.96 66.09 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.715 1.206 . . . . 15.0 111.228 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 4.2 m-20 -65.24 -6.84 10.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.03 0.932 . . . . 15.0 113.387 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.497 ' HB3' HD12 ' A' ' 427' ' ' LEU . 12.6 tp10 -74.22 -41.49 61.29 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.033 0.933 . . . . 15.0 112.106 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.642 HD11 HG21 ' A' ' 130' ' ' VAL . 5.3 mp -89.54 -68.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.035 0.534 . . . . 15.0 111.031 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 428' ' ' MET . 1.2 mpt? -74.36 -49.62 21.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.847 0.459 . . . . 15.0 110.668 -175.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 1.7 m-20 . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 386' ' ' VAL . . . . . 0.461 ' HB ' ' HA3' ' A' ' 179' ' ' GLY . 24.0 m -71.91 95.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.668 0.747 . . . . 0.0 111.051 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.536 HD11 ' HZ ' ' A' ' 217' ' ' PHE . 13.5 tt -155.82 162.64 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.62 0.768 . . . . 0.0 108.97 165.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.425 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 121.364 0.602 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.24 0.567 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.155 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.712 0.291 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 64.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.144 1.378 . . . . 0.0 111.681 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -89.78 116.28 27.76 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 27.9 m -68.62 106.49 2.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.406 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -89.34 131.62 35.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -86.48 25.96 1.15 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.633 0.773 . . . . 0.0 112.285 -165.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.09 -41.79 90.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.425 0.69 . . . . 0.0 109.271 166.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.523 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.033 168.331 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 15.8 ptm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' THR . 7.8 tt0 -87.04 97.52 10.77 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.328 -0.989 . . . . 15.0 108.328 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.02 157.58 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.844 0.458 . . . . 15.0 111.305 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 25.4 m -131.04 86.43 2.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 15' ' ' VAL . 4.8 p -73.77 87.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 122.658 1.218 . . . . 15.0 110.508 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.96 178.2 5.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.97 -1.468 . . . . 15.0 109.546 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 58.1 m -136.63 125.96 24.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -66.24 -58.75 4.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.538 0.735 . . . . 15.0 109.842 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -167.46 120.62 0.94 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.02 0.528 . . . . 15.0 109.998 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.82 -100.67 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 O-C-N 124.423 1.077 . . . . 15.0 114.398 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.36 -43.39 27.79 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.203 1.001 . . . . 15.0 110.076 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.2 88.88 0.08 OUTLIER Glycine 0 C--N 1.344 1.024 0 O-C-N 124.065 0.853 . . . . 15.0 112.5 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.9 ttm180 -95.78 129.11 43.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 15.0 110.326 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -106.04 90.75 3.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.283 1.033 . . . . 15.0 110.416 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 5' ' ' VAL . 46.1 t -81.68 87.02 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.906 -1.146 . . . . 15.0 107.906 173.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 82.0 m -71.67 87.55 0.94 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.281 0.633 . . . . 15.0 110.189 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 74' ' ' ASN . 48.8 mt -80.07 128.22 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.56 -0.745 . . . . 15.0 109.135 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 56.7 m -118.23 104.08 10.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.713 -1.218 . . . . 15.0 107.713 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' HE1' ' A' ' 105' ' ' TYR . 24.7 mt -66.39 129.91 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.98 137.54 57.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.189 0.931 . . . . 15.0 111.038 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.08 61.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.032 1.333 . . . . 15.0 112.789 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.68 -40.88 92.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.849 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.7 m -70.08 -34.63 73.41 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.278 -0.874 . . . . 15.0 111.079 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -68.75 -50.98 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.859 0.464 . . . . 15.0 109.85 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -59.2 -33.73 71.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.265 0.626 . . . . 15.0 111.271 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.1 m -76.72 -43.17 38.5 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.367 0.667 . . . . 15.0 111.283 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -42.2 78.87 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.032 0.533 . . . . 15.0 112.249 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' HG11 ' A' ' 66' ' ' VAL . 69.5 t -60.91 -47.77 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.683 0.793 . . . . 15.0 109.838 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -58.04 -40.06 79.94 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.083 0.953 . . . . 15.0 111.731 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.4 m -70.56 -28.96 65.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.827 0.851 . . . . 15.0 110.822 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.4 tp10 -80.35 -29.07 37.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.021 0.528 . . . . 15.0 110.725 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -70.69 -35.7 72.91 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.702 0.801 . . . . 15.0 111.534 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.0 p -71.18 -29.71 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.764 -0.458 . . . . 15.0 109.764 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -67.16 -36.67 82.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.934 0.494 . . . . 15.0 110.517 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 57.8 t -63.4 -43.1 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.31 73.88 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.45 -0.796 . . . . 15.0 111.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 97.8 mttt -75.12 -33.98 61.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.218 0.607 . . . . 15.0 111.098 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -65.27 -36.52 84.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.688 0.795 . . . . 15.0 110.617 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.8 t -96.13 -1.51 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.163 0.585 . . . . 15.0 110.562 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 66.95 10.42 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.506 1.522 . . . . 15.0 113.792 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -79.29 -11.24 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.896 0.878 . . . . 15.0 111.388 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -57.13 -38.51 73.59 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.818 0.847 . . . . 15.0 111.907 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.97 -19.81 64.47 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.742 -0.663 . . . . 15.0 112.529 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.02 -20.75 34.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.197 0.599 . . . . 15.0 110.57 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.36 107.81 3.95 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.24 6.56 13.68 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.832 0.853 . . . . 15.0 111.777 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 10.5 74.05 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.964 -0.354 . . . . 15.0 113.035 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -65.38 -35.09 79.89 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.759 0.824 . . . . 15.0 109.86 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.37 122.47 59.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 159.05 47.74 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.899 2.4 . . . . 15.0 112.016 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 tpt -72.51 -20.26 61.39 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.908 -0.587 . . . . 15.0 112.09 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -65.44 -43.04 91.65 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.268 -0.271 . . . . 15.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' A' ' 57' ' ' ARG . 62.7 mt -66.19 -44.97 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.87 0.868 . . . . 15.0 111.288 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -71.05 -21.7 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 116.582 -0.281 . . . . 15.0 111.471 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.09 -42.13 14.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.892 0.477 . . . . 15.0 112.041 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 2.4 pt20 -82.6 -42.63 18.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.09 0.556 . . . . 15.0 111.253 -171.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 98.3 mtt180 -91.63 -60.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.111 0.564 . . . . 15.0 110.435 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.53 -46.51 63.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.607 -0.724 . . . . 15.0 110.471 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.51 12.16 35.11 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.015 -0.881 . . . . 15.0 114.083 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.86 -32.86 72.83 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 117.875 0.837 . . . . 15.0 110.613 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -74.37 -52.0 13.42 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.2 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.0 78.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 15.0 109.629 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -132.14 -63.73 0.8 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.466 1.107 . . . . 15.0 109.114 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -60.67 -29.33 69.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 123.794 0.684 . . . . 15.0 110.404 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.39 -49.44 69.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.824 1.25 . . . . 15.0 110.758 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 28' ' ' VAL . 21.2 t -75.35 -38.65 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.056 -0.975 . . . . 15.0 110.075 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.472 HD23 HD12 ' A' ' 70' ' ' LEU . 96.3 mt -59.17 -33.1 70.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.729 0.812 . . . . 15.0 111.692 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.87 -39.73 88.74 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.433 0.458 . . . . 15.0 112.932 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.91 -46.84 22.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.878 0.871 . . . . 15.0 110.334 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 67' ' ' LEU . 80.0 mt -56.91 -37.19 71.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.852 0.861 . . . . 15.0 112.236 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 72.5 mtm -59.4 -39.24 82.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.362 0.665 . . . . 15.0 111.169 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -75.14 -30.37 60.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.155 -0.929 . . . . 15.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 70' ' ' LEU . 6.9 mmm180 -71.78 -42.31 67.3 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.511 -0.551 . . . . 15.0 109.511 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.427 ' HB3' HG21 ' A' ' 17' ' ' ILE . 53.2 m-80 -71.83 -27.47 62.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.786 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -66.62 -56.57 10.1 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.341 0.4 . . . . 15.0 110.557 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.79 -30.56 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 O-C-N 123.875 0.735 . . . . 15.0 110.456 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.37 -49.05 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.638 0.775 . . . . 15.0 110.077 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.51 -57.3 11.69 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.376 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.1 pt -61.2 -29.14 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 112.83 0.678 . . . . 15.0 112.83 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.74 -49.06 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.263 0.625 . . . . 15.0 110.968 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -74.62 -25.85 59.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.541 0.21 . . . . 15.0 111.312 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -83.34 -16.71 45.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.727 0.811 . . . . 15.0 111.14 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 64.15 25.75 13.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.763 1.225 . . . . 15.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' A' ' 109' ' ' PHE . 51.8 mt -91.01 127.01 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.406 0.682 . . . . 15.0 109.718 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.55 117.22 61.76 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 164.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.35 97.17 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.375 2.05 . . . . 15.0 113.382 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.53 -171.12 3.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.081 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 58.71 -145.03 43.4 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.293 -0.323 . . . . 15.0 112.293 -168.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.28 122.5 17.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.404 -1.702 . . . . 15.0 106.404 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.92 106.51 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.513 2.142 . . . . 15.0 111.7 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -102.16 98.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.672 0.789 . . . . 15.0 109.468 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -84.54 94.35 8.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.33 98.48 0.92 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.928 -0.768 . . . . 15.0 108.928 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 112.23 3.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.857 2.371 . . . . 15.0 111.352 -173.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.5 -62.61 5.95 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.298 -0.721 . . . . 15.0 111.298 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.32 168.41 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.048 0.939 . . . . 15.0 110.629 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -138.75 121.81 16.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.236 1.014 . . . . 15.0 108.864 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 60.6 mttp -94.63 170.46 9.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.36 97.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.655 0.782 . . . . 15.0 111.469 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.45 80.24 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.447 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.7 mt-10 -98.67 -176.8 3.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.722 0.809 . . . . 15.0 110.805 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.29 137.9 57.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.716 0.806 . . . . 15.0 111.588 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -108.87 99.54 8.87 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.936 0.894 . . . . 15.0 109.546 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -79.72 131.28 35.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.731 0.813 . . . . 15.0 110.084 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.525 ' HE1' HG13 ' A' ' 19' ' ' ILE . 28.8 p90 -152.18 125.25 8.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.609 0.764 . . . . 15.0 109.869 173.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.9 m -82.8 100.55 10.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.445 1.098 . . . . 15.0 110.259 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.67 97.9 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.578 -0.527 . . . . 15.0 109.578 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.46 116.65 30.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.605 0.762 . . . . 15.0 110.494 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HE2' HG21 ' A' ' 84' ' ' ILE . 43.2 p90 -145.3 170.18 16.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.758 1.223 . . . . 15.0 107.73 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -94.71 156.58 16.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.392 0.615 . . . . 15.0 111.312 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 ' NH1' ' A' ' 13' ' ' ARG . 32.9 m -115.63 162.82 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.462 1.105 . . . . 15.0 108.272 170.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.05 119.87 70.53 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.86 -175.48 2.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.111 2.541 . . . . 15.0 112.46 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.71 128.39 35.36 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -102.48 129.76 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.816 0.846 . . . . 15.0 109.278 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -118.37 113.14 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 15.0 110.751 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.1 mt -82.0 130.69 35.15 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 123.648 0.593 . . . . 15.0 109.611 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.39 154.92 14.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.679 0.792 . . . . 15.0 109.87 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 64.55 20.73 66.15 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.681 0.613 . . . . 15.0 113.481 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 117' ' ' LEU . 68.0 mt -65.04 -42.64 94.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.886 0.874 . . . . 15.0 110.505 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -78.16 -18.65 55.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.636 -1.166 . . . . 15.0 110.646 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.95 47.47 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.234 0.613 . . . . 15.0 111.34 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.519 HG23 ' HA3' ' A' ' 293' ' ' GLY . 61.1 mt -58.35 124.33 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.245 0.966 . . . . 15.0 110.666 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.0 103.92 14.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.421 0.688 . . . . 15.0 109.296 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 417' ' ' VAL . 41.5 t -107.32 161.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.46 1.104 . . . . 15.0 108.417 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -123.1 138.13 54.74 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.561 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.1 tttt -114.7 88.67 16.82 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.336 -0.987 . . . . 15.0 108.336 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.11 100.81 0.95 Allowed 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.049 1.833 . . . . 15.0 111.298 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.561 HD11 ' HE2' ' A' ' 127' ' ' LYS . 42.1 mm -67.87 84.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 168.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 278' ' ' LEU . 21.3 t -98.38 136.73 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.22 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -132.66 162.52 31.15 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 167.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.16 79.83 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.2 p -61.93 170.06 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.761 0.824 . . . . 15.0 110.448 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.27 -31.43 65.58 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.955 0.502 . . . . 15.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.96 92.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.782 0.833 . . . . 15.0 110.895 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -73.16 -40.55 64.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.314 0.646 . . . . 15.0 111.113 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.06 -61.87 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.211 1.004 . . . . 15.0 109.514 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.48 -34.49 65.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.574 -0.739 . . . . 15.0 110.934 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.22 -45.67 92.97 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.639 0.587 . . . . 15.0 113.14 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -75.29 -41.82 56.2 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.058 0.543 . . . . 15.0 111.033 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 270' ' ' VAL . 32.2 mt -52.23 -40.01 61.05 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.095 0.558 . . . . 15.0 111.841 167.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.54 -41.37 84.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.409 0.684 . . . . 15.0 110.605 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 m -60.41 -39.3 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.836 0.71 . . . . 15.0 110.339 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -40.33 96.07 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 15.0 111.014 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 47.7 mtm180 -62.33 -40.7 97.2 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.621 0.575 . . . . 15.0 110.558 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 87.5 mttt -80.29 -16.4 54.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.324 0.65 . . . . 15.0 112.386 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -82.48 -40.8 20.6 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.883 0.473 . . . . 15.0 109.748 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -100.0 35.81 1.97 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.788 0.835 . . . . 15.0 109.889 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.19 143.97 34.88 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.011 0.925 . . . . 15.0 112.562 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.4 m -74.19 129.4 37.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 15.0 109.643 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -79.18 129.99 35.02 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.21 163.36 36.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 45.7 mt-10 -118.12 157.15 27.42 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.145 0.498 . . . . 15.0 109.839 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 23.4 pttt -136.63 155.09 50.38 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.34 -0.846 . . . . 15.0 109.982 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.77 96.57 7.0 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.613 -0.721 . . . . 15.0 110.242 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 240' ' ' VAL . . . 60.07 62.36 6.15 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 113.965 -1.47 . . . . 15.0 116.392 165.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.683 ' H ' HG11 ' A' ' 240' ' ' VAL . . . -155.02 107.66 2.75 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 117.344 0.572 . . . . 15.0 110.291 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 203' ' ' LYS . 41.6 t -109.22 137.54 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.488 0.586 . . . . 15.0 109.66 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.61 -176.99 4.22 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.788 1.235 . . . . 15.0 109.315 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.22 67.6 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.892 1.441 . . . . 15.0 114.892 -167.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.9 17.68 9.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.971 0.509 . . . . 15.0 111.305 -170.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.51 -159.57 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.929 0.491 . . . . 15.0 111.815 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 32.3 ttp180 -137.17 153.87 50.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 44.5 t -144.12 155.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 15.0 108.768 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 23.5 m -122.74 124.39 43.26 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 164.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.09 161.34 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.778 0.831 . . . . 15.0 111.012 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.78 121.12 33.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.466 -2.05 . . . . 15.0 105.466 159.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -112.39 163.08 14.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.746 -0.596 . . . . 15.0 110.3 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.5 t -139.78 93.31 2.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -98.12 162.74 21.01 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.205 -1.361 . . . . 15.0 113.295 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 m -149.98 127.45 11.51 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.025 -1.102 . . . . 15.0 108.025 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 71.2 t -97.35 115.97 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.803 0.841 . . . . 15.0 109.422 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 36.6 t70 69.62 3.47 4.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.652 0.781 . . . . 15.0 111.486 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 115.32 -11.9 19.36 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.587 -0.563 . . . . 15.0 113.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 10.3 pt-20 -92.37 131.79 37.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.4 94.58 1.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.217 -1.772 . . . . 15.0 106.217 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.499 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 3.0 p90 -71.78 -160.78 0.06 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.509 -1.678 . . . . 15.0 112.419 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -51.66 103.96 0.07 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.155 0.982 . . . . 15.0 110.571 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.51 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 91.56 -62.72 2.69 Favored Glycine 0 C--O 1.239 0.435 0 O-C-N 124.366 1.041 . . . . 15.0 113.195 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.27 -59.42 4.91 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.2 158.03 16.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.566 0.58 . . . . 15.0 112.566 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.16 93.51 2.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.5 m -79.58 130.71 35.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.196 -0.911 . . . . 15.0 112.193 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 58.17 31.12 20.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.749 1.22 . . . . 15.0 113.309 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.414 ' CD2' HD23 ' B' ' 385' ' ' LEU . 72.6 t80 -71.4 133.96 46.31 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.133 0.492 . . . . 15.0 109.86 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.7 100.69 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 124.26 1.024 . . . . 15.0 108.912 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.17 98.66 11.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.146 0.979 . . . . 15.0 111.406 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.03 101.65 3.3 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.679 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER -60.08 116.61 4.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.306 0.643 . . . . 15.0 109.641 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.9 -6.61 7.82 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.816 -0.629 . . . . 15.0 112.148 -166.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -81.52 -179.83 7.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.509 0.724 . . . . 15.0 111.097 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.97 52.73 0.68 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.877 -0.602 . . . . 15.0 112.226 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.7 13.52 21.15 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.94 0.876 . . . . 15.0 109.169 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -152.2 154.62 36.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.407 1.083 . . . . 15.0 109.169 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 pt -86.3 164.57 37.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.442 0.697 . . . . 15.0 111.342 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.13 153.57 68.56 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.241 1.961 . . . . 15.0 111.373 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.73 -50.59 1.77 Allowed Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.872 -0.891 . . . . 15.0 110.872 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 213' ' ' ILE . 65.6 t80 -68.66 -59.98 2.74 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.197 0.599 . . . . 15.0 109.547 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.18 -32.71 73.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.313 1.008 . . . . 15.0 111.623 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 4.8 m-20 -69.53 -23.43 63.59 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.849 0.86 . . . . 15.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -83.77 -9.99 81.99 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.461 0.476 . . . . 15.0 113.182 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.1 -46.86 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.677 0.791 . . . . 15.0 110.061 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HB3' ' SD ' ' A' ' 189' ' ' MET . 62.3 pttt -84.7 30.88 0.54 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.13 1.159 . . . . 15.0 114.13 -161.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -155.89 35.91 0.62 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.785 -0.526 . . . . 15.0 111.785 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.62 -170.95 3.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.352 0.661 . . . . 15.0 111.29 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -139.42 155.89 47.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.577 1.151 . . . . 15.0 111.226 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.1 147.09 51.96 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 15.0 111.084 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.6 -40.98 2.26 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.229 -0.749 . . . . 15.0 111.229 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.8 pt-20 -78.8 126.79 31.18 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.613 0.72 . . . . 15.0 109.434 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.36 106.4 13.6 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.302 -1.369 . . . . 15.0 107.302 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -126.29 -177.43 3.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.344 1.058 . . . . 15.0 109.877 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.8 t -117.25 158.15 24.82 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.504 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.0 pt -128.01 150.2 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 173.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.12 117.58 34.43 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 163.92 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 15.0 107.332 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 59.1 m -141.92 134.47 28.23 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.29 128.93 76.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.111 -0.471 . . . . 15.0 109.767 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.06 163.51 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.713 2.942 . . . . 15.0 115.146 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.61 -24.44 53.42 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.397 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.36 -18.63 48.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.363 1.065 . . . . 15.0 110.628 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.434 ' HE2' HD12 ' A' ' 226' ' ' LEU . 30.7 t80 -61.11 111.62 1.78 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 15.0 109.923 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -66.71 -14.39 62.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.163 1.172 . . . . 15.0 114.163 -168.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.16 101.04 10.18 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.74 -31.39 72.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 15.0 111.727 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.575 HD21 HG11 ' B' ' 388' ' ' VAL . 7.0 p30 -70.41 -11.68 61.08 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.862 0.465 . . . . 15.0 111.596 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.616 HD11 ' H ' ' B' ' 388' ' ' VAL . 57.5 mt -112.61 -30.84 6.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.932 0.893 . . . . 15.0 110.765 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.17 121.48 6.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.583 1.153 . . . . 15.0 112.497 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.69 -22.98 25.19 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.903 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 96.1 mttt -75.99 143.02 41.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.232 0.613 . . . . 15.0 110.964 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.22 115.01 27.71 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.879 0.871 . . . . 15.0 109.825 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.38 118.47 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.553 0.741 . . . . 15.0 111.594 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -92.34 124.16 36.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.113 0.965 . . . . 15.0 108.726 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.2 113.83 19.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.067 0.547 . . . . 15.0 109.79 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 93.62 4.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.63 -0.507 . . . . 15.0 109.63 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.8 mm -82.82 122.55 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.352 1.061 . . . . 15.0 110.324 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -107.67 99.75 9.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 109.569 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.29 111.95 11.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.913 -0.403 . . . . 15.0 109.913 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 239' ' ' LYS . 17.7 ptpt -109.7 -35.46 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 116.461 -0.336 . . . . 15.0 110.597 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 238' ' ' LYS . 74.6 mmtt -129.29 133.0 47.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.241 0.616 . . . . 15.0 110.327 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.683 HG11 ' H ' ' A' ' 157' ' ' ALA . 77.7 t -106.92 123.62 62.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 26.1 mt-10 -124.55 169.98 11.36 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.557 0.743 . . . . 15.0 109.457 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.797 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.2 tt0 -139.21 130.48 26.81 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.896 0.878 . . . . 15.0 109.411 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -83.65 84.68 7.46 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.575 -1.268 . . . . 15.0 107.575 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.95 141.2 53.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.844 -1.526 . . . . 15.0 111.239 -173.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' A' ' 146' ' ' LYS . 96.7 mt -58.26 126.29 77.78 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.343 0.657 . . . . 15.0 110.714 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -77.78 173.22 14.41 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.892 2.395 . . . . 15.0 111.249 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -79.82 127.06 31.76 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.722 -0.672 . . . . 15.0 110.069 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 17.0 tp -86.87 52.96 2.66 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.558 -0.904 . . . . 15.0 108.558 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 253' ' ' ILE . 59.9 m -55.0 143.54 26.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.825 1.65 . . . . 15.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.81 -45.37 59.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.748 0.819 . . . . 15.0 112.346 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.62 -14.97 63.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.132 0.973 . . . . 15.0 113.446 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.55 -51.32 4.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.76 0.824 . . . . 15.0 110.305 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.727 HG13 HD22 ' A' ' 266' ' ' LEU . 7.3 tt -63.63 -33.08 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.147 0.979 . . . . 15.0 111.893 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.32 -29.63 67.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 120.757 0.313 . . . . 15.0 111.353 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -72.69 -13.56 61.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.588 0.755 . . . . 15.0 111.031 -172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.57 6.76 22.51 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.394 0.678 . . . . 15.0 111.929 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.63 8.91 Favored Glycine 0 N--CA 1.476 1.361 0 CA-C-N 117.554 0.161 . . . . 15.0 113.17 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 261' ' ' GLY . 14.4 t -102.82 132.88 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.2 -62.89 1.2 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.87 0.367 . . . . 15.0 110.588 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -83.8 -22.31 31.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.65 0.78 . . . . 15.0 111.383 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 90.7 26.93 21.27 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.631 -0.539 . . . . 15.0 113.449 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 55.3 p -72.22 136.23 46.3 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 117.607 0.703 . . . . 15.0 110.535 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.495 ' HA ' HD11 ' A' ' 253' ' ' ILE . 61.0 t -55.62 -46.97 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.896 0.878 . . . . 15.0 110.468 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.5 -26.69 68.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.701 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.54 -26.28 61.43 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 111.464 -0.654 . . . . 15.0 111.464 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.727 HD22 HG13 ' A' ' 253' ' ' ILE . 53.9 tp -77.27 -41.79 39.56 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.86 -0.422 . . . . 15.0 109.86 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -60.77 -39.7 89.77 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 124.026 0.829 . . . . 15.0 110.026 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.83 -42.24 77.44 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.398 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -64.6 -44.64 89.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.473 0.709 . . . . 15.0 111.107 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 141' ' ' LEU . 28.3 m -76.93 -25.21 15.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 119.282 -0.39 . . . . 15.0 110.89 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -55.34 -59.64 4.52 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.8 -36.35 82.19 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.03 0.752 . . . . 15.0 113.03 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -70.42 -52.48 21.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.214 0.461 . . . . 15.0 111.168 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.51 -33.47 75.99 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 118.391 -0.814 . . . . 15.0 110.206 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 45.5 mt-10 -72.21 -30.58 65.07 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -69.59 -38.83 77.48 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -65.12 -46.7 79.92 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.867 -1.06 . . . . 15.0 110.232 169.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.49 ' HA ' ' HE1' ' A' ' 428' ' ' MET . 42.9 tp -63.6 -59.4 4.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.397 -1.274 . . . . 15.0 112.788 -168.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.87 -30.2 70.76 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.718 0.636 . . . . 15.0 111.745 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 m -70.24 -37.6 75.0 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.214 0.53 . . . . 15.0 110.019 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.98 61.05 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 115.74 -0.664 . . . . 15.0 111.873 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.4 mt -69.32 -40.08 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.941 -1.133 . . . . 15.0 107.941 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 15.9 tpt180 -59.83 -50.5 73.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.602 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.44 -39.09 86.24 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.911 0.757 . . . . 15.0 111.765 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -56.44 -66.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.133 0.973 . . . . 15.0 110.8 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.79 -40.34 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.835 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.59 -46.53 79.01 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 115.6 -0.727 . . . . 15.0 110.724 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.0 p -69.13 -31.85 70.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.226 0.329 . . . . 15.0 111.712 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.7 mt-30 -64.56 -47.19 79.66 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.403 0.281 . . . . 15.0 110.779 173.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.07 -44.37 96.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.227 0.611 . . . . 15.0 111.26 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 351' ' ' LEU . 1.2 mp -64.44 -45.91 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.684 1.594 . . . . 15.0 111.445 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' B' ' 400' ' ' ALA . 15.4 tp10 -67.59 -43.13 81.29 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.766 -0.457 . . . . 15.0 109.766 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -56.9 -41.43 91.66 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 124.151 0.907 . . . . 15.0 112.186 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.5 -59.62 5.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 15.0 111.292 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.62 -51.47 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 120.936 0.398 . . . . 15.0 110.302 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -62.93 -35.07 78.87 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.985 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.62 -24.64 49.51 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.669 0.618 . . . . 15.0 112.669 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 14.2 m-80 -118.26 152.67 35.28 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.991 0.424 . . . . 15.0 111.887 -162.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -121.61 135.46 54.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.081 0.952 . . . . 15.0 109.713 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 349' ' ' LEU . 12.0 tt -168.67 144.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.392 1.077 . . . . 15.0 109.447 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.93 120.74 26.07 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.589 -1.263 . . . . 15.0 107.589 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.15 120.29 65.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.783 0.833 . . . . 15.0 111.219 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.8 126.73 17.19 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.142 2.561 . . . . 15.0 112.776 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -57.82 -23.18 51.44 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.836 1.254 . . . . 15.0 112.341 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.612 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -56.04 -56.05 25.51 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.385 1.074 . . . . 15.0 111.529 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 37.1 mt -71.8 -33.2 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.622 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 304' ' ' ALA . 69.2 mt -60.82 -44.57 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.549 0.74 . . . . 15.0 110.054 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.59 91.77 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.675 0.79 . . . . 15.0 110.821 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 56.6 m -62.64 -49.9 73.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.669 0.605 . . . . 15.0 112.171 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 341' ' ' ALA . 4.8 mm-40 -68.65 -40.69 80.11 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.304 0.378 . . . . 15.0 110.542 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.511 HD13 ' HG3' ' A' ' 334' ' ' ARG . 60.6 mt -56.81 -45.26 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.898 0.879 . . . . 15.0 109.736 173.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.47 -46.75 88.96 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.325 1.016 . . . . 15.0 111.583 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.8 -40.72 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 123.722 0.639 . . . . 15.0 110.424 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.23 -26.71 63.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.307 0.643 . . . . 15.0 112.039 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.0 mtm180 -73.79 -41.63 62.11 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 320' ' ' GLN . 57.9 mtt180 -64.06 -44.62 91.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.852 -0.613 . . . . 15.0 109.698 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.481 ' HG3' HD11 ' B' ' 439' ' ' LEU . 35.0 tt0 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.699 1.199 . . . . 15.0 111.65 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.6 -58.75 4.13 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.316 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 332' ' ' LEU . . . -53.6 -38.6 64.13 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.463 1.102 . . . . 15.0 111.77 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.506 HE21 ' HG ' ' B' ' 439' ' ' LEU . 0.6 OUTLIER -49.45 -43.3 44.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.6 1.56 . . . . 15.0 110.825 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -104.12 -9.21 18.89 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.342 0.657 . . . . 15.0 111.831 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -93.87 44.63 1.13 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.481 1.113 . . . . 15.0 109.343 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.25 79.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.069 -0.514 . . . . 15.0 113.4 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 83.1 35.97 16.5 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.436 -0.647 . . . . 15.0 113.456 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 5.1 m-20 -51.82 108.39 0.27 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.79 1.236 . . . . 15.0 111.451 -175.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.28 91.05 0.71 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.615 1.166 . . . . 15.0 110.634 -165.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm 59.19 15.55 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.28 1.432 . . . . 15.0 113.085 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 23.2 tm0? -76.52 -13.19 60.11 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.92 0.888 . . . . 15.0 108.758 169.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.21 -41.97 1.98 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.206 1.803 . . . . 15.0 113.669 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.92 -38.73 62.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.446 1.098 . . . . 15.0 111.877 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.17 -16.82 56.03 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.407 1.083 . . . . 15.0 112.861 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 319' ' ' ALA . 57.4 mt -54.97 137.99 65.29 Favored Pre-proline 0 N--CA 1.5 2.036 0 CA-C-N 118.477 0.581 . . . . 15.0 111.937 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.13 107.9 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.796 2.997 . . . . 15.0 114.088 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HG3' HD13 ' A' ' 311' ' ' ILE . 25.7 ttt85 -53.53 -39.25 64.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.208 1.403 . . . . 15.0 112.412 -174.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.31 -26.04 60.27 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 15.0 113.226 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.5 -31.96 71.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.245 0.545 . . . . 15.0 110.533 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.414 ' HA ' HE21 ' A' ' 340' ' ' GLN . 26.4 m-85 -105.53 -19.83 13.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.005 0.922 . . . . 15.0 111.341 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.413 ' HA ' HD11 ' A' ' 311' ' ' ILE . 5.9 tp10 -49.21 -61.15 2.23 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.879 1.272 . . . . 15.0 113.28 -169.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.15 -52.16 50.95 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.432 0.693 . . . . 15.0 111.666 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.3 pt20 -63.38 -34.46 77.78 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.757 0.66 . . . . 15.0 111.903 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -68.97 -49.34 58.73 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.445 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.2 tttt -55.55 -39.4 70.56 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.138 0.899 . . . . 15.0 110.636 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.4 mmt180 -59.09 -44.8 91.95 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.419 171.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -68.87 -24.19 64.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.491 0.716 . . . . 15.0 110.718 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.0 t -71.53 -50.9 36.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 123.181 0.592 . . . . 15.0 110.176 173.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 342' ' ' LYS . 39.7 t -56.33 -37.4 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 123.846 0.716 . . . . 15.0 109.887 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 343' ' ' ARG . 60.4 t -54.31 -53.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 15.0 110.972 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.22 -32.76 85.27 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.619 0.575 . . . . 15.0 114.049 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 300' ' ' ILE . 89.7 mt -73.28 -50.48 22.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.605 0.762 . . . . 15.0 110.159 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 354' ' ' VAL . 89.6 mt -70.37 -46.82 63.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.631 -0.713 . . . . 15.0 110.825 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 291' ' ' ILE . 52.9 mt -64.16 -37.13 86.35 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.439 0.462 . . . . 15.0 111.388 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.76 -40.2 98.91 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.593 0.558 . . . . 15.0 111.918 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.23 -29.27 67.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.107 -0.547 . . . . 15.0 111.304 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.1 t -74.33 -32.3 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.811 0.444 . . . . 15.0 110.357 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 351' ' ' LEU . 95.7 mt -63.45 -42.77 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.26 -0.645 . . . . 15.0 109.26 172.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.406 ' HD2' ' HB3' ' B' ' 459' ' ' ASP . 12.7 ttp180 -65.0 -55.45 18.93 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.076 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.2 m -60.31 -44.9 95.02 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.426 1.09 . . . . 15.0 111.535 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -88.26 4.27 46.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.125 0.57 . . . . 15.0 111.696 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 39.08 65.03 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.87 1.668 . . . . 15.0 113.886 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 154.12 18.34 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.5 -1.227 . . . . 15.0 111.204 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.36 144.05 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.538 -1.282 . . . . 15.0 107.538 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -66.14 132.59 48.83 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.63 0.372 . . . . 15.0 111.781 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.72 123.79 37.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.728 0.811 . . . . 15.0 110.265 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.44 -40.29 82.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.273 0.629 . . . . 15.0 112.383 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.86 -27.59 66.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.655 0.382 . . . . 15.0 111.751 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 406' ' ' GLN . 27.6 ttt180 -74.57 -43.32 56.23 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 371' ' ' ILE . 46.5 t -59.58 -42.0 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.697 -1.138 . . . . 15.0 109.719 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -58.14 -50.17 74.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.651 0.78 . . . . 15.0 110.865 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.76 -46.46 82.75 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 124.193 0.933 . . . . 15.0 112.664 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 96.5 mt -55.47 -48.84 73.89 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.416 0.686 . . . . 15.0 111.11 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.645 HD11 ' HG2' ' A' ' 398' ' ' MET . 35.6 mm -58.32 -58.94 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.534 0.733 . . . . 15.0 111.705 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.64 -36.21 83.51 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 124.329 1.018 . . . . 15.0 111.491 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -78.36 -39.06 40.48 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.46 0.541 . . . . 15.0 112.46 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.435 ' HG2' HG22 ' B' ' 441' ' ' ILE . 53.2 ttp -63.15 -36.12 82.55 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.343 0.592 . . . . 15.0 109.96 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.711 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -81.62 -28.16 33.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.173 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 35.4 t -64.65 -15.42 61.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.792 0.837 . . . . 15.0 111.669 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.09 -5.26 34.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.352 0.661 . . . . 15.0 111.945 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.79 165.58 20.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.327 1.051 . . . . 15.0 110.004 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.18 17.78 7.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.558 0.743 . . . . 15.0 110.354 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 381' ' ' PRO . 1.6 p30 -133.45 41.7 0.73 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.149 0.98 . . . . 15.0 112.626 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.711 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 44.1 Cg_exo -58.06 -43.48 47.79 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 122.128 1.886 . . . . 15.0 113.98 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.47 -50.1 63.36 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.897 0.879 . . . . 15.0 112.711 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.7 -22.04 64.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.594 0.559 . . . . 15.0 111.752 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.451 HG11 HG21 ' B' ' 441' ' ' ILE . 99.6 t -77.06 -45.71 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.191 0.597 . . . . 15.0 109.446 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.98 -39.28 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.04 -0.982 . . . . 15.0 109.776 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.67 -42.12 71.17 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.121 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -60.66 -35.91 77.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.295 0.638 . . . . 15.0 111.701 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 51.7 m-85 -88.38 -61.11 1.79 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.636 0.374 . . . . 15.0 111.745 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . 0.473 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 38.9 m -70.54 -21.33 62.73 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.616 0.969 . . . . 15.0 113.616 -167.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -96.01 11.49 33.85 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.417 0.287 . . . . 15.0 111.055 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -136.8 103.54 5.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.84 -31.61 71.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.065 0.546 . . . . 15.0 111.512 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.08 -47.74 84.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.387 0.675 . . . . 15.0 110.87 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 41.8 tp -83.51 -24.71 31.58 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.896 -0.593 . . . . 15.0 111.209 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.51 ' HE3' ' HB3' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -71.08 -37.61 72.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.43 -36.19 82.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.761 1.224 . . . . 15.0 110.569 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 400' ' ' ASN . 51.9 t-20 -62.37 -42.48 99.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.742 0.782 . . . . 15.0 109.854 173.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.645 ' HG2' HD11 ' A' ' 371' ' ' ILE . 3.8 tpt -79.23 -17.26 55.14 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.564 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.11 -35.97 64.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 168.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 397' ' ' ASN . 6.8 t30 -59.22 -53.61 56.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.374 0.669 . . . . 15.0 110.421 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.2 p -65.47 -37.11 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 O-C-N 123.577 0.548 . . . . 15.0 111.354 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -62.01 -44.87 95.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.902 0.481 . . . . 15.0 110.96 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 23.5 tp -72.04 -30.46 65.2 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.846 -1.07 . . . . 15.0 111.03 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 33.7 tt0 -67.56 -39.35 84.95 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.949 0.9 . . . . 15.0 109.492 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 33.1 mm-40 -69.49 -36.2 76.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.551 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -62.25 -39.15 91.92 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.387 0.675 . . . . 15.0 110.098 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.85 -41.77 95.43 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 124.07 0.857 . . . . 15.0 111.534 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 96.2 t -57.94 -55.47 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 123.474 0.484 . . . . 15.0 110.031 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.463 ' HG2' HD12 ' A' ' 412' ' ' LEU . 43.5 mt-10 -67.29 -22.89 65.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.553 0.575 . . . . 15.0 112.553 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 414' ' ' LYS . . . -66.13 -37.66 86.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.57 0.544 . . . . 15.0 110.621 169.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 45.8 t -74.61 -33.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 409' ' ' GLU . 96.9 mt -64.33 -40.1 95.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.076 0.55 . . . . 15.0 110.935 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.21 -15.56 57.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.35 0.66 . . . . 15.0 112.492 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 410' ' ' ALA . 24.1 mtpp -101.12 -33.77 9.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.178 0.991 . . . . 15.0 110.672 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.3 160.66 20.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.284 1.033 . . . . 15.0 112.402 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.6 80.29 1.99 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.163 0.985 . . . . 15.0 109.816 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 125' ' ' VAL . 49.1 t -97.73 109.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.605 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.0 t -87.95 103.4 15.65 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.277 0.631 . . . . 15.0 110.134 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -85.37 129.39 34.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.661 0.785 . . . . 15.0 110.068 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -139.33 153.93 47.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.361 0.664 . . . . 15.0 109.588 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.56 133.3 52.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.592 -0.892 . . . . 15.0 108.592 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.436 HG23 HG22 ' A' ' 130' ' ' VAL . 7.9 t -159.64 172.12 18.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.763 0.425 . . . . 15.0 111.521 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 77.9 p -91.78 168.28 11.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.22 1.008 . . . . 15.0 111.396 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -54.17 -26.66 29.2 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.459 1.503 . . . . 15.0 112.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.93 -20.62 16.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.06 0.944 . . . . 15.0 113.338 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.466 0.706 . . . . 15.0 112.256 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 278' ' ' LEU . 22.4 tp -70.48 -78.79 0.07 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.514 0.931 . . . . 15.0 113.514 -153.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.49 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.0 OUTLIER -87.19 -22.79 25.07 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.608 0.363 . . . . 15.0 110.39 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.93 21.41 0.16 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.964 0.906 . . . . 15.0 111.904 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.31 81.21 4.68 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.334 -1.358 . . . . 15.0 107.334 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -95.04 40.3 1.1 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 15.0 109.563 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.329 1.051 . . . . 15.0 108.413 -175.225 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 36.9 t . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.65 55.96 1.78 Allowed 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.77 -28.47 58.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.474 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.19 -16.92 61.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.09 1.356 . . . . 0.0 112.497 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -83.26 -42.1 17.58 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.337 0.655 . . . . 0.0 110.302 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.7 67.41 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.622 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 19.4 m -103.33 1.16 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.212 1.005 . . . . 0.0 111.605 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -28.36 -67.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 126.735 2.014 . . . . 0.0 115.177 -164.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -101.32 -79.05 0.52 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' B' ' 378' ' ' ALA . . . -106.24 -73.43 0.68 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 160.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.39 -71.84 0.74 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 166.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' B' ' 379' ' ' LYS . 23.0 mt-10 -103.55 -75.58 0.61 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.86 -80.13 0.52 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 165.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' B' ' 374' ' ' ALA . . . -100.35 -80.32 0.48 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 154.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' B' ' 376' ' ' GLU . 28.4 mmtp -106.93 -85.79 0.5 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 155.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -151.91 127.72 10.25 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.121 0.568 . . . . 0.0 110.082 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 56.53 -171.5 0.08 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 113.562 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -139.6 -158.33 7.59 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.63 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -172.2 165.46 6.02 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.416 1.087 . . . . 0.0 109.254 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -55.15 -51.13 67.44 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.497 1.119 . . . . 0.0 111.727 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.414 HD23 ' CD2' ' A' ' 185' ' ' PHE . 1.9 tm? -136.46 97.74 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.51 HG11 ' HA3' ' A' ' 179' ' ' GLY . 27.2 m -69.4 98.72 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 121.834 0.826 . . . . 0.0 113.086 -166.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.42 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 20.9 pt -144.02 157.54 15.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.763 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 158.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 226' ' ' LEU . 30.2 t -79.27 109.57 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 31.8 m -64.95 100.29 0.41 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 124.153 0.908 . . . . 0.0 111.357 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -89.24 148.12 23.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -79.16 164.33 24.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.289 0.566 . . . . 0.0 109.806 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -139.46 72.28 1.4 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -74.9 75.16 2.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.997 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -120.63 -72.43 0.69 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 165.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 57.75 -157.86 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.371 1.069 . . . . 0.0 111.22 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 21.4 t -77.05 -0.94 26.49 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.917 0.487 . . . . 0.0 111.043 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -73.09 98.67 2.61 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.881 0.872 . . . . 0.0 108.708 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 27.6 pt -67.18 157.06 6.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 110.734 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.94 93.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 109.669 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 292' ' ' GLU . . . -145.52 -56.21 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.988 0.915 . . . . 0.0 110.676 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' B' ' 400' ' ' ALA . 69.5 Cg_endo -79.89 178.74 6.92 Favored 'Trans proline' 0 C--N 1.39 2.723 0 CA-C-N 121.666 1.631 . . . . 0.0 111.526 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.79 -82.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 406' ' ' PRO . 2.8 m 47.48 45.11 17.27 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 125.138 1.375 . . . . 0.0 112.433 172.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -66.41 -26.64 67.33 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.006 0.522 . . . . 0.0 112.106 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -126.54 87.53 56.21 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 123.695 0.798 . . . . 0.0 109.211 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' B' ' 403' ' ' THR . 94.4 Cg_endo -76.51 -31.27 4.49 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.954 2.436 . . . . 0.0 112.987 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.45 -101.37 0.62 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -167.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 42.3 tp 60.72 107.33 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.025 1.33 . . . . 0.0 112.093 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 22.8 m -77.07 82.18 3.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.118 0.567 . . . . 0.0 110.528 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 74.27 -62.38 0.46 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.959 1.703 . . . . 0.0 112.734 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 67.63 -169.22 0.19 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.637 1.175 . . . . 0.0 111.258 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.7 87.78 2.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.59 -84.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.581 1.552 . . . . 0.0 112.447 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 414' ' ' THR . . . . . 0.445 HG23 ' H ' ' B' ' 415' ' ' LYS . 3.6 t -163.16 -63.63 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.631 0.772 . . . . 0.0 109.508 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' B' ' 418' ' ' ALA . 21.9 tptm -96.59 126.18 41.58 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -142.42 -60.6 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.733 0.813 . . . . 0.0 109.492 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -68.35 112.66 4.82 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.545 0.528 . . . . 0.0 112.406 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 418' ' ' ALA . . . . . 0.491 ' HB2' ' HE2' ' B' ' 415' ' ' LYS . . . -157.42 -62.69 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.177 0.591 . . . . 0.0 110.32 -172.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 21.2 m -83.82 -10.06 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.105 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 24.3 ptm -134.4 142.88 47.31 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.716 0.807 . . . . 0.0 109.103 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.436 HG13 ' H ' ' B' ' 423' ' ' SER . 12.9 p -95.41 -15.09 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.483 0.713 . . . . 0.0 110.999 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 83.7 mtp 67.12 29.71 7.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.92 1.288 . . . . 0.0 111.295 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.436 ' H ' HG13 ' B' ' 421' ' ' VAL . 41.8 t -154.68 164.19 39.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.358 0.663 . . . . 0.0 111.209 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 53.75 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.673 1.589 . . . . 0.0 112.604 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.61 27.99 0.02 OUTLIER Glycine 0 C--O 1.223 -0.556 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -99.21 98.53 9.5 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.912 0.885 . . . . 0.0 110.74 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 50.8 m -148.96 -78.14 0.15 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.978 0.911 . . . . 0.0 109.293 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -70.08 142.35 52.66 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' B' ' 432' ' ' GLN . 60.9 mm-40 -53.7 -25.11 16.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.125 0.97 . . . . 0.0 113.137 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -53.27 -55.19 26.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.253 1.021 . . . . 0.0 110.638 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 22.9 t -107.52 2.74 24.33 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.58 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.476 ' HB3' ' HA ' ' B' ' 429' ' ' GLU . 18.5 tm0? -73.87 -35.29 64.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.337 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 161.01 26.82 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 22.7 m80 63.59 -72.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.993 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 37.9 p -82.75 56.5 3.41 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.376 0.67 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -82.73 61.81 4.7 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 18.0 t -118.01 97.9 6.05 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.51 18.99 0.54 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.775 1.23 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.506 ' HG ' HE21 ' A' ' 320' ' ' GLN . 75.1 mt 65.06 33.3 9.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.748 1.219 . . . . 0.0 111.192 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.69 121.49 12.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.597 0.759 . . . . 0.0 109.763 172.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.451 HG21 HG11 ' A' ' 384' ' ' VAL 0.292 2.8 pp 46.62 102.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 C-N-CA 126.407 1.883 . . . . 0.0 112.951 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -87.07 160.01 18.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -164.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -154.93 147.65 24.36 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -79.02 139.28 38.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.907 0.883 . . . . 0.0 111.047 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -117.91 78.43 0.3 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.42 -11.15 24.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.08 2.52 . . . . 0.0 114.261 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 m80 85.43 143.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.613 1.965 . . . . 0.0 110.78 -167.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 66.37 -173.28 0.19 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.065 1.346 . . . . 0.0 112.782 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -85.93 49.22 1.73 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.002 0.921 . . . . 0.0 112.294 -174.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 9.7 m120 60.87 -80.7 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.516 1.527 . . . . 0.0 111.91 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.48 -36.64 75.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.9 0.88 . . . . 0.0 109.804 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 47.8 t 76.16 -55.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.864 1.666 . . . . 0.0 110.376 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 160.48 -53.59 0.34 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 4.6 tt -89.9 104.01 16.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 6.2 t -118.86 -29.24 5.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.095 0.958 . . . . 0.0 108.531 164.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.71 -83.51 0.02 OUTLIER 'General case' 0 C--N 1.364 1.222 0 C-N-CA 125.564 1.546 . . . . 0.0 111.585 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -157.82 85.83 0.9 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 14.8 m -71.98 -11.87 60.97 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 168.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 459' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 356' ' ' ARG . 18.4 t70 79.05 11.52 1.45 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.513 1.925 . . . . 0.0 111.212 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.25 165.2 15.2 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.866 . . . . 0.0 110.508 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.64 -1.29 38.4 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.612 0.765 . . . . 0.0 111.418 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -164.6 135.86 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 89.3 m -63.3 99.37 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.5 ttt -78.43 120.17 22.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.674 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.1 OUTLIER -125.62 75.82 1.52 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 122.482 1.134 . . . . 0.0 109.18 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.15 -40.8 36.83 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.58 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -152.6 144.6 23.74 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 113.845 -1.525 . . . . 0.0 108.776 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -157.46 135.12 10.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.534 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . -88.57 -135.54 5.25 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.449 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 469' ' ' GLY 0.287 4.0 pp 64.88 -30.61 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 128.031 2.532 . . . . 0.0 115.793 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 CA--C 1.555 1.14 0 N-CA-C 109.029 -0.73 . . . . 12.06 109.029 -178.105 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.779 0.323 . . . . 15.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -126.96 142.67 51.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.883 -1.154 . . . . 15.0 107.883 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -126.78 152.22 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.505 0.722 . . . . 15.0 110.051 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.529 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 48.7 m -146.9 100.63 3.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.349 0.66 . . . . 15.0 110.052 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.26 128.23 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.967 -0.561 . . . . 15.0 109.855 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.03 97.38 3.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 15.0 108.921 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -76.87 93.88 3.82 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.704 -0.85 . . . . 15.0 108.704 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.2 p -66.12 -39.94 90.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.139 0.976 . . . . 15.0 111.858 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -170.13 104.1 0.3 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.393 0.677 . . . . 15.0 109.979 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.67 -100.93 0.47 Allowed Glycine 0 C--N 1.354 1.529 0 O-C-N 124.083 0.864 . . . . 15.0 113.275 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.2 mp -76.99 -39.42 50.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 15.0 110.152 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.7 104.05 0.34 Allowed Glycine 0 C--N 1.353 1.477 0 O-C-N 124.603 1.19 . . . . 15.0 111.634 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' NH1' HG11 ' A' ' 111' ' ' VAL . 33.8 ttm180 -134.82 120.87 19.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.38 1.072 . . . . 15.0 109.972 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 43.3 ttm180 -93.76 146.38 23.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.46 -1.245 . . . . 15.0 109.468 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.47 93.69 2.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 107.332 -1.359 . . . . 15.0 107.332 165.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 33.3 m -73.19 108.55 6.13 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.137 -0.938 . . . . 15.0 108.953 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 3' ' ' VAL . 47.8 mt -107.92 123.95 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.025 0.53 . . . . 15.0 109.617 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 m -99.93 104.83 16.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.518 0.727 . . . . 15.0 109.156 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.5 mt -80.52 112.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 160.07 24.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.206 0.603 . . . . 15.0 111.997 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.96 79.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.324 1.049 . . . . 15.0 112.056 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -65.09 -36.2 83.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.741 0.816 . . . . 15.0 111.121 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -70.14 -37.0 75.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.528 0.731 . . . . 15.0 110.459 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 28' ' ' VAL . 73.8 mt -70.67 -44.05 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 114.905 -1.043 . . . . 15.0 109.943 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.26 -41.72 99.08 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.065 0.546 . . . . 15.0 111.799 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 m -56.11 -45.87 79.34 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -64.85 -44.81 88.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.462 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 24' ' ' ILE . 71.3 t -60.99 -55.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.284 0.634 . . . . 15.0 110.658 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -61.75 -41.5 97.76 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.27 -11.5 59.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.418 0.687 . . . . 15.0 111.767 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 8.8 tp10 -88.64 -43.03 11.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.721 0.408 . . . . 15.0 110.383 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.692 HD11 ' HA3' ' A' ' 59' ' ' GLY . 92.4 mt -70.27 -23.97 62.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.564 0.746 . . . . 15.0 112.386 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.2 p -69.98 -32.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 123.339 0.4 . . . . 15.0 110.054 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -69.36 -43.53 73.4 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.588 0.755 . . . . 15.0 109.613 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' VAL . 46.9 t -63.36 -38.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.885 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.524 0.73 . . . . 15.0 110.926 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 95.6 mttt -67.29 -31.49 71.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.169 0.587 . . . . 15.0 111.392 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.28 -46.05 29.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.694 0.798 . . . . 15.0 110.951 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.7 t -82.85 -5.93 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 122.924 0.49 . . . . 15.0 110.005 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 74.45 8.79 4.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.85 1.66 . . . . 15.0 112.15 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.419 HG13 ' HB ' ' A' ' 39' ' ' VAL . 56.8 mt -63.89 -22.9 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 15.0 110.931 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.99 -33.97 74.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.424 0.69 . . . . 15.0 111.148 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -39.05 15.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.749 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -71.03 -16.97 62.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.157 0.583 . . . . 15.0 111.162 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.412 HH21 ' HA ' ' A' ' 50' ' ' PRO . 49.0 ttt-85 -76.63 105.93 7.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -85.79 13.22 7.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.406 0.683 . . . . 15.0 112.153 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -34.29 4.66 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.85 -0.417 . . . . 15.0 112.354 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -52.03 -36.14 49.24 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.998 1.319 . . . . 15.0 112.384 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.31 108.92 32.23 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.564 -0.902 . . . . 15.0 108.564 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 53' ' ' ILE . 38.8 Cg_exo -64.02 138.94 64.86 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 15.0 111.681 173.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.6 tpp -67.92 -25.74 65.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.196 0.598 . . . . 15.0 111.12 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.13 -33.89 77.1 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.326 0.25 . . . . 15.0 111.13 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 50' ' ' PRO . 32.1 mt -67.55 -46.15 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.018 0.527 . . . . 15.0 110.234 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -74.14 -21.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 111.567 0.21 . . . . 15.0 111.567 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.23 -45.58 39.3 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.201 0.6 . . . . 15.0 111.4 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -75.57 -26.56 58.05 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.502 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -92.01 -72.52 0.59 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.839 0.455 . . . . 15.0 110.9 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -84.33 -34.44 23.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.077 0.551 . . . . 15.0 111.466 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -74.97 -13.23 82.8 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.156 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.68 59.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 15.0 112.163 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.9 p -81.89 -42.75 19.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.293 0.637 . . . . 15.0 109.346 171.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -70.86 88.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.793 0.837 . . . . 15.0 109.152 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.46 -38.28 6.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.625 0.77 . . . . 15.0 110.129 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.14 -46.01 90.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.765 0.826 . . . . 15.0 112.271 -171.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.98 -49.24 71.02 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.301 0.641 . . . . 15.0 110.376 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.6 -63.78 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.543 -1.208 . . . . 15.0 110.76 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 71' ' ' MET . 84.1 mt -64.74 -38.21 90.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.781 0.832 . . . . 15.0 111.511 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.27 -40.72 98.99 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.812 0.695 . . . . 15.0 113.15 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 28.7 t70 -78.87 -37.57 39.93 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.004 0.522 . . . . 15.0 110.076 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.0 mt -54.87 -42.4 72.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.005 0.922 . . . . 15.0 111.29 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 48.2 mtm -58.6 -42.75 88.85 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.675 0.609 . . . . 15.0 110.76 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.9 t -70.28 -43.78 69.75 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.907 -1.042 . . . . 15.0 111.008 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 20.8 mtm180 -69.17 -36.05 76.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.698 0.399 . . . . 15.0 111.502 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -36.67 68.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.968 0.507 . . . . 15.0 110.274 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -70.01 -50.25 43.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.886 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.41 -33.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.646 0.591 . . . . 15.0 111.012 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.23 -51.73 62.24 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.254 0.621 . . . . 15.0 110.707 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.79 85.49 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.99 -1.004 . . . . 15.0 112.438 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 pt -75.33 -32.01 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 112.383 0.512 . . . . 15.0 112.383 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.44 -50.62 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 120.841 0.353 . . . . 15.0 110.558 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 17.1 ptpt -73.66 -50.63 19.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.949 -0.569 . . . . 15.0 111.449 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 50.6 mm-40 -84.81 -1.99 57.12 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.133 0.573 . . . . 15.0 111.941 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 63.25 28.26 15.73 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.53 1.144 . . . . 15.0 111.091 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.19 90.37 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 108.399 -0.963 . . . . 15.0 108.399 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.556 HD22 ' HD2' ' A' ' 112' ' ' TYR . 2.1 t-20 -70.91 107.5 2.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.381 1.073 . . . . 15.0 110.425 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.37 141.78 12.87 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.345 2.03 . . . . 15.0 112.737 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.16 -177.3 6.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.578 0.751 . . . . 15.0 110.683 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.66 11.85 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.4 -0.818 . . . . 15.0 111.473 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.99 100.64 4.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.732 -1.211 . . . . 15.0 107.732 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 51.9 Cg_exo -57.78 107.9 0.34 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.972 2.448 . . . . 15.0 112.622 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.0 m -88.86 100.14 12.94 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.679 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -76.85 75.61 3.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.663 -0.866 . . . . 15.0 108.663 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.17 112.57 4.79 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 123.532 0.733 . . . . 15.0 109.361 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -69.43 92.3 0.48 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.407 2.072 . . . . 15.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -59.61 -63.5 5.05 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.964 0.79 . . . . 15.0 112.004 -176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -167.87 155.75 8.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.983 0.913 . . . . 15.0 109.792 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HE1' HD13 ' A' ' 24' ' ' ILE . 47.0 t80 -135.94 147.27 48.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.12 0.568 . . . . 15.0 109.551 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -124.87 125.22 43.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.748 -1.205 . . . . 15.0 107.748 175.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.39 107.59 0.95 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.675 0.79 . . . . 15.0 111.453 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.76 59.26 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.591 -0.731 . . . . 15.0 113.287 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -106.14 -165.95 1.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.318 1.047 . . . . 15.0 109.379 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -62.93 155.87 26.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.331 1.052 . . . . 15.0 113.287 -171.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.1 t80 -123.66 142.92 50.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 15.0 108.304 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.2 m -137.06 137.59 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.273 0.629 . . . . 15.0 109.371 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.412 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 11.6 p90 -154.35 156.46 36.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.984 0.914 . . . . 15.0 109.086 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 47.7 m -125.13 98.28 5.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.844 0.858 . . . . 15.0 109.648 -170.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.26 97.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.852 -0.796 . . . . 15.0 108.852 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.9 119.05 33.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.799 0.44 . . . . 15.0 110.253 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 22.4 p90 -146.61 -166.78 2.58 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.527 1.131 . . . . 15.0 108.941 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.67 177.17 5.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.63 0.772 . . . . 15.0 110.356 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 11' ' ' LEU . 27.0 m -119.72 154.46 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 122.992 0.517 . . . . 15.0 109.626 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.556 ' HD2' HD22 ' A' ' 85' ' ' ASN . 48.6 m-85 -82.75 105.89 5.81 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 108.334 -0.987 . . . . 15.0 108.334 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' HD11 ' A' ' 300' ' ' ILE . 64.5 Cg_endo -89.03 149.45 5.69 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.629 2.219 . . . . 15.0 113.704 -172.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.58 132.14 33.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.202 1.001 . . . . 15.0 108.882 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 350' ' ' LEU . 7.3 p -86.3 151.57 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.256 0.551 . . . . 15.0 111.937 -170.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.34 94.03 8.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.476 -0.784 . . . . 15.0 108.914 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.3 139.08 58.73 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.47 0.481 . . . . 15.0 110.555 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -163.06 155.12 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.915 0.886 . . . . 15.0 109.545 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.98 74.76 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.124 0.89 . . . . 15.0 114.049 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.45 -28.73 67.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.227 0.611 . . . . 15.0 110.935 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 18.3 mp0 -75.65 -34.08 60.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.657 -1.156 . . . . 15.0 109.852 174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.464 ' HA ' ' HE3' ' A' ' 416' ' ' LYS . . . -78.93 -7.15 57.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.61 0.764 . . . . 15.0 112.255 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.632 HG23 ' HA3' ' A' ' 293' ' ' GLY . 77.6 mt -70.83 120.89 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.439 0.695 . . . . 15.0 109.467 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.08 104.11 15.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.376 0.67 . . . . 15.0 109.685 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 417' ' ' VAL . 45.6 t -106.05 159.55 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.934 -1.135 . . . . 15.0 107.934 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.47 126.37 46.62 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.724 -0.843 . . . . 15.0 108.724 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -107.43 99.21 26.97 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.529 0.732 . . . . 15.0 109.197 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.02 97.85 0.84 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.468 2.112 . . . . 15.0 111.502 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.52 93.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 166.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 12.4 t -122.51 140.48 46.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.535 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.68 154.37 48.6 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.984 -1.117 . . . . 15.0 107.984 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.82 83.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.3 p -68.39 176.9 2.59 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.489 1.116 . . . . 15.0 110.368 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.99 -45.6 64.57 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.429 0.692 . . . . 15.0 111.771 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.19 97.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.92 -1.036 . . . . 15.0 111.338 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.4 -44.15 68.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.173 0.589 . . . . 15.0 111.298 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.9 t -55.51 -62.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.348 1.059 . . . . 15.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -75.45 -31.31 60.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.676 -0.693 . . . . 15.0 111.307 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.86 -43.8 81.98 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.887 0.742 . . . . 15.0 112.713 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -78.16 -37.5 45.76 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.091 0.556 . . . . 15.0 110.878 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.554 HD21 HG11 ' A' ' 270' ' ' VAL . 18.5 mt -54.83 -42.39 71.86 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.253 0.621 . . . . 15.0 111.574 165.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.38 -40.1 95.15 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.375 -0.83 . . . . 15.0 109.997 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.9 m -61.67 -46.27 90.42 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.721 0.638 . . . . 15.0 110.953 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -45.95 91.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.651 0.78 . . . . 15.0 110.66 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -58.27 -37.66 75.4 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.808 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.618 ' HD3' HH12 ' A' ' 243' ' ' ARG . 83.3 mttt -85.41 -12.23 52.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.34 0.656 . . . . 15.0 112.533 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.82 -22.79 34.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.81 0.444 . . . . 15.0 110.005 167.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -97.06 8.4 44.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.262 0.625 . . . . 15.0 111.324 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.71 159.53 31.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 15.0 112.312 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.6 m -123.93 155.93 37.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.091 0.956 . . . . 15.0 108.917 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.627 ' HZ3' ' HB3' ' A' ' 243' ' ' ARG . 3.5 m95 -78.91 153.17 30.69 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.817 0.341 . . . . 15.0 111.151 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -151.65 104.77 3.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.043 -0.981 . . . . 15.0 109.368 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.35 98.45 0.11 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.02 170.73 16.23 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.477 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.95 97.24 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.838 0.455 . . . . 15.0 110.729 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 207' ' ' ALA . . . 55.22 53.26 41.77 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 124.589 1.181 . . . . 15.0 115.5 161.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -153.91 140.86 19.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.334 0.654 . . . . 15.0 109.315 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 202' ' ' ILE . 17.0 t -119.32 131.33 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.177 -0.675 . . . . 15.0 109.177 172.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.85 -176.16 3.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.283 . . . . 15.0 109.423 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.82 -27.49 64.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.28 13.88 16.75 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.435 0.532 . . . . 15.0 112.435 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -79.03 136.16 37.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.971 0.415 . . . . 15.0 111.602 -173.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -84.94 90.91 7.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.823 -1.547 . . . . 15.0 106.823 173.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 44.0 t -90.58 150.79 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.002 0.921 . . . . 15.0 109.847 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.669 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 32.9 m -130.09 126.75 38.36 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 165.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.83 163.71 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.341 1.057 . . . . 15.0 110.314 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -116.69 122.21 43.89 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.294 -1.743 . . . . 15.0 106.294 167.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -129.14 160.69 32.06 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.724 0.773 . . . . 15.0 111.235 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.0 t -140.85 111.87 7.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.262 -1.385 . . . . 15.0 107.262 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -80.02 160.34 44.47 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.596 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.0 m -149.53 111.15 4.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.543 0.737 . . . . 15.0 109.194 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 177' ' ' PHE . 59.7 t -93.85 134.87 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.297 -1.001 . . . . 15.0 108.297 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.0 p30 51.39 18.98 0.71 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.138 1.775 . . . . 15.0 113.472 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.36 -11.57 12.71 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-O 118.665 -1.075 . . . . 15.0 115.545 172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.82 147.73 50.82 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.214 1.507 . . . . 15.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.69 112.66 2.61 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.836 0.71 . . . . 15.0 109.217 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -72.32 156.22 39.33 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.596 0.56 . . . . 15.0 110.829 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.38 126.63 28.09 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.763 0.664 . . . . 15.0 111.124 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.77 77.55 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.051 -0.977 . . . . 15.0 112.175 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.69 47.81 1.39 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 114.672 0.629 . . . . 15.0 114.672 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -136.03 150.72 49.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.018 0.527 . . . . 15.0 110.625 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.12 92.27 0.83 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.154 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.2 p -76.57 127.81 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.357 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.478 ' HB3' HG13 ' B' ' 421' ' ' VAL . 15.3 m-20 71.6 36.15 1.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 15.0 112.731 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -66.05 138.85 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 15.0 109.909 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -104.35 110.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.977 0.911 . . . . 15.0 109.719 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -101.93 89.96 3.82 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.675 0.79 . . . . 15.0 111.22 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -78.45 90.3 4.45 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.387 -0.968 . . . . 15.0 108.387 171.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.7 mtp -71.76 169.68 15.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.43 -0.805 . . . . 15.0 113.024 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.67 ' HA3' HH21 ' A' ' 243' ' ' ARG . . . 91.53 10.66 61.67 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.99 -1.004 . . . . 15.0 113.523 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.446 ' HG3' ' HG2' ' A' ' 193' ' ' ARG . 8.8 pt20 -137.75 160.55 38.94 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.169 0.588 . . . . 15.0 110.077 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.91 89.83 0.06 OUTLIER Glycine 0 C--N 1.353 1.484 0 O-C-N 123.715 0.635 . . . . 15.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 191' ' ' GLN . 29.7 mmt180 -121.03 -60.78 1.62 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.67 0.788 . . . . 15.0 111.227 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 198' ' ' PHE . 63.4 mmm -98.17 148.89 23.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.679 0.622 . . . . 15.0 112.679 -165.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.8 pt -61.27 145.27 90.54 Favored Pre-proline 0 CA--C 1.556 1.207 0 O-C-N 124.74 1.275 . . . . 15.0 109.904 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.62 114.76 1.91 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.472 2.781 . . . . 15.0 111.811 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 128.4 -37.31 2.29 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.71 -0.677 . . . . 15.0 112.385 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 194' ' ' MET . 37.6 t80 -69.64 -67.78 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.423 0.289 . . . . 15.0 110.386 -175.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.41 -18.84 65.08 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.382 0.426 . . . . 15.0 111.859 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.28 -41.13 67.01 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.965 0.906 . . . . 15.0 110.2 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.22 -24.44 77.0 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.176 -0.92 . . . . 15.0 112.484 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 198' ' ' PHE . 44.9 mm -73.2 -51.85 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.239 0.616 . . . . 15.0 110.134 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -79.01 12.78 2.04 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.508 0.929 . . . . 15.0 113.508 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.55 20.4 15.59 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -144.18 -176.05 4.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.484 1.114 . . . . 15.0 109.991 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.5 OUTLIER -147.37 143.42 27.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.436 0.694 . . . . 15.0 110.101 -176.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.599 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . . . -59.66 145.67 43.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.414 0.894 . . . . 15.0 113.414 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.09 -34.16 4.84 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.478 -0.783 . . . . 15.0 111.553 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.6 pt-20 -87.19 140.74 29.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.588 0.709 . . . . 15.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.14 125.37 52.23 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.67 1.188 . . . . 15.0 107.969 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -148.92 -167.05 2.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.425 1.09 . . . . 15.0 109.633 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.4 t -133.17 150.37 52.01 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.199 -1.037 . . . . 15.0 108.199 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 38.5 pt -113.57 147.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 172.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.04 113.7 26.95 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.93 167.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.302 -1.37 . . . . 15.0 107.302 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.9 m -135.03 137.73 43.24 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -72.58 125.5 91.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 123.873 0.733 . . . . 15.0 109.621 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.48 168.15 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.785 2.99 . . . . 15.0 115.21 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.88 -19.97 53.83 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.937 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -80.3 -22.49 41.52 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.325 1.05 . . . . 15.0 110.75 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.59 116.23 4.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.84 . . . . 15.0 110.46 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -68.14 -32.19 72.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -162.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.42 92.57 1.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.039 -1.467 . . . . 15.0 107.039 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 33.0 tt0 -73.53 -18.11 61.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.744 0.817 . . . . 15.0 111.391 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -65.32 -13.23 58.02 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.365 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 172' ' ' VAL . 95.4 mt -119.26 -29.89 5.07 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.949 1.3 . . . . 15.0 111.773 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 36.8 ttmt -51.61 121.36 6.33 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.998 1.319 . . . . 15.0 111.645 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.63 -25.33 25.32 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.409 -0.359 . . . . 15.0 113.591 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.15 150.44 31.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.524 0.73 . . . . 15.0 111.328 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.8 122.79 37.79 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.646 0.778 . . . . 15.0 109.927 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.43 122.37 47.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.667 0.787 . . . . 15.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 63.9 mttm -93.73 118.4 31.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.193 0.997 . . . . 15.0 109.571 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 89.5 m-85 -108.4 118.44 36.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.01 89.16 2.98 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.507 0.504 . . . . 15.0 110.323 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 40.9 mm -83.24 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.537 0.735 . . . . 15.0 110.209 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -120.59 99.33 6.49 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.43 99.3 4.83 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.53 0.732 . . . . 15.0 111.005 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -104.12 -43.65 5.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.52 0.728 . . . . 15.0 110.145 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.3 mmtt -124.51 125.87 44.92 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.561 1.144 . . . . 15.0 108.22 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 157' ' ' ALA . 18.6 t -128.5 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.74 -1.578 . . . . 15.0 106.74 165.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -86.53 163.99 17.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.542 -1.208 . . . . 15.0 108.23 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -130.2 129.46 43.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.453 -0.943 . . . . 15.0 108.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.67 HH21 ' HA3' ' A' ' 190' ' ' GLY . 27.8 ptt85 -74.41 84.4 1.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.366 -0.976 . . . . 15.0 108.366 167.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.36 145.92 37.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.783 -1.553 . . . . 15.0 110.689 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 146' ' ' LYS . 55.1 mt -57.47 120.73 42.84 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.984 0.914 . . . . 15.0 110.133 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.25 -165.57 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.903 3.736 . . . . 15.0 113.613 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -46.77 136.51 7.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.773 -1.103 . . . . 15.0 110.461 165.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.0 tp -140.66 37.37 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.137 -1.06 . . . . 15.0 108.137 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.6 m -66.03 161.04 22.43 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.47 1.108 . . . . 15.0 109.922 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.83 -44.88 14.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.88 1.272 . . . . 15.0 112.929 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.82 -27.28 64.74 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.981 -0.554 . . . . 15.0 112.173 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -77.58 -49.18 15.15 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.567 HG13 HD22 ' A' ' 266' ' ' LEU . 12.1 tt -64.52 -32.78 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.381 0.672 . . . . 15.0 110.981 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 258' ' ' VAL . 21.1 ptmt -79.23 -18.47 52.82 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 112.147 0.425 . . . . 15.0 112.147 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -65.58 -24.12 67.0 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 15.0 111.672 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -64.23 -22.77 67.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.283 0.633 . . . . 15.0 111.551 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.5 -1.45 0.73 Allowed Glycine 0 C--N 1.356 1.691 0 CA-C-O 119.845 -0.42 . . . . 15.0 113.853 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 2.9 t -80.82 134.94 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.192 0.597 . . . . 15.0 109.403 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -76.51 -47.68 21.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.7 0.4 . . . . 15.0 111.039 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.69 -36.04 16.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.704 0.288 . . . . 15.0 111.116 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 94.14 22.68 24.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.994 -0.548 . . . . 15.0 113.902 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 29.1 p -70.07 142.56 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 117.532 0.666 . . . . 15.0 110.154 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 253' ' ' ILE . 49.0 t -54.44 -50.91 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.746 0.654 . . . . 15.0 109.283 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.72 -27.45 67.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.034 -0.985 . . . . 15.0 111.44 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.91 -21.1 63.98 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.659 0.599 . . . . 15.0 111.634 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 253' ' ' ILE . 55.7 tp -78.35 -42.29 30.96 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -62.15 -39.44 92.61 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.821 -1.081 . . . . 15.0 110.195 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.54 -43.51 80.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.071 0.948 . . . . 15.0 111.045 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -56.59 -56.98 14.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 141' ' ' LEU . 17.4 m -76.52 -20.22 14.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.363 -0.835 . . . . 15.0 111.534 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -57.41 -63.13 1.33 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.15 -36.77 82.56 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.0 0.37 . . . . 15.0 112.0 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -72.88 -50.02 26.34 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.383 0.673 . . . . 15.0 111.502 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 66.7 mtt -72.04 -28.19 63.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.394 -0.812 . . . . 15.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 47.1 mt-10 -71.09 -26.12 62.91 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 118.881 0.764 . . . . 15.0 111.539 170.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -70.71 -44.63 66.53 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.492 -0.559 . . . . 15.0 109.492 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -62.39 -45.35 93.53 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.572 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 64.9 tp -61.89 -50.88 70.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.025 -1.443 . . . . 15.0 112.175 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.49 -30.86 71.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.52 0.728 . . . . 15.0 110.688 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.5 t -66.12 -45.92 79.4 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.044 -0.725 . . . . 15.0 109.044 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.01 79.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.368 0.667 . . . . 15.0 112.078 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.5 mt -67.03 -45.18 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.775 0.83 . . . . 15.0 109.092 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 23.2 tpt180 -62.05 -46.87 87.22 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.604 -0.725 . . . . 15.0 110.535 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -62.99 -38.5 91.42 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.033 -0.531 . . . . 15.0 110.961 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -56.63 -63.84 1.07 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.66 0.784 . . . . 15.0 110.658 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.05 -46.04 92.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.042 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.1 tttt -64.55 -45.53 86.74 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.844 -0.617 . . . . 15.0 111.105 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.4 p -68.02 -31.9 71.89 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.44 0.296 . . . . 15.0 111.359 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.458 ' HB2' HG13 ' A' ' 125' ' ' VAL . 55.9 mt-30 -73.31 -34.0 65.48 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.354 0.409 . . . . 15.0 111.719 176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.93 62.83 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 110.05 -0.352 . . . . 15.0 110.05 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.95 -42.87 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.358 1.463 . . . . 15.0 110.958 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.91 -59.43 4.9 Favored 'General case' 0 C--O 1.246 0.897 0 C-N-CA 124.227 1.011 . . . . 15.0 110.231 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.632 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.52 -32.77 79.66 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.918 -1.037 . . . . 15.0 113.295 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.703 ' HB3' HD13 ' A' ' 350' ' ' LEU . 9.9 mt -59.85 -53.97 51.74 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 15.0 111.0 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.3 -44.73 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.83 -0.433 . . . . 15.0 109.83 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.18 -32.78 66.78 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.853 0.861 . . . . 15.0 111.746 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.4 -29.95 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.462 0.705 . . . . 15.0 111.611 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -131.92 123.44 27.44 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.096 0.474 . . . . 15.0 111.903 -162.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.58 148.95 26.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.324 1.05 . . . . 15.0 109.363 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.641 HD13 HD13 ' A' ' 349' ' ' LEU . 14.2 tt -162.87 148.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.514 0.726 . . . . 15.0 110.106 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.85 131.94 42.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.472 HG13 HG11 ' A' ' 345' ' ' VAL . 71.2 t -119.88 126.06 27.07 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.259 0.624 . . . . 15.0 111.153 -165.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.86 136.82 17.11 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.692 2.261 . . . . 15.0 112.475 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.55 -15.18 57.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.624 1.17 . . . . 15.0 113.337 -174.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.13 64.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.756 0.822 . . . . 15.0 110.703 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' B' ' 467' ' ' ALA . 71.7 mt -71.45 -38.43 71.32 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 114.121 -1.4 . . . . 15.0 110.442 -175.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 304' ' ' ALA . 55.2 mt -57.28 -50.5 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.233 -1.349 . . . . 15.0 108.516 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.36 -32.35 73.92 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.216 0.948 . . . . 15.0 111.451 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 73.4 m -62.33 -52.88 61.89 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.671 0.389 . . . . 15.0 111.882 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.4 -35.44 79.31 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.561 -0.29 . . . . 15.0 111.124 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.591 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.0 mt -61.65 -38.35 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.416 -0.587 . . . . 15.0 109.416 173.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.469 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 9.1 t70 -64.44 -46.42 83.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.752 0.821 . . . . 15.0 109.423 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.02 -40.77 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 124.155 0.91 . . . . 15.0 110.259 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.55 -19.26 60.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.377 0.671 . . . . 15.0 112.32 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 21.7 mtm180 -81.06 -34.16 32.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.795 0.838 . . . . 15.0 109.811 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 81.4 mtt180 -66.98 -46.79 73.54 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 171.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.49 ' HG3' HD21 ' B' ' 439' ' ' LEU . 34.1 tt0 -56.05 -47.43 77.9 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.27 72.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.157 0.583 . . . . 15.0 110.591 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -59.5 -30.01 68.26 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.831 0.707 . . . . 15.0 111.741 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.14 -37.72 80.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.418 0.687 . . . . 15.0 109.802 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -23.64 24.34 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.69 0.796 . . . . 15.0 110.356 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 12.5 t80 -100.05 31.84 3.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 15.0 111.462 -170.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.89 65.56 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 115.153 0.821 . . . . 15.0 115.153 168.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 65.26 69.11 1.42 Allowed Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.14 0.4 . . . . 15.0 112.918 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 9.6 m120 -72.22 112.01 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.486 0.714 . . . . 15.0 110.592 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.99 90.05 0.08 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.376 1.07 . . . . 15.0 110.466 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 70.29 -10.21 0.69 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.183 1.393 . . . . 15.0 113.001 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.4 tm0? -72.2 -15.9 61.95 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 124.151 0.98 . . . . 15.0 109.545 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.03 -39.2 26.23 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 124.173 0.989 . . . . 15.0 111.432 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.67 -28.1 68.34 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.08 0.952 . . . . 15.0 111.811 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.75 -16.17 45.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.678 0.791 . . . . 15.0 112.001 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 67.2 mt -53.06 125.89 42.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.812 0.445 . . . . 15.0 111.973 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.484 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 84.0 Cg_exo -46.48 120.24 3.73 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.659 3.572 . . . . 15.0 115.453 -166.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.591 ' HG3' HD13 ' A' ' 311' ' ' ILE . 68.6 ttt180 -55.93 -37.04 68.41 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.922 0.889 . . . . 15.0 112.061 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -63.38 -17.31 62.48 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.319 0.648 . . . . 15.0 112.465 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 89.1 mt -73.51 -32.27 64.17 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.368 0.604 . . . . 15.0 110.34 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -115.62 -6.07 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.971 -170.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -47.19 -71.79 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.222 1.409 . . . . 15.0 113.166 -173.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.54 -51.74 68.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.625 0.77 . . . . 15.0 111.686 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -61.72 -45.93 91.81 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.774 0.671 . . . . 15.0 112.043 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.97 56.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.484 . . . . 15.0 110.346 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.19 -34.88 64.26 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.572 0.749 . . . . 15.0 111.027 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -70.95 -35.29 72.13 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.239 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -66.93 -28.65 68.47 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.158 0.286 . . . . 15.0 110.266 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 302' ' ' VAL . 46.2 t -69.6 -47.55 70.81 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.228 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 67.4 t -51.81 -48.44 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.613 -0.884 . . . . 15.0 108.613 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.73 -43.14 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.201 1.001 . . . . 15.0 111.741 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.91 -34.77 90.82 Favored Glycine 0 N--CA 1.472 1.083 0 O-C-N 123.233 0.333 . . . . 15.0 112.851 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.641 HD13 HD13 ' A' ' 300' ' ' ILE . 65.8 mt -76.46 -38.77 54.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.657 0.783 . . . . 15.0 109.764 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.703 HD13 ' HB3' ' A' ' 294' ' ' LEU . 81.3 mt -62.14 -62.05 2.04 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.451 1.101 . . . . 15.0 110.555 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.96 -30.77 71.83 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.26 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.63 95.74 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.866 0.729 . . . . 15.0 111.996 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.13 -34.17 77.44 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.109 -0.545 . . . . 15.0 110.766 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.0 t -67.06 -40.86 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.632 0.373 . . . . 15.0 110.484 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.21 -38.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.599 0.759 . . . . 15.0 110.055 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -70.28 -53.94 14.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.16 0.288 . . . . 15.0 111.518 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -61.45 -35.08 76.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.042 0.937 . . . . 15.0 111.836 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -102.13 10.52 39.38 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 118.962 -0.542 . . . . 15.0 111.348 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 36.83 40.17 0.13 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 126.489 1.916 . . . . 15.0 114.495 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.84 133.36 50.78 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.316 1.046 . . . . 15.0 112.24 -170.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -109.28 142.21 40.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.751 0.82 . . . . 15.0 109.785 176.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.55 115.36 8.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.752 0.421 . . . . 15.0 110.35 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.23 127.94 34.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 15.0 111.408 -171.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.45 -34.38 76.69 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.306 1.042 . . . . 15.0 113.481 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -71.77 -26.64 62.52 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.108 0.255 . . . . 15.0 110.641 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -76.16 -44.95 35.84 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.017 -0.734 . . . . 15.0 109.017 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 398' ' ' MET . 60.9 t -52.28 -56.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.407 1.083 . . . . 15.0 110.341 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.7 -40.37 92.2 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.122 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.17 -40.78 97.7 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.621 0.575 . . . . 15.0 113.336 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 73.6 mt -61.73 -51.7 67.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.686 0.794 . . . . 15.0 109.549 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' A' ' 398' ' ' MET . 34.5 mm -47.54 -56.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.589 1.181 . . . . 15.0 111.216 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.21 -61.32 2.55 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.459 -0.791 . . . . 15.0 111.637 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.12 -24.5 61.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.151 0.797 . . . . 15.0 113.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -78.03 -46.96 19.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.639 0.654 . . . . 15.0 109.304 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -69.48 -32.35 71.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.828 0.451 . . . . 15.0 111.292 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.8 t -63.88 -18.26 64.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.561 0.745 . . . . 15.0 112.214 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.91 66.74 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.289 0.636 . . . . 15.0 111.3 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -97.9 -175.02 3.03 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.696 -0.684 . . . . 15.0 111.01 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.94 -56.19 24.04 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.974 0.91 . . . . 15.0 111.517 -168.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -131.15 116.09 16.59 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.442 -0.799 . . . . 15.0 109.494 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 22.2 Cg_exo -68.23 -37.81 13.4 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.649 2.232 . . . . 15.0 113.227 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -54.82 -48.04 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.301 1.041 . . . . 15.0 111.873 -164.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.23 -28.2 68.55 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.57 -1.195 . . . . 15.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.33 -41.4 30.07 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 C-N-CA 123.573 0.749 . . . . 15.0 109.541 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.67 -48.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.28 -33.39 65.2 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.302 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -70.4 -24.32 62.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.3 0.64 . . . . 15.0 111.068 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.455 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 23.7 m-85 -92.68 -56.14 3.12 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.053 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . 0.662 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -58.66 -43.64 89.93 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 112.526 0.565 . . . . 15.0 112.526 -170.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -87.22 3.83 44.97 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.348 0.659 . . . . 15.0 111.963 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -129.44 90.75 3.05 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.547 -0.908 . . . . 15.0 108.547 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -54.22 -34.57 60.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.388 1.075 . . . . 15.0 112.16 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.2 -43.58 82.86 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.806 0.842 . . . . 15.0 110.841 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.81 -24.34 17.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 15.0 111.291 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.9 OUTLIER -62.94 -37.25 86.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.79 0.836 . . . . 15.0 109.741 176.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.63 -44.4 94.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.496 -1.229 . . . . 15.0 109.843 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.95 -32.05 69.27 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.212 0.605 . . . . 15.0 111.427 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 367' ' ' VAL . 31.5 tpp -69.7 -31.24 69.15 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.441 0.463 . . . . 15.0 111.774 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -67.66 -38.76 84.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 110.135 -0.32 . . . . 15.0 110.135 168.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 400' ' ' ASN . 0.8 OUTLIER -65.52 -48.1 73.67 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.562 0.745 . . . . 15.0 111.408 -176.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 8.3 p -67.49 -37.86 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 123.634 0.584 . . . . 15.0 110.174 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.01 85.34 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.69 0.757 . . . . 15.0 110.502 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 16.7 tp -68.57 -32.76 72.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.076 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.9 tt0 -67.2 -38.1 84.75 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.867 0.467 . . . . 15.0 110.028 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 60.9 mm-40 -62.7 -41.51 99.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.845 0.458 . . . . 15.0 110.019 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -66.74 -39.0 87.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.051 -0.977 . . . . 15.0 111.734 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.02 -42.23 99.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.849 0.718 . . . . 15.0 110.327 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 287' ' ' LYS . 64.4 t -59.36 -54.04 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.548 173.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.407 ' HA ' HD12 ' A' ' 412' ' ' LEU . 80.0 mt-10 -62.01 -28.07 69.32 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.459 0.704 . . . . 15.0 112.88 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.44 71.87 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.793 0.437 . . . . 15.0 110.297 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.85 -32.54 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.223 -0.658 . . . . 15.0 109.223 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 409' ' ' GLU . 93.4 mt -63.28 -43.77 96.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.33 0.652 . . . . 15.0 110.65 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.88 -25.63 65.24 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.599 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 26.1 mtpp -94.85 -22.4 18.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.408 1.083 . . . . 15.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.47 13.18 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.075 0.95 . . . . 15.0 113.211 -171.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 85.7 mttt -77.74 77.3 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.402 1.081 . . . . 15.0 109.459 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 125' ' ' VAL . 38.1 t -91.62 91.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.3 t -71.01 95.37 1.18 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 122.298 1.047 . . . . 15.0 110.448 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.87 117.32 19.86 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.245 -1.343 . . . . 15.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -122.58 157.52 31.95 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.942 0.897 . . . . 15.0 109.064 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.39 117.57 32.13 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -143.95 176.36 9.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.523 0.329 . . . . 15.0 110.611 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.8 p -101.03 159.83 14.89 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.268 1.027 . . . . 15.0 111.128 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.76 -31.57 69.77 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.979 1.311 . . . . 15.0 110.976 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -65.96 -9.2 27.76 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.363 -0.835 . . . . 15.0 112.299 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.91 -73.34 0.57 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 170.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 35.3 tp -36.99 -59.15 0.73 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 125.323 1.449 . . . . 15.0 114.871 -158.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -35.18 13.99 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.07 0.548 . . . . 15.0 110.819 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.36 39.26 0.77 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.474 0.71 . . . . 15.0 111.85 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -80.54 18.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.521 0.729 . . . . 15.0 112.441 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.56 -40.43 94.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.844 0.858 . . . . 15.0 110.795 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.018 0 N-CA-C 108.372 -0.973 . . . . 15.0 108.372 175.322 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.07 -161.57 0.86 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -32.43 -63.03 0.21 Allowed 'General case' 0 C--N 1.369 1.449 0 C-N-CA 126.238 1.815 . . . . 0.0 112.587 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.511 ' HB3' ' HA ' ' B' ' 373' ' ' ARG . 10.3 t70 -106.08 -82.55 0.53 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.644 -0.217 . . . . 0.0 110.44 170.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.09 -79.78 0.55 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.891 0.476 . . . . 0.0 111.544 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 374' ' ' ALA . . . -107.46 -61.29 1.58 Allowed 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.461 -165.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.13 -84.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 122.309 -0.244 . . . . 0.0 110.699 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -97.91 -73.86 0.6 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.511 ' HA ' ' HB3' ' B' ' 368' ' ' ASP . 36.4 mmt180 -101.63 -82.56 0.47 Allowed 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' B' ' 370' ' ' ALA . . . -99.11 -72.29 0.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 167.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 53.4 tp -97.86 -78.51 0.48 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -105.1 -70.13 0.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -100.87 -80.97 0.48 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.5 -77.83 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -107.42 -85.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 175.44 132.17 0.04 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.486 1.515 . . . . 0.0 107.702 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 73.46 143.17 0.07 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.233 1.413 . . . . 0.0 112.488 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -158.34 -16.37 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.786 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.36 -31.47 37.88 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.694 0.798 . . . . 0.0 110.084 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 16.5 m -109.31 154.14 22.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.252 1.021 . . . . 0.0 109.074 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.7 mp -86.91 163.39 17.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.554 0.741 . . . . 0.0 111.014 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.32 130.56 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.124 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -140.5 162.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.222 1.409 . . . . 0.0 109.077 169.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 177' ' ' PHE . 97.3 t -53.84 114.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.081 0.952 . . . . 0.0 112.405 -163.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 56.9 m -145.01 144.77 31.19 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.784 1.234 . . . . 0.0 108.434 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.77 55.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.216 0.606 . . . . 0.0 110.098 172.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.44 86.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.58 0.705 . . . . 0.0 110.929 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 48.27 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.008 1.723 . . . . 0.0 111.67 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -164.54 89.06 0.51 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -60.05 -44.01 94.98 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.024 0.93 . . . . 0.0 110.771 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 62.84 -72.26 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.81 1.644 . . . . 0.0 113.014 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 24.5 m -62.41 97.45 0.09 Allowed 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.713 1.205 . . . . 0.0 110.288 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -163.86 150.19 11.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 108.194 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 77.9 mt 65.52 119.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.48 1.112 . . . . 0.0 110.791 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 96.8 t 73.84 -53.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 125.304 1.441 . . . . 0.0 110.066 -172.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -84.73 110.2 25.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 165.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.48 -29.59 61.96 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.871 2.381 . . . . 0.0 113.091 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 31.6 t70 62.69 97.99 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.048 1.339 . . . . 0.0 110.064 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 24.2 m -124.83 106.62 10.17 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -149.55 162.96 39.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -94.52 121.49 63.17 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.151 0.98 . . . . 0.0 109.112 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.85 -21.32 71.98 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.36 2.707 . . . . 0.0 113.39 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.72 -134.03 1.66 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.613 HD22 HD21 ' B' ' 413' ' ' ASN . 4.2 tt -74.4 -67.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 27.9 m -147.7 100.59 3.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 65.87 -87.26 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.803 1.241 . . . . 0.0 110.868 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -172.48 127.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.127 0.971 . . . . 0.0 109.613 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 69.8 mt 52.31 38.2 24.29 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.057 1.343 . . . . 0.0 112.476 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 413' ' ' ASN . . . . . 0.613 HD21 HD22 ' B' ' 408' ' ' LEU . 19.6 p-10 -66.37 -39.17 88.96 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.296 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 34.0 p -81.88 64.67 6.68 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.153 0.981 . . . . 0.0 109.176 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -83.32 98.79 9.63 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.851 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.32 -44.77 92.55 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.541 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 178.71 -147.7 7.97 Favored Glycine 0 C--O 1.241 0.573 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.883 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.47 77.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 88.9 t 71.32 -65.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.927 1.691 . . . . 0.0 111.388 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 15.3 ptp 58.04 -177.18 0.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.636 1.974 . . . . 0.0 113.256 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 184' ' ' ASP . 31.1 m -63.77 151.96 8.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-O 121.251 0.548 . . . . 0.0 110.277 172.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 45.0 ttm -88.17 24.5 1.84 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 14.3 m 61.42 -162.01 0.28 Allowed 'General case' 0 C--N 1.367 1.335 0 C-N-CA 124.979 1.312 . . . . 0.0 109.952 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 64.56 -153.28 0.29 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.554 0.742 . . . . 0.0 109.96 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 84.9 65.35 1.49 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.03 90.46 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.493 1.117 . . . . 0.0 112.232 -173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.608 ' H ' ' HZ2' ' A' ' 151' ' ' TRP . 31.8 p -78.17 86.19 4.32 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.236 1.014 . . . . 0.0 110.549 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 22.91 12.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.489 1.116 . . . . 0.0 109.633 172.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.1 -29.39 70.25 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.948 0.899 . . . . 0.0 111.563 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -75.28 -16.12 60.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.201 0.6 . . . . 0.0 111.941 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 34.5 m -71.28 -28.48 64.17 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.804 0.442 . . . . 0.0 110.689 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.82 -47.01 70.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.747 0.819 . . . . 0.0 110.126 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 433' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' B' ' 434' ' ' HIS . 1.4 tm-20 60.32 -100.64 0.1 Allowed 'General case' 0 CA--C 1.562 1.43 0 O-C-N 124.725 1.266 . . . . 0.0 108.332 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 434' ' ' HIS . . . . . 0.412 ' H ' ' HB3' ' B' ' 433' ' ' GLU . 24.2 p80 178.4 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.704 1.602 . . . . 0.0 108.423 169.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 1.7 t 52.45 -179.66 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 127.267 2.227 . . . . 0.0 113.639 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -112.94 106.03 1.77 Allowed Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 19.0 m -62.25 137.8 58.32 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.458 0.703 . . . . 0.0 111.484 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.76 166.45 20.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.624 0.769 . . . . 0.0 109.998 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.49 HD21 ' HG3' ' A' ' 317' ' ' GLN . 3.3 mm? -95.45 18.61 12.32 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.727 0.811 . . . . 0.0 109.589 172.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 78.3 -33.67 0.17 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 126.489 1.915 . . . . 0.0 111.912 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 2.8 pt -148.38 172.18 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.163 1.385 . . . . 0.0 108.501 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.83 -70.24 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 57.04 11.93 1.11 Allowed 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.26 151.1 45.7 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.36 0.664 . . . . 0.0 110.412 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 127.81 -36.72 2.47 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-O 117.3 -1.833 . . . . 0.0 117.266 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.09 82.1 2.27 Favored 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.693 3.247 . . . . 0.0 112.12 -166.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -101.26 100.0 10.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 81.69 -46.16 0.2 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 126.015 1.726 . . . . 0.0 111.854 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -162.2 -172.02 3.05 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.34 1.056 . . . . 0.0 110.482 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.36 1.01 20.2 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.629 0.372 . . . . 0.0 111.56 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.3 t 68.75 83.79 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 124.693 1.197 . . . . 0.0 109.913 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 11.0 m -90.76 84.23 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.4 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -156.22 65.59 0.31 Allowed Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' B' ' 462' ' ' TYR . 55.6 tp -65.06 91.07 0.09 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.428 1.091 . . . . 0.0 109.345 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.1 p 53.81 60.98 3.31 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.175 1.39 . . . . 0.0 111.099 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.52 -75.16 0.44 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.118 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -94.97 -7.04 41.02 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.989 0.516 . . . . 0.0 111.993 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 8.9 t -164.3 155.98 16.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.016 0.927 . . . . 0.0 109.242 168.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -106.47 136.58 45.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.379 0.671 . . . . 0.0 110.836 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 21.21 0.99 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.471 1.108 . . . . 0.0 109.996 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 35.9 t80 58.57 103.31 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.583 1.553 . . . . 0.0 109.435 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 462' ' ' TYR . . . . . 0.428 ' HA ' HD12 ' B' ' 454' ' ' LEU . 35.9 t80 65.22 -172.44 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.2 m -141.15 104.47 4.64 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.94 21.34 4.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.922 0.889 . . . . 0.0 111.368 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 70.4 -175.54 0.19 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.974 1.31 . . . . 0.0 111.168 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 68.87 -61.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.074 1.35 . . . . 0.0 110.107 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.489 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . -95.53 123.98 39.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.29 1.036 . . . . 0.0 108.505 163.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.6 155.1 16.89 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.308 0.643 . . . . 0.0 109.74 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -137.96 39.76 1.56 Allowed Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.256 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.74 166.09 32.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.041 0.448 . . . . 0.0 111.639 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 17.8 pttm . . . . . 0 C--O 1.252 1.216 0 CA-C-N 114.879 -1.055 . . . . 12.06 109.018 168.398 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.025 0.44 . . . . 15.0 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -146.68 146.99 30.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.588 -0.893 . . . . 15.0 108.588 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -137.55 148.72 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.942 0.897 . . . . 15.0 109.467 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.463 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 55.6 p -126.2 101.16 6.63 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.96 77.21 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.682 1.229 . . . . 15.0 110.569 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 46.3 mt-10 -75.77 173.45 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.662 -1.154 . . . . 15.0 109.758 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 77.6 m -143.49 112.8 6.82 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.392 -0.966 . . . . 15.0 108.392 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -78.39 -41.3 33.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.431 0.693 . . . . 15.0 110.562 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -164.04 84.46 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.822 0.849 . . . . 15.0 109.512 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.77 -94.76 0.07 OUTLIER Glycine 0 C--N 1.354 1.531 0 O-C-N 123.825 0.703 . . . . 15.0 113.671 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.6 mp -62.07 -50.21 72.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.526 1.13 . . . . 15.0 110.602 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.8 86.5 0.21 Allowed Glycine 0 C--N 1.346 1.113 0 O-C-N 124.195 0.934 . . . . 15.0 112.11 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 98.7 mtt180 -99.78 134.04 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.293 1.037 . . . . 15.0 110.378 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.5 ttm180 -103.01 88.27 3.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.282 1.033 . . . . 15.0 110.737 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -81.57 91.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.3 m -75.98 100.41 4.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.853 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 51.6 mt -87.98 109.38 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.97 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -84.95 94.24 8.74 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.995 -0.743 . . . . 15.0 108.995 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 70' ' ' LEU . 43.4 mt -73.32 106.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.963 -1.125 . . . . 15.0 107.963 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 150.79 44.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 122.556 0.342 . . . . 15.0 111.315 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.51 -16.88 58.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.603 1.161 . . . . 15.0 114.096 -169.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -64.71 -44.84 88.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.225 0.61 . . . . 15.0 110.429 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.4 m -75.13 -36.79 61.57 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 115.44 -0.8 . . . . 15.0 110.776 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 103' ' ' PHE . 57.9 mt -62.39 -50.58 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.702 0.626 . . . . 15.0 109.881 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -57.53 -50.49 72.92 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.067 0.947 . . . . 15.0 111.098 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.5 m -65.4 -37.77 87.97 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.218 -0.901 . . . . 15.0 111.742 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.28 63.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.123 0.569 . . . . 15.0 112.128 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.794 HG21 ' HD3' ' A' ' 63' ' ' ARG . 93.7 t -65.32 -41.63 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -65.52 -34.99 79.54 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.509 1.124 . . . . 15.0 110.759 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -39.08 91.1 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.55 0.74 . . . . 15.0 110.05 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -74.82 -25.77 59.26 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.524 0.515 . . . . 15.0 111.387 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD11 ' HA3' ' A' ' 59' ' ' GLY . 94.0 mt -73.09 -38.76 66.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.808 0.443 . . . . 15.0 110.983 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.45 -19.6 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 O-C-N 123.158 0.286 . . . . 15.0 110.329 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.18 -57.7 8.74 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.11 -38.53 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.198 0.999 . . . . 15.0 111.365 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.191 0.596 . . . . 15.0 110.559 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.17 -26.68 35.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.814 0.446 . . . . 15.0 112.095 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -77.32 -35.17 55.06 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.711 1.204 . . . . 15.0 110.935 -173.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.64 5.44 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.788 0.835 . . . . 15.0 109.531 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 65.66 22.39 11.64 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.838 1.655 . . . . 15.0 112.601 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 54.0 mt -78.24 -19.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.448 1.099 . . . . 15.0 111.261 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.26 -30.2 71.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.682 0.793 . . . . 15.0 112.061 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.19 -23.76 73.21 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.59 0.556 . . . . 15.0 112.844 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 88.9 m-85 -83.68 -24.0 31.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.462 0.705 . . . . 15.0 110.78 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -79.53 88.47 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -92.14 50.06 1.6 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.589 0.755 . . . . 15.0 110.384 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.3 67.68 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.633 -0.712 . . . . 15.0 113.129 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -73.25 -58.79 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.633 0.773 . . . . 15.0 110.147 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.4 t -101.11 122.11 49.7 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.846 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 53' ' ' ILE . 73.6 Cg_exo -53.54 138.92 66.74 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.063 2.509 . . . . 15.0 112.409 167.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.8 tpt -70.48 -25.26 63.08 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.817 0.847 . . . . 15.0 112.078 -171.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -70.63 -28.79 65.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.549 0.34 . . . . 15.0 111.163 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.491 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.9 mt -65.44 -53.02 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.817 . . . . 15.0 110.241 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 30.1 m -69.1 -16.98 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 111.92 0.341 . . . . 15.0 111.92 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -73.65 -65.58 0.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.513 0.725 . . . . 15.0 112.0 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -73.97 -33.79 64.0 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.672 -0.695 . . . . 15.0 111.93 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -87.49 -73.97 0.46 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.798 0.439 . . . . 15.0 110.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 96.5 m-85 -72.52 -28.1 62.65 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.044 0.537 . . . . 15.0 111.814 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -86.17 10.2 67.0 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.733 -0.481 . . . . 15.0 113.607 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.47 66.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 15.0 111.896 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 p -84.04 -36.37 23.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.185 0.994 . . . . 15.0 111.059 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.84 -18.78 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.306 1.042 . . . . 15.0 111.218 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.794 ' HD3' HG21 ' A' ' 28' ' ' VAL . 20.9 mmt180 -49.88 -42.67 48.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.42 1.088 . . . . 15.0 111.917 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -49.32 -57.58 6.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.882 1.273 . . . . 15.0 112.317 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.72 -33.39 53.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.638 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' A' ' 28' ' ' VAL . 66.6 t -68.07 -28.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.2 mt -56.49 -41.95 77.5 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.56 0.344 . . . . 15.0 110.75 173.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.18 -46.74 93.87 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.793 0.683 . . . . 15.0 112.72 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.55 -38.94 89.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.306 1.042 . . . . 15.0 111.583 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 19' ' ' ILE . 57.3 mt -65.46 -41.58 93.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.93 0.892 . . . . 15.0 110.651 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 64.5 mtm -64.0 -38.38 90.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.083 0.553 . . . . 15.0 110.682 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -64.76 -52.7 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.408 -0.815 . . . . 15.0 110.976 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 mtm105 -74.91 -30.69 61.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.639 -0.71 . . . . 15.0 112.575 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.49 -32.88 54.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.605 0.362 . . . . 15.0 110.513 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.78 -51.39 27.3 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.282 0.364 . . . . 15.0 110.95 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.45 -33.34 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 123.272 0.357 . . . . 15.0 110.261 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.06 -44.84 96.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.579 0.751 . . . . 15.0 110.428 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.18 -53.03 55.71 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.698 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 pt -65.4 -22.19 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -74.94 -51.83 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 15.0 110.196 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -75.4 -25.32 57.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.695 0.398 . . . . 15.0 111.881 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -89.45 -21.57 22.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.29 0.636 . . . . 15.0 110.544 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 62.96 19.74 11.8 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.707 1.203 . . . . 15.0 112.01 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -104.49 85.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.74 141.66 41.64 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.015 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.78 128.35 18.76 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.682 2.255 . . . . 15.0 112.211 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.63 72.83 4.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.414 0.686 . . . . 15.0 109.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.6 -98.67 0.69 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.534 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.46 138.18 31.86 Favored Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 123.289 0.636 . . . . 15.0 112.248 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -95.09 132.03 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.784 2.989 . . . . 15.0 113.27 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -96.38 105.73 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.405 ' HD2' ' HE2' ' A' ' 105' ' ' TYR . 68.1 m-85 -83.45 118.19 23.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.49 90.8 4.32 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.017 0.927 . . . . 15.0 108.594 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.5 119.8 5.65 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.77 2.314 . . . . 15.0 112.44 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.38 -80.21 0.31 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.636 -0.585 . . . . 15.0 111.636 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.42 170.43 8.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.695 0.798 . . . . 15.0 110.332 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -136.35 136.12 39.41 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.273 1.029 . . . . 15.0 109.255 174.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -115.5 137.17 52.34 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.437 -1.32 . . . . 15.0 107.437 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.5 tp -57.22 113.63 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.759 0.824 . . . . 15.0 111.132 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.38 18.53 60.34 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.788 0.68 . . . . 15.0 113.184 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 102' ' ' ASP . 28.1 tt0 -126.58 166.77 16.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.59 0.756 . . . . 15.0 109.382 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 2.9 m-20 -73.02 133.04 44.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.212 1.005 . . . . 15.0 110.703 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.492 ' H ' HD11 ' A' ' 24' ' ' ILE . 39.5 t80 -83.52 143.6 30.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.431 0.693 . . . . 15.0 109.398 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.5 m -140.45 135.76 32.32 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.132 0.573 . . . . 15.0 109.645 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.405 ' HE2' ' HD2' ' A' ' 92' ' ' TYR . 8.2 p90 -157.04 156.57 33.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.013 0.925 . . . . 15.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.1 m -111.37 108.93 18.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.473 1.109 . . . . 15.0 111.192 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.28 97.88 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.41 99.84 12.72 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.648 0.779 . . . . 15.0 109.46 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.55 149.19 45.56 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 15.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.92 140.58 30.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.711 0.804 . . . . 15.0 109.302 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 11' ' ' LEU . 15.5 m -109.72 179.42 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.236 0.614 . . . . 15.0 110.728 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.84 113.28 31.29 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.86 0.864 . . . . 15.0 110.034 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.673 ' HB2' HD11 ' A' ' 300' ' ' ILE . 84.2 Cg_endo -82.68 115.62 2.48 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.345 2.03 . . . . 15.0 112.887 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -71.32 89.1 0.88 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.216 1.006 . . . . 15.0 109.064 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.2 131.0 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.219 -168.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -80.12 109.75 14.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.869 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.19 147.9 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.996 0.81 . . . . 15.0 110.465 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.54 158.69 21.07 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.965 0.906 . . . . 15.0 109.739 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 68.28 22.6 74.67 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.629 -0.714 . . . . 15.0 113.843 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.3 mt -68.06 -45.49 73.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.58 1.152 . . . . 15.0 110.673 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.07 -27.87 63.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.647 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.09 -17.55 60.93 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.879 0.472 . . . . 15.0 111.803 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 119' ' ' GLY . 57.4 mt -64.78 120.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.638 0.375 . . . . 15.0 110.332 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.22 109.18 21.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.604 -0.887 . . . . 15.0 108.604 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.0 t -110.7 150.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -87.31 109.44 25.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.205 1.002 . . . . 15.0 109.729 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 68.6 Cg_endo -92.44 104.62 0.2 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.492 2.128 . . . . 15.0 112.282 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 127' ' ' LYS . 50.2 mm -70.44 89.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 422' ' ' THR . 41.4 t -108.81 135.28 48.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.677 -1.147 . . . . 15.0 109.467 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -122.9 154.54 38.2 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.409 -1.33 . . . . 15.0 107.409 160.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.468 HG23 HD22 ' A' ' 278' ' ' LEU . 34.9 t -81.42 84.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 107.591 -1.263 . . . . 15.0 107.591 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.6 p -63.25 176.39 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.139 0.976 . . . . 15.0 110.744 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.18 -40.21 76.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.065 0.459 . . . . 15.0 111.086 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.98 98.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.178 -0.919 . . . . 15.0 110.975 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -74.0 -39.83 63.35 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.009 0.524 . . . . 15.0 111.721 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 t -60.29 -62.54 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.103 0 C-N-CA 124.546 1.138 . . . . 15.0 108.734 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.99 -27.28 43.35 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 114.13 -1.396 . . . . 15.0 110.693 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.96 -36.13 47.83 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.749 0.656 . . . . 15.0 113.414 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -71.74 -47.42 53.88 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.008 -0.367 . . . . 15.0 110.008 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.605 HD21 HG11 ' A' ' 270' ' ' VAL . 57.1 mt -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.944 0.498 . . . . 15.0 111.915 167.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.38 -45.32 93.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.152 0.981 . . . . 15.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -63.5 -40.17 96.36 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.029 0.83 . . . . 15.0 110.917 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.23 -42.84 99.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.39 0.676 . . . . 15.0 110.938 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.661 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.2 mtp180 -68.62 -29.31 67.79 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.453 -0.794 . . . . 15.0 110.607 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.1 mttt -80.94 -15.61 55.78 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.103 0.561 . . . . 15.0 111.937 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -83.34 -31.12 26.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.69 0.396 . . . . 15.0 110.219 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -104.35 34.58 3.03 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.723 0.809 . . . . 15.0 110.616 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -78.1 156.34 30.02 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.734 1.383 . . . . 15.0 114.734 -166.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.8 m -92.39 128.69 38.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.292 -1.322 . . . . 15.0 108.784 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -84.71 108.32 17.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -123.75 126.49 46.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.277 1.031 . . . . 15.0 110.047 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 74.4 mt-10 -75.72 117.67 17.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.455 -0.572 . . . . 15.0 109.455 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.684 ' HG3' HG12 ' A' ' 240' ' ' VAL . 36.8 pttt -104.61 178.86 4.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.494 0.718 . . . . 15.0 110.735 173.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.65 141.74 43.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.685 0.794 . . . . 15.0 109.335 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.17 -51.06 0.8 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.483 -0.621 . . . . 15.0 113.845 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 146.91 24.1 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.82 0.81 . . . . 15.0 112.479 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 43.0 t -105.29 155.49 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.668 1.187 . . . . 15.0 108.408 168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 160' ' ' ALA . 16.8 tt0 -148.5 -175.15 4.81 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.855 0.862 . . . . 15.0 109.043 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.5 ' H ' ' HG2' ' A' ' 159' ' ' GLU . . . -73.19 -25.54 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.809 1.411 . . . . 15.0 114.809 -164.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -111.22 26.01 11.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.206 0.602 . . . . 15.0 110.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.5 -165.52 1.24 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.664 0.745 . . . . 15.0 112.753 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' A' ' 188' ' ' ALA . 0.3 OUTLIER -139.23 135.18 33.65 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.796 -1.927 . . . . 15.0 105.796 -176.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.28 156.23 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.6 m -129.14 126.51 39.45 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.593 -1.262 . . . . 15.0 107.593 161.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.654 HG22 HD23 ' A' ' 237' ' ' LEU . 28.3 pt -125.05 176.33 6.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.342 1.057 . . . . 15.0 110.791 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.68 122.65 12.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.373 -1.714 . . . . 15.0 106.373 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' B' ' 385' ' ' LEU . 29.3 p90 -140.6 160.81 39.21 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.68 0.752 . . . . 15.0 112.667 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.6 t -141.28 115.73 9.5 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.853 -1.521 . . . . 15.0 108.435 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -89.17 161.93 30.61 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.015 -0.539 . . . . 15.0 113.425 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 m -151.28 127.97 10.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.066 0.947 . . . . 15.0 108.593 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 231' ' ' ALA . 58.0 t -107.81 134.31 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.618 0.767 . . . . 15.0 109.207 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 t70 70.53 3.81 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.202 1.001 . . . . 15.0 112.569 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.27 -3.0 16.27 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.522 -0.599 . . . . 15.0 114.002 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.13 166.59 24.95 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.43 0.692 . . . . 15.0 109.665 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -62.33 175.26 0.77 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 121.704 0.764 . . . . 15.0 111.477 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.632 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 1.7 p90 -149.82 170.35 18.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.103 0.961 . . . . 15.0 109.142 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' B' ' 388' ' ' VAL . 1.9 pm0 -59.72 116.62 4.19 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.929 0.768 . . . . 15.0 109.42 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.89 80.59 0.68 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.354 -1.498 . . . . 15.0 109.354 -163.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -102.81 -15.75 23.59 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.166 -0.797 . . . . 15.0 113.492 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -140.65 146.81 38.39 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 117.925 0.862 . . . . 15.0 112.335 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.15 93.35 2.43 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.448 -1.316 . . . . 15.0 107.448 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.8 m -81.98 138.85 34.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.825 -1.079 . . . . 15.0 110.944 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 62.64 22.55 13.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.07 0.948 . . . . 15.0 113.061 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD2' HD11 ' B' ' 385' ' ' LEU . 83.6 t80 -66.22 138.99 58.07 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.588 0.232 . . . . 15.0 110.863 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.35 109.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.952 0.901 . . . . 15.0 109.754 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 202' ' ' ILE . 26.4 tp -93.58 90.33 6.61 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.404 0.682 . . . . 15.0 111.347 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.428 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -83.57 92.87 7.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.406 ' HG2' ' HG ' ' A' ' 187' ' ' LEU . 17.7 mtp -54.57 128.62 33.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.591 0.756 . . . . 15.0 112.311 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.63 -26.94 5.33 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 -165.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.73 129.13 37.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.487 0.715 . . . . 15.0 109.744 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.2 72.47 0.23 Allowed Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.483 0.489 . . . . 15.0 112.571 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' B' ' 384' ' ' THR . 23.6 mtm180 -125.99 22.22 7.38 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.266 0.627 . . . . 15.0 111.279 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.561 ' HB3' HD23 ' B' ' 385' ' ' LEU . 1.6 pmm? -140.77 171.35 14.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.467 0.707 . . . . 15.0 109.973 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.3 pt -100.69 157.28 34.01 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.784 0.834 . . . . 15.0 110.239 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.33 147.1 86.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.676 2.25 . . . . 15.0 112.229 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.78 -46.87 1.45 Allowed Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.4 -0.68 . . . . 15.0 111.4 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -63.63 -51.82 63.52 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.18 -41.97 80.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.618 -1.173 . . . . 15.0 111.662 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.32 -33.08 75.12 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.307 1.043 . . . . 15.0 110.873 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -78.35 -13.73 82.95 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.268 -0.878 . . . . 15.0 113.286 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.461 HG21 HD23 ' A' ' 187' ' ' LEU . 34.3 mm -90.39 -51.59 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.282 -0.636 . . . . 15.0 109.282 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -84.52 21.48 1.47 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.774 -166.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.44 32.34 2.07 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.24 -0.744 . . . . 15.0 111.24 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -147.12 -174.24 4.45 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.2 1.0 . . . . 15.0 110.329 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 21.5 pttp -146.69 159.85 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.726 0.81 . . . . 15.0 110.349 -174.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -67.54 152.51 45.53 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.452 0.569 . . . . 15.0 112.287 -171.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.65 -41.29 2.17 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.56 -0.745 . . . . 15.0 111.766 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.2 pt-20 -76.61 114.18 15.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.797 0.808 . . . . 15.0 108.937 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.96 104.2 16.21 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.004 -1.48 . . . . 15.0 107.004 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.02 -169.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.42 1.088 . . . . 15.0 109.295 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.6 t -133.28 141.46 48.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.23 -1.026 . . . . 15.0 108.23 168.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 47.0 pt -104.71 139.36 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -102.0 104.01 14.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.707 -0.849 . . . . 15.0 108.707 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.1 t -97.56 158.36 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.547 -1.279 . . . . 15.0 107.547 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -131.81 129.38 40.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.078 -1.082 . . . . 15.0 108.078 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -78.55 124.46 85.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.564 0.745 . . . . 15.0 110.008 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -51.04 165.99 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.928 3.086 . . . . 15.0 115.403 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -27.76 62.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.61 -0.723 . . . . 15.0 109.724 168.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.86 -17.14 59.16 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.952 1.301 . . . . 15.0 111.451 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.475 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 64.9 t80 -63.04 133.58 54.77 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.914 0.886 . . . . 15.0 110.327 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -76.97 -42.6 38.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.346 1.239 . . . . 15.0 114.346 -166.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.475 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -70.72 100.21 1.84 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.33 -23.41 60.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.676 0.79 . . . . 15.0 112.835 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.48 -24.89 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.654 0.382 . . . . 15.0 110.906 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.57 HD11 ' H ' ' B' ' 388' ' ' VAL . 40.7 mt -93.7 -33.68 13.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.945 0.898 . . . . 15.0 111.643 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.33 116.41 1.87 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.59 1.156 . . . . 15.0 111.542 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.56 -34.83 4.87 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.45 171.51 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.668 0.787 . . . . 15.0 111.936 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -123.94 138.67 54.44 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.9 -1.045 . . . . 15.0 109.833 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -117.44 131.55 56.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.218 0.607 . . . . 15.0 110.127 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 65.7 mttm -98.12 116.22 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.744 -1.206 . . . . 15.0 107.744 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 99.3 m-85 -108.81 114.24 27.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -75.92 89.66 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 15.0 110.231 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 mm -82.01 115.85 25.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.425 0.69 . . . . 15.0 109.669 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -103.73 101.17 11.0 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.526 -1.287 . . . . 15.0 107.526 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 166' ' ' ILE . 88.2 mt -76.9 93.21 3.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -85.34 -31.81 22.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.301 -0.863 . . . . 15.0 110.531 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -132.66 123.43 26.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.174 0.59 . . . . 15.0 110.907 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 207' ' ' ALA . 88.9 t -101.29 105.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.675 -1.972 . . . . 15.0 105.675 160.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 31.9 mt-10 -113.23 -174.94 2.56 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.5 tt0 -155.88 126.67 6.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -73.8 83.12 1.64 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 163.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.49 148.16 39.22 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 113.494 -1.685 . . . . 15.0 110.813 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.93 121.57 59.44 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.544 0.738 . . . . 15.0 110.42 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 91.0 Cg_endo -75.54 -167.95 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.538 2.826 . . . . 15.0 111.965 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 249' ' ' THR . 39.9 tt0 -55.78 147.15 19.53 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.323 0.649 . . . . 15.0 111.22 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.4 tp -147.33 25.94 1.08 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.699 1.2 . . . . 15.0 108.047 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.451 ' H ' ' HG2' ' A' ' 247' ' ' GLU . 6.3 m -73.76 164.83 26.12 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.682 -1.145 . . . . 15.0 109.192 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -36.83 -51.88 0.91 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.801 1.64 . . . . 15.0 114.492 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -67.62 -30.13 69.63 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -80.23 -55.61 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.895 0.478 . . . . 15.0 109.976 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.721 HG13 HD22 ' A' ' 266' ' ' LEU . 12.9 tt -63.87 -28.94 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.829 0.852 . . . . 15.0 112.494 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -66.1 -27.52 68.12 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 112.005 0.372 . . . . 15.0 112.005 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.59 -19.64 65.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.59 0.756 . . . . 15.0 111.976 -172.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -68.66 -23.98 64.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.831 0.453 . . . . 15.0 111.835 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.94 -22.48 1.44 Allowed Glycine 0 C--N 1.351 1.415 0 O-C-N 122.944 0.152 . . . . 15.0 112.771 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 261' ' ' GLY . 21.5 t -68.14 133.15 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 15.0 110.071 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.64 -60.98 2.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.78 0.432 . . . . 15.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.75 -36.1 32.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.072 0.549 . . . . 15.0 111.074 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 98.88 36.09 4.62 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.476 -0.784 . . . . 15.0 112.755 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 p -78.44 139.45 38.72 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.645 0.723 . . . . 15.0 110.362 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 62.3 t -57.16 -58.77 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.189 0.996 . . . . 15.0 110.789 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.33 -15.4 47.85 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.729 0.812 . . . . 15.0 112.108 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.14 -32.84 37.97 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 253' ' ' ILE . 56.3 tp -75.84 -38.51 57.97 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.787 -0.449 . . . . 15.0 109.787 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 39.2 mtp-105 -62.9 -39.58 94.94 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.539 0.524 . . . . 15.0 109.639 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.93 73.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 110.992 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.37 -50.35 73.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.022 0.929 . . . . 15.0 111.196 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.605 HG11 HD21 ' A' ' 141' ' ' LEU . 21.6 m -75.97 -25.13 16.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.235 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -57.79 -60.89 3.01 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.106 -0.701 . . . . 15.0 109.106 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -64.61 -37.56 88.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.916 0.71 . . . . 15.0 112.916 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.92 -51.81 23.79 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 117.966 0.348 . . . . 15.0 111.274 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.21 -30.13 70.99 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 118.582 -0.723 . . . . 15.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.62 -30.06 59.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.443 0.534 . . . . 15.0 112.443 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -64.4 -44.2 92.02 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.272 -0.64 . . . . 15.0 109.272 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.92 -38.17 79.37 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.593 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.496 HD12 HD23 ' A' ' 427' ' ' LEU . 22.5 tp -60.65 -47.04 88.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.647 1.179 . . . . 15.0 111.638 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -59.85 -40.22 87.8 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.798 0.687 . . . . 15.0 111.053 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.1 t -68.11 -33.9 75.37 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.867 0.729 . . . . 15.0 110.401 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -80.36 -32.0 37.82 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 88.2 mt -68.31 -43.08 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -64.04 -40.12 95.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.108 -0.951 . . . . 15.0 109.691 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.78 -46.78 88.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.525 0.73 . . . . 15.0 110.047 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.493 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 8.5 tpt180 -57.05 -63.27 1.27 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.681 1.192 . . . . 15.0 111.128 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.5 -47.47 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.359 1.064 . . . . 15.0 111.5 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 408' ' ' VAL . 86.4 tttt -71.5 -36.76 71.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.745 -0.662 . . . . 15.0 111.437 -175.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -68.55 -37.99 80.4 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 119.357 -0.354 . . . . 15.0 110.39 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -69.85 -35.97 75.16 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.56 0.537 . . . . 15.0 111.673 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.476 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.2 -52.9 60.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.114 0.483 . . . . 15.0 110.712 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.37 -35.02 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.345 1.458 . . . . 15.0 111.248 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.546 ' HA ' HH21 ' A' ' 343' ' ' ARG . 14.0 tp10 -64.04 -53.85 43.43 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -60.12 -39.43 95.83 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 124.598 1.186 . . . . 15.0 112.579 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 -63.5 1.17 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.321 1.048 . . . . 15.0 111.66 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.594 HG11 ' HG2' ' A' ' 343' ' ' ARG . 91.7 t -63.14 -44.07 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 122.481 0.312 . . . . 15.0 110.232 -176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -55.57 -37.33 67.89 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.287 1.035 . . . . 15.0 111.213 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.49 -28.46 37.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.872 0.869 . . . . 15.0 112.344 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -123.18 113.61 19.18 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.802 0.441 . . . . 15.0 111.278 -167.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.59 148.11 26.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.102 -1.073 . . . . 15.0 108.102 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 113' ' ' PRO . 7.4 tt -163.91 153.77 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.622 0.769 . . . . 15.0 109.814 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.45 112.45 7.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.494 -1.299 . . . . 15.0 107.494 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 300' ' ' ILE . 21.8 t -103.97 132.27 21.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.71 0.804 . . . . 15.0 109.46 -172.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.48 ' HG3' HD23 ' A' ' 11' ' ' LEU . 23.6 Cg_exo -62.94 110.59 1.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.699 2.266 . . . . 15.0 112.117 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -54.74 -21.48 11.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.861 1.665 . . . . 15.0 113.104 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.25 29.34 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.232 1.013 . . . . 15.0 111.196 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.698 HD13 ' HA ' ' B' ' 467' ' ' ALA . 75.9 mt -63.01 -38.73 92.35 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.59 0.71 . . . . 15.0 110.011 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 304' ' ' ALA . 77.4 mt -58.62 -48.13 86.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 CA-C-N 114.239 -1.346 . . . . 15.0 109.712 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HA ' HD12 ' A' ' 311' ' ' ILE . 22.9 t70 -63.1 -29.92 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.062 0.851 . . . . 15.0 111.309 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -69.61 -44.79 70.0 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.562 0.345 . . . . 15.0 111.545 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.3 -28.75 66.55 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.481 0.658 . . . . 15.0 111.571 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 334' ' ' ARG . 78.0 mt -64.66 -42.04 93.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 N-CA-C 108.195 -1.039 . . . . 15.0 108.195 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.89 -41.14 90.98 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.37 1.044 . . . . 15.0 110.481 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.28 -50.62 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 123.802 0.689 . . . . 15.0 109.909 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.62 -17.92 62.88 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.127 0.788 . . . . 15.0 113.127 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 329' ' ' ALA . 20.9 mtm180 -81.6 -32.7 31.93 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.577 0.751 . . . . 15.0 109.234 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -71.11 -39.45 72.07 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.405 0.682 . . . . 15.0 110.326 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -58.75 -50.45 73.87 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.588 -0.733 . . . . 15.0 110.324 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.07 90.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.475 0.71 . . . . 15.0 110.752 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -53.81 -37.39 63.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.477 1.111 . . . . 15.0 111.671 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -66.12 -39.21 89.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.822 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.42 ' HG3' ' HB ' ' B' ' 435' ' ' THR . 10.8 mpt_? -81.85 -11.7 58.83 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.982 0.513 . . . . 15.0 109.967 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.459 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 66.6 t80 -92.5 13.18 20.48 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.139 1.376 . . . . 15.0 109.784 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.01 21.25 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 116.118 -0.492 . . . . 15.0 113.358 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 71.96 62.69 3.26 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 112.134 -0.386 . . . . 15.0 112.134 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.674 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 23.9 t-20 -63.11 147.46 50.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.784 0.834 . . . . 15.0 110.292 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.58 88.85 2.84 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.986 1.315 . . . . 15.0 110.018 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm 67.45 -5.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.401 1.481 . . . . 15.0 114.551 170.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -84.24 -10.32 57.78 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.119 0.967 . . . . 15.0 108.989 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -51.96 -33.12 36.28 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.2 1.4 . . . . 15.0 112.347 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.9 tp -51.18 -32.32 23.03 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.808 1.243 . . . . 15.0 112.263 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.17 -22.38 39.0 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.1 0.96 . . . . 15.0 112.174 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.5 mt -52.9 119.6 16.68 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-O 118.091 -0.957 . . . . 15.0 110.317 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.71 107.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 124.588 3.525 . . . . 15.0 113.55 -169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 311' ' ' ILE . 9.0 ptm180 -61.21 -31.32 71.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.782 -1.099 . . . . 15.0 112.572 -170.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.65 -18.11 64.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.222 1.009 . . . . 15.0 112.822 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.49 -37.86 88.04 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.689 0.757 . . . . 15.0 109.73 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.55 ' HB2' HG23 ' A' ' 311' ' ' ILE . 33.2 m-85 -103.38 -20.51 14.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.388 -1.278 . . . . 15.0 111.097 -168.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -54.83 -36.5 65.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.304 1.041 . . . . 15.0 112.976 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.06 -48.06 83.45 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.661 0.384 . . . . 15.0 111.713 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.04 -38.59 44.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.941 0.496 . . . . 15.0 111.358 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.33 -55.17 26.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.393 0.677 . . . . 15.0 110.937 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.543 ' HA ' HG12 ' A' ' 307' ' ' ILE . 86.3 tttt -48.74 -44.34 38.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.692 1.197 . . . . 15.0 111.146 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.594 ' HG2' HG11 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -60.32 -39.26 86.38 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.603 1.19 . . . . 15.0 110.207 178.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -73.18 -28.11 62.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.817 0.281 . . . . 15.0 111.463 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 20.4 t -71.7 -38.24 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.495 -0.558 . . . . 15.0 109.495 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.3 t -59.39 -44.98 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 343' ' ' ARG . 61.1 t -54.22 -46.7 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.82 0.848 . . . . 15.0 110.818 172.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.42 -30.51 75.28 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.433 0.458 . . . . 15.0 113.789 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 300' ' ' ILE . 95.7 mt -74.6 -49.35 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.453 0.701 . . . . 15.0 109.955 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.6 mt -64.06 -54.77 28.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.939 0.896 . . . . 15.0 110.548 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.6 -34.94 78.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.035 0.834 . . . . 15.0 111.098 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.88 -38.61 96.84 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 123.49 0.493 . . . . 15.0 112.611 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.17 -35.12 73.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.371 0.669 . . . . 15.0 110.862 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 350' ' ' LEU . 96.4 t -66.6 -37.33 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.927 0.491 . . . . 15.0 110.218 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 352' ' ' GLY . 76.7 mt -64.26 -42.16 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.352 0.661 . . . . 15.0 110.074 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -60.65 -62.57 1.76 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.827 -0.624 . . . . 15.0 110.096 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.1 m -66.26 -33.8 76.57 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.149 0.98 . . . . 15.0 112.482 -173.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -94.35 11.01 31.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.924 0.49 . . . . 15.0 111.322 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.82 38.58 4.48 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 125.766 1.627 . . . . 15.0 113.888 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.68 147.89 43.25 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.632 0.773 . . . . 15.0 111.85 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 148.51 39.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.229 1.012 . . . . 15.0 108.615 172.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.17 137.39 57.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -172.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 122.07 37.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.042 0.937 . . . . 15.0 109.77 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.65 -46.82 83.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.263 1.025 . . . . 15.0 111.829 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.69 -21.06 61.12 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.082 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 21.1 ttt85 -72.62 -46.66 53.01 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.553 -0.906 . . . . 15.0 108.553 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 399' ' ' ARG . 31.7 t -55.41 -47.52 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 124.55 1.156 . . . . 15.0 109.591 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -51.89 -54.99 22.94 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.237 0.961 . . . . 15.0 111.718 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.73 92.77 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.98 0.8 . . . . 15.0 113.428 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 94.8 mt -60.93 -51.45 69.21 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.515 0.726 . . . . 15.0 110.34 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 367' ' ' VAL . 38.6 mm -54.94 -56.38 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.434 0.694 . . . . 15.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.69 -49.21 78.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.927 -1.488 . . . . 15.0 111.967 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.74 -39.57 64.17 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.615 0.598 . . . . 15.0 112.615 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 56.7 ttp -56.06 -47.49 77.82 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.296 0.639 . . . . 15.0 109.597 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -73.31 -36.42 66.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.8 -1.091 . . . . 15.0 112.183 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 33.5 t -70.55 -12.04 61.32 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.394 0.677 . . . . 15.0 111.811 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.16 -7.95 56.69 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.204 0.601 . . . . 15.0 111.422 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.35 179.53 4.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.225 1.01 . . . . 15.0 110.403 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.01 0.924 . . . . 15.0 110.512 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -114.9 109.89 46.82 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.833 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.709 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 89.3 Cg_endo -80.56 -29.66 2.24 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 121.995 1.796 . . . . 15.0 112.648 168.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.07 -48.54 75.87 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.933 0.893 . . . . 15.0 112.383 -161.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.78 -37.74 85.44 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.992 0.808 . . . . 15.0 110.402 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.46 -46.66 69.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 123.744 0.653 . . . . 15.0 110.087 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -49.3 82.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.06 -12.18 60.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.253 0.621 . . . . 15.0 112.431 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -88.2 -39.66 14.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.212 0.605 . . . . 15.0 111.382 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -86.5 -48.3 8.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.744 0.417 . . . . 15.0 112.083 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.6 p -49.73 -48.04 50.29 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.535 1.134 . . . . 15.0 113.731 -165.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -109.58 14.95 23.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.335 0.654 . . . . 15.0 111.52 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -110.69 88.97 2.9 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.272 -1.381 . . . . 15.0 107.272 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt -66.47 -23.18 66.23 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.413 -0.812 . . . . 15.0 111.691 -170.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.73 -56.88 12.28 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.697 0.799 . . . . 15.0 110.047 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.68 -24.39 58.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.036 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 46.1 tpp -59.52 -46.06 89.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.457 -0.572 . . . . 15.0 109.457 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.417 ' HB3' HD21 ' B' ' 450' ' ' ASN . 6.3 t70 -54.39 -49.83 68.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.893 0.877 . . . . 15.0 111.462 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.18 -33.83 74.08 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 124.023 0.827 . . . . 15.0 110.976 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.597 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -84.69 -11.97 54.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.392 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 367' ' ' VAL . 50.0 mtp180 -85.87 -24.89 26.51 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -71.16 -40.27 71.42 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.235 0.614 . . . . 15.0 110.066 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.3 p -71.57 -28.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 117.748 0.249 . . . . 15.0 111.254 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -68.57 -37.5 79.93 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.419 0.628 . . . . 15.0 110.553 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.74 -31.38 57.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.284 -0.871 . . . . 15.0 110.493 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 408' ' ' VAL . 29.2 tt0 -59.89 -46.3 89.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.383 1.073 . . . . 15.0 109.596 169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 9.1 mm-40 -53.49 -55.09 28.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.524 1.129 . . . . 15.0 111.487 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -58.76 -37.48 76.33 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.483 -0.78 . . . . 15.0 111.953 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.09 -41.68 97.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 15.0 111.278 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.9 t -58.16 -48.39 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 123.757 0.661 . . . . 15.0 109.534 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 57.1 mt-10 -61.87 -36.86 82.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.896 0.748 . . . . 15.0 111.99 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.11 64.73 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.704 -0.68 . . . . 15.0 111.705 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 54.7 t -88.05 -29.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 290' ' ' ALA . 97.0 mt -72.04 -27.36 62.65 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.417 0.687 . . . . 15.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.97 70.17 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 15.0 110.873 170.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -95.91 -28.3 14.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.373 1.069 . . . . 15.0 111.368 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.85 154.95 21.18 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.955 0.902 . . . . 15.0 110.924 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.88 84.18 5.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.786 0.834 . . . . 15.0 109.645 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.0 t -95.57 89.3 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.262 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -72.51 112.01 8.19 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.216 0.606 . . . . 15.0 110.295 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.24 132.55 36.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.261 0.625 . . . . 15.0 110.153 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -140.83 141.55 34.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.36 0.664 . . . . 15.0 110.212 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.92 125.13 36.51 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 130' ' ' VAL . 9.8 t -157.31 173.72 16.52 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.947 0.499 . . . . 15.0 111.345 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 64.9 p -96.47 174.62 6.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.656 0.783 . . . . 15.0 112.145 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.99 -25.23 57.99 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.47 1.908 . . . . 15.0 111.702 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 429' ' ' ASN . 33.6 m-80 -65.53 -34.24 77.79 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.865 1.266 . . . . 15.0 112.21 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.403 ' HG2' HG21 ' A' ' 422' ' ' THR . 13.0 tp10 -66.68 -37.4 84.69 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.321 0.581 . . . . 15.0 111.739 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.496 HD23 HD12 ' A' ' 278' ' ' LEU . 15.6 tp -85.24 -77.5 0.28 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.377 -0.829 . . . . 15.0 111.124 -165.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.01 -30.51 9.26 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.214 -0.304 . . . . 15.0 111.425 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 425' ' ' ASN . 65.1 t30 -86.85 46.89 1.42 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.308 1.051 . . . . 15.0 110.5 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -77.38 -7.92 56.87 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.833 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -63.4 -20.72 65.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.604 1.162 . . . . 15.0 111.503 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.411 0.684 . . . . 15.0 109.302 171.708 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -125.35 121.46 34.01 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.666 HD22 ' H ' ' B' ' 368' ' ' ASP . 0.0 OUTLIER -55.71 -61.6 2.25 Favored 'General case' 0 CA--C 1.558 1.275 0 O-C-N 124.041 0.838 . . . . 0.0 111.886 -176.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.666 ' H ' HD22 ' B' ' 367' ' ' LEU . 13.1 t70 -108.54 -88.21 0.48 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 164.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -112.73 -77.22 0.58 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 156.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -107.49 -75.25 0.64 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.92 -72.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 162.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -103.81 -76.64 0.59 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 164.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -98.74 -75.53 0.56 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -102.58 -72.74 0.68 Allowed 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 165.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.585 HD22 ' H ' ' B' ' 375' ' ' LEU . 0.0 OUTLIER -107.06 -77.99 0.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.0 -83.39 0.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 164.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -109.2 -88.13 0.49 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 118.81 0.732 . . . . 0.0 110.403 160.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.58 -67.9 0.87 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.658 0.783 . . . . 0.0 110.416 -172.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -110.81 -84.31 0.56 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.179 0.591 . . . . 0.0 109.77 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? 167.62 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.39 126.67 19.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.471 0.709 . . . . 0.0 109.976 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.07 51.12 0.26 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.797 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -129.81 150.13 51.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 384' ' ' THR . . . . . 0.524 HG23 ' HB3' ' A' ' 193' ' ' ARG . 6.4 m 68.94 -179.09 0.23 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.197 0.999 . . . . 0.0 108.89 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.5 mm? -73.37 120.83 19.52 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.11 -0.994 . . . . 0.0 108.617 168.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 13.5 m -64.37 98.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 125.168 1.542 . . . . 0.0 112.311 -164.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.632 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 5.8 pt -125.08 160.64 30.29 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.035 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.57 ' H ' HD11 ' A' ' 226' ' ' LEU . 54.5 t -55.44 150.54 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.755 0.422 . . . . 0.0 110.414 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 12.2 t -46.79 173.94 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 126.358 1.863 . . . . 0.0 113.709 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -51.89 175.6 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.747 1.219 . . . . 0.0 113.78 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -49.36 159.44 0.32 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.801 1.241 . . . . 0.0 112.639 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -51.2 -33.42 27.48 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.634 0.774 . . . . 0.0 110.837 175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -87.28 92.85 9.21 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 161.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -64.99 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.914 0.886 . . . . 0.0 113.034 -166.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -163.08 116.74 1.63 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.369 0.668 . . . . 0.0 110.382 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 60.0 m -68.84 150.45 47.8 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.519 0.728 . . . . 0.0 110.339 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 137.11 57.03 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.132 0.491 . . . . 0.0 111.32 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.419 HG12 ' N ' ' B' ' 399' ' ' VAL . 12.3 tt -169.76 170.58 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 C-N-CA 125.257 1.423 . . . . 0.0 107.72 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.419 ' N ' HG12 ' B' ' 398' ' ' ILE . 7.6 p -59.0 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.398 1.094 . . . . 0.0 109.152 167.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.716 ' H ' ' HD2' ' B' ' 401' ' ' PRO . . . -135.46 -47.9 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.368 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.716 ' HD2' ' H ' ' B' ' 400' ' ' ALA . 1.8 Cg_endo -44.35 -62.08 0.49 Allowed 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.229 2.619 . . . . 0.0 113.52 175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.78 -98.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.35 0.66 . . . . 0.0 109.703 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 14.5 t -164.56 -163.69 0.76 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 72.8 -70.0 0.17 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -133.71 71.01 75.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.764 0.826 . . . . 0.0 110.907 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -103.31 9.47 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.23 2.62 . . . . 0.0 112.835 169.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 81.47 171.25 45.14 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.514 0.509 . . . . 0.0 112.532 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.21 10.23 34.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.243 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 61.9 m -65.38 91.63 0.12 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.736 0.814 . . . . 0.0 109.71 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 64.82 175.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.227 1.411 . . . . 0.0 111.759 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -164.33 114.99 1.25 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' B' ' 415' ' ' LYS . 2.3 pt? -61.69 106.24 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -61.69 -57.73 10.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.779 0.832 . . . . 0.0 110.265 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 34.7 m -96.08 -69.32 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.242 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.482 ' HA ' HD12 ' B' ' 412' ' ' LEU . 60.1 tttm -172.27 135.79 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.552 0.741 . . . . 0.0 109.21 -176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.04 -62.83 1.57 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.242 0.617 . . . . 0.0 110.624 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -82.29 71.51 2.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.972 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -79.21 76.63 5.74 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.0 110.262 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 47.2 t 60.1 -82.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.735 1.614 . . . . 0.0 111.211 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 50.3 ttm -160.19 -25.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.841 0.856 . . . . 0.0 109.982 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 41.2 t 59.62 74.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.157 1.383 . . . . 0.0 110.094 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 25.5 ptm -71.59 107.23 4.36 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.343 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 33.9 p -156.74 167.7 29.67 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.019 0.927 . . . . 0.0 109.445 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -77.68 90.76 3.99 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -80.82 64.37 4.11 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.872 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -99.89 -11.16 20.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.915 0.886 . . . . 0.0 109.793 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 26.7 m -139.57 178.47 7.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.235 1.014 . . . . 0.0 109.787 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.56 -163.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.133 0.973 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.76 -65.24 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.155 0.582 . . . . 0.0 110.164 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.44 -80.48 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.3 m -108.71 -61.21 1.64 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.519 ' HG3' ' HG3' ' B' ' 433' ' ' GLU . 20.6 tp60 -112.63 -61.54 1.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.124 0.97 . . . . 0.0 108.473 168.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 433' ' ' GLU . . . . . 0.519 ' HG3' ' HG3' ' B' ' 432' ' ' GLN . 41.6 mt-10 -116.29 -161.28 0.79 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.727 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.19 130.48 42.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.108 0.563 . . . . 0.0 110.083 174.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.42 ' HB ' ' HG3' ' A' ' 321' ' ' ARG . 26.4 m 61.32 87.98 0.09 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.645 1.178 . . . . 0.0 110.972 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -116.83 -55.02 0.31 Allowed Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.348 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 41.6 m -78.93 69.31 5.07 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.781 0.833 . . . . 0.0 109.935 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -147.57 74.17 1.31 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.98 88.93 0.77 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.481 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -74.36 -45.16 48.78 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 -171.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 15.9 pt -137.37 174.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.306 0.642 . . . . 0.0 110.936 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -131.15 147.06 52.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.996 0.518 . . . . 0.0 111.831 -171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -165.63 126.53 1.88 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.613 0.765 . . . . 0.0 110.455 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -95.36 168.46 10.7 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 0.0 110.489 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 56.18 71.88 0.66 Allowed Glycine 0 C--N 1.35 1.343 0 O-C-N 124.263 0.977 . . . . 0.0 114.562 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.02 -27.43 8.43 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.831 2.354 . . . . 0.0 112.083 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -89.71 49.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.81 0.844 . . . . 0.0 109.571 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -130.92 135.57 47.79 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.567 0.747 . . . . 0.0 110.022 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.29 61.93 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.849 0.718 . . . . 0.0 110.325 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 450' ' ' ASN . . . . . 0.417 HD21 ' HB3' ' A' ' 396' ' ' ASP . 1.3 t30 67.6 -89.45 0.03 OUTLIER 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.718 1.607 . . . . 0.0 109.315 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 59.2 t 53.3 91.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.567 1.147 . . . . 0.0 111.579 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.483 HG21 ' HG2' ' A' ' 392' ' ' LYS . 42.4 t -58.85 104.99 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.333 1.053 . . . . 0.0 111.247 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -169.39 -143.87 4.04 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.337 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' B' ' 470' ' ' LEU . 80.4 mt 61.5 81.9 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.359 1.463 . . . . 0.0 112.196 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 4.7 t -100.3 70.05 1.5 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.834 0.854 . . . . 0.0 109.423 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -82.16 139.95 34.04 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.893 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -110.52 -25.27 10.11 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.237 1.015 . . . . 0.0 109.995 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 6.8 m -73.88 -55.79 5.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.424 0.69 . . . . 0.0 111.584 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -119.38 -88.39 0.62 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.767 -167.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 41.6 tp -108.38 111.01 22.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -67.27 -33.56 75.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.23 109.12 4.75 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 61.2 p -77.43 164.66 25.26 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.667 0.787 . . . . 0.0 111.066 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 35.4 mtm -125.15 -178.16 4.11 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.558 0.694 . . . . 0.0 111.696 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.482 ' HA ' HD23 ' B' ' 468' ' ' LEU . 49.6 mmtm -91.46 -175.25 4.16 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.019 171.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 65.68 -72.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.877 1.271 . . . . 0.0 109.217 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.698 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . -79.73 79.79 6.19 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' B' ' 465' ' ' LYS . 78.8 mt -65.39 90.54 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.367 1.067 . . . . 0.0 111.051 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -86.42 58.83 4.68 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.529 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.585 ' HB2' HD11 ' B' ' 454' ' ' LEU . 75.9 mt 75.57 -43.29 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.813 1.645 . . . . 0.0 112.55 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp . . . . . 0 CA--C 1.554 1.122 0 C-N-CA 124.401 1.081 . . . . 12.06 109.21 -179.374 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.522 0.201 . . . . 15.0 110.689 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.1 tt0 -142.71 118.41 10.46 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.909 -0.775 . . . . 15.0 108.909 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 17' ' ' ILE . 26.7 m -106.25 131.96 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.82 -0.437 . . . . 15.0 109.82 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -142.55 94.65 2.67 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.611 0.765 . . . . 15.0 109.217 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -77.2 95.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.184 0.992 . . . . 15.0 110.696 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 48.5 mt-10 -76.21 100.11 4.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.709 -1.132 . . . . 15.0 109.468 173.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -78.43 85.91 4.51 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 107.967 -1.123 . . . . 15.0 107.967 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -61.94 -44.43 96.79 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.685 -1.143 . . . . 15.0 110.749 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -169.36 97.41 0.33 Allowed 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.632 0.582 . . . . 15.0 109.925 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -98.44 0.35 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.747 0.654 . . . . 15.0 113.645 172.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.634 HD21 ' HG3' ' A' ' 113' ' ' PRO . 8.1 mp -69.83 -25.13 63.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.653 0.781 . . . . 15.0 111.311 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.63 79.53 0.69 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.573 0.546 . . . . 15.0 112.832 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HD2' HG11 ' A' ' 111' ' ' VAL . 92.8 mtt180 -99.81 89.99 4.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.6 ttm180 -75.89 95.77 3.59 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.004 -0.998 . . . . 15.0 109.677 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.57 87.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.9 m -82.62 109.74 17.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.813 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 3' ' ' VAL . 53.6 mt -110.58 116.56 52.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.912 -0.586 . . . . 15.0 109.729 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 67.6 m -87.39 105.25 17.14 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.866 -0.79 . . . . 15.0 108.866 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' LEU . 62.4 mt -74.37 126.2 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 147.77 51.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.911 0.485 . . . . 15.0 111.26 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.67 94.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 15.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.71 -30.21 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.116 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -69.13 -38.5 78.89 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.841 0.456 . . . . 15.0 110.369 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.23 -42.41 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -61.55 -42.82 99.4 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.914 0.886 . . . . 15.0 111.101 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -75.48 -35.39 60.84 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.71 62.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.891 0.477 . . . . 15.0 111.889 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.77 HG21 ' HD3' ' A' ' 63' ' ' ARG . 86.8 t -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.625 0.77 . . . . 15.0 109.916 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.0 -42.62 94.32 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.384 0.674 . . . . 15.0 111.304 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 65.7 m -69.34 -18.58 63.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.865 0.866 . . . . 15.0 110.638 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.9 tp10 -86.83 -33.05 19.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.071 0.548 . . . . 15.0 110.689 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.5 mt -74.68 -27.34 60.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.335 0.494 . . . . 15.0 112.335 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.51 -29.63 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -68.85 -48.98 62.11 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.0 t -60.74 -35.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.343 1.057 . . . . 15.0 111.294 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.49 -49.0 73.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.092 0.557 . . . . 15.0 110.609 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.57 -29.13 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.34 0.656 . . . . 15.0 112.171 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -80.35 -32.44 37.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.534 1.134 . . . . 15.0 111.15 -171.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.9 t -96.33 1.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.515 0.726 . . . . 15.0 109.621 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 70.06 12.61 7.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.609 1.564 . . . . 15.0 112.635 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 39' ' ' VAL . 69.8 mt -61.59 -24.11 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.154 0.982 . . . . 15.0 110.917 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 11.7 p-10 -65.39 -34.02 77.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.998 0.919 . . . . 15.0 111.614 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.03 -23.9 77.64 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.678 0.611 . . . . 15.0 112.207 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -93.82 -21.7 19.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.722 0.809 . . . . 15.0 110.68 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 48.1 ttt85 -75.89 130.67 38.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.36 1.064 . . . . 15.0 109.084 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.0 16.78 21.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.521 0.728 . . . . 15.0 111.53 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 45' ' ' ARG . . . 73.02 27.0 69.52 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 115.433 -0.803 . . . . 15.0 113.83 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -100.35 -38.89 8.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.355 0.662 . . . . 15.0 111.315 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.26 118.61 67.5 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-O 118.894 -0.574 . . . . 15.0 109.944 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.7 Cg_exo -64.24 147.78 91.12 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.068 2.512 . . . . 15.0 112.257 175.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.2 tpp -74.78 -29.37 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.361 0.664 . . . . 15.0 111.632 -172.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 29.9 p-10 -65.47 -36.72 84.72 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.833 0.453 . . . . 15.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.47 HD12 ' HD2' ' A' ' 50' ' ' PRO . 38.7 mt -61.49 -52.18 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.641 0.776 . . . . 15.0 110.519 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' HA ' ' CD1' ' A' ' 58' ' ' TYR . 28.8 m -72.38 -26.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -63.71 -53.83 45.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.216 0.606 . . . . 15.0 111.273 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.7 pt20 -83.66 -45.59 13.27 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.546 -0.752 . . . . 15.0 112.127 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -79.9 -63.04 1.5 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.489 0.316 . . . . 15.0 110.513 -171.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 3.6 m-85 -68.97 -38.8 79.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.542 0.737 . . . . 15.0 110.157 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.15 -2.04 86.56 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.576 -1.193 . . . . 15.0 113.965 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.19 -29.92 69.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.413 0.685 . . . . 15.0 111.573 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.0 p -80.13 -39.73 28.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.517 0.727 . . . . 15.0 110.65 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.07 -17.26 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 124.369 1.068 . . . . 15.0 111.711 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.77 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -48.14 -46.72 34.68 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.342 1.057 . . . . 15.0 111.467 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.64 -53.85 49.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.557 1.543 . . . . 15.0 112.26 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.84 -29.97 66.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.241 -0.89 . . . . 15.0 111.728 -171.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -74.2 -27.87 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.947 -0.57 . . . . 15.0 110.594 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.1 mt -57.77 -39.21 76.92 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.828 0.451 . . . . 15.0 111.151 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.85 -42.88 98.33 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.211 0.319 . . . . 15.0 112.794 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.15 -41.69 94.52 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.231 1.012 . . . . 15.0 111.056 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' HD13 ' A' ' 19' ' ' ILE . 86.3 mt -69.49 -40.19 77.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.694 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 75.2 mtm -67.18 -36.86 82.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.917 0.487 . . . . 15.0 111.033 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -63.38 -47.42 82.12 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.025 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.2 mtm105 -83.08 -51.11 7.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.983 -0.553 . . . . 15.0 112.204 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.81 -23.52 44.21 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 122.858 0.463 . . . . 15.0 111.655 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -72.12 -52.2 17.84 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.568 0.543 . . . . 15.0 111.229 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.469 ' HA ' HG12 ' A' ' 79' ' ' ILE . 12.2 tt -67.28 -39.34 82.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.141 0 CA-C-N 117.899 0.318 . . . . 15.0 110.956 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -59.21 -34.68 72.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.467 0.707 . . . . 15.0 111.181 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.94 -54.88 7.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.528 0.731 . . . . 15.0 111.146 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 76' ' ' ILE . 21.8 pt -68.32 -22.23 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.145 0.794 . . . . 15.0 113.145 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.38 -49.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.536 0.335 . . . . 15.0 110.454 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -72.14 -36.83 69.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.332 0.253 . . . . 15.0 111.293 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -76.72 -12.74 60.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.959 0.504 . . . . 15.0 111.542 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 61.13 29.78 19.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.766 1.226 . . . . 15.0 112.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -82.29 125.0 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.47 104.03 31.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.61 147.28 24.86 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.464 2.109 . . . . 15.0 112.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.18 178.44 10.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.74 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.81 -124.95 18.76 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.117 -0.947 . . . . 15.0 112.054 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.18 99.76 28.96 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.565 0.746 . . . . 15.0 110.188 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.5 Cg_endo -76.57 108.09 2.59 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.119 1.879 . . . . 15.0 110.528 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -102.75 100.64 10.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.634 -0.712 . . . . 15.0 109.963 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -85.95 80.87 8.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.453 0.701 . . . . 15.0 109.383 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.76 113.69 34.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.332 -0.849 . . . . 15.0 108.988 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.81 96.23 0.67 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.381 2.054 . . . . 15.0 110.459 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.542 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -51.28 -51.07 37.99 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.818 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -174.65 137.73 0.48 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.914 0.886 . . . . 15.0 110.668 172.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -106.34 135.46 47.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 38.3 mtpt -129.71 114.24 15.74 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.158 -1.423 . . . . 15.0 107.158 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.27 118.37 9.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.891 0.477 . . . . 15.0 109.716 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.25 39.08 Favored Glycine 0 N--CA 1.47 0.94 0 CA-C-N 115.985 -0.552 . . . . 15.0 112.659 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.3 mt-10 -112.34 -178.81 3.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.117 0.967 . . . . 15.0 109.652 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.28 151.22 46.51 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.706 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 19' ' ' ILE . 48.7 t80 -95.16 146.45 24.3 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.4 m -134.46 133.31 40.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.333 0.653 . . . . 15.0 109.574 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.542 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 13.7 p90 -138.34 171.15 14.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.925 0.89 . . . . 15.0 109.051 172.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.3 m -140.77 124.37 16.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.888 0.875 . . . . 15.0 109.349 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.19 104.3 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -102.04 114.93 29.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.949 0.9 . . . . 15.0 109.417 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 33.6 p90 -139.64 164.04 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.604 0.761 . . . . 15.0 110.619 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.86 113.72 20.67 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.364 -0.835 . . . . 15.0 109.705 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.595 HG11 ' HD2' ' A' ' 13' ' ' ARG . 12.1 m -89.43 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.671 -0.492 . . . . 15.0 109.671 171.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -89.33 126.37 58.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.674 . . . . 15.0 110.224 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.634 ' HG3' HD21 ' A' ' 11' ' ' LEU . 14.5 Cg_exo -69.39 145.29 58.86 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.441 2.094 . . . . 15.0 110.868 170.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.45 100.15 1.05 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.301 0.64 . . . . 15.0 109.351 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.37 123.8 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.724 0.773 . . . . 15.0 112.057 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.96 107.82 15.03 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.537 1.135 . . . . 15.0 108.705 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.95 131.5 45.19 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.645 0.591 . . . . 15.0 109.995 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -136.6 155.9 49.3 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.169 0.988 . . . . 15.0 109.586 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 60.65 20.77 56.94 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 124.442 1.089 . . . . 15.0 114.823 171.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.03 -39.46 94.81 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.368 0.667 . . . . 15.0 111.029 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.05 -20.31 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.239 0.615 . . . . 15.0 111.305 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.89 -15.92 42.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.63 0.772 . . . . 15.0 111.652 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.54 HG22 HG23 ' A' ' 125' ' ' VAL . 58.5 mt -65.11 124.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.158 0.583 . . . . 15.0 109.758 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.629 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.7 mt-10 -116.2 85.91 2.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.925 0.869 . . . . 15.0 109.948 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.8 t -83.03 164.78 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.51 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.7 141.23 49.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.744 0.817 . . . . 15.0 109.45 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -114.38 94.75 37.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.872 -1.159 . . . . 15.0 107.872 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.64 ' HG3' ' HD2' ' A' ' 285' ' ' ARG . 85.0 Cg_endo -78.16 103.49 1.7 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.984 1.789 . . . . 15.0 111.38 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -69.12 92.73 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.619 HG21 HD11 ' A' ' 427' ' ' LEU . 25.5 t -118.29 134.06 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.219 -0.901 . . . . 15.0 110.196 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.44 154.73 48.38 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 106.664 -1.606 . . . . 15.0 106.664 167.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 274' ' ' MET . 3.4 t -83.29 89.66 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.814 -1.18 . . . . 15.0 107.814 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.9 p -69.52 173.96 5.44 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.257 0.623 . . . . 15.0 109.79 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -55.26 -43.72 74.93 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.561 0.344 . . . . 15.0 111.474 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.41 -25.65 64.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.557 0.743 . . . . 15.0 111.929 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -78.81 -45.11 21.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.754 0.422 . . . . 15.0 110.675 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -56.06 -58.09 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.938 0.895 . . . . 15.0 109.129 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -61.69 -47.01 87.23 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.844 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.17 72.16 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.13 0.894 . . . . 15.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.8 ttt -69.54 -50.71 42.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.771 0.428 . . . . 15.0 111.151 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.18 -37.51 69.68 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.143 0.577 . . . . 15.0 112.067 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.413 ' HA ' ' HE ' ' A' ' 145' ' ' ARG . 17.1 t70 -67.75 -41.75 82.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.107 0.963 . . . . 15.0 109.929 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 82.7 m -58.95 -43.2 91.21 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.188 0.93 . . . . 15.0 110.574 173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' MET . 81.0 mt -61.3 -42.94 99.5 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.425 0.69 . . . . 15.0 111.076 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.42 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 69.3 mtm180 -63.57 -35.89 81.99 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.297 -0.865 . . . . 15.0 110.676 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 85.6 mttt -85.06 -5.33 59.35 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.37 0.668 . . . . 15.0 112.537 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 143' ' ' THR . 96.8 mt-30 -79.74 -44.62 20.39 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.914 -0.772 . . . . 15.0 108.914 163.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -97.59 37.94 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.367 0.667 . . . . 15.0 110.864 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -71.51 141.13 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.458 0.703 . . . . 15.0 112.092 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.1 m -82.18 127.02 32.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.379 1.072 . . . . 15.0 109.353 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -86.95 126.61 34.82 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.02 0.528 . . . . 15.0 110.269 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -148.52 122.58 9.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 15.0 110.032 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 43.5 mt-10 -75.57 143.78 42.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.01 0.524 . . . . 15.0 110.263 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.687 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 36.6 pttt -137.05 -179.3 5.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.706 0.802 . . . . 15.0 111.031 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -147.14 153.74 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.06 -51.81 0.79 Allowed Glycine 0 N--CA 1.467 0.707 0 CA-C-O 119.548 -0.584 . . . . 15.0 112.757 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -155.53 148.07 23.99 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 117.415 0.608 . . . . 15.0 111.158 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.405 HG22 HG13 ' A' ' 240' ' ' VAL . 21.9 t -98.83 153.01 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 107.902 -1.147 . . . . 15.0 107.902 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.07 -169.88 2.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.457 1.103 . . . . 15.0 109.711 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.51 96.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.397 1.079 . . . . 15.0 113.245 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.65 33.25 5.14 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.889 0.7 . . . . 15.0 112.889 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -87.84 -164.26 1.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 120.934 0.397 . . . . 15.0 111.795 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.777 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 18.7 mtm180 -122.88 160.44 26.1 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.027 -1.101 . . . . 15.0 108.027 161.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.404 HG12 HG23 ' A' ' 166' ' ' ILE . 2.8 t -144.62 116.92 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.685 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 15.2 m -95.63 116.46 28.88 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' LEU . 40.1 pt -130.13 168.77 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.752 0.821 . . . . 15.0 110.346 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -127.64 161.2 29.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.424 -1.325 . . . . 15.0 107.424 161.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.63 174.92 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.333 0.587 . . . . 15.0 111.385 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.649 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 6.6 t -158.62 131.64 7.24 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.658 -1.608 . . . . 15.0 106.658 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.48 -177.13 26.67 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.602 -0.808 . . . . 15.0 113.407 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 p -148.2 131.67 16.7 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.754 0.822 . . . . 15.0 109.306 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 226' ' ' LEU . 45.7 t -93.08 102.81 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 27.7 t70 77.7 -0.65 2.73 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 125.296 1.439 . . . . 15.0 111.047 -170.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.45 37.35 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 121.868 -0.52 . . . . 15.0 113.092 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.2 pt-20 -105.77 137.41 43.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.267 0.627 . . . . 15.0 109.353 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.18 95.16 5.54 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.659 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 172' ' ' VAL . 39.7 p90 -59.48 158.77 9.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.659 -1.155 . . . . 15.0 110.655 174.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -54.14 135.45 43.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 15.0 111.195 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' ' 386' ' ' VAL . . . 78.99 -70.49 2.75 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 123.985 0.803 . . . . 15.0 111.675 -170.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.61 -69.77 2.78 Favored Glycine 0 C--N 1.348 1.201 0 C-N-CA 123.212 0.434 . . . . 15.0 112.605 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.649 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 6.5 tmtt? -86.29 137.37 32.66 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.252 1.021 . . . . 15.0 110.185 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB2' HG12 ' B' ' 386' ' ' VAL . . . -127.89 155.52 44.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.887 0.875 . . . . 15.0 108.816 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 m -139.35 128.51 23.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 15.0 110.663 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 63.09 37.81 11.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.603 1.161 . . . . 15.0 112.255 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 44.6 t80 -71.22 136.06 47.84 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.39 -0.823 . . . . 15.0 108.915 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.5 t -107.16 119.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.008 0.923 . . . . 15.0 109.573 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 24.6 tp -112.66 93.64 4.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.986 0.914 . . . . 15.0 110.867 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.19 105.01 3.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.3 mmt -77.25 165.07 24.98 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 114.872 -1.058 . . . . 15.0 111.063 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.42 11.69 56.87 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.056 -0.974 . . . . 15.0 112.029 -170.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.14 143.84 22.73 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 125.125 1.37 . . . . 15.0 107.767 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -79.15 82.84 1.33 Allowed Glycine 0 C--N 1.344 0.978 0 O-C-N 123.148 0.28 . . . . 15.0 112.692 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.03 -19.95 26.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.966 0.506 . . . . 15.0 111.374 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.86 156.91 43.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.606 0.362 . . . . 15.0 110.69 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.04 140.85 98.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.761 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.89 105.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.217 2.612 . . . . 15.0 112.665 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.55 -49.44 0.66 Allowed Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.153 -0.931 . . . . 15.0 111.102 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' B' ' 385' ' ' LEU . 43.5 t80 -69.04 -64.65 0.83 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.488 0.315 . . . . 15.0 110.291 -176.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 203' ' ' LYS . 8.4 pt-20 -62.58 -27.6 69.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.108 0.88 . . . . 15.0 112.429 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.23 -30.58 67.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.957 0.903 . . . . 15.0 110.527 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.43 -5.66 85.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.167 -0.924 . . . . 15.0 112.98 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 33.6 mm -103.74 -47.97 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 123.429 0.692 . . . . 15.0 110.47 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 199' ' ' GLU . 22.6 pttm -85.4 16.5 3.7 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.782 1.03 . . . . 15.0 113.782 -169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -127.91 32.28 3.5 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.744 -0.942 . . . . 15.0 110.744 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -146.52 -167.83 2.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 15.0 110.473 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -151.86 161.67 42.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.598 0.759 . . . . 15.0 110.01 177.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.96 139.09 52.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.139 0.576 . . . . 15.0 111.892 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.54 8.63 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.501 -0.772 . . . . 15.0 112.429 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.8 pt-20 -92.45 137.63 32.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.496 0.719 . . . . 15.0 109.485 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.18 112.11 18.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.929 -1.137 . . . . 15.0 107.929 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -131.89 -178.31 4.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.788 1.235 . . . . 15.0 109.878 -171.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 43.3 m -131.11 120.35 23.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.775 0.83 . . . . 15.0 108.98 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.04 156.35 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.274 0.63 . . . . 15.0 110.514 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -116.18 105.28 12.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.095 0.958 . . . . 15.0 108.996 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.1 167.1 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 91.3 m -141.09 133.61 28.47 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.355 -0.98 . . . . 15.0 108.355 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.462 ' HZ ' HD12 ' B' ' 387' ' ' ILE . 49.0 m-85 -76.42 138.64 67.46 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 123.432 0.457 . . . . 15.0 111.837 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.8 158.35 11.03 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.695 2.93 . . . . 15.0 113.61 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.35 -31.01 63.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.67 -23.97 67.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.346 1.058 . . . . 15.0 111.657 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 227' ' ' LYS . 1.9 t80 -74.35 74.69 1.87 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.076 0.95 . . . . 15.0 109.052 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -67.8 4.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.049 1.5 . . . . 15.0 115.049 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.21 93.1 0.8 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.183 -1.414 . . . . 15.0 107.183 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.1 tt0 -64.08 -29.0 70.17 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.761 0.652 . . . . 15.0 112.761 -166.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -61.2 -22.57 64.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.835 0.854 . . . . 15.0 110.961 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 172' ' ' VAL . 76.4 mt -102.55 -43.37 5.65 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.72 1.208 . . . . 15.0 110.82 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 221' ' ' TYR . 0.7 OUTLIER -54.82 130.62 41.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.889 1.675 . . . . 15.0 112.759 -165.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.48 -18.91 7.69 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.832 0.708 . . . . 15.0 114.398 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 93.0 mttt -89.85 143.25 26.96 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.874 0.87 . . . . 15.0 110.562 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.0 106.88 11.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.552 0.741 . . . . 15.0 110.174 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.81 115.97 27.54 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.896 -1.047 . . . . 15.0 110.759 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -106.13 107.64 18.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.411 -0.588 . . . . 15.0 109.411 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -104.9 119.71 39.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.038 0.935 . . . . 15.0 109.121 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.51 93.74 4.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.326 0.65 . . . . 15.0 109.405 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.96 125.89 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 15.0 110.421 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -109.34 98.52 7.91 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.336 -1.357 . . . . 15.0 107.336 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.59 99.52 6.57 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 -175.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -93.43 -40.92 10.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.229 -0.442 . . . . 15.0 110.985 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 35.3 mmtp -131.89 139.36 48.75 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.051 0.54 . . . . 15.0 110.687 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 207' ' ' ALA . 86.0 t -104.03 141.93 18.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.112 -1.811 . . . . 15.0 106.112 159.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.2 mt-10 -133.1 -176.26 4.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.687 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 41.4 tt0 -154.36 130.64 10.43 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.551 0.741 . . . . 15.0 109.358 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 146' ' ' LYS . 23.4 ptt180 -86.24 86.03 7.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.19 0.995 . . . . 15.0 108.356 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.89 141.78 58.13 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.116 -1.402 . . . . 15.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.61 132.76 94.61 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.1 -0.704 . . . . 15.0 109.1 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 59.9 Cg_endo -67.83 176.52 5.12 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.468 2.112 . . . . 15.0 112.002 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.97 88.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.19 69.92 4.47 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.934 0.873 . . . . 15.0 109.006 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.9 p -101.83 163.89 12.02 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.591 1.156 . . . . 15.0 109.282 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.11 -41.27 48.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.98 0.912 . . . . 15.0 111.195 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.2 -39.46 86.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.179 1.392 . . . . 15.0 111.312 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.14 -59.9 2.59 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.897 . . . . 15.0 109.146 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 258' ' ' VAL . 9.5 tt -57.78 -42.0 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.954 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -67.71 -26.68 66.29 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.687 0.254 . . . . 15.0 111.687 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -72.79 -19.06 61.42 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.622 0.769 . . . . 15.0 110.949 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -87.63 -6.58 58.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.452 0.701 . . . . 15.0 111.322 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.5 5.1 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 119.428 -0.651 . . . . 15.0 114.721 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 261' ' ' GLY . 44.2 t -62.72 111.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 117.483 0.642 . . . . 15.0 110.902 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -58.78 -48.57 80.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.599 1.16 . . . . 15.0 112.001 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.663 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 5.3 t70 -76.69 -43.49 37.46 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.458 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 82.96 18.97 64.02 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 115.866 -0.606 . . . . 15.0 114.337 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -148.78 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.902 0.881 . . . . 15.0 109.602 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 95.7 t -50.4 -52.97 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 124.364 1.066 . . . . 15.0 113.457 -165.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -31.04 68.53 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.979 0.512 . . . . 15.0 111.549 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 260' ' ' ASP . . . -80.28 -24.08 59.84 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.145 -0.382 . . . . 15.0 112.145 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 270' ' ' VAL . 38.5 tp -77.67 -28.16 51.06 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.504 ' HA ' HG22 ' A' ' 270' ' ' VAL . 77.3 mtp180 -72.45 -37.6 68.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.956 0.902 . . . . 15.0 109.666 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.65 88.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.751 -0.659 . . . . 15.0 110.411 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.37 -48.7 55.11 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.328 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 274' ' ' MET . 19.2 m -67.4 -25.58 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-O 120.64 0.257 . . . . 15.0 110.634 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -60.01 -66.1 0.57 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.76 0.424 . . . . 15.0 110.48 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.28 -7.84 53.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.233 0.613 . . . . 15.0 112.61 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -101.22 -68.91 0.8 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.424 0.69 . . . . 15.0 109.965 170.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.564 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.6 mpt? -66.84 -43.79 82.77 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 117.698 -1.144 . . . . 15.0 111.694 -170.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.12 -49.63 71.44 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.441 1.473 . . . . 15.0 109.95 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -51.81 -49.16 63.32 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 113.509 -1.678 . . . . 15.0 111.989 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -84.35 -37.77 21.15 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.558 0.536 . . . . 15.0 111.348 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 130' ' ' VAL . 61.6 tp -67.16 -56.92 7.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.737 0.415 . . . . 15.0 111.894 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.78 -31.65 72.97 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.481 0.488 . . . . 15.0 110.194 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.9 t -64.86 -45.57 85.51 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.954 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.43 65.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 15.0 112.26 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 130' ' ' VAL . 98.6 mt -66.28 -51.43 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.802 HH21 ' HB3' ' A' ' 405' ' ' GLU . 28.8 tpt180 -62.14 -37.5 85.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.65 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.67 -23.77 45.5 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.388 0.675 . . . . 15.0 111.05 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.64 ' HD2' ' HG3' ' A' ' 128' ' ' PRO . 25.1 ttm180 -70.33 -49.31 50.71 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.577 0.626 . . . . 15.0 109.452 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 282' ' ' ILE . 98.6 t -57.56 -48.25 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.761 0.791 . . . . 15.0 110.008 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -64.21 -46.44 83.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.58 -1.191 . . . . 15.0 111.463 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -65.89 -39.21 90.44 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 119.256 -0.402 . . . . 15.0 110.935 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 125' ' ' VAL . 56.8 mt-30 -69.95 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.553 0.533 . . . . 15.0 111.172 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.21 -50.84 66.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.625 0.37 . . . . 15.0 110.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.9 mm -67.76 -41.17 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.796 0.839 . . . . 15.0 111.01 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 12.4 tp10 -64.43 -36.19 83.35 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.732 0.813 . . . . 15.0 109.474 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.54 -43.87 93.86 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.926 -1.034 . . . . 15.0 112.005 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.59 -45.49 81.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.108 0.963 . . . . 15.0 110.841 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.37 -58.67 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.051 0.94 . . . . 15.0 110.26 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.4 mttm -60.86 -23.47 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.641 0.776 . . . . 15.0 112.348 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -79.52 -33.65 41.86 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.547 0.739 . . . . 15.0 111.508 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.52 138.22 7.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 112.719 0.637 . . . . 15.0 112.719 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.08 144.48 29.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.167 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.48 HG12 HD22 ' A' ' 349' ' ' LEU . 6.5 tp -138.89 123.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . 7.6 m-20 -79.0 137.43 37.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.24 130.98 21.44 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.192 0.597 . . . . 15.0 109.449 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.88 130.03 32.74 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.029 2.486 . . . . 15.0 112.501 168.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.58 -9.67 20.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.759 1.022 . . . . 15.0 113.759 -173.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.22 91.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.244 0.618 . . . . 15.0 110.925 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.526 HD11 HD11 ' B' ' 468' ' ' LEU . 90.4 mt -72.31 -38.66 68.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 15.0 111.122 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.61 -52.13 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -38.57 89.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.832 0.853 . . . . 15.0 111.453 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.9 t -59.07 -50.57 73.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 15.0 111.226 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.91 -26.33 43.78 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.381 -0.372 . . . . 15.0 111.42 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.41 HG22 ' NE ' ' A' ' 315' ' ' ARG . 62.9 mt -62.29 -35.52 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 166.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.573 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.0 t70 -70.88 -39.36 72.89 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.97 0.508 . . . . 15.0 111.01 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.08 -48.07 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 123.792 0.683 . . . . 15.0 109.27 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 341' ' ' ALA . 83.2 mt -73.68 -21.3 60.3 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.117 -0.947 . . . . 15.0 113.237 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.573 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 72.1 mtm180 -75.23 -39.78 59.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.055 0.542 . . . . 15.0 109.806 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -70.38 -41.17 73.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.079 0.552 . . . . 15.0 110.499 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -69.31 -31.09 69.33 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.89 -51.45 55.26 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.161 -0.681 . . . . 15.0 109.161 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -56.12 -30.65 62.4 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.41 1.069 . . . . 15.0 112.27 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -60.37 -38.75 84.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.791 0.836 . . . . 15.0 111.502 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -95.44 -15.41 23.0 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.797 0.439 . . . . 15.0 111.525 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.509 ' HE2' ' HG2' ' A' ' 326' ' ' GLU . 42.1 t80 -80.17 -12.75 59.62 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.764 0.826 . . . . 15.0 109.489 173.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.1 33.45 8.17 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.385 -0.825 . . . . 15.0 114.431 166.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 327' ' ' LYS . . . 66.15 3.47 17.97 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 120.134 -0.259 . . . . 15.0 113.44 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -69.23 148.76 49.36 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 109.004 -0.739 . . . . 15.0 109.004 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.509 ' HG2' ' HE2' ' A' ' 322' ' ' PHE . 21.8 mm-40 75.48 -67.24 0.25 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.429 1.492 . . . . 15.0 110.566 -170.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 324' ' ' GLY . 27.3 mtmm 62.47 18.87 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.414 1.086 . . . . 15.0 110.639 -164.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -100.83 15.1 29.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.508 1.923 . . . . 15.0 108.954 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.608 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -52.73 -22.9 5.76 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 126.211 1.804 . . . . 15.0 114.271 -172.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.56 -26.62 55.62 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.275 0.63 . . . . 15.0 111.358 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -113.68 21.96 14.52 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.065 0.946 . . . . 15.0 111.055 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.608 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 24.2 mt -64.65 128.79 93.88 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.603 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 87.9 Cg_exo -47.7 118.29 2.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.664 2.909 . . . . 15.0 114.328 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -56.02 -36.55 68.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.091 0.957 . . . . 15.0 111.235 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.31 -12.05 47.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.468 0.914 . . . . 15.0 113.468 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 96.9 mt -71.76 -40.15 69.52 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.368 -0.604 . . . . 15.0 109.368 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -107.01 -10.77 15.83 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.271 -168.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -48.66 -57.75 5.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.147 1.379 . . . . 15.0 113.021 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.1 -59.21 4.95 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 111.397 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.01 -36.55 69.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.617 -0.72 . . . . 15.0 112.416 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -70.7 -50.79 32.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.547 . . . . 15.0 110.04 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.8 tttt -60.11 -34.94 74.19 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.03 0.832 . . . . 15.0 110.328 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.6 mmt85 -62.89 -38.1 89.56 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.003 -0.522 . . . . 15.0 111.26 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.73 -28.8 66.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 123.286 0.366 . . . . 15.0 110.853 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' B' ' 466' ' ' ALA . 24.9 t -75.48 -36.01 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.98 -0.378 . . . . 15.0 109.98 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -65.8 -35.03 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.561 0.744 . . . . 15.0 109.863 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 351' ' ' LEU . 55.4 t -60.47 -54.64 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.809 -0.811 . . . . 15.0 108.809 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.66 97.48 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.388 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 300' ' ' ILE . 6.5 tt -78.15 -55.32 5.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.046 0.538 . . . . 15.0 110.234 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 354' ' ' VAL . 72.3 mt -67.1 -49.27 65.53 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.039 0.212 . . . . 15.0 110.694 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 347' ' ' VAL . 64.9 mt -69.2 -28.26 66.22 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 119.334 -0.365 . . . . 15.0 111.055 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.2 -42.36 99.72 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.923 -0.471 . . . . 15.0 111.923 172.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.21 -39.14 93.35 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.238 -0.481 . . . . 15.0 110.58 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -59.57 -37.04 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 122.888 0.475 . . . . 15.0 111.041 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.572 HD12 ' HA2' ' A' ' 352' ' ' GLY . 75.9 mt -65.2 -46.85 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.744 0.818 . . . . 15.0 110.543 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.95 -53.25 41.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.525 0.203 . . . . 15.0 110.908 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.0 m -60.27 -40.72 91.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.588 1.155 . . . . 15.0 112.053 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.39 17.98 18.86 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.174 0.589 . . . . 15.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 46.33 30.02 0.96 Allowed 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 125.703 1.601 . . . . 15.0 114.626 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.72 148.28 52.02 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.072 0.949 . . . . 15.0 112.811 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -129.31 158.09 40.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.522 1.129 . . . . 15.0 108.83 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.67 90.33 2.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 367' ' ' VAL . 5.2 t70 -67.73 120.93 14.88 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.11 0.964 . . . . 15.0 110.758 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.26 -23.67 67.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.826 0.85 . . . . 15.0 113.0 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.61 -34.11 73.62 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 30.9 tpt85 -77.82 -36.81 49.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.725 0.81 . . . . 15.0 109.951 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.3 t -63.99 -55.01 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.617 0.767 . . . . 15.0 109.746 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -36.18 81.59 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.813 -1.085 . . . . 15.0 109.778 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.95 96.75 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.787 0.679 . . . . 15.0 112.711 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 367' ' ' VAL . 69.3 mt -57.44 -48.15 79.9 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.636 0.774 . . . . 15.0 111.07 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.632 HG21 ' HA ' ' A' ' 385' ' ' ILE . 17.8 mm -56.35 -44.69 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 124.183 0.927 . . . . 15.0 110.81 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -61.57 -54.46 42.77 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 15.0 110.782 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -61.6 -37.7 84.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.499 0.72 . . . . 15.0 112.769 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.485 ' SD ' HD12 ' B' ' 441' ' ' ILE . 18.2 tmm? -74.76 -45.76 41.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.423 0.689 . . . . 15.0 109.931 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -73.28 -16.83 61.38 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.184 0.594 . . . . 15.0 111.959 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -73.1 -0.18 13.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.991 0.917 . . . . 15.0 111.692 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -98.54 -10.11 23.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.583 0.753 . . . . 15.0 111.268 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.497 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 79.1 m-85 -111.31 157.56 20.03 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.108 0.963 . . . . 15.0 109.604 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.0 -45.06 71.51 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.211 0.604 . . . . 15.0 110.834 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.88 100.71 17.5 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 124.596 1.158 . . . . 15.0 110.26 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.9 -41.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.605 2.204 . . . . 15.0 115.794 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -68.92 -28.97 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -163.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.32 -28.69 67.38 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.344 0.403 . . . . 15.0 110.095 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.74 -38.81 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.556 0.742 . . . . 15.0 109.261 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.632 ' HA ' HG21 ' A' ' 371' ' ' ILE . 1.8 mp -55.55 -48.56 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.493 -0.558 . . . . 15.0 109.493 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.74 -34.01 76.0 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.591 0.756 . . . . 15.0 111.668 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -64.35 -40.04 95.08 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.794 0.838 . . . . 15.0 110.961 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.509 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 29.9 m-85 -79.0 -50.51 10.98 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.916 0.135 . . . . 15.0 111.014 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . 0.58 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -169.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.02 0.07 54.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.184 0.594 . . . . 15.0 112.052 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -113.52 118.84 35.58 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -63.84 -61.47 2.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.434 0.693 . . . . 15.0 112.164 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.59 ' HA ' HD22 ' B' ' 450' ' ' ASN . 5.0 mp0 -59.98 -30.66 69.26 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.426 0.69 . . . . 15.0 112.173 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' B' ' 442' ' ' ALA . 42.0 tp -84.16 -38.9 20.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.984 0.513 . . . . 15.0 111.441 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -62.13 -48.26 80.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 175.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.56 ' HA ' ' HD2' ' A' ' 399' ' ' ARG . 13.2 t70 -62.95 -39.7 95.44 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.575 1.172 . . . . 15.0 110.826 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 401' ' ' VAL . 9.5 t30 -59.8 -40.64 89.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.245 0.545 . . . . 15.0 110.391 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 -16.75 56.96 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.301 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.56 ' HD2' ' HA ' ' A' ' 396' ' ' ASP . 97.9 mtt180 -71.81 -36.25 70.19 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 15.0 109.429 167.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -64.2 -42.27 96.7 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.525 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 397' ' ' ASN . 24.9 t -62.48 -42.36 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 123.851 0.719 . . . . 15.0 110.867 175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.51 85.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.491 0.716 . . . . 15.0 111.188 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.33 -35.17 71.12 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.465 -1.243 . . . . 15.0 111.001 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.04 -54.49 45.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.292 1.037 . . . . 15.0 110.327 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.802 ' HB3' HH21 ' A' ' 283' ' ' ARG . 47.8 mt-10 -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.384 -0.826 . . . . 15.0 111.92 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -67.47 -37.58 83.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.21 0.604 . . . . 15.0 109.857 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.6 78.58 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.474 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.22 -56.13 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.86 -25.52 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.429 1.092 . . . . 15.0 112.409 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.13 66.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.038 0.535 . . . . 15.0 111.233 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.49 -34.81 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.911 -0.774 . . . . 15.0 108.911 172.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 80.9 mt -70.06 -31.08 68.52 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.458 0.703 . . . . 15.0 111.502 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.7 0.8 . . . . 15.0 110.812 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -86.41 -34.17 20.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.739 0.816 . . . . 15.0 109.881 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -86.34 -171.81 3.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.73 1.212 . . . . 15.0 112.126 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.629 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 79.0 mttt -114.9 117.47 30.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.911 -1.041 . . . . 15.0 108.696 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.53 101.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 109.19 -0.67 . . . . 15.0 109.19 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 t -71.32 89.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.132 0.968 . . . . 15.0 109.466 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.52 110.02 8.48 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.286 -1.325 . . . . 15.0 109.566 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -133.99 137.88 45.06 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 15.0 110.157 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.05 131.41 39.47 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.384 0.674 . . . . 15.0 109.233 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.2 t -158.76 170.66 21.64 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.214 0.605 . . . . 15.0 110.372 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.6 p -90.68 176.98 6.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.471 0.709 . . . . 15.0 112.313 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -63.7 -23.91 67.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.777 1.231 . . . . 15.0 110.935 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -66.93 -17.78 65.07 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.64 1.176 . . . . 15.0 112.301 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.512 ' HB3' HD12 ' A' ' 427' ' ' LEU . 13.2 tp10 -63.83 -36.15 82.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.029 0.932 . . . . 15.0 111.38 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 130' ' ' VAL . 3.1 mp -104.16 -69.58 0.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.87 0.468 . . . . 15.0 111.476 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.528 ' SD ' ' HB2' ' A' ' 427' ' ' LEU . 1.6 mpt? -92.54 -50.19 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.054 0.39 . . . . 15.0 112.054 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -88.71 49.69 1.83 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.842 0.829 . . . . 15.0 110.997 -165.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -71.35 168.28 17.73 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.61 1.164 . . . . 15.0 111.405 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' B' ' 402' ' ' ASP . 36.0 mt-30 -79.57 -13.43 59.53 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.653 175.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 C-N-CA 124.742 1.217 . . . . 15.0 108.681 175.692 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -118.26 -168.8 1.59 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.93 0.892 . . . . 0.0 109.585 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.16 -73.4 0.59 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.053 0.541 . . . . 0.0 110.086 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -103.95 -82.87 0.5 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 120.964 0.411 . . . . 0.0 111.75 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -109.33 -69.67 0.85 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.888 0.875 . . . . 0.0 112.522 -168.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.53 -79.59 0.42 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.462 HG13 ' H ' ' B' ' 372' ' ' GLN . 1.2 p -113.02 -82.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.462 ' H ' HG13 ' B' ' 371' ' ' VAL . 6.6 tp60 -100.17 -82.51 0.45 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -105.25 -82.88 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.861 0.464 . . . . 0.0 109.756 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -101.37 -71.93 0.7 Allowed 'General case' 0 C--N 1.351 0.632 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.403 HD22 ' HG3' ' B' ' 376' ' ' GLU . 6.6 tt -107.27 -75.92 0.62 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' B' ' 377' ' ' PHE . 0.0 OUTLIER -103.64 -89.27 0.4 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.15 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.428 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 89.0 t80 -102.37 -62.88 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.377 1.071 . . . . 0.0 109.851 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.13 -83.57 0.48 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.564 ' HG2' ' H ' ' B' ' 380' ' ' LYS . 0.0 OUTLIER -110.76 -66.81 1.04 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.916 0.487 . . . . 0.0 111.327 -172.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.564 ' H ' ' HG2' ' B' ' 379' ' ' LYS . 2.0 ptpp? -160.11 132.23 6.26 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.676 1.19 . . . . 0.0 109.127 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 381' ' ' GLU . . . . . 0.49 ' HB2' ' ND2' ' B' ' 383' ' ' ASN . 36.1 mt-10 67.88 156.43 0.12 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.817 1.247 . . . . 0.0 113.515 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -75.51 69.48 2.03 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.821 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 383' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' B' ' 381' ' ' GLU . 44.2 m-80 -86.14 -157.58 0.35 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.797 0.839 . . . . 0.0 111.041 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 384' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' B' ' 383' ' ' ASN . 11.4 m 72.1 60.27 0.14 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.75 1.22 . . . . 0.0 109.169 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 198' ' ' PHE . 5.4 tt -67.38 131.32 45.48 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.005 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.623 HG21 ' HA3' ' A' ' 179' ' ' GLY . 7.5 p -77.88 91.74 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.69 1.233 . . . . 0.0 110.995 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.462 HD12 ' HZ ' ' A' ' 217' ' ' PHE . 8.3 mm -150.98 141.71 16.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 127.805 2.442 . . . . 0.0 104.484 162.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.26 93.99 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 119.099 0.863 . . . . 0.0 110.266 -164.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 42.0 m -177.91 95.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.415 2.686 . . . . 0.0 105.399 166.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -91.24 84.38 5.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.784 0.72 . . . . 0.0 111.033 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 25.5 t70 169.22 110.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 126.447 1.899 . . . . 0.0 108.404 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -154.01 82.36 1.14 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.42 0.688 . . . . 0.0 110.264 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.1 116.72 1.0 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.742 0.817 . . . . 0.0 110.04 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -115.31 -82.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.616 0.767 . . . . 0.0 109.407 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 178.38 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.556 1.143 . . . . 0.0 109.049 -173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 25.6 m -141.53 116.7 10.01 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -126.32 166.08 17.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.539 1.136 . . . . 0.0 108.736 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 21.4 mt 62.63 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.167 0.984 . . . . 0.0 110.694 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.28 -30.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.395 0.678 . . . . 0.0 110.284 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -137.72 137.44 21.74 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 166.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.35 158.87 38.19 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.881 2.387 . . . . 0.0 113.191 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 402' ' ' ASP . . . . . 0.4 ' H ' ' NE2' ' A' ' 431' ' ' GLN . 9.8 t70 -64.38 150.69 45.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.165 0.986 . . . . 0.0 110.566 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 2.8 m -130.82 17.26 5.2 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.399 0.679 . . . . 0.0 110.99 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.627 ' HD3' ' HA3' ' B' ' 407' ' ' GLY . 64.1 tttp -155.05 -59.85 0.11 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.865 -0.522 . . . . 0.0 111.675 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . 0.31 . . 100.69 -66.4 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.206 0 C-N-CA 127.965 2.506 . . . . 0.0 113.489 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.99 38.93 0.69 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 CA-C-N 122.646 1.981 . . . . 0.0 111.989 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 407' ' ' GLY . . . . . 0.627 ' HA3' ' HD3' ' B' ' 404' ' ' LYS . . . -118.21 32.45 5.26 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.883 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.91 112.34 11.04 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.6 m -65.14 86.83 0.06 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.909 0.884 . . . . 0.0 110.065 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 64.0 -174.32 0.16 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.942 -176.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -145.78 -40.75 0.22 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.443 0.697 . . . . 0.0 110.16 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 54.8 tp 70.93 -75.35 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.203 1.401 . . . . 0.0 111.2 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -163.06 -167.57 1.52 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.153 0.981 . . . . 0.0 109.922 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 59.7 m -133.31 102.89 5.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -157.36 137.95 13.05 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.06 -37.64 84.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.444 0.698 . . . . 0.0 111.285 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -87.48 -11.55 68.67 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.212 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 66.27 -70.45 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.449 1.5 . . . . 0.0 111.737 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.8 98.94 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.237 1.015 . . . . 0.0 108.728 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.441 ' HG3' HG12 ' B' ' 421' ' ' VAL . 50.7 tpp 65.25 -85.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 420' ' ' MET . 10.4 p -168.75 140.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.12 0.968 . . . . 0.0 108.914 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 13.3 tpt -159.43 75.99 0.67 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 35.0 t -88.22 -51.27 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.844 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.07 155.12 46.2 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.533 1.133 . . . . 0.0 109.635 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -164.27 58.49 0.27 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -93.52 167.01 11.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.577 0.751 . . . . 0.0 110.652 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 63.3 m -73.87 108.62 6.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 110.323 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.42 -59.25 2.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.249 0.619 . . . . 0.0 111.034 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.69 ' HG2' ' H ' ' B' ' 430' ' ' ASP . 0.7 OUTLIER -107.43 -79.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.913 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 430' ' ' ASP . . . . . 0.69 ' H ' ' HG2' ' B' ' 429' ' ' GLU . 21.0 t70 -88.1 -82.37 0.23 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 170.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 9.6 t -112.08 -82.41 0.59 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 154.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -114.82 -40.29 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.704 0.802 . . . . 0.0 109.211 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.88 -35.36 0.22 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.177 0.991 . . . . 0.0 109.589 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -141.92 162.62 35.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 24.6 p -54.79 -44.2 73.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.538 0.735 . . . . 0.0 112.082 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 148.49 -136.43 5.9 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 19.5 m -84.45 22.06 1.34 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.737 0.815 . . . . 0.0 111.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? 82.36 -53.97 0.22 Allowed 'General case' 0 C--N 1.367 1.334 0 C-N-CA 126.504 1.922 . . . . 0.0 111.257 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.44 135.19 55.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.892 0.477 . . . . 0.0 111.339 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -60.0 -63.03 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.574 1.15 . . . . 0.0 111.881 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.485 HD12 ' SD ' ' A' ' 374' ' ' MET . 0.0 OUTLIER -145.42 137.08 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -172.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 442' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 394' ' ' LEU . . . -169.34 177.77 4.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.539 1.136 . . . . 0.0 110.702 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -92.26 -66.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.045 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -110.83 -177.56 3.25 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.646 0.778 . . . . 0.0 110.993 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.31 128.43 3.68 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.59 -1.116 . . . . 0.0 110.475 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.8 123.59 13.29 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.009 2.472 . . . . 0.0 112.246 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -74.3 -15.91 60.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.219 0.608 . . . . 0.0 111.319 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.24 51.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 0.0 108.983 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -65.42 125.27 24.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 450' ' ' ASN . . . . . 0.59 HD22 ' HA ' ' A' ' 393' ' ' GLU . 74.5 m-20 -72.36 -44.1 63.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.322 0.649 . . . . 0.0 110.578 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 75.9 t 66.22 -71.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 124.735 1.214 . . . . 0.0 111.981 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.48 126.5 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -70.75 76.63 0.53 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 48.9 tp -70.36 92.5 0.8 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.661 1.184 . . . . 0.0 110.111 -170.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.0 m -84.82 84.97 7.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.784 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.96 -74.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 457' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' B' ' 463' ' ' THR . 10.8 mm100 54.67 22.8 4.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.614 1.566 . . . . 0.0 113.058 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.8 m 70.08 -65.2 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.683 1.593 . . . . 0.0 110.366 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.05 156.55 46.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.767 1.227 . . . . 0.0 108.124 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 3.5 tt 66.53 99.38 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -170.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -45.89 -53.1 10.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.564 1.146 . . . . 0.0 113.142 -169.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -131.87 115.07 15.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' B' ' 457' ' ' GLN . 88.3 m -68.83 104.99 2.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 124.163 0.914 . . . . 0.0 109.759 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -83.08 177.44 8.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.813 0.445 . . . . 0.0 110.062 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.69 150.08 37.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.127 0.571 . . . . 0.0 109.507 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 466' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 345' ' ' VAL . . . 68.02 8.01 6.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.05 1.34 . . . . 0.0 112.565 -171.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -122.78 168.51 12.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.969 0.908 . . . . 0.0 110.667 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 306' ' ' LEU . 2.6 mm? -111.34 163.41 14.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.687 0.795 . . . . 0.0 110.974 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.24 -134.93 4.39 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.262 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 41.5 tp 52.38 -98.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.217 1.007 . . . . 0.0 109.49 -170.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.687 1.195 . . . . 12.06 108.079 176.067 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.665 0.269 . . . . 15.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -158.31 149.61 21.01 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.753 1.221 . . . . 15.0 109.054 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 17' ' ' ILE . 13.5 m -133.68 77.96 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.838 0.855 . . . . 15.0 110.537 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -78.95 91.01 4.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 15.0 110.497 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 2.6 p -80.51 93.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 122.2 1.0 . . . . 15.0 111.433 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.94 98.2 7.79 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.501 1.12 . . . . 15.0 109.989 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -64.55 112.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.102 0.561 . . . . 15.0 109.962 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -76.32 -54.74 6.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -167.43 120.16 0.93 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 15.0 109.671 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.55 -101.6 0.47 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 124.157 0.91 . . . . 15.0 113.551 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' A' ' 113' ' ' PRO . 1.8 mm? -90.54 -22.08 21.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.175 0.59 . . . . 15.0 110.884 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.46 122.8 30.31 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.359 1.037 . . . . 15.0 112.223 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.471 HH12 ' HA ' ' A' ' 11' ' ' LEU . 68.7 mtt85 -140.86 108.16 5.52 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.751 1.22 . . . . 15.0 109.892 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 31.0 ttm180 -83.94 82.95 8.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.564 1.146 . . . . 15.0 109.131 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 t -76.49 88.46 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 61.6 m -75.94 96.62 3.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.273 -0.876 . . . . 15.0 109.633 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 3' ' ' VAL . 54.1 mt -84.21 106.07 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.555 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 35.9 m -83.72 100.6 10.99 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 70' ' ' LEU . 39.0 mt -77.01 130.85 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 140.54 58.88 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 123.92 0.763 . . . . 15.0 110.517 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.12 63.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.979 1.312 . . . . 15.0 112.208 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -38.65 78.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.114 -0.948 . . . . 15.0 111.285 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.4 m -68.62 -30.92 69.76 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.406 0.682 . . . . 15.0 111.158 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 103' ' ' PHE . 78.8 mt -65.25 -54.08 33.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 CA-C-N 115.496 -0.774 . . . . 15.0 109.087 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -59.22 -29.45 67.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.192 0.997 . . . . 15.0 111.841 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.7 m -74.8 -52.76 10.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.768 0.827 . . . . 15.0 110.317 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.06 85.04 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.395 0.678 . . . . 15.0 112.287 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 63' ' ' ARG . 58.6 t -67.59 -45.36 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.09 0.556 . . . . 15.0 109.868 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.9 -31.45 72.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.178 0.591 . . . . 15.0 111.32 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -63.35 -44.51 94.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.437 0.695 . . . . 15.0 109.78 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 35' ' ' VAL . 14.4 tp10 -63.81 -42.36 97.71 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.434 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 55' ' ' ALA . 79.6 mt -66.77 -39.23 87.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.909 0.884 . . . . 15.0 112.891 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.44 -28.07 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -71.72 -34.16 69.35 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 118.994 -0.527 . . . . 15.0 111.074 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 31' ' ' GLU . 77.2 t -60.68 -35.46 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.259 0.624 . . . . 15.0 110.163 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.05 -49.08 78.14 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.449 -0.796 . . . . 15.0 110.721 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -69.56 -42.95 73.88 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.895 0.878 . . . . 15.0 110.779 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.81 -34.43 66.87 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.743 1.617 . . . . 15.0 111.286 -169.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.54 10.87 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-O 121.338 0.59 . . . . 15.0 109.794 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 59.26 23.37 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.821 1.248 . . . . 15.0 112.796 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 60.0 mt -72.99 -22.92 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.416 1.086 . . . . 15.0 109.862 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 8.2 p-10 -58.08 -29.56 65.52 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.556 1.142 . . . . 15.0 112.758 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.49 -41.37 94.28 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.588 -0.605 . . . . 15.0 111.588 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -79.13 -24.29 43.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.964 0.906 . . . . 15.0 110.169 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 28.3 tpt180 -79.97 90.13 5.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.232 1.013 . . . . 15.0 109.335 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -92.62 -7.44 46.98 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.832 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 49.44 3.29 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.6 0.563 . . . . 15.0 112.503 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -77.27 -58.56 3.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.197 0.599 . . . . 15.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.61 122.66 70.36 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.712 -0.847 . . . . 15.0 108.712 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.1 148.28 7.14 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.844 3.029 . . . . 15.0 114.488 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.7 tpp -64.52 -34.51 78.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.369 1.068 . . . . 15.0 112.118 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.35 -37.36 86.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.715 0.406 . . . . 15.0 111.1 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.25 -42.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.985 0.914 . . . . 15.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 19.5 m -71.61 -21.18 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 122.342 -0.224 . . . . 15.0 110.871 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -76.9 -46.65 23.66 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.187 0.595 . . . . 15.0 111.801 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.743 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.5 pt20 -81.63 -30.1 32.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.517 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 75.2 mtt180 -103.1 -60.78 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.062 0.545 . . . . 15.0 110.9 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.556 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 68.5 m-85 -76.95 -19.43 57.36 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 15.0 111.142 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -100.89 9.18 58.18 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.247 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.02 -30.07 69.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.542 0.737 . . . . 15.0 111.088 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.9 p -81.39 -33.19 32.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.76 0.824 . . . . 15.0 110.866 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.06 -16.26 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.068 0.947 . . . . 15.0 111.279 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HD3' HG21 ' A' ' 28' ' ' VAL . 19.8 mmt180 -48.2 -42.33 29.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.277 1.031 . . . . 15.0 111.442 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -52.03 -54.23 32.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.975 1.31 . . . . 15.0 112.185 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.04 -24.61 58.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.86 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 28' ' ' VAL . 44.0 t -79.23 -23.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 122.546 0.338 . . . . 15.0 110.234 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 HD12 ' A' ' 70' ' ' LEU . 66.1 mt -57.69 -29.59 64.79 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.35 -0.357 . . . . 15.0 111.66 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.82 -38.66 95.65 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 117.844 0.293 . . . . 15.0 112.935 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 29.8 t70 -74.49 -36.44 63.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.771 0.828 . . . . 15.0 109.972 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.524 HD12 HD23 ' A' ' 67' ' ' LEU . 96.4 mt -73.24 -19.28 61.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.003 -0.999 . . . . 15.0 111.917 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 76.7 mtm -104.81 -66.35 0.97 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.762 0.425 . . . . 15.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.3 t -70.83 -35.56 72.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.48 0.712 . . . . 15.0 112.503 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 76' ' ' ILE . 4.9 tmm_? -87.76 -43.67 11.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -58.99 -25.55 63.72 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.467 0.576 . . . . 15.0 111.606 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -54.81 -50.73 67.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.098 0.959 . . . . 15.0 111.73 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 73' ' ' ARG . 13.2 tt -69.32 -37.34 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 110.11 -0.33 . . . . 15.0 110.11 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 -23.38 67.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.321 0.649 . . . . 15.0 111.729 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -83.52 -42.19 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.873 0.869 . . . . 15.0 111.677 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.558 HD12 ' HD3' ' A' ' 86' ' ' PRO . 28.2 pt -85.28 -30.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.203 0.816 . . . . 15.0 113.203 -169.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.26 -50.17 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.4 0.68 . . . . 15.0 111.042 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.9 ptpt -60.79 -39.65 89.66 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.705 0.628 . . . . 15.0 111.486 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 24.5 mm-40 -87.85 5.63 39.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.384 0.673 . . . . 15.0 111.706 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.62 17.81 11.09 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.068 1.347 . . . . 15.0 112.281 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.63 112.87 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.192 0.997 . . . . 15.0 109.939 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -101.2 114.75 65.75 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.361 -0.977 . . . . 15.0 108.361 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.558 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.1 Cg_endo -74.11 153.07 46.31 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.838 2.359 . . . . 15.0 112.989 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.72 18.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.804 1.242 . . . . 15.0 108.318 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 94.48 -151.71 20.28 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.731 -0.548 . . . . 15.0 111.731 -174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.99 128.66 27.23 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.552 0.741 . . . . 15.0 110.678 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.0 Cg_endo -81.83 107.3 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.383 2.055 . . . . 15.0 111.626 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.5 m -76.96 96.09 4.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.607 0.763 . . . . 15.0 110.824 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -74.1 94.49 2.42 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.081 -0.711 . . . . 15.0 109.081 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.8 t -90.96 102.15 4.95 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.949 -0.76 . . . . 15.0 108.949 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.52 95.74 0.86 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.648 2.232 . . . . 15.0 109.995 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -46.45 93.49 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.172 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.49 146.14 4.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.557 0.743 . . . . 15.0 110.745 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -128.49 142.7 51.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.548 1.139 . . . . 15.0 108.41 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 95.0 mttt -129.83 158.61 38.97 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.235 1.014 . . . . 15.0 108.619 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.07 98.44 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.591 0.756 . . . . 15.0 110.235 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.51 19.02 74.22 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.599 -0.728 . . . . 15.0 114.39 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.743 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.1 mt-10 -110.67 158.86 18.14 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.467 0.707 . . . . 15.0 110.421 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.25 107.13 0.13 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.171 1.544 . . . . 15.0 112.896 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.482 ' H ' HD11 ' A' ' 24' ' ' ILE . 13.3 t80 -80.42 96.28 6.67 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.488 -0.778 . . . . 15.0 109.539 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.0 m -95.14 105.54 17.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.106 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -129.92 143.75 50.97 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.341 0.657 . . . . 15.0 109.905 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.1 m -99.47 105.59 17.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.7 1.2 . . . . 15.0 111.672 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 t -86.01 99.93 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.927 0.491 . . . . 15.0 109.724 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.65 106.02 18.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.419 0.688 . . . . 15.0 110.26 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.657 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.7 p90 -142.06 174.21 10.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.962 0.905 . . . . 15.0 109.233 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -116.61 164.82 14.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.779 0.831 . . . . 15.0 109.934 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.66 -177.52 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.988 0.915 . . . . 15.0 109.152 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -72.83 143.79 84.83 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.029 0.532 . . . . 15.0 110.211 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 11' ' ' LEU . 23.9 Cg_endo -89.4 -167.95 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.426 2.751 . . . . 15.0 114.946 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -88.66 155.37 19.64 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.581 -1.19 . . . . 15.0 109.433 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 123.02 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.16 0.584 . . . . 15.0 110.096 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -119.94 119.36 33.23 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.66 146.77 28.9 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.79 -0.818 . . . . 15.0 108.79 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -88.67 -171.24 3.24 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.377 0.271 . . . . 15.0 110.495 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.9 102.43 0.28 Allowed Glycine 0 C--N 1.351 1.405 0 O-C-N 123.962 0.789 . . . . 15.0 111.726 173.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.38 -23.91 67.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.963 0.905 . . . . 15.0 110.386 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.97 -24.52 66.06 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.86 1.264 . . . . 15.0 111.256 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.58 61.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.348 0.659 . . . . 15.0 110.929 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.6 mt -65.48 120.28 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.065 0.853 . . . . 15.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.29 102.89 13.32 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.606 0.762 . . . . 15.0 109.245 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.44 162.65 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.908 1.283 . . . . 15.0 107.802 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -113.69 148.69 35.92 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HE2' HD11 ' A' ' 129' ' ' ILE . 84.0 tttt -127.65 89.8 49.97 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.904 0.882 . . . . 15.0 108.753 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.36 102.66 1.63 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.218 1.945 . . . . 15.0 111.738 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.543 HD11 ' HE2' ' A' ' 127' ' ' LYS . 47.3 mm -73.02 106.35 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 169.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 427' ' ' LEU . 15.3 t -132.24 147.27 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.779 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.47 157.37 46.32 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.777 1.231 . . . . 15.0 107.894 166.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.46 87.75 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 107.454 -1.313 . . . . 15.0 107.454 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 137' ' ' VAL . 28.7 p -65.56 175.51 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.72 0.808 . . . . 15.0 110.147 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.93 -36.97 78.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.042 0.448 . . . . 15.0 110.863 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.51 91.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.831 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 71.7 m-20 -74.98 -42.61 57.22 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.451 0.701 . . . . 15.0 111.717 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 133' ' ' THR . 89.6 t -62.62 -57.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.29 -31.12 62.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.206 -0.907 . . . . 15.0 111.058 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.79 -36.38 57.93 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.518 0.511 . . . . 15.0 113.033 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -71.5 -45.1 63.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.935 0.494 . . . . 15.0 109.683 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.83 -36.12 67.13 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.477 0.711 . . . . 15.0 111.676 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.95 -45.17 86.85 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.325 1.05 . . . . 15.0 110.144 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.1 m -58.92 -46.85 86.95 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.254 0.971 . . . . 15.0 110.094 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.97 -40.21 94.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.975 0.91 . . . . 15.0 111.562 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -66.88 -36.8 83.13 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.533 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 83.4 mttt -83.63 -16.82 43.73 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -80.92 -40.62 24.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -96.6 25.34 5.21 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.656 0.783 . . . . 15.0 110.535 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.15 149.37 41.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.522 0.729 . . . . 15.0 112.336 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.5 m -70.32 120.41 15.94 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.064 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -79.43 105.71 10.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -118.69 160.25 22.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.308 1.043 . . . . 15.0 108.698 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 51.6 mt-10 -107.64 147.13 31.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.283 0.633 . . . . 15.0 110.215 173.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 240' ' ' VAL . 49.5 pttt -145.22 -178.92 6.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.109 0.964 . . . . 15.0 111.001 171.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -155.01 161.68 41.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.525 1.13 . . . . 15.0 108.001 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 -50.81 0.82 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.225 -0.75 . . . . 15.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.04 134.8 13.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.929 0.491 . . . . 15.0 110.72 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 240' ' ' VAL . 53.8 t -88.0 137.12 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 167.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.61 170.25 8.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.67 -0.863 . . . . 15.0 108.67 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.25 61.24 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.83 1.048 . . . . 15.0 113.83 -169.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.89 16.99 18.25 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.94 -176.02 4.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.946 0.879 . . . . 15.0 112.539 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 11.5 mtm180 -106.52 150.4 26.15 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.305 -1.316 . . . . 15.0 108.533 166.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.09 114.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 20.5 m -94.06 117.08 29.6 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.792 -1.188 . . . . 15.0 107.792 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.45 163.98 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.807 0.813 . . . . 15.0 111.495 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 15.7 t70 -106.58 155.14 19.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 105.703 -1.962 . . . . 15.0 105.703 159.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -154.41 169.31 24.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.348 0.594 . . . . 15.0 110.34 168.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 t -157.92 124.32 4.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.041 -1.436 . . . . 15.0 107.975 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -127.81 177.71 17.43 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 122.04 -0.412 . . . . 15.0 113.822 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.3 p -150.71 130.89 13.56 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.127 0.971 . . . . 15.0 109.715 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.59 HG11 HD23 ' A' ' 226' ' ' LEU . 47.0 t -94.7 117.72 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.5 t70 73.83 -5.36 2.04 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.768 1.227 . . . . 15.0 112.11 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.39 -0.13 23.61 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.731 -0.483 . . . . 15.0 112.471 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 15.0 pt-20 -113.04 139.46 48.66 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.63 0.715 . . . . 15.0 109.408 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.44 149.59 45.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.738 0.415 . . . . 15.0 110.728 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.517 ' HD2' HG23 ' A' ' 172' ' ' VAL . 4.5 p90 -106.84 -175.71 2.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.92 0.888 . . . . 15.0 111.794 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.556 ' HG3' HG12 ' B' ' 388' ' ' VAL . 55.7 mt-10 -53.73 116.32 2.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.1 0.96 . . . . 15.0 110.134 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 -63.67 4.38 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.037 0.836 . . . . 15.0 112.341 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.18 -62.22 4.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.471 -0.252 . . . . 15.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -88.2 150.35 23.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.086 0.954 . . . . 15.0 111.931 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 167' ' ' ASP . . . -145.37 94.02 2.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.775 -1.102 . . . . 15.0 109.576 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.6 m -78.91 121.2 24.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.935 0.494 . . . . 15.0 110.494 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.5 42.2 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.447 1.099 . . . . 15.0 112.248 171.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -71.03 129.17 38.3 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.47 -0.567 . . . . 15.0 109.47 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.72 105.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.057 0.943 . . . . 15.0 109.258 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 202' ' ' ILE . 30.8 tp -91.68 89.95 7.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.868 0.867 . . . . 15.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.3 87.18 5.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.582 -0.896 . . . . 15.0 108.582 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.6 mtp -62.19 139.17 58.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.119 0.967 . . . . 15.0 111.596 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.66 -26.86 5.6 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.81 0.694 . . . . 15.0 112.235 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -92.02 147.81 22.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.343 0.657 . . . . 15.0 110.206 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.75 65.28 3.94 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 123.021 0.343 . . . . 15.0 113.766 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -105.77 -36.0 7.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.027 0.931 . . . . 15.0 110.221 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.417 ' HE1' HD13 ' B' ' 385' ' ' LEU . 23.4 mmt -99.36 150.87 21.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.254 0.621 . . . . 15.0 111.266 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.1 pt -99.07 153.92 37.56 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 114.937 -1.029 . . . . 15.0 109.619 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.22 116.82 3.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.952 2.435 . . . . 15.0 112.281 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.9 -41.8 1.39 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.38 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.38 -59.75 2.61 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.945 0.498 . . . . 15.0 110.426 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.81 -23.14 67.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.902 -1.044 . . . . 15.0 112.278 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.04 -36.43 83.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.186 0.994 . . . . 15.0 110.927 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.581 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -72.55 -17.22 77.79 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.248 -0.887 . . . . 15.0 113.097 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 187' ' ' LEU . 31.7 mm -92.59 -48.32 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.56 0.744 . . . . 15.0 110.459 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.1 19.94 2.05 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.144 1.165 . . . . 15.0 114.144 -166.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -137.33 24.15 3.1 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.865 -0.494 . . . . 15.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -144.07 -171.33 3.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.19 0.996 . . . . 15.0 110.232 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -151.19 156.79 41.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 15.0 110.101 -178.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.564 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.46 142.67 58.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.735 0.814 . . . . 15.0 111.521 -171.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.04 -32.96 4.39 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.455 -0.793 . . . . 15.0 111.516 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.3 pt-20 -93.2 138.12 31.89 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.563 0.697 . . . . 15.0 110.572 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -121.22 105.74 10.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.653 1.181 . . . . 15.0 108.28 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -121.7 177.45 5.25 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.52 1.128 . . . . 15.0 109.568 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 57.0 m -121.04 128.32 52.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.581 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.2 pt -101.78 160.91 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.557 0.743 . . . . 15.0 109.83 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -113.46 111.07 21.31 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.739 0.815 . . . . 15.0 109.396 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.22 160.86 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.478 -1.304 . . . . 15.0 107.478 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.1 m -143.48 132.89 23.39 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.8 -1.185 . . . . 15.0 107.8 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 90.1 m-85 -85.81 139.66 35.24 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -47.68 157.93 0.83 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.283 3.322 . . . . 15.0 116.016 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -23.84 63.64 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.88 167.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.96 -18.92 55.46 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.387 1.075 . . . . 15.0 111.16 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.62 141.26 56.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.02 0.528 . . . . 15.0 112.299 -170.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.659 ' HB2' ' H ' ' B' ' 392' ' ' HIS . 18.8 p80 -78.03 17.83 0.56 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 125.163 1.385 . . . . 15.0 114.626 -168.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.47 119.47 15.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.614 ' HB3' ' HA ' ' B' ' 394' ' ' HIS . 42.0 tt0 -63.5 -40.66 97.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 123.928 0.768 . . . . 15.0 111.972 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -63.1 -19.61 64.58 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.142 0.577 . . . . 15.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.59 HD23 HG11 ' A' ' 172' ' ' VAL . 39.9 mt -99.42 -29.85 12.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.195 0.998 . . . . 15.0 111.691 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -57.83 105.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.77 1.228 . . . . 15.0 111.117 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.74 -19.49 28.91 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.57 -0.741 . . . . 15.0 113.408 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.94 145.48 31.24 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.64 0.776 . . . . 15.0 111.468 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -88.34 126.13 35.04 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.897 -1.047 . . . . 15.0 110.185 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.93 113.94 27.85 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.944 0.898 . . . . 15.0 109.238 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -103.78 101.69 11.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.723 0.809 . . . . 15.0 110.145 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -95.68 117.52 30.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.255 1.022 . . . . 15.0 109.998 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.55 96.76 4.84 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.16 116.39 26.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.036 0.934 . . . . 15.0 110.084 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 9.8 m120 -99.3 91.92 5.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.097 -1.075 . . . . 15.0 108.097 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 74.8 mt -68.47 109.25 3.61 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.099 -0.704 . . . . 15.0 109.099 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.84 -37.58 5.83 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 73.1 mmtt -133.99 122.58 23.24 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.844 0.858 . . . . 15.0 110.017 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 207' ' ' ALA . 89.0 t -95.58 132.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 105.55 -2.019 . . . . 15.0 105.55 161.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 37.6 mt-10 -120.01 179.35 4.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.96 117.5 5.73 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.871 0.868 . . . . 15.0 109.171 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -84.75 86.6 7.32 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.244 1.021 . . . . 15.0 108.348 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.04 146.7 28.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.682 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 75.1 mt -54.32 122.7 38.83 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 123.836 0.854 . . . . 15.0 110.592 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.14 -169.95 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.371 2.714 . . . . 15.0 112.944 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.58 106.53 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.216 -0.661 . . . . 15.0 109.216 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 252' ' ' PHE . 33.3 tp -82.99 14.95 2.99 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.343 1.057 . . . . 15.0 110.299 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.2 p -60.19 174.96 0.46 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.103 1.361 . . . . 15.0 112.321 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.49 -54.78 3.04 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.807 1.643 . . . . 15.0 113.86 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.45 -22.78 67.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 248' ' ' LEU . 71.2 t80 -90.37 -52.26 5.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.37 0.668 . . . . 15.0 110.254 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 266' ' ' LEU . 15.8 tt -66.4 -26.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.691 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.672 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 20.8 ptmt -82.6 -16.36 48.73 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 111.932 0.345 . . . . 15.0 111.932 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -58.83 -34.53 71.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.047 0.939 . . . . 15.0 110.95 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -62.76 -28.18 69.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.763 -1.108 . . . . 15.0 111.96 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.82 1.6 0.82 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.583 -0.565 . . . . 15.0 113.461 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 21.3 t -72.83 151.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.272 0.629 . . . . 15.0 110.06 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -67.57 -64.06 0.93 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.527 1.131 . . . . 15.0 110.483 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -102.64 -40.53 6.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.338 -1.301 . . . . 15.0 109.836 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 128.34 12.8 2.73 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.558 -0.746 . . . . 15.0 113.21 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 p -64.97 138.24 58.24 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.579 0.689 . . . . 15.0 110.375 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.89 -38.14 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.245 1.018 . . . . 15.0 111.711 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -55.48 -34.7 64.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.498 0.719 . . . . 15.0 111.388 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.21 -28.08 62.78 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.598 -0.601 . . . . 15.0 111.598 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 270' ' ' VAL . 58.9 tp -73.39 -32.72 64.61 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.37 -42.04 93.14 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.34 0.656 . . . . 15.0 109.699 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.03 90.61 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.928 -1.033 . . . . 15.0 110.39 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 15.6 tp10 -67.15 -39.99 86.61 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.729 -1.123 . . . . 15.0 111.465 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 266' ' ' LEU . 24.6 m -75.57 -24.42 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.044 -0.41 . . . . 15.0 110.253 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -69.03 -60.56 2.27 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 121.947 -0.471 . . . . 15.0 110.856 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.7 ptmt -61.9 -23.26 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 15.0 112.32 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -88.65 -69.48 0.7 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.403 0.281 . . . . 15.0 110.406 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 53.6 mtt -71.83 -45.33 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.895 -0.574 . . . . 15.0 112.361 -166.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.14 -42.16 72.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.625 0.648 . . . . 15.0 110.383 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 44.9 ttp85 -58.7 -53.55 57.14 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.167 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.26 -27.68 64.62 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.98 0.8 . . . . 15.0 111.084 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' VAL . 59.9 tp -67.5 -54.96 15.64 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.557 0.743 . . . . 15.0 110.562 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.02 -31.36 72.48 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.583 0.753 . . . . 15.0 110.316 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.2 t -68.89 -43.18 75.78 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 123.801 0.84 . . . . 15.0 110.0 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.86 98.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.146 0.578 . . . . 15.0 110.386 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 130' ' ' VAL . 73.4 mt -63.08 -49.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.011 0.924 . . . . 15.0 109.17 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.98 -54.96 38.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.648 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.22 -35.1 80.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.16 0.984 . . . . 15.0 111.019 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -65.57 -55.0 20.11 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.577 0.626 . . . . 15.0 110.996 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.66 -42.57 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.303 0.641 . . . . 15.0 110.366 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.5 tttt -58.36 -51.31 70.35 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.567 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 292' ' ' GLU . 90.2 p -69.11 -31.68 70.56 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.531 0.519 . . . . 15.0 111.292 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -69.1 -39.44 78.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.907 0.483 . . . . 15.0 110.093 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.419 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.5 -48.27 75.82 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.352 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 33.4 mm -67.12 -36.89 78.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 123.803 0.689 . . . . 15.0 110.709 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 288' ' ' SER . 8.4 tp10 -62.88 -47.76 81.95 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.271 -0.64 . . . . 15.0 109.271 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.28 94.05 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 124.698 1.249 . . . . 15.0 112.531 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB3' HD13 ' A' ' 350' ' ' LEU . 28.3 mt -59.96 -57.86 11.02 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 123.439 0.696 . . . . 15.0 110.39 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.4 t -56.09 -46.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.528 0.731 . . . . 15.0 110.159 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.84 -35.29 74.43 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.892 0.877 . . . . 15.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.15 -4.61 42.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.125 0.57 . . . . 15.0 112.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -133.9 115.12 14.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.972 0.805 . . . . 15.0 111.05 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.42 130.57 47.66 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.476 HD13 HD13 ' A' ' 349' ' ' LEU . 3.3 tt -149.13 146.11 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.344 1.058 . . . . 15.0 109.051 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 113' ' ' PRO . 29.3 t70 -72.05 140.67 49.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 307' ' ' ILE . 40.4 t -117.73 105.29 48.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.57 130.36 29.62 Favored 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 123.217 2.611 . . . . 15.0 112.563 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.43 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.21 -29.93 67.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.872 1.269 . . . . 15.0 112.554 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.549 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -54.1 -39.14 66.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.127 0.971 . . . . 15.0 111.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.78 -30.54 56.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.467 -0.788 . . . . 15.0 111.222 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -62.58 -49.96 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.841 -0.8 . . . . 15.0 108.841 173.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.33 -42.02 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.238 -0.892 . . . . 15.0 110.58 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 313' ' ' VAL . 36.5 t -57.44 -60.91 2.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.169 0.918 . . . . 15.0 111.219 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -69.8 -39.47 76.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.386 0.513 . . . . 15.0 112.386 -171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 14.9 mt -61.38 -43.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 119.035 -0.507 . . . . 15.0 109.694 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.26 -43.57 87.96 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.851 0.461 . . . . 15.0 111.208 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 309' ' ' SER . 81.2 t -54.74 -51.08 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.73 0.812 . . . . 15.0 110.339 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 341' ' ' ALA . 72.6 mt -71.4 -27.5 63.36 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.075 -0.966 . . . . 15.0 112.459 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 29.1 mtm180 -72.85 -38.41 67.08 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.563 -0.532 . . . . 15.0 109.563 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.5 -31.59 67.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.148 0.579 . . . . 15.0 110.978 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.21 -43.9 90.07 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.009 0.924 . . . . 15.0 110.432 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.38 -46.0 64.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.58 -0.736 . . . . 15.0 110.131 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -29.2 67.88 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.773 0.829 . . . . 15.0 111.594 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -62.72 -39.67 94.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.737 0.815 . . . . 15.0 109.652 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -81.8 -21.95 37.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.019 -0.537 . . . . 15.0 110.368 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -80.71 0.3 35.07 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.519 1.128 . . . . 15.0 110.16 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.89 82.73 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 123.16 0.41 . . . . 15.0 113.651 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 73.56 15.06 79.29 Favored Glycine 0 C--N 1.344 0.996 0 C-N-CA 123.313 0.483 . . . . 15.0 112.816 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.36 142.31 48.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.949 0.9 . . . . 15.0 110.434 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.82 -42.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.377 1.871 . . . . 15.0 112.942 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm 58.73 26.77 15.05 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.197 1.399 . . . . 15.0 111.571 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -91.9 13.8 17.46 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.723 1.209 . . . . 15.0 110.736 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -53.26 -25.16 13.44 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.089 1.356 . . . . 15.0 113.025 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp -43.8 -35.84 2.07 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.723 1.209 . . . . 15.0 112.166 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.01 72.66 1.42 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.966 0.889 . . . . 15.0 110.089 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 73.1 mt -81.05 153.71 72.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 153.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.29 108.73 0.21 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.959 2.439 . . . . 15.0 113.369 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -55.95 -29.09 59.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.254 1.022 . . . . 15.0 110.859 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.08 -21.42 31.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.572 1.149 . . . . 15.0 111.878 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.06 -35.31 20.37 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.542 0.737 . . . . 15.0 111.118 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -107.34 -14.38 14.89 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.879 0.696 . . . . 15.0 112.879 -167.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.96 -62.55 1.58 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.851 1.26 . . . . 15.0 112.029 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.45 -46.29 73.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.728 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -67.99 -37.24 81.25 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.624 0.578 . . . . 15.0 111.623 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -64.94 -52.71 54.87 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -51.57 -40.67 60.21 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 124.642 1.214 . . . . 15.0 110.83 176.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 347' ' ' VAL . 15.6 mmt180 -60.26 -46.87 88.32 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 123.418 0.687 . . . . 15.0 110.402 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -63.63 -34.21 77.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.473 0.483 . . . . 15.0 111.219 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.81 -53.89 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 15.0 110.148 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 62.5 t -65.43 -31.06 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.313 0.645 . . . . 15.0 110.957 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 343' ' ' ARG . 40.3 t -60.46 -50.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.522 0.729 . . . . 15.0 109.095 170.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.76 -33.74 88.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.636 -0.711 . . . . 15.0 113.759 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.476 HD13 HD13 ' A' ' 300' ' ' ILE . 96.0 mt -73.82 -54.7 7.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.929 0.491 . . . . 15.0 110.574 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 294' ' ' LEU . 75.6 mt -68.87 -52.67 27.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.891 0.476 . . . . 15.0 110.812 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.14 -38.11 89.55 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 119.275 -0.393 . . . . 15.0 110.834 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.98 -38.41 88.98 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.753 0.658 . . . . 15.0 112.544 176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -69.25 -40.6 77.77 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 119.295 -0.383 . . . . 15.0 111.316 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 350' ' ' LEU . 81.2 t -57.39 -39.94 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.211 0.529 . . . . 15.0 110.575 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.84 -45.46 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.756 1.222 . . . . 15.0 110.755 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.458 ' HA ' ' HE2' ' B' ' 461' ' ' PHE . 20.2 ttp180 -61.28 -53.14 60.56 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.021 0.529 . . . . 15.0 110.785 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 33.0 m -57.13 -50.37 73.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.62 1.168 . . . . 15.0 111.433 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -90.66 14.8 12.39 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.638 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 43.04 36.2 0.89 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 125.375 1.47 . . . . 15.0 114.136 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.26 149.17 50.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.047 0.939 . . . . 15.0 112.159 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.61 150.91 52.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.333 1.053 . . . . 15.0 109.699 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.77 104.49 3.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.38 -0.6 . . . . 15.0 109.38 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.78 132.64 42.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.149 0.58 . . . . 15.0 110.395 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -63.94 -30.85 71.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.88 0.872 . . . . 15.0 112.48 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -86.04 -10.64 54.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.961 0.504 . . . . 15.0 111.436 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.5 tpt85 -81.33 -38.13 27.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 371' ' ' ILE . 89.7 t -58.16 -58.29 7.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.837 1.255 . . . . 15.0 109.18 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 372' ' ' GLU . 24.0 mmmt -59.49 -39.62 84.35 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 115.628 -0.715 . . . . 15.0 111.589 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.33 67.06 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.934 0.772 . . . . 15.0 112.436 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.08 -42.49 84.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.31 0.644 . . . . 15.0 111.96 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 367' ' ' VAL . 50.5 mm -52.77 -44.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 123.992 0.807 . . . . 15.0 110.686 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 368' ' ' LYS . 14.7 mm-40 -70.06 -54.71 11.9 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.46 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -52.43 -36.97 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.837 0.855 . . . . 15.0 112.463 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 60.4 ttp -80.09 -69.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.774 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.87 79.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.858 0.863 . . . . 15.0 113.297 -164.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -21.44 64.92 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.037 0.535 . . . . 15.0 112.166 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -66.79 -20.32 65.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.739 0.816 . . . . 15.0 112.591 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.49 167.83 9.89 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.383 0.673 . . . . 15.0 110.646 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -80.01 -9.73 59.71 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.851 . . . . 15.0 110.809 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.42 59.78 46.08 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.991 1.317 . . . . 15.0 110.545 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.75 -27.95 4.51 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 121.931 1.754 . . . . 15.0 112.301 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -54.79 -45.78 74.37 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.254 1.022 . . . . 15.0 111.042 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 12.7 pt-20 -65.57 -31.46 72.51 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.84 -1.073 . . . . 15.0 111.242 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.96 -37.84 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.277 0.631 . . . . 15.0 109.912 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.95 -54.21 37.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 108.607 -0.886 . . . . 15.0 108.607 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.35 -27.52 67.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.525 0.73 . . . . 15.0 111.527 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 383' ' ' GLU . 24.0 t80 -62.19 -44.01 97.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.99 0.916 . . . . 15.0 109.877 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -82.71 -66.27 0.91 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.638 0.607 . . . . 15.0 112.638 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . 0.586 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 84.4 p -56.45 -27.23 56.27 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.474 1.287 . . . . 15.0 114.474 -169.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -103.36 27.72 7.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.079 0.551 . . . . 15.0 110.396 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -149.8 105.35 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.296 -1.002 . . . . 15.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -55.6 -38.73 69.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.264 1.026 . . . . 15.0 111.726 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.34 -36.61 66.2 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 123.782 0.676 . . . . 15.0 111.625 -174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 397' ' ' ASN . 11.3 mt -74.98 -32.98 61.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.763 0.425 . . . . 15.0 111.117 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 90.0 mmm -62.83 -38.88 92.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 171.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.27 -38.21 78.27 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 123.719 0.637 . . . . 15.0 109.983 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.44 HD22 HD23 ' A' ' 394' ' ' LEU . 88.6 m-20 -62.1 -39.66 93.25 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 123.559 0.744 . . . . 15.0 110.54 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.449 ' HA ' HG12 ' A' ' 401' ' ' VAL . 43.1 tpp -77.34 -23.78 50.86 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.543 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' B' ' 463' ' ' THR . 43.2 mtm-85 -74.95 -31.83 61.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.143 0.577 . . . . 15.0 110.318 169.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -55.87 22.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.478 0.711 . . . . 15.0 109.398 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.5 p -69.43 -29.97 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 123.788 0.68 . . . . 15.0 111.745 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.66 -53.62 55.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.861 -0.422 . . . . 15.0 109.861 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.656 HD22 HG23 ' B' ' 463' ' ' THR . 48.1 tp -71.3 -30.11 65.86 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.903 -1.044 . . . . 15.0 111.687 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.25 -57.07 10.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.723 1.209 . . . . 15.0 109.953 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -67.12 -32.43 73.56 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.27 -0.877 . . . . 15.0 110.633 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -63.91 -37.77 88.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.042 0.537 . . . . 15.0 110.388 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.49 85.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.748 0.819 . . . . 15.0 110.891 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 74.8 t -55.81 -53.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 123.955 0.784 . . . . 15.0 109.306 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -30.35 70.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.104 0.962 . . . . 15.0 112.023 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.4 -30.86 68.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.929 0.491 . . . . 15.0 110.895 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.01 -39.51 57.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 77.0 mt -72.84 -26.37 61.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.436 1.094 . . . . 15.0 112.007 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.72 73.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.96 0.904 . . . . 15.0 110.054 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.3 -34.94 13.32 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.593 -1.185 . . . . 15.0 110.094 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -81.93 154.61 25.69 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.316 1.046 . . . . 15.0 111.465 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.5 86.73 3.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.952 -1.022 . . . . 15.0 110.147 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -84.61 94.12 3.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.57 0.7 . . . . 15.0 109.712 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -70.48 95.19 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.115 -0.948 . . . . 15.0 108.647 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.33 138.87 37.87 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 114.991 -1.004 . . . . 15.0 110.131 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.415 ' HE3' HG21 ' A' ' 422' ' ' THR . 62.1 pttt -144.42 137.35 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 173.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.89 122.4 30.7 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.128 -1.064 . . . . 15.0 108.128 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.415 HG21 ' HE3' ' A' ' 420' ' ' LYS . 8.8 t -149.78 175.52 11.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.008 0.523 . . . . 15.0 110.69 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -89.92 161.07 16.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.71 1.204 . . . . 15.0 112.119 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 26.5 t80 -52.68 -48.59 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.234 1.414 . . . . 15.0 111.253 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -58.79 -19.4 40.56 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.161 0.913 . . . . 15.0 112.886 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 427' ' ' LEU . 7.7 tp10 -54.06 -49.95 67.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.382 1.073 . . . . 15.0 112.127 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 130' ' ' VAL . 5.5 mp -75.37 -29.18 59.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.788 0.835 . . . . 15.0 111.507 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -77.14 -41.97 39.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 174.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -80.72 33.46 0.32 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.16 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 75.69 10.02 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.843 -1.169 . . . . 15.0 107.843 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -87.74 -11.61 47.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.618 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.481 0.712 . . . . 15.0 109.559 174.054 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 121.996 0.903 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -151.67 95.45 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 66.2 mt -77.77 -77.05 0.16 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.536 0.334 . . . . 0.0 110.85 -172.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' B' ' 411' ' ' ALA . 7.0 t0 -102.98 -82.58 0.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' B' ' 373' ' ' ARG . 43.8 mt-10 -90.08 -75.51 0.45 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.017 -0.427 . . . . 0.0 110.018 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -103.4 -79.72 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.558 HG13 ' H ' ' B' ' 372' ' ' GLN . 2.6 p -108.85 -81.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.611 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.558 ' H ' HG13 ' B' ' 371' ' ' VAL . 28.2 mp0 -85.06 -80.1 0.22 Allowed 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 120.159 1.345 . . . . 0.0 108.44 170.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' B' ' 369' ' ' GLU . 15.6 mmm180 -102.52 -83.66 0.47 Allowed 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 163.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -102.54 -73.91 0.65 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' B' ' 376' ' ' GLU . 0.3 OUTLIER -109.65 -78.05 0.59 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.736 0.414 . . . . 0.0 110.932 173.302 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.412 ' H ' ' HG ' ' B' ' 375' ' ' LEU . 45.2 mt-10 -103.78 -80.93 0.52 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.666 -0.646 . . . . 0.0 111.598 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.452 ' HD2' ' HA ' ' B' ' 380' ' ' LYS . 91.2 m-85 -95.63 -85.18 0.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.82 -68.92 0.79 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 158.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -101.22 -79.13 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 163.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' B' ' 381' ' ' GLU . 47.6 pttt -161.18 -74.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.01 0.924 . . . . 0.0 109.26 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 381' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' B' ' 380' ' ' LYS . 32.9 tt0 -172.65 152.35 2.53 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.662 0.785 . . . . 0.0 109.327 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -171.81 98.61 0.13 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.01 142.39 21.65 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.397 0.679 . . . . 0.0 110.616 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 4.1 t -173.35 -55.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.564 1.146 . . . . 0.0 109.69 171.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.417 HD13 ' HE1' ' A' ' 194' ' ' MET . 18.9 tp -145.56 159.21 43.45 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 124.846 1.258 . . . . 0.0 107.68 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 178' ' ' GLU . 8.1 p -77.39 97.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 122.895 1.331 . . . . 0.0 109.279 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.472 HG23 HG23 ' B' ' 389' ' ' THR . 2.9 tp -149.78 156.24 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 113.954 -1.476 . . . . 0.0 107.043 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.556 HG12 ' HG3' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -58.11 106.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 389' ' ' THR . . . . . 0.472 HG23 HG23 ' B' ' 387' ' ' ILE . 9.3 p -125.7 93.79 3.94 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.451 0.643 . . . . 0.0 110.4 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 390' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' B' ' 393' ' ' ALA . . . -94.16 176.14 6.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 161.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -133.76 131.39 39.3 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 392' ' ' HIS . . . . . 0.659 ' H ' ' HB2' ' A' ' 222' ' ' HIS . 19.8 p-80 47.06 18.14 0.07 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.019 2.128 . . . . 0.0 113.293 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.551 ' HB3' ' HB1' ' B' ' 390' ' ' ALA . . . -117.4 162.96 17.09 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.157 0.983 . . . . 0.0 110.119 -169.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 394' ' ' HIS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 224' ' ' GLU . 32.5 m-70 -96.01 -57.65 2.29 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.898 -170.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -85.12 167.29 15.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.567 0.747 . . . . 0.0 111.145 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 24.3 m -128.34 170.18 13.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.263 1.025 . . . . 0.0 109.499 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 58.97 -80.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.919 1.288 . . . . 0.0 111.052 -170.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.537 ' H ' HD13 ' B' ' 398' ' ' ILE . 0.2 OUTLIER -121.04 90.44 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 122.246 1.022 . . . . 0.0 109.973 -177.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.14 -46.84 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -165.66 163.45 12.69 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.994 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.24 72.38 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.448 2.099 . . . . 0.0 111.495 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.46 157.91 22.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.931 0.892 . . . . 0.0 108.785 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 50.7 p 52.14 27.65 4.79 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.393 1.477 . . . . 0.0 112.493 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -147.1 11.45 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.017 1.327 . . . . 0.0 109.505 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.623 ' H ' ' HD2' ' B' ' 406' ' ' PRO . . . -164.32 -45.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 116.265 -1.826 . . . . 0.0 114.139 -164.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.623 ' HD2' ' H ' ' B' ' 405' ' ' ALA . 4.5 Cg_exo -33.03 96.95 0.02 OUTLIER 'Trans proline' 1 C--N 1.416 4.111 0 C-N-CA 124.609 3.539 . . . . 0.0 114.407 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 79.39 -96.62 1.51 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -170.1 146.05 2.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.089 0.956 . . . . 0.0 109.214 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 31.9 p -70.95 91.37 0.86 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.734 0.814 . . . . 0.0 110.256 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.43 -56.73 4.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.935 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 411' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' B' ' 368' ' ' ASP . . . -90.46 -168.46 2.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.5 -173.87 2.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.62 1.168 . . . . 0.0 110.032 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -51.06 -46.27 61.65 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.934 0.894 . . . . 0.0 112.068 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 17.2 m 59.55 85.15 0.1 Allowed 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.486 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -67.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.019 0.927 . . . . 0.0 112.8 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -62.84 -49.02 76.54 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.786 0.834 . . . . 0.0 110.968 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 67.24 71.54 0.91 Allowed Glycine 0 C--N 1.352 1.461 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.14 56.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.756 0.822 . . . . 0.0 112.169 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 48.7 t 64.95 97.7 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 125.497 1.519 . . . . 0.0 112.132 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 27.0 ttt -111.49 118.65 36.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.95 148.2 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 110.524 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 96.0 mmm -89.13 121.06 31.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 53.1 p -141.15 139.64 33.94 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.651 0.78 . . . . 0.0 109.732 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 44.3 p90 50.89 -168.82 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.381 1.872 . . . . 0.0 114.129 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 81.59 -173.42 53.93 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.871 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 66.84 3.57 3.1 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.863 1.265 . . . . 0.0 113.486 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.6 m 56.92 23.44 8.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.424 1.09 . . . . 0.0 111.94 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -138.4 -67.9 0.46 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.64 -4.62 28.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.169 0.988 . . . . 0.0 111.235 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -53.68 -61.28 2.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.554 1.542 . . . . 0.0 112.624 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 38.5 t -69.95 -31.36 69.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.424 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.593 ' HB3' ' HB ' ' B' ' 435' ' ' THR . 1.3 mp0 -78.35 -24.36 46.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.319 0.648 . . . . 0.0 111.622 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 59.51 -85.5 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.492 1.517 . . . . 0.0 112.684 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -93.58 28.82 2.17 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.719 0.808 . . . . 0.0 111.166 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' B' ' 432' ' ' GLN . 19.0 m -128.87 141.47 51.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.387 0.675 . . . . 0.0 109.549 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -63.6 -29.09 73.62 Favored Glycine 0 C--N 1.357 1.749 0 O-C-N 124.054 0.846 . . . . 0.0 113.853 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 13.3 m 57.26 76.07 0.34 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.066 1.347 . . . . 0.0 111.53 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -160.48 23.96 0.15 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.206 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 39.5 tp -86.48 76.45 9.6 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.742 0.782 . . . . 0.0 110.53 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -109.61 -39.67 5.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.441 166.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 35.1 mt -124.44 138.01 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.151 0.98 . . . . 0.0 109.683 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.98 31.67 0.96 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.768 1.227 . . . . 0.0 111.496 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.65 96.37 0.71 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.502 0.721 . . . . 0.0 110.528 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -65.39 145.07 56.63 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 0.0 110.254 171.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -67.74 109.02 2.68 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.31 -33.62 5.45 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.586 2.19 . . . . 0.0 113.944 -167.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 447' ' ' HIS . . . . . 0.402 ' HB2' HG22 ' A' ' 313' ' ' VAL . 11.0 t-160 65.35 5.44 3.13 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.874 1.269 . . . . 0.0 112.426 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 58.18 27.27 14.85 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.89 1.276 . . . . 0.0 112.76 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -60.53 -24.84 65.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -106.6 -15.34 14.8 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.938 0.895 . . . . 0.0 111.117 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.07 -59.37 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 0.0 110.177 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.42 -36.51 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -70.06 156.87 53.5 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.69 81.38 0.85 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.401 0.68 . . . . 0.0 110.027 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.451 HG23 ' H ' ' B' ' 456' ' ' ASP 0.251 5.5 t 36.31 -76.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 127.448 2.299 . . . . 0.0 115.041 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 456' ' ' ASP . . . . . 0.526 ' HA ' ' HD1' ' B' ' 462' ' ' TYR . 16.0 m-20 -74.64 169.02 18.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.575 0.75 . . . . 0.0 111.264 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -91.02 159.9 15.9 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.058 0.943 . . . . 0.0 109.676 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.4 t -67.22 -24.92 65.88 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.793 0.837 . . . . 0.0 113.112 -167.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 459' ' ' ASP . . . . . 0.411 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 32.7 t70 -163.05 69.49 0.23 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.118 0.567 . . . . 0.0 110.036 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.0 tp -172.25 174.22 4.01 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 461' ' ' PHE . . . . . 0.458 ' HE2' ' HA ' ' A' ' 356' ' ' ARG . 97.4 m-85 -77.22 24.4 0.18 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.576 1.15 . . . . 0.0 113.751 -174.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 462' ' ' TYR . . . . . 0.526 ' HD1' ' HA ' ' B' ' 456' ' ' ASP . 19.5 t80 76.92 -49.49 0.55 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.723 1.209 . . . . 0.0 113.412 173.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.656 HG23 HD22 ' A' ' 403' ' ' LEU . 11.8 t -84.16 20.54 1.57 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.533 1.133 . . . . 0.0 113.668 -156.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 25.0 ptm -141.03 129.81 22.95 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.58 -62.12 1.74 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.514 0.725 . . . . 0.0 109.685 -173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.38 0.39 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.077 0.951 . . . . 0.0 110.522 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 176.23 -53.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.615 1.566 . . . . 0.0 108.254 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 10.1 mp 67.69 -70.01 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 O-C-N 125.099 1.5 . . . . 0.0 111.59 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' B' ' 459' ' ' ASP . . . 171.26 -175.26 44.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.839 -0.22 . . . . 0.0 113.11 176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.66 -19.07 25.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.086 0.554 . . . . 0.0 110.624 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.887 0.875 . . . . 12.06 109.107 173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.654 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -78.11 97.08 5.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.162 0.585 . . . . 15.0 109.817 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -111.1 128.49 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.348 0.659 . . . . 15.0 109.479 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.3 p -129.63 110.7 12.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.094 0.558 . . . . 15.0 109.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.26 126.59 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.601 0.76 . . . . 15.0 110.417 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 32.5 mt-10 -125.55 133.22 52.4 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.8 1.24 . . . . 15.0 108.5 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 m -94.0 98.22 10.87 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.493 -0.929 . . . . 15.0 108.493 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -84.29 -51.23 7.16 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.291 0.636 . . . . 15.0 111.937 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -151.2 90.95 1.64 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.16 -100.74 0.43 Allowed Glycine 0 C--N 1.35 1.338 0 O-C-N 123.867 0.73 . . . . 15.0 113.363 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 5.2 mp -77.85 -33.14 52.34 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 15.0 109.56 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 122.72 30.63 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.363 1.039 . . . . 15.0 112.867 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -135.46 129.03 32.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.572 1.149 . . . . 15.0 110.259 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 43.4 ttm180 -96.64 101.82 13.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.431 1.092 . . . . 15.0 110.022 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.03 94.41 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 169.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 85.8 m -78.32 102.74 7.84 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.482 -0.781 . . . . 15.0 109.467 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -95.74 131.92 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.737 0.815 . . . . 15.0 109.315 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 33.9 m -116.07 118.81 33.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 70' ' ' LEU . 58.6 mt -93.03 120.12 41.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.77 154.11 42.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.173 0.589 . . . . 15.0 111.166 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.65 -39.99 62.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.238 1.415 . . . . 15.0 113.183 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.65 -38.64 77.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.407 0.683 . . . . 15.0 110.984 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -70.22 -32.31 70.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.61 0.764 . . . . 15.0 110.824 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 76.4 mt -66.79 -54.14 27.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.962 0.905 . . . . 15.0 109.384 173.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -59.94 -38.79 83.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.421 1.076 . . . . 15.0 111.761 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -63.75 -45.18 91.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.779 0.674 . . . . 15.0 110.27 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -33.64 73.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.543 0.737 . . . . 15.0 112.277 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.643 ' HA ' HG21 ' A' ' 66' ' ' VAL . 68.0 t -69.54 -42.47 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.261 0.624 . . . . 15.0 109.423 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -68.02 -31.03 70.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.263 -0.88 . . . . 15.0 111.079 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 m -69.1 -37.39 78.37 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.474 -0.785 . . . . 15.0 109.702 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.6 tp10 -69.37 -39.53 78.01 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.826 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 91.6 mt -67.24 -34.69 77.99 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.316 0.646 . . . . 15.0 111.725 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 p -80.97 -17.63 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 O-C-N 123.317 0.386 . . . . 15.0 110.604 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.44 -46.64 66.29 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.452 -0.574 . . . . 15.0 109.452 168.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 40.0 t -65.09 -39.11 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 123.876 0.735 . . . . 15.0 109.891 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.55 -55.38 31.55 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 115.198 -0.91 . . . . 15.0 110.671 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 97.2 mttt -66.18 -30.03 70.42 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.423 0.452 . . . . 15.0 111.98 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 36.5 ttpt -64.29 -46.71 82.44 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.491 0.717 . . . . 15.0 111.118 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.1 t -94.03 3.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.348 0.659 . . . . 15.0 110.154 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 24.8 mmt180 65.17 16.8 10.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.866 1.666 . . . . 15.0 112.43 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.1 mt -54.08 -31.04 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.562 1.545 . . . . 15.0 111.784 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.756 0.822 . . . . 15.0 111.037 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -39.13 79.26 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.08 -0.509 . . . . 15.0 112.03 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.99 -22.17 59.71 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.142 0.577 . . . . 15.0 111.003 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -65.93 116.55 7.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.386 1.074 . . . . 15.0 110.145 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.82 1.99 48.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.064 0.945 . . . . 15.0 111.329 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.91 69.85 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.28 0.362 . . . . 15.0 112.706 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -77.15 -49.4 15.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.636 0.774 . . . . 15.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.88 117.36 61.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 108.486 -0.931 . . . . 15.0 108.486 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD2' HD12 ' A' ' 53' ' ' ILE . 87.5 Cg_exo -48.75 142.39 18.93 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.417 2.745 . . . . 15.0 113.484 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 54' ' ' VAL . 56.4 tpp -64.01 -26.57 68.63 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 15.0 111.298 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.27 -35.18 77.49 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.592 0.357 . . . . 15.0 111.64 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 50' ' ' PRO . 43.1 mt -72.68 -46.93 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.685 0.794 . . . . 15.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 51' ' ' MET . 31.1 m -68.66 -21.14 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 122.429 -0.169 . . . . 15.0 111.291 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.21 -47.77 60.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.059 0.544 . . . . 15.0 111.862 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -79.59 -19.79 48.51 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.755 -0.657 . . . . 15.0 111.627 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -94.45 -70.15 0.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.551 0.34 . . . . 15.0 111.252 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.61 -22.8 59.91 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.287 0.635 . . . . 15.0 111.613 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.84 14.56 59.94 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.305 -0.72 . . . . 15.0 114.041 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 -42.61 66.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.497 0.719 . . . . 15.0 111.574 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 p -77.11 -32.76 56.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.291 0.636 . . . . 15.0 110.298 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.7 t -67.17 -18.79 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.616 1.166 . . . . 15.0 111.321 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HD3' HG21 ' A' ' 28' ' ' VAL . 17.1 mmt180 -51.05 -44.8 61.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.283 0.633 . . . . 15.0 110.599 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -51.85 -55.48 19.74 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.429 1.092 . . . . 15.0 111.456 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.76 -48.96 79.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.625 -1.17 . . . . 15.0 111.095 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 28' ' ' VAL . 79.6 t -64.24 -49.17 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.367 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.7 mt -56.84 -43.44 81.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 123.837 0.711 . . . . 15.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.7 -47.57 90.27 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.294 0.996 . . . . 15.0 112.002 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.97 -41.39 97.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.649 1.18 . . . . 15.0 111.454 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.425 ' HB3' HD13 ' A' ' 19' ' ' ILE . 59.2 mt -64.59 -27.2 68.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.262 -0.881 . . . . 15.0 111.235 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.448 ' SD ' ' HG3' ' A' ' 94' ' ' PRO . 68.4 mtm -59.21 -40.93 87.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.361 0.413 . . . . 15.0 111.049 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -81.59 -50.01 9.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.779 0.432 . . . . 15.0 111.105 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -75.19 -24.14 57.77 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -81.31 -25.85 36.14 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.927 0.33 . . . . 15.0 110.288 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -77.96 -42.23 33.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.686 0.394 . . . . 15.0 111.171 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.0 -27.4 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.26 0.552 . . . . 15.0 110.081 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.57 -41.49 54.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.429 0.692 . . . . 15.0 109.981 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -62.8 -47.09 84.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 15.0 111.869 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -60.13 -27.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 112.79 0.663 . . . . 15.0 112.79 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.9 mt -71.81 -47.33 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.942 0.897 . . . . 15.0 110.568 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.4 ptpt -75.96 -29.97 58.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.622 0.369 . . . . 15.0 110.785 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.87 -22.28 53.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.757 . . . . 15.0 111.132 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.725 ' HB3' ' HG3' ' B' ' 471' ' ' LYS . 46.3 mmtm 62.85 23.86 14.23 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.482 1.113 . . . . 15.0 111.428 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.6 mt -105.35 97.9 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.314 -0.995 . . . . 15.0 108.314 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -72.53 116.92 54.44 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.528 -0.916 . . . . 15.0 108.528 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.7 158.65 35.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.521 2.147 . . . . 15.0 113.127 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.59 167.88 21.98 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.81 -1.086 . . . . 15.0 108.956 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 82.14 -136.15 15.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.697 -0.683 . . . . 15.0 111.458 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.14 97.65 45.35 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 108.263 -1.014 . . . . 15.0 108.263 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.4 106.36 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.018 1.812 . . . . 15.0 110.792 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.6 m -92.25 98.3 11.43 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.277 0.631 . . . . 15.0 109.58 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -76.45 83.42 3.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.158 0.983 . . . . 15.0 109.316 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.51 106.33 10.09 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 118.536 -0.745 . . . . 15.0 109.147 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HG3' ' SD ' ' A' ' 71' ' ' MET . 16.3 Cg_exo -68.79 110.42 2.35 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.4 2.067 . . . . 15.0 111.33 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -59.12 11.36 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.773 0.671 . . . . 15.0 111.99 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.27 168.05 13.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 15.0 111.483 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HB2' ' HD1' ' A' ' 103' ' ' PHE . 76.1 t80 -147.29 143.57 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.571 1.149 . . . . 15.0 109.17 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 49.1 mtmt -122.52 144.4 49.1 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 170.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.58 108.41 0.82 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.943 0.897 . . . . 15.0 111.86 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.58 62.29 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.578 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.9 mt-10 -99.23 -173.17 2.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.482 1.113 . . . . 15.0 109.392 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.1 154.12 42.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.647 0.736 . . . . 15.0 112.897 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' HD1' ' HB2' ' A' ' 97' ' ' TYR . 56.2 t80 -119.01 141.61 48.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.153 1.381 . . . . 15.0 108.392 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -132.57 140.31 48.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -147.35 136.23 22.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.789 0.836 . . . . 15.0 109.535 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 70.8 m -103.5 123.77 47.52 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.324 1.05 . . . . 15.0 109.589 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.88 110.3 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.101 0.56 . . . . 15.0 110.253 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -101.1 130.41 47.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.68 0.392 . . . . 15.0 110.298 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.6 157.05 37.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 15.0 109.544 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.85 164.66 23.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.284 0.634 . . . . 15.0 109.632 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.5 m -123.23 178.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.239 0.615 . . . . 15.0 109.442 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -86.3 108.01 15.74 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 15.0 108.489 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.54 163.64 26.73 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.451 2.101 . . . . 15.0 113.018 -170.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.92 89.22 5.87 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.67 111.48 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.514 -1.221 . . . . 15.0 110.017 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -96.14 98.49 10.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.892 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 120' ' ' LEU . 85.7 mt -73.03 129.01 37.13 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -136.98 111.14 8.36 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.32 75.89 0.21 Allowed Glycine 0 C--N 1.353 1.504 0 O-C-N 124.324 1.015 . . . . 15.0 113.519 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 117' ' ' LEU . 17.8 mt -75.59 -11.64 60.05 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.055 0.428 . . . . 15.0 110.874 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 13.2 mp0 -74.53 -28.08 60.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.303 1.041 . . . . 15.0 110.146 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.76 62.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.044 0.937 . . . . 15.0 112.078 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.476 HG23 ' HA3' ' A' ' 293' ' ' GLY . 65.2 mt -68.88 134.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.717 0.807 . . . . 15.0 109.731 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.1 mt-10 -118.29 110.87 18.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.458 0.703 . . . . 15.0 109.263 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 417' ' ' VAL . 47.1 t -115.97 156.19 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.529 1.132 . . . . 15.0 109.68 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.53 141.04 39.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.993 0.917 . . . . 15.0 108.692 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 83.1 tttt -112.43 89.9 13.43 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 107.344 -1.354 . . . . 15.0 107.344 170.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.54 95.41 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.403 2.068 . . . . 15.0 111.087 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.15 87.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.202 -1.407 . . . . 15.0 107.202 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 282' ' ' ILE . 3.2 t -122.38 141.24 43.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.576 -1.193 . . . . 15.0 109.56 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.94 165.5 24.86 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.813 -1.551 . . . . 15.0 106.813 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.53 85.9 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.683 -1.599 . . . . 15.0 106.683 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 137' ' ' VAL . 26.6 p -69.12 175.78 3.61 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.554 0.742 . . . . 15.0 110.238 -175.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.21 -43.38 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.022 0.374 . . . . 15.0 110.296 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.34 80.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.875 0.87 . . . . 15.0 111.298 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.44 -39.03 54.59 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.743 0.417 . . . . 15.0 111.662 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 133' ' ' THR . 91.5 t -65.09 -53.71 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 108.933 -0.766 . . . . 15.0 108.933 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -63.5 -48.63 76.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.148 0.905 . . . . 15.0 110.385 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.01 93.85 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 123.877 0.735 . . . . 15.0 114.195 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -80.51 -45.44 17.49 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.978 0.511 . . . . 15.0 111.111 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 270' ' ' VAL . 48.1 mt -54.52 -34.56 61.93 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.457 0.572 . . . . 15.0 112.025 167.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.74 -45.8 84.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.403 1.081 . . . . 15.0 109.623 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -60.78 -36.84 80.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.624 0.77 . . . . 15.0 111.628 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 HD23 ' A' ' 141' ' ' LEU . 96.1 mt -70.31 -40.33 74.28 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.254 0.621 . . . . 15.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.64 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 68.0 mtm180 -74.44 -18.78 60.59 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.743 -0.662 . . . . 15.0 111.619 174.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 97.0 mttt -85.36 -22.56 28.39 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.077 0.399 . . . . 15.0 111.233 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -72.13 -42.17 66.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 15.0 109.362 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -104.87 41.32 1.35 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.003 . . . . 15.0 110.1 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.12 139.06 41.14 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.6 m -81.36 126.77 32.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.132 0.973 . . . . 15.0 109.398 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -80.97 111.01 17.05 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -120.66 114.87 22.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.909 0.883 . . . . 15.0 109.79 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 52.7 mt-10 -73.19 119.57 17.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.847 0.459 . . . . 15.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 28.6 pttt -106.02 176.8 5.05 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.39 0.676 . . . . 15.0 110.32 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -115.55 99.4 7.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.133 0.573 . . . . 15.0 111.487 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.505 ' HA2' ' H ' ' A' ' 207' ' ' ALA . . . 58.66 58.76 12.85 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.589 168.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 98.89 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.298 0.549 . . . . 15.0 109.688 172.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 203' ' ' LYS . 14.2 t -96.98 130.2 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 120.914 0.388 . . . . 15.0 110.953 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 -168.4 2.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.749 1.62 . . . . 15.0 109.18 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.76 -2.64 54.96 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.031 0.932 . . . . 15.0 112.585 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -97.49 8.4 44.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.22 0.608 . . . . 15.0 111.829 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 1.1 m-20 -92.41 176.41 6.48 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.388 1.089 . . . . 15.0 113.873 -166.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 3.1 tmt_? -143.42 90.21 2.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.519 -2.4 . . . . 15.0 104.519 167.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 166' ' ' ILE . 33.2 t -93.36 152.28 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.766 0.826 . . . . 15.0 110.561 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.717 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 11.4 m -126.1 117.68 23.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.773 -1.195 . . . . 15.0 107.773 173.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 237' ' ' LEU . 38.6 pt -128.24 173.4 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.982 0.913 . . . . 15.0 111.963 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.35 134.1 50.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.766 -1.198 . . . . 15.0 107.766 163.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -127.72 149.85 50.04 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.709 0.231 . . . . 15.0 110.483 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.56 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 9.0 t -131.81 113.32 13.36 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 165.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.44 148.81 18.78 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.9 -0.591 . . . . 15.0 113.725 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.3 m -146.07 118.08 8.26 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.312 -1.366 . . . . 15.0 107.312 167.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 98.9 t -88.69 114.97 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.967 0.907 . . . . 15.0 109.334 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 67.91 7.8 6.02 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.405 1.082 . . . . 15.0 111.325 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.92 26.14 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 121.769 -0.582 . . . . 15.0 113.507 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.6 pt-20 -98.64 134.89 40.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.552 0.676 . . . . 15.0 109.196 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.81 85.59 3.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.048 0.451 . . . . 15.0 110.069 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.511 ' HD2' HG23 ' B' ' 388' ' ' VAL . 0.1 OUTLIER -43.44 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.755 1.622 . . . . 15.0 111.85 172.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.24 172.69 7.01 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.961 1.304 . . . . 15.0 109.313 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.6 71.52 0.67 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.22 -1.552 . . . . 15.0 109.22 155.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.79 57.48 4.25 Favored Glycine 0 C--N 1.356 1.684 0 C-N-CA 123.915 0.769 . . . . 15.0 114.401 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 24.6 mmtt -107.15 149.87 27.21 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.617 1.167 . . . . 15.0 110.163 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.19 93.36 0.69 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.988 0.805 . . . . 15.0 109.204 173.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 129.6 36.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.2 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 66.23 32.64 7.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.312 1.045 . . . . 15.0 111.483 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.16 130.27 43.87 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.76 102.7 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.549 0.74 . . . . 15.0 109.536 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 202' ' ' ILE . 27.0 tp -93.95 91.85 7.09 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 170.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -70.15 92.7 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 173.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER -66.5 154.57 39.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.789 0.836 . . . . 15.0 111.241 -175.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.45 -19.03 13.16 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.173 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -102.69 122.82 45.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.495 0.718 . . . . 15.0 109.38 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.23 61.34 4.78 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.239 -0.744 . . . . 15.0 111.239 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -31.23 11.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.884 0.874 . . . . 15.0 109.174 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 25.9 mmt -75.07 160.78 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.973 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.2 pt -59.72 130.96 88.55 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 115.057 -0.974 . . . . 15.0 110.426 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.64 115.85 2.69 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.25 2.633 . . . . 15.0 112.215 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.53 -42.1 1.53 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.475 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.05 -65.0 0.73 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 122.687 0.395 . . . . 15.0 110.109 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 189' ' ' MET . 10.8 pt-20 -66.59 -26.43 67.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.019 0.825 . . . . 15.0 111.42 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.0 m-20 -68.31 -32.28 72.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.98 0.912 . . . . 15.0 110.62 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.45 -11.08 85.83 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.39 -0.823 . . . . 15.0 112.837 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.409 HG21 HD23 ' A' ' 187' ' ' LEU . 23.7 mm -92.11 -53.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.962 -0.755 . . . . 15.0 108.962 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.563 ' HA ' HG12 ' A' ' 158' ' ' VAL . 57.9 pttt -83.12 31.79 0.44 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.63 1.172 . . . . 15.0 112.577 -170.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.59 25.99 2.42 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.896 -0.882 . . . . 15.0 110.896 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -145.91 -166.04 2.35 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.271 1.028 . . . . 15.0 110.41 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 8.8 ptpp? -146.44 159.16 43.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.14 0.976 . . . . 15.0 110.425 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.67 145.59 55.84 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 120.733 0.302 . . . . 15.0 111.517 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.82 -44.03 1.51 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.984 -0.846 . . . . 15.0 110.984 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.6 pt-20 -77.6 129.95 36.27 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.921 -0.639 . . . . 15.0 109.695 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.94 109.8 18.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.693 -1.225 . . . . 15.0 107.693 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -128.45 -171.05 2.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.011 1.324 . . . . 15.0 110.133 -169.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 72.9 m -132.02 129.09 39.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.917 0.887 . . . . 15.0 108.867 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.9 pt -98.55 150.24 5.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.032 0.533 . . . . 15.0 110.396 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.26 112.3 24.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.84 -1.073 . . . . 15.0 108.973 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.6 166.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 67.6 m -141.44 129.19 21.64 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.22 133.41 81.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.733 -0.651 . . . . 15.0 109.584 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 221' ' ' TYR . 35.8 Cg_exo -44.45 161.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 124.234 3.289 . . . . 15.0 115.412 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -75.92 -30.08 58.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.652 -0.704 . . . . 15.0 110.349 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.38 -31.39 68.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.17 0.588 . . . . 15.0 110.525 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 218' ' ' PRO . 25.8 t80 -48.59 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.821 1.648 . . . . 15.0 110.554 -172.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.999 1.111 . . . . 15.0 113.999 -160.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.99 92.91 0.54 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 165.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.33 -41.87 85.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.952 0.901 . . . . 15.0 111.289 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.59 -15.92 43.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.082 0.953 . . . . 15.0 112.825 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.499 HD22 HG21 ' A' ' 172' ' ' VAL . 64.7 mt -107.46 -30.9 8.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.915 0.886 . . . . 15.0 111.197 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -51.78 121.31 6.36 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.336 1.455 . . . . 15.0 112.036 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.06 -22.84 12.68 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.772 0.67 . . . . 15.0 113.942 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.1 147.16 40.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.304 0.552 . . . . 15.0 111.037 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.21 111.92 23.82 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.499 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.92 133.43 34.78 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.574 0.749 . . . . 15.0 111.874 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -90.0 107.68 19.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.198 0.999 . . . . 15.0 108.574 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.26 108.64 19.31 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.397 -0.964 . . . . 15.0 108.397 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.38 96.36 4.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.765 0.426 . . . . 15.0 109.993 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 mm -87.47 128.6 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.179 0.992 . . . . 15.0 110.651 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.9 100.93 8.8 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.313 1.045 . . . . 15.0 108.216 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 166' ' ' ILE . 87.5 mt -78.6 94.61 5.05 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.036 0.446 . . . . 15.0 109.816 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.19 -44.63 7.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.123 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.717 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.7 mmtt -127.31 135.84 51.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.239 0.616 . . . . 15.0 110.036 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 207' ' ' ALA . 98.6 t -127.6 103.68 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.573 1.149 . . . . 15.0 108.623 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 29.2 mt-10 -104.03 -175.26 2.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.639 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.0 tt0 -142.89 129.64 20.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.21 -0.663 . . . . 15.0 109.21 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 -78.55 84.39 4.68 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.37 144.14 30.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.984 -1.462 . . . . 15.0 110.79 -174.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.61 119.76 53.53 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.838 0.855 . . . . 15.0 109.636 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 69.4 Cg_endo -68.2 -169.58 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.418 2.745 . . . . 15.0 112.558 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.4 148.0 46.76 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.209 -0.905 . . . . 15.0 110.759 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 25.6 tp -121.65 15.8 11.1 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.9 p -66.66 179.55 1.04 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.627 1.171 . . . . 15.0 112.135 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.13 -61.85 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.689 1.595 . . . . 15.0 114.635 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.91 -1.76 27.03 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.48 0.712 . . . . 15.0 112.806 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -99.22 -50.57 4.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.357 0.663 . . . . 15.0 109.563 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 266' ' ' LEU . 18.0 tt -64.56 -29.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.961 0.504 . . . . 15.0 111.357 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . 18.7 ptmt -76.99 -18.04 58.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.385 0.513 . . . . 15.0 112.385 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -69.11 -18.85 64.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.388 0.675 . . . . 15.0 110.909 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -74.16 -22.3 59.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.788 0.835 . . . . 15.0 111.495 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 139.74 -28.97 2.5 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 112.569 -0.212 . . . . 15.0 112.569 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.17 84.58 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.68 0.792 . . . . 15.0 109.671 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -63.69 -27.63 69.35 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.044 1.127 . . . . 15.0 114.044 -167.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -31.12 47.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.43 20.36 27.47 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.409 -0.662 . . . . 15.0 113.799 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 54.3 p -62.28 123.59 18.63 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.456 0.702 . . . . 15.0 111.091 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.81 -54.66 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.454 1.102 . . . . 15.0 111.242 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.62 -24.78 64.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.754 0.821 . . . . 15.0 111.991 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.7 -27.2 54.74 Favored Glycine 0 C--N 1.36 1.869 0 N-CA-C 110.609 -0.996 . . . . 15.0 110.609 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 253' ' ' ILE . 41.3 tp -75.1 -35.11 61.78 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -61.86 -41.79 98.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.576 0.548 . . . . 15.0 109.646 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.92 63.57 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.133 0.973 . . . . 15.0 111.065 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.05 -54.63 44.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.772 -1.104 . . . . 15.0 111.327 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 141' ' ' LEU . 30.8 m -69.07 -37.85 77.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.989 -1.005 . . . . 15.0 110.867 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -65.84 -42.98 89.84 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 119.104 0.865 . . . . 15.0 110.049 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -73.38 -26.08 60.85 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 118.364 0.529 . . . . 15.0 111.592 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -65.48 -52.8 50.32 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.659 0.742 . . . . 15.0 109.697 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.477 ' HE3' ' HB ' ' A' ' 270' ' ' VAL . 57.6 mtt -72.7 -14.97 61.69 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-N 114.59 -1.186 . . . . 15.0 111.415 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.23 -38.66 15.08 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.661 0.664 . . . . 15.0 109.922 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.45 -25.4 67.21 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.183 0.593 . . . . 15.0 110.235 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -84.5 -71.81 0.5 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.445 0.698 . . . . 15.0 110.77 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.539 HD21 HG12 ' A' ' 130' ' ' VAL . 43.3 tp -62.7 -54.23 42.46 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.042 1.337 . . . . 15.0 113.453 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 282' ' ' ILE . 38.2 ttpt -70.93 -28.57 64.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 123.454 0.471 . . . . 15.0 110.79 -172.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -64.79 -46.9 80.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.779 -0.823 . . . . 15.0 108.779 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.0 71.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.572 0.749 . . . . 15.0 111.622 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.606 HD11 ' HB ' ' A' ' 130' ' ' VAL . 96.0 mt -66.87 -55.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 N-CA-C 108.77 -0.826 . . . . 15.0 108.77 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 16.9 tpt180 -58.03 -41.53 83.39 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.087 0.867 . . . . 15.0 110.705 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.67 -32.75 70.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.154 0.582 . . . . 15.0 111.09 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -65.62 -51.94 55.75 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.1 0.409 . . . . 15.0 110.423 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 282' ' ' ILE . 21.8 t -62.03 -45.75 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.957 0.786 . . . . 15.0 109.778 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.7 tttt -64.95 -41.36 95.56 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.117 -0.947 . . . . 15.0 111.624 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.589 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 77.6 p -65.61 -42.61 91.41 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.726 0.239 . . . . 15.0 110.92 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.6 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.0 mt-30 -66.86 -34.81 78.61 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.324 0.39 . . . . 15.0 111.005 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.4 -50.31 68.11 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.807 0.443 . . . . 15.0 111.537 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 287' ' ' LYS . 31.4 mm -73.29 -55.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.408 0.683 . . . . 15.0 111.322 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.94 -27.03 68.57 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.728 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.476 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.54 -41.57 94.07 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 119.432 -0.649 . . . . 15.0 112.524 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 350' ' ' LEU . 23.0 mt -56.91 -47.43 80.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.772 0.829 . . . . 15.0 110.552 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 22.9 t -58.28 -53.89 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.689 0.757 . . . . 15.0 109.593 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.24 -18.78 65.37 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.568 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.02 -25.69 22.98 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -157.9 155.03 28.85 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.887 1.069 . . . . 15.0 113.887 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.82 145.31 55.63 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.108 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 5.9 tp -143.38 117.19 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.687 -0.688 . . . . 15.0 109.594 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -81.19 118.37 22.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.262 -1.014 . . . . 15.0 108.262 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 307' ' ' ILE . 47.0 t -110.88 100.33 45.88 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.38 1.072 . . . . 15.0 109.289 -168.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.519 ' HD2' HD11 ' A' ' 349' ' ' LEU . 58.8 Cg_endo -73.59 132.07 16.92 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.573 2.182 . . . . 15.0 112.255 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -60.21 -18.02 45.54 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.874 1.27 . . . . 15.0 112.201 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -45.86 -56.21 5.69 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.399 1.479 . . . . 15.0 111.578 171.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.44 -27.73 41.68 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.242 -1.344 . . . . 15.0 110.815 -172.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -61.21 -54.25 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.347 -0.983 . . . . 15.0 108.347 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.83 -31.47 70.46 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.81 0.694 . . . . 15.0 110.429 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 313' ' ' VAL . 41.3 t -61.8 -53.43 56.05 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 123.837 0.71 . . . . 15.0 111.231 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -80.23 -31.0 38.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.581 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 27.1 mt -59.04 -46.57 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 166.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.31 -41.63 80.26 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.888 0.875 . . . . 15.0 112.055 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' B' ' 447' ' ' HIS . 94.5 t -51.23 -58.35 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 124.291 0.994 . . . . 15.0 109.591 171.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.77 -17.0 62.21 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 113.806 -1.543 . . . . 15.0 112.436 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.5 mtm180 -76.47 -48.96 17.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.333 0.653 . . . . 15.0 109.75 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -65.32 -42.25 93.16 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.253 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.07 -38.01 89.5 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 114.915 -1.038 . . . . 15.0 110.809 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.18 -59.61 4.8 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 123.456 0.473 . . . . 15.0 109.957 175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 329' ' ' ALA . . . -56.26 -33.28 65.3 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.021 0.826 . . . . 15.0 112.405 -176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.86 -40.87 95.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.904 0.881 . . . . 15.0 110.47 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -93.31 -3.25 53.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.512 0.725 . . . . 15.0 110.955 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -95.72 9.52 40.11 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.642 1.177 . . . . 15.0 109.835 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.43 83.73 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.134 -0.484 . . . . 15.0 113.622 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.68 15.38 81.62 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 122.772 0.225 . . . . 15.0 113.017 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -74.86 152.54 38.91 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.549 0.739 . . . . 15.0 109.626 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 72.41 -70.1 0.17 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.526 1.53 . . . . 15.0 111.801 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 65.03 9.22 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.618 1.167 . . . . 15.0 112.371 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -89.3 15.56 8.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.888 1.275 . . . . 15.0 109.29 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.737 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -48.62 -33.2 9.44 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 125.754 1.622 . . . . 15.0 113.588 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.88 -29.08 26.13 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.045 0.938 . . . . 15.0 112.193 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -114.15 31.45 6.57 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.509 1.124 . . . . 15.0 110.828 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 19.6 mt -63.32 134.03 95.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-O 118.84 -0.6 . . . . 15.0 109.82 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -42.64 123.6 3.0 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 124.266 3.311 . . . . 15.0 113.479 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -52.73 -47.32 67.45 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 124.149 0.905 . . . . 15.0 111.498 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.78 -7.04 2.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.12 -43.95 63.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.397 0.544 . . . . 15.0 110.076 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.99 2.13 8.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.526 0.73 . . . . 15.0 112.614 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -58.57 -55.33 36.48 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.735 0.814 . . . . 15.0 111.007 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 40.6 tt0 -56.14 -60.9 2.83 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.796 1.31 . . . . 15.0 111.215 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.68 -38.16 90.03 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.85 -52.89 17.54 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 110.429 -0.212 . . . . 15.0 110.429 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.36 -28.1 64.81 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.908 0.755 . . . . 15.0 110.685 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.589 ' NH2' ' HA ' ' A' ' 288' ' ' SER . 0.2 OUTLIER -72.5 -36.9 68.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.887 0.875 . . . . 15.0 109.563 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.525 HH12 HG11 ' A' ' 313' ' ' VAL . 75.4 mtt180 -64.36 -35.09 79.76 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.886 0.312 . . . . 15.0 110.206 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.58 -53.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.883 0.873 . . . . 15.0 110.227 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.78 -47.28 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 114.304 -1.316 . . . . 15.0 111.239 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 351' ' ' LEU . 53.9 t -61.8 -48.25 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 15.0 110.722 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.58 95.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.695 0.622 . . . . 15.0 113.575 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.519 HD11 ' HD2' ' A' ' 303' ' ' PRO . 94.7 mt -79.74 -58.01 3.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.536 0.735 . . . . 15.0 110.96 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 294' ' ' LEU . 91.1 mt -65.31 -51.81 58.18 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.673 0.608 . . . . 15.0 111.044 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.652 HD12 HG13 ' A' ' 347' ' ' VAL . 39.8 mt -71.17 -33.68 70.23 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 118.843 -0.599 . . . . 15.0 111.222 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.66 92.05 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.78 -0.528 . . . . 15.0 111.78 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.59 -42.83 91.25 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.742 -0.729 . . . . 15.0 111.041 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 350' ' ' LEU . 89.7 t -58.99 -39.95 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 122.976 0.511 . . . . 15.0 111.3 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 360' ' ' LEU . 73.0 mt -68.83 -41.25 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.572 0.749 . . . . 15.0 110.198 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.4 ' HD3' ' OD2' ' B' ' 459' ' ' ASP . 27.9 ttp180 -60.23 -54.75 42.13 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.528 0.517 . . . . 15.0 110.631 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.3 m -60.64 -40.0 90.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.256 1.022 . . . . 15.0 111.945 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -96.6 8.62 43.74 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.511 0.725 . . . . 15.0 111.763 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 40.56 51.99 2.99 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.823 1.649 . . . . 15.0 113.648 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.618 ' HB2' HG23 ' A' ' 355' ' ' ILE . 78.5 mt -84.1 142.19 30.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.844 -1.071 . . . . 15.0 111.505 -176.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.62 151.67 49.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 167.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.24 94.87 0.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.036 0.535 . . . . 15.0 110.258 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.8 135.29 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.613 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -58.97 -35.87 73.91 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.12 0.888 . . . . 15.0 111.693 -170.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.49 -33.79 76.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.852 0.461 . . . . 15.0 110.755 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -80.89 -35.8 32.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.112 -0.495 . . . . 15.0 110.424 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 398' ' ' MET . 86.4 t -56.99 -57.57 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.441 0.697 . . . . 15.0 109.544 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -62.89 -33.11 74.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.654 0.781 . . . . 15.0 111.413 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -54.97 -55.21 29.1 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.067 0.855 . . . . 15.0 111.627 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.52 -46.02 80.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.542 0.737 . . . . 15.0 111.26 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.611 HD11 ' HG2' ' A' ' 398' ' ' MET . 47.0 mm -48.85 -61.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 124.539 1.149 . . . . 15.0 110.729 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.68 -37.69 73.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.775 0.658 . . . . 15.0 112.775 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.54 -46.84 77.98 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.043 0.449 . . . . 15.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.2 ttp -69.93 -35.98 74.98 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.432 1.093 . . . . 15.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.72 60.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.138 0.575 . . . . 15.0 112.038 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.4 t -65.83 -17.23 64.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.792 0.837 . . . . 15.0 111.501 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.03 -7.25 50.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.18 0.592 . . . . 15.0 111.664 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -103.31 166.23 10.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.238 1.015 . . . . 15.0 110.874 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.21 -29.2 63.74 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.278 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -155.12 112.71 2.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 15.0 107.7 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.46 -3.94 3.64 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.032 2.488 . . . . 15.0 115.469 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -60.69 -36.93 80.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.668 0.618 . . . . 15.0 112.668 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.1 -36.22 82.85 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.625 0.578 . . . . 15.0 109.897 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.33 -49.14 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.52 0.728 . . . . 15.0 110.121 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.93 -52.24 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 123.831 0.707 . . . . 15.0 109.9 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.33 -54.75 39.68 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.228 0.955 . . . . 15.0 110.674 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -51.09 -57.78 7.8 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.744 1.278 . . . . 15.0 111.566 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -58.37 -53.4 58.76 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.82 0.7 . . . . 15.0 110.662 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.1 p -62.71 -19.05 63.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.69 -7.01 21.01 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.448 0.699 . . . . 15.0 111.861 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 395' ' ' MET . 51.0 t-20 -121.69 86.26 2.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.959 -0.756 . . . . 15.0 108.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -58.62 -32.09 68.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.159 1.384 . . . . 15.0 111.41 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.6 -32.47 73.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.675 0.61 . . . . 15.0 110.754 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 22.3 tp -94.42 -20.18 19.94 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-O 119.464 -0.303 . . . . 15.0 111.112 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 77.2 mmm -59.38 -38.03 79.46 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.196 -0.668 . . . . 15.0 109.196 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.4 -60.24 1.57 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.869 1.268 . . . . 15.0 112.072 168.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -66.34 -34.93 79.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.178 0.991 . . . . 15.0 110.808 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.611 ' HG2' HD11 ' A' ' 371' ' ' ILE . 26.3 tpp -70.27 -27.32 64.33 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.851 0.861 . . . . 15.0 111.226 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 395' ' ' MET . 64.0 mtp85 -79.14 -35.18 42.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.48 -44.91 93.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.611 0.569 . . . . 15.0 110.244 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.0 p -75.7 -28.47 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 123.118 0.261 . . . . 15.0 111.33 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.71 -40.23 96.5 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.275 0.489 . . . . 15.0 110.278 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 355' ' ' ILE . 27.8 tp -73.38 -36.4 66.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.521 -1.218 . . . . 15.0 110.238 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.79 -51.98 67.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.26 1.024 . . . . 15.0 111.187 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 75.3 mm-40 -67.08 -40.77 87.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.401 0.68 . . . . 15.0 110.865 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 360' ' ' LEU . 23.9 tt0 -63.2 -34.3 77.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.794 0.838 . . . . 15.0 110.56 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.71 85.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.538 0.735 . . . . 15.0 111.505 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 94.4 t -52.98 -54.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 O-C-N 123.982 0.801 . . . . 15.0 108.914 171.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 412' ' ' LEU . 31.2 mt-10 -62.47 -26.61 68.61 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.799 -1.091 . . . . 15.0 112.744 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.56 74.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.036 0.534 . . . . 15.0 110.882 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 294' ' ' LEU . 57.8 t -72.63 -35.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.847 -0.798 . . . . 15.0 108.847 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 409' ' ' GLU . 81.6 mt -65.77 -37.35 86.1 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.978 0.798 . . . . 15.0 110.89 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.28 64.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.365 -0.834 . . . . 15.0 112.125 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -106.71 -27.27 10.91 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.959 0.904 . . . . 15.0 111.867 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.21 158.94 16.97 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.743 0.817 . . . . 15.0 111.93 -171.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 88.4 mttt -69.04 78.77 0.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.454 1.101 . . . . 15.0 110.351 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 125' ' ' VAL . 25.5 t -97.9 103.11 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -78.41 119.9 22.38 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.368 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 32.2 tt0 -78.61 87.23 4.56 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.733 0.778 . . . . 15.0 109.263 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -95.66 100.74 12.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.859 -1.064 . . . . 15.0 110.704 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.03 128.54 35.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 15.0 109.279 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.484 HG23 HG22 ' A' ' 130' ' ' VAL . 7.7 t -161.93 176.88 10.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.725 0.41 . . . . 15.0 111.126 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 40.6 p -106.41 171.02 7.58 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.213 1.005 . . . . 15.0 111.669 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -43.57 -60.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.042 1.737 . . . . 15.0 113.593 -168.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.36 -23.02 65.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.732 1.012 . . . . 15.0 113.732 -167.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.442 ' HG2' HG21 ' A' ' 422' ' ' THR . 15.4 tp10 -45.21 -46.78 12.48 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.895 1.278 . . . . 15.0 112.966 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.66 -31.06 41.42 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.799 0.84 . . . . 15.0 110.943 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -71.74 -31.83 67.08 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.448 0.699 . . . . 15.0 110.04 175.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -75.72 20.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.27 1.028 . . . . 15.0 113.627 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.79 64.41 5.57 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.515 0.674 . . . . 15.0 109.831 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.01 102.18 14.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.23 1.012 . . . . 15.0 110.408 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ALA . . . . . 0.426 ' HB3' ' HD1' ' B' ' 377' ' ' PHE . . . . . . . . 0 CA--C 1.552 1.028 0 C-N-CA 124.518 1.127 . . . . 15.0 109.683 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.443 0.639 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.83 136.09 5.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.395 1.078 . . . . 0.0 108.84 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.87 -81.94 0.48 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' B' ' 372' ' ' GLN . 12.4 t70 -91.45 -75.71 0.47 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' B' ' 373' ' ' ARG . 39.7 tt0 -104.02 -78.68 0.55 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.661 0.384 . . . . 0.0 110.428 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -104.38 -77.63 0.57 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.102 0.561 . . . . 0.0 110.258 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.62 -82.96 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.502 ' O ' ' HB3' ' B' ' 368' ' ' ASP . 0.0 OUTLIER -101.69 -79.54 0.51 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 161.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.487 ' H ' ' HG2' ' B' ' 372' ' ' GLN . 35.8 tpt85 -100.07 -85.18 0.41 Allowed 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.737 1.153 . . . . 0.0 111.653 -176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -106.67 -80.8 0.56 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -168.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.49 ' H ' HD12 ' B' ' 375' ' ' LEU . 0.2 OUTLIER -109.37 -79.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.797 0.439 . . . . 0.0 111.921 -169.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.22 -75.79 0.5 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.426 ' HD1' ' HB3' ' A' ' 432' ' ' ALA . 90.1 m-85 -105.31 -87.63 0.45 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.712 0.405 . . . . 0.0 110.546 167.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -106.35 -81.13 0.55 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.561 0.744 . . . . 0.0 111.902 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 -56.27 2.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.855 0.862 . . . . 0.0 113.237 -165.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? 75.02 149.04 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.368 1.467 . . . . 0.0 109.852 -158.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.83 166.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 382' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' B' ' 391' ' ' ASP . . . -148.75 84.17 0.17 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.189 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -61.41 97.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.791 0.836 . . . . 0.0 111.419 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 3.3 t -85.61 85.31 7.42 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 122.088 0.947 . . . . 0.0 110.347 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 19.6 tp -146.11 167.58 23.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.776 1.23 . . . . 0.0 107.745 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.38 91.32 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 118.999 0.818 . . . . 0.0 109.173 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.426 HG13 ' OH ' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -145.14 162.6 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 126.107 1.763 . . . . 0.0 108.088 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 177' ' ' PHE . 28.8 t -55.78 138.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 8.7 t -57.4 96.13 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.934 1.35 . . . . 0.0 112.277 -170.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -92.8 -169.39 2.17 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.738 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.497 ' O ' ' HA2' ' B' ' 382' ' ' GLY . 5.6 m-20 -40.86 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.393 1.477 . . . . 0.0 111.497 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -120.92 60.06 0.92 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -79.07 75.73 5.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.149 0.976 . . . . 0.0 110.248 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -100.94 -23.45 14.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.898 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 66.09 -72.97 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.505 1.522 . . . . 0.0 111.963 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t 69.0 13.94 8.82 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.797 1.239 . . . . 0.0 111.819 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 62.0 -74.57 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.349 1.46 . . . . 0.0 110.624 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.26 125.84 43.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.26 94.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -166.94 145.01 4.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.281 1.032 . . . . 0.0 108.817 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.25 109.93 1.67 Allowed 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.392 2.061 . . . . 0.0 110.77 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.14 170.79 14.2 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.105 0.562 . . . . 0.0 110.581 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 14.8 t -143.22 155.56 44.55 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.616 0.366 . . . . 0.0 110.731 -171.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 7.27 6.15 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.765 1.626 . . . . 0.0 112.625 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' B' ' 406' ' ' PRO . . . -70.75 -37.21 6.15 Favored Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.721 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 405' ' ' ALA . 30.7 Cg_endo -61.68 -10.68 17.57 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 122.037 1.825 . . . . 0.0 113.324 172.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -78.75 78.91 1.61 Allowed Glycine 0 C--N 1.353 1.479 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.45 81.27 2.5 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.329 0.652 . . . . 0.0 110.506 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 36.1 p -79.14 99.91 7.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 171.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -79.11 70.87 5.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.377 0.608 . . . . 0.0 109.809 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.43 -23.24 61.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.903 0.881 . . . . 0.0 111.227 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.81 -11.39 55.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.463 0.705 . . . . 0.0 111.149 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -105.46 -82.62 0.52 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 15.0 t -172.57 167.25 5.51 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.142 0.977 . . . . 0.0 110.192 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -158.4 149.57 20.81 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 108.943 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -67.31 -49.1 65.55 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.326 0.65 . . . . 0.0 110.413 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 53.75 -97.83 0.03 OUTLIER Glycine 0 C--N 1.362 1.992 0 O-C-N 124.11 0.881 . . . . 0.0 113.534 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.48 145.69 47.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 46.2 t -70.87 82.75 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 122.187 0.994 . . . . 0.0 109.471 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 52.0 tpp -98.41 -76.51 0.53 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.857 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 44.6 t 50.77 -79.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.96 1.704 . . . . 0.0 112.69 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 22.2 mmt 66.56 175.5 0.24 Allowed 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.702 1.601 . . . . 0.0 111.778 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 50.9 p -73.37 -40.92 64.0 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 2.5 t80 65.64 -69.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.923 1.689 . . . . 0.0 111.035 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.08 -95.13 0.1 OUTLIER Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -177.83 -54.92 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.098 0.959 . . . . 0.0 109.291 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 34.2 t -148.42 77.19 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.11 -21.11 3.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.521 1.128 . . . . 0.0 111.328 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.54 -36.62 84.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.38 1.072 . . . . 0.0 110.045 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 430' ' ' ASP . . . . . 0.454 ' HB2' ' CZ ' ' B' ' 440' ' ' ARG . 8.6 p-10 -84.22 -23.52 30.44 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.593 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 32.9 t -67.28 -21.22 65.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.65 0.78 . . . . 0.0 111.018 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -64.98 -24.46 67.52 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.026 0.931 . . . . 0.0 110.852 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.25 -78.2 0.09 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 162.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -164.34 177.37 8.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.297 1.439 . . . . 0.0 108.964 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 30.7 m -69.42 100.57 1.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.691 0.796 . . . . 0.0 109.718 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 83.32 163.81 35.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.004 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 124.4 20.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.439 0.696 . . . . 0.0 111.063 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -116.53 -30.07 5.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.293 1.037 . . . . 0.0 110.213 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.03 -83.31 0.42 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' B' ' 441' ' ' ILE . 23.8 ttm180 53.46 -161.23 0.12 Allowed 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 124.475 1.11 . . . . 0.0 111.9 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.584 ' H ' ' HG2' ' B' ' 440' ' ' ARG 0.306 0.0 OUTLIER 58.09 -78.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 C-N-CA 126.508 1.923 . . . . 0.0 113.353 163.428 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 442' ' ' ALA . . . . . 0.447 ' H ' HG23 ' B' ' 441' ' ' ILE . . . -155.41 -84.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 59.43 13.03 2.99 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 124.501 1.121 . . . . 0.0 113.457 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 59.45 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.215 1.406 . . . . 0.0 112.929 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.19 88.33 0.35 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.655 -2.578 . . . . 0.0 106.655 -165.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -88.82 176.7 3.27 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.441 2.761 . . . . 0.0 111.89 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 447' ' ' HIS . . . . . 0.648 ' HA ' HG22 ' A' ' 313' ' ' VAL . 3.1 t60 -71.5 93.62 1.21 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.887 0.475 . . . . 0.0 110.54 -173.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 66.4 -72.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.546 1.538 . . . . 0.0 110.512 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -111.23 176.53 4.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.105 0.962 . . . . 0.0 109.189 171.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.6 -63.47 1.29 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.791 . . . . 0.0 111.129 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.1 -47.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 165.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.1 t 53.32 74.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 124.932 1.293 . . . . 0.0 110.034 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 83.88 119.54 0.75 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.964 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.38 -48.04 74.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.807 0.843 . . . . 0.0 110.207 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 65.9 p 48.35 31.04 2.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.117 1.767 . . . . 0.0 113.664 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -149.86 138.59 20.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -65.0 -33.29 75.69 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.823 0.702 . . . . 0.0 111.911 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 8.0 t 32.48 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.95 2.1 . . . . 0.0 114.971 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 459' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 356' ' ' ARG . 2.3 p-10 -56.22 -31.32 63.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.132 -168.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.611 HD13 ' HB ' ' B' ' 463' ' ' THR . 0.3 OUTLIER -101.38 36.47 2.01 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.182 -177.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . 0.304 19.3 p90 67.76 -39.91 0.4 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 128.256 2.622 . . . . 0.0 116.656 169.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -177.83 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.274 1.03 . . . . 0.0 109.652 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.611 ' HB ' HD13 ' B' ' 460' ' ' LEU . 72.4 m -34.95 118.2 0.42 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.719 1.607 . . . . 0.0 114.612 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' B' ' 467' ' ' ALA . 24.5 mmt 64.71 119.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.161 1.384 . . . . 0.0 112.302 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.25 -25.01 66.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.085 0.554 . . . . 0.0 110.521 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -96.03 17.99 14.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.528 1.131 . . . . 0.0 111.454 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' B' ' 464' ' ' MET . . . -146.22 94.53 2.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.121 0.569 . . . . 0.0 109.675 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.78 -166.36 1.45 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.722 0.809 . . . . 0.0 109.889 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.75 -169.26 22.94 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.567 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -155.55 -36.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.412 0.685 . . . . 0.0 110.408 -174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.725 ' HG3' ' HB3' ' A' ' 83' ' ' LYS . 4.2 ttmp? . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.304 1.042 . . . . 12.06 108.293 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 23.3 ptm . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.5 -0.185 . . . . 15.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -150.91 113.29 4.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 17' ' ' ILE . 28.9 m -123.67 146.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.695 0.798 . . . . 15.0 110.29 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 p -137.36 115.47 11.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.377 0.671 . . . . 15.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.33 131.99 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.096 0.559 . . . . 15.0 111.094 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -135.34 148.71 49.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.841 1.256 . . . . 15.0 108.443 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 m -93.46 112.06 23.87 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.538 -0.541 . . . . 15.0 109.538 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -80.52 -44.33 19.3 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.974 0.51 . . . . 15.0 111.284 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -167.42 94.52 0.44 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.344 0.657 . . . . 15.0 109.786 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.36 -102.86 0.41 Allowed Glycine 0 C--N 1.352 1.461 0 O-C-N 123.958 0.786 . . . . 15.0 113.765 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD13 ' HB3' ' A' ' 113' ' ' PRO . 50.9 tp -68.49 -35.25 77.25 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.879 0.872 . . . . 15.0 110.733 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.43 135.26 22.03 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.138 -0.937 . . . . 15.0 112.079 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.6 -177.31 4.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.921 1.288 . . . . 15.0 109.757 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -150.15 110.52 4.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.89 0.876 . . . . 15.0 109.709 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.3 t -98.56 92.03 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.709 -0.848 . . . . 15.0 108.709 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 44.8 m -75.11 105.03 5.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.554 0.742 . . . . 15.0 109.87 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 3' ' ' VAL . 35.8 mt -93.31 115.77 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.857 -0.611 . . . . 15.0 109.6 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -92.71 96.41 10.15 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.433 -0.951 . . . . 15.0 108.433 166.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 70' ' ' LEU . 74.3 mt -73.27 98.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 171.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.93 162.64 23.84 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.232 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.6 -22.35 55.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.572 1.149 . . . . 15.0 113.955 -170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.84 -42.89 89.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.884 0.474 . . . . 15.0 110.508 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -73.68 -36.57 65.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.493 -0.776 . . . . 15.0 110.923 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 28' ' ' VAL . 56.5 mt -68.07 -59.05 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.933 0.493 . . . . 15.0 110.204 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.37 -41.84 97.74 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.217 1.007 . . . . 15.0 112.291 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 m -64.99 -42.11 94.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.647 0.592 . . . . 15.0 110.979 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.31 71.41 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 15.0 112.007 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.446 ' HA ' HG21 ' A' ' 66' ' ' VAL . 79.5 t -62.82 -45.43 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 15.0 110.31 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 3.8 ttmp? -66.27 -39.27 89.33 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.249 -1.341 . . . . 15.0 110.367 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 m -72.27 -21.91 61.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.12 0.968 . . . . 15.0 111.01 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.8 tp10 -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.658 0.383 . . . . 15.0 111.221 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 55' ' ' ALA . 36.2 mt -68.53 -26.54 65.48 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.382 0.273 . . . . 15.0 111.7 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 p -76.54 -29.2 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 123.245 0.34 . . . . 15.0 110.097 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -66.29 -46.33 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.967 0.507 . . . . 15.0 109.934 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 61.0 t -65.54 -37.54 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.983 0.913 . . . . 15.0 110.167 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.24 92.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.32 0.648 . . . . 15.0 111.182 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.58 -23.87 39.59 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.923 0.489 . . . . 15.0 111.513 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.98 -49.3 38.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.613 0.765 . . . . 15.0 110.188 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.38 -5.91 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.944 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 69.47 21.1 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.097 1.359 . . . . 15.0 111.95 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -64.37 -26.28 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 124.331 1.052 . . . . 15.0 111.126 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -59.38 -36.69 76.25 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.112 0.965 . . . . 15.0 111.627 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.54 -10.92 80.08 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.359 -0.382 . . . . 15.0 113.598 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -119.23 2.23 11.36 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.037 0.935 . . . . 15.0 110.774 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.5 ttt85 -76.86 94.86 3.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.288 0.635 . . . . 15.0 110.027 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -80.3 86.5 5.67 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.397 -0.82 . . . . 15.0 110.835 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 37.26 -56.57 0.0 OUTLIER Glycine 0 CA--C 1.55 2.266 0 N-CA-C 120.142 2.817 . . . . 15.0 120.142 160.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -43.09 -47.9 6.13 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.205 1.802 . . . . 15.0 114.228 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.44 106.37 16.31 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.75 0.42 . . . . 15.0 110.192 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 53' ' ' ILE . 3.5 Cg_exo -78.84 156.63 27.31 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.514 2.809 . . . . 15.0 112.299 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 54' ' ' VAL . 58.9 tpp -70.58 -27.18 63.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.863 0.865 . . . . 15.0 111.752 -172.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.7 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 34.0 p-10 -69.84 -28.97 66.13 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.849 0.46 . . . . 15.0 111.924 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.524 HG23 ' HD2' ' A' ' 57' ' ' ARG . 12.3 mt -72.36 -51.89 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.665 0.786 . . . . 15.0 110.14 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 33.8 m -68.61 -25.6 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.47 0.545 . . . . 15.0 112.47 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -60.35 -41.12 92.96 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.393 0.677 . . . . 15.0 112.59 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.25 -3.56 11.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 -170.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 53' ' ' ILE . 75.9 mtt180 -115.64 -45.84 2.88 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.135 0.425 . . . . 15.0 111.623 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.46 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 94.9 m-85 -104.69 -39.01 6.5 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.202 0.816 . . . . 15.0 113.202 -168.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.84 39.5 2.78 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 112.492 -0.243 . . . . 15.0 112.492 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.58 61.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.906 0.882 . . . . 15.0 112.098 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p -73.71 -35.58 65.13 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.062 0.945 . . . . 15.0 111.088 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -69.13 -25.22 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.724 0.81 . . . . 15.0 110.622 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.543 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 25.3 mtp180 -61.1 -22.1 64.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.643 0.777 . . . . 15.0 111.951 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.73 -54.23 49.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.136 0.975 . . . . 15.0 111.232 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 -27.46 66.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 28' ' ' VAL . 94.7 t -64.85 -43.28 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 123.61 0.568 . . . . 15.0 109.76 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 91.5 mt -62.37 -41.65 98.8 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.997 0.519 . . . . 15.0 111.162 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.62 99.13 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.644 0.59 . . . . 15.0 112.282 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.66 -41.17 96.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.384 1.074 . . . . 15.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.692 ' HB3' HD13 ' A' ' 19' ' ' ILE . 71.2 mt -67.84 -34.53 76.89 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.661 -0.7 . . . . 15.0 111.01 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.2 mtm -67.8 -20.69 65.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.566 0.346 . . . . 15.0 111.255 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -87.2 -55.7 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 15.0 110.203 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -72.76 -39.09 67.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.463 0.705 . . . . 15.0 112.544 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -73.22 -27.07 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 117.875 0.307 . . . . 15.0 110.704 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.87 -54.12 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.222 -0.288 . . . . 15.0 110.222 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.421 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.3 tt -65.04 -37.32 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 123.423 0.452 . . . . 15.0 110.896 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.665 0.786 . . . . 15.0 110.653 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.03 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.48 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 33.3 pt -67.06 -23.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 112.717 0.636 . . . . 15.0 112.717 -172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.39 -53.4 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.452 0.701 . . . . 15.0 110.652 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -75.1 -29.5 60.62 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.607 0.363 . . . . 15.0 111.455 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -84.31 -16.35 43.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.278 0.631 . . . . 15.0 111.454 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 66.77 14.06 9.64 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.64 1.176 . . . . 15.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.436 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 74.7 mt -77.24 105.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' ND2' ' HG ' ' B' ' 470' ' ' LEU . 43.7 t30 -81.0 110.03 15.98 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.45 148.53 38.14 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.585 2.19 . . . . 15.0 112.957 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 303' ' ' PRO . . . -152.65 -177.74 6.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.505 0.722 . . . . 15.0 109.856 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 305' ' ' ALA . . . 64.1 -102.13 0.56 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.86 116.34 2.43 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 107.826 -1.175 . . . . 15.0 107.826 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 43.5 Cg_exo -59.59 105.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 121.687 1.591 . . . . 15.0 110.249 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 m -101.71 99.26 9.5 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.247 -0.649 . . . . 15.0 109.247 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.39 78.19 3.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.636 0.774 . . . . 15.0 109.134 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.05 109.47 3.29 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.46 106.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.118 2.545 . . . . 15.0 111.961 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.85 -79.32 0.57 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.243 -0.743 . . . . 15.0 111.243 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -168.16 151.2 5.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.4 0.68 . . . . 15.0 111.533 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.79 142.21 44.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.601 1.16 . . . . 15.0 109.398 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.2 mttt -133.54 142.83 48.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.259 1.024 . . . . 15.0 108.773 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -61.61 106.18 0.63 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 15.0 110.251 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.64 -17.52 58.79 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 116.038 -0.528 . . . . 15.0 113.477 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 43.4 mt-10 -97.94 -173.52 2.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.563 0.745 . . . . 15.0 110.095 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -72.78 160.09 32.74 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.909 0.883 . . . . 15.0 112.492 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -121.55 106.12 11.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.73 1.212 . . . . 15.0 108.56 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 m -105.07 139.52 39.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.624 0.77 . . . . 15.0 109.93 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -159.96 143.58 14.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.027 0.931 . . . . 15.0 108.818 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.8 m -100.64 107.99 19.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.72 0.808 . . . . 15.0 110.565 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.15 97.69 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.98 -0.748 . . . . 15.0 108.98 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.3 123.05 35.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.229 0.612 . . . . 15.0 109.882 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 47.1 p90 -159.52 157.85 30.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.772 0.829 . . . . 15.0 110.276 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.3 176.63 7.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 15.0 109.994 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.36 175.96 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' B' ' 471' ' ' LYS . 94.4 m-85 -89.76 118.08 68.67 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.63 ' HG2' HD11 ' A' ' 300' ' ' ILE . 58.6 Cg_endo -88.53 173.03 4.63 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.606 2.204 . . . . 15.0 114.427 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.65 134.68 33.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.123 -1.399 . . . . 15.0 109.059 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.49 126.98 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.417 -0.586 . . . . 15.0 109.417 172.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -84.3 94.13 8.38 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.4 145.25 54.5 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.141 -0.936 . . . . 15.0 108.763 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -79.15 173.83 12.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.58 109.86 2.43 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.548 -1.021 . . . . 15.0 110.548 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.433 HD13 HG22 ' A' ' 411' ' ' VAL . 47.1 mt -66.8 -14.12 62.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.609 0.763 . . . . 15.0 111.246 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.96 -22.61 63.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.289 . . . . 15.0 111.289 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.74 62.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.773 0.829 . . . . 15.0 110.947 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.04 131.34 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.619 0.768 . . . . 15.0 109.657 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.25 123.84 49.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.911 0.884 . . . . 15.0 109.618 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 417' ' ' VAL . 61.4 t -125.27 163.66 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.838 1.255 . . . . 15.0 107.917 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.34 143.97 48.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.532 0.733 . . . . 15.0 109.262 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 129' ' ' ILE . 80.6 tttt -114.87 93.52 34.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.133 -1.062 . . . . 15.0 108.133 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.79 98.61 1.22 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.17 1.914 . . . . 15.0 112.289 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 127' ' ' LYS . 48.5 mm -72.52 96.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 427' ' ' LEU . 21.0 t -122.74 142.82 37.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.526 -0.761 . . . . 15.0 109.997 -173.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.47 146.25 39.81 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.817 0.847 . . . . 15.0 108.932 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.54 88.81 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.5 p -76.24 -179.85 5.31 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.894 0.878 . . . . 15.0 110.339 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.92 -37.59 74.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.444 0.698 . . . . 15.0 111.689 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.8 96.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 15.0 111.492 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.45 -42.94 52.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.808 0.843 . . . . 15.0 111.556 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.79 -56.44 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.902 0.881 . . . . 15.0 109.489 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.37 -45.89 92.49 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.175 0.99 . . . . 15.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.33 -46.91 89.35 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.919 0.762 . . . . 15.0 113.333 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.24 -51.68 50.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.143 0.577 . . . . 15.0 110.896 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.2 mt -53.91 -39.39 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.569 0.748 . . . . 15.0 111.86 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.43 -40.9 85.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.925 0.49 . . . . 15.0 111.027 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 m -67.89 -26.74 66.16 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.752 0.421 . . . . 15.0 110.756 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.86 -37.73 76.19 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.852 0.461 . . . . 15.0 110.333 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -64.68 -35.06 79.82 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.707 0.289 . . . . 15.0 110.424 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -69.3 -34.6 74.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.306 0.642 . . . . 15.0 111.099 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.66 -41.26 79.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 15.0 109.98 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -95.1 29.66 2.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.027 0.931 . . . . 15.0 111.184 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.09 135.48 46.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.106 0.562 . . . . 15.0 112.434 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.1 m -83.54 138.85 33.22 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.625 1.17 . . . . 15.0 110.25 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -80.16 139.17 36.91 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.829 0.452 . . . . 15.0 110.236 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 33.1 ttpt -156.98 172.99 17.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.09 -1.078 . . . . 15.0 108.09 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 41.6 mt-10 -121.64 165.72 15.33 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.97 0.908 . . . . 15.0 110.035 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.533 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 41.6 pttt -156.78 -179.92 8.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.031 0.933 . . . . 15.0 110.87 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.03 146.95 28.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.977 0.511 . . . . 15.0 109.655 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.19 -50.21 0.88 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.0 -0.889 . . . . 15.0 113.533 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 206' ' ' LYS . . . -153.57 153.89 33.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.465 1.132 . . . . 15.0 112.234 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.84 157.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.47 1.108 . . . . 15.0 109.517 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -138.51 -174.88 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.485 1.914 . . . . 15.0 108.252 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.531 ' HA ' ' HE1' ' A' ' 189' ' ' MET . . . -84.08 -8.73 59.03 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.459 0.911 . . . . 15.0 113.459 -174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.52 -6.5 20.55 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.143 0.429 . . . . 15.0 112.021 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -81.61 178.4 8.36 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.054 1.131 . . . . 15.0 114.054 -165.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.717 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 16.0 mtm180 -116.27 98.77 6.78 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.833 -1.076 . . . . 15.0 108.503 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.01 97.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 -169.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 9.0 m -73.32 111.73 8.72 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.851 -1.166 . . . . 15.0 107.851 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.8 pt -132.95 179.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.422 1.089 . . . . 15.0 110.924 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.8 t70 -130.04 157.53 42.1 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.179 1.391 . . . . 15.0 107.713 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' B' ' 385' ' ' LEU . 24.4 p90 -144.61 150.59 37.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.636 0.731 . . . . 15.0 111.074 164.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.536 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 1.8 t -125.99 95.12 4.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 106.467 -1.679 . . . . 15.0 106.467 166.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.96 166.77 31.34 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 114.93 -1.032 . . . . 15.0 115.067 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -151.19 141.97 22.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.964 1.306 . . . . 15.0 108.283 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.3 t -118.55 137.52 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.584 0.754 . . . . 15.0 109.141 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.544 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 35.3 t70 70.48 5.83 5.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.721 1.208 . . . . 15.0 111.875 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.31 -1.0 46.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.722 -0.488 . . . . 15.0 113.37 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.01 145.41 49.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.627 0.771 . . . . 15.0 110.576 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -76.01 110.48 10.52 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.149 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 172' ' ' VAL . 32.7 p90 -70.84 170.38 12.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.219 0.608 . . . . 15.0 111.259 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -69.68 134.56 48.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.63 -1.168 . . . . 15.0 111.057 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.587 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 88.25 -78.64 1.75 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 -52.4 4.17 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.412 0.925 . . . . 15.0 115.412 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.536 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 40.6 mmtt -85.9 145.97 26.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.913 1.079 . . . . 15.0 113.913 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.05 92.48 1.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.658 -1.61 . . . . 15.0 106.933 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -96.32 143.78 27.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.308 -0.86 . . . . 15.0 110.967 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' B' ' 379' ' ' LYS . 7.5 t70 65.75 21.92 11.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.338 1.055 . . . . 15.0 111.373 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 165' ' ' THR . 46.7 t80 -71.59 134.23 46.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.225 0.61 . . . . 15.0 110.579 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.35 103.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.794 -0.817 . . . . 15.0 108.794 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HG ' ' HG2' ' A' ' 189' ' ' MET . 27.0 tp -82.8 80.1 8.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 15.0 110.047 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.54 92.44 0.31 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.691 -1.226 . . . . 15.0 107.691 167.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.531 ' HE1' ' HA ' ' A' ' 160' ' ' ALA . 62.5 mtp -66.98 144.64 56.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.394 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.12 14.57 Favored Glycine 0 N--CA 1.471 0.978 0 O-C-N 123.496 0.498 . . . . 15.0 112.494 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.44 -178.96 3.65 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.27 1.028 . . . . 15.0 110.339 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.17 6.93 56.5 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 115.912 -0.586 . . . . 15.0 113.518 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -77.84 2.09 18.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.098 0.559 . . . . 15.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.7 mmt -134.74 154.53 51.54 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.911 0.884 . . . . 15.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.57 152.84 37.94 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 114.757 -1.11 . . . . 15.0 109.374 170.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.93 143.97 46.95 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.03 2.487 . . . . 15.0 112.928 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.24 -40.29 2.47 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 115.803 -0.635 . . . . 15.0 112.164 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -67.85 -63.81 0.99 Allowed 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.28 -24.57 67.36 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.437 -0.801 . . . . 15.0 112.077 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.91 -37.59 81.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.083 0.953 . . . . 15.0 110.682 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.78 -10.95 80.79 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.468 -0.787 . . . . 15.0 113.075 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.448 HG21 HD23 ' A' ' 187' ' ' LEU . 42.9 mm -94.84 -47.12 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.763 0.825 . . . . 15.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -82.41 19.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.325 1.232 . . . . 15.0 114.325 -167.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.78 25.39 5.31 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.99 -1.244 . . . . 15.0 109.99 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -140.71 -169.96 2.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.729 1.211 . . . . 15.0 110.213 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -153.52 163.56 39.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.996 0.918 . . . . 15.0 110.675 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -68.07 132.2 46.81 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.38 0.672 . . . . 15.0 112.06 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 126.77 -28.24 4.71 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.761 -1.109 . . . . 15.0 111.799 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.8 pt-20 -96.14 139.32 32.48 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.727 0.775 . . . . 15.0 111.455 -174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.27 125.8 51.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.981 1.313 . . . . 15.0 108.948 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -144.38 169.67 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.073 0.949 . . . . 15.0 109.769 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 70.2 m -124.34 120.45 32.17 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -95.64 160.48 2.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.497 0.719 . . . . 15.0 111.207 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -104.92 118.42 36.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.99 -1.005 . . . . 15.0 109.903 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.6 163.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 87.3 m -146.26 131.9 18.86 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.971 -1.122 . . . . 15.0 107.971 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.473 ' HZ ' ' HB ' ' B' ' 387' ' ' ILE . 73.0 m-85 -68.23 135.47 91.32 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 110.128 -0.323 . . . . 15.0 110.128 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.21 156.68 19.91 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.161 2.574 . . . . 15.0 113.515 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.609 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -75.22 -20.71 59.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.917 169.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.22 -16.7 57.59 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.914 0.886 . . . . 15.0 111.21 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.443 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 69.5 t80 -60.66 142.09 56.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.069 0.948 . . . . 15.0 111.616 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -65.03 -44.95 87.45 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.027 0.931 . . . . 15.0 112.76 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.443 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -88.2 104.11 16.4 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.8 tt0 -63.3 -21.08 66.03 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.672 1.189 . . . . 15.0 112.428 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.448 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 29.6 p30 -68.14 -10.56 55.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.809 0.843 . . . . 15.0 112.518 174.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 388' ' ' VAL . 79.1 mt -121.39 -36.91 2.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.235 1.014 . . . . 15.0 110.05 175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.799 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 9.3 tttm -53.48 128.89 30.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.779 1.632 . . . . 15.0 111.991 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.02 16.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.998 -0.547 . . . . 15.0 113.22 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 173' ' ' ASP . 93.3 mttt -86.24 147.44 26.1 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.379 0.672 . . . . 15.0 110.343 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.25 166.63 22.48 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.728 0.643 . . . . 15.0 110.416 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.02 119.62 5.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.39 0.676 . . . . 15.0 109.816 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -98.86 134.45 41.72 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -128.54 110.73 12.54 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.87 0.468 . . . . 15.0 110.273 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.8 91.73 4.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.405 0.622 . . . . 15.0 109.342 176.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 168' ' ' PHE . 33.6 mm -81.16 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.926 1.29 . . . . 15.0 110.636 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 2.3 m120 -111.3 97.25 6.64 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.463 -1.31 . . . . 15.0 107.463 176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -81.41 118.55 22.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -115.46 -37.49 4.0 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.588 0.355 . . . . 15.0 111.618 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.723 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.0 mmtt -135.87 142.97 44.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.999 0.52 . . . . 15.0 110.235 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 207' ' ' ALA . 41.8 t -118.45 94.49 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.644 -1.243 . . . . 15.0 107.644 169.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.7 mt-10 -88.28 167.01 13.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.8 tt0 -138.9 130.54 27.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.949 0.499 . . . . 15.0 109.823 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -86.14 85.8 7.35 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.673 -1.232 . . . . 15.0 107.673 166.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.76 134.7 53.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.856 -1.065 . . . . 15.0 109.837 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.41 126.59 87.46 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.788 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 63.9 Cg_endo -68.93 157.95 59.84 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.958 2.439 . . . . 15.0 111.917 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -70.9 160.13 33.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.938 -1.028 . . . . 15.0 110.415 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.4 tp -88.3 30.01 0.92 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.622 0.769 . . . . 15.0 109.83 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.6 p -70.14 169.57 13.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.518 1.127 . . . . 15.0 111.623 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -37.97 -65.86 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.082 1.753 . . . . 15.0 114.72 -166.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.01 -22.57 66.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.678 0.791 . . . . 15.0 112.611 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -86.74 -49.87 7.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.061 0.544 . . . . 15.0 110.465 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.41 -31.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.758 0.423 . . . . 15.0 110.78 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.3 ptmt -98.97 5.14 47.33 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -61.27 -31.11 70.93 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.377 0.671 . . . . 15.0 110.777 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.12 -18.72 64.71 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.087 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.67 45.45 1.79 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.703 -0.559 . . . . 15.0 111.703 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 260' ' ' ASP . 65.8 t -71.91 149.28 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.717 0.807 . . . . 15.0 111.431 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -55.97 -41.51 74.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.478 1.111 . . . . 15.0 111.601 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.518 ' H ' HG12 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -128.36 -47.97 1.31 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.581 -175.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 114.73 -12.62 20.57 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.634 -0.536 . . . . 15.0 113.373 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 94.2 p -73.47 167.64 20.88 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.558 0.679 . . . . 15.0 110.955 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.85 -49.41 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.124 0.97 . . . . 15.0 111.257 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.32 -28.8 68.42 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.314 0.646 . . . . 15.0 111.715 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.67 -26.13 57.11 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.129 -0.788 . . . . 15.0 111.129 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 270' ' ' VAL . 63.9 tp -74.71 -33.7 62.46 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -61.57 -40.08 93.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.396 0.679 . . . . 15.0 109.919 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.6 86.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.698 0.799 . . . . 15.0 111.317 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.3 -49.49 64.01 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.661 0.784 . . . . 15.0 110.516 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.483 ' HA ' ' SD ' ' A' ' 274' ' ' MET . 70.2 t -61.67 -33.67 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.736 1.214 . . . . 15.0 109.75 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -62.85 -61.65 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.493 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -71.71 -15.73 62.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.774 0.657 . . . . 15.0 112.774 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -89.27 -78.78 0.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' A' ' 270' ' ' VAL . 1.7 mpt? -62.85 -50.58 70.37 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.656 -0.687 . . . . 15.0 111.553 -169.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.15 -34.32 56.49 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.586 0.63 . . . . 15.0 111.656 -170.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -73.57 -44.08 58.21 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.942 -0.392 . . . . 15.0 109.942 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.03 -37.87 88.92 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.609 0.568 . . . . 15.0 109.783 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.13 -60.87 2.85 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.405 0.682 . . . . 15.0 111.354 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.83 -29.47 69.94 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.726 0.641 . . . . 15.0 111.281 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -65.34 -46.11 81.55 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.68 -30.72 68.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.772 0.829 . . . . 15.0 111.761 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.1 mt -67.88 -51.42 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.565 HH21 ' HB3' ' A' ' 405' ' ' GLU . 22.9 tpt180 -61.05 -41.84 97.36 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.351 -0.84 . . . . 15.0 110.429 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -72.09 -30.27 64.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.799 -0.619 . . . . 15.0 110.851 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -64.24 -57.89 8.15 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.985 0.514 . . . . 15.0 109.672 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 282' ' ' ILE . 42.1 t -57.33 -46.17 85.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 124.263 0.977 . . . . 15.0 110.216 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -59.45 -55.75 30.67 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.749 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -65.15 -28.86 69.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.311 0.644 . . . . 15.0 111.995 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.496 ' HB2' HG13 ' A' ' 125' ' ' VAL . 58.6 mt-30 -68.29 -44.32 75.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.563 0.345 . . . . 15.0 110.506 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.34 -42.32 96.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.578 0.351 . . . . 15.0 111.202 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -60.35 -53.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 15.0 111.01 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.78 -41.23 99.16 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.985 0.803 . . . . 15.0 110.271 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.19 91.88 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.939 0.775 . . . . 15.0 112.095 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 411' ' ' VAL . 35.1 mt -59.03 -56.73 18.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.96 0.904 . . . . 15.0 111.846 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.31 -53.73 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.581 0.551 . . . . 15.0 110.3 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.88 -40.3 75.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.499 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.58 -33.93 67.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.022 -0.536 . . . . 15.0 112.224 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -116.76 103.85 10.76 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.038 0.381 . . . . 15.0 111.433 -163.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -74.11 144.52 44.9 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.63 HD11 ' HG2' ' A' ' 113' ' ' PRO . 5.3 tp -165.08 130.39 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.408 0.683 . . . . 15.0 110.214 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.58 95.88 4.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.505 HG11 HG12 ' A' ' 345' ' ' VAL . 22.7 t -89.04 128.02 53.43 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 109.264 -0.643 . . . . 15.0 109.264 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 54.3 Cg_endo -68.2 135.12 33.44 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.466 2.111 . . . . 15.0 111.858 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -64.5 -4.77 4.33 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.095 1.146 . . . . 15.0 114.095 -171.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 88' ' ' GLY . . . -56.83 -55.14 38.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.989 0.915 . . . . 15.0 110.803 174.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.57 -35.63 77.64 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.654 1.221 . . . . 15.0 110.89 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.626 ' HA ' HG21 ' A' ' 345' ' ' VAL . 2.1 mp -60.33 -56.68 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.964 -0.754 . . . . 15.0 108.964 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.16 -28.43 68.11 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.789 0.681 . . . . 15.0 111.135 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.0 t -60.67 -53.54 56.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.028 0.931 . . . . 15.0 111.222 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -76.73 -30.14 56.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.329 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.647 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.3 mt -60.99 -39.18 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 168.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 27.5 t70 -66.41 -40.22 89.46 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-O 118.398 -0.811 . . . . 15.0 110.607 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.67 -47.74 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.164 0.507 . . . . 15.0 110.281 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.1 mt -70.43 -27.01 63.93 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.202 -0.908 . . . . 15.0 112.047 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 84.1 mtm180 -71.85 -39.25 69.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.584 0.753 . . . . 15.0 110.54 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 22.0 mmt180 -65.21 -42.76 93.19 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.222 -0.658 . . . . 15.0 109.222 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -56.63 -50.34 72.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.651 1.181 . . . . 15.0 111.176 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.86 -59.31 5.63 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.278 0.631 . . . . 15.0 110.797 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.48 66.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.607 0.763 . . . . 15.0 112.366 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -65.44 -40.92 93.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.391 1.076 . . . . 15.0 110.552 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.432 ' NH2' ' HB2' ' B' ' 437' ' ' SER . 56.1 mtp180 -87.66 -8.35 56.27 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.062 0.458 . . . . 15.0 110.268 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -90.46 17.48 7.31 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 124.27 1.028 . . . . 15.0 109.753 167.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 432' ' ' GLN . . . 92.6 17.61 44.62 Favored Glycine 0 C--N 1.356 1.694 0 CA-C-O 119.543 -0.587 . . . . 15.0 113.799 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 66.07 43.71 92.81 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 117.131 0.465 . . . . 15.0 112.075 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -63.55 92.11 0.06 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.834 0.854 . . . . 15.0 112.75 -170.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 52.3 20.43 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.457 1.651 . . . . 15.0 115.457 164.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 58.65 30.11 19.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.364 1.066 . . . . 15.0 111.594 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -79.19 10.71 3.34 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.645 1.178 . . . . 15.0 112.359 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.03 -46.77 33.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.255 1.422 . . . . 15.0 112.537 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.41 -32.66 65.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.515 0.726 . . . . 15.0 112.178 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.53 -27.97 60.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.092 0.557 . . . . 15.0 111.496 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.84 128.23 63.05 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 123.455 0.472 . . . . 15.0 110.363 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.6 Cg_exo -47.96 118.23 2.99 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.56 2.84 . . . . 15.0 113.649 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.647 ' HG3' HD13 ' A' ' 311' ' ' ILE . 66.3 ttt180 -52.79 -37.5 59.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.075 0.95 . . . . 15.0 112.028 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -10.22 48.84 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.572 0.749 . . . . 15.0 112.964 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.9 mt -71.27 -30.0 65.76 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.16 0.436 . . . . 15.0 110.653 171.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 311' ' ' ILE . 32.6 m-85 -122.9 -4.63 8.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.524 0.73 . . . . 15.0 111.541 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.425 ' HA ' HD11 ' A' ' 311' ' ' ILE . 8.9 tp10 -45.96 -68.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.565 1.146 . . . . 15.0 112.836 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.76 -48.84 80.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.702 0.626 . . . . 15.0 112.042 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.76 -45.95 73.44 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 123.575 0.547 . . . . 15.0 111.362 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.421 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -66.26 -56.34 11.74 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.231 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -53.53 -35.61 60.88 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.316 1.01 . . . . 15.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -61.5 -51.15 69.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.966 -0.561 . . . . 15.0 109.677 171.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -68.38 -18.77 64.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.119 0.568 . . . . 15.0 111.906 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 307' ' ' ILE . 69.5 t -77.57 -45.3 29.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.12 0.968 . . . . 15.0 110.167 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 77.6 t -58.9 -44.71 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.7 t -56.06 -46.47 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.338 1.055 . . . . 15.0 110.878 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.51 72.64 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.763 -0.653 . . . . 15.0 113.258 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.67 -44.34 56.96 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.2 mt -70.72 -46.42 63.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.216 0.607 . . . . 15.0 110.65 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.18 -38.74 92.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.136 0.574 . . . . 15.0 110.417 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.23 94.09 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.783 0.677 . . . . 15.0 112.512 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.82 -36.64 78.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.088 0.555 . . . . 15.0 110.945 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -64.97 -40.8 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.91 0.484 . . . . 15.0 110.201 174.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.481 ' HA ' HD12 ' A' ' 360' ' ' LEU . 96.1 mt -63.56 -41.79 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.984 0.913 . . . . 15.0 110.428 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.668 ' HA ' HD13 ' B' ' 460' ' ' LEU . 35.9 ttp180 -69.92 -58.94 3.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.775 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 51.9 m -61.25 -37.3 82.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.189 0.996 . . . . 15.0 112.059 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.73 8.23 41.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.138 0.421 . . . . 15.0 112.138 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 41.4 48.54 3.32 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.233 1.413 . . . . 15.0 113.383 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 355' ' ' ILE . 96.0 mt -70.79 148.39 47.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.847 -1.07 . . . . 15.0 111.709 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.55 143.78 41.76 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.681 0.792 . . . . 15.0 110.053 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -78.28 111.68 14.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.05 0.94 . . . . 15.0 110.12 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.81 140.47 29.63 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.744 0.818 . . . . 15.0 110.719 -172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -60.23 -40.33 89.83 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.785 0.834 . . . . 15.0 112.366 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.33 -25.85 64.41 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.248 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.423 HH21 ' HB2' ' A' ' 405' ' ' GLU . 58.7 ttt85 -74.79 -40.97 60.83 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 371' ' ' ILE . 61.0 t -58.83 -47.24 89.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.004 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -51.96 -47.73 64.66 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.156 0.91 . . . . 15.0 111.684 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.89 -51.02 48.08 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.277 0.986 . . . . 15.0 112.771 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 402' ' ' ALA . 90.7 mt -62.62 -46.69 87.11 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.662 0.785 . . . . 15.0 112.378 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 367' ' ' VAL . 48.4 mm -54.68 -53.35 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.041 0.937 . . . . 15.0 110.164 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.84 -35.26 74.6 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.37 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.0 -50.17 75.11 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.618 0.767 . . . . 15.0 112.031 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.471 ' HE2' HD13 ' A' ' 371' ' ' ILE . 26.6 ptt? -74.06 -43.66 57.0 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.277 -0.419 . . . . 15.0 110.703 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -43.05 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.345 0.658 . . . . 15.0 112.241 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.3 t -60.19 -25.8 65.87 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 124.024 0.828 . . . . 15.0 111.699 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.8 58.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.73 0.812 . . . . 15.0 112.25 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -92.41 169.53 10.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.317 0.647 . . . . 15.0 111.151 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.8 -36.57 82.69 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.442 -1.254 . . . . 15.0 110.365 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -131.86 100.97 15.63 Favored Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.987 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.7 -24.53 18.25 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.389 2.06 . . . . 15.0 112.703 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -54.46 -48.53 71.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.349 1.06 . . . . 15.0 111.544 -168.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -65.85 -30.45 71.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.26 0.975 . . . . 15.0 111.177 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.16 -45.27 54.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.64 -55.06 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.681 0.613 . . . . 15.0 109.397 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.92 -34.84 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.546 0.738 . . . . 15.0 112.493 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.99 -54.54 6.72 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.738 0.304 . . . . 15.0 111.139 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -47.71 33.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.248 0.619 . . . . 15.0 111.409 -166.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.7 p -58.83 -30.07 67.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.704 0.802 . . . . 15.0 112.534 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -86.12 -26.33 25.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.511 -0.768 . . . . 15.0 111.681 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.43 95.54 6.56 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 2.9 ttmt -71.31 -18.93 62.38 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.262 1.025 . . . . 15.0 111.6 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -66.76 -41.53 87.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.564 0.746 . . . . 15.0 110.489 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.407 HD11 ' HB1' ' B' ' 443' ' ' ALA . 58.6 tp -88.24 -31.46 19.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.555 0.742 . . . . 15.0 109.846 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.682 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 55.4 ttm -61.92 -26.64 68.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.74 0.416 . . . . 15.0 110.835 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -48.17 81.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.073 0.549 . . . . 15.0 110.125 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.47 -26.87 66.58 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.563 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.562 ' HA ' HG12 ' A' ' 401' ' ' VAL . 10.5 tpt -74.55 -27.39 60.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.975 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 395' ' ' MET . 82.2 mtp180 -72.06 -34.62 68.87 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 170.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -42.95 94.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.918 0.487 . . . . 15.0 111.235 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.9 p -73.97 -27.79 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 121.215 -0.194 . . . . 15.0 111.243 174.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -61.36 -44.04 97.85 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.36 0.6 . . . . 15.0 109.449 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 21.1 tp -73.41 -32.52 64.48 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.183 -1.371 . . . . 15.0 110.672 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -66.22 -51.91 53.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 15.0 110.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.565 ' HB3' HH21 ' A' ' 283' ' ' ARG . 77.9 mm-40 -61.92 -35.38 78.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.464 0.706 . . . . 15.0 110.833 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -74.2 -32.74 63.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.433 0.693 . . . . 15.0 110.791 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.75 99.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.193 0.597 . . . . 15.0 110.244 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.78 -53.96 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.693 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.69 -21.57 66.55 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.754 0.822 . . . . 15.0 113.193 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.13 -31.69 64.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.023 0.529 . . . . 15.0 110.523 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 294' ' ' LEU . 75.4 t -77.38 -36.35 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.88 -37.83 82.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.939 0.896 . . . . 15.0 111.246 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.24 68.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.616 0.767 . . . . 15.0 111.038 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -95.96 -29.73 14.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.028 0.931 . . . . 15.0 111.555 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.39 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.63 0.772 . . . . 15.0 112.29 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -79.02 78.93 5.44 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.248 -0.887 . . . . 15.0 109.709 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 125' ' ' VAL . 48.5 t -90.17 92.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.456 0.702 . . . . 15.0 109.567 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 39.8 p -74.07 94.66 2.42 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.779 0.832 . . . . 15.0 110.859 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.28 119.9 17.13 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.2 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 422' ' ' THR . 0.0 OUTLIER -135.35 145.74 47.71 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.438 -0.578 . . . . 15.0 109.438 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.94 136.91 39.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 15.0 109.675 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.424 HG21 ' HE3' ' A' ' 420' ' ' LYS . 11.9 t -163.41 176.66 9.6 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.822 0.449 . . . . 15.0 111.382 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.3 p -93.55 173.4 7.71 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.142 0.977 . . . . 15.0 111.389 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.24 -19.05 42.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.303 1.441 . . . . 15.0 112.05 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -66.43 -5.41 10.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.939 1.296 . . . . 15.0 113.526 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.595 ' HB3' HD12 ' A' ' 427' ' ' LEU . 14.4 tp10 -74.95 -55.41 5.8 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.529 0.732 . . . . 15.0 112.472 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.4 mp -90.35 -71.84 0.6 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.332 0.493 . . . . 15.0 112.332 -163.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -107.15 33.54 3.93 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.358 0.663 . . . . 15.0 111.873 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -82.78 45.41 0.99 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.091 0.948 . . . . 15.0 111.867 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -133.24 85.38 2.21 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -67.65 -33.05 74.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.499 0.72 . . . . 15.0 109.979 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 108.043 -1.095 . . . . 15.0 108.043 167.139 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.79 -166.84 1.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.451 0.7 . . . . 0.0 111.692 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.98 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 123.614 0.766 . . . . 0.0 110.074 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -104.47 -90.3 0.39 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -114.71 -83.13 0.61 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.412 0.685 . . . . 0.0 109.331 160.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 370' ' ' ALA . . . . . 0.496 ' HB3' HH21 ' B' ' 373' ' ' ARG . . . -113.53 5.48 16.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.337 1.055 . . . . 0.0 111.98 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 7.2 p -28.39 -44.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -97.63 3.33 50.41 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.496 HH21 ' HB3' ' B' ' 370' ' ' ALA . 0.8 OUTLIER -42.88 -72.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -154.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.431 ' N ' ' HG2' ' B' ' 373' ' ' ARG . . . -108.41 -76.96 0.6 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.233 0.924 . . . . 0.0 112.812 -170.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.597 ' H ' HD23 ' B' ' 375' ' ' LEU . 2.4 pt? -111.68 2.16 17.1 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -159.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -54.62 -33.82 61.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -164.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -103.21 -68.84 0.82 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.074 0.464 . . . . 0.0 111.511 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -82.22 -1.74 50.15 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -158.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' B' ' 375' ' ' LEU . 0.0 OUTLIER -69.5 -27.59 65.33 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 117.984 0.356 . . . . 0.0 111.758 -173.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -100.04 150.34 22.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 112.143 -169.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -162.25 -71.11 0.05 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.504 1.122 . . . . 0.0 108.328 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 136.76 -143.23 14.51 Favored Glycine 0 C--N 1.355 1.586 0 O-C-N 123.182 0.301 . . . . 0.0 112.942 176.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.12 -169.14 1.26 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 125.11 1.364 . . . . 0.0 110.373 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 42.8 p 70.72 87.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.725 2.01 . . . . 0.0 110.92 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.8 mm? -77.17 108.83 10.55 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.519 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.587 HG11 ' HA3' ' A' ' 179' ' ' GLY . 11.4 t -75.32 98.21 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.473 ' HB ' ' HZ ' ' A' ' 217' ' ' PHE . 22.5 pt -136.66 84.58 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 159.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.862 ' HA ' HD11 ' A' ' 226' ' ' LEU . 5.4 p -154.67 165.93 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.845 171.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 41.8 m -79.74 96.34 6.23 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 160.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -94.29 105.41 17.39 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.413 0.685 . . . . 0.0 112.739 -162.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -155.68 97.48 1.85 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 63.43 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.15 1.38 . . . . 0.0 110.83 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -157.61 166.11 33.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 107.441 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -66.75 -28.33 68.33 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.937 0.335 . . . . 0.0 110.468 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.11 70.16 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.337 0.655 . . . . 0.0 111.011 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 42.6 t 70.54 -72.58 0.11 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.562 1.545 . . . . 0.0 112.028 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -71.37 -39.55 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.892 0.877 . . . . 0.0 111.432 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.538 HG22 HG12 ' B' ' 399' ' ' VAL . 0.7 OUTLIER 78.08 -46.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 125.231 1.412 . . . . 0.0 111.932 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.602 HG13 ' H ' ' B' ' 400' ' ' ALA . 2.4 p -150.55 -68.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.482 0.713 . . . . 0.0 109.722 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.602 ' H ' HG13 ' B' ' 399' ' ' VAL . . . 177.06 -56.67 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 125.549 1.54 . . . . 0.0 109.474 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 400' ' ' ALA . 1.1 Cg_endo -85.64 130.37 3.75 Favored 'Trans proline' 0 C--N 1.393 2.897 0 C-N-CA 122.023 1.815 . . . . 0.0 111.831 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.6 177.7 6.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.491 0.716 . . . . 0.0 109.243 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 50.8 p -77.42 73.53 3.99 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.471 0.653 . . . . 0.0 110.112 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -70.64 -36.79 73.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.267 1.027 . . . . 0.0 109.771 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' B' ' 406' ' ' PRO . . . -81.96 140.77 46.72 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.859 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 405' ' ' ALA . 7.3 Cg_exo -71.76 82.75 1.18 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.84 2.36 . . . . 0.0 111.774 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -164.78 45.82 0.3 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.62 105.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 2.0 t 53.79 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.362 1.865 . . . . 0.0 113.072 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 410' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' B' ' 412' ' ' LEU . 0.1 OUTLIER 75.9 -60.01 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.367 1.467 . . . . 0.0 110.46 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 66.49 37.12 4.72 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.34 1.056 . . . . 0.0 111.499 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.41 ' HA ' HE22 ' B' ' 410' ' ' GLN . 4.1 pp 50.0 25.02 1.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.659 1.584 . . . . 0.0 113.618 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 8.3 t30 59.34 80.33 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.355 1.062 . . . . 0.0 109.409 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 97.4 m -71.9 101.98 2.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.47 0.708 . . . . 0.0 111.468 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.28 -76.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.39 1.876 . . . . 0.0 113.662 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -53.04 61.64 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.253 1.421 . . . . 0.0 110.603 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 80.44 -56.18 4.68 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.508 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.9 129.77 13.36 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 108.934 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.27 93.05 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 74.62 131.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 110.777 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.19 -36.7 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.881 0.472 . . . . 0.0 111.318 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -165.14 -42.58 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.089 0.555 . . . . 0.0 111.142 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.2 m 59.6 -177.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.49 1.116 . . . . 0.0 110.7 -170.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 50.0 t80 68.6 -65.73 0.26 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.351 1.061 . . . . 0.0 113.805 166.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -51.59 125.03 25.06 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.745 0.688 . . . . 0.0 113.26 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 78.03 -24.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.648 1.979 . . . . 0.0 112.62 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' B' ' 431' ' ' SER . 48.0 t -68.94 -53.45 20.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.183 0.593 . . . . 0.0 109.444 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.19 -37.64 78.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.514 0.725 . . . . 0.0 111.815 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.5 -46.64 21.8 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.024 -0.422 . . . . 0.0 110.282 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -113.34 -67.16 1.02 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -169.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 431' ' ' SER . . . . . 0.519 ' HB2' ' HA ' ' B' ' 427' ' ' SER . 19.7 m -72.77 -28.19 62.46 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -154.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.539 ' HB2' ' HA2' ' A' ' 323' ' ' GLY . 0.6 OUTLIER -83.98 -22.14 31.51 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.665 0.666 . . . . 0.0 110.492 -174.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 75.17 -57.14 0.61 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.183 1.793 . . . . 0.0 111.899 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -76.82 97.35 4.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.39 0.676 . . . . 0.0 109.723 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 41.3 p -53.5 109.69 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.455 1.102 . . . . 0.0 111.841 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -85.08 -26.7 36.18 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.053 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 437' ' ' SER . . . . . 0.432 ' HB2' ' NH2' ' A' ' 321' ' ' ARG . 17.7 t -90.83 73.0 6.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.959 0.904 . . . . 0.0 108.964 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -95.26 53.66 1.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.49 75.74 7.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -173.47 148.17 1.55 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.567 -1.652 . . . . 0.0 107.535 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 6.7 pt 55.93 175.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 126.64 1.976 . . . . 0.0 112.974 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.51 111.9 24.4 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.407 ' HB1' HD11 ' A' ' 394' ' ' LEU . . . -150.5 98.77 2.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -80.55 131.78 35.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 111.274 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -101.27 93.54 1.15 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.67 175.5 7.84 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.607 2.204 . . . . 0.0 113.289 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -83.04 82.64 8.16 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 60.92 -144.76 0.47 Allowed 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.308 1.005 . . . . 0.0 109.834 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 452' ' ' VAL . . . 66.56 -166.02 0.22 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.189 0.996 . . . . 0.0 111.302 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 69.8 -68.82 0.18 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.393 1.077 . . . . 0.0 110.211 -172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 42.6 t -62.93 -36.72 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.665 0.786 . . . . 0.0 110.001 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 3.7 p -123.14 119.09 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.787 0.835 . . . . 0.0 109.324 174.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -157.49 -60.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.623 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 65.64 -83.92 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.431 1.492 . . . . 0.0 110.251 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 m 60.36 71.27 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.822 1.249 . . . . 0.0 111.32 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.21 -37.15 66.54 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.558 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 457' ' ' GLN . . . . . 0.404 ' NE2' ' H ' ' B' ' 457' ' ' GLN . 0.0 OUTLIER -68.42 138.9 55.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.332 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 33.8 m -86.76 96.01 10.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 109.811 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 459' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 469' ' ' GLY . 26.4 t70 -138.2 -62.1 0.59 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.668 HD13 ' HA ' ' A' ' 356' ' ' ARG . 23.5 tp -140.0 119.04 12.63 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 166.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -48.23 -33.72 9.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.099 1.76 . . . . 0.0 114.65 -166.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -136.86 -70.21 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 110.839 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 70.35 136.29 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.451 1.5 . . . . 0.0 111.587 -172.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.12 166.02 24.08 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.028 0.531 . . . . 0.0 110.233 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.26 90.92 2.12 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.107 0.48 . . . . 0.0 109.816 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -173.15 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.219 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.98 9.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.804 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.433 ' HB3' HD23 ' B' ' 470' ' ' LEU . 11.1 mp -101.77 163.17 12.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.35 0.66 . . . . 0.0 110.852 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' B' ' 459' ' ' ASP . . . -82.71 22.18 6.85 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.742 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.433 HD23 ' HB3' ' B' ' 468' ' ' LEU . 2.5 pt? -161.68 154.89 20.96 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.096 1.358 . . . . 0.0 109.604 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 34.4 mmtp . . . . . 0 C--O 1.255 1.367 0 C-N-CA 123.751 0.82 . . . . 12.06 109.844 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 18.7 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.326 -0.25 . . . . 15.0 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -168.01 97.36 0.44 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.84 -1.17 . . . . 15.0 107.84 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 17' ' ' ILE . 22.9 m -111.62 152.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.709 0.804 . . . . 15.0 111.873 -169.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -137.64 92.04 2.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 15.0 109.018 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.46 89.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 122.559 1.171 . . . . 15.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -94.08 92.6 7.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.67 -1.15 . . . . 15.0 109.494 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 32.4 m -67.41 94.18 0.38 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.388 -0.824 . . . . 15.0 109.896 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 p -75.18 -66.96 0.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.137 0.975 . . . . 15.0 111.343 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -151.23 121.6 7.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.927 0.491 . . . . 15.0 110.368 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -103.96 0.64 Allowed Glycine 0 C--N 1.35 1.325 0 O-C-N 124.38 1.05 . . . . 15.0 114.239 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 2.5 mm? -77.33 -34.29 55.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.508 0.723 . . . . 15.0 110.083 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.37 97.4 0.11 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 124.622 1.201 . . . . 15.0 114.06 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD2' HG11 ' A' ' 111' ' ' VAL . 50.9 mtt85 -112.59 86.81 2.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.354 -1.35 . . . . 15.0 107.354 168.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -72.53 91.53 1.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.47 -1.241 . . . . 15.0 110.376 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.7 t -79.27 87.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.774 -0.824 . . . . 15.0 108.774 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 88.8 m -74.77 105.36 5.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.321 -0.854 . . . . 15.0 109.779 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 HG12 ' A' ' 3' ' ' VAL . 33.6 mt -101.28 118.49 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.679 0.791 . . . . 15.0 110.301 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.1 m -88.75 104.87 17.3 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.366 0.666 . . . . 15.0 109.214 165.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -81.29 108.16 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.939 -1.134 . . . . 15.0 107.939 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.95 160.12 33.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.929 0.491 . . . . 15.0 111.869 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.27 -22.5 66.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.363 1.065 . . . . 15.0 113.419 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.35 -42.03 88.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.836 0.455 . . . . 15.0 109.963 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 m -70.95 -40.16 72.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.161 -0.927 . . . . 15.0 110.278 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.0 mt -69.85 -51.97 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.656 0.782 . . . . 15.0 111.087 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.86 -39.83 90.63 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.758 0.823 . . . . 15.0 111.077 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.7 m -66.24 -44.7 83.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.609 -0.723 . . . . 15.0 110.952 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.23 -39.86 78.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.217 0.607 . . . . 15.0 112.522 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' ILE . 66.7 t -61.18 -44.95 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.131 0.572 . . . . 15.0 109.728 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -67.82 -39.49 83.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -73.41 -16.93 61.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.414 1.085 . . . . 15.0 111.424 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -88.6 -39.98 13.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.937 0.495 . . . . 15.0 110.439 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 59' ' ' GLY . 81.6 mt -74.23 -20.79 60.05 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.89 0.7 . . . . 15.0 112.89 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.2 p -66.39 -32.19 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 109.854 -0.424 . . . . 15.0 109.854 174.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -67.97 -45.3 74.54 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.901 0.88 . . . . 15.0 109.917 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.5 -40.08 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 114.923 -1.035 . . . . 15.0 110.506 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.65 85.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.889 0.876 . . . . 15.0 110.85 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -66.82 -44.19 81.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.652 -0.704 . . . . 15.0 111.462 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.08 -51.24 68.76 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.731 0.644 . . . . 15.0 110.752 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.43 -5.35 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 115.544 -0.753 . . . . 15.0 110.904 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 76.05 10.77 3.09 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.598 1.559 . . . . 15.0 112.39 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.11 -33.5 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.264 1.026 . . . . 15.0 110.607 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.76 -41.47 77.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 15.0 110.276 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.11 -36.23 92.03 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 124.204 0.94 . . . . 15.0 112.947 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -77.81 -31.96 52.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.167 0.587 . . . . 15.0 110.794 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -75.57 117.3 17.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.937 0.495 . . . . 15.0 110.989 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.95 21.36 17.67 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.776 0.83 . . . . 15.0 110.205 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.67 48.41 50.05 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.465 -0.789 . . . . 15.0 112.426 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.26 -60.71 3.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.115 0.566 . . . . 15.0 110.713 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 t -103.86 128.73 26.66 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.4 148.74 4.86 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 124.045 3.163 . . . . 15.0 114.917 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.453 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.6 tpp -65.18 -36.56 84.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.338 1.055 . . . . 15.0 111.984 -172.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -58.59 -37.68 76.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.501 0.721 . . . . 15.0 111.964 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.77 -54.25 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.153 0.981 . . . . 15.0 110.557 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 51' ' ' MET . 35.6 m -68.56 -34.24 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.488 0.551 . . . . 15.0 112.488 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.11 63.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.89 0.476 . . . . 15.0 112.058 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -70.04 -19.94 63.27 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.125 0.417 . . . . 15.0 112.125 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.34 -58.92 2.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.1 0.56 . . . . 15.0 111.142 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.65 -23.27 66.13 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.993 0.517 . . . . 15.0 111.98 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -93.4 21.55 40.01 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.715 -0.491 . . . . 15.0 113.935 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.82 73.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.501 0.721 . . . . 15.0 110.865 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 p -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.48 0.712 . . . . 15.0 111.096 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.17 -6.99 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 124.306 1.043 . . . . 15.0 112.05 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -55.07 -38.42 68.02 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.849 0.46 . . . . 15.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -58.2 -47.4 83.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.682 0.793 . . . . 15.0 111.469 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.17 -43.76 98.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.559 0.744 . . . . 15.0 110.551 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.38 -44.33 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.414 -1.266 . . . . 15.0 110.946 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 71' ' ' MET . 91.2 mt -66.95 -36.75 82.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.939 0.495 . . . . 15.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.24 -43.72 95.33 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.734 0.646 . . . . 15.0 111.873 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 27.4 t70 -64.08 -48.38 76.43 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.48 0.712 . . . . 15.0 110.512 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 80.5 mt -63.38 -32.46 73.89 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.191 0.996 . . . . 15.0 112.556 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 58.8 mtm -61.62 -41.52 97.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.613 0.365 . . . . 15.0 110.561 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -72.85 -36.86 67.52 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.597 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 29.4 mmt180 -60.63 -52.32 65.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.411 0.684 . . . . 15.0 110.65 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 17' ' ' ILE . 33.7 m-80 -75.65 -26.06 57.39 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.188 -0.914 . . . . 15.0 111.756 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -68.7 -58.07 4.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.577 0.351 . . . . 15.0 110.925 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.39 -40.44 87.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 123.721 0.638 . . . . 15.0 110.288 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.92 -40.37 96.33 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.219 1.008 . . . . 15.0 110.85 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.26 -61.77 2.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.595 -0.729 . . . . 15.0 111.446 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 pt -60.73 -24.45 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.63 0.772 . . . . 15.0 112.975 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.6 -58.08 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.543 0.737 . . . . 15.0 110.532 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.4 ptpt -77.57 -23.41 50.0 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.055 0.391 . . . . 15.0 112.055 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -86.89 -17.24 33.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.21 0.604 . . . . 15.0 110.749 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 62.0 33.47 17.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.417 1.087 . . . . 15.0 111.416 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.9 mt -77.96 106.5 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.96 -1.126 . . . . 15.0 107.96 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -78.07 102.4 0.94 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.8 0.84 . . . . 15.0 109.047 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -94.5 -177.0 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.237 2.625 . . . . 15.0 112.662 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.89 166.17 11.39 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.447 1.099 . . . . 15.0 109.635 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.43 -156.43 51.1 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.472 -0.786 . . . . 15.0 113.675 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.29 67.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.661 0.785 . . . . 15.0 109.665 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.26 107.35 0.56 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.416 2.077 . . . . 15.0 111.041 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -87.13 94.88 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.482 0.713 . . . . 15.0 109.912 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.99 91.53 4.86 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.21 109.37 6.21 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.596 -0.89 . . . . 15.0 108.596 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.07 98.63 0.73 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.363 2.042 . . . . 15.0 110.861 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.82 -71.23 0.88 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.187 -0.915 . . . . 15.0 112.329 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -169.89 133.42 1.21 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.919 0.887 . . . . 15.0 110.238 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -107.96 123.57 48.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.097 0.559 . . . . 15.0 109.642 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 93.3 mttt -97.41 129.59 44.62 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 171.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.2 101.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.279 1.031 . . . . 15.0 112.16 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.51 79.21 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.68 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.2 mt-10 -116.43 -163.92 0.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 15.0 108.383 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -73.54 116.01 13.61 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.095 0.558 . . . . 15.0 111.06 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -79.37 138.57 37.72 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.201 1.0 . . . . 15.0 109.3 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.2 m -133.83 132.83 40.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.109 -0.7 . . . . 15.0 109.109 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.58 169.42 21.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.064 0.946 . . . . 15.0 108.866 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 52.1 m -125.71 119.56 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.324 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -98.33 106.42 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.84 133.58 45.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -154.27 167.11 31.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.498 0.719 . . . . 15.0 109.536 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.715 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 31.8 mt-10 -84.71 170.38 13.33 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 15.0 110.238 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.0 m -136.83 155.12 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.85 0.86 . . . . 15.0 108.941 174.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HE1' HD11 ' A' ' 306' ' ' LEU . 68.3 m-85 -78.91 109.82 12.28 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.34 -173.62 1.78 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.035 2.49 . . . . 15.0 112.771 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -78.15 104.34 8.67 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.744 -175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.56 103.0 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.943 0.877 . . . . 15.0 108.671 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -102.59 101.04 11.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.598 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.69 140.34 32.21 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.281 -0.637 . . . . 15.0 109.281 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.95 -166.83 1.31 Allowed 'General case' 0 C--O 1.246 0.896 0 N-CA-C 108.747 -0.834 . . . . 15.0 108.747 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.67 109.35 2.31 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.247 -0.741 . . . . 15.0 111.247 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 414' ' ' LYS . 69.0 mt -66.16 -14.61 62.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.33 0.652 . . . . 15.0 111.063 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.68 -32.89 69.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.371 1.469 . . . . 15.0 111.698 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.33 75.43 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.873 0.869 . . . . 15.0 112.145 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -65.15 130.98 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.276 1.03 . . . . 15.0 110.397 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.52 115.39 29.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.636 0.774 . . . . 15.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.3 t -120.13 159.14 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 125.241 1.416 . . . . 15.0 108.47 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.55 149.46 34.41 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.0 tttt -124.11 105.56 31.57 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 107.86 -1.163 . . . . 15.0 107.86 168.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.73 99.12 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 121.77 1.646 . . . . 15.0 110.54 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 41.4 mm -66.42 97.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.552 -1.277 . . . . 15.0 107.552 169.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 427' ' ' LEU . 40.3 t -132.42 145.74 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.475 0.655 . . . . 15.0 111.362 -172.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -142.94 150.96 40.43 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.513 1.525 . . . . 15.0 107.553 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.556 HG11 ' SD ' ' A' ' 274' ' ' MET . 6.6 t -80.89 87.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.672 -1.233 . . . . 15.0 107.672 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.1 p -69.85 171.87 8.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.416 0.686 . . . . 15.0 110.117 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -58.1 -33.33 69.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.81 0.444 . . . . 15.0 111.285 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.54 82.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 15.0 110.512 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.16 -42.57 72.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.206 -0.906 . . . . 15.0 111.811 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.05 -54.6 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.85 0.86 . . . . 15.0 109.827 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.56 -44.8 93.07 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.124 0.89 . . . . 15.0 110.549 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.5 -40.92 99.29 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.845 0.716 . . . . 15.0 113.475 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.402 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.6 tpt -67.42 -57.48 6.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.554 0.742 . . . . 15.0 110.476 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 144' ' ' LEU . 90.7 mt -55.24 -32.92 62.7 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.631 0.772 . . . . 15.0 112.583 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.63 -51.91 63.14 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.329 1.052 . . . . 15.0 109.961 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.9 m -67.18 -24.37 65.86 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.5 0.72 . . . . 15.0 111.533 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 141' ' ' LEU . 74.9 mt -71.94 -47.29 53.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.83 0.452 . . . . 15.0 110.326 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 47.2 mtm180 -74.82 -19.36 60.22 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 111.696 0.258 . . . . 15.0 111.696 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.403 ' HB3' HH11 ' A' ' 243' ' ' ARG . 87.5 mttt -79.52 -23.41 42.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.827 -0.546 . . . . 15.0 110.461 169.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.09 -35.24 69.17 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.476 -0.565 . . . . 15.0 109.476 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 22.7 mm-40 -87.74 42.39 1.05 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.997 0.919 . . . . 15.0 109.656 172.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.32 118.18 4.51 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.167 1.387 . . . . 15.0 114.245 -168.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 244' ' ' GLU . 17.4 m -79.33 114.68 18.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.69 -0.855 . . . . 15.0 108.69 169.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.431 ' HZ3' ' HG3' ' A' ' 163' ' ' ARG . 36.3 m95 -79.88 110.9 15.68 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.414 -0.587 . . . . 15.0 109.414 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -141.59 115.18 9.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.36 0.664 . . . . 15.0 110.397 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 45.9 mt-10 -61.82 131.6 50.35 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.145 0.578 . . . . 15.0 110.527 172.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HE3' ' HB2' ' A' ' 242' ' ' GLU . 18.1 ptpt -108.37 172.02 7.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.528 0.731 . . . . 15.0 110.801 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.4 91.82 8.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.718 -0.674 . . . . 15.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.55 -56.48 1.25 Allowed Glycine 0 CA--C 1.544 1.902 0 N-CA-C 118.277 2.071 . . . . 15.0 118.277 159.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.15 132.46 47.86 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.67 1.235 . . . . 15.0 111.631 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 202' ' ' ILE . 20.0 t -95.54 136.52 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 122.9 0.48 . . . . 15.0 110.079 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.85 171.87 8.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.943 1.297 . . . . 15.0 108.823 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.77 65.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.793 0.837 . . . . 15.0 112.021 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -95.34 13.54 25.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.326 0.65 . . . . 15.0 111.713 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -84.33 178.65 7.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.868 0.842 . . . . 15.0 113.068 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.431 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 1.7 tmm_? -131.94 92.52 3.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 106.687 -1.597 . . . . 15.0 106.687 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 HG23 ' A' ' 166' ' ' ILE . 38.7 t -89.42 157.22 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.461 1.105 . . . . 15.0 110.378 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 61.5 m -132.77 134.84 45.24 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.867 -1.16 . . . . 15.0 107.867 166.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.8 pt -148.33 169.68 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.652 1.181 . . . . 15.0 110.303 -171.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -104.6 155.57 18.72 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 106.269 -1.752 . . . . 15.0 106.269 156.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 24.4 p90 -151.2 165.08 35.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.019 0.438 . . . . 15.0 111.131 167.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.1 t -142.75 103.15 4.16 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.006 -0.997 . . . . 15.0 108.626 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.84 140.33 15.81 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 114.914 -1.039 . . . . 15.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.3 p -150.13 116.59 5.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.974 0.91 . . . . 15.0 108.741 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 25.6 t -86.57 115.48 27.65 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 C-N-CA 123.498 0.719 . . . . 15.0 110.066 -168.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.1 t70 71.16 -1.26 2.78 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.063 1.345 . . . . 15.0 111.092 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.76 31.66 6.59 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.315 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 19.9 pt-20 -131.29 150.47 52.14 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 123.485 0.714 . . . . 15.0 110.542 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -90.86 81.63 5.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.756 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.602 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 0.0 OUTLIER -52.28 -70.12 0.1 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.4 1.48 . . . . 15.0 110.839 165.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.727 ' HB2' HG13 ' B' ' 386' ' ' VAL . 65.4 mm-40 -99.39 176.35 5.54 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.021 1.328 . . . . 15.0 109.487 168.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.97 5.72 0.12 Allowed Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.346 1.698 . . . . 15.0 117.346 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.43 -60.87 3.26 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 117.754 0.777 . . . . 15.0 113.493 168.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.67 160.74 14.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.627 0.973 . . . . 15.0 113.627 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.85 94.19 1.84 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.452 -1.249 . . . . 15.0 109.025 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.3 m -69.53 125.1 25.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.233 1.013 . . . . 15.0 112.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.03 41.8 10.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.64 1.176 . . . . 15.0 112.393 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' B' ' 385' ' ' LEU . 18.7 t80 -67.92 131.85 46.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.345 -0.843 . . . . 15.0 109.365 170.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.78 104.15 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.019 1.328 . . . . 15.0 108.357 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.4 tp -90.95 98.44 11.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 15.0 111.542 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -79.46 83.55 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 170.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.8 mtp -57.02 134.03 55.45 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.547 0.739 . . . . 15.0 110.941 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.91 -28.68 4.84 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 -168.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -71.38 114.62 9.65 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.008 0.523 . . . . 15.0 109.899 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.53 3.15 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.22 -0.446 . . . . 15.0 112.647 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.543 ' NH2' HD22 ' B' ' 385' ' ' LEU . 2.9 tmm_? -87.12 -33.88 19.3 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.485 -0.931 . . . . 15.0 108.485 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.1 mmt -84.37 154.14 23.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.196 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.5 pt -86.75 163.7 40.07 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.244 0.618 . . . . 15.0 110.824 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.17 144.75 46.28 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.72 2.28 . . . . 15.0 112.276 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.88 -52.93 0.61 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.839 -0.904 . . . . 15.0 110.839 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -66.47 -54.4 24.52 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.454 -0.573 . . . . 15.0 109.454 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.66 -40.77 69.36 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.79 -32.54 71.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.02 0.928 . . . . 15.0 110.465 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -71.15 -16.85 75.35 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.105 -0.952 . . . . 15.0 113.293 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.509 HG22 HG11 ' A' ' 158' ' ' VAL . 36.1 mm -93.68 -54.51 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.771 0.828 . . . . 15.0 109.553 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -79.55 14.02 1.8 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.676 0.991 . . . . 15.0 113.676 -169.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -122.06 20.21 8.11 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.099 -0.801 . . . . 15.0 111.099 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -142.37 -171.11 3.33 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.968 0.907 . . . . 15.0 111.175 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -149.89 154.03 37.66 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.279 1.032 . . . . 15.0 109.797 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -60.57 148.26 38.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.095 0.958 . . . . 15.0 112.598 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.72 -48.41 0.94 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.175 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.7 pt-20 -74.08 133.46 42.87 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.519 0.676 . . . . 15.0 110.419 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.53 105.56 10.58 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.147 0.979 . . . . 15.0 108.539 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -124.02 -169.16 1.91 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.944 1.298 . . . . 15.0 110.278 -168.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 44.8 m -136.3 125.69 24.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.897 0.879 . . . . 15.0 109.402 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.6 pt -102.6 154.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.633 0.773 . . . . 15.0 109.435 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -116.45 104.6 11.6 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.264 1.025 . . . . 15.0 108.395 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.2 t -92.35 154.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 107.087 -1.449 . . . . 15.0 107.087 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 m -137.5 121.33 17.56 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.087 0.858 . . . . 15.0 109.3 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 51.1 m-85 -92.21 136.47 25.73 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 119.539 -0.267 . . . . 15.0 111.373 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 81.1 Cg_exo -54.57 170.9 0.49 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.977 3.784 . . . . 15.0 117.3 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 22.6 mm-40 -79.74 -26.36 40.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.147 -1.388 . . . . 15.0 110.473 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -25.28 63.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.873 0.869 . . . . 15.0 110.383 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 226' ' ' LEU . 6.9 t80 -68.15 106.56 2.45 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.612 -0.885 . . . . 15.0 108.612 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.68 -19.29 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.882 0.873 . . . . 15.0 113.208 -167.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.88 101.85 3.9 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.672 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 41.3 tt0 -67.38 -24.99 65.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 15.0 112.287 -173.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -63.92 -17.85 63.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.686 0.794 . . . . 15.0 112.222 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 172' ' ' VAL . 16.7 mt -114.35 -30.61 6.53 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.27 0.628 . . . . 15.0 111.316 173.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.672 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 55.2 tttm -55.68 116.67 3.05 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.227 1.411 . . . . 15.0 111.809 -172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.58 -19.94 8.26 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.834 0.709 . . . . 15.0 113.885 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -87.29 156.99 19.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.806 0.842 . . . . 15.0 110.847 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -109.28 112.96 25.4 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -80.71 113.36 18.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 15.0 111.35 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -83.67 97.32 9.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.638 -0.71 . . . . 15.0 109.966 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.499 ' HZ ' HD13 ' B' ' 387' ' ' ILE . 95.9 m-85 -93.83 109.02 20.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.92 92.24 4.26 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.63 126.09 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.56 0.744 . . . . 15.0 110.46 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -113.16 91.07 3.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.204 1.002 . . . . 15.0 109.198 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 84.5 mt -68.41 108.0 3.09 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 110.152 -0.314 . . . . 15.0 110.152 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -110.87 -40.43 4.53 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.391 0.676 . . . . 15.0 110.103 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.5 mmtt -131.44 136.61 48.11 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.185 0.994 . . . . 15.0 109.594 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 207' ' ' ALA . 25.6 t -130.74 115.01 29.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.768 -1.567 . . . . 15.0 106.768 168.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 34.7 mt-10 -112.31 -175.37 2.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.583 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 35.4 tt0 -133.58 130.85 38.96 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 175.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.403 HH11 ' HB3' ' A' ' 146' ' ' LYS . 11.4 ptt180 -79.18 82.79 5.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.1 -1.445 . . . . 15.0 107.1 164.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 42.0 tt0 -73.89 147.62 43.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.72 -1.582 . . . . 15.0 111.353 -171.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.21 114.64 19.6 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.728 0.811 . . . . 15.0 109.173 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 30.2 Cg_endo -59.74 150.55 76.37 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.257 2.638 . . . . 15.0 111.291 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -53.54 106.82 0.2 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.422 1.076 . . . . 15.0 110.033 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 252' ' ' PHE . 31.8 tp -77.06 73.54 3.64 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 253' ' ' ILE . 67.5 p -91.55 168.68 11.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.014 -0.994 . . . . 15.0 108.805 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.97 -45.55 42.28 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.751 1.22 . . . . 15.0 111.979 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 48.0 mt-10 -73.36 -21.1 60.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.911 0.884 . . . . 15.0 112.886 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.526 ' HD2' HD12 ' A' ' 248' ' ' LEU . 59.6 t80 -85.69 -49.99 7.54 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.508 -0.553 . . . . 15.0 109.508 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 249' ' ' THR . 6.2 tt -67.29 -28.34 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.044 0.538 . . . . 15.0 111.564 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.647 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.4 ptmt -79.61 -12.43 59.84 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.826 0.676 . . . . 15.0 112.826 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.92 -25.7 65.35 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.093 0.557 . . . . 15.0 111.51 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -68.15 -33.83 75.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.089 0.956 . . . . 15.0 111.932 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.68 7.22 0.46 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 116.664 -0.244 . . . . 15.0 113.271 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 20.5 t -79.26 157.75 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.652 0.781 . . . . 15.0 110.119 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -59.82 -72.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.832 1.253 . . . . 15.0 111.92 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -121.86 6.61 9.87 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.554 0.742 . . . . 15.0 110.456 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.95 4.93 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.953 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 7.1 m -64.21 132.02 49.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.136 0.975 . . . . 15.0 110.561 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.42 -47.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 124.049 0.843 . . . . 15.0 110.241 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.6 -32.87 63.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.729 0.812 . . . . 15.0 111.609 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.552 ' HA3' HG13 ' A' ' 258' ' ' VAL . . . -79.28 -25.06 60.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 111.276 -0.73 . . . . 15.0 111.276 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.24 -33.62 56.02 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -67.75 -38.72 83.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.418 0.687 . . . . 15.0 109.641 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.02 82.5 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.198 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.19 -48.18 76.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.127 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.37 -27.88 36.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.318 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -65.05 -52.45 55.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.218 0.463 . . . . 15.0 110.296 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 377' ' ' ALA . 13.2 ptmm? -73.79 -16.7 61.15 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.983 0.734 . . . . 15.0 112.983 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -95.1 -47.39 6.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 118.167 0.439 . . . . 15.0 111.796 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.556 ' SD ' HG11 ' A' ' 132' ' ' VAL . 66.4 mtt -73.83 -26.23 60.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 118.653 -0.689 . . . . 15.0 111.459 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.6 -32.88 41.93 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 119.062 0.846 . . . . 15.0 110.443 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' NH2' ' HB3' ' A' ' 377' ' ' ALA . 24.2 tpp180 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.923 0.489 . . . . 15.0 110.186 174.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -76.96 -60.29 2.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.309 -0.86 . . . . 15.0 109.881 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.474 HD11 HG11 ' A' ' 130' ' ' VAL . 58.8 tp -70.69 -59.73 2.65 Favored 'General case' 0 C--O 1.211 -0.947 0 C-N-CA 124.022 0.929 . . . . 15.0 112.933 -168.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.76 -32.61 73.79 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.797 0.439 . . . . 15.0 110.713 -171.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -68.92 -46.56 67.97 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.08 -0.964 . . . . 15.0 109.658 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.38 72.53 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.336 0.655 . . . . 15.0 111.949 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 286' ' ' VAL . 79.8 mt -70.94 -51.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -58.34 -42.15 86.23 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.992 0.808 . . . . 15.0 110.338 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -74.89 -30.13 61.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 15.0 110.947 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -63.94 -59.44 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 282' ' ' ILE . 40.2 t -58.53 -44.3 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 114.95 -1.023 . . . . 15.0 110.457 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -68.78 -41.15 79.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.668 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.4 p -65.25 -40.35 93.9 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.991 0.359 . . . . 15.0 110.489 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.462 ' HB2' HG13 ' A' ' 125' ' ' VAL . 51.5 mt-30 -68.68 -34.93 76.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.53 0.519 . . . . 15.0 111.245 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.8 -50.22 67.59 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.132 0.573 . . . . 15.0 110.519 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 295' ' ' VAL . 27.0 mm -65.07 -54.62 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.676 0.791 . . . . 15.0 110.907 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.64 -38.54 90.66 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.761 0.663 . . . . 15.0 110.383 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.96 -35.3 89.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.581 -0.736 . . . . 15.0 112.758 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.5 OUTLIER -66.32 -42.59 88.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.97 0.908 . . . . 15.0 110.299 177.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 291' ' ' ILE . 47.6 t -62.13 -53.43 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.799 -0.815 . . . . 15.0 108.799 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.26 -27.64 69.15 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.593 -1.185 . . . . 15.0 111.613 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.17 59.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 15.0 113.171 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.79 150.63 15.64 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.204 0.816 . . . . 15.0 113.204 -169.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.06 143.27 58.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.774 0.829 . . . . 15.0 111.113 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 346' ' ' VAL . 6.1 tp -147.62 115.04 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.0 130.77 54.59 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.217 1.007 . . . . 15.0 108.57 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 349' ' ' LEU . 45.6 t -131.95 131.26 22.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.935 0.894 . . . . 15.0 110.097 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.412 ' HB2' ' HG ' ' A' ' 306' ' ' LEU . 53.0 Cg_exo -55.06 130.14 39.11 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.144 2.562 . . . . 15.0 112.468 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -63.61 -24.83 67.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.506 1.122 . . . . 15.0 112.902 -173.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.12 73.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.201 0.6 . . . . 15.0 111.536 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.446 HD11 ' HE1' ' A' ' 112' ' ' TYR . 19.5 mt -69.86 -43.39 71.97 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.379 -0.6 . . . . 15.0 109.379 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 304' ' ' ALA . 3.2 mp -59.09 -50.21 80.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.013 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.17 -35.74 81.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.783 0.833 . . . . 15.0 111.738 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -44.03 94.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.376 0.671 . . . . 15.0 110.339 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -79.13 -27.4 42.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.647 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 337' ' ' PHE . 34.0 mt -65.76 -35.88 76.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 108.585 -0.895 . . . . 15.0 108.585 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.579 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 14.9 t70 -63.67 -44.07 94.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.653 0.781 . . . . 15.0 110.575 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.67 -52.12 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 123.72 0.637 . . . . 15.0 110.114 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.9 mt -70.27 -21.41 62.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.897 -1.047 . . . . 15.0 112.426 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 58.9 mtm180 -76.62 -42.51 42.04 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.908 0.883 . . . . 15.0 109.871 176.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -66.36 -40.18 89.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.907 0.483 . . . . 15.0 110.417 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -67.92 -38.02 82.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.348 -0.842 . . . . 15.0 110.622 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.75 70.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.911 0.484 . . . . 15.0 109.946 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.22 -34.79 66.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.171 -0.922 . . . . 15.0 111.525 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -66.34 -37.3 85.02 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.865 0.866 . . . . 15.0 110.689 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -79.87 -15.14 57.97 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.655 0.782 . . . . 15.0 110.007 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.518 ' HE2' ' HG2' ' A' ' 326' ' ' GLU . 18.5 t80 -91.33 10.28 28.05 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.967 1.307 . . . . 15.0 110.469 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 85.47 8.06 81.35 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.126 0.393 . . . . 15.0 114.031 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 83.52 13.28 76.41 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.297 0.475 . . . . 15.0 113.028 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -78.62 156.9 28.86 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.732 0.813 . . . . 15.0 111.367 -173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.518 ' HG2' ' HE2' ' A' ' 322' ' ' PHE . 16.5 mm-40 79.34 -54.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.976 2.111 . . . . 15.0 112.618 176.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 63.39 24.7 14.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.293 1.037 . . . . 15.0 110.388 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -101.34 16.58 25.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.257 1.423 . . . . 15.0 110.006 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.47 -42.76 15.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.559 1.544 . . . . 15.0 113.736 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 50.0 tp -59.17 -27.9 66.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.299 0.64 . . . . 15.0 111.926 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.06 -8.58 53.66 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.489 0.716 . . . . 15.0 112.388 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 69.0 mt -54.03 130.31 58.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 118.587 0.63 . . . . 15.0 110.248 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 86.2 Cg_exo -48.35 116.04 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.634 2.889 . . . . 15.0 113.759 -170.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -51.7 -37.78 52.27 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.925 0.89 . . . . 15.0 111.519 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -54.5 -33.13 59.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.174 0.989 . . . . 15.0 112.851 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.523 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 95.3 mt -62.7 -30.16 71.2 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.274 0.559 . . . . 15.0 110.891 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.511 ' HA ' HE21 ' A' ' 340' ' ' GLN . 28.2 m-85 -116.47 -3.04 11.9 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.246 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.414 ' HA ' HD11 ' A' ' 311' ' ' ILE . 11.3 tp10 -55.83 -63.05 1.3 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.304 1.042 . . . . 15.0 111.965 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.05 -47.18 85.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.15 0.906 . . . . 15.0 111.589 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 337' ' ' PHE . 16.8 pt20 -67.72 -51.93 43.54 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.683 0.614 . . . . 15.0 111.558 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -63.3 -43.21 98.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.776 0.43 . . . . 15.0 110.627 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 346' ' ' VAL . 75.5 tttt -58.38 -43.24 88.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 123.883 0.739 . . . . 15.0 110.164 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 347' ' ' VAL . 45.3 mmt-85 -61.31 -35.75 78.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.655 -0.688 . . . . 15.0 111.268 172.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.5 mtt-85 -69.33 -34.01 73.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.807 0.443 . . . . 15.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.701 ' HA ' ' HB3' ' B' ' 467' ' ' ALA . 9.9 t -77.69 -41.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.856 0.36 . . . . 15.0 110.069 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 300' ' ' ILE . 53.6 t -58.88 -35.05 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.455 -0.793 . . . . 15.0 110.449 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 343' ' ' ARG . 11.8 t -51.28 -54.55 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.675 0.79 . . . . 15.0 109.316 169.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.99 -37.85 93.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.404 -0.816 . . . . 15.0 114.334 -174.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 302' ' ' VAL . 10.3 mp -72.02 -50.11 31.26 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.858 0.829 . . . . 15.0 111.124 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 87.6 mt -63.05 -52.85 61.16 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.271 0.357 . . . . 15.0 110.337 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.471 HD12 HG13 ' A' ' 347' ' ' VAL . 81.5 mt -69.85 -31.19 68.91 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.904 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.548 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.42 -39.22 97.51 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 111.779 -0.528 . . . . 15.0 111.779 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.67 -38.63 84.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.096 -0.552 . . . . 15.0 110.429 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -60.6 -36.43 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 122.746 0.418 . . . . 15.0 111.07 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.548 HD12 ' HA2' ' A' ' 352' ' ' GLY . 85.3 mt -62.96 -52.58 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.876 0.87 . . . . 15.0 109.902 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -62.14 -56.42 18.93 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.52 0.513 . . . . 15.0 110.912 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.1 m -54.67 -48.25 72.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 15.0 112.192 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -92.2 16.34 11.69 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 119.323 -0.37 . . . . 15.0 111.919 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 44.46 41.34 4.55 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 125.746 1.618 . . . . 15.0 113.776 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 355' ' ' ILE . 96.8 mt -74.7 150.51 39.46 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.021 -0.99 . . . . 15.0 112.184 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 147.29 52.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.456 1.102 . . . . 15.0 109.555 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.23 92.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.117 0.567 . . . . 15.0 110.438 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 367' ' ' VAL . 13.9 t70 -70.54 127.01 31.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.834 0.854 . . . . 15.0 110.44 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.47 -32.96 74.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.631 1.172 . . . . 15.0 112.783 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.15 -23.76 60.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.461 0.304 . . . . 15.0 110.336 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.45 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 40.6 tpt85 -80.51 -33.58 36.35 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.129 0.572 . . . . 15.0 109.585 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 363' ' ' ASP . 44.6 t -61.68 -54.46 34.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -65.69 -28.7 69.27 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.859 0.724 . . . . 15.0 110.868 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.55 -54.01 37.48 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 111.66 -0.576 . . . . 15.0 111.66 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.34 -56.52 20.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.592 0.757 . . . . 15.0 110.698 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.669 HD11 ' HG2' ' A' ' 398' ' ' MET . 44.9 mm -50.75 -53.4 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 124.771 1.294 . . . . 15.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.04 -41.51 61.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.004 0.521 . . . . 15.0 111.133 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.59 -23.28 62.55 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.64 0.607 . . . . 15.0 112.64 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 -33.3 12.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 119.159 -0.448 . . . . 15.0 111.57 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -93.24 -40.64 10.33 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 112.671 0.619 . . . . 15.0 112.671 -171.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 381' ' ' PRO . 22.1 t -70.06 -13.29 62.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.01 0.374 . . . . 15.0 112.01 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 272' ' ' LYS . . . -86.92 -0.56 56.74 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.136 0.574 . . . . 15.0 111.664 174.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -94.69 -175.31 3.55 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.426 0.69 . . . . 15.0 110.367 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.85 -51.67 17.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.437 1.095 . . . . 15.0 110.305 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.409 ' HB3' ' NH1' ' B' ' 440' ' ' ARG . 11.6 t70 -123.33 106.92 32.71 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.46 ' HB3' ' HA ' ' A' ' 376' ' ' SER . 97.1 Cg_endo -84.93 -23.56 2.47 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.599 2.199 . . . . 15.0 113.61 170.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -57.23 -49.54 75.7 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.453 0.701 . . . . 15.0 112.288 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.61 -16.06 60.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.267 -0.879 . . . . 15.0 111.383 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.654 HG13 HD13 ' B' ' 441' ' ' ILE . 88.7 t -76.58 -50.26 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.604 -0.888 . . . . 15.0 108.604 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.22 -49.53 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.635 0.774 . . . . 15.0 109.078 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.94 -36.14 80.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.237 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.05 -57.99 10.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.754 0.422 . . . . 15.0 110.451 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.459 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 87.0 m-85 -64.09 -53.05 55.87 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.892 0.745 . . . . 15.0 111.352 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.0 p -56.05 -33.94 65.45 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -98.13 -4.61 35.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.075 0.55 . . . . 15.0 112.461 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -119.49 90.18 3.28 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -56.09 -29.28 60.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.765 1.226 . . . . 15.0 113.031 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.85 -57.88 10.99 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.407 0.683 . . . . 15.0 111.056 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' B' ' 443' ' ' ALA . 2.0 tt -87.66 -18.9 28.54 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.243 -0.89 . . . . 15.0 109.775 -174.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 7.4 tpt -67.13 -43.32 82.69 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -40.03 95.77 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.065 0.946 . . . . 15.0 110.403 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.86 -44.1 90.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.258 0.623 . . . . 15.0 110.378 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.669 ' HG2' HD11 ' A' ' 371' ' ' ILE . 37.7 tpp -72.72 -23.52 60.86 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.488 -0.778 . . . . 15.0 111.671 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HG2' HG21 ' A' ' 367' ' ' VAL . 12.7 mtp180 -76.53 -35.32 58.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.599 0.76 . . . . 15.0 109.85 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' B' ' 464' ' ' MET . 0.9 OUTLIER -69.19 -38.4 78.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.139 0.576 . . . . 15.0 110.269 178.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.1 p -79.09 -22.86 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 119.49 -0.291 . . . . 15.0 111.11 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.41 96.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.866 0.757 . . . . 15.0 109.468 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.96 -34.92 64.45 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.844 -1.525 . . . . 15.0 111.77 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 401' ' ' VAL . 0.6 OUTLIER -67.93 -48.01 67.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.376 1.07 . . . . 15.0 109.965 177.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.45 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 6.1 mm-40 -56.49 -46.99 80.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.024 1.329 . . . . 15.0 111.199 171.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.32 -35.11 78.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.803 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -67.78 -38.07 82.88 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.244 0.618 . . . . 15.0 110.997 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 59.5 t -56.1 -53.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.969 -0.752 . . . . 15.0 108.969 170.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -63.08 -26.45 68.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.163 0.985 . . . . 15.0 112.959 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -74.71 -27.36 60.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.06 0.544 . . . . 15.0 111.148 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 407' ' ' ALA . 89.0 t -75.79 -38.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.521 -0.918 . . . . 15.0 108.521 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 290' ' ' ALA . 92.8 mt -67.56 -35.16 78.51 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.78 0.832 . . . . 15.0 111.32 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.57 -20.83 65.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.648 0.779 . . . . 15.0 111.592 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.522 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.8 mtpp -105.67 -30.15 9.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.059 0.944 . . . . 15.0 111.556 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.82 159.25 22.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.071 0.948 . . . . 15.0 111.741 -172.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -75.61 82.63 2.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.972 0.909 . . . . 15.0 109.464 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 125' ' ' VAL . 42.5 t -90.15 92.15 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -70.67 96.03 1.17 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.402 1.096 . . . . 15.0 110.493 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.54 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 37.1 mt-10 -75.2 105.01 6.0 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.253 -1.34 . . . . 15.0 109.562 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -114.41 138.29 50.75 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.279 0.562 . . . . 15.0 109.951 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 28.4 mt-10 -81.44 130.89 35.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.959 0.904 . . . . 15.0 109.193 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.446 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -163.64 169.55 18.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.285 0.634 . . . . 15.0 110.446 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.2 p -93.22 171.83 8.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.243 1.017 . . . . 15.0 111.487 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 428' ' ' MET . 57.0 t80 -52.54 -47.27 66.82 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.888 1.275 . . . . 15.0 110.828 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -54.93 -22.94 16.62 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.945 1.091 . . . . 15.0 113.945 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 427' ' ' LEU . 10.0 tp10 -54.34 -55.7 25.82 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.647 0.779 . . . . 15.0 112.068 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 426' ' ' GLU . 5.4 mp -74.87 -29.5 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.42 -0.809 . . . . 15.0 111.709 -167.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.1 OUTLIER -80.69 -42.87 21.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.992 0.517 . . . . 15.0 109.832 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 41.02 0.85 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.002 0.521 . . . . 15.0 111.109 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -91.18 71.27 6.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -79.81 -54.32 5.95 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.993 0.917 . . . . 15.0 108.664 176.322 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -139.89 107.44 5.59 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.4 tt -74.16 -81.97 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' B' ' 372' ' ' GLN . 11.7 t70 -104.83 -86.02 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.335 0.516 . . . . 0.0 110.777 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' B' ' 370' ' ' ALA . 5.8 pt-20 -105.35 -67.92 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.954 0.502 . . . . 0.0 111.835 -169.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 370' ' ' ALA . . . . . 0.454 ' H ' ' HG3' ' B' ' 369' ' ' GLU . . . -96.2 -77.42 0.48 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.84 -80.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.673 ' HB3' ' HA ' ' B' ' 377' ' ' PHE . 24.0 tm0? -100.7 -78.2 0.52 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 167.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' B' ' 377' ' ' PHE . 10.2 mmm180 -102.09 -84.65 0.45 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.578 0.626 . . . . 0.0 110.754 168.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -104.48 -75.47 0.62 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -165.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 81.9 mt -88.8 -78.62 0.34 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.4 -70.81 0.76 Allowed 'General case' 0 C--N 1.345 0.402 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 165.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.673 ' HA ' ' HB3' ' B' ' 372' ' ' GLN . 82.1 m-85 -99.86 -92.11 0.29 Allowed 'General case' 0 C--N 1.351 0.65 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.777 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -104.21 -82.64 0.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.205 0.911 . . . . 0.0 110.616 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -107.02 -32.15 7.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.849 0.86 . . . . 0.0 110.626 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm 72.08 83.47 0.13 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.528 1.531 . . . . 0.0 111.112 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -170.77 139.66 1.54 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.317 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 160.41 164.6 15.7 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.005 0.19 . . . . 0.0 112.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 383' ' ' ASN . . . . . 0.457 HD22 ' H ' ' B' ' 383' ' ' ASN . 0.1 OUTLIER -80.66 154.08 27.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.668 0.787 . . . . 0.0 111.256 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 48.3 p -80.77 -16.19 54.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.944 0.898 . . . . 0.0 111.479 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.543 HD22 ' NH2' ' A' ' 193' ' ' ARG . 5.6 mp -70.6 134.52 47.68 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 178' ' ' GLU . 50.9 t -81.93 90.06 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 123.771 1.748 . . . . 0.0 109.265 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.602 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 7.6 tp -153.17 173.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 110.983 -2.826 . . . . 0.0 105.329 170.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.489 ' H ' HG13 ' B' ' 387' ' ' ILE . 0.1 OUTLIER -39.94 167.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -150.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 389' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' B' ' 394' ' ' HIS . 61.0 p -36.75 99.01 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 110.02 -3.263 . . . . 0.0 115.327 -157.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -85.79 -177.76 6.44 Favored 'General case' 0 C--O 1.251 1.177 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 153.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' B' ' 377' ' ' PHE . 1.6 m-20 -75.61 88.89 2.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 112.461 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.93 -49.01 0.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.363 1.865 . . . . 0.0 107.149 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.38 114.34 4.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.246 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 394' ' ' HIS . . . . . 0.453 ' HA ' ' HB ' ' B' ' 389' ' ' THR . 67.1 m-70 -99.47 -82.23 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.294 0.497 . . . . 0.0 112.027 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 52.86 -93.61 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.728 0.811 . . . . 0.0 110.417 -162.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 50.3 m 54.97 21.62 3.84 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.852 1.261 . . . . 0.0 113.997 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 66.62 -72.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.146 1.379 . . . . 0.0 110.316 -172.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.94 -175.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.68 1.192 . . . . 0.0 110.241 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.98 42.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.336 1.065 . . . . 0.0 111.704 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -162.04 156.07 18.49 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 0.0 109.785 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.78 -16.57 33.27 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.445 2.097 . . . . 0.0 112.382 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.75 153.54 10.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.467 1.107 . . . . 0.0 109.269 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 15.1 t -144.41 44.88 1.41 Allowed 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 121.586 0.708 . . . . 0.0 111.649 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.99 -42.14 98.81 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.267 0.556 . . . . 0.0 110.152 170.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -112.61 104.19 55.83 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.5 -7.28 20.59 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.792 2.328 . . . . 0.0 113.006 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 86.03 -81.93 1.69 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.3 tt 61.73 -82.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.256 1.422 . . . . 0.0 110.013 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 91.8 m -74.16 -40.63 62.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.905 1.282 . . . . 0.0 110.392 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.83 102.74 4.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.528 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -88.04 113.42 23.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.621 0.768 . . . . 0.0 108.994 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.0 -37.4 47.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.371 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -68.18 92.75 0.41 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 123.44 0.696 . . . . 0.0 110.138 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 37.3 m -77.5 83.29 3.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.013 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -156.15 -63.0 0.11 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.01 -42.87 6.57 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.829 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -97.82 60.83 0.99 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -60.83 110.63 1.38 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.764 0.826 . . . . 0.0 110.81 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.16 92.81 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.244 1.018 . . . . 0.0 110.187 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 55.5 ttp 58.37 -83.68 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.254 1.422 . . . . 0.0 111.415 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.552 HG13 ' H ' ' B' ' 422' ' ' MET 0.282 3.2 p 33.99 -93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.369 1.419 0 C-N-CA 126.911 2.084 . . . . 0.0 113.651 -175.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.552 ' H ' HG13 ' B' ' 421' ' ' VAL . 8.3 ptm 65.33 -34.98 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.061 2.145 . . . . 0.0 114.985 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' B' ' 438' ' ' GLN . 21.7 t 60.89 -161.65 0.28 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -117.27 149.59 40.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.663 0.785 . . . . 0.0 109.511 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 161.86 -147.11 13.05 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.672 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -149.48 -108.85 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 117.475 -1.25 . . . . 0.0 108.385 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 70.0 p 41.52 -72.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 126.862 2.065 . . . . 0.0 114.332 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.49 -28.51 67.1 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.372 1.069 . . . . 0.0 111.313 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.44 -24.81 61.23 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.048 1.339 . . . . 0.0 111.339 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -50.42 -21.39 1.44 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 124.195 0.998 . . . . 0.0 113.193 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 67.8 p -59.42 -48.57 81.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.607 0.763 . . . . 0.0 111.273 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -90.94 -13.15 34.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 79.02 -30.75 0.14 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.154 1.781 . . . . 0.0 115.227 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -165.8 29.17 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.076 0.853 . . . . 0.0 112.681 -169.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 10.9 m -134.68 95.22 3.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.32 0.648 . . . . 0.0 109.352 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -81.95 41.8 2.78 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.222 -0.21 . . . . 0.0 113.418 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 25.6 p -74.15 90.45 2.05 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.756 0.822 . . . . 0.0 109.878 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 438' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' B' ' 423' ' ' SER . 50.3 mt-30 -134.21 116.32 15.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.34 1.056 . . . . 0.0 108.807 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 94.5 mt 61.79 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.985 1.314 . . . . 0.0 110.953 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 380' ' ' ASP . 24.3 ptt180 -69.76 159.67 33.11 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 170.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.654 HD13 HG13 ' A' ' 384' ' ' VAL . 32.3 mm 62.85 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -162.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.28 89.59 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 394' ' ' LEU . . . 68.06 -77.39 0.05 OUTLIER 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.105 1.503 . . . . 0.0 110.327 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.7 t80 52.4 94.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.258 1.423 . . . . 0.0 113.075 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.48 -172.93 26.23 Favored Glycine 0 C--O 1.244 0.769 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.709 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 446' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' B' ' 467' ' ' ALA . 89.1 Cg_endo -76.02 -168.88 0.6 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.806 2.337 . . . . 0.0 112.769 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 447' ' ' HIS . . . . . 0.461 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 19.4 t-160 -61.42 122.46 15.23 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 69.81 8.31 6.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 72.19 -49.19 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.704 1.602 . . . . 0.0 113.029 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 450' ' ' ASN . . . . . 0.596 ' HA ' ' HE3' ' B' ' 465' ' ' LYS . 14.7 t-20 -132.98 164.17 27.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.051 0.941 . . . . 0.0 109.447 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.71 149.64 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 125.236 1.414 . . . . 0.0 109.963 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.15 -37.76 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.214 0.606 . . . . 0.0 111.442 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -117.89 137.29 13.04 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.43 42.47 0.51 Allowed 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.179 0.991 . . . . 0.0 112.275 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 10.1 m 72.09 -0.84 3.09 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.463 1.505 . . . . 0.0 112.136 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.7 t70 63.93 -75.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.274 1.43 . . . . 0.0 110.017 -172.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -96.85 100.02 11.57 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 108.446 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 4.8 t -80.03 71.64 6.77 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.368 1.08 . . . . 0.0 109.065 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.41 -16.4 64.21 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.533 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.581 ' H ' HD13 ' B' ' 460' ' ' LEU . 0.0 OUTLIER -91.42 34.0 0.97 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.953 0.901 . . . . 0.0 110.798 175.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 66.82 -84.52 0.03 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.737 1.615 . . . . 0.0 111.644 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -91.33 135.31 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 59.6 m -58.16 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 O-C-N 124.243 0.964 . . . . 0.0 110.815 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.451 ' HA ' ' OD1' ' A' ' 400' ' ' ASN . 1.3 tmt? -129.48 110.17 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 108.576 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.0 OUTLIER -80.86 121.16 25.63 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -51.38 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.942 1.401 . . . . 0.0 112.318 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.701 ' HB3' ' HA ' ' A' ' 345' ' ' VAL . . . -169.77 80.87 0.11 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -161.61 163.39 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.759 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' B' ' 447' ' ' HIS . . . -166.08 60.49 0.23 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.91 -47.23 87.38 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.829 0.851 . . . . 0.0 108.934 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 85.8 tttt . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.252 1.021 . . . . 12.06 108.525 178.814 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 52.5 tt0 -82.2 108.33 15.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.42 -0.585 . . . . 15.0 109.42 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 HG12 ' A' ' 17' ' ' ILE . 33.0 m -121.25 141.18 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 15.0 109.552 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 9.2 m -140.33 92.64 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.332 0.653 . . . . 15.0 109.405 -174.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.03 102.14 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-O 121.91 0.862 . . . . 15.0 110.492 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 38.6 mt-10 -92.41 107.2 19.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.781 0.832 . . . . 15.0 109.595 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -72.4 90.96 1.32 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.5 m -64.13 -51.67 62.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.69 1.196 . . . . 15.0 111.031 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -155.7 84.9 1.03 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.23 -0.441 . . . . 15.0 109.934 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.42 0.23 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 123.558 0.536 . . . . 15.0 113.063 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.515 ' HA ' HH12 ' A' ' 13' ' ' ARG . 10.0 mp -66.91 -37.74 84.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.655 0.782 . . . . 15.0 110.982 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.26 97.41 0.17 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 124.362 1.039 . . . . 15.0 112.311 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.515 HH12 ' HA ' ' A' ' 11' ' ' LEU . 66.9 mtt85 -108.75 143.14 38.28 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.799 1.24 . . . . 15.0 109.684 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 42.2 ttm180 -119.9 88.95 3.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.845 1.258 . . . . 15.0 107.868 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.75 91.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.581 0.705 . . . . 15.0 109.179 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 91.0 m -81.28 105.2 12.29 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.418 -1.265 . . . . 15.0 109.905 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 3' ' ' VAL . 52.8 mt -107.29 127.73 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.167 0.587 . . . . 15.0 110.211 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 85.5 m -100.61 111.86 24.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.188 0.995 . . . . 15.0 108.649 171.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.7 mt -88.91 130.99 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.45 138.24 58.31 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.587 0.755 . . . . 15.0 110.815 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.53 -39.9 74.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.941 1.297 . . . . 15.0 112.598 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.29 -40.24 93.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.267 -0.879 . . . . 15.0 110.324 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -71.65 -26.18 62.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.524 0.729 . . . . 15.0 111.549 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -70.81 -51.12 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.638 0.775 . . . . 15.0 109.685 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.25 -24.15 59.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.463 -0.335 . . . . 15.0 111.587 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.579 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 87.5 m -68.35 -39.64 81.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.459 0.704 . . . . 15.0 109.776 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.15 -42.14 94.07 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.148 0.579 . . . . 15.0 111.011 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 66' ' ' VAL . 95.9 t -59.68 -44.78 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 121.625 0.726 . . . . 15.0 109.974 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.1 ttmp? -63.7 -36.11 82.78 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.592 -1.186 . . . . 15.0 111.089 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -92.67 -1.99 56.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.605 1.162 . . . . 15.0 111.245 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -99.71 -39.9 8.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.376 0.67 . . . . 15.0 109.782 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 55' ' ' ALA . 52.8 mt -82.12 -8.64 59.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.412 -0.813 . . . . 15.0 112.225 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.9 -31.62 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 109.241 -0.651 . . . . 15.0 109.241 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -71.98 -43.76 64.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.04 0.936 . . . . 15.0 109.334 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.91 -37.95 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.4 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -46.1 90.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.656 . . . . 15.0 110.853 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -69.58 -34.97 74.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.616 0.366 . . . . 15.0 111.698 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.28 -53.01 59.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.893 0.877 . . . . 15.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.85 2.19 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.718 0.807 . . . . 15.0 110.645 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 74.26 9.44 4.49 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.764 1.625 . . . . 15.0 112.695 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mt -58.31 -27.73 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.155 1.382 . . . . 15.0 111.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.58 -32.54 74.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.564 0.746 . . . . 15.0 111.122 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.32 -33.68 64.39 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.668 0.605 . . . . 15.0 111.852 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.5 -18.18 42.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.368 0.667 . . . . 15.0 110.766 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -70.58 108.34 4.3 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.518 0.727 . . . . 15.0 109.059 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -91.0 -2.81 57.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.278 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -7.87 79.39 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-O 119.548 -0.585 . . . . 15.0 113.859 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -65.82 -48.66 70.92 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.289 0.636 . . . . 15.0 110.768 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.08 121.79 80.98 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.474 -0.935 . . . . 15.0 108.474 174.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.68 131.68 45.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.882 2.388 . . . . 15.0 112.25 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.7 tpt -63.23 -32.6 74.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.308 1.043 . . . . 15.0 111.602 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.3 p30 -57.97 -38.8 76.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.587 0.755 . . . . 15.0 112.765 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.44 -51.93 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.085 0.954 . . . . 15.0 110.429 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.495 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 29.6 m -72.39 -19.34 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.754 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -74.18 -58.42 3.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.043 0.537 . . . . 15.0 110.983 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.551 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 14.2 pt20 -73.31 -34.71 65.86 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.878 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.1 mtt180 -96.51 -70.38 0.72 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.072 0.549 . . . . 15.0 111.091 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 91.8 m-85 -72.29 -18.89 61.76 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.473 0.709 . . . . 15.0 112.177 -169.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.27 23.4 15.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.526 -0.597 . . . . 15.0 112.704 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -21.82 66.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.088 0.955 . . . . 15.0 111.882 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.8 p -62.56 -32.44 73.41 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.563 0.745 . . . . 15.0 111.32 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 78.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.173 0.989 . . . . 15.0 109.692 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -108.07 -48.18 3.42 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.184 -0.673 . . . . 15.0 109.184 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -56.72 -45.34 81.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.677 1.191 . . . . 15.0 111.576 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.53 -34.1 77.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.85 -1.068 . . . . 15.0 111.206 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 28' ' ' VAL . 42.5 t -80.18 -63.64 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.24 -44.58 83.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.962 0.905 . . . . 15.0 112.773 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.4 94.73 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.542 0.526 . . . . 15.0 112.606 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.35 -33.5 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.984 0.914 . . . . 15.0 111.122 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 70.4 mt -70.06 -32.5 70.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.955 0.502 . . . . 15.0 110.432 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.5 mtm -63.14 -37.64 88.01 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 123.413 0.445 . . . . 15.0 110.455 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 -55.6 5.81 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.488 0.715 . . . . 15.0 110.799 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -67.92 -37.15 81.3 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.117 0.567 . . . . 15.0 112.425 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -75.47 -30.02 59.78 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 117.875 0.307 . . . . 15.0 111.026 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -64.31 -54.54 31.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.073 0.549 . . . . 15.0 110.666 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.6 -35.13 71.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 123.74 0.65 . . . . 15.0 110.618 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.71 -47.66 82.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.63 0.772 . . . . 15.0 110.611 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -56.46 20.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.929 -1.032 . . . . 15.0 111.325 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.559 HD12 ' HD3' ' A' ' 86' ' ' PRO . 21.4 pt -64.88 -31.86 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.914 0.709 . . . . 15.0 112.914 -170.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.87 -49.23 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.798 0.439 . . . . 15.0 110.519 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -72.12 -29.71 64.34 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.641 -0.254 . . . . 15.0 111.053 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -87.3 1.34 53.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.514 0.726 . . . . 15.0 111.57 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 66.96 12.99 9.29 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.86 1.264 . . . . 15.0 112.942 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 70.4 mt -87.06 122.1 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.919 0.888 . . . . 15.0 108.727 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.9 117.27 35.66 Favored Pre-proline 0 N--CA 1.481 1.075 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.559 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.9 Cg_endo -71.6 152.71 59.76 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 15.0 113.383 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.67 52.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.099 -1.41 . . . . 15.0 107.218 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 304' ' ' ALA . . . -162.23 146.2 11.69 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.031 -1.44 . . . . 15.0 110.002 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -58.57 108.26 1.25 Allowed Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.415 0.607 . . . . 15.0 109.859 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 11.3 Cg_exo -69.16 109.8 2.28 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.439 2.093 . . . . 15.0 111.802 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 47.4 m -69.89 92.39 0.7 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.775 0.83 . . . . 15.0 109.971 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.43 104.71 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.92 103.56 3.45 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.021 -1.103 . . . . 15.0 108.021 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 104.24 1.32 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.076 1.851 . . . . 15.0 109.848 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.59 176.75 38.42 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.764 -0.653 . . . . 15.0 113.166 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.8 116.81 20.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.212 0.53 . . . . 15.0 110.07 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -102.01 98.78 8.94 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.783 -1.191 . . . . 15.0 107.783 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.7 mttt -77.84 136.47 38.09 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.769 -1.197 . . . . 15.0 107.769 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.01 106.94 2.51 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.394 -0.595 . . . . 15.0 109.394 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.64 10.46 40.78 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 116.238 -0.437 . . . . 15.0 112.693 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.3 mt-10 -134.71 -179.75 5.79 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.996 1.318 . . . . 15.0 109.221 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -81.04 173.71 12.32 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.597 0.759 . . . . 15.0 111.76 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -115.27 92.34 3.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 15.0 108.723 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -92.55 96.08 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.847 0.859 . . . . 15.0 109.228 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -108.98 178.23 4.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.43 0.692 . . . . 15.0 109.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.6 m -139.49 150.12 44.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.86 0.864 . . . . 15.0 109.284 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.97 117.22 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -98.07 136.91 37.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.401 1.08 . . . . 15.0 109.366 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -167.58 165.74 14.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.509 0.723 . . . . 15.0 109.823 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.89 174.67 5.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.306 0.643 . . . . 15.0 109.379 170.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.16 -166.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.161 0.984 . . . . 15.0 109.174 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 114.4 58.5 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 122.853 0.461 . . . . 15.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.03 112.47 3.26 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.681 2.254 . . . . 15.0 111.787 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.39 96.42 0.88 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.611 0.764 . . . . 15.0 109.421 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.97 134.38 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.054 0.941 . . . . 15.0 110.992 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.8 110.53 22.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.48 0.712 . . . . 15.0 109.379 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 120' ' ' LEU . 94.1 mt -75.08 128.85 36.49 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -124.6 112.47 16.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.627 0.771 . . . . 15.0 109.784 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.0 67.1 2.28 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 124.469 1.106 . . . . 15.0 113.536 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 117' ' ' LEU . 38.5 mt -66.33 -25.15 66.69 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.59 0.356 . . . . 15.0 110.547 175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 2.8 mp0 -71.82 -35.99 70.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.084 0.953 . . . . 15.0 110.75 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.29 -22.09 63.83 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.538 0.735 . . . . 15.0 111.548 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.34 127.43 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.951 0.9 . . . . 15.0 109.991 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 38.2 mt-10 -108.47 110.14 21.58 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.835 0.854 . . . . 15.0 109.778 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HB ' HG12 ' A' ' 417' ' ' VAL . 37.9 t -119.82 165.06 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.789 1.236 . . . . 15.0 107.853 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.04 149.01 32.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.625 -0.88 . . . . 15.0 108.625 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -116.64 85.51 16.97 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.42 102.01 1.38 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.2 1.933 . . . . 15.0 111.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.496 HD11 ' HE2' ' A' ' 127' ' ' LYS . 41.1 mm -73.95 86.98 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.852 -1.166 . . . . 15.0 107.852 171.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.728 HG22 HG23 ' A' ' 422' ' ' THR . 28.7 t -107.27 148.37 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.08 -0.964 . . . . 15.0 110.502 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.12 165.17 37.06 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.246 1.018 . . . . 15.0 109.696 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 ' SD ' ' A' ' 274' ' ' MET . 2.8 t -96.77 88.54 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.8 p -77.21 -175.94 3.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.032 0.933 . . . . 15.0 110.352 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.99 -55.12 34.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.53 0.732 . . . . 15.0 111.366 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.05 66.97 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.977 0.798 . . . . 15.0 111.799 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -79.03 -45.33 20.39 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.362 0.665 . . . . 15.0 110.889 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.64 -54.94 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.204 0.602 . . . . 15.0 109.434 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.77 -48.04 82.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.96 99.09 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.91 0.757 . . . . 15.0 113.379 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.2 tpt -68.51 -50.86 48.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.599 0.759 . . . . 15.0 111.038 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.26 -38.33 68.4 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.024 0.53 . . . . 15.0 111.817 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 t70 -68.05 -39.17 83.09 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.45 -0.796 . . . . 15.0 110.571 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 71.1 m -61.97 -39.82 93.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.186 0.594 . . . . 15.0 110.128 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 140' ' ' MET . 83.4 mt -63.48 -38.26 90.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.166 0.587 . . . . 15.0 110.06 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 63.7 mtm180 -64.59 -34.41 78.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.223 173.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 142' ' ' ASP . 87.1 mttt -67.85 -35.94 79.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.513 0.325 . . . . 15.0 110.885 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 143' ' ' THR . 92.8 mt-30 -70.47 -33.32 71.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.859 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -103.59 29.47 5.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.848 . . . . 15.0 111.241 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.88 24.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.276 0.843 . . . . 15.0 113.276 -171.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -96.05 136.24 36.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.46 1.104 . . . . 15.0 110.306 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -81.78 111.82 18.36 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.225 0.61 . . . . 15.0 110.238 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -125.81 113.04 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 15.0 110.406 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.7 mt-10 -65.04 119.37 10.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.385 0.674 . . . . 15.0 111.063 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 47.0 pttt -123.78 -179.57 4.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.385 1.074 . . . . 15.0 110.009 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -165.58 154.12 11.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.916 0.887 . . . . 15.0 108.827 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.27 -38.75 2.39 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.436 -0.666 . . . . 15.0 111.436 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.02 123.68 7.28 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.608 0.363 . . . . 15.0 110.786 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 206' ' ' LYS . 40.5 t -85.43 131.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 171.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -121.85 -177.63 3.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.149 0.979 . . . . 15.0 109.72 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -81.43 -9.23 59.77 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.505 0.722 . . . . 15.0 111.893 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -97.62 19.33 13.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.958 0.903 . . . . 15.0 111.718 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.8 m-20 -94.11 158.78 15.45 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.102 0.953 . . . . 15.0 112.301 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 6.5 tmm_? -120.85 91.53 3.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.068 -2.197 . . . . 15.0 105.068 165.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 166' ' ' ILE . 28.4 t -90.22 148.75 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.392 1.077 . . . . 15.0 110.791 -174.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 41.0 m -126.19 121.63 33.33 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.759 -1.2 . . . . 15.0 107.759 171.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.611 HG22 HD23 ' A' ' 237' ' ' LEU . 36.3 pt -128.95 174.08 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.577 0.751 . . . . 15.0 111.914 -172.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -118.49 116.57 26.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.163 -1.792 . . . . 15.0 106.163 158.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.562 ' HE1' HG23 ' B' ' 387' ' ' ILE . 11.6 p90 -107.88 140.99 40.16 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 234' ' ' ALA . 1.5 t -137.28 113.65 10.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.923 -1.14 . . . . 15.0 107.923 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -101.25 154.79 19.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 116.131 -0.486 . . . . 15.0 113.072 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 p -136.88 104.17 5.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.741 0.816 . . . . 15.0 109.206 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 231' ' ' ALA . 52.9 t -77.39 112.95 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.141 -0.936 . . . . 15.0 109.271 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.9 t70 64.44 25.34 13.32 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 124.703 1.252 . . . . 15.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.47 21.15 52.56 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.04 -0.982 . . . . 15.0 114.524 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.12 150.43 49.98 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.02 0.91 . . . . 15.0 110.911 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.97 81.44 5.24 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.996 -1.113 . . . . 15.0 107.996 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.538 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 1.1 p90 -59.48 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 112.712 -2.04 . . . . 15.0 112.387 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.46 ' HG2' ' HD2' ' A' ' 177' ' ' PHE . 12.0 mm-40 -101.0 176.52 5.23 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.574 1.55 . . . . 15.0 109.231 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.61 60.68 2.45 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 165.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -99.97 83.42 0.56 Allowed Glycine 0 C--N 1.344 0.985 0 C-N-CA 123.335 0.493 . . . . 15.0 111.985 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -148.39 165.22 31.75 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.909 0.883 . . . . 15.0 109.399 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.52 94.94 1.52 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.855 -0.611 . . . . 15.0 109.855 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 128.69 37.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.631 -1.168 . . . . 15.0 109.335 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 65.25 33.28 9.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.073 0.949 . . . . 15.0 111.145 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.01 127.65 32.38 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 122.784 0.434 . . . . 15.0 109.945 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.83 95.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.624 0.77 . . . . 15.0 110.263 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.603 HD22 ' HE3' ' A' ' 194' ' ' MET . 36.7 tp -86.79 90.08 8.18 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.433 0.635 . . . . 15.0 110.285 170.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.461 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -83.27 89.72 7.03 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.811 -1.181 . . . . 15.0 107.811 169.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 46.7 mtp -57.07 137.48 55.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.321 0.648 . . . . 15.0 111.83 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.87 5.18 Favored Glycine 0 N--CA 1.47 0.95 0 N-CA-C 112.077 -0.409 . . . . 15.0 112.077 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 10.4 pt20 -98.98 158.72 15.46 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.296 0.639 . . . . 15.0 110.553 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.98 66.32 2.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.986 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -107.7 10.63 28.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.54 0.736 . . . . 15.0 110.859 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.603 ' HE3' HD22 ' A' ' 187' ' ' LEU . 24.6 mmt -129.7 149.13 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.944 0.898 . . . . 15.0 110.583 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.8 pt -95.34 141.31 23.04 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.946 -1.025 . . . . 15.0 108.711 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.43 120.99 7.68 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.383 2.722 . . . . 15.0 112.918 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.89 -34.03 3.38 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.107 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 213' ' ' ILE . 5.4 t80 -78.07 -57.05 4.0 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.097 0.559 . . . . 15.0 110.233 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -19.93 65.47 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.953 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.669 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 21.2 m-20 -58.16 -41.15 83.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.426 0.69 . . . . 15.0 110.815 170.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.628 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -67.71 -30.51 74.7 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.92 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 187' ' ' LEU . 39.1 mm -75.99 -52.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.982 0.513 . . . . 15.0 110.346 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 55.8 pttt -80.16 20.19 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.053 0.941 . . . . 15.0 113.365 -167.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.48 31.22 2.15 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.367 -0.693 . . . . 15.0 111.367 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -146.99 -161.73 1.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.342 1.057 . . . . 15.0 109.695 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 158' ' ' VAL . 9.9 ptpp? -148.89 168.75 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.189 0.596 . . . . 15.0 109.671 172.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.4 148.64 51.37 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 117.987 0.358 . . . . 15.0 110.626 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.75 -45.63 1.28 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.804 -0.634 . . . . 15.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.92 122.95 28.93 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.471 0.653 . . . . 15.0 110.375 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.43 135.95 40.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.19 0.996 . . . . 15.0 110.11 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -144.46 173.03 12.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.033 0.933 . . . . 15.0 109.172 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.7 m -129.79 116.81 19.28 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.89 -0.781 . . . . 15.0 108.89 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.628 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.1 pt -92.32 170.58 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.029 0.932 . . . . 15.0 110.071 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.93 124.6 33.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.379 0.672 . . . . 15.0 109.441 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.01 163.64 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.586 -1.264 . . . . 15.0 107.586 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.3 m -129.83 140.13 51.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.723 0.809 . . . . 15.0 109.38 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.84 143.11 45.92 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 122.977 0.511 . . . . 15.0 110.549 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.63 155.51 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 124.295 3.33 . . . . 15.0 115.587 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.29 -25.79 63.5 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.176 -0.92 . . . . 15.0 110.406 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.29 -13.13 35.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.277 1.031 . . . . 15.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -55.67 140.98 39.64 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 123.259 0.623 . . . . 15.0 111.275 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -46.84 -67.61 0.27 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 125.178 1.549 . . . . 15.0 112.806 -171.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.69 125.57 28.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 15.0 110.45 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.18 -31.94 62.88 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.6 0.76 . . . . 15.0 111.587 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 229' ' ' LYS . 27.8 p-10 -64.23 -17.2 63.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.447 0.699 . . . . 15.0 111.416 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.824 HD11 ' HA ' ' B' ' 388' ' ' VAL . 28.8 mt -100.01 -39.31 8.2 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.172 0.989 . . . . 15.0 110.601 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -46.63 113.58 0.67 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.136 1.774 . . . . 15.0 112.813 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.65 -18.93 27.32 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.608 0.567 . . . . 15.0 114.253 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 98.4 mttt -84.17 154.28 23.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.619 0.768 . . . . 15.0 112.453 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.44 23.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.363 1.065 . . . . 15.0 110.638 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -90.23 135.67 33.53 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.215 1.006 . . . . 15.0 111.067 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.74 100.85 11.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.479 ' HE1' HG21 ' B' ' 387' ' ' ILE . 90.6 m-85 -96.53 107.74 20.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.555 0.342 . . . . 15.0 110.563 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.23 102.68 6.77 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.078 -0.712 . . . . 15.0 109.078 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.52 134.38 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.865 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -115.99 100.44 7.97 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 166' ' ' ILE . 95.0 mt -74.08 110.15 8.14 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.874 -0.787 . . . . 15.0 108.874 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -108.96 -33.37 6.94 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.096 0.474 . . . . 15.0 110.142 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.694 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.4 mmtt -133.28 122.99 24.69 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.108 0.963 . . . . 15.0 109.498 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 207' ' ' ALA . 97.5 t -114.97 87.44 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 106.872 -1.529 . . . . 15.0 106.872 169.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 163' ' ' ARG . 44.7 mt-10 -93.77 169.18 10.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.62 -0.881 . . . . 15.0 108.62 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 32.2 tt0 -134.42 122.84 23.1 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -74.1 83.99 1.81 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.132 -1.432 . . . . 15.0 107.132 167.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 127.17 31.6 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.752 -1.567 . . . . 15.0 110.746 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.38 115.0 9.36 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.389 1.076 . . . . 15.0 109.247 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 78.7 Cg_endo -75.52 -176.56 3.02 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.047 2.498 . . . . 15.0 112.407 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.96 142.53 56.42 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.964 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 24.4 tp -107.1 23.04 15.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 p -71.56 176.7 4.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.509 1.124 . . . . 15.0 111.216 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -38.05 -59.49 0.84 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.944 1.698 . . . . 15.0 114.573 -166.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.28 -22.82 65.63 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.31 -50.21 6.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.095 0.558 . . . . 15.0 109.786 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.609 HG13 HD22 ' A' ' 266' ' ' LEU . 15.6 tt -65.36 -27.29 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.012 0.525 . . . . 15.0 111.841 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -22.65 42.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.022 0.378 . . . . 15.0 112.022 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -62.81 -22.15 66.42 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.052 0.941 . . . . 15.0 111.568 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -39.95 90.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 15.0 110.857 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 150.1 26.5 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 O-C-N 123.416 0.447 . . . . 15.0 113.452 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.11 143.56 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 117.558 0.679 . . . . 15.0 109.185 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -69.65 -57.2 5.45 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.386 0.674 . . . . 15.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -91.54 -38.3 12.59 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.745 0.418 . . . . 15.0 110.51 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.17 32.43 5.27 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.147 -0.479 . . . . 15.0 112.645 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.7 p -78.65 145.64 34.51 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.392 0.596 . . . . 15.0 109.738 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 253' ' ' ILE . 44.7 t -58.16 -41.59 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.127 0.971 . . . . 15.0 111.126 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.22 -34.66 61.16 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.853 0.861 . . . . 15.0 111.858 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.88 -25.36 58.2 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 111.366 -0.694 . . . . 15.0 111.366 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.609 HD22 HG13 ' A' ' 253' ' ' ILE . 54.7 tp -75.97 -28.46 57.9 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.44 -45.88 78.33 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.071 -0.714 . . . . 15.0 109.071 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.99 82.05 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.307 -1.315 . . . . 15.0 110.419 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -68.13 -45.55 73.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.222 0.951 . . . . 15.0 111.855 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.04 -22.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 122.506 0.322 . . . . 15.0 110.649 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -68.47 -53.14 25.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.948 -0.39 . . . . 15.0 109.948 169.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -77.43 -2.18 33.98 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 112.537 0.569 . . . . 15.0 112.537 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -98.85 -59.37 1.75 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.271 0.628 . . . . 15.0 110.39 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.485 ' SD ' HG11 ' A' ' 132' ' ' VAL . 64.2 mtt -74.23 -38.0 63.65 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-O 118.045 -0.979 . . . . 15.0 112.055 -169.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -71.2 -37.81 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 120.044 1.293 . . . . 15.0 109.804 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.486 ' NH2' ' HA ' ' A' ' 378' ' ' TYR . 5.8 tpp180 -56.58 -40.36 75.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.714 0.805 . . . . 15.0 110.939 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.12 -60.38 2.36 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.891 -0.595 . . . . 15.0 110.581 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 130' ' ' VAL . 39.8 tp -64.24 -60.47 3.16 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 125.174 1.39 . . . . 15.0 112.775 -171.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.06 -32.53 73.92 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.03 0.443 . . . . 15.0 110.756 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.1 t -69.82 -38.53 76.6 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.075 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.65 98.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 15.0 110.734 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.45 -51.52 71.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 O-C-N 123.593 0.558 . . . . 15.0 109.558 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.4 HH22 ' HG3' ' A' ' 409' ' ' GLU . 12.5 tpt180 -57.5 -52.23 66.24 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.639 0.587 . . . . 15.0 111.35 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -69.24 -28.7 66.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.922 0.889 . . . . 15.0 111.456 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -64.22 -57.62 8.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.814 0.445 . . . . 15.0 110.084 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.51 -35.84 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.677 0.791 . . . . 15.0 110.534 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.6 tttt -64.05 -48.74 75.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.931 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.9 p -67.69 -31.1 70.83 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.182 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.25 -35.98 74.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.09 0.556 . . . . 15.0 110.701 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -52.43 57.76 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 123.446 0.467 . . . . 15.0 109.929 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 HG22 ' A' ' 347' ' ' VAL . 34.0 mm -61.78 -50.25 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.847 0.717 . . . . 15.0 111.486 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.45 -35.34 80.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.802 -0.635 . . . . 15.0 109.707 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.41 -40.57 96.43 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.009 0.818 . . . . 15.0 112.474 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 350' ' ' LEU . 45.7 mt -60.76 -46.33 90.89 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.18 0.992 . . . . 15.0 111.109 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 291' ' ' ILE . 41.4 t -64.2 -48.23 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.696 0.76 . . . . 15.0 109.784 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -66.37 -24.07 66.43 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.028 -0.987 . . . . 15.0 110.685 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.09 53.25 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.863 . . . . 15.0 112.473 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.38 149.39 10.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 -169.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.41 136.37 47.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.776 -0.647 . . . . 15.0 110.314 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 346' ' ' VAL . 4.8 tp -117.8 115.91 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.001 0.92 . . . . 15.0 109.228 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.82 141.76 35.93 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.469 HG12 HD11 ' A' ' 307' ' ' ILE . 24.7 t -126.93 115.33 22.14 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.747 0.819 . . . . 15.0 109.633 -165.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.02 141.13 16.37 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.275 2.65 . . . . 15.0 112.974 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.497 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -64.55 -33.65 76.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.267 1.21 . . . . 15.0 114.267 -166.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.63 65.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.753 0.421 . . . . 15.0 111.552 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 345' ' ' VAL . 14.5 mt -88.16 -29.83 20.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.417 -0.811 . . . . 15.0 110.271 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 302' ' ' VAL . 2.2 mp -59.39 -51.63 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 167.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.82 -57.21 11.75 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 114.438 -1.255 . . . . 15.0 110.342 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 313' ' ' VAL . 32.3 t -60.77 -56.32 22.63 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.401 1.063 . . . . 15.0 111.848 -173.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.78 -45.47 78.35 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 111.744 0.275 . . . . 15.0 111.744 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 46.7 mt -64.83 -37.02 79.12 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 N-CA-C 109.803 -0.443 . . . . 15.0 109.803 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 8.2 t70 -57.59 -46.68 83.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.694 0.797 . . . . 15.0 110.934 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' B' ' 471' ' ' LYS . 96.3 t -55.55 -52.0 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 123.837 0.711 . . . . 15.0 110.573 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 341' ' ' ALA . 84.1 mt -70.57 -21.96 62.63 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.803 -1.09 . . . . 15.0 112.3 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 329' ' ' ALA . 49.8 mtm180 -83.4 -27.89 29.28 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.125 0.57 . . . . 15.0 110.783 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 64.5 mtt180 -70.46 -42.66 71.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 172.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.18 -51.55 69.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.088 0.955 . . . . 15.0 110.502 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.46 31.11 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.499 -0.773 . . . . 15.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.29 74.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 123.965 0.791 . . . . 15.0 111.476 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -59.48 -36.04 75.26 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.2 0.6 . . . . 15.0 110.789 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -87.51 -19.76 27.47 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.52 0.728 . . . . 15.0 110.45 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -86.81 -5.84 58.99 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.826 1.25 . . . . 15.0 110.508 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.83 61.65 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.035 -0.53 . . . . 15.0 113.308 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.95 17.36 74.95 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 122.613 -0.345 . . . . 15.0 113.246 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.443 HD22 HD13 ' B' ' 408' ' ' LEU . 53.9 t30 -70.55 159.56 34.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 122.887 0.475 . . . . 15.0 109.771 174.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 76.82 -55.5 0.56 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.236 1.815 . . . . 15.0 111.354 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.494 ' HE3' ' HA2' ' B' ' 417' ' ' GLY . 48.6 mttm 65.39 21.03 11.88 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.128 1.371 . . . . 15.0 110.937 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -97.79 15.25 24.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.781 1.632 . . . . 15.0 110.083 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -50.72 -19.87 1.08 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 126.013 1.725 . . . . 15.0 114.692 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 59.1 tp -49.77 -34.96 20.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.931 0.893 . . . . 15.0 111.601 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.7 -29.3 68.52 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.937 1.695 . . . . 15.0 113.04 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 337' ' ' PHE . 53.1 mt -43.76 123.26 3.84 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 123.853 0.861 . . . . 15.0 112.556 -171.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 53.5 Cg_exo -43.03 127.8 5.15 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 124.995 3.797 . . . . 15.0 115.189 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -52.91 -48.42 67.26 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.655 1.182 . . . . 15.0 112.076 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.52 -18.79 4.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.332 1.053 . . . . 15.0 113.447 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.1 mt -74.8 -38.02 62.22 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.224 0.465 . . . . 15.0 110.878 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 332' ' ' LEU . 41.9 m-85 -120.03 -51.94 2.21 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.095 0.558 . . . . 15.0 112.241 -168.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -47.53 -40.21 18.24 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.987 1.315 . . . . 15.0 113.301 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.56 -34.9 59.92 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.279 1.032 . . . . 15.0 112.469 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -104.22 -30.78 9.95 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.154 0.982 . . . . 15.0 111.126 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -76.49 -60.63 2.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.249 1.02 . . . . 15.0 110.971 -173.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.439 ' HG3' HG11 ' A' ' 302' ' ' VAL . 88.3 tttt -62.32 -25.03 67.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.428 -0.805 . . . . 15.0 109.792 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 347' ' ' VAL . 29.5 ttt85 -71.69 -35.09 70.14 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 118.421 -0.8 . . . . 15.0 110.719 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -57.36 -43.16 83.3 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 119.243 0.929 . . . . 15.0 109.306 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 306' ' ' LEU . 41.3 t -60.73 -49.8 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.265 -1.334 . . . . 15.0 110.704 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 300' ' ' ILE . 68.2 t -59.59 -48.95 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.611 0.764 . . . . 15.0 111.058 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 291' ' ' ILE . 71.6 t -52.64 -43.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.138 0.975 . . . . 15.0 110.267 173.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -70.36 -37.87 70.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 15.0 113.854 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.88 -47.2 54.45 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.267 0.627 . . . . 15.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HB3' HD13 ' A' ' 294' ' ' LEU . 76.9 mt -62.38 -57.88 9.7 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.998 0.811 . . . . 15.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 355' ' ' ILE . 53.2 mt -65.65 -34.45 78.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.125 0.57 . . . . 15.0 112.216 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.5 99.0 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.696 -0.562 . . . . 15.0 111.696 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.25 -37.42 85.46 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.072 -0.564 . . . . 15.0 110.687 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 350' ' ' LEU . 62.5 t -63.49 -36.28 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 117.956 0.343 . . . . 15.0 110.786 176.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 360' ' ' LEU . 97.1 mt -64.0 -44.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.367 0.667 . . . . 15.0 109.807 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.23 -56.4 11.46 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.488 -0.324 . . . . 15.0 111.361 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 77.0 m -54.48 -42.65 70.96 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.982 1.313 . . . . 15.0 111.985 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -101.19 14.65 31.31 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.155 0.582 . . . . 15.0 111.547 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 48.65 33.56 4.32 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 125.729 1.612 . . . . 15.0 114.205 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 355' ' ' ILE . 65.9 mt -72.42 157.04 38.38 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.087 0.955 . . . . 15.0 113.055 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 152.68 40.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.967 0.907 . . . . 15.0 110.415 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.69 111.62 17.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.477 0.711 . . . . 15.0 109.556 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 15.2 t70 -107.55 137.39 45.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.327 0.651 . . . . 15.0 110.884 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -64.48 -31.76 73.1 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.739 0.815 . . . . 15.0 113.03 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -66.08 -32.74 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 10.7 tpp180 -71.75 -44.99 63.13 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 371' ' ' ILE . 94.1 t -55.56 -60.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.111 0.882 . . . . 15.0 109.819 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -59.48 -35.83 74.85 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.161 0.913 . . . . 15.0 111.897 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.62 -55.7 27.41 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.902 0.751 . . . . 15.0 111.816 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.04 -42.97 81.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.641 0.776 . . . . 15.0 111.014 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 398' ' ' MET . 51.2 mm -51.22 -60.22 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.467 1.104 . . . . 15.0 110.461 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.54 -42.87 95.45 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.755 0.659 . . . . 15.0 112.14 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.59 -44.89 93.21 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 124.017 0.823 . . . . 15.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -77.09 -35.45 56.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 119.658 -0.211 . . . . 15.0 110.668 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 378' ' ' TYR . . . -69.19 -27.09 65.2 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.482 0.713 . . . . 15.0 111.798 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.6 t -65.78 -19.64 65.96 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 123.916 0.76 . . . . 15.0 110.908 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -95.75 3.03 54.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.972 0.909 . . . . 15.0 111.933 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.486 ' HA ' ' NH2' ' A' ' 276' ' ' ARG . 2.8 m-85 -88.74 177.57 6.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.065 0.546 . . . . 15.0 109.686 172.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.29 -47.22 62.15 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.173 -0.921 . . . . 15.0 109.359 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.37 122.31 13.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.379 1.072 . . . . 15.0 109.233 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -70.69 -40.28 4.0 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.708 2.272 . . . . 15.0 114.178 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -54.32 -47.79 72.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.359 0.874 . . . . 15.0 113.359 -167.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.93 -24.68 66.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.236 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.07 -45.79 29.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 123.859 0.864 . . . . 15.0 109.164 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.04 -47.04 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.053 0.541 . . . . 15.0 109.57 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.66 -39.93 80.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.142 0.577 . . . . 15.0 112.36 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.4 -36.65 84.44 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.527 0.731 . . . . 15.0 111.08 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.453 ' HA ' HD23 ' A' ' 394' ' ' LEU . 34.8 m-85 -73.84 -62.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.922 -0.581 . . . . 15.0 110.599 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.2 p -57.6 -32.17 66.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.32 17.42 11.29 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 15.0 111.98 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.637 HD21 HG22 ' B' ' 435' ' ' THR . 56.7 t-20 -139.84 106.14 5.27 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.35 -0.982 . . . . 15.0 108.35 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -65.83 -41.2 92.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.998 0.519 . . . . 15.0 111.345 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.67 -41.97 96.13 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.932 0.77 . . . . 15.0 110.517 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 388' ' ' TYR . 22.5 tp -72.14 -38.92 69.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.691 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 93.0 mmm -66.26 -30.76 71.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.92 0.488 . . . . 15.0 110.69 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.9 -39.96 69.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.285 1.034 . . . . 15.0 109.852 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -75.43 -21.58 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.916 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 371' ' ' ILE . 5.8 tpt -87.69 -20.07 26.79 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.586 0.217 . . . . 15.0 111.586 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.57 -36.89 57.33 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 167.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -52.02 -61.59 2.17 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.736 -1.12 . . . . 15.0 110.343 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.8 p -66.32 -27.47 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 118.154 0.434 . . . . 15.0 111.685 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.73 -58.01 10.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.033 0.533 . . . . 15.0 110.355 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 24.3 tp -77.76 -23.32 49.27 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.76 -1.109 . . . . 15.0 111.582 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.52 -51.66 33.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.99 0.516 . . . . 15.0 109.625 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.28 -35.8 82.03 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.8 -0.636 . . . . 15.0 111.176 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -69.85 -33.55 72.42 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.012 0.525 . . . . 15.0 111.205 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.97 93.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.84 0.456 . . . . 15.0 110.303 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.5 t -58.12 -53.6 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.815 -0.63 . . . . 15.0 109.752 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.4 ' HG3' HH22 ' A' ' 283' ' ' ARG . 43.6 mt-10 -60.38 -25.6 66.01 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.987 0.915 . . . . 15.0 112.908 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.94 -30.59 62.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.783 0.433 . . . . 15.0 111.317 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 294' ' ' LEU . 43.5 t -70.67 -43.27 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.077 -1.082 . . . . 15.0 108.077 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 83.4 mt -65.23 -40.7 94.42 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.362 1.039 . . . . 15.0 111.57 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.35 -23.16 67.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.836 0.854 . . . . 15.0 111.564 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 24.4 mtpp -98.96 -27.42 13.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 15.0 111.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.966 0.907 . . . . 15.0 111.348 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.8 mttt -69.93 83.51 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.692 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 125' ' ' VAL . 5.0 m -93.8 91.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.033 0.921 . . . . 15.0 109.487 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.7 t -70.72 95.2 1.09 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.513 -1.221 . . . . 15.0 109.188 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 131.81 40.59 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 115.055 -0.975 . . . . 15.0 110.505 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -146.86 145.43 29.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.27 135.12 33.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.728 HG23 HG22 ' A' ' 130' ' ' VAL . 4.5 t -159.86 174.03 15.06 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.495 0.497 . . . . 15.0 110.657 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.5 p -100.61 175.34 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.475 1.11 . . . . 15.0 111.948 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.454 ' HD2' HD22 ' A' ' 278' ' ' LEU . 38.4 t80 -52.71 -28.06 20.33 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.578 1.551 . . . . 15.0 111.691 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 23.2 m-80 -65.12 -15.61 62.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.775 1.23 . . . . 15.0 112.945 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' A' ' 427' ' ' LEU . 23.4 tp10 -60.7 -37.21 80.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.582 1.153 . . . . 15.0 111.414 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.8 mp -109.23 -77.85 0.59 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.435 -0.165 . . . . 15.0 111.192 -174.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -68.35 -50.54 52.56 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.838 0.455 . . . . 15.0 112.1 -171.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 15.9 m120 -82.84 47.88 1.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -174.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -102.09 76.02 1.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.18 -38.71 11.42 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.574 0.75 . . . . 15.0 109.437 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.017 0.927 . . . . 15.0 109.482 -176.241 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.35 120.5 13.95 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.599 HD23 ' H ' ' B' ' 367' ' ' LEU . 1.1 pt? -94.46 -70.42 0.71 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -161.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.473 ' H ' ' HG ' ' B' ' 367' ' ' LEU . 7.2 t70 -79.93 -81.22 0.12 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.014 0.825 . . . . 0.0 109.243 -169.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' B' ' 370' ' ' ALA . 1.7 pm0 -104.26 -73.19 0.68 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 160.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 370' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' B' ' 369' ' ' GLU . . . -107.25 -85.19 0.51 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.197 0.908 . . . . 0.0 110.426 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.582 HG13 ' H ' ' B' ' 372' ' ' GLN . 1.7 p -110.71 -78.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.582 ' H ' HG13 ' B' ' 371' ' ' VAL . 46.4 tt0 -95.13 -78.89 0.44 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.562 ' HB3' ' O ' ' B' ' 377' ' ' PHE . 26.1 tpt180 -104.83 -84.0 0.5 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 163.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' B' ' 378' ' ' ALA . . . -105.67 -78.73 0.57 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.952 0.797 . . . . 0.0 111.834 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.48 HD13 ' H ' ' B' ' 375' ' ' LEU 0.292 0.0 OUTLIER -111.65 -58.28 2.14 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.212 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.475 ' H ' HD22 ' B' ' 375' ' ' LEU . 4.8 tm-20 -102.43 -82.58 0.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' B' ' 373' ' ' ARG . 3.0 m-85 -98.73 -87.91 0.33 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 161.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 378' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' B' ' 374' ' ' ALA . . . -91.56 -84.92 0.25 Allowed 'General case' 0 C--N 1.358 0.946 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -107.48 -85.66 0.51 Allowed 'General case' 0 C--O 1.242 0.71 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 166.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.492 ' HG3' ' HA ' ' B' ' 393' ' ' ALA . 40.2 tptt 176.0 80.55 0.0 OUTLIER 'General case' 0 C--N 1.35 0.595 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.27 -69.52 0.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.72 -167.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 74.73 -87.98 0.74 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.367 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.82 134.93 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.387 0.675 . . . . 0.0 111.233 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 55.1 m -144.99 -73.74 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 166.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.515 HD13 ' SD ' ' A' ' 194' ' ' MET . 2.3 pt? -142.88 147.8 35.95 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 157.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.6 91.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -164.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 168' ' ' PHE . 0.1 OUTLIER -146.37 87.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 156.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.824 ' HA ' HD11 ' A' ' 226' ' ' LEU . 9.8 p -152.5 154.69 7.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.406 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 97.8 m -64.08 128.12 34.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 160.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -41.5 112.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.17 1.388 . . . . 0.0 112.82 -167.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -149.02 146.14 27.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.358 0.663 . . . . 0.0 110.137 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -152.21 137.94 17.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.272 1.029 . . . . 0.0 109.782 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' B' ' 380' ' ' LYS . . . -77.61 148.41 35.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.113 0.965 . . . . 0.0 111.733 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -91.05 4.06 53.12 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.859 0.864 . . . . 0.0 111.101 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -54.46 107.86 0.32 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.145 0.978 . . . . 0.0 111.264 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 39.3 m 70.44 178.61 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.126 1.516 . . . . 0.0 112.373 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 64.34 -87.44 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.06 1.344 . . . . 0.0 110.516 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.523 HG13 ' H ' ' B' ' 399' ' ' VAL . 11.4 pt 32.71 -83.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 126.136 1.774 . . . . 0.0 114.128 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.523 ' H ' HG13 ' B' ' 398' ' ' ILE . 2.6 p -60.87 108.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.456 0.702 . . . . 0.0 109.234 171.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 63.23 91.39 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -164.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.57 -25.68 26.47 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.538 2.825 . . . . 0.0 113.961 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.04 -78.17 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 54.6 m -157.23 -42.27 0.07 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 63.93 -168.44 0.2 Allowed 'General case' 0 C--N 1.36 1.035 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.045 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -74.59 113.64 26.15 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.791 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.13 149.01 74.71 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.927 2.418 . . . . 0.0 112.703 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -66.48 -20.69 70.0 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.717 0.635 . . . . 0.0 113.574 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.443 HD13 HD22 ' A' ' 325' ' ' ASN . 98.3 mt -99.3 27.39 5.21 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 54.2 p 65.72 -60.36 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 126.759 2.024 . . . . 0.0 112.152 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.52 -167.07 1.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.496 1.119 . . . . 0.0 109.571 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.39 -17.53 60.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.539 0.735 . . . . 0.0 111.321 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 25.9 tp 72.53 159.18 0.21 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.732 1.613 . . . . 0.0 111.521 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.26 -74.94 0.09 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.348 0.659 . . . . 0.0 110.321 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 48.3 m -162.19 -60.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.951 0.9 . . . . 0.0 109.054 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.05 94.1 0.07 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.947 1.299 . . . . 0.0 110.591 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -54.19 -57.96 9.18 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.189 1.796 . . . . 0.0 113.355 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 417' ' ' GLY . . . . . 0.494 ' HA2' ' HE3' ' A' ' 327' ' ' LYS . . . -168.1 -64.98 0.03 OUTLIER Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.044 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 59.04 -150.22 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.934 0.894 . . . . 0.0 111.147 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.488 HG13 ' H ' ' B' ' 420' ' ' MET 0.281 7.2 p 47.58 -78.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 126.762 2.025 . . . . 0.0 114.948 177.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.488 ' H ' HG13 ' B' ' 419' ' ' VAL . 12.5 tmm? -156.38 106.82 2.38 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 422' ' ' MET . 0.5 OUTLIER 59.91 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.38 1.872 . . . . 0.0 112.948 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.41 ' H ' HG22 ' B' ' 421' ' ' VAL . 13.5 ttt 63.69 33.48 13.0 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.999 1.32 . . . . 0.0 111.286 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -4.43 41.85 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.511 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -104.8 120.16 40.72 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.42 58.86 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.536 0.522 . . . . 0.0 112.823 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 426' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' B' ' 429' ' ' GLU . 65.7 t30 59.7 20.73 9.43 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.889 1.276 . . . . 0.0 111.31 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 65.5 p -78.42 173.35 12.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.64 0.776 . . . . 0.0 111.335 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 63.94 8.0 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.925 1.29 . . . . 0.0 112.379 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' B' ' 432' ' ' GLN . 3.5 tm-20 -70.0 -32.14 70.17 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.47 1.108 . . . . 0.0 110.027 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -55.5 -40.14 71.37 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.453 1.101 . . . . 0.0 110.905 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 22.7 t -101.13 -7.5 23.11 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.204 -169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.42 ' HG2' ' HA ' ' B' ' 429' ' ' GLU . 29.4 mm-40 -56.92 -56.01 27.16 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.2 0.455 . . . . 0.0 110.995 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.31 111.85 20.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -88.14 48.95 1.71 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.742 0.817 . . . . 0.0 111.414 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.637 HG22 HD21 ' A' ' 391' ' ' ASN . 19.8 m -66.71 -24.72 66.28 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.15 0.98 . . . . 0.0 110.998 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -137.44 -179.19 16.63 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 38.6 t 62.1 -90.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.863 1.265 . . . . 0.0 111.915 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 61.21 36.48 17.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.152 0.981 . . . . 0.0 110.022 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 99.0 mt 64.2 18.33 11.21 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.179 1.392 . . . . 0.0 112.337 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.673 ' HG3' HG12 ' B' ' 441' ' ' ILE . 35.3 ptt180 -151.9 -159.81 1.07 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.665 1.186 . . . . 0.0 108.175 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.673 HG12 ' HG3' ' B' ' 440' ' ' ARG . 34.0 mm 68.55 110.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.78 0.832 . . . . 0.0 112.066 168.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.73 92.47 1.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -142.93 167.3 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.183 -169.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 444' ' ' TYR . . . . . 0.482 ' HB3' HD11 ' B' ' 470' ' ' LEU . 97.3 m-85 -121.3 169.77 10.26 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.306 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -125.46 156.2 19.16 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -89.52 156.08 5.33 Favored 'Trans proline' 0 CA--C 1.555 1.57 0 C-N-CA 122.569 2.179 . . . . 0.0 113.109 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -137.58 75.88 1.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 62.86 21.27 12.73 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.997 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -83.88 -34.65 24.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.89 4.17 2.78 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.683 0.793 . . . . 0.0 112.21 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.15 -19.73 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 123.485 0.714 . . . . 0.0 110.759 168.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 14.0 p -62.46 -35.83 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.562 1.145 . . . . 0.0 110.928 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.4 -73.63 2.01 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.004 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -168.86 -34.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.461 1.504 . . . . 0.0 107.237 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 72.4 p 57.83 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.946 2.098 . . . . 0.0 112.219 -172.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.6 138.28 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.336 1.454 . . . . 0.0 111.953 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 73.25 -19.15 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.635 1.174 . . . . 0.0 113.038 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 35.2 p -65.84 -59.28 4.03 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.511 1.124 . . . . 0.0 111.802 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -173.52 -63.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.764 1.226 . . . . 0.0 107.752 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.76 126.35 47.31 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -66.28 -72.45 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.23 0.612 . . . . 0.0 109.561 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -166.69 -128.96 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.342 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' B' ' 464' ' ' MET . 53.3 m 79.62 152.33 0.12 Allowed 'General case' 0 C--N 1.366 1.326 0 C-N-CA 124.597 1.159 . . . . 0.0 110.413 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' B' ' 463' ' ' THR . 2.7 ptp 75.35 -47.95 0.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.248 2.619 . . . . 0.0 111.242 -173.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 70.72 -30.38 0.2 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.908 1.683 . . . . 0.0 112.943 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.36 -11.51 4.39 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 124.491 1.116 . . . . 0.0 112.649 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.37 -19.56 56.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.437 1.095 . . . . 0.0 112.37 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 16.3 mt -152.96 -2.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.017 0.927 . . . . 0.0 112.662 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.95 97.67 0.14 Allowed Glycine 0 C--N 1.355 1.609 0 N-CA-C 115.115 0.806 . . . . 0.0 115.115 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' B' ' 444' ' ' TYR . 51.7 tp -106.96 152.33 24.1 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.592 ' HA ' HG11 ' A' ' 313' ' ' VAL . 3.5 tmmm? . . . . . 0 C--O 1.249 1.031 0 N-CA-C 107.711 -1.218 . . . . 12.06 107.711 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -76.37 116.09 16.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.763 . . . . 15.0 109.039 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.68 161.57 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.053 0.454 . . . . 15.0 111.224 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 9.4 p -152.92 103.45 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.111 -0.95 . . . . 15.0 109.137 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.79 107.3 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.646 0.736 . . . . 15.0 110.233 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.2 100.54 10.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.323 1.049 . . . . 15.0 109.375 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 m -69.19 97.66 0.94 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.676 -0.861 . . . . 15.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.7 p -75.6 -61.35 1.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.912 0.885 . . . . 15.0 111.402 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -149.46 103.99 3.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.663 -0.495 . . . . 15.0 109.663 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.02 -108.02 1.95 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 124.018 0.824 . . . . 15.0 113.644 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.26 -29.64 61.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 15.0 110.682 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 119.35 12.41 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 124.164 0.915 . . . . 15.0 112.968 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HD2' HG11 ' A' ' 111' ' ' VAL . 64.6 mtt85 -133.39 118.95 19.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.527 1.131 . . . . 15.0 109.515 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 37.5 ttm180 -89.94 96.74 10.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.001 1.32 . . . . 15.0 110.248 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG11 ' HB1' ' A' ' 78' ' ' ALA . 41.0 t -89.11 88.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.558 -0.905 . . . . 15.0 108.558 173.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 31.5 m -77.65 114.26 16.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.087 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -105.08 112.95 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.752 0.821 . . . . 15.0 109.19 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 87.3 m -94.62 105.07 17.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.547 0.739 . . . . 15.0 109.885 174.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 23' ' ' SER . 60.8 mt -91.47 101.25 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.9 0.88 . . . . 15.0 109.53 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.8 173.6 9.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.151 0.58 . . . . 15.0 111.365 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.12 59.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.385 1.474 . . . . 15.0 113.798 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.11 -32.34 73.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.64 0.776 . . . . 15.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 19' ' ' ILE . 50.1 m -92.03 -29.62 16.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.991 0.516 . . . . 15.0 111.473 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.7 mt -59.49 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.72 78.88 5.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.947 0.879 . . . . 15.0 109.374 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.4 m -158.72 -55.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.612 -1.995 . . . . 15.0 105.612 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.97 70.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.331 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 66' ' ' VAL . 89.1 t -58.29 -62.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 123.945 0.778 . . . . 15.0 110.125 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -63.51 -39.83 95.46 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.736 -1.12 . . . . 15.0 111.86 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.3 m -68.66 -25.34 64.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.622 -0.717 . . . . 15.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -80.57 -43.25 20.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.7 0.286 . . . . 15.0 110.239 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.771 HD21 HG11 ' A' ' 62' ' ' VAL . 68.4 mt -74.15 -18.74 60.74 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.928 0.714 . . . . 15.0 112.928 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 p -76.71 -31.98 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 171.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -67.89 -49.03 64.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.342 0.657 . . . . 15.0 109.517 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.5 -33.64 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.288 1.035 . . . . 15.0 110.538 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.5 -54.12 50.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.994 0.518 . . . . 15.0 110.908 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.65 -42.54 86.49 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.291 0.636 . . . . 15.0 111.641 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -66.88 -51.84 50.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.643 1.177 . . . . 15.0 111.52 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.84 2.71 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.515 0.726 . . . . 15.0 110.407 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 71.11 17.28 6.14 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.265 1.426 . . . . 15.0 112.736 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 48.3 mt -66.57 -25.09 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.55 1.14 . . . . 15.0 110.771 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 -33.47 73.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.945 0.898 . . . . 15.0 111.201 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.91 -30.55 74.33 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.861 0.725 . . . . 15.0 112.855 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.5 m-85 -80.51 -24.79 39.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.358 0.663 . . . . 15.0 110.444 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -71.31 105.38 3.47 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.983 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.77 6.54 45.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.151 0.981 . . . . 15.0 110.774 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.79 68.56 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.211 0.319 . . . . 15.0 112.588 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -69.02 -49.06 61.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.087 0.955 . . . . 15.0 110.092 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.01 127.84 30.02 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.0 -1.0 . . . . 15.0 108.644 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.67 144.91 51.23 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.202 2.601 . . . . 15.0 113.337 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.58 -29.02 68.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.865 0.866 . . . . 15.0 112.351 -170.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -67.35 -38.94 85.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.648 0.379 . . . . 15.0 110.85 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.742 HG23 ' HD2' ' A' ' 57' ' ' ARG . 61.4 mt -73.28 -32.61 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.959 0.904 . . . . 15.0 111.202 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 15.8 m -75.3 -20.1 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.922 -0.486 . . . . 15.0 111.358 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -86.9 -62.97 1.39 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.255 0.622 . . . . 15.0 111.438 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -79.82 -41.49 26.3 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.742 ' HD2' HG23 ' A' ' 53' ' ' ILE . 95.2 mtt180 -86.78 -63.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.814 0.446 . . . . 15.0 110.648 -173.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 40.3 m-85 -75.73 -21.57 57.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 111.803 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.38 25.51 12.61 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.432 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.41 69.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.354 0.662 . . . . 15.0 112.581 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 m -77.45 -8.13 57.27 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.617 0.767 . . . . 15.0 112.61 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.771 HG11 HD21 ' A' ' 32' ' ' LEU . 2.7 p -119.36 86.58 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 122.537 1.16 . . . . 15.0 109.814 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 4.5 mmp_? -115.66 -47.98 2.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.567 -1.197 . . . . 15.0 108.959 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.88 -50.0 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.996 1.318 . . . . 15.0 111.993 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.03 -35.61 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.991 0.916 . . . . 15.0 111.151 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 28' ' ' VAL . 96.3 t -66.79 -38.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 114.813 -1.085 . . . . 15.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 HD21 ' CZ ' ' A' ' 97' ' ' TYR . 57.8 mt -62.0 -27.56 68.95 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.595 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.01 86.74 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.567 0.542 . . . . 15.0 112.507 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.68 -47.54 83.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.733 0.813 . . . . 15.0 110.943 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.94 -57.38 13.04 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.377 -1.283 . . . . 15.0 111.547 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 71.6 mtm -69.98 -30.49 67.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.5 0.72 . . . . 15.0 112.288 -174.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 t -68.62 -51.31 43.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.002 0.521 . . . . 15.0 111.06 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.692 -0.686 . . . . 15.0 110.456 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.03 -26.45 64.04 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.538 0.524 . . . . 15.0 112.153 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -63.05 -59.31 4.97 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.469 0.308 . . . . 15.0 110.517 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.86 -25.61 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.936 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -58.32 7.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.289 0.636 . . . . 15.0 109.384 171.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HB1' HG11 ' A' ' 15' ' ' VAL . . . -59.74 -53.87 52.98 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.052 -0.976 . . . . 15.0 112.077 -171.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.451 HD12 ' HG3' ' A' ' 86' ' ' PRO . 30.1 pt -58.79 -35.11 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.792 0.664 . . . . 15.0 112.792 -172.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.6 -42.35 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.086 0.554 . . . . 15.0 111.028 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -73.74 -31.9 63.59 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.242 0.217 . . . . 15.0 111.226 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.09 -0.96 33.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.683 0.793 . . . . 15.0 110.951 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 67.58 12.34 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.134 1.373 . . . . 15.0 112.432 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -78.26 118.69 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.653 0.781 . . . . 15.0 109.349 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -87.86 96.67 0.64 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 79' ' ' ILE . 55.2 Cg_endo -87.3 145.79 7.26 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.086 2.524 . . . . 15.0 114.164 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.3 46.98 0.82 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.945 0.898 . . . . 15.0 109.079 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 110' ' ' GLU . . . -144.24 153.68 25.22 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.443 -0.798 . . . . 15.0 112.088 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 113.0 12.65 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 15.0 109.785 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.26 106.97 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.953 1.769 . . . . 15.0 111.334 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -88.27 92.8 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.934 -0.765 . . . . 15.0 108.934 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -74.76 111.73 10.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.18 0.592 . . . . 15.0 109.508 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.38 93.62 27.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.173 0.989 . . . . 15.0 108.797 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.69 91.65 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.911 2.407 . . . . 15.0 111.951 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.24 -27.15 70.16 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.456 -0.793 . . . . 15.0 113.121 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 98' ' ' LYS . 14.7 pt-20 -165.47 161.58 18.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.503 0.721 . . . . 15.0 110.456 172.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 13.8 t80 -157.22 108.35 2.33 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.685 -1.228 . . . . 15.0 107.685 168.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -125.7 130.01 50.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.163 0.985 . . . . 15.0 108.423 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 tp -67.16 104.8 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.693 0.621 . . . . 15.0 109.484 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.74 12.24 44.47 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.602 -0.554 . . . . 15.0 113.467 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.0 mt-10 -130.09 -97.43 0.35 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 118.738 -0.649 . . . . 15.0 109.841 172.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -140.93 160.05 40.9 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.274 0.943 . . . . 15.0 112.105 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -131.8 74.5 1.59 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.437 1.495 . . . . 15.0 107.058 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.481 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 43.1 m -80.66 124.54 29.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.8 -1.091 . . . . 15.0 109.319 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -143.82 129.54 19.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.921 0.488 . . . . 15.0 109.871 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 70.2 m -84.89 120.02 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.172 0.989 . . . . 15.0 110.423 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.7 94.3 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -99.27 113.37 25.61 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.41 0.684 . . . . 15.0 110.505 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -142.66 162.74 34.69 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.205 0.602 . . . . 15.0 110.504 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 36.1 mt-10 -85.41 167.33 15.62 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.192 -0.913 . . . . 15.0 110.116 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.5 m -127.67 170.09 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.484 0.714 . . . . 15.0 110.726 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -75.22 113.49 25.99 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.532 -0.914 . . . . 15.0 108.532 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.35 161.84 19.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.064 1.843 . . . . 15.0 110.848 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.27 111.51 5.93 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 300' ' ' ILE . 4.8 p -71.1 124.83 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.862 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.33 122.8 43.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.48 -0.782 . . . . 15.0 110.79 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 91.3 mt -93.71 133.77 36.73 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 163.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -137.82 112.53 8.9 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.552 0.741 . . . . 15.0 109.063 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.96 63.79 4.32 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.747 0.654 . . . . 15.0 114.239 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 29.2 mt -70.79 -30.6 67.1 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.144 0.497 . . . . 15.0 110.346 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -72.3 -23.04 61.11 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.654 1.182 . . . . 15.0 111.212 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.8 43.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.232 0.613 . . . . 15.0 111.503 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.412 HG23 ' HA3' ' A' ' 293' ' ' GLY . 67.6 mt -65.79 123.59 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.717 0.807 . . . . 15.0 109.982 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -105.89 109.57 21.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 15.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 289' ' ' GLN . 59.1 t -109.02 154.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.866 1.266 . . . . 15.0 107.714 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 286' ' ' VAL . 42.7 tt0 -103.36 142.66 33.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 119.24 0.927 . . . . 15.0 109.973 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 417' ' ' VAL . 82.5 tttt -123.56 87.36 52.23 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.941 0.897 . . . . 15.0 109.083 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 282' ' ' ILE . 6.7 Cg_exo -72.66 97.5 0.89 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.884 1.723 . . . . 15.0 111.554 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.549 HD11 ' HE2' ' A' ' 127' ' ' LYS . 40.2 mm -69.25 92.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.768 -1.197 . . . . 15.0 107.768 166.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 427' ' ' LEU . 37.5 t -116.04 142.55 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.487 -0.779 . . . . 15.0 110.128 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.39 159.23 32.36 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.242 -1.345 . . . . 15.0 108.578 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.93 86.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' VAL . 43.6 p -64.4 174.89 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.701 0.8 . . . . 15.0 110.317 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.73 -33.02 72.28 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 120.95 0.405 . . . . 15.0 110.853 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.41 83.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.979 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 69.2 m-20 -74.59 -41.64 60.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.884 0.474 . . . . 15.0 111.195 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 133' ' ' THR . 82.4 t -61.79 -61.03 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.65 -33.84 73.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.856 0.722 . . . . 15.0 111.359 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.53 Favored Glycine 0 N--CA 1.478 1.476 0 O-C-N 123.62 0.575 . . . . 15.0 113.676 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.411 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 12.1 tpt -68.57 -46.36 69.6 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.069 0.548 . . . . 15.0 110.082 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 78.4 mt -58.07 -31.96 67.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.14 0.576 . . . . 15.0 111.748 172.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.56 -41.48 72.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.34 1.056 . . . . 15.0 110.216 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 86.0 m -58.2 -44.09 87.91 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.07 0.856 . . . . 15.0 109.71 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 141' ' ' LEU . 89.9 mt -63.65 -40.93 98.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.918 0.887 . . . . 15.0 111.208 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 39.0 mtm-85 -64.51 -31.5 72.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.325 0.65 . . . . 15.0 110.157 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.2 mttt -87.32 -15.9 36.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.235 0.614 . . . . 15.0 112.443 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 143' ' ' THR . 97.5 mt-30 -78.17 -30.42 49.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.642 -0.503 . . . . 15.0 109.642 167.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.45 36.54 2.78 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.102 0.961 . . . . 15.0 110.538 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.19 152.82 36.52 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.629 0.974 . . . . 15.0 113.629 -172.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -81.75 122.18 27.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.616 -1.175 . . . . 15.0 110.027 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 26.5 m95 -80.8 125.28 29.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 28.9 ttpt -158.83 128.32 5.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.914 -0.773 . . . . 15.0 108.914 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.629 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.4 mt-10 -77.26 134.39 38.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.885 0.374 . . . . 15.0 111.184 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 34.0 pttt -120.74 179.99 4.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.574 1.15 . . . . 15.0 109.816 169.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -142.92 152.91 42.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.566 0.746 . . . . 15.0 109.296 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -49.77 0.88 Allowed Glycine 0 N--CA 1.465 0.581 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.339 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.71 43.17 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.356 0.578 . . . . 15.0 111.417 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 t -116.79 134.39 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.347 1.059 . . . . 15.0 108.821 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -107.21 -179.58 3.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.31 1.044 . . . . 15.0 109.878 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.67 28.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.407 0.891 . . . . 15.0 113.407 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.27 40.83 3.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.227 0.537 . . . . 15.0 110.349 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -122.27 -170.52 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.045 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.771 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 15.2 mtm180 -119.94 124.07 45.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 171.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.61 100.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.784 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 12.5 m -83.31 110.02 17.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.13 -1.063 . . . . 15.0 108.13 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.6 pt -132.79 164.48 35.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.288 1.035 . . . . 15.0 110.4 -172.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -111.47 126.69 55.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.526 -1.657 . . . . 15.0 106.526 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.85 150.01 49.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.52 0.676 . . . . 15.0 111.281 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.1 t -139.16 123.78 18.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.147 -1.427 . . . . 15.0 107.147 165.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -113.53 166.66 12.17 Favored Glycine 0 C--O 1.241 0.585 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.065 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -145.1 134.93 23.6 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.308 0.643 . . . . 15.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 226' ' ' LEU . 61.6 t -118.54 137.89 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 171.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.66 16.35 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.982 0.896 . . . . 15.0 110.889 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.77 1.98 76.21 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 115.781 -0.645 . . . . 15.0 113.946 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -136.98 163.12 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.509 0.724 . . . . 15.0 110.654 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.24 165.5 22.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.23 0.612 . . . . 15.0 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.83 -159.78 0.97 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.405 1.082 . . . . 15.0 110.186 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.72 118.28 5.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.459 0.703 . . . . 15.0 111.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.461 ' HA3' ' HB ' ' B' ' 386' ' ' VAL . . . 85.15 -57.12 4.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.941 -1.027 . . . . 15.0 111.827 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.12 -60.37 4.78 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.384 -0.286 . . . . 15.0 112.384 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -116.36 150.92 36.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.611 0.764 . . . . 15.0 111.801 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -153.91 93.1 1.61 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.801 -1.09 . . . . 15.0 108.87 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.2 m -73.69 137.94 44.39 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.682 -1.144 . . . . 15.0 110.172 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' B' ' 380' ' ' LYS . 2.9 m-20 60.67 29.21 18.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.703 0.801 . . . . 15.0 113.018 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.84 132.77 49.48 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.144 0.577 . . . . 15.0 110.292 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.8 t -97.96 113.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 202' ' ' ILE . 12.5 tp -97.54 89.0 4.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.692 0.397 . . . . 15.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.22 86.36 1.08 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 15.0 109.543 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.8 OUTLIER -51.78 132.09 31.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.012 0.925 . . . . 15.0 110.878 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.0 49.78 1.86 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.213 -0.755 . . . . 15.0 111.213 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.7 150.43 48.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.628 0.771 . . . . 15.0 111.082 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.36 56.32 3.91 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.589 -0.732 . . . . 15.0 113.046 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -136.7 1.89 2.6 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.95 0.9 . . . . 15.0 109.672 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 187' ' ' LEU . 33.1 mmt -94.09 154.25 17.71 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.87 0.868 . . . . 15.0 111.107 -173.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.76 143.3 46.1 Favored Pre-proline 0 C--O 1.248 0.991 0 CA-C-N 114.887 -1.051 . . . . 15.0 108.438 172.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.65 109.79 0.47 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.796 2.331 . . . . 15.0 111.226 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.01 -44.26 1.2 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.798 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 202' ' ' ILE . 86.4 t80 -73.09 -62.25 1.53 Allowed 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -59.39 -32.93 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.259 -1.337 . . . . 15.0 111.984 -176.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.546 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 14.8 t70 -71.02 -31.94 68.57 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.665 0.786 . . . . 15.0 110.835 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -5.53 89.21 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.836 0.71 . . . . 15.0 113.134 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 187' ' ' LEU . 31.6 mm -104.54 -51.07 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.399 0.68 . . . . 15.0 110.947 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 58.5 pttt -76.88 6.35 6.34 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.475 1.11 . . . . 15.0 113.817 -163.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -131.87 27.32 3.69 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.507 -1.037 . . . . 15.0 110.507 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -125.08 -161.6 1.04 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.357 1.063 . . . . 15.0 110.361 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -154.85 153.28 30.9 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.516 0.727 . . . . 15.0 110.894 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.81 120.25 15.27 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.886 0.474 . . . . 15.0 111.392 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.69 -35.04 2.2 Favored Glycine 0 C--N 1.334 0.455 0 O-C-N 124.237 0.961 . . . . 15.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.72 126.21 32.66 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.442 -0.577 . . . . 15.0 109.442 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.0 123.82 48.73 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.08 -1.082 . . . . 15.0 108.08 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -145.08 178.04 8.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.333 1.053 . . . . 15.0 110.612 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.2 m -130.93 130.97 44.15 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.529 -1.286 . . . . 15.0 107.529 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.1 pt -104.06 160.48 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.378 0.671 . . . . 15.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.11 106.05 13.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 15.0 109.549 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.41 166.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.416 -1.327 . . . . 15.0 107.416 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 65.9 m -147.02 135.33 21.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.536 ' HZ ' HD11 ' B' ' 387' ' ' ILE . 95.5 m-85 -86.23 142.39 35.73 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 109.874 -0.417 . . . . 15.0 109.874 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.3 154.49 46.37 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.493 2.129 . . . . 15.0 111.834 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.14 -17.64 60.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.061 167.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.56 -24.5 61.93 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.294 1.438 . . . . 15.0 111.235 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 79.7 t80 -61.96 147.0 48.36 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.029 0.931 . . . . 15.0 111.238 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -71.12 -61.74 1.65 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.769 0.828 . . . . 15.0 113.109 -166.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.467 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -63.98 113.94 3.8 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.011 0.524 . . . . 15.0 110.356 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 42.7 tt0 -65.02 -36.66 85.11 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.819 0.848 . . . . 15.0 112.652 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.46 -27.89 69.3 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.079 0.551 . . . . 15.0 111.429 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.558 ' HA ' HG11 ' A' ' 172' ' ' VAL . 81.7 mt -90.33 -40.51 12.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.848 0.859 . . . . 15.0 110.315 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 14.6 ttmm -47.89 128.62 13.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.631 1.972 . . . . 15.0 113.001 -171.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.9 -31.44 3.66 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.379 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -98.04 163.73 12.64 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.636 0.774 . . . . 15.0 112.123 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -88.75 144.58 26.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.522 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -117.98 108.38 15.2 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.178 0.991 . . . . 15.0 109.837 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.12 101.04 12.52 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.24 0.616 . . . . 15.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -96.18 120.47 36.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.878 0.871 . . . . 15.0 109.752 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.24 98.55 9.45 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.96 -0.756 . . . . 15.0 108.96 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.1 mm -88.26 133.6 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.081 0.952 . . . . 15.0 110.611 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.81 95.15 4.71 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.456 -1.313 . . . . 15.0 107.456 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.551 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.06 97.36 5.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 -173.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -96.58 -38.63 9.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.633 0.373 . . . . 15.0 111.475 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.784 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.4 mmtt -131.63 148.73 52.63 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.095 0.558 . . . . 15.0 110.775 -176.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 207' ' ' ALA . 21.2 t -121.44 99.0 6.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 34.1 mt-10 -83.14 169.23 16.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.277 -1.009 . . . . 15.0 108.277 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 38.9 tt0 -140.24 139.76 35.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.725 0.41 . . . . 15.0 110.278 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.468 HH12 ' HD3' ' A' ' 146' ' ' LYS . 26.3 ptt85 -98.97 83.89 2.98 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 164.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.1 154.36 31.37 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.829 -1.078 . . . . 15.0 109.681 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.404 HD21 ' HE3' ' A' ' 146' ' ' LYS . 97.5 mt -59.12 133.25 87.57 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 122.715 0.406 . . . . 15.0 110.022 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 95.5 Cg_endo -77.71 -179.23 5.24 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.642 2.228 . . . . 15.0 111.351 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 249' ' ' THR . 47.1 mt-10 -70.56 116.73 11.22 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.516 -0.765 . . . . 15.0 108.964 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.82 43.81 1.07 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.046 0.927 . . . . 15.0 108.992 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.489 HG23 ' HB3' ' A' ' 247' ' ' GLU . 25.5 p -76.23 166.65 23.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.054 1.342 . . . . 15.0 110.174 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.6 -45.74 13.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.701 1.2 . . . . 15.0 113.063 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.01 -31.85 71.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.545 0.738 . . . . 15.0 112.592 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -81.57 -49.77 10.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.048 0.539 . . . . 15.0 110.379 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.689 HG13 HD22 ' A' ' 266' ' ' LEU . 12.8 tt -65.16 -29.54 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 122.974 0.51 . . . . 15.0 111.249 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.58 -17.12 56.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 111.944 0.35 . . . . 15.0 111.944 174.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -70.14 -19.32 63.22 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.113 0.565 . . . . 15.0 110.675 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -71.43 -17.86 62.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.251 0.62 . . . . 15.0 111.152 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 146.05 -24.44 1.76 Allowed Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.417 -0.657 . . . . 15.0 113.184 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 10.8 t -54.91 144.46 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.185 0.994 . . . . 15.0 111.394 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.79 -46.96 50.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.563 0.745 . . . . 15.0 111.001 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -106.22 -43.82 4.71 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.545 0.738 . . . . 15.0 110.587 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 112.35 24.85 4.9 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.892 -0.393 . . . . 15.0 113.1 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.1 p -71.96 144.3 48.94 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 117.471 0.635 . . . . 15.0 109.776 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 253' ' ' ILE . 60.9 t -59.37 -48.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.219 0.608 . . . . 15.0 110.165 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -58.71 -25.11 62.57 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.506 1.123 . . . . 15.0 112.237 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.29 -27.68 54.8 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.077 -0.809 . . . . 15.0 111.077 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.689 HD22 HG13 ' A' ' 253' ' ' ILE . 60.6 tp -76.28 -30.09 57.66 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.009 -0.737 . . . . 15.0 109.009 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.442 ' HA ' HG22 ' A' ' 270' ' ' VAL . 73.5 mtp180 -67.48 -37.41 82.83 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.61 93.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.76 . . . . 15.0 110.892 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -66.72 -40.83 88.55 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.349 -0.841 . . . . 15.0 111.314 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 267' ' ' ARG . 19.3 m -81.56 -19.62 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.592 0.357 . . . . 15.0 110.512 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt85 -59.79 -66.16 0.56 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -59.28 -44.17 92.49 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.483 0.49 . . . . 15.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -74.06 -42.06 60.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.26 -13.28 55.58 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.532 0.605 . . . . 15.0 111.432 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.89 -47.01 49.59 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.096 0.862 . . . . 15.0 108.707 162.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.588 ' HB2' ' HB1' ' A' ' 377' ' ' ALA . 74.8 ttt180 -60.41 -27.51 67.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.489 1.516 . . . . 15.0 111.904 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.78 -59.72 2.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.826 0.45 . . . . 15.0 110.199 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.426 HD11 HG11 ' A' ' 130' ' ' VAL . 62.7 tp -67.85 -57.58 6.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.358 0.503 . . . . 15.0 112.358 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.74 -27.66 67.79 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.196 0.31 . . . . 15.0 110.185 -172.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.3 t -66.63 -50.1 64.11 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.82 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.41 88.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.786 0.834 . . . . 15.0 111.94 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.7 mt -64.14 -50.32 77.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 C-N-CA 123.947 0.899 . . . . 15.0 108.823 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.369 0.668 . . . . 15.0 110.776 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -68.52 -45.53 71.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.992 -0.744 . . . . 15.0 108.992 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -57.69 -54.85 42.18 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.04 0.838 . . . . 15.0 110.599 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 282' ' ' ILE . 59.1 t -60.63 -52.96 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.113 -0.949 . . . . 15.0 110.725 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.29 -39.84 93.07 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.539 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.6 p -64.3 -43.83 93.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 119.47 -0.3 . . . . 15.0 110.588 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.441 ' HB2' HG13 ' A' ' 125' ' ' VAL . 57.0 mt-30 -68.01 -33.88 75.44 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.96 0.788 . . . . 15.0 111.832 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.4 -55.1 27.11 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 123.511 0.507 . . . . 15.0 109.865 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 295' ' ' VAL . 25.7 mm -61.65 -44.03 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.067 0.947 . . . . 15.0 111.774 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.24 -48.0 80.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.382 0.61 . . . . 15.0 109.491 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.8 -40.85 99.74 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 114.038 -1.437 . . . . 15.0 112.246 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.518 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.8 mt -55.7 -60.14 3.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.237 1.015 . . . . 15.0 110.987 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 291' ' ' ILE . 40.6 t -56.07 -51.45 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 124.039 0.837 . . . . 15.0 109.638 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -64.27 -26.84 68.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.638 0.775 . . . . 15.0 112.138 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.67 -24.77 53.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.564 0.579 . . . . 15.0 112.564 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 164.62 29.77 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.516 0.932 . . . . 15.0 113.516 -168.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.6 133.66 49.98 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.036 -0.984 . . . . 15.0 109.835 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.1 tp -155.77 116.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.695 0.798 . . . . 15.0 108.96 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.36 94.76 9.87 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.614 -0.884 . . . . 15.0 108.614 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.694 HG21 HG22 ' A' ' 346' ' ' VAL . 19.0 t -79.93 127.33 77.64 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 114.466 -1.243 . . . . 15.0 110.513 -168.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.77 124.11 12.29 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.138 2.559 . . . . 15.0 112.896 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.75 -20.05 54.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.142 1.377 . . . . 15.0 114.196 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.17 94.7 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.947 0.499 . . . . 15.0 111.588 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.74 -35.39 80.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.635 0.774 . . . . 15.0 110.86 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 304' ' ' ALA . 2.7 mp -65.78 -53.28 40.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.501 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.22 -33.52 74.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.461 0.704 . . . . 15.0 111.14 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.6 t -58.07 -58.39 8.62 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 124.027 0.829 . . . . 15.0 110.607 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.414 ' HA ' HG23 ' A' ' 313' ' ' VAL . 17.4 mm-40 -77.02 -18.96 57.81 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.1 -42.84 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.736 ' HA ' ' HD2' ' A' ' 315' ' ' ARG . 15.1 t70 -59.04 -39.25 81.41 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 123.958 0.786 . . . . 15.0 111.349 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' B' ' 447' ' ' HIS . 23.4 t -58.33 -51.85 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.19 0.519 . . . . 15.0 110.819 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 341' ' ' ALA . 76.0 mt -68.71 -21.39 64.41 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.46 -0.791 . . . . 15.0 112.093 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.736 ' HD2' ' HA ' ' A' ' 312' ' ' ASP . 77.0 mtt180 -69.97 -44.82 68.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.168 0.987 . . . . 15.0 108.86 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -66.8 -35.62 80.48 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.815 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.13 -41.2 98.03 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.436 0.695 . . . . 15.0 110.996 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.26 -46.87 78.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.083 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.86 70.82 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.148 0.979 . . . . 15.0 111.839 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -59.86 -43.41 94.69 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.968 0.907 . . . . 15.0 109.882 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -83.81 -16.69 43.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.569 0.748 . . . . 15.0 110.099 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -82.06 10.24 7.0 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.706 1.202 . . . . 15.0 110.353 171.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.22 46.25 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.061 -0.518 . . . . 15.0 113.85 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.57 17.45 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 114.107 0.403 . . . . 15.0 114.107 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.05 158.57 19.19 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 124.437 1.095 . . . . 15.0 109.79 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.626 ' HB3' ' HG2' ' A' ' 328' ' ' GLN . 34.6 mm-40 80.8 -53.06 0.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.789 1.636 . . . . 15.0 112.547 173.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm 58.4 28.52 16.93 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.469 1.107 . . . . 15.0 110.764 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.626 ' HG2' ' HB3' ' A' ' 326' ' ' GLU . 81.2 mm-40 -87.3 11.77 13.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.573 1.149 . . . . 15.0 109.968 174.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 315' ' ' ARG . . . -40.17 -45.95 2.12 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 126.823 2.049 . . . . 15.0 113.498 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.54 -18.06 26.52 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.871 0.869 . . . . 15.0 112.895 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -98.55 -11.43 22.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.623 0.769 . . . . 15.0 112.174 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 92.8 mt -55.59 131.78 71.45 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 123.244 0.618 . . . . 15.0 111.024 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.413 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 77.6 Cg_exo -52.24 125.26 16.96 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.142 3.228 . . . . 15.0 114.501 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -51.82 -44.23 63.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.703 1.201 . . . . 15.0 112.416 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -60.35 -18.91 53.26 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 15.0 113.114 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 84.8 mt -69.5 -32.68 71.7 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.997 0.427 . . . . 15.0 110.468 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.89 -17.3 12.05 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.237 1.015 . . . . 15.0 111.238 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -49.95 -46.8 52.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.435 1.894 . . . . 15.0 113.213 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.46 -60.74 2.7 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.794 1.309 . . . . 15.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.7 pt20 -80.87 -32.4 34.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 15.0 111.387 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -60.71 -61.85 2.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 15.0 110.844 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -55.4 -41.41 72.65 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.113 0.883 . . . . 15.0 109.869 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt-85 -59.42 -36.1 75.25 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.113 0.883 . . . . 15.0 110.909 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 70.3 mtt-85 -76.22 -29.4 57.57 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.807 0.443 . . . . 15.0 110.34 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.53 -37.95 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 302' ' ' VAL . 43.1 t -67.59 -34.42 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 351' ' ' LEU . 41.2 t -56.97 -50.22 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.553 0.741 . . . . 15.0 109.216 167.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.13 80.27 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.255 -0.884 . . . . 15.0 113.912 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.47 -58.61 3.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.124 0.57 . . . . 15.0 111.528 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' A' ' 294' ' ' LEU . 89.9 mt -60.29 -53.52 56.63 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.919 0.888 . . . . 15.0 110.872 -176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.564 HD12 HG13 ' A' ' 347' ' ' VAL . 44.8 mt -68.38 -30.72 69.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -59.47 -38.62 93.8 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.504 0.502 . . . . 15.0 112.478 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.43 -42.34 83.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.956 -0.622 . . . . 15.0 110.387 174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.7 -34.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.115 0.566 . . . . 15.0 111.146 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.0 mt -66.73 -49.68 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.819 0.848 . . . . 15.0 110.057 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -60.15 -54.36 46.81 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 116.064 -0.517 . . . . 15.0 110.988 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.4 m -61.22 -43.99 97.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.196 0.999 . . . . 15.0 111.72 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -91.9 12.61 21.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.066 0.546 . . . . 15.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 47.38 30.9 1.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.312 1.845 . . . . 15.0 114.181 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.532 HD22 HE21 ' A' ' 406' ' ' GLN . 73.7 mt -66.72 158.1 31.06 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.339 1.056 . . . . 15.0 113.032 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.9 167.27 27.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.856 -1.52 . . . . 15.0 107.799 170.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.0 90.99 0.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.701 -0.481 . . . . 15.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.74 131.29 45.97 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.254 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -51.71 -41.98 61.91 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.699 1.249 . . . . 15.0 112.12 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.5 -19.69 49.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.582 -0.735 . . . . 15.0 111.643 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -86.23 -35.0 20.28 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 110.025 -0.361 . . . . 15.0 110.025 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.78 -52.47 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -51.06 -45.24 61.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.66 1.184 . . . . 15.0 111.381 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.75 5.88 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.851 1.344 . . . . 15.0 112.155 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 402' ' ' ALA . 66.6 mt -55.73 -52.27 64.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.394 0.678 . . . . 15.0 111.675 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 398' ' ' MET . 39.9 mm -50.55 -57.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 124.387 1.054 . . . . 15.0 111.417 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.36 -36.57 60.95 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.467 0.48 . . . . 15.0 111.781 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -51.04 71.08 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.279 0.561 . . . . 15.0 110.266 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.634 ' SD ' ' HB3' ' B' ' 442' ' ' ALA . 54.6 ttp -67.18 -44.08 80.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.224 1.409 . . . . 15.0 111.016 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -70.56 -44.78 66.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.68 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.4 m -69.5 -16.97 63.56 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.801 0.334 . . . . 15.0 111.458 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 276' ' ' ARG . . . -74.2 -29.33 61.69 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.513 0.725 . . . . 15.0 110.31 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.425 ' HB3' ' HG3' ' B' ' 440' ' ' ARG . 20.8 m-85 -87.61 -168.6 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.773 0.829 . . . . 15.0 111.178 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -70.87 -66.22 0.64 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.122 0.969 . . . . 15.0 110.822 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.16 108.29 48.33 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.599 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 24.6 Cg_endo -63.08 -40.29 34.58 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.553 2.169 . . . . 15.0 113.953 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -57.39 -51.71 68.33 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.907 0.883 . . . . 15.0 113.041 -161.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.755 ' HB3' HH12 ' B' ' 440' ' ' ARG . 31.3 tt0 -70.11 -20.07 63.2 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 68.4 t -76.44 -45.29 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.51 -52.58 19.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.04 -32.07 73.33 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.188 -0.915 . . . . 15.0 112.647 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -64.78 -50.66 65.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.088 0.555 . . . . 15.0 109.771 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -72.41 -50.92 22.9 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.518 0.511 . . . . 15.0 111.437 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.5 p -62.07 -28.05 69.33 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.695 0.628 . . . . 15.0 112.695 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.46 17.08 23.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.589 0.755 . . . . 15.0 111.034 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 395' ' ' MET . 50.5 t-20 -137.26 93.58 2.84 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.776 -1.194 . . . . 15.0 107.776 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.57 -33.81 70.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.258 1.023 . . . . 15.0 112.204 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.82 -63.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.269 0.98 . . . . 15.0 110.243 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.87 -18.33 58.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.307 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER -67.03 -48.85 67.07 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.544 -0.91 . . . . 15.0 108.544 177.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.62 -34.32 73.9 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 114.962 -1.017 . . . . 15.0 110.695 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.54 -45.12 95.03 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.463 0.649 . . . . 15.0 110.201 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.533 ' HG2' HD11 ' A' ' 371' ' ' ILE . 32.6 tpp -66.92 -30.99 71.29 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.111 -0.95 . . . . 15.0 110.855 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -71.95 -32.72 67.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.154 0.582 . . . . 15.0 111.205 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -51.49 61.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.0 p -72.63 -20.35 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.377 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -70.12 -43.62 70.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.899 0.479 . . . . 15.0 110.412 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.97 -26.59 59.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.228 -0.896 . . . . 15.0 110.721 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 408' ' ' VAL . 73.2 tt0 -60.63 -51.29 70.03 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 109.69 -0.485 . . . . 15.0 109.69 170.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -56.35 -49.2 75.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.074 0.949 . . . . 15.0 111.017 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.532 HE21 HD22 ' A' ' 360' ' ' LEU . 53.4 tt0 -64.8 -36.36 84.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.752 1.221 . . . . 15.0 111.614 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.39 66.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.02 -0.536 . . . . 15.0 111.063 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 404' ' ' GLU . 68.8 t -55.18 -54.18 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.925 -0.768 . . . . 15.0 108.925 168.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.6 mt-10 -61.21 -30.7 70.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.635 1.174 . . . . 15.0 112.425 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.55 73.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.992 0.517 . . . . 15.0 111.342 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.27 -31.56 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.061 -0.718 . . . . 15.0 109.061 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 409' ' ' GLU . 91.6 mt -67.45 -35.3 78.94 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 15.0 110.864 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.13 -17.43 63.46 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.298 0.639 . . . . 15.0 111.978 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -109.58 -26.26 10.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.575 1.15 . . . . 15.0 112.076 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.94 158.38 16.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.919 0.888 . . . . 15.0 110.875 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -73.41 84.78 1.47 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.306 0.642 . . . . 15.0 109.751 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 127' ' ' LYS . 21.2 t -86.8 94.78 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.59 -0.892 . . . . 15.0 108.59 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.9 t -68.92 94.5 0.63 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 122.429 1.109 . . . . 15.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -76.25 130.82 38.75 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.027 -1.442 . . . . 15.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -133.69 136.87 44.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.759 0.824 . . . . 15.0 108.905 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -98.72 127.82 44.78 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.287 -0.635 . . . . 15.0 109.287 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.469 HG21 ' HG2' ' A' ' 426' ' ' GLU . 9.7 t -160.89 176.61 11.25 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 122.78 0.432 . . . . 15.0 111.724 -173.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 33.6 p -92.96 165.92 12.63 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 111.488 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 56.7 t80 -58.6 -28.96 66.09 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.715 1.206 . . . . 15.0 111.228 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 4.2 m-20 -65.24 -6.84 10.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.03 0.932 . . . . 15.0 113.387 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.497 ' HB3' HD12 ' A' ' 427' ' ' LEU . 12.6 tp10 -74.22 -41.49 61.29 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.033 0.933 . . . . 15.0 112.106 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.642 HD11 HG21 ' A' ' 130' ' ' VAL . 5.3 mp -89.54 -68.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.035 0.534 . . . . 15.0 111.031 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 428' ' ' MET . 1.2 mpt? -74.36 -49.62 21.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.847 0.459 . . . . 15.0 110.668 -175.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 1.7 m-20 -79.38 31.57 0.23 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -170.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -43.19 99.29 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.297 0.57 . . . . 15.0 109.754 172.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -98.99 40.49 1.2 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.12 0.968 . . . . 15.0 110.796 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.744 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.65 61.54 1.51 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.698 1.237 . . . . 0.0 109.103 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.11 14.77 30.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.725 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -46.22 -49.09 17.55 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.383 1.873 . . . . 0.0 114.131 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -88.82 0.24 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -167.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -114.48 -75.21 0.59 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 109.694 169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.24 -84.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.962 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -104.55 -78.45 0.56 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -102.62 -69.98 0.77 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -103.99 -73.61 0.67 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.067 0.547 . . . . 0.0 109.672 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.61 -75.96 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.697 ' HB3' ' HG2' ' B' ' 381' ' ' GLU . 32.5 tt0 -103.07 -75.79 0.6 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.541 0.736 . . . . 0.0 109.483 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -102.58 -85.09 0.45 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.15 0.58 . . . . 0.0 112.264 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.29 -84.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -166.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 -69.24 0.86 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.665 0.386 . . . . 0.0 111.446 -164.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -141.49 111.58 6.77 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.696 0.76 . . . . 0.0 109.518 177.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 381' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' B' ' 376' ' ' GLU . 6.4 mp0 -105.73 147.99 27.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.271 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.64 -138.71 25.34 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.047 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -165.62 -87.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 117.186 0.493 . . . . 0.0 110.504 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 23.7 m 53.41 98.29 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 125.559 1.544 . . . . 0.0 114.524 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.63 108.78 19.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 165.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.461 ' HB ' ' HA3' ' A' ' 179' ' ' GLY . 24.0 m -71.91 95.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.668 0.747 . . . . 0.0 111.051 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.536 HD11 ' HZ ' ' A' ' 217' ' ' PHE . 13.5 tt -155.82 162.64 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.62 0.768 . . . . 0.0 108.97 165.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 10.6 t -56.81 109.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 22.6 m -74.09 99.11 3.26 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.346 0.658 . . . . 0.0 110.91 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -89.45 170.25 10.69 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.481 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.5 170.81 14.97 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.633 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -151.82 -154.08 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.592 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.87 177.77 0.53 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.015 0.926 . . . . 0.0 113.194 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -55.74 -39.88 71.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.748 1.219 . . . . 0.0 112.351 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.65 -71.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.208 1.403 . . . . 0.0 111.67 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 48.8 m 66.86 -178.1 0.2 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.069 1.348 . . . . 0.0 111.686 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 397' ' ' GLN . . . . . 0.645 HE22 HG12 ' B' ' 399' ' ' VAL . 0.9 OUTLIER 47.89 -172.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.124 1.769 . . . . 0.0 113.162 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 29.1 pt -133.94 118.38 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 110.91 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.645 HG12 HE22 ' B' ' 397' ' ' GLN . 9.4 p -157.54 116.85 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.137 0.975 . . . . 0.0 108.692 170.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -167.18 101.55 0.63 Allowed Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 124.288 1.035 . . . . 0.0 108.302 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.98 -67.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.509 2.139 . . . . 0.0 111.631 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -173.95 -69.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 23.2 m 68.49 -75.81 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.474 1.51 . . . . 0.0 112.92 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.07 115.16 19.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 0.0 110.309 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . 55.95 82.4 0.24 Allowed Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.605 1.162 . . . . 0.0 110.746 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -52.72 94.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.754 2.969 . . . . 0.0 114.02 -170.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -86.33 -83.43 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.391 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 4.8 tt 60.42 -83.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.359 1.464 . . . . 0.0 110.514 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 23.7 p 40.46 83.62 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 125.974 1.71 . . . . 0.0 112.997 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.62 147.8 52.78 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -103.57 138.03 40.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.85 -33.9 57.86 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 109.934 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 31.7 t30 66.65 103.54 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.902 1.376 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 11.3 t -73.16 -24.8 60.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.358 0.663 . . . . 0.0 111.731 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' B' ' 417' ' ' GLY . 57.0 tttm -87.32 150.05 24.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.0 -21.57 61.54 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.629 0.372 . . . . 0.0 110.614 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 417' ' ' GLY . . . . . 0.45 ' H ' ' HG2' ' B' ' 415' ' ' LYS . . . -75.57 -154.23 4.57 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.392 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 69.29 -67.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 125.236 1.414 . . . . 0.0 110.721 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.15 157.1 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 C-N-CA 124.384 1.073 . . . . 0.0 109.97 168.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 42.7 mtm 81.35 -32.92 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.122 1.769 . . . . 0.0 112.308 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 59.6 t 64.12 -81.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 111.082 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.63 138.99 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 66.5 p -158.18 -171.52 3.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.756 0.823 . . . . 0.0 110.212 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 65.6 t80 66.32 93.5 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.809 1.244 . . . . 0.0 110.263 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.32 130.52 6.23 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.549 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -94.0 -86.0 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.567 0.747 . . . . 0.0 109.792 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.1 t -116.4 -86.49 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.868 0.467 . . . . 0.0 111.667 -168.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 66.62 9.06 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.241 1.02 . . . . 0.0 110.785 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -93.27 -61.34 1.59 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.738 -173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.57 -83.09 0.16 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.882 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 9.0 p -111.61 -78.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.46 0.704 . . . . 0.0 109.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -104.58 -46.37 4.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.281 0.633 . . . . 0.0 111.926 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.13 169.09 19.42 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.247 0.619 . . . . 0.0 109.838 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -143.29 -61.16 0.42 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.146 0.978 . . . . 0.0 108.676 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 6.6 t -164.77 4.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.527 0.731 . . . . 0.0 110.677 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.62 48.22 Favored Glycine 0 C--N 1.359 1.853 0 C-N-CA 123.751 0.691 . . . . 0.0 114.805 -168.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 437' ' ' SER . . . . . 0.505 ' HA ' ' HB ' ' B' ' 441' ' ' ILE . 10.7 p -53.22 -58.96 5.26 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.746 0.818 . . . . 0.0 110.564 166.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 44.57 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.934 1.694 . . . . 0.0 113.729 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.4 -57.41 0.95 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.472 1.109 . . . . 0.0 109.553 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.755 HH12 ' HB3' ' A' ' 383' ' ' GLU . 28.0 ttp85 -86.76 -8.43 57.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.428 0.691 . . . . 0.0 112.469 -165.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' B' ' 437' ' ' SER . 31.1 mm -117.03 125.21 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 442' ' ' ALA . . . . . 0.634 ' HB3' ' SD ' ' A' ' 374' ' ' MET . . . -105.95 -147.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 70.75 165.98 0.29 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.345 1.058 . . . . 0.0 111.609 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.06 136.4 10.98 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.155 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -75.91 140.97 26.6 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.148 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.28 94.94 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.437 2.092 . . . . 0.0 109.437 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 447' ' ' HIS . . . . . 0.503 ' HA ' HG22 ' A' ' 313' ' ' VAL . 3.6 t60 72.34 -71.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.921 1.688 . . . . 0.0 112.402 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -139.89 -151.96 0.39 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.782 0.833 . . . . 0.0 109.29 -171.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -56.23 114.49 1.99 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.499 0.72 . . . . 0.0 110.797 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.88 142.28 56.14 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 0.0 110.608 -174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 48.1 t -75.57 -26.28 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.011 0.924 . . . . 0.0 110.411 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 73.2 t 67.63 -72.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.546 1.538 . . . . 0.0 112.131 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -89.08 119.17 5.37 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 120.026 -0.319 . . . . 0.0 112.585 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.552 HD23 HG21 ' B' ' 463' ' ' THR . 43.9 tp -148.92 128.81 13.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 5.6 t -138.79 161.55 36.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.196 0.998 . . . . 0.0 109.454 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.54 135.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.956 1.302 . . . . 0.0 112.189 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 60.74 17.87 8.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.891 1.277 . . . . 0.0 111.987 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 14.2 m -138.71 85.03 2.05 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -94.4 24.83 4.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.099 1.36 . . . . 0.0 113.188 -162.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.425 ' H ' HD13 ' B' ' 460' ' ' LEU . 0.0 OUTLIER -105.19 30.49 5.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.58 0.752 . . . . 0.0 110.271 174.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 64.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.144 1.378 . . . . 0.0 111.681 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -89.78 116.28 27.76 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.552 HG21 HD23 ' B' ' 454' ' ' LEU . 27.9 m -68.62 106.49 2.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.406 175.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -89.34 131.62 35.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -86.48 25.96 1.15 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.633 0.773 . . . . 0.0 112.285 -165.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.09 -41.79 90.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.425 0.69 . . . . 0.0 109.271 166.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.42 32.82 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.033 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.23 -86.38 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.629 0.772 . . . . 0.0 111.0 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 71.43 -84.32 0.44 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.901 -172.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.73 79.23 0.22 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.021 1.328 . . . . 0.0 111.463 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.064 -1.087 . . . . 12.06 108.064 177.062 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 15.8 ptm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' THR . 7.8 tt0 -87.04 97.52 10.77 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.328 -0.989 . . . . 15.0 108.328 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.02 157.58 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.844 0.458 . . . . 15.0 111.305 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 25.4 m -131.04 86.43 2.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 15' ' ' VAL . 4.8 p -73.77 87.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 122.658 1.218 . . . . 15.0 110.508 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.96 178.2 5.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.97 -1.468 . . . . 15.0 109.546 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 58.1 m -136.63 125.96 24.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -66.24 -58.75 4.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.538 0.735 . . . . 15.0 109.842 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -167.46 120.62 0.94 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.02 0.528 . . . . 15.0 109.998 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.82 -100.67 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 O-C-N 124.423 1.077 . . . . 15.0 114.398 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.36 -43.39 27.79 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.203 1.001 . . . . 15.0 110.076 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.2 88.88 0.08 OUTLIER Glycine 0 C--N 1.344 1.024 0 O-C-N 124.065 0.853 . . . . 15.0 112.5 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.9 ttm180 -95.78 129.11 43.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 15.0 110.326 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -106.04 90.75 3.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.283 1.033 . . . . 15.0 110.416 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 5' ' ' VAL . 46.1 t -81.68 87.02 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.906 -1.146 . . . . 15.0 107.906 173.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 82.0 m -71.67 87.55 0.94 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.281 0.633 . . . . 15.0 110.189 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 74' ' ' ASN . 48.8 mt -80.07 128.22 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.56 -0.745 . . . . 15.0 109.135 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 56.7 m -118.23 104.08 10.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.713 -1.218 . . . . 15.0 107.713 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' HE1' ' A' ' 105' ' ' TYR . 24.7 mt -66.39 129.91 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.98 137.54 57.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.189 0.931 . . . . 15.0 111.038 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.08 61.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.032 1.333 . . . . 15.0 112.789 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.68 -40.88 92.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.849 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.7 m -70.08 -34.63 73.41 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.278 -0.874 . . . . 15.0 111.079 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -68.75 -50.98 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.859 0.464 . . . . 15.0 109.85 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -59.2 -33.73 71.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.265 0.626 . . . . 15.0 111.271 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.1 m -76.72 -43.17 38.5 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.367 0.667 . . . . 15.0 111.283 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -42.2 78.87 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.032 0.533 . . . . 15.0 112.249 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' HG11 ' A' ' 66' ' ' VAL . 69.5 t -60.91 -47.77 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.683 0.793 . . . . 15.0 109.838 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -58.04 -40.06 79.94 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.083 0.953 . . . . 15.0 111.731 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.4 m -70.56 -28.96 65.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.827 0.851 . . . . 15.0 110.822 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.4 tp10 -80.35 -29.07 37.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.021 0.528 . . . . 15.0 110.725 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -70.69 -35.7 72.91 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.702 0.801 . . . . 15.0 111.534 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.0 p -71.18 -29.71 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.764 -0.458 . . . . 15.0 109.764 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -67.16 -36.67 82.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.934 0.494 . . . . 15.0 110.517 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 57.8 t -63.4 -43.1 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.31 73.88 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.45 -0.796 . . . . 15.0 111.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 97.8 mttt -75.12 -33.98 61.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.218 0.607 . . . . 15.0 111.098 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -65.27 -36.52 84.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.688 0.795 . . . . 15.0 110.617 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.8 t -96.13 -1.51 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.163 0.585 . . . . 15.0 110.562 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 66.95 10.42 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.506 1.522 . . . . 15.0 113.792 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -79.29 -11.24 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.896 0.878 . . . . 15.0 111.388 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -57.13 -38.51 73.59 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.818 0.847 . . . . 15.0 111.907 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.97 -19.81 64.47 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.742 -0.663 . . . . 15.0 112.529 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.02 -20.75 34.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.197 0.599 . . . . 15.0 110.57 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.36 107.81 3.95 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.24 6.56 13.68 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.832 0.853 . . . . 15.0 111.777 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 10.5 74.05 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.964 -0.354 . . . . 15.0 113.035 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -65.38 -35.09 79.89 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.759 0.824 . . . . 15.0 109.86 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.37 122.47 59.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 159.05 47.74 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.899 2.4 . . . . 15.0 112.016 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 tpt -72.51 -20.26 61.39 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.908 -0.587 . . . . 15.0 112.09 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -65.44 -43.04 91.65 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.268 -0.271 . . . . 15.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' A' ' 57' ' ' ARG . 62.7 mt -66.19 -44.97 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.87 0.868 . . . . 15.0 111.288 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -71.05 -21.7 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 116.582 -0.281 . . . . 15.0 111.471 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.09 -42.13 14.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.892 0.477 . . . . 15.0 112.041 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 2.4 pt20 -82.6 -42.63 18.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.09 0.556 . . . . 15.0 111.253 -171.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 98.3 mtt180 -91.63 -60.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.111 0.564 . . . . 15.0 110.435 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.53 -46.51 63.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.607 -0.724 . . . . 15.0 110.471 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.51 12.16 35.11 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.015 -0.881 . . . . 15.0 114.083 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.86 -32.86 72.83 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 117.875 0.837 . . . . 15.0 110.613 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -74.37 -52.0 13.42 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.2 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.0 78.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 15.0 109.629 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -132.14 -63.73 0.8 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.466 1.107 . . . . 15.0 109.114 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -60.67 -29.33 69.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 123.794 0.684 . . . . 15.0 110.404 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.39 -49.44 69.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.824 1.25 . . . . 15.0 110.758 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 28' ' ' VAL . 21.2 t -75.35 -38.65 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.056 -0.975 . . . . 15.0 110.075 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.472 HD23 HD12 ' A' ' 70' ' ' LEU . 96.3 mt -59.17 -33.1 70.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.729 0.812 . . . . 15.0 111.692 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.87 -39.73 88.74 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.433 0.458 . . . . 15.0 112.932 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.91 -46.84 22.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.878 0.871 . . . . 15.0 110.334 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 67' ' ' LEU . 80.0 mt -56.91 -37.19 71.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.852 0.861 . . . . 15.0 112.236 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 72.5 mtm -59.4 -39.24 82.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.362 0.665 . . . . 15.0 111.169 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -75.14 -30.37 60.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.155 -0.929 . . . . 15.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 70' ' ' LEU . 6.9 mmm180 -71.78 -42.31 67.3 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.511 -0.551 . . . . 15.0 109.511 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.427 ' HB3' HG21 ' A' ' 17' ' ' ILE . 53.2 m-80 -71.83 -27.47 62.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.786 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -66.62 -56.57 10.1 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.341 0.4 . . . . 15.0 110.557 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.79 -30.56 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 O-C-N 123.875 0.735 . . . . 15.0 110.456 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.37 -49.05 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.638 0.775 . . . . 15.0 110.077 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.51 -57.3 11.69 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.376 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.1 pt -61.2 -29.14 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 112.83 0.678 . . . . 15.0 112.83 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.74 -49.06 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.263 0.625 . . . . 15.0 110.968 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -74.62 -25.85 59.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.541 0.21 . . . . 15.0 111.312 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -83.34 -16.71 45.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.727 0.811 . . . . 15.0 111.14 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 64.15 25.75 13.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.763 1.225 . . . . 15.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' A' ' 109' ' ' PHE . 51.8 mt -91.01 127.01 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.406 0.682 . . . . 15.0 109.718 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.55 117.22 61.76 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 164.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.35 97.17 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.375 2.05 . . . . 15.0 113.382 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.53 -171.12 3.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.081 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 58.71 -145.03 43.4 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.293 -0.323 . . . . 15.0 112.293 -168.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.28 122.5 17.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.404 -1.702 . . . . 15.0 106.404 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.92 106.51 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.513 2.142 . . . . 15.0 111.7 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -102.16 98.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.672 0.789 . . . . 15.0 109.468 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -84.54 94.35 8.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.33 98.48 0.92 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.928 -0.768 . . . . 15.0 108.928 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 112.23 3.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.857 2.371 . . . . 15.0 111.352 -173.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.5 -62.61 5.95 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.298 -0.721 . . . . 15.0 111.298 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.32 168.41 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.048 0.939 . . . . 15.0 110.629 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -138.75 121.81 16.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.236 1.014 . . . . 15.0 108.864 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 60.6 mttp -94.63 170.46 9.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.36 97.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.655 0.782 . . . . 15.0 111.469 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.45 80.24 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.447 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.7 mt-10 -98.67 -176.8 3.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.722 0.809 . . . . 15.0 110.805 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.29 137.9 57.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.716 0.806 . . . . 15.0 111.588 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -108.87 99.54 8.87 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.936 0.894 . . . . 15.0 109.546 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -79.72 131.28 35.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.731 0.813 . . . . 15.0 110.084 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.525 ' HE1' HG13 ' A' ' 19' ' ' ILE . 28.8 p90 -152.18 125.25 8.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.609 0.764 . . . . 15.0 109.869 173.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.9 m -82.8 100.55 10.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.445 1.098 . . . . 15.0 110.259 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.67 97.9 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.578 -0.527 . . . . 15.0 109.578 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.46 116.65 30.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.605 0.762 . . . . 15.0 110.494 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HE2' HG21 ' A' ' 84' ' ' ILE . 43.2 p90 -145.3 170.18 16.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.758 1.223 . . . . 15.0 107.73 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -94.71 156.58 16.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.392 0.615 . . . . 15.0 111.312 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 ' NH1' ' A' ' 13' ' ' ARG . 32.9 m -115.63 162.82 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.462 1.105 . . . . 15.0 108.272 170.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.05 119.87 70.53 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.86 -175.48 2.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.111 2.541 . . . . 15.0 112.46 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.71 128.39 35.36 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -102.48 129.76 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.816 0.846 . . . . 15.0 109.278 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -118.37 113.14 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 15.0 110.751 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.1 mt -82.0 130.69 35.15 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 123.648 0.593 . . . . 15.0 109.611 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.39 154.92 14.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.679 0.792 . . . . 15.0 109.87 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 64.55 20.73 66.15 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.681 0.613 . . . . 15.0 113.481 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 117' ' ' LEU . 68.0 mt -65.04 -42.64 94.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.886 0.874 . . . . 15.0 110.505 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -78.16 -18.65 55.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.636 -1.166 . . . . 15.0 110.646 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.95 47.47 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.234 0.613 . . . . 15.0 111.34 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.519 HG23 ' HA3' ' A' ' 293' ' ' GLY . 61.1 mt -58.35 124.33 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.245 0.966 . . . . 15.0 110.666 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.0 103.92 14.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.421 0.688 . . . . 15.0 109.296 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 417' ' ' VAL . 41.5 t -107.32 161.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.46 1.104 . . . . 15.0 108.417 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -123.1 138.13 54.74 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.561 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.1 tttt -114.7 88.67 16.82 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.336 -0.987 . . . . 15.0 108.336 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.11 100.81 0.95 Allowed 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.049 1.833 . . . . 15.0 111.298 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.561 HD11 ' HE2' ' A' ' 127' ' ' LYS . 42.1 mm -67.87 84.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 168.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 278' ' ' LEU . 21.3 t -98.38 136.73 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.22 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -132.66 162.52 31.15 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 167.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.16 79.83 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.2 p -61.93 170.06 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.761 0.824 . . . . 15.0 110.448 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.27 -31.43 65.58 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.955 0.502 . . . . 15.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.96 92.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.782 0.833 . . . . 15.0 110.895 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -73.16 -40.55 64.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.314 0.646 . . . . 15.0 111.113 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.06 -61.87 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.211 1.004 . . . . 15.0 109.514 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.48 -34.49 65.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.574 -0.739 . . . . 15.0 110.934 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.22 -45.67 92.97 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.639 0.587 . . . . 15.0 113.14 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -75.29 -41.82 56.2 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.058 0.543 . . . . 15.0 111.033 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 270' ' ' VAL . 32.2 mt -52.23 -40.01 61.05 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.095 0.558 . . . . 15.0 111.841 167.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.54 -41.37 84.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.409 0.684 . . . . 15.0 110.605 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 m -60.41 -39.3 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.836 0.71 . . . . 15.0 110.339 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -40.33 96.07 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 15.0 111.014 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 47.7 mtm180 -62.33 -40.7 97.2 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.621 0.575 . . . . 15.0 110.558 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 87.5 mttt -80.29 -16.4 54.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.324 0.65 . . . . 15.0 112.386 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -82.48 -40.8 20.6 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.883 0.473 . . . . 15.0 109.748 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -100.0 35.81 1.97 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.788 0.835 . . . . 15.0 109.889 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.19 143.97 34.88 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.011 0.925 . . . . 15.0 112.562 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.4 m -74.19 129.4 37.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 15.0 109.643 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -79.18 129.99 35.02 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.21 163.36 36.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 45.7 mt-10 -118.12 157.15 27.42 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.145 0.498 . . . . 15.0 109.839 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 23.4 pttt -136.63 155.09 50.38 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.34 -0.846 . . . . 15.0 109.982 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.77 96.57 7.0 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.613 -0.721 . . . . 15.0 110.242 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 240' ' ' VAL . . . 60.07 62.36 6.15 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 113.965 -1.47 . . . . 15.0 116.392 165.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.683 ' H ' HG11 ' A' ' 240' ' ' VAL . . . -155.02 107.66 2.75 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 117.344 0.572 . . . . 15.0 110.291 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 203' ' ' LYS . 41.6 t -109.22 137.54 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.488 0.586 . . . . 15.0 109.66 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.61 -176.99 4.22 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.788 1.235 . . . . 15.0 109.315 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.22 67.6 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.892 1.441 . . . . 15.0 114.892 -167.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.9 17.68 9.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.971 0.509 . . . . 15.0 111.305 -170.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.51 -159.57 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.929 0.491 . . . . 15.0 111.815 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 32.3 ttp180 -137.17 153.87 50.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 44.5 t -144.12 155.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 15.0 108.768 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 23.5 m -122.74 124.39 43.26 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 164.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.09 161.34 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.778 0.831 . . . . 15.0 111.012 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.78 121.12 33.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.466 -2.05 . . . . 15.0 105.466 159.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -112.39 163.08 14.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.746 -0.596 . . . . 15.0 110.3 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.5 t -139.78 93.31 2.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -98.12 162.74 21.01 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.205 -1.361 . . . . 15.0 113.295 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 m -149.98 127.45 11.51 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.025 -1.102 . . . . 15.0 108.025 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 71.2 t -97.35 115.97 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.803 0.841 . . . . 15.0 109.422 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 36.6 t70 69.62 3.47 4.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.652 0.781 . . . . 15.0 111.486 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 115.32 -11.9 19.36 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.587 -0.563 . . . . 15.0 113.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 10.3 pt-20 -92.37 131.79 37.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.4 94.58 1.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.217 -1.772 . . . . 15.0 106.217 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.499 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 3.0 p90 -71.78 -160.78 0.06 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.509 -1.678 . . . . 15.0 112.419 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -51.66 103.96 0.07 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.155 0.982 . . . . 15.0 110.571 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.51 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 91.56 -62.72 2.69 Favored Glycine 0 C--O 1.239 0.435 0 O-C-N 124.366 1.041 . . . . 15.0 113.195 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.27 -59.42 4.91 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.2 158.03 16.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.566 0.58 . . . . 15.0 112.566 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.16 93.51 2.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.5 m -79.58 130.71 35.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.196 -0.911 . . . . 15.0 112.193 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 58.17 31.12 20.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.749 1.22 . . . . 15.0 113.309 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.414 ' CD2' HD23 ' B' ' 385' ' ' LEU . 72.6 t80 -71.4 133.96 46.31 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.133 0.492 . . . . 15.0 109.86 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.7 100.69 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 124.26 1.024 . . . . 15.0 108.912 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.17 98.66 11.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.146 0.979 . . . . 15.0 111.406 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.03 101.65 3.3 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.679 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER -60.08 116.61 4.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.306 0.643 . . . . 15.0 109.641 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.9 -6.61 7.82 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.816 -0.629 . . . . 15.0 112.148 -166.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -81.52 -179.83 7.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.509 0.724 . . . . 15.0 111.097 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.97 52.73 0.68 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.877 -0.602 . . . . 15.0 112.226 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.7 13.52 21.15 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.94 0.876 . . . . 15.0 109.169 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -152.2 154.62 36.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.407 1.083 . . . . 15.0 109.169 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 pt -86.3 164.57 37.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.442 0.697 . . . . 15.0 111.342 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.13 153.57 68.56 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.241 1.961 . . . . 15.0 111.373 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.73 -50.59 1.77 Allowed Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.872 -0.891 . . . . 15.0 110.872 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 213' ' ' ILE . 65.6 t80 -68.66 -59.98 2.74 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.197 0.599 . . . . 15.0 109.547 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.18 -32.71 73.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.313 1.008 . . . . 15.0 111.623 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 4.8 m-20 -69.53 -23.43 63.59 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.849 0.86 . . . . 15.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -83.77 -9.99 81.99 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.461 0.476 . . . . 15.0 113.182 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.1 -46.86 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.677 0.791 . . . . 15.0 110.061 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HB3' ' SD ' ' A' ' 189' ' ' MET . 62.3 pttt -84.7 30.88 0.54 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.13 1.159 . . . . 15.0 114.13 -161.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -155.89 35.91 0.62 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.785 -0.526 . . . . 15.0 111.785 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.62 -170.95 3.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.352 0.661 . . . . 15.0 111.29 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -139.42 155.89 47.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.577 1.151 . . . . 15.0 111.226 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.1 147.09 51.96 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 15.0 111.084 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.6 -40.98 2.26 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.229 -0.749 . . . . 15.0 111.229 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.8 pt-20 -78.8 126.79 31.18 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.613 0.72 . . . . 15.0 109.434 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.36 106.4 13.6 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.302 -1.369 . . . . 15.0 107.302 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -126.29 -177.43 3.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.344 1.058 . . . . 15.0 109.877 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.8 t -117.25 158.15 24.82 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.504 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.0 pt -128.01 150.2 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 173.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.12 117.58 34.43 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 163.92 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 15.0 107.332 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 59.1 m -141.92 134.47 28.23 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.29 128.93 76.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.111 -0.471 . . . . 15.0 109.767 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.06 163.51 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.713 2.942 . . . . 15.0 115.146 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.61 -24.44 53.42 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.397 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.36 -18.63 48.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.363 1.065 . . . . 15.0 110.628 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.434 ' HE2' HD12 ' A' ' 226' ' ' LEU . 30.7 t80 -61.11 111.62 1.78 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 15.0 109.923 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -66.71 -14.39 62.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.163 1.172 . . . . 15.0 114.163 -168.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.16 101.04 10.18 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.74 -31.39 72.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 15.0 111.727 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.575 HD21 HG11 ' B' ' 388' ' ' VAL . 7.0 p30 -70.41 -11.68 61.08 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.862 0.465 . . . . 15.0 111.596 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.616 HD11 ' H ' ' B' ' 388' ' ' VAL . 57.5 mt -112.61 -30.84 6.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.932 0.893 . . . . 15.0 110.765 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.17 121.48 6.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.583 1.153 . . . . 15.0 112.497 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.69 -22.98 25.19 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.903 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 96.1 mttt -75.99 143.02 41.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.232 0.613 . . . . 15.0 110.964 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.22 115.01 27.71 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.879 0.871 . . . . 15.0 109.825 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.38 118.47 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.553 0.741 . . . . 15.0 111.594 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -92.34 124.16 36.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.113 0.965 . . . . 15.0 108.726 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.2 113.83 19.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.067 0.547 . . . . 15.0 109.79 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 93.62 4.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.63 -0.507 . . . . 15.0 109.63 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.8 mm -82.82 122.55 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.352 1.061 . . . . 15.0 110.324 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -107.67 99.75 9.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 109.569 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.29 111.95 11.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.913 -0.403 . . . . 15.0 109.913 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 239' ' ' LYS . 17.7 ptpt -109.7 -35.46 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 116.461 -0.336 . . . . 15.0 110.597 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 238' ' ' LYS . 74.6 mmtt -129.29 133.0 47.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.241 0.616 . . . . 15.0 110.327 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.683 HG11 ' H ' ' A' ' 157' ' ' ALA . 77.7 t -106.92 123.62 62.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 26.1 mt-10 -124.55 169.98 11.36 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.557 0.743 . . . . 15.0 109.457 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.797 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.2 tt0 -139.21 130.48 26.81 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.896 0.878 . . . . 15.0 109.411 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -83.65 84.68 7.46 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.575 -1.268 . . . . 15.0 107.575 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.95 141.2 53.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.844 -1.526 . . . . 15.0 111.239 -173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' A' ' 146' ' ' LYS . 96.7 mt -58.26 126.29 77.78 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.343 0.657 . . . . 15.0 110.714 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -77.78 173.22 14.41 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.892 2.395 . . . . 15.0 111.249 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -79.82 127.06 31.76 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.722 -0.672 . . . . 15.0 110.069 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 17.0 tp -86.87 52.96 2.66 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.558 -0.904 . . . . 15.0 108.558 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 253' ' ' ILE . 59.9 m -55.0 143.54 26.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.825 1.65 . . . . 15.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.81 -45.37 59.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.748 0.819 . . . . 15.0 112.346 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.62 -14.97 63.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.132 0.973 . . . . 15.0 113.446 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.55 -51.32 4.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.76 0.824 . . . . 15.0 110.305 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.727 HG13 HD22 ' A' ' 266' ' ' LEU . 7.3 tt -63.63 -33.08 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.147 0.979 . . . . 15.0 111.893 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.32 -29.63 67.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 120.757 0.313 . . . . 15.0 111.353 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -72.69 -13.56 61.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.588 0.755 . . . . 15.0 111.031 -172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.57 6.76 22.51 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.394 0.678 . . . . 15.0 111.929 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.63 8.91 Favored Glycine 0 N--CA 1.476 1.361 0 CA-C-N 117.554 0.161 . . . . 15.0 113.17 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 261' ' ' GLY . 14.4 t -102.82 132.88 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.2 -62.89 1.2 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.87 0.367 . . . . 15.0 110.588 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -83.8 -22.31 31.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.65 0.78 . . . . 15.0 111.383 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 90.7 26.93 21.27 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.631 -0.539 . . . . 15.0 113.449 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 55.3 p -72.22 136.23 46.3 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 117.607 0.703 . . . . 15.0 110.535 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.495 ' HA ' HD11 ' A' ' 253' ' ' ILE . 61.0 t -55.62 -46.97 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.896 0.878 . . . . 15.0 110.468 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.5 -26.69 68.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.701 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.54 -26.28 61.43 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 111.464 -0.654 . . . . 15.0 111.464 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.727 HD22 HG13 ' A' ' 253' ' ' ILE . 53.9 tp -77.27 -41.79 39.56 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.86 -0.422 . . . . 15.0 109.86 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -60.77 -39.7 89.77 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 124.026 0.829 . . . . 15.0 110.026 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.83 -42.24 77.44 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.398 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -64.6 -44.64 89.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.473 0.709 . . . . 15.0 111.107 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 141' ' ' LEU . 28.3 m -76.93 -25.21 15.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 119.282 -0.39 . . . . 15.0 110.89 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -55.34 -59.64 4.52 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.8 -36.35 82.19 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.03 0.752 . . . . 15.0 113.03 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -70.42 -52.48 21.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.214 0.461 . . . . 15.0 111.168 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.51 -33.47 75.99 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 118.391 -0.814 . . . . 15.0 110.206 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 45.5 mt-10 -72.21 -30.58 65.07 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -69.59 -38.83 77.48 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -65.12 -46.7 79.92 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.867 -1.06 . . . . 15.0 110.232 169.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.49 ' HA ' ' HE1' ' A' ' 428' ' ' MET . 42.9 tp -63.6 -59.4 4.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.397 -1.274 . . . . 15.0 112.788 -168.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.87 -30.2 70.76 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.718 0.636 . . . . 15.0 111.745 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 m -70.24 -37.6 75.0 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.214 0.53 . . . . 15.0 110.019 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.98 61.05 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 115.74 -0.664 . . . . 15.0 111.873 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.4 mt -69.32 -40.08 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.941 -1.133 . . . . 15.0 107.941 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 15.9 tpt180 -59.83 -50.5 73.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.602 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.44 -39.09 86.24 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.911 0.757 . . . . 15.0 111.765 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -56.44 -66.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.133 0.973 . . . . 15.0 110.8 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.79 -40.34 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.835 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.59 -46.53 79.01 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 115.6 -0.727 . . . . 15.0 110.724 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.0 p -69.13 -31.85 70.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.226 0.329 . . . . 15.0 111.712 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.7 mt-30 -64.56 -47.19 79.66 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.403 0.281 . . . . 15.0 110.779 173.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.07 -44.37 96.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.227 0.611 . . . . 15.0 111.26 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 351' ' ' LEU . 1.2 mp -64.44 -45.91 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.684 1.594 . . . . 15.0 111.445 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -67.59 -43.13 81.29 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.766 -0.457 . . . . 15.0 109.766 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -56.9 -41.43 91.66 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 124.151 0.907 . . . . 15.0 112.186 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.5 -59.62 5.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 15.0 111.292 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.62 -51.47 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 120.936 0.398 . . . . 15.0 110.302 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -62.93 -35.07 78.87 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.985 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.62 -24.64 49.51 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.669 0.618 . . . . 15.0 112.669 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 14.2 m-80 -118.26 152.67 35.28 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.991 0.424 . . . . 15.0 111.887 -162.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -121.61 135.46 54.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.081 0.952 . . . . 15.0 109.713 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 349' ' ' LEU . 12.0 tt -168.67 144.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.392 1.077 . . . . 15.0 109.447 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.93 120.74 26.07 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.589 -1.263 . . . . 15.0 107.589 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.15 120.29 65.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.783 0.833 . . . . 15.0 111.219 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.8 126.73 17.19 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.142 2.561 . . . . 15.0 112.776 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -57.82 -23.18 51.44 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.836 1.254 . . . . 15.0 112.341 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.612 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -56.04 -56.05 25.51 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.385 1.074 . . . . 15.0 111.529 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 37.1 mt -71.8 -33.2 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.622 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 304' ' ' ALA . 69.2 mt -60.82 -44.57 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.549 0.74 . . . . 15.0 110.054 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.59 91.77 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.675 0.79 . . . . 15.0 110.821 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 56.6 m -62.64 -49.9 73.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.669 0.605 . . . . 15.0 112.171 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 341' ' ' ALA . 4.8 mm-40 -68.65 -40.69 80.11 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.304 0.378 . . . . 15.0 110.542 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.511 HD13 ' HG3' ' A' ' 334' ' ' ARG . 60.6 mt -56.81 -45.26 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.898 0.879 . . . . 15.0 109.736 173.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.47 -46.75 88.96 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.325 1.016 . . . . 15.0 111.583 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.8 -40.72 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 123.722 0.639 . . . . 15.0 110.424 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.23 -26.71 63.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.307 0.643 . . . . 15.0 112.039 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.0 mtm180 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.877 0.325 . . . . 15.0 111.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.17 -16.82 56.03 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.407 1.083 . . . . 15.0 112.861 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 57.4 mt -54.97 137.99 65.29 Favored Pre-proline 0 N--CA 1.5 2.036 0 CA-C-N 118.477 0.581 . . . . 15.0 111.937 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.13 107.9 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.796 2.997 . . . . 15.0 114.088 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HG3' HD13 ' A' ' 311' ' ' ILE . 25.7 ttt85 -53.53 -39.25 64.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.208 1.403 . . . . 15.0 112.412 -174.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.31 -26.04 60.27 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 15.0 113.226 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.5 -31.96 71.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.245 0.545 . . . . 15.0 110.533 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.414 ' HA ' HE21 ' A' ' 340' ' ' GLN . 26.4 m-85 -105.53 -19.83 13.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.005 0.922 . . . . 15.0 111.341 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.413 ' HA ' HD11 ' A' ' 311' ' ' ILE . 5.9 tp10 -49.21 -61.15 2.23 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.879 1.272 . . . . 15.0 113.28 -169.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.15 -52.16 50.95 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.432 0.693 . . . . 15.0 111.666 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.3 pt20 -63.38 -34.46 77.78 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.757 0.66 . . . . 15.0 111.903 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -68.97 -49.34 58.73 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.445 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.2 tttt -55.55 -39.4 70.56 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.138 0.899 . . . . 15.0 110.636 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.4 mmt180 -59.09 -44.8 91.95 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.419 171.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -68.87 -24.19 64.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.491 0.716 . . . . 15.0 110.718 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.0 t -71.53 -50.9 36.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 123.181 0.592 . . . . 15.0 110.176 173.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 342' ' ' LYS . 39.7 t -56.33 -37.4 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 123.846 0.716 . . . . 15.0 109.887 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 343' ' ' ARG . 60.4 t -54.31 -53.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 15.0 110.972 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.22 -32.76 85.27 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.619 0.575 . . . . 15.0 114.049 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 300' ' ' ILE . 89.7 mt -73.28 -50.48 22.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.605 0.762 . . . . 15.0 110.159 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 354' ' ' VAL . 89.6 mt -70.37 -46.82 63.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.631 -0.713 . . . . 15.0 110.825 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 291' ' ' ILE . 52.9 mt -64.16 -37.13 86.35 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.439 0.462 . . . . 15.0 111.388 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.76 -40.2 98.91 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.593 0.558 . . . . 15.0 111.918 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.23 -29.27 67.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.107 -0.547 . . . . 15.0 111.304 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.1 t -74.33 -32.3 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.811 0.444 . . . . 15.0 110.357 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 351' ' ' LEU . 95.7 mt -63.45 -42.77 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.26 -0.645 . . . . 15.0 109.26 172.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -65.0 -55.45 18.93 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.2 m -60.31 -44.9 95.02 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.426 1.09 . . . . 15.0 111.535 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -88.26 4.27 46.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.125 0.57 . . . . 15.0 111.696 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 39.08 65.03 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.87 1.668 . . . . 15.0 113.886 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 154.12 18.34 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.5 -1.227 . . . . 15.0 111.204 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.36 144.05 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.538 -1.282 . . . . 15.0 107.538 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -66.14 132.59 48.83 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.63 0.372 . . . . 15.0 111.781 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.72 123.79 37.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.728 0.811 . . . . 15.0 110.265 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.44 -40.29 82.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.273 0.629 . . . . 15.0 112.383 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.86 -27.59 66.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.655 0.382 . . . . 15.0 111.751 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 406' ' ' GLN . 27.6 ttt180 -74.57 -43.32 56.23 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 371' ' ' ILE . 46.5 t -59.58 -42.0 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.697 -1.138 . . . . 15.0 109.719 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -58.14 -50.17 74.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.651 0.78 . . . . 15.0 110.865 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.76 -46.46 82.75 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 124.193 0.933 . . . . 15.0 112.664 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 96.5 mt -55.47 -48.84 73.89 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.416 0.686 . . . . 15.0 111.11 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.645 HD11 ' HG2' ' A' ' 398' ' ' MET . 35.6 mm -58.32 -58.94 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.534 0.733 . . . . 15.0 111.705 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.64 -36.21 83.51 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 124.329 1.018 . . . . 15.0 111.491 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -78.36 -39.06 40.48 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.46 0.541 . . . . 15.0 112.46 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.15 -36.12 82.55 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.343 0.592 . . . . 15.0 109.96 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.711 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -81.62 -28.16 33.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.173 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 35.4 t -64.65 -15.42 61.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.792 0.837 . . . . 15.0 111.669 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.09 -5.26 34.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.352 0.661 . . . . 15.0 111.945 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.79 165.58 20.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.327 1.051 . . . . 15.0 110.004 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.18 17.78 7.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.558 0.743 . . . . 15.0 110.354 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 381' ' ' PRO . 1.6 p30 -133.45 41.7 0.73 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.149 0.98 . . . . 15.0 112.626 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.711 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 44.1 Cg_exo -58.06 -43.48 47.79 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 122.128 1.886 . . . . 15.0 113.98 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.47 -50.1 63.36 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.897 0.879 . . . . 15.0 112.711 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.7 -22.04 64.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.594 0.559 . . . . 15.0 111.752 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.06 -45.71 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.191 0.597 . . . . 15.0 109.446 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.98 -39.28 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.04 -0.982 . . . . 15.0 109.776 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.67 -42.12 71.17 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.121 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -60.66 -35.91 77.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.295 0.638 . . . . 15.0 111.701 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 51.7 m-85 -88.38 -61.11 1.79 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.636 0.374 . . . . 15.0 111.745 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . 0.473 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 38.9 m -70.54 -21.33 62.73 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.616 0.969 . . . . 15.0 113.616 -167.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -96.01 11.49 33.85 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.417 0.287 . . . . 15.0 111.055 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -136.8 103.54 5.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.84 -31.61 71.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.065 0.546 . . . . 15.0 111.512 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.08 -47.74 84.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.387 0.675 . . . . 15.0 110.87 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 41.8 tp -83.51 -24.71 31.58 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.896 -0.593 . . . . 15.0 111.209 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.51 ' HE3' ' HB3' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -71.08 -37.61 72.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.43 -36.19 82.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.761 1.224 . . . . 15.0 110.569 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 400' ' ' ASN . 51.9 t-20 -62.37 -42.48 99.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.742 0.782 . . . . 15.0 109.854 173.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.645 ' HG2' HD11 ' A' ' 371' ' ' ILE . 3.8 tpt -79.23 -17.26 55.14 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.564 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.11 -35.97 64.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 168.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 397' ' ' ASN . 6.8 t30 -59.22 -53.61 56.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.374 0.669 . . . . 15.0 110.421 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.2 p -65.47 -37.11 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 O-C-N 123.577 0.548 . . . . 15.0 111.354 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -62.01 -44.87 95.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.902 0.481 . . . . 15.0 110.96 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 23.5 tp -72.04 -30.46 65.2 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.846 -1.07 . . . . 15.0 111.03 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 33.7 tt0 -67.56 -39.35 84.95 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.949 0.9 . . . . 15.0 109.492 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 33.1 mm-40 -69.49 -36.2 76.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.551 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -62.25 -39.15 91.92 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.387 0.675 . . . . 15.0 110.098 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.85 -41.77 95.43 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 124.07 0.857 . . . . 15.0 111.534 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 96.2 t -57.94 -55.47 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 123.474 0.484 . . . . 15.0 110.031 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.463 ' HG2' HD12 ' A' ' 412' ' ' LEU . 43.5 mt-10 -67.29 -22.89 65.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.553 0.575 . . . . 15.0 112.553 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 414' ' ' LYS . . . -66.13 -37.66 86.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.57 0.544 . . . . 15.0 110.621 169.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 45.8 t -74.61 -33.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 409' ' ' GLU . 96.9 mt -64.33 -40.1 95.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.076 0.55 . . . . 15.0 110.935 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.21 -15.56 57.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.35 0.66 . . . . 15.0 112.492 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 410' ' ' ALA . 24.1 mtpp -101.12 -33.77 9.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.178 0.991 . . . . 15.0 110.672 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.3 160.66 20.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.284 1.033 . . . . 15.0 112.402 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.6 80.29 1.99 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.163 0.985 . . . . 15.0 109.816 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 125' ' ' VAL . 49.1 t -97.73 109.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.605 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.0 t -87.95 103.4 15.65 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.277 0.631 . . . . 15.0 110.134 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -85.37 129.39 34.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.661 0.785 . . . . 15.0 110.068 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -139.33 153.93 47.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.361 0.664 . . . . 15.0 109.588 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.56 133.3 52.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.592 -0.892 . . . . 15.0 108.592 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.436 HG23 HG22 ' A' ' 130' ' ' VAL . 7.9 t -159.64 172.12 18.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.763 0.425 . . . . 15.0 111.521 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 77.9 p -91.78 168.28 11.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.22 1.008 . . . . 15.0 111.396 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -54.17 -26.66 29.2 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.459 1.503 . . . . 15.0 112.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.93 -20.62 16.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.06 0.944 . . . . 15.0 113.338 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.466 0.706 . . . . 15.0 112.256 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 278' ' ' LEU . 22.4 tp -70.48 -78.79 0.07 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.514 0.931 . . . . 15.0 113.514 -153.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.49 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.0 OUTLIER -87.19 -22.79 25.07 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.608 0.363 . . . . 15.0 110.39 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 8.6 t30 . . . . . 0 CA--C 1.564 1.505 0 C-N-CA 123.964 0.906 . . . . 15.0 111.904 -172.362 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . 0.414 HD23 ' CD2' ' A' ' 185' ' ' PHE . 1.9 tm? . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . 0.51 HG11 ' HA3' ' A' ' 179' ' ' GLY . 27.2 m -69.4 98.72 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 121.834 0.826 . . . . 0.0 113.086 -166.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.42 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 20.9 pt -144.02 157.54 15.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.763 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 158.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 226' ' ' LEU . 30.2 t . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.482 1.133 0 C-N-CA 123.907 0.883 . . . . 0.0 111.047 178.625 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.907 0.384 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.64 -1.29 38.4 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.612 0.765 . . . . 0.0 111.418 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -164.6 135.86 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 89.3 m -63.3 99.37 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.5 ttt -78.43 120.17 22.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.674 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.1 OUTLIER -125.62 75.82 1.52 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 122.482 1.134 . . . . 0.0 109.18 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.15 -40.8 36.83 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.58 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 113.845 -1.525 . . . . 0.0 108.776 -172.416 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.779 0.323 . . . . 15.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -126.96 142.67 51.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.883 -1.154 . . . . 15.0 107.883 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -126.78 152.22 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.505 0.722 . . . . 15.0 110.051 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.529 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 48.7 m -146.9 100.63 3.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.349 0.66 . . . . 15.0 110.052 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.26 128.23 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.967 -0.561 . . . . 15.0 109.855 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.03 97.38 3.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 15.0 108.921 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -76.87 93.88 3.82 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.704 -0.85 . . . . 15.0 108.704 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.2 p -66.12 -39.94 90.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.139 0.976 . . . . 15.0 111.858 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -170.13 104.1 0.3 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.393 0.677 . . . . 15.0 109.979 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.67 -100.93 0.47 Allowed Glycine 0 C--N 1.354 1.529 0 O-C-N 124.083 0.864 . . . . 15.0 113.275 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.2 mp -76.99 -39.42 50.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 15.0 110.152 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.7 104.05 0.34 Allowed Glycine 0 C--N 1.353 1.477 0 O-C-N 124.603 1.19 . . . . 15.0 111.634 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' NH1' HG11 ' A' ' 111' ' ' VAL . 33.8 ttm180 -134.82 120.87 19.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.38 1.072 . . . . 15.0 109.972 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 43.3 ttm180 -93.76 146.38 23.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.46 -1.245 . . . . 15.0 109.468 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.47 93.69 2.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 107.332 -1.359 . . . . 15.0 107.332 165.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 33.3 m -73.19 108.55 6.13 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.137 -0.938 . . . . 15.0 108.953 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 3' ' ' VAL . 47.8 mt -107.92 123.95 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.025 0.53 . . . . 15.0 109.617 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 m -99.93 104.83 16.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.518 0.727 . . . . 15.0 109.156 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.5 mt -80.52 112.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 160.07 24.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.206 0.603 . . . . 15.0 111.997 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.96 79.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.324 1.049 . . . . 15.0 112.056 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -65.09 -36.2 83.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.741 0.816 . . . . 15.0 111.121 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -70.14 -37.0 75.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.528 0.731 . . . . 15.0 110.459 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 28' ' ' VAL . 73.8 mt -70.67 -44.05 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 114.905 -1.043 . . . . 15.0 109.943 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.26 -41.72 99.08 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.065 0.546 . . . . 15.0 111.799 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 m -56.11 -45.87 79.34 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -64.85 -44.81 88.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.462 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 24' ' ' ILE . 71.3 t -60.99 -55.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.284 0.634 . . . . 15.0 110.658 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -61.75 -41.5 97.76 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.27 -11.5 59.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.418 0.687 . . . . 15.0 111.767 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 8.8 tp10 -88.64 -43.03 11.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.721 0.408 . . . . 15.0 110.383 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.692 HD11 ' HA3' ' A' ' 59' ' ' GLY . 92.4 mt -70.27 -23.97 62.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.564 0.746 . . . . 15.0 112.386 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.2 p -69.98 -32.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 123.339 0.4 . . . . 15.0 110.054 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -69.36 -43.53 73.4 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.588 0.755 . . . . 15.0 109.613 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' VAL . 46.9 t -63.36 -38.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.885 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.524 0.73 . . . . 15.0 110.926 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 95.6 mttt -67.29 -31.49 71.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.169 0.587 . . . . 15.0 111.392 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.28 -46.05 29.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.694 0.798 . . . . 15.0 110.951 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.7 t -82.85 -5.93 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 122.924 0.49 . . . . 15.0 110.005 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 74.45 8.79 4.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.85 1.66 . . . . 15.0 112.15 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.419 HG13 ' HB ' ' A' ' 39' ' ' VAL . 56.8 mt -63.89 -22.9 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 15.0 110.931 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.99 -33.97 74.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.424 0.69 . . . . 15.0 111.148 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -39.05 15.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.749 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -71.03 -16.97 62.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.157 0.583 . . . . 15.0 111.162 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.412 HH21 ' HA ' ' A' ' 50' ' ' PRO . 49.0 ttt-85 -76.63 105.93 7.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -85.79 13.22 7.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.406 0.683 . . . . 15.0 112.153 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -34.29 4.66 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.85 -0.417 . . . . 15.0 112.354 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -52.03 -36.14 49.24 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.998 1.319 . . . . 15.0 112.384 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.31 108.92 32.23 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.564 -0.902 . . . . 15.0 108.564 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 53' ' ' ILE . 38.8 Cg_exo -64.02 138.94 64.86 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 15.0 111.681 173.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.6 tpp -67.92 -25.74 65.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.196 0.598 . . . . 15.0 111.12 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.13 -33.89 77.1 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.326 0.25 . . . . 15.0 111.13 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 50' ' ' PRO . 32.1 mt -67.55 -46.15 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.018 0.527 . . . . 15.0 110.234 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -74.14 -21.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 111.567 0.21 . . . . 15.0 111.567 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.23 -45.58 39.3 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.201 0.6 . . . . 15.0 111.4 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.57 -26.56 58.05 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.502 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -92.01 -72.52 0.59 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.839 0.455 . . . . 15.0 110.9 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -84.33 -34.44 23.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.077 0.551 . . . . 15.0 111.466 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -74.97 -13.23 82.8 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.156 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.68 59.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 15.0 112.163 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.9 p -81.89 -42.75 19.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.293 0.637 . . . . 15.0 109.346 171.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -70.86 88.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.793 0.837 . . . . 15.0 109.152 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.46 -38.28 6.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.625 0.77 . . . . 15.0 110.129 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.14 -46.01 90.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.765 0.826 . . . . 15.0 112.271 -171.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.98 -49.24 71.02 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.301 0.641 . . . . 15.0 110.376 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.6 -63.78 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.543 -1.208 . . . . 15.0 110.76 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 71' ' ' MET . 84.1 mt -64.74 -38.21 90.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.781 0.832 . . . . 15.0 111.511 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.27 -40.72 98.99 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.812 0.695 . . . . 15.0 113.15 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 28.7 t70 -78.87 -37.57 39.93 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.004 0.522 . . . . 15.0 110.076 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.0 mt -54.87 -42.4 72.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.005 0.922 . . . . 15.0 111.29 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 48.2 mtm -58.6 -42.75 88.85 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.675 0.609 . . . . 15.0 110.76 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.9 t -70.28 -43.78 69.75 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.907 -1.042 . . . . 15.0 111.008 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 20.8 mtm180 -69.17 -36.05 76.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.698 0.399 . . . . 15.0 111.502 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -36.67 68.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.968 0.507 . . . . 15.0 110.274 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -70.01 -50.25 43.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.886 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.41 -33.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.646 0.591 . . . . 15.0 111.012 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.23 -51.73 62.24 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.254 0.621 . . . . 15.0 110.707 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.79 85.49 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.99 -1.004 . . . . 15.0 112.438 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 pt -75.33 -32.01 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 112.383 0.512 . . . . 15.0 112.383 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.44 -50.62 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 120.841 0.353 . . . . 15.0 110.558 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 17.1 ptpt -73.66 -50.63 19.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.949 -0.569 . . . . 15.0 111.449 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 50.6 mm-40 -84.81 -1.99 57.12 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.133 0.573 . . . . 15.0 111.941 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 63.25 28.26 15.73 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.53 1.144 . . . . 15.0 111.091 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.19 90.37 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 108.399 -0.963 . . . . 15.0 108.399 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.744 HD21 ' HB2' ' A' ' 112' ' ' TYR . 45.9 t30 -70.91 107.5 2.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.381 1.073 . . . . 15.0 110.425 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.37 141.78 12.87 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.345 2.03 . . . . 15.0 112.737 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.16 -177.3 6.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.578 0.751 . . . . 15.0 110.683 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.66 11.85 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.4 -0.818 . . . . 15.0 111.473 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.99 100.64 4.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.732 -1.211 . . . . 15.0 107.732 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 51.9 Cg_exo -57.78 107.9 0.34 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.972 2.448 . . . . 15.0 112.622 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.0 m -88.86 100.14 12.94 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.679 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -76.85 75.61 3.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.663 -0.866 . . . . 15.0 108.663 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.17 112.57 4.79 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 123.532 0.733 . . . . 15.0 109.361 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -69.43 92.3 0.48 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.407 2.072 . . . . 15.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -59.61 -63.5 5.05 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.964 0.79 . . . . 15.0 112.004 -176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -167.87 155.75 8.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.983 0.913 . . . . 15.0 109.792 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HE1' HD13 ' A' ' 24' ' ' ILE . 47.0 t80 -135.94 147.27 48.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.12 0.568 . . . . 15.0 109.551 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -124.87 125.22 43.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.748 -1.205 . . . . 15.0 107.748 175.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.39 107.59 0.95 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.675 0.79 . . . . 15.0 111.453 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.76 59.26 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.591 -0.731 . . . . 15.0 113.287 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -106.14 -165.95 1.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.318 1.047 . . . . 15.0 109.379 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -62.93 155.87 26.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.331 1.052 . . . . 15.0 113.287 -171.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.1 t80 -123.66 142.92 50.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 15.0 108.304 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.2 m -137.06 137.59 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.273 0.629 . . . . 15.0 109.371 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.412 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 11.6 p90 -154.35 156.46 36.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.984 0.914 . . . . 15.0 109.086 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 47.7 m -125.13 98.28 5.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.844 0.858 . . . . 15.0 109.648 -170.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.26 97.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.852 -0.796 . . . . 15.0 108.852 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.9 119.05 33.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.799 0.44 . . . . 15.0 110.253 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 22.4 p90 -146.61 -166.78 2.58 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.527 1.131 . . . . 15.0 108.941 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.67 177.17 5.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.63 0.772 . . . . 15.0 110.356 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 11' ' ' LEU . 27.0 m -119.72 154.46 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 122.992 0.517 . . . . 15.0 109.626 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.744 ' HB2' HD21 ' A' ' 85' ' ' ASN . 48.6 m-85 -82.75 105.89 5.81 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 108.334 -0.987 . . . . 15.0 108.334 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' HD11 ' A' ' 300' ' ' ILE . 64.5 Cg_endo -89.03 149.45 5.69 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.629 2.219 . . . . 15.0 113.704 -172.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.58 132.14 33.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.202 1.001 . . . . 15.0 108.882 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 350' ' ' LEU . 7.3 p -86.3 151.57 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.256 0.551 . . . . 15.0 111.937 -170.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.34 94.03 8.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.476 -0.784 . . . . 15.0 108.914 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.3 139.08 58.73 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.47 0.481 . . . . 15.0 110.555 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -163.06 155.12 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.915 0.886 . . . . 15.0 109.545 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.98 74.76 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.124 0.89 . . . . 15.0 114.049 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.45 -28.73 67.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.227 0.611 . . . . 15.0 110.935 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 18.3 mp0 -75.65 -34.08 60.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.657 -1.156 . . . . 15.0 109.852 174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.464 ' HA ' ' HE3' ' A' ' 416' ' ' LYS . . . -78.93 -7.15 57.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.61 0.764 . . . . 15.0 112.255 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.632 HG23 ' HA3' ' A' ' 293' ' ' GLY . 77.6 mt -70.83 120.89 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.439 0.695 . . . . 15.0 109.467 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.08 104.11 15.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.376 0.67 . . . . 15.0 109.685 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 417' ' ' VAL . 45.6 t -106.05 159.55 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.934 -1.135 . . . . 15.0 107.934 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.47 126.37 46.62 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.724 -0.843 . . . . 15.0 108.724 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -107.43 99.21 26.97 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.529 0.732 . . . . 15.0 109.197 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.02 97.85 0.84 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.468 2.112 . . . . 15.0 111.502 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.52 93.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 166.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 12.4 t -122.51 140.48 46.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.535 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.68 154.37 48.6 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.984 -1.117 . . . . 15.0 107.984 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.82 83.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.3 p -68.39 176.9 2.59 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.489 1.116 . . . . 15.0 110.368 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.99 -45.6 64.57 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.429 0.692 . . . . 15.0 111.771 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.19 97.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.92 -1.036 . . . . 15.0 111.338 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.4 -44.15 68.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.173 0.589 . . . . 15.0 111.298 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.9 t -55.51 -62.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.348 1.059 . . . . 15.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -75.45 -31.31 60.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.676 -0.693 . . . . 15.0 111.307 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.86 -43.8 81.98 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.887 0.742 . . . . 15.0 112.713 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -78.16 -37.5 45.76 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.091 0.556 . . . . 15.0 110.878 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.554 HD21 HG11 ' A' ' 270' ' ' VAL . 18.5 mt -54.83 -42.39 71.86 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.253 0.621 . . . . 15.0 111.574 165.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.38 -40.1 95.15 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.375 -0.83 . . . . 15.0 109.997 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.9 m -61.67 -46.27 90.42 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.721 0.638 . . . . 15.0 110.953 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -45.95 91.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.651 0.78 . . . . 15.0 110.66 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -58.27 -37.66 75.4 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.808 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.618 ' HD3' HH12 ' A' ' 243' ' ' ARG . 83.3 mttt -85.41 -12.23 52.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.34 0.656 . . . . 15.0 112.533 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.82 -22.79 34.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.81 0.444 . . . . 15.0 110.005 167.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -97.06 8.4 44.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.262 0.625 . . . . 15.0 111.324 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.71 159.53 31.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 15.0 112.312 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.6 m -123.93 155.93 37.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.091 0.956 . . . . 15.0 108.917 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.627 ' HZ3' ' HB3' ' A' ' 243' ' ' ARG . 3.5 m95 -78.91 153.17 30.69 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.817 0.341 . . . . 15.0 111.151 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -151.65 104.77 3.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.043 -0.981 . . . . 15.0 109.368 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.35 98.45 0.11 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.02 170.73 16.23 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.477 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.95 97.24 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.838 0.455 . . . . 15.0 110.729 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 207' ' ' ALA . . . 55.22 53.26 41.77 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 124.589 1.181 . . . . 15.0 115.5 161.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -153.91 140.86 19.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.334 0.654 . . . . 15.0 109.315 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 202' ' ' ILE . 17.0 t -119.32 131.33 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.177 -0.675 . . . . 15.0 109.177 172.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.85 -176.16 3.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.283 . . . . 15.0 109.423 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.82 -27.49 64.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.28 13.88 16.75 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.435 0.532 . . . . 15.0 112.435 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -79.03 136.16 37.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.971 0.415 . . . . 15.0 111.602 -173.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -84.94 90.91 7.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.823 -1.547 . . . . 15.0 106.823 173.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 44.0 t -90.58 150.79 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.002 0.921 . . . . 15.0 109.847 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.669 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 32.9 m -130.09 126.75 38.36 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 165.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.83 163.71 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.341 1.057 . . . . 15.0 110.314 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -116.69 122.21 43.89 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.294 -1.743 . . . . 15.0 106.294 167.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -129.14 160.69 32.06 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.724 0.773 . . . . 15.0 111.235 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.0 t -140.85 111.87 7.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.262 -1.385 . . . . 15.0 107.262 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -80.02 160.34 44.47 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.596 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.0 m -149.53 111.15 4.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.543 0.737 . . . . 15.0 109.194 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 177' ' ' PHE . 59.7 t -93.85 134.87 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.297 -1.001 . . . . 15.0 108.297 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.0 p30 51.39 18.98 0.71 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.138 1.775 . . . . 15.0 113.472 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.36 -11.57 12.71 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-O 118.665 -1.075 . . . . 15.0 115.545 172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.82 147.73 50.82 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.214 1.507 . . . . 15.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.69 112.66 2.61 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.836 0.71 . . . . 15.0 109.217 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -72.32 156.22 39.33 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.596 0.56 . . . . 15.0 110.829 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.38 126.63 28.09 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.763 0.664 . . . . 15.0 111.124 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.77 77.55 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.051 -0.977 . . . . 15.0 112.175 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.69 47.81 1.39 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 114.672 0.629 . . . . 15.0 114.672 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -136.03 150.72 49.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.018 0.527 . . . . 15.0 110.625 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.12 92.27 0.83 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.154 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.2 p -76.57 127.81 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.357 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 71.6 36.15 1.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 15.0 112.731 174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -66.05 138.85 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 15.0 109.909 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -104.35 110.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.977 0.911 . . . . 15.0 109.719 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -101.93 89.96 3.82 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.675 0.79 . . . . 15.0 111.22 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -78.45 90.3 4.45 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.387 -0.968 . . . . 15.0 108.387 171.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.7 mtp -71.76 169.68 15.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.43 -0.805 . . . . 15.0 113.024 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.67 ' HA3' HH21 ' A' ' 243' ' ' ARG . . . 91.53 10.66 61.67 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.99 -1.004 . . . . 15.0 113.523 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.446 ' HG3' ' HG2' ' A' ' 193' ' ' ARG . 8.8 pt20 -137.75 160.55 38.94 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.169 0.588 . . . . 15.0 110.077 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.91 89.83 0.06 OUTLIER Glycine 0 C--N 1.353 1.484 0 O-C-N 123.715 0.635 . . . . 15.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 191' ' ' GLN . 29.7 mmt180 -121.03 -60.78 1.62 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.67 0.788 . . . . 15.0 111.227 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 198' ' ' PHE . 63.4 mmm -98.17 148.89 23.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.679 0.622 . . . . 15.0 112.679 -165.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.8 pt -61.27 145.27 90.54 Favored Pre-proline 0 CA--C 1.556 1.207 0 O-C-N 124.74 1.275 . . . . 15.0 109.904 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.62 114.76 1.91 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.472 2.781 . . . . 15.0 111.811 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 128.4 -37.31 2.29 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.71 -0.677 . . . . 15.0 112.385 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 194' ' ' MET . 37.6 t80 -69.64 -67.78 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.423 0.289 . . . . 15.0 110.386 -175.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.41 -18.84 65.08 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.382 0.426 . . . . 15.0 111.859 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.28 -41.13 67.01 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.965 0.906 . . . . 15.0 110.2 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.22 -24.44 77.0 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.176 -0.92 . . . . 15.0 112.484 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 198' ' ' PHE . 44.9 mm -73.2 -51.85 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.239 0.616 . . . . 15.0 110.134 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -79.01 12.78 2.04 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.508 0.929 . . . . 15.0 113.508 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.55 20.4 15.59 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -144.18 -176.05 4.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.484 1.114 . . . . 15.0 109.991 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.5 OUTLIER -147.37 143.42 27.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.436 0.694 . . . . 15.0 110.101 -176.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.599 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . . . -59.66 145.67 43.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.414 0.894 . . . . 15.0 113.414 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.09 -34.16 4.84 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.478 -0.783 . . . . 15.0 111.553 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.6 pt-20 -87.19 140.74 29.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.588 0.709 . . . . 15.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.14 125.37 52.23 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.67 1.188 . . . . 15.0 107.969 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -148.92 -167.05 2.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.425 1.09 . . . . 15.0 109.633 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.4 t -133.17 150.37 52.01 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.199 -1.037 . . . . 15.0 108.199 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 38.5 pt -113.57 147.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 172.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.04 113.7 26.95 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.93 167.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.302 -1.37 . . . . 15.0 107.302 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.9 m -135.03 137.73 43.24 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -72.58 125.5 91.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 123.873 0.733 . . . . 15.0 109.621 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.48 168.15 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.785 2.99 . . . . 15.0 115.21 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.88 -19.97 53.83 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.937 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -80.3 -22.49 41.52 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.325 1.05 . . . . 15.0 110.75 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.59 116.23 4.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.84 . . . . 15.0 110.46 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -68.14 -32.19 72.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -162.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.42 92.57 1.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.039 -1.467 . . . . 15.0 107.039 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 33.0 tt0 -73.53 -18.11 61.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.744 0.817 . . . . 15.0 111.391 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -65.32 -13.23 58.02 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.365 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 172' ' ' VAL . 95.4 mt -119.26 -29.89 5.07 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.949 1.3 . . . . 15.0 111.773 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 36.8 ttmt -51.61 121.36 6.33 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.998 1.319 . . . . 15.0 111.645 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.63 -25.33 25.32 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.409 -0.359 . . . . 15.0 113.591 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.15 150.44 31.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.524 0.73 . . . . 15.0 111.328 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.8 122.79 37.79 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.646 0.778 . . . . 15.0 109.927 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.43 122.37 47.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.667 0.787 . . . . 15.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 63.9 mttm -93.73 118.4 31.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.193 0.997 . . . . 15.0 109.571 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 89.5 m-85 -108.4 118.44 36.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.01 89.16 2.98 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.507 0.504 . . . . 15.0 110.323 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 40.9 mm -83.24 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.537 0.735 . . . . 15.0 110.209 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -120.59 99.33 6.49 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.43 99.3 4.83 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.53 0.732 . . . . 15.0 111.005 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -104.12 -43.65 5.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.52 0.728 . . . . 15.0 110.145 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.3 mmtt -124.51 125.87 44.92 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.561 1.144 . . . . 15.0 108.22 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 157' ' ' ALA . 18.6 t -128.5 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.74 -1.578 . . . . 15.0 106.74 165.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -86.53 163.99 17.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.542 -1.208 . . . . 15.0 108.23 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -130.2 129.46 43.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.453 -0.943 . . . . 15.0 108.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.67 HH21 ' HA3' ' A' ' 190' ' ' GLY . 27.8 ptt85 -74.41 84.4 1.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.366 -0.976 . . . . 15.0 108.366 167.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.36 145.92 37.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.783 -1.553 . . . . 15.0 110.689 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 146' ' ' LYS . 55.1 mt -57.47 120.73 42.84 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.984 0.914 . . . . 15.0 110.133 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.25 -165.57 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.903 3.736 . . . . 15.0 113.613 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -46.77 136.51 7.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.773 -1.103 . . . . 15.0 110.461 165.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.0 tp -140.66 37.37 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.137 -1.06 . . . . 15.0 108.137 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.6 m -66.03 161.04 22.43 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.47 1.108 . . . . 15.0 109.922 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.83 -44.88 14.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.88 1.272 . . . . 15.0 112.929 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.82 -27.28 64.74 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.981 -0.554 . . . . 15.0 112.173 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -77.58 -49.18 15.15 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.567 HG13 HD22 ' A' ' 266' ' ' LEU . 12.1 tt -64.52 -32.78 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.381 0.672 . . . . 15.0 110.981 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 258' ' ' VAL . 21.1 ptmt -79.23 -18.47 52.82 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 112.147 0.425 . . . . 15.0 112.147 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -65.58 -24.12 67.0 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 15.0 111.672 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -64.23 -22.77 67.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.283 0.633 . . . . 15.0 111.551 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.5 -1.45 0.73 Allowed Glycine 0 C--N 1.356 1.691 0 CA-C-O 119.845 -0.42 . . . . 15.0 113.853 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 2.9 t -80.82 134.94 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.192 0.597 . . . . 15.0 109.403 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -76.51 -47.68 21.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.7 0.4 . . . . 15.0 111.039 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.69 -36.04 16.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.704 0.288 . . . . 15.0 111.116 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 94.14 22.68 24.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.994 -0.548 . . . . 15.0 113.902 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 29.1 p -70.07 142.56 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 117.532 0.666 . . . . 15.0 110.154 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 253' ' ' ILE . 49.0 t -54.44 -50.91 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.746 0.654 . . . . 15.0 109.283 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.72 -27.45 67.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.034 -0.985 . . . . 15.0 111.44 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.91 -21.1 63.98 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.659 0.599 . . . . 15.0 111.634 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 253' ' ' ILE . 55.7 tp -78.35 -42.29 30.96 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -62.15 -39.44 92.61 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.821 -1.081 . . . . 15.0 110.195 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.54 -43.51 80.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.071 0.948 . . . . 15.0 111.045 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -56.59 -56.98 14.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 141' ' ' LEU . 17.4 m -76.52 -20.22 14.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.363 -0.835 . . . . 15.0 111.534 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -57.41 -63.13 1.33 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.15 -36.77 82.56 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.0 0.37 . . . . 15.0 112.0 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -72.88 -50.02 26.34 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.383 0.673 . . . . 15.0 111.502 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 66.7 mtt -72.04 -28.19 63.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.394 -0.812 . . . . 15.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 47.1 mt-10 -71.09 -26.12 62.91 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 118.881 0.764 . . . . 15.0 111.539 170.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -70.71 -44.63 66.53 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.492 -0.559 . . . . 15.0 109.492 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -62.39 -45.35 93.53 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.572 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 64.9 tp -61.89 -50.88 70.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.025 -1.443 . . . . 15.0 112.175 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.49 -30.86 71.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.52 0.728 . . . . 15.0 110.688 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.5 t -66.12 -45.92 79.4 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.044 -0.725 . . . . 15.0 109.044 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.01 79.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.368 0.667 . . . . 15.0 112.078 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.5 mt -67.03 -45.18 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.775 0.83 . . . . 15.0 109.092 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 23.2 tpt180 -62.05 -46.87 87.22 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.604 -0.725 . . . . 15.0 110.535 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -62.99 -38.5 91.42 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.033 -0.531 . . . . 15.0 110.961 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -56.63 -63.84 1.07 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.66 0.784 . . . . 15.0 110.658 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.05 -46.04 92.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.042 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.1 tttt -64.55 -45.53 86.74 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.844 -0.617 . . . . 15.0 111.105 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.4 p -68.02 -31.9 71.89 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.44 0.296 . . . . 15.0 111.359 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.458 ' HB2' HG13 ' A' ' 125' ' ' VAL . 55.9 mt-30 -73.31 -34.0 65.48 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.354 0.409 . . . . 15.0 111.719 176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.93 62.83 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 110.05 -0.352 . . . . 15.0 110.05 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.95 -42.87 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.358 1.463 . . . . 15.0 110.958 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.91 -59.43 4.9 Favored 'General case' 0 C--O 1.246 0.897 0 C-N-CA 124.227 1.011 . . . . 15.0 110.231 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.632 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.52 -32.77 79.66 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.918 -1.037 . . . . 15.0 113.295 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.703 ' HB3' HD13 ' A' ' 350' ' ' LEU . 9.9 mt -59.85 -53.97 51.74 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 15.0 111.0 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.3 -44.73 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.83 -0.433 . . . . 15.0 109.83 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.18 -32.78 66.78 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.853 0.861 . . . . 15.0 111.746 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.4 -29.95 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.462 0.705 . . . . 15.0 111.611 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -131.92 123.44 27.44 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.096 0.474 . . . . 15.0 111.903 -162.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.58 148.95 26.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.324 1.05 . . . . 15.0 109.363 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.641 HD13 HD13 ' A' ' 349' ' ' LEU . 14.2 tt -162.87 148.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.514 0.726 . . . . 15.0 110.106 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.85 131.94 42.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.472 HG13 HG11 ' A' ' 345' ' ' VAL . 71.2 t -119.88 126.06 27.07 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.259 0.624 . . . . 15.0 111.153 -165.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.86 136.82 17.11 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.692 2.261 . . . . 15.0 112.475 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.55 -15.18 57.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.624 1.17 . . . . 15.0 113.337 -174.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.13 64.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.756 0.822 . . . . 15.0 110.703 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' B' ' 467' ' ' ALA . 71.7 mt -71.45 -38.43 71.32 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 114.121 -1.4 . . . . 15.0 110.442 -175.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 304' ' ' ALA . 55.2 mt -57.28 -50.5 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.233 -1.349 . . . . 15.0 108.516 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.36 -32.35 73.92 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.216 0.948 . . . . 15.0 111.451 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 73.4 m -62.33 -52.88 61.89 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.671 0.389 . . . . 15.0 111.882 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.4 -35.44 79.31 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.561 -0.29 . . . . 15.0 111.124 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.591 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.0 mt -61.65 -38.35 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.416 -0.587 . . . . 15.0 109.416 173.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.469 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 9.1 t70 -64.44 -46.42 83.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.752 0.821 . . . . 15.0 109.423 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.02 -40.77 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 124.155 0.91 . . . . 15.0 110.259 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.55 -19.26 60.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.377 0.671 . . . . 15.0 112.32 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 21.7 mtm180 . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 123.795 0.838 . . . . 15.0 109.811 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 CA--C 1.554 1.131 0 N-CA-C 111.811 0.3 . . . . 15.0 111.811 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.75 -16.17 45.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.678 0.791 . . . . 15.0 112.001 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 67.2 mt -53.06 125.89 42.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.812 0.445 . . . . 15.0 111.973 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.484 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 84.0 Cg_exo -46.48 120.24 3.73 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.659 3.572 . . . . 15.0 115.453 -166.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.591 ' HG3' HD13 ' A' ' 311' ' ' ILE . 68.6 ttt180 -55.93 -37.04 68.41 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.922 0.889 . . . . 15.0 112.061 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -63.38 -17.31 62.48 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.319 0.648 . . . . 15.0 112.465 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 89.1 mt -73.51 -32.27 64.17 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.368 0.604 . . . . 15.0 110.34 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.491 ' HA ' HE21 ' A' ' 340' ' ' GLN . 22.7 m-85 -115.62 -6.07 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.971 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -47.19 -71.79 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.222 1.409 . . . . 15.0 113.166 -173.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.54 -51.74 68.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.625 0.77 . . . . 15.0 111.686 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.491 HE21 ' HA ' ' A' ' 337' ' ' PHE . 20.9 pt20 -61.72 -45.93 91.81 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.774 0.671 . . . . 15.0 112.043 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.97 56.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.484 . . . . 15.0 110.346 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.19 -34.88 64.26 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.572 0.749 . . . . 15.0 111.027 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -70.95 -35.29 72.13 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.239 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -66.93 -28.65 68.47 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.158 0.286 . . . . 15.0 110.266 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 302' ' ' VAL . 46.2 t -69.6 -47.55 70.81 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.228 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 67.4 t -51.81 -48.44 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.613 -0.884 . . . . 15.0 108.613 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.73 -43.14 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.201 1.001 . . . . 15.0 111.741 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.91 -34.77 90.82 Favored Glycine 0 N--CA 1.472 1.083 0 O-C-N 123.233 0.333 . . . . 15.0 112.851 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.641 HD13 HD13 ' A' ' 300' ' ' ILE . 65.8 mt -76.46 -38.77 54.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.657 0.783 . . . . 15.0 109.764 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.703 HD13 ' HB3' ' A' ' 294' ' ' LEU . 81.3 mt -62.14 -62.05 2.04 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.451 1.101 . . . . 15.0 110.555 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.96 -30.77 71.83 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.26 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.63 95.74 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.866 0.729 . . . . 15.0 111.996 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.13 -34.17 77.44 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.109 -0.545 . . . . 15.0 110.766 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.0 t -67.06 -40.86 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.632 0.373 . . . . 15.0 110.484 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.21 -38.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.599 0.759 . . . . 15.0 110.055 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -70.28 -53.94 14.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.16 0.288 . . . . 15.0 111.518 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -61.45 -35.08 76.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.042 0.937 . . . . 15.0 111.836 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -102.13 10.52 39.38 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 118.962 -0.542 . . . . 15.0 111.348 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 36.83 40.17 0.13 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 126.489 1.916 . . . . 15.0 114.495 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.84 133.36 50.78 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.316 1.046 . . . . 15.0 112.24 -170.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -109.28 142.21 40.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.751 0.82 . . . . 15.0 109.785 176.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.55 115.36 8.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.752 0.421 . . . . 15.0 110.35 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.23 127.94 34.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 15.0 111.408 -171.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.45 -34.38 76.69 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.306 1.042 . . . . 15.0 113.481 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -71.77 -26.64 62.52 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.108 0.255 . . . . 15.0 110.641 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -76.16 -44.95 35.84 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.017 -0.734 . . . . 15.0 109.017 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 398' ' ' MET . 60.9 t -52.28 -56.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.407 1.083 . . . . 15.0 110.341 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.7 -40.37 92.2 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.122 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.17 -40.78 97.7 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.621 0.575 . . . . 15.0 113.336 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 73.6 mt -61.73 -51.7 67.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.686 0.794 . . . . 15.0 109.549 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' A' ' 398' ' ' MET . 34.5 mm -47.54 -56.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.589 1.181 . . . . 15.0 111.216 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.21 -61.32 2.55 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.459 -0.791 . . . . 15.0 111.637 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.12 -24.5 61.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.151 0.797 . . . . 15.0 113.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -78.03 -46.96 19.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.639 0.654 . . . . 15.0 109.304 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -69.48 -32.35 71.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.828 0.451 . . . . 15.0 111.292 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.8 t -63.88 -18.26 64.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.561 0.745 . . . . 15.0 112.214 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.91 66.74 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.289 0.636 . . . . 15.0 111.3 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -97.9 -175.02 3.03 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.696 -0.684 . . . . 15.0 111.01 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.94 -56.19 24.04 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.974 0.91 . . . . 15.0 111.517 -168.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -131.15 116.09 16.59 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.442 -0.799 . . . . 15.0 109.494 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 22.2 Cg_exo -68.23 -37.81 13.4 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.649 2.232 . . . . 15.0 113.227 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -54.82 -48.04 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.301 1.041 . . . . 15.0 111.873 -164.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.23 -28.2 68.55 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.57 -1.195 . . . . 15.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.33 -41.4 30.07 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 C-N-CA 123.573 0.749 . . . . 15.0 109.541 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.67 -48.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.28 -33.39 65.2 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.302 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -70.4 -24.32 62.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.3 0.64 . . . . 15.0 111.068 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.455 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 23.7 m-85 -92.68 -56.14 3.12 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.053 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . 0.662 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -58.66 -43.64 89.93 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 112.526 0.565 . . . . 15.0 112.526 -170.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -87.22 3.83 44.97 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.348 0.659 . . . . 15.0 111.963 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -129.44 90.75 3.05 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.547 -0.908 . . . . 15.0 108.547 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -54.22 -34.57 60.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.388 1.075 . . . . 15.0 112.16 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.2 -43.58 82.86 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.806 0.842 . . . . 15.0 110.841 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.81 -24.34 17.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 15.0 111.291 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.9 OUTLIER -62.94 -37.25 86.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.79 0.836 . . . . 15.0 109.741 176.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.63 -44.4 94.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.496 -1.229 . . . . 15.0 109.843 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.95 -32.05 69.27 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.212 0.605 . . . . 15.0 111.427 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 367' ' ' VAL . 31.5 tpp -69.7 -31.24 69.15 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.441 0.463 . . . . 15.0 111.774 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -67.66 -38.76 84.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 110.135 -0.32 . . . . 15.0 110.135 168.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 400' ' ' ASN . 0.8 OUTLIER -65.52 -48.1 73.67 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.562 0.745 . . . . 15.0 111.408 -176.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 8.3 p -67.49 -37.86 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 123.634 0.584 . . . . 15.0 110.174 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.01 85.34 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.69 0.757 . . . . 15.0 110.502 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 16.7 tp -68.57 -32.76 72.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.076 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.9 tt0 -67.2 -38.1 84.75 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.867 0.467 . . . . 15.0 110.028 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 60.9 mm-40 -62.7 -41.51 99.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.845 0.458 . . . . 15.0 110.019 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -66.74 -39.0 87.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.051 -0.977 . . . . 15.0 111.734 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.02 -42.23 99.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.849 0.718 . . . . 15.0 110.327 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 287' ' ' LYS . 64.4 t -59.36 -54.04 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.548 173.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.407 ' HA ' HD12 ' A' ' 412' ' ' LEU . 80.0 mt-10 -62.01 -28.07 69.32 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.459 0.704 . . . . 15.0 112.88 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.44 71.87 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.793 0.437 . . . . 15.0 110.297 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.85 -32.54 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.223 -0.658 . . . . 15.0 109.223 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 409' ' ' GLU . 93.4 mt -63.28 -43.77 96.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.33 0.652 . . . . 15.0 110.65 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.88 -25.63 65.24 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.599 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 26.1 mtpp -94.85 -22.4 18.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.408 1.083 . . . . 15.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.47 13.18 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.075 0.95 . . . . 15.0 113.211 -171.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 85.7 mttt -77.74 77.3 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.402 1.081 . . . . 15.0 109.459 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 125' ' ' VAL . 38.1 t -91.62 91.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.3 t -71.01 95.37 1.18 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 122.298 1.047 . . . . 15.0 110.448 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.87 117.32 19.86 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.245 -1.343 . . . . 15.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -122.58 157.52 31.95 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.942 0.897 . . . . 15.0 109.064 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.39 117.57 32.13 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -143.95 176.36 9.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.523 0.329 . . . . 15.0 110.611 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.8 p -101.03 159.83 14.89 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.268 1.027 . . . . 15.0 111.128 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.76 -31.57 69.77 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.979 1.311 . . . . 15.0 110.976 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.577 ' HA ' HD22 ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.96 -9.2 27.76 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.363 -0.835 . . . . 15.0 112.299 178.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.91 -73.34 0.57 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 170.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 35.3 tp -36.99 -59.15 0.73 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 125.323 1.449 . . . . 15.0 114.871 -158.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -35.18 13.99 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.07 0.548 . . . . 15.0 110.819 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.577 HD22 ' HA ' ' A' ' 425' ' ' ASN . 73.0 m-20 . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 123.474 0.71 . . . . 15.0 111.85 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.409 0.623 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.32 130.56 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.124 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -140.5 162.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.222 1.409 . . . . 0.0 109.077 169.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 177' ' ' PHE . 97.3 t . . . . . 0 N--CA 1.495 1.8 0 C-N-CA 124.081 0.952 . . . . 0.0 112.405 -163.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.209 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 18.5 p90 . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 123.36 0.664 . . . . 0.0 110.412 -175.021 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 35.9 t80 58.57 103.31 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.583 1.553 . . . . 0.0 109.435 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 35.9 t80 65.22 -172.44 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.2 m -141.15 104.47 4.64 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.94 21.34 4.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.922 0.889 . . . . 0.0 111.368 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 70.4 -175.54 0.19 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.974 1.31 . . . . 0.0 111.168 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 68.87 -61.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.074 1.35 . . . . 0.0 110.107 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . 0.489 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 124.29 1.036 . . . . 0.0 108.505 163.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.025 0.44 . . . . 15.0 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -146.68 146.99 30.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.588 -0.893 . . . . 15.0 108.588 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -137.55 148.72 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.942 0.897 . . . . 15.0 109.467 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.463 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 55.6 p -126.2 101.16 6.63 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.96 77.21 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.682 1.229 . . . . 15.0 110.569 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 46.3 mt-10 -75.77 173.45 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.662 -1.154 . . . . 15.0 109.758 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 77.6 m -143.49 112.8 6.82 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.392 -0.966 . . . . 15.0 108.392 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -78.39 -41.3 33.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.431 0.693 . . . . 15.0 110.562 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -164.04 84.46 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.822 0.849 . . . . 15.0 109.512 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.77 -94.76 0.07 OUTLIER Glycine 0 C--N 1.354 1.531 0 O-C-N 123.825 0.703 . . . . 15.0 113.671 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.6 mp -62.07 -50.21 72.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.526 1.13 . . . . 15.0 110.602 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.8 86.5 0.21 Allowed Glycine 0 C--N 1.346 1.113 0 O-C-N 124.195 0.934 . . . . 15.0 112.11 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 98.7 mtt180 -99.78 134.04 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.293 1.037 . . . . 15.0 110.378 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.5 ttm180 -103.01 88.27 3.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.282 1.033 . . . . 15.0 110.737 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -81.57 91.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.3 m -75.98 100.41 4.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.853 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 51.6 mt -87.98 109.38 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.97 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -84.95 94.24 8.74 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.995 -0.743 . . . . 15.0 108.995 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 70' ' ' LEU . 43.4 mt -73.32 106.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.963 -1.125 . . . . 15.0 107.963 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 150.79 44.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 122.556 0.342 . . . . 15.0 111.315 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.51 -16.88 58.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.603 1.161 . . . . 15.0 114.096 -169.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -64.71 -44.84 88.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.225 0.61 . . . . 15.0 110.429 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.4 m -75.13 -36.79 61.57 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 115.44 -0.8 . . . . 15.0 110.776 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 103' ' ' PHE . 57.9 mt -62.39 -50.58 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.702 0.626 . . . . 15.0 109.881 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -57.53 -50.49 72.92 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.067 0.947 . . . . 15.0 111.098 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.5 m -65.4 -37.77 87.97 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.218 -0.901 . . . . 15.0 111.742 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.28 63.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.123 0.569 . . . . 15.0 112.128 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.794 HG21 ' HD3' ' A' ' 63' ' ' ARG . 93.7 t -65.32 -41.63 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -65.52 -34.99 79.54 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.509 1.124 . . . . 15.0 110.759 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -39.08 91.1 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.55 0.74 . . . . 15.0 110.05 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -74.82 -25.77 59.26 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.524 0.515 . . . . 15.0 111.387 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD11 ' HA3' ' A' ' 59' ' ' GLY . 94.0 mt -73.09 -38.76 66.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.808 0.443 . . . . 15.0 110.983 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.45 -19.6 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 O-C-N 123.158 0.286 . . . . 15.0 110.329 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.18 -57.7 8.74 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.11 -38.53 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.198 0.999 . . . . 15.0 111.365 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.191 0.596 . . . . 15.0 110.559 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.17 -26.68 35.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.814 0.446 . . . . 15.0 112.095 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -77.32 -35.17 55.06 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.711 1.204 . . . . 15.0 110.935 -173.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.64 5.44 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.788 0.835 . . . . 15.0 109.531 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 65.66 22.39 11.64 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.838 1.655 . . . . 15.0 112.601 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 54.0 mt -78.24 -19.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.448 1.099 . . . . 15.0 111.261 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.26 -30.2 71.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.682 0.793 . . . . 15.0 112.061 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.19 -23.76 73.21 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.59 0.556 . . . . 15.0 112.844 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 88.9 m-85 -83.68 -24.0 31.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.462 0.705 . . . . 15.0 110.78 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -79.53 88.47 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -92.14 50.06 1.6 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.589 0.755 . . . . 15.0 110.384 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.3 67.68 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.633 -0.712 . . . . 15.0 113.129 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -73.25 -58.79 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.633 0.773 . . . . 15.0 110.147 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.4 t -101.11 122.11 49.7 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.846 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 53' ' ' ILE . 73.6 Cg_exo -53.54 138.92 66.74 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.063 2.509 . . . . 15.0 112.409 167.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.8 tpt -70.48 -25.26 63.08 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.817 0.847 . . . . 15.0 112.078 -171.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -70.63 -28.79 65.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.549 0.34 . . . . 15.0 111.163 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.491 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.9 mt -65.44 -53.02 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.817 . . . . 15.0 110.241 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 30.1 m -69.1 -16.98 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 111.92 0.341 . . . . 15.0 111.92 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -73.65 -65.58 0.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.513 0.725 . . . . 15.0 112.0 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -73.97 -33.79 64.0 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.672 -0.695 . . . . 15.0 111.93 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -87.49 -73.97 0.46 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.798 0.439 . . . . 15.0 110.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 96.5 m-85 -72.52 -28.1 62.65 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.044 0.537 . . . . 15.0 111.814 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -86.17 10.2 67.0 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.733 -0.481 . . . . 15.0 113.607 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.47 66.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 15.0 111.896 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 p -84.04 -36.37 23.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.185 0.994 . . . . 15.0 111.059 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.84 -18.78 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.306 1.042 . . . . 15.0 111.218 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.794 ' HD3' HG21 ' A' ' 28' ' ' VAL . 20.9 mmt180 -49.88 -42.67 48.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.42 1.088 . . . . 15.0 111.917 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -49.32 -57.58 6.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.882 1.273 . . . . 15.0 112.317 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.72 -33.39 53.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.638 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' A' ' 28' ' ' VAL . 66.6 t -68.07 -28.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.2 mt -56.49 -41.95 77.5 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.56 0.344 . . . . 15.0 110.75 173.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.18 -46.74 93.87 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.793 0.683 . . . . 15.0 112.72 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.55 -38.94 89.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.306 1.042 . . . . 15.0 111.583 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 19' ' ' ILE . 57.3 mt -65.46 -41.58 93.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.93 0.892 . . . . 15.0 110.651 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 64.5 mtm -64.0 -38.38 90.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.083 0.553 . . . . 15.0 110.682 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -64.76 -52.7 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.408 -0.815 . . . . 15.0 110.976 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 mtm105 -74.91 -30.69 61.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.639 -0.71 . . . . 15.0 112.575 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.49 -32.88 54.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.605 0.362 . . . . 15.0 110.513 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.78 -51.39 27.3 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.282 0.364 . . . . 15.0 110.95 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.45 -33.34 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 123.272 0.357 . . . . 15.0 110.261 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.06 -44.84 96.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.579 0.751 . . . . 15.0 110.428 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.18 -53.03 55.71 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.698 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 pt -65.4 -22.19 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -74.94 -51.83 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 15.0 110.196 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -75.4 -25.32 57.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.695 0.398 . . . . 15.0 111.881 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -89.45 -21.57 22.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.29 0.636 . . . . 15.0 110.544 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 62.96 19.74 11.8 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.707 1.203 . . . . 15.0 112.01 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -104.49 85.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.74 141.66 41.64 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.015 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.78 128.35 18.76 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.682 2.255 . . . . 15.0 112.211 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.63 72.83 4.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.414 0.686 . . . . 15.0 109.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.6 -98.67 0.69 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.534 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.46 138.18 31.86 Favored Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 123.289 0.636 . . . . 15.0 112.248 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -95.09 132.03 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.784 2.989 . . . . 15.0 113.27 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -96.38 105.73 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.405 ' HD2' ' HE2' ' A' ' 105' ' ' TYR . 68.1 m-85 -83.45 118.19 23.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.49 90.8 4.32 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.017 0.927 . . . . 15.0 108.594 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.5 119.8 5.65 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.77 2.314 . . . . 15.0 112.44 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.38 -80.21 0.31 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.636 -0.585 . . . . 15.0 111.636 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.42 170.43 8.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.695 0.798 . . . . 15.0 110.332 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -136.35 136.12 39.41 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.273 1.029 . . . . 15.0 109.255 174.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -115.5 137.17 52.34 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.437 -1.32 . . . . 15.0 107.437 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.5 tp -57.22 113.63 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.759 0.824 . . . . 15.0 111.132 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.38 18.53 60.34 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.788 0.68 . . . . 15.0 113.184 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 102' ' ' ASP . 28.1 tt0 -126.58 166.77 16.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.59 0.756 . . . . 15.0 109.382 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 2.9 m-20 -73.02 133.04 44.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.212 1.005 . . . . 15.0 110.703 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.492 ' H ' HD11 ' A' ' 24' ' ' ILE . 39.5 t80 -83.52 143.6 30.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.431 0.693 . . . . 15.0 109.398 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.5 m -140.45 135.76 32.32 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.132 0.573 . . . . 15.0 109.645 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.405 ' HE2' ' HD2' ' A' ' 92' ' ' TYR . 8.2 p90 -157.04 156.57 33.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.013 0.925 . . . . 15.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.1 m -111.37 108.93 18.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.473 1.109 . . . . 15.0 111.192 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.28 97.88 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.41 99.84 12.72 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.648 0.779 . . . . 15.0 109.46 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.55 149.19 45.56 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 15.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.92 140.58 30.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.711 0.804 . . . . 15.0 109.302 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 11' ' ' LEU . 15.5 m -109.72 179.42 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.236 0.614 . . . . 15.0 110.728 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.84 113.28 31.29 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.86 0.864 . . . . 15.0 110.034 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.673 ' HB2' HD11 ' A' ' 300' ' ' ILE . 84.2 Cg_endo -82.68 115.62 2.48 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.345 2.03 . . . . 15.0 112.887 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -71.32 89.1 0.88 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.216 1.006 . . . . 15.0 109.064 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.2 131.0 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.219 -168.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -80.12 109.75 14.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.869 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.19 147.9 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.996 0.81 . . . . 15.0 110.465 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.54 158.69 21.07 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.965 0.906 . . . . 15.0 109.739 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 68.28 22.6 74.67 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.629 -0.714 . . . . 15.0 113.843 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.3 mt -68.06 -45.49 73.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.58 1.152 . . . . 15.0 110.673 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.07 -27.87 63.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.647 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.09 -17.55 60.93 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.879 0.472 . . . . 15.0 111.803 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 119' ' ' GLY . 57.4 mt -64.78 120.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.638 0.375 . . . . 15.0 110.332 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.22 109.18 21.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.604 -0.887 . . . . 15.0 108.604 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.0 t -110.7 150.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -87.31 109.44 25.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.205 1.002 . . . . 15.0 109.729 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 68.6 Cg_endo -92.44 104.62 0.2 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.492 2.128 . . . . 15.0 112.282 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 127' ' ' LYS . 50.2 mm -70.44 89.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 422' ' ' THR . 41.4 t -108.81 135.28 48.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.677 -1.147 . . . . 15.0 109.467 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -122.9 154.54 38.2 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.409 -1.33 . . . . 15.0 107.409 160.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.468 HG23 HD22 ' A' ' 278' ' ' LEU . 34.9 t -81.42 84.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 107.591 -1.263 . . . . 15.0 107.591 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.6 p -63.25 176.39 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.139 0.976 . . . . 15.0 110.744 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.18 -40.21 76.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.065 0.459 . . . . 15.0 111.086 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.98 98.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.178 -0.919 . . . . 15.0 110.975 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -74.0 -39.83 63.35 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.009 0.524 . . . . 15.0 111.721 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 t -60.29 -62.54 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.103 0 C-N-CA 124.546 1.138 . . . . 15.0 108.734 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.99 -27.28 43.35 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 114.13 -1.396 . . . . 15.0 110.693 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.96 -36.13 47.83 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.749 0.656 . . . . 15.0 113.414 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -71.74 -47.42 53.88 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.008 -0.367 . . . . 15.0 110.008 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.605 HD21 HG11 ' A' ' 270' ' ' VAL . 57.1 mt -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.944 0.498 . . . . 15.0 111.915 167.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.38 -45.32 93.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.152 0.981 . . . . 15.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -63.5 -40.17 96.36 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.029 0.83 . . . . 15.0 110.917 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.23 -42.84 99.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.39 0.676 . . . . 15.0 110.938 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.661 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.2 mtp180 -68.62 -29.31 67.79 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.453 -0.794 . . . . 15.0 110.607 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.1 mttt -80.94 -15.61 55.78 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.103 0.561 . . . . 15.0 111.937 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -83.34 -31.12 26.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.69 0.396 . . . . 15.0 110.219 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -104.35 34.58 3.03 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.723 0.809 . . . . 15.0 110.616 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -78.1 156.34 30.02 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.734 1.383 . . . . 15.0 114.734 -166.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.8 m -92.39 128.69 38.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.292 -1.322 . . . . 15.0 108.784 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -84.71 108.32 17.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -123.75 126.49 46.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.277 1.031 . . . . 15.0 110.047 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 74.4 mt-10 -75.72 117.67 17.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.455 -0.572 . . . . 15.0 109.455 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.684 ' HG3' HG12 ' A' ' 240' ' ' VAL . 36.8 pttt -104.61 178.86 4.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.494 0.718 . . . . 15.0 110.735 173.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.65 141.74 43.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.685 0.794 . . . . 15.0 109.335 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.17 -51.06 0.8 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.483 -0.621 . . . . 15.0 113.845 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 146.91 24.1 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.82 0.81 . . . . 15.0 112.479 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 43.0 t -105.29 155.49 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.668 1.187 . . . . 15.0 108.408 168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 160' ' ' ALA . 16.8 tt0 -148.5 -175.15 4.81 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.855 0.862 . . . . 15.0 109.043 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.5 ' H ' ' HG2' ' A' ' 159' ' ' GLU . . . -73.19 -25.54 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.809 1.411 . . . . 15.0 114.809 -164.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -111.22 26.01 11.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.206 0.602 . . . . 15.0 110.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.5 -165.52 1.24 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.664 0.745 . . . . 15.0 112.753 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' A' ' 188' ' ' ALA . 0.3 OUTLIER -139.23 135.18 33.65 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.796 -1.927 . . . . 15.0 105.796 -176.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.28 156.23 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.6 m -129.14 126.51 39.45 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.593 -1.262 . . . . 15.0 107.593 161.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.654 HG22 HD23 ' A' ' 237' ' ' LEU . 28.3 pt -125.05 176.33 6.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.342 1.057 . . . . 15.0 110.791 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.68 122.65 12.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.373 -1.714 . . . . 15.0 106.373 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' B' ' 385' ' ' LEU . 29.3 p90 -140.6 160.81 39.21 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.68 0.752 . . . . 15.0 112.667 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.6 t -141.28 115.73 9.5 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.853 -1.521 . . . . 15.0 108.435 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -89.17 161.93 30.61 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.015 -0.539 . . . . 15.0 113.425 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 m -151.28 127.97 10.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.066 0.947 . . . . 15.0 108.593 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 231' ' ' ALA . 58.0 t -107.81 134.31 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.618 0.767 . . . . 15.0 109.207 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 t70 70.53 3.81 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.202 1.001 . . . . 15.0 112.569 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.27 -3.0 16.27 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.522 -0.599 . . . . 15.0 114.002 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.13 166.59 24.95 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.43 0.692 . . . . 15.0 109.665 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -62.33 175.26 0.77 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 121.704 0.764 . . . . 15.0 111.477 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.632 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 1.7 p90 -149.82 170.35 18.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.103 0.961 . . . . 15.0 109.142 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' B' ' 388' ' ' VAL . 1.9 pm0 -59.72 116.62 4.19 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.929 0.768 . . . . 15.0 109.42 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.89 80.59 0.68 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.354 -1.498 . . . . 15.0 109.354 -163.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -102.81 -15.75 23.59 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.166 -0.797 . . . . 15.0 113.492 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -140.65 146.81 38.39 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 117.925 0.862 . . . . 15.0 112.335 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.15 93.35 2.43 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.448 -1.316 . . . . 15.0 107.448 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.8 m -81.98 138.85 34.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.825 -1.079 . . . . 15.0 110.944 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 62.64 22.55 13.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.07 0.948 . . . . 15.0 113.061 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD2' HD11 ' B' ' 385' ' ' LEU . 83.6 t80 -66.22 138.99 58.07 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.588 0.232 . . . . 15.0 110.863 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.35 109.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.952 0.901 . . . . 15.0 109.754 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 202' ' ' ILE . 26.4 tp -93.58 90.33 6.61 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.404 0.682 . . . . 15.0 111.347 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.428 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -83.57 92.87 7.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.406 ' HG2' ' HG ' ' A' ' 187' ' ' LEU . 17.7 mtp -54.57 128.62 33.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.591 0.756 . . . . 15.0 112.311 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.63 -26.94 5.33 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 -165.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.73 129.13 37.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.487 0.715 . . . . 15.0 109.744 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.2 72.47 0.23 Allowed Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.483 0.489 . . . . 15.0 112.571 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -125.99 22.22 7.38 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.266 0.627 . . . . 15.0 111.279 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.561 ' HB3' HD23 ' B' ' 385' ' ' LEU . 1.6 pmm? -140.77 171.35 14.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.467 0.707 . . . . 15.0 109.973 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.3 pt -100.69 157.28 34.01 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.784 0.834 . . . . 15.0 110.239 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.33 147.1 86.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.676 2.25 . . . . 15.0 112.229 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.78 -46.87 1.45 Allowed Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.4 -0.68 . . . . 15.0 111.4 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -63.63 -51.82 63.52 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.18 -41.97 80.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.618 -1.173 . . . . 15.0 111.662 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.32 -33.08 75.12 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.307 1.043 . . . . 15.0 110.873 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -78.35 -13.73 82.95 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.268 -0.878 . . . . 15.0 113.286 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.461 HG21 HD23 ' A' ' 187' ' ' LEU . 34.3 mm -90.39 -51.59 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.282 -0.636 . . . . 15.0 109.282 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -84.52 21.48 1.47 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.774 -166.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.44 32.34 2.07 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.24 -0.744 . . . . 15.0 111.24 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -147.12 -174.24 4.45 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.2 1.0 . . . . 15.0 110.329 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 21.5 pttp -146.69 159.85 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.726 0.81 . . . . 15.0 110.349 -174.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -67.54 152.51 45.53 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.452 0.569 . . . . 15.0 112.287 -171.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.65 -41.29 2.17 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.56 -0.745 . . . . 15.0 111.766 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.2 pt-20 -76.61 114.18 15.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.797 0.808 . . . . 15.0 108.937 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.96 104.2 16.21 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.004 -1.48 . . . . 15.0 107.004 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.02 -169.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.42 1.088 . . . . 15.0 109.295 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.6 t -133.28 141.46 48.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.23 -1.026 . . . . 15.0 108.23 168.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 47.0 pt -104.71 139.36 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -102.0 104.01 14.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.707 -0.849 . . . . 15.0 108.707 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.1 t -97.56 158.36 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.547 -1.279 . . . . 15.0 107.547 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -131.81 129.38 40.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.078 -1.082 . . . . 15.0 108.078 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -78.55 124.46 85.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.564 0.745 . . . . 15.0 110.008 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -51.04 165.99 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.928 3.086 . . . . 15.0 115.403 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -27.76 62.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.61 -0.723 . . . . 15.0 109.724 168.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.86 -17.14 59.16 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.952 1.301 . . . . 15.0 111.451 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.475 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 64.9 t80 -63.04 133.58 54.77 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.914 0.886 . . . . 15.0 110.327 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -76.97 -42.6 38.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.346 1.239 . . . . 15.0 114.346 -166.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.475 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -70.72 100.21 1.84 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.33 -23.41 60.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.676 0.79 . . . . 15.0 112.835 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.48 -24.89 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.654 0.382 . . . . 15.0 110.906 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.57 HD11 ' H ' ' B' ' 388' ' ' VAL . 40.7 mt -93.7 -33.68 13.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.945 0.898 . . . . 15.0 111.643 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.33 116.41 1.87 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.59 1.156 . . . . 15.0 111.542 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.56 -34.83 4.87 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.45 171.51 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.668 0.787 . . . . 15.0 111.936 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -123.94 138.67 54.44 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.9 -1.045 . . . . 15.0 109.833 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -117.44 131.55 56.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.218 0.607 . . . . 15.0 110.127 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 65.7 mttm -98.12 116.22 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.744 -1.206 . . . . 15.0 107.744 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 99.3 m-85 -108.81 114.24 27.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -75.92 89.66 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 15.0 110.231 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 mm -82.01 115.85 25.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.425 0.69 . . . . 15.0 109.669 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -103.73 101.17 11.0 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.526 -1.287 . . . . 15.0 107.526 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 166' ' ' ILE . 88.2 mt -76.9 93.21 3.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -85.34 -31.81 22.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.301 -0.863 . . . . 15.0 110.531 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -132.66 123.43 26.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.174 0.59 . . . . 15.0 110.907 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 207' ' ' ALA . 88.9 t -101.29 105.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.675 -1.972 . . . . 15.0 105.675 160.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 31.9 mt-10 -113.23 -174.94 2.56 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.5 tt0 -155.88 126.67 6.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -73.8 83.12 1.64 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 163.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.49 148.16 39.22 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 113.494 -1.685 . . . . 15.0 110.813 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.93 121.57 59.44 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.544 0.738 . . . . 15.0 110.42 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 91.0 Cg_endo -75.54 -167.95 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.538 2.826 . . . . 15.0 111.965 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 249' ' ' THR . 39.9 tt0 -55.78 147.15 19.53 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.323 0.649 . . . . 15.0 111.22 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.4 tp -147.33 25.94 1.08 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.699 1.2 . . . . 15.0 108.047 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.451 ' H ' ' HG2' ' A' ' 247' ' ' GLU . 6.3 m -73.76 164.83 26.12 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.682 -1.145 . . . . 15.0 109.192 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -36.83 -51.88 0.91 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.801 1.64 . . . . 15.0 114.492 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -67.62 -30.13 69.63 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -80.23 -55.61 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.895 0.478 . . . . 15.0 109.976 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.721 HG13 HD22 ' A' ' 266' ' ' LEU . 12.9 tt -63.87 -28.94 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.829 0.852 . . . . 15.0 112.494 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -66.1 -27.52 68.12 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 112.005 0.372 . . . . 15.0 112.005 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.59 -19.64 65.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.59 0.756 . . . . 15.0 111.976 -172.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -68.66 -23.98 64.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.831 0.453 . . . . 15.0 111.835 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.94 -22.48 1.44 Allowed Glycine 0 C--N 1.351 1.415 0 O-C-N 122.944 0.152 . . . . 15.0 112.771 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 261' ' ' GLY . 21.5 t -68.14 133.15 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 15.0 110.071 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.64 -60.98 2.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.78 0.432 . . . . 15.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.75 -36.1 32.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.072 0.549 . . . . 15.0 111.074 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 98.88 36.09 4.62 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.476 -0.784 . . . . 15.0 112.755 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 p -78.44 139.45 38.72 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.645 0.723 . . . . 15.0 110.362 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 62.3 t -57.16 -58.77 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.189 0.996 . . . . 15.0 110.789 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.33 -15.4 47.85 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.729 0.812 . . . . 15.0 112.108 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.14 -32.84 37.97 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 253' ' ' ILE . 56.3 tp -75.84 -38.51 57.97 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.787 -0.449 . . . . 15.0 109.787 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 39.2 mtp-105 -62.9 -39.58 94.94 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.539 0.524 . . . . 15.0 109.639 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.93 73.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 110.992 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.37 -50.35 73.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.022 0.929 . . . . 15.0 111.196 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.605 HG11 HD21 ' A' ' 141' ' ' LEU . 21.6 m -75.97 -25.13 16.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.235 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -57.79 -60.89 3.01 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.106 -0.701 . . . . 15.0 109.106 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -64.61 -37.56 88.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.916 0.71 . . . . 15.0 112.916 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.92 -51.81 23.79 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 117.966 0.348 . . . . 15.0 111.274 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.21 -30.13 70.99 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 118.582 -0.723 . . . . 15.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.62 -30.06 59.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.443 0.534 . . . . 15.0 112.443 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -64.4 -44.2 92.02 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.272 -0.64 . . . . 15.0 109.272 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.92 -38.17 79.37 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.593 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.496 HD12 HD23 ' A' ' 427' ' ' LEU . 22.5 tp -60.65 -47.04 88.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.647 1.179 . . . . 15.0 111.638 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -59.85 -40.22 87.8 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.798 0.687 . . . . 15.0 111.053 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.1 t -68.11 -33.9 75.37 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.867 0.729 . . . . 15.0 110.401 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -80.36 -32.0 37.82 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 88.2 mt -68.31 -43.08 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -64.04 -40.12 95.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.108 -0.951 . . . . 15.0 109.691 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.78 -46.78 88.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.525 0.73 . . . . 15.0 110.047 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.493 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 8.5 tpt180 -57.05 -63.27 1.27 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.681 1.192 . . . . 15.0 111.128 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.5 -47.47 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.359 1.064 . . . . 15.0 111.5 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 408' ' ' VAL . 86.4 tttt -71.5 -36.76 71.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.745 -0.662 . . . . 15.0 111.437 -175.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -68.55 -37.99 80.4 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 119.357 -0.354 . . . . 15.0 110.39 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -69.85 -35.97 75.16 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.56 0.537 . . . . 15.0 111.673 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.476 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.2 -52.9 60.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.114 0.483 . . . . 15.0 110.712 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.37 -35.02 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.345 1.458 . . . . 15.0 111.248 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.546 ' HA ' HH21 ' A' ' 343' ' ' ARG . 14.0 tp10 -64.04 -53.85 43.43 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -60.12 -39.43 95.83 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 124.598 1.186 . . . . 15.0 112.579 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 -63.5 1.17 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.321 1.048 . . . . 15.0 111.66 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.594 HG11 ' HG2' ' A' ' 343' ' ' ARG . 91.7 t -63.14 -44.07 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 122.481 0.312 . . . . 15.0 110.232 -176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -55.57 -37.33 67.89 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.287 1.035 . . . . 15.0 111.213 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.49 -28.46 37.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.872 0.869 . . . . 15.0 112.344 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -123.18 113.61 19.18 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.802 0.441 . . . . 15.0 111.278 -167.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.59 148.11 26.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.102 -1.073 . . . . 15.0 108.102 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 113' ' ' PRO . 7.4 tt -163.91 153.77 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.622 0.769 . . . . 15.0 109.814 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.45 112.45 7.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.494 -1.299 . . . . 15.0 107.494 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 300' ' ' ILE . 21.8 t -103.97 132.27 21.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.71 0.804 . . . . 15.0 109.46 -172.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.48 ' HG3' HD23 ' A' ' 11' ' ' LEU . 23.6 Cg_exo -62.94 110.59 1.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.699 2.266 . . . . 15.0 112.117 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -54.74 -21.48 11.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.861 1.665 . . . . 15.0 113.104 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.25 29.34 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.232 1.013 . . . . 15.0 111.196 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.698 HD13 ' HA ' ' B' ' 467' ' ' ALA . 75.9 mt -63.01 -38.73 92.35 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.59 0.71 . . . . 15.0 110.011 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 304' ' ' ALA . 77.4 mt -58.62 -48.13 86.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 CA-C-N 114.239 -1.346 . . . . 15.0 109.712 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HA ' HD12 ' A' ' 311' ' ' ILE . 22.9 t70 -63.1 -29.92 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.062 0.851 . . . . 15.0 111.309 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -69.61 -44.79 70.0 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.562 0.345 . . . . 15.0 111.545 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.3 -28.75 66.55 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.481 0.658 . . . . 15.0 111.571 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 334' ' ' ARG . 78.0 mt -64.66 -42.04 93.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 N-CA-C 108.195 -1.039 . . . . 15.0 108.195 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.89 -41.14 90.98 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.37 1.044 . . . . 15.0 110.481 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.28 -50.62 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 123.802 0.689 . . . . 15.0 109.909 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.62 -17.92 62.88 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.127 0.788 . . . . 15.0 113.127 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 123.577 0.751 . . . . 15.0 109.234 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.9 tp . . . . . 0 CA--C 1.561 1.373 0 N-CA-C 112.263 0.468 . . . . 15.0 112.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.17 -22.38 39.0 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.1 0.96 . . . . 15.0 112.174 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.5 mt -52.9 119.6 16.68 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-O 118.091 -0.957 . . . . 15.0 110.317 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.71 107.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 124.588 3.525 . . . . 15.0 113.55 -169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 311' ' ' ILE . 9.0 ptm180 -61.21 -31.32 71.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.782 -1.099 . . . . 15.0 112.572 -170.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.65 -18.11 64.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.222 1.009 . . . . 15.0 112.822 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.49 -37.86 88.04 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.689 0.757 . . . . 15.0 109.73 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.55 ' HB2' HG23 ' A' ' 311' ' ' ILE . 33.2 m-85 -103.38 -20.51 14.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.388 -1.278 . . . . 15.0 111.097 -168.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -54.83 -36.5 65.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.304 1.041 . . . . 15.0 112.976 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.06 -48.06 83.45 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.661 0.384 . . . . 15.0 111.713 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.04 -38.59 44.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.941 0.496 . . . . 15.0 111.358 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.33 -55.17 26.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.393 0.677 . . . . 15.0 110.937 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.543 ' HA ' HG12 ' A' ' 307' ' ' ILE . 86.3 tttt -48.74 -44.34 38.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.692 1.197 . . . . 15.0 111.146 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.594 ' HG2' HG11 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -60.32 -39.26 86.38 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.603 1.19 . . . . 15.0 110.207 178.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -73.18 -28.11 62.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.817 0.281 . . . . 15.0 111.463 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 20.4 t -71.7 -38.24 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.495 -0.558 . . . . 15.0 109.495 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.3 t -59.39 -44.98 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 343' ' ' ARG . 61.1 t -54.22 -46.7 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.82 0.848 . . . . 15.0 110.818 172.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.42 -30.51 75.28 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.433 0.458 . . . . 15.0 113.789 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 300' ' ' ILE . 95.7 mt -74.6 -49.35 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.453 0.701 . . . . 15.0 109.955 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.6 mt -64.06 -54.77 28.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.939 0.896 . . . . 15.0 110.548 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.6 -34.94 78.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.035 0.834 . . . . 15.0 111.098 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.88 -38.61 96.84 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 123.49 0.493 . . . . 15.0 112.611 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.17 -35.12 73.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.371 0.669 . . . . 15.0 110.862 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 350' ' ' LEU . 96.4 t -66.6 -37.33 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.927 0.491 . . . . 15.0 110.218 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 352' ' ' GLY . 76.7 mt -64.26 -42.16 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.352 0.661 . . . . 15.0 110.074 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -60.65 -62.57 1.76 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.827 -0.624 . . . . 15.0 110.096 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.1 m -66.26 -33.8 76.57 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.149 0.98 . . . . 15.0 112.482 -173.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -94.35 11.01 31.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.924 0.49 . . . . 15.0 111.322 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.82 38.58 4.48 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 125.766 1.627 . . . . 15.0 113.888 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.68 147.89 43.25 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.632 0.773 . . . . 15.0 111.85 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 148.51 39.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.229 1.012 . . . . 15.0 108.615 172.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.17 137.39 57.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -172.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 122.07 37.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.042 0.937 . . . . 15.0 109.77 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.65 -46.82 83.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.263 1.025 . . . . 15.0 111.829 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.69 -21.06 61.12 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.082 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 21.1 ttt85 -72.62 -46.66 53.01 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.553 -0.906 . . . . 15.0 108.553 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 399' ' ' ARG . 31.7 t -55.41 -47.52 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 124.55 1.156 . . . . 15.0 109.591 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -51.89 -54.99 22.94 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.237 0.961 . . . . 15.0 111.718 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.73 92.77 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.98 0.8 . . . . 15.0 113.428 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 94.8 mt -60.93 -51.45 69.21 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.515 0.726 . . . . 15.0 110.34 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 367' ' ' VAL . 38.6 mm -54.94 -56.38 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.434 0.694 . . . . 15.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.69 -49.21 78.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.927 -1.488 . . . . 15.0 111.967 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.74 -39.57 64.17 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.615 0.598 . . . . 15.0 112.615 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 56.7 ttp -56.06 -47.49 77.82 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.296 0.639 . . . . 15.0 109.597 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -73.31 -36.42 66.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.8 -1.091 . . . . 15.0 112.183 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 33.5 t -70.55 -12.04 61.32 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.394 0.677 . . . . 15.0 111.811 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.16 -7.95 56.69 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.204 0.601 . . . . 15.0 111.422 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.35 179.53 4.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.225 1.01 . . . . 15.0 110.403 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.01 0.924 . . . . 15.0 110.512 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -114.9 109.89 46.82 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.833 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.709 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 89.3 Cg_endo -80.56 -29.66 2.24 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 121.995 1.796 . . . . 15.0 112.648 168.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.07 -48.54 75.87 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.933 0.893 . . . . 15.0 112.383 -161.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.78 -37.74 85.44 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.992 0.808 . . . . 15.0 110.402 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.46 -46.66 69.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 123.744 0.653 . . . . 15.0 110.087 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -49.3 82.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.06 -12.18 60.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.253 0.621 . . . . 15.0 112.431 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -88.2 -39.66 14.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.212 0.605 . . . . 15.0 111.382 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -86.5 -48.3 8.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.744 0.417 . . . . 15.0 112.083 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.6 p -49.73 -48.04 50.29 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.535 1.134 . . . . 15.0 113.731 -165.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -109.58 14.95 23.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.335 0.654 . . . . 15.0 111.52 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -110.69 88.97 2.9 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.272 -1.381 . . . . 15.0 107.272 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt -66.47 -23.18 66.23 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.413 -0.812 . . . . 15.0 111.691 -170.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.73 -56.88 12.28 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.697 0.799 . . . . 15.0 110.047 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.68 -24.39 58.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.036 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 46.1 tpp -59.52 -46.06 89.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.457 -0.572 . . . . 15.0 109.457 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -54.39 -49.83 68.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.893 0.877 . . . . 15.0 111.462 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.18 -33.83 74.08 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 124.023 0.827 . . . . 15.0 110.976 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.597 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -84.69 -11.97 54.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.392 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 367' ' ' VAL . 50.0 mtp180 -85.87 -24.89 26.51 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -71.16 -40.27 71.42 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.235 0.614 . . . . 15.0 110.066 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.3 p -71.57 -28.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 117.748 0.249 . . . . 15.0 111.254 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -68.57 -37.5 79.93 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.419 0.628 . . . . 15.0 110.553 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.74 -31.38 57.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.284 -0.871 . . . . 15.0 110.493 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 408' ' ' VAL . 29.2 tt0 -59.89 -46.3 89.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.383 1.073 . . . . 15.0 109.596 169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 9.1 mm-40 -53.49 -55.09 28.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.524 1.129 . . . . 15.0 111.487 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -58.76 -37.48 76.33 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.483 -0.78 . . . . 15.0 111.953 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.09 -41.68 97.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 15.0 111.278 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.9 t -58.16 -48.39 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 123.757 0.661 . . . . 15.0 109.534 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 57.1 mt-10 -61.87 -36.86 82.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.896 0.748 . . . . 15.0 111.99 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.11 64.73 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.704 -0.68 . . . . 15.0 111.705 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 54.7 t -88.05 -29.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 290' ' ' ALA . 97.0 mt -72.04 -27.36 62.65 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.417 0.687 . . . . 15.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.97 70.17 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 15.0 110.873 170.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -95.91 -28.3 14.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.373 1.069 . . . . 15.0 111.368 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.85 154.95 21.18 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.955 0.902 . . . . 15.0 110.924 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.88 84.18 5.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.786 0.834 . . . . 15.0 109.645 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.0 t -95.57 89.3 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.262 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -72.51 112.01 8.19 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.216 0.606 . . . . 15.0 110.295 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.24 132.55 36.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.261 0.625 . . . . 15.0 110.153 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -140.83 141.55 34.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.36 0.664 . . . . 15.0 110.212 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.92 125.13 36.51 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 130' ' ' VAL . 9.8 t -157.31 173.72 16.52 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.947 0.499 . . . . 15.0 111.345 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 64.9 p -96.47 174.62 6.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.656 0.783 . . . . 15.0 112.145 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.99 -25.23 57.99 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.47 1.908 . . . . 15.0 111.702 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 429' ' ' ASN . 33.6 m-80 -65.53 -34.24 77.79 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.865 1.266 . . . . 15.0 112.21 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.403 ' HG2' HG21 ' A' ' 422' ' ' THR . 13.0 tp10 -66.68 -37.4 84.69 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.321 0.581 . . . . 15.0 111.739 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.496 HD23 HD12 ' A' ' 278' ' ' LEU . 15.6 tp -85.24 -77.5 0.28 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.377 -0.829 . . . . 15.0 111.124 -165.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.01 -30.51 9.26 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.214 -0.304 . . . . 15.0 111.425 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 425' ' ' ASN . 65.1 t30 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 122.308 1.051 . . . . 15.0 110.5 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.5 mm? . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 13.5 m -64.37 98.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 125.168 1.542 . . . . 0.0 112.311 -164.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.632 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 5.8 pt -125.08 160.64 30.29 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.035 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.57 ' H ' HD11 ' A' ' 226' ' ' LEU . 54.5 t . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 122.755 0.422 . . . . 0.0 110.414 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 0.0 110.489 177.591 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -67.27 -33.56 75.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.23 109.12 4.75 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 61.2 p -77.43 164.66 25.26 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.667 0.787 . . . . 0.0 111.066 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 35.4 mtm -125.15 -178.16 4.11 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.558 0.694 . . . . 0.0 111.696 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -91.46 -175.25 4.16 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.019 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 65.68 -72.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.877 1.271 . . . . 0.0 109.217 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . 0.698 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.522 0.201 . . . . 15.0 110.689 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.1 tt0 -142.71 118.41 10.46 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.909 -0.775 . . . . 15.0 108.909 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 17' ' ' ILE . 26.7 m -106.25 131.96 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.82 -0.437 . . . . 15.0 109.82 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -142.55 94.65 2.67 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.611 0.765 . . . . 15.0 109.217 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -77.2 95.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.184 0.992 . . . . 15.0 110.696 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 48.5 mt-10 -76.21 100.11 4.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.709 -1.132 . . . . 15.0 109.468 173.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -78.43 85.91 4.51 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 107.967 -1.123 . . . . 15.0 107.967 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -61.94 -44.43 96.79 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.685 -1.143 . . . . 15.0 110.749 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -169.36 97.41 0.33 Allowed 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.632 0.582 . . . . 15.0 109.925 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -98.44 0.35 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.747 0.654 . . . . 15.0 113.645 172.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.634 HD21 ' HG3' ' A' ' 113' ' ' PRO . 8.1 mp -69.83 -25.13 63.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.653 0.781 . . . . 15.0 111.311 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.63 79.53 0.69 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.573 0.546 . . . . 15.0 112.832 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HD2' HG11 ' A' ' 111' ' ' VAL . 92.8 mtt180 -99.81 89.99 4.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.6 ttm180 -75.89 95.77 3.59 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.004 -0.998 . . . . 15.0 109.677 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.57 87.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.9 m -82.62 109.74 17.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.813 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 3' ' ' VAL . 53.6 mt -110.58 116.56 52.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.912 -0.586 . . . . 15.0 109.729 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 67.6 m -87.39 105.25 17.14 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.866 -0.79 . . . . 15.0 108.866 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' LEU . 62.4 mt -74.37 126.2 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 147.77 51.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.911 0.485 . . . . 15.0 111.26 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.67 94.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 15.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.71 -30.21 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.116 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -69.13 -38.5 78.89 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.841 0.456 . . . . 15.0 110.369 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.23 -42.41 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -61.55 -42.82 99.4 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.914 0.886 . . . . 15.0 111.101 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -75.48 -35.39 60.84 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.71 62.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.891 0.477 . . . . 15.0 111.889 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.77 HG21 ' HD3' ' A' ' 63' ' ' ARG . 86.8 t -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.625 0.77 . . . . 15.0 109.916 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.0 -42.62 94.32 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.384 0.674 . . . . 15.0 111.304 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 65.7 m -69.34 -18.58 63.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.865 0.866 . . . . 15.0 110.638 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.9 tp10 -86.83 -33.05 19.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.071 0.548 . . . . 15.0 110.689 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.5 mt -74.68 -27.34 60.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.335 0.494 . . . . 15.0 112.335 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.51 -29.63 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -68.85 -48.98 62.11 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.0 t -60.74 -35.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.343 1.057 . . . . 15.0 111.294 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.49 -49.0 73.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.092 0.557 . . . . 15.0 110.609 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.57 -29.13 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.34 0.656 . . . . 15.0 112.171 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -80.35 -32.44 37.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.534 1.134 . . . . 15.0 111.15 -171.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.9 t -96.33 1.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.515 0.726 . . . . 15.0 109.621 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 70.06 12.61 7.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.609 1.564 . . . . 15.0 112.635 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 39' ' ' VAL . 69.8 mt -61.59 -24.11 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.154 0.982 . . . . 15.0 110.917 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 11.7 p-10 -65.39 -34.02 77.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.998 0.919 . . . . 15.0 111.614 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.03 -23.9 77.64 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.678 0.611 . . . . 15.0 112.207 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -93.82 -21.7 19.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.722 0.809 . . . . 15.0 110.68 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 48.1 ttt85 -75.89 130.67 38.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.36 1.064 . . . . 15.0 109.084 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.0 16.78 21.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.521 0.728 . . . . 15.0 111.53 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 45' ' ' ARG . . . 73.02 27.0 69.52 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 115.433 -0.803 . . . . 15.0 113.83 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -100.35 -38.89 8.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.355 0.662 . . . . 15.0 111.315 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.26 118.61 67.5 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-O 118.894 -0.574 . . . . 15.0 109.944 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.7 Cg_exo -64.24 147.78 91.12 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.068 2.512 . . . . 15.0 112.257 175.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.2 tpp -74.78 -29.37 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.361 0.664 . . . . 15.0 111.632 -172.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 29.9 p-10 -65.47 -36.72 84.72 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.833 0.453 . . . . 15.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.47 HD12 ' HD2' ' A' ' 50' ' ' PRO . 38.7 mt -61.49 -52.18 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.641 0.776 . . . . 15.0 110.519 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' HA ' ' CD1' ' A' ' 58' ' ' TYR . 28.8 m -72.38 -26.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -63.71 -53.83 45.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.216 0.606 . . . . 15.0 111.273 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 2.7 pt20 -83.66 -45.59 13.27 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.546 -0.752 . . . . 15.0 112.127 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -79.9 -63.04 1.5 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.489 0.316 . . . . 15.0 110.513 -171.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 3.6 m-85 -68.97 -38.8 79.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.542 0.737 . . . . 15.0 110.157 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.15 -2.04 86.56 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.576 -1.193 . . . . 15.0 113.965 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.19 -29.92 69.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.413 0.685 . . . . 15.0 111.573 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.0 p -80.13 -39.73 28.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.517 0.727 . . . . 15.0 110.65 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.07 -17.26 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 124.369 1.068 . . . . 15.0 111.711 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.77 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -48.14 -46.72 34.68 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.342 1.057 . . . . 15.0 111.467 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.64 -53.85 49.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.557 1.543 . . . . 15.0 112.26 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.84 -29.97 66.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.241 -0.89 . . . . 15.0 111.728 -171.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -74.2 -27.87 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.947 -0.57 . . . . 15.0 110.594 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.1 mt -57.77 -39.21 76.92 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.828 0.451 . . . . 15.0 111.151 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.85 -42.88 98.33 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.211 0.319 . . . . 15.0 112.794 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.15 -41.69 94.52 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.231 1.012 . . . . 15.0 111.056 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' HD13 ' A' ' 19' ' ' ILE . 86.3 mt -69.49 -40.19 77.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.694 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 75.2 mtm -67.18 -36.86 82.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.917 0.487 . . . . 15.0 111.033 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -63.38 -47.42 82.12 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.025 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.2 mtm105 -83.08 -51.11 7.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.983 -0.553 . . . . 15.0 112.204 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -23.52 44.21 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 122.858 0.463 . . . . 15.0 111.655 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -72.12 -52.2 17.84 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.568 0.543 . . . . 15.0 111.229 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.469 ' HA ' HG12 ' A' ' 79' ' ' ILE . 12.2 tt -67.28 -39.34 82.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.141 0 CA-C-N 117.899 0.318 . . . . 15.0 110.956 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -59.21 -34.68 72.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.467 0.707 . . . . 15.0 111.181 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.94 -54.88 7.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.528 0.731 . . . . 15.0 111.146 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 76' ' ' ILE . 21.8 pt -68.32 -22.23 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.145 0.794 . . . . 15.0 113.145 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.38 -49.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.536 0.335 . . . . 15.0 110.454 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -72.14 -36.83 69.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.332 0.253 . . . . 15.0 111.293 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -76.72 -12.74 60.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.959 0.504 . . . . 15.0 111.542 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 61.13 29.78 19.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.766 1.226 . . . . 15.0 112.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -82.29 125.0 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.47 104.03 31.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.61 147.28 24.86 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.464 2.109 . . . . 15.0 112.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.18 178.44 10.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.74 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.81 -124.95 18.76 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.117 -0.947 . . . . 15.0 112.054 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.18 99.76 28.96 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.565 0.746 . . . . 15.0 110.188 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.5 Cg_endo -76.57 108.09 2.59 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.119 1.879 . . . . 15.0 110.528 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -102.75 100.64 10.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.634 -0.712 . . . . 15.0 109.963 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -85.95 80.87 8.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.453 0.701 . . . . 15.0 109.383 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.76 113.69 34.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.332 -0.849 . . . . 15.0 108.988 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.81 96.23 0.67 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.381 2.054 . . . . 15.0 110.459 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.542 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -51.28 -51.07 37.99 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.818 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -174.65 137.73 0.48 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.914 0.886 . . . . 15.0 110.668 172.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -106.34 135.46 47.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 38.3 mtpt -129.71 114.24 15.74 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.158 -1.423 . . . . 15.0 107.158 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.27 118.37 9.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.891 0.477 . . . . 15.0 109.716 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.25 39.08 Favored Glycine 0 N--CA 1.47 0.94 0 CA-C-N 115.985 -0.552 . . . . 15.0 112.659 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.3 mt-10 -112.34 -178.81 3.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.117 0.967 . . . . 15.0 109.652 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.28 151.22 46.51 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.706 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 19' ' ' ILE . 48.7 t80 -95.16 146.45 24.3 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.4 m -134.46 133.31 40.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.333 0.653 . . . . 15.0 109.574 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.542 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 13.7 p90 -138.34 171.15 14.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.925 0.89 . . . . 15.0 109.051 172.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.3 m -140.77 124.37 16.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.888 0.875 . . . . 15.0 109.349 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.19 104.3 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -102.04 114.93 29.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.949 0.9 . . . . 15.0 109.417 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 33.6 p90 -139.64 164.04 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.604 0.761 . . . . 15.0 110.619 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.86 113.72 20.67 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.364 -0.835 . . . . 15.0 109.705 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.595 HG11 ' HD2' ' A' ' 13' ' ' ARG . 12.1 m -89.43 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.671 -0.492 . . . . 15.0 109.671 171.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -89.33 126.37 58.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.674 . . . . 15.0 110.224 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.634 ' HG3' HD21 ' A' ' 11' ' ' LEU . 14.5 Cg_exo -69.39 145.29 58.86 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.441 2.094 . . . . 15.0 110.868 170.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.45 100.15 1.05 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.301 0.64 . . . . 15.0 109.351 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.37 123.8 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.724 0.773 . . . . 15.0 112.057 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.96 107.82 15.03 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.537 1.135 . . . . 15.0 108.705 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.95 131.5 45.19 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.645 0.591 . . . . 15.0 109.995 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -136.6 155.9 49.3 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.169 0.988 . . . . 15.0 109.586 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 60.65 20.77 56.94 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 124.442 1.089 . . . . 15.0 114.823 171.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.03 -39.46 94.81 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.368 0.667 . . . . 15.0 111.029 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.05 -20.31 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.239 0.615 . . . . 15.0 111.305 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.89 -15.92 42.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.63 0.772 . . . . 15.0 111.652 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.54 HG22 HG23 ' A' ' 125' ' ' VAL . 58.5 mt -65.11 124.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.158 0.583 . . . . 15.0 109.758 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.629 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.7 mt-10 -116.2 85.91 2.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.925 0.869 . . . . 15.0 109.948 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.8 t -83.03 164.78 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.51 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.7 141.23 49.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.744 0.817 . . . . 15.0 109.45 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -114.38 94.75 37.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.872 -1.159 . . . . 15.0 107.872 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.64 ' HG3' ' HD2' ' A' ' 285' ' ' ARG . 85.0 Cg_endo -78.16 103.49 1.7 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.984 1.789 . . . . 15.0 111.38 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -69.12 92.73 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.619 HG21 HD11 ' A' ' 427' ' ' LEU . 25.5 t -118.29 134.06 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.219 -0.901 . . . . 15.0 110.196 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.44 154.73 48.38 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 106.664 -1.606 . . . . 15.0 106.664 167.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 274' ' ' MET . 3.4 t -83.29 89.66 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.814 -1.18 . . . . 15.0 107.814 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.9 p -69.52 173.96 5.44 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.257 0.623 . . . . 15.0 109.79 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -55.26 -43.72 74.93 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.561 0.344 . . . . 15.0 111.474 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.41 -25.65 64.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.557 0.743 . . . . 15.0 111.929 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -78.81 -45.11 21.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.754 0.422 . . . . 15.0 110.675 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -56.06 -58.09 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.938 0.895 . . . . 15.0 109.129 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -61.69 -47.01 87.23 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.844 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.17 72.16 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.13 0.894 . . . . 15.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.8 ttt -69.54 -50.71 42.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.771 0.428 . . . . 15.0 111.151 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.18 -37.51 69.68 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.143 0.577 . . . . 15.0 112.067 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.413 ' HA ' ' HE ' ' A' ' 145' ' ' ARG . 17.1 t70 -67.75 -41.75 82.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.107 0.963 . . . . 15.0 109.929 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 82.7 m -58.95 -43.2 91.21 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.188 0.93 . . . . 15.0 110.574 173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' MET . 81.0 mt -61.3 -42.94 99.5 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.425 0.69 . . . . 15.0 111.076 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.42 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 69.3 mtm180 -63.57 -35.89 81.99 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.297 -0.865 . . . . 15.0 110.676 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 85.6 mttt -85.06 -5.33 59.35 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.37 0.668 . . . . 15.0 112.537 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 143' ' ' THR . 96.8 mt-30 -79.74 -44.62 20.39 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.914 -0.772 . . . . 15.0 108.914 163.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -97.59 37.94 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.367 0.667 . . . . 15.0 110.864 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -71.51 141.13 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.458 0.703 . . . . 15.0 112.092 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.1 m -82.18 127.02 32.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.379 1.072 . . . . 15.0 109.353 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -86.95 126.61 34.82 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.02 0.528 . . . . 15.0 110.269 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -148.52 122.58 9.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 15.0 110.032 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 43.5 mt-10 -75.57 143.78 42.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.01 0.524 . . . . 15.0 110.263 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.687 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 36.6 pttt -137.05 -179.3 5.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.706 0.802 . . . . 15.0 111.031 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -147.14 153.74 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.06 -51.81 0.79 Allowed Glycine 0 N--CA 1.467 0.707 0 CA-C-O 119.548 -0.584 . . . . 15.0 112.757 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -155.53 148.07 23.99 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 117.415 0.608 . . . . 15.0 111.158 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.405 HG22 HG13 ' A' ' 240' ' ' VAL . 21.9 t -98.83 153.01 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 107.902 -1.147 . . . . 15.0 107.902 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.07 -169.88 2.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.457 1.103 . . . . 15.0 109.711 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.51 96.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.397 1.079 . . . . 15.0 113.245 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.65 33.25 5.14 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.889 0.7 . . . . 15.0 112.889 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -87.84 -164.26 1.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 120.934 0.397 . . . . 15.0 111.795 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.777 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 18.7 mtm180 -122.88 160.44 26.1 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.027 -1.101 . . . . 15.0 108.027 161.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.404 HG12 HG23 ' A' ' 166' ' ' ILE . 2.8 t -144.62 116.92 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.685 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 15.2 m -95.63 116.46 28.88 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' LEU . 40.1 pt -130.13 168.77 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.752 0.821 . . . . 15.0 110.346 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -127.64 161.2 29.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.424 -1.325 . . . . 15.0 107.424 161.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.63 174.92 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.333 0.587 . . . . 15.0 111.385 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.649 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 6.6 t -158.62 131.64 7.24 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.658 -1.608 . . . . 15.0 106.658 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.48 -177.13 26.67 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.602 -0.808 . . . . 15.0 113.407 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 p -148.2 131.67 16.7 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.754 0.822 . . . . 15.0 109.306 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 226' ' ' LEU . 45.7 t -93.08 102.81 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 27.7 t70 77.7 -0.65 2.73 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 125.296 1.439 . . . . 15.0 111.047 -170.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.45 37.35 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 121.868 -0.52 . . . . 15.0 113.092 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.2 pt-20 -105.77 137.41 43.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.267 0.627 . . . . 15.0 109.353 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.18 95.16 5.54 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.659 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 172' ' ' VAL . 39.7 p90 -59.48 158.77 9.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.659 -1.155 . . . . 15.0 110.655 174.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -54.14 135.45 43.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 15.0 111.195 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' ' 386' ' ' VAL . . . 78.99 -70.49 2.75 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 123.985 0.803 . . . . 15.0 111.675 -170.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.61 -69.77 2.78 Favored Glycine 0 C--N 1.348 1.201 0 C-N-CA 123.212 0.434 . . . . 15.0 112.605 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.649 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 6.5 tmtt? -86.29 137.37 32.66 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.252 1.021 . . . . 15.0 110.185 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB2' HG12 ' B' ' 386' ' ' VAL . . . -127.89 155.52 44.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.887 0.875 . . . . 15.0 108.816 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 m -139.35 128.51 23.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 15.0 110.663 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 63.09 37.81 11.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.603 1.161 . . . . 15.0 112.255 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 44.6 t80 -71.22 136.06 47.84 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.39 -0.823 . . . . 15.0 108.915 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.5 t -107.16 119.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.008 0.923 . . . . 15.0 109.573 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 24.6 tp -112.66 93.64 4.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.986 0.914 . . . . 15.0 110.867 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.19 105.01 3.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.3 mmt -77.25 165.07 24.98 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 114.872 -1.058 . . . . 15.0 111.063 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.42 11.69 56.87 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.056 -0.974 . . . . 15.0 112.029 -170.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.14 143.84 22.73 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 125.125 1.37 . . . . 15.0 107.767 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -79.15 82.84 1.33 Allowed Glycine 0 C--N 1.344 0.978 0 O-C-N 123.148 0.28 . . . . 15.0 112.692 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.03 -19.95 26.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.966 0.506 . . . . 15.0 111.374 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.86 156.91 43.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.606 0.362 . . . . 15.0 110.69 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.04 140.85 98.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.761 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.89 105.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.217 2.612 . . . . 15.0 112.665 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.55 -49.44 0.66 Allowed Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.153 -0.931 . . . . 15.0 111.102 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' B' ' 385' ' ' LEU . 43.5 t80 -69.04 -64.65 0.83 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.488 0.315 . . . . 15.0 110.291 -176.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 203' ' ' LYS . 8.4 pt-20 -62.58 -27.6 69.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.108 0.88 . . . . 15.0 112.429 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.23 -30.58 67.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.957 0.903 . . . . 15.0 110.527 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.43 -5.66 85.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.167 -0.924 . . . . 15.0 112.98 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 33.6 mm -103.74 -47.97 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 123.429 0.692 . . . . 15.0 110.47 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 199' ' ' GLU . 22.6 pttm -85.4 16.5 3.7 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.782 1.03 . . . . 15.0 113.782 -169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -127.91 32.28 3.5 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.744 -0.942 . . . . 15.0 110.744 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -146.52 -167.83 2.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 15.0 110.473 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -151.86 161.67 42.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.598 0.759 . . . . 15.0 110.01 177.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.96 139.09 52.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.139 0.576 . . . . 15.0 111.892 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.54 8.63 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.501 -0.772 . . . . 15.0 112.429 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.8 pt-20 -92.45 137.63 32.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.496 0.719 . . . . 15.0 109.485 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.18 112.11 18.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.929 -1.137 . . . . 15.0 107.929 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -131.89 -178.31 4.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.788 1.235 . . . . 15.0 109.878 -171.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 43.3 m -131.11 120.35 23.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.775 0.83 . . . . 15.0 108.98 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.04 156.35 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.274 0.63 . . . . 15.0 110.514 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -116.18 105.28 12.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.095 0.958 . . . . 15.0 108.996 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.1 167.1 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 91.3 m -141.09 133.61 28.47 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.355 -0.98 . . . . 15.0 108.355 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.462 ' HZ ' HD12 ' B' ' 387' ' ' ILE . 49.0 m-85 -76.42 138.64 67.46 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 123.432 0.457 . . . . 15.0 111.837 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.8 158.35 11.03 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.695 2.93 . . . . 15.0 113.61 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.35 -31.01 63.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.67 -23.97 67.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.346 1.058 . . . . 15.0 111.657 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 227' ' ' LYS . 1.9 t80 -74.35 74.69 1.87 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.076 0.95 . . . . 15.0 109.052 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -67.8 4.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.049 1.5 . . . . 15.0 115.049 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.21 93.1 0.8 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.183 -1.414 . . . . 15.0 107.183 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.1 tt0 -64.08 -29.0 70.17 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.761 0.652 . . . . 15.0 112.761 -166.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -61.2 -22.57 64.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.835 0.854 . . . . 15.0 110.961 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 172' ' ' VAL . 76.4 mt -102.55 -43.37 5.65 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.72 1.208 . . . . 15.0 110.82 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 221' ' ' TYR . 0.7 OUTLIER -54.82 130.62 41.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.889 1.675 . . . . 15.0 112.759 -165.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.48 -18.91 7.69 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.832 0.708 . . . . 15.0 114.398 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 93.0 mttt -89.85 143.25 26.96 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.874 0.87 . . . . 15.0 110.562 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.0 106.88 11.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.552 0.741 . . . . 15.0 110.174 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.81 115.97 27.54 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.896 -1.047 . . . . 15.0 110.759 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -106.13 107.64 18.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.411 -0.588 . . . . 15.0 109.411 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -104.9 119.71 39.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.038 0.935 . . . . 15.0 109.121 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.51 93.74 4.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.326 0.65 . . . . 15.0 109.405 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.96 125.89 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 15.0 110.421 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -109.34 98.52 7.91 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.336 -1.357 . . . . 15.0 107.336 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.59 99.52 6.57 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 -175.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -93.43 -40.92 10.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.229 -0.442 . . . . 15.0 110.985 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 35.3 mmtp -131.89 139.36 48.75 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.051 0.54 . . . . 15.0 110.687 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 207' ' ' ALA . 86.0 t -104.03 141.93 18.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.112 -1.811 . . . . 15.0 106.112 159.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.2 mt-10 -133.1 -176.26 4.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.687 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 41.4 tt0 -154.36 130.64 10.43 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.551 0.741 . . . . 15.0 109.358 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 146' ' ' LYS . 23.4 ptt180 -86.24 86.03 7.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.19 0.995 . . . . 15.0 108.356 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.89 141.78 58.13 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.116 -1.402 . . . . 15.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.61 132.76 94.61 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.1 -0.704 . . . . 15.0 109.1 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 59.9 Cg_endo -67.83 176.52 5.12 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.468 2.112 . . . . 15.0 112.002 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.97 88.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.19 69.92 4.47 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.934 0.873 . . . . 15.0 109.006 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.9 p -101.83 163.89 12.02 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.591 1.156 . . . . 15.0 109.282 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.11 -41.27 48.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.98 0.912 . . . . 15.0 111.195 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.2 -39.46 86.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.179 1.392 . . . . 15.0 111.312 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.14 -59.9 2.59 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.897 . . . . 15.0 109.146 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 258' ' ' VAL . 9.5 tt -57.78 -42.0 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.954 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -67.71 -26.68 66.29 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.687 0.254 . . . . 15.0 111.687 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -72.79 -19.06 61.42 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.622 0.769 . . . . 15.0 110.949 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -87.63 -6.58 58.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.452 0.701 . . . . 15.0 111.322 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.5 5.1 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 119.428 -0.651 . . . . 15.0 114.721 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 261' ' ' GLY . 44.2 t -62.72 111.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 117.483 0.642 . . . . 15.0 110.902 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -58.78 -48.57 80.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.599 1.16 . . . . 15.0 112.001 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.663 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 5.3 t70 -76.69 -43.49 37.46 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.458 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 82.96 18.97 64.02 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 115.866 -0.606 . . . . 15.0 114.337 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -148.78 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.902 0.881 . . . . 15.0 109.602 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 95.7 t -50.4 -52.97 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 124.364 1.066 . . . . 15.0 113.457 -165.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -31.04 68.53 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.979 0.512 . . . . 15.0 111.549 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 260' ' ' ASP . . . -80.28 -24.08 59.84 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.145 -0.382 . . . . 15.0 112.145 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 270' ' ' VAL . 38.5 tp -77.67 -28.16 51.06 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.504 ' HA ' HG22 ' A' ' 270' ' ' VAL . 77.3 mtp180 -72.45 -37.6 68.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.956 0.902 . . . . 15.0 109.666 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.65 88.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.751 -0.659 . . . . 15.0 110.411 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.37 -48.7 55.11 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.328 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 274' ' ' MET . 19.2 m -67.4 -25.58 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-O 120.64 0.257 . . . . 15.0 110.634 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -60.01 -66.1 0.57 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.76 0.424 . . . . 15.0 110.48 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.28 -7.84 53.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.233 0.613 . . . . 15.0 112.61 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -101.22 -68.91 0.8 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.424 0.69 . . . . 15.0 109.965 170.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.564 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.6 mpt? -66.84 -43.79 82.77 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 117.698 -1.144 . . . . 15.0 111.694 -170.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.12 -49.63 71.44 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.441 1.473 . . . . 15.0 109.95 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -51.81 -49.16 63.32 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 113.509 -1.678 . . . . 15.0 111.989 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -84.35 -37.77 21.15 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.558 0.536 . . . . 15.0 111.348 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 130' ' ' VAL . 61.6 tp -67.16 -56.92 7.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.737 0.415 . . . . 15.0 111.894 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.78 -31.65 72.97 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.481 0.488 . . . . 15.0 110.194 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.9 t -64.86 -45.57 85.51 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.954 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.43 65.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 15.0 112.26 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 130' ' ' VAL . 98.6 mt -66.28 -51.43 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.802 HH21 ' HB3' ' A' ' 405' ' ' GLU . 28.8 tpt180 -62.14 -37.5 85.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.65 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.67 -23.77 45.5 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.388 0.675 . . . . 15.0 111.05 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.64 ' HD2' ' HG3' ' A' ' 128' ' ' PRO . 25.1 ttm180 -70.33 -49.31 50.71 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.577 0.626 . . . . 15.0 109.452 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 282' ' ' ILE . 98.6 t -57.56 -48.25 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.761 0.791 . . . . 15.0 110.008 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -64.21 -46.44 83.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.58 -1.191 . . . . 15.0 111.463 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -65.89 -39.21 90.44 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 119.256 -0.402 . . . . 15.0 110.935 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 125' ' ' VAL . 56.8 mt-30 -69.95 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.553 0.533 . . . . 15.0 111.172 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.21 -50.84 66.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.625 0.37 . . . . 15.0 110.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.9 mm -67.76 -41.17 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.796 0.839 . . . . 15.0 111.01 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 12.4 tp10 -64.43 -36.19 83.35 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.732 0.813 . . . . 15.0 109.474 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.54 -43.87 93.86 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.926 -1.034 . . . . 15.0 112.005 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.59 -45.49 81.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.108 0.963 . . . . 15.0 110.841 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.37 -58.67 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.051 0.94 . . . . 15.0 110.26 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.4 mttm -60.86 -23.47 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.641 0.776 . . . . 15.0 112.348 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -79.52 -33.65 41.86 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.547 0.739 . . . . 15.0 111.508 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.52 138.22 7.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 112.719 0.637 . . . . 15.0 112.719 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.08 144.48 29.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.167 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.48 HG12 HD22 ' A' ' 349' ' ' LEU . 6.5 tp -138.89 123.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . 7.6 m-20 -79.0 137.43 37.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.24 130.98 21.44 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.192 0.597 . . . . 15.0 109.449 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.88 130.03 32.74 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.029 2.486 . . . . 15.0 112.501 168.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.58 -9.67 20.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.759 1.022 . . . . 15.0 113.759 -173.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.22 91.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.244 0.618 . . . . 15.0 110.925 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.31 -38.66 68.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 15.0 111.122 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.61 -52.13 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -38.57 89.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.832 0.853 . . . . 15.0 111.453 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.9 t -59.07 -50.57 73.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 15.0 111.226 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.91 -26.33 43.78 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.381 -0.372 . . . . 15.0 111.42 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.41 HG22 ' NE ' ' A' ' 315' ' ' ARG . 62.9 mt -62.29 -35.52 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 166.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.573 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.0 t70 -70.88 -39.36 72.89 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.97 0.508 . . . . 15.0 111.01 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.08 -48.07 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 123.792 0.683 . . . . 15.0 109.27 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 341' ' ' ALA . 83.2 mt -73.68 -21.3 60.3 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.117 -0.947 . . . . 15.0 113.237 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.573 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 72.1 mtm180 . . . . . 0 N--CA 1.483 1.223 0 C-N-CA 123.055 0.542 . . . . 15.0 109.806 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.0 tp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.944 0.402 . . . . 15.0 111.358 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -113.68 21.96 14.52 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.065 0.946 . . . . 15.0 111.055 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 24.2 mt -64.65 128.79 93.88 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.603 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 87.9 Cg_exo -47.7 118.29 2.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.664 2.909 . . . . 15.0 114.328 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -56.02 -36.55 68.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.091 0.957 . . . . 15.0 111.235 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.31 -12.05 47.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.468 0.914 . . . . 15.0 113.468 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 96.9 mt -71.76 -40.15 69.52 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.368 -0.604 . . . . 15.0 109.368 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -107.01 -10.77 15.83 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.271 -168.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -48.66 -57.75 5.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.147 1.379 . . . . 15.0 113.021 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.1 -59.21 4.95 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 111.397 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.01 -36.55 69.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.617 -0.72 . . . . 15.0 112.416 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -70.7 -50.79 32.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.547 . . . . 15.0 110.04 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.8 tttt -60.11 -34.94 74.19 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.03 0.832 . . . . 15.0 110.328 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.6 mmt85 -62.89 -38.1 89.56 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.003 -0.522 . . . . 15.0 111.26 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.73 -28.8 66.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 123.286 0.366 . . . . 15.0 110.853 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' B' ' 466' ' ' ALA . 24.9 t -75.48 -36.01 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.98 -0.378 . . . . 15.0 109.98 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -65.8 -35.03 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.561 0.744 . . . . 15.0 109.863 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 351' ' ' LEU . 55.4 t -60.47 -54.64 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.809 -0.811 . . . . 15.0 108.809 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.66 97.48 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.388 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 300' ' ' ILE . 6.5 tt -78.15 -55.32 5.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.046 0.538 . . . . 15.0 110.234 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 354' ' ' VAL . 72.3 mt -67.1 -49.27 65.53 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.039 0.212 . . . . 15.0 110.694 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 347' ' ' VAL . 64.9 mt -69.2 -28.26 66.22 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 119.334 -0.365 . . . . 15.0 111.055 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.2 -42.36 99.72 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.923 -0.471 . . . . 15.0 111.923 172.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.21 -39.14 93.35 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.238 -0.481 . . . . 15.0 110.58 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -59.57 -37.04 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 122.888 0.475 . . . . 15.0 111.041 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.572 HD12 ' HA2' ' A' ' 352' ' ' GLY . 75.9 mt -65.2 -46.85 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.744 0.818 . . . . 15.0 110.543 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.95 -53.25 41.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.525 0.203 . . . . 15.0 110.908 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.0 m -60.27 -40.72 91.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.588 1.155 . . . . 15.0 112.053 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.39 17.98 18.86 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.174 0.589 . . . . 15.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 46.33 30.02 0.96 Allowed 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 125.703 1.601 . . . . 15.0 114.626 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.617 ' HB3' HE21 ' A' ' 406' ' ' GLN . 83.1 mt -65.72 148.28 52.02 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.072 0.949 . . . . 15.0 112.811 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -129.31 158.09 40.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.522 1.129 . . . . 15.0 108.83 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.67 90.33 2.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 367' ' ' VAL . 5.2 t70 -67.73 120.93 14.88 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.11 0.964 . . . . 15.0 110.758 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.26 -23.67 67.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.826 0.85 . . . . 15.0 113.0 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.61 -34.11 73.62 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 30.9 tpt85 -77.82 -36.81 49.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.725 0.81 . . . . 15.0 109.951 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.3 t -63.99 -55.01 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.617 0.767 . . . . 15.0 109.746 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -36.18 81.59 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.813 -1.085 . . . . 15.0 109.778 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.95 96.75 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.787 0.679 . . . . 15.0 112.711 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 367' ' ' VAL . 69.3 mt -57.44 -48.15 79.9 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.636 0.774 . . . . 15.0 111.07 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.632 HG21 ' HA ' ' A' ' 385' ' ' ILE . 17.8 mm -56.35 -44.69 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 124.183 0.927 . . . . 15.0 110.81 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -61.57 -54.46 42.77 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 15.0 110.782 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -61.6 -37.7 84.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.499 0.72 . . . . 15.0 112.769 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -74.76 -45.76 41.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.423 0.689 . . . . 15.0 109.931 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -73.28 -16.83 61.38 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.184 0.594 . . . . 15.0 111.959 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -73.1 -0.18 13.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.991 0.917 . . . . 15.0 111.692 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -98.54 -10.11 23.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.583 0.753 . . . . 15.0 111.268 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.497 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 79.1 m-85 -111.31 157.56 20.03 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.108 0.963 . . . . 15.0 109.604 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.0 -45.06 71.51 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.211 0.604 . . . . 15.0 110.834 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.88 100.71 17.5 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 124.596 1.158 . . . . 15.0 110.26 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.9 -41.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.605 2.204 . . . . 15.0 115.794 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -68.92 -28.97 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -163.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.32 -28.69 67.38 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.344 0.403 . . . . 15.0 110.095 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.74 -38.81 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.556 0.742 . . . . 15.0 109.261 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.632 ' HA ' HG21 ' A' ' 371' ' ' ILE . 1.8 mp -55.55 -48.56 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.493 -0.558 . . . . 15.0 109.493 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.74 -34.01 76.0 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.591 0.756 . . . . 15.0 111.668 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -64.35 -40.04 95.08 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.794 0.838 . . . . 15.0 110.961 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.509 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 29.9 m-85 -79.0 -50.51 10.98 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.916 0.135 . . . . 15.0 111.014 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . 0.58 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -169.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.02 0.07 54.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.184 0.594 . . . . 15.0 112.052 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -113.52 118.84 35.58 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -63.84 -61.47 2.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.434 0.693 . . . . 15.0 112.164 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.98 -30.66 69.26 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.426 0.69 . . . . 15.0 112.173 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 42.0 tp -84.16 -38.9 20.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.984 0.513 . . . . 15.0 111.441 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -62.13 -48.26 80.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 175.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.56 ' HA ' ' HD2' ' A' ' 399' ' ' ARG . 13.2 t70 -62.95 -39.7 95.44 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.575 1.172 . . . . 15.0 110.826 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 401' ' ' VAL . 9.5 t30 -59.8 -40.64 89.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.245 0.545 . . . . 15.0 110.391 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 -16.75 56.96 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.301 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.56 ' HD2' ' HA ' ' A' ' 396' ' ' ASP . 97.9 mtt180 -71.81 -36.25 70.19 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 15.0 109.429 167.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -64.2 -42.27 96.7 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.525 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 397' ' ' ASN . 24.9 t -62.48 -42.36 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 123.851 0.719 . . . . 15.0 110.867 175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.51 85.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.491 0.716 . . . . 15.0 111.188 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.33 -35.17 71.12 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.465 -1.243 . . . . 15.0 111.001 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.04 -54.49 45.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.292 1.037 . . . . 15.0 110.327 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.802 ' HB3' HH21 ' A' ' 283' ' ' ARG . 47.8 mt-10 -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.384 -0.826 . . . . 15.0 111.92 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.617 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.5 tt0 -67.47 -37.58 83.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.21 0.604 . . . . 15.0 109.857 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.6 78.58 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.474 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.22 -56.13 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.86 -25.52 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.429 1.092 . . . . 15.0 112.409 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.13 66.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.038 0.535 . . . . 15.0 111.233 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.49 -34.81 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.911 -0.774 . . . . 15.0 108.911 172.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 80.9 mt -70.06 -31.08 68.52 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.458 0.703 . . . . 15.0 111.502 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.7 0.8 . . . . 15.0 110.812 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -86.41 -34.17 20.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.739 0.816 . . . . 15.0 109.881 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -86.34 -171.81 3.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.73 1.212 . . . . 15.0 112.126 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.629 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 79.0 mttt -114.9 117.47 30.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.911 -1.041 . . . . 15.0 108.696 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.53 101.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 109.19 -0.67 . . . . 15.0 109.19 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 t -71.32 89.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.132 0.968 . . . . 15.0 109.466 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.52 110.02 8.48 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.286 -1.325 . . . . 15.0 109.566 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -133.99 137.88 45.06 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 15.0 110.157 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.05 131.41 39.47 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.384 0.674 . . . . 15.0 109.233 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.2 t -158.76 170.66 21.64 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.214 0.605 . . . . 15.0 110.372 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.6 p -90.68 176.98 6.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.471 0.709 . . . . 15.0 112.313 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -63.7 -23.91 67.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.777 1.231 . . . . 15.0 110.935 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -66.93 -17.78 65.07 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.64 1.176 . . . . 15.0 112.301 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.512 ' HB3' HD12 ' A' ' 427' ' ' LEU . 13.2 tp10 -63.83 -36.15 82.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.029 0.932 . . . . 15.0 111.38 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 130' ' ' VAL . 3.1 mp -104.16 -69.58 0.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.87 0.468 . . . . 15.0 111.476 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.528 ' SD ' ' HB2' ' A' ' 427' ' ' LEU . 1.6 mpt? -92.54 -50.19 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.054 0.39 . . . . 15.0 112.054 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 59.4 t30 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.842 0.829 . . . . 15.0 110.997 -165.404 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 198' ' ' PHE . 5.4 tt . . . . . 0 C--O 1.246 0.913 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . 0.623 HG21 ' HA3' ' A' ' 179' ' ' GLY . 7.5 p -77.88 91.74 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.69 1.233 . . . . 0.0 110.995 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.462 HD12 ' HZ ' ' A' ' 217' ' ' PHE . 8.3 mm -150.98 141.71 16.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 127.805 2.442 . . . . 0.0 104.484 162.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.557 1.224 0 CA-C-N 119.099 0.863 . . . . 0.0 110.266 -164.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 N--CA 1.487 1.387 0 C-N-CA 123.646 0.778 . . . . 0.0 110.993 -174.634 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -45.89 -53.1 10.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.564 1.146 . . . . 0.0 113.142 -169.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -131.87 115.07 15.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 88.3 m -68.83 104.99 2.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 124.163 0.914 . . . . 0.0 109.759 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -83.08 177.44 8.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.813 0.445 . . . . 0.0 110.062 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.69 150.08 37.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.127 0.571 . . . . 0.0 109.507 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 345' ' ' VAL . . . 68.02 8.01 6.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.05 1.34 . . . . 0.0 112.565 -171.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 123.969 0.908 . . . . 0.0 110.667 -177.111 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.665 0.269 . . . . 15.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -158.31 149.61 21.01 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.753 1.221 . . . . 15.0 109.054 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 17' ' ' ILE . 13.5 m -133.68 77.96 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.838 0.855 . . . . 15.0 110.537 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -78.95 91.01 4.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 15.0 110.497 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 2.6 p -80.51 93.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 122.2 1.0 . . . . 15.0 111.433 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.94 98.2 7.79 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.501 1.12 . . . . 15.0 109.989 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -64.55 112.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.102 0.561 . . . . 15.0 109.962 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -76.32 -54.74 6.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -167.43 120.16 0.93 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 15.0 109.671 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.55 -101.6 0.47 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 124.157 0.91 . . . . 15.0 113.551 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' A' ' 113' ' ' PRO . 1.8 mm? -90.54 -22.08 21.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.175 0.59 . . . . 15.0 110.884 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.46 122.8 30.31 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.359 1.037 . . . . 15.0 112.223 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.471 HH12 ' HA ' ' A' ' 11' ' ' LEU . 68.7 mtt85 -140.86 108.16 5.52 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.751 1.22 . . . . 15.0 109.892 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 31.0 ttm180 -83.94 82.95 8.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.564 1.146 . . . . 15.0 109.131 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 t -76.49 88.46 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 61.6 m -75.94 96.62 3.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.273 -0.876 . . . . 15.0 109.633 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 3' ' ' VAL . 54.1 mt -84.21 106.07 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.555 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 35.9 m -83.72 100.6 10.99 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 70' ' ' LEU . 39.0 mt -77.01 130.85 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 140.54 58.88 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 123.92 0.763 . . . . 15.0 110.517 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.12 63.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.979 1.312 . . . . 15.0 112.208 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -38.65 78.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.114 -0.948 . . . . 15.0 111.285 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.4 m -68.62 -30.92 69.76 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.406 0.682 . . . . 15.0 111.158 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 103' ' ' PHE . 78.8 mt -65.25 -54.08 33.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 CA-C-N 115.496 -0.774 . . . . 15.0 109.087 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -59.22 -29.45 67.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.192 0.997 . . . . 15.0 111.841 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.7 m -74.8 -52.76 10.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.768 0.827 . . . . 15.0 110.317 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.06 85.04 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.395 0.678 . . . . 15.0 112.287 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 63' ' ' ARG . 58.6 t -67.59 -45.36 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.09 0.556 . . . . 15.0 109.868 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.9 -31.45 72.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.178 0.591 . . . . 15.0 111.32 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -63.35 -44.51 94.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.437 0.695 . . . . 15.0 109.78 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 35' ' ' VAL . 14.4 tp10 -63.81 -42.36 97.71 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.434 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 55' ' ' ALA . 79.6 mt -66.77 -39.23 87.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.909 0.884 . . . . 15.0 112.891 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.44 -28.07 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -71.72 -34.16 69.35 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 118.994 -0.527 . . . . 15.0 111.074 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 31' ' ' GLU . 77.2 t -60.68 -35.46 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.259 0.624 . . . . 15.0 110.163 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.05 -49.08 78.14 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.449 -0.796 . . . . 15.0 110.721 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -69.56 -42.95 73.88 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.895 0.878 . . . . 15.0 110.779 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.81 -34.43 66.87 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.743 1.617 . . . . 15.0 111.286 -169.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.54 10.87 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-O 121.338 0.59 . . . . 15.0 109.794 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 59.26 23.37 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.821 1.248 . . . . 15.0 112.796 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 60.0 mt -72.99 -22.92 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.416 1.086 . . . . 15.0 109.862 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 8.2 p-10 -58.08 -29.56 65.52 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.556 1.142 . . . . 15.0 112.758 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.49 -41.37 94.28 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.588 -0.605 . . . . 15.0 111.588 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -79.13 -24.29 43.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.964 0.906 . . . . 15.0 110.169 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 28.3 tpt180 -79.97 90.13 5.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.232 1.013 . . . . 15.0 109.335 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -92.62 -7.44 46.98 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.832 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 49.44 3.29 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.6 0.563 . . . . 15.0 112.503 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -77.27 -58.56 3.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.197 0.599 . . . . 15.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.61 122.66 70.36 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.712 -0.847 . . . . 15.0 108.712 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.1 148.28 7.14 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.844 3.029 . . . . 15.0 114.488 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.7 tpp -64.52 -34.51 78.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.369 1.068 . . . . 15.0 112.118 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.35 -37.36 86.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.715 0.406 . . . . 15.0 111.1 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.25 -42.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.985 0.914 . . . . 15.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 19.5 m -71.61 -21.18 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 122.342 -0.224 . . . . 15.0 110.871 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -76.9 -46.65 23.66 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.187 0.595 . . . . 15.0 111.801 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.743 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.5 pt20 -81.63 -30.1 32.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.517 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 75.2 mtt180 -103.1 -60.78 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.062 0.545 . . . . 15.0 110.9 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.556 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 68.5 m-85 -76.95 -19.43 57.36 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 15.0 111.142 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -100.89 9.18 58.18 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.247 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.02 -30.07 69.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.542 0.737 . . . . 15.0 111.088 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.9 p -81.39 -33.19 32.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.76 0.824 . . . . 15.0 110.866 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.06 -16.26 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.068 0.947 . . . . 15.0 111.279 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HD3' HG21 ' A' ' 28' ' ' VAL . 19.8 mmt180 -48.2 -42.33 29.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.277 1.031 . . . . 15.0 111.442 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -52.03 -54.23 32.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.975 1.31 . . . . 15.0 112.185 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.04 -24.61 58.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.86 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 28' ' ' VAL . 44.0 t -79.23 -23.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 122.546 0.338 . . . . 15.0 110.234 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 HD12 ' A' ' 70' ' ' LEU . 66.1 mt -57.69 -29.59 64.79 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.35 -0.357 . . . . 15.0 111.66 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.82 -38.66 95.65 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 117.844 0.293 . . . . 15.0 112.935 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 29.8 t70 -74.49 -36.44 63.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.771 0.828 . . . . 15.0 109.972 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.524 HD12 HD23 ' A' ' 67' ' ' LEU . 96.4 mt -73.24 -19.28 61.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.003 -0.999 . . . . 15.0 111.917 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 76.7 mtm -104.81 -66.35 0.97 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.762 0.425 . . . . 15.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.3 t -70.83 -35.56 72.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.48 0.712 . . . . 15.0 112.503 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 76' ' ' ILE . 4.9 tmm_? -87.76 -43.67 11.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -58.99 -25.55 63.72 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.467 0.576 . . . . 15.0 111.606 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -54.81 -50.73 67.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.098 0.959 . . . . 15.0 111.73 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 73' ' ' ARG . 13.2 tt -69.32 -37.34 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 110.11 -0.33 . . . . 15.0 110.11 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 -23.38 67.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.321 0.649 . . . . 15.0 111.729 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -83.52 -42.19 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.873 0.869 . . . . 15.0 111.677 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.558 HD12 ' HD3' ' A' ' 86' ' ' PRO . 28.2 pt -85.28 -30.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.203 0.816 . . . . 15.0 113.203 -169.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.26 -50.17 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.4 0.68 . . . . 15.0 111.042 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.9 ptpt -60.79 -39.65 89.66 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.705 0.628 . . . . 15.0 111.486 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 24.5 mm-40 -87.85 5.63 39.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.384 0.673 . . . . 15.0 111.706 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.62 17.81 11.09 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.068 1.347 . . . . 15.0 112.281 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.63 112.87 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.192 0.997 . . . . 15.0 109.939 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -101.2 114.75 65.75 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.361 -0.977 . . . . 15.0 108.361 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.558 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.1 Cg_endo -74.11 153.07 46.31 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.838 2.359 . . . . 15.0 112.989 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.72 18.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.804 1.242 . . . . 15.0 108.318 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 94.48 -151.71 20.28 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.731 -0.548 . . . . 15.0 111.731 -174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.99 128.66 27.23 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.552 0.741 . . . . 15.0 110.678 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.0 Cg_endo -81.83 107.3 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.383 2.055 . . . . 15.0 111.626 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.5 m -76.96 96.09 4.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.607 0.763 . . . . 15.0 110.824 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -74.1 94.49 2.42 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.081 -0.711 . . . . 15.0 109.081 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.8 t -90.96 102.15 4.95 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.949 -0.76 . . . . 15.0 108.949 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.52 95.74 0.86 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.648 2.232 . . . . 15.0 109.995 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -46.45 93.49 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.172 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.49 146.14 4.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.557 0.743 . . . . 15.0 110.745 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -128.49 142.7 51.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.548 1.139 . . . . 15.0 108.41 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 95.0 mttt -129.83 158.61 38.97 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.235 1.014 . . . . 15.0 108.619 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.07 98.44 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.591 0.756 . . . . 15.0 110.235 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.51 19.02 74.22 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.599 -0.728 . . . . 15.0 114.39 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.743 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.1 mt-10 -110.67 158.86 18.14 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.467 0.707 . . . . 15.0 110.421 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.25 107.13 0.13 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.171 1.544 . . . . 15.0 112.896 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.482 ' H ' HD11 ' A' ' 24' ' ' ILE . 13.3 t80 -80.42 96.28 6.67 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.488 -0.778 . . . . 15.0 109.539 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.0 m -95.14 105.54 17.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.106 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -129.92 143.75 50.97 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.341 0.657 . . . . 15.0 109.905 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.1 m -99.47 105.59 17.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.7 1.2 . . . . 15.0 111.672 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 t -86.01 99.93 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.927 0.491 . . . . 15.0 109.724 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.65 106.02 18.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.419 0.688 . . . . 15.0 110.26 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.657 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.7 p90 -142.06 174.21 10.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.962 0.905 . . . . 15.0 109.233 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -116.61 164.82 14.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.779 0.831 . . . . 15.0 109.934 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.66 -177.52 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.988 0.915 . . . . 15.0 109.152 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -72.83 143.79 84.83 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.029 0.532 . . . . 15.0 110.211 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 11' ' ' LEU . 23.9 Cg_endo -89.4 -167.95 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.426 2.751 . . . . 15.0 114.946 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -88.66 155.37 19.64 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.581 -1.19 . . . . 15.0 109.433 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 123.02 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.16 0.584 . . . . 15.0 110.096 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -119.94 119.36 33.23 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.66 146.77 28.9 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.79 -0.818 . . . . 15.0 108.79 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -88.67 -171.24 3.24 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.377 0.271 . . . . 15.0 110.495 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.9 102.43 0.28 Allowed Glycine 0 C--N 1.351 1.405 0 O-C-N 123.962 0.789 . . . . 15.0 111.726 173.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.38 -23.91 67.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.963 0.905 . . . . 15.0 110.386 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.97 -24.52 66.06 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.86 1.264 . . . . 15.0 111.256 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.58 61.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.348 0.659 . . . . 15.0 110.929 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.6 mt -65.48 120.28 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.065 0.853 . . . . 15.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.29 102.89 13.32 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.606 0.762 . . . . 15.0 109.245 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.44 162.65 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.908 1.283 . . . . 15.0 107.802 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -113.69 148.69 35.92 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HE2' HD11 ' A' ' 129' ' ' ILE . 84.0 tttt -127.65 89.8 49.97 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.904 0.882 . . . . 15.0 108.753 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.36 102.66 1.63 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.218 1.945 . . . . 15.0 111.738 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.543 HD11 ' HE2' ' A' ' 127' ' ' LYS . 47.3 mm -73.02 106.35 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 169.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 427' ' ' LEU . 15.3 t -132.24 147.27 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.779 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.47 157.37 46.32 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.777 1.231 . . . . 15.0 107.894 166.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.46 87.75 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 107.454 -1.313 . . . . 15.0 107.454 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 137' ' ' VAL . 28.7 p -65.56 175.51 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.72 0.808 . . . . 15.0 110.147 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.93 -36.97 78.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.042 0.448 . . . . 15.0 110.863 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.51 91.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.831 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 71.7 m-20 -74.98 -42.61 57.22 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.451 0.701 . . . . 15.0 111.717 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 133' ' ' THR . 89.6 t -62.62 -57.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.29 -31.12 62.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.206 -0.907 . . . . 15.0 111.058 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.79 -36.38 57.93 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.518 0.511 . . . . 15.0 113.033 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -71.5 -45.1 63.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.935 0.494 . . . . 15.0 109.683 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.83 -36.12 67.13 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.477 0.711 . . . . 15.0 111.676 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.95 -45.17 86.85 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.325 1.05 . . . . 15.0 110.144 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.1 m -58.92 -46.85 86.95 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.254 0.971 . . . . 15.0 110.094 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.97 -40.21 94.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.975 0.91 . . . . 15.0 111.562 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -66.88 -36.8 83.13 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.533 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 83.4 mttt -83.63 -16.82 43.73 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -80.92 -40.62 24.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -96.6 25.34 5.21 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.656 0.783 . . . . 15.0 110.535 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.15 149.37 41.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.522 0.729 . . . . 15.0 112.336 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.5 m -70.32 120.41 15.94 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.064 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -79.43 105.71 10.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -118.69 160.25 22.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.308 1.043 . . . . 15.0 108.698 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 51.6 mt-10 -107.64 147.13 31.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.283 0.633 . . . . 15.0 110.215 173.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 240' ' ' VAL . 49.5 pttt -145.22 -178.92 6.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.109 0.964 . . . . 15.0 111.001 171.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -155.01 161.68 41.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.525 1.13 . . . . 15.0 108.001 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 -50.81 0.82 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.225 -0.75 . . . . 15.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.04 134.8 13.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.929 0.491 . . . . 15.0 110.72 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 240' ' ' VAL . 53.8 t -88.0 137.12 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 167.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.61 170.25 8.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.67 -0.863 . . . . 15.0 108.67 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.25 61.24 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.83 1.048 . . . . 15.0 113.83 -169.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.89 16.99 18.25 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.94 -176.02 4.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.946 0.879 . . . . 15.0 112.539 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 11.5 mtm180 -106.52 150.4 26.15 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.305 -1.316 . . . . 15.0 108.533 166.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.09 114.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 20.5 m -94.06 117.08 29.6 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.792 -1.188 . . . . 15.0 107.792 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.45 163.98 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.807 0.813 . . . . 15.0 111.495 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 15.7 t70 -106.58 155.14 19.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 105.703 -1.962 . . . . 15.0 105.703 159.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -154.41 169.31 24.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.348 0.594 . . . . 15.0 110.34 168.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 t -157.92 124.32 4.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.041 -1.436 . . . . 15.0 107.975 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -127.81 177.71 17.43 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 122.04 -0.412 . . . . 15.0 113.822 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.3 p -150.71 130.89 13.56 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.127 0.971 . . . . 15.0 109.715 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.59 HG11 HD23 ' A' ' 226' ' ' LEU . 47.0 t -94.7 117.72 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.5 t70 73.83 -5.36 2.04 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.768 1.227 . . . . 15.0 112.11 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.39 -0.13 23.61 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.731 -0.483 . . . . 15.0 112.471 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 15.0 pt-20 -113.04 139.46 48.66 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.63 0.715 . . . . 15.0 109.408 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.44 149.59 45.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.738 0.415 . . . . 15.0 110.728 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.517 ' HD2' HG23 ' A' ' 172' ' ' VAL . 4.5 p90 -106.84 -175.71 2.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.92 0.888 . . . . 15.0 111.794 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.556 ' HG3' HG12 ' B' ' 388' ' ' VAL . 55.7 mt-10 -53.73 116.32 2.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.1 0.96 . . . . 15.0 110.134 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 -63.67 4.38 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.037 0.836 . . . . 15.0 112.341 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.18 -62.22 4.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.471 -0.252 . . . . 15.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -88.2 150.35 23.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.086 0.954 . . . . 15.0 111.931 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 167' ' ' ASP . . . -145.37 94.02 2.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.775 -1.102 . . . . 15.0 109.576 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.6 m -78.91 121.2 24.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.935 0.494 . . . . 15.0 110.494 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.5 42.2 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.447 1.099 . . . . 15.0 112.248 171.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -71.03 129.17 38.3 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.47 -0.567 . . . . 15.0 109.47 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.72 105.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.057 0.943 . . . . 15.0 109.258 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 202' ' ' ILE . 30.8 tp -91.68 89.95 7.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.868 0.867 . . . . 15.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.3 87.18 5.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.582 -0.896 . . . . 15.0 108.582 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.6 mtp -62.19 139.17 58.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.119 0.967 . . . . 15.0 111.596 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.66 -26.86 5.6 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.81 0.694 . . . . 15.0 112.235 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -92.02 147.81 22.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.343 0.657 . . . . 15.0 110.206 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.75 65.28 3.94 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 123.021 0.343 . . . . 15.0 113.766 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -105.77 -36.0 7.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.027 0.931 . . . . 15.0 110.221 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.417 ' HE1' HD13 ' B' ' 385' ' ' LEU . 23.4 mmt -99.36 150.87 21.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.254 0.621 . . . . 15.0 111.266 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.1 pt -99.07 153.92 37.56 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 114.937 -1.029 . . . . 15.0 109.619 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.22 116.82 3.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.952 2.435 . . . . 15.0 112.281 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.9 -41.8 1.39 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.38 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.38 -59.75 2.61 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.945 0.498 . . . . 15.0 110.426 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.81 -23.14 67.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.902 -1.044 . . . . 15.0 112.278 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.04 -36.43 83.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.186 0.994 . . . . 15.0 110.927 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.581 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -72.55 -17.22 77.79 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.248 -0.887 . . . . 15.0 113.097 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 187' ' ' LEU . 31.7 mm -92.59 -48.32 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.56 0.744 . . . . 15.0 110.459 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.1 19.94 2.05 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.144 1.165 . . . . 15.0 114.144 -166.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -137.33 24.15 3.1 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.865 -0.494 . . . . 15.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -144.07 -171.33 3.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.19 0.996 . . . . 15.0 110.232 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -151.19 156.79 41.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 15.0 110.101 -178.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.564 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.46 142.67 58.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.735 0.814 . . . . 15.0 111.521 -171.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.04 -32.96 4.39 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.455 -0.793 . . . . 15.0 111.516 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.3 pt-20 -93.2 138.12 31.89 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.563 0.697 . . . . 15.0 110.572 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -121.22 105.74 10.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.653 1.181 . . . . 15.0 108.28 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -121.7 177.45 5.25 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.52 1.128 . . . . 15.0 109.568 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 57.0 m -121.04 128.32 52.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.581 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.2 pt -101.78 160.91 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.557 0.743 . . . . 15.0 109.83 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -113.46 111.07 21.31 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.739 0.815 . . . . 15.0 109.396 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.22 160.86 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.478 -1.304 . . . . 15.0 107.478 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.1 m -143.48 132.89 23.39 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.8 -1.185 . . . . 15.0 107.8 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 90.1 m-85 -85.81 139.66 35.24 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -47.68 157.93 0.83 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.283 3.322 . . . . 15.0 116.016 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -23.84 63.64 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.88 167.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.96 -18.92 55.46 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.387 1.075 . . . . 15.0 111.16 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.62 141.26 56.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.02 0.528 . . . . 15.0 112.299 -170.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -78.03 17.83 0.56 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 125.163 1.385 . . . . 15.0 114.626 -168.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.47 119.47 15.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.5 -40.66 97.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 123.928 0.768 . . . . 15.0 111.972 -175.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -63.1 -19.61 64.58 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.142 0.577 . . . . 15.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.59 HD23 HG11 ' A' ' 172' ' ' VAL . 39.9 mt -99.42 -29.85 12.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.195 0.998 . . . . 15.0 111.691 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -57.83 105.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.77 1.228 . . . . 15.0 111.117 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.74 -19.49 28.91 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.57 -0.741 . . . . 15.0 113.408 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.94 145.48 31.24 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.64 0.776 . . . . 15.0 111.468 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -88.34 126.13 35.04 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.897 -1.047 . . . . 15.0 110.185 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.93 113.94 27.85 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.944 0.898 . . . . 15.0 109.238 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -103.78 101.69 11.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.723 0.809 . . . . 15.0 110.145 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -95.68 117.52 30.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.255 1.022 . . . . 15.0 109.998 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.55 96.76 4.84 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.16 116.39 26.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.036 0.934 . . . . 15.0 110.084 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 9.8 m120 -99.3 91.92 5.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.097 -1.075 . . . . 15.0 108.097 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 74.8 mt -68.47 109.25 3.61 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.099 -0.704 . . . . 15.0 109.099 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.84 -37.58 5.83 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 73.1 mmtt -133.99 122.58 23.24 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.844 0.858 . . . . 15.0 110.017 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 207' ' ' ALA . 89.0 t -95.58 132.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 105.55 -2.019 . . . . 15.0 105.55 161.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 37.6 mt-10 -120.01 179.35 4.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.96 117.5 5.73 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.871 0.868 . . . . 15.0 109.171 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -84.75 86.6 7.32 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.244 1.021 . . . . 15.0 108.348 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.04 146.7 28.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.682 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 75.1 mt -54.32 122.7 38.83 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 123.836 0.854 . . . . 15.0 110.592 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.14 -169.95 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.371 2.714 . . . . 15.0 112.944 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.58 106.53 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.216 -0.661 . . . . 15.0 109.216 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 252' ' ' PHE . 33.3 tp -82.99 14.95 2.99 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.343 1.057 . . . . 15.0 110.299 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.2 p -60.19 174.96 0.46 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.103 1.361 . . . . 15.0 112.321 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.49 -54.78 3.04 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.807 1.643 . . . . 15.0 113.86 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.45 -22.78 67.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 248' ' ' LEU . 71.2 t80 -90.37 -52.26 5.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.37 0.668 . . . . 15.0 110.254 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 266' ' ' LEU . 15.8 tt -66.4 -26.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.691 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.672 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 20.8 ptmt -82.6 -16.36 48.73 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 111.932 0.345 . . . . 15.0 111.932 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -58.83 -34.53 71.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.047 0.939 . . . . 15.0 110.95 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -62.76 -28.18 69.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.763 -1.108 . . . . 15.0 111.96 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.82 1.6 0.82 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.583 -0.565 . . . . 15.0 113.461 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 21.3 t -72.83 151.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.272 0.629 . . . . 15.0 110.06 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -67.57 -64.06 0.93 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.527 1.131 . . . . 15.0 110.483 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -102.64 -40.53 6.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.338 -1.301 . . . . 15.0 109.836 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 128.34 12.8 2.73 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.558 -0.746 . . . . 15.0 113.21 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 p -64.97 138.24 58.24 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.579 0.689 . . . . 15.0 110.375 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.89 -38.14 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.245 1.018 . . . . 15.0 111.711 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -55.48 -34.7 64.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.498 0.719 . . . . 15.0 111.388 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.21 -28.08 62.78 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.598 -0.601 . . . . 15.0 111.598 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 270' ' ' VAL . 58.9 tp -73.39 -32.72 64.61 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.37 -42.04 93.14 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.34 0.656 . . . . 15.0 109.699 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.03 90.61 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.928 -1.033 . . . . 15.0 110.39 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 15.6 tp10 -67.15 -39.99 86.61 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.729 -1.123 . . . . 15.0 111.465 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 266' ' ' LEU . 24.6 m -75.57 -24.42 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.044 -0.41 . . . . 15.0 110.253 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -69.03 -60.56 2.27 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 121.947 -0.471 . . . . 15.0 110.856 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.7 ptmt -61.9 -23.26 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 15.0 112.32 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -88.65 -69.48 0.7 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.403 0.281 . . . . 15.0 110.406 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 53.6 mtt -71.83 -45.33 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.895 -0.574 . . . . 15.0 112.361 -166.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.14 -42.16 72.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.625 0.648 . . . . 15.0 110.383 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 44.9 ttp85 -58.7 -53.55 57.14 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.167 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.26 -27.68 64.62 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.98 0.8 . . . . 15.0 111.084 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' VAL . 59.9 tp -67.5 -54.96 15.64 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.557 0.743 . . . . 15.0 110.562 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.02 -31.36 72.48 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.583 0.753 . . . . 15.0 110.316 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.2 t -68.89 -43.18 75.78 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 123.801 0.84 . . . . 15.0 110.0 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.86 98.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.146 0.578 . . . . 15.0 110.386 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 130' ' ' VAL . 73.4 mt -63.08 -49.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.011 0.924 . . . . 15.0 109.17 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.98 -54.96 38.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.648 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.22 -35.1 80.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.16 0.984 . . . . 15.0 111.019 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -65.57 -55.0 20.11 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.577 0.626 . . . . 15.0 110.996 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.66 -42.57 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.303 0.641 . . . . 15.0 110.366 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.5 tttt -58.36 -51.31 70.35 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.567 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 292' ' ' GLU . 90.2 p -69.11 -31.68 70.56 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.531 0.519 . . . . 15.0 111.292 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -69.1 -39.44 78.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.907 0.483 . . . . 15.0 110.093 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.419 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.5 -48.27 75.82 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.352 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 33.4 mm -67.12 -36.89 78.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 123.803 0.689 . . . . 15.0 110.709 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 288' ' ' SER . 8.4 tp10 -62.88 -47.76 81.95 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.271 -0.64 . . . . 15.0 109.271 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.28 94.05 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 124.698 1.249 . . . . 15.0 112.531 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB3' HD13 ' A' ' 350' ' ' LEU . 28.3 mt -59.96 -57.86 11.02 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 123.439 0.696 . . . . 15.0 110.39 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.4 t -56.09 -46.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.528 0.731 . . . . 15.0 110.159 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.84 -35.29 74.43 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.892 0.877 . . . . 15.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.15 -4.61 42.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.125 0.57 . . . . 15.0 112.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -133.9 115.12 14.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.972 0.805 . . . . 15.0 111.05 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.42 130.57 47.66 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.476 HD13 HD13 ' A' ' 349' ' ' LEU . 3.3 tt -149.13 146.11 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.344 1.058 . . . . 15.0 109.051 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 113' ' ' PRO . 29.3 t70 -72.05 140.67 49.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 307' ' ' ILE . 40.4 t -117.73 105.29 48.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.57 130.36 29.62 Favored 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 123.217 2.611 . . . . 15.0 112.563 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.43 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.21 -29.93 67.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.872 1.269 . . . . 15.0 112.554 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.549 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -54.1 -39.14 66.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.127 0.971 . . . . 15.0 111.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.78 -30.54 56.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.467 -0.788 . . . . 15.0 111.222 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -62.58 -49.96 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.841 -0.8 . . . . 15.0 108.841 173.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.33 -42.02 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.238 -0.892 . . . . 15.0 110.58 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 313' ' ' VAL . 36.5 t -57.44 -60.91 2.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.169 0.918 . . . . 15.0 111.219 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -69.8 -39.47 76.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.386 0.513 . . . . 15.0 112.386 -171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 14.9 mt -61.38 -43.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 119.035 -0.507 . . . . 15.0 109.694 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.26 -43.57 87.96 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.851 0.461 . . . . 15.0 111.208 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 309' ' ' SER . 81.2 t -54.74 -51.08 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.73 0.812 . . . . 15.0 110.339 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 341' ' ' ALA . 72.6 mt -71.4 -27.5 63.36 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.075 -0.966 . . . . 15.0 112.459 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 29.1 mtm180 . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 109.563 -0.532 . . . . 15.0 109.563 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.105 0.478 . . . . 15.0 112.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.01 72.66 1.42 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.966 0.889 . . . . 15.0 110.089 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 73.1 mt -81.05 153.71 72.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 153.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.29 108.73 0.21 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.959 2.439 . . . . 15.0 113.369 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -55.95 -29.09 59.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.254 1.022 . . . . 15.0 110.859 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.08 -21.42 31.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.572 1.149 . . . . 15.0 111.878 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.06 -35.31 20.37 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.542 0.737 . . . . 15.0 111.118 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.523 ' HA ' HE21 ' A' ' 340' ' ' GLN . 23.5 m-85 -107.34 -14.38 14.89 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.879 0.696 . . . . 15.0 112.879 -167.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.96 -62.55 1.58 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.851 1.26 . . . . 15.0 112.029 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.45 -46.29 73.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.728 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.523 HE21 ' HA ' ' A' ' 337' ' ' PHE . 25.4 pt20 -67.99 -37.24 81.25 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.624 0.578 . . . . 15.0 111.623 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -64.94 -52.71 54.87 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -51.57 -40.67 60.21 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 124.642 1.214 . . . . 15.0 110.83 176.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 347' ' ' VAL . 15.6 mmt180 -60.26 -46.87 88.32 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 123.418 0.687 . . . . 15.0 110.402 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -63.63 -34.21 77.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.473 0.483 . . . . 15.0 111.219 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.81 -53.89 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 15.0 110.148 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 62.5 t -65.43 -31.06 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.313 0.645 . . . . 15.0 110.957 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 343' ' ' ARG . 40.3 t -60.46 -50.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.522 0.729 . . . . 15.0 109.095 170.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.76 -33.74 88.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.636 -0.711 . . . . 15.0 113.759 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.476 HD13 HD13 ' A' ' 300' ' ' ILE . 96.0 mt -73.82 -54.7 7.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.929 0.491 . . . . 15.0 110.574 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 294' ' ' LEU . 75.6 mt -68.87 -52.67 27.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.891 0.476 . . . . 15.0 110.812 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.14 -38.11 89.55 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 119.275 -0.393 . . . . 15.0 110.834 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.98 -38.41 88.98 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.753 0.658 . . . . 15.0 112.544 176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -69.25 -40.6 77.77 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 119.295 -0.383 . . . . 15.0 111.316 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 350' ' ' LEU . 81.2 t -57.39 -39.94 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.211 0.529 . . . . 15.0 110.575 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.84 -45.46 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.756 1.222 . . . . 15.0 110.755 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.458 ' HA ' ' HE2' ' B' ' 461' ' ' PHE . 20.2 ttp180 -61.28 -53.14 60.56 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.021 0.529 . . . . 15.0 110.785 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 33.0 m -57.13 -50.37 73.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.62 1.168 . . . . 15.0 111.433 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -90.66 14.8 12.39 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.638 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 43.04 36.2 0.89 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 125.375 1.47 . . . . 15.0 114.136 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.532 ' HB3' HE21 ' A' ' 406' ' ' GLN . 99.0 mt -67.26 149.17 50.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.047 0.939 . . . . 15.0 112.159 -176.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.61 150.91 52.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.333 1.053 . . . . 15.0 109.699 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.77 104.49 3.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.38 -0.6 . . . . 15.0 109.38 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.78 132.64 42.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.149 0.58 . . . . 15.0 110.395 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -63.94 -30.85 71.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.88 0.872 . . . . 15.0 112.48 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -86.04 -10.64 54.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.961 0.504 . . . . 15.0 111.436 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.5 tpt85 -81.33 -38.13 27.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 371' ' ' ILE . 89.7 t -58.16 -58.29 7.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.837 1.255 . . . . 15.0 109.18 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 372' ' ' GLU . 24.0 mmmt -59.49 -39.62 84.35 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 115.628 -0.715 . . . . 15.0 111.589 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.33 67.06 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.934 0.772 . . . . 15.0 112.436 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.08 -42.49 84.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.31 0.644 . . . . 15.0 111.96 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 367' ' ' VAL . 50.5 mm -52.77 -44.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 123.992 0.807 . . . . 15.0 110.686 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 368' ' ' LYS . 14.7 mm-40 -70.06 -54.71 11.9 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.46 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -52.43 -36.97 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.837 0.855 . . . . 15.0 112.463 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 60.4 ttp -80.09 -69.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.774 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.87 79.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.858 0.863 . . . . 15.0 113.297 -164.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -21.44 64.92 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.037 0.535 . . . . 15.0 112.166 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -66.79 -20.32 65.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.739 0.816 . . . . 15.0 112.591 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.49 167.83 9.89 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.383 0.673 . . . . 15.0 110.646 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -80.01 -9.73 59.71 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.851 . . . . 15.0 110.809 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.42 59.78 46.08 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.991 1.317 . . . . 15.0 110.545 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.75 -27.95 4.51 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 121.931 1.754 . . . . 15.0 112.301 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -54.79 -45.78 74.37 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.254 1.022 . . . . 15.0 111.042 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 12.7 pt-20 -65.57 -31.46 72.51 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.84 -1.073 . . . . 15.0 111.242 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.96 -37.84 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.277 0.631 . . . . 15.0 109.912 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.95 -54.21 37.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 108.607 -0.886 . . . . 15.0 108.607 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.35 -27.52 67.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.525 0.73 . . . . 15.0 111.527 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 383' ' ' GLU . 24.0 t80 -62.19 -44.01 97.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.99 0.916 . . . . 15.0 109.877 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -82.71 -66.27 0.91 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.638 0.607 . . . . 15.0 112.638 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . 0.586 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 84.4 p -56.45 -27.23 56.27 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.474 1.287 . . . . 15.0 114.474 -169.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -103.36 27.72 7.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.079 0.551 . . . . 15.0 110.396 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -149.8 105.35 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.296 -1.002 . . . . 15.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -55.6 -38.73 69.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.264 1.026 . . . . 15.0 111.726 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.34 -36.61 66.2 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 123.782 0.676 . . . . 15.0 111.625 -174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 397' ' ' ASN . 11.3 mt -74.98 -32.98 61.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.763 0.425 . . . . 15.0 111.117 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 90.0 mmm -62.83 -38.88 92.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 171.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.27 -38.21 78.27 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 123.719 0.637 . . . . 15.0 109.983 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.44 HD22 HD23 ' A' ' 394' ' ' LEU . 88.6 m-20 -62.1 -39.66 93.25 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 123.559 0.744 . . . . 15.0 110.54 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.449 ' HA ' HG12 ' A' ' 401' ' ' VAL . 43.1 tpp -77.34 -23.78 50.86 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.543 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' B' ' 463' ' ' THR . 43.2 mtm-85 -74.95 -31.83 61.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.143 0.577 . . . . 15.0 110.318 169.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -55.87 22.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.478 0.711 . . . . 15.0 109.398 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.5 p -69.43 -29.97 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 123.788 0.68 . . . . 15.0 111.745 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.66 -53.62 55.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.861 -0.422 . . . . 15.0 109.861 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.656 HD22 HG23 ' B' ' 463' ' ' THR . 48.1 tp -71.3 -30.11 65.86 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.903 -1.044 . . . . 15.0 111.687 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.25 -57.07 10.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.723 1.209 . . . . 15.0 109.953 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -67.12 -32.43 73.56 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.27 -0.877 . . . . 15.0 110.633 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.532 HE21 ' HB3' ' A' ' 360' ' ' LEU . 25.0 tt0 -63.91 -37.77 88.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.042 0.537 . . . . 15.0 110.388 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.49 85.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.748 0.819 . . . . 15.0 110.891 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 74.8 t -55.81 -53.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 123.955 0.784 . . . . 15.0 109.306 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -30.35 70.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.104 0.962 . . . . 15.0 112.023 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.4 -30.86 68.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.929 0.491 . . . . 15.0 110.895 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.01 -39.51 57.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 77.0 mt -72.84 -26.37 61.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.436 1.094 . . . . 15.0 112.007 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.72 73.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.96 0.904 . . . . 15.0 110.054 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.3 -34.94 13.32 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.593 -1.185 . . . . 15.0 110.094 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -81.93 154.61 25.69 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.316 1.046 . . . . 15.0 111.465 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.5 86.73 3.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.952 -1.022 . . . . 15.0 110.147 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -84.61 94.12 3.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.57 0.7 . . . . 15.0 109.712 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -70.48 95.19 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.115 -0.948 . . . . 15.0 108.647 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.33 138.87 37.87 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 114.991 -1.004 . . . . 15.0 110.131 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.415 ' HE3' HG21 ' A' ' 422' ' ' THR . 62.1 pttt -144.42 137.35 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 173.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.89 122.4 30.7 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.128 -1.064 . . . . 15.0 108.128 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.415 HG21 ' HE3' ' A' ' 420' ' ' LYS . 8.8 t -149.78 175.52 11.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.008 0.523 . . . . 15.0 110.69 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -89.92 161.07 16.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.71 1.204 . . . . 15.0 112.119 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 26.5 t80 -52.68 -48.59 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.234 1.414 . . . . 15.0 111.253 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -58.79 -19.4 40.56 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.161 0.913 . . . . 15.0 112.886 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 427' ' ' LEU . 7.7 tp10 -54.06 -49.95 67.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.382 1.073 . . . . 15.0 112.127 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 130' ' ' VAL . 5.5 mp -75.37 -29.18 59.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.788 0.835 . . . . 15.0 111.507 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -77.14 -41.97 39.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 174.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 N--CA 1.482 1.131 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.16 179.504 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . 0.417 HD13 ' HE1' ' A' ' 194' ' ' MET . 18.9 tp . . . . . 0 C--O 1.248 0.986 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 178' ' ' GLU . 8.1 p -77.39 97.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 122.895 1.331 . . . . 0.0 109.279 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 2.9 tp -149.78 156.24 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 113.954 -1.476 . . . . 0.0 107.043 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.556 HG12 ' HG3' ' A' ' 178' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 0.0 110.254 171.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.618 0.247 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . 0.458 ' HE2' ' HA ' ' A' ' 356' ' ' ARG . 97.4 m-85 -77.22 24.4 0.18 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.576 1.15 . . . . 0.0 113.751 -174.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 19.5 t80 76.92 -49.49 0.55 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.723 1.209 . . . . 0.0 113.412 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . 0.656 HG23 HD22 ' A' ' 403' ' ' LEU . 11.8 t -84.16 20.54 1.57 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.533 1.133 . . . . 0.0 113.668 -156.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 25.0 ptm -141.03 129.81 22.95 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.58 -62.12 1.74 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.514 0.725 . . . . 0.0 109.685 -173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.38 0.39 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.077 0.951 . . . . 0.0 110.522 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 125.615 1.566 . . . . 0.0 108.254 -178.717 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.654 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -78.11 97.08 5.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.162 0.585 . . . . 15.0 109.817 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -111.1 128.49 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.348 0.659 . . . . 15.0 109.479 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.3 p -129.63 110.7 12.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.094 0.558 . . . . 15.0 109.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.26 126.59 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.601 0.76 . . . . 15.0 110.417 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 32.5 mt-10 -125.55 133.22 52.4 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.8 1.24 . . . . 15.0 108.5 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 m -94.0 98.22 10.87 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.493 -0.929 . . . . 15.0 108.493 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -84.29 -51.23 7.16 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.291 0.636 . . . . 15.0 111.937 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -151.2 90.95 1.64 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.16 -100.74 0.43 Allowed Glycine 0 C--N 1.35 1.338 0 O-C-N 123.867 0.73 . . . . 15.0 113.363 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 5.2 mp -77.85 -33.14 52.34 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 15.0 109.56 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 122.72 30.63 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.363 1.039 . . . . 15.0 112.867 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -135.46 129.03 32.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.572 1.149 . . . . 15.0 110.259 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 43.4 ttm180 -96.64 101.82 13.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.431 1.092 . . . . 15.0 110.022 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.03 94.41 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 169.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 85.8 m -78.32 102.74 7.84 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.482 -0.781 . . . . 15.0 109.467 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -95.74 131.92 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.737 0.815 . . . . 15.0 109.315 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 33.9 m -116.07 118.81 33.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 70' ' ' LEU . 58.6 mt -93.03 120.12 41.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.77 154.11 42.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.173 0.589 . . . . 15.0 111.166 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.65 -39.99 62.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.238 1.415 . . . . 15.0 113.183 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.65 -38.64 77.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.407 0.683 . . . . 15.0 110.984 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -70.22 -32.31 70.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.61 0.764 . . . . 15.0 110.824 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 76.4 mt -66.79 -54.14 27.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.962 0.905 . . . . 15.0 109.384 173.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -59.94 -38.79 83.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.421 1.076 . . . . 15.0 111.761 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -63.75 -45.18 91.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.779 0.674 . . . . 15.0 110.27 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -33.64 73.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.543 0.737 . . . . 15.0 112.277 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.643 ' HA ' HG21 ' A' ' 66' ' ' VAL . 68.0 t -69.54 -42.47 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.261 0.624 . . . . 15.0 109.423 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -68.02 -31.03 70.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.263 -0.88 . . . . 15.0 111.079 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 m -69.1 -37.39 78.37 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.474 -0.785 . . . . 15.0 109.702 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.6 tp10 -69.37 -39.53 78.01 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.826 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 91.6 mt -67.24 -34.69 77.99 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.316 0.646 . . . . 15.0 111.725 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 p -80.97 -17.63 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 O-C-N 123.317 0.386 . . . . 15.0 110.604 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.44 -46.64 66.29 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.452 -0.574 . . . . 15.0 109.452 168.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 40.0 t -65.09 -39.11 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 123.876 0.735 . . . . 15.0 109.891 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.55 -55.38 31.55 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 115.198 -0.91 . . . . 15.0 110.671 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 97.2 mttt -66.18 -30.03 70.42 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.423 0.452 . . . . 15.0 111.98 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 36.5 ttpt -64.29 -46.71 82.44 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.491 0.717 . . . . 15.0 111.118 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.1 t -94.03 3.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.348 0.659 . . . . 15.0 110.154 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 24.8 mmt180 65.17 16.8 10.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.866 1.666 . . . . 15.0 112.43 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.1 mt -54.08 -31.04 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.562 1.545 . . . . 15.0 111.784 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.756 0.822 . . . . 15.0 111.037 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -39.13 79.26 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.08 -0.509 . . . . 15.0 112.03 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.99 -22.17 59.71 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.142 0.577 . . . . 15.0 111.003 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -65.93 116.55 7.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.386 1.074 . . . . 15.0 110.145 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.82 1.99 48.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.064 0.945 . . . . 15.0 111.329 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.91 69.85 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.28 0.362 . . . . 15.0 112.706 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -77.15 -49.4 15.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.636 0.774 . . . . 15.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.88 117.36 61.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 108.486 -0.931 . . . . 15.0 108.486 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD2' HD12 ' A' ' 53' ' ' ILE . 87.5 Cg_exo -48.75 142.39 18.93 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.417 2.745 . . . . 15.0 113.484 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 54' ' ' VAL . 56.4 tpp -64.01 -26.57 68.63 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 15.0 111.298 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.27 -35.18 77.49 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.592 0.357 . . . . 15.0 111.64 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 50' ' ' PRO . 43.1 mt -72.68 -46.93 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.685 0.794 . . . . 15.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 51' ' ' MET . 31.1 m -68.66 -21.14 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 122.429 -0.169 . . . . 15.0 111.291 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.21 -47.77 60.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.059 0.544 . . . . 15.0 111.862 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.59 -19.79 48.51 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.755 -0.657 . . . . 15.0 111.627 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -94.45 -70.15 0.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.551 0.34 . . . . 15.0 111.252 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.61 -22.8 59.91 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.287 0.635 . . . . 15.0 111.613 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.84 14.56 59.94 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.305 -0.72 . . . . 15.0 114.041 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 -42.61 66.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.497 0.719 . . . . 15.0 111.574 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 p -77.11 -32.76 56.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.291 0.636 . . . . 15.0 110.298 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.7 t -67.17 -18.79 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.616 1.166 . . . . 15.0 111.321 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HD3' HG21 ' A' ' 28' ' ' VAL . 17.1 mmt180 -51.05 -44.8 61.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.283 0.633 . . . . 15.0 110.599 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -51.85 -55.48 19.74 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.429 1.092 . . . . 15.0 111.456 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.76 -48.96 79.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.625 -1.17 . . . . 15.0 111.095 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 28' ' ' VAL . 79.6 t -64.24 -49.17 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.367 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.7 mt -56.84 -43.44 81.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 123.837 0.711 . . . . 15.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.7 -47.57 90.27 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.294 0.996 . . . . 15.0 112.002 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.97 -41.39 97.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.649 1.18 . . . . 15.0 111.454 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.425 ' HB3' HD13 ' A' ' 19' ' ' ILE . 59.2 mt -64.59 -27.2 68.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.262 -0.881 . . . . 15.0 111.235 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.448 ' SD ' ' HG3' ' A' ' 94' ' ' PRO . 68.4 mtm -59.21 -40.93 87.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.361 0.413 . . . . 15.0 111.049 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -81.59 -50.01 9.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.779 0.432 . . . . 15.0 111.105 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -75.19 -24.14 57.77 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.404 HD21 HD22 ' A' ' 70' ' ' LEU . 26.1 m-80 -81.31 -25.85 36.14 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.927 0.33 . . . . 15.0 110.288 172.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -77.96 -42.23 33.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.686 0.394 . . . . 15.0 111.171 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.0 -27.4 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.26 0.552 . . . . 15.0 110.081 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.57 -41.49 54.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.429 0.692 . . . . 15.0 109.981 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -62.8 -47.09 84.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 15.0 111.869 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -60.13 -27.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 112.79 0.663 . . . . 15.0 112.79 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.9 mt -71.81 -47.33 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.942 0.897 . . . . 15.0 110.568 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.4 ptpt -75.96 -29.97 58.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.622 0.369 . . . . 15.0 110.785 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.87 -22.28 53.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.757 . . . . 15.0 111.132 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 62.85 23.86 14.23 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.482 1.113 . . . . 15.0 111.428 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.6 mt -105.35 97.9 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.314 -0.995 . . . . 15.0 108.314 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -72.53 116.92 54.44 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.528 -0.916 . . . . 15.0 108.528 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.7 158.65 35.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.521 2.147 . . . . 15.0 113.127 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.59 167.88 21.98 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.81 -1.086 . . . . 15.0 108.956 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 82.14 -136.15 15.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.697 -0.683 . . . . 15.0 111.458 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.14 97.65 45.35 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 108.263 -1.014 . . . . 15.0 108.263 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.4 106.36 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.018 1.812 . . . . 15.0 110.792 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.6 m -92.25 98.3 11.43 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.277 0.631 . . . . 15.0 109.58 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -76.45 83.42 3.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.158 0.983 . . . . 15.0 109.316 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.51 106.33 10.09 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 118.536 -0.745 . . . . 15.0 109.147 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HG3' ' SD ' ' A' ' 71' ' ' MET . 16.3 Cg_exo -68.79 110.42 2.35 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.4 2.067 . . . . 15.0 111.33 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -59.12 11.36 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.773 0.671 . . . . 15.0 111.99 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.27 168.05 13.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 15.0 111.483 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HB2' ' HD1' ' A' ' 103' ' ' PHE . 76.1 t80 -147.29 143.57 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.571 1.149 . . . . 15.0 109.17 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 49.1 mtmt -122.52 144.4 49.1 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 170.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.58 108.41 0.82 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.943 0.897 . . . . 15.0 111.86 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.58 62.29 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.578 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.9 mt-10 -99.23 -173.17 2.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.482 1.113 . . . . 15.0 109.392 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.1 154.12 42.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.647 0.736 . . . . 15.0 112.897 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' HD1' ' HB2' ' A' ' 97' ' ' TYR . 56.2 t80 -119.01 141.61 48.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.153 1.381 . . . . 15.0 108.392 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -132.57 140.31 48.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -147.35 136.23 22.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.789 0.836 . . . . 15.0 109.535 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 70.8 m -103.5 123.77 47.52 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.324 1.05 . . . . 15.0 109.589 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.88 110.3 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.101 0.56 . . . . 15.0 110.253 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -101.1 130.41 47.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.68 0.392 . . . . 15.0 110.298 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.6 157.05 37.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 15.0 109.544 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.85 164.66 23.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.284 0.634 . . . . 15.0 109.632 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.5 m -123.23 178.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.239 0.615 . . . . 15.0 109.442 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -86.3 108.01 15.74 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 15.0 108.489 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.54 163.64 26.73 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.451 2.101 . . . . 15.0 113.018 -170.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.92 89.22 5.87 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.67 111.48 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.514 -1.221 . . . . 15.0 110.017 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -96.14 98.49 10.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.892 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 120' ' ' LEU . 85.7 mt -73.03 129.01 37.13 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -136.98 111.14 8.36 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.32 75.89 0.21 Allowed Glycine 0 C--N 1.353 1.504 0 O-C-N 124.324 1.015 . . . . 15.0 113.519 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 117' ' ' LEU . 17.8 mt -75.59 -11.64 60.05 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.055 0.428 . . . . 15.0 110.874 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 13.2 mp0 -74.53 -28.08 60.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.303 1.041 . . . . 15.0 110.146 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.76 62.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.044 0.937 . . . . 15.0 112.078 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.476 HG23 ' HA3' ' A' ' 293' ' ' GLY . 65.2 mt -68.88 134.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.717 0.807 . . . . 15.0 109.731 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.1 mt-10 -118.29 110.87 18.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.458 0.703 . . . . 15.0 109.263 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 417' ' ' VAL . 47.1 t -115.97 156.19 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.529 1.132 . . . . 15.0 109.68 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.53 141.04 39.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.993 0.917 . . . . 15.0 108.692 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 83.1 tttt -112.43 89.9 13.43 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 107.344 -1.354 . . . . 15.0 107.344 170.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.54 95.41 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.403 2.068 . . . . 15.0 111.087 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.15 87.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.202 -1.407 . . . . 15.0 107.202 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 282' ' ' ILE . 3.2 t -122.38 141.24 43.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.576 -1.193 . . . . 15.0 109.56 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.94 165.5 24.86 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.813 -1.551 . . . . 15.0 106.813 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.53 85.9 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.683 -1.599 . . . . 15.0 106.683 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 137' ' ' VAL . 26.6 p -69.12 175.78 3.61 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.554 0.742 . . . . 15.0 110.238 -175.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.21 -43.38 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.022 0.374 . . . . 15.0 110.296 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.34 80.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.875 0.87 . . . . 15.0 111.298 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.44 -39.03 54.59 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.743 0.417 . . . . 15.0 111.662 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 133' ' ' THR . 91.5 t -65.09 -53.71 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 108.933 -0.766 . . . . 15.0 108.933 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -63.5 -48.63 76.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.148 0.905 . . . . 15.0 110.385 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.01 93.85 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 123.877 0.735 . . . . 15.0 114.195 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -80.51 -45.44 17.49 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.978 0.511 . . . . 15.0 111.111 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 270' ' ' VAL . 48.1 mt -54.52 -34.56 61.93 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.457 0.572 . . . . 15.0 112.025 167.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.74 -45.8 84.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.403 1.081 . . . . 15.0 109.623 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -60.78 -36.84 80.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.624 0.77 . . . . 15.0 111.628 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 HD23 ' A' ' 141' ' ' LEU . 96.1 mt -70.31 -40.33 74.28 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.254 0.621 . . . . 15.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.64 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 68.0 mtm180 -74.44 -18.78 60.59 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.743 -0.662 . . . . 15.0 111.619 174.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 97.0 mttt -85.36 -22.56 28.39 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.077 0.399 . . . . 15.0 111.233 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.461 ' HG2' HE21 ' A' ' 148' ' ' GLN . 46.4 tt0 -72.13 -42.17 66.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 15.0 109.362 171.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.461 HE21 ' HG2' ' A' ' 147' ' ' GLN . 30.8 mm-40 -104.87 41.32 1.35 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.003 . . . . 15.0 110.1 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.12 139.06 41.14 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.6 m -81.36 126.77 32.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.132 0.973 . . . . 15.0 109.398 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -80.97 111.01 17.05 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -120.66 114.87 22.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.909 0.883 . . . . 15.0 109.79 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 52.7 mt-10 -73.19 119.57 17.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.847 0.459 . . . . 15.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 28.6 pttt -106.02 176.8 5.05 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.39 0.676 . . . . 15.0 110.32 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -115.55 99.4 7.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.133 0.573 . . . . 15.0 111.487 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.505 ' HA2' ' H ' ' A' ' 207' ' ' ALA . . . 58.66 58.76 12.85 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.589 168.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 98.89 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.298 0.549 . . . . 15.0 109.688 172.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 203' ' ' LYS . 14.2 t -96.98 130.2 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 120.914 0.388 . . . . 15.0 110.953 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 -168.4 2.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.749 1.62 . . . . 15.0 109.18 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.76 -2.64 54.96 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.031 0.932 . . . . 15.0 112.585 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -97.49 8.4 44.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.22 0.608 . . . . 15.0 111.829 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 1.1 m-20 -92.41 176.41 6.48 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.388 1.089 . . . . 15.0 113.873 -166.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 3.1 tmt_? -143.42 90.21 2.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.519 -2.4 . . . . 15.0 104.519 167.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 166' ' ' ILE . 33.2 t -93.36 152.28 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.766 0.826 . . . . 15.0 110.561 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.717 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 11.4 m -126.1 117.68 23.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.773 -1.195 . . . . 15.0 107.773 173.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 237' ' ' LEU . 38.6 pt -128.24 173.4 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.982 0.913 . . . . 15.0 111.963 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.35 134.1 50.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.766 -1.198 . . . . 15.0 107.766 163.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -127.72 149.85 50.04 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.709 0.231 . . . . 15.0 110.483 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.56 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 9.0 t -131.81 113.32 13.36 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 165.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.44 148.81 18.78 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.9 -0.591 . . . . 15.0 113.725 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.3 m -146.07 118.08 8.26 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.312 -1.366 . . . . 15.0 107.312 167.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 98.9 t -88.69 114.97 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.967 0.907 . . . . 15.0 109.334 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 67.91 7.8 6.02 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.405 1.082 . . . . 15.0 111.325 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.92 26.14 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 121.769 -0.582 . . . . 15.0 113.507 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.6 pt-20 -98.64 134.89 40.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.552 0.676 . . . . 15.0 109.196 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.81 85.59 3.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.048 0.451 . . . . 15.0 110.069 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.511 ' HD2' HG23 ' B' ' 388' ' ' VAL . 0.1 OUTLIER -43.44 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.755 1.622 . . . . 15.0 111.85 172.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.24 172.69 7.01 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.961 1.304 . . . . 15.0 109.313 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.6 71.52 0.67 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.22 -1.552 . . . . 15.0 109.22 155.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.79 57.48 4.25 Favored Glycine 0 C--N 1.356 1.684 0 C-N-CA 123.915 0.769 . . . . 15.0 114.401 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 24.6 mmtt -107.15 149.87 27.21 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.617 1.167 . . . . 15.0 110.163 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.19 93.36 0.69 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.988 0.805 . . . . 15.0 109.204 173.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 129.6 36.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.2 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 66.23 32.64 7.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.312 1.045 . . . . 15.0 111.483 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.16 130.27 43.87 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.76 102.7 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.549 0.74 . . . . 15.0 109.536 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 202' ' ' ILE . 27.0 tp -93.95 91.85 7.09 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 170.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -70.15 92.7 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 173.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER -66.5 154.57 39.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.789 0.836 . . . . 15.0 111.241 -175.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.45 -19.03 13.16 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.173 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -102.69 122.82 45.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.495 0.718 . . . . 15.0 109.38 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.23 61.34 4.78 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.239 -0.744 . . . . 15.0 111.239 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -31.23 11.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.884 0.874 . . . . 15.0 109.174 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 25.9 mmt -75.07 160.78 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.973 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.2 pt -59.72 130.96 88.55 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 115.057 -0.974 . . . . 15.0 110.426 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.64 115.85 2.69 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.25 2.633 . . . . 15.0 112.215 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.53 -42.1 1.53 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.475 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.05 -65.0 0.73 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 122.687 0.395 . . . . 15.0 110.109 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 189' ' ' MET . 10.8 pt-20 -66.59 -26.43 67.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.019 0.825 . . . . 15.0 111.42 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.0 m-20 -68.31 -32.28 72.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.98 0.912 . . . . 15.0 110.62 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.45 -11.08 85.83 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.39 -0.823 . . . . 15.0 112.837 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.409 HG21 HD23 ' A' ' 187' ' ' LEU . 23.7 mm -92.11 -53.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.962 -0.755 . . . . 15.0 108.962 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.563 ' HA ' HG12 ' A' ' 158' ' ' VAL . 57.9 pttt -83.12 31.79 0.44 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.63 1.172 . . . . 15.0 112.577 -170.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.59 25.99 2.42 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.896 -0.882 . . . . 15.0 110.896 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -145.91 -166.04 2.35 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.271 1.028 . . . . 15.0 110.41 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 8.8 ptpp? -146.44 159.16 43.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.14 0.976 . . . . 15.0 110.425 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.67 145.59 55.84 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 120.733 0.302 . . . . 15.0 111.517 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.82 -44.03 1.51 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.984 -0.846 . . . . 15.0 110.984 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.6 pt-20 -77.6 129.95 36.27 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.921 -0.639 . . . . 15.0 109.695 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.94 109.8 18.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.693 -1.225 . . . . 15.0 107.693 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -128.45 -171.05 2.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.011 1.324 . . . . 15.0 110.133 -169.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 72.9 m -132.02 129.09 39.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.917 0.887 . . . . 15.0 108.867 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.9 pt -98.55 150.24 5.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.032 0.533 . . . . 15.0 110.396 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.26 112.3 24.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.84 -1.073 . . . . 15.0 108.973 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.6 166.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 67.6 m -141.44 129.19 21.64 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.22 133.41 81.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.733 -0.651 . . . . 15.0 109.584 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 221' ' ' TYR . 35.8 Cg_exo -44.45 161.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 124.234 3.289 . . . . 15.0 115.412 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -75.92 -30.08 58.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.652 -0.704 . . . . 15.0 110.349 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.38 -31.39 68.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.17 0.588 . . . . 15.0 110.525 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 218' ' ' PRO . 25.8 t80 -48.59 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.821 1.648 . . . . 15.0 110.554 -172.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.999 1.111 . . . . 15.0 113.999 -160.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.99 92.91 0.54 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 165.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.33 -41.87 85.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.952 0.901 . . . . 15.0 111.289 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.59 -15.92 43.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.082 0.953 . . . . 15.0 112.825 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.499 HD22 HG21 ' A' ' 172' ' ' VAL . 64.7 mt -107.46 -30.9 8.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.915 0.886 . . . . 15.0 111.197 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -51.78 121.31 6.36 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.336 1.455 . . . . 15.0 112.036 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.06 -22.84 12.68 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.772 0.67 . . . . 15.0 113.942 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.1 147.16 40.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.304 0.552 . . . . 15.0 111.037 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.21 111.92 23.82 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.499 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.92 133.43 34.78 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.574 0.749 . . . . 15.0 111.874 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -90.0 107.68 19.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.198 0.999 . . . . 15.0 108.574 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.26 108.64 19.31 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.397 -0.964 . . . . 15.0 108.397 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.38 96.36 4.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.765 0.426 . . . . 15.0 109.993 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 mm -87.47 128.6 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.179 0.992 . . . . 15.0 110.651 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.9 100.93 8.8 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.313 1.045 . . . . 15.0 108.216 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 166' ' ' ILE . 87.5 mt -78.6 94.61 5.05 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.036 0.446 . . . . 15.0 109.816 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.19 -44.63 7.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.123 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.717 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.7 mmtt -127.31 135.84 51.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.239 0.616 . . . . 15.0 110.036 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 207' ' ' ALA . 98.6 t -127.6 103.68 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.573 1.149 . . . . 15.0 108.623 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 29.2 mt-10 -104.03 -175.26 2.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.639 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.0 tt0 -142.89 129.64 20.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.21 -0.663 . . . . 15.0 109.21 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 -78.55 84.39 4.68 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.37 144.14 30.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.984 -1.462 . . . . 15.0 110.79 -174.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.61 119.76 53.53 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.838 0.855 . . . . 15.0 109.636 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 69.4 Cg_endo -68.2 -169.58 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.418 2.745 . . . . 15.0 112.558 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.4 148.0 46.76 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.209 -0.905 . . . . 15.0 110.759 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 25.6 tp -121.65 15.8 11.1 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.9 p -66.66 179.55 1.04 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.627 1.171 . . . . 15.0 112.135 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.13 -61.85 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.689 1.595 . . . . 15.0 114.635 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.91 -1.76 27.03 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.48 0.712 . . . . 15.0 112.806 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -99.22 -50.57 4.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.357 0.663 . . . . 15.0 109.563 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 266' ' ' LEU . 18.0 tt -64.56 -29.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.961 0.504 . . . . 15.0 111.357 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . 18.7 ptmt -76.99 -18.04 58.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.385 0.513 . . . . 15.0 112.385 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -69.11 -18.85 64.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.388 0.675 . . . . 15.0 110.909 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -74.16 -22.3 59.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.788 0.835 . . . . 15.0 111.495 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 139.74 -28.97 2.5 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 112.569 -0.212 . . . . 15.0 112.569 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.17 84.58 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.68 0.792 . . . . 15.0 109.671 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -63.69 -27.63 69.35 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.044 1.127 . . . . 15.0 114.044 -167.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -31.12 47.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.43 20.36 27.47 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.409 -0.662 . . . . 15.0 113.799 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 54.3 p -62.28 123.59 18.63 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.456 0.702 . . . . 15.0 111.091 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.81 -54.66 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.454 1.102 . . . . 15.0 111.242 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.62 -24.78 64.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.754 0.821 . . . . 15.0 111.991 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.7 -27.2 54.74 Favored Glycine 0 C--N 1.36 1.869 0 N-CA-C 110.609 -0.996 . . . . 15.0 110.609 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 253' ' ' ILE . 41.3 tp -75.1 -35.11 61.78 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -61.86 -41.79 98.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.576 0.548 . . . . 15.0 109.646 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.92 63.57 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.133 0.973 . . . . 15.0 111.065 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.05 -54.63 44.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.772 -1.104 . . . . 15.0 111.327 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 141' ' ' LEU . 30.8 m -69.07 -37.85 77.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.989 -1.005 . . . . 15.0 110.867 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -65.84 -42.98 89.84 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 119.104 0.865 . . . . 15.0 110.049 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -73.38 -26.08 60.85 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 118.364 0.529 . . . . 15.0 111.592 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -65.48 -52.8 50.32 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.659 0.742 . . . . 15.0 109.697 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.477 ' HE3' ' HB ' ' A' ' 270' ' ' VAL . 57.6 mtt -72.7 -14.97 61.69 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-N 114.59 -1.186 . . . . 15.0 111.415 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.23 -38.66 15.08 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.661 0.664 . . . . 15.0 109.922 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.45 -25.4 67.21 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.183 0.593 . . . . 15.0 110.235 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -84.5 -71.81 0.5 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.445 0.698 . . . . 15.0 110.77 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.539 HD21 HG12 ' A' ' 130' ' ' VAL . 43.3 tp -62.7 -54.23 42.46 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.042 1.337 . . . . 15.0 113.453 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 282' ' ' ILE . 38.2 ttpt -70.93 -28.57 64.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 123.454 0.471 . . . . 15.0 110.79 -172.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -64.79 -46.9 80.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.779 -0.823 . . . . 15.0 108.779 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.0 71.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.572 0.749 . . . . 15.0 111.622 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.606 HD11 ' HB ' ' A' ' 130' ' ' VAL . 96.0 mt -66.87 -55.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 N-CA-C 108.77 -0.826 . . . . 15.0 108.77 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 16.9 tpt180 -58.03 -41.53 83.39 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.087 0.867 . . . . 15.0 110.705 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.67 -32.75 70.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.154 0.582 . . . . 15.0 111.09 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -65.62 -51.94 55.75 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.1 0.409 . . . . 15.0 110.423 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 282' ' ' ILE . 21.8 t -62.03 -45.75 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.957 0.786 . . . . 15.0 109.778 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.7 tttt -64.95 -41.36 95.56 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.117 -0.947 . . . . 15.0 111.624 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.589 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 77.6 p -65.61 -42.61 91.41 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.726 0.239 . . . . 15.0 110.92 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.6 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.0 mt-30 -66.86 -34.81 78.61 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.324 0.39 . . . . 15.0 111.005 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.4 -50.31 68.11 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.807 0.443 . . . . 15.0 111.537 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 287' ' ' LYS . 31.4 mm -73.29 -55.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.408 0.683 . . . . 15.0 111.322 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.94 -27.03 68.57 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.728 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.476 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.54 -41.57 94.07 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 119.432 -0.649 . . . . 15.0 112.524 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 350' ' ' LEU . 23.0 mt -56.91 -47.43 80.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.772 0.829 . . . . 15.0 110.552 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 22.9 t -58.28 -53.89 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.689 0.757 . . . . 15.0 109.593 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.24 -18.78 65.37 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.568 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.02 -25.69 22.98 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.9 155.03 28.85 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.887 1.069 . . . . 15.0 113.887 -168.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.82 145.31 55.63 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.108 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 5.9 tp -143.38 117.19 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.687 -0.688 . . . . 15.0 109.594 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -81.19 118.37 22.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.262 -1.014 . . . . 15.0 108.262 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 307' ' ' ILE . 47.0 t -110.88 100.33 45.88 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.38 1.072 . . . . 15.0 109.289 -168.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.519 ' HD2' HD11 ' A' ' 349' ' ' LEU . 58.8 Cg_endo -73.59 132.07 16.92 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.573 2.182 . . . . 15.0 112.255 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -60.21 -18.02 45.54 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.874 1.27 . . . . 15.0 112.201 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -45.86 -56.21 5.69 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.399 1.479 . . . . 15.0 111.578 171.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.44 -27.73 41.68 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.242 -1.344 . . . . 15.0 110.815 -172.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -61.21 -54.25 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.347 -0.983 . . . . 15.0 108.347 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.83 -31.47 70.46 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.81 0.694 . . . . 15.0 110.429 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 313' ' ' VAL . 41.3 t -61.8 -53.43 56.05 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 123.837 0.71 . . . . 15.0 111.231 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -80.23 -31.0 38.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.581 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 27.1 mt -59.04 -46.57 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 166.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.31 -41.63 80.26 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.888 0.875 . . . . 15.0 112.055 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.525 HG11 HH12 ' A' ' 344' ' ' ARG . 94.5 t -51.23 -58.35 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 124.291 0.994 . . . . 15.0 109.591 171.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.77 -17.0 62.21 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 113.806 -1.543 . . . . 15.0 112.436 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.5 mtm180 . . . . . 0 N--CA 1.483 1.184 0 C-N-CA 123.333 0.653 . . . . 15.0 109.75 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.179 0.514 . . . . 15.0 112.193 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -114.15 31.45 6.57 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.509 1.124 . . . . 15.0 110.828 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.32 134.03 95.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-O 118.84 -0.6 . . . . 15.0 109.82 172.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -42.64 123.6 3.0 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 124.266 3.311 . . . . 15.0 113.479 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -52.73 -47.32 67.45 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 124.149 0.905 . . . . 15.0 111.498 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.78 -7.04 2.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.12 -43.95 63.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.397 0.544 . . . . 15.0 110.076 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.99 2.13 8.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.526 0.73 . . . . 15.0 112.614 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -58.57 -55.33 36.48 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.735 0.814 . . . . 15.0 111.007 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 40.6 tt0 -56.14 -60.9 2.83 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.796 1.31 . . . . 15.0 111.215 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -64.68 -38.16 90.03 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.85 -52.89 17.54 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 110.429 -0.212 . . . . 15.0 110.429 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.36 -28.1 64.81 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.908 0.755 . . . . 15.0 110.685 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.589 ' NH2' ' HA ' ' A' ' 288' ' ' SER . 0.2 OUTLIER -72.5 -36.9 68.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.887 0.875 . . . . 15.0 109.563 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.525 HH12 HG11 ' A' ' 313' ' ' VAL . 75.4 mtt180 -64.36 -35.09 79.76 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.886 0.312 . . . . 15.0 110.206 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.58 -53.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.883 0.873 . . . . 15.0 110.227 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.78 -47.28 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 114.304 -1.316 . . . . 15.0 111.239 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 351' ' ' LEU . 53.9 t -61.8 -48.25 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 15.0 110.722 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.58 95.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.695 0.622 . . . . 15.0 113.575 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.519 HD11 ' HD2' ' A' ' 303' ' ' PRO . 94.7 mt -79.74 -58.01 3.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.536 0.735 . . . . 15.0 110.96 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 294' ' ' LEU . 91.1 mt -65.31 -51.81 58.18 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.673 0.608 . . . . 15.0 111.044 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.652 HD12 HG13 ' A' ' 347' ' ' VAL . 39.8 mt -71.17 -33.68 70.23 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 118.843 -0.599 . . . . 15.0 111.222 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.66 92.05 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.78 -0.528 . . . . 15.0 111.78 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.59 -42.83 91.25 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.742 -0.729 . . . . 15.0 111.041 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 350' ' ' LEU . 89.7 t -58.99 -39.95 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 122.976 0.511 . . . . 15.0 111.3 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 360' ' ' LEU . 73.0 mt -68.83 -41.25 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.572 0.749 . . . . 15.0 110.198 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -60.23 -54.75 42.13 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.528 0.517 . . . . 15.0 110.631 174.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.3 m -60.64 -40.0 90.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.256 1.022 . . . . 15.0 111.945 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.6 8.62 43.74 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.511 0.725 . . . . 15.0 111.763 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 40.56 51.99 2.99 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.823 1.649 . . . . 15.0 113.648 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.618 ' HB2' HG23 ' A' ' 355' ' ' ILE . 78.5 mt -84.1 142.19 30.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.844 -1.071 . . . . 15.0 111.505 -176.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.62 151.67 49.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 167.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.24 94.87 0.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.036 0.535 . . . . 15.0 110.258 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.8 135.29 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.613 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -58.97 -35.87 73.91 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.12 0.888 . . . . 15.0 111.693 -170.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.49 -33.79 76.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.852 0.461 . . . . 15.0 110.755 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -80.89 -35.8 32.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.112 -0.495 . . . . 15.0 110.424 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 398' ' ' MET . 86.4 t -56.99 -57.57 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.441 0.697 . . . . 15.0 109.544 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -62.89 -33.11 74.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.654 0.781 . . . . 15.0 111.413 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -54.97 -55.21 29.1 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.067 0.855 . . . . 15.0 111.627 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.52 -46.02 80.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.542 0.737 . . . . 15.0 111.26 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.611 HD11 ' HG2' ' A' ' 398' ' ' MET . 47.0 mm -48.85 -61.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 124.539 1.149 . . . . 15.0 110.729 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.68 -37.69 73.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.775 0.658 . . . . 15.0 112.775 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.54 -46.84 77.98 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.043 0.449 . . . . 15.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.2 ttp -69.93 -35.98 74.98 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.432 1.093 . . . . 15.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.72 60.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.138 0.575 . . . . 15.0 112.038 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.4 t -65.83 -17.23 64.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.792 0.837 . . . . 15.0 111.501 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.03 -7.25 50.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.18 0.592 . . . . 15.0 111.664 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -103.31 166.23 10.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.238 1.015 . . . . 15.0 110.874 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.21 -29.2 63.74 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.278 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -155.12 112.71 2.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 15.0 107.7 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.46 -3.94 3.64 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.032 2.488 . . . . 15.0 115.469 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -60.69 -36.93 80.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.668 0.618 . . . . 15.0 112.668 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.1 -36.22 82.85 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.625 0.578 . . . . 15.0 109.897 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.33 -49.14 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.52 0.728 . . . . 15.0 110.121 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.93 -52.24 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 123.831 0.707 . . . . 15.0 109.9 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.33 -54.75 39.68 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.228 0.955 . . . . 15.0 110.674 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -51.09 -57.78 7.8 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.744 1.278 . . . . 15.0 111.566 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -58.37 -53.4 58.76 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.82 0.7 . . . . 15.0 110.662 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.1 p -62.71 -19.05 63.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.69 -7.01 21.01 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.448 0.699 . . . . 15.0 111.861 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 395' ' ' MET . 51.0 t-20 -121.69 86.26 2.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.959 -0.756 . . . . 15.0 108.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -58.62 -32.09 68.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.159 1.384 . . . . 15.0 111.41 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.6 -32.47 73.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.675 0.61 . . . . 15.0 110.754 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 22.3 tp -94.42 -20.18 19.94 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-O 119.464 -0.303 . . . . 15.0 111.112 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 77.2 mmm -59.38 -38.03 79.46 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.196 -0.668 . . . . 15.0 109.196 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.4 -60.24 1.57 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.869 1.268 . . . . 15.0 112.072 168.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -66.34 -34.93 79.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.178 0.991 . . . . 15.0 110.808 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.611 ' HG2' HD11 ' A' ' 371' ' ' ILE . 26.3 tpp -70.27 -27.32 64.33 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.851 0.861 . . . . 15.0 111.226 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 395' ' ' MET . 64.0 mtp85 -79.14 -35.18 42.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.48 -44.91 93.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.611 0.569 . . . . 15.0 110.244 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.0 p -75.7 -28.47 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 123.118 0.261 . . . . 15.0 111.33 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.71 -40.23 96.5 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.275 0.489 . . . . 15.0 110.278 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 355' ' ' ILE . 27.8 tp -73.38 -36.4 66.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.521 -1.218 . . . . 15.0 110.238 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.79 -51.98 67.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.26 1.024 . . . . 15.0 111.187 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 75.3 mm-40 -67.08 -40.77 87.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.401 0.68 . . . . 15.0 110.865 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 360' ' ' LEU . 23.9 tt0 -63.2 -34.3 77.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.794 0.838 . . . . 15.0 110.56 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.71 85.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.538 0.735 . . . . 15.0 111.505 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 94.4 t -52.98 -54.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 O-C-N 123.982 0.801 . . . . 15.0 108.914 171.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 412' ' ' LEU . 31.2 mt-10 -62.47 -26.61 68.61 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.799 -1.091 . . . . 15.0 112.744 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.56 74.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.036 0.534 . . . . 15.0 110.882 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 294' ' ' LEU . 57.8 t -72.63 -35.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.847 -0.798 . . . . 15.0 108.847 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 409' ' ' GLU . 81.6 mt -65.77 -37.35 86.1 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.978 0.798 . . . . 15.0 110.89 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.28 64.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.365 -0.834 . . . . 15.0 112.125 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -106.71 -27.27 10.91 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.959 0.904 . . . . 15.0 111.867 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.21 158.94 16.97 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.743 0.817 . . . . 15.0 111.93 -171.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 88.4 mttt -69.04 78.77 0.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.454 1.101 . . . . 15.0 110.351 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 125' ' ' VAL . 25.5 t -97.9 103.11 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -78.41 119.9 22.38 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.368 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 32.2 tt0 -78.61 87.23 4.56 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.733 0.778 . . . . 15.0 109.263 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -95.66 100.74 12.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.859 -1.064 . . . . 15.0 110.704 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.03 128.54 35.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 15.0 109.279 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.484 HG23 HG22 ' A' ' 130' ' ' VAL . 7.7 t -161.93 176.88 10.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.725 0.41 . . . . 15.0 111.126 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 40.6 p -106.41 171.02 7.58 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.213 1.005 . . . . 15.0 111.669 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -43.57 -60.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.042 1.737 . . . . 15.0 113.593 -168.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.36 -23.02 65.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.732 1.012 . . . . 15.0 113.732 -167.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.442 ' HG2' HG21 ' A' ' 422' ' ' THR . 15.4 tp10 -45.21 -46.78 12.48 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.895 1.278 . . . . 15.0 112.966 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.66 -31.06 41.42 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.799 0.84 . . . . 15.0 110.943 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -71.74 -31.83 67.08 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.448 0.699 . . . . 15.0 110.04 175.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 124.27 1.028 . . . . 15.0 113.627 -173.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.38 91.32 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 118.999 0.818 . . . . 0.0 109.173 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.426 HG13 ' OH ' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -145.14 162.6 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 126.107 1.763 . . . . 0.0 108.088 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 177' ' ' PHE . 28.8 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 125.215 1.406 . . . . 0.0 112.929 -177.721 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.611 HD13 ' HB ' ' B' ' 463' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.551 1.007 0 CA-C-O 120.48 0.181 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . 0.304 19.3 p90 67.76 -39.91 0.4 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 128.256 2.622 . . . . 0.0 116.656 169.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -177.83 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.274 1.03 . . . . 0.0 109.652 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . 0.611 ' HB ' HD13 ' B' ' 460' ' ' LEU . 72.4 m -34.95 118.2 0.42 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.719 1.607 . . . . 0.0 114.612 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' B' ' 467' ' ' ALA . 24.5 mmt 64.71 119.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.161 1.384 . . . . 0.0 112.302 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.25 -25.01 66.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.085 0.554 . . . . 0.0 110.521 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -96.03 17.99 14.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.528 1.131 . . . . 0.0 111.454 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' B' ' 464' ' ' MET . . . . . . . . 0 N--CA 1.479 0.98 0 C-N-CA 123.121 0.569 . . . . 0.0 109.675 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 23.3 ptm . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.5 -0.185 . . . . 15.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -150.91 113.29 4.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 17' ' ' ILE . 28.9 m -123.67 146.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.695 0.798 . . . . 15.0 110.29 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 p -137.36 115.47 11.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.377 0.671 . . . . 15.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.33 131.99 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.096 0.559 . . . . 15.0 111.094 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -135.34 148.71 49.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.841 1.256 . . . . 15.0 108.443 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 m -93.46 112.06 23.87 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.538 -0.541 . . . . 15.0 109.538 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -80.52 -44.33 19.3 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.974 0.51 . . . . 15.0 111.284 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -167.42 94.52 0.44 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.344 0.657 . . . . 15.0 109.786 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.36 -102.86 0.41 Allowed Glycine 0 C--N 1.352 1.461 0 O-C-N 123.958 0.786 . . . . 15.0 113.765 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD13 ' HB3' ' A' ' 113' ' ' PRO . 50.9 tp -68.49 -35.25 77.25 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.879 0.872 . . . . 15.0 110.733 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.43 135.26 22.03 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.138 -0.937 . . . . 15.0 112.079 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.6 -177.31 4.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.921 1.288 . . . . 15.0 109.757 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -150.15 110.52 4.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.89 0.876 . . . . 15.0 109.709 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.3 t -98.56 92.03 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.709 -0.848 . . . . 15.0 108.709 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 44.8 m -75.11 105.03 5.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.554 0.742 . . . . 15.0 109.87 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 3' ' ' VAL . 35.8 mt -93.31 115.77 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.857 -0.611 . . . . 15.0 109.6 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -92.71 96.41 10.15 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.433 -0.951 . . . . 15.0 108.433 166.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 70' ' ' LEU . 74.3 mt -73.27 98.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 171.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.93 162.64 23.84 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.232 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.6 -22.35 55.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.572 1.149 . . . . 15.0 113.955 -170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.84 -42.89 89.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.884 0.474 . . . . 15.0 110.508 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -73.68 -36.57 65.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.493 -0.776 . . . . 15.0 110.923 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 28' ' ' VAL . 56.5 mt -68.07 -59.05 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.933 0.493 . . . . 15.0 110.204 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.37 -41.84 97.74 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.217 1.007 . . . . 15.0 112.291 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 m -64.99 -42.11 94.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.647 0.592 . . . . 15.0 110.979 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.31 71.41 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 15.0 112.007 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.446 ' HA ' HG21 ' A' ' 66' ' ' VAL . 79.5 t -62.82 -45.43 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 15.0 110.31 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 3.8 ttmp? -66.27 -39.27 89.33 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.249 -1.341 . . . . 15.0 110.367 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 m -72.27 -21.91 61.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.12 0.968 . . . . 15.0 111.01 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.8 tp10 -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.658 0.383 . . . . 15.0 111.221 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 55' ' ' ALA . 36.2 mt -68.53 -26.54 65.48 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.382 0.273 . . . . 15.0 111.7 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 p -76.54 -29.2 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 123.245 0.34 . . . . 15.0 110.097 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -66.29 -46.33 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.967 0.507 . . . . 15.0 109.934 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 61.0 t -65.54 -37.54 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.983 0.913 . . . . 15.0 110.167 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.24 92.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.32 0.648 . . . . 15.0 111.182 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.58 -23.87 39.59 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.923 0.489 . . . . 15.0 111.513 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.98 -49.3 38.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.613 0.765 . . . . 15.0 110.188 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.38 -5.91 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.944 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 69.47 21.1 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.097 1.359 . . . . 15.0 111.95 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -64.37 -26.28 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 124.331 1.052 . . . . 15.0 111.126 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -59.38 -36.69 76.25 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.112 0.965 . . . . 15.0 111.627 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.54 -10.92 80.08 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.359 -0.382 . . . . 15.0 113.598 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -119.23 2.23 11.36 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.037 0.935 . . . . 15.0 110.774 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.5 ttt85 -76.86 94.86 3.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.288 0.635 . . . . 15.0 110.027 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -80.3 86.5 5.67 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.397 -0.82 . . . . 15.0 110.835 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 37.26 -56.57 0.0 OUTLIER Glycine 0 CA--C 1.55 2.266 0 N-CA-C 120.142 2.817 . . . . 15.0 120.142 160.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -43.09 -47.9 6.13 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.205 1.802 . . . . 15.0 114.228 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.44 106.37 16.31 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.75 0.42 . . . . 15.0 110.192 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 53' ' ' ILE . 3.5 Cg_exo -78.84 156.63 27.31 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.514 2.809 . . . . 15.0 112.299 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 54' ' ' VAL . 58.9 tpp -70.58 -27.18 63.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.863 0.865 . . . . 15.0 111.752 -172.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.7 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 34.0 p-10 -69.84 -28.97 66.13 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.849 0.46 . . . . 15.0 111.924 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.524 HG23 ' HD2' ' A' ' 57' ' ' ARG . 12.3 mt -72.36 -51.89 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.665 0.786 . . . . 15.0 110.14 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 33.8 m -68.61 -25.6 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.47 0.545 . . . . 15.0 112.47 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -60.35 -41.12 92.96 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.393 0.677 . . . . 15.0 112.59 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -117.25 -3.56 11.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 -170.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 53' ' ' ILE . 75.9 mtt180 -115.64 -45.84 2.88 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.135 0.425 . . . . 15.0 111.623 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.46 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 94.9 m-85 -104.69 -39.01 6.5 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.202 0.816 . . . . 15.0 113.202 -168.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.84 39.5 2.78 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 112.492 -0.243 . . . . 15.0 112.492 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.58 61.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.906 0.882 . . . . 15.0 112.098 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p -73.71 -35.58 65.13 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.062 0.945 . . . . 15.0 111.088 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -69.13 -25.22 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.724 0.81 . . . . 15.0 110.622 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.543 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 25.3 mtp180 -61.1 -22.1 64.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.643 0.777 . . . . 15.0 111.951 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.73 -54.23 49.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.136 0.975 . . . . 15.0 111.232 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 -27.46 66.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 28' ' ' VAL . 94.7 t -64.85 -43.28 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 123.61 0.568 . . . . 15.0 109.76 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 91.5 mt -62.37 -41.65 98.8 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.997 0.519 . . . . 15.0 111.162 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.62 99.13 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.644 0.59 . . . . 15.0 112.282 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.66 -41.17 96.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.384 1.074 . . . . 15.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.692 ' HB3' HD13 ' A' ' 19' ' ' ILE . 71.2 mt -67.84 -34.53 76.89 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.661 -0.7 . . . . 15.0 111.01 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.2 mtm -67.8 -20.69 65.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.566 0.346 . . . . 15.0 111.255 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -87.2 -55.7 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 15.0 110.203 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -72.76 -39.09 67.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.463 0.705 . . . . 15.0 112.544 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -73.22 -27.07 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 117.875 0.307 . . . . 15.0 110.704 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.87 -54.12 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.222 -0.288 . . . . 15.0 110.222 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.421 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.3 tt -65.04 -37.32 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 123.423 0.452 . . . . 15.0 110.896 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.665 0.786 . . . . 15.0 110.653 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.03 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.48 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 33.3 pt -67.06 -23.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 112.717 0.636 . . . . 15.0 112.717 -172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.39 -53.4 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.452 0.701 . . . . 15.0 110.652 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -75.1 -29.5 60.62 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.607 0.363 . . . . 15.0 111.455 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -84.31 -16.35 43.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.278 0.631 . . . . 15.0 111.454 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 66.77 14.06 9.64 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.64 1.176 . . . . 15.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.436 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 74.7 mt -77.24 105.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -81.0 110.03 15.98 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.45 148.53 38.14 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.585 2.19 . . . . 15.0 112.957 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 303' ' ' PRO . . . -152.65 -177.74 6.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.505 0.722 . . . . 15.0 109.856 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 305' ' ' ALA . . . 64.1 -102.13 0.56 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.86 116.34 2.43 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 107.826 -1.175 . . . . 15.0 107.826 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 43.5 Cg_exo -59.59 105.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 121.687 1.591 . . . . 15.0 110.249 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 m -101.71 99.26 9.5 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.247 -0.649 . . . . 15.0 109.247 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.39 78.19 3.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.636 0.774 . . . . 15.0 109.134 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.05 109.47 3.29 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.46 106.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.118 2.545 . . . . 15.0 111.961 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.85 -79.32 0.57 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.243 -0.743 . . . . 15.0 111.243 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -168.16 151.2 5.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.4 0.68 . . . . 15.0 111.533 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.79 142.21 44.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.601 1.16 . . . . 15.0 109.398 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.2 mttt -133.54 142.83 48.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.259 1.024 . . . . 15.0 108.773 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -61.61 106.18 0.63 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 15.0 110.251 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.64 -17.52 58.79 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 116.038 -0.528 . . . . 15.0 113.477 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 43.4 mt-10 -97.94 -173.52 2.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.563 0.745 . . . . 15.0 110.095 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -72.78 160.09 32.74 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.909 0.883 . . . . 15.0 112.492 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -121.55 106.12 11.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.73 1.212 . . . . 15.0 108.56 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 m -105.07 139.52 39.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.624 0.77 . . . . 15.0 109.93 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -159.96 143.58 14.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.027 0.931 . . . . 15.0 108.818 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.8 m -100.64 107.99 19.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.72 0.808 . . . . 15.0 110.565 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.15 97.69 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.98 -0.748 . . . . 15.0 108.98 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.3 123.05 35.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.229 0.612 . . . . 15.0 109.882 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 47.1 p90 -159.52 157.85 30.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.772 0.829 . . . . 15.0 110.276 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.3 176.63 7.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 15.0 109.994 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.36 175.96 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -89.76 118.08 68.67 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.63 ' HG2' HD11 ' A' ' 300' ' ' ILE . 58.6 Cg_endo -88.53 173.03 4.63 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.606 2.204 . . . . 15.0 114.427 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.65 134.68 33.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.123 -1.399 . . . . 15.0 109.059 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.49 126.98 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.417 -0.586 . . . . 15.0 109.417 172.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -84.3 94.13 8.38 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.4 145.25 54.5 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.141 -0.936 . . . . 15.0 108.763 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -79.15 173.83 12.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.58 109.86 2.43 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.548 -1.021 . . . . 15.0 110.548 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.433 HD13 HG22 ' A' ' 411' ' ' VAL . 47.1 mt -66.8 -14.12 62.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.609 0.763 . . . . 15.0 111.246 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.96 -22.61 63.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.289 . . . . 15.0 111.289 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.74 62.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.773 0.829 . . . . 15.0 110.947 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.04 131.34 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.619 0.768 . . . . 15.0 109.657 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.25 123.84 49.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.911 0.884 . . . . 15.0 109.618 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 417' ' ' VAL . 61.4 t -125.27 163.66 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.838 1.255 . . . . 15.0 107.917 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.34 143.97 48.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.532 0.733 . . . . 15.0 109.262 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 129' ' ' ILE . 80.6 tttt -114.87 93.52 34.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.133 -1.062 . . . . 15.0 108.133 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.79 98.61 1.22 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.17 1.914 . . . . 15.0 112.289 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 127' ' ' LYS . 48.5 mm -72.52 96.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 427' ' ' LEU . 21.0 t -122.74 142.82 37.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.526 -0.761 . . . . 15.0 109.997 -173.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.47 146.25 39.81 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.817 0.847 . . . . 15.0 108.932 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.54 88.81 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.5 p -76.24 -179.85 5.31 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.894 0.878 . . . . 15.0 110.339 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.92 -37.59 74.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.444 0.698 . . . . 15.0 111.689 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.8 96.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 15.0 111.492 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.45 -42.94 52.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.808 0.843 . . . . 15.0 111.556 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.79 -56.44 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.902 0.881 . . . . 15.0 109.489 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.37 -45.89 92.49 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.175 0.99 . . . . 15.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.33 -46.91 89.35 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.919 0.762 . . . . 15.0 113.333 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.24 -51.68 50.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.143 0.577 . . . . 15.0 110.896 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.2 mt -53.91 -39.39 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.569 0.748 . . . . 15.0 111.86 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.43 -40.9 85.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.925 0.49 . . . . 15.0 111.027 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 m -67.89 -26.74 66.16 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.752 0.421 . . . . 15.0 110.756 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.86 -37.73 76.19 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.852 0.461 . . . . 15.0 110.333 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -64.68 -35.06 79.82 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.707 0.289 . . . . 15.0 110.424 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -69.3 -34.6 74.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.306 0.642 . . . . 15.0 111.099 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.66 -41.26 79.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 15.0 109.98 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -95.1 29.66 2.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.027 0.931 . . . . 15.0 111.184 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.09 135.48 46.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.106 0.562 . . . . 15.0 112.434 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.1 m -83.54 138.85 33.22 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.625 1.17 . . . . 15.0 110.25 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -80.16 139.17 36.91 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.829 0.452 . . . . 15.0 110.236 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 33.1 ttpt -156.98 172.99 17.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.09 -1.078 . . . . 15.0 108.09 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 41.6 mt-10 -121.64 165.72 15.33 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.97 0.908 . . . . 15.0 110.035 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.533 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 41.6 pttt -156.78 -179.92 8.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.031 0.933 . . . . 15.0 110.87 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.03 146.95 28.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.977 0.511 . . . . 15.0 109.655 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.19 -50.21 0.88 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.0 -0.889 . . . . 15.0 113.533 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 206' ' ' LYS . . . -153.57 153.89 33.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.465 1.132 . . . . 15.0 112.234 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.84 157.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.47 1.108 . . . . 15.0 109.517 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -138.51 -174.88 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.485 1.914 . . . . 15.0 108.252 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.531 ' HA ' ' HE1' ' A' ' 189' ' ' MET . . . -84.08 -8.73 59.03 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.459 0.911 . . . . 15.0 113.459 -174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.52 -6.5 20.55 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.143 0.429 . . . . 15.0 112.021 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -81.61 178.4 8.36 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.054 1.131 . . . . 15.0 114.054 -165.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.717 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 16.0 mtm180 -116.27 98.77 6.78 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.833 -1.076 . . . . 15.0 108.503 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.01 97.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 -169.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 9.0 m -73.32 111.73 8.72 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.851 -1.166 . . . . 15.0 107.851 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.8 pt -132.95 179.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.422 1.089 . . . . 15.0 110.924 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.8 t70 -130.04 157.53 42.1 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.179 1.391 . . . . 15.0 107.713 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' B' ' 385' ' ' LEU . 24.4 p90 -144.61 150.59 37.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.636 0.731 . . . . 15.0 111.074 164.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.536 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 1.8 t -125.99 95.12 4.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 106.467 -1.679 . . . . 15.0 106.467 166.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.96 166.77 31.34 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 114.93 -1.032 . . . . 15.0 115.067 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -151.19 141.97 22.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.964 1.306 . . . . 15.0 108.283 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.3 t -118.55 137.52 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.584 0.754 . . . . 15.0 109.141 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.544 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 35.3 t70 70.48 5.83 5.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.721 1.208 . . . . 15.0 111.875 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.31 -1.0 46.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.722 -0.488 . . . . 15.0 113.37 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.01 145.41 49.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.627 0.771 . . . . 15.0 110.576 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -76.01 110.48 10.52 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.149 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 172' ' ' VAL . 32.7 p90 -70.84 170.38 12.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.219 0.608 . . . . 15.0 111.259 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -69.68 134.56 48.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.63 -1.168 . . . . 15.0 111.057 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.587 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 88.25 -78.64 1.75 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 -52.4 4.17 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.412 0.925 . . . . 15.0 115.412 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.536 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 40.6 mmtt -85.9 145.97 26.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.913 1.079 . . . . 15.0 113.913 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.05 92.48 1.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.658 -1.61 . . . . 15.0 106.933 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -96.32 143.78 27.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.308 -0.86 . . . . 15.0 110.967 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.5 t70 65.75 21.92 11.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.338 1.055 . . . . 15.0 111.373 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 165' ' ' THR . 46.7 t80 -71.59 134.23 46.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.225 0.61 . . . . 15.0 110.579 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.35 103.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.794 -0.817 . . . . 15.0 108.794 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HG ' ' HG2' ' A' ' 189' ' ' MET . 27.0 tp -82.8 80.1 8.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 15.0 110.047 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.54 92.44 0.31 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.691 -1.226 . . . . 15.0 107.691 167.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.531 ' HE1' ' HA ' ' A' ' 160' ' ' ALA . 62.5 mtp -66.98 144.64 56.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.394 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.12 14.57 Favored Glycine 0 N--CA 1.471 0.978 0 O-C-N 123.496 0.498 . . . . 15.0 112.494 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.44 -178.96 3.65 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.27 1.028 . . . . 15.0 110.339 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.17 6.93 56.5 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 115.912 -0.586 . . . . 15.0 113.518 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -77.84 2.09 18.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.098 0.559 . . . . 15.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.7 mmt -134.74 154.53 51.54 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.911 0.884 . . . . 15.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.57 152.84 37.94 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 114.757 -1.11 . . . . 15.0 109.374 170.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.93 143.97 46.95 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.03 2.487 . . . . 15.0 112.928 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.24 -40.29 2.47 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 115.803 -0.635 . . . . 15.0 112.164 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -67.85 -63.81 0.99 Allowed 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.28 -24.57 67.36 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.437 -0.801 . . . . 15.0 112.077 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.91 -37.59 81.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.083 0.953 . . . . 15.0 110.682 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.78 -10.95 80.79 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.468 -0.787 . . . . 15.0 113.075 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.448 HG21 HD23 ' A' ' 187' ' ' LEU . 42.9 mm -94.84 -47.12 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.763 0.825 . . . . 15.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -82.41 19.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.325 1.232 . . . . 15.0 114.325 -167.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.78 25.39 5.31 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.99 -1.244 . . . . 15.0 109.99 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -140.71 -169.96 2.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.729 1.211 . . . . 15.0 110.213 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -153.52 163.56 39.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.996 0.918 . . . . 15.0 110.675 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -68.07 132.2 46.81 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.38 0.672 . . . . 15.0 112.06 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 126.77 -28.24 4.71 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.761 -1.109 . . . . 15.0 111.799 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.8 pt-20 -96.14 139.32 32.48 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.727 0.775 . . . . 15.0 111.455 -174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.27 125.8 51.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.981 1.313 . . . . 15.0 108.948 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -144.38 169.67 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.073 0.949 . . . . 15.0 109.769 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 70.2 m -124.34 120.45 32.17 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -95.64 160.48 2.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.497 0.719 . . . . 15.0 111.207 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -104.92 118.42 36.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.99 -1.005 . . . . 15.0 109.903 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.6 163.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 87.3 m -146.26 131.9 18.86 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.971 -1.122 . . . . 15.0 107.971 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.473 ' HZ ' ' HB ' ' B' ' 387' ' ' ILE . 73.0 m-85 -68.23 135.47 91.32 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 110.128 -0.323 . . . . 15.0 110.128 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.21 156.68 19.91 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.161 2.574 . . . . 15.0 113.515 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.609 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -75.22 -20.71 59.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.917 169.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.22 -16.7 57.59 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.914 0.886 . . . . 15.0 111.21 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.443 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 69.5 t80 -60.66 142.09 56.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.069 0.948 . . . . 15.0 111.616 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -65.03 -44.95 87.45 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.027 0.931 . . . . 15.0 112.76 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.443 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -88.2 104.11 16.4 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.8 tt0 -63.3 -21.08 66.03 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.672 1.189 . . . . 15.0 112.428 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.448 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 29.6 p30 -68.14 -10.56 55.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.809 0.843 . . . . 15.0 112.518 174.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 388' ' ' VAL . 79.1 mt -121.39 -36.91 2.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.235 1.014 . . . . 15.0 110.05 175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.799 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 9.3 tttm -53.48 128.89 30.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.779 1.632 . . . . 15.0 111.991 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.02 16.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.998 -0.547 . . . . 15.0 113.22 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 173' ' ' ASP . 93.3 mttt -86.24 147.44 26.1 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.379 0.672 . . . . 15.0 110.343 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.25 166.63 22.48 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.728 0.643 . . . . 15.0 110.416 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.02 119.62 5.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.39 0.676 . . . . 15.0 109.816 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -98.86 134.45 41.72 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -128.54 110.73 12.54 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.87 0.468 . . . . 15.0 110.273 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.8 91.73 4.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.405 0.622 . . . . 15.0 109.342 176.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 168' ' ' PHE . 33.6 mm -81.16 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.926 1.29 . . . . 15.0 110.636 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -111.3 97.25 6.64 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.463 -1.31 . . . . 15.0 107.463 176.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -81.41 118.55 22.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -115.46 -37.49 4.0 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.588 0.355 . . . . 15.0 111.618 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.723 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.0 mmtt -135.87 142.97 44.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.999 0.52 . . . . 15.0 110.235 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 207' ' ' ALA . 41.8 t -118.45 94.49 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.644 -1.243 . . . . 15.0 107.644 169.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.7 mt-10 -88.28 167.01 13.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.8 tt0 -138.9 130.54 27.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.949 0.499 . . . . 15.0 109.823 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -86.14 85.8 7.35 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.673 -1.232 . . . . 15.0 107.673 166.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.76 134.7 53.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.856 -1.065 . . . . 15.0 109.837 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.41 126.59 87.46 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.788 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 63.9 Cg_endo -68.93 157.95 59.84 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.958 2.439 . . . . 15.0 111.917 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -70.9 160.13 33.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.938 -1.028 . . . . 15.0 110.415 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.4 tp -88.3 30.01 0.92 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.622 0.769 . . . . 15.0 109.83 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.6 p -70.14 169.57 13.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.518 1.127 . . . . 15.0 111.623 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -37.97 -65.86 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.082 1.753 . . . . 15.0 114.72 -166.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.01 -22.57 66.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.678 0.791 . . . . 15.0 112.611 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -86.74 -49.87 7.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.061 0.544 . . . . 15.0 110.465 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.41 -31.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.758 0.423 . . . . 15.0 110.78 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.3 ptmt -98.97 5.14 47.33 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -61.27 -31.11 70.93 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.377 0.671 . . . . 15.0 110.777 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.12 -18.72 64.71 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.087 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.67 45.45 1.79 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.703 -0.559 . . . . 15.0 111.703 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 260' ' ' ASP . 65.8 t -71.91 149.28 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.717 0.807 . . . . 15.0 111.431 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -55.97 -41.51 74.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.478 1.111 . . . . 15.0 111.601 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.518 ' H ' HG12 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -128.36 -47.97 1.31 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.581 -175.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 114.73 -12.62 20.57 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.634 -0.536 . . . . 15.0 113.373 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 94.2 p -73.47 167.64 20.88 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.558 0.679 . . . . 15.0 110.955 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.85 -49.41 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.124 0.97 . . . . 15.0 111.257 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.32 -28.8 68.42 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.314 0.646 . . . . 15.0 111.715 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.67 -26.13 57.11 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.129 -0.788 . . . . 15.0 111.129 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 270' ' ' VAL . 63.9 tp -74.71 -33.7 62.46 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -61.57 -40.08 93.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.396 0.679 . . . . 15.0 109.919 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.6 86.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.698 0.799 . . . . 15.0 111.317 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.3 -49.49 64.01 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.661 0.784 . . . . 15.0 110.516 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.483 ' HA ' ' SD ' ' A' ' 274' ' ' MET . 70.2 t -61.67 -33.67 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.736 1.214 . . . . 15.0 109.75 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -62.85 -61.65 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.493 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -71.71 -15.73 62.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.774 0.657 . . . . 15.0 112.774 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -89.27 -78.78 0.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' A' ' 270' ' ' VAL . 1.7 mpt? -62.85 -50.58 70.37 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.656 -0.687 . . . . 15.0 111.553 -169.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.15 -34.32 56.49 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.586 0.63 . . . . 15.0 111.656 -170.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -73.57 -44.08 58.21 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.942 -0.392 . . . . 15.0 109.942 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.03 -37.87 88.92 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.609 0.568 . . . . 15.0 109.783 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.13 -60.87 2.85 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.405 0.682 . . . . 15.0 111.354 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.83 -29.47 69.94 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.726 0.641 . . . . 15.0 111.281 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -65.34 -46.11 81.55 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.68 -30.72 68.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.772 0.829 . . . . 15.0 111.761 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.1 mt -67.88 -51.42 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.565 HH21 ' HB3' ' A' ' 405' ' ' GLU . 22.9 tpt180 -61.05 -41.84 97.36 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.351 -0.84 . . . . 15.0 110.429 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -72.09 -30.27 64.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.799 -0.619 . . . . 15.0 110.851 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -64.24 -57.89 8.15 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.985 0.514 . . . . 15.0 109.672 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 282' ' ' ILE . 42.1 t -57.33 -46.17 85.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 124.263 0.977 . . . . 15.0 110.216 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -59.45 -55.75 30.67 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.749 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -65.15 -28.86 69.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.311 0.644 . . . . 15.0 111.995 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.496 ' HB2' HG13 ' A' ' 125' ' ' VAL . 58.6 mt-30 -68.29 -44.32 75.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.563 0.345 . . . . 15.0 110.506 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.34 -42.32 96.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.578 0.351 . . . . 15.0 111.202 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -60.35 -53.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 15.0 111.01 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.78 -41.23 99.16 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.985 0.803 . . . . 15.0 110.271 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.19 91.88 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.939 0.775 . . . . 15.0 112.095 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 411' ' ' VAL . 35.1 mt -59.03 -56.73 18.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.96 0.904 . . . . 15.0 111.846 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.31 -53.73 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.581 0.551 . . . . 15.0 110.3 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.88 -40.3 75.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.499 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.58 -33.93 67.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.022 -0.536 . . . . 15.0 112.224 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -116.76 103.85 10.76 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.038 0.381 . . . . 15.0 111.433 -163.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -74.11 144.52 44.9 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.63 HD11 ' HG2' ' A' ' 113' ' ' PRO . 5.3 tp -165.08 130.39 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.408 0.683 . . . . 15.0 110.214 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.58 95.88 4.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.505 HG11 HG12 ' A' ' 345' ' ' VAL . 22.7 t -89.04 128.02 53.43 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 109.264 -0.643 . . . . 15.0 109.264 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 54.3 Cg_endo -68.2 135.12 33.44 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.466 2.111 . . . . 15.0 111.858 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -64.5 -4.77 4.33 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.095 1.146 . . . . 15.0 114.095 -171.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 88' ' ' GLY . . . -56.83 -55.14 38.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.989 0.915 . . . . 15.0 110.803 174.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.57 -35.63 77.64 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.654 1.221 . . . . 15.0 110.89 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.626 ' HA ' HG21 ' A' ' 345' ' ' VAL . 2.1 mp -60.33 -56.68 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.964 -0.754 . . . . 15.0 108.964 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.16 -28.43 68.11 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.789 0.681 . . . . 15.0 111.135 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.0 t -60.67 -53.54 56.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.028 0.931 . . . . 15.0 111.222 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -76.73 -30.14 56.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.329 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.647 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.3 mt -60.99 -39.18 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 168.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.502 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.5 t70 -66.41 -40.22 89.46 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-O 118.398 -0.811 . . . . 15.0 110.607 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.67 -47.74 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.164 0.507 . . . . 15.0 110.281 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.1 mt -70.43 -27.01 63.93 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.202 -0.908 . . . . 15.0 112.047 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 84.1 mtm180 . . . . . 0 N--CA 1.48 1.059 0 C-N-CA 123.584 0.753 . . . . 15.0 110.54 172.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.9 tp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 112.178 0.436 . . . . 15.0 112.178 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.53 -27.97 60.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.092 0.557 . . . . 15.0 111.496 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.84 128.23 63.05 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 123.455 0.472 . . . . 15.0 110.363 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.6 Cg_exo -47.96 118.23 2.99 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.56 2.84 . . . . 15.0 113.649 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.647 ' HG3' HD13 ' A' ' 311' ' ' ILE . 66.3 ttt180 -52.79 -37.5 59.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.075 0.95 . . . . 15.0 112.028 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -10.22 48.84 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.572 0.749 . . . . 15.0 112.964 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.9 mt -71.27 -30.0 65.76 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.16 0.436 . . . . 15.0 110.653 171.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 311' ' ' ILE . 32.6 m-85 -122.9 -4.63 8.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.524 0.73 . . . . 15.0 111.541 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.425 ' HA ' HD11 ' A' ' 311' ' ' ILE . 8.9 tp10 -45.96 -68.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.565 1.146 . . . . 15.0 112.836 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.76 -48.84 80.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.702 0.626 . . . . 15.0 112.042 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.76 -45.95 73.44 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 123.575 0.547 . . . . 15.0 111.362 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.421 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -66.26 -56.34 11.74 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.231 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -53.53 -35.61 60.88 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.316 1.01 . . . . 15.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -61.5 -51.15 69.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.966 -0.561 . . . . 15.0 109.677 171.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -68.38 -18.77 64.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.119 0.568 . . . . 15.0 111.906 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 307' ' ' ILE . 69.5 t -77.57 -45.3 29.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.12 0.968 . . . . 15.0 110.167 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 77.6 t -58.9 -44.71 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.7 t -56.06 -46.47 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.338 1.055 . . . . 15.0 110.878 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.51 72.64 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.763 -0.653 . . . . 15.0 113.258 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.67 -44.34 56.96 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.2 mt -70.72 -46.42 63.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.216 0.607 . . . . 15.0 110.65 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.18 -38.74 92.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.136 0.574 . . . . 15.0 110.417 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.23 94.09 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.783 0.677 . . . . 15.0 112.512 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.82 -36.64 78.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.088 0.555 . . . . 15.0 110.945 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -64.97 -40.8 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.91 0.484 . . . . 15.0 110.201 174.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.481 ' HA ' HD12 ' A' ' 360' ' ' LEU . 96.1 mt -63.56 -41.79 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.984 0.913 . . . . 15.0 110.428 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.668 ' HA ' HD13 ' B' ' 460' ' ' LEU . 35.9 ttp180 -69.92 -58.94 3.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.775 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 51.9 m -61.25 -37.3 82.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.189 0.996 . . . . 15.0 112.059 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.73 8.23 41.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.138 0.421 . . . . 15.0 112.138 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 41.4 48.54 3.32 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.233 1.413 . . . . 15.0 113.383 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.625 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.0 mt -70.79 148.39 47.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.847 -1.07 . . . . 15.0 111.709 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.55 143.78 41.76 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.681 0.792 . . . . 15.0 110.053 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -78.28 111.68 14.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.05 0.94 . . . . 15.0 110.12 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.81 140.47 29.63 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.744 0.818 . . . . 15.0 110.719 -172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -60.23 -40.33 89.83 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.785 0.834 . . . . 15.0 112.366 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.33 -25.85 64.41 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.248 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.423 HH21 ' HB2' ' A' ' 405' ' ' GLU . 58.7 ttt85 -74.79 -40.97 60.83 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 371' ' ' ILE . 61.0 t -58.83 -47.24 89.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.004 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -51.96 -47.73 64.66 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.156 0.91 . . . . 15.0 111.684 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.89 -51.02 48.08 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.277 0.986 . . . . 15.0 112.771 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 402' ' ' ALA . 90.7 mt -62.62 -46.69 87.11 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.662 0.785 . . . . 15.0 112.378 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 367' ' ' VAL . 48.4 mm -54.68 -53.35 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.041 0.937 . . . . 15.0 110.164 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.84 -35.26 74.6 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.37 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.0 -50.17 75.11 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.618 0.767 . . . . 15.0 112.031 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -74.06 -43.66 57.0 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.277 -0.419 . . . . 15.0 110.703 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -43.05 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.345 0.658 . . . . 15.0 112.241 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.3 t -60.19 -25.8 65.87 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 124.024 0.828 . . . . 15.0 111.699 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.8 58.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.73 0.812 . . . . 15.0 112.25 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -92.41 169.53 10.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.317 0.647 . . . . 15.0 111.151 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.8 -36.57 82.69 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.442 -1.254 . . . . 15.0 110.365 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -131.86 100.97 15.63 Favored Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.987 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.7 -24.53 18.25 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.389 2.06 . . . . 15.0 112.703 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -54.46 -48.53 71.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.349 1.06 . . . . 15.0 111.544 -168.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -65.85 -30.45 71.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.26 0.975 . . . . 15.0 111.177 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.16 -45.27 54.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.64 -55.06 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.681 0.613 . . . . 15.0 109.397 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.92 -34.84 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.546 0.738 . . . . 15.0 112.493 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.99 -54.54 6.72 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.738 0.304 . . . . 15.0 111.139 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -47.71 33.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.248 0.619 . . . . 15.0 111.409 -166.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.7 p -58.83 -30.07 67.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.704 0.802 . . . . 15.0 112.534 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -86.12 -26.33 25.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.511 -0.768 . . . . 15.0 111.681 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.43 95.54 6.56 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 2.9 ttmt -71.31 -18.93 62.38 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.262 1.025 . . . . 15.0 111.6 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -66.76 -41.53 87.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.564 0.746 . . . . 15.0 110.489 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.407 HD11 ' HB1' ' B' ' 443' ' ' ALA . 58.6 tp -88.24 -31.46 19.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.555 0.742 . . . . 15.0 109.846 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.682 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 55.4 ttm -61.92 -26.64 68.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.74 0.416 . . . . 15.0 110.835 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -48.17 81.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.073 0.549 . . . . 15.0 110.125 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.47 -26.87 66.58 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.563 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.562 ' HA ' HG12 ' A' ' 401' ' ' VAL . 10.5 tpt -74.55 -27.39 60.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.975 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 395' ' ' MET . 82.2 mtp180 -72.06 -34.62 68.87 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 170.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -42.95 94.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.918 0.487 . . . . 15.0 111.235 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.9 p -73.97 -27.79 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 121.215 -0.194 . . . . 15.0 111.243 174.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -61.36 -44.04 97.85 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.36 0.6 . . . . 15.0 109.449 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 21.1 tp -73.41 -32.52 64.48 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.183 -1.371 . . . . 15.0 110.672 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -66.22 -51.91 53.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 15.0 110.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.565 ' HB3' HH21 ' A' ' 283' ' ' ARG . 77.9 mm-40 -61.92 -35.38 78.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.464 0.706 . . . . 15.0 110.833 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.625 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.8 tt0 -74.2 -32.74 63.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.433 0.693 . . . . 15.0 110.791 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.75 99.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.193 0.597 . . . . 15.0 110.244 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.78 -53.96 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.693 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.69 -21.57 66.55 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.754 0.822 . . . . 15.0 113.193 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.13 -31.69 64.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.023 0.529 . . . . 15.0 110.523 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 294' ' ' LEU . 75.4 t -77.38 -36.35 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.88 -37.83 82.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.939 0.896 . . . . 15.0 111.246 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.24 68.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.616 0.767 . . . . 15.0 111.038 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -95.96 -29.73 14.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.028 0.931 . . . . 15.0 111.555 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.39 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.63 0.772 . . . . 15.0 112.29 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -79.02 78.93 5.44 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.248 -0.887 . . . . 15.0 109.709 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 125' ' ' VAL . 48.5 t -90.17 92.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.456 0.702 . . . . 15.0 109.567 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 39.8 p -74.07 94.66 2.42 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.779 0.832 . . . . 15.0 110.859 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.28 119.9 17.13 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.2 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 422' ' ' THR . 0.0 OUTLIER -135.35 145.74 47.71 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.438 -0.578 . . . . 15.0 109.438 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.94 136.91 39.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 15.0 109.675 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.424 HG21 ' HE3' ' A' ' 420' ' ' LYS . 11.9 t -163.41 176.66 9.6 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.822 0.449 . . . . 15.0 111.382 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.3 p -93.55 173.4 7.71 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.142 0.977 . . . . 15.0 111.389 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.24 -19.05 42.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.303 1.441 . . . . 15.0 112.05 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -66.43 -5.41 10.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.939 1.296 . . . . 15.0 113.526 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.595 ' HB3' HD12 ' A' ' 427' ' ' LEU . 14.4 tp10 -74.95 -55.41 5.8 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.529 0.732 . . . . 15.0 112.472 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.4 mp -90.35 -71.84 0.6 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.332 0.493 . . . . 15.0 112.332 -163.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -107.15 33.54 3.93 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.358 0.663 . . . . 15.0 111.873 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.8 t30 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 122.091 0.948 . . . . 15.0 111.867 -174.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.8 mm? . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . 0.587 HG11 ' HA3' ' A' ' 179' ' ' GLY . 11.4 t -75.32 98.21 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.473 ' HB ' ' HZ ' ' A' ' 217' ' ' PHE . 22.5 pt -136.66 84.58 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 159.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.862 ' HA ' HD11 ' A' ' 226' ' ' LEU . 5.4 p . . . . . 0 CA--C 1.544 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.845 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . 0.407 ' HB1' HD11 ' A' ' 394' ' ' LEU . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.474 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 111.274 -174.79 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . 0.668 HD13 ' HA ' ' A' ' 356' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -48.23 -33.72 9.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.099 1.76 . . . . 0.0 114.65 -166.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -136.86 -70.21 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 110.839 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 70.35 136.29 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.451 1.5 . . . . 0.0 111.587 -172.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.12 166.02 24.08 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.028 0.531 . . . . 0.0 110.233 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.26 90.92 2.12 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.107 0.48 . . . . 0.0 109.816 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -173.15 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.219 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.804 172.679 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 18.7 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.326 -0.25 . . . . 15.0 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -168.01 97.36 0.44 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.84 -1.17 . . . . 15.0 107.84 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 17' ' ' ILE . 22.9 m -111.62 152.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.709 0.804 . . . . 15.0 111.873 -169.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -137.64 92.04 2.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 15.0 109.018 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.46 89.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 122.559 1.171 . . . . 15.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -94.08 92.6 7.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.67 -1.15 . . . . 15.0 109.494 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 32.4 m -67.41 94.18 0.38 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.388 -0.824 . . . . 15.0 109.896 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 p -75.18 -66.96 0.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.137 0.975 . . . . 15.0 111.343 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -151.23 121.6 7.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.927 0.491 . . . . 15.0 110.368 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -103.96 0.64 Allowed Glycine 0 C--N 1.35 1.325 0 O-C-N 124.38 1.05 . . . . 15.0 114.239 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 2.5 mm? -77.33 -34.29 55.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.508 0.723 . . . . 15.0 110.083 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.37 97.4 0.11 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 124.622 1.201 . . . . 15.0 114.06 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD2' HG11 ' A' ' 111' ' ' VAL . 50.9 mtt85 -112.59 86.81 2.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.354 -1.35 . . . . 15.0 107.354 168.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -72.53 91.53 1.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.47 -1.241 . . . . 15.0 110.376 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.7 t -79.27 87.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.774 -0.824 . . . . 15.0 108.774 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 88.8 m -74.77 105.36 5.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.321 -0.854 . . . . 15.0 109.779 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 HG12 ' A' ' 3' ' ' VAL . 33.6 mt -101.28 118.49 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.679 0.791 . . . . 15.0 110.301 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.1 m -88.75 104.87 17.3 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.366 0.666 . . . . 15.0 109.214 165.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -81.29 108.16 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.939 -1.134 . . . . 15.0 107.939 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.95 160.12 33.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.929 0.491 . . . . 15.0 111.869 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.27 -22.5 66.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.363 1.065 . . . . 15.0 113.419 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.35 -42.03 88.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.836 0.455 . . . . 15.0 109.963 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 m -70.95 -40.16 72.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.161 -0.927 . . . . 15.0 110.278 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.0 mt -69.85 -51.97 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.656 0.782 . . . . 15.0 111.087 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.86 -39.83 90.63 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.758 0.823 . . . . 15.0 111.077 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.7 m -66.24 -44.7 83.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.609 -0.723 . . . . 15.0 110.952 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.23 -39.86 78.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.217 0.607 . . . . 15.0 112.522 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' ILE . 66.7 t -61.18 -44.95 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.131 0.572 . . . . 15.0 109.728 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -67.82 -39.49 83.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -73.41 -16.93 61.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.414 1.085 . . . . 15.0 111.424 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -88.6 -39.98 13.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.937 0.495 . . . . 15.0 110.439 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 59' ' ' GLY . 81.6 mt -74.23 -20.79 60.05 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.89 0.7 . . . . 15.0 112.89 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.2 p -66.39 -32.19 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 109.854 -0.424 . . . . 15.0 109.854 174.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -67.97 -45.3 74.54 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.901 0.88 . . . . 15.0 109.917 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.5 -40.08 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 114.923 -1.035 . . . . 15.0 110.506 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.65 85.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.889 0.876 . . . . 15.0 110.85 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -66.82 -44.19 81.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.652 -0.704 . . . . 15.0 111.462 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.08 -51.24 68.76 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.731 0.644 . . . . 15.0 110.752 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.43 -5.35 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 115.544 -0.753 . . . . 15.0 110.904 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 76.05 10.77 3.09 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.598 1.559 . . . . 15.0 112.39 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.11 -33.5 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.264 1.026 . . . . 15.0 110.607 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.76 -41.47 77.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 15.0 110.276 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.11 -36.23 92.03 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 124.204 0.94 . . . . 15.0 112.947 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -77.81 -31.96 52.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.167 0.587 . . . . 15.0 110.794 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -75.57 117.3 17.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.937 0.495 . . . . 15.0 110.989 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.95 21.36 17.67 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.776 0.83 . . . . 15.0 110.205 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.67 48.41 50.05 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.465 -0.789 . . . . 15.0 112.426 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.26 -60.71 3.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.115 0.566 . . . . 15.0 110.713 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 t -103.86 128.73 26.66 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.4 148.74 4.86 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 124.045 3.163 . . . . 15.0 114.917 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.453 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.6 tpp -65.18 -36.56 84.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.338 1.055 . . . . 15.0 111.984 -172.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -58.59 -37.68 76.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.501 0.721 . . . . 15.0 111.964 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.77 -54.25 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.153 0.981 . . . . 15.0 110.557 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 51' ' ' MET . 35.6 m -68.56 -34.24 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.488 0.551 . . . . 15.0 112.488 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.11 63.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.89 0.476 . . . . 15.0 112.058 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -70.04 -19.94 63.27 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.125 0.417 . . . . 15.0 112.125 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.34 -58.92 2.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.1 0.56 . . . . 15.0 111.142 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.65 -23.27 66.13 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.993 0.517 . . . . 15.0 111.98 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -93.4 21.55 40.01 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.715 -0.491 . . . . 15.0 113.935 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.82 73.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.501 0.721 . . . . 15.0 110.865 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 p -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.48 0.712 . . . . 15.0 111.096 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.17 -6.99 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 124.306 1.043 . . . . 15.0 112.05 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -55.07 -38.42 68.02 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.849 0.46 . . . . 15.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -58.2 -47.4 83.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.682 0.793 . . . . 15.0 111.469 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.17 -43.76 98.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.559 0.744 . . . . 15.0 110.551 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.38 -44.33 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.414 -1.266 . . . . 15.0 110.946 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 71' ' ' MET . 91.2 mt -66.95 -36.75 82.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.939 0.495 . . . . 15.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.24 -43.72 95.33 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.734 0.646 . . . . 15.0 111.873 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 27.4 t70 -64.08 -48.38 76.43 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.48 0.712 . . . . 15.0 110.512 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 80.5 mt -63.38 -32.46 73.89 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.191 0.996 . . . . 15.0 112.556 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 58.8 mtm -61.62 -41.52 97.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.613 0.365 . . . . 15.0 110.561 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -72.85 -36.86 67.52 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.597 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 29.4 mmt180 -60.63 -52.32 65.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.411 0.684 . . . . 15.0 110.65 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 17' ' ' ILE . 33.7 m-80 -75.65 -26.06 57.39 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.188 -0.914 . . . . 15.0 111.756 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -68.7 -58.07 4.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.577 0.351 . . . . 15.0 110.925 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.39 -40.44 87.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 123.721 0.638 . . . . 15.0 110.288 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.92 -40.37 96.33 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.219 1.008 . . . . 15.0 110.85 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.26 -61.77 2.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.595 -0.729 . . . . 15.0 111.446 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 pt -60.73 -24.45 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.63 0.772 . . . . 15.0 112.975 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.6 -58.08 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.543 0.737 . . . . 15.0 110.532 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.4 ptpt -77.57 -23.41 50.0 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.055 0.391 . . . . 15.0 112.055 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -86.89 -17.24 33.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.21 0.604 . . . . 15.0 110.749 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 62.0 33.47 17.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.417 1.087 . . . . 15.0 111.416 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.9 mt -77.96 106.5 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.96 -1.126 . . . . 15.0 107.96 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.54 HD21 ' HB2' ' A' ' 112' ' ' TYR . 8.0 t30 -78.07 102.4 0.94 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.8 0.84 . . . . 15.0 109.047 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -94.5 -177.0 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.237 2.625 . . . . 15.0 112.662 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.89 166.17 11.39 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.447 1.099 . . . . 15.0 109.635 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.43 -156.43 51.1 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.472 -0.786 . . . . 15.0 113.675 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.29 67.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.661 0.785 . . . . 15.0 109.665 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.26 107.35 0.56 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.416 2.077 . . . . 15.0 111.041 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -87.13 94.88 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.482 0.713 . . . . 15.0 109.912 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.99 91.53 4.86 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.21 109.37 6.21 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.596 -0.89 . . . . 15.0 108.596 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.07 98.63 0.73 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.363 2.042 . . . . 15.0 110.861 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.82 -71.23 0.88 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.187 -0.915 . . . . 15.0 112.329 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -169.89 133.42 1.21 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.919 0.887 . . . . 15.0 110.238 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -107.96 123.57 48.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.097 0.559 . . . . 15.0 109.642 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 93.3 mttt -97.41 129.59 44.62 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 171.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.2 101.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.279 1.031 . . . . 15.0 112.16 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.51 79.21 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.68 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.2 mt-10 -116.43 -163.92 0.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 15.0 108.383 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -73.54 116.01 13.61 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.095 0.558 . . . . 15.0 111.06 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -79.37 138.57 37.72 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.201 1.0 . . . . 15.0 109.3 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.2 m -133.83 132.83 40.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.109 -0.7 . . . . 15.0 109.109 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.58 169.42 21.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.064 0.946 . . . . 15.0 108.866 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 52.1 m -125.71 119.56 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.324 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -98.33 106.42 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.84 133.58 45.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -154.27 167.11 31.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.498 0.719 . . . . 15.0 109.536 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.715 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 31.8 mt-10 -84.71 170.38 13.33 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 15.0 110.238 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.0 m -136.83 155.12 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.85 0.86 . . . . 15.0 108.941 174.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.54 ' HB2' HD21 ' A' ' 85' ' ' ASN . 68.3 m-85 -78.91 109.82 12.28 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.34 -173.62 1.78 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.035 2.49 . . . . 15.0 112.771 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -78.15 104.34 8.67 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.744 -175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.56 103.0 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.943 0.877 . . . . 15.0 108.671 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -102.59 101.04 11.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.598 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.69 140.34 32.21 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.281 -0.637 . . . . 15.0 109.281 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.95 -166.83 1.31 Allowed 'General case' 0 C--O 1.246 0.896 0 N-CA-C 108.747 -0.834 . . . . 15.0 108.747 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.67 109.35 2.31 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.247 -0.741 . . . . 15.0 111.247 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 414' ' ' LYS . 69.0 mt -66.16 -14.61 62.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.33 0.652 . . . . 15.0 111.063 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.68 -32.89 69.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.371 1.469 . . . . 15.0 111.698 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.33 75.43 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.873 0.869 . . . . 15.0 112.145 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -65.15 130.98 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.276 1.03 . . . . 15.0 110.397 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.52 115.39 29.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.636 0.774 . . . . 15.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.3 t -120.13 159.14 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 125.241 1.416 . . . . 15.0 108.47 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.55 149.46 34.41 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.0 tttt -124.11 105.56 31.57 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 107.86 -1.163 . . . . 15.0 107.86 168.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.73 99.12 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 121.77 1.646 . . . . 15.0 110.54 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 41.4 mm -66.42 97.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.552 -1.277 . . . . 15.0 107.552 169.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 427' ' ' LEU . 40.3 t -132.42 145.74 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.475 0.655 . . . . 15.0 111.362 -172.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -142.94 150.96 40.43 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.513 1.525 . . . . 15.0 107.553 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.556 HG11 ' SD ' ' A' ' 274' ' ' MET . 6.6 t -80.89 87.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.672 -1.233 . . . . 15.0 107.672 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.1 p -69.85 171.87 8.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.416 0.686 . . . . 15.0 110.117 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -58.1 -33.33 69.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.81 0.444 . . . . 15.0 111.285 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.54 82.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 15.0 110.512 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.16 -42.57 72.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.206 -0.906 . . . . 15.0 111.811 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.05 -54.6 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.85 0.86 . . . . 15.0 109.827 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.56 -44.8 93.07 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.124 0.89 . . . . 15.0 110.549 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.5 -40.92 99.29 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.845 0.716 . . . . 15.0 113.475 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.402 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.6 tpt -67.42 -57.48 6.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.554 0.742 . . . . 15.0 110.476 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 144' ' ' LEU . 90.7 mt -55.24 -32.92 62.7 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.631 0.772 . . . . 15.0 112.583 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.63 -51.91 63.14 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.329 1.052 . . . . 15.0 109.961 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.9 m -67.18 -24.37 65.86 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.5 0.72 . . . . 15.0 111.533 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 141' ' ' LEU . 74.9 mt -71.94 -47.29 53.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.83 0.452 . . . . 15.0 110.326 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 47.2 mtm180 -74.82 -19.36 60.22 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 111.696 0.258 . . . . 15.0 111.696 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.403 ' HB3' HH11 ' A' ' 243' ' ' ARG . 87.5 mttt -79.52 -23.41 42.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.827 -0.546 . . . . 15.0 110.461 169.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.09 -35.24 69.17 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.476 -0.565 . . . . 15.0 109.476 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 22.7 mm-40 -87.74 42.39 1.05 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.997 0.919 . . . . 15.0 109.656 172.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.32 118.18 4.51 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.167 1.387 . . . . 15.0 114.245 -168.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 244' ' ' GLU . 17.4 m -79.33 114.68 18.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.69 -0.855 . . . . 15.0 108.69 169.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.431 ' HZ3' ' HG3' ' A' ' 163' ' ' ARG . 36.3 m95 -79.88 110.9 15.68 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.414 -0.587 . . . . 15.0 109.414 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -141.59 115.18 9.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.36 0.664 . . . . 15.0 110.397 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 45.9 mt-10 -61.82 131.6 50.35 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.145 0.578 . . . . 15.0 110.527 172.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HE3' ' HB2' ' A' ' 242' ' ' GLU . 18.1 ptpt -108.37 172.02 7.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.528 0.731 . . . . 15.0 110.801 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.4 91.82 8.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.718 -0.674 . . . . 15.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.55 -56.48 1.25 Allowed Glycine 0 CA--C 1.544 1.902 0 N-CA-C 118.277 2.071 . . . . 15.0 118.277 159.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.15 132.46 47.86 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.67 1.235 . . . . 15.0 111.631 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 202' ' ' ILE . 20.0 t -95.54 136.52 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 122.9 0.48 . . . . 15.0 110.079 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.85 171.87 8.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.943 1.297 . . . . 15.0 108.823 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.77 65.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.793 0.837 . . . . 15.0 112.021 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -95.34 13.54 25.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.326 0.65 . . . . 15.0 111.713 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -84.33 178.65 7.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.868 0.842 . . . . 15.0 113.068 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.431 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 1.7 tmm_? -131.94 92.52 3.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 106.687 -1.597 . . . . 15.0 106.687 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 HG23 ' A' ' 166' ' ' ILE . 38.7 t -89.42 157.22 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.461 1.105 . . . . 15.0 110.378 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 61.5 m -132.77 134.84 45.24 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.867 -1.16 . . . . 15.0 107.867 166.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.8 pt -148.33 169.68 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.652 1.181 . . . . 15.0 110.303 -171.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -104.6 155.57 18.72 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 106.269 -1.752 . . . . 15.0 106.269 156.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 24.4 p90 -151.2 165.08 35.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.019 0.438 . . . . 15.0 111.131 167.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.1 t -142.75 103.15 4.16 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.006 -0.997 . . . . 15.0 108.626 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.84 140.33 15.81 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 114.914 -1.039 . . . . 15.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.3 p -150.13 116.59 5.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.974 0.91 . . . . 15.0 108.741 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 25.6 t -86.57 115.48 27.65 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 C-N-CA 123.498 0.719 . . . . 15.0 110.066 -168.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.1 t70 71.16 -1.26 2.78 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.063 1.345 . . . . 15.0 111.092 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.76 31.66 6.59 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.315 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 19.9 pt-20 -131.29 150.47 52.14 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 123.485 0.714 . . . . 15.0 110.542 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -90.86 81.63 5.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.756 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.602 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 0.0 OUTLIER -52.28 -70.12 0.1 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.4 1.48 . . . . 15.0 110.839 165.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.727 ' HB2' HG13 ' B' ' 386' ' ' VAL . 65.4 mm-40 -99.39 176.35 5.54 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.021 1.328 . . . . 15.0 109.487 168.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.97 5.72 0.12 Allowed Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.346 1.698 . . . . 15.0 117.346 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.43 -60.87 3.26 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 117.754 0.777 . . . . 15.0 113.493 168.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.67 160.74 14.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.627 0.973 . . . . 15.0 113.627 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.85 94.19 1.84 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.452 -1.249 . . . . 15.0 109.025 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.3 m -69.53 125.1 25.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.233 1.013 . . . . 15.0 112.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.03 41.8 10.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.64 1.176 . . . . 15.0 112.393 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' B' ' 385' ' ' LEU . 18.7 t80 -67.92 131.85 46.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.345 -0.843 . . . . 15.0 109.365 170.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.78 104.15 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.019 1.328 . . . . 15.0 108.357 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.4 tp -90.95 98.44 11.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 15.0 111.542 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -79.46 83.55 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 170.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.8 mtp -57.02 134.03 55.45 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.547 0.739 . . . . 15.0 110.941 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.91 -28.68 4.84 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 -168.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.38 114.62 9.65 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.008 0.523 . . . . 15.0 109.899 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.53 3.15 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.22 -0.446 . . . . 15.0 112.647 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.543 ' NH2' HD22 ' B' ' 385' ' ' LEU . 2.9 tmm_? -87.12 -33.88 19.3 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.485 -0.931 . . . . 15.0 108.485 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.1 mmt -84.37 154.14 23.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.196 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.5 pt -86.75 163.7 40.07 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.244 0.618 . . . . 15.0 110.824 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.17 144.75 46.28 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.72 2.28 . . . . 15.0 112.276 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.88 -52.93 0.61 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.839 -0.904 . . . . 15.0 110.839 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -66.47 -54.4 24.52 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.454 -0.573 . . . . 15.0 109.454 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.66 -40.77 69.36 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.79 -32.54 71.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.02 0.928 . . . . 15.0 110.465 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -71.15 -16.85 75.35 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.105 -0.952 . . . . 15.0 113.293 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.509 HG22 HG11 ' A' ' 158' ' ' VAL . 36.1 mm -93.68 -54.51 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.771 0.828 . . . . 15.0 109.553 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -79.55 14.02 1.8 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.676 0.991 . . . . 15.0 113.676 -169.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -122.06 20.21 8.11 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.099 -0.801 . . . . 15.0 111.099 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -142.37 -171.11 3.33 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.968 0.907 . . . . 15.0 111.175 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -149.89 154.03 37.66 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.279 1.032 . . . . 15.0 109.797 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -60.57 148.26 38.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.095 0.958 . . . . 15.0 112.598 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.72 -48.41 0.94 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.175 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.7 pt-20 -74.08 133.46 42.87 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.519 0.676 . . . . 15.0 110.419 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.53 105.56 10.58 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.147 0.979 . . . . 15.0 108.539 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -124.02 -169.16 1.91 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.944 1.298 . . . . 15.0 110.278 -168.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 44.8 m -136.3 125.69 24.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.897 0.879 . . . . 15.0 109.402 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.6 pt -102.6 154.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.633 0.773 . . . . 15.0 109.435 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -116.45 104.6 11.6 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.264 1.025 . . . . 15.0 108.395 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.2 t -92.35 154.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 107.087 -1.449 . . . . 15.0 107.087 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 m -137.5 121.33 17.56 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.087 0.858 . . . . 15.0 109.3 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 51.1 m-85 -92.21 136.47 25.73 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 119.539 -0.267 . . . . 15.0 111.373 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 81.1 Cg_exo -54.57 170.9 0.49 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.977 3.784 . . . . 15.0 117.3 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 22.6 mm-40 -79.74 -26.36 40.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.147 -1.388 . . . . 15.0 110.473 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -25.28 63.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.873 0.869 . . . . 15.0 110.383 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 226' ' ' LEU . 6.9 t80 -68.15 106.56 2.45 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.612 -0.885 . . . . 15.0 108.612 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.68 -19.29 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.882 0.873 . . . . 15.0 113.208 -167.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.88 101.85 3.9 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.672 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 41.3 tt0 -67.38 -24.99 65.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 15.0 112.287 -173.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -63.92 -17.85 63.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.686 0.794 . . . . 15.0 112.222 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 172' ' ' VAL . 16.7 mt -114.35 -30.61 6.53 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.27 0.628 . . . . 15.0 111.316 173.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.672 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 55.2 tttm -55.68 116.67 3.05 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.227 1.411 . . . . 15.0 111.809 -172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.58 -19.94 8.26 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.834 0.709 . . . . 15.0 113.885 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -87.29 156.99 19.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.806 0.842 . . . . 15.0 110.847 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -109.28 112.96 25.4 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -80.71 113.36 18.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 15.0 111.35 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -83.67 97.32 9.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.638 -0.71 . . . . 15.0 109.966 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.499 ' HZ ' HD13 ' B' ' 387' ' ' ILE . 95.9 m-85 -93.83 109.02 20.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.92 92.24 4.26 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.63 126.09 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.56 0.744 . . . . 15.0 110.46 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.16 91.07 3.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.204 1.002 . . . . 15.0 109.198 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 84.5 mt -68.41 108.0 3.09 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 110.152 -0.314 . . . . 15.0 110.152 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -110.87 -40.43 4.53 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.391 0.676 . . . . 15.0 110.103 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.5 mmtt -131.44 136.61 48.11 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.185 0.994 . . . . 15.0 109.594 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 207' ' ' ALA . 25.6 t -130.74 115.01 29.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.768 -1.567 . . . . 15.0 106.768 168.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 34.7 mt-10 -112.31 -175.37 2.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.583 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 35.4 tt0 -133.58 130.85 38.96 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 175.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.403 HH11 ' HB3' ' A' ' 146' ' ' LYS . 11.4 ptt180 -79.18 82.79 5.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.1 -1.445 . . . . 15.0 107.1 164.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 42.0 tt0 -73.89 147.62 43.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.72 -1.582 . . . . 15.0 111.353 -171.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.21 114.64 19.6 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.728 0.811 . . . . 15.0 109.173 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 30.2 Cg_endo -59.74 150.55 76.37 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.257 2.638 . . . . 15.0 111.291 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -53.54 106.82 0.2 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.422 1.076 . . . . 15.0 110.033 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 252' ' ' PHE . 31.8 tp -77.06 73.54 3.64 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 253' ' ' ILE . 67.5 p -91.55 168.68 11.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.014 -0.994 . . . . 15.0 108.805 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.97 -45.55 42.28 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.751 1.22 . . . . 15.0 111.979 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 48.0 mt-10 -73.36 -21.1 60.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.911 0.884 . . . . 15.0 112.886 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.526 ' HD2' HD12 ' A' ' 248' ' ' LEU . 59.6 t80 -85.69 -49.99 7.54 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.508 -0.553 . . . . 15.0 109.508 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 249' ' ' THR . 6.2 tt -67.29 -28.34 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.044 0.538 . . . . 15.0 111.564 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.647 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.4 ptmt -79.61 -12.43 59.84 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.826 0.676 . . . . 15.0 112.826 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.92 -25.7 65.35 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.093 0.557 . . . . 15.0 111.51 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -68.15 -33.83 75.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.089 0.956 . . . . 15.0 111.932 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.68 7.22 0.46 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 116.664 -0.244 . . . . 15.0 113.271 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 20.5 t -79.26 157.75 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.652 0.781 . . . . 15.0 110.119 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -59.82 -72.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.832 1.253 . . . . 15.0 111.92 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -121.86 6.61 9.87 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.554 0.742 . . . . 15.0 110.456 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.95 4.93 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.953 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 7.1 m -64.21 132.02 49.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.136 0.975 . . . . 15.0 110.561 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.42 -47.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 124.049 0.843 . . . . 15.0 110.241 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.6 -32.87 63.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.729 0.812 . . . . 15.0 111.609 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.552 ' HA3' HG13 ' A' ' 258' ' ' VAL . . . -79.28 -25.06 60.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 111.276 -0.73 . . . . 15.0 111.276 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.24 -33.62 56.02 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -67.75 -38.72 83.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.418 0.687 . . . . 15.0 109.641 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.02 82.5 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.198 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.19 -48.18 76.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.127 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.37 -27.88 36.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.318 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -65.05 -52.45 55.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.218 0.463 . . . . 15.0 110.296 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 377' ' ' ALA . 13.2 ptmm? -73.79 -16.7 61.15 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.983 0.734 . . . . 15.0 112.983 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -95.1 -47.39 6.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 118.167 0.439 . . . . 15.0 111.796 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.556 ' SD ' HG11 ' A' ' 132' ' ' VAL . 66.4 mtt -73.83 -26.23 60.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 118.653 -0.689 . . . . 15.0 111.459 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.6 -32.88 41.93 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 119.062 0.846 . . . . 15.0 110.443 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' NH2' ' HB3' ' A' ' 377' ' ' ALA . 24.2 tpp180 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.923 0.489 . . . . 15.0 110.186 174.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -76.96 -60.29 2.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.309 -0.86 . . . . 15.0 109.881 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.474 HD11 HG11 ' A' ' 130' ' ' VAL . 58.8 tp -70.69 -59.73 2.65 Favored 'General case' 0 C--O 1.211 -0.947 0 C-N-CA 124.022 0.929 . . . . 15.0 112.933 -168.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.76 -32.61 73.79 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.797 0.439 . . . . 15.0 110.713 -171.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -68.92 -46.56 67.97 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.08 -0.964 . . . . 15.0 109.658 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.38 72.53 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.336 0.655 . . . . 15.0 111.949 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 286' ' ' VAL . 79.8 mt -70.94 -51.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -58.34 -42.15 86.23 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.992 0.808 . . . . 15.0 110.338 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.13 61.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 15.0 110.947 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -63.94 -59.44 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 282' ' ' ILE . 40.2 t -58.53 -44.3 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 114.95 -1.023 . . . . 15.0 110.457 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -68.78 -41.15 79.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.668 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.4 p -65.25 -40.35 93.9 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.991 0.359 . . . . 15.0 110.489 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.462 ' HB2' HG13 ' A' ' 125' ' ' VAL . 51.5 mt-30 -68.68 -34.93 76.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.53 0.519 . . . . 15.0 111.245 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.8 -50.22 67.59 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.132 0.573 . . . . 15.0 110.519 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 295' ' ' VAL . 27.0 mm -65.07 -54.62 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.676 0.791 . . . . 15.0 110.907 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.64 -38.54 90.66 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.761 0.663 . . . . 15.0 110.383 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.96 -35.3 89.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.581 -0.736 . . . . 15.0 112.758 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.5 OUTLIER -66.32 -42.59 88.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.97 0.908 . . . . 15.0 110.299 177.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 291' ' ' ILE . 47.6 t -62.13 -53.43 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.799 -0.815 . . . . 15.0 108.799 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.26 -27.64 69.15 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.593 -1.185 . . . . 15.0 111.613 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.17 59.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 15.0 113.171 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.79 150.63 15.64 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.204 0.816 . . . . 15.0 113.204 -169.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.06 143.27 58.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.774 0.829 . . . . 15.0 111.113 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 346' ' ' VAL . 6.1 tp -147.62 115.04 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.0 130.77 54.59 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.217 1.007 . . . . 15.0 108.57 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 349' ' ' LEU . 45.6 t -131.95 131.26 22.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.935 0.894 . . . . 15.0 110.097 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.412 ' HB2' ' HG ' ' A' ' 306' ' ' LEU . 53.0 Cg_exo -55.06 130.14 39.11 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.144 2.562 . . . . 15.0 112.468 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -63.61 -24.83 67.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.506 1.122 . . . . 15.0 112.902 -173.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.12 73.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.201 0.6 . . . . 15.0 111.536 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.446 HD11 ' HE1' ' A' ' 112' ' ' TYR . 19.5 mt -69.86 -43.39 71.97 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.379 -0.6 . . . . 15.0 109.379 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 304' ' ' ALA . 3.2 mp -59.09 -50.21 80.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.013 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.17 -35.74 81.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.783 0.833 . . . . 15.0 111.738 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -44.03 94.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.376 0.671 . . . . 15.0 110.339 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -79.13 -27.4 42.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.647 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 337' ' ' PHE . 34.0 mt -65.76 -35.88 76.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 108.585 -0.895 . . . . 15.0 108.585 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.579 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 14.9 t70 -63.67 -44.07 94.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.653 0.781 . . . . 15.0 110.575 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.67 -52.12 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 123.72 0.637 . . . . 15.0 110.114 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.9 mt -70.27 -21.41 62.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.897 -1.047 . . . . 15.0 112.426 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 58.9 mtm180 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 123.908 0.883 . . . . 15.0 109.871 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 50.0 tp . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 111.926 0.343 . . . . 15.0 111.926 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.06 -8.58 53.66 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.489 0.716 . . . . 15.0 112.388 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 69.0 mt -54.03 130.31 58.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 118.587 0.63 . . . . 15.0 110.248 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 86.2 Cg_exo -48.35 116.04 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.634 2.889 . . . . 15.0 113.759 -170.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -51.7 -37.78 52.27 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.925 0.89 . . . . 15.0 111.519 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -54.5 -33.13 59.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.174 0.989 . . . . 15.0 112.851 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.523 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 95.3 mt -62.7 -30.16 71.2 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.274 0.559 . . . . 15.0 110.891 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.511 ' HA ' HE21 ' A' ' 340' ' ' GLN . 28.2 m-85 -116.47 -3.04 11.9 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.246 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.414 ' HA ' HD11 ' A' ' 311' ' ' ILE . 11.3 tp10 -55.83 -63.05 1.3 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.304 1.042 . . . . 15.0 111.965 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.05 -47.18 85.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.15 0.906 . . . . 15.0 111.589 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 337' ' ' PHE . 16.8 pt20 -67.72 -51.93 43.54 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.683 0.614 . . . . 15.0 111.558 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -63.3 -43.21 98.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.776 0.43 . . . . 15.0 110.627 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 346' ' ' VAL . 75.5 tttt -58.38 -43.24 88.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 123.883 0.739 . . . . 15.0 110.164 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 347' ' ' VAL . 45.3 mmt-85 -61.31 -35.75 78.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.655 -0.688 . . . . 15.0 111.268 172.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.5 mtt-85 -69.33 -34.01 73.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.807 0.443 . . . . 15.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.701 ' HA ' ' HB3' ' B' ' 467' ' ' ALA . 9.9 t -77.69 -41.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.856 0.36 . . . . 15.0 110.069 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 300' ' ' ILE . 53.6 t -58.88 -35.05 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.455 -0.793 . . . . 15.0 110.449 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 343' ' ' ARG . 11.8 t -51.28 -54.55 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.675 0.79 . . . . 15.0 109.316 169.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.99 -37.85 93.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.404 -0.816 . . . . 15.0 114.334 -174.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 302' ' ' VAL . 10.3 mp -72.02 -50.11 31.26 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.858 0.829 . . . . 15.0 111.124 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 87.6 mt -63.05 -52.85 61.16 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.271 0.357 . . . . 15.0 110.337 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.471 HD12 HG13 ' A' ' 347' ' ' VAL . 81.5 mt -69.85 -31.19 68.91 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.904 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.548 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.42 -39.22 97.51 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 111.779 -0.528 . . . . 15.0 111.779 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.67 -38.63 84.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.096 -0.552 . . . . 15.0 110.429 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -60.6 -36.43 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 122.746 0.418 . . . . 15.0 111.07 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.548 HD12 ' HA2' ' A' ' 352' ' ' GLY . 85.3 mt -62.96 -52.58 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.876 0.87 . . . . 15.0 109.902 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -62.14 -56.42 18.93 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.52 0.513 . . . . 15.0 110.912 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.1 m -54.67 -48.25 72.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 15.0 112.192 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.2 16.34 11.69 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 119.323 -0.37 . . . . 15.0 111.919 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 44.46 41.34 4.55 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 125.746 1.618 . . . . 15.0 113.776 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.512 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.8 mt -74.7 150.51 39.46 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.021 -0.99 . . . . 15.0 112.184 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 147.29 52.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.456 1.102 . . . . 15.0 109.555 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.23 92.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.117 0.567 . . . . 15.0 110.438 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 367' ' ' VAL . 13.9 t70 -70.54 127.01 31.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.834 0.854 . . . . 15.0 110.44 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.47 -32.96 74.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.631 1.172 . . . . 15.0 112.783 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.15 -23.76 60.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.461 0.304 . . . . 15.0 110.336 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.45 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 40.6 tpt85 -80.51 -33.58 36.35 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.129 0.572 . . . . 15.0 109.585 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 363' ' ' ASP . 44.6 t -61.68 -54.46 34.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -65.69 -28.7 69.27 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.859 0.724 . . . . 15.0 110.868 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.55 -54.01 37.48 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 111.66 -0.576 . . . . 15.0 111.66 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.34 -56.52 20.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.592 0.757 . . . . 15.0 110.698 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.669 HD11 ' HG2' ' A' ' 398' ' ' MET . 44.9 mm -50.75 -53.4 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 124.771 1.294 . . . . 15.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.04 -41.51 61.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.004 0.521 . . . . 15.0 111.133 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.59 -23.28 62.55 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.64 0.607 . . . . 15.0 112.64 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 -33.3 12.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 119.159 -0.448 . . . . 15.0 111.57 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -93.24 -40.64 10.33 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 112.671 0.619 . . . . 15.0 112.671 -171.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 381' ' ' PRO . 22.1 t -70.06 -13.29 62.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.01 0.374 . . . . 15.0 112.01 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 272' ' ' LYS . . . -86.92 -0.56 56.74 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.136 0.574 . . . . 15.0 111.664 174.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -94.69 -175.31 3.55 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.426 0.69 . . . . 15.0 110.367 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.85 -51.67 17.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.437 1.095 . . . . 15.0 110.305 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -123.33 106.92 32.71 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 174.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.46 ' HB3' ' HA ' ' A' ' 376' ' ' SER . 97.1 Cg_endo -84.93 -23.56 2.47 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.599 2.199 . . . . 15.0 113.61 170.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -57.23 -49.54 75.7 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.453 0.701 . . . . 15.0 112.288 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.61 -16.06 60.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.267 -0.879 . . . . 15.0 111.383 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.426 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 88.7 t -76.58 -50.26 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.604 -0.888 . . . . 15.0 108.604 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.22 -49.53 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.635 0.774 . . . . 15.0 109.078 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.94 -36.14 80.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.237 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.05 -57.99 10.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.754 0.422 . . . . 15.0 110.451 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.459 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 87.0 m-85 -64.09 -53.05 55.87 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.892 0.745 . . . . 15.0 111.352 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.0 p -56.05 -33.94 65.45 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -98.13 -4.61 35.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.075 0.55 . . . . 15.0 112.461 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -119.49 90.18 3.28 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -56.09 -29.28 60.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.765 1.226 . . . . 15.0 113.031 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.85 -57.88 10.99 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.407 0.683 . . . . 15.0 111.056 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' B' ' 443' ' ' ALA . 2.0 tt -87.66 -18.9 28.54 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.243 -0.89 . . . . 15.0 109.775 -174.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 7.4 tpt -67.13 -43.32 82.69 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -40.03 95.77 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.065 0.946 . . . . 15.0 110.403 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.86 -44.1 90.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.258 0.623 . . . . 15.0 110.378 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.669 ' HG2' HD11 ' A' ' 371' ' ' ILE . 37.7 tpp -72.72 -23.52 60.86 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.488 -0.778 . . . . 15.0 111.671 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HG2' HG21 ' A' ' 367' ' ' VAL . 12.7 mtp180 -76.53 -35.32 58.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.599 0.76 . . . . 15.0 109.85 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' B' ' 464' ' ' MET . 0.9 OUTLIER -69.19 -38.4 78.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.139 0.576 . . . . 15.0 110.269 178.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.1 p -79.09 -22.86 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 119.49 -0.291 . . . . 15.0 111.11 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.41 96.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.866 0.757 . . . . 15.0 109.468 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.96 -34.92 64.45 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.844 -1.525 . . . . 15.0 111.77 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 401' ' ' VAL . 0.6 OUTLIER -67.93 -48.01 67.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.376 1.07 . . . . 15.0 109.965 177.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.45 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 6.1 mm-40 -56.49 -46.99 80.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.024 1.329 . . . . 15.0 111.199 171.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.512 HE21 ' HB3' ' A' ' 360' ' ' LEU . 27.4 tt0 -62.32 -35.11 78.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.803 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -67.78 -38.07 82.88 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.244 0.618 . . . . 15.0 110.997 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 59.5 t -56.1 -53.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.969 -0.752 . . . . 15.0 108.969 170.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -63.08 -26.45 68.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.163 0.985 . . . . 15.0 112.959 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -74.71 -27.36 60.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.06 0.544 . . . . 15.0 111.148 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 407' ' ' ALA . 89.0 t -75.79 -38.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.521 -0.918 . . . . 15.0 108.521 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 290' ' ' ALA . 92.8 mt -67.56 -35.16 78.51 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.78 0.832 . . . . 15.0 111.32 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.57 -20.83 65.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.648 0.779 . . . . 15.0 111.592 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.522 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.8 mtpp -105.67 -30.15 9.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.059 0.944 . . . . 15.0 111.556 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.82 159.25 22.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.071 0.948 . . . . 15.0 111.741 -172.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -75.61 82.63 2.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.972 0.909 . . . . 15.0 109.464 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 125' ' ' VAL . 42.5 t -90.15 92.15 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -70.67 96.03 1.17 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.402 1.096 . . . . 15.0 110.493 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.54 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 37.1 mt-10 -75.2 105.01 6.0 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.253 -1.34 . . . . 15.0 109.562 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -114.41 138.29 50.75 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.279 0.562 . . . . 15.0 109.951 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 28.4 mt-10 -81.44 130.89 35.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.959 0.904 . . . . 15.0 109.193 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.446 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -163.64 169.55 18.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.285 0.634 . . . . 15.0 110.446 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.2 p -93.22 171.83 8.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.243 1.017 . . . . 15.0 111.487 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 428' ' ' MET . 57.0 t80 -52.54 -47.27 66.82 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.888 1.275 . . . . 15.0 110.828 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -54.93 -22.94 16.62 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.945 1.091 . . . . 15.0 113.945 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 427' ' ' LEU . 10.0 tp10 -54.34 -55.7 25.82 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.647 0.779 . . . . 15.0 112.068 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 426' ' ' GLU . 5.4 mp -74.87 -29.5 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.42 -0.809 . . . . 15.0 111.709 -167.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.1 OUTLIER -80.69 -42.87 21.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.992 0.517 . . . . 15.0 109.832 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 123.002 0.521 . . . . 15.0 111.109 -178.108 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . 0.543 HD22 ' NH2' ' A' ' 193' ' ' ARG . 5.6 mp . . . . . 0 C--O 1.243 0.758 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 178' ' ' GLU . 50.9 t -81.93 90.06 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 123.771 1.748 . . . . 0.0 109.265 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.602 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 7.6 tp -153.17 173.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 110.983 -2.826 . . . . 0.0 105.329 170.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.489 ' H ' HG13 ' B' ' 387' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -150.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 394' ' ' LEU . . . . . . . . 0 C--O 1.241 0.629 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.7 t80 . . . . . 0 N--CA 1.483 1.176 0 C-N-CA 125.258 1.423 . . . . 0.0 113.075 168.893 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.142 0 CA-C-O 120.741 0.305 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 66.82 -84.52 0.03 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.737 1.615 . . . . 0.0 111.644 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -91.33 135.31 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 59.6 m -58.16 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 O-C-N 124.243 0.964 . . . . 0.0 110.815 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . 0.451 ' HA ' ' OD1' ' A' ' 400' ' ' ASN . 1.3 tmt? -129.48 110.17 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 108.576 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.0 OUTLIER -80.86 121.16 25.63 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -51.38 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.942 1.401 . . . . 0.0 112.318 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . 0.701 ' HB3' ' HA ' ' A' ' 345' ' ' VAL . . . . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -82.2 108.33 15.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.42 -0.585 . . . . 15.0 109.42 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 HG12 ' A' ' 17' ' ' ILE . 33.0 m -121.25 141.18 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 15.0 109.552 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 9.2 m -140.33 92.64 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.332 0.653 . . . . 15.0 109.405 -174.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.03 102.14 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-O 121.91 0.862 . . . . 15.0 110.492 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 38.6 mt-10 -92.41 107.2 19.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.781 0.832 . . . . 15.0 109.595 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -72.4 90.96 1.32 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.5 m -64.13 -51.67 62.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.69 1.196 . . . . 15.0 111.031 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -155.7 84.9 1.03 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.23 -0.441 . . . . 15.0 109.934 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.42 0.23 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 123.558 0.536 . . . . 15.0 113.063 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.515 ' HA ' HH12 ' A' ' 13' ' ' ARG . 10.0 mp -66.91 -37.74 84.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.655 0.782 . . . . 15.0 110.982 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.26 97.41 0.17 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 124.362 1.039 . . . . 15.0 112.311 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.515 HH12 ' HA ' ' A' ' 11' ' ' LEU . 66.9 mtt85 -108.75 143.14 38.28 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.799 1.24 . . . . 15.0 109.684 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 42.2 ttm180 -119.9 88.95 3.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.845 1.258 . . . . 15.0 107.868 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.75 91.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.581 0.705 . . . . 15.0 109.179 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 91.0 m -81.28 105.2 12.29 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.418 -1.265 . . . . 15.0 109.905 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 3' ' ' VAL . 52.8 mt -107.29 127.73 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.167 0.587 . . . . 15.0 110.211 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 85.5 m -100.61 111.86 24.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.188 0.995 . . . . 15.0 108.649 171.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.7 mt -88.91 130.99 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.45 138.24 58.31 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.587 0.755 . . . . 15.0 110.815 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.53 -39.9 74.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.941 1.297 . . . . 15.0 112.598 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.29 -40.24 93.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.267 -0.879 . . . . 15.0 110.324 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -71.65 -26.18 62.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.524 0.729 . . . . 15.0 111.549 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -70.81 -51.12 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.638 0.775 . . . . 15.0 109.685 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.25 -24.15 59.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.463 -0.335 . . . . 15.0 111.587 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.579 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 87.5 m -68.35 -39.64 81.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.459 0.704 . . . . 15.0 109.776 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.15 -42.14 94.07 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.148 0.579 . . . . 15.0 111.011 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 66' ' ' VAL . 95.9 t -59.68 -44.78 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 121.625 0.726 . . . . 15.0 109.974 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.1 ttmp? -63.7 -36.11 82.78 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.592 -1.186 . . . . 15.0 111.089 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -92.67 -1.99 56.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.605 1.162 . . . . 15.0 111.245 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -99.71 -39.9 8.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.376 0.67 . . . . 15.0 109.782 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 55' ' ' ALA . 52.8 mt -82.12 -8.64 59.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.412 -0.813 . . . . 15.0 112.225 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.9 -31.62 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 109.241 -0.651 . . . . 15.0 109.241 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -71.98 -43.76 64.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.04 0.936 . . . . 15.0 109.334 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.91 -37.95 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.4 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -46.1 90.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.656 . . . . 15.0 110.853 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -69.58 -34.97 74.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.616 0.366 . . . . 15.0 111.698 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.28 -53.01 59.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.893 0.877 . . . . 15.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.85 2.19 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.718 0.807 . . . . 15.0 110.645 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 74.26 9.44 4.49 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.764 1.625 . . . . 15.0 112.695 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mt -58.31 -27.73 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.155 1.382 . . . . 15.0 111.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.58 -32.54 74.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.564 0.746 . . . . 15.0 111.122 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.32 -33.68 64.39 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.668 0.605 . . . . 15.0 111.852 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.5 -18.18 42.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.368 0.667 . . . . 15.0 110.766 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -70.58 108.34 4.3 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.518 0.727 . . . . 15.0 109.059 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -91.0 -2.81 57.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.278 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -7.87 79.39 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-O 119.548 -0.585 . . . . 15.0 113.859 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -65.82 -48.66 70.92 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.289 0.636 . . . . 15.0 110.768 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.08 121.79 80.98 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.474 -0.935 . . . . 15.0 108.474 174.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.68 131.68 45.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.882 2.388 . . . . 15.0 112.25 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.7 tpt -63.23 -32.6 74.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.308 1.043 . . . . 15.0 111.602 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.3 p30 -57.97 -38.8 76.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.587 0.755 . . . . 15.0 112.765 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.44 -51.93 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.085 0.954 . . . . 15.0 110.429 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.495 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 29.6 m -72.39 -19.34 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.754 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -74.18 -58.42 3.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.043 0.537 . . . . 15.0 110.983 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.551 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.7 pt20 -73.31 -34.71 65.86 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.878 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.1 mtt180 -96.51 -70.38 0.72 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.072 0.549 . . . . 15.0 111.091 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 91.8 m-85 -72.29 -18.89 61.76 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.473 0.709 . . . . 15.0 112.177 -169.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.27 23.4 15.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.526 -0.597 . . . . 15.0 112.704 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -21.82 66.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.088 0.955 . . . . 15.0 111.882 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.8 p -62.56 -32.44 73.41 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.563 0.745 . . . . 15.0 111.32 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 78.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.173 0.989 . . . . 15.0 109.692 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -108.07 -48.18 3.42 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.184 -0.673 . . . . 15.0 109.184 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -56.72 -45.34 81.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.677 1.191 . . . . 15.0 111.576 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.53 -34.1 77.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.85 -1.068 . . . . 15.0 111.206 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 28' ' ' VAL . 42.5 t -80.18 -63.64 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.24 -44.58 83.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.962 0.905 . . . . 15.0 112.773 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.4 94.73 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.542 0.526 . . . . 15.0 112.606 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.35 -33.5 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.984 0.914 . . . . 15.0 111.122 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 70.4 mt -70.06 -32.5 70.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.955 0.502 . . . . 15.0 110.432 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.5 mtm -63.14 -37.64 88.01 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 123.413 0.445 . . . . 15.0 110.455 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 -55.6 5.81 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.488 0.715 . . . . 15.0 110.799 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -67.92 -37.15 81.3 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.117 0.567 . . . . 15.0 112.425 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -75.47 -30.02 59.78 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 117.875 0.307 . . . . 15.0 111.026 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -64.31 -54.54 31.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.073 0.549 . . . . 15.0 110.666 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.6 -35.13 71.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 123.74 0.65 . . . . 15.0 110.618 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.71 -47.66 82.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.63 0.772 . . . . 15.0 110.611 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -56.46 20.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.929 -1.032 . . . . 15.0 111.325 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.559 HD12 ' HD3' ' A' ' 86' ' ' PRO . 21.4 pt -64.88 -31.86 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.914 0.709 . . . . 15.0 112.914 -170.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.87 -49.23 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.798 0.439 . . . . 15.0 110.519 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -72.12 -29.71 64.34 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.641 -0.254 . . . . 15.0 111.053 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -87.3 1.34 53.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.514 0.726 . . . . 15.0 111.57 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 66.96 12.99 9.29 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.86 1.264 . . . . 15.0 112.942 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 70.4 mt -87.06 122.1 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.919 0.888 . . . . 15.0 108.727 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.9 117.27 35.66 Favored Pre-proline 0 N--CA 1.481 1.075 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.559 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.9 Cg_endo -71.6 152.71 59.76 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 15.0 113.383 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.67 52.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.099 -1.41 . . . . 15.0 107.218 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 304' ' ' ALA . . . -162.23 146.2 11.69 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.031 -1.44 . . . . 15.0 110.002 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -58.57 108.26 1.25 Allowed Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.415 0.607 . . . . 15.0 109.859 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 11.3 Cg_exo -69.16 109.8 2.28 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.439 2.093 . . . . 15.0 111.802 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 47.4 m -69.89 92.39 0.7 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.775 0.83 . . . . 15.0 109.971 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.43 104.71 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.92 103.56 3.45 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.021 -1.103 . . . . 15.0 108.021 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 104.24 1.32 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.076 1.851 . . . . 15.0 109.848 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.59 176.75 38.42 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.764 -0.653 . . . . 15.0 113.166 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.8 116.81 20.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.212 0.53 . . . . 15.0 110.07 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -102.01 98.78 8.94 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.783 -1.191 . . . . 15.0 107.783 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.7 mttt -77.84 136.47 38.09 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.769 -1.197 . . . . 15.0 107.769 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.01 106.94 2.51 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.394 -0.595 . . . . 15.0 109.394 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.64 10.46 40.78 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 116.238 -0.437 . . . . 15.0 112.693 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.3 mt-10 -134.71 -179.75 5.79 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.996 1.318 . . . . 15.0 109.221 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -81.04 173.71 12.32 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.597 0.759 . . . . 15.0 111.76 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -115.27 92.34 3.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 15.0 108.723 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -92.55 96.08 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.847 0.859 . . . . 15.0 109.228 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -108.98 178.23 4.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.43 0.692 . . . . 15.0 109.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.6 m -139.49 150.12 44.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.86 0.864 . . . . 15.0 109.284 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.97 117.22 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -98.07 136.91 37.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.401 1.08 . . . . 15.0 109.366 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -167.58 165.74 14.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.509 0.723 . . . . 15.0 109.823 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.89 174.67 5.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.306 0.643 . . . . 15.0 109.379 170.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.16 -166.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.161 0.984 . . . . 15.0 109.174 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 114.4 58.5 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 122.853 0.461 . . . . 15.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.03 112.47 3.26 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.681 2.254 . . . . 15.0 111.787 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.39 96.42 0.88 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.611 0.764 . . . . 15.0 109.421 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.97 134.38 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.054 0.941 . . . . 15.0 110.992 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.8 110.53 22.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.48 0.712 . . . . 15.0 109.379 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 120' ' ' LEU . 94.1 mt -75.08 128.85 36.49 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -124.6 112.47 16.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.627 0.771 . . . . 15.0 109.784 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.0 67.1 2.28 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 124.469 1.106 . . . . 15.0 113.536 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 117' ' ' LEU . 38.5 mt -66.33 -25.15 66.69 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.59 0.356 . . . . 15.0 110.547 175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 2.8 mp0 -71.82 -35.99 70.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.084 0.953 . . . . 15.0 110.75 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.29 -22.09 63.83 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.538 0.735 . . . . 15.0 111.548 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.34 127.43 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.951 0.9 . . . . 15.0 109.991 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 38.2 mt-10 -108.47 110.14 21.58 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.835 0.854 . . . . 15.0 109.778 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HB ' HG12 ' A' ' 417' ' ' VAL . 37.9 t -119.82 165.06 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.789 1.236 . . . . 15.0 107.853 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.04 149.01 32.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.625 -0.88 . . . . 15.0 108.625 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -116.64 85.51 16.97 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.42 102.01 1.38 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.2 1.933 . . . . 15.0 111.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.496 HD11 ' HE2' ' A' ' 127' ' ' LYS . 41.1 mm -73.95 86.98 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.852 -1.166 . . . . 15.0 107.852 171.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.728 HG22 HG23 ' A' ' 422' ' ' THR . 28.7 t -107.27 148.37 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.08 -0.964 . . . . 15.0 110.502 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.12 165.17 37.06 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.246 1.018 . . . . 15.0 109.696 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 ' SD ' ' A' ' 274' ' ' MET . 2.8 t -96.77 88.54 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.8 p -77.21 -175.94 3.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.032 0.933 . . . . 15.0 110.352 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.99 -55.12 34.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.53 0.732 . . . . 15.0 111.366 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.05 66.97 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.977 0.798 . . . . 15.0 111.799 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -79.03 -45.33 20.39 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.362 0.665 . . . . 15.0 110.889 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.64 -54.94 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.204 0.602 . . . . 15.0 109.434 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.77 -48.04 82.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.96 99.09 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.91 0.757 . . . . 15.0 113.379 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.2 tpt -68.51 -50.86 48.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.599 0.759 . . . . 15.0 111.038 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.26 -38.33 68.4 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.024 0.53 . . . . 15.0 111.817 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 t70 -68.05 -39.17 83.09 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.45 -0.796 . . . . 15.0 110.571 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 71.1 m -61.97 -39.82 93.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.186 0.594 . . . . 15.0 110.128 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 140' ' ' MET . 83.4 mt -63.48 -38.26 90.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.166 0.587 . . . . 15.0 110.06 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 63.7 mtm180 -64.59 -34.41 78.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.223 173.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 142' ' ' ASP . 87.1 mttt -67.85 -35.94 79.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.513 0.325 . . . . 15.0 110.885 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 143' ' ' THR . 92.8 mt-30 -70.47 -33.32 71.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.859 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -103.59 29.47 5.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.848 . . . . 15.0 111.241 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.88 24.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.276 0.843 . . . . 15.0 113.276 -171.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -96.05 136.24 36.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.46 1.104 . . . . 15.0 110.306 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -81.78 111.82 18.36 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.225 0.61 . . . . 15.0 110.238 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -125.81 113.04 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 15.0 110.406 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.7 mt-10 -65.04 119.37 10.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.385 0.674 . . . . 15.0 111.063 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 47.0 pttt -123.78 -179.57 4.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.385 1.074 . . . . 15.0 110.009 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -165.58 154.12 11.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.916 0.887 . . . . 15.0 108.827 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.27 -38.75 2.39 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.436 -0.666 . . . . 15.0 111.436 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.02 123.68 7.28 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.608 0.363 . . . . 15.0 110.786 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 206' ' ' LYS . 40.5 t -85.43 131.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 171.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -121.85 -177.63 3.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.149 0.979 . . . . 15.0 109.72 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -81.43 -9.23 59.77 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.505 0.722 . . . . 15.0 111.893 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -97.62 19.33 13.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.958 0.903 . . . . 15.0 111.718 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.8 m-20 -94.11 158.78 15.45 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.102 0.953 . . . . 15.0 112.301 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 6.5 tmm_? -120.85 91.53 3.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.068 -2.197 . . . . 15.0 105.068 165.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 166' ' ' ILE . 28.4 t -90.22 148.75 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.392 1.077 . . . . 15.0 110.791 -174.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 41.0 m -126.19 121.63 33.33 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.759 -1.2 . . . . 15.0 107.759 171.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.611 HG22 HD23 ' A' ' 237' ' ' LEU . 36.3 pt -128.95 174.08 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.577 0.751 . . . . 15.0 111.914 -172.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -118.49 116.57 26.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.163 -1.792 . . . . 15.0 106.163 158.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.562 ' HE1' HG23 ' B' ' 387' ' ' ILE . 11.6 p90 -107.88 140.99 40.16 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 234' ' ' ALA . 1.5 t -137.28 113.65 10.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.923 -1.14 . . . . 15.0 107.923 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -101.25 154.79 19.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 116.131 -0.486 . . . . 15.0 113.072 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 p -136.88 104.17 5.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.741 0.816 . . . . 15.0 109.206 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 231' ' ' ALA . 52.9 t -77.39 112.95 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.141 -0.936 . . . . 15.0 109.271 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.9 t70 64.44 25.34 13.32 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 124.703 1.252 . . . . 15.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.47 21.15 52.56 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.04 -0.982 . . . . 15.0 114.524 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.12 150.43 49.98 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.02 0.91 . . . . 15.0 110.911 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.97 81.44 5.24 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.996 -1.113 . . . . 15.0 107.996 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.538 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 1.1 p90 -59.48 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 112.712 -2.04 . . . . 15.0 112.387 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.46 ' HG2' ' HD2' ' A' ' 177' ' ' PHE . 12.0 mm-40 -101.0 176.52 5.23 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.574 1.55 . . . . 15.0 109.231 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.61 60.68 2.45 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 165.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -99.97 83.42 0.56 Allowed Glycine 0 C--N 1.344 0.985 0 C-N-CA 123.335 0.493 . . . . 15.0 111.985 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -148.39 165.22 31.75 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.909 0.883 . . . . 15.0 109.399 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.52 94.94 1.52 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.855 -0.611 . . . . 15.0 109.855 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 128.69 37.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.631 -1.168 . . . . 15.0 109.335 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 65.25 33.28 9.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.073 0.949 . . . . 15.0 111.145 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.01 127.65 32.38 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 122.784 0.434 . . . . 15.0 109.945 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.83 95.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.624 0.77 . . . . 15.0 110.263 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.603 HD22 ' HE3' ' A' ' 194' ' ' MET . 36.7 tp -86.79 90.08 8.18 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.433 0.635 . . . . 15.0 110.285 170.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.461 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -83.27 89.72 7.03 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.811 -1.181 . . . . 15.0 107.811 169.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 46.7 mtp -57.07 137.48 55.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.321 0.648 . . . . 15.0 111.83 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.87 5.18 Favored Glycine 0 N--CA 1.47 0.95 0 N-CA-C 112.077 -0.409 . . . . 15.0 112.077 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 10.4 pt20 -98.98 158.72 15.46 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.296 0.639 . . . . 15.0 110.553 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.98 66.32 2.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.986 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -107.7 10.63 28.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.54 0.736 . . . . 15.0 110.859 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.603 ' HE3' HD22 ' A' ' 187' ' ' LEU . 24.6 mmt -129.7 149.13 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.944 0.898 . . . . 15.0 110.583 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.8 pt -95.34 141.31 23.04 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.946 -1.025 . . . . 15.0 108.711 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.43 120.99 7.68 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.383 2.722 . . . . 15.0 112.918 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.89 -34.03 3.38 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.107 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 213' ' ' ILE . 5.4 t80 -78.07 -57.05 4.0 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.097 0.559 . . . . 15.0 110.233 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -19.93 65.47 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.953 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.669 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 21.2 m-20 -58.16 -41.15 83.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.426 0.69 . . . . 15.0 110.815 170.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.628 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -67.71 -30.51 74.7 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.92 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 187' ' ' LEU . 39.1 mm -75.99 -52.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.982 0.513 . . . . 15.0 110.346 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 55.8 pttt -80.16 20.19 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.053 0.941 . . . . 15.0 113.365 -167.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.48 31.22 2.15 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.367 -0.693 . . . . 15.0 111.367 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -146.99 -161.73 1.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.342 1.057 . . . . 15.0 109.695 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 158' ' ' VAL . 9.9 ptpp? -148.89 168.75 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.189 0.596 . . . . 15.0 109.671 172.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.4 148.64 51.37 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 117.987 0.358 . . . . 15.0 110.626 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.75 -45.63 1.28 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.804 -0.634 . . . . 15.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.92 122.95 28.93 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.471 0.653 . . . . 15.0 110.375 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.43 135.95 40.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.19 0.996 . . . . 15.0 110.11 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -144.46 173.03 12.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.033 0.933 . . . . 15.0 109.172 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.7 m -129.79 116.81 19.28 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.89 -0.781 . . . . 15.0 108.89 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.628 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.1 pt -92.32 170.58 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.029 0.932 . . . . 15.0 110.071 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.93 124.6 33.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.379 0.672 . . . . 15.0 109.441 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.01 163.64 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.586 -1.264 . . . . 15.0 107.586 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.3 m -129.83 140.13 51.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.723 0.809 . . . . 15.0 109.38 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.84 143.11 45.92 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 122.977 0.511 . . . . 15.0 110.549 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.63 155.51 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 124.295 3.33 . . . . 15.0 115.587 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.29 -25.79 63.5 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.176 -0.92 . . . . 15.0 110.406 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.29 -13.13 35.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.277 1.031 . . . . 15.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -55.67 140.98 39.64 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 123.259 0.623 . . . . 15.0 111.275 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -46.84 -67.61 0.27 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 125.178 1.549 . . . . 15.0 112.806 -171.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.69 125.57 28.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 15.0 110.45 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.18 -31.94 62.88 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.6 0.76 . . . . 15.0 111.587 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 229' ' ' LYS . 27.8 p-10 -64.23 -17.2 63.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.447 0.699 . . . . 15.0 111.416 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.824 HD11 ' HA ' ' B' ' 388' ' ' VAL . 28.8 mt -100.01 -39.31 8.2 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.172 0.989 . . . . 15.0 110.601 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -46.63 113.58 0.67 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.136 1.774 . . . . 15.0 112.813 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.65 -18.93 27.32 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.608 0.567 . . . . 15.0 114.253 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 98.4 mttt -84.17 154.28 23.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.619 0.768 . . . . 15.0 112.453 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.44 23.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.363 1.065 . . . . 15.0 110.638 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -90.23 135.67 33.53 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.215 1.006 . . . . 15.0 111.067 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.74 100.85 11.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.479 ' HE1' HG21 ' B' ' 387' ' ' ILE . 90.6 m-85 -96.53 107.74 20.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.555 0.342 . . . . 15.0 110.563 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.23 102.68 6.77 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.078 -0.712 . . . . 15.0 109.078 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.52 134.38 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.865 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -115.99 100.44 7.97 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 166' ' ' ILE . 95.0 mt -74.08 110.15 8.14 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.874 -0.787 . . . . 15.0 108.874 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -108.96 -33.37 6.94 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.096 0.474 . . . . 15.0 110.142 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.694 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.4 mmtt -133.28 122.99 24.69 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.108 0.963 . . . . 15.0 109.498 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 207' ' ' ALA . 97.5 t -114.97 87.44 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 106.872 -1.529 . . . . 15.0 106.872 169.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 163' ' ' ARG . 44.7 mt-10 -93.77 169.18 10.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.62 -0.881 . . . . 15.0 108.62 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 32.2 tt0 -134.42 122.84 23.1 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -74.1 83.99 1.81 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.132 -1.432 . . . . 15.0 107.132 167.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 127.17 31.6 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.752 -1.567 . . . . 15.0 110.746 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.38 115.0 9.36 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.389 1.076 . . . . 15.0 109.247 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 78.7 Cg_endo -75.52 -176.56 3.02 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.047 2.498 . . . . 15.0 112.407 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.96 142.53 56.42 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.964 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 24.4 tp -107.1 23.04 15.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 p -71.56 176.7 4.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.509 1.124 . . . . 15.0 111.216 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -38.05 -59.49 0.84 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.944 1.698 . . . . 15.0 114.573 -166.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.28 -22.82 65.63 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.31 -50.21 6.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.095 0.558 . . . . 15.0 109.786 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.609 HG13 HD22 ' A' ' 266' ' ' LEU . 15.6 tt -65.36 -27.29 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.012 0.525 . . . . 15.0 111.841 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -22.65 42.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.022 0.378 . . . . 15.0 112.022 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -62.81 -22.15 66.42 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.052 0.941 . . . . 15.0 111.568 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -39.95 90.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 15.0 110.857 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 150.1 26.5 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 O-C-N 123.416 0.447 . . . . 15.0 113.452 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.11 143.56 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 117.558 0.679 . . . . 15.0 109.185 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -69.65 -57.2 5.45 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.386 0.674 . . . . 15.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -91.54 -38.3 12.59 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.745 0.418 . . . . 15.0 110.51 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.17 32.43 5.27 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.147 -0.479 . . . . 15.0 112.645 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.7 p -78.65 145.64 34.51 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.392 0.596 . . . . 15.0 109.738 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 253' ' ' ILE . 44.7 t -58.16 -41.59 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.127 0.971 . . . . 15.0 111.126 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.22 -34.66 61.16 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.853 0.861 . . . . 15.0 111.858 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.88 -25.36 58.2 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 111.366 -0.694 . . . . 15.0 111.366 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.609 HD22 HG13 ' A' ' 253' ' ' ILE . 54.7 tp -75.97 -28.46 57.9 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.44 -45.88 78.33 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.071 -0.714 . . . . 15.0 109.071 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.99 82.05 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.307 -1.315 . . . . 15.0 110.419 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -68.13 -45.55 73.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.222 0.951 . . . . 15.0 111.855 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.04 -22.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 122.506 0.322 . . . . 15.0 110.649 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -68.47 -53.14 25.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.948 -0.39 . . . . 15.0 109.948 169.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -77.43 -2.18 33.98 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 112.537 0.569 . . . . 15.0 112.537 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.85 -59.37 1.75 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.271 0.628 . . . . 15.0 110.39 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.485 ' SD ' HG11 ' A' ' 132' ' ' VAL . 64.2 mtt -74.23 -38.0 63.65 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-O 118.045 -0.979 . . . . 15.0 112.055 -169.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -71.2 -37.81 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 120.044 1.293 . . . . 15.0 109.804 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.486 ' NH2' ' HA ' ' A' ' 378' ' ' TYR . 5.8 tpp180 -56.58 -40.36 75.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.714 0.805 . . . . 15.0 110.939 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.12 -60.38 2.36 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.891 -0.595 . . . . 15.0 110.581 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 130' ' ' VAL . 39.8 tp -64.24 -60.47 3.16 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 125.174 1.39 . . . . 15.0 112.775 -171.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.06 -32.53 73.92 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.03 0.443 . . . . 15.0 110.756 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.1 t -69.82 -38.53 76.6 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.075 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.65 98.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 15.0 110.734 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.45 -51.52 71.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 O-C-N 123.593 0.558 . . . . 15.0 109.558 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.4 HH22 ' HG3' ' A' ' 409' ' ' GLU . 12.5 tpt180 -57.5 -52.23 66.24 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.639 0.587 . . . . 15.0 111.35 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -69.24 -28.7 66.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.922 0.889 . . . . 15.0 111.456 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -64.22 -57.62 8.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.814 0.445 . . . . 15.0 110.084 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.51 -35.84 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.677 0.791 . . . . 15.0 110.534 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.6 tttt -64.05 -48.74 75.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.931 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.9 p -67.69 -31.1 70.83 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.182 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.25 -35.98 74.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.09 0.556 . . . . 15.0 110.701 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -52.43 57.76 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 123.446 0.467 . . . . 15.0 109.929 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 HG22 ' A' ' 347' ' ' VAL . 34.0 mm -61.78 -50.25 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.847 0.717 . . . . 15.0 111.486 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.45 -35.34 80.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.802 -0.635 . . . . 15.0 109.707 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.41 -40.57 96.43 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.009 0.818 . . . . 15.0 112.474 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 350' ' ' LEU . 45.7 mt -60.76 -46.33 90.89 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.18 0.992 . . . . 15.0 111.109 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 291' ' ' ILE . 41.4 t -64.2 -48.23 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.696 0.76 . . . . 15.0 109.784 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -66.37 -24.07 66.43 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.028 -0.987 . . . . 15.0 110.685 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.09 53.25 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.863 . . . . 15.0 112.473 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.38 149.39 10.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 -169.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.41 136.37 47.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.776 -0.647 . . . . 15.0 110.314 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 346' ' ' VAL . 4.8 tp -117.8 115.91 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.001 0.92 . . . . 15.0 109.228 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.82 141.76 35.93 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.469 HG12 HD11 ' A' ' 307' ' ' ILE . 24.7 t -126.93 115.33 22.14 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.747 0.819 . . . . 15.0 109.633 -165.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.02 141.13 16.37 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.275 2.65 . . . . 15.0 112.974 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.497 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -64.55 -33.65 76.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.267 1.21 . . . . 15.0 114.267 -166.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.63 65.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.753 0.421 . . . . 15.0 111.552 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 345' ' ' VAL . 14.5 mt -88.16 -29.83 20.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.417 -0.811 . . . . 15.0 110.271 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 302' ' ' VAL . 2.2 mp -59.39 -51.63 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 167.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.82 -57.21 11.75 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 114.438 -1.255 . . . . 15.0 110.342 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 313' ' ' VAL . 32.3 t -60.77 -56.32 22.63 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.401 1.063 . . . . 15.0 111.848 -173.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.78 -45.47 78.35 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 111.744 0.275 . . . . 15.0 111.744 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 46.7 mt -64.83 -37.02 79.12 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 N-CA-C 109.803 -0.443 . . . . 15.0 109.803 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.59 -46.68 83.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.694 0.797 . . . . 15.0 110.934 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 309' ' ' SER . 96.3 t -55.55 -52.0 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 123.837 0.711 . . . . 15.0 110.573 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 341' ' ' ALA . 84.1 mt -70.57 -21.96 62.63 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.803 -1.09 . . . . 15.0 112.3 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 . . . . . 0 N--CA 1.484 1.232 0 C-N-CA 123.125 0.57 . . . . 15.0 110.783 175.611 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.45 0.643 . . . . 15.0 111.601 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.7 -29.3 68.52 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.937 1.695 . . . . 15.0 113.04 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 337' ' ' PHE . 53.1 mt -43.76 123.26 3.84 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 123.853 0.861 . . . . 15.0 112.556 -171.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 53.5 Cg_exo -43.03 127.8 5.15 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 124.995 3.797 . . . . 15.0 115.189 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -52.91 -48.42 67.26 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.655 1.182 . . . . 15.0 112.076 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.52 -18.79 4.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.332 1.053 . . . . 15.0 113.447 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.1 mt -74.8 -38.02 62.22 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.224 0.465 . . . . 15.0 110.878 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 332' ' ' LEU . 41.9 m-85 -120.03 -51.94 2.21 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.095 0.558 . . . . 15.0 112.241 -168.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -47.53 -40.21 18.24 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.987 1.315 . . . . 15.0 113.301 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.56 -34.9 59.92 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.279 1.032 . . . . 15.0 112.469 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -104.22 -30.78 9.95 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.154 0.982 . . . . 15.0 111.126 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -76.49 -60.63 2.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.249 1.02 . . . . 15.0 110.971 -173.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.439 ' HG3' HG11 ' A' ' 302' ' ' VAL . 88.3 tttt -62.32 -25.03 67.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.428 -0.805 . . . . 15.0 109.792 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 347' ' ' VAL . 29.5 ttt85 -71.69 -35.09 70.14 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 118.421 -0.8 . . . . 15.0 110.719 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -57.36 -43.16 83.3 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 119.243 0.929 . . . . 15.0 109.306 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 306' ' ' LEU . 41.3 t -60.73 -49.8 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.265 -1.334 . . . . 15.0 110.704 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 300' ' ' ILE . 68.2 t -59.59 -48.95 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.611 0.764 . . . . 15.0 111.058 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 291' ' ' ILE . 71.6 t -52.64 -43.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.138 0.975 . . . . 15.0 110.267 173.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -70.36 -37.87 70.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 15.0 113.854 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.88 -47.2 54.45 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.267 0.627 . . . . 15.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HB3' HD13 ' A' ' 294' ' ' LEU . 76.9 mt -62.38 -57.88 9.7 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.998 0.811 . . . . 15.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 355' ' ' ILE . 53.2 mt -65.65 -34.45 78.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.125 0.57 . . . . 15.0 112.216 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.5 99.0 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.696 -0.562 . . . . 15.0 111.696 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.25 -37.42 85.46 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.072 -0.564 . . . . 15.0 110.687 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 350' ' ' LEU . 62.5 t -63.49 -36.28 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 117.956 0.343 . . . . 15.0 110.786 176.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 360' ' ' LEU . 97.1 mt -64.0 -44.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.367 0.667 . . . . 15.0 109.807 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.23 -56.4 11.46 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.488 -0.324 . . . . 15.0 111.361 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 77.0 m -54.48 -42.65 70.96 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.982 1.313 . . . . 15.0 111.985 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -101.19 14.65 31.31 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.155 0.582 . . . . 15.0 111.547 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 48.65 33.56 4.32 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 125.729 1.612 . . . . 15.0 114.205 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 355' ' ' ILE . 65.9 mt -72.42 157.04 38.38 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.087 0.955 . . . . 15.0 113.055 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 152.68 40.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.967 0.907 . . . . 15.0 110.415 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.69 111.62 17.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.477 0.711 . . . . 15.0 109.556 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 15.2 t70 -107.55 137.39 45.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.327 0.651 . . . . 15.0 110.884 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -64.48 -31.76 73.1 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.739 0.815 . . . . 15.0 113.03 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -66.08 -32.74 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 10.7 tpp180 -71.75 -44.99 63.13 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 371' ' ' ILE . 94.1 t -55.56 -60.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.111 0.882 . . . . 15.0 109.819 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -59.48 -35.83 74.85 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.161 0.913 . . . . 15.0 111.897 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.62 -55.7 27.41 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.902 0.751 . . . . 15.0 111.816 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.04 -42.97 81.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.641 0.776 . . . . 15.0 111.014 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 398' ' ' MET . 51.2 mm -51.22 -60.22 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.467 1.104 . . . . 15.0 110.461 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.54 -42.87 95.45 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.755 0.659 . . . . 15.0 112.14 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.59 -44.89 93.21 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 124.017 0.823 . . . . 15.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -77.09 -35.45 56.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 119.658 -0.211 . . . . 15.0 110.668 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 378' ' ' TYR . . . -69.19 -27.09 65.2 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.482 0.713 . . . . 15.0 111.798 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.6 t -65.78 -19.64 65.96 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 123.916 0.76 . . . . 15.0 110.908 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -95.75 3.03 54.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.972 0.909 . . . . 15.0 111.933 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.486 ' HA ' ' NH2' ' A' ' 276' ' ' ARG . 2.8 m-85 -88.74 177.57 6.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.065 0.546 . . . . 15.0 109.686 172.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.29 -47.22 62.15 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.173 -0.921 . . . . 15.0 109.359 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.37 122.31 13.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.379 1.072 . . . . 15.0 109.233 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -70.69 -40.28 4.0 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.708 2.272 . . . . 15.0 114.178 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -54.32 -47.79 72.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.359 0.874 . . . . 15.0 113.359 -167.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.93 -24.68 66.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.236 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.07 -45.79 29.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 123.859 0.864 . . . . 15.0 109.164 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.04 -47.04 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.053 0.541 . . . . 15.0 109.57 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.66 -39.93 80.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.142 0.577 . . . . 15.0 112.36 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.4 -36.65 84.44 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.527 0.731 . . . . 15.0 111.08 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.453 ' HA ' HD23 ' A' ' 394' ' ' LEU . 34.8 m-85 -73.84 -62.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.922 -0.581 . . . . 15.0 110.599 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.2 p -57.6 -32.17 66.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.32 17.42 11.29 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 15.0 111.98 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -139.84 106.14 5.27 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.35 -0.982 . . . . 15.0 108.35 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -65.83 -41.2 92.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.998 0.519 . . . . 15.0 111.345 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.67 -41.97 96.13 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.932 0.77 . . . . 15.0 110.517 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 388' ' ' TYR . 22.5 tp -72.14 -38.92 69.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.691 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 93.0 mmm -66.26 -30.76 71.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.92 0.488 . . . . 15.0 110.69 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.9 -39.96 69.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.285 1.034 . . . . 15.0 109.852 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -75.43 -21.58 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.916 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 371' ' ' ILE . 5.8 tpt -87.69 -20.07 26.79 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.586 0.217 . . . . 15.0 111.586 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.57 -36.89 57.33 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 167.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -52.02 -61.59 2.17 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.736 -1.12 . . . . 15.0 110.343 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.8 p -66.32 -27.47 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 118.154 0.434 . . . . 15.0 111.685 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.73 -58.01 10.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.033 0.533 . . . . 15.0 110.355 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 24.3 tp -77.76 -23.32 49.27 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.76 -1.109 . . . . 15.0 111.582 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.52 -51.66 33.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.99 0.516 . . . . 15.0 109.625 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.28 -35.8 82.03 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.8 -0.636 . . . . 15.0 111.176 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -69.85 -33.55 72.42 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.012 0.525 . . . . 15.0 111.205 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.97 93.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.84 0.456 . . . . 15.0 110.303 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.5 t -58.12 -53.6 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.815 -0.63 . . . . 15.0 109.752 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.4 ' HG3' HH22 ' A' ' 283' ' ' ARG . 43.6 mt-10 -60.38 -25.6 66.01 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.987 0.915 . . . . 15.0 112.908 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.94 -30.59 62.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.783 0.433 . . . . 15.0 111.317 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 294' ' ' LEU . 43.5 t -70.67 -43.27 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.077 -1.082 . . . . 15.0 108.077 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 83.4 mt -65.23 -40.7 94.42 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.362 1.039 . . . . 15.0 111.57 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.35 -23.16 67.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.836 0.854 . . . . 15.0 111.564 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 24.4 mtpp -98.96 -27.42 13.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 15.0 111.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.966 0.907 . . . . 15.0 111.348 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.8 mttt -69.93 83.51 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.692 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 125' ' ' VAL . 5.0 m -93.8 91.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.033 0.921 . . . . 15.0 109.487 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.7 t -70.72 95.2 1.09 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.513 -1.221 . . . . 15.0 109.188 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 131.81 40.59 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 115.055 -0.975 . . . . 15.0 110.505 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -146.86 145.43 29.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.27 135.12 33.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.728 HG23 HG22 ' A' ' 130' ' ' VAL . 4.5 t -159.86 174.03 15.06 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.495 0.497 . . . . 15.0 110.657 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.5 p -100.61 175.34 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.475 1.11 . . . . 15.0 111.948 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.454 ' HD2' HD22 ' A' ' 278' ' ' LEU . 38.4 t80 -52.71 -28.06 20.33 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.578 1.551 . . . . 15.0 111.691 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 23.2 m-80 -65.12 -15.61 62.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.775 1.23 . . . . 15.0 112.945 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' A' ' 427' ' ' LEU . 23.4 tp10 -60.7 -37.21 80.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.582 1.153 . . . . 15.0 111.414 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.8 mp -109.23 -77.85 0.59 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.435 -0.165 . . . . 15.0 111.192 -174.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -68.35 -50.54 52.56 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.838 0.455 . . . . 15.0 112.1 -171.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 15.9 m120 . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . 0.515 HD13 ' SD ' ' A' ' 194' ' ' MET . 2.3 pt? . . . . . 0 C--O 1.244 0.774 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.6 91.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -164.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 168' ' ' PHE . 0.1 OUTLIER -146.37 87.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 156.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . 0.824 ' HA ' HD11 ' A' ' 226' ' ' LEU . 9.8 p . . . . . 0 C--O 1.24 0.602 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.406 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . 0.455 ' HE2' ' HB ' ' A' ' 401' ' ' VAL . 97.3 m-85 . . . . . 0 C--O 1.242 0.661 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.306 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -66.28 -72.45 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.23 0.612 . . . . 0.0 109.561 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -166.69 -128.96 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.342 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' B' ' 464' ' ' MET . 53.3 m 79.62 152.33 0.12 Allowed 'General case' 0 C--N 1.366 1.326 0 C-N-CA 124.597 1.159 . . . . 0.0 110.413 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' B' ' 463' ' ' THR . 2.7 ptp 75.35 -47.95 0.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.248 2.619 . . . . 0.0 111.242 -173.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 70.72 -30.38 0.2 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.908 1.683 . . . . 0.0 112.943 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.36 -11.51 4.39 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 124.491 1.116 . . . . 0.0 112.649 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.437 1.095 . . . . 0.0 112.37 172.471 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.37 116.09 16.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.763 . . . . 15.0 109.039 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.68 161.57 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.053 0.454 . . . . 15.0 111.224 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 9.4 p -152.92 103.45 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.111 -0.95 . . . . 15.0 109.137 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.79 107.3 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.646 0.736 . . . . 15.0 110.233 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.2 100.54 10.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.323 1.049 . . . . 15.0 109.375 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 m -69.19 97.66 0.94 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.676 -0.861 . . . . 15.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.7 p -75.6 -61.35 1.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.912 0.885 . . . . 15.0 111.402 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -149.46 103.99 3.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.663 -0.495 . . . . 15.0 109.663 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.02 -108.02 1.95 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 124.018 0.824 . . . . 15.0 113.644 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.26 -29.64 61.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 15.0 110.682 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 119.35 12.41 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 124.164 0.915 . . . . 15.0 112.968 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HD2' HG11 ' A' ' 111' ' ' VAL . 64.6 mtt85 -133.39 118.95 19.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.527 1.131 . . . . 15.0 109.515 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 37.5 ttm180 -89.94 96.74 10.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.001 1.32 . . . . 15.0 110.248 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG11 ' HB1' ' A' ' 78' ' ' ALA . 41.0 t -89.11 88.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.558 -0.905 . . . . 15.0 108.558 173.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 31.5 m -77.65 114.26 16.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.087 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -105.08 112.95 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.752 0.821 . . . . 15.0 109.19 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 87.3 m -94.62 105.07 17.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.547 0.739 . . . . 15.0 109.885 174.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 23' ' ' SER . 60.8 mt -91.47 101.25 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.9 0.88 . . . . 15.0 109.53 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.8 173.6 9.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.151 0.58 . . . . 15.0 111.365 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.12 59.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.385 1.474 . . . . 15.0 113.798 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.11 -32.34 73.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.64 0.776 . . . . 15.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 19' ' ' ILE . 50.1 m -92.03 -29.62 16.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.991 0.516 . . . . 15.0 111.473 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.7 mt -59.49 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.72 78.88 5.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.947 0.879 . . . . 15.0 109.374 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.4 m -158.72 -55.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.612 -1.995 . . . . 15.0 105.612 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.97 70.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.331 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 66' ' ' VAL . 89.1 t -58.29 -62.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 123.945 0.778 . . . . 15.0 110.125 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -63.51 -39.83 95.46 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.736 -1.12 . . . . 15.0 111.86 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.3 m -68.66 -25.34 64.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.622 -0.717 . . . . 15.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -80.57 -43.25 20.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.7 0.286 . . . . 15.0 110.239 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.771 HD21 HG11 ' A' ' 62' ' ' VAL . 68.4 mt -74.15 -18.74 60.74 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.928 0.714 . . . . 15.0 112.928 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 p -76.71 -31.98 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 171.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -67.89 -49.03 64.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.342 0.657 . . . . 15.0 109.517 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.5 -33.64 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.288 1.035 . . . . 15.0 110.538 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.5 -54.12 50.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.994 0.518 . . . . 15.0 110.908 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.65 -42.54 86.49 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.291 0.636 . . . . 15.0 111.641 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -66.88 -51.84 50.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.643 1.177 . . . . 15.0 111.52 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.84 2.71 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.515 0.726 . . . . 15.0 110.407 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 71.11 17.28 6.14 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.265 1.426 . . . . 15.0 112.736 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 48.3 mt -66.57 -25.09 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.55 1.14 . . . . 15.0 110.771 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 -33.47 73.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.945 0.898 . . . . 15.0 111.201 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.91 -30.55 74.33 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.861 0.725 . . . . 15.0 112.855 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.5 m-85 -80.51 -24.79 39.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.358 0.663 . . . . 15.0 110.444 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -71.31 105.38 3.47 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.983 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.77 6.54 45.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.151 0.981 . . . . 15.0 110.774 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.79 68.56 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.211 0.319 . . . . 15.0 112.588 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -69.02 -49.06 61.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.087 0.955 . . . . 15.0 110.092 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.01 127.84 30.02 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.0 -1.0 . . . . 15.0 108.644 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.67 144.91 51.23 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.202 2.601 . . . . 15.0 113.337 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.58 -29.02 68.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.865 0.866 . . . . 15.0 112.351 -170.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -67.35 -38.94 85.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.648 0.379 . . . . 15.0 110.85 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.742 HG23 ' HD2' ' A' ' 57' ' ' ARG . 61.4 mt -73.28 -32.61 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.959 0.904 . . . . 15.0 111.202 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 15.8 m -75.3 -20.1 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.922 -0.486 . . . . 15.0 111.358 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -86.9 -62.97 1.39 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.255 0.622 . . . . 15.0 111.438 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.82 -41.49 26.3 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.742 ' HD2' HG23 ' A' ' 53' ' ' ILE . 95.2 mtt180 -86.78 -63.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.814 0.446 . . . . 15.0 110.648 -173.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 40.3 m-85 -75.73 -21.57 57.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 111.803 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.38 25.51 12.61 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.432 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.41 69.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.354 0.662 . . . . 15.0 112.581 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 m -77.45 -8.13 57.27 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.617 0.767 . . . . 15.0 112.61 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.771 HG11 HD21 ' A' ' 32' ' ' LEU . 2.7 p -119.36 86.58 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 122.537 1.16 . . . . 15.0 109.814 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 4.5 mmp_? -115.66 -47.98 2.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.567 -1.197 . . . . 15.0 108.959 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.88 -50.0 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.996 1.318 . . . . 15.0 111.993 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.03 -35.61 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.991 0.916 . . . . 15.0 111.151 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 28' ' ' VAL . 96.3 t -66.79 -38.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 114.813 -1.085 . . . . 15.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 HD21 ' CZ ' ' A' ' 97' ' ' TYR . 57.8 mt -62.0 -27.56 68.95 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.595 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.01 86.74 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.567 0.542 . . . . 15.0 112.507 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.68 -47.54 83.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.733 0.813 . . . . 15.0 110.943 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.94 -57.38 13.04 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.377 -1.283 . . . . 15.0 111.547 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 71.6 mtm -69.98 -30.49 67.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.5 0.72 . . . . 15.0 112.288 -174.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 t -68.62 -51.31 43.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.002 0.521 . . . . 15.0 111.06 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.692 -0.686 . . . . 15.0 110.456 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.03 -26.45 64.04 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.538 0.524 . . . . 15.0 112.153 -171.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -63.05 -59.31 4.97 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.469 0.308 . . . . 15.0 110.517 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.86 -25.61 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.936 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -58.32 7.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.289 0.636 . . . . 15.0 109.384 171.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HB1' HG11 ' A' ' 15' ' ' VAL . . . -59.74 -53.87 52.98 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.052 -0.976 . . . . 15.0 112.077 -171.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.451 HD12 ' HG3' ' A' ' 86' ' ' PRO . 30.1 pt -58.79 -35.11 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.792 0.664 . . . . 15.0 112.792 -172.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.6 -42.35 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.086 0.554 . . . . 15.0 111.028 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -73.74 -31.9 63.59 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.242 0.217 . . . . 15.0 111.226 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.09 -0.96 33.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.683 0.793 . . . . 15.0 110.951 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 67.58 12.34 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.134 1.373 . . . . 15.0 112.432 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -78.26 118.69 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.653 0.781 . . . . 15.0 109.349 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -87.86 96.67 0.64 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 79' ' ' ILE . 55.2 Cg_endo -87.3 145.79 7.26 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.086 2.524 . . . . 15.0 114.164 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.3 46.98 0.82 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.945 0.898 . . . . 15.0 109.079 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 110' ' ' GLU . . . -144.24 153.68 25.22 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.443 -0.798 . . . . 15.0 112.088 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 113.0 12.65 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 15.0 109.785 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.26 106.97 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.953 1.769 . . . . 15.0 111.334 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -88.27 92.8 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.934 -0.765 . . . . 15.0 108.934 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -74.76 111.73 10.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.18 0.592 . . . . 15.0 109.508 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.38 93.62 27.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.173 0.989 . . . . 15.0 108.797 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.69 91.65 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.911 2.407 . . . . 15.0 111.951 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.24 -27.15 70.16 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.456 -0.793 . . . . 15.0 113.121 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 98' ' ' LYS . 14.7 pt-20 -165.47 161.58 18.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.503 0.721 . . . . 15.0 110.456 172.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 13.8 t80 -157.22 108.35 2.33 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.685 -1.228 . . . . 15.0 107.685 168.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -125.7 130.01 50.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.163 0.985 . . . . 15.0 108.423 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 tp -67.16 104.8 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.693 0.621 . . . . 15.0 109.484 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.74 12.24 44.47 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.602 -0.554 . . . . 15.0 113.467 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.0 mt-10 -130.09 -97.43 0.35 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 118.738 -0.649 . . . . 15.0 109.841 172.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -140.93 160.05 40.9 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.274 0.943 . . . . 15.0 112.105 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -131.8 74.5 1.59 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.437 1.495 . . . . 15.0 107.058 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.481 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 43.1 m -80.66 124.54 29.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.8 -1.091 . . . . 15.0 109.319 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -143.82 129.54 19.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.921 0.488 . . . . 15.0 109.871 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 70.2 m -84.89 120.02 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.172 0.989 . . . . 15.0 110.423 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.7 94.3 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -99.27 113.37 25.61 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.41 0.684 . . . . 15.0 110.505 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -142.66 162.74 34.69 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.205 0.602 . . . . 15.0 110.504 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.586 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 36.1 mt-10 -85.41 167.33 15.62 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.192 -0.913 . . . . 15.0 110.116 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.5 m -127.67 170.09 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.484 0.714 . . . . 15.0 110.726 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -75.22 113.49 25.99 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.532 -0.914 . . . . 15.0 108.532 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.35 161.84 19.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.064 1.843 . . . . 15.0 110.848 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.27 111.51 5.93 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 300' ' ' ILE . 4.8 p -71.1 124.83 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.862 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.33 122.8 43.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.48 -0.782 . . . . 15.0 110.79 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 91.3 mt -93.71 133.77 36.73 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 163.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -137.82 112.53 8.9 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.552 0.741 . . . . 15.0 109.063 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.96 63.79 4.32 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.747 0.654 . . . . 15.0 114.239 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 29.2 mt -70.79 -30.6 67.1 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.144 0.497 . . . . 15.0 110.346 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -72.3 -23.04 61.11 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.654 1.182 . . . . 15.0 111.212 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.8 43.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.232 0.613 . . . . 15.0 111.503 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.412 HG23 ' HA3' ' A' ' 293' ' ' GLY . 67.6 mt -65.79 123.59 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.717 0.807 . . . . 15.0 109.982 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -105.89 109.57 21.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 15.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 289' ' ' GLN . 59.1 t -109.02 154.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.866 1.266 . . . . 15.0 107.714 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 286' ' ' VAL . 42.7 tt0 -103.36 142.66 33.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 119.24 0.927 . . . . 15.0 109.973 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 417' ' ' VAL . 82.5 tttt -123.56 87.36 52.23 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.941 0.897 . . . . 15.0 109.083 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 282' ' ' ILE . 6.7 Cg_exo -72.66 97.5 0.89 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.884 1.723 . . . . 15.0 111.554 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.549 HD11 ' HE2' ' A' ' 127' ' ' LYS . 40.2 mm -69.25 92.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.768 -1.197 . . . . 15.0 107.768 166.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 427' ' ' LEU . 37.5 t -116.04 142.55 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.487 -0.779 . . . . 15.0 110.128 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.39 159.23 32.36 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.242 -1.345 . . . . 15.0 108.578 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.93 86.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' VAL . 43.6 p -64.4 174.89 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.701 0.8 . . . . 15.0 110.317 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.73 -33.02 72.28 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 120.95 0.405 . . . . 15.0 110.853 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.41 83.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.979 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 69.2 m-20 -74.59 -41.64 60.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.884 0.474 . . . . 15.0 111.195 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 133' ' ' THR . 82.4 t -61.79 -61.03 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.65 -33.84 73.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.856 0.722 . . . . 15.0 111.359 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.53 Favored Glycine 0 N--CA 1.478 1.476 0 O-C-N 123.62 0.575 . . . . 15.0 113.676 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.411 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 12.1 tpt -68.57 -46.36 69.6 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.069 0.548 . . . . 15.0 110.082 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 78.4 mt -58.07 -31.96 67.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.14 0.576 . . . . 15.0 111.748 172.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.56 -41.48 72.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.34 1.056 . . . . 15.0 110.216 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 86.0 m -58.2 -44.09 87.91 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.07 0.856 . . . . 15.0 109.71 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 141' ' ' LEU . 89.9 mt -63.65 -40.93 98.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.918 0.887 . . . . 15.0 111.208 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 39.0 mtm-85 -64.51 -31.5 72.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.325 0.65 . . . . 15.0 110.157 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.2 mttt -87.32 -15.9 36.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.235 0.614 . . . . 15.0 112.443 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 143' ' ' THR . 97.5 mt-30 -78.17 -30.42 49.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.642 -0.503 . . . . 15.0 109.642 167.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.45 36.54 2.78 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.102 0.961 . . . . 15.0 110.538 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.19 152.82 36.52 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.629 0.974 . . . . 15.0 113.629 -172.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -81.75 122.18 27.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.616 -1.175 . . . . 15.0 110.027 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 26.5 m95 -80.8 125.28 29.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 28.9 ttpt -158.83 128.32 5.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.914 -0.773 . . . . 15.0 108.914 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.629 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.4 mt-10 -77.26 134.39 38.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.885 0.374 . . . . 15.0 111.184 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 34.0 pttt -120.74 179.99 4.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.574 1.15 . . . . 15.0 109.816 169.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -142.92 152.91 42.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.566 0.746 . . . . 15.0 109.296 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -49.77 0.88 Allowed Glycine 0 N--CA 1.465 0.581 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.339 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.71 43.17 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.356 0.578 . . . . 15.0 111.417 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 t -116.79 134.39 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.347 1.059 . . . . 15.0 108.821 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -107.21 -179.58 3.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.31 1.044 . . . . 15.0 109.878 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.67 28.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.407 0.891 . . . . 15.0 113.407 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.27 40.83 3.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.227 0.537 . . . . 15.0 110.349 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -122.27 -170.52 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.045 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.771 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 15.2 mtm180 -119.94 124.07 45.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 171.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.61 100.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.784 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 12.5 m -83.31 110.02 17.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.13 -1.063 . . . . 15.0 108.13 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.6 pt -132.79 164.48 35.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.288 1.035 . . . . 15.0 110.4 -172.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -111.47 126.69 55.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.526 -1.657 . . . . 15.0 106.526 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.85 150.01 49.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.52 0.676 . . . . 15.0 111.281 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.1 t -139.16 123.78 18.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.147 -1.427 . . . . 15.0 107.147 165.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -113.53 166.66 12.17 Favored Glycine 0 C--O 1.241 0.585 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.065 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -145.1 134.93 23.6 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.308 0.643 . . . . 15.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 226' ' ' LEU . 61.6 t -118.54 137.89 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 171.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.66 16.35 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.982 0.896 . . . . 15.0 110.889 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.77 1.98 76.21 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 115.781 -0.645 . . . . 15.0 113.946 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -136.98 163.12 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.509 0.724 . . . . 15.0 110.654 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.24 165.5 22.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.23 0.612 . . . . 15.0 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.83 -159.78 0.97 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.405 1.082 . . . . 15.0 110.186 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.72 118.28 5.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.459 0.703 . . . . 15.0 111.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.461 ' HA3' ' HB ' ' B' ' 386' ' ' VAL . . . 85.15 -57.12 4.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.941 -1.027 . . . . 15.0 111.827 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.12 -60.37 4.78 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.384 -0.286 . . . . 15.0 112.384 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -116.36 150.92 36.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.611 0.764 . . . . 15.0 111.801 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -153.91 93.1 1.61 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.801 -1.09 . . . . 15.0 108.87 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.2 m -73.69 137.94 44.39 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.682 -1.144 . . . . 15.0 110.172 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.67 29.21 18.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.703 0.801 . . . . 15.0 113.018 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.84 132.77 49.48 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.144 0.577 . . . . 15.0 110.292 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.8 t -97.96 113.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 202' ' ' ILE . 12.5 tp -97.54 89.0 4.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.692 0.397 . . . . 15.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.22 86.36 1.08 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 15.0 109.543 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.8 OUTLIER -51.78 132.09 31.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.012 0.925 . . . . 15.0 110.878 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.0 49.78 1.86 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.213 -0.755 . . . . 15.0 111.213 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.7 150.43 48.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.628 0.771 . . . . 15.0 111.082 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.36 56.32 3.91 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.589 -0.732 . . . . 15.0 113.046 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -136.7 1.89 2.6 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.95 0.9 . . . . 15.0 109.672 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 187' ' ' LEU . 33.1 mmt -94.09 154.25 17.71 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.87 0.868 . . . . 15.0 111.107 -173.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.76 143.3 46.1 Favored Pre-proline 0 C--O 1.248 0.991 0 CA-C-N 114.887 -1.051 . . . . 15.0 108.438 172.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.65 109.79 0.47 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.796 2.331 . . . . 15.0 111.226 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.01 -44.26 1.2 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.798 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 202' ' ' ILE . 86.4 t80 -73.09 -62.25 1.53 Allowed 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -59.39 -32.93 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.259 -1.337 . . . . 15.0 111.984 -176.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.546 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 14.8 t70 -71.02 -31.94 68.57 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.665 0.786 . . . . 15.0 110.835 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -5.53 89.21 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.836 0.71 . . . . 15.0 113.134 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 187' ' ' LEU . 31.6 mm -104.54 -51.07 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.399 0.68 . . . . 15.0 110.947 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 58.5 pttt -76.88 6.35 6.34 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.475 1.11 . . . . 15.0 113.817 -163.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -131.87 27.32 3.69 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.507 -1.037 . . . . 15.0 110.507 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -125.08 -161.6 1.04 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.357 1.063 . . . . 15.0 110.361 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -154.85 153.28 30.9 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.516 0.727 . . . . 15.0 110.894 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.81 120.25 15.27 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.886 0.474 . . . . 15.0 111.392 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.69 -35.04 2.2 Favored Glycine 0 C--N 1.334 0.455 0 O-C-N 124.237 0.961 . . . . 15.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.72 126.21 32.66 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.442 -0.577 . . . . 15.0 109.442 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.0 123.82 48.73 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.08 -1.082 . . . . 15.0 108.08 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -145.08 178.04 8.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.333 1.053 . . . . 15.0 110.612 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.2 m -130.93 130.97 44.15 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.529 -1.286 . . . . 15.0 107.529 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.1 pt -104.06 160.48 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.378 0.671 . . . . 15.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.11 106.05 13.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 15.0 109.549 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.41 166.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.416 -1.327 . . . . 15.0 107.416 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 65.9 m -147.02 135.33 21.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.536 ' HZ ' HD11 ' B' ' 387' ' ' ILE . 95.5 m-85 -86.23 142.39 35.73 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 109.874 -0.417 . . . . 15.0 109.874 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.3 154.49 46.37 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.493 2.129 . . . . 15.0 111.834 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.14 -17.64 60.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.061 167.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.56 -24.5 61.93 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.294 1.438 . . . . 15.0 111.235 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 79.7 t80 -61.96 147.0 48.36 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.029 0.931 . . . . 15.0 111.238 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -71.12 -61.74 1.65 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.769 0.828 . . . . 15.0 113.109 -166.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.467 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -63.98 113.94 3.8 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.011 0.524 . . . . 15.0 110.356 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 42.7 tt0 -65.02 -36.66 85.11 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.819 0.848 . . . . 15.0 112.652 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.46 -27.89 69.3 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.079 0.551 . . . . 15.0 111.429 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.558 ' HA ' HG11 ' A' ' 172' ' ' VAL . 81.7 mt -90.33 -40.51 12.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.848 0.859 . . . . 15.0 110.315 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 14.6 ttmm -47.89 128.62 13.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.631 1.972 . . . . 15.0 113.001 -171.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.9 -31.44 3.66 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.379 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -98.04 163.73 12.64 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.636 0.774 . . . . 15.0 112.123 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -88.75 144.58 26.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.522 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -117.98 108.38 15.2 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.178 0.991 . . . . 15.0 109.837 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.12 101.04 12.52 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.24 0.616 . . . . 15.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -96.18 120.47 36.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.878 0.871 . . . . 15.0 109.752 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.24 98.55 9.45 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.96 -0.756 . . . . 15.0 108.96 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.1 mm -88.26 133.6 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.081 0.952 . . . . 15.0 110.611 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.81 95.15 4.71 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.456 -1.313 . . . . 15.0 107.456 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.551 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.06 97.36 5.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 -173.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -96.58 -38.63 9.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.633 0.373 . . . . 15.0 111.475 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.784 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.4 mmtt -131.63 148.73 52.63 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.095 0.558 . . . . 15.0 110.775 -176.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 207' ' ' ALA . 21.2 t -121.44 99.0 6.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 34.1 mt-10 -83.14 169.23 16.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.277 -1.009 . . . . 15.0 108.277 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 38.9 tt0 -140.24 139.76 35.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.725 0.41 . . . . 15.0 110.278 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.468 HH12 ' HD3' ' A' ' 146' ' ' LYS . 26.3 ptt85 -98.97 83.89 2.98 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 164.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.1 154.36 31.37 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.829 -1.078 . . . . 15.0 109.681 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.404 HD21 ' HE3' ' A' ' 146' ' ' LYS . 97.5 mt -59.12 133.25 87.57 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 122.715 0.406 . . . . 15.0 110.022 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 95.5 Cg_endo -77.71 -179.23 5.24 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.642 2.228 . . . . 15.0 111.351 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 249' ' ' THR . 47.1 mt-10 -70.56 116.73 11.22 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.516 -0.765 . . . . 15.0 108.964 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.82 43.81 1.07 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.046 0.927 . . . . 15.0 108.992 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.489 HG23 ' HB3' ' A' ' 247' ' ' GLU . 25.5 p -76.23 166.65 23.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.054 1.342 . . . . 15.0 110.174 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.6 -45.74 13.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.701 1.2 . . . . 15.0 113.063 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.01 -31.85 71.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.545 0.738 . . . . 15.0 112.592 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -81.57 -49.77 10.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.048 0.539 . . . . 15.0 110.379 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.689 HG13 HD22 ' A' ' 266' ' ' LEU . 12.8 tt -65.16 -29.54 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 122.974 0.51 . . . . 15.0 111.249 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.58 -17.12 56.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 111.944 0.35 . . . . 15.0 111.944 174.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -70.14 -19.32 63.22 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.113 0.565 . . . . 15.0 110.675 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -71.43 -17.86 62.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.251 0.62 . . . . 15.0 111.152 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 146.05 -24.44 1.76 Allowed Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.417 -0.657 . . . . 15.0 113.184 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 10.8 t -54.91 144.46 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.185 0.994 . . . . 15.0 111.394 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.79 -46.96 50.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.563 0.745 . . . . 15.0 111.001 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -106.22 -43.82 4.71 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.545 0.738 . . . . 15.0 110.587 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 112.35 24.85 4.9 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.892 -0.393 . . . . 15.0 113.1 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.1 p -71.96 144.3 48.94 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 117.471 0.635 . . . . 15.0 109.776 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 253' ' ' ILE . 60.9 t -59.37 -48.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.219 0.608 . . . . 15.0 110.165 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -58.71 -25.11 62.57 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.506 1.123 . . . . 15.0 112.237 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.29 -27.68 54.8 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.077 -0.809 . . . . 15.0 111.077 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.689 HD22 HG13 ' A' ' 253' ' ' ILE . 60.6 tp -76.28 -30.09 57.66 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.009 -0.737 . . . . 15.0 109.009 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.442 ' HA ' HG22 ' A' ' 270' ' ' VAL . 73.5 mtp180 -67.48 -37.41 82.83 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.61 93.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.76 . . . . 15.0 110.892 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -66.72 -40.83 88.55 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.349 -0.841 . . . . 15.0 111.314 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 267' ' ' ARG . 19.3 m -81.56 -19.62 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.592 0.357 . . . . 15.0 110.512 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt85 -59.79 -66.16 0.56 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -59.28 -44.17 92.49 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.483 0.49 . . . . 15.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -74.06 -42.06 60.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.26 -13.28 55.58 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.532 0.605 . . . . 15.0 111.432 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.89 -47.01 49.59 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.096 0.862 . . . . 15.0 108.707 162.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.588 ' HB2' ' HB1' ' A' ' 377' ' ' ALA . 74.8 ttt180 -60.41 -27.51 67.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.489 1.516 . . . . 15.0 111.904 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.78 -59.72 2.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.826 0.45 . . . . 15.0 110.199 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.426 HD11 HG11 ' A' ' 130' ' ' VAL . 62.7 tp -67.85 -57.58 6.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.358 0.503 . . . . 15.0 112.358 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.74 -27.66 67.79 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.196 0.31 . . . . 15.0 110.185 -172.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.3 t -66.63 -50.1 64.11 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.82 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.41 88.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.786 0.834 . . . . 15.0 111.94 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.7 mt -64.14 -50.32 77.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 C-N-CA 123.947 0.899 . . . . 15.0 108.823 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.369 0.668 . . . . 15.0 110.776 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -68.52 -45.53 71.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.992 -0.744 . . . . 15.0 108.992 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -57.69 -54.85 42.18 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.04 0.838 . . . . 15.0 110.599 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 282' ' ' ILE . 59.1 t -60.63 -52.96 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.113 -0.949 . . . . 15.0 110.725 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.29 -39.84 93.07 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.539 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.6 p -64.3 -43.83 93.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 119.47 -0.3 . . . . 15.0 110.588 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.441 ' HB2' HG13 ' A' ' 125' ' ' VAL . 57.0 mt-30 -68.01 -33.88 75.44 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.96 0.788 . . . . 15.0 111.832 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.4 -55.1 27.11 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 123.511 0.507 . . . . 15.0 109.865 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 295' ' ' VAL . 25.7 mm -61.65 -44.03 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.067 0.947 . . . . 15.0 111.774 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.24 -48.0 80.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.382 0.61 . . . . 15.0 109.491 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.8 -40.85 99.74 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 114.038 -1.437 . . . . 15.0 112.246 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.518 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.8 mt -55.7 -60.14 3.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.237 1.015 . . . . 15.0 110.987 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 291' ' ' ILE . 40.6 t -56.07 -51.45 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 124.039 0.837 . . . . 15.0 109.638 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -64.27 -26.84 68.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.638 0.775 . . . . 15.0 112.138 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.67 -24.77 53.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.564 0.579 . . . . 15.0 112.564 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 164.62 29.77 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.516 0.932 . . . . 15.0 113.516 -168.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.6 133.66 49.98 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.036 -0.984 . . . . 15.0 109.835 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.1 tp -155.77 116.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.695 0.798 . . . . 15.0 108.96 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.36 94.76 9.87 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.614 -0.884 . . . . 15.0 108.614 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.694 HG21 HG22 ' A' ' 346' ' ' VAL . 19.0 t -79.93 127.33 77.64 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 114.466 -1.243 . . . . 15.0 110.513 -168.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.77 124.11 12.29 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.138 2.559 . . . . 15.0 112.896 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.75 -20.05 54.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.142 1.377 . . . . 15.0 114.196 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.17 94.7 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.947 0.499 . . . . 15.0 111.588 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.74 -35.39 80.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.635 0.774 . . . . 15.0 110.86 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 304' ' ' ALA . 2.7 mp -65.78 -53.28 40.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.501 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.22 -33.52 74.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.461 0.704 . . . . 15.0 111.14 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.6 t -58.07 -58.39 8.62 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 124.027 0.829 . . . . 15.0 110.607 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.414 ' HA ' HG23 ' A' ' 313' ' ' VAL . 17.4 mm-40 -77.02 -18.96 57.81 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.1 -42.84 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.736 ' HA ' ' HD2' ' A' ' 315' ' ' ARG . 15.1 t70 -59.04 -39.25 81.41 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 123.958 0.786 . . . . 15.0 111.349 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 310' ' ' GLU . 23.4 t -58.33 -51.85 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.19 0.519 . . . . 15.0 110.819 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 341' ' ' ALA . 76.0 mt -68.71 -21.39 64.41 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.46 -0.791 . . . . 15.0 112.093 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.736 ' HD2' ' HA ' ' A' ' 312' ' ' ASP . 77.0 mtt180 . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 124.168 0.987 . . . . 15.0 108.86 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.567 1.616 0 N-CA-C 112.895 0.702 . . . . 15.0 112.895 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -98.55 -11.43 22.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.623 0.769 . . . . 15.0 112.174 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 92.8 mt -55.59 131.78 71.45 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 123.244 0.618 . . . . 15.0 111.024 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.413 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 77.6 Cg_exo -52.24 125.26 16.96 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.142 3.228 . . . . 15.0 114.501 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -51.82 -44.23 63.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.703 1.201 . . . . 15.0 112.416 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -60.35 -18.91 53.26 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 15.0 113.114 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 84.8 mt -69.5 -32.68 71.7 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.997 0.427 . . . . 15.0 110.468 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.89 -17.3 12.05 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.237 1.015 . . . . 15.0 111.238 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -49.95 -46.8 52.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.435 1.894 . . . . 15.0 113.213 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.46 -60.74 2.7 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.794 1.309 . . . . 15.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.7 pt20 -80.87 -32.4 34.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 15.0 111.387 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -60.71 -61.85 2.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 15.0 110.844 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -55.4 -41.41 72.65 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.113 0.883 . . . . 15.0 109.869 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt-85 -59.42 -36.1 75.25 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.113 0.883 . . . . 15.0 110.909 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 70.3 mtt-85 -76.22 -29.4 57.57 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.807 0.443 . . . . 15.0 110.34 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.53 -37.95 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 302' ' ' VAL . 43.1 t -67.59 -34.42 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 351' ' ' LEU . 41.2 t -56.97 -50.22 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.553 0.741 . . . . 15.0 109.216 167.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.13 80.27 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.255 -0.884 . . . . 15.0 113.912 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.47 -58.61 3.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.124 0.57 . . . . 15.0 111.528 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' A' ' 294' ' ' LEU . 89.9 mt -60.29 -53.52 56.63 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.919 0.888 . . . . 15.0 110.872 -176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.564 HD12 HG13 ' A' ' 347' ' ' VAL . 44.8 mt -68.38 -30.72 69.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -59.47 -38.62 93.8 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.504 0.502 . . . . 15.0 112.478 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.43 -42.34 83.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.956 -0.622 . . . . 15.0 110.387 174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.7 -34.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.115 0.566 . . . . 15.0 111.146 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.0 mt -66.73 -49.68 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.819 0.848 . . . . 15.0 110.057 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -60.15 -54.36 46.81 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 116.064 -0.517 . . . . 15.0 110.988 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.4 m -61.22 -43.99 97.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.196 0.999 . . . . 15.0 111.72 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -91.9 12.61 21.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.066 0.546 . . . . 15.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 47.38 30.9 1.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.312 1.845 . . . . 15.0 114.181 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.532 HD22 HE21 ' A' ' 406' ' ' GLN . 73.7 mt -66.72 158.1 31.06 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.339 1.056 . . . . 15.0 113.032 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.9 167.27 27.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.856 -1.52 . . . . 15.0 107.799 170.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.0 90.99 0.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.701 -0.481 . . . . 15.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.74 131.29 45.97 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.254 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -51.71 -41.98 61.91 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.699 1.249 . . . . 15.0 112.12 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.5 -19.69 49.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.582 -0.735 . . . . 15.0 111.643 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -86.23 -35.0 20.28 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 110.025 -0.361 . . . . 15.0 110.025 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.78 -52.47 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -51.06 -45.24 61.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.66 1.184 . . . . 15.0 111.381 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.75 5.88 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.851 1.344 . . . . 15.0 112.155 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 402' ' ' ALA . 66.6 mt -55.73 -52.27 64.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.394 0.678 . . . . 15.0 111.675 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 398' ' ' MET . 39.9 mm -50.55 -57.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 124.387 1.054 . . . . 15.0 111.417 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.36 -36.57 60.95 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.467 0.48 . . . . 15.0 111.781 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -51.04 71.08 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.279 0.561 . . . . 15.0 110.266 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -67.18 -44.08 80.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.224 1.409 . . . . 15.0 111.016 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -70.56 -44.78 66.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.68 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.4 m -69.5 -16.97 63.56 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.801 0.334 . . . . 15.0 111.458 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 276' ' ' ARG . . . -74.2 -29.33 61.69 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.513 0.725 . . . . 15.0 110.31 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -87.61 -168.6 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.773 0.829 . . . . 15.0 111.178 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -70.87 -66.22 0.64 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.122 0.969 . . . . 15.0 110.822 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.16 108.29 48.33 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.599 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 24.6 Cg_endo -63.08 -40.29 34.58 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.553 2.169 . . . . 15.0 113.953 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -57.39 -51.71 68.33 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.907 0.883 . . . . 15.0 113.041 -161.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.11 -20.07 63.2 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.131 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 68.4 t -76.44 -45.29 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.51 -52.58 19.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.04 -32.07 73.33 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.188 -0.915 . . . . 15.0 112.647 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -64.78 -50.66 65.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.088 0.555 . . . . 15.0 109.771 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -72.41 -50.92 22.9 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.518 0.511 . . . . 15.0 111.437 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.5 p -62.07 -28.05 69.33 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.695 0.628 . . . . 15.0 112.695 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.46 17.08 23.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.589 0.755 . . . . 15.0 111.034 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 395' ' ' MET . 50.5 t-20 -137.26 93.58 2.84 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.776 -1.194 . . . . 15.0 107.776 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.57 -33.81 70.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.258 1.023 . . . . 15.0 112.204 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.82 -63.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.269 0.98 . . . . 15.0 110.243 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.87 -18.33 58.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.307 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER -67.03 -48.85 67.07 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.544 -0.91 . . . . 15.0 108.544 177.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.62 -34.32 73.9 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 114.962 -1.017 . . . . 15.0 110.695 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.54 -45.12 95.03 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.463 0.649 . . . . 15.0 110.201 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.533 ' HG2' HD11 ' A' ' 371' ' ' ILE . 32.6 tpp -66.92 -30.99 71.29 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.111 -0.95 . . . . 15.0 110.855 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -71.95 -32.72 67.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.154 0.582 . . . . 15.0 111.205 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -51.49 61.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.0 p -72.63 -20.35 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.377 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -70.12 -43.62 70.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.899 0.479 . . . . 15.0 110.412 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.97 -26.59 59.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.228 -0.896 . . . . 15.0 110.721 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 408' ' ' VAL . 73.2 tt0 -60.63 -51.29 70.03 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 109.69 -0.485 . . . . 15.0 109.69 170.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -56.35 -49.2 75.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.074 0.949 . . . . 15.0 111.017 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.532 HE21 HD22 ' A' ' 360' ' ' LEU . 53.4 tt0 -64.8 -36.36 84.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.752 1.221 . . . . 15.0 111.614 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.39 66.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.02 -0.536 . . . . 15.0 111.063 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 404' ' ' GLU . 68.8 t -55.18 -54.18 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.925 -0.768 . . . . 15.0 108.925 168.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.6 mt-10 -61.21 -30.7 70.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.635 1.174 . . . . 15.0 112.425 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.55 73.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.992 0.517 . . . . 15.0 111.342 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.27 -31.56 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.061 -0.718 . . . . 15.0 109.061 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 409' ' ' GLU . 91.6 mt -67.45 -35.3 78.94 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 15.0 110.864 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.13 -17.43 63.46 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.298 0.639 . . . . 15.0 111.978 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -109.58 -26.26 10.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.575 1.15 . . . . 15.0 112.076 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.94 158.38 16.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.919 0.888 . . . . 15.0 110.875 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -73.41 84.78 1.47 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.306 0.642 . . . . 15.0 109.751 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 127' ' ' LYS . 21.2 t -86.8 94.78 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.59 -0.892 . . . . 15.0 108.59 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.9 t -68.92 94.5 0.63 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 122.429 1.109 . . . . 15.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -76.25 130.82 38.75 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.027 -1.442 . . . . 15.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -133.69 136.87 44.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.759 0.824 . . . . 15.0 108.905 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -98.72 127.82 44.78 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.287 -0.635 . . . . 15.0 109.287 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.469 HG21 ' HG2' ' A' ' 426' ' ' GLU . 9.7 t -160.89 176.61 11.25 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 122.78 0.432 . . . . 15.0 111.724 -173.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 33.6 p -92.96 165.92 12.63 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 111.488 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 56.7 t80 -58.6 -28.96 66.09 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.715 1.206 . . . . 15.0 111.228 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.24 -6.84 10.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.03 0.932 . . . . 15.0 113.387 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.497 ' HB3' HD12 ' A' ' 427' ' ' LEU . 12.6 tp10 -74.22 -41.49 61.29 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.033 0.933 . . . . 15.0 112.106 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.642 HD11 HG21 ' A' ' 130' ' ' VAL . 5.3 mp -89.54 -68.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.035 0.534 . . . . 15.0 111.031 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 428' ' ' MET . 1.2 mpt? -74.36 -49.62 21.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.847 0.459 . . . . 15.0 110.668 -175.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 1.7 m-20 . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 386' ' ' VAL . . . . . 0.461 ' HB ' ' HA3' ' A' ' 179' ' ' GLY . 24.0 m -71.91 95.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.668 0.747 . . . . 0.0 111.051 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.536 HD11 ' HZ ' ' A' ' 217' ' ' PHE . 13.5 tt -155.82 162.64 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.62 0.768 . . . . 0.0 108.97 165.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.425 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 121.364 0.602 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.24 0.567 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.155 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.712 0.291 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 64.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.144 1.378 . . . . 0.0 111.681 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -89.78 116.28 27.76 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 27.9 m -68.62 106.49 2.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.406 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -89.34 131.62 35.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -86.48 25.96 1.15 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.633 0.773 . . . . 0.0 112.285 -165.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.09 -41.79 90.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.425 0.69 . . . . 0.0 109.271 166.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.523 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.033 168.331 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 15.8 ptm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' THR . 7.8 tt0 -87.04 97.52 10.77 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.328 -0.989 . . . . 15.0 108.328 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.02 157.58 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.844 0.458 . . . . 15.0 111.305 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 25.4 m -131.04 86.43 2.37 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 15' ' ' VAL . 4.8 p -73.77 87.91 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 CA-C-O 122.658 1.218 . . . . 15.0 110.508 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.96 178.2 5.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.97 -1.468 . . . . 15.0 109.546 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 58.1 m -136.63 125.96 24.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -66.24 -58.75 4.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.538 0.735 . . . . 15.0 109.842 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -167.46 120.62 0.94 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.02 0.528 . . . . 15.0 109.998 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.82 -100.67 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 O-C-N 124.423 1.077 . . . . 15.0 114.398 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.36 -43.39 27.79 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.203 1.001 . . . . 15.0 110.076 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.2 88.88 0.08 OUTLIER Glycine 0 C--N 1.344 1.024 0 O-C-N 124.065 0.853 . . . . 15.0 112.5 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.9 ttm180 -95.78 129.11 43.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 15.0 110.326 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -106.04 90.75 3.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.283 1.033 . . . . 15.0 110.416 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 5' ' ' VAL . 46.1 t -81.68 87.02 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.906 -1.146 . . . . 15.0 107.906 173.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 82.0 m -71.67 87.55 0.94 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.281 0.633 . . . . 15.0 110.189 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 74' ' ' ASN . 48.8 mt -80.07 128.22 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.56 -0.745 . . . . 15.0 109.135 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 56.7 m -118.23 104.08 10.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.713 -1.218 . . . . 15.0 107.713 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' HE1' ' A' ' 105' ' ' TYR . 24.7 mt -66.39 129.91 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.98 137.54 57.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 124.189 0.931 . . . . 15.0 111.038 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.08 61.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.032 1.333 . . . . 15.0 112.789 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.68 -40.88 92.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.17 -0.923 . . . . 15.0 110.849 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.7 m -70.08 -34.63 73.41 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.278 -0.874 . . . . 15.0 111.079 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -68.75 -50.98 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.859 0.464 . . . . 15.0 109.85 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -59.2 -33.73 71.31 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.265 0.626 . . . . 15.0 111.271 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.1 m -76.72 -43.17 38.5 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.367 0.667 . . . . 15.0 111.283 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.52 -42.2 78.87 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.032 0.533 . . . . 15.0 112.249 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' HG11 ' A' ' 66' ' ' VAL . 69.5 t -60.91 -47.77 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.683 0.793 . . . . 15.0 109.838 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -58.04 -40.06 79.94 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.083 0.953 . . . . 15.0 111.731 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.4 m -70.56 -28.96 65.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.827 0.851 . . . . 15.0 110.822 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.4 tp10 -80.35 -29.07 37.94 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.021 0.528 . . . . 15.0 110.725 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 96.6 mt -70.69 -35.7 72.91 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.702 0.801 . . . . 15.0 111.534 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.0 p -71.18 -29.71 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.764 -0.458 . . . . 15.0 109.764 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -67.16 -36.67 82.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.934 0.494 . . . . 15.0 110.517 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 57.8 t -63.4 -43.1 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.31 73.88 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.45 -0.796 . . . . 15.0 111.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 97.8 mttt -75.12 -33.98 61.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.218 0.607 . . . . 15.0 111.098 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -65.27 -36.52 84.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.688 0.795 . . . . 15.0 110.617 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.8 t -96.13 -1.51 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.163 0.585 . . . . 15.0 110.562 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 66.95 10.42 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.506 1.522 . . . . 15.0 113.792 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -79.29 -11.24 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.896 0.878 . . . . 15.0 111.388 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -57.13 -38.51 73.59 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.818 0.847 . . . . 15.0 111.907 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.97 -19.81 64.47 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.742 -0.663 . . . . 15.0 112.529 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.02 -20.75 34.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.197 0.599 . . . . 15.0 110.57 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -70.36 107.81 3.95 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.24 6.56 13.68 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.832 0.853 . . . . 15.0 111.777 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.19 10.5 74.05 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-O 119.964 -0.354 . . . . 15.0 113.035 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -65.38 -35.09 79.89 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 123.759 0.824 . . . . 15.0 109.86 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.37 122.47 59.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 159.05 47.74 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.899 2.4 . . . . 15.0 112.016 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 tpt -72.51 -20.26 61.39 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.908 -0.587 . . . . 15.0 112.09 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -65.44 -43.04 91.65 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.268 -0.271 . . . . 15.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' A' ' 57' ' ' ARG . 62.7 mt -66.19 -44.97 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.87 0.868 . . . . 15.0 111.288 -176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.9 m -71.05 -21.7 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 116.582 -0.281 . . . . 15.0 111.471 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.09 -42.13 14.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.892 0.477 . . . . 15.0 112.041 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 2.4 pt20 -82.6 -42.63 18.01 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.09 0.556 . . . . 15.0 111.253 -171.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 98.3 mtt180 -91.63 -60.02 1.98 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.111 0.564 . . . . 15.0 110.435 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.53 -46.51 63.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.607 -0.724 . . . . 15.0 110.471 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.51 12.16 35.11 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.015 -0.881 . . . . 15.0 114.083 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.86 -32.86 72.83 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 117.875 0.837 . . . . 15.0 110.613 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -74.37 -52.0 13.42 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.2 174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.0 78.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 15.0 109.629 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -132.14 -63.73 0.8 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.466 1.107 . . . . 15.0 109.114 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -60.67 -29.33 69.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 123.794 0.684 . . . . 15.0 110.404 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.39 -49.44 69.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.824 1.25 . . . . 15.0 110.758 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 28' ' ' VAL . 21.2 t -75.35 -38.65 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.056 -0.975 . . . . 15.0 110.075 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.472 HD23 HD12 ' A' ' 70' ' ' LEU . 96.3 mt -59.17 -33.1 70.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.729 0.812 . . . . 15.0 111.692 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.87 -39.73 88.74 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.433 0.458 . . . . 15.0 112.932 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.91 -46.84 22.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.878 0.871 . . . . 15.0 110.334 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 67' ' ' LEU . 80.0 mt -56.91 -37.19 71.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.852 0.861 . . . . 15.0 112.236 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 72.5 mtm -59.4 -39.24 82.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.362 0.665 . . . . 15.0 111.169 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -75.14 -30.37 60.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.155 -0.929 . . . . 15.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 70' ' ' LEU . 6.9 mmm180 -71.78 -42.31 67.3 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.511 -0.551 . . . . 15.0 109.511 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.427 ' HB3' HG21 ' A' ' 17' ' ' ILE . 53.2 m-80 -71.83 -27.47 62.93 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.786 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -66.62 -56.57 10.1 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.341 0.4 . . . . 15.0 110.557 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.79 -30.56 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 O-C-N 123.875 0.735 . . . . 15.0 110.456 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.37 -49.05 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.638 0.775 . . . . 15.0 110.077 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.51 -57.3 11.69 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.148 -0.933 . . . . 15.0 111.376 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.1 pt -61.2 -29.14 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 112.83 0.678 . . . . 15.0 112.83 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.74 -49.06 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.263 0.625 . . . . 15.0 110.968 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -74.62 -25.85 59.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.541 0.21 . . . . 15.0 111.312 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -83.34 -16.71 45.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.727 0.811 . . . . 15.0 111.14 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 64.15 25.75 13.74 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.763 1.225 . . . . 15.0 112.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' A' ' 109' ' ' PHE . 51.8 mt -91.01 127.01 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.406 0.682 . . . . 15.0 109.718 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -75.55 117.22 61.76 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 164.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.35 97.17 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.375 2.05 . . . . 15.0 113.382 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.53 -171.12 3.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.081 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 58.71 -145.03 43.4 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 112.293 -0.323 . . . . 15.0 112.293 -168.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.28 122.5 17.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.404 -1.702 . . . . 15.0 106.404 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.92 106.51 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.513 2.142 . . . . 15.0 111.7 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -102.16 98.88 8.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.672 0.789 . . . . 15.0 109.468 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -84.54 94.35 8.55 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.198 -0.667 . . . . 15.0 109.198 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.33 98.48 0.92 Allowed Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.928 -0.768 . . . . 15.0 108.928 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.73 112.23 3.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.857 2.371 . . . . 15.0 111.352 -173.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.5 -62.61 5.95 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.298 -0.721 . . . . 15.0 111.298 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.32 168.41 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.048 0.939 . . . . 15.0 110.629 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -138.75 121.81 16.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.236 1.014 . . . . 15.0 108.864 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 60.6 mttp -94.63 170.46 9.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.304 -0.628 . . . . 15.0 109.304 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.36 97.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.655 0.782 . . . . 15.0 111.469 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.55 11.45 80.24 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.447 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.7 mt-10 -98.67 -176.8 3.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.722 0.809 . . . . 15.0 110.805 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.29 137.9 57.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.716 0.806 . . . . 15.0 111.588 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -108.87 99.54 8.87 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.936 0.894 . . . . 15.0 109.546 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -79.72 131.28 35.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.731 0.813 . . . . 15.0 110.084 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.525 ' HE1' HG13 ' A' ' 19' ' ' ILE . 28.8 p90 -152.18 125.25 8.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.609 0.764 . . . . 15.0 109.869 173.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.9 m -82.8 100.55 10.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.445 1.098 . . . . 15.0 110.259 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.67 97.9 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.578 -0.527 . . . . 15.0 109.578 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.46 116.65 30.07 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.605 0.762 . . . . 15.0 110.494 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HE2' HG21 ' A' ' 84' ' ' ILE . 43.2 p90 -145.3 170.18 16.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.758 1.223 . . . . 15.0 107.73 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -94.71 156.58 16.34 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.392 0.615 . . . . 15.0 111.312 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 ' NH1' ' A' ' 13' ' ' ARG . 32.9 m -115.63 162.82 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.462 1.105 . . . . 15.0 108.272 170.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.05 119.87 70.53 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.86 -175.48 2.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.111 2.541 . . . . 15.0 112.46 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.71 128.39 35.36 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.631 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 p -102.48 129.76 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.816 0.846 . . . . 15.0 109.278 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -118.37 113.14 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 15.0 110.751 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.619 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.1 mt -82.0 130.69 35.15 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 123.648 0.593 . . . . 15.0 109.611 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.39 154.92 14.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.679 0.792 . . . . 15.0 109.87 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 64.55 20.73 66.15 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.681 0.613 . . . . 15.0 113.481 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 117' ' ' LEU . 68.0 mt -65.04 -42.64 94.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.886 0.874 . . . . 15.0 110.505 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -78.16 -18.65 55.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.636 -1.166 . . . . 15.0 110.646 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.95 47.47 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.234 0.613 . . . . 15.0 111.34 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.519 HG23 ' HA3' ' A' ' 293' ' ' GLY . 61.1 mt -58.35 124.33 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.245 0.966 . . . . 15.0 110.666 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.0 103.92 14.56 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.421 0.688 . . . . 15.0 109.296 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 417' ' ' VAL . 41.5 t -107.32 161.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.46 1.104 . . . . 15.0 108.417 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -123.1 138.13 54.74 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.561 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.1 tttt -114.7 88.67 16.82 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.336 -0.987 . . . . 15.0 108.336 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.11 100.81 0.95 Allowed 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.049 1.833 . . . . 15.0 111.298 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.561 HD11 ' HE2' ' A' ' 127' ' ' LYS . 42.1 mm -67.87 84.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.382 -0.97 . . . . 15.0 108.382 168.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 278' ' ' LEU . 21.3 t -98.38 136.73 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.22 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -132.66 162.52 31.15 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 167.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.16 79.83 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.2 p -61.93 170.06 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.761 0.824 . . . . 15.0 110.448 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.27 -31.43 65.58 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.955 0.502 . . . . 15.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.96 92.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.782 0.833 . . . . 15.0 110.895 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -73.16 -40.55 64.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.314 0.646 . . . . 15.0 111.113 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.06 -61.87 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.211 1.004 . . . . 15.0 109.514 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -73.48 -34.49 65.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.574 -0.739 . . . . 15.0 110.934 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.22 -45.67 92.97 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.639 0.587 . . . . 15.0 113.14 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -75.29 -41.82 56.2 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.058 0.543 . . . . 15.0 111.033 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 270' ' ' VAL . 32.2 mt -52.23 -40.01 61.05 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.095 0.558 . . . . 15.0 111.841 167.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.54 -41.37 84.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.409 0.684 . . . . 15.0 110.605 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 m -60.41 -39.3 86.86 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.836 0.71 . . . . 15.0 110.339 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -40.33 96.07 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.62 0.768 . . . . 15.0 111.014 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 47.7 mtm180 -62.33 -40.7 97.2 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.621 0.575 . . . . 15.0 110.558 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 87.5 mttt -80.29 -16.4 54.74 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.324 0.65 . . . . 15.0 112.386 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -82.48 -40.8 20.6 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.883 0.473 . . . . 15.0 109.748 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -100.0 35.81 1.97 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.788 0.835 . . . . 15.0 109.889 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.19 143.97 34.88 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.011 0.925 . . . . 15.0 112.562 -173.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.4 m -74.19 129.4 37.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 15.0 109.643 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -79.18 129.99 35.02 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.785 -0.45 . . . . 15.0 109.785 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -147.21 163.36 36.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.331 -0.989 . . . . 15.0 108.331 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 45.7 mt-10 -118.12 157.15 27.42 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.145 0.498 . . . . 15.0 109.839 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.797 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 23.4 pttt -136.63 155.09 50.38 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.34 -0.846 . . . . 15.0 109.982 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.77 96.57 7.0 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.613 -0.721 . . . . 15.0 110.242 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 240' ' ' VAL . . . 60.07 62.36 6.15 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 113.965 -1.47 . . . . 15.0 116.392 165.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.683 ' H ' HG11 ' A' ' 240' ' ' VAL . . . -155.02 107.66 2.75 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 117.344 0.572 . . . . 15.0 110.291 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 203' ' ' LYS . 41.6 t -109.22 137.54 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 118.488 0.586 . . . . 15.0 109.66 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.61 -176.99 4.22 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.788 1.235 . . . . 15.0 109.315 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.22 67.6 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.892 1.441 . . . . 15.0 114.892 -167.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.9 17.68 9.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.971 0.509 . . . . 15.0 111.305 -170.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.51 -159.57 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.929 0.491 . . . . 15.0 111.815 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 32.3 ttp180 -137.17 153.87 50.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 44.5 t -144.12 155.21 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.262 1.025 . . . . 15.0 108.768 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 23.5 m -122.74 124.39 43.26 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 164.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.09 161.34 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.778 0.831 . . . . 15.0 111.012 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.78 121.12 33.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.466 -2.05 . . . . 15.0 105.466 159.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -112.39 163.08 14.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.746 -0.596 . . . . 15.0 110.3 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.5 t -139.78 93.31 2.64 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.74 -1.207 . . . . 15.0 107.74 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -98.12 162.74 21.01 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.205 -1.361 . . . . 15.0 113.295 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.4 m -149.98 127.45 11.51 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.025 -1.102 . . . . 15.0 108.025 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 71.2 t -97.35 115.97 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.803 0.841 . . . . 15.0 109.422 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 36.6 t70 69.62 3.47 4.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.652 0.781 . . . . 15.0 111.486 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 115.32 -11.9 19.36 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.587 -0.563 . . . . 15.0 113.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 10.3 pt-20 -92.37 131.79 37.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.4 94.58 1.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.217 -1.772 . . . . 15.0 106.217 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.499 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 3.0 p90 -71.78 -160.78 0.06 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.509 -1.678 . . . . 15.0 112.419 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -51.66 103.96 0.07 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 124.155 0.982 . . . . 15.0 110.571 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.51 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 91.56 -62.72 2.69 Favored Glycine 0 C--O 1.239 0.435 0 O-C-N 124.366 1.041 . . . . 15.0 113.195 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.27 -59.42 4.91 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -101.2 158.03 16.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.566 0.58 . . . . 15.0 112.566 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.16 93.51 2.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.5 m -79.58 130.71 35.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.196 -0.911 . . . . 15.0 112.193 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 58.17 31.12 20.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.749 1.22 . . . . 15.0 113.309 168.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.414 ' CD2' HD23 ' B' ' 385' ' ' LEU . 72.6 t80 -71.4 133.96 46.31 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.133 0.492 . . . . 15.0 109.86 173.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.7 100.69 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 124.26 1.024 . . . . 15.0 108.912 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.17 98.66 11.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.146 0.979 . . . . 15.0 111.406 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.03 101.65 3.3 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.679 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER -60.08 116.61 4.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.306 0.643 . . . . 15.0 109.641 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.9 -6.61 7.82 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.816 -0.629 . . . . 15.0 112.148 -166.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -81.52 -179.83 7.54 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.509 0.724 . . . . 15.0 111.097 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.97 52.73 0.68 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.877 -0.602 . . . . 15.0 112.226 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.7 13.52 21.15 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.94 0.876 . . . . 15.0 109.169 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -152.2 154.62 36.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.407 1.083 . . . . 15.0 109.169 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 pt -86.3 164.57 37.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.442 0.697 . . . . 15.0 111.342 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.13 153.57 68.56 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.241 1.961 . . . . 15.0 111.373 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 95.73 -50.59 1.77 Allowed Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.872 -0.891 . . . . 15.0 110.872 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 213' ' ' ILE . 65.6 t80 -68.66 -59.98 2.74 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.197 0.599 . . . . 15.0 109.547 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -62.18 -32.71 73.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 124.313 1.008 . . . . 15.0 111.623 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 4.8 m-20 -69.53 -23.43 63.59 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.849 0.86 . . . . 15.0 111.201 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -83.77 -9.99 81.99 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.461 0.476 . . . . 15.0 113.182 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.0 mm -97.1 -46.86 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.677 0.791 . . . . 15.0 110.061 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HB3' ' SD ' ' A' ' 189' ' ' MET . 62.3 pttt -84.7 30.88 0.54 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.13 1.159 . . . . 15.0 114.13 -161.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -155.89 35.91 0.62 Allowed Glycine 0 C--N 1.341 0.823 0 N-CA-C 111.785 -0.526 . . . . 15.0 111.785 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.62 -170.95 3.22 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.352 0.661 . . . . 15.0 111.29 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -139.42 155.89 47.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.577 1.151 . . . . 15.0 111.226 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.557 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.1 147.09 51.96 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 15.0 111.084 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.6 -40.98 2.26 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.229 -0.749 . . . . 15.0 111.229 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 15.8 pt-20 -78.8 126.79 31.18 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.613 0.72 . . . . 15.0 109.434 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -116.36 106.4 13.6 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.302 -1.369 . . . . 15.0 107.302 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -126.29 -177.43 3.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.344 1.058 . . . . 15.0 109.877 -170.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.8 t -117.25 158.15 24.82 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.504 HG21 ' HA3' ' A' ' 201' ' ' GLY . 38.0 pt -128.01 150.2 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 173.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.12 117.58 34.43 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 163.92 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 15.0 107.332 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 59.1 m -141.92 134.47 28.23 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.29 128.93 76.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.111 -0.471 . . . . 15.0 109.767 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.06 163.51 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.713 2.942 . . . . 15.0 115.146 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.61 -24.44 53.42 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.397 172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.36 -18.63 48.48 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.363 1.065 . . . . 15.0 110.628 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.434 ' HE2' HD12 ' A' ' 226' ' ' LEU . 30.7 t80 -61.11 111.62 1.78 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 15.0 109.923 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -66.71 -14.39 62.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.163 1.172 . . . . 15.0 114.163 -168.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.16 101.04 10.18 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.74 -31.39 72.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 15.0 111.727 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.575 HD21 HG11 ' B' ' 388' ' ' VAL . 7.0 p30 -70.41 -11.68 61.08 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.862 0.465 . . . . 15.0 111.596 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.616 HD11 ' H ' ' B' ' 388' ' ' VAL . 57.5 mt -112.61 -30.84 6.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.932 0.893 . . . . 15.0 110.765 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.17 121.48 6.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.583 1.153 . . . . 15.0 112.497 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.69 -22.98 25.19 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.903 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 96.1 mttt -75.99 143.02 41.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.232 0.613 . . . . 15.0 110.964 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -92.22 115.01 27.71 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.879 0.871 . . . . 15.0 109.825 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.38 118.47 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.553 0.741 . . . . 15.0 111.594 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -92.34 124.16 36.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.113 0.965 . . . . 15.0 108.726 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.2 113.83 19.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.067 0.547 . . . . 15.0 109.79 -174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 93.62 4.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.63 -0.507 . . . . 15.0 109.63 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.8 mm -82.82 122.55 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.352 1.061 . . . . 15.0 110.324 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -107.67 99.75 9.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.343 0.657 . . . . 15.0 109.569 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.29 111.95 11.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.913 -0.403 . . . . 15.0 109.913 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 239' ' ' LYS . 17.7 ptpt -109.7 -35.46 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 116.461 -0.336 . . . . 15.0 110.597 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 238' ' ' LYS . 74.6 mmtt -129.29 133.0 47.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.241 0.616 . . . . 15.0 110.327 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.683 HG11 ' H ' ' A' ' 157' ' ' ALA . 77.7 t -106.92 123.62 62.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 107.884 -1.154 . . . . 15.0 107.884 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 26.1 mt-10 -124.55 169.98 11.36 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.557 0.743 . . . . 15.0 109.457 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.797 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.2 tt0 -139.21 130.48 26.81 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.896 0.878 . . . . 15.0 109.411 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -83.65 84.68 7.46 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.575 -1.268 . . . . 15.0 107.575 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.95 141.2 53.07 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 113.844 -1.526 . . . . 15.0 111.239 -173.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.421 HD21 ' HE3' ' A' ' 146' ' ' LYS . 96.7 mt -58.26 126.29 77.78 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.343 0.657 . . . . 15.0 110.714 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -77.78 173.22 14.41 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.892 2.395 . . . . 15.0 111.249 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -79.82 127.06 31.76 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.722 -0.672 . . . . 15.0 110.069 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 17.0 tp -86.87 52.96 2.66 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.558 -0.904 . . . . 15.0 108.558 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 253' ' ' ILE . 59.9 m -55.0 143.54 26.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.825 1.65 . . . . 15.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.81 -45.37 59.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.748 0.819 . . . . 15.0 112.346 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -68.62 -14.97 63.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.132 0.973 . . . . 15.0 113.446 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.55 -51.32 4.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.76 0.824 . . . . 15.0 110.305 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.727 HG13 HD22 ' A' ' 266' ' ' LEU . 7.3 tt -63.63 -33.08 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.147 0.979 . . . . 15.0 111.893 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.32 -29.63 67.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 120.757 0.313 . . . . 15.0 111.353 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -72.69 -13.56 61.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.588 0.755 . . . . 15.0 111.031 -172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.57 6.76 22.51 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.394 0.678 . . . . 15.0 111.929 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.02 19.63 8.91 Favored Glycine 0 N--CA 1.476 1.361 0 CA-C-N 117.554 0.161 . . . . 15.0 113.17 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 261' ' ' GLY . 14.4 t -102.82 132.88 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.164 -1.05 . . . . 15.0 108.164 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.2 -62.89 1.2 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.87 0.367 . . . . 15.0 110.588 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -83.8 -22.31 31.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.65 0.78 . . . . 15.0 111.383 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.467 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 90.7 26.93 21.27 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.631 -0.539 . . . . 15.0 113.449 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 55.3 p -72.22 136.23 46.3 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 117.607 0.703 . . . . 15.0 110.535 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.495 ' HA ' HD11 ' A' ' 253' ' ' ILE . 61.0 t -55.62 -46.97 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.896 0.878 . . . . 15.0 110.468 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.5 -26.69 68.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.701 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.54 -26.28 61.43 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 111.464 -0.654 . . . . 15.0 111.464 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.727 HD22 HG13 ' A' ' 253' ' ' ILE . 53.9 tp -77.27 -41.79 39.56 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.86 -0.422 . . . . 15.0 109.86 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -60.77 -39.7 89.77 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 124.026 0.829 . . . . 15.0 110.026 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.83 -42.24 77.44 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.398 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -64.6 -44.64 89.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.473 0.709 . . . . 15.0 111.107 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 141' ' ' LEU . 28.3 m -76.93 -25.21 15.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 119.282 -0.39 . . . . 15.0 110.89 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -55.34 -59.64 4.52 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -66.8 -36.35 82.19 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.03 0.752 . . . . 15.0 113.03 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -70.42 -52.48 21.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.214 0.461 . . . . 15.0 111.168 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.51 -33.47 75.99 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 118.391 -0.814 . . . . 15.0 110.206 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 45.5 mt-10 -72.21 -30.58 65.07 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -69.59 -38.83 77.48 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -65.12 -46.7 79.92 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.867 -1.06 . . . . 15.0 110.232 169.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.49 ' HA ' ' HE1' ' A' ' 428' ' ' MET . 42.9 tp -63.6 -59.4 4.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.397 -1.274 . . . . 15.0 112.788 -168.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.87 -30.2 70.76 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.718 0.636 . . . . 15.0 111.745 -172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.4 m -70.24 -37.6 75.0 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.214 0.53 . . . . 15.0 110.019 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.61 -26.98 61.05 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-N 115.74 -0.664 . . . . 15.0 111.873 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.4 mt -69.32 -40.08 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.941 -1.133 . . . . 15.0 107.941 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 15.9 tpt180 -59.83 -50.5 73.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.602 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.44 -39.09 86.24 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.911 0.757 . . . . 15.0 111.765 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -56.44 -66.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.133 0.973 . . . . 15.0 110.8 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.79 -40.34 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.835 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.59 -46.53 79.01 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 115.6 -0.727 . . . . 15.0 110.724 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.0 p -69.13 -31.85 70.81 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.226 0.329 . . . . 15.0 111.712 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.48 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.7 mt-30 -64.56 -47.19 79.66 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.403 0.281 . . . . 15.0 110.779 173.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -62.07 -44.37 96.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.227 0.611 . . . . 15.0 111.26 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 351' ' ' LEU . 1.2 mp -64.44 -45.91 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.684 1.594 . . . . 15.0 111.445 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' B' ' 400' ' ' ALA . 15.4 tp10 -67.59 -43.13 81.29 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.766 -0.457 . . . . 15.0 109.766 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -56.9 -41.43 91.66 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 124.151 0.907 . . . . 15.0 112.186 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 30.1 mt -60.5 -59.62 5.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 15.0 111.292 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.62 -51.47 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 120.936 0.398 . . . . 15.0 110.302 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -62.93 -35.07 78.87 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.985 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.62 -24.64 49.51 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.669 0.618 . . . . 15.0 112.669 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 117' ' ' LEU . 14.2 m-80 -118.26 152.67 35.28 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.991 0.424 . . . . 15.0 111.887 -162.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -121.61 135.46 54.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.081 0.952 . . . . 15.0 109.713 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 349' ' ' LEU . 12.0 tt -168.67 144.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.392 1.077 . . . . 15.0 109.447 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.93 120.74 26.07 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.589 -1.263 . . . . 15.0 107.589 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 58.6 t -94.15 120.29 65.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.783 0.833 . . . . 15.0 111.219 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.8 126.73 17.19 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.142 2.561 . . . . 15.0 112.776 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -57.82 -23.18 51.44 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.836 1.254 . . . . 15.0 112.341 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.612 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -56.04 -56.05 25.51 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.385 1.074 . . . . 15.0 111.529 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 37.1 mt -71.8 -33.2 68.36 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.622 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 304' ' ' ALA . 69.2 mt -60.82 -44.57 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.549 0.74 . . . . 15.0 110.054 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.59 91.77 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.675 0.79 . . . . 15.0 110.821 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 56.6 m -62.64 -49.9 73.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.669 0.605 . . . . 15.0 112.171 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 341' ' ' ALA . 4.8 mm-40 -68.65 -40.69 80.11 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.304 0.378 . . . . 15.0 110.542 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.511 HD13 ' HG3' ' A' ' 334' ' ' ARG . 60.6 mt -56.81 -45.26 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.898 0.879 . . . . 15.0 109.736 173.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -60.47 -46.75 88.96 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.325 1.016 . . . . 15.0 111.583 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.8 -40.72 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 123.722 0.639 . . . . 15.0 110.424 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.23 -26.71 63.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.307 0.643 . . . . 15.0 112.039 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.0 mtm180 -73.79 -41.63 62.11 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 320' ' ' GLN . 57.9 mtt180 -64.06 -44.62 91.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.852 -0.613 . . . . 15.0 109.698 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.481 ' HG3' HD11 ' B' ' 439' ' ' LEU . 35.0 tt0 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.699 1.199 . . . . 15.0 111.65 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.6 -58.75 4.13 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.316 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 332' ' ' LEU . . . -53.6 -38.6 64.13 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.463 1.102 . . . . 15.0 111.77 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.629 HE22 HG21 ' B' ' 421' ' ' VAL . 0.8 OUTLIER -49.45 -43.3 44.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.6 1.56 . . . . 15.0 110.825 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -104.12 -9.21 18.89 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.342 0.657 . . . . 15.0 111.831 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -93.87 44.63 1.13 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.481 1.113 . . . . 15.0 109.343 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.25 79.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.069 -0.514 . . . . 15.0 113.4 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 83.1 35.97 16.5 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.436 -0.647 . . . . 15.0 113.456 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 5.1 m-20 -51.82 108.39 0.27 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.79 1.236 . . . . 15.0 111.451 -175.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.28 91.05 0.71 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.615 1.166 . . . . 15.0 110.634 -165.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm 59.19 15.55 4.26 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.28 1.432 . . . . 15.0 113.085 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 23.2 tm0? -76.52 -13.19 60.11 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.92 0.888 . . . . 15.0 108.758 169.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.21 -41.97 1.98 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 126.206 1.803 . . . . 15.0 113.669 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.92 -38.73 62.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.446 1.098 . . . . 15.0 111.877 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.17 -16.82 56.03 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.407 1.083 . . . . 15.0 112.861 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 319' ' ' ALA . 57.4 mt -54.97 137.99 65.29 Favored Pre-proline 0 N--CA 1.5 2.036 0 CA-C-N 118.477 0.581 . . . . 15.0 111.937 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.13 107.9 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.796 2.997 . . . . 15.0 114.088 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.511 ' HG3' HD13 ' A' ' 311' ' ' ILE . 25.7 ttt85 -53.53 -39.25 64.52 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.208 1.403 . . . . 15.0 112.412 -174.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.31 -26.04 60.27 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 15.0 113.226 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 62.9 mt -68.5 -31.96 71.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.245 0.545 . . . . 15.0 110.533 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.414 ' HA ' HE21 ' A' ' 340' ' ' GLN . 26.4 m-85 -105.53 -19.83 13.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.005 0.922 . . . . 15.0 111.341 -171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.413 ' HA ' HD11 ' A' ' 311' ' ' ILE . 5.9 tp10 -49.21 -61.15 2.23 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.879 1.272 . . . . 15.0 113.28 -169.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.15 -52.16 50.95 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.432 0.693 . . . . 15.0 111.666 -173.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.3 pt20 -63.38 -34.46 77.78 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.757 0.66 . . . . 15.0 111.903 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -68.97 -49.34 58.73 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.445 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.2 tttt -55.55 -39.4 70.56 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.138 0.899 . . . . 15.0 110.636 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.4 mmt180 -59.09 -44.8 91.95 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.419 171.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -68.87 -24.19 64.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.491 0.716 . . . . 15.0 110.718 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 58.0 t -71.53 -50.9 36.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 123.181 0.592 . . . . 15.0 110.176 173.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 342' ' ' LYS . 39.7 t -56.33 -37.4 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 123.846 0.716 . . . . 15.0 109.887 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 343' ' ' ARG . 60.4 t -54.31 -53.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 15.0 110.972 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.22 -32.76 85.27 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.619 0.575 . . . . 15.0 114.049 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 300' ' ' ILE . 89.7 mt -73.28 -50.48 22.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.605 0.762 . . . . 15.0 110.159 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 354' ' ' VAL . 89.6 mt -70.37 -46.82 63.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.631 -0.713 . . . . 15.0 110.825 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 291' ' ' ILE . 52.9 mt -64.16 -37.13 86.35 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 123.439 0.462 . . . . 15.0 111.388 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.76 -40.2 98.91 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.593 0.558 . . . . 15.0 111.918 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.23 -29.27 67.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.107 -0.547 . . . . 15.0 111.304 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 350' ' ' LEU . 79.1 t -74.33 -32.3 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.811 0.444 . . . . 15.0 110.357 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 351' ' ' LEU . 95.7 mt -63.45 -42.77 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.26 -0.645 . . . . 15.0 109.26 172.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.406 ' HD2' ' HB3' ' B' ' 459' ' ' ASP . 12.7 ttp180 -65.0 -55.45 18.93 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.076 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 92.2 m -60.31 -44.9 95.02 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.426 1.09 . . . . 15.0 111.535 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -88.26 4.27 46.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.125 0.57 . . . . 15.0 111.696 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 39.08 65.03 0.72 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.87 1.668 . . . . 15.0 113.886 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 154.12 18.34 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.5 -1.227 . . . . 15.0 111.204 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.36 144.05 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.538 -1.282 . . . . 15.0 107.538 171.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -66.14 132.59 48.83 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.63 0.372 . . . . 15.0 111.781 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.72 123.79 37.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.728 0.811 . . . . 15.0 110.265 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -58.44 -40.29 82.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.273 0.629 . . . . 15.0 112.383 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.86 -27.59 66.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.655 0.382 . . . . 15.0 111.751 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 406' ' ' GLN . 27.6 ttt180 -74.57 -43.32 56.23 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 371' ' ' ILE . 46.5 t -59.58 -42.0 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.697 -1.138 . . . . 15.0 109.719 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -58.14 -50.17 74.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.651 0.78 . . . . 15.0 110.865 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.76 -46.46 82.75 Favored Glycine 0 C--N 1.354 1.534 0 O-C-N 124.193 0.933 . . . . 15.0 112.664 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 96.5 mt -55.47 -48.84 73.89 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.416 0.686 . . . . 15.0 111.11 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.645 HD11 ' HG2' ' A' ' 398' ' ' MET . 35.6 mm -58.32 -58.94 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.534 0.733 . . . . 15.0 111.705 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.64 -36.21 83.51 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 124.329 1.018 . . . . 15.0 111.491 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -78.36 -39.06 40.48 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.46 0.541 . . . . 15.0 112.46 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.435 ' HG2' HG22 ' B' ' 441' ' ' ILE . 53.2 ttp -63.15 -36.12 82.55 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.343 0.592 . . . . 15.0 109.96 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.711 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -81.62 -28.16 33.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.173 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 35.4 t -64.65 -15.42 61.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.792 0.837 . . . . 15.0 111.669 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.09 -5.26 34.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.352 0.661 . . . . 15.0 111.945 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.79 165.58 20.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.327 1.051 . . . . 15.0 110.004 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.18 17.78 7.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.558 0.743 . . . . 15.0 110.354 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.478 ' N ' ' HD3' ' A' ' 381' ' ' PRO . 1.6 p30 -133.45 41.7 0.73 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.149 0.98 . . . . 15.0 112.626 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.711 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 44.1 Cg_exo -58.06 -43.48 47.79 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 122.128 1.886 . . . . 15.0 113.98 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.47 -50.1 63.36 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.897 0.879 . . . . 15.0 112.711 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.7 -22.04 64.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.594 0.559 . . . . 15.0 111.752 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.451 HG11 HG21 ' B' ' 441' ' ' ILE . 99.6 t -77.06 -45.71 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.191 0.597 . . . . 15.0 109.446 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.98 -39.28 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.04 -0.982 . . . . 15.0 109.776 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.67 -42.12 71.17 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.121 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -60.66 -35.91 77.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.295 0.638 . . . . 15.0 111.701 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.51 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 51.7 m-85 -88.38 -61.11 1.79 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.636 0.374 . . . . 15.0 111.745 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . 0.473 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 38.9 m -70.54 -21.33 62.73 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.616 0.969 . . . . 15.0 113.616 -167.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -96.01 11.49 33.85 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.417 0.287 . . . . 15.0 111.055 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -136.8 103.54 5.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.84 -31.61 71.87 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.065 0.546 . . . . 15.0 111.512 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.08 -47.74 84.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.387 0.675 . . . . 15.0 110.87 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 41.8 tp -83.51 -24.71 31.58 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.896 -0.593 . . . . 15.0 111.209 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.51 ' HE3' ' HB3' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -71.08 -37.61 72.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 175.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.43 -36.19 82.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.761 1.224 . . . . 15.0 110.569 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 400' ' ' ASN . 51.9 t-20 -62.37 -42.48 99.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.742 0.782 . . . . 15.0 109.854 173.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.645 ' HG2' HD11 ' A' ' 371' ' ' ILE . 3.8 tpt -79.23 -17.26 55.14 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.564 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.11 -35.97 64.18 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 168.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 397' ' ' ASN . 6.8 t30 -59.22 -53.61 56.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.374 0.669 . . . . 15.0 110.421 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.2 p -65.47 -37.11 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 O-C-N 123.577 0.548 . . . . 15.0 111.354 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -62.01 -44.87 95.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.902 0.481 . . . . 15.0 110.96 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 23.5 tp -72.04 -30.46 65.2 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.846 -1.07 . . . . 15.0 111.03 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 33.7 tt0 -67.56 -39.35 84.95 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.949 0.9 . . . . 15.0 109.492 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 33.1 mm-40 -69.49 -36.2 76.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.551 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -62.25 -39.15 91.92 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.387 0.675 . . . . 15.0 110.098 172.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.85 -41.77 95.43 Favored 'General case' 0 C--N 1.348 0.5 0 O-C-N 124.07 0.857 . . . . 15.0 111.534 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 96.2 t -57.94 -55.47 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 123.474 0.484 . . . . 15.0 110.031 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.463 ' HG2' HD12 ' A' ' 412' ' ' LEU . 43.5 mt-10 -67.29 -22.89 65.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.553 0.575 . . . . 15.0 112.553 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 414' ' ' LYS . . . -66.13 -37.66 86.23 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.57 0.544 . . . . 15.0 110.621 169.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 45.8 t -74.61 -33.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 409' ' ' GLU . 96.9 mt -64.33 -40.1 95.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.076 0.55 . . . . 15.0 110.935 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.21 -15.56 57.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.35 0.66 . . . . 15.0 112.492 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 410' ' ' ALA . 24.1 mtpp -101.12 -33.77 9.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.178 0.991 . . . . 15.0 110.672 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.3 160.66 20.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.284 1.033 . . . . 15.0 112.402 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.6 80.29 1.99 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.163 0.985 . . . . 15.0 109.816 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 125' ' ' VAL . 49.1 t -97.73 109.69 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.605 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.0 t -87.95 103.4 15.65 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.277 0.631 . . . . 15.0 110.134 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -85.37 129.39 34.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.661 0.785 . . . . 15.0 110.068 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -139.33 153.93 47.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.361 0.664 . . . . 15.0 109.588 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.56 133.3 52.22 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.592 -0.892 . . . . 15.0 108.592 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.436 HG23 HG22 ' A' ' 130' ' ' VAL . 7.9 t -159.64 172.12 18.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.763 0.425 . . . . 15.0 111.521 -170.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 77.9 p -91.78 168.28 11.56 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.22 1.008 . . . . 15.0 111.396 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -54.17 -26.66 29.2 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.459 1.503 . . . . 15.0 112.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.93 -20.62 16.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.06 0.944 . . . . 15.0 113.338 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -70.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.466 0.706 . . . . 15.0 112.256 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 278' ' ' LEU . 22.4 tp -70.48 -78.79 0.07 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.514 0.931 . . . . 15.0 113.514 -153.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.49 ' HE1' ' HA ' ' A' ' 278' ' ' LEU . 1.0 OUTLIER -87.19 -22.79 25.07 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.608 0.363 . . . . 15.0 110.39 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.93 21.41 0.16 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.964 0.906 . . . . 15.0 111.904 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.31 81.21 4.68 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.334 -1.358 . . . . 15.0 107.334 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -95.04 40.3 1.1 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 15.0 109.563 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.329 1.051 . . . . 15.0 108.413 -175.225 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 36.9 t . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 121.102 0.477 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.65 55.96 1.78 Allowed 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.77 -28.47 58.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.474 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.19 -16.92 61.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.09 1.356 . . . . 0.0 112.497 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -83.26 -42.1 17.58 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.337 0.655 . . . . 0.0 110.302 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -70.63 -30.7 67.41 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.622 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 19.4 m -103.33 1.16 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.212 1.005 . . . . 0.0 111.605 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -28.36 -67.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 126.735 2.014 . . . . 0.0 115.177 -164.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 7.1 tpt85 -101.32 -79.05 0.52 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' B' ' 378' ' ' ALA . . . -106.24 -73.43 0.68 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 160.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.39 -71.84 0.74 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 166.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' B' ' 379' ' ' LYS . 23.0 mt-10 -103.55 -75.58 0.61 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -102.86 -80.13 0.52 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 165.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' B' ' 374' ' ' ALA . . . -100.35 -80.32 0.48 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 154.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' B' ' 376' ' ' GLU . 28.4 mmtp -106.93 -85.79 0.5 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 155.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -151.91 127.72 10.25 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.121 0.568 . . . . 0.0 110.082 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 56.53 -171.5 0.08 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 113.562 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -139.6 -158.33 7.59 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.63 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -172.2 165.46 6.02 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.416 1.087 . . . . 0.0 109.254 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -55.15 -51.13 67.44 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.497 1.119 . . . . 0.0 111.727 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.414 HD23 ' CD2' ' A' ' 185' ' ' PHE . 1.9 tm? -136.46 97.74 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.51 HG11 ' HA3' ' A' ' 179' ' ' GLY . 27.2 m -69.4 98.72 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 121.834 0.826 . . . . 0.0 113.086 -166.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.42 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 20.9 pt -144.02 157.54 15.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.763 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 158.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 226' ' ' LEU . 30.2 t -79.27 109.57 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 31.8 m -64.95 100.29 0.41 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 124.153 0.908 . . . . 0.0 111.357 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -89.24 148.12 23.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -79.16 164.33 24.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.289 0.566 . . . . 0.0 109.806 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -139.46 72.28 1.4 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -74.9 75.16 2.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.997 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -120.63 -72.43 0.69 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 165.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 57.75 -157.86 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.371 1.069 . . . . 0.0 111.22 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 21.4 t -77.05 -0.94 26.49 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.917 0.487 . . . . 0.0 111.043 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -73.09 98.67 2.61 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.881 0.872 . . . . 0.0 108.708 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 27.6 pt -67.18 157.06 6.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 110.734 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.94 93.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.272 0.629 . . . . 0.0 109.669 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 292' ' ' GLU . . . -145.52 -56.21 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.988 0.915 . . . . 0.0 110.676 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' B' ' 400' ' ' ALA . 69.5 Cg_endo -79.89 178.74 6.92 Favored 'Trans proline' 0 C--N 1.39 2.723 0 CA-C-N 121.666 1.631 . . . . 0.0 111.526 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.79 -82.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 406' ' ' PRO . 2.8 m 47.48 45.11 17.27 Favored 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 125.138 1.375 . . . . 0.0 112.433 172.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -66.41 -26.64 67.33 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.006 0.522 . . . . 0.0 112.106 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -126.54 87.53 56.21 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 123.695 0.798 . . . . 0.0 109.211 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' B' ' 403' ' ' THR . 94.4 Cg_endo -76.51 -31.27 4.49 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.954 2.436 . . . . 0.0 112.987 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.45 -101.37 0.62 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -167.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 42.3 tp 60.72 107.33 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.025 1.33 . . . . 0.0 112.093 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 22.8 m -77.07 82.18 3.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.118 0.567 . . . . 0.0 110.528 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 74.27 -62.38 0.46 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.959 1.703 . . . . 0.0 112.734 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 67.63 -169.22 0.19 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.637 1.175 . . . . 0.0 111.258 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.7 87.78 2.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.59 -84.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.581 1.552 . . . . 0.0 112.447 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . 0.445 HG23 ' H ' ' B' ' 415' ' ' LYS . 3.6 t -163.16 -63.63 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.631 0.772 . . . . 0.0 109.508 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' B' ' 418' ' ' ALA . 21.9 tptm -96.59 126.18 41.58 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -142.42 -60.6 0.45 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.733 0.813 . . . . 0.0 109.492 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -68.35 112.66 4.82 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.545 0.528 . . . . 0.0 112.406 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . 0.491 ' HB2' ' HE2' ' B' ' 415' ' ' LYS . . . -157.42 -62.69 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.177 0.591 . . . . 0.0 110.32 -172.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 21.2 m -83.82 -10.06 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.105 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 24.3 ptm -134.4 142.88 47.31 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.716 0.807 . . . . 0.0 109.103 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.629 HG21 HE22 ' A' ' 320' ' ' GLN . 12.9 p -95.41 -15.09 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.483 0.713 . . . . 0.0 110.999 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 83.7 mtp 67.12 29.71 7.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.92 1.288 . . . . 0.0 111.295 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.436 ' H ' HG13 ' B' ' 421' ' ' VAL . 41.8 t -154.68 164.19 39.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.358 0.663 . . . . 0.0 111.209 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 53.75 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.673 1.589 . . . . 0.0 112.604 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.61 27.99 0.02 OUTLIER Glycine 0 C--O 1.223 -0.556 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.508 ' ND2' ' HG2' ' B' ' 432' ' ' GLN . 25.5 t-20 -99.21 98.53 9.5 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.912 0.885 . . . . 0.0 110.74 -167.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 50.8 m -148.96 -78.14 0.15 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.978 0.911 . . . . 0.0 109.293 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -70.08 142.35 52.66 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' B' ' 432' ' ' GLN . 60.9 mm-40 -53.7 -25.11 16.9 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.125 0.97 . . . . 0.0 113.137 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -53.27 -55.19 26.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.253 1.021 . . . . 0.0 110.638 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 22.9 t -107.52 2.74 24.33 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.58 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.508 ' HG2' ' ND2' ' B' ' 426' ' ' ASN . 1.3 tm0? -73.87 -35.29 64.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.694 0.798 . . . . 0.0 109.337 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 161.01 26.82 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.475 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 22.7 m80 63.59 -72.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.993 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 37.9 p -82.75 56.5 3.41 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.376 0.67 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . 0.442 ' HA2' ' ND2' ' B' ' 426' ' ' ASN . . . -82.73 61.81 4.7 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 18.0 t -118.01 97.9 6.05 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.416 ' NE2' HD21 ' B' ' 426' ' ' ASN . 1.1 pm0 -153.51 18.99 0.54 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.775 1.23 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.481 HD11 ' HG3' ' A' ' 317' ' ' GLN . 75.1 mt 65.06 33.3 9.7 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.748 1.219 . . . . 0.0 111.192 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.69 121.49 12.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.597 0.759 . . . . 0.0 109.763 172.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.451 HG21 HG11 ' A' ' 384' ' ' VAL 0.292 2.8 pp 46.62 102.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 C-N-CA 126.407 1.883 . . . . 0.0 112.951 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -87.07 160.01 18.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -164.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -154.93 147.65 24.36 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -79.02 139.28 38.21 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.907 0.883 . . . . 0.0 111.047 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -117.91 78.43 0.3 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.42 -11.15 24.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.08 2.52 . . . . 0.0 114.261 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 36.1 m80 85.43 143.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.613 1.965 . . . . 0.0 110.78 -167.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 66.37 -173.28 0.19 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.065 1.346 . . . . 0.0 112.782 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -85.93 49.22 1.73 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.002 0.921 . . . . 0.0 112.294 -174.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 60.87 -80.7 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.516 1.527 . . . . 0.0 111.91 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.48 -36.64 75.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.9 0.88 . . . . 0.0 109.804 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 47.8 t 76.16 -55.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 125.864 1.666 . . . . 0.0 110.376 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 160.48 -53.59 0.34 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 4.6 tt -89.9 104.01 16.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 6.2 t -118.86 -29.24 5.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.095 0.958 . . . . 0.0 108.531 164.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 19.5 t70 57.71 -83.51 0.02 OUTLIER 'General case' 0 C--N 1.364 1.222 0 C-N-CA 125.564 1.546 . . . . 0.0 111.585 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -157.82 85.83 0.9 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 14.8 m -71.98 -11.87 60.97 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 168.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 356' ' ' ARG . 18.4 t70 79.05 11.52 1.45 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 126.513 1.925 . . . . 0.0 111.212 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.25 165.2 15.2 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.866 . . . . 0.0 110.508 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.64 -1.29 38.4 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.612 0.765 . . . . 0.0 111.418 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -164.6 135.86 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 89.3 m -63.3 99.37 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.5 ttt -78.43 120.17 22.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.674 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.1 OUTLIER -125.62 75.82 1.52 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 122.482 1.134 . . . . 0.0 109.18 178.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.15 -40.8 36.83 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.58 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -152.6 144.6 23.74 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 113.845 -1.525 . . . . 0.0 108.776 -172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -157.46 135.12 10.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.534 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . -88.57 -135.54 5.25 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.449 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 469' ' ' GLY 0.287 4.0 pp 64.88 -30.61 0.12 Allowed 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 128.031 2.532 . . . . 0.0 115.793 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 CA--C 1.555 1.14 0 N-CA-C 109.029 -0.73 . . . . 12.06 109.029 -178.105 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.779 0.323 . . . . 15.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -126.96 142.67 51.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.883 -1.154 . . . . 15.0 107.883 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -126.78 152.22 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.505 0.722 . . . . 15.0 110.051 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.529 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 48.7 m -146.9 100.63 3.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.349 0.66 . . . . 15.0 110.052 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.26 128.23 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.967 -0.561 . . . . 15.0 109.855 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.03 97.38 3.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 15.0 108.921 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.6 m -76.87 93.88 3.82 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.704 -0.85 . . . . 15.0 108.704 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.2 p -66.12 -39.94 90.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.139 0.976 . . . . 15.0 111.858 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -170.13 104.1 0.3 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.393 0.677 . . . . 15.0 109.979 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.67 -100.93 0.47 Allowed Glycine 0 C--N 1.354 1.529 0 O-C-N 124.083 0.864 . . . . 15.0 113.275 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.2 mp -76.99 -39.42 50.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 15.0 110.152 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.7 104.05 0.34 Allowed Glycine 0 C--N 1.353 1.477 0 O-C-N 124.603 1.19 . . . . 15.0 111.634 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' NH1' HG11 ' A' ' 111' ' ' VAL . 33.8 ttm180 -134.82 120.87 19.89 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.38 1.072 . . . . 15.0 109.972 -173.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 43.3 ttm180 -93.76 146.38 23.9 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.46 -1.245 . . . . 15.0 109.468 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -128.47 93.69 2.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 107.332 -1.359 . . . . 15.0 107.332 165.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 33.3 m -73.19 108.55 6.13 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.137 -0.938 . . . . 15.0 108.953 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 3' ' ' VAL . 47.8 mt -107.92 123.95 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.025 0.53 . . . . 15.0 109.617 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 m -99.93 104.83 16.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.518 0.727 . . . . 15.0 109.156 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.73 HD13 ' HB3' ' A' ' 70' ' ' LEU . 56.5 mt -80.52 112.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.17 160.07 24.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.206 0.603 . . . . 15.0 111.997 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -37.96 79.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.324 1.049 . . . . 15.0 112.056 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -65.09 -36.2 83.55 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.741 0.816 . . . . 15.0 111.121 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -70.14 -37.0 75.17 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.528 0.731 . . . . 15.0 110.459 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 28' ' ' VAL . 73.8 mt -70.67 -44.05 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 114.905 -1.043 . . . . 15.0 109.943 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.26 -41.72 99.08 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.065 0.546 . . . . 15.0 111.799 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 m -56.11 -45.87 79.34 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -64.85 -44.81 88.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.462 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 24' ' ' ILE . 71.3 t -60.99 -55.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.284 0.634 . . . . 15.0 110.658 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -61.75 -41.5 97.76 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.27 -11.5 59.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.418 0.687 . . . . 15.0 111.767 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 8.8 tp10 -88.64 -43.03 11.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.721 0.408 . . . . 15.0 110.383 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.692 HD11 ' HA3' ' A' ' 59' ' ' GLY . 92.4 mt -70.27 -23.97 62.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.564 0.746 . . . . 15.0 112.386 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.2 p -69.98 -32.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 123.339 0.4 . . . . 15.0 110.054 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -69.36 -43.53 73.4 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.588 0.755 . . . . 15.0 109.613 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 39' ' ' VAL . 46.9 t -63.36 -38.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.885 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.14 86.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.524 0.73 . . . . 15.0 110.926 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 95.6 mttt -67.29 -31.49 71.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.169 0.587 . . . . 15.0 111.392 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -76.28 -46.05 29.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.694 0.798 . . . . 15.0 110.951 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 35' ' ' VAL . 3.7 t -82.85 -5.93 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 122.924 0.49 . . . . 15.0 110.005 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 74.45 8.79 4.43 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.85 1.66 . . . . 15.0 112.15 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.419 HG13 ' HB ' ' A' ' 39' ' ' VAL . 56.8 mt -63.89 -22.9 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 15.0 110.931 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.99 -33.97 74.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.424 0.69 . . . . 15.0 111.148 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -39.05 15.02 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.749 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -71.03 -16.97 62.64 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.157 0.583 . . . . 15.0 111.162 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.412 HH21 ' HA ' ' A' ' 50' ' ' PRO . 49.0 ttt-85 -76.63 105.93 7.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -85.79 13.22 7.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.406 0.683 . . . . 15.0 112.153 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -34.29 4.66 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.85 -0.417 . . . . 15.0 112.354 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -52.03 -36.14 49.24 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.998 1.319 . . . . 15.0 112.384 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.31 108.92 32.23 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.564 -0.902 . . . . 15.0 108.564 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 53' ' ' ILE . 38.8 Cg_exo -64.02 138.94 64.86 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 15.0 111.681 173.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.6 tpp -67.92 -25.74 65.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.196 0.598 . . . . 15.0 111.12 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.13 -33.89 77.1 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.326 0.25 . . . . 15.0 111.13 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 50' ' ' PRO . 32.1 mt -67.55 -46.15 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.018 0.527 . . . . 15.0 110.234 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.4 m -74.14 -21.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 111.567 0.21 . . . . 15.0 111.567 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.23 -45.58 39.3 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.201 0.6 . . . . 15.0 111.4 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.57 -26.56 58.05 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.502 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -92.01 -72.52 0.59 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.839 0.455 . . . . 15.0 110.9 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -84.33 -34.44 23.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.077 0.551 . . . . 15.0 111.466 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -74.97 -13.23 82.8 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.156 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.68 59.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.086 0.954 . . . . 15.0 112.163 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.9 p -81.89 -42.75 19.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.293 0.637 . . . . 15.0 109.346 171.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -70.86 88.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.793 0.837 . . . . 15.0 109.152 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -105.46 -38.28 6.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.625 0.77 . . . . 15.0 110.129 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.14 -46.01 90.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.765 0.826 . . . . 15.0 112.271 -171.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.98 -49.24 71.02 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.301 0.641 . . . . 15.0 110.376 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.6 -63.78 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.543 -1.208 . . . . 15.0 110.76 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 71' ' ' MET . 84.1 mt -64.74 -38.21 90.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.781 0.832 . . . . 15.0 111.511 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.27 -40.72 98.99 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.812 0.695 . . . . 15.0 113.15 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 28.7 t70 -78.87 -37.57 39.93 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.004 0.522 . . . . 15.0 110.076 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 19' ' ' ILE . 21.0 mt -54.87 -42.4 72.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.005 0.922 . . . . 15.0 111.29 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 48.2 mtm -58.6 -42.75 88.85 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.675 0.609 . . . . 15.0 110.76 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.9 t -70.28 -43.78 69.75 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.907 -1.042 . . . . 15.0 111.008 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 20.8 mtm180 -69.17 -36.05 76.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.698 0.399 . . . . 15.0 111.502 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -36.67 68.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.968 0.507 . . . . 15.0 110.274 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -70.01 -50.25 43.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.886 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.41 -33.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.646 0.591 . . . . 15.0 111.012 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.23 -51.73 62.24 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.254 0.621 . . . . 15.0 110.707 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.79 85.49 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.99 -1.004 . . . . 15.0 112.438 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 pt -75.33 -32.01 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 112.383 0.512 . . . . 15.0 112.383 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.44 -50.62 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 120.841 0.353 . . . . 15.0 110.558 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 17.1 ptpt -73.66 -50.63 19.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.949 -0.569 . . . . 15.0 111.449 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 50.6 mm-40 -84.81 -1.99 57.12 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.133 0.573 . . . . 15.0 111.941 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 63.25 28.26 15.73 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.53 1.144 . . . . 15.0 111.091 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -71.19 90.37 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 108.399 -0.963 . . . . 15.0 108.399 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.744 HD21 ' HB2' ' A' ' 112' ' ' TYR . 45.9 t30 -70.91 107.5 2.66 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.381 1.073 . . . . 15.0 110.425 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.37 141.78 12.87 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.345 2.03 . . . . 15.0 112.737 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.16 -177.3 6.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.578 0.751 . . . . 15.0 110.683 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.4 -119.66 11.85 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.4 -0.818 . . . . 15.0 111.473 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.99 100.64 4.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.732 -1.211 . . . . 15.0 107.732 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 51.9 Cg_exo -57.78 107.9 0.34 Allowed 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.972 2.448 . . . . 15.0 112.622 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.0 m -88.86 100.14 12.94 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.679 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -76.85 75.61 3.46 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.663 -0.866 . . . . 15.0 108.663 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.17 112.57 4.79 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 123.532 0.733 . . . . 15.0 109.361 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -69.43 92.3 0.48 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.407 2.072 . . . . 15.0 109.26 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -59.61 -63.5 5.05 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.964 0.79 . . . . 15.0 112.004 -176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -167.87 155.75 8.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.983 0.913 . . . . 15.0 109.792 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HE1' HD13 ' A' ' 24' ' ' ILE . 47.0 t80 -135.94 147.27 48.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.12 0.568 . . . . 15.0 109.551 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -124.87 125.22 43.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.748 -1.205 . . . . 15.0 107.748 175.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.39 107.59 0.95 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.675 0.79 . . . . 15.0 111.453 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.3 -13.76 59.26 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.591 -0.731 . . . . 15.0 113.287 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 42.8 mt-10 -106.14 -165.95 1.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.318 1.047 . . . . 15.0 109.379 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -62.93 155.87 26.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.331 1.052 . . . . 15.0 113.287 -171.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.1 t80 -123.66 142.92 50.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 15.0 108.304 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.2 m -137.06 137.59 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.273 0.629 . . . . 15.0 109.371 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.412 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 11.6 p90 -154.35 156.46 36.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.984 0.914 . . . . 15.0 109.086 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 47.7 m -125.13 98.28 5.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.844 0.858 . . . . 15.0 109.648 -170.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.26 97.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.852 -0.796 . . . . 15.0 108.852 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.9 119.05 33.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.799 0.44 . . . . 15.0 110.253 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 22.4 p90 -146.61 -166.78 2.58 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.527 1.131 . . . . 15.0 108.941 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.67 177.17 5.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.63 0.772 . . . . 15.0 110.356 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 11' ' ' LEU . 27.0 m -119.72 154.46 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 122.992 0.517 . . . . 15.0 109.626 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.744 ' HB2' HD21 ' A' ' 85' ' ' ASN . 48.6 m-85 -82.75 105.89 5.81 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 108.334 -0.987 . . . . 15.0 108.334 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' HD11 ' A' ' 300' ' ' ILE . 64.5 Cg_endo -89.03 149.45 5.69 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.629 2.219 . . . . 15.0 113.704 -172.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.58 132.14 33.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.202 1.001 . . . . 15.0 108.882 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 350' ' ' LEU . 7.3 p -86.3 151.57 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 121.256 0.551 . . . . 15.0 111.937 -170.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.34 94.03 8.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.476 -0.784 . . . . 15.0 108.914 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.3 139.08 58.73 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.47 0.481 . . . . 15.0 110.555 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -163.06 155.12 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.915 0.886 . . . . 15.0 109.545 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 59.54 32.98 74.76 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.124 0.89 . . . . 15.0 114.049 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.45 -28.73 67.31 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.227 0.611 . . . . 15.0 110.935 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 18.3 mp0 -75.65 -34.08 60.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.657 -1.156 . . . . 15.0 109.852 174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.464 ' HA ' ' HE3' ' A' ' 416' ' ' LYS . . . -78.93 -7.15 57.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.61 0.764 . . . . 15.0 112.255 -173.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.632 HG23 ' HA3' ' A' ' 293' ' ' GLY . 77.6 mt -70.83 120.89 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.439 0.695 . . . . 15.0 109.467 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.08 104.11 15.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.376 0.67 . . . . 15.0 109.685 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 417' ' ' VAL . 45.6 t -106.05 159.55 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.934 -1.135 . . . . 15.0 107.934 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.47 126.37 46.62 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.724 -0.843 . . . . 15.0 108.724 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -107.43 99.21 26.97 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.529 0.732 . . . . 15.0 109.197 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.02 97.85 0.84 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.468 2.112 . . . . 15.0 111.502 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.52 93.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 166.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 12.4 t -122.51 140.48 46.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.535 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.68 154.37 48.6 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.984 -1.117 . . . . 15.0 107.984 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.82 83.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.3 p -68.39 176.9 2.59 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.489 1.116 . . . . 15.0 110.368 -175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.99 -45.6 64.57 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.429 0.692 . . . . 15.0 111.771 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.19 97.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.92 -1.036 . . . . 15.0 111.338 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.4 -44.15 68.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.173 0.589 . . . . 15.0 111.298 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.9 t -55.51 -62.58 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.348 1.059 . . . . 15.0 109.454 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -75.45 -31.31 60.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.676 -0.693 . . . . 15.0 111.307 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.86 -43.8 81.98 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.887 0.742 . . . . 15.0 112.713 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -78.16 -37.5 45.76 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.091 0.556 . . . . 15.0 110.878 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.554 HD21 HG11 ' A' ' 270' ' ' VAL . 18.5 mt -54.83 -42.39 71.86 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.253 0.621 . . . . 15.0 111.574 165.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.38 -40.1 95.15 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.375 -0.83 . . . . 15.0 109.997 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.9 m -61.67 -46.27 90.42 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.721 0.638 . . . . 15.0 110.953 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -45.95 91.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.651 0.78 . . . . 15.0 110.66 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -58.27 -37.66 75.4 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.808 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.618 ' HD3' HH12 ' A' ' 243' ' ' ARG . 83.3 mttt -85.41 -12.23 52.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.34 0.656 . . . . 15.0 112.533 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.82 -22.79 34.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.81 0.444 . . . . 15.0 110.005 167.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -97.06 8.4 44.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.262 0.625 . . . . 15.0 111.324 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.71 159.53 31.93 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 15.0 112.312 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.6 m -123.93 155.93 37.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.091 0.956 . . . . 15.0 108.917 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.627 ' HZ3' ' HB3' ' A' ' 243' ' ' ARG . 3.5 m95 -78.91 153.17 30.69 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 120.817 0.341 . . . . 15.0 111.151 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -151.65 104.77 3.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.043 -0.981 . . . . 15.0 109.368 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.35 98.45 0.11 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 175.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.02 170.73 16.23 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.477 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.95 97.24 9.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.838 0.455 . . . . 15.0 110.729 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 207' ' ' ALA . . . 55.22 53.26 41.77 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 124.589 1.181 . . . . 15.0 115.5 161.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -153.91 140.86 19.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.334 0.654 . . . . 15.0 109.315 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 202' ' ' ILE . 17.0 t -119.32 131.33 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.177 -0.675 . . . . 15.0 109.177 172.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.85 -176.16 3.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.909 1.283 . . . . 15.0 109.423 -176.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.82 -27.49 64.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.28 13.88 16.75 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.435 0.532 . . . . 15.0 112.435 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -79.03 136.16 37.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.971 0.415 . . . . 15.0 111.602 -173.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -84.94 90.91 7.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.823 -1.547 . . . . 15.0 106.823 173.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 44.0 t -90.58 150.79 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.002 0.921 . . . . 15.0 109.847 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.669 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 32.9 m -130.09 126.75 38.36 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 165.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.83 163.71 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.341 1.057 . . . . 15.0 110.314 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -116.69 122.21 43.89 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.294 -1.743 . . . . 15.0 106.294 167.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -129.14 160.69 32.06 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.724 0.773 . . . . 15.0 111.235 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.0 t -140.85 111.87 7.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.262 -1.385 . . . . 15.0 107.262 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -80.02 160.34 44.47 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.596 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.0 m -149.53 111.15 4.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.543 0.737 . . . . 15.0 109.194 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 177' ' ' PHE . 59.7 t -93.85 134.87 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.297 -1.001 . . . . 15.0 108.297 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.0 p30 51.39 18.98 0.71 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.138 1.775 . . . . 15.0 113.472 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.36 -11.57 12.71 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-O 118.665 -1.075 . . . . 15.0 115.545 172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.82 147.73 50.82 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.214 1.507 . . . . 15.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.69 112.66 2.61 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.836 0.71 . . . . 15.0 109.217 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 172' ' ' VAL . 37.3 p90 -72.32 156.22 39.33 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.596 0.56 . . . . 15.0 110.829 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.38 126.63 28.09 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.763 0.664 . . . . 15.0 111.124 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.77 77.55 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.051 -0.977 . . . . 15.0 112.175 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.69 47.81 1.39 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 114.672 0.629 . . . . 15.0 114.672 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -136.03 150.72 49.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.018 0.527 . . . . 15.0 110.625 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.12 92.27 0.83 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.154 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.2 p -76.57 127.81 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.205 -0.907 . . . . 15.0 110.357 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.478 ' HB3' HG13 ' B' ' 421' ' ' VAL . 15.3 m-20 71.6 36.15 1.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 15.0 112.731 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -66.05 138.85 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 15.0 109.909 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.8 t -104.35 110.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.977 0.911 . . . . 15.0 109.719 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.3 tp -101.93 89.96 3.82 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.675 0.79 . . . . 15.0 111.22 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -78.45 90.3 4.45 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.387 -0.968 . . . . 15.0 108.387 171.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.7 mtp -71.76 169.68 15.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.43 -0.805 . . . . 15.0 113.024 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.67 ' HA3' HH21 ' A' ' 243' ' ' ARG . . . 91.53 10.66 61.67 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.99 -1.004 . . . . 15.0 113.523 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.446 ' HG3' ' HG2' ' A' ' 193' ' ' ARG . 8.8 pt20 -137.75 160.55 38.94 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.169 0.588 . . . . 15.0 110.077 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -62.91 89.83 0.06 OUTLIER Glycine 0 C--N 1.353 1.484 0 O-C-N 123.715 0.635 . . . . 15.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 191' ' ' GLN . 29.7 mmt180 -121.03 -60.78 1.62 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.67 0.788 . . . . 15.0 111.227 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.475 ' HB3' ' HB3' ' A' ' 198' ' ' PHE . 63.4 mmm -98.17 148.89 23.12 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.679 0.622 . . . . 15.0 112.679 -165.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 40.8 pt -61.27 145.27 90.54 Favored Pre-proline 0 CA--C 1.556 1.207 0 O-C-N 124.74 1.275 . . . . 15.0 109.904 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -53.62 114.76 1.91 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.472 2.781 . . . . 15.0 111.811 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 128.4 -37.31 2.29 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.71 -0.677 . . . . 15.0 112.385 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 194' ' ' MET . 37.6 t80 -69.64 -67.78 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.423 0.289 . . . . 15.0 110.386 -175.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.41 -18.84 65.08 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.382 0.426 . . . . 15.0 111.859 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.28 -41.13 67.01 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.965 0.906 . . . . 15.0 110.2 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.22 -24.44 77.0 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.176 -0.92 . . . . 15.0 112.484 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 198' ' ' PHE . 44.9 mm -73.2 -51.85 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.239 0.616 . . . . 15.0 110.134 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -79.01 12.78 2.04 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 113.508 0.929 . . . . 15.0 113.508 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.55 20.4 15.59 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -144.18 -176.05 4.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.484 1.114 . . . . 15.0 109.991 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.5 OUTLIER -147.37 143.42 27.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.436 0.694 . . . . 15.0 110.101 -176.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.599 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . . . -59.66 145.67 43.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.414 0.894 . . . . 15.0 113.414 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.09 -34.16 4.84 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.478 -0.783 . . . . 15.0 111.553 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.6 pt-20 -87.19 140.74 29.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.588 0.709 . . . . 15.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -116.14 125.37 52.23 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.67 1.188 . . . . 15.0 107.969 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -148.92 -167.05 2.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.425 1.09 . . . . 15.0 109.633 -168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.4 t -133.17 150.37 52.01 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.199 -1.037 . . . . 15.0 108.199 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 38.5 pt -113.57 147.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 172.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.04 113.7 26.95 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.93 167.16 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.302 -1.37 . . . . 15.0 107.302 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.9 m -135.03 137.73 43.24 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.545 -0.909 . . . . 15.0 108.545 171.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -72.58 125.5 91.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 123.873 0.733 . . . . 15.0 109.621 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.48 168.15 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.785 2.99 . . . . 15.0 115.21 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.88 -19.97 53.83 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.337 -0.847 . . . . 15.0 110.937 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -80.3 -22.49 41.52 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.325 1.05 . . . . 15.0 110.75 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.59 116.23 4.21 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.84 . . . . 15.0 110.46 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -68.14 -32.19 72.3 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.775 1.028 . . . . 15.0 113.775 -162.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.42 92.57 1.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.039 -1.467 . . . . 15.0 107.039 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 33.0 tt0 -73.53 -18.11 61.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.744 0.817 . . . . 15.0 111.391 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -65.32 -13.23 58.02 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.365 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 172' ' ' VAL . 95.4 mt -119.26 -29.89 5.07 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.949 1.3 . . . . 15.0 111.773 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 36.8 ttmt -51.61 121.36 6.33 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.998 1.319 . . . . 15.0 111.645 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.63 -25.33 25.32 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.409 -0.359 . . . . 15.0 113.591 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.15 150.44 31.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.524 0.73 . . . . 15.0 111.328 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.8 122.79 37.79 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.646 0.778 . . . . 15.0 109.927 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.43 122.37 47.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.667 0.787 . . . . 15.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 63.9 mttm -93.73 118.4 31.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.193 0.997 . . . . 15.0 109.571 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 89.5 m-85 -108.4 118.44 36.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.01 89.16 2.98 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.507 0.504 . . . . 15.0 110.323 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 40.9 mm -83.24 123.01 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.537 0.735 . . . . 15.0 110.209 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -120.59 99.33 6.49 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.9 mt -76.43 99.3 4.83 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.53 0.732 . . . . 15.0 111.005 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -104.12 -43.65 5.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.52 0.728 . . . . 15.0 110.145 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.3 mmtt -124.51 125.87 44.92 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.561 1.144 . . . . 15.0 108.22 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 157' ' ' ALA . 18.6 t -128.5 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 106.74 -1.578 . . . . 15.0 106.74 165.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -86.53 163.99 17.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.542 -1.208 . . . . 15.0 108.23 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -130.2 129.46 43.43 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.453 -0.943 . . . . 15.0 108.453 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.67 HH21 ' HA3' ' A' ' 190' ' ' GLY . 27.8 ptt85 -74.41 84.4 1.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.366 -0.976 . . . . 15.0 108.366 167.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.36 145.92 37.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 113.783 -1.553 . . . . 15.0 110.689 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 146' ' ' LYS . 55.1 mt -57.47 120.73 42.84 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.984 0.914 . . . . 15.0 110.133 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.25 -165.57 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.903 3.736 . . . . 15.0 113.613 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -46.77 136.51 7.95 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.773 -1.103 . . . . 15.0 110.461 165.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 16.0 tp -140.66 37.37 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.137 -1.06 . . . . 15.0 108.137 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.6 m -66.03 161.04 22.43 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.47 1.108 . . . . 15.0 109.922 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.83 -44.88 14.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.88 1.272 . . . . 15.0 112.929 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.82 -27.28 64.74 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.981 -0.554 . . . . 15.0 112.173 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -77.58 -49.18 15.15 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.567 HG13 HD22 ' A' ' 266' ' ' LEU . 12.1 tt -64.52 -32.78 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.381 0.672 . . . . 15.0 110.981 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 258' ' ' VAL . 21.1 ptmt -79.23 -18.47 52.82 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 112.147 0.425 . . . . 15.0 112.147 175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -65.58 -24.12 67.0 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 15.0 111.672 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -64.23 -22.77 67.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.283 0.633 . . . . 15.0 111.551 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.5 -1.45 0.73 Allowed Glycine 0 C--N 1.356 1.691 0 CA-C-O 119.845 -0.42 . . . . 15.0 113.853 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 2.9 t -80.82 134.94 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.192 0.597 . . . . 15.0 109.403 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -76.51 -47.68 21.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.7 0.4 . . . . 15.0 111.039 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.69 -36.04 16.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.704 0.288 . . . . 15.0 111.116 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 94.14 22.68 24.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.994 -0.548 . . . . 15.0 113.902 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 29.1 p -70.07 142.56 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 117.532 0.666 . . . . 15.0 110.154 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 253' ' ' ILE . 49.0 t -54.44 -50.91 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 123.746 0.654 . . . . 15.0 109.283 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.72 -27.45 67.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.034 -0.985 . . . . 15.0 111.44 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.91 -21.1 63.98 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.659 0.599 . . . . 15.0 111.634 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 253' ' ' ILE . 55.7 tp -78.35 -42.29 30.96 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -62.15 -39.44 92.61 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.821 -1.081 . . . . 15.0 110.195 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.54 -43.51 80.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.071 0.948 . . . . 15.0 111.045 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -56.59 -56.98 14.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.554 HG11 HD21 ' A' ' 141' ' ' LEU . 17.4 m -76.52 -20.22 14.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.363 -0.835 . . . . 15.0 111.534 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -57.41 -63.13 1.33 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.15 -36.77 82.56 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.0 0.37 . . . . 15.0 112.0 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -72.88 -50.02 26.34 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.383 0.673 . . . . 15.0 111.502 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 66.7 mtt -72.04 -28.19 63.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.394 -0.812 . . . . 15.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 47.1 mt-10 -71.09 -26.12 62.91 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 118.881 0.764 . . . . 15.0 111.539 170.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -70.71 -44.63 66.53 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.492 -0.559 . . . . 15.0 109.492 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -62.39 -45.35 93.53 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.572 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 64.9 tp -61.89 -50.88 70.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.025 -1.443 . . . . 15.0 112.175 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.49 -30.86 71.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.52 0.728 . . . . 15.0 110.688 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.5 t -66.12 -45.92 79.4 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.044 -0.725 . . . . 15.0 109.044 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.3 -35.01 79.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.368 0.667 . . . . 15.0 112.078 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.5 mt -67.03 -45.18 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.775 0.83 . . . . 15.0 109.092 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 23.2 tpt180 -62.05 -46.87 87.22 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.604 -0.725 . . . . 15.0 110.535 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -62.99 -38.5 91.42 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.033 -0.531 . . . . 15.0 110.961 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -56.63 -63.84 1.07 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.66 0.784 . . . . 15.0 110.658 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.05 -46.04 92.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.042 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.1 tttt -64.55 -45.53 86.74 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.844 -0.617 . . . . 15.0 111.105 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.4 p -68.02 -31.9 71.89 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.44 0.296 . . . . 15.0 111.359 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.458 ' HB2' HG13 ' A' ' 125' ' ' VAL . 55.9 mt-30 -73.31 -34.0 65.48 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.354 0.409 . . . . 15.0 111.719 176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.93 62.83 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 110.05 -0.352 . . . . 15.0 110.05 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.95 -42.87 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 125.358 1.463 . . . . 15.0 110.958 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.91 -59.43 4.9 Favored 'General case' 0 C--O 1.246 0.897 0 C-N-CA 124.227 1.011 . . . . 15.0 110.231 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.632 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.52 -32.77 79.66 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.918 -1.037 . . . . 15.0 113.295 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.703 ' HB3' HD13 ' A' ' 350' ' ' LEU . 9.9 mt -59.85 -53.97 51.74 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 15.0 111.0 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.3 -44.73 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.83 -0.433 . . . . 15.0 109.83 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -57.18 -32.78 66.78 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.853 0.861 . . . . 15.0 111.746 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.4 -29.95 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.462 0.705 . . . . 15.0 111.611 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -131.92 123.44 27.44 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.096 0.474 . . . . 15.0 111.903 -162.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.58 148.95 26.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.324 1.05 . . . . 15.0 109.363 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.641 HD13 HD13 ' A' ' 349' ' ' LEU . 14.2 tt -162.87 148.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.514 0.726 . . . . 15.0 110.106 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.85 131.94 42.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.472 HG13 HG11 ' A' ' 345' ' ' VAL . 71.2 t -119.88 126.06 27.07 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.259 0.624 . . . . 15.0 111.153 -165.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.86 136.82 17.11 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.692 2.261 . . . . 15.0 112.475 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -63.55 -15.18 57.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.624 1.17 . . . . 15.0 113.337 -174.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.13 64.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.756 0.822 . . . . 15.0 110.703 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' B' ' 467' ' ' ALA . 71.7 mt -71.45 -38.43 71.32 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 114.121 -1.4 . . . . 15.0 110.442 -175.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 304' ' ' ALA . 55.2 mt -57.28 -50.5 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.233 -1.349 . . . . 15.0 108.516 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.36 -32.35 73.92 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.216 0.948 . . . . 15.0 111.451 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 73.4 m -62.33 -52.88 61.89 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.671 0.389 . . . . 15.0 111.882 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.4 -35.44 79.31 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.561 -0.29 . . . . 15.0 111.124 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.591 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.0 mt -61.65 -38.35 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.416 -0.587 . . . . 15.0 109.416 173.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.469 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 9.1 t70 -64.44 -46.42 83.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.752 0.821 . . . . 15.0 109.423 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.02 -40.77 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 O-C-N 124.155 0.91 . . . . 15.0 110.259 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.55 -19.26 60.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.377 0.671 . . . . 15.0 112.32 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 21.7 mtm180 -81.06 -34.16 32.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.795 0.838 . . . . 15.0 109.811 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 81.4 mtt180 -66.98 -46.79 73.54 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 171.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.49 ' HG3' HD21 ' B' ' 439' ' ' LEU . 34.1 tt0 -56.05 -47.43 77.9 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.27 72.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.157 0.583 . . . . 15.0 110.591 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -59.5 -30.01 68.26 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.831 0.707 . . . . 15.0 111.741 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.14 -37.72 80.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.418 0.687 . . . . 15.0 109.802 174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -23.64 24.34 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.69 0.796 . . . . 15.0 110.356 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 12.5 t80 -100.05 31.84 3.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.032 0.933 . . . . 15.0 111.462 -170.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.89 65.56 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 115.153 0.821 . . . . 15.0 115.153 168.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 65.26 69.11 1.42 Allowed Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.14 0.4 . . . . 15.0 112.918 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 9.6 m120 -72.22 112.01 7.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.486 0.714 . . . . 15.0 110.592 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.99 90.05 0.08 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.376 1.07 . . . . 15.0 110.466 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm 70.29 -10.21 0.69 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.183 1.393 . . . . 15.0 113.001 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.4 tm0? -72.2 -15.9 61.95 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 124.151 0.98 . . . . 15.0 109.545 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.03 -39.2 26.23 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 124.173 0.989 . . . . 15.0 111.432 174.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.67 -28.1 68.34 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.08 0.952 . . . . 15.0 111.811 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.75 -16.17 45.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.678 0.791 . . . . 15.0 112.001 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 67.2 mt -53.06 125.89 42.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.812 0.445 . . . . 15.0 111.973 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.484 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 84.0 Cg_exo -46.48 120.24 3.73 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.659 3.572 . . . . 15.0 115.453 -166.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.591 ' HG3' HD13 ' A' ' 311' ' ' ILE . 68.6 ttt180 -55.93 -37.04 68.41 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.922 0.889 . . . . 15.0 112.061 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -63.38 -17.31 62.48 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.319 0.648 . . . . 15.0 112.465 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 89.1 mt -73.51 -32.27 64.17 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.368 0.604 . . . . 15.0 110.34 174.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.491 ' HA ' HE21 ' A' ' 340' ' ' GLN . 22.7 m-85 -115.62 -6.07 12.19 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.431 -0.804 . . . . 15.0 111.971 -170.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -47.19 -71.79 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.222 1.409 . . . . 15.0 113.166 -173.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.54 -51.74 68.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.625 0.77 . . . . 15.0 111.686 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.491 HE21 ' HA ' ' A' ' 337' ' ' PHE . 20.9 pt20 -61.72 -45.93 91.81 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.774 0.671 . . . . 15.0 112.043 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -68.3 -49.97 56.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.484 . . . . 15.0 110.346 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.19 -34.88 64.26 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.572 0.749 . . . . 15.0 111.027 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -70.95 -35.29 72.13 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.239 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -66.93 -28.65 68.47 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.158 0.286 . . . . 15.0 110.266 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 302' ' ' VAL . 46.2 t -69.6 -47.55 70.81 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.228 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 67.4 t -51.81 -48.44 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.613 -0.884 . . . . 15.0 108.613 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.73 -43.14 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.201 1.001 . . . . 15.0 111.741 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.91 -34.77 90.82 Favored Glycine 0 N--CA 1.472 1.083 0 O-C-N 123.233 0.333 . . . . 15.0 112.851 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.641 HD13 HD13 ' A' ' 300' ' ' ILE . 65.8 mt -76.46 -38.77 54.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.657 0.783 . . . . 15.0 109.764 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.703 HD13 ' HB3' ' A' ' 294' ' ' LEU . 81.3 mt -62.14 -62.05 2.04 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.451 1.101 . . . . 15.0 110.555 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.96 -30.77 71.83 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.26 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.63 95.74 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.866 0.729 . . . . 15.0 111.996 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.13 -34.17 77.44 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.109 -0.545 . . . . 15.0 110.766 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.0 t -67.06 -40.86 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.632 0.373 . . . . 15.0 110.484 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.21 -38.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.599 0.759 . . . . 15.0 110.055 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -70.28 -53.94 14.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.16 0.288 . . . . 15.0 111.518 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -61.45 -35.08 76.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.042 0.937 . . . . 15.0 111.836 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -102.13 10.52 39.38 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 118.962 -0.542 . . . . 15.0 111.348 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 36.83 40.17 0.13 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 126.489 1.916 . . . . 15.0 114.495 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.0 mt -65.84 133.36 50.78 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.316 1.046 . . . . 15.0 112.24 -170.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -109.28 142.21 40.49 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.751 0.82 . . . . 15.0 109.785 176.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -69.55 115.36 8.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.752 0.421 . . . . 15.0 110.35 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.23 127.94 34.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 15.0 111.408 -171.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.45 -34.38 76.69 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.306 1.042 . . . . 15.0 113.481 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -71.77 -26.64 62.52 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.108 0.255 . . . . 15.0 110.641 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -76.16 -44.95 35.84 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.017 -0.734 . . . . 15.0 109.017 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 398' ' ' MET . 60.9 t -52.28 -56.0 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.407 1.083 . . . . 15.0 110.341 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.7 -40.37 92.2 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.122 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.17 -40.78 97.7 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.621 0.575 . . . . 15.0 113.336 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 73.6 mt -61.73 -51.7 67.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.686 0.794 . . . . 15.0 109.549 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' A' ' 398' ' ' MET . 34.5 mm -47.54 -56.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.589 1.181 . . . . 15.0 111.216 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.21 -61.32 2.55 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.459 -0.791 . . . . 15.0 111.637 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.12 -24.5 61.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.151 0.797 . . . . 15.0 113.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -78.03 -46.96 19.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.639 0.654 . . . . 15.0 109.304 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -69.48 -32.35 71.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.828 0.451 . . . . 15.0 111.292 -173.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.8 t -63.88 -18.26 64.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.561 0.745 . . . . 15.0 112.214 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.91 66.74 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.289 0.636 . . . . 15.0 111.3 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -97.9 -175.02 3.03 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.696 -0.684 . . . . 15.0 111.01 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.94 -56.19 24.04 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.974 0.91 . . . . 15.0 111.517 -168.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -131.15 116.09 16.59 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.442 -0.799 . . . . 15.0 109.494 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 22.2 Cg_exo -68.23 -37.81 13.4 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.649 2.232 . . . . 15.0 113.227 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -54.82 -48.04 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.301 1.041 . . . . 15.0 111.873 -164.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.23 -28.2 68.55 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.57 -1.195 . . . . 15.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.33 -41.4 30.07 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 C-N-CA 123.573 0.749 . . . . 15.0 109.541 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.67 -48.05 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.28 -33.39 65.2 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.302 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -70.4 -24.32 62.91 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.3 0.64 . . . . 15.0 111.068 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.455 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 23.7 m-85 -92.68 -56.14 3.12 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.299 -0.41 . . . . 15.0 111.053 170.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . 0.662 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -58.66 -43.64 89.93 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 112.526 0.565 . . . . 15.0 112.526 -170.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -87.22 3.83 44.97 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.348 0.659 . . . . 15.0 111.963 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -129.44 90.75 3.05 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.547 -0.908 . . . . 15.0 108.547 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -54.22 -34.57 60.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.388 1.075 . . . . 15.0 112.16 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.2 -43.58 82.86 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.806 0.842 . . . . 15.0 110.841 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.81 -24.34 17.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.74 0.816 . . . . 15.0 111.291 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.9 OUTLIER -62.94 -37.25 86.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.79 0.836 . . . . 15.0 109.741 176.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.63 -44.4 94.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 114.496 -1.229 . . . . 15.0 109.843 173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.95 -32.05 69.27 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.212 0.605 . . . . 15.0 111.427 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 367' ' ' VAL . 31.5 tpp -69.7 -31.24 69.15 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.441 0.463 . . . . 15.0 111.774 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -67.66 -38.76 84.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 110.135 -0.32 . . . . 15.0 110.135 168.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 400' ' ' ASN . 0.8 OUTLIER -65.52 -48.1 73.67 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.562 0.745 . . . . 15.0 111.408 -176.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 405' ' ' GLU . 8.3 p -67.49 -37.86 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 123.634 0.584 . . . . 15.0 110.174 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.01 85.34 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.69 0.757 . . . . 15.0 110.502 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 16.7 tp -68.57 -32.76 72.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.076 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.9 tt0 -67.2 -38.1 84.75 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.867 0.467 . . . . 15.0 110.028 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 401' ' ' VAL . 60.9 mm-40 -62.7 -41.51 99.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.845 0.458 . . . . 15.0 110.019 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -66.74 -39.0 87.78 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.051 -0.977 . . . . 15.0 111.734 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.02 -42.23 99.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.849 0.718 . . . . 15.0 110.327 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.436 HG21 ' HG3' ' A' ' 287' ' ' LYS . 64.4 t -59.36 -54.04 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.137 -0.938 . . . . 15.0 109.548 173.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.407 ' HA ' HD12 ' A' ' 412' ' ' LEU . 80.0 mt-10 -62.01 -28.07 69.32 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.459 0.704 . . . . 15.0 112.88 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.44 71.87 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.793 0.437 . . . . 15.0 110.297 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.85 -32.54 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.223 -0.658 . . . . 15.0 109.223 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 409' ' ' GLU . 93.4 mt -63.28 -43.77 96.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.33 0.652 . . . . 15.0 110.65 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.88 -25.63 65.24 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.599 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 26.1 mtpp -94.85 -22.4 18.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.408 1.083 . . . . 15.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.47 13.18 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.075 0.95 . . . . 15.0 113.211 -171.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 122' ' ' ALA . 85.7 mttt -77.74 77.3 4.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.402 1.081 . . . . 15.0 109.459 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 125' ' ' VAL . 38.1 t -91.62 91.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.3 t -71.01 95.37 1.18 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 122.298 1.047 . . . . 15.0 110.448 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.87 117.32 19.86 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.245 -1.343 . . . . 15.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -122.58 157.52 31.95 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.942 0.897 . . . . 15.0 109.064 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -113.39 117.57 32.13 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.024 -0.732 . . . . 15.0 109.024 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -143.95 176.36 9.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.523 0.329 . . . . 15.0 110.611 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.8 p -101.03 159.83 14.89 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.268 1.027 . . . . 15.0 111.128 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.76 -31.57 69.77 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.979 1.311 . . . . 15.0 110.976 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.577 ' HA ' HD22 ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.96 -9.2 27.76 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.363 -0.835 . . . . 15.0 112.299 178.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.91 -73.34 0.57 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 170.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 35.3 tp -36.99 -59.15 0.73 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 125.323 1.449 . . . . 15.0 114.871 -158.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.17 -35.18 13.99 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.07 0.548 . . . . 15.0 110.819 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.577 HD22 ' HA ' ' A' ' 425' ' ' ASN . 73.0 m-20 -85.36 39.26 0.77 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.474 0.71 . . . . 15.0 111.85 -171.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -80.54 18.4 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.521 0.729 . . . . 15.0 112.441 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.56 -40.43 94.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.844 0.858 . . . . 15.0 110.795 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.018 0 N-CA-C 108.372 -0.973 . . . . 15.0 108.372 175.322 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.07 -161.57 0.86 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -32.43 -63.03 0.21 Allowed 'General case' 0 C--N 1.369 1.449 0 C-N-CA 126.238 1.815 . . . . 0.0 112.587 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.511 ' HB3' ' HA ' ' B' ' 373' ' ' ARG . 10.3 t70 -106.08 -82.55 0.53 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 119.644 -0.217 . . . . 0.0 110.44 170.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.09 -79.78 0.55 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.891 0.476 . . . . 0.0 111.544 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 374' ' ' ALA . . . -107.46 -61.29 1.58 Allowed 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.461 -165.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.13 -84.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 122.309 -0.244 . . . . 0.0 110.699 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -97.91 -73.86 0.6 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.511 ' HA ' ' HB3' ' B' ' 368' ' ' ASP . 36.4 mmt180 -101.63 -82.56 0.47 Allowed 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 168.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' B' ' 370' ' ' ALA . . . -99.11 -72.29 0.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 167.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 53.4 tp -97.86 -78.51 0.48 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -105.1 -70.13 0.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -100.87 -80.97 0.48 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.5 -77.83 0.52 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -107.42 -85.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 175.44 132.17 0.04 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.486 1.515 . . . . 0.0 107.702 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 73.46 143.17 0.07 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.233 1.413 . . . . 0.0 112.488 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -158.34 -16.37 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.786 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.36 -31.47 37.88 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.694 0.798 . . . . 0.0 110.084 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 16.5 m -109.31 154.14 22.9 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.252 1.021 . . . . 0.0 109.074 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.7 mp -86.91 163.39 17.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.554 0.741 . . . . 0.0 111.014 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.32 130.56 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.124 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.43 ' HA ' ' CE2' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -140.5 162.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.222 1.409 . . . . 0.0 109.077 169.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 177' ' ' PHE . 97.3 t -53.84 114.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.081 0.952 . . . . 0.0 112.405 -163.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 56.9 m -145.01 144.77 31.19 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.784 1.234 . . . . 0.0 108.434 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.77 55.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.216 0.606 . . . . 0.0 110.098 172.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.44 86.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.58 0.705 . . . . 0.0 110.929 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 48.27 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.008 1.723 . . . . 0.0 111.67 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -164.54 89.06 0.51 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -60.05 -44.01 94.98 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.024 0.93 . . . . 0.0 110.771 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 62.84 -72.26 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.81 1.644 . . . . 0.0 113.014 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 24.5 m -62.41 97.45 0.09 Allowed 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.713 1.205 . . . . 0.0 110.288 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -163.86 150.19 11.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 108.194 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 77.9 mt 65.52 119.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.48 1.112 . . . . 0.0 110.791 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 96.8 t 73.84 -53.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 125.304 1.441 . . . . 0.0 110.066 -172.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -84.73 110.2 25.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 165.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.48 -29.59 61.96 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.871 2.381 . . . . 0.0 113.091 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 31.6 t70 62.69 97.99 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.048 1.339 . . . . 0.0 110.064 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 24.2 m -124.83 106.62 10.17 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -149.55 162.96 39.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -94.52 121.49 63.17 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.151 0.98 . . . . 0.0 109.112 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.85 -21.32 71.98 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.36 2.707 . . . . 0.0 113.39 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.72 -134.03 1.66 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.613 HD22 HD21 ' B' ' 413' ' ' ASN . 4.2 tt -74.4 -67.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 27.9 m -147.7 100.59 3.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 65.87 -87.26 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.803 1.241 . . . . 0.0 110.868 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -172.48 127.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.127 0.971 . . . . 0.0 109.613 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 69.8 mt 52.31 38.2 24.29 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.057 1.343 . . . . 0.0 112.476 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . 0.613 HD21 HD22 ' B' ' 408' ' ' LEU . 19.6 p-10 -66.37 -39.17 88.96 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.296 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 34.0 p -81.88 64.67 6.68 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.153 0.981 . . . . 0.0 109.176 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -83.32 98.79 9.63 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.851 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.32 -44.77 92.55 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.541 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 178.71 -147.7 7.97 Favored Glycine 0 C--O 1.241 0.573 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.883 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.47 77.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 88.9 t 71.32 -65.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.927 1.691 . . . . 0.0 111.388 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 15.3 ptp 58.04 -177.18 0.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.636 1.974 . . . . 0.0 113.256 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 184' ' ' ASP . 31.1 m -63.77 151.96 8.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-O 121.251 0.548 . . . . 0.0 110.277 172.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 45.0 ttm -88.17 24.5 1.84 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.622 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 14.3 m 61.42 -162.01 0.28 Allowed 'General case' 0 C--N 1.367 1.335 0 C-N-CA 124.979 1.312 . . . . 0.0 109.952 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 64.56 -153.28 0.29 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.554 0.742 . . . . 0.0 109.96 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 84.9 65.35 1.49 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -59.03 90.46 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.493 1.117 . . . . 0.0 112.232 -173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.608 ' H ' ' HZ2' ' A' ' 151' ' ' TRP . 31.8 p -78.17 86.19 4.32 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.236 1.014 . . . . 0.0 110.549 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 22.91 12.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.489 1.116 . . . . 0.0 109.633 172.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.1 -29.39 70.25 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.948 0.899 . . . . 0.0 111.563 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -75.28 -16.12 60.46 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.201 0.6 . . . . 0.0 111.941 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 34.5 m -71.28 -28.48 64.17 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.804 0.442 . . . . 0.0 110.689 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.82 -47.01 70.25 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.747 0.819 . . . . 0.0 110.126 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' B' ' 434' ' ' HIS . 1.4 tm-20 60.32 -100.64 0.1 Allowed 'General case' 0 CA--C 1.562 1.43 0 O-C-N 124.725 1.266 . . . . 0.0 108.332 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . 0.412 ' H ' ' HB3' ' B' ' 433' ' ' GLU . 24.2 p80 178.4 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.704 1.602 . . . . 0.0 108.423 169.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 1.7 t 52.45 -179.66 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 127.267 2.227 . . . . 0.0 113.639 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -112.94 106.03 1.77 Allowed Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 19.0 m -62.25 137.8 58.32 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.458 0.703 . . . . 0.0 111.484 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.76 166.45 20.04 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.624 0.769 . . . . 0.0 109.998 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.49 HD21 ' HG3' ' A' ' 317' ' ' GLN . 3.3 mm? -95.45 18.61 12.32 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.727 0.811 . . . . 0.0 109.589 172.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 78.3 -33.67 0.17 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 126.489 1.915 . . . . 0.0 111.912 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 2.8 pt -148.38 172.18 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.163 1.385 . . . . 0.0 108.501 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.83 -70.24 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 57.04 11.93 1.11 Allowed 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.26 151.1 45.7 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.36 0.664 . . . . 0.0 110.412 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 127.81 -36.72 2.47 Favored Glycine 0 CA--C 1.55 2.248 0 CA-C-O 117.3 -1.833 . . . . 0.0 117.266 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.09 82.1 2.27 Favored 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.693 3.247 . . . . 0.0 112.12 -166.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -101.26 100.0 10.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 81.69 -46.16 0.2 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 126.015 1.726 . . . . 0.0 111.854 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -162.2 -172.02 3.05 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.34 1.056 . . . . 0.0 110.482 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.36 1.01 20.2 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.629 0.372 . . . . 0.0 111.56 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.3 t 68.75 83.79 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 124.693 1.197 . . . . 0.0 109.913 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 11.0 m -90.76 84.23 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.4 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -156.22 65.59 0.31 Allowed Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.724 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' B' ' 462' ' ' TYR . 55.6 tp -65.06 91.07 0.09 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.428 1.091 . . . . 0.0 109.345 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.1 p 53.81 60.98 3.31 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.175 1.39 . . . . 0.0 111.099 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.52 -75.16 0.44 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.118 -169.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -94.97 -7.04 41.02 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.989 0.516 . . . . 0.0 111.993 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 8.9 t -164.3 155.98 16.13 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.016 0.927 . . . . 0.0 109.242 168.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -106.47 136.58 45.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.379 0.671 . . . . 0.0 110.836 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 21.21 0.99 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.471 1.108 . . . . 0.0 109.996 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 35.9 t80 58.57 103.31 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.583 1.553 . . . . 0.0 109.435 -171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . 0.428 ' HA ' HD12 ' B' ' 454' ' ' LEU . 35.9 t80 65.22 -172.44 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.2 m -141.15 104.47 4.64 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.94 21.34 4.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.922 0.889 . . . . 0.0 111.368 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 70.4 -175.54 0.19 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.974 1.31 . . . . 0.0 111.168 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 68.87 -61.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.074 1.35 . . . . 0.0 110.107 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.489 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . -95.53 123.98 39.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.29 1.036 . . . . 0.0 108.505 163.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.6 155.1 16.89 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.308 0.643 . . . . 0.0 109.74 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -137.96 39.76 1.56 Allowed Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.256 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.74 166.09 32.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.041 0.448 . . . . 0.0 111.639 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 17.8 pttm . . . . . 0 C--O 1.252 1.216 0 CA-C-N 114.879 -1.055 . . . . 12.06 109.018 168.398 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.025 0.44 . . . . 15.0 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -146.68 146.99 30.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.588 -0.893 . . . . 15.0 108.588 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.502 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -137.55 148.72 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.942 0.897 . . . . 15.0 109.467 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.463 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 55.6 p -126.2 101.16 6.63 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 172.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.96 77.21 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 122.682 1.229 . . . . 15.0 110.569 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 46.3 mt-10 -75.77 173.45 11.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.662 -1.154 . . . . 15.0 109.758 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 77.6 m -143.49 112.8 6.82 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.392 -0.966 . . . . 15.0 108.392 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -78.39 -41.3 33.56 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.431 0.693 . . . . 15.0 110.562 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -164.04 84.46 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.822 0.849 . . . . 15.0 109.512 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.77 -94.76 0.07 OUTLIER Glycine 0 C--N 1.354 1.531 0 O-C-N 123.825 0.703 . . . . 15.0 113.671 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' HA ' HG22 ' A' ' 111' ' ' VAL . 7.6 mp -62.07 -50.21 72.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.526 1.13 . . . . 15.0 110.602 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.8 86.5 0.21 Allowed Glycine 0 C--N 1.346 1.113 0 O-C-N 124.195 0.934 . . . . 15.0 112.11 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 98.7 mtt180 -99.78 134.04 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.293 1.037 . . . . 15.0 110.378 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.5 ttm180 -103.01 88.27 3.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.282 1.033 . . . . 15.0 110.737 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -81.57 91.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.185 -1.043 . . . . 15.0 108.185 172.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 87.3 m -75.98 100.41 4.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.853 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.502 HG12 HG12 ' A' ' 3' ' ' VAL . 51.6 mt -87.98 109.38 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.97 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -84.95 94.24 8.74 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.995 -0.743 . . . . 15.0 108.995 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 70' ' ' LEU . 43.4 mt -73.32 106.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.963 -1.125 . . . . 15.0 107.963 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 150.79 44.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 122.556 0.342 . . . . 15.0 111.315 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.51 -16.88 58.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.603 1.161 . . . . 15.0 114.096 -169.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -64.71 -44.84 88.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.225 0.61 . . . . 15.0 110.429 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.4 m -75.13 -36.79 61.57 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 115.44 -0.8 . . . . 15.0 110.776 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 103' ' ' PHE . 57.9 mt -62.39 -50.58 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.702 0.626 . . . . 15.0 109.881 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -57.53 -50.49 72.92 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.067 0.947 . . . . 15.0 111.098 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.5 m -65.4 -37.77 87.97 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.218 -0.901 . . . . 15.0 111.742 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.28 63.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.123 0.569 . . . . 15.0 112.128 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.794 HG21 ' HD3' ' A' ' 63' ' ' ARG . 93.7 t -65.32 -41.63 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -65.52 -34.99 79.54 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.509 1.124 . . . . 15.0 110.759 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 m -65.62 -39.08 91.1 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.55 0.74 . . . . 15.0 110.05 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -74.82 -25.77 59.26 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.524 0.515 . . . . 15.0 111.387 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD11 ' HA3' ' A' ' 59' ' ' GLY . 94.0 mt -73.09 -38.76 66.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.808 0.443 . . . . 15.0 110.983 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.45 -19.6 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 O-C-N 123.158 0.286 . . . . 15.0 110.329 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.18 -57.7 8.74 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 167.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.11 -38.53 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.198 0.999 . . . . 15.0 111.365 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.191 0.596 . . . . 15.0 110.559 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.17 -26.68 35.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.814 0.446 . . . . 15.0 112.095 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -77.32 -35.17 55.06 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.711 1.204 . . . . 15.0 110.935 -173.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 t -100.64 5.44 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.788 0.835 . . . . 15.0 109.531 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 65.66 22.39 11.64 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.838 1.655 . . . . 15.0 112.601 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 44' ' ' PHE . 54.0 mt -78.24 -19.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.448 1.099 . . . . 15.0 111.261 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.26 -30.2 71.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.682 0.793 . . . . 15.0 112.061 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.19 -23.76 73.21 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.59 0.556 . . . . 15.0 112.844 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 88.9 m-85 -83.68 -24.0 31.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.462 0.705 . . . . 15.0 110.78 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -79.53 88.47 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -92.14 50.06 1.6 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.589 0.755 . . . . 15.0 110.384 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.3 67.68 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.633 -0.712 . . . . 15.0 113.129 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -73.25 -58.79 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.633 0.773 . . . . 15.0 110.147 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.4 t -101.11 122.11 49.7 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.846 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 53' ' ' ILE . 73.6 Cg_exo -53.54 138.92 66.74 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.063 2.509 . . . . 15.0 112.409 167.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.8 tpt -70.48 -25.26 63.08 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.817 0.847 . . . . 15.0 112.078 -171.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -70.63 -28.79 65.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.549 0.34 . . . . 15.0 111.163 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.491 HD12 ' HD2' ' A' ' 50' ' ' PRO . 33.9 mt -65.44 -53.02 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.744 0.817 . . . . 15.0 110.241 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 30.1 m -69.1 -16.98 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 111.92 0.341 . . . . 15.0 111.92 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -73.65 -65.58 0.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.513 0.725 . . . . 15.0 112.0 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -73.97 -33.79 64.0 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.672 -0.695 . . . . 15.0 111.93 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -87.49 -73.97 0.46 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.798 0.439 . . . . 15.0 110.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 96.5 m-85 -72.52 -28.1 62.65 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.044 0.537 . . . . 15.0 111.814 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -86.17 10.2 67.0 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.733 -0.481 . . . . 15.0 113.607 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.81 -23.47 66.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 15.0 111.896 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 p -84.04 -36.37 23.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.185 0.994 . . . . 15.0 111.059 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.84 -18.78 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.306 1.042 . . . . 15.0 111.218 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.794 ' HD3' HG21 ' A' ' 28' ' ' VAL . 20.9 mmt180 -49.88 -42.67 48.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.42 1.088 . . . . 15.0 111.917 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -49.32 -57.58 6.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.882 1.273 . . . . 15.0 112.317 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.72 -33.39 53.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.638 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG21 ' HA ' ' A' ' 28' ' ' VAL . 66.6 t -68.07 -28.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.2 mt -56.49 -41.95 77.5 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.56 0.344 . . . . 15.0 110.75 173.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.18 -46.74 93.87 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.793 0.683 . . . . 15.0 112.72 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -61.55 -38.94 89.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.306 1.042 . . . . 15.0 111.583 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.666 ' HB3' HD13 ' A' ' 19' ' ' ILE . 57.3 mt -65.46 -41.58 93.21 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.93 0.892 . . . . 15.0 110.651 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 64.5 mtm -64.0 -38.38 90.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.083 0.553 . . . . 15.0 110.682 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -64.76 -52.7 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.408 -0.815 . . . . 15.0 110.976 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 mtm105 -74.91 -30.69 61.35 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.639 -0.71 . . . . 15.0 112.575 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.49 -32.88 54.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.605 0.362 . . . . 15.0 110.513 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.78 -51.39 27.3 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.282 0.364 . . . . 15.0 110.95 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -64.45 -33.34 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 123.272 0.357 . . . . 15.0 110.261 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -61.06 -44.84 96.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.579 0.751 . . . . 15.0 110.428 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.18 -53.03 55.71 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.698 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 pt -65.4 -22.19 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -74.94 -51.83 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 15.0 110.196 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -75.4 -25.32 57.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.695 0.398 . . . . 15.0 111.881 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -89.45 -21.57 22.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.29 0.636 . . . . 15.0 110.544 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 62.96 19.74 11.8 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.707 1.203 . . . . 15.0 112.01 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.6 mt -104.49 85.3 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.519 -0.919 . . . . 15.0 108.519 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.74 141.66 41.64 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.015 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.78 128.35 18.76 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.682 2.255 . . . . 15.0 112.211 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.63 72.83 4.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.414 0.686 . . . . 15.0 109.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 120.6 -98.67 0.69 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.534 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.46 138.18 31.86 Favored Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 123.289 0.636 . . . . 15.0 112.248 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -95.09 132.03 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.784 2.989 . . . . 15.0 113.27 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -96.38 105.73 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.453 -0.573 . . . . 15.0 109.453 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.405 ' HD2' ' HE2' ' A' ' 105' ' ' TYR . 68.1 m-85 -83.45 118.19 23.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.49 90.8 4.32 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.017 0.927 . . . . 15.0 108.594 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.5 119.8 5.65 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.77 2.314 . . . . 15.0 112.44 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.38 -80.21 0.31 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.636 -0.585 . . . . 15.0 111.636 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.42 170.43 8.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.695 0.798 . . . . 15.0 110.332 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -136.35 136.12 39.41 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.273 1.029 . . . . 15.0 109.255 174.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -115.5 137.17 52.34 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.437 -1.32 . . . . 15.0 107.437 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.5 tp -57.22 113.63 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.759 0.824 . . . . 15.0 111.132 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.38 18.53 60.34 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.788 0.68 . . . . 15.0 113.184 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 102' ' ' ASP . 28.1 tt0 -126.58 166.77 16.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.59 0.756 . . . . 15.0 109.382 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 2.9 m-20 -73.02 133.04 44.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.212 1.005 . . . . 15.0 110.703 -176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.492 ' H ' HD11 ' A' ' 24' ' ' ILE . 39.5 t80 -83.52 143.6 30.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.431 0.693 . . . . 15.0 109.398 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.5 m -140.45 135.76 32.32 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.132 0.573 . . . . 15.0 109.645 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.405 ' HE2' ' HD2' ' A' ' 92' ' ' TYR . 8.2 p90 -157.04 156.57 33.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.013 0.925 . . . . 15.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 55.1 m -111.37 108.93 18.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.473 1.109 . . . . 15.0 111.192 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.1 t -89.28 97.88 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.41 99.84 12.72 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.648 0.779 . . . . 15.0 109.46 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.55 149.19 45.56 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 15.0 110.663 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.92 140.58 30.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.711 0.804 . . . . 15.0 109.302 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.665 HG22 ' HA ' ' A' ' 11' ' ' LEU . 15.5 m -109.72 179.42 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.236 0.614 . . . . 15.0 110.728 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.84 113.28 31.29 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.86 0.864 . . . . 15.0 110.034 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.673 ' HB2' HD11 ' A' ' 300' ' ' ILE . 84.2 Cg_endo -82.68 115.62 2.48 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.345 2.03 . . . . 15.0 112.887 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -71.32 89.1 0.88 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.216 1.006 . . . . 15.0 109.064 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.2 131.0 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.219 -168.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -80.12 109.75 14.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.869 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.19 147.9 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.996 0.81 . . . . 15.0 110.465 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.54 158.69 21.07 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.965 0.906 . . . . 15.0 109.739 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 68.28 22.6 74.67 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.629 -0.714 . . . . 15.0 113.843 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.3 mt -68.06 -45.49 73.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.58 1.152 . . . . 15.0 110.673 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.07 -27.87 63.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.647 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.09 -17.55 60.93 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.879 0.472 . . . . 15.0 111.803 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 119' ' ' GLY . 57.4 mt -64.78 120.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.638 0.375 . . . . 15.0 110.332 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.22 109.18 21.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.604 -0.887 . . . . 15.0 108.604 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.0 t -110.7 150.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -87.31 109.44 25.68 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.205 1.002 . . . . 15.0 109.729 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HG3' ' HG2' ' A' ' 285' ' ' ARG . 68.6 Cg_endo -92.44 104.62 0.2 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.492 2.128 . . . . 15.0 112.282 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.44 HD11 ' HE2' ' A' ' 127' ' ' LYS . 50.2 mm -70.44 89.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 422' ' ' THR . 41.4 t -108.81 135.28 48.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.677 -1.147 . . . . 15.0 109.467 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -122.9 154.54 38.2 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.409 -1.33 . . . . 15.0 107.409 160.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.468 HG23 HD22 ' A' ' 278' ' ' LEU . 34.9 t -81.42 84.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 107.591 -1.263 . . . . 15.0 107.591 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.6 p -63.25 176.39 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.139 0.976 . . . . 15.0 110.744 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.18 -40.21 76.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.065 0.459 . . . . 15.0 111.086 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.98 98.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.178 -0.919 . . . . 15.0 110.975 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -74.0 -39.83 63.35 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.009 0.524 . . . . 15.0 111.721 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 t -60.29 -62.54 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.103 0 C-N-CA 124.546 1.138 . . . . 15.0 108.734 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.99 -27.28 43.35 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 114.13 -1.396 . . . . 15.0 110.693 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.96 -36.13 47.83 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.749 0.656 . . . . 15.0 113.414 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -71.74 -47.42 53.88 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.008 -0.367 . . . . 15.0 110.008 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.605 HD21 HG11 ' A' ' 270' ' ' VAL . 57.1 mt -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.944 0.498 . . . . 15.0 111.915 167.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.38 -45.32 93.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.152 0.981 . . . . 15.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 89.1 m -63.5 -40.17 96.36 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.029 0.83 . . . . 15.0 110.917 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.23 -42.84 99.68 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.39 0.676 . . . . 15.0 110.938 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.661 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 74.2 mtp180 -68.62 -29.31 67.79 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.453 -0.794 . . . . 15.0 110.607 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.1 mttt -80.94 -15.61 55.78 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.103 0.561 . . . . 15.0 111.937 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -83.34 -31.12 26.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.69 0.396 . . . . 15.0 110.219 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -104.35 34.58 3.03 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.723 0.809 . . . . 15.0 110.616 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -78.1 156.34 30.02 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.734 1.383 . . . . 15.0 114.734 -166.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.8 m -92.39 128.69 38.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.292 -1.322 . . . . 15.0 108.784 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -84.71 108.32 17.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -123.75 126.49 46.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.277 1.031 . . . . 15.0 110.047 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 74.4 mt-10 -75.72 117.67 17.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.455 -0.572 . . . . 15.0 109.455 170.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.684 ' HG3' HG12 ' A' ' 240' ' ' VAL . 36.8 pttt -104.61 178.86 4.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.494 0.718 . . . . 15.0 110.735 173.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -136.65 141.74 43.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.685 0.794 . . . . 15.0 109.335 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.17 -51.06 0.8 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.483 -0.621 . . . . 15.0 113.845 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 146.91 24.1 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.82 0.81 . . . . 15.0 112.479 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.409 HG22 HG13 ' A' ' 240' ' ' VAL . 43.0 t -105.29 155.49 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.668 1.187 . . . . 15.0 108.408 168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 160' ' ' ALA . 16.8 tt0 -148.5 -175.15 4.81 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.855 0.862 . . . . 15.0 109.043 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.5 ' H ' ' HG2' ' A' ' 159' ' ' GLU . . . -73.19 -25.54 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.809 1.411 . . . . 15.0 114.809 -164.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -111.22 26.01 11.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.206 0.602 . . . . 15.0 110.984 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.5 -165.52 1.24 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.664 0.745 . . . . 15.0 112.753 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' A' ' 188' ' ' ALA . 0.3 OUTLIER -139.23 135.18 33.65 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.796 -1.927 . . . . 15.0 105.796 -176.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.28 156.23 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.6 m -129.14 126.51 39.45 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.593 -1.262 . . . . 15.0 107.593 161.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.654 HG22 HD23 ' A' ' 237' ' ' LEU . 28.3 pt -125.05 176.33 6.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.342 1.057 . . . . 15.0 110.791 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.68 122.65 12.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.373 -1.714 . . . . 15.0 106.373 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' B' ' 385' ' ' LEU . 29.3 p90 -140.6 160.81 39.21 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.68 0.752 . . . . 15.0 112.667 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.6 t -141.28 115.73 9.5 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.853 -1.521 . . . . 15.0 108.435 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 233' ' ' PHE . . . -89.17 161.93 30.61 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.015 -0.539 . . . . 15.0 113.425 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 m -151.28 127.97 10.86 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.066 0.947 . . . . 15.0 108.593 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 231' ' ' ALA . 58.0 t -107.81 134.31 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.618 0.767 . . . . 15.0 109.207 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 t70 70.53 3.81 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.202 1.001 . . . . 15.0 112.569 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.27 -3.0 16.27 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.522 -0.599 . . . . 15.0 114.002 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.13 166.59 24.95 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.43 0.692 . . . . 15.0 109.665 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -62.33 175.26 0.77 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 121.704 0.764 . . . . 15.0 111.477 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.632 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 1.7 p90 -149.82 170.35 18.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.103 0.961 . . . . 15.0 109.142 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' B' ' 388' ' ' VAL . 1.9 pm0 -59.72 116.62 4.19 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.929 0.768 . . . . 15.0 109.42 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.89 80.59 0.68 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 109.354 -1.498 . . . . 15.0 109.354 -163.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -102.81 -15.75 23.59 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.166 -0.797 . . . . 15.0 113.492 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -140.65 146.81 38.39 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 117.925 0.862 . . . . 15.0 112.335 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.15 93.35 2.43 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.448 -1.316 . . . . 15.0 107.448 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 31.8 m -81.98 138.85 34.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.825 -1.079 . . . . 15.0 110.944 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 62.64 22.55 13.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.07 0.948 . . . . 15.0 113.061 167.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD2' HD11 ' B' ' 385' ' ' LEU . 83.6 t80 -66.22 138.99 58.07 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.588 0.232 . . . . 15.0 110.863 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.35 109.89 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.952 0.901 . . . . 15.0 109.754 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 202' ' ' ILE . 26.4 tp -93.58 90.33 6.61 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.404 0.682 . . . . 15.0 111.347 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.428 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -83.57 92.87 7.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.406 ' HG2' ' HG ' ' A' ' 187' ' ' LEU . 17.7 mtp -54.57 128.62 33.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.591 0.756 . . . . 15.0 112.311 -168.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.63 -26.94 5.33 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 -165.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.73 129.13 37.29 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.487 0.715 . . . . 15.0 109.744 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.2 72.47 0.23 Allowed Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.483 0.489 . . . . 15.0 112.571 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' B' ' 384' ' ' THR . 23.6 mtm180 -125.99 22.22 7.38 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.266 0.627 . . . . 15.0 111.279 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.561 ' HB3' HD23 ' B' ' 385' ' ' LEU . 1.6 pmm? -140.77 171.35 14.21 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.467 0.707 . . . . 15.0 109.973 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 39.3 pt -100.69 157.28 34.01 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.784 0.834 . . . . 15.0 110.239 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.33 147.1 86.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.676 2.25 . . . . 15.0 112.229 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.78 -46.87 1.45 Allowed Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.4 -0.68 . . . . 15.0 111.4 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -63.63 -51.82 63.52 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.18 -41.97 80.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.618 -1.173 . . . . 15.0 111.662 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.32 -33.08 75.12 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.307 1.043 . . . . 15.0 110.873 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.41 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -78.35 -13.73 82.95 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.268 -0.878 . . . . 15.0 113.286 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.461 HG21 HD23 ' A' ' 187' ' ' LEU . 34.3 mm -90.39 -51.59 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.282 -0.636 . . . . 15.0 109.282 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -84.52 21.48 1.47 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.774 -166.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.44 32.34 2.07 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.24 -0.744 . . . . 15.0 111.24 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -147.12 -174.24 4.45 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.2 1.0 . . . . 15.0 110.329 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 21.5 pttp -146.69 159.85 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.726 0.81 . . . . 15.0 110.349 -174.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -67.54 152.51 45.53 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.452 0.569 . . . . 15.0 112.287 -171.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.65 -41.29 2.17 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.56 -0.745 . . . . 15.0 111.766 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.2 pt-20 -76.61 114.18 15.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.797 0.808 . . . . 15.0 108.937 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -97.96 104.2 16.21 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.004 -1.48 . . . . 15.0 107.004 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.02 -169.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.42 1.088 . . . . 15.0 109.295 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.6 t -133.28 141.46 48.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 108.23 -1.026 . . . . 15.0 108.23 168.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 47.0 pt -104.71 139.36 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.125 -0.695 . . . . 15.0 109.125 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -102.0 104.01 14.67 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.707 -0.849 . . . . 15.0 108.707 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.1 t -97.56 158.36 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.547 -1.279 . . . . 15.0 107.547 173.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -131.81 129.38 40.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.078 -1.082 . . . . 15.0 108.078 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -78.55 124.46 85.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.564 0.745 . . . . 15.0 110.008 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -51.04 165.99 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.928 3.086 . . . . 15.0 115.403 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -27.76 62.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.61 -0.723 . . . . 15.0 109.724 168.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.86 -17.14 59.16 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.952 1.301 . . . . 15.0 111.451 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.475 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 64.9 t80 -63.04 133.58 54.77 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.914 0.886 . . . . 15.0 110.327 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -76.97 -42.6 38.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.346 1.239 . . . . 15.0 114.346 -166.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.475 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -70.72 100.21 1.84 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.33 -23.41 60.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.676 0.79 . . . . 15.0 112.835 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.48 -24.89 67.77 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.654 0.382 . . . . 15.0 110.906 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.57 HD11 ' H ' ' B' ' 388' ' ' VAL . 40.7 mt -93.7 -33.68 13.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.945 0.898 . . . . 15.0 111.643 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -50.33 116.41 1.87 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.59 1.156 . . . . 15.0 111.542 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.56 -34.83 4.87 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.45 171.51 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.668 0.787 . . . . 15.0 111.936 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -123.94 138.67 54.44 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.9 -1.045 . . . . 15.0 109.833 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -117.44 131.55 56.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.218 0.607 . . . . 15.0 110.127 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 65.7 mttm -98.12 116.22 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.744 -1.206 . . . . 15.0 107.744 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 99.3 m-85 -108.81 114.24 27.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 -177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -75.92 89.66 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 15.0 110.231 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 mm -82.01 115.85 25.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.425 0.69 . . . . 15.0 109.669 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -103.73 101.17 11.0 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.526 -1.287 . . . . 15.0 107.526 177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 166' ' ' ILE . 88.2 mt -76.9 93.21 3.73 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -85.34 -31.81 22.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.301 -0.863 . . . . 15.0 110.531 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -132.66 123.43 26.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.174 0.59 . . . . 15.0 110.907 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 207' ' ' ALA . 88.9 t -101.29 105.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.675 -1.972 . . . . 15.0 105.675 160.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 31.9 mt-10 -113.23 -174.94 2.56 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.5 tt0 -155.88 126.67 6.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -73.8 83.12 1.64 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 163.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.49 148.16 39.22 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 113.494 -1.685 . . . . 15.0 110.813 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.93 121.57 59.44 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.544 0.738 . . . . 15.0 110.42 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 91.0 Cg_endo -75.54 -167.95 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.538 2.826 . . . . 15.0 111.965 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 249' ' ' THR . 39.9 tt0 -55.78 147.15 19.53 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.323 0.649 . . . . 15.0 111.22 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.4 tp -147.33 25.94 1.08 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.699 1.2 . . . . 15.0 108.047 173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.451 ' H ' ' HG2' ' A' ' 247' ' ' GLU . 6.3 m -73.76 164.83 26.12 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.682 -1.145 . . . . 15.0 109.192 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -36.83 -51.88 0.91 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.801 1.64 . . . . 15.0 114.492 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -67.62 -30.13 69.63 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -80.23 -55.61 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.895 0.478 . . . . 15.0 109.976 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.721 HG13 HD22 ' A' ' 266' ' ' LEU . 12.9 tt -63.87 -28.94 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.829 0.852 . . . . 15.0 112.494 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -66.1 -27.52 68.12 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 112.005 0.372 . . . . 15.0 112.005 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.59 -19.64 65.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.59 0.756 . . . . 15.0 111.976 -172.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -68.66 -23.98 64.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.831 0.453 . . . . 15.0 111.835 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 147.94 -22.48 1.44 Allowed Glycine 0 C--N 1.351 1.415 0 O-C-N 122.944 0.152 . . . . 15.0 112.771 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 261' ' ' GLY . 21.5 t -68.14 133.15 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.109 0.963 . . . . 15.0 110.071 -176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -67.64 -60.98 2.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.78 0.432 . . . . 15.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.75 -36.1 32.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.072 0.549 . . . . 15.0 111.074 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 98.88 36.09 4.62 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.476 -0.784 . . . . 15.0 112.755 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 p -78.44 139.45 38.72 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 117.645 0.723 . . . . 15.0 110.362 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 62.3 t -57.16 -58.77 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.189 0.996 . . . . 15.0 110.789 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.33 -15.4 47.85 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.729 0.812 . . . . 15.0 112.108 174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.14 -32.84 37.97 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 253' ' ' ILE . 56.3 tp -75.84 -38.51 57.97 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 109.787 -0.449 . . . . 15.0 109.787 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 39.2 mtp-105 -62.9 -39.58 94.94 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.539 0.524 . . . . 15.0 109.639 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.93 73.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.863 0.865 . . . . 15.0 110.992 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.37 -50.35 73.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.022 0.929 . . . . 15.0 111.196 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.605 HG11 HD21 ' A' ' 141' ' ' LEU . 21.6 m -75.97 -25.13 16.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.235 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -57.79 -60.89 3.01 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.106 -0.701 . . . . 15.0 109.106 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -64.61 -37.56 88.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.916 0.71 . . . . 15.0 112.916 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.92 -51.81 23.79 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 117.966 0.348 . . . . 15.0 111.274 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 65.8 mtt -65.21 -30.13 70.99 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 118.582 -0.723 . . . . 15.0 110.303 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.62 -30.06 59.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.443 0.534 . . . . 15.0 112.443 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -64.4 -44.2 92.02 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 109.272 -0.64 . . . . 15.0 109.272 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.92 -38.17 79.37 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.676 -1.147 . . . . 15.0 110.593 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.496 HD12 HD23 ' A' ' 427' ' ' LEU . 22.5 tp -60.65 -47.04 88.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.647 1.179 . . . . 15.0 111.638 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -59.85 -40.22 87.8 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.798 0.687 . . . . 15.0 111.053 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.1 t -68.11 -33.9 75.37 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.867 0.729 . . . . 15.0 110.401 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -80.36 -32.0 37.82 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 112.731 0.641 . . . . 15.0 112.731 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 88.2 mt -68.31 -43.08 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -64.04 -40.12 95.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.108 -0.951 . . . . 15.0 109.691 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.78 -46.78 88.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.525 0.73 . . . . 15.0 110.047 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.493 ' HG2' ' HG3' ' A' ' 128' ' ' PRO . 8.5 tpt180 -57.05 -63.27 1.27 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.681 1.192 . . . . 15.0 111.128 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.5 -47.47 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 124.359 1.064 . . . . 15.0 111.5 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.405 ' HE3' HG21 ' A' ' 408' ' ' VAL . 86.4 tttt -71.5 -36.76 71.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.745 -0.662 . . . . 15.0 111.437 -175.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -68.55 -37.99 80.4 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 119.357 -0.354 . . . . 15.0 110.39 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -69.85 -35.97 75.16 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.56 0.537 . . . . 15.0 111.673 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.476 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.2 -52.9 60.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.114 0.483 . . . . 15.0 110.712 175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.37 -35.02 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.345 1.458 . . . . 15.0 111.248 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.546 ' HA ' HH21 ' A' ' 343' ' ' ARG . 14.0 tp10 -64.04 -53.85 43.43 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -60.12 -39.43 95.83 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 124.598 1.186 . . . . 15.0 112.579 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 -63.5 1.17 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.321 1.048 . . . . 15.0 111.66 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.594 HG11 ' HG2' ' A' ' 343' ' ' ARG . 91.7 t -63.14 -44.07 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 122.481 0.312 . . . . 15.0 110.232 -176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -55.57 -37.33 67.89 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.287 1.035 . . . . 15.0 111.213 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -80.49 -28.46 37.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.872 0.869 . . . . 15.0 112.344 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -123.18 113.61 19.18 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.802 0.441 . . . . 15.0 111.278 -167.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.59 148.11 26.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.102 -1.073 . . . . 15.0 108.102 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 113' ' ' PRO . 7.4 tt -163.91 153.77 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.622 0.769 . . . . 15.0 109.814 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.45 112.45 7.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.494 -1.299 . . . . 15.0 107.494 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 300' ' ' ILE . 21.8 t -103.97 132.27 21.18 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.71 0.804 . . . . 15.0 109.46 -172.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.48 ' HG3' HD23 ' A' ' 11' ' ' LEU . 23.6 Cg_exo -62.94 110.59 1.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.699 2.266 . . . . 15.0 112.117 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -54.74 -21.48 11.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.861 1.665 . . . . 15.0 113.104 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.14 -49.25 29.34 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.232 1.013 . . . . 15.0 111.196 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.698 HD13 ' HA ' ' B' ' 467' ' ' ALA . 75.9 mt -63.01 -38.73 92.35 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.59 0.71 . . . . 15.0 110.011 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 304' ' ' ALA . 77.4 mt -58.62 -48.13 86.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 CA-C-N 114.239 -1.346 . . . . 15.0 109.712 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HA ' HD12 ' A' ' 311' ' ' ILE . 22.9 t70 -63.1 -29.92 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.062 0.851 . . . . 15.0 111.309 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -69.61 -44.79 70.0 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.562 0.345 . . . . 15.0 111.545 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.3 -28.75 66.55 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.481 0.658 . . . . 15.0 111.571 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 334' ' ' ARG . 78.0 mt -64.66 -42.04 93.93 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 N-CA-C 108.195 -1.039 . . . . 15.0 108.195 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.89 -41.14 90.98 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.37 1.044 . . . . 15.0 110.481 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.28 -50.62 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 123.802 0.689 . . . . 15.0 109.909 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.62 -17.92 62.88 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.127 0.788 . . . . 15.0 113.127 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 329' ' ' ALA . 20.9 mtm180 -81.6 -32.7 31.93 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.577 0.751 . . . . 15.0 109.234 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -71.11 -39.45 72.07 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.405 0.682 . . . . 15.0 110.326 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -58.75 -50.45 73.87 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.588 -0.733 . . . . 15.0 110.324 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.07 90.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.475 0.71 . . . . 15.0 110.752 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -53.81 -37.39 63.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.477 1.111 . . . . 15.0 111.671 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -66.12 -39.21 89.75 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.822 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.42 ' HG3' ' HB ' ' B' ' 435' ' ' THR . 10.8 mpt_? -81.85 -11.7 58.83 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.982 0.513 . . . . 15.0 109.967 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.459 ' HD2' ' HB2' ' A' ' 325' ' ' ASN . 66.6 t80 -92.5 13.18 20.48 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.139 1.376 . . . . 15.0 109.784 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.01 21.25 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-N 116.118 -0.492 . . . . 15.0 113.358 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 71.96 62.69 3.26 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 112.134 -0.386 . . . . 15.0 112.134 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.674 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 23.9 t-20 -63.11 147.46 50.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.784 0.834 . . . . 15.0 110.292 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.58 88.85 2.84 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.986 1.315 . . . . 15.0 110.018 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm 67.45 -5.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.401 1.481 . . . . 15.0 114.551 170.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -84.24 -10.32 57.78 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.119 0.967 . . . . 15.0 108.989 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -51.96 -33.12 36.28 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.2 1.4 . . . . 15.0 112.347 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.9 tp -51.18 -32.32 23.03 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.808 1.243 . . . . 15.0 112.263 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.17 -22.38 39.0 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.1 0.96 . . . . 15.0 112.174 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.5 mt -52.9 119.6 16.68 Favored Pre-proline 0 N--CA 1.495 1.798 0 CA-C-O 118.091 -0.957 . . . . 15.0 110.317 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.71 107.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 124.588 3.525 . . . . 15.0 113.55 -169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.597 ' HB2' HD13 ' A' ' 311' ' ' ILE . 9.0 ptm180 -61.21 -31.32 71.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.782 -1.099 . . . . 15.0 112.572 -170.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.65 -18.11 64.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.222 1.009 . . . . 15.0 112.822 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.49 -37.86 88.04 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.689 0.757 . . . . 15.0 109.73 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.55 ' HB2' HG23 ' A' ' 311' ' ' ILE . 33.2 m-85 -103.38 -20.51 14.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.388 -1.278 . . . . 15.0 111.097 -168.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -54.83 -36.5 65.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.304 1.041 . . . . 15.0 112.976 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.06 -48.06 83.45 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.661 0.384 . . . . 15.0 111.713 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.04 -38.59 44.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.941 0.496 . . . . 15.0 111.358 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.33 -55.17 26.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.393 0.677 . . . . 15.0 110.937 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.543 ' HA ' HG12 ' A' ' 307' ' ' ILE . 86.3 tttt -48.74 -44.34 38.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.692 1.197 . . . . 15.0 111.146 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.594 ' HG2' HG11 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -60.32 -39.26 86.38 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.603 1.19 . . . . 15.0 110.207 178.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -73.18 -28.11 62.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.817 0.281 . . . . 15.0 111.463 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 20.4 t -71.7 -38.24 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.495 -0.558 . . . . 15.0 109.495 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.3 t -59.39 -44.98 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 343' ' ' ARG . 61.1 t -54.22 -46.7 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.82 0.848 . . . . 15.0 110.818 172.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.42 -30.51 75.28 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.433 0.458 . . . . 15.0 113.789 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 300' ' ' ILE . 95.7 mt -74.6 -49.35 22.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.453 0.701 . . . . 15.0 109.955 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.6 mt -64.06 -54.77 28.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.939 0.896 . . . . 15.0 110.548 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.6 -34.94 78.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.035 0.834 . . . . 15.0 111.098 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.88 -38.61 96.84 Favored Glycine 0 C--N 1.353 1.48 0 O-C-N 123.49 0.493 . . . . 15.0 112.611 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.17 -35.12 73.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.371 0.669 . . . . 15.0 110.862 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 350' ' ' LEU . 96.4 t -66.6 -37.33 79.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 122.927 0.491 . . . . 15.0 110.218 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 352' ' ' GLY . 76.7 mt -64.26 -42.16 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.352 0.661 . . . . 15.0 110.074 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 ttm-85 -60.65 -62.57 1.76 Allowed 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.827 -0.624 . . . . 15.0 110.096 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 27.1 m -66.26 -33.8 76.57 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.149 0.98 . . . . 15.0 112.482 -173.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -94.35 11.01 31.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.924 0.49 . . . . 15.0 111.322 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.82 38.58 4.48 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 125.766 1.627 . . . . 15.0 113.888 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.68 147.89 43.25 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.632 0.773 . . . . 15.0 111.85 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 148.51 39.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.229 1.012 . . . . 15.0 108.615 172.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.17 137.39 57.93 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.639 0.607 . . . . 15.0 112.639 -172.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 122.07 37.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.042 0.937 . . . . 15.0 109.77 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.65 -46.82 83.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.263 1.025 . . . . 15.0 111.829 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.69 -21.06 61.12 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.082 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 21.1 ttt85 -72.62 -46.66 53.01 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.553 -0.906 . . . . 15.0 108.553 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 399' ' ' ARG . 31.7 t -55.41 -47.52 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 124.55 1.156 . . . . 15.0 109.591 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -51.89 -54.99 22.94 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.237 0.961 . . . . 15.0 111.718 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.73 92.77 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.98 0.8 . . . . 15.0 113.428 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 366' ' ' ARG . 94.8 mt -60.93 -51.45 69.21 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.515 0.726 . . . . 15.0 110.34 177.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 367' ' ' VAL . 38.6 mm -54.94 -56.38 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.434 0.694 . . . . 15.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.69 -49.21 78.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.927 -1.488 . . . . 15.0 111.967 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.74 -39.57 64.17 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.615 0.598 . . . . 15.0 112.615 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 56.7 ttp -56.06 -47.49 77.82 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.296 0.639 . . . . 15.0 109.597 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -73.31 -36.42 66.25 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.8 -1.091 . . . . 15.0 112.183 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 33.5 t -70.55 -12.04 61.32 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.394 0.677 . . . . 15.0 111.811 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.16 -7.95 56.69 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.204 0.601 . . . . 15.0 111.422 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.35 179.53 4.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.225 1.01 . . . . 15.0 110.403 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -65.23 -50.34 66.21 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.01 0.924 . . . . 15.0 110.512 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -114.9 109.89 46.82 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.399 -0.819 . . . . 15.0 109.833 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.709 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 89.3 Cg_endo -80.56 -29.66 2.24 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 121.995 1.796 . . . . 15.0 112.648 168.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.07 -48.54 75.87 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.933 0.893 . . . . 15.0 112.383 -161.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.78 -37.74 85.44 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.992 0.808 . . . . 15.0 110.402 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.46 -46.66 69.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 123.744 0.653 . . . . 15.0 110.087 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -49.3 82.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 108.753 -0.832 . . . . 15.0 108.753 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.06 -12.18 60.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.253 0.621 . . . . 15.0 112.431 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -88.2 -39.66 14.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.212 0.605 . . . . 15.0 111.382 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -86.5 -48.3 8.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.744 0.417 . . . . 15.0 112.083 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.6 p -49.73 -48.04 50.29 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.535 1.134 . . . . 15.0 113.731 -165.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -109.58 14.95 23.23 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.335 0.654 . . . . 15.0 111.52 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -110.69 88.97 2.9 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.272 -1.381 . . . . 15.0 107.272 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 38.6 ttmt -66.47 -23.18 66.23 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.413 -0.812 . . . . 15.0 111.691 -170.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.73 -56.88 12.28 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.697 0.799 . . . . 15.0 110.047 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 45.1 tp -74.68 -24.39 58.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.036 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 46.1 tpp -59.52 -46.06 89.95 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.457 -0.572 . . . . 15.0 109.457 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.417 ' HB3' HD21 ' B' ' 450' ' ' ASN . 6.3 t70 -54.39 -49.83 68.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.893 0.877 . . . . 15.0 111.462 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.18 -33.83 74.08 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 124.023 0.827 . . . . 15.0 110.976 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.597 ' HA ' HG12 ' A' ' 401' ' ' VAL . 5.8 tpt -84.69 -11.97 54.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.392 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 367' ' ' VAL . 50.0 mtp180 -85.87 -24.89 26.51 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.726 -0.842 . . . . 15.0 108.726 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -71.16 -40.27 71.42 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.235 0.614 . . . . 15.0 110.066 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 398' ' ' MET . 11.3 p -71.57 -28.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-N 117.748 0.249 . . . . 15.0 111.254 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -68.57 -37.5 79.93 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.419 0.628 . . . . 15.0 110.553 174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.74 -31.38 57.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.284 -0.871 . . . . 15.0 110.493 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 408' ' ' VAL . 29.2 tt0 -59.89 -46.3 89.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.383 1.073 . . . . 15.0 109.596 169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 9.1 mm-40 -53.49 -55.09 28.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.524 1.129 . . . . 15.0 111.487 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -58.76 -37.48 76.33 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.483 -0.78 . . . . 15.0 111.953 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -64.09 -41.68 97.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 15.0 111.278 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.9 t -58.16 -48.39 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 123.757 0.661 . . . . 15.0 109.534 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 57.1 mt-10 -61.87 -36.86 82.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 123.896 0.748 . . . . 15.0 111.99 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.11 64.73 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.704 -0.68 . . . . 15.0 111.705 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 407' ' ' ALA . 54.7 t -88.05 -29.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 171.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 290' ' ' ALA . 97.0 mt -72.04 -27.36 62.65 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.417 0.687 . . . . 15.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.97 70.17 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.591 -0.731 . . . . 15.0 110.873 170.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -95.91 -28.3 14.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.373 1.069 . . . . 15.0 111.368 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.85 154.95 21.18 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.955 0.902 . . . . 15.0 110.924 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.88 84.18 5.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.786 0.834 . . . . 15.0 109.645 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.0 t -95.57 89.3 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.262 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -72.51 112.01 8.19 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.216 0.606 . . . . 15.0 110.295 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.24 132.55 36.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.261 0.625 . . . . 15.0 110.153 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -140.83 141.55 34.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.36 0.664 . . . . 15.0 110.212 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.92 125.13 36.51 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 130' ' ' VAL . 9.8 t -157.31 173.72 16.52 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.947 0.499 . . . . 15.0 111.345 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 64.9 p -96.47 174.62 6.76 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.656 0.783 . . . . 15.0 112.145 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.99 -25.23 57.99 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 126.47 1.908 . . . . 15.0 111.702 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 429' ' ' ASN . 33.6 m-80 -65.53 -34.24 77.79 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.865 1.266 . . . . 15.0 112.21 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.403 ' HG2' HG21 ' A' ' 422' ' ' THR . 13.0 tp10 -66.68 -37.4 84.69 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.321 0.581 . . . . 15.0 111.739 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.496 HD23 HD12 ' A' ' 278' ' ' LEU . 15.6 tp -85.24 -77.5 0.28 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.377 -0.829 . . . . 15.0 111.124 -165.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.01 -30.51 9.26 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.214 -0.304 . . . . 15.0 111.425 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 425' ' ' ASN . 65.1 t30 -86.85 46.89 1.42 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.308 1.051 . . . . 15.0 110.5 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -77.38 -7.92 56.87 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.833 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -63.4 -20.72 65.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.604 1.162 . . . . 15.0 111.503 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 123.411 0.684 . . . . 15.0 109.302 171.708 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -125.35 121.46 34.01 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.666 HD22 ' H ' ' B' ' 368' ' ' ASP . 0.0 OUTLIER -55.71 -61.6 2.25 Favored 'General case' 0 CA--C 1.558 1.275 0 O-C-N 124.041 0.838 . . . . 0.0 111.886 -176.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.666 ' H ' HD22 ' B' ' 367' ' ' LEU . 13.1 t70 -108.54 -88.21 0.48 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 164.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -112.73 -77.22 0.58 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 156.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -107.49 -75.25 0.64 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 166.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.92 -72.03 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 162.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -103.81 -76.64 0.59 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 164.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -98.74 -75.53 0.56 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -102.58 -72.74 0.68 Allowed 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 165.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.585 HD22 ' H ' ' B' ' 375' ' ' LEU . 0.0 OUTLIER -107.06 -77.99 0.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 168.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.0 -83.39 0.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 164.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -109.2 -88.13 0.49 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 118.81 0.732 . . . . 0.0 110.403 160.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.58 -67.9 0.87 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.658 0.783 . . . . 0.0 110.416 -172.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -110.81 -84.31 0.56 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.179 0.591 . . . . 0.0 109.77 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? 167.62 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.39 126.67 19.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.471 0.709 . . . . 0.0 109.976 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.07 51.12 0.26 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.797 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -129.81 150.13 51.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . 0.524 HG23 ' HB3' ' A' ' 193' ' ' ARG . 6.4 m 68.94 -179.09 0.23 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.197 0.999 . . . . 0.0 108.89 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.609 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.5 mm? -73.37 120.83 19.52 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.11 -0.994 . . . . 0.0 108.617 168.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 13.5 m -64.37 98.6 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 125.168 1.542 . . . . 0.0 112.311 -164.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.632 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 5.8 pt -125.08 160.64 30.29 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.035 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.57 ' H ' HD11 ' A' ' 226' ' ' LEU . 54.5 t -55.44 150.54 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.755 0.422 . . . . 0.0 110.414 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 12.2 t -46.79 173.94 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 126.358 1.863 . . . . 0.0 113.709 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -51.89 175.6 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.747 1.219 . . . . 0.0 113.78 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -49.36 159.44 0.32 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.801 1.241 . . . . 0.0 112.639 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -51.2 -33.42 27.48 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.634 0.774 . . . . 0.0 110.837 175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -87.28 92.85 9.21 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 161.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -64.99 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.914 0.886 . . . . 0.0 113.034 -166.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -163.08 116.74 1.63 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.369 0.668 . . . . 0.0 110.382 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 60.0 m -68.84 150.45 47.8 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.519 0.728 . . . . 0.0 110.339 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 137.11 57.03 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.132 0.491 . . . . 0.0 111.32 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.419 HG12 ' N ' ' B' ' 399' ' ' VAL . 12.3 tt -169.76 170.58 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 C-N-CA 125.257 1.423 . . . . 0.0 107.72 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.419 ' N ' HG12 ' B' ' 398' ' ' ILE . 7.6 p -59.0 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.398 1.094 . . . . 0.0 109.152 167.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.716 ' H ' ' HD2' ' B' ' 401' ' ' PRO . . . -135.46 -47.9 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.368 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.716 ' HD2' ' H ' ' B' ' 400' ' ' ALA . 1.8 Cg_endo -44.35 -62.08 0.49 Allowed 'Trans proline' 0 C--N 1.407 3.608 0 C-N-CA 123.229 2.619 . . . . 0.0 113.52 175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.78 -98.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.35 0.66 . . . . 0.0 109.703 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 14.5 t -164.56 -163.69 0.76 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 72.8 -70.0 0.17 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -133.71 71.01 75.37 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.764 0.826 . . . . 0.0 110.907 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -103.31 9.47 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.23 2.62 . . . . 0.0 112.835 169.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 81.47 171.25 45.14 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.514 0.509 . . . . 0.0 112.532 -169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.21 10.23 34.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.243 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 61.9 m -65.38 91.63 0.12 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.736 0.814 . . . . 0.0 109.71 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 64.82 175.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.227 1.411 . . . . 0.0 111.759 -172.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -164.33 114.99 1.25 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' B' ' 415' ' ' LYS . 2.3 pt? -61.69 106.24 0.65 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -61.69 -57.73 10.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.779 0.832 . . . . 0.0 110.265 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 34.7 m -96.08 -69.32 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.242 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.482 ' HA ' HD12 ' B' ' 412' ' ' LEU . 60.1 tttm -172.27 135.79 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.552 0.741 . . . . 0.0 109.21 -176.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.04 -62.83 1.57 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.242 0.617 . . . . 0.0 110.624 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -82.29 71.51 2.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.972 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -79.21 76.63 5.74 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.0 110.262 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 47.2 t 60.1 -82.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.735 1.614 . . . . 0.0 111.211 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 50.3 ttm -160.19 -25.49 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.841 0.856 . . . . 0.0 109.982 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 41.2 t 59.62 74.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.157 1.383 . . . . 0.0 110.094 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 25.5 ptm -71.59 107.23 4.36 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.343 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 33.9 p -156.74 167.7 29.67 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.019 0.927 . . . . 0.0 109.445 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -77.68 90.76 3.99 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -80.82 64.37 4.11 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.872 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -99.89 -11.16 20.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.915 0.886 . . . . 0.0 109.793 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 26.7 m -139.57 178.47 7.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.235 1.014 . . . . 0.0 109.787 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -74.56 -163.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.133 0.973 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -67.76 -65.24 0.72 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.155 0.582 . . . . 0.0 110.164 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.44 -80.48 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.3 m -108.71 -61.21 1.64 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.519 ' HG3' ' HG3' ' B' ' 433' ' ' GLU . 20.6 tp60 -112.63 -61.54 1.71 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.124 0.97 . . . . 0.0 108.473 168.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . 0.519 ' HG3' ' HG3' ' B' ' 432' ' ' GLN . 41.6 mt-10 -116.29 -161.28 0.79 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.727 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.19 130.48 42.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.108 0.563 . . . . 0.0 110.083 174.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.42 ' HB ' ' HG3' ' A' ' 321' ' ' ARG . 26.4 m 61.32 87.98 0.09 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.645 1.178 . . . . 0.0 110.972 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -116.83 -55.02 0.31 Allowed Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.348 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 41.6 m -78.93 69.31 5.07 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.781 0.833 . . . . 0.0 109.935 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -147.57 74.17 1.31 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -160.98 88.93 0.77 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.481 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -74.36 -45.16 48.78 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.177 -171.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 15.9 pt -137.37 174.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.306 0.642 . . . . 0.0 110.936 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -131.15 147.06 52.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.996 0.518 . . . . 0.0 111.831 -171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -165.63 126.53 1.88 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.613 0.765 . . . . 0.0 110.455 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -95.36 168.46 10.7 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 0.0 110.489 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 56.18 71.88 0.66 Allowed Glycine 0 C--N 1.35 1.343 0 O-C-N 124.263 0.977 . . . . 0.0 114.562 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.02 -27.43 8.43 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.831 2.354 . . . . 0.0 112.083 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -89.71 49.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.81 0.844 . . . . 0.0 109.571 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -130.92 135.57 47.79 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.567 0.747 . . . . 0.0 110.022 -175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.29 61.93 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.849 0.718 . . . . 0.0 110.325 171.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.417 HD21 ' HB3' ' A' ' 396' ' ' ASP . 1.3 t30 67.6 -89.45 0.03 OUTLIER 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.718 1.607 . . . . 0.0 109.315 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 59.2 t 53.3 91.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 124.567 1.147 . . . . 0.0 111.579 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.483 HG21 ' HG2' ' A' ' 392' ' ' LYS . 42.4 t -58.85 104.99 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.333 1.053 . . . . 0.0 111.247 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -169.39 -143.87 4.04 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.337 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' B' ' 470' ' ' LEU . 80.4 mt 61.5 81.9 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.359 1.463 . . . . 0.0 112.196 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 4.7 t -100.3 70.05 1.5 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.834 0.854 . . . . 0.0 109.423 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -82.16 139.95 34.04 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.893 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -110.52 -25.27 10.11 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.237 1.015 . . . . 0.0 109.995 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 6.8 m -73.88 -55.79 5.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.424 0.69 . . . . 0.0 111.584 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -119.38 -88.39 0.62 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.767 -167.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 41.6 tp -108.38 111.01 22.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -67.27 -33.56 75.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.23 109.12 4.75 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 61.2 p -77.43 164.66 25.26 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.667 0.787 . . . . 0.0 111.066 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 35.4 mtm -125.15 -178.16 4.11 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.558 0.694 . . . . 0.0 111.696 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.482 ' HA ' HD23 ' B' ' 468' ' ' LEU . 49.6 mmtm -91.46 -175.25 4.16 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.019 171.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 65.68 -72.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.877 1.271 . . . . 0.0 109.217 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.698 ' HA ' HD13 ' A' ' 306' ' ' LEU . . . -79.73 79.79 6.19 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' B' ' 465' ' ' LYS . 78.8 mt -65.39 90.54 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.367 1.067 . . . . 0.0 111.051 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -86.42 58.83 4.68 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.529 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.585 ' HB2' HD11 ' B' ' 454' ' ' LEU . 75.9 mt 75.57 -43.29 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.813 1.645 . . . . 0.0 112.55 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp . . . . . 0 CA--C 1.554 1.122 0 C-N-CA 124.401 1.081 . . . . 12.06 109.21 -179.374 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.522 0.201 . . . . 15.0 110.689 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.1 tt0 -142.71 118.41 10.46 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.909 -0.775 . . . . 15.0 108.909 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 17' ' ' ILE . 26.7 m -106.25 131.96 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.82 -0.437 . . . . 15.0 109.82 177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -142.55 94.65 2.67 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.611 0.765 . . . . 15.0 109.217 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -77.2 95.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 122.184 0.992 . . . . 15.0 110.696 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 48.5 mt-10 -76.21 100.11 4.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.709 -1.132 . . . . 15.0 109.468 173.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -78.43 85.91 4.51 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 107.967 -1.123 . . . . 15.0 107.967 174.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -61.94 -44.43 96.79 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.685 -1.143 . . . . 15.0 110.749 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -169.36 97.41 0.33 Allowed 'General case' 0 C--N 1.351 0.642 0 O-C-N 123.632 0.582 . . . . 15.0 109.925 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.79 -98.44 0.35 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.747 0.654 . . . . 15.0 113.645 172.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.634 HD21 ' HG3' ' A' ' 113' ' ' PRO . 8.1 mp -69.83 -25.13 63.6 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.653 0.781 . . . . 15.0 111.311 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.63 79.53 0.69 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.573 0.546 . . . . 15.0 112.832 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HD2' HG11 ' A' ' 111' ' ' VAL . 92.8 mtt180 -99.81 89.99 4.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.6 ttm180 -75.89 95.77 3.59 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.004 -0.998 . . . . 15.0 109.677 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.57 87.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 58.9 m -82.62 109.74 17.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.944 -1.025 . . . . 15.0 109.813 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 3' ' ' VAL . 53.6 mt -110.58 116.56 52.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.912 -0.586 . . . . 15.0 109.729 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 67.6 m -87.39 105.25 17.14 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.866 -0.79 . . . . 15.0 108.866 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' LEU . 62.4 mt -74.37 126.2 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 147.77 51.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 122.911 0.485 . . . . 15.0 111.26 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.67 94.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.47 1.108 . . . . 15.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -68.71 -30.21 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.116 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.8 m -69.13 -38.5 78.89 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.841 0.456 . . . . 15.0 110.369 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.23 -42.41 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -61.55 -42.82 99.4 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.914 0.886 . . . . 15.0 111.101 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.5 m -75.48 -35.39 60.84 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.087 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.71 62.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.891 0.477 . . . . 15.0 111.889 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.77 HG21 ' HD3' ' A' ' 63' ' ' ARG . 86.8 t -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.625 0.77 . . . . 15.0 109.916 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.0 -42.62 94.32 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.384 0.674 . . . . 15.0 111.304 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 65.7 m -69.34 -18.58 63.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.865 0.866 . . . . 15.0 110.638 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.9 tp10 -86.83 -33.05 19.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.071 0.548 . . . . 15.0 110.689 175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.5 mt -74.68 -27.34 60.36 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.335 0.494 . . . . 15.0 112.335 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.51 -29.63 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 170.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -68.85 -48.98 62.11 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 31' ' ' GLU . 76.0 t -60.74 -35.65 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.343 1.057 . . . . 15.0 111.294 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.49 -49.0 73.69 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.092 0.557 . . . . 15.0 110.609 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.57 -29.13 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.34 0.656 . . . . 15.0 112.171 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -80.35 -32.44 37.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.534 1.134 . . . . 15.0 111.15 -171.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.9 t -96.33 1.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.515 0.726 . . . . 15.0 109.621 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 70.06 12.61 7.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.609 1.564 . . . . 15.0 112.635 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 39' ' ' VAL . 69.8 mt -61.59 -24.11 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 124.154 0.982 . . . . 15.0 110.917 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 11.7 p-10 -65.39 -34.02 77.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.998 0.919 . . . . 15.0 111.614 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.03 -23.9 77.64 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.678 0.611 . . . . 15.0 112.207 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -93.82 -21.7 19.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.722 0.809 . . . . 15.0 110.68 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 48.1 ttt85 -75.89 130.67 38.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.36 1.064 . . . . 15.0 109.084 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -110.0 16.78 21.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.521 0.728 . . . . 15.0 111.53 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 45' ' ' ARG . . . 73.02 27.0 69.52 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 115.433 -0.803 . . . . 15.0 113.83 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -100.35 -38.89 8.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.355 0.662 . . . . 15.0 111.315 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.26 118.61 67.5 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-O 118.894 -0.574 . . . . 15.0 109.944 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.7 Cg_exo -64.24 147.78 91.12 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.068 2.512 . . . . 15.0 112.257 175.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.2 tpp -74.78 -29.37 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.361 0.664 . . . . 15.0 111.632 -172.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 29.9 p-10 -65.47 -36.72 84.72 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.833 0.453 . . . . 15.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.47 HD12 ' HD2' ' A' ' 50' ' ' PRO . 38.7 mt -61.49 -52.18 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.641 0.776 . . . . 15.0 110.519 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' HA ' ' CD1' ' A' ' 58' ' ' TYR . 28.8 m -72.38 -26.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -63.71 -53.83 45.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.216 0.606 . . . . 15.0 111.273 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 2.7 pt20 -83.66 -45.59 13.27 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.546 -0.752 . . . . 15.0 112.127 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -79.9 -63.04 1.5 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.489 0.316 . . . . 15.0 110.513 -171.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 3.6 m-85 -68.97 -38.8 79.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.542 0.737 . . . . 15.0 110.157 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -79.15 -2.04 86.56 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.576 -1.193 . . . . 15.0 113.965 -175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.19 -29.92 69.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.413 0.685 . . . . 15.0 111.573 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.0 p -80.13 -39.73 28.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.517 0.727 . . . . 15.0 110.65 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.07 -17.26 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 124.369 1.068 . . . . 15.0 111.711 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.77 ' HD3' HG21 ' A' ' 28' ' ' VAL . 16.0 mmt180 -48.14 -46.72 34.68 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.342 1.057 . . . . 15.0 111.467 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.64 -53.85 49.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.557 1.543 . . . . 15.0 112.26 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.84 -29.97 66.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.241 -0.89 . . . . 15.0 111.728 -171.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -74.2 -27.87 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.947 -0.57 . . . . 15.0 110.594 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.1 mt -57.77 -39.21 76.92 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.828 0.451 . . . . 15.0 111.151 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.85 -42.88 98.33 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.211 0.319 . . . . 15.0 112.794 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.15 -41.69 94.52 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.231 1.012 . . . . 15.0 111.056 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HB3' HD13 ' A' ' 19' ' ' ILE . 86.3 mt -69.49 -40.19 77.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.694 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 75.2 mtm -67.18 -36.86 82.67 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.917 0.487 . . . . 15.0 111.033 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -63.38 -47.42 82.12 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.026 -0.988 . . . . 15.0 111.025 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.2 mtm105 -83.08 -51.11 7.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.983 -0.553 . . . . 15.0 112.204 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -23.52 44.21 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 122.858 0.463 . . . . 15.0 111.655 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -72.12 -52.2 17.84 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.568 0.543 . . . . 15.0 111.229 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.469 ' HA ' HG12 ' A' ' 79' ' ' ILE . 12.2 tt -67.28 -39.34 82.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.141 0 CA-C-N 117.899 0.318 . . . . 15.0 110.956 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -59.21 -34.68 72.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.467 0.707 . . . . 15.0 111.181 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.94 -54.88 7.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.528 0.731 . . . . 15.0 111.146 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 76' ' ' ILE . 21.8 pt -68.32 -22.23 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.145 0.794 . . . . 15.0 113.145 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.38 -49.83 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.536 0.335 . . . . 15.0 110.454 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -72.14 -36.83 69.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.332 0.253 . . . . 15.0 111.293 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -76.72 -12.74 60.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.959 0.504 . . . . 15.0 111.542 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 61.13 29.78 19.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.766 1.226 . . . . 15.0 112.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.5 mt -82.29 125.0 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.763 -0.828 . . . . 15.0 108.763 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.47 104.03 31.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 173.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.61 147.28 24.86 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.464 2.109 . . . . 15.0 112.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.18 178.44 10.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.74 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.81 -124.95 18.76 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.117 -0.947 . . . . 15.0 112.054 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.18 99.76 28.96 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.565 0.746 . . . . 15.0 110.188 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.5 Cg_endo -76.57 108.09 2.59 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.119 1.879 . . . . 15.0 110.528 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -102.75 100.64 10.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.634 -0.712 . . . . 15.0 109.963 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -85.95 80.87 8.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.453 0.701 . . . . 15.0 109.383 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.76 113.69 34.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.332 -0.849 . . . . 15.0 108.988 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.81 96.23 0.67 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.381 2.054 . . . . 15.0 110.459 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.542 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -51.28 -51.07 37.99 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.818 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -174.65 137.73 0.48 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.914 0.886 . . . . 15.0 110.668 172.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -106.34 135.46 47.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 38.3 mtpt -129.71 114.24 15.74 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.158 -1.423 . . . . 15.0 107.158 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.27 118.37 9.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.891 0.477 . . . . 15.0 109.716 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.83 -22.25 39.08 Favored Glycine 0 N--CA 1.47 0.94 0 CA-C-N 115.985 -0.552 . . . . 15.0 112.659 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 47.3 mt-10 -112.34 -178.81 3.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.117 0.967 . . . . 15.0 109.652 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.28 151.22 46.51 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.706 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 19' ' ' ILE . 48.7 t80 -95.16 146.45 24.3 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.961 -0.755 . . . . 15.0 108.961 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.4 m -134.46 133.31 40.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.333 0.653 . . . . 15.0 109.574 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.542 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 13.7 p90 -138.34 171.15 14.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.925 0.89 . . . . 15.0 109.051 172.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.3 m -140.77 124.37 16.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.888 0.875 . . . . 15.0 109.349 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.19 104.3 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -102.04 114.93 29.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.949 0.9 . . . . 15.0 109.417 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 33.6 p90 -139.64 164.04 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.604 0.761 . . . . 15.0 110.619 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.86 113.72 20.67 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.364 -0.835 . . . . 15.0 109.705 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.595 HG11 ' HD2' ' A' ' 13' ' ' ARG . 12.1 m -89.43 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.671 -0.492 . . . . 15.0 109.671 171.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -89.33 126.37 58.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.674 . . . . 15.0 110.224 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.634 ' HG3' HD21 ' A' ' 11' ' ' LEU . 14.5 Cg_exo -69.39 145.29 58.86 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.441 2.094 . . . . 15.0 110.868 170.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.45 100.15 1.05 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.301 0.64 . . . . 15.0 109.351 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.37 123.8 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.724 0.773 . . . . 15.0 112.057 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -116.96 107.82 15.03 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.537 1.135 . . . . 15.0 108.705 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.95 131.5 45.19 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.645 0.591 . . . . 15.0 109.995 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -136.6 155.9 49.3 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.169 0.988 . . . . 15.0 109.586 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 60.65 20.77 56.94 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 124.442 1.089 . . . . 15.0 114.823 171.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.03 -39.46 94.81 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.368 0.667 . . . . 15.0 111.029 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.05 -20.31 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.239 0.615 . . . . 15.0 111.305 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.89 -15.92 42.92 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.63 0.772 . . . . 15.0 111.652 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.54 HG22 HG23 ' A' ' 125' ' ' VAL . 58.5 mt -65.11 124.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.158 0.583 . . . . 15.0 109.758 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.629 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.7 mt-10 -116.2 85.91 2.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.925 0.869 . . . . 15.0 109.948 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 289' ' ' GLN . 67.8 t -83.03 164.78 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 113.574 -1.648 . . . . 15.0 109.51 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.7 141.23 49.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.744 0.817 . . . . 15.0 109.45 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -114.38 94.75 37.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 107.872 -1.159 . . . . 15.0 107.872 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.64 ' HG3' ' HD2' ' A' ' 285' ' ' ARG . 85.0 Cg_endo -78.16 103.49 1.7 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.984 1.789 . . . . 15.0 111.38 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.8 mm -69.12 92.73 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.619 HG21 HD11 ' A' ' 427' ' ' LEU . 25.5 t -118.29 134.06 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.219 -0.901 . . . . 15.0 110.196 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.44 154.73 48.38 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 106.664 -1.606 . . . . 15.0 106.664 167.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 274' ' ' MET . 3.4 t -83.29 89.66 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.814 -1.18 . . . . 15.0 107.814 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.9 p -69.52 173.96 5.44 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.257 0.623 . . . . 15.0 109.79 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -55.26 -43.72 74.93 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.561 0.344 . . . . 15.0 111.474 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.41 -25.65 64.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.557 0.743 . . . . 15.0 111.929 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -78.81 -45.11 21.62 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.754 0.422 . . . . 15.0 110.675 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -56.06 -58.09 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.938 0.895 . . . . 15.0 109.129 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -61.69 -47.01 87.23 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.844 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.17 72.16 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.13 0.894 . . . . 15.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.8 ttt -69.54 -50.71 42.39 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 122.771 0.428 . . . . 15.0 111.151 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.18 -37.51 69.68 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.143 0.577 . . . . 15.0 112.067 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.413 ' HA ' ' HE ' ' A' ' 145' ' ' ARG . 17.1 t70 -67.75 -41.75 82.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.107 0.963 . . . . 15.0 109.929 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 82.7 m -58.95 -43.2 91.21 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.188 0.93 . . . . 15.0 110.574 173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 140' ' ' MET . 81.0 mt -61.3 -42.94 99.5 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.425 0.69 . . . . 15.0 111.076 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.42 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 69.3 mtm180 -63.57 -35.89 81.99 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.297 -0.865 . . . . 15.0 110.676 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 85.6 mttt -85.06 -5.33 59.35 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.37 0.668 . . . . 15.0 112.537 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 143' ' ' THR . 96.8 mt-30 -79.74 -44.62 20.39 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.914 -0.772 . . . . 15.0 108.914 163.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -97.59 37.94 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.367 0.667 . . . . 15.0 110.864 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -71.51 141.13 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.458 0.703 . . . . 15.0 112.092 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.1 m -82.18 127.02 32.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.379 1.072 . . . . 15.0 109.353 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -86.95 126.61 34.82 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.02 0.528 . . . . 15.0 110.269 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -148.52 122.58 9.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 15.0 110.032 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 43.5 mt-10 -75.57 143.78 42.22 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.01 0.524 . . . . 15.0 110.263 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.687 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 36.6 pttt -137.05 -179.3 5.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.706 0.802 . . . . 15.0 111.031 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -147.14 153.74 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.06 -51.81 0.79 Allowed Glycine 0 N--CA 1.467 0.707 0 CA-C-O 119.548 -0.584 . . . . 15.0 112.757 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -155.53 148.07 23.99 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 117.415 0.608 . . . . 15.0 111.158 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.405 HG22 HG13 ' A' ' 240' ' ' VAL . 21.9 t -98.83 153.01 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 107.902 -1.147 . . . . 15.0 107.902 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.07 -169.88 2.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.457 1.103 . . . . 15.0 109.711 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.51 96.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.397 1.079 . . . . 15.0 113.245 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -125.65 33.25 5.14 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.889 0.7 . . . . 15.0 112.889 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -87.84 -164.26 1.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 120.934 0.397 . . . . 15.0 111.795 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.777 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 18.7 mtm180 -122.88 160.44 26.1 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.027 -1.101 . . . . 15.0 108.027 161.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.404 HG12 HG23 ' A' ' 166' ' ' ILE . 2.8 t -144.62 116.92 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.685 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 15.2 m -95.63 116.46 28.88 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' LEU . 40.1 pt -130.13 168.77 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.752 0.821 . . . . 15.0 110.346 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -127.64 161.2 29.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.424 -1.325 . . . . 15.0 107.424 161.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -160.63 174.92 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.333 0.587 . . . . 15.0 111.385 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.649 ' HB ' ' HG2' ' A' ' 181' ' ' LYS . 6.6 t -158.62 131.64 7.24 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.658 -1.608 . . . . 15.0 106.658 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -153.48 -177.13 26.67 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.602 -0.808 . . . . 15.0 113.407 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 p -148.2 131.67 16.7 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.754 0.822 . . . . 15.0 109.306 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 226' ' ' LEU . 45.7 t -93.08 102.81 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.789 -0.819 . . . . 15.0 108.789 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 229' ' ' LYS . 27.7 t70 77.7 -0.65 2.73 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 125.296 1.439 . . . . 15.0 111.047 -170.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.45 37.35 Favored Glycine 0 C--N 1.348 1.198 0 O-C-N 121.868 -0.52 . . . . 15.0 113.092 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.2 pt-20 -105.77 137.41 43.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.267 0.627 . . . . 15.0 109.353 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.18 95.16 5.54 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.477 -0.783 . . . . 15.0 109.659 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 172' ' ' VAL . 39.7 p90 -59.48 158.77 9.12 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.659 -1.155 . . . . 15.0 110.655 174.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -54.14 135.45 43.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 15.0 111.195 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' ' 386' ' ' VAL . . . 78.99 -70.49 2.75 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 123.985 0.803 . . . . 15.0 111.675 -170.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.61 -69.77 2.78 Favored Glycine 0 C--N 1.348 1.201 0 C-N-CA 123.212 0.434 . . . . 15.0 112.605 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.649 ' HG2' ' HB ' ' A' ' 169' ' ' THR . 6.5 tmtt? -86.29 137.37 32.66 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.252 1.021 . . . . 15.0 110.185 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB2' HG12 ' B' ' 386' ' ' VAL . . . -127.89 155.52 44.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.887 0.875 . . . . 15.0 108.816 169.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 m -139.35 128.51 23.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.151 0.58 . . . . 15.0 110.663 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 63.09 37.81 11.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.603 1.161 . . . . 15.0 112.255 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 44.6 t80 -71.22 136.06 47.84 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.39 -0.823 . . . . 15.0 108.915 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.5 t -107.16 119.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.008 0.923 . . . . 15.0 109.573 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 185' ' ' PHE . 24.6 tp -112.66 93.64 4.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.986 0.914 . . . . 15.0 110.867 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.19 105.01 3.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.3 mmt -77.25 165.07 24.98 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 114.872 -1.058 . . . . 15.0 111.063 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.42 11.69 56.87 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.056 -0.974 . . . . 15.0 112.029 -170.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -153.14 143.84 22.73 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 125.125 1.37 . . . . 15.0 107.767 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -79.15 82.84 1.33 Allowed Glycine 0 C--N 1.344 0.978 0 O-C-N 123.148 0.28 . . . . 15.0 112.692 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.03 -19.95 26.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.966 0.506 . . . . 15.0 111.374 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 19.0 mmt -129.86 156.91 43.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.606 0.362 . . . . 15.0 110.69 -173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.5 pt -65.04 140.85 98.19 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.662 -0.699 . . . . 15.0 109.761 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.89 105.24 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.217 2.612 . . . . 15.0 112.665 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 145.55 -49.44 0.66 Allowed Glycine 0 C--O 1.24 0.498 0 CA-C-N 115.153 -0.931 . . . . 15.0 111.102 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' B' ' 385' ' ' LEU . 43.5 t80 -69.04 -64.65 0.83 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.488 0.315 . . . . 15.0 110.291 -176.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 203' ' ' LYS . 8.4 pt-20 -62.58 -27.6 69.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.108 0.88 . . . . 15.0 112.429 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.23 -30.58 67.69 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.957 0.903 . . . . 15.0 110.527 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.43 -5.66 85.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.167 -0.924 . . . . 15.0 112.98 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 33.6 mm -103.74 -47.97 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 123.429 0.692 . . . . 15.0 110.47 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 199' ' ' GLU . 22.6 pttm -85.4 16.5 3.7 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.782 1.03 . . . . 15.0 113.782 -169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -127.91 32.28 3.5 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.744 -0.942 . . . . 15.0 110.744 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -146.52 -167.83 2.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 15.0 110.473 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -151.86 161.67 42.28 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.598 0.759 . . . . 15.0 110.01 177.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.96 139.09 52.78 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.139 0.576 . . . . 15.0 111.892 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.39 -21.54 8.63 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 115.501 -0.772 . . . . 15.0 112.429 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 14.8 pt-20 -92.45 137.63 32.2 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.496 0.719 . . . . 15.0 109.485 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.18 112.11 18.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.929 -1.137 . . . . 15.0 107.929 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -131.89 -178.31 4.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.788 1.235 . . . . 15.0 109.878 -171.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 43.3 m -131.11 120.35 23.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.775 0.83 . . . . 15.0 108.98 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.04 156.35 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.274 0.63 . . . . 15.0 110.514 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -116.18 105.28 12.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.095 0.958 . . . . 15.0 108.996 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.1 167.1 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 107.95 -1.13 . . . . 15.0 107.95 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 91.3 m -141.09 133.61 28.47 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.355 -0.98 . . . . 15.0 108.355 170.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.462 ' HZ ' HD12 ' B' ' 387' ' ' ILE . 49.0 m-85 -76.42 138.64 67.46 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 123.432 0.457 . . . . 15.0 111.837 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.8 158.35 11.03 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 123.695 2.93 . . . . 15.0 113.61 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.35 -31.01 63.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.67 -23.97 67.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.346 1.058 . . . . 15.0 111.657 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 227' ' ' LYS . 1.9 t80 -74.35 74.69 1.87 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.076 0.95 . . . . 15.0 109.052 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -67.8 4.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.049 1.5 . . . . 15.0 115.049 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.21 93.1 0.8 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.183 -1.414 . . . . 15.0 107.183 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.1 tt0 -64.08 -29.0 70.17 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.761 0.652 . . . . 15.0 112.761 -166.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -61.2 -22.57 64.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.835 0.854 . . . . 15.0 110.961 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 172' ' ' VAL . 76.4 mt -102.55 -43.37 5.65 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.72 1.208 . . . . 15.0 110.82 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 221' ' ' TYR . 0.7 OUTLIER -54.82 130.62 41.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.889 1.675 . . . . 15.0 112.759 -165.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.48 -18.91 7.69 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.832 0.708 . . . . 15.0 114.398 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 173' ' ' ASP . 93.0 mttt -89.85 143.25 26.96 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.874 0.87 . . . . 15.0 110.562 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.0 106.88 11.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.552 0.741 . . . . 15.0 110.174 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.81 115.97 27.54 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.896 -1.047 . . . . 15.0 110.759 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -106.13 107.64 18.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.411 -0.588 . . . . 15.0 109.411 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -104.9 119.71 39.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.038 0.935 . . . . 15.0 109.121 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.51 93.74 4.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.326 0.65 . . . . 15.0 109.405 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 41.2 mm -81.96 125.89 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.621 1.168 . . . . 15.0 110.421 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -109.34 98.52 7.91 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.336 -1.357 . . . . 15.0 107.336 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.508 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.59 99.52 6.57 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.902 -0.777 . . . . 15.0 108.902 -175.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -93.43 -40.92 10.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.229 -0.442 . . . . 15.0 110.985 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 35.3 mmtp -131.89 139.36 48.75 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.051 0.54 . . . . 15.0 110.687 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 207' ' ' ALA . 86.0 t -104.03 141.93 18.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.112 -1.811 . . . . 15.0 106.112 159.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.2 mt-10 -133.1 -176.26 4.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.147 -0.686 . . . . 15.0 109.147 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.687 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 41.4 tt0 -154.36 130.64 10.43 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.551 0.741 . . . . 15.0 109.358 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' A' ' 146' ' ' LYS . 23.4 ptt180 -86.24 86.03 7.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.19 0.995 . . . . 15.0 108.356 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.89 141.78 58.13 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.116 -1.402 . . . . 15.0 109.873 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.61 132.76 94.61 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.1 -0.704 . . . . 15.0 109.1 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 59.9 Cg_endo -67.83 176.52 5.12 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.468 2.112 . . . . 15.0 112.002 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -68.97 88.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.927 -0.768 . . . . 15.0 108.927 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.19 69.92 4.47 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.934 0.873 . . . . 15.0 109.006 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.9 p -101.83 163.89 12.02 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.591 1.156 . . . . 15.0 109.282 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -50.11 -41.27 48.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.98 0.912 . . . . 15.0 111.195 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.2 -39.46 86.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.179 1.392 . . . . 15.0 111.312 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.14 -59.9 2.59 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.897 . . . . 15.0 109.146 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 258' ' ' VAL . 9.5 tt -57.78 -42.0 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.954 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -67.71 -26.68 66.29 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.687 0.254 . . . . 15.0 111.687 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -72.79 -19.06 61.42 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.622 0.769 . . . . 15.0 110.949 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -87.63 -6.58 58.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.452 0.701 . . . . 15.0 111.322 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.5 5.1 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 119.428 -0.651 . . . . 15.0 114.721 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 261' ' ' GLY . 44.2 t -62.72 111.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 117.483 0.642 . . . . 15.0 110.902 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -58.78 -48.57 80.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.599 1.16 . . . . 15.0 112.001 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.663 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 5.3 t70 -76.69 -43.49 37.46 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.458 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 258' ' ' VAL . . . 82.96 18.97 64.02 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 115.866 -0.606 . . . . 15.0 114.337 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 3.4 p -148.78 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.902 0.881 . . . . 15.0 109.602 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 95.7 t -50.4 -52.97 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 124.364 1.066 . . . . 15.0 113.457 -165.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -31.04 68.53 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.979 0.512 . . . . 15.0 111.549 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 260' ' ' ASP . . . -80.28 -24.08 59.84 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.145 -0.382 . . . . 15.0 112.145 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 270' ' ' VAL . 38.5 tp -77.67 -28.16 51.06 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 176.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.504 ' HA ' HG22 ' A' ' 270' ' ' VAL . 77.3 mtp180 -72.45 -37.6 68.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.956 0.902 . . . . 15.0 109.666 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.65 88.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.751 -0.659 . . . . 15.0 110.411 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.37 -48.7 55.11 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.328 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 274' ' ' MET . 19.2 m -67.4 -25.58 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-O 120.64 0.257 . . . . 15.0 110.634 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -60.01 -66.1 0.57 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.76 0.424 . . . . 15.0 110.48 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -73.28 -7.84 53.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.233 0.613 . . . . 15.0 112.61 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -101.22 -68.91 0.8 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.424 0.69 . . . . 15.0 109.965 170.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.564 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.6 mpt? -66.84 -43.79 82.77 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-O 117.698 -1.144 . . . . 15.0 111.694 -170.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.12 -49.63 71.44 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.441 1.473 . . . . 15.0 109.95 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -51.81 -49.16 63.32 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 113.509 -1.678 . . . . 15.0 111.989 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -84.35 -37.77 21.15 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.558 0.536 . . . . 15.0 111.348 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 130' ' ' VAL . 61.6 tp -67.16 -56.92 7.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.737 0.415 . . . . 15.0 111.894 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.78 -31.65 72.97 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 123.481 0.488 . . . . 15.0 110.194 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.9 t -64.86 -45.57 85.51 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.954 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.25 -31.43 65.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 15.0 112.26 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.556 HD11 ' HB ' ' A' ' 130' ' ' VAL . 98.6 mt -66.28 -51.43 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.802 HH21 ' HB3' ' A' ' 405' ' ' GLU . 28.8 tpt180 -62.14 -37.5 85.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.828 -1.078 . . . . 15.0 110.65 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.67 -23.77 45.5 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.388 0.675 . . . . 15.0 111.05 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.64 ' HD2' ' HG3' ' A' ' 128' ' ' PRO . 25.1 ttm180 -70.33 -49.31 50.71 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 118.577 0.626 . . . . 15.0 109.452 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 282' ' ' ILE . 98.6 t -57.56 -48.25 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.761 0.791 . . . . 15.0 110.008 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -64.21 -46.44 83.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.58 -1.191 . . . . 15.0 111.463 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.2 p -65.89 -39.21 90.44 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 119.256 -0.402 . . . . 15.0 110.935 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.555 ' HB2' HG13 ' A' ' 125' ' ' VAL . 56.8 mt-30 -69.95 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.553 0.533 . . . . 15.0 111.172 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.21 -50.84 66.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.625 0.37 . . . . 15.0 110.607 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 287' ' ' LYS . 30.9 mm -67.76 -41.17 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.796 0.839 . . . . 15.0 111.01 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.425 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 12.4 tp10 -64.43 -36.19 83.35 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.732 0.813 . . . . 15.0 109.474 178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.436 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.54 -43.87 93.86 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.926 -1.034 . . . . 15.0 112.005 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.59 -45.49 81.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.108 0.963 . . . . 15.0 110.841 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.37 -58.67 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.051 0.94 . . . . 15.0 110.26 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.425 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.4 mttm -60.86 -23.47 65.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.641 0.776 . . . . 15.0 112.348 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -79.52 -33.65 41.86 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.547 0.739 . . . . 15.0 111.508 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.52 138.22 7.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 112.719 0.637 . . . . 15.0 112.719 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.08 144.48 29.02 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 15.0 109.167 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.48 HG12 HD22 ' A' ' 349' ' ' LEU . 6.5 tp -138.89 123.76 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . 7.6 m-20 -79.0 137.43 37.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.24 130.98 21.44 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.192 0.597 . . . . 15.0 109.449 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.88 130.03 32.74 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.029 2.486 . . . . 15.0 112.501 168.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.58 -9.67 20.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.759 1.022 . . . . 15.0 113.759 -173.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.22 91.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.244 0.618 . . . . 15.0 110.925 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.526 HD11 HD11 ' B' ' 468' ' ' LEU . 90.4 mt -72.31 -38.66 68.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 15.0 111.122 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.61 -52.13 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.14 -38.57 89.47 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.832 0.853 . . . . 15.0 111.453 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.9 t -59.07 -50.57 73.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 15.0 111.226 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.91 -26.33 43.78 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.381 -0.372 . . . . 15.0 111.42 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.41 HG22 ' NE ' ' A' ' 315' ' ' ARG . 62.9 mt -62.29 -35.52 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 166.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.573 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.0 t70 -70.88 -39.36 72.89 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.97 0.508 . . . . 15.0 111.01 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.08 -48.07 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 123.792 0.683 . . . . 15.0 109.27 170.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 341' ' ' ALA . 83.2 mt -73.68 -21.3 60.3 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.117 -0.947 . . . . 15.0 113.237 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.573 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 72.1 mtm180 -75.23 -39.78 59.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.055 0.542 . . . . 15.0 109.806 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -70.38 -41.17 73.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.079 0.552 . . . . 15.0 110.499 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -69.31 -31.09 69.33 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.89 -51.45 55.26 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.161 -0.681 . . . . 15.0 109.161 171.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -56.12 -30.65 62.4 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.41 1.069 . . . . 15.0 112.27 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -60.37 -38.75 84.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.791 0.836 . . . . 15.0 111.502 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -95.44 -15.41 23.0 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.797 0.439 . . . . 15.0 111.525 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.509 ' HE2' ' HG2' ' A' ' 326' ' ' GLU . 42.1 t80 -80.17 -12.75 59.62 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.764 0.826 . . . . 15.0 109.489 173.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.1 33.45 8.17 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.385 -0.825 . . . . 15.0 114.431 166.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 327' ' ' LYS . . . 66.15 3.47 17.97 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 120.134 -0.259 . . . . 15.0 113.44 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -69.23 148.76 49.36 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 109.004 -0.739 . . . . 15.0 109.004 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.509 ' HG2' ' HE2' ' A' ' 322' ' ' PHE . 21.8 mm-40 75.48 -67.24 0.25 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.429 1.492 . . . . 15.0 110.566 -170.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 324' ' ' GLY . 27.3 mtmm 62.47 18.87 10.75 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.414 1.086 . . . . 15.0 110.639 -164.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -100.83 15.1 29.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.508 1.923 . . . . 15.0 108.954 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.608 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -52.73 -22.9 5.76 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 126.211 1.804 . . . . 15.0 114.271 -172.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.56 -26.62 55.62 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.275 0.63 . . . . 15.0 111.358 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -113.68 21.96 14.52 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.065 0.946 . . . . 15.0 111.055 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.608 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 24.2 mt -64.65 128.79 93.88 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.603 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 87.9 Cg_exo -47.7 118.29 2.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.664 2.909 . . . . 15.0 114.328 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -56.02 -36.55 68.09 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.091 0.957 . . . . 15.0 111.235 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.31 -12.05 47.88 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.468 0.914 . . . . 15.0 113.468 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 96.9 mt -71.76 -40.15 69.52 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.368 -0.604 . . . . 15.0 109.368 170.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -107.01 -10.77 15.83 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.271 -168.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -48.66 -57.75 5.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.147 1.379 . . . . 15.0 113.021 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.1 -59.21 4.95 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.265 1.026 . . . . 15.0 111.397 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.01 -36.55 69.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.617 -0.72 . . . . 15.0 112.416 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -70.7 -50.79 32.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.069 0.547 . . . . 15.0 110.04 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 83.8 tttt -60.11 -34.94 74.19 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.03 0.832 . . . . 15.0 110.328 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.6 mmt85 -62.89 -38.1 89.56 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.003 -0.522 . . . . 15.0 111.26 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.73 -28.8 66.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 123.286 0.366 . . . . 15.0 110.853 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.644 ' HA ' ' HB1' ' B' ' 466' ' ' ALA . 24.9 t -75.48 -36.01 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.98 -0.378 . . . . 15.0 109.98 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -65.8 -35.03 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 123.561 0.744 . . . . 15.0 109.863 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 351' ' ' LEU . 55.4 t -60.47 -54.64 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.809 -0.811 . . . . 15.0 108.809 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.66 97.48 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.388 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 300' ' ' ILE . 6.5 tt -78.15 -55.32 5.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.046 0.538 . . . . 15.0 110.234 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 354' ' ' VAL . 72.3 mt -67.1 -49.27 65.53 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.039 0.212 . . . . 15.0 110.694 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 347' ' ' VAL . 64.9 mt -69.2 -28.26 66.22 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 119.334 -0.365 . . . . 15.0 111.055 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.572 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.2 -42.36 99.72 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.923 -0.471 . . . . 15.0 111.923 172.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.21 -39.14 93.35 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.238 -0.481 . . . . 15.0 110.58 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -59.57 -37.04 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 122.888 0.475 . . . . 15.0 111.041 174.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.572 HD12 ' HA2' ' A' ' 352' ' ' GLY . 75.9 mt -65.2 -46.85 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.744 0.818 . . . . 15.0 110.543 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.95 -53.25 41.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.525 0.203 . . . . 15.0 110.908 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.0 m -60.27 -40.72 91.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.588 1.155 . . . . 15.0 112.053 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.39 17.98 18.86 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.174 0.589 . . . . 15.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 46.33 30.02 0.96 Allowed 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 125.703 1.601 . . . . 15.0 114.626 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.617 ' HB3' HE21 ' A' ' 406' ' ' GLN . 83.1 mt -65.72 148.28 52.02 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.072 0.949 . . . . 15.0 112.811 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -129.31 158.09 40.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.522 1.129 . . . . 15.0 108.83 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -74.67 90.33 2.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 367' ' ' VAL . 5.2 t70 -67.73 120.93 14.88 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.11 0.964 . . . . 15.0 110.758 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -63.26 -23.67 67.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.826 0.85 . . . . 15.0 113.0 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.61 -34.11 73.62 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 30.9 tpt85 -77.82 -36.81 49.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.725 0.81 . . . . 15.0 109.951 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 399' ' ' ARG . 41.3 t -63.99 -55.01 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.617 0.767 . . . . 15.0 109.746 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -36.18 81.59 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.813 -1.085 . . . . 15.0 109.778 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.95 96.75 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.787 0.679 . . . . 15.0 112.711 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 367' ' ' VAL . 69.3 mt -57.44 -48.15 79.9 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.636 0.774 . . . . 15.0 111.07 172.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.632 HG21 ' HA ' ' A' ' 385' ' ' ILE . 17.8 mm -56.35 -44.69 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 124.183 0.927 . . . . 15.0 110.81 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -61.57 -54.46 42.77 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 15.0 110.782 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -61.6 -37.7 84.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.499 0.72 . . . . 15.0 112.769 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.485 ' SD ' HD12 ' B' ' 441' ' ' ILE . 18.2 tmm? -74.76 -45.76 41.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.423 0.689 . . . . 15.0 109.931 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -73.28 -16.83 61.38 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.184 0.594 . . . . 15.0 111.959 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.1 t -73.1 -0.18 13.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.991 0.917 . . . . 15.0 111.692 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -98.54 -10.11 23.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.583 0.753 . . . . 15.0 111.268 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.497 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 79.1 m-85 -111.31 157.56 20.03 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.108 0.963 . . . . 15.0 109.604 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.0 -45.06 71.51 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.211 0.604 . . . . 15.0 110.834 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.88 100.71 17.5 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 124.596 1.158 . . . . 15.0 110.26 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.9 -41.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.605 2.204 . . . . 15.0 115.794 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -68.92 -28.97 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -163.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.32 -28.69 67.38 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.344 0.403 . . . . 15.0 110.095 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.74 -38.81 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.556 0.742 . . . . 15.0 109.261 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.632 ' HA ' HG21 ' A' ' 371' ' ' ILE . 1.8 mp -55.55 -48.56 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.493 -0.558 . . . . 15.0 109.493 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -67.74 -34.01 76.0 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.591 0.756 . . . . 15.0 111.668 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -64.35 -40.04 95.08 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.794 0.838 . . . . 15.0 110.961 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.509 ' HB3' ' HE3' ' A' ' 395' ' ' MET . 29.9 m-85 -79.0 -50.51 10.98 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.916 0.135 . . . . 15.0 111.014 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . 0.58 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 93.5 p -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.62 0.6 . . . . 15.0 112.62 -169.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.02 0.07 54.23 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.184 0.594 . . . . 15.0 112.052 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -113.52 118.84 35.58 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -63.84 -61.47 2.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.434 0.693 . . . . 15.0 112.164 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.59 ' HA ' HD22 ' B' ' 450' ' ' ASN . 5.0 mp0 -59.98 -30.66 69.26 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.426 0.69 . . . . 15.0 112.173 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' B' ' 442' ' ' ALA . 42.0 tp -84.16 -38.9 20.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.984 0.513 . . . . 15.0 111.441 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -62.13 -48.26 80.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 175.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.56 ' HA ' ' HD2' ' A' ' 399' ' ' ARG . 13.2 t70 -62.95 -39.7 95.44 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.575 1.172 . . . . 15.0 110.826 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 401' ' ' VAL . 9.5 t30 -59.8 -40.64 89.02 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.245 0.545 . . . . 15.0 110.391 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.0 tpt -78.64 -16.75 56.96 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.301 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.56 ' HD2' ' HA ' ' A' ' 396' ' ' ASP . 97.9 mtt180 -71.81 -36.25 70.19 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.175 0.59 . . . . 15.0 109.429 167.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -64.2 -42.27 96.7 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.525 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 397' ' ' ASN . 24.9 t -62.48 -42.36 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 123.851 0.719 . . . . 15.0 110.867 175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.51 85.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.491 0.716 . . . . 15.0 111.188 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.33 -35.17 71.12 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.465 -1.243 . . . . 15.0 111.001 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -60.04 -54.49 45.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.292 1.037 . . . . 15.0 110.327 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.802 ' HB3' HH21 ' A' ' 283' ' ' ARG . 47.8 mt-10 -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.384 -0.826 . . . . 15.0 111.92 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.617 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.5 tt0 -67.47 -37.58 83.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.21 0.604 . . . . 15.0 109.857 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.6 78.58 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.474 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.22 -56.13 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.86 -25.52 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.429 1.092 . . . . 15.0 112.409 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -71.18 -30.13 66.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.038 0.535 . . . . 15.0 111.233 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.49 -34.81 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.911 -0.774 . . . . 15.0 108.911 172.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 80.9 mt -70.06 -31.08 68.52 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.458 0.703 . . . . 15.0 111.502 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.7 0.8 . . . . 15.0 110.812 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -86.41 -34.17 20.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.739 0.816 . . . . 15.0 109.881 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -86.34 -171.81 3.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.73 1.212 . . . . 15.0 112.126 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.629 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 79.0 mttt -114.9 117.47 30.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.911 -1.041 . . . . 15.0 108.696 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.53 101.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 109.19 -0.67 . . . . 15.0 109.19 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 t -71.32 89.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 122.132 0.968 . . . . 15.0 109.466 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.52 110.02 8.48 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.286 -1.325 . . . . 15.0 109.566 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -133.99 137.88 45.06 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 15.0 110.157 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.05 131.41 39.47 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.384 0.674 . . . . 15.0 109.233 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.2 t -158.76 170.66 21.64 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.214 0.605 . . . . 15.0 110.372 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.6 p -90.68 176.98 6.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.471 0.709 . . . . 15.0 112.313 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -63.7 -23.91 67.56 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.777 1.231 . . . . 15.0 110.935 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -66.93 -17.78 65.07 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.64 1.176 . . . . 15.0 112.301 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.512 ' HB3' HD12 ' A' ' 427' ' ' LEU . 13.2 tp10 -63.83 -36.15 82.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.029 0.932 . . . . 15.0 111.38 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 130' ' ' VAL . 3.1 mp -104.16 -69.58 0.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.87 0.468 . . . . 15.0 111.476 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.528 ' SD ' ' HB2' ' A' ' 427' ' ' LEU . 1.6 mpt? -92.54 -50.19 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.054 0.39 . . . . 15.0 112.054 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -88.71 49.69 1.83 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.842 0.829 . . . . 15.0 110.997 -165.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -71.35 168.28 17.73 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.61 1.164 . . . . 15.0 111.405 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' B' ' 402' ' ' ASP . 36.0 mt-30 -79.57 -13.43 59.53 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.653 175.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 C-N-CA 124.742 1.217 . . . . 15.0 108.681 175.692 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -118.26 -168.8 1.59 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.93 0.892 . . . . 0.0 109.585 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.16 -73.4 0.59 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.053 0.541 . . . . 0.0 110.086 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -103.95 -82.87 0.5 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 120.964 0.411 . . . . 0.0 111.75 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -109.33 -69.67 0.85 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.888 0.875 . . . . 0.0 112.522 -168.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.53 -79.59 0.42 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.462 HG13 ' H ' ' B' ' 372' ' ' GLN . 1.2 p -113.02 -82.45 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 171.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.462 ' H ' HG13 ' B' ' 371' ' ' VAL . 6.6 tp60 -100.17 -82.51 0.45 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -105.25 -82.88 0.52 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.861 0.464 . . . . 0.0 109.756 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -101.37 -71.93 0.7 Allowed 'General case' 0 C--N 1.351 0.632 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.403 HD22 ' HG3' ' B' ' 376' ' ' GLU . 6.6 tt -107.27 -75.92 0.62 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 166.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' B' ' 377' ' ' PHE . 0.0 OUTLIER -103.64 -89.27 0.4 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.15 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.428 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 89.0 t80 -102.37 -62.88 1.21 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.377 1.071 . . . . 0.0 109.851 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.13 -83.57 0.48 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -171.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.564 ' HG2' ' H ' ' B' ' 380' ' ' LYS . 0.0 OUTLIER -110.76 -66.81 1.04 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.916 0.487 . . . . 0.0 111.327 -172.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.564 ' H ' ' HG2' ' B' ' 379' ' ' LYS . 2.0 ptpp? -160.11 132.23 6.26 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.676 1.19 . . . . 0.0 109.127 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . 0.49 ' HB2' ' ND2' ' B' ' 383' ' ' ASN . 36.1 mt-10 67.88 156.43 0.12 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.817 1.247 . . . . 0.0 113.515 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -75.51 69.48 2.03 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.821 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' B' ' 381' ' ' GLU . 44.2 m-80 -86.14 -157.58 0.35 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.797 0.839 . . . . 0.0 111.041 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' B' ' 383' ' ' ASN . 11.4 m 72.1 60.27 0.14 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.75 1.22 . . . . 0.0 109.169 -172.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 198' ' ' PHE . 5.4 tt -67.38 131.32 45.48 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.005 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.623 HG21 ' HA3' ' A' ' 179' ' ' GLY . 7.5 p -77.88 91.74 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-O 122.69 1.233 . . . . 0.0 110.995 -173.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.462 HD12 ' HZ ' ' A' ' 217' ' ' PHE . 8.3 mm -150.98 141.71 16.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 C-N-CA 127.805 2.442 . . . . 0.0 104.484 162.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.26 93.99 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 119.099 0.863 . . . . 0.0 110.266 -164.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 42.0 m -177.91 95.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.415 2.686 . . . . 0.0 105.399 166.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -91.24 84.38 5.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.784 0.72 . . . . 0.0 111.033 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 25.5 t70 169.22 110.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 126.447 1.899 . . . . 0.0 108.404 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -154.01 82.36 1.14 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.42 0.688 . . . . 0.0 110.264 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.1 116.72 1.0 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.742 0.817 . . . . 0.0 110.04 172.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -115.31 -82.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.616 0.767 . . . . 0.0 109.407 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 178.38 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.556 1.143 . . . . 0.0 109.049 -173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 25.6 m -141.53 116.7 10.01 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -126.32 166.08 17.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.539 1.136 . . . . 0.0 108.736 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 21.4 mt 62.63 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.167 0.984 . . . . 0.0 110.694 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.28 -30.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.395 0.678 . . . . 0.0 110.284 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -137.72 137.44 21.74 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 166.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.35 158.87 38.19 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.881 2.387 . . . . 0.0 113.191 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . 0.4 ' H ' ' NE2' ' A' ' 431' ' ' GLN . 9.8 t70 -64.38 150.69 45.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.165 0.986 . . . . 0.0 110.566 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 2.8 m -130.82 17.26 5.2 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.399 0.679 . . . . 0.0 110.99 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.627 ' HD3' ' HA3' ' B' ' 407' ' ' GLY . 64.1 tttp -155.05 -59.85 0.11 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.865 -0.522 . . . . 0.0 111.675 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . 0.31 . . 100.69 -66.4 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.206 0 C-N-CA 127.965 2.506 . . . . 0.0 113.489 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.99 38.93 0.69 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 CA-C-N 122.646 1.981 . . . . 0.0 111.989 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . 0.627 ' HA3' ' HD3' ' B' ' 404' ' ' LYS . . . -118.21 32.45 5.26 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.883 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.91 112.34 11.04 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.6 m -65.14 86.83 0.06 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.909 0.884 . . . . 0.0 110.065 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 64.0 -174.32 0.16 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.942 -176.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -145.78 -40.75 0.22 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.443 0.697 . . . . 0.0 110.16 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 54.8 tp 70.93 -75.35 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.203 1.401 . . . . 0.0 111.2 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -163.06 -167.57 1.52 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.153 0.981 . . . . 0.0 109.922 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 59.7 m -133.31 102.89 5.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -157.36 137.95 13.05 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.06 -37.64 84.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.444 0.698 . . . . 0.0 111.285 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -87.48 -11.55 68.67 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.212 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 66.27 -70.45 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.449 1.5 . . . . 0.0 111.737 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.8 98.94 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.237 1.015 . . . . 0.0 108.728 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.441 ' HG3' HG12 ' B' ' 421' ' ' VAL . 50.7 tpp 65.25 -85.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 420' ' ' MET . 10.4 p -168.75 140.43 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.12 0.968 . . . . 0.0 108.914 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 13.3 tpt -159.43 75.99 0.67 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 35.0 t -88.22 -51.27 5.86 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.844 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.07 155.12 46.2 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.533 1.133 . . . . 0.0 109.635 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -164.27 58.49 0.27 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -93.52 167.01 11.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.577 0.751 . . . . 0.0 110.652 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 63.3 m -73.87 108.62 6.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.938 0.895 . . . . 0.0 110.323 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.42 -59.25 2.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.249 0.619 . . . . 0.0 111.034 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.69 ' HG2' ' H ' ' B' ' 430' ' ' ASP . 0.7 OUTLIER -107.43 -79.97 0.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.913 179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . 0.69 ' H ' ' HG2' ' B' ' 429' ' ' GLU . 21.0 t70 -88.1 -82.37 0.23 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 170.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 9.6 t -112.08 -82.41 0.59 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 154.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -114.82 -40.29 3.56 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.704 0.802 . . . . 0.0 109.211 170.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.88 -35.36 0.22 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.177 0.991 . . . . 0.0 109.589 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -141.92 162.62 35.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 24.6 p -54.79 -44.2 73.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.538 0.735 . . . . 0.0 112.082 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 148.49 -136.43 5.9 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 19.5 m -84.45 22.06 1.34 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.737 0.815 . . . . 0.0 111.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? 82.36 -53.97 0.22 Allowed 'General case' 0 C--N 1.367 1.334 0 C-N-CA 126.504 1.922 . . . . 0.0 111.257 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.44 135.19 55.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.892 0.477 . . . . 0.0 111.339 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -60.0 -63.03 1.44 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.574 1.15 . . . . 0.0 111.881 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.485 HD12 ' SD ' ' A' ' 374' ' ' MET . 0.0 OUTLIER -145.42 137.08 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -172.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 394' ' ' LEU . . . -169.34 177.77 4.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.539 1.136 . . . . 0.0 110.702 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -92.26 -66.9 0.89 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.045 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -110.83 -177.56 3.25 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.646 0.778 . . . . 0.0 110.993 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.31 128.43 3.68 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 118.59 -1.116 . . . . 0.0 110.475 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.8 123.59 13.29 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 123.009 2.472 . . . . 0.0 112.246 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -74.3 -15.91 60.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.219 0.608 . . . . 0.0 111.319 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.24 51.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 0.0 108.983 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -65.42 125.27 24.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.59 HD22 ' HA ' ' A' ' 393' ' ' GLU . 74.5 m-20 -72.36 -44.1 63.08 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.322 0.649 . . . . 0.0 110.578 -171.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 75.9 t 66.22 -71.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 124.735 1.214 . . . . 0.0 111.981 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 87.2 t -132.48 126.5 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -70.75 76.63 0.53 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 48.9 tp -70.36 92.5 0.8 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.661 1.184 . . . . 0.0 110.111 -170.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 25.0 m -84.82 84.97 7.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.784 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.96 -74.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' B' ' 463' ' ' THR . 23.2 mm-40 54.67 22.8 4.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.614 1.566 . . . . 0.0 113.058 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.8 m 70.08 -65.2 0.33 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.683 1.593 . . . . 0.0 110.366 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.05 156.55 46.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.767 1.227 . . . . 0.0 108.124 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 3.5 tt 66.53 99.38 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -170.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -45.89 -53.1 10.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.564 1.146 . . . . 0.0 113.142 -169.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -131.87 115.07 15.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' B' ' 457' ' ' GLN . 88.3 m -68.83 104.99 2.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 124.163 0.914 . . . . 0.0 109.759 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -83.08 177.44 8.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.813 0.445 . . . . 0.0 110.062 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -75.69 150.08 37.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.127 0.571 . . . . 0.0 109.507 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 345' ' ' VAL . . . 68.02 8.01 6.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.05 1.34 . . . . 0.0 112.565 -171.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -122.78 168.51 12.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.969 0.908 . . . . 0.0 110.667 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 306' ' ' LEU . 2.6 mm? -111.34 163.41 14.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.687 0.795 . . . . 0.0 110.974 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.24 -134.93 4.39 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.262 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 41.5 tp 52.38 -98.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.217 1.007 . . . . 0.0 109.49 -170.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.687 1.195 . . . . 12.06 108.079 176.067 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.665 0.269 . . . . 15.0 110.939 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -158.31 149.61 21.01 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.753 1.221 . . . . 15.0 109.054 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 17' ' ' ILE . 13.5 m -133.68 77.96 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.838 0.855 . . . . 15.0 110.537 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 p -78.95 91.01 4.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 15.0 110.497 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 2.6 p -80.51 93.65 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 122.2 1.0 . . . . 15.0 111.433 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.94 98.2 7.79 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.501 1.12 . . . . 15.0 109.989 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 m -64.55 112.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.102 0.561 . . . . 15.0 109.962 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -76.32 -54.74 6.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 110.108 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -167.43 120.16 0.93 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.767 0.827 . . . . 15.0 109.671 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.55 -101.6 0.47 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 124.157 0.91 . . . . 15.0 113.551 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 ' HA ' ' A' ' 113' ' ' PRO . 1.8 mm? -90.54 -22.08 21.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.175 0.59 . . . . 15.0 110.884 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.46 122.8 30.31 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 124.359 1.037 . . . . 15.0 112.223 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.471 HH12 ' HA ' ' A' ' 11' ' ' LEU . 68.7 mtt85 -140.86 108.16 5.52 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.751 1.22 . . . . 15.0 109.892 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 31.0 ttm180 -83.94 82.95 8.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.564 1.146 . . . . 15.0 109.131 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 t -76.49 88.46 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 61.6 m -75.94 96.62 3.79 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.273 -0.876 . . . . 15.0 109.633 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 3' ' ' VAL . 54.1 mt -84.21 106.07 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.555 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 35.9 m -83.72 100.6 10.99 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.554 -0.906 . . . . 15.0 108.554 170.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 70' ' ' LEU . 39.0 mt -77.01 130.85 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 140.54 58.88 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 123.92 0.763 . . . . 15.0 110.517 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.12 63.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.979 1.312 . . . . 15.0 112.208 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -38.65 78.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.114 -0.948 . . . . 15.0 111.285 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.4 m -68.62 -30.92 69.76 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.406 0.682 . . . . 15.0 111.158 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 103' ' ' PHE . 78.8 mt -65.25 -54.08 33.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 CA-C-N 115.496 -0.774 . . . . 15.0 109.087 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -59.22 -29.45 67.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.192 0.997 . . . . 15.0 111.841 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.7 m -74.8 -52.76 10.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.768 0.827 . . . . 15.0 110.317 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.06 85.04 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.395 0.678 . . . . 15.0 112.287 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 63' ' ' ARG . 58.6 t -67.59 -45.36 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.09 0.556 . . . . 15.0 109.868 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -65.9 -31.45 72.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.178 0.591 . . . . 15.0 111.32 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -63.35 -44.51 94.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.437 0.695 . . . . 15.0 109.78 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 35' ' ' VAL . 14.4 tp10 -63.81 -42.36 97.71 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.434 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 55' ' ' ALA . 79.6 mt -66.77 -39.23 87.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.909 0.884 . . . . 15.0 112.891 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.44 -28.07 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -71.72 -34.16 69.35 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 118.994 -0.527 . . . . 15.0 111.074 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 31' ' ' GLU . 77.2 t -60.68 -35.46 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.259 0.624 . . . . 15.0 110.163 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.05 -49.08 78.14 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.449 -0.796 . . . . 15.0 110.721 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -69.56 -42.95 73.88 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.895 0.878 . . . . 15.0 110.779 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.81 -34.43 66.87 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.743 1.617 . . . . 15.0 111.286 -169.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -107.54 10.87 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-O 121.338 0.59 . . . . 15.0 109.794 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 59.26 23.37 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.821 1.248 . . . . 15.0 112.796 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 60.0 mt -72.99 -22.92 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.416 1.086 . . . . 15.0 109.862 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 45' ' ' ARG . 8.2 p-10 -58.08 -29.56 65.52 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.556 1.142 . . . . 15.0 112.758 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.49 -41.37 94.28 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.588 -0.605 . . . . 15.0 111.588 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -79.13 -24.29 43.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.964 0.906 . . . . 15.0 110.169 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 42' ' ' ASP . 28.3 tpt180 -79.97 90.13 5.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.232 1.013 . . . . 15.0 109.335 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -92.62 -7.44 46.98 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.941 -1.027 . . . . 15.0 110.832 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 49.44 3.29 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.6 0.563 . . . . 15.0 112.503 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -77.27 -58.56 3.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.197 0.599 . . . . 15.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.61 122.66 70.36 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.712 -0.847 . . . . 15.0 108.712 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.1 148.28 7.14 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.844 3.029 . . . . 15.0 114.488 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.7 tpp -64.52 -34.51 78.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.369 1.068 . . . . 15.0 112.118 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.35 -37.36 86.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.715 0.406 . . . . 15.0 111.1 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.25 -42.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.985 0.914 . . . . 15.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 19.5 m -71.61 -21.18 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 122.342 -0.224 . . . . 15.0 110.871 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -76.9 -46.65 23.66 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.187 0.595 . . . . 15.0 111.801 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.743 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.5 pt20 -81.63 -30.1 32.95 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.517 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.743 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 75.2 mtt180 -103.1 -60.78 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.062 0.545 . . . . 15.0 110.9 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.556 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 68.5 m-85 -76.95 -19.43 57.36 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 15.0 111.142 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -100.89 9.18 58.18 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.917 -0.583 . . . . 15.0 113.247 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.02 -30.07 69.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.542 0.737 . . . . 15.0 111.088 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.9 p -81.39 -33.19 32.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.76 0.824 . . . . 15.0 110.866 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.06 -16.26 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.068 0.947 . . . . 15.0 111.279 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HD3' HG21 ' A' ' 28' ' ' VAL . 19.8 mmt180 -48.2 -42.33 29.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.277 1.031 . . . . 15.0 111.442 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -52.03 -54.23 32.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.975 1.31 . . . . 15.0 112.185 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.04 -24.61 58.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.86 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 28' ' ' VAL . 44.0 t -79.23 -23.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 122.546 0.338 . . . . 15.0 110.234 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 HD12 ' A' ' 70' ' ' LEU . 66.1 mt -57.69 -29.59 64.79 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.35 -0.357 . . . . 15.0 111.66 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.82 -38.66 95.65 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 117.844 0.293 . . . . 15.0 112.935 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 29.8 t70 -74.49 -36.44 63.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.771 0.828 . . . . 15.0 109.972 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.524 HD12 HD23 ' A' ' 67' ' ' LEU . 96.4 mt -73.24 -19.28 61.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.003 -0.999 . . . . 15.0 111.917 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 76.7 mtm -104.81 -66.35 0.97 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.762 0.425 . . . . 15.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.3 t -70.83 -35.56 72.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.48 0.712 . . . . 15.0 112.503 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 76' ' ' ILE . 4.9 tmm_? -87.76 -43.67 11.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -58.99 -25.55 63.72 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.467 0.576 . . . . 15.0 111.606 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -54.81 -50.73 67.85 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.098 0.959 . . . . 15.0 111.73 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 73' ' ' ARG . 13.2 tt -69.32 -37.34 75.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 110.11 -0.33 . . . . 15.0 110.11 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 -23.38 67.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.321 0.649 . . . . 15.0 111.729 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' HB1' HG11 ' A' ' 3' ' ' VAL . . . -83.52 -42.19 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.873 0.869 . . . . 15.0 111.677 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.558 HD12 ' HD3' ' A' ' 86' ' ' PRO . 28.2 pt -85.28 -30.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.203 0.816 . . . . 15.0 113.203 -169.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.2 mt -57.26 -50.17 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.4 0.68 . . . . 15.0 111.042 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.9 ptpt -60.79 -39.65 89.66 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.705 0.628 . . . . 15.0 111.486 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 24.5 mm-40 -87.85 5.63 39.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.384 0.673 . . . . 15.0 111.706 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm 64.62 17.81 11.09 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.068 1.347 . . . . 15.0 112.281 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.63 112.87 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.192 0.997 . . . . 15.0 109.939 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -101.2 114.75 65.75 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.361 -0.977 . . . . 15.0 108.361 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.558 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.1 Cg_endo -74.11 153.07 46.31 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.838 2.359 . . . . 15.0 112.989 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.72 18.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.804 1.242 . . . . 15.0 108.318 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 94.48 -151.71 20.28 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.731 -0.548 . . . . 15.0 111.731 -174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.99 128.66 27.23 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.552 0.741 . . . . 15.0 110.678 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.0 Cg_endo -81.83 107.3 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.383 2.055 . . . . 15.0 111.626 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.5 m -76.96 96.09 4.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.607 0.763 . . . . 15.0 110.824 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -74.1 94.49 2.42 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.081 -0.711 . . . . 15.0 109.081 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.8 t -90.96 102.15 4.95 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.949 -0.76 . . . . 15.0 108.949 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.52 95.74 0.86 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.648 2.232 . . . . 15.0 109.995 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -46.45 93.49 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.172 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.49 146.14 4.86 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.557 0.743 . . . . 15.0 110.745 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -128.49 142.7 51.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.548 1.139 . . . . 15.0 108.41 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 95.0 mttt -129.83 158.61 38.97 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.235 1.014 . . . . 15.0 108.619 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.07 98.44 0.1 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.591 0.756 . . . . 15.0 110.235 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.51 19.02 74.22 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.599 -0.728 . . . . 15.0 114.39 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.743 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 44.1 mt-10 -110.67 158.86 18.14 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.467 0.707 . . . . 15.0 110.421 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -49.25 107.13 0.13 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.171 1.544 . . . . 15.0 112.896 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.482 ' H ' HD11 ' A' ' 24' ' ' ILE . 13.3 t80 -80.42 96.28 6.67 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.488 -0.778 . . . . 15.0 109.539 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.0 m -95.14 105.54 17.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.106 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -129.92 143.75 50.97 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.341 0.657 . . . . 15.0 109.905 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.1 m -99.47 105.59 17.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.7 1.2 . . . . 15.0 111.672 -173.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 t -86.01 99.93 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.927 0.491 . . . . 15.0 109.724 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.65 106.02 18.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.419 0.688 . . . . 15.0 110.26 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.657 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 30.7 p90 -142.06 174.21 10.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.962 0.905 . . . . 15.0 109.233 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -116.61 164.82 14.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.779 0.831 . . . . 15.0 109.934 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.8 m -120.66 -177.52 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.988 0.915 . . . . 15.0 109.152 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -72.83 143.79 84.83 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.029 0.532 . . . . 15.0 110.211 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 11' ' ' LEU . 23.9 Cg_endo -89.4 -167.95 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.426 2.751 . . . . 15.0 114.946 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -88.66 155.37 19.64 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.581 -1.19 . . . . 15.0 109.433 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 123.02 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.16 0.584 . . . . 15.0 110.096 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -119.94 119.36 33.23 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.376 -0.972 . . . . 15.0 108.376 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.0 mt -82.66 146.77 28.9 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.79 -0.818 . . . . 15.0 108.79 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -88.67 -171.24 3.24 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.377 0.271 . . . . 15.0 110.495 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.9 102.43 0.28 Allowed Glycine 0 C--N 1.351 1.405 0 O-C-N 123.962 0.789 . . . . 15.0 111.726 173.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.38 -23.91 67.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.963 0.905 . . . . 15.0 110.386 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.97 -24.52 66.06 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.86 1.264 . . . . 15.0 111.256 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.81 -31.58 61.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.348 0.659 . . . . 15.0 110.929 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.6 mt -65.48 120.28 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.065 0.853 . . . . 15.0 109.651 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.29 102.89 13.32 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.606 0.762 . . . . 15.0 109.245 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.44 162.65 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.908 1.283 . . . . 15.0 107.802 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -113.69 148.69 35.92 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HE2' HD11 ' A' ' 129' ' ' ILE . 84.0 tttt -127.65 89.8 49.97 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.904 0.882 . . . . 15.0 108.753 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.36 102.66 1.63 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.218 1.945 . . . . 15.0 111.738 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.543 HD11 ' HE2' ' A' ' 127' ' ' LYS . 47.3 mm -73.02 106.35 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 169.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 427' ' ' LEU . 15.3 t -132.24 147.27 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.779 -172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.47 157.37 46.32 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.777 1.231 . . . . 15.0 107.894 166.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.46 87.75 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 107.454 -1.313 . . . . 15.0 107.454 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 137' ' ' VAL . 28.7 p -65.56 175.51 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.72 0.808 . . . . 15.0 110.147 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.93 -36.97 78.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.042 0.448 . . . . 15.0 110.863 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.51 91.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.831 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 71.7 m-20 -74.98 -42.61 57.22 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.451 0.701 . . . . 15.0 111.717 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 133' ' ' THR . 89.6 t -62.62 -57.64 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.29 -31.12 62.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.206 -0.907 . . . . 15.0 111.058 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.79 -36.38 57.93 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.518 0.511 . . . . 15.0 113.033 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -71.5 -45.1 63.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.935 0.494 . . . . 15.0 109.683 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.83 -36.12 67.13 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.477 0.711 . . . . 15.0 111.676 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.95 -45.17 86.85 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.325 1.05 . . . . 15.0 110.144 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.1 m -58.92 -46.85 86.95 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.254 0.971 . . . . 15.0 110.094 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.97 -40.21 94.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.975 0.91 . . . . 15.0 111.562 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -66.88 -36.8 83.13 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.533 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 83.4 mttt -83.63 -16.82 43.73 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -80.92 -40.62 24.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -96.6 25.34 5.21 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.656 0.783 . . . . 15.0 110.535 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -74.15 149.37 41.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.522 0.729 . . . . 15.0 112.336 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.5 m -70.32 120.41 15.94 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.064 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -79.43 105.71 10.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -118.69 160.25 22.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.308 1.043 . . . . 15.0 108.698 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 51.6 mt-10 -107.64 147.13 31.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.283 0.633 . . . . 15.0 110.215 173.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' HG3' HG12 ' A' ' 240' ' ' VAL . 49.5 pttt -145.22 -178.92 6.31 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.109 0.964 . . . . 15.0 111.001 171.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -155.01 161.68 41.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.525 1.13 . . . . 15.0 108.001 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.53 -50.81 0.82 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.225 -0.75 . . . . 15.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.04 134.8 13.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.929 0.491 . . . . 15.0 110.72 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.412 HG22 HG13 ' A' ' 240' ' ' VAL . 53.8 t -88.0 137.12 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.819 -1.178 . . . . 15.0 107.819 167.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.61 170.25 8.15 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.67 -0.863 . . . . 15.0 108.67 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.25 61.24 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.83 1.048 . . . . 15.0 113.83 -169.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.89 16.99 18.25 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -90.94 -176.02 4.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.946 0.879 . . . . 15.0 112.539 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 11.5 mtm180 -106.52 150.4 26.15 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.305 -1.316 . . . . 15.0 108.533 166.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.09 114.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 20.5 m -94.06 117.08 29.6 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.792 -1.188 . . . . 15.0 107.792 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.45 163.98 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.807 0.813 . . . . 15.0 111.495 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 15.7 t70 -106.58 155.14 19.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 105.703 -1.962 . . . . 15.0 105.703 159.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -154.41 169.31 24.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.348 0.594 . . . . 15.0 110.34 168.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 t -157.92 124.32 4.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.041 -1.436 . . . . 15.0 107.975 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -127.81 177.71 17.43 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 122.04 -0.412 . . . . 15.0 113.822 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.3 p -150.71 130.89 13.56 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.127 0.971 . . . . 15.0 109.715 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.59 HG11 HD23 ' A' ' 226' ' ' LEU . 47.0 t -94.7 117.72 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 30.5 t70 73.83 -5.36 2.04 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.768 1.227 . . . . 15.0 112.11 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 114.39 -0.13 23.61 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.731 -0.483 . . . . 15.0 112.471 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 15.0 pt-20 -113.04 139.46 48.66 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.63 0.715 . . . . 15.0 109.408 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.44 149.59 45.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.738 0.415 . . . . 15.0 110.728 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.517 ' HD2' HG23 ' A' ' 172' ' ' VAL . 4.5 p90 -106.84 -175.71 2.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.92 0.888 . . . . 15.0 111.794 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.556 ' HG3' HG12 ' B' ' 388' ' ' VAL . 55.7 mt-10 -53.73 116.32 2.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.1 0.96 . . . . 15.0 110.134 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 -63.67 4.38 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 124.037 0.836 . . . . 15.0 112.341 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.18 -62.22 4.17 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.471 -0.252 . . . . 15.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -88.2 150.35 23.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.086 0.954 . . . . 15.0 111.931 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 167' ' ' ASP . . . -145.37 94.02 2.45 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.775 -1.102 . . . . 15.0 109.576 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.6 m -78.91 121.2 24.57 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.935 0.494 . . . . 15.0 110.494 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.5 42.2 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.447 1.099 . . . . 15.0 112.248 171.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -71.03 129.17 38.3 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.47 -0.567 . . . . 15.0 109.47 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.72 105.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.057 0.943 . . . . 15.0 109.258 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.462 HD23 HG21 ' A' ' 202' ' ' ILE . 30.8 tp -91.68 89.95 7.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.868 0.867 . . . . 15.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.3 87.18 5.6 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.582 -0.896 . . . . 15.0 108.582 172.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.6 mtp -62.19 139.17 58.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.119 0.967 . . . . 15.0 111.596 -175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.66 -26.86 5.6 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.81 0.694 . . . . 15.0 112.235 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -92.02 147.81 22.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.343 0.657 . . . . 15.0 110.206 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.75 65.28 3.94 Favored Glycine 0 C--N 1.35 1.307 0 C-N-CA 123.021 0.343 . . . . 15.0 113.766 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -105.77 -36.0 7.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.027 0.931 . . . . 15.0 110.221 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.417 ' HE1' HD13 ' B' ' 385' ' ' LEU . 23.4 mmt -99.36 150.87 21.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.254 0.621 . . . . 15.0 111.266 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.1 pt -99.07 153.92 37.56 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 114.937 -1.029 . . . . 15.0 109.619 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.22 116.82 3.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.952 2.435 . . . . 15.0 112.281 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 135.9 -41.8 1.39 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.38 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.38 -59.75 2.61 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.945 0.498 . . . . 15.0 110.426 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.81 -23.14 67.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.902 -1.044 . . . . 15.0 112.278 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.04 -36.43 83.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.186 0.994 . . . . 15.0 110.927 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.581 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -72.55 -17.22 77.79 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.248 -0.887 . . . . 15.0 113.097 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 187' ' ' LEU . 31.7 mm -92.59 -48.32 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.56 0.744 . . . . 15.0 110.459 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.1 19.94 2.05 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.144 1.165 . . . . 15.0 114.144 -166.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -137.33 24.15 3.1 Favored Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.865 -0.494 . . . . 15.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -144.07 -171.33 3.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.19 0.996 . . . . 15.0 110.232 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -151.19 156.79 41.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 15.0 110.101 -178.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.564 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.46 142.67 58.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.735 0.814 . . . . 15.0 111.521 -171.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.04 -32.96 4.39 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.455 -0.793 . . . . 15.0 111.516 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.3 pt-20 -93.2 138.12 31.89 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.563 0.697 . . . . 15.0 110.572 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -121.22 105.74 10.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.653 1.181 . . . . 15.0 108.28 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -121.7 177.45 5.25 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.52 1.128 . . . . 15.0 109.568 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 57.0 m -121.04 128.32 52.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.581 HG21 ' HA3' ' A' ' 201' ' ' GLY . 43.2 pt -101.78 160.91 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.557 0.743 . . . . 15.0 109.83 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -113.46 111.07 21.31 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.739 0.815 . . . . 15.0 109.396 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.22 160.86 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.478 -1.304 . . . . 15.0 107.478 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.1 m -143.48 132.89 23.39 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.8 -1.185 . . . . 15.0 107.8 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 90.1 m-85 -85.81 139.66 35.24 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -47.68 157.93 0.83 Allowed 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 124.283 3.322 . . . . 15.0 116.016 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -23.84 63.64 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.88 167.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -77.96 -18.92 55.46 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.387 1.075 . . . . 15.0 111.16 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.62 141.26 56.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.02 0.528 . . . . 15.0 112.299 -170.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.659 ' HB2' ' H ' ' B' ' 392' ' ' HIS . 6.8 p-80 -78.03 17.83 0.56 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 125.163 1.385 . . . . 15.0 114.626 -168.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -137.47 119.47 15.4 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.614 ' HB3' ' HA ' ' B' ' 394' ' ' HIS . 42.0 tt0 -63.5 -40.66 97.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 123.928 0.768 . . . . 15.0 111.972 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -63.1 -19.61 64.58 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.142 0.577 . . . . 15.0 111.871 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.59 HD23 HG11 ' A' ' 172' ' ' VAL . 39.9 mt -99.42 -29.85 12.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.195 0.998 . . . . 15.0 111.691 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -57.83 105.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.77 1.228 . . . . 15.0 111.117 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.74 -19.49 28.91 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.57 -0.741 . . . . 15.0 113.408 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.94 145.48 31.24 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.64 0.776 . . . . 15.0 111.468 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -88.34 126.13 35.04 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.897 -1.047 . . . . 15.0 110.185 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.93 113.94 27.85 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.944 0.898 . . . . 15.0 109.238 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -103.78 101.69 11.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.723 0.809 . . . . 15.0 110.145 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -95.68 117.52 30.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.255 1.022 . . . . 15.0 109.998 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.55 96.76 4.84 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.16 116.39 26.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.036 0.934 . . . . 15.0 110.084 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 9.8 m120 -99.3 91.92 5.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.097 -1.075 . . . . 15.0 108.097 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 74.8 mt -68.47 109.25 3.61 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.099 -0.704 . . . . 15.0 109.099 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.84 -37.58 5.83 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.74 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 73.1 mmtt -133.99 122.58 23.24 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.844 0.858 . . . . 15.0 110.017 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 207' ' ' ALA . 89.0 t -95.58 132.81 38.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 105.55 -2.019 . . . . 15.0 105.55 161.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 37.6 mt-10 -120.01 179.35 4.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -150.96 117.5 5.73 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.871 0.868 . . . . 15.0 109.171 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -84.75 86.6 7.32 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.244 1.021 . . . . 15.0 108.348 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.04 146.7 28.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.682 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 75.1 mt -54.32 122.7 38.83 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 123.836 0.854 . . . . 15.0 110.592 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.14 -169.95 0.83 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.371 2.714 . . . . 15.0 112.944 -171.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.58 106.53 4.06 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.216 -0.661 . . . . 15.0 109.216 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 252' ' ' PHE . 33.3 tp -82.99 14.95 2.99 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.343 1.057 . . . . 15.0 110.299 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.2 p -60.19 174.96 0.46 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.103 1.361 . . . . 15.0 112.321 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.49 -54.78 3.04 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.807 1.643 . . . . 15.0 113.86 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.45 -22.78 67.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 248' ' ' LEU . 71.2 t80 -90.37 -52.26 5.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.37 0.668 . . . . 15.0 110.254 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.442 HG13 HD22 ' A' ' 266' ' ' LEU . 15.8 tt -66.4 -26.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.691 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.672 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 20.8 ptmt -82.6 -16.36 48.73 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 111.932 0.345 . . . . 15.0 111.932 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -58.83 -34.53 71.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.047 0.939 . . . . 15.0 110.95 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -62.76 -28.18 69.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.763 -1.108 . . . . 15.0 111.96 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.82 1.6 0.82 Allowed Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.583 -0.565 . . . . 15.0 113.461 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 21.3 t -72.83 151.09 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.272 0.629 . . . . 15.0 110.06 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -67.57 -64.06 0.93 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.527 1.131 . . . . 15.0 110.483 -170.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -102.64 -40.53 6.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.338 -1.301 . . . . 15.0 109.836 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 128.34 12.8 2.73 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.558 -0.746 . . . . 15.0 113.21 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 p -64.97 138.24 58.24 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.579 0.689 . . . . 15.0 110.375 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.89 -38.14 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.245 1.018 . . . . 15.0 111.711 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -55.48 -34.7 64.79 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.498 0.719 . . . . 15.0 111.388 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.21 -28.08 62.78 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.598 -0.601 . . . . 15.0 111.598 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 270' ' ' VAL . 58.9 tp -73.39 -32.72 64.61 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -65.37 -42.04 93.14 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.34 0.656 . . . . 15.0 109.699 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.03 90.61 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.928 -1.033 . . . . 15.0 110.39 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 15.6 tp10 -67.15 -39.99 86.61 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.729 -1.123 . . . . 15.0 111.465 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 266' ' ' LEU . 24.6 m -75.57 -24.42 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 122.044 -0.41 . . . . 15.0 110.253 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -69.03 -60.56 2.27 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 121.947 -0.471 . . . . 15.0 110.856 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.7 ptmt -61.9 -23.26 66.21 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 15.0 112.32 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -88.65 -69.48 0.7 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.403 0.281 . . . . 15.0 110.406 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 53.6 mtt -71.83 -45.33 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 118.895 -0.574 . . . . 15.0 112.361 -166.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -70.14 -42.16 72.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.625 0.648 . . . . 15.0 110.383 -176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 44.9 ttp85 -58.7 -53.55 57.14 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.167 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.26 -27.68 64.62 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.98 0.8 . . . . 15.0 111.084 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' VAL . 59.9 tp -67.5 -54.96 15.64 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.557 0.743 . . . . 15.0 110.562 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.02 -31.36 72.48 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.583 0.753 . . . . 15.0 110.316 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.2 t -68.89 -43.18 75.78 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 123.801 0.84 . . . . 15.0 110.0 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.86 98.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.146 0.578 . . . . 15.0 110.386 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 130' ' ' VAL . 73.4 mt -63.08 -49.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.011 0.924 . . . . 15.0 109.17 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.98 -54.96 38.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.173 -0.921 . . . . 15.0 110.648 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.22 -35.1 80.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.16 0.984 . . . . 15.0 111.019 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -65.57 -55.0 20.11 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.577 0.626 . . . . 15.0 110.996 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.66 -42.57 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.303 0.641 . . . . 15.0 110.366 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.5 tttt -58.36 -51.31 70.35 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.567 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 292' ' ' GLU . 90.2 p -69.11 -31.68 70.56 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.531 0.519 . . . . 15.0 111.292 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -69.1 -39.44 78.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.907 0.483 . . . . 15.0 110.093 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.419 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.5 -48.27 75.82 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.352 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 33.4 mm -67.12 -36.89 78.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 O-C-N 123.803 0.689 . . . . 15.0 110.709 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 288' ' ' SER . 8.4 tp10 -62.88 -47.76 81.95 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.271 -0.64 . . . . 15.0 109.271 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.28 94.05 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 124.698 1.249 . . . . 15.0 112.531 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.428 ' HB3' HD13 ' A' ' 350' ' ' LEU . 28.3 mt -59.96 -57.86 11.02 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 123.439 0.696 . . . . 15.0 110.39 175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.4 t -56.09 -46.4 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.528 0.731 . . . . 15.0 110.159 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -59.84 -35.29 74.43 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.892 0.877 . . . . 15.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.15 -4.61 42.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.125 0.57 . . . . 15.0 112.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -133.9 115.12 14.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.972 0.805 . . . . 15.0 111.05 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.42 130.57 47.66 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.476 HD13 HD13 ' A' ' 349' ' ' LEU . 3.3 tt -149.13 146.11 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.344 1.058 . . . . 15.0 109.051 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 113' ' ' PRO . 29.3 t70 -72.05 140.67 49.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 307' ' ' ILE . 40.4 t -117.73 105.29 48.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.57 130.36 29.62 Favored 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 123.217 2.611 . . . . 15.0 112.563 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.43 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.21 -29.93 67.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.872 1.269 . . . . 15.0 112.554 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.549 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -54.1 -39.14 66.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.127 0.971 . . . . 15.0 111.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.78 -30.54 56.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.467 -0.788 . . . . 15.0 111.222 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -62.58 -49.96 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.841 -0.8 . . . . 15.0 108.841 173.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.33 -42.02 90.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.238 -0.892 . . . . 15.0 110.58 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 313' ' ' VAL . 36.5 t -57.44 -60.91 2.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.169 0.918 . . . . 15.0 111.219 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -69.8 -39.47 76.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.386 0.513 . . . . 15.0 112.386 -171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 14.9 mt -61.38 -43.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 119.035 -0.507 . . . . 15.0 109.694 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -58.26 -43.57 87.96 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.851 0.461 . . . . 15.0 111.208 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 309' ' ' SER . 81.2 t -54.74 -51.08 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.73 0.812 . . . . 15.0 110.339 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 341' ' ' ALA . 72.6 mt -71.4 -27.5 63.36 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.075 -0.966 . . . . 15.0 112.459 -175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 29.1 mtm180 -72.85 -38.41 67.08 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.563 -0.532 . . . . 15.0 109.563 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.5 -31.59 67.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.148 0.579 . . . . 15.0 110.978 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.21 -43.9 90.07 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.009 0.924 . . . . 15.0 110.432 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.38 -46.0 64.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.58 -0.736 . . . . 15.0 110.131 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -29.2 67.88 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.773 0.829 . . . . 15.0 111.594 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -62.72 -39.67 94.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.737 0.815 . . . . 15.0 109.652 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -81.8 -21.95 37.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.019 -0.537 . . . . 15.0 110.368 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -80.71 0.3 35.07 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.519 1.128 . . . . 15.0 110.16 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 80.18 12.89 82.73 Favored Glycine 0 C--N 1.357 1.717 0 C-N-CA 123.16 0.41 . . . . 15.0 113.651 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 73.56 15.06 79.29 Favored Glycine 0 C--N 1.344 0.996 0 C-N-CA 123.313 0.483 . . . . 15.0 112.816 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -72.36 142.31 48.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.949 0.9 . . . . 15.0 110.434 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 74.82 -42.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.377 1.871 . . . . 15.0 112.942 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm 58.73 26.77 15.05 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.197 1.399 . . . . 15.0 111.571 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -91.9 13.8 17.46 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.723 1.209 . . . . 15.0 110.736 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -53.26 -25.16 13.44 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.089 1.356 . . . . 15.0 113.025 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp -43.8 -35.84 2.07 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.723 1.209 . . . . 15.0 112.166 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.01 72.66 1.42 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.966 0.889 . . . . 15.0 110.089 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 73.1 mt -81.05 153.71 72.3 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 153.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.29 108.73 0.21 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.959 2.439 . . . . 15.0 113.369 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -55.95 -29.09 59.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.254 1.022 . . . . 15.0 110.859 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.08 -21.42 31.61 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.572 1.149 . . . . 15.0 111.878 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.06 -35.31 20.37 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.542 0.737 . . . . 15.0 111.118 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.523 ' HA ' HE21 ' A' ' 340' ' ' GLN . 23.5 m-85 -107.34 -14.38 14.89 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 112.879 0.696 . . . . 15.0 112.879 -167.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.96 -62.55 1.58 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.851 1.26 . . . . 15.0 112.029 -170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.45 -46.29 73.49 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.728 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.523 HE21 ' HA ' ' A' ' 337' ' ' PHE . 25.4 pt20 -67.99 -37.24 81.25 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.624 0.578 . . . . 15.0 111.623 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -64.94 -52.71 54.87 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -51.57 -40.67 60.21 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 124.642 1.214 . . . . 15.0 110.83 176.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 347' ' ' VAL . 15.6 mmt180 -60.26 -46.87 88.32 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 123.418 0.687 . . . . 15.0 110.402 173.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -63.63 -34.21 77.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.473 0.483 . . . . 15.0 111.219 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.81 -53.89 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 15.0 110.148 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 342' ' ' LYS . 62.5 t -65.43 -31.06 52.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.313 0.645 . . . . 15.0 110.957 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 343' ' ' ARG . 40.3 t -60.46 -50.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.522 0.729 . . . . 15.0 109.095 170.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.76 -33.74 88.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.636 -0.711 . . . . 15.0 113.759 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.476 HD13 HD13 ' A' ' 300' ' ' ILE . 96.0 mt -73.82 -54.7 7.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.929 0.491 . . . . 15.0 110.574 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 294' ' ' LEU . 75.6 mt -68.87 -52.67 27.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.891 0.476 . . . . 15.0 110.812 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.14 -38.11 89.55 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 119.275 -0.393 . . . . 15.0 110.834 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.98 -38.41 88.98 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.753 0.658 . . . . 15.0 112.544 176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -69.25 -40.6 77.77 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 119.295 -0.383 . . . . 15.0 111.316 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 350' ' ' LEU . 81.2 t -57.39 -39.94 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.211 0.529 . . . . 15.0 110.575 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.84 -45.46 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.756 1.222 . . . . 15.0 110.755 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.458 ' HA ' ' HE2' ' B' ' 461' ' ' PHE . 20.2 ttp180 -61.28 -53.14 60.56 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.021 0.529 . . . . 15.0 110.785 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 33.0 m -57.13 -50.37 73.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.62 1.168 . . . . 15.0 111.433 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -90.66 14.8 12.39 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.638 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 43.04 36.2 0.89 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 125.375 1.47 . . . . 15.0 114.136 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.532 ' HB3' HE21 ' A' ' 406' ' ' GLN . 99.0 mt -67.26 149.17 50.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.047 0.939 . . . . 15.0 112.159 -176.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.61 150.91 52.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.333 1.053 . . . . 15.0 109.699 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -72.77 104.49 3.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.38 -0.6 . . . . 15.0 109.38 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.78 132.64 42.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.149 0.58 . . . . 15.0 110.395 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -63.94 -30.85 71.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.88 0.872 . . . . 15.0 112.48 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -86.04 -10.64 54.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.961 0.504 . . . . 15.0 111.436 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.5 tpt85 -81.33 -38.13 27.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 171.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 371' ' ' ILE . 89.7 t -58.16 -58.29 7.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 124.837 1.255 . . . . 15.0 109.18 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 372' ' ' GLU . 24.0 mmmt -59.49 -39.62 84.35 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-N 115.628 -0.715 . . . . 15.0 111.589 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.33 67.06 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.934 0.772 . . . . 15.0 112.436 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.08 -42.49 84.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.31 0.644 . . . . 15.0 111.96 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 367' ' ' VAL . 50.5 mm -52.77 -44.17 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 123.992 0.807 . . . . 15.0 110.686 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 368' ' ' LYS . 14.7 mm-40 -70.06 -54.71 11.9 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.46 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -52.43 -36.97 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.837 0.855 . . . . 15.0 112.463 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 60.4 ttp -80.09 -69.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.774 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.87 79.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.858 0.863 . . . . 15.0 113.297 -164.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -21.44 64.92 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.037 0.535 . . . . 15.0 112.166 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -66.79 -20.32 65.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.739 0.816 . . . . 15.0 112.591 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.49 167.83 9.89 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.383 0.673 . . . . 15.0 110.646 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -80.01 -9.73 59.71 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.851 . . . . 15.0 110.809 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.42 59.78 46.08 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.991 1.317 . . . . 15.0 110.545 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.75 -27.95 4.51 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 121.931 1.754 . . . . 15.0 112.301 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -54.79 -45.78 74.37 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.254 1.022 . . . . 15.0 111.042 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 12.7 pt-20 -65.57 -31.46 72.51 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.84 -1.073 . . . . 15.0 111.242 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.96 -37.84 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.277 0.631 . . . . 15.0 109.912 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.95 -54.21 37.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 N-CA-C 108.607 -0.886 . . . . 15.0 108.607 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.35 -27.52 67.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.525 0.73 . . . . 15.0 111.527 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 383' ' ' GLU . 24.0 t80 -62.19 -44.01 97.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.99 0.916 . . . . 15.0 109.877 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -82.71 -66.27 0.91 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.638 0.607 . . . . 15.0 112.638 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . 0.586 ' HA ' ' SD ' ' A' ' 395' ' ' MET . 84.4 p -56.45 -27.23 56.27 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.474 1.287 . . . . 15.0 114.474 -169.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -103.36 27.72 7.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.079 0.551 . . . . 15.0 110.396 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -149.8 105.35 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.296 -1.002 . . . . 15.0 108.296 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -55.6 -38.73 69.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.264 1.026 . . . . 15.0 111.726 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.34 -36.61 66.2 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 123.782 0.676 . . . . 15.0 111.625 -174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.44 HD23 HD22 ' A' ' 397' ' ' ASN . 11.3 mt -74.98 -32.98 61.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.763 0.425 . . . . 15.0 111.117 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 389' ' ' SER . 90.0 mmm -62.83 -38.88 92.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 171.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.27 -38.21 78.27 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 123.719 0.637 . . . . 15.0 109.983 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.44 HD22 HD23 ' A' ' 394' ' ' LEU . 88.6 m-20 -62.1 -39.66 93.25 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 123.559 0.744 . . . . 15.0 110.54 175.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.449 ' HA ' HG12 ' A' ' 401' ' ' VAL . 43.1 tpp -77.34 -23.78 50.86 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.543 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' B' ' 463' ' ' THR . 43.2 mtm-85 -74.95 -31.83 61.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.143 0.577 . . . . 15.0 110.318 169.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -55.87 22.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.478 0.711 . . . . 15.0 109.398 176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 398' ' ' MET . 7.5 p -69.43 -29.97 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 123.788 0.68 . . . . 15.0 111.745 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -59.66 -53.62 55.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.861 -0.422 . . . . 15.0 109.861 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.656 HD22 HG23 ' B' ' 463' ' ' THR . 48.1 tp -71.3 -30.11 65.86 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.903 -1.044 . . . . 15.0 111.687 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.25 -57.07 10.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.723 1.209 . . . . 15.0 109.953 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -67.12 -32.43 73.56 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.27 -0.877 . . . . 15.0 110.633 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.532 HE21 ' HB3' ' A' ' 360' ' ' LEU . 25.0 tt0 -63.91 -37.77 88.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.042 0.537 . . . . 15.0 110.388 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.49 85.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.748 0.819 . . . . 15.0 110.891 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 74.8 t -55.81 -53.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 123.955 0.784 . . . . 15.0 109.306 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -30.35 70.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.104 0.962 . . . . 15.0 112.023 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.4 -30.86 68.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.929 0.491 . . . . 15.0 110.895 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.01 -39.51 57.72 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.007 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 77.0 mt -72.84 -26.37 61.45 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.436 1.094 . . . . 15.0 112.007 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.72 73.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.96 0.904 . . . . 15.0 110.054 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -93.3 -34.94 13.32 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.593 -1.185 . . . . 15.0 110.094 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -81.93 154.61 25.69 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.316 1.046 . . . . 15.0 111.465 -172.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.5 86.73 3.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.952 -1.022 . . . . 15.0 110.147 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -84.61 94.12 3.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.57 0.7 . . . . 15.0 109.712 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.0 t -70.48 95.19 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.115 -0.948 . . . . 15.0 108.647 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.33 138.87 37.87 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 114.991 -1.004 . . . . 15.0 110.131 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.415 ' HE3' HG21 ' A' ' 422' ' ' THR . 62.1 pttt -144.42 137.35 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 173.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.89 122.4 30.7 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.128 -1.064 . . . . 15.0 108.128 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.415 HG21 ' HE3' ' A' ' 420' ' ' LYS . 8.8 t -149.78 175.52 11.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.008 0.523 . . . . 15.0 110.69 -173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -89.92 161.07 16.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.71 1.204 . . . . 15.0 112.119 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 26.5 t80 -52.68 -48.59 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.234 1.414 . . . . 15.0 111.253 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -58.79 -19.4 40.56 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.161 0.913 . . . . 15.0 112.886 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 427' ' ' LEU . 7.7 tp10 -54.06 -49.95 67.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.382 1.073 . . . . 15.0 112.127 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 130' ' ' VAL . 5.5 mp -75.37 -29.18 59.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.788 0.835 . . . . 15.0 111.507 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -77.14 -41.97 39.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 174.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -80.72 33.46 0.32 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.16 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.78 75.69 10.02 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.843 -1.169 . . . . 15.0 107.843 170.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -87.74 -11.61 47.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.618 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.481 0.712 . . . . 15.0 109.559 174.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 121.996 0.903 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -151.67 95.45 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 66.2 mt -77.77 -77.05 0.16 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.536 0.334 . . . . 0.0 110.85 -172.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' B' ' 411' ' ' ALA . 7.0 t0 -102.98 -82.58 0.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' B' ' 373' ' ' ARG . 43.8 mt-10 -90.08 -75.51 0.45 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.017 -0.427 . . . . 0.0 110.018 -173.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -103.4 -79.72 0.53 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.558 HG13 ' H ' ' B' ' 372' ' ' GLN . 2.6 p -108.85 -81.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.611 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.558 ' H ' HG13 ' B' ' 371' ' ' VAL . 2.2 mp0 -85.06 -80.1 0.22 Allowed 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 120.159 1.345 . . . . 0.0 108.44 170.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' B' ' 369' ' ' GLU . 15.6 mmm180 -102.52 -83.66 0.47 Allowed 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 163.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -102.54 -73.91 0.65 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' B' ' 376' ' ' GLU . 0.3 OUTLIER -109.65 -78.05 0.59 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.736 0.414 . . . . 0.0 110.932 173.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.412 ' H ' ' HG ' ' B' ' 375' ' ' LEU . 45.2 mt-10 -103.78 -80.93 0.52 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.666 -0.646 . . . . 0.0 111.598 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.452 ' HD2' ' HA ' ' B' ' 380' ' ' LYS . 91.2 m-85 -95.63 -85.18 0.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.82 -68.92 0.79 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 158.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -101.22 -79.13 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 163.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' B' ' 381' ' ' GLU . 47.6 pttt -161.18 -74.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.01 0.924 . . . . 0.0 109.26 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' B' ' 380' ' ' LYS . 32.9 tt0 -172.65 152.35 2.53 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.662 0.785 . . . . 0.0 109.327 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -171.81 98.61 0.13 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.01 142.39 21.65 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.397 0.679 . . . . 0.0 110.616 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 4.1 t -173.35 -55.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.564 1.146 . . . . 0.0 109.69 171.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.417 HD13 ' HE1' ' A' ' 194' ' ' MET . 18.9 tp -145.56 159.21 43.45 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 124.846 1.258 . . . . 0.0 107.68 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 178' ' ' GLU . 8.1 p -77.39 97.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 122.895 1.331 . . . . 0.0 109.279 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.472 HG23 HG23 ' B' ' 389' ' ' THR . 2.9 tp -149.78 156.24 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 113.954 -1.476 . . . . 0.0 107.043 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.556 HG12 ' HG3' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -58.11 106.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . 0.472 HG23 HG23 ' B' ' 387' ' ' ILE . 9.3 p -125.7 93.79 3.94 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.451 0.643 . . . . 0.0 110.4 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' B' ' 393' ' ' ALA . . . -94.16 176.14 6.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 161.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -133.76 131.39 39.3 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . 0.659 ' H ' ' HB2' ' A' ' 222' ' ' HIS . 19.8 p-80 47.06 18.14 0.07 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.019 2.128 . . . . 0.0 113.293 -172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.551 ' HB3' ' HB1' ' B' ' 390' ' ' ALA . . . -117.4 162.96 17.09 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.157 0.983 . . . . 0.0 110.119 -169.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 224' ' ' GLU . 32.5 m-70 -96.01 -57.65 2.29 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.898 -170.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -85.12 167.29 15.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.567 0.747 . . . . 0.0 111.145 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 24.3 m -128.34 170.18 13.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.263 1.025 . . . . 0.0 109.499 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.561 HE21 ' HA ' ' B' ' 397' ' ' GLN . 0.0 OUTLIER 58.97 -80.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.919 1.288 . . . . 0.0 111.052 -170.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.537 ' H ' HD13 ' B' ' 398' ' ' ILE . 0.2 OUTLIER -121.04 90.44 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 122.246 1.022 . . . . 0.0 109.973 -177.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.14 -46.84 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -165.66 163.45 12.69 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.994 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.24 72.38 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.448 2.099 . . . . 0.0 111.495 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.46 157.91 22.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.931 0.892 . . . . 0.0 108.785 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 50.7 p 52.14 27.65 4.79 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.393 1.477 . . . . 0.0 112.493 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -147.1 11.45 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.017 1.327 . . . . 0.0 109.505 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.623 ' H ' ' HD2' ' B' ' 406' ' ' PRO . . . -164.32 -45.98 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 116.265 -1.826 . . . . 0.0 114.139 -164.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.623 ' HD2' ' H ' ' B' ' 405' ' ' ALA . 4.5 Cg_exo -33.03 96.95 0.02 OUTLIER 'Trans proline' 1 C--N 1.416 4.111 0 C-N-CA 124.609 3.539 . . . . 0.0 114.407 -178.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 79.39 -96.62 1.51 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -170.1 146.05 2.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.089 0.956 . . . . 0.0 109.214 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 31.9 p -70.95 91.37 0.86 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.734 0.814 . . . . 0.0 110.256 176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.43 -56.73 4.42 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.935 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' B' ' 368' ' ' ASP . . . -90.46 -168.46 2.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.432 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.5 -173.87 2.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.62 1.168 . . . . 0.0 110.032 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -51.06 -46.27 61.65 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.934 0.894 . . . . 0.0 112.068 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 17.2 m 59.55 85.15 0.1 Allowed 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.486 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -67.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.019 0.927 . . . . 0.0 112.8 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -62.84 -49.02 76.54 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.786 0.834 . . . . 0.0 110.968 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 67.24 71.54 0.91 Allowed Glycine 0 C--N 1.352 1.461 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -66.58 137.14 56.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.756 0.822 . . . . 0.0 112.169 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 48.7 t 64.95 97.7 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 125.497 1.519 . . . . 0.0 112.132 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 27.0 ttt -111.49 118.65 36.34 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.95 148.2 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 110.524 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 96.0 mmm -89.13 121.06 31.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 53.1 p -141.15 139.64 33.94 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.651 0.78 . . . . 0.0 109.732 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 44.3 p90 50.89 -168.82 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.381 1.872 . . . . 0.0 114.129 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 81.59 -173.42 53.93 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.871 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 66.84 3.57 3.1 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.863 1.265 . . . . 0.0 113.486 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.6 m 56.92 23.44 8.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.424 1.09 . . . . 0.0 111.94 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -138.4 -67.9 0.46 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.64 -4.62 28.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.169 0.988 . . . . 0.0 111.235 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -53.68 -61.28 2.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.554 1.542 . . . . 0.0 112.624 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 38.5 t -69.95 -31.36 69.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.424 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.593 ' HB3' ' HB ' ' B' ' 435' ' ' THR . 1.3 mp0 -78.35 -24.36 46.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.319 0.648 . . . . 0.0 111.622 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 59.51 -85.5 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.492 1.517 . . . . 0.0 112.684 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -93.58 28.82 2.17 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.719 0.808 . . . . 0.0 111.166 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' B' ' 432' ' ' GLN . 19.0 m -128.87 141.47 51.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.387 0.675 . . . . 0.0 109.549 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -63.6 -29.09 73.62 Favored Glycine 0 C--N 1.357 1.749 0 O-C-N 124.054 0.846 . . . . 0.0 113.853 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 13.3 m 57.26 76.07 0.34 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.066 1.347 . . . . 0.0 111.53 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -160.48 23.96 0.15 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.547 0.689 . . . . 0.0 110.206 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 39.5 tp -86.48 76.45 9.6 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.742 0.782 . . . . 0.0 110.53 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -109.61 -39.67 5.07 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.441 166.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 35.1 mt -124.44 138.01 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.151 0.98 . . . . 0.0 109.683 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -89.98 31.67 0.96 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.768 1.227 . . . . 0.0 111.496 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -68.65 96.37 0.71 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.502 0.721 . . . . 0.0 110.528 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -65.39 145.07 56.63 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 0.0 110.254 171.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -67.74 109.02 2.68 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.31 -33.62 5.45 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.586 2.19 . . . . 0.0 113.944 -167.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . 0.402 ' HB2' HG22 ' A' ' 313' ' ' VAL . 11.0 t-160 65.35 5.44 3.13 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.874 1.269 . . . . 0.0 112.426 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 58.18 27.27 14.85 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.89 1.276 . . . . 0.0 112.76 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -60.53 -24.84 65.67 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -106.6 -15.34 14.8 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.938 0.895 . . . . 0.0 111.117 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.07 -59.37 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 0.0 110.177 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.42 -36.51 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -70.06 156.87 53.5 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 50.7 tp -71.69 81.38 0.85 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.401 0.68 . . . . 0.0 110.027 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.451 HG23 ' H ' ' B' ' 456' ' ' ASP 0.251 5.5 t 36.31 -76.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 127.448 2.299 . . . . 0.0 115.041 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . 0.526 ' HA ' ' HD1' ' B' ' 462' ' ' TYR . 16.0 m-20 -74.64 169.02 18.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.575 0.75 . . . . 0.0 111.264 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -91.02 159.9 15.9 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.058 0.943 . . . . 0.0 109.676 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.4 t -67.22 -24.92 65.88 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.793 0.837 . . . . 0.0 113.112 -167.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . 0.411 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 32.7 t70 -163.05 69.49 0.23 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.118 0.567 . . . . 0.0 110.036 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.0 tp -172.25 174.22 4.01 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . 0.458 ' HE2' ' HA ' ' A' ' 356' ' ' ARG . 97.4 m-85 -77.22 24.4 0.18 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.576 1.15 . . . . 0.0 113.751 -174.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . 0.526 ' HD1' ' HA ' ' B' ' 456' ' ' ASP . 19.5 t80 76.92 -49.49 0.55 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.723 1.209 . . . . 0.0 113.412 173.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.656 HG23 HD22 ' A' ' 403' ' ' LEU . 11.8 t -84.16 20.54 1.57 Allowed 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.533 1.133 . . . . 0.0 113.668 -156.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 25.0 ptm -141.03 129.81 22.95 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -81.58 -62.12 1.74 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.514 0.725 . . . . 0.0 109.685 -173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.19 86.38 0.39 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.077 0.951 . . . . 0.0 110.522 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 176.23 -53.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.615 1.566 . . . . 0.0 108.254 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 10.1 mp 67.69 -70.01 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 O-C-N 125.099 1.5 . . . . 0.0 111.59 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' B' ' 459' ' ' ASP . . . 171.26 -175.26 44.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.839 -0.22 . . . . 0.0 113.11 176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.66 -19.07 25.3 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.086 0.554 . . . . 0.0 110.624 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.887 0.875 . . . . 12.06 109.107 173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.654 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -78.11 97.08 5.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.162 0.585 . . . . 15.0 109.817 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 17' ' ' ILE . 24.9 m -111.1 128.49 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.348 0.659 . . . . 15.0 109.479 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.3 p -129.63 110.7 12.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.094 0.558 . . . . 15.0 109.879 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.26 126.59 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.601 0.76 . . . . 15.0 110.417 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 32.5 mt-10 -125.55 133.22 52.4 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.8 1.24 . . . . 15.0 108.5 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 m -94.0 98.22 10.87 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.493 -0.929 . . . . 15.0 108.493 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -84.29 -51.23 7.16 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.291 0.636 . . . . 15.0 111.937 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -151.2 90.95 1.64 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 110.176 -0.305 . . . . 15.0 110.176 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.16 -100.74 0.43 Allowed Glycine 0 C--N 1.35 1.338 0 O-C-N 123.867 0.73 . . . . 15.0 113.363 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB3' ' H ' ' A' ' 111' ' ' VAL . 5.2 mp -77.85 -33.14 52.34 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 15.0 109.56 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 122.72 30.63 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.363 1.039 . . . . 15.0 112.867 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -135.46 129.03 32.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.572 1.149 . . . . 15.0 110.259 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 43.4 ttm180 -96.64 101.82 13.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.431 1.092 . . . . 15.0 110.022 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.03 94.41 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.775 -1.194 . . . . 15.0 107.775 169.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 85.8 m -78.32 102.74 7.84 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.482 -0.781 . . . . 15.0 109.467 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 3' ' ' VAL . 54.0 mt -95.74 131.92 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.737 0.815 . . . . 15.0 109.315 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 33.9 m -116.07 118.81 33.91 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.933 -1.136 . . . . 15.0 107.933 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 70' ' ' LEU . 58.6 mt -93.03 120.12 41.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.77 154.11 42.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.173 0.589 . . . . 15.0 111.166 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.65 -39.99 62.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.238 1.415 . . . . 15.0 113.183 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.65 -38.64 77.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.407 0.683 . . . . 15.0 110.984 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -70.22 -32.31 70.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.61 0.764 . . . . 15.0 110.824 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 76.4 mt -66.79 -54.14 27.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 C-N-CA 123.962 0.905 . . . . 15.0 109.384 173.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -59.94 -38.79 83.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.421 1.076 . . . . 15.0 111.761 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -63.75 -45.18 91.01 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 123.779 0.674 . . . . 15.0 110.27 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.29 -33.64 73.5 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.543 0.737 . . . . 15.0 112.277 -176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.643 ' HA ' HG21 ' A' ' 66' ' ' VAL . 68.0 t -69.54 -42.47 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.261 0.624 . . . . 15.0 109.423 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.3 ttmp? -68.02 -31.03 70.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.263 -0.88 . . . . 15.0 111.079 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 m -69.1 -37.39 78.37 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.474 -0.785 . . . . 15.0 109.702 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.6 tp10 -69.37 -39.53 78.01 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.826 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 91.6 mt -67.24 -34.69 77.99 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.316 0.646 . . . . 15.0 111.725 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 p -80.97 -17.63 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 O-C-N 123.317 0.386 . . . . 15.0 110.604 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.44 -46.64 66.29 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.452 -0.574 . . . . 15.0 109.452 168.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 40.0 t -65.09 -39.11 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 123.876 0.735 . . . . 15.0 109.891 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -61.55 -55.38 31.55 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-N 115.198 -0.91 . . . . 15.0 110.671 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 97.2 mttt -66.18 -30.03 70.42 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.423 0.452 . . . . 15.0 111.98 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 36.5 ttpt -64.29 -46.71 82.44 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.491 0.717 . . . . 15.0 111.118 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 41' ' ' ILE . 12.1 t -94.03 3.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.348 0.659 . . . . 15.0 110.154 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 24.8 mmt180 65.17 16.8 10.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.866 1.666 . . . . 15.0 112.43 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 39' ' ' VAL . 81.1 mt -54.08 -31.04 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.562 1.545 . . . . 15.0 111.784 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.756 0.822 . . . . 15.0 111.037 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -39.13 79.26 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.08 -0.509 . . . . 15.0 112.03 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.99 -22.17 59.71 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.142 0.577 . . . . 15.0 111.003 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -65.93 116.55 7.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.386 1.074 . . . . 15.0 110.145 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.82 1.99 48.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.064 0.945 . . . . 15.0 111.329 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.95 32.91 69.85 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.28 0.362 . . . . 15.0 112.706 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -77.15 -49.4 15.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.636 0.774 . . . . 15.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.88 117.36 61.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 108.486 -0.931 . . . . 15.0 108.486 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD2' HD12 ' A' ' 53' ' ' ILE . 87.5 Cg_exo -48.75 142.39 18.93 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.417 2.745 . . . . 15.0 113.484 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 54' ' ' VAL . 56.4 tpp -64.01 -26.57 68.63 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 15.0 111.298 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -68.27 -35.18 77.49 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.592 0.357 . . . . 15.0 111.64 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 50' ' ' PRO . 43.1 mt -72.68 -46.93 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.685 0.794 . . . . 15.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 51' ' ' MET . 31.1 m -68.66 -21.14 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 122.429 -0.169 . . . . 15.0 111.291 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.21 -47.77 60.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.059 0.544 . . . . 15.0 111.862 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.59 -19.79 48.51 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.755 -0.657 . . . . 15.0 111.627 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -94.45 -70.15 0.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.551 0.34 . . . . 15.0 111.252 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.61 -22.8 59.91 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.287 0.635 . . . . 15.0 111.613 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.84 14.56 59.94 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.305 -0.72 . . . . 15.0 114.041 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.99 -42.61 66.28 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.497 0.719 . . . . 15.0 111.574 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.4 p -77.11 -32.76 56.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.291 0.636 . . . . 15.0 110.298 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.7 t -67.17 -18.79 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.616 1.166 . . . . 15.0 111.321 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HD3' HG21 ' A' ' 28' ' ' VAL . 17.1 mmt180 -51.05 -44.8 61.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.283 0.633 . . . . 15.0 110.599 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -51.85 -55.48 19.74 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.429 1.092 . . . . 15.0 111.456 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.76 -48.96 79.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.625 -1.17 . . . . 15.0 111.095 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' A' ' 28' ' ' VAL . 79.6 t -64.24 -49.17 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.367 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 94.7 mt -56.84 -43.44 81.11 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 123.837 0.711 . . . . 15.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.7 -47.57 90.27 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.294 0.996 . . . . 15.0 112.002 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -61.97 -41.39 97.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.649 1.18 . . . . 15.0 111.454 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.425 ' HB3' HD13 ' A' ' 19' ' ' ILE . 59.2 mt -64.59 -27.2 68.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.262 -0.881 . . . . 15.0 111.235 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.448 ' SD ' ' HG3' ' A' ' 94' ' ' PRO . 68.4 mtm -59.21 -40.93 87.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.361 0.413 . . . . 15.0 111.049 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 t -81.59 -50.01 9.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.779 0.432 . . . . 15.0 111.105 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -75.19 -24.14 57.77 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.404 HD21 HD22 ' A' ' 70' ' ' LEU . 26.1 m-80 -81.31 -25.85 36.14 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.927 0.33 . . . . 15.0 110.288 172.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -77.96 -42.23 33.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.686 0.394 . . . . 15.0 111.171 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.0 -27.4 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.26 0.552 . . . . 15.0 110.081 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.57 -41.49 54.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.429 0.692 . . . . 15.0 109.981 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -62.8 -47.09 84.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 15.0 111.869 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 pt -60.13 -27.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 112.79 0.663 . . . . 15.0 112.79 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.9 mt -71.81 -47.33 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.942 0.897 . . . . 15.0 110.568 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.4 ptpt -75.96 -29.97 58.46 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.622 0.369 . . . . 15.0 110.785 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.87 -22.28 53.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.757 . . . . 15.0 111.132 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.725 ' HB3' ' HG3' ' B' ' 471' ' ' LYS . 46.3 mmtm 62.85 23.86 14.23 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.482 1.113 . . . . 15.0 111.428 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.6 mt -105.35 97.9 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.314 -0.995 . . . . 15.0 108.314 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -72.53 116.92 54.44 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.528 -0.916 . . . . 15.0 108.528 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.7 158.65 35.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.521 2.147 . . . . 15.0 113.127 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.59 167.88 21.98 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.81 -1.086 . . . . 15.0 108.956 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 305' ' ' ALA . . . 82.14 -136.15 15.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.697 -0.683 . . . . 15.0 111.458 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.14 97.65 45.35 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 108.263 -1.014 . . . . 15.0 108.263 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.4 106.36 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.018 1.812 . . . . 15.0 110.792 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.6 m -92.25 98.3 11.43 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.277 0.631 . . . . 15.0 109.58 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -76.45 83.42 3.17 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.158 0.983 . . . . 15.0 109.316 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.51 106.33 10.09 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 118.536 -0.745 . . . . 15.0 109.147 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HG3' ' SD ' ' A' ' 71' ' ' MET . 16.3 Cg_exo -68.79 110.42 2.35 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.4 2.067 . . . . 15.0 111.33 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.82 -59.12 11.36 Favored Glycine 0 C--N 1.35 1.332 0 O-C-N 123.773 0.671 . . . . 15.0 111.99 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.27 168.05 13.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 15.0 111.483 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HB2' ' HD1' ' A' ' 103' ' ' PHE . 76.1 t80 -147.29 143.57 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.571 1.149 . . . . 15.0 109.17 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 49.1 mtmt -122.52 144.4 49.1 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 170.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -60.58 108.41 0.82 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.943 0.897 . . . . 15.0 111.86 -169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.58 62.29 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.691 -0.686 . . . . 15.0 113.578 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.9 mt-10 -99.23 -173.17 2.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.482 1.113 . . . . 15.0 109.392 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.1 154.12 42.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.647 0.736 . . . . 15.0 112.897 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' HD1' ' HB2' ' A' ' 97' ' ' TYR . 56.2 t80 -119.01 141.61 48.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.153 1.381 . . . . 15.0 108.392 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -132.57 140.31 48.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.191 -0.67 . . . . 15.0 109.191 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -147.35 136.23 22.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.789 0.836 . . . . 15.0 109.535 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 70.8 m -103.5 123.77 47.52 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.324 1.05 . . . . 15.0 109.589 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.88 110.3 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.101 0.56 . . . . 15.0 110.253 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -101.1 130.41 47.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.68 0.392 . . . . 15.0 110.298 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -154.6 157.05 37.65 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 15.0 109.544 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.85 164.66 23.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.284 0.634 . . . . 15.0 109.632 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.549 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 34.5 m -123.23 178.33 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.239 0.615 . . . . 15.0 109.442 173.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -86.3 108.01 15.74 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 108.489 -0.93 . . . . 15.0 108.489 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.54 163.64 26.73 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.451 2.101 . . . . 15.0 113.018 -170.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.92 89.22 5.87 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.67 111.48 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.514 -1.221 . . . . 15.0 110.017 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -96.14 98.49 10.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.892 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 120' ' ' LEU . 85.7 mt -73.03 129.01 37.13 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -136.98 111.14 8.36 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 -173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 54.32 75.89 0.21 Allowed Glycine 0 C--N 1.353 1.504 0 O-C-N 124.324 1.015 . . . . 15.0 113.519 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.642 HD11 HD13 ' A' ' 117' ' ' LEU . 17.8 mt -75.59 -11.64 60.05 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.055 0.428 . . . . 15.0 110.874 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 13.2 mp0 -74.53 -28.08 60.81 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.303 1.041 . . . . 15.0 110.146 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.76 62.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.044 0.937 . . . . 15.0 112.078 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.476 HG23 ' HA3' ' A' ' 293' ' ' GLY . 65.2 mt -68.88 134.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.717 0.807 . . . . 15.0 109.731 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 49.1 mt-10 -118.29 110.87 18.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.458 0.703 . . . . 15.0 109.263 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 417' ' ' VAL . 47.1 t -115.97 156.19 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.529 1.132 . . . . 15.0 109.68 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.53 141.04 39.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.993 0.917 . . . . 15.0 108.692 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 83.1 tttt -112.43 89.9 13.43 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 107.344 -1.354 . . . . 15.0 107.344 170.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.54 95.41 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.403 2.068 . . . . 15.0 111.087 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.15 87.49 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.202 -1.407 . . . . 15.0 107.202 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 282' ' ' ILE . 3.2 t -122.38 141.24 43.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.576 -1.193 . . . . 15.0 109.56 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.94 165.5 24.86 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.813 -1.551 . . . . 15.0 106.813 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 t -85.53 85.9 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.683 -1.599 . . . . 15.0 106.683 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 137' ' ' VAL . 26.6 p -69.12 175.78 3.61 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.554 0.742 . . . . 15.0 110.238 -175.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.21 -43.38 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.022 0.374 . . . . 15.0 110.296 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.34 80.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.875 0.87 . . . . 15.0 111.298 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -76.44 -39.03 54.59 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.743 0.417 . . . . 15.0 111.662 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 133' ' ' THR . 91.5 t -65.09 -53.71 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 108.933 -0.766 . . . . 15.0 108.933 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -63.5 -48.63 76.79 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.148 0.905 . . . . 15.0 110.385 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.01 93.85 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 123.877 0.735 . . . . 15.0 114.195 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.8 tpt -80.51 -45.44 17.49 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.978 0.511 . . . . 15.0 111.111 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 270' ' ' VAL . 48.1 mt -54.52 -34.56 61.93 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.457 0.572 . . . . 15.0 112.025 167.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.74 -45.8 84.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.403 1.081 . . . . 15.0 109.623 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 m -60.78 -36.84 80.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.624 0.77 . . . . 15.0 111.628 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 HD23 ' A' ' 141' ' ' LEU . 96.1 mt -70.31 -40.33 74.28 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.254 0.621 . . . . 15.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.64 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 68.0 mtm180 -74.44 -18.78 60.59 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.743 -0.662 . . . . 15.0 111.619 174.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 97.0 mttt -85.36 -22.56 28.39 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.077 0.399 . . . . 15.0 111.233 170.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.461 ' HG2' HE21 ' A' ' 148' ' ' GLN . 46.4 tt0 -72.13 -42.17 66.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.498 0.719 . . . . 15.0 109.362 171.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.461 HE21 ' HG2' ' A' ' 147' ' ' GLN . 30.8 mm-40 -104.87 41.32 1.35 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.003 . . . . 15.0 110.1 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.12 139.06 41.14 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.6 m -81.36 126.77 32.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.132 0.973 . . . . 15.0 109.398 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -80.97 111.01 17.05 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -120.66 114.87 22.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.909 0.883 . . . . 15.0 109.79 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 52.7 mt-10 -73.19 119.57 17.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.847 0.459 . . . . 15.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 28.6 pttt -106.02 176.8 5.05 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.39 0.676 . . . . 15.0 110.32 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -115.55 99.4 7.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.133 0.573 . . . . 15.0 111.487 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.505 ' HA2' ' H ' ' A' ' 207' ' ' ALA . . . 58.66 58.76 12.85 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.398 -1.274 . . . . 15.0 115.589 168.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 98.89 2.15 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.298 0.549 . . . . 15.0 109.688 172.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 203' ' ' LYS . 14.2 t -96.98 130.2 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 120.914 0.388 . . . . 15.0 110.953 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 -168.4 2.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.749 1.62 . . . . 15.0 109.18 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.76 -2.64 54.96 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.031 0.932 . . . . 15.0 112.585 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -97.49 8.4 44.68 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.22 0.608 . . . . 15.0 111.829 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 1.1 m-20 -92.41 176.41 6.48 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.388 1.089 . . . . 15.0 113.873 -166.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 3.1 tmt_? -143.42 90.21 2.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.519 -2.4 . . . . 15.0 104.519 167.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 166' ' ' ILE . 33.2 t -93.36 152.28 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.766 0.826 . . . . 15.0 110.561 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.717 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 11.4 m -126.1 117.68 23.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.773 -1.195 . . . . 15.0 107.773 173.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.516 HG22 HD23 ' A' ' 237' ' ' LEU . 38.6 pt -128.24 173.4 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.982 0.913 . . . . 15.0 111.963 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.35 134.1 50.0 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.766 -1.198 . . . . 15.0 107.766 163.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -127.72 149.85 50.04 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.709 0.231 . . . . 15.0 110.483 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.56 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 9.0 t -131.81 113.32 13.36 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.524 -0.917 . . . . 15.0 108.524 165.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.44 148.81 18.78 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.9 -0.591 . . . . 15.0 113.725 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.3 m -146.07 118.08 8.26 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.312 -1.366 . . . . 15.0 107.312 167.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 175' ' ' GLU . 98.9 t -88.69 114.97 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.967 0.907 . . . . 15.0 109.334 -169.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 67.91 7.8 6.02 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.405 1.082 . . . . 15.0 111.325 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.92 26.14 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 121.769 -0.582 . . . . 15.0 113.507 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 9.6 pt-20 -98.64 134.89 40.94 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.552 0.676 . . . . 15.0 109.196 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.81 85.59 3.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.048 0.451 . . . . 15.0 110.069 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.511 ' HD2' HG23 ' B' ' 388' ' ' VAL . 0.1 OUTLIER -43.44 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.755 1.622 . . . . 15.0 111.85 172.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.24 172.69 7.01 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.961 1.304 . . . . 15.0 109.313 171.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.6 71.52 0.67 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.22 -1.552 . . . . 15.0 109.22 155.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.79 57.48 4.25 Favored Glycine 0 C--N 1.356 1.684 0 C-N-CA 123.915 0.769 . . . . 15.0 114.401 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 24.6 mmtt -107.15 149.87 27.21 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.617 1.167 . . . . 15.0 110.163 172.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.19 93.36 0.69 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.988 0.805 . . . . 15.0 109.204 173.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 m -76.85 129.6 36.46 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.2 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 66.23 32.64 7.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.312 1.045 . . . . 15.0 111.483 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.16 130.27 43.87 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.76 102.7 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.549 0.74 . . . . 15.0 109.536 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 202' ' ' ILE . 27.0 tp -93.95 91.85 7.09 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 170.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -70.15 92.7 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 173.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER -66.5 154.57 39.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.789 0.836 . . . . 15.0 111.241 -175.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.45 -19.03 13.16 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.561 -0.745 . . . . 15.0 112.173 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -102.69 122.82 45.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.495 0.718 . . . . 15.0 109.38 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.23 61.34 4.78 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.239 -0.744 . . . . 15.0 111.239 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -31.23 11.2 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.884 0.874 . . . . 15.0 109.174 -170.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 25.9 mmt -75.07 160.78 30.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.973 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.2 pt -59.72 130.96 88.55 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 115.057 -0.974 . . . . 15.0 110.426 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.64 115.85 2.69 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.25 2.633 . . . . 15.0 112.215 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 126.53 -42.1 1.53 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.475 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.05 -65.0 0.73 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 122.687 0.395 . . . . 15.0 110.109 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 189' ' ' MET . 10.8 pt-20 -66.59 -26.43 67.1 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.019 0.825 . . . . 15.0 111.42 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.0 m-20 -68.31 -32.28 72.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.98 0.912 . . . . 15.0 110.62 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.45 -11.08 85.83 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.39 -0.823 . . . . 15.0 112.837 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.409 HG21 HD23 ' A' ' 187' ' ' LEU . 23.7 mm -92.11 -53.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.962 -0.755 . . . . 15.0 108.962 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.563 ' HA ' HG12 ' A' ' 158' ' ' VAL . 57.9 pttt -83.12 31.79 0.44 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.63 1.172 . . . . 15.0 112.577 -170.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.59 25.99 2.42 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.896 -0.882 . . . . 15.0 110.896 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -145.91 -166.04 2.35 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.271 1.028 . . . . 15.0 110.41 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 8.8 ptpp? -146.44 159.16 43.75 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.14 0.976 . . . . 15.0 110.425 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.67 145.59 55.84 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 120.733 0.302 . . . . 15.0 111.517 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.82 -44.03 1.51 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 110.984 -0.846 . . . . 15.0 110.984 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.6 pt-20 -77.6 129.95 36.27 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 114.921 -0.639 . . . . 15.0 109.695 177.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.94 109.8 18.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.693 -1.225 . . . . 15.0 107.693 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -128.45 -171.05 2.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.011 1.324 . . . . 15.0 110.133 -169.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 72.9 m -132.02 129.09 39.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.917 0.887 . . . . 15.0 108.867 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.9 pt -98.55 150.24 5.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.032 0.533 . . . . 15.0 110.396 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.26 112.3 24.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.84 -1.073 . . . . 15.0 108.973 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.6 166.07 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 67.6 m -141.44 129.19 21.64 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -73.22 133.41 81.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-O 118.733 -0.651 . . . . 15.0 109.584 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 221' ' ' TYR . 35.8 Cg_exo -44.45 161.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 124.234 3.289 . . . . 15.0 115.412 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -75.92 -30.08 58.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.652 -0.704 . . . . 15.0 110.349 174.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.38 -31.39 68.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.17 0.588 . . . . 15.0 110.525 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 218' ' ' PRO . 25.8 t80 -48.59 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.821 1.648 . . . . 15.0 110.554 -172.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.999 1.111 . . . . 15.0 113.999 -160.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.99 92.91 0.54 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 165.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -58.33 -41.87 85.53 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.952 0.901 . . . . 15.0 111.289 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.59 -15.92 43.4 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.082 0.953 . . . . 15.0 112.825 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.499 HD22 HG21 ' A' ' 172' ' ' VAL . 64.7 mt -107.46 -30.9 8.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.915 0.886 . . . . 15.0 111.197 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -51.78 121.31 6.36 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.336 1.455 . . . . 15.0 112.036 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.06 -22.84 12.68 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.772 0.67 . . . . 15.0 113.942 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -75.1 147.16 40.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.304 0.552 . . . . 15.0 111.037 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.21 111.92 23.82 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.908 -1.042 . . . . 15.0 109.499 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -89.92 133.43 34.78 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.574 0.749 . . . . 15.0 111.874 -175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -90.0 107.68 19.27 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.198 0.999 . . . . 15.0 108.574 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -109.26 108.64 19.31 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.397 -0.964 . . . . 15.0 108.397 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.38 96.36 4.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.765 0.426 . . . . 15.0 109.993 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 mm -87.47 128.6 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.179 0.992 . . . . 15.0 110.651 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.9 100.93 8.8 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.313 1.045 . . . . 15.0 108.216 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 166' ' ' ILE . 87.5 mt -78.6 94.61 5.05 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.036 0.446 . . . . 15.0 109.816 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.19 -44.63 7.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.569 -0.741 . . . . 15.0 111.123 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.717 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.7 mmtt -127.31 135.84 51.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.239 0.616 . . . . 15.0 110.036 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 207' ' ' ALA . 98.6 t -127.6 103.68 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.573 1.149 . . . . 15.0 108.623 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 29.2 mt-10 -104.03 -175.26 2.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.639 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 35.0 tt0 -142.89 129.64 20.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.21 -0.663 . . . . 15.0 109.21 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 -78.55 84.39 4.68 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.945 -1.132 . . . . 15.0 107.945 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -82.37 144.14 30.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 113.984 -1.462 . . . . 15.0 110.79 -174.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.61 119.76 53.53 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.838 0.855 . . . . 15.0 109.636 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 69.4 Cg_endo -68.2 -169.58 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.418 2.745 . . . . 15.0 112.558 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.4 148.0 46.76 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.209 -0.905 . . . . 15.0 110.759 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 25.6 tp -121.65 15.8 11.1 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.9 p -66.66 179.55 1.04 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.627 1.171 . . . . 15.0 112.135 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -41.13 -61.85 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.689 1.595 . . . . 15.0 114.635 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.91 -1.76 27.03 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.48 0.712 . . . . 15.0 112.806 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -99.22 -50.57 4.09 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.357 0.663 . . . . 15.0 109.563 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.539 HG13 HD22 ' A' ' 266' ' ' LEU . 18.0 tt -64.56 -29.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.961 0.504 . . . . 15.0 111.357 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 259' ' ' GLU . 18.7 ptmt -76.99 -18.04 58.47 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.385 0.513 . . . . 15.0 112.385 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -69.11 -18.85 64.02 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.388 0.675 . . . . 15.0 110.909 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -74.16 -22.3 59.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.788 0.835 . . . . 15.0 111.495 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 139.74 -28.97 2.5 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 112.569 -0.212 . . . . 15.0 112.569 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.17 84.58 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.68 0.792 . . . . 15.0 109.671 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -63.69 -27.63 69.35 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.044 1.127 . . . . 15.0 114.044 -167.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -31.12 47.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 175.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.43 20.36 27.47 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.409 -0.662 . . . . 15.0 113.799 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 54.3 p -62.28 123.59 18.63 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.456 0.702 . . . . 15.0 111.091 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.81 -54.66 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 124.454 1.102 . . . . 15.0 111.242 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.62 -24.78 64.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.754 0.821 . . . . 15.0 111.991 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.7 -27.2 54.74 Favored Glycine 0 C--N 1.36 1.869 0 N-CA-C 110.609 -0.996 . . . . 15.0 110.609 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.539 HD22 HG13 ' A' ' 253' ' ' ILE . 41.3 tp -75.1 -35.11 61.78 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.764 -0.828 . . . . 15.0 108.764 177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -61.86 -41.79 98.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.576 0.548 . . . . 15.0 109.646 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.92 63.57 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.133 0.973 . . . . 15.0 111.065 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.05 -54.63 44.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.772 -1.104 . . . . 15.0 111.327 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 141' ' ' LEU . 30.8 m -69.07 -37.85 77.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.989 -1.005 . . . . 15.0 110.867 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -65.84 -42.98 89.84 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 119.104 0.865 . . . . 15.0 110.049 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -73.38 -26.08 60.85 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 118.364 0.529 . . . . 15.0 111.592 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -65.48 -52.8 50.32 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.659 0.742 . . . . 15.0 109.697 167.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.477 ' HE3' ' HB ' ' A' ' 270' ' ' VAL . 57.6 mtt -72.7 -14.97 61.69 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-N 114.59 -1.186 . . . . 15.0 111.415 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.23 -38.66 15.08 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.661 0.664 . . . . 15.0 109.922 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.45 -25.4 67.21 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.183 0.593 . . . . 15.0 110.235 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -84.5 -71.81 0.5 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.445 0.698 . . . . 15.0 110.77 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.539 HD21 HG12 ' A' ' 130' ' ' VAL . 43.3 tp -62.7 -54.23 42.46 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.042 1.337 . . . . 15.0 113.453 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.447 ' HA ' HD12 ' A' ' 282' ' ' ILE . 38.2 ttpt -70.93 -28.57 64.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 123.454 0.471 . . . . 15.0 110.79 -172.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -64.79 -46.9 80.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.779 -0.823 . . . . 15.0 108.779 169.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.27 -30.0 71.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.572 0.749 . . . . 15.0 111.622 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.606 HD11 ' HB ' ' A' ' 130' ' ' VAL . 96.0 mt -66.87 -55.13 19.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 N-CA-C 108.77 -0.826 . . . . 15.0 108.77 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 16.9 tpt180 -58.03 -41.53 83.39 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.087 0.867 . . . . 15.0 110.705 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.67 -32.75 70.13 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.154 0.582 . . . . 15.0 111.09 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -65.62 -51.94 55.75 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.1 0.409 . . . . 15.0 110.423 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 282' ' ' ILE . 21.8 t -62.03 -45.75 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.957 0.786 . . . . 15.0 109.778 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 291' ' ' ILE . 86.7 tttt -64.95 -41.36 95.56 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.117 -0.947 . . . . 15.0 111.624 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.589 ' HA ' ' NH2' ' A' ' 343' ' ' ARG . 77.6 p -65.61 -42.61 91.41 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.726 0.239 . . . . 15.0 110.92 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.6 ' HB2' HG13 ' A' ' 125' ' ' VAL . 54.0 mt-30 -66.86 -34.81 78.61 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.324 0.39 . . . . 15.0 111.005 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.4 -50.31 68.11 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.807 0.443 . . . . 15.0 111.537 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 287' ' ' LYS . 31.4 mm -73.29 -55.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.408 0.683 . . . . 15.0 111.322 -174.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.94 -27.03 68.57 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.728 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.476 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -66.54 -41.57 94.07 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 119.432 -0.649 . . . . 15.0 112.524 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 350' ' ' LEU . 23.0 mt -56.91 -47.43 80.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.772 0.829 . . . . 15.0 110.552 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 22.9 t -58.28 -53.89 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.689 0.757 . . . . 15.0 109.593 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.24 -18.78 65.37 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.568 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.02 -25.69 22.98 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.571 0.582 . . . . 15.0 112.571 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.9 155.03 28.85 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.887 1.069 . . . . 15.0 113.887 -168.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.82 145.31 55.63 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.641 -1.163 . . . . 15.0 110.108 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 5.9 tp -143.38 117.19 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.687 -0.688 . . . . 15.0 109.594 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -81.19 118.37 22.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.262 -1.014 . . . . 15.0 108.262 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 307' ' ' ILE . 47.0 t -110.88 100.33 45.88 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.38 1.072 . . . . 15.0 109.289 -168.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.519 ' HD2' HD11 ' A' ' 349' ' ' LEU . 58.8 Cg_endo -73.59 132.07 16.92 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.573 2.182 . . . . 15.0 112.255 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -60.21 -18.02 45.54 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.874 1.27 . . . . 15.0 112.201 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' GLY . . . -45.86 -56.21 5.69 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.399 1.479 . . . . 15.0 111.578 171.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.44 -27.73 41.68 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.242 -1.344 . . . . 15.0 110.815 -172.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.607 HD11 HG12 ' A' ' 302' ' ' VAL . 2.0 mp -61.21 -54.25 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.347 -0.983 . . . . 15.0 108.347 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.83 -31.47 70.46 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.81 0.694 . . . . 15.0 110.429 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 313' ' ' VAL . 41.3 t -61.8 -53.43 56.05 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 123.837 0.71 . . . . 15.0 111.231 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -80.23 -31.0 38.61 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.581 -172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.524 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 27.1 mt -59.04 -46.57 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 166.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.31 -41.63 80.26 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.888 0.875 . . . . 15.0 112.055 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' B' ' 447' ' ' HIS . 94.5 t -51.23 -58.35 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 124.291 0.994 . . . . 15.0 109.591 171.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.77 -17.0 62.21 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 113.806 -1.543 . . . . 15.0 112.436 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.5 mtm180 -76.47 -48.96 17.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.333 0.653 . . . . 15.0 109.75 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -65.32 -42.25 93.16 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.253 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.07 -38.01 89.5 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 114.915 -1.038 . . . . 15.0 110.809 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.18 -59.61 4.8 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 123.456 0.473 . . . . 15.0 109.957 175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 329' ' ' ALA . . . -56.26 -33.28 65.3 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.021 0.826 . . . . 15.0 112.405 -176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.86 -40.87 95.84 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.904 0.881 . . . . 15.0 110.47 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -93.31 -3.25 53.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.512 0.725 . . . . 15.0 110.955 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -95.72 9.52 40.11 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.642 1.177 . . . . 15.0 109.835 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.43 83.73 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.134 -0.484 . . . . 15.0 113.622 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.68 15.38 81.62 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 122.772 0.225 . . . . 15.0 113.017 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -74.86 152.54 38.91 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.549 0.739 . . . . 15.0 109.626 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 72.41 -70.1 0.17 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.526 1.53 . . . . 15.0 111.801 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 65.03 9.22 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.618 1.167 . . . . 15.0 112.371 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -89.3 15.56 8.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.888 1.275 . . . . 15.0 109.29 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.737 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -48.62 -33.2 9.44 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 125.754 1.622 . . . . 15.0 113.588 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.88 -29.08 26.13 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.045 0.938 . . . . 15.0 112.193 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -114.15 31.45 6.57 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.509 1.124 . . . . 15.0 110.828 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 19.6 mt -63.32 134.03 95.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-O 118.84 -0.6 . . . . 15.0 109.82 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -42.64 123.6 3.0 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 124.266 3.311 . . . . 15.0 113.479 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -52.73 -47.32 67.45 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 124.149 0.905 . . . . 15.0 111.498 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.78 -7.04 2.03 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.12 -43.95 63.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.397 0.544 . . . . 15.0 110.076 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.99 2.13 8.66 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.526 0.73 . . . . 15.0 112.614 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -58.57 -55.33 36.48 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.735 0.814 . . . . 15.0 111.007 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 40.6 tt0 -56.14 -60.9 2.83 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.796 1.31 . . . . 15.0 111.215 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -64.68 -38.16 90.03 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -70.85 -52.89 17.54 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 110.429 -0.212 . . . . 15.0 110.429 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.36 -28.1 64.81 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.908 0.755 . . . . 15.0 110.685 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.589 ' NH2' ' HA ' ' A' ' 288' ' ' SER . 0.2 OUTLIER -72.5 -36.9 68.51 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.887 0.875 . . . . 15.0 109.563 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.525 HH12 HG11 ' A' ' 313' ' ' VAL . 75.4 mtt180 -64.36 -35.09 79.76 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.886 0.312 . . . . 15.0 110.206 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.58 -53.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.883 0.873 . . . . 15.0 110.227 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.78 -47.28 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 114.304 -1.316 . . . . 15.0 111.239 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 351' ' ' LEU . 53.9 t -61.8 -48.25 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.968 0.907 . . . . 15.0 110.722 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.58 95.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.695 0.622 . . . . 15.0 113.575 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.519 HD11 ' HD2' ' A' ' 303' ' ' PRO . 94.7 mt -79.74 -58.01 3.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.536 0.735 . . . . 15.0 110.96 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 294' ' ' LEU . 91.1 mt -65.31 -51.81 58.18 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.673 0.608 . . . . 15.0 111.044 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.652 HD12 HG13 ' A' ' 347' ' ' VAL . 39.8 mt -71.17 -33.68 70.23 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 118.843 -0.599 . . . . 15.0 111.222 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.66 92.05 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.78 -0.528 . . . . 15.0 111.78 174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.59 -42.83 91.25 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.742 -0.729 . . . . 15.0 111.041 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 350' ' ' LEU . 89.7 t -58.99 -39.95 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 122.976 0.511 . . . . 15.0 111.3 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 360' ' ' LEU . 73.0 mt -68.83 -41.25 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.572 0.749 . . . . 15.0 110.198 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.4 ' HD3' ' OD2' ' B' ' 459' ' ' ASP . 27.9 ttp180 -60.23 -54.75 42.13 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.528 0.517 . . . . 15.0 110.631 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.3 m -60.64 -40.0 90.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.256 1.022 . . . . 15.0 111.945 -176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -96.6 8.62 43.74 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.511 0.725 . . . . 15.0 111.763 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 40.56 51.99 2.99 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.823 1.649 . . . . 15.0 113.648 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.618 ' HB2' HG23 ' A' ' 355' ' ' ILE . 78.5 mt -84.1 142.19 30.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.844 -1.071 . . . . 15.0 111.505 -176.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.62 151.67 49.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 167.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.24 94.87 0.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.036 0.535 . . . . 15.0 110.258 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.8 135.29 50.96 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.613 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -58.97 -35.87 73.91 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.12 0.888 . . . . 15.0 111.693 -170.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.49 -33.79 76.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.852 0.461 . . . . 15.0 110.755 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -80.89 -35.8 32.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.112 -0.495 . . . . 15.0 110.424 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.477 HG13 ' HG3' ' A' ' 398' ' ' MET . 86.4 t -56.99 -57.57 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.441 0.697 . . . . 15.0 109.544 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -62.89 -33.11 74.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.654 0.781 . . . . 15.0 111.413 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -54.97 -55.21 29.1 Favored Glycine 0 C--N 1.354 1.582 0 O-C-N 124.067 0.855 . . . . 15.0 111.627 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.52 -46.02 80.81 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.542 0.737 . . . . 15.0 111.26 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.611 HD11 ' HG2' ' A' ' 398' ' ' MET . 47.0 mm -48.85 -61.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 124.539 1.149 . . . . 15.0 110.729 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.68 -37.69 73.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.775 0.658 . . . . 15.0 112.775 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.54 -46.84 77.98 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.043 0.449 . . . . 15.0 111.044 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.2 ttp -69.93 -35.98 74.98 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.432 1.093 . . . . 15.0 110.98 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.72 60.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.138 0.575 . . . . 15.0 112.038 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.4 t -65.83 -17.23 64.5 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.792 0.837 . . . . 15.0 111.501 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -73.03 -7.25 50.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.18 0.592 . . . . 15.0 111.664 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -103.31 166.23 10.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.238 1.015 . . . . 15.0 110.874 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.21 -29.2 63.74 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.855 -1.066 . . . . 15.0 111.278 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -155.12 112.71 2.3 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 15.0 107.7 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.46 -3.94 3.64 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.032 2.488 . . . . 15.0 115.469 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -60.69 -36.93 80.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.668 0.618 . . . . 15.0 112.668 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.1 -36.22 82.85 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.625 0.578 . . . . 15.0 109.897 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.33 -49.14 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.52 0.728 . . . . 15.0 110.121 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.93 -52.24 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 123.831 0.707 . . . . 15.0 109.9 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.33 -54.75 39.68 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.228 0.955 . . . . 15.0 110.674 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -51.09 -57.78 7.8 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.744 1.278 . . . . 15.0 111.566 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -58.37 -53.4 58.76 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.82 0.7 . . . . 15.0 110.662 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.1 p -62.71 -19.05 63.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.69 -7.01 21.01 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.448 0.699 . . . . 15.0 111.861 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 395' ' ' MET . 51.0 t-20 -121.69 86.26 2.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.959 -0.756 . . . . 15.0 108.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -58.62 -32.09 68.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.159 1.384 . . . . 15.0 111.41 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.6 -32.47 73.82 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.675 0.61 . . . . 15.0 110.754 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.564 HD12 HD21 ' B' ' 450' ' ' ASN . 22.3 tp -94.42 -20.18 19.94 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-O 119.464 -0.303 . . . . 15.0 111.112 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 77.2 mmm -59.38 -38.03 79.46 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.196 -0.668 . . . . 15.0 109.196 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.4 -60.24 1.57 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.869 1.268 . . . . 15.0 112.072 168.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -66.34 -34.93 79.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.178 0.991 . . . . 15.0 110.808 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.611 ' HG2' HD11 ' A' ' 371' ' ' ILE . 26.3 tpp -70.27 -27.32 64.33 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.851 0.861 . . . . 15.0 111.226 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 395' ' ' MET . 64.0 mtp85 -79.14 -35.18 42.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -63.48 -44.91 93.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.611 0.569 . . . . 15.0 110.244 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.0 p -75.7 -28.47 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 123.118 0.261 . . . . 15.0 111.33 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.71 -40.23 96.5 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.275 0.489 . . . . 15.0 110.278 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 355' ' ' ILE . 27.8 tp -73.38 -36.4 66.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.521 -1.218 . . . . 15.0 110.238 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.79 -51.98 67.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.26 1.024 . . . . 15.0 111.187 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 283' ' ' ARG . 75.3 mm-40 -67.08 -40.77 87.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.401 0.68 . . . . 15.0 110.865 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.558 HE21 ' HB3' ' A' ' 360' ' ' LEU . 23.9 tt0 -63.2 -34.3 77.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.794 0.838 . . . . 15.0 110.56 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.71 85.71 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.538 0.735 . . . . 15.0 111.505 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 94.4 t -52.98 -54.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 O-C-N 123.982 0.801 . . . . 15.0 108.914 171.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 412' ' ' LEU . 31.2 mt-10 -62.47 -26.61 68.61 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.799 -1.091 . . . . 15.0 112.744 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.56 74.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.036 0.534 . . . . 15.0 110.882 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 294' ' ' LEU . 57.8 t -72.63 -35.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.847 -0.798 . . . . 15.0 108.847 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 409' ' ' GLU . 81.6 mt -65.77 -37.35 86.1 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.978 0.798 . . . . 15.0 110.89 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.28 64.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.365 -0.834 . . . . 15.0 112.125 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -106.71 -27.27 10.91 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.959 0.904 . . . . 15.0 111.867 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.21 158.94 16.97 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.743 0.817 . . . . 15.0 111.93 -171.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 88.4 mttt -69.04 78.77 0.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.454 1.101 . . . . 15.0 110.351 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 125' ' ' VAL . 25.5 t -97.9 103.11 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -78.41 119.9 22.38 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.368 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 32.2 tt0 -78.61 87.23 4.56 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.733 0.778 . . . . 15.0 109.263 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -95.66 100.74 12.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.859 -1.064 . . . . 15.0 110.704 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.03 128.54 35.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 15.0 109.279 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.484 HG23 HG22 ' A' ' 130' ' ' VAL . 7.7 t -161.93 176.88 10.34 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.725 0.41 . . . . 15.0 111.126 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 40.6 p -106.41 171.02 7.58 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.213 1.005 . . . . 15.0 111.669 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -43.57 -60.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.042 1.737 . . . . 15.0 113.593 -168.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.36 -23.02 65.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.732 1.012 . . . . 15.0 113.732 -167.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.442 ' HG2' HG21 ' A' ' 422' ' ' THR . 15.4 tp10 -45.21 -46.78 12.48 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.895 1.278 . . . . 15.0 112.966 -177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.66 -31.06 41.42 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.799 0.84 . . . . 15.0 110.943 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.0 OUTLIER -71.74 -31.83 67.08 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.448 0.699 . . . . 15.0 110.04 175.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -75.72 20.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.27 1.028 . . . . 15.0 113.627 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.79 64.41 5.57 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.515 0.674 . . . . 15.0 109.831 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.01 102.18 14.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.23 1.012 . . . . 15.0 110.408 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . 0.426 ' HB3' ' HD1' ' B' ' 377' ' ' PHE . . . . . . . . 0 CA--C 1.552 1.028 0 C-N-CA 124.518 1.127 . . . . 15.0 109.683 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.443 0.639 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.83 136.09 5.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.395 1.078 . . . . 0.0 108.84 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.87 -81.94 0.48 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' B' ' 372' ' ' GLN . 12.4 t70 -91.45 -75.71 0.47 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' B' ' 373' ' ' ARG . 39.7 tt0 -104.02 -78.68 0.55 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.661 0.384 . . . . 0.0 110.428 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -104.38 -77.63 0.57 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.102 0.561 . . . . 0.0 110.258 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.42 HG23 ' NE2' ' B' ' 372' ' ' GLN . 0.6 OUTLIER -98.62 -82.96 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.502 ' O ' ' HB3' ' B' ' 368' ' ' ASP . 0.5 OUTLIER -101.69 -79.54 0.51 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 161.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.487 ' H ' ' HG2' ' B' ' 372' ' ' GLN . 35.8 tpt85 -100.07 -85.18 0.41 Allowed 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.737 1.153 . . . . 0.0 111.653 -176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -106.67 -80.8 0.56 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -168.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.49 ' H ' HD12 ' B' ' 375' ' ' LEU . 0.2 OUTLIER -109.37 -79.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.797 0.439 . . . . 0.0 111.921 -169.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.22 -75.79 0.5 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.426 ' HD1' ' HB3' ' A' ' 432' ' ' ALA . 90.1 m-85 -105.31 -87.63 0.45 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.712 0.405 . . . . 0.0 110.546 167.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -106.35 -81.13 0.55 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.561 0.744 . . . . 0.0 111.902 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 -56.27 2.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.855 0.862 . . . . 0.0 113.237 -165.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? 75.02 149.04 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.368 1.467 . . . . 0.0 109.852 -158.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.83 166.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' B' ' 391' ' ' ASP . . . -148.75 84.17 0.17 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.189 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -61.41 97.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.791 0.836 . . . . 0.0 111.419 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 3.3 t -85.61 85.31 7.42 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-O 122.088 0.947 . . . . 0.0 110.347 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 19.6 tp -146.11 167.58 23.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.776 1.23 . . . . 0.0 107.745 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.38 91.32 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 118.999 0.818 . . . . 0.0 109.173 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.426 HG13 ' OH ' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -145.14 162.6 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 126.107 1.763 . . . . 0.0 108.088 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 177' ' ' PHE . 28.8 t -55.78 138.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 8.7 t -57.4 96.13 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.934 1.35 . . . . 0.0 112.277 -170.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -92.8 -169.39 2.17 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.738 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.497 ' O ' ' HA2' ' B' ' 382' ' ' GLY . 5.6 m-20 -40.86 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.393 1.477 . . . . 0.0 111.497 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -120.92 60.06 0.92 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -79.07 75.73 5.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.149 0.976 . . . . 0.0 110.248 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -100.94 -23.45 14.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.898 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 66.09 -72.97 0.07 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.505 1.522 . . . . 0.0 111.963 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.0 t 69.0 13.94 8.82 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.797 1.239 . . . . 0.0 111.819 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 62.0 -74.57 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.349 1.46 . . . . 0.0 110.624 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.26 125.84 43.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.26 94.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -166.94 145.01 4.21 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.281 1.032 . . . . 0.0 108.817 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.25 109.93 1.67 Allowed 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.392 2.061 . . . . 0.0 110.77 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -73.14 170.79 14.2 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.105 0.562 . . . . 0.0 110.581 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 14.8 t -143.22 155.56 44.55 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.616 0.366 . . . . 0.0 110.731 -171.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 7.27 6.15 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.765 1.626 . . . . 0.0 112.625 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' B' ' 406' ' ' PRO . . . -70.75 -37.21 6.15 Favored Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.721 174.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 405' ' ' ALA . 30.7 Cg_endo -61.68 -10.68 17.57 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 122.037 1.825 . . . . 0.0 113.324 172.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -78.75 78.91 1.61 Allowed Glycine 0 C--N 1.353 1.479 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.45 81.27 2.5 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.329 0.652 . . . . 0.0 110.506 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 36.1 p -79.14 99.91 7.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 171.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -79.11 70.87 5.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.377 0.608 . . . . 0.0 109.809 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.43 -23.24 61.05 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.903 0.881 . . . . 0.0 111.227 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.81 -11.39 55.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.463 0.705 . . . . 0.0 111.149 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -105.46 -82.62 0.52 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 15.0 t -172.57 167.25 5.51 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.142 0.977 . . . . 0.0 110.192 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -158.4 149.57 20.81 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 108.943 172.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -67.31 -49.1 65.55 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.326 0.65 . . . . 0.0 110.413 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 53.75 -97.83 0.03 OUTLIER Glycine 0 C--N 1.362 1.992 0 O-C-N 124.11 0.881 . . . . 0.0 113.534 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.48 145.69 47.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 46.2 t -70.87 82.75 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 122.187 0.994 . . . . 0.0 109.471 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 52.0 tpp -98.41 -76.51 0.53 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.857 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 44.6 t 50.77 -79.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.96 1.704 . . . . 0.0 112.69 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 22.2 mmt 66.56 175.5 0.24 Allowed 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.702 1.601 . . . . 0.0 111.778 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 50.9 p -73.37 -40.92 64.0 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 2.5 t80 65.64 -69.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.923 1.689 . . . . 0.0 111.035 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.08 -95.13 0.1 OUTLIER Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -177.83 -54.92 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.098 0.959 . . . . 0.0 109.291 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 34.2 t -148.42 77.19 1.39 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.11 -21.11 3.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.521 1.128 . . . . 0.0 111.328 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.54 -36.62 84.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.38 1.072 . . . . 0.0 110.045 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . 0.454 ' HB2' ' CZ ' ' B' ' 440' ' ' ARG . 8.6 p-10 -84.22 -23.52 30.44 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.593 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 32.9 t -67.28 -21.22 65.71 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.65 0.78 . . . . 0.0 111.018 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -64.98 -24.46 67.52 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.026 0.931 . . . . 0.0 110.852 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.25 -78.2 0.09 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 162.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -164.34 177.37 8.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.297 1.439 . . . . 0.0 108.964 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 30.7 m -69.42 100.57 1.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.691 0.796 . . . . 0.0 109.718 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 83.32 163.81 35.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.004 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 124.4 20.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.439 0.696 . . . . 0.0 111.063 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -116.53 -30.07 5.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.293 1.037 . . . . 0.0 110.213 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.03 -83.31 0.42 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 168.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' B' ' 441' ' ' ILE . 23.8 ttm180 53.46 -161.23 0.12 Allowed 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 124.475 1.11 . . . . 0.0 111.9 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.584 ' H ' ' HG2' ' B' ' 440' ' ' ARG 0.306 0.0 OUTLIER 58.09 -78.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 C-N-CA 126.508 1.923 . . . . 0.0 113.353 163.428 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . 0.447 ' H ' HG23 ' B' ' 441' ' ' ILE . . . -155.41 -84.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 59.43 13.03 2.99 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 124.501 1.121 . . . . 0.0 113.457 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 59.45 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.215 1.406 . . . . 0.0 112.929 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 133.19 88.33 0.35 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.655 -2.578 . . . . 0.0 106.655 -165.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -88.82 176.7 3.27 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.441 2.761 . . . . 0.0 111.89 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . 0.648 ' HA ' HG22 ' A' ' 313' ' ' VAL . 3.1 t60 -71.5 93.62 1.21 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.887 0.475 . . . . 0.0 110.54 -173.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 66.4 -72.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.546 1.538 . . . . 0.0 110.512 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -111.23 176.53 4.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.105 0.962 . . . . 0.0 109.189 171.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.564 HD21 HD12 ' A' ' 394' ' ' LEU . 6.3 m-20 -59.6 -63.47 1.29 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.679 0.791 . . . . 0.0 111.129 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 11.1 p -158.1 -47.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 165.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.1 t 53.32 74.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 124.932 1.293 . . . . 0.0 110.034 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 83.88 119.54 0.75 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.964 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.38 -48.04 74.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.807 0.843 . . . . 0.0 110.207 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 65.9 p 48.35 31.04 2.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.117 1.767 . . . . 0.0 113.664 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -149.86 138.59 20.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -65.0 -33.29 75.69 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.823 0.702 . . . . 0.0 111.911 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 8.0 t 32.48 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.95 2.1 . . . . 0.0 114.971 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 356' ' ' ARG . 2.3 p-10 -56.22 -31.32 63.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.915 0.886 . . . . 0.0 113.132 -168.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.611 HD13 ' HB ' ' B' ' 463' ' ' THR . 0.3 OUTLIER -101.38 36.47 2.01 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.185 0.994 . . . . 0.0 111.182 -177.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . 0.304 19.3 p90 67.76 -39.91 0.4 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 128.256 2.622 . . . . 0.0 116.656 169.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -177.83 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.274 1.03 . . . . 0.0 109.652 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.611 ' HB ' HD13 ' B' ' 460' ' ' LEU . 72.4 m -34.95 118.2 0.42 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.719 1.607 . . . . 0.0 114.612 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' B' ' 467' ' ' ALA . 24.5 mmt 64.71 119.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.161 1.384 . . . . 0.0 112.302 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -66.25 -25.01 66.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.085 0.554 . . . . 0.0 110.521 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -96.03 17.99 14.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.528 1.131 . . . . 0.0 111.454 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' B' ' 464' ' ' MET . . . -146.22 94.53 2.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.121 0.569 . . . . 0.0 109.675 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.78 -166.36 1.45 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.722 0.809 . . . . 0.0 109.889 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.75 -169.26 22.94 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.567 172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -155.55 -36.02 0.09 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.412 0.685 . . . . 0.0 110.408 -174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.725 ' HG3' ' HB3' ' A' ' 83' ' ' LYS . 4.2 ttmp? . . . . . 0 C--O 1.247 0.935 0 C-N-CA 124.304 1.042 . . . . 12.06 108.293 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 23.3 ptm . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.5 -0.185 . . . . 15.0 110.5 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -150.91 113.29 4.62 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 17' ' ' ILE . 28.9 m -123.67 146.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.695 0.798 . . . . 15.0 110.29 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.4 p -137.36 115.47 11.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.377 0.671 . . . . 15.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.33 131.99 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.096 0.559 . . . . 15.0 111.094 -174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -135.34 148.71 49.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.841 1.256 . . . . 15.0 108.443 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 m -93.46 112.06 23.87 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.538 -0.541 . . . . 15.0 109.538 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -80.52 -44.33 19.3 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.974 0.51 . . . . 15.0 111.284 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -167.42 94.52 0.44 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.344 0.657 . . . . 15.0 109.786 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.36 -102.86 0.41 Allowed Glycine 0 C--N 1.352 1.461 0 O-C-N 123.958 0.786 . . . . 15.0 113.765 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD13 ' HB3' ' A' ' 113' ' ' PRO . 50.9 tp -68.49 -35.25 77.25 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.879 0.872 . . . . 15.0 110.733 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.43 135.26 22.03 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.138 -0.937 . . . . 15.0 112.079 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -136.6 -177.31 4.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.921 1.288 . . . . 15.0 109.757 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -150.15 110.52 4.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.89 0.876 . . . . 15.0 109.709 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.3 t -98.56 92.03 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.709 -0.848 . . . . 15.0 108.709 170.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 44.8 m -75.11 105.03 5.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.554 0.742 . . . . 15.0 109.87 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 3' ' ' VAL . 35.8 mt -93.31 115.77 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.857 -0.611 . . . . 15.0 109.6 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.7 m -92.71 96.41 10.15 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.433 -0.951 . . . . 15.0 108.433 166.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 70' ' ' LEU . 74.3 mt -73.27 98.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 171.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.93 162.64 23.84 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.232 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.6 -22.35 55.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.572 1.149 . . . . 15.0 113.955 -170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.84 -42.89 89.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.884 0.474 . . . . 15.0 110.508 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -73.68 -36.57 65.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.493 -0.776 . . . . 15.0 110.923 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 28' ' ' VAL . 56.5 mt -68.07 -59.05 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.933 0.493 . . . . 15.0 110.204 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -61.37 -41.84 97.74 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.217 1.007 . . . . 15.0 112.291 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 m -64.99 -42.11 94.81 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.647 0.592 . . . . 15.0 110.979 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.31 71.41 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 15.0 112.007 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.446 ' HA ' HG21 ' A' ' 66' ' ' VAL . 79.5 t -62.82 -45.43 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.733 0.813 . . . . 15.0 110.31 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 3.8 ttmp? -66.27 -39.27 89.33 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.249 -1.341 . . . . 15.0 110.367 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 m -72.27 -21.91 61.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.12 0.968 . . . . 15.0 111.01 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 21.8 tp10 -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.658 0.383 . . . . 15.0 111.221 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 55' ' ' ALA . 36.2 mt -68.53 -26.54 65.48 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.382 0.273 . . . . 15.0 111.7 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 p -76.54 -29.2 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 123.245 0.34 . . . . 15.0 110.097 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -66.29 -46.33 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.967 0.507 . . . . 15.0 109.934 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 31' ' ' GLU . 61.0 t -65.54 -37.54 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.983 0.913 . . . . 15.0 110.167 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.24 92.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.32 0.648 . . . . 15.0 111.182 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.58 -23.87 39.59 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.923 0.489 . . . . 15.0 111.513 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.98 -49.3 38.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.613 0.765 . . . . 15.0 110.188 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.38 -5.91 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.944 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 69.47 21.1 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.097 1.359 . . . . 15.0 111.95 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -64.37 -26.28 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 124.331 1.052 . . . . 15.0 111.126 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -59.38 -36.69 76.25 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.112 0.965 . . . . 15.0 111.627 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.54 -10.92 80.08 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.359 -0.382 . . . . 15.0 113.598 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -119.23 2.23 11.36 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.037 0.935 . . . . 15.0 110.774 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.5 ttt85 -76.86 94.86 3.97 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.288 0.635 . . . . 15.0 110.027 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -80.3 86.5 5.67 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.397 -0.82 . . . . 15.0 110.835 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 37.26 -56.57 0.0 OUTLIER Glycine 0 CA--C 1.55 2.266 0 N-CA-C 120.142 2.817 . . . . 15.0 120.142 160.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -43.09 -47.9 6.13 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.205 1.802 . . . . 15.0 114.228 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.44 106.37 16.31 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.75 0.42 . . . . 15.0 110.192 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 53' ' ' ILE . 3.5 Cg_exo -78.84 156.63 27.31 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.514 2.809 . . . . 15.0 112.299 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 54' ' ' VAL . 58.9 tpp -70.58 -27.18 63.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.863 0.865 . . . . 15.0 111.752 -172.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.7 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 34.0 p-10 -69.84 -28.97 66.13 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.849 0.46 . . . . 15.0 111.924 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.524 HG23 ' HD2' ' A' ' 57' ' ' ARG . 12.3 mt -72.36 -51.89 26.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.665 0.786 . . . . 15.0 110.14 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . 33.8 m -68.61 -25.6 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.47 0.545 . . . . 15.0 112.47 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -60.35 -41.12 92.96 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.393 0.677 . . . . 15.0 112.59 -177.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -117.25 -3.56 11.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 -170.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 53' ' ' ILE . 75.9 mtt180 -115.64 -45.84 2.88 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.135 0.425 . . . . 15.0 111.623 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.46 ' HD2' ' HA ' ' A' ' 54' ' ' VAL . 94.9 m-85 -104.69 -39.01 6.5 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.202 0.816 . . . . 15.0 113.202 -168.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.84 39.5 2.78 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 112.492 -0.243 . . . . 15.0 112.492 -174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.58 61.29 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.906 0.882 . . . . 15.0 112.098 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p -73.71 -35.58 65.13 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.062 0.945 . . . . 15.0 111.088 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -69.13 -25.22 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.724 0.81 . . . . 15.0 110.622 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.543 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 25.3 mtp180 -61.1 -22.1 64.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.643 0.777 . . . . 15.0 111.951 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -58.73 -54.23 49.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.136 0.975 . . . . 15.0 111.232 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.03 -27.46 66.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 28' ' ' VAL . 94.7 t -64.85 -43.28 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 123.61 0.568 . . . . 15.0 109.76 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 91.5 mt -62.37 -41.65 98.8 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.997 0.519 . . . . 15.0 111.162 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.62 99.13 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.644 0.59 . . . . 15.0 112.282 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.66 -41.17 96.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.384 1.074 . . . . 15.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.692 ' HB3' HD13 ' A' ' 19' ' ' ILE . 71.2 mt -67.84 -34.53 76.89 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.661 -0.7 . . . . 15.0 111.01 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.2 mtm -67.8 -20.69 65.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.566 0.346 . . . . 15.0 111.255 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -87.2 -55.7 3.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 15.0 110.203 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -72.76 -39.09 67.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.463 0.705 . . . . 15.0 112.544 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -73.22 -27.07 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 117.875 0.307 . . . . 15.0 110.704 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.87 -54.12 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.222 -0.288 . . . . 15.0 110.222 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.421 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.3 tt -65.04 -37.32 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 O-C-N 123.423 0.452 . . . . 15.0 110.896 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.665 0.786 . . . . 15.0 110.653 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -55.03 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.48 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 33.3 pt -67.06 -23.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 112.717 0.636 . . . . 15.0 112.717 -172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.39 -53.4 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.452 0.701 . . . . 15.0 110.652 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.9 ptpt -75.1 -29.5 60.62 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.607 0.363 . . . . 15.0 111.455 -176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -84.31 -16.35 43.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.278 0.631 . . . . 15.0 111.454 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 66.77 14.06 9.64 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.64 1.176 . . . . 15.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.436 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 74.7 mt -77.24 105.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' ND2' ' HG ' ' B' ' 470' ' ' LEU . 43.7 t30 -81.0 110.03 15.98 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.45 148.53 38.14 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.585 2.19 . . . . 15.0 112.957 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 303' ' ' PRO . . . -152.65 -177.74 6.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.505 0.722 . . . . 15.0 109.856 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 305' ' ' ALA . . . 64.1 -102.13 0.56 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.86 116.34 2.43 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 107.826 -1.175 . . . . 15.0 107.826 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 43.5 Cg_exo -59.59 105.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 121.687 1.591 . . . . 15.0 110.249 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 m -101.71 99.26 9.5 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.247 -0.649 . . . . 15.0 109.247 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -77.39 78.19 3.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.636 0.774 . . . . 15.0 109.134 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.05 109.47 3.29 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.46 106.56 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.118 2.545 . . . . 15.0 111.961 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.85 -79.32 0.57 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.243 -0.743 . . . . 15.0 111.243 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -168.16 151.2 5.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.4 0.68 . . . . 15.0 111.533 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.79 142.21 44.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.601 1.16 . . . . 15.0 109.398 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.2 mttt -133.54 142.83 48.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.259 1.024 . . . . 15.0 108.773 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -61.61 106.18 0.63 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 15.0 110.251 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.64 -17.52 58.79 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 116.038 -0.528 . . . . 15.0 113.477 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 43.4 mt-10 -97.94 -173.52 2.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.563 0.745 . . . . 15.0 110.095 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -72.78 160.09 32.74 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.909 0.883 . . . . 15.0 112.492 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -121.55 106.12 11.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.73 1.212 . . . . 15.0 108.56 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 m -105.07 139.52 39.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.624 0.77 . . . . 15.0 109.93 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -159.96 143.58 14.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.027 0.931 . . . . 15.0 108.818 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 48.8 m -100.64 107.99 19.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.72 0.808 . . . . 15.0 110.565 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.15 97.69 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.98 -0.748 . . . . 15.0 108.98 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.3 123.05 35.34 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.229 0.612 . . . . 15.0 109.882 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 47.1 p90 -159.52 157.85 30.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.772 0.829 . . . . 15.0 110.276 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.3 176.63 7.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.137 0.975 . . . . 15.0 109.994 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.36 175.96 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' B' ' 471' ' ' LYS . 94.4 m-85 -89.76 118.08 68.67 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 109.266 -0.642 . . . . 15.0 109.266 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.63 ' HG2' HD11 ' A' ' 300' ' ' ILE . 58.6 Cg_endo -88.53 173.03 4.63 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.606 2.204 . . . . 15.0 114.427 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.65 134.68 33.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.123 -1.399 . . . . 15.0 109.059 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.49 126.98 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.417 -0.586 . . . . 15.0 109.417 172.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -84.3 94.13 8.38 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.4 145.25 54.5 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.141 -0.936 . . . . 15.0 108.763 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -79.15 173.83 12.18 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.58 109.86 2.43 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.548 -1.021 . . . . 15.0 110.548 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.433 HD13 HG22 ' A' ' 411' ' ' VAL . 47.1 mt -66.8 -14.12 62.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.609 0.763 . . . . 15.0 111.246 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.96 -22.61 63.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.289 . . . . 15.0 111.289 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.74 62.85 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.773 0.829 . . . . 15.0 110.947 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -66.04 131.34 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.619 0.768 . . . . 15.0 109.657 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.25 123.84 49.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.911 0.884 . . . . 15.0 109.618 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 417' ' ' VAL . 61.4 t -125.27 163.66 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.838 1.255 . . . . 15.0 107.917 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.34 143.97 48.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.532 0.733 . . . . 15.0 109.262 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 129' ' ' ILE . 80.6 tttt -114.87 93.52 34.41 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.133 -1.062 . . . . 15.0 108.133 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.79 98.61 1.22 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.17 1.914 . . . . 15.0 112.289 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.483 HD11 ' HE2' ' A' ' 127' ' ' LYS . 48.5 mm -72.52 96.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 170.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 427' ' ' LEU . 21.0 t -122.74 142.82 37.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.526 -0.761 . . . . 15.0 109.997 -173.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.47 146.25 39.81 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.817 0.847 . . . . 15.0 108.932 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t -82.54 88.81 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.5 p -76.24 -179.85 5.31 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.894 0.878 . . . . 15.0 110.339 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.92 -37.59 74.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.444 0.698 . . . . 15.0 111.689 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.8 96.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 15.0 111.492 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.45 -42.94 52.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.808 0.843 . . . . 15.0 111.556 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.79 -56.44 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.902 0.881 . . . . 15.0 109.489 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.37 -45.89 92.49 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.175 0.99 . . . . 15.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.33 -46.91 89.35 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.919 0.762 . . . . 15.0 113.333 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.24 -51.68 50.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.143 0.577 . . . . 15.0 110.896 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.2 mt -53.91 -39.39 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.569 0.748 . . . . 15.0 111.86 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.43 -40.9 85.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.925 0.49 . . . . 15.0 111.027 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 m -67.89 -26.74 66.16 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.752 0.421 . . . . 15.0 110.756 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.86 -37.73 76.19 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.852 0.461 . . . . 15.0 110.333 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -64.68 -35.06 79.82 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.707 0.289 . . . . 15.0 110.424 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -69.3 -34.6 74.95 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.306 0.642 . . . . 15.0 111.099 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.66 -41.26 79.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 15.0 109.98 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -95.1 29.66 2.38 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.027 0.931 . . . . 15.0 111.184 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.554 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.09 135.48 46.28 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.106 0.562 . . . . 15.0 112.434 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.1 m -83.54 138.85 33.22 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.625 1.17 . . . . 15.0 110.25 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -80.16 139.17 36.91 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.829 0.452 . . . . 15.0 110.236 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 153' ' ' GLU . 33.1 ttpt -156.98 172.99 17.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.09 -1.078 . . . . 15.0 108.09 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 241' ' ' GLU . 41.6 mt-10 -121.64 165.72 15.33 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.97 0.908 . . . . 15.0 110.035 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.533 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 41.6 pttt -156.78 -179.92 8.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.031 0.933 . . . . 15.0 110.87 172.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -149.03 146.95 28.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.977 0.511 . . . . 15.0 109.655 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.19 -50.21 0.88 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.0 -0.889 . . . . 15.0 113.533 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 206' ' ' LYS . . . -153.57 153.89 33.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 118.465 1.132 . . . . 15.0 112.234 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.84 157.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.47 1.108 . . . . 15.0 109.517 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -138.51 -174.88 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.485 1.914 . . . . 15.0 108.252 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.531 ' HA ' ' HE1' ' A' ' 189' ' ' MET . . . -84.08 -8.73 59.03 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.459 0.911 . . . . 15.0 113.459 -174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -104.52 -6.5 20.55 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.143 0.429 . . . . 15.0 112.021 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -81.61 178.4 8.36 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.054 1.131 . . . . 15.0 114.054 -165.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.717 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 16.0 mtm180 -116.27 98.77 6.78 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.833 -1.076 . . . . 15.0 108.503 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.01 97.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 -169.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 9.0 m -73.32 111.73 8.72 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.851 -1.166 . . . . 15.0 107.851 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 41.8 pt -132.95 179.43 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.422 1.089 . . . . 15.0 110.924 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 236' ' ' ASN . 2.8 t70 -130.04 157.53 42.1 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.179 1.391 . . . . 15.0 107.713 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' B' ' 385' ' ' LEU . 24.4 p90 -144.61 150.59 37.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.636 0.731 . . . . 15.0 111.074 164.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.536 ' HB ' ' HE2' ' A' ' 181' ' ' LYS . 1.8 t -125.99 95.12 4.3 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 106.467 -1.679 . . . . 15.0 106.467 166.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.96 166.77 31.34 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 114.93 -1.032 . . . . 15.0 115.067 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -151.19 141.97 22.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.964 1.306 . . . . 15.0 108.283 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.3 t -118.55 137.52 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.584 0.754 . . . . 15.0 109.141 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.544 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 35.3 t70 70.48 5.83 5.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.721 1.208 . . . . 15.0 111.875 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.31 -1.0 46.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.722 -0.488 . . . . 15.0 113.37 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.01 145.41 49.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.627 0.771 . . . . 15.0 110.576 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -76.01 110.48 10.52 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.149 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 172' ' ' VAL . 32.7 p90 -70.84 170.38 12.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.219 0.608 . . . . 15.0 111.259 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -69.68 134.56 48.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.63 -1.168 . . . . 15.0 111.057 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.587 ' HA3' HG11 ' B' ' 386' ' ' VAL . . . 88.25 -78.64 1.75 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -170.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 -52.4 4.17 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.412 0.925 . . . . 15.0 115.412 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.536 ' HE2' ' HB ' ' A' ' 169' ' ' THR . 40.6 mmtt -85.9 145.97 26.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.913 1.079 . . . . 15.0 113.913 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.05 92.48 1.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.658 -1.61 . . . . 15.0 106.933 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -96.32 143.78 27.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.308 -0.86 . . . . 15.0 110.967 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' B' ' 379' ' ' LYS . 7.5 t70 65.75 21.92 11.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.338 1.055 . . . . 15.0 111.373 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 165' ' ' THR . 46.7 t80 -71.59 134.23 46.27 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.225 0.61 . . . . 15.0 110.579 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.35 103.66 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.794 -0.817 . . . . 15.0 108.794 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.449 ' HG ' ' HG2' ' A' ' 189' ' ' MET . 27.0 tp -82.8 80.1 8.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.298 0.571 . . . . 15.0 110.047 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.54 92.44 0.31 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.691 -1.226 . . . . 15.0 107.691 167.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.531 ' HE1' ' HA ' ' A' ' 160' ' ' ALA . 62.5 mtp -66.98 144.64 56.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.499 -0.773 . . . . 15.0 110.394 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.12 14.57 Favored Glycine 0 N--CA 1.471 0.978 0 O-C-N 123.496 0.498 . . . . 15.0 112.494 -172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.44 -178.96 3.65 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.27 1.028 . . . . 15.0 110.339 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.17 6.93 56.5 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 115.912 -0.586 . . . . 15.0 113.518 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -77.84 2.09 18.31 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.098 0.559 . . . . 15.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.7 mmt -134.74 154.53 51.54 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.911 0.884 . . . . 15.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.57 152.84 37.94 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 114.757 -1.11 . . . . 15.0 109.374 170.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.93 143.97 46.95 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.03 2.487 . . . . 15.0 112.928 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.24 -40.29 2.47 Favored Glycine 0 N--CA 1.468 0.802 0 CA-C-N 115.803 -0.635 . . . . 15.0 112.164 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -67.85 -63.81 0.99 Allowed 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.28 -24.57 67.36 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.437 -0.801 . . . . 15.0 112.077 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.91 -37.59 81.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.083 0.953 . . . . 15.0 110.682 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.78 -10.95 80.79 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.468 -0.787 . . . . 15.0 113.075 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.448 HG21 HD23 ' A' ' 187' ' ' LEU . 42.9 mm -94.84 -47.12 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.763 0.825 . . . . 15.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -82.41 19.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.325 1.232 . . . . 15.0 114.325 -167.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.78 25.39 5.31 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.99 -1.244 . . . . 15.0 109.99 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -140.71 -169.96 2.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.729 1.211 . . . . 15.0 110.213 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -153.52 163.56 39.74 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.996 0.918 . . . . 15.0 110.675 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -68.07 132.2 46.81 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.38 0.672 . . . . 15.0 112.06 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 126.77 -28.24 4.71 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 114.761 -1.109 . . . . 15.0 111.799 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.8 pt-20 -96.14 139.32 32.48 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 121.727 0.775 . . . . 15.0 111.455 -174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -106.27 125.8 51.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.981 1.313 . . . . 15.0 108.948 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -144.38 169.67 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.073 0.949 . . . . 15.0 109.769 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 70.2 m -124.34 120.45 32.17 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -95.64 160.48 2.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.497 0.719 . . . . 15.0 111.207 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -104.92 118.42 36.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.99 -1.005 . . . . 15.0 109.903 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.6 163.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 87.3 m -146.26 131.9 18.86 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.971 -1.122 . . . . 15.0 107.971 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.473 ' HZ ' ' HB ' ' B' ' 387' ' ' ILE . 73.0 m-85 -68.23 135.47 91.32 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 110.128 -0.323 . . . . 15.0 110.128 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.21 156.68 19.91 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.161 2.574 . . . . 15.0 113.515 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.609 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -75.22 -20.71 59.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.917 169.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.22 -16.7 57.59 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.914 0.886 . . . . 15.0 111.21 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.443 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 69.5 t80 -60.66 142.09 56.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.069 0.948 . . . . 15.0 111.616 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -65.03 -44.95 87.45 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.027 0.931 . . . . 15.0 112.76 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.443 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -88.2 104.11 16.4 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.799 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 40.8 tt0 -63.3 -21.08 66.03 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.672 1.189 . . . . 15.0 112.428 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.448 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 29.6 p30 -68.14 -10.56 55.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.809 0.843 . . . . 15.0 112.518 174.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 388' ' ' VAL . 79.1 mt -121.39 -36.91 2.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.235 1.014 . . . . 15.0 110.05 175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.799 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 9.3 tttm -53.48 128.89 30.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.779 1.632 . . . . 15.0 111.991 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.02 16.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.998 -0.547 . . . . 15.0 113.22 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 173' ' ' ASP . 93.3 mttt -86.24 147.44 26.1 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.379 0.672 . . . . 15.0 110.343 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.25 166.63 22.48 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.728 0.643 . . . . 15.0 110.416 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -153.02 119.62 5.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.39 0.676 . . . . 15.0 109.816 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -98.86 134.45 41.72 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -128.54 110.73 12.54 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.87 0.468 . . . . 15.0 110.273 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.8 91.73 4.14 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.405 0.622 . . . . 15.0 109.342 176.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 168' ' ' PHE . 33.6 mm -81.16 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.926 1.29 . . . . 15.0 110.636 -176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -111.3 97.25 6.64 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.463 -1.31 . . . . 15.0 107.463 176.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -81.41 118.55 22.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.54 -0.911 . . . . 15.0 108.54 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -115.46 -37.49 4.0 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.588 0.355 . . . . 15.0 111.618 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.723 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.0 mmtt -135.87 142.97 44.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.999 0.52 . . . . 15.0 110.235 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 207' ' ' ALA . 41.8 t -118.45 94.49 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.644 -1.243 . . . . 15.0 107.644 169.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 36.7 mt-10 -88.28 167.01 13.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 34.8 tt0 -138.9 130.54 27.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.949 0.499 . . . . 15.0 109.823 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -86.14 85.8 7.35 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.673 -1.232 . . . . 15.0 107.673 166.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -65.76 134.7 53.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.856 -1.065 . . . . 15.0 109.837 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.41 126.59 87.46 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.788 -174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 63.9 Cg_endo -68.93 157.95 59.84 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.958 2.439 . . . . 15.0 111.917 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -70.9 160.13 33.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.938 -1.028 . . . . 15.0 110.415 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.4 tp -88.3 30.01 0.92 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.622 0.769 . . . . 15.0 109.83 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.6 p -70.14 169.57 13.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.518 1.127 . . . . 15.0 111.623 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -37.97 -65.86 0.3 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.082 1.753 . . . . 15.0 114.72 -166.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.01 -22.57 66.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.678 0.791 . . . . 15.0 112.611 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -86.74 -49.87 7.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.061 0.544 . . . . 15.0 110.465 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.41 -31.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.758 0.423 . . . . 15.0 110.78 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.3 ptmt -98.97 5.14 47.33 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -61.27 -31.11 70.93 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.377 0.671 . . . . 15.0 110.777 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -68.12 -18.72 64.71 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.087 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.67 45.45 1.79 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.703 -0.559 . . . . 15.0 111.703 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 260' ' ' ASP . 65.8 t -71.91 149.28 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.717 0.807 . . . . 15.0 111.431 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -55.97 -41.51 74.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.478 1.111 . . . . 15.0 111.601 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.518 ' H ' HG12 ' A' ' 258' ' ' VAL . 0.8 OUTLIER -128.36 -47.97 1.31 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.581 -175.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 114.73 -12.62 20.57 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.634 -0.536 . . . . 15.0 113.373 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 94.2 p -73.47 167.64 20.88 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.558 0.679 . . . . 15.0 110.955 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.85 -49.41 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.124 0.97 . . . . 15.0 111.257 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.32 -28.8 68.42 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.314 0.646 . . . . 15.0 111.715 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.67 -26.13 57.11 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.129 -0.788 . . . . 15.0 111.129 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 270' ' ' VAL . 63.9 tp -74.71 -33.7 62.46 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -61.57 -40.08 93.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.396 0.679 . . . . 15.0 109.919 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.6 86.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.698 0.799 . . . . 15.0 111.317 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.3 -49.49 64.01 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.661 0.784 . . . . 15.0 110.516 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.483 ' HA ' ' SD ' ' A' ' 274' ' ' MET . 70.2 t -61.67 -33.67 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.736 1.214 . . . . 15.0 109.75 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -62.85 -61.65 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.493 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -71.71 -15.73 62.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 112.774 0.657 . . . . 15.0 112.774 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -89.27 -78.78 0.34 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.656 -0.868 . . . . 15.0 108.656 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' A' ' 270' ' ' VAL . 1.7 mpt? -62.85 -50.58 70.37 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.656 -0.687 . . . . 15.0 111.553 -169.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.15 -34.32 56.49 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.586 0.63 . . . . 15.0 111.656 -170.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -73.57 -44.08 58.21 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.942 -0.392 . . . . 15.0 109.942 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -63.03 -37.87 88.92 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.609 0.568 . . . . 15.0 109.783 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.8 tp -63.13 -60.87 2.85 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.405 0.682 . . . . 15.0 111.354 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.83 -29.47 69.94 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.726 0.641 . . . . 15.0 111.281 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 35.3 t -65.34 -46.11 81.55 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -69.68 -30.72 68.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.772 0.829 . . . . 15.0 111.761 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 130' ' ' VAL . 90.1 mt -67.88 -51.42 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.498 -0.927 . . . . 15.0 108.498 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.565 HH21 ' HB3' ' A' ' 405' ' ' GLU . 22.9 tpt180 -61.05 -41.84 97.36 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.351 -0.84 . . . . 15.0 110.429 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -72.09 -30.27 64.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.799 -0.619 . . . . 15.0 110.851 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -64.24 -57.89 8.15 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.985 0.514 . . . . 15.0 109.672 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 282' ' ' ILE . 42.1 t -57.33 -46.17 85.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.215 0 O-C-N 124.263 0.977 . . . . 15.0 110.216 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.503 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.7 tttt -59.45 -55.75 30.67 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.749 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.7 p -65.15 -28.86 69.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.311 0.644 . . . . 15.0 111.995 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.496 ' HB2' HG13 ' A' ' 125' ' ' VAL . 58.6 mt-30 -68.29 -44.32 75.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.563 0.345 . . . . 15.0 110.506 173.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.34 -42.32 96.32 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.578 0.351 . . . . 15.0 111.202 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 287' ' ' LYS . 15.9 mm -60.35 -53.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 15.0 111.01 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.78 -41.23 99.16 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.985 0.803 . . . . 15.0 110.271 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.96 -47.19 91.88 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.939 0.775 . . . . 15.0 112.095 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 411' ' ' VAL . 35.1 mt -59.03 -56.73 18.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.96 0.904 . . . . 15.0 111.846 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.31 -53.73 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.581 0.551 . . . . 15.0 110.3 -176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.88 -40.3 75.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.499 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.58 -33.93 67.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.022 -0.536 . . . . 15.0 112.224 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -116.76 103.85 10.76 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.038 0.381 . . . . 15.0 111.433 -163.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -74.11 144.52 44.9 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 168.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.63 HD11 ' HG2' ' A' ' 113' ' ' PRO . 5.3 tp -165.08 130.39 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.408 0.683 . . . . 15.0 110.214 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.58 95.88 4.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 173.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.505 HG11 HG12 ' A' ' 345' ' ' VAL . 22.7 t -89.04 128.02 53.43 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 109.264 -0.643 . . . . 15.0 109.264 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 54.3 Cg_endo -68.2 135.12 33.44 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.466 2.111 . . . . 15.0 111.858 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -64.5 -4.77 4.33 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.095 1.146 . . . . 15.0 114.095 -171.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 88' ' ' GLY . . . -56.83 -55.14 38.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.989 0.915 . . . . 15.0 110.803 174.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.57 -35.63 77.64 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.654 1.221 . . . . 15.0 110.89 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.626 ' HA ' HG21 ' A' ' 345' ' ' VAL . 2.1 mp -60.33 -56.68 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.964 -0.754 . . . . 15.0 108.964 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.16 -28.43 68.11 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.789 0.681 . . . . 15.0 111.135 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.0 t -60.67 -53.54 56.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.028 0.931 . . . . 15.0 111.222 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -76.73 -30.14 56.5 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.329 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.647 HD13 ' HG3' ' A' ' 334' ' ' ARG . 71.3 mt -60.99 -39.18 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 168.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 27.5 t70 -66.41 -40.22 89.46 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-O 118.398 -0.811 . . . . 15.0 110.607 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.5 t -56.67 -47.74 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.164 0.507 . . . . 15.0 110.281 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.1 mt -70.43 -27.01 63.93 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.202 -0.908 . . . . 15.0 112.047 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 84.1 mtm180 -71.85 -39.25 69.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.584 0.753 . . . . 15.0 110.54 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 22.0 mmt180 -65.21 -42.76 93.19 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.222 -0.658 . . . . 15.0 109.222 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -56.63 -50.34 72.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.651 1.181 . . . . 15.0 111.176 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.86 -59.31 5.63 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.278 0.631 . . . . 15.0 110.797 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.48 66.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.607 0.763 . . . . 15.0 112.366 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -65.44 -40.92 93.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.391 1.076 . . . . 15.0 110.552 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.432 ' NH2' ' HB2' ' B' ' 437' ' ' SER . 56.1 mtp180 -87.66 -8.35 56.27 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.062 0.458 . . . . 15.0 110.268 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -90.46 17.48 7.31 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 124.27 1.028 . . . . 15.0 109.753 167.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 432' ' ' GLN . . . 92.6 17.61 44.62 Favored Glycine 0 C--N 1.356 1.694 0 CA-C-O 119.543 -0.587 . . . . 15.0 113.799 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 66.07 43.71 92.81 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 117.131 0.465 . . . . 15.0 112.075 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -63.55 92.11 0.06 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.834 0.854 . . . . 15.0 112.75 -170.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 52.3 20.43 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.457 1.651 . . . . 15.0 115.457 164.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 58.65 30.11 19.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.364 1.066 . . . . 15.0 111.594 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.19 10.71 3.34 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.645 1.178 . . . . 15.0 112.359 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.03 -46.77 33.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.255 1.422 . . . . 15.0 112.537 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.41 -32.66 65.05 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.515 0.726 . . . . 15.0 112.178 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.53 -27.97 60.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.092 0.557 . . . . 15.0 111.496 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.84 128.23 63.05 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 123.455 0.472 . . . . 15.0 110.363 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.557 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.6 Cg_exo -47.96 118.23 2.99 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.56 2.84 . . . . 15.0 113.649 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.647 ' HG3' HD13 ' A' ' 311' ' ' ILE . 66.3 ttt180 -52.79 -37.5 59.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.075 0.95 . . . . 15.0 112.028 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -10.22 48.84 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.572 0.749 . . . . 15.0 112.964 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.9 mt -71.27 -30.0 65.76 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.16 0.436 . . . . 15.0 110.653 171.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 311' ' ' ILE . 32.6 m-85 -122.9 -4.63 8.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.524 0.73 . . . . 15.0 111.541 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.425 ' HA ' HD11 ' A' ' 311' ' ' ILE . 8.9 tp10 -45.96 -68.0 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.565 1.146 . . . . 15.0 112.836 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.76 -48.84 80.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.702 0.626 . . . . 15.0 112.042 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.76 -45.95 73.44 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 123.575 0.547 . . . . 15.0 111.362 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.421 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -66.26 -56.34 11.74 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 119.271 -0.395 . . . . 15.0 110.231 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -53.53 -35.61 60.88 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.316 1.01 . . . . 15.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -61.5 -51.15 69.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.966 -0.561 . . . . 15.0 109.677 171.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -68.38 -18.77 64.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.119 0.568 . . . . 15.0 111.906 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 307' ' ' ILE . 69.5 t -77.57 -45.3 29.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.12 0.968 . . . . 15.0 110.167 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 77.6 t -58.9 -44.71 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.7 t -56.06 -46.47 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.338 1.055 . . . . 15.0 110.878 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.95 -31.51 72.64 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.763 -0.653 . . . . 15.0 113.258 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.67 -44.34 56.96 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 76.2 mt -70.72 -46.42 63.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.216 0.607 . . . . 15.0 110.65 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.18 -38.74 92.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.136 0.574 . . . . 15.0 110.417 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.23 94.09 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.783 0.677 . . . . 15.0 112.512 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.82 -36.64 78.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.088 0.555 . . . . 15.0 110.945 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -64.97 -40.8 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.91 0.484 . . . . 15.0 110.201 174.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.481 ' HA ' HD12 ' A' ' 360' ' ' LEU . 96.1 mt -63.56 -41.79 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.984 0.913 . . . . 15.0 110.428 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.668 ' HA ' HD13 ' B' ' 460' ' ' LEU . 35.9 ttp180 -69.92 -58.94 3.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.775 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 51.9 m -61.25 -37.3 82.58 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.189 0.996 . . . . 15.0 112.059 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.73 8.23 41.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.138 0.421 . . . . 15.0 112.138 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 41.4 48.54 3.32 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.233 1.413 . . . . 15.0 113.383 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.625 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.0 mt -70.79 148.39 47.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.847 -1.07 . . . . 15.0 111.709 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.55 143.78 41.76 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.681 0.792 . . . . 15.0 110.053 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -78.28 111.68 14.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.05 0.94 . . . . 15.0 110.12 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.81 140.47 29.63 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.744 0.818 . . . . 15.0 110.719 -172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -60.23 -40.33 89.83 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.785 0.834 . . . . 15.0 112.366 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.33 -25.85 64.41 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.248 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.423 HH21 ' HB2' ' A' ' 405' ' ' GLU . 58.7 ttt85 -74.79 -40.97 60.83 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 371' ' ' ILE . 61.0 t -58.83 -47.24 89.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.004 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -51.96 -47.73 64.66 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.156 0.91 . . . . 15.0 111.684 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.89 -51.02 48.08 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.277 0.986 . . . . 15.0 112.771 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 402' ' ' ALA . 90.7 mt -62.62 -46.69 87.11 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.662 0.785 . . . . 15.0 112.378 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 367' ' ' VAL . 48.4 mm -54.68 -53.35 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.041 0.937 . . . . 15.0 110.164 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.84 -35.26 74.6 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.656 -0.702 . . . . 15.0 111.37 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.0 -50.17 75.11 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.618 0.767 . . . . 15.0 112.031 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.471 ' HE2' HD13 ' A' ' 371' ' ' ILE . 26.6 ptt? -74.06 -43.66 57.0 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.277 -0.419 . . . . 15.0 110.703 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -43.05 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.345 0.658 . . . . 15.0 112.241 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.3 t -60.19 -25.8 65.87 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 124.024 0.828 . . . . 15.0 111.699 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.8 58.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.73 0.812 . . . . 15.0 112.25 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -92.41 169.53 10.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.317 0.647 . . . . 15.0 111.151 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.8 -36.57 82.69 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.442 -1.254 . . . . 15.0 110.365 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -131.86 100.97 15.63 Favored Pre-proline 0 C--O 1.242 0.666 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.987 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.7 -24.53 18.25 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.389 2.06 . . . . 15.0 112.703 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -54.46 -48.53 71.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.349 1.06 . . . . 15.0 111.544 -168.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -65.85 -30.45 71.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.26 0.975 . . . . 15.0 111.177 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.16 -45.27 54.19 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 108.868 -0.79 . . . . 15.0 108.868 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.64 -55.06 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.681 0.613 . . . . 15.0 109.397 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.92 -34.84 75.31 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.546 0.738 . . . . 15.0 112.493 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.99 -54.54 6.72 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.738 0.304 . . . . 15.0 111.139 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -47.71 33.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.248 0.619 . . . . 15.0 111.409 -166.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.7 p -58.83 -30.07 67.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.704 0.802 . . . . 15.0 112.534 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -86.12 -26.33 25.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.511 -0.768 . . . . 15.0 111.681 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.43 95.54 6.56 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 2.9 ttmt -71.31 -18.93 62.38 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.262 1.025 . . . . 15.0 111.6 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -66.76 -41.53 87.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.564 0.746 . . . . 15.0 110.489 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.407 HD11 ' HB1' ' B' ' 443' ' ' ALA . 58.6 tp -88.24 -31.46 19.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.555 0.742 . . . . 15.0 109.846 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.682 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 55.4 ttm -61.92 -26.64 68.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.74 0.416 . . . . 15.0 110.835 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.86 -48.17 81.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.073 0.549 . . . . 15.0 110.125 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.47 -26.87 66.58 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.563 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.562 ' HA ' HG12 ' A' ' 401' ' ' VAL . 10.5 tpt -74.55 -27.39 60.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.975 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 395' ' ' MET . 82.2 mtp180 -72.06 -34.62 68.87 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 170.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -42.95 94.7 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.918 0.487 . . . . 15.0 111.235 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 398' ' ' MET . 13.9 p -73.97 -27.79 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 121.215 -0.194 . . . . 15.0 111.243 174.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -61.36 -44.04 97.85 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.36 0.6 . . . . 15.0 109.449 172.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 21.1 tp -73.41 -32.52 64.48 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.183 -1.371 . . . . 15.0 110.672 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -66.22 -51.91 53.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 15.0 110.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.565 ' HB3' HH21 ' A' ' 283' ' ' ARG . 77.9 mm-40 -61.92 -35.38 78.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.464 0.706 . . . . 15.0 110.833 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.625 HE21 ' HB3' ' A' ' 360' ' ' LEU . 26.8 tt0 -74.2 -32.74 63.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.433 0.693 . . . . 15.0 110.791 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.75 99.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.193 0.597 . . . . 15.0 110.244 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.78 -53.96 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.693 172.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.69 -21.57 66.55 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.754 0.822 . . . . 15.0 113.193 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.13 -31.69 64.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.023 0.529 . . . . 15.0 110.523 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 294' ' ' LEU . 75.4 t -77.38 -36.35 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.88 -37.83 82.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.939 0.896 . . . . 15.0 111.246 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.19 -30.24 68.07 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.616 0.767 . . . . 15.0 111.038 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -95.96 -29.73 14.0 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.028 0.931 . . . . 15.0 111.555 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.39 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.63 0.772 . . . . 15.0 112.29 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -79.02 78.93 5.44 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.248 -0.887 . . . . 15.0 109.709 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 125' ' ' VAL . 48.5 t -90.17 92.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.456 0.702 . . . . 15.0 109.567 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 39.8 p -74.07 94.66 2.42 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.779 0.832 . . . . 15.0 110.859 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.28 119.9 17.13 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.2 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 422' ' ' THR . 0.0 OUTLIER -135.35 145.74 47.71 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.438 -0.578 . . . . 15.0 109.438 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.94 136.91 39.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 15.0 109.675 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.424 HG21 ' HE3' ' A' ' 420' ' ' LYS . 11.9 t -163.41 176.66 9.6 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.822 0.449 . . . . 15.0 111.382 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 71.3 p -93.55 173.4 7.71 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.142 0.977 . . . . 15.0 111.389 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.24 -19.05 42.35 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.303 1.441 . . . . 15.0 112.05 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -66.43 -5.41 10.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.939 1.296 . . . . 15.0 113.526 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.595 ' HB3' HD12 ' A' ' 427' ' ' LEU . 14.4 tp10 -74.95 -55.41 5.8 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.529 0.732 . . . . 15.0 112.472 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.4 mp -90.35 -71.84 0.6 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.332 0.493 . . . . 15.0 112.332 -163.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -107.15 33.54 3.93 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.358 0.663 . . . . 15.0 111.873 -167.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -82.78 45.41 0.99 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.091 0.948 . . . . 15.0 111.867 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -133.24 85.38 2.21 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.427 -1.323 . . . . 15.0 107.427 169.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -67.65 -33.05 74.17 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.499 0.72 . . . . 15.0 109.979 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 108.043 -1.095 . . . . 15.0 108.043 167.139 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.79 -166.84 1.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.451 0.7 . . . . 0.0 111.692 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.98 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 123.614 0.766 . . . . 0.0 110.074 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -104.47 -90.3 0.39 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -114.71 -83.13 0.61 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.412 0.685 . . . . 0.0 109.331 160.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.496 ' HB3' HH21 ' B' ' 373' ' ' ARG . . . -113.53 5.48 16.64 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.337 1.055 . . . . 0.0 111.98 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 7.2 p -28.39 -44.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -97.63 3.33 50.41 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.496 HH21 ' HB3' ' B' ' 370' ' ' ALA . 0.8 OUTLIER -42.88 -72.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -154.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.431 ' N ' ' HG2' ' B' ' 373' ' ' ARG . . . -108.41 -76.96 0.6 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.233 0.924 . . . . 0.0 112.812 -170.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.597 ' H ' HD23 ' B' ' 375' ' ' LEU . 2.4 pt? -111.68 2.16 17.1 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -159.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -54.62 -33.82 61.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -164.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -103.21 -68.84 0.82 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.074 0.464 . . . . 0.0 111.511 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -82.22 -1.74 50.15 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -158.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' B' ' 375' ' ' LEU . 0.0 OUTLIER -69.5 -27.59 65.33 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 117.984 0.356 . . . . 0.0 111.758 -173.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -100.04 150.34 22.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 112.143 -169.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -162.25 -71.11 0.05 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.504 1.122 . . . . 0.0 108.328 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 136.76 -143.23 14.51 Favored Glycine 0 C--N 1.355 1.586 0 O-C-N 123.182 0.301 . . . . 0.0 112.942 176.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.12 -169.14 1.26 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 125.11 1.364 . . . . 0.0 110.373 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 42.8 p 70.72 87.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.725 2.01 . . . . 0.0 110.92 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 168' ' ' PHE . 1.8 mm? -77.17 108.83 10.55 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.519 -176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.587 HG11 ' HA3' ' A' ' 179' ' ' GLY . 11.4 t -75.32 98.21 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.473 ' HB ' ' HZ ' ' A' ' 217' ' ' PHE . 22.5 pt -136.66 84.58 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 159.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.862 ' HA ' HD11 ' A' ' 226' ' ' LEU . 5.4 p -154.67 165.93 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.845 171.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 41.8 m -79.74 96.34 6.23 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 160.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -94.29 105.41 17.39 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.413 0.685 . . . . 0.0 112.739 -162.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -155.68 97.48 1.85 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 170.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 63.43 -80.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.15 1.38 . . . . 0.0 110.83 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -157.61 166.11 33.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 107.441 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -66.75 -28.33 68.33 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.937 0.335 . . . . 0.0 110.468 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.11 70.16 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.337 0.655 . . . . 0.0 111.011 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 42.6 t 70.54 -72.58 0.11 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.562 1.545 . . . . 0.0 112.028 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -71.37 -39.55 71.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.892 0.877 . . . . 0.0 111.432 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.538 HG22 HG12 ' B' ' 399' ' ' VAL . 0.7 OUTLIER 78.08 -46.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 125.231 1.412 . . . . 0.0 111.932 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.602 HG13 ' H ' ' B' ' 400' ' ' ALA . 2.4 p -150.55 -68.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.482 0.713 . . . . 0.0 109.722 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.602 ' H ' HG13 ' B' ' 399' ' ' VAL . . . 177.06 -56.67 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 125.549 1.54 . . . . 0.0 109.474 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 400' ' ' ALA . 1.1 Cg_endo -85.64 130.37 3.75 Favored 'Trans proline' 0 C--N 1.393 2.897 0 C-N-CA 122.023 1.815 . . . . 0.0 111.831 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.6 177.7 6.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.491 0.716 . . . . 0.0 109.243 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 50.8 p -77.42 73.53 3.99 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.471 0.653 . . . . 0.0 110.112 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -70.64 -36.79 73.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.267 1.027 . . . . 0.0 109.771 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' B' ' 406' ' ' PRO . . . -81.96 140.77 46.72 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.859 173.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 405' ' ' ALA . 7.3 Cg_exo -71.76 82.75 1.18 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.84 2.36 . . . . 0.0 111.774 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -164.78 45.82 0.3 Allowed Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.62 105.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 2.0 t 53.79 -176.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.362 1.865 . . . . 0.0 113.072 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' B' ' 412' ' ' LEU . 0.1 OUTLIER 75.9 -60.01 0.5 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.367 1.467 . . . . 0.0 110.46 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 66.49 37.12 4.72 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.34 1.056 . . . . 0.0 111.499 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.41 ' HA ' HE22 ' B' ' 410' ' ' GLN . 4.1 pp 50.0 25.02 1.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.659 1.584 . . . . 0.0 113.618 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 8.3 t30 59.34 80.33 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.355 1.062 . . . . 0.0 109.409 -174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 97.4 m -71.9 101.98 2.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.47 0.708 . . . . 0.0 111.468 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.28 -76.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.39 1.876 . . . . 0.0 113.662 169.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -53.04 61.64 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.253 1.421 . . . . 0.0 110.603 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 80.44 -56.18 4.68 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.508 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.9 129.77 13.36 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 108.934 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.27 93.05 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 74.62 131.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 110.777 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.19 -36.7 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 122.881 0.472 . . . . 0.0 111.318 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -165.14 -42.58 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.089 0.555 . . . . 0.0 111.142 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.2 m 59.6 -177.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.49 1.116 . . . . 0.0 110.7 -170.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 50.0 t80 68.6 -65.73 0.26 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 124.351 1.061 . . . . 0.0 113.805 166.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -51.59 125.03 25.06 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.745 0.688 . . . . 0.0 113.26 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 78.03 -24.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 126.648 1.979 . . . . 0.0 112.62 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' B' ' 431' ' ' SER . 48.0 t -68.94 -53.45 20.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.183 0.593 . . . . 0.0 109.444 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.19 -37.64 78.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.514 0.725 . . . . 0.0 111.815 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.5 -46.64 21.8 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.024 -0.422 . . . . 0.0 110.282 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -113.34 -67.16 1.02 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -169.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . 0.519 ' HB2' ' HA ' ' B' ' 427' ' ' SER . 19.7 m -72.77 -28.19 62.46 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -154.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.539 ' HB2' ' HA2' ' A' ' 323' ' ' GLY . 0.6 OUTLIER -83.98 -22.14 31.51 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.665 0.666 . . . . 0.0 110.492 -174.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 75.17 -57.14 0.61 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.183 1.793 . . . . 0.0 111.899 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -76.82 97.35 4.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.39 0.676 . . . . 0.0 109.723 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 41.3 p -53.5 109.69 0.47 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.455 1.102 . . . . 0.0 111.841 -174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -85.08 -26.7 36.18 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.053 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . 0.432 ' HB2' ' NH2' ' A' ' 321' ' ' ARG . 17.7 t -90.83 73.0 6.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.959 0.904 . . . . 0.0 108.964 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -95.26 53.66 1.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.49 75.74 7.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -173.47 148.17 1.55 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 113.567 -1.652 . . . . 0.0 107.535 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . . . . . . . . . 6.7 pt 55.93 175.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 126.64 1.976 . . . . 0.0 112.974 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.51 111.9 24.4 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.407 ' HB1' HD11 ' A' ' 394' ' ' LEU . . . -150.5 98.77 2.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -80.55 131.78 35.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 111.274 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -101.27 93.54 1.15 Allowed Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.67 175.5 7.84 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.607 2.204 . . . . 0.0 113.289 -169.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -83.04 82.64 8.16 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 60.92 -144.76 0.47 Allowed 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.308 1.005 . . . . 0.0 109.834 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 452' ' ' VAL . . . 66.56 -166.02 0.22 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.189 0.996 . . . . 0.0 111.302 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 69.8 -68.82 0.18 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 124.393 1.077 . . . . 0.0 110.211 -172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 42.6 t -62.93 -36.72 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.665 0.786 . . . . 0.0 110.001 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 3.7 p -123.14 119.09 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.787 0.835 . . . . 0.0 109.324 174.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -157.49 -60.54 0.01 OUTLIER Glycine 0 N--CA 1.465 0.623 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 65.64 -83.92 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.431 1.492 . . . . 0.0 110.251 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 m 60.36 71.27 0.58 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.822 1.249 . . . . 0.0 111.32 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.21 -37.15 66.54 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.558 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . 0.404 ' NE2' ' H ' ' B' ' 457' ' ' GLN . 0.0 OUTLIER -68.42 138.9 55.68 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.332 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 33.8 m -86.76 96.01 10.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.587 0.755 . . . . 0.0 109.811 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 469' ' ' GLY . 26.4 t70 -138.2 -62.1 0.59 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.668 HD13 ' HA ' ' A' ' 356' ' ' ARG . 23.5 tp -140.0 119.04 12.63 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 166.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -48.23 -33.72 9.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.099 1.76 . . . . 0.0 114.65 -166.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -136.86 -70.21 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 110.839 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 70.35 136.29 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.451 1.5 . . . . 0.0 111.587 -172.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.12 166.02 24.08 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.028 0.531 . . . . 0.0 110.233 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.26 90.92 2.12 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.107 0.48 . . . . 0.0 109.816 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -173.15 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.219 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.98 9.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.804 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.433 ' HB3' HD23 ' B' ' 470' ' ' LEU . 11.1 mp -101.77 163.17 12.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.35 0.66 . . . . 0.0 110.852 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' B' ' 459' ' ' ASP . . . -82.71 22.18 6.85 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.742 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.433 HD23 ' HB3' ' B' ' 468' ' ' LEU . 2.5 pt? -161.68 154.89 20.96 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.096 1.358 . . . . 0.0 109.604 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 34.4 mmtp . . . . . 0 C--O 1.255 1.367 0 C-N-CA 123.751 0.82 . . . . 12.06 109.844 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 81' ' ' LYS . 18.7 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.326 -0.25 . . . . 15.0 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -168.01 97.36 0.44 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.84 -1.17 . . . . 15.0 107.84 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 17' ' ' ILE . 22.9 m -111.62 152.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.709 0.804 . . . . 15.0 111.873 -169.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -137.64 92.04 2.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 15.0 109.018 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.46 89.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-O 122.559 1.171 . . . . 15.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -94.08 92.6 7.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.67 -1.15 . . . . 15.0 109.494 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 32.4 m -67.41 94.18 0.38 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.388 -0.824 . . . . 15.0 109.896 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 p -75.18 -66.96 0.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.137 0.975 . . . . 15.0 111.343 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -151.23 121.6 7.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.927 0.491 . . . . 15.0 110.368 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.56 -103.96 0.64 Allowed Glycine 0 C--N 1.35 1.325 0 O-C-N 124.38 1.05 . . . . 15.0 114.239 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 2.5 mm? -77.33 -34.29 55.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.508 0.723 . . . . 15.0 110.083 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.37 97.4 0.11 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 124.622 1.201 . . . . 15.0 114.06 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD2' HG11 ' A' ' 111' ' ' VAL . 50.9 mtt85 -112.59 86.81 2.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.354 -1.35 . . . . 15.0 107.354 168.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -72.53 91.53 1.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.47 -1.241 . . . . 15.0 110.376 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.7 t -79.27 87.66 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.774 -0.824 . . . . 15.0 108.774 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 88.8 m -74.77 105.36 5.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.321 -0.854 . . . . 15.0 109.779 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 HG12 ' A' ' 3' ' ' VAL . 33.6 mt -101.28 118.49 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.679 0.791 . . . . 15.0 110.301 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.1 m -88.75 104.87 17.3 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.366 0.666 . . . . 15.0 109.214 165.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 70' ' ' LEU . 52.0 mt -81.29 108.16 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.939 -1.134 . . . . 15.0 107.939 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.95 160.12 33.45 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.929 0.491 . . . . 15.0 111.869 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.27 -22.5 66.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.363 1.065 . . . . 15.0 113.419 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.35 -42.03 88.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.836 0.455 . . . . 15.0 109.963 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 m -70.95 -40.16 72.16 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.161 -0.927 . . . . 15.0 110.278 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.0 mt -69.85 -51.97 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.656 0.782 . . . . 15.0 111.087 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.86 -39.83 90.63 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.758 0.823 . . . . 15.0 111.077 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.7 m -66.24 -44.7 83.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.609 -0.723 . . . . 15.0 110.952 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.23 -39.86 78.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.217 0.607 . . . . 15.0 112.522 -173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' ILE . 66.7 t -61.18 -44.95 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 123.131 0.572 . . . . 15.0 109.728 176.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -67.82 -39.49 83.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -73.41 -16.93 61.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.414 1.085 . . . . 15.0 111.424 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -88.6 -39.98 13.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.937 0.495 . . . . 15.0 110.439 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' HA3' ' A' ' 59' ' ' GLY . 81.6 mt -74.23 -20.79 60.05 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.89 0.7 . . . . 15.0 112.89 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.2 p -66.39 -32.19 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 109.854 -0.424 . . . . 15.0 109.854 174.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -67.97 -45.3 74.54 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.901 0.88 . . . . 15.0 109.917 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.5 -40.08 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 114.923 -1.035 . . . . 15.0 110.506 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 -47.65 85.19 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.889 0.876 . . . . 15.0 110.85 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -66.82 -44.19 81.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.652 -0.704 . . . . 15.0 111.462 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -62.08 -51.24 68.76 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.731 0.644 . . . . 15.0 110.752 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.43 -5.35 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-N 115.544 -0.753 . . . . 15.0 110.904 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 76.05 10.77 3.09 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.598 1.559 . . . . 15.0 112.39 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.11 -33.5 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.264 1.026 . . . . 15.0 110.607 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.76 -41.47 77.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 15.0 110.276 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.11 -36.23 92.03 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 124.204 0.94 . . . . 15.0 112.947 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -77.81 -31.96 52.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.167 0.587 . . . . 15.0 110.794 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -75.57 117.3 17.2 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.937 0.495 . . . . 15.0 110.989 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.95 21.36 17.67 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.776 0.83 . . . . 15.0 110.205 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.67 48.41 50.05 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.465 -0.789 . . . . 15.0 112.426 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.26 -60.71 3.18 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.115 0.566 . . . . 15.0 110.713 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 t -103.86 128.73 26.66 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.4 148.74 4.86 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 124.045 3.163 . . . . 15.0 114.917 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.453 ' HA ' HG22 ' A' ' 54' ' ' VAL . 53.6 tpp -65.18 -36.56 84.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.338 1.055 . . . . 15.0 111.984 -172.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -58.59 -37.68 76.33 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.501 0.721 . . . . 15.0 111.964 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.77 -54.25 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.153 0.981 . . . . 15.0 110.557 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 51' ' ' MET . 35.6 m -68.56 -34.24 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 112.488 0.551 . . . . 15.0 112.488 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.21 -51.11 63.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.89 0.476 . . . . 15.0 112.058 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -70.04 -19.94 63.27 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 112.125 0.417 . . . . 15.0 112.125 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.34 -58.92 2.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.1 0.56 . . . . 15.0 111.142 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -66.65 -23.27 66.13 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.993 0.517 . . . . 15.0 111.98 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.409 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -93.4 21.55 40.01 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.715 -0.491 . . . . 15.0 113.935 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.82 73.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.501 0.721 . . . . 15.0 110.865 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.6 p -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.48 0.712 . . . . 15.0 111.096 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.17 -6.99 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 124.306 1.043 . . . . 15.0 112.05 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -55.07 -38.42 68.02 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.849 0.46 . . . . 15.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -58.2 -47.4 83.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.682 0.793 . . . . 15.0 111.469 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -62.17 -43.76 98.11 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.559 0.744 . . . . 15.0 110.551 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.38 -44.33 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 114.414 -1.266 . . . . 15.0 110.946 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 71' ' ' MET . 91.2 mt -66.95 -36.75 82.93 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.939 0.495 . . . . 15.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.24 -43.72 95.33 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.734 0.646 . . . . 15.0 111.873 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 27.4 t70 -64.08 -48.38 76.43 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.48 0.712 . . . . 15.0 110.512 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.594 ' HB3' HD13 ' A' ' 19' ' ' ILE . 80.5 mt -63.38 -32.46 73.89 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.191 0.996 . . . . 15.0 112.556 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 58.8 mtm -61.62 -41.52 97.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.613 0.365 . . . . 15.0 110.561 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.3 t -72.85 -36.86 67.52 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.597 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 29.4 mmt180 -60.63 -52.32 65.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.411 0.684 . . . . 15.0 110.65 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 17' ' ' ILE . 33.7 m-80 -75.65 -26.06 57.39 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.188 -0.914 . . . . 15.0 111.756 -174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -68.7 -58.07 4.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.577 0.351 . . . . 15.0 110.925 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.39 -40.44 87.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 123.721 0.638 . . . . 15.0 110.288 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.92 -40.37 96.33 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.219 1.008 . . . . 15.0 110.85 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.26 -61.77 2.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.595 -0.729 . . . . 15.0 111.446 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 pt -60.73 -24.45 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.63 0.772 . . . . 15.0 112.975 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.6 -58.08 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.543 0.737 . . . . 15.0 110.532 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 15.4 ptpt -77.57 -23.41 50.0 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.055 0.391 . . . . 15.0 112.055 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -86.89 -17.24 33.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.21 0.604 . . . . 15.0 110.749 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 62.0 33.47 17.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.417 1.087 . . . . 15.0 111.416 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.9 mt -77.96 106.5 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.96 -1.126 . . . . 15.0 107.96 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.54 HD21 ' HB2' ' A' ' 112' ' ' TYR . 8.0 t30 -78.07 102.4 0.94 Allowed Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.8 0.84 . . . . 15.0 109.047 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -94.5 -177.0 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.237 2.625 . . . . 15.0 112.662 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.89 166.17 11.39 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.447 1.099 . . . . 15.0 109.635 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.43 -156.43 51.1 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.472 -0.786 . . . . 15.0 113.675 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.29 67.05 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.661 0.785 . . . . 15.0 109.665 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.26 107.35 0.56 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.416 2.077 . . . . 15.0 111.041 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.9 m -87.13 94.88 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.482 0.713 . . . . 15.0 109.912 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -78.99 91.53 4.86 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.21 109.37 6.21 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 108.596 -0.89 . . . . 15.0 108.596 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.07 98.63 0.73 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.363 2.042 . . . . 15.0 110.861 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.82 -71.23 0.88 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.187 -0.915 . . . . 15.0 112.329 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -169.89 133.42 1.21 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.919 0.887 . . . . 15.0 110.238 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -107.96 123.57 48.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.097 0.559 . . . . 15.0 109.642 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 93.3 mttt -97.41 129.59 44.62 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 171.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.2 101.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.279 1.031 . . . . 15.0 112.16 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.32 14.51 79.21 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.68 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.2 mt-10 -116.43 -163.92 0.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.738 1.215 . . . . 15.0 108.383 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -73.54 116.01 13.61 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.095 0.558 . . . . 15.0 111.06 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -79.37 138.57 37.72 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.201 1.0 . . . . 15.0 109.3 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.2 m -133.83 132.83 40.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.109 -0.7 . . . . 15.0 109.109 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.58 169.42 21.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.064 0.946 . . . . 15.0 108.866 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 52.1 m -125.71 119.56 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.324 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 t -98.33 106.42 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -100.84 133.58 45.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.313 -0.995 . . . . 15.0 108.313 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -154.27 167.11 31.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.498 0.719 . . . . 15.0 109.536 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.715 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 31.8 mt-10 -84.71 170.38 13.33 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 15.0 110.238 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.0 m -136.83 155.12 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.85 0.86 . . . . 15.0 108.941 174.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.54 ' HB2' HD21 ' A' ' 85' ' ' ASN . 68.3 m-85 -78.91 109.82 12.28 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.34 -173.62 1.78 Allowed 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.035 2.49 . . . . 15.0 112.771 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -78.15 104.34 8.67 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.744 -175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.56 103.0 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.943 0.877 . . . . 15.0 108.671 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -102.59 101.04 11.16 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.598 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.69 140.34 32.21 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.281 -0.637 . . . . 15.0 109.281 171.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.95 -166.83 1.31 Allowed 'General case' 0 C--O 1.246 0.896 0 N-CA-C 108.747 -0.834 . . . . 15.0 108.747 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.67 109.35 2.31 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.247 -0.741 . . . . 15.0 111.247 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 414' ' ' LYS . 69.0 mt -66.16 -14.61 62.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.33 0.652 . . . . 15.0 111.063 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.68 -32.89 69.54 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.371 1.469 . . . . 15.0 111.698 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.33 75.43 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.873 0.869 . . . . 15.0 112.145 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -65.15 130.98 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.276 1.03 . . . . 15.0 110.397 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -109.52 115.39 29.83 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.636 0.774 . . . . 15.0 109.576 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.3 t -120.13 159.14 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 125.241 1.416 . . . . 15.0 108.47 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -113.55 149.46 34.41 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.0 tttt -124.11 105.56 31.57 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 107.86 -1.163 . . . . 15.0 107.86 168.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.73 99.12 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 121.77 1.646 . . . . 15.0 110.54 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 41.4 mm -66.42 97.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.552 -1.277 . . . . 15.0 107.552 169.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 427' ' ' LEU . 40.3 t -132.42 145.74 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.475 0.655 . . . . 15.0 111.362 -172.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -142.94 150.96 40.43 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.513 1.525 . . . . 15.0 107.553 168.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.556 HG11 ' SD ' ' A' ' 274' ' ' MET . 6.6 t -80.89 87.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.672 -1.233 . . . . 15.0 107.672 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.1 p -69.85 171.87 8.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.416 0.686 . . . . 15.0 110.117 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -58.1 -33.33 69.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.81 0.444 . . . . 15.0 111.285 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -47.54 82.29 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 15.0 110.512 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.16 -42.57 72.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.206 -0.906 . . . . 15.0 111.811 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.05 -54.6 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.85 0.86 . . . . 15.0 109.827 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.56 -44.8 93.07 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.124 0.89 . . . . 15.0 110.549 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.5 -40.92 99.29 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.845 0.716 . . . . 15.0 113.475 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.402 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.6 tpt -67.42 -57.48 6.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.554 0.742 . . . . 15.0 110.476 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 144' ' ' LEU . 90.7 mt -55.24 -32.92 62.7 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.631 0.772 . . . . 15.0 112.583 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.63 -51.91 63.14 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.329 1.052 . . . . 15.0 109.961 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.9 m -67.18 -24.37 65.86 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.5 0.72 . . . . 15.0 111.533 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 141' ' ' LEU . 74.9 mt -71.94 -47.29 53.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.83 0.452 . . . . 15.0 110.326 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 47.2 mtm180 -74.82 -19.36 60.22 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 111.696 0.258 . . . . 15.0 111.696 175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.403 ' HB3' HH11 ' A' ' 243' ' ' ARG . 87.5 mttt -79.52 -23.41 42.91 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.827 -0.546 . . . . 15.0 110.461 169.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.09 -35.24 69.17 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.476 -0.565 . . . . 15.0 109.476 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 144' ' ' LEU . 22.7 mm-40 -87.74 42.39 1.05 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.997 0.919 . . . . 15.0 109.656 172.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.32 118.18 4.51 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.167 1.387 . . . . 15.0 114.245 -168.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 244' ' ' GLU . 17.4 m -79.33 114.68 18.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.69 -0.855 . . . . 15.0 108.69 169.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.431 ' HZ3' ' HG3' ' A' ' 163' ' ' ARG . 36.3 m95 -79.88 110.9 15.68 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.414 -0.587 . . . . 15.0 109.414 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -141.59 115.18 9.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.36 0.664 . . . . 15.0 110.397 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 45.9 mt-10 -61.82 131.6 50.35 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.145 0.578 . . . . 15.0 110.527 172.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HE3' ' HB2' ' A' ' 242' ' ' GLU . 18.1 ptpt -108.37 172.02 7.08 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.528 0.731 . . . . 15.0 110.801 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.4 91.82 8.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.718 -0.674 . . . . 15.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.55 -56.48 1.25 Allowed Glycine 0 CA--C 1.544 1.902 0 N-CA-C 118.277 2.071 . . . . 15.0 118.277 159.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.15 132.46 47.86 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.67 1.235 . . . . 15.0 111.631 -169.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 202' ' ' ILE . 20.0 t -95.54 136.52 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 122.9 0.48 . . . . 15.0 110.079 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.85 171.87 8.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.943 1.297 . . . . 15.0 108.823 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 -29.77 65.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.793 0.837 . . . . 15.0 112.021 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -95.34 13.54 25.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.326 0.65 . . . . 15.0 111.713 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -84.33 178.65 7.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.868 0.842 . . . . 15.0 113.068 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.431 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 1.7 tmm_? -131.94 92.52 3.14 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 106.687 -1.597 . . . . 15.0 106.687 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 HG23 ' A' ' 166' ' ' ILE . 38.7 t -89.42 157.22 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.461 1.105 . . . . 15.0 110.378 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 61.5 m -132.77 134.84 45.24 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.867 -1.16 . . . . 15.0 107.867 166.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 237' ' ' LEU . 27.8 pt -148.33 169.68 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.652 1.181 . . . . 15.0 110.303 -171.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -104.6 155.57 18.72 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 106.269 -1.752 . . . . 15.0 106.269 156.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 234' ' ' ALA . 24.4 p90 -151.2 165.08 35.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.019 0.438 . . . . 15.0 111.131 167.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.1 t -142.75 103.15 4.16 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.006 -0.997 . . . . 15.0 108.626 172.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.84 140.33 15.81 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 114.914 -1.039 . . . . 15.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.3 p -150.13 116.59 5.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.974 0.91 . . . . 15.0 108.741 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 25.6 t -86.57 115.48 27.65 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 C-N-CA 123.498 0.719 . . . . 15.0 110.066 -168.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.1 t70 71.16 -1.26 2.78 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.063 1.345 . . . . 15.0 111.092 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.76 31.66 6.59 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-O 119.667 -0.518 . . . . 15.0 113.315 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 172' ' ' VAL . 19.9 pt-20 -131.29 150.47 52.14 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 123.485 0.714 . . . . 15.0 110.542 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -90.86 81.63 5.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.756 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.602 ' HE2' ' HA ' ' B' ' 387' ' ' ILE . 0.0 OUTLIER -52.28 -70.12 0.1 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.4 1.48 . . . . 15.0 110.839 165.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.727 ' HB2' HG13 ' B' ' 386' ' ' VAL . 65.4 mm-40 -99.39 176.35 5.54 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 125.021 1.328 . . . . 15.0 109.487 168.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -59.97 5.72 0.12 Allowed Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.346 1.698 . . . . 15.0 117.346 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.43 -60.87 3.26 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 117.754 0.777 . . . . 15.0 113.493 168.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.67 160.74 14.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.627 0.973 . . . . 15.0 113.627 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.85 94.19 1.84 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.452 -1.249 . . . . 15.0 109.025 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.3 m -69.53 125.1 25.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.233 1.013 . . . . 15.0 112.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.03 41.8 10.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.64 1.176 . . . . 15.0 112.393 169.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' B' ' 385' ' ' LEU . 18.7 t80 -67.92 131.85 46.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.345 -0.843 . . . . 15.0 109.365 170.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.78 104.15 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.019 1.328 . . . . 15.0 108.357 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.4 tp -90.95 98.44 11.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 15.0 111.542 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 163' ' ' ARG . . . -79.46 83.55 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.594 -0.891 . . . . 15.0 108.594 170.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.8 mtp -57.02 134.03 55.45 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.547 0.739 . . . . 15.0 110.941 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 125.91 -28.68 4.84 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 -168.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.38 114.62 9.65 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.008 0.523 . . . . 15.0 109.899 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.53 3.15 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.22 -0.446 . . . . 15.0 112.647 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.543 ' NH2' HD22 ' B' ' 385' ' ' LEU . 2.9 tmm_? -87.12 -33.88 19.3 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.485 -0.931 . . . . 15.0 108.485 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.1 mmt -84.37 154.14 23.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.196 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.5 pt -86.75 163.7 40.07 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.244 0.618 . . . . 15.0 110.824 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.17 144.75 46.28 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.72 2.28 . . . . 15.0 112.276 167.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.88 -52.93 0.61 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.839 -0.904 . . . . 15.0 110.839 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -66.47 -54.4 24.52 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.454 -0.573 . . . . 15.0 109.454 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.66 -40.77 69.36 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.79 -32.54 71.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.02 0.928 . . . . 15.0 110.465 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -71.15 -16.85 75.35 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.105 -0.952 . . . . 15.0 113.293 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.509 HG22 HG11 ' A' ' 158' ' ' VAL . 36.1 mm -93.68 -54.51 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 123.771 0.828 . . . . 15.0 109.553 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -79.55 14.02 1.8 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.676 0.991 . . . . 15.0 113.676 -169.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -122.06 20.21 8.11 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.099 -0.801 . . . . 15.0 111.099 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -142.37 -171.11 3.33 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.968 0.907 . . . . 15.0 111.175 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -149.89 154.03 37.66 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.279 1.032 . . . . 15.0 109.797 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -60.57 148.26 38.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.095 0.958 . . . . 15.0 112.598 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.72 -48.41 0.94 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.491 -0.777 . . . . 15.0 111.175 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 206' ' ' LYS . 16.7 pt-20 -74.08 133.46 42.87 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.519 0.676 . . . . 15.0 110.419 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -121.53 105.56 10.58 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.147 0.979 . . . . 15.0 108.539 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -124.02 -169.16 1.91 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.944 1.298 . . . . 15.0 110.278 -168.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 234' ' ' ALA . 44.8 m -136.3 125.69 24.99 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.897 0.879 . . . . 15.0 109.402 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 201' ' ' GLY . 46.6 pt -102.6 154.51 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.633 0.773 . . . . 15.0 109.435 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -116.45 104.6 11.6 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.264 1.025 . . . . 15.0 108.395 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.2 t -92.35 154.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 107.087 -1.449 . . . . 15.0 107.087 171.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 m -137.5 121.33 17.56 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.087 0.858 . . . . 15.0 109.3 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 51.1 m-85 -92.21 136.47 25.73 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 119.539 -0.267 . . . . 15.0 111.373 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 81.1 Cg_exo -54.57 170.9 0.49 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.977 3.784 . . . . 15.0 117.3 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 227' ' ' LYS . 22.6 mm-40 -79.74 -26.36 40.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.147 -1.388 . . . . 15.0 110.473 170.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -25.28 63.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.873 0.869 . . . . 15.0 110.383 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 226' ' ' LEU . 6.9 t80 -68.15 106.56 2.45 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.612 -0.885 . . . . 15.0 108.612 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.68 -19.29 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.882 0.873 . . . . 15.0 113.208 -167.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.88 101.85 3.9 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.672 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 41.3 tt0 -67.38 -24.99 65.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.937 0.895 . . . . 15.0 112.287 -173.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -63.92 -17.85 63.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.686 0.794 . . . . 15.0 112.222 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 172' ' ' VAL . 16.7 mt -114.35 -30.61 6.53 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.27 0.628 . . . . 15.0 111.316 173.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.672 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 55.2 tttm -55.68 116.67 3.05 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.227 1.411 . . . . 15.0 111.809 -172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.58 -19.94 8.26 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.834 0.709 . . . . 15.0 113.885 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -87.29 156.99 19.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.806 0.842 . . . . 15.0 110.847 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -109.28 112.96 25.4 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.786 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -80.71 113.36 18.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 15.0 111.35 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -83.67 97.32 9.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.638 -0.71 . . . . 15.0 109.966 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.499 ' HZ ' HD13 ' B' ' 387' ' ' ILE . 95.9 m-85 -93.83 109.02 20.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -77.92 92.24 4.26 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.62 -0.511 . . . . 15.0 109.62 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.6 mm -82.63 126.09 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.56 0.744 . . . . 15.0 110.46 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.16 91.07 3.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.204 1.002 . . . . 15.0 109.198 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 84.5 mt -68.41 108.0 3.09 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 110.152 -0.314 . . . . 15.0 110.152 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -110.87 -40.43 4.53 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.391 0.676 . . . . 15.0 110.103 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.699 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.5 mmtt -131.44 136.61 48.11 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.185 0.994 . . . . 15.0 109.594 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 207' ' ' ALA . 25.6 t -130.74 115.01 29.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.768 -1.567 . . . . 15.0 106.768 168.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' GLU . 34.7 mt-10 -112.31 -175.37 2.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.583 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 35.4 tt0 -133.58 130.85 38.96 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 175.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.403 HH11 ' HB3' ' A' ' 146' ' ' LYS . 11.4 ptt180 -79.18 82.79 5.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.1 -1.445 . . . . 15.0 107.1 164.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 42.0 tt0 -73.89 147.62 43.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.72 -1.582 . . . . 15.0 111.353 -171.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.21 114.64 19.6 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.728 0.811 . . . . 15.0 109.173 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 30.2 Cg_endo -59.74 150.55 76.37 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.257 2.638 . . . . 15.0 111.291 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -53.54 106.82 0.2 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.422 1.076 . . . . 15.0 110.033 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 252' ' ' PHE . 31.8 tp -77.06 73.54 3.64 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 253' ' ' ILE . 67.5 p -91.55 168.68 11.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.014 -0.994 . . . . 15.0 108.805 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.97 -45.55 42.28 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.751 1.22 . . . . 15.0 111.979 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 254' ' ' LYS . 48.0 mt-10 -73.36 -21.1 60.61 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.911 0.884 . . . . 15.0 112.886 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.526 ' HD2' HD12 ' A' ' 248' ' ' LEU . 59.6 t80 -85.69 -49.99 7.54 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.508 -0.553 . . . . 15.0 109.508 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 249' ' ' THR . 6.2 tt -67.29 -28.34 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.044 0.538 . . . . 15.0 111.564 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.647 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 21.4 ptmt -79.61 -12.43 59.84 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.826 0.676 . . . . 15.0 112.826 174.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.92 -25.7 65.35 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.093 0.557 . . . . 15.0 111.51 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -68.15 -33.83 75.2 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.089 0.956 . . . . 15.0 111.932 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 144.68 7.22 0.46 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 116.664 -0.244 . . . . 15.0 113.271 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 20.5 t -79.26 157.75 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.652 0.781 . . . . 15.0 110.119 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -59.82 -72.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.832 1.253 . . . . 15.0 111.92 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -121.86 6.61 9.87 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.554 0.742 . . . . 15.0 110.456 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.95 4.93 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.953 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 7.1 m -64.21 132.02 49.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.136 0.975 . . . . 15.0 110.561 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.42 -47.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 124.049 0.843 . . . . 15.0 110.241 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.6 -32.87 63.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.729 0.812 . . . . 15.0 111.609 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.552 ' HA3' HG13 ' A' ' 258' ' ' VAL . . . -79.28 -25.06 60.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 111.276 -0.73 . . . . 15.0 111.276 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 60.0 tp -77.24 -33.62 56.02 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.514 -0.921 . . . . 15.0 108.514 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -67.75 -38.72 83.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.418 0.687 . . . . 15.0 109.641 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.02 82.5 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.886 -1.052 . . . . 15.0 110.198 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.19 -48.18 76.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.127 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.37 -27.88 36.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.011 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.318 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -65.05 -52.45 55.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.218 0.463 . . . . 15.0 110.296 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 377' ' ' ALA . 13.2 ptmm? -73.79 -16.7 61.15 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.983 0.734 . . . . 15.0 112.983 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -95.1 -47.39 6.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 118.167 0.439 . . . . 15.0 111.796 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.556 ' SD ' HG11 ' A' ' 132' ' ' VAL . 66.4 mtt -73.83 -26.23 60.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 118.653 -0.689 . . . . 15.0 111.459 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.6 -32.88 41.93 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 119.062 0.846 . . . . 15.0 110.443 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' NH2' ' HB3' ' A' ' 377' ' ' ALA . 24.2 tpp180 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.923 0.489 . . . . 15.0 110.186 174.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -76.96 -60.29 2.42 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.309 -0.86 . . . . 15.0 109.881 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.474 HD11 HG11 ' A' ' 130' ' ' VAL . 58.8 tp -70.69 -59.73 2.65 Favored 'General case' 0 C--O 1.211 -0.947 0 C-N-CA 124.022 0.929 . . . . 15.0 112.933 -168.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.76 -32.61 73.79 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.797 0.439 . . . . 15.0 110.713 -171.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -68.92 -46.56 67.97 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.08 -0.964 . . . . 15.0 109.658 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.38 72.53 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.336 0.655 . . . . 15.0 111.949 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 286' ' ' VAL . 79.8 mt -70.94 -51.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -58.34 -42.15 86.23 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.992 0.808 . . . . 15.0 110.338 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.13 61.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 15.0 110.947 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -63.94 -59.44 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 282' ' ' ILE . 40.2 t -58.53 -44.3 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 114.95 -1.023 . . . . 15.0 110.457 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' A' ' 291' ' ' ILE . 84.6 tttt -68.78 -41.15 79.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.668 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 91.4 p -65.25 -40.35 93.9 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.991 0.359 . . . . 15.0 110.489 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.462 ' HB2' HG13 ' A' ' 125' ' ' VAL . 51.5 mt-30 -68.68 -34.93 76.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.53 0.519 . . . . 15.0 111.245 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.8 -50.22 67.59 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.132 0.573 . . . . 15.0 110.519 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 295' ' ' VAL . 27.0 mm -65.07 -54.62 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.676 0.791 . . . . 15.0 110.907 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.64 -38.54 90.66 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.761 0.663 . . . . 15.0 110.383 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.96 -35.3 89.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.581 -0.736 . . . . 15.0 112.758 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.5 OUTLIER -66.32 -42.59 88.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.97 0.908 . . . . 15.0 110.299 177.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 291' ' ' ILE . 47.6 t -62.13 -53.43 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.799 -0.815 . . . . 15.0 108.799 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.26 -27.64 69.15 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.593 -1.185 . . . . 15.0 111.613 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.17 59.59 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 15.0 113.171 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.79 150.63 15.64 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.204 0.816 . . . . 15.0 113.204 -169.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.06 143.27 58.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.774 0.829 . . . . 15.0 111.113 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 346' ' ' VAL . 6.1 tp -147.62 115.04 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.421 -0.809 . . . . 15.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.0 130.77 54.59 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.217 1.007 . . . . 15.0 108.57 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 349' ' ' LEU . 45.6 t -131.95 131.26 22.49 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.935 0.894 . . . . 15.0 110.097 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.412 ' HB2' ' HG ' ' A' ' 306' ' ' LEU . 53.0 Cg_exo -55.06 130.14 39.11 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.144 2.562 . . . . 15.0 112.468 171.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -63.61 -24.83 67.96 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.506 1.122 . . . . 15.0 112.902 -173.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.12 73.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.201 0.6 . . . . 15.0 111.536 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.446 HD11 ' HE1' ' A' ' 112' ' ' TYR . 19.5 mt -69.86 -43.39 71.97 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.379 -0.6 . . . . 15.0 109.379 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 304' ' ' ALA . 3.2 mp -59.09 -50.21 80.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-N 115.382 -0.826 . . . . 15.0 109.013 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.17 -35.74 81.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.783 0.833 . . . . 15.0 111.738 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -44.03 94.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.376 0.671 . . . . 15.0 110.339 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -79.13 -27.4 42.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.647 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 337' ' ' PHE . 34.0 mt -65.76 -35.88 76.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 N-CA-C 108.585 -0.895 . . . . 15.0 108.585 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.579 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 14.9 t70 -63.67 -44.07 94.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.653 0.781 . . . . 15.0 110.575 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.67 -52.12 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 123.72 0.637 . . . . 15.0 110.114 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 341' ' ' ALA . 87.9 mt -70.27 -21.41 62.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.897 -1.047 . . . . 15.0 112.426 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 58.9 mtm180 -76.62 -42.51 42.04 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.908 0.883 . . . . 15.0 109.871 176.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -66.36 -40.18 89.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.907 0.483 . . . . 15.0 110.417 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -67.92 -38.02 82.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.348 -0.842 . . . . 15.0 110.622 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.75 70.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.911 0.484 . . . . 15.0 109.946 175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.22 -34.79 66.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.171 -0.922 . . . . 15.0 111.525 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -66.34 -37.3 85.02 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.865 0.866 . . . . 15.0 110.689 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -79.87 -15.14 57.97 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.655 0.782 . . . . 15.0 110.007 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.518 ' HE2' ' HG2' ' A' ' 326' ' ' GLU . 18.5 t80 -91.33 10.28 28.05 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.967 1.307 . . . . 15.0 110.469 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 85.47 8.06 81.35 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.126 0.393 . . . . 15.0 114.031 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 83.52 13.28 76.41 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.297 0.475 . . . . 15.0 113.028 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -78.62 156.9 28.86 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.732 0.813 . . . . 15.0 111.367 -173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.518 ' HG2' ' HE2' ' A' ' 322' ' ' PHE . 16.5 mm-40 79.34 -54.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.976 2.111 . . . . 15.0 112.618 176.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 63.39 24.7 14.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.293 1.037 . . . . 15.0 110.388 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -101.34 16.58 25.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.257 1.423 . . . . 15.0 110.006 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.47 -42.76 15.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.559 1.544 . . . . 15.0 113.736 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 50.0 tp -59.17 -27.9 66.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.299 0.64 . . . . 15.0 111.926 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.06 -8.58 53.66 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.489 0.716 . . . . 15.0 112.388 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 69.0 mt -54.03 130.31 58.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-N 118.587 0.63 . . . . 15.0 110.248 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.523 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 86.2 Cg_exo -48.35 116.04 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.634 2.889 . . . . 15.0 113.759 -170.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -51.7 -37.78 52.27 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.925 0.89 . . . . 15.0 111.519 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -54.5 -33.13 59.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.174 0.989 . . . . 15.0 112.851 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.523 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 95.3 mt -62.7 -30.16 71.2 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.274 0.559 . . . . 15.0 110.891 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.511 ' HA ' HE21 ' A' ' 340' ' ' GLN . 28.2 m-85 -116.47 -3.04 11.9 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.271 -0.877 . . . . 15.0 111.246 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.414 ' HA ' HD11 ' A' ' 311' ' ' ILE . 11.3 tp10 -55.83 -63.05 1.3 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.304 1.042 . . . . 15.0 111.965 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.05 -47.18 85.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.15 0.906 . . . . 15.0 111.589 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 337' ' ' PHE . 16.8 pt20 -67.72 -51.93 43.54 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.683 0.614 . . . . 15.0 111.558 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -63.3 -43.21 98.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.776 0.43 . . . . 15.0 110.627 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 346' ' ' VAL . 75.5 tttt -58.38 -43.24 88.42 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 123.883 0.739 . . . . 15.0 110.164 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 347' ' ' VAL . 45.3 mmt-85 -61.31 -35.75 78.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.655 -0.688 . . . . 15.0 111.268 172.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.5 mtt-85 -69.33 -34.01 73.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.807 0.443 . . . . 15.0 110.89 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.701 ' HA ' ' HB3' ' B' ' 467' ' ' ALA . 9.9 t -77.69 -41.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.856 0.36 . . . . 15.0 110.069 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 300' ' ' ILE . 53.6 t -58.88 -35.05 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.455 -0.793 . . . . 15.0 110.449 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 343' ' ' ARG . 11.8 t -51.28 -54.55 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.675 0.79 . . . . 15.0 109.316 169.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.99 -37.85 93.57 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.404 -0.816 . . . . 15.0 114.334 -174.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 302' ' ' VAL . 10.3 mp -72.02 -50.11 31.26 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.858 0.829 . . . . 15.0 111.124 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 354' ' ' VAL . 87.6 mt -63.05 -52.85 61.16 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.271 0.357 . . . . 15.0 110.337 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.471 HD12 HG13 ' A' ' 347' ' ' VAL . 81.5 mt -69.85 -31.19 68.91 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.904 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.548 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.42 -39.22 97.51 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 111.779 -0.528 . . . . 15.0 111.779 173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.67 -38.63 84.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.096 -0.552 . . . . 15.0 110.429 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.0 t -60.6 -36.43 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 122.746 0.418 . . . . 15.0 111.07 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.548 HD12 ' HA2' ' A' ' 352' ' ' GLY . 85.3 mt -62.96 -52.58 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.876 0.87 . . . . 15.0 109.902 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -62.14 -56.42 18.93 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 123.52 0.513 . . . . 15.0 110.912 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.1 m -54.67 -48.25 72.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.708 1.203 . . . . 15.0 112.192 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.2 16.34 11.69 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 119.323 -0.37 . . . . 15.0 111.919 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 44.46 41.34 4.55 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 125.746 1.618 . . . . 15.0 113.776 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.512 ' HB3' HE21 ' A' ' 406' ' ' GLN . 96.8 mt -74.7 150.51 39.46 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.021 -0.99 . . . . 15.0 112.184 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.99 147.29 52.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.456 1.102 . . . . 15.0 109.555 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.23 92.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.117 0.567 . . . . 15.0 110.438 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 367' ' ' VAL . 13.9 t70 -70.54 127.01 31.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.834 0.854 . . . . 15.0 110.44 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.47 -32.96 74.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.631 1.172 . . . . 15.0 112.783 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.15 -23.76 60.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.461 0.304 . . . . 15.0 110.336 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.45 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 40.6 tpt85 -80.51 -33.58 36.35 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.129 0.572 . . . . 15.0 109.585 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 363' ' ' ASP . 44.6 t -61.68 -54.46 34.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 108.908 -0.775 . . . . 15.0 108.908 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -65.69 -28.7 69.27 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.859 0.724 . . . . 15.0 110.868 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.55 -54.01 37.48 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 111.66 -0.576 . . . . 15.0 111.66 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.34 -56.52 20.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.592 0.757 . . . . 15.0 110.698 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.669 HD11 ' HG2' ' A' ' 398' ' ' MET . 44.9 mm -50.75 -53.4 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 124.771 1.294 . . . . 15.0 111.945 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.04 -41.51 61.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.004 0.521 . . . . 15.0 111.133 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -70.59 -23.28 62.55 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.64 0.607 . . . . 15.0 112.64 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 -33.3 12.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 119.159 -0.448 . . . . 15.0 111.57 176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -93.24 -40.64 10.33 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 112.671 0.619 . . . . 15.0 112.671 -171.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 381' ' ' PRO . 22.1 t -70.06 -13.29 62.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.01 0.374 . . . . 15.0 112.01 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 272' ' ' LYS . . . -86.92 -0.56 56.74 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.136 0.574 . . . . 15.0 111.664 174.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -94.69 -175.31 3.55 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.426 0.69 . . . . 15.0 110.367 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.85 -51.67 17.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.437 1.095 . . . . 15.0 110.305 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.409 ' HB3' ' NH1' ' B' ' 440' ' ' ARG . 11.6 t70 -123.33 106.92 32.71 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.46 ' HB3' ' HA ' ' A' ' 376' ' ' SER . 97.1 Cg_endo -84.93 -23.56 2.47 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.599 2.199 . . . . 15.0 113.61 170.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -57.23 -49.54 75.7 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.453 0.701 . . . . 15.0 112.288 -162.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.61 -16.06 60.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.267 -0.879 . . . . 15.0 111.383 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.654 HG13 HD13 ' B' ' 441' ' ' ILE . 88.7 t -76.58 -50.26 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.604 -0.888 . . . . 15.0 108.604 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.22 -49.53 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.635 0.774 . . . . 15.0 109.078 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.94 -36.14 80.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.355 -0.839 . . . . 15.0 112.237 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.05 -57.99 10.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.754 0.422 . . . . 15.0 110.451 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.459 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 87.0 m-85 -64.09 -53.05 55.87 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.892 0.745 . . . . 15.0 111.352 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 79.0 p -56.05 -33.94 65.45 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.147 0.795 . . . . 15.0 113.147 -172.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -98.13 -4.61 35.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.075 0.55 . . . . 15.0 112.461 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -119.49 90.18 3.28 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -56.09 -29.28 60.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.765 1.226 . . . . 15.0 113.031 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.85 -57.88 10.99 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.407 0.683 . . . . 15.0 111.056 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' B' ' 443' ' ' ALA . 2.0 tt -87.66 -18.9 28.54 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.243 -0.89 . . . . 15.0 109.775 -174.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 7.4 tpt -67.13 -43.32 82.69 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 172.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.66 -40.03 95.77 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.065 0.946 . . . . 15.0 110.403 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.86 -44.1 90.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.258 0.623 . . . . 15.0 110.378 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.669 ' HG2' HD11 ' A' ' 371' ' ' ILE . 37.7 tpp -72.72 -23.52 60.86 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 115.488 -0.778 . . . . 15.0 111.671 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HG2' HG21 ' A' ' 367' ' ' VAL . 12.7 mtp180 -76.53 -35.32 58.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.599 0.76 . . . . 15.0 109.85 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' B' ' 464' ' ' MET . 0.9 OUTLIER -69.19 -38.4 78.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.139 0.576 . . . . 15.0 110.269 178.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.1 p -79.09 -22.86 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 119.49 -0.291 . . . . 15.0 111.11 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.41 96.9 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.866 0.757 . . . . 15.0 109.468 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.96 -34.92 64.45 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.844 -1.525 . . . . 15.0 111.77 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 401' ' ' VAL . 0.6 OUTLIER -67.93 -48.01 67.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.376 1.07 . . . . 15.0 109.965 177.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.45 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 6.1 mm-40 -56.49 -46.99 80.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.024 1.329 . . . . 15.0 111.199 171.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.512 HE21 ' HB3' ' A' ' 360' ' ' LEU . 27.4 tt0 -62.32 -35.11 78.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.165 -0.925 . . . . 15.0 110.803 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -67.78 -38.07 82.88 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.244 0.618 . . . . 15.0 110.997 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 59.5 t -56.1 -53.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.969 -0.752 . . . . 15.0 108.969 170.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -63.08 -26.45 68.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.163 0.985 . . . . 15.0 112.959 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -74.71 -27.36 60.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.06 0.544 . . . . 15.0 111.148 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 407' ' ' ALA . 89.0 t -75.79 -38.33 36.88 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 108.521 -0.918 . . . . 15.0 108.521 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 290' ' ' ALA . 92.8 mt -67.56 -35.16 78.51 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.78 0.832 . . . . 15.0 111.32 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.57 -20.83 65.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.648 0.779 . . . . 15.0 111.592 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.522 ' HD3' HD12 ' A' ' 120' ' ' LEU . 27.8 mtpp -105.67 -30.15 9.65 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.059 0.944 . . . . 15.0 111.556 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.82 159.25 22.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.071 0.948 . . . . 15.0 111.741 -172.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -75.61 82.63 2.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.972 0.909 . . . . 15.0 109.464 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 125' ' ' VAL . 42.5 t -90.15 92.15 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -70.67 96.03 1.17 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 122.402 1.096 . . . . 15.0 110.493 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.54 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 37.1 mt-10 -75.2 105.01 6.0 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.253 -1.34 . . . . 15.0 109.562 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -114.41 138.29 50.75 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.279 0.562 . . . . 15.0 109.951 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 28.4 mt-10 -81.44 130.89 35.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.959 0.904 . . . . 15.0 109.193 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.446 HG21 ' HG2' ' A' ' 426' ' ' GLU . 8.8 t -163.64 169.55 18.4 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.285 0.634 . . . . 15.0 110.446 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.2 p -93.22 171.83 8.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.243 1.017 . . . . 15.0 111.487 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 428' ' ' MET . 57.0 t80 -52.54 -47.27 66.82 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.888 1.275 . . . . 15.0 110.828 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -54.93 -22.94 16.62 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.945 1.091 . . . . 15.0 113.945 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 427' ' ' LEU . 10.0 tp10 -54.34 -55.7 25.82 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.647 0.779 . . . . 15.0 112.068 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 426' ' ' GLU . 5.4 mp -74.87 -29.5 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.42 -0.809 . . . . 15.0 111.709 -167.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' A' ' 428' ' ' MET . 0.1 OUTLIER -80.69 -42.87 21.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.992 0.517 . . . . 15.0 109.832 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 41.02 0.85 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.002 0.521 . . . . 15.0 111.109 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -91.18 71.27 6.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 15.0 109.254 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -79.81 -54.32 5.95 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.993 0.917 . . . . 15.0 108.664 176.322 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 72.4 t . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -139.89 107.44 5.59 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.4 tt -74.16 -81.97 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' B' ' 372' ' ' GLN . 11.7 t70 -104.83 -86.02 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.335 0.516 . . . . 0.0 110.777 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' B' ' 370' ' ' ALA . 5.8 pt-20 -105.35 -67.92 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.954 0.502 . . . . 0.0 111.835 -169.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.454 ' H ' ' HG3' ' B' ' 369' ' ' GLU . . . -96.2 -77.42 0.48 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.84 -80.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 165.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.673 ' HB3' ' HA ' ' B' ' 377' ' ' PHE . 24.0 tm0? -100.7 -78.2 0.52 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 167.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' B' ' 377' ' ' PHE . 10.2 mmm180 -102.09 -84.65 0.45 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.578 0.626 . . . . 0.0 110.754 168.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -104.48 -75.47 0.62 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -165.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 81.9 mt -88.8 -78.62 0.34 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -104.4 -70.81 0.76 Allowed 'General case' 0 C--N 1.345 0.402 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 165.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.673 ' HA ' ' HB3' ' B' ' 372' ' ' GLN . 82.1 m-85 -99.86 -92.11 0.29 Allowed 'General case' 0 C--N 1.351 0.65 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.777 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -104.21 -82.64 0.51 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.205 0.911 . . . . 0.0 110.616 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -107.02 -32.15 7.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.849 0.86 . . . . 0.0 110.626 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm 72.08 83.47 0.13 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.528 1.531 . . . . 0.0 111.112 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -170.77 139.66 1.54 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.317 173.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 160.41 164.6 15.7 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.005 0.19 . . . . 0.0 112.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . 0.457 HD22 ' H ' ' B' ' 383' ' ' ASN . 0.1 OUTLIER -80.66 154.08 27.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.668 0.787 . . . . 0.0 111.256 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 48.3 p -80.77 -16.19 54.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.944 0.898 . . . . 0.0 111.479 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.543 HD22 ' NH2' ' A' ' 193' ' ' ARG . 5.6 mp -70.6 134.52 47.68 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 178' ' ' GLU . 50.9 t -81.93 90.06 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 123.771 1.748 . . . . 0.0 109.265 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.602 ' HA ' ' HE2' ' A' ' 177' ' ' PHE . 7.6 tp -153.17 173.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 110.983 -2.826 . . . . 0.0 105.329 170.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.489 ' H ' HG13 ' B' ' 387' ' ' ILE . 0.1 OUTLIER -39.94 167.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -150.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' B' ' 394' ' ' HIS . 61.0 p -36.75 99.01 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 110.02 -3.263 . . . . 0.0 115.327 -157.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -85.79 -177.76 6.44 Favored 'General case' 0 C--O 1.251 1.177 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 153.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' B' ' 377' ' ' PHE . 1.6 m-20 -75.61 88.89 2.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 112.461 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -147.93 -49.01 0.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.363 1.865 . . . . 0.0 107.149 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.38 114.34 4.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.246 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . 0.453 ' HA ' ' HB ' ' B' ' 389' ' ' THR . 67.1 m-70 -99.47 -82.23 0.44 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.294 0.497 . . . . 0.0 112.027 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 52.86 -93.61 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.728 0.811 . . . . 0.0 110.417 -162.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 50.3 m 54.97 21.62 3.84 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.852 1.261 . . . . 0.0 113.997 171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 66.62 -72.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.146 1.379 . . . . 0.0 110.316 -172.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.1 pp -121.94 -175.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.68 1.192 . . . . 0.0 110.241 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.98 42.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.336 1.065 . . . . 0.0 111.704 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -162.04 156.07 18.49 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 0.0 109.785 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.78 -16.57 33.27 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.445 2.097 . . . . 0.0 112.382 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.75 153.54 10.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.467 1.107 . . . . 0.0 109.269 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 15.1 t -144.41 44.88 1.41 Allowed 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 121.586 0.708 . . . . 0.0 111.649 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.99 -42.14 98.81 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.267 0.556 . . . . 0.0 110.152 170.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -112.61 104.19 55.83 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.5 -7.28 20.59 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.792 2.328 . . . . 0.0 113.006 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 86.03 -81.93 1.69 Allowed Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.3 tt 61.73 -82.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.256 1.422 . . . . 0.0 110.013 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 91.8 m -74.16 -40.63 62.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.905 1.282 . . . . 0.0 110.392 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -73.83 102.74 4.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.528 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -88.04 113.42 23.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.621 0.768 . . . . 0.0 108.994 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.0 -37.4 47.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.371 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -68.18 92.75 0.41 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 123.44 0.696 . . . . 0.0 110.138 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 37.3 m -77.5 83.29 3.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.013 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 2.6 tpmt? -156.15 -63.0 0.11 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.01 -42.87 6.57 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.829 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -97.82 60.83 0.99 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -60.83 110.63 1.38 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.764 0.826 . . . . 0.0 110.81 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.16 92.81 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.244 1.018 . . . . 0.0 110.187 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 55.5 ttp 58.37 -83.68 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.254 1.422 . . . . 0.0 111.415 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.552 HG13 ' H ' ' B' ' 422' ' ' MET 0.282 3.2 p 33.99 -93.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.369 1.419 0 C-N-CA 126.911 2.084 . . . . 0.0 113.651 -175.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.552 ' H ' HG13 ' B' ' 421' ' ' VAL . 8.3 ptm 65.33 -34.98 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.061 2.145 . . . . 0.0 114.985 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' B' ' 438' ' ' GLN . 21.7 t 60.89 -161.65 0.28 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -117.27 149.59 40.19 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.663 0.785 . . . . 0.0 109.511 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 161.86 -147.11 13.05 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.672 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -149.48 -108.85 0.07 Allowed 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 117.475 -1.25 . . . . 0.0 108.385 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 70.0 p 41.52 -72.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 126.862 2.065 . . . . 0.0 114.332 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.49 -28.51 67.1 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.372 1.069 . . . . 0.0 111.313 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.44 -24.81 61.23 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.048 1.339 . . . . 0.0 111.339 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -50.42 -21.39 1.44 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 124.195 0.998 . . . . 0.0 113.193 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 67.8 p -59.42 -48.57 81.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.607 0.763 . . . . 0.0 111.273 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -90.94 -13.15 34.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.305 1.042 . . . . 0.0 111.129 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 79.02 -30.75 0.14 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.154 1.781 . . . . 0.0 115.227 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -165.8 29.17 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 119.076 0.853 . . . . 0.0 112.681 -169.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 10.9 m -134.68 95.22 3.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.32 0.648 . . . . 0.0 109.352 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -81.95 41.8 2.78 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.222 -0.21 . . . . 0.0 113.418 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 25.6 p -74.15 90.45 2.05 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.756 0.822 . . . . 0.0 109.878 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' B' ' 423' ' ' SER . 50.3 mt-30 -134.21 116.32 15.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.34 1.056 . . . . 0.0 108.807 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 94.5 mt 61.79 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.985 1.314 . . . . 0.0 110.953 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 380' ' ' ASP . 24.3 ptt180 -69.76 159.67 33.11 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 170.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.654 HD13 HG13 ' A' ' 384' ' ' VAL . 32.3 mm 62.85 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -162.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.28 89.59 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 394' ' ' LEU . . . 68.06 -77.39 0.05 OUTLIER 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.105 1.503 . . . . 0.0 110.327 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 14.7 t80 52.4 94.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.258 1.423 . . . . 0.0 113.075 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.48 -172.93 26.23 Favored Glycine 0 C--O 1.244 0.769 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.709 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' B' ' 467' ' ' ALA . 89.1 Cg_endo -76.02 -168.88 0.6 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 122.806 2.337 . . . . 0.0 112.769 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . 0.461 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 19.4 t-160 -61.42 122.46 15.23 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 69.81 8.31 6.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 72.19 -49.19 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.704 1.602 . . . . 0.0 113.029 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.596 ' HA ' ' HE3' ' B' ' 465' ' ' LYS . 14.7 t-20 -132.98 164.17 27.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.051 0.941 . . . . 0.0 109.447 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.71 149.64 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 125.236 1.414 . . . . 0.0 109.963 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.15 -37.76 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 123.214 0.606 . . . . 0.0 111.442 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -117.89 137.29 13.04 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.43 42.47 0.51 Allowed 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.179 0.991 . . . . 0.0 112.275 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 10.1 m 72.09 -0.84 3.09 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.463 1.505 . . . . 0.0 112.136 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.7 t70 63.93 -75.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.274 1.43 . . . . 0.0 110.017 -172.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -96.85 100.02 11.57 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.313 1.045 . . . . 0.0 108.446 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 4.8 t -80.03 71.64 6.77 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.368 1.08 . . . . 0.0 109.065 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.41 -16.4 64.21 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.533 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.581 ' H ' HD13 ' B' ' 460' ' ' LEU . 0.0 OUTLIER -91.42 34.0 0.97 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.953 0.901 . . . . 0.0 110.798 175.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 66.82 -84.52 0.03 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.737 1.615 . . . . 0.0 111.644 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -91.33 135.31 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 59.6 m -58.16 99.13 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 O-C-N 124.243 0.964 . . . . 0.0 110.815 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.451 ' HA ' ' OD1' ' A' ' 400' ' ' ASN . 1.3 tmt? -129.48 110.17 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 108.576 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.0 OUTLIER -80.86 121.16 25.63 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -51.38 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.942 1.401 . . . . 0.0 112.318 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.701 ' HB3' ' HA ' ' A' ' 345' ' ' VAL . . . -169.77 80.87 0.11 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -161.61 163.39 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.759 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' B' ' 447' ' ' HIS . . . -166.08 60.49 0.23 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.91 -47.23 87.38 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.829 0.851 . . . . 0.0 108.934 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 85.8 tttt . . . . . 0 C--O 1.25 1.102 0 C-N-CA 124.252 1.021 . . . . 12.06 108.525 178.814 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.519 -0.549 . . . . 15.0 109.519 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.5 tt0 -82.2 108.33 15.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.42 -0.585 . . . . 15.0 109.42 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 HG12 ' A' ' 17' ' ' ILE . 33.0 m -121.25 141.18 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 15.0 109.552 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 9.2 m -140.33 92.64 2.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.332 0.653 . . . . 15.0 109.405 -174.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.03 102.14 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-O 121.91 0.862 . . . . 15.0 110.492 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 38.6 mt-10 -92.41 107.2 19.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.781 0.832 . . . . 15.0 109.595 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -72.4 90.96 1.32 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.5 m -64.13 -51.67 62.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.69 1.196 . . . . 15.0 111.031 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -155.7 84.9 1.03 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.23 -0.441 . . . . 15.0 109.934 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.42 0.23 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 123.558 0.536 . . . . 15.0 113.063 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.515 ' HA ' HH12 ' A' ' 13' ' ' ARG . 10.0 mp -66.91 -37.74 84.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.655 0.782 . . . . 15.0 110.982 175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.26 97.41 0.17 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 124.362 1.039 . . . . 15.0 112.311 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.515 HH12 ' HA ' ' A' ' 11' ' ' LEU . 66.9 mtt85 -108.75 143.14 38.28 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.799 1.24 . . . . 15.0 109.684 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 42.2 ttm180 -119.9 88.95 3.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.845 1.258 . . . . 15.0 107.868 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.7 t -77.75 91.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.581 0.705 . . . . 15.0 109.179 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 91.0 m -81.28 105.2 12.29 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.418 -1.265 . . . . 15.0 109.905 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 3' ' ' VAL . 52.8 mt -107.29 127.73 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.167 0.587 . . . . 15.0 110.211 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 85.5 m -100.61 111.86 24.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.188 0.995 . . . . 15.0 108.649 171.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.7 mt -88.91 130.99 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.45 138.24 58.31 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.587 0.755 . . . . 15.0 110.815 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -56.53 -39.9 74.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.941 1.297 . . . . 15.0 112.598 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.29 -40.24 93.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.267 -0.879 . . . . 15.0 110.324 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -71.65 -26.18 62.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.524 0.729 . . . . 15.0 111.549 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 21' ' ' ALA . 80.1 mt -70.81 -51.12 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.638 0.775 . . . . 15.0 109.685 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.25 -24.15 59.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.463 -0.335 . . . . 15.0 111.587 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.579 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 87.5 m -68.35 -39.64 81.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.459 0.704 . . . . 15.0 109.776 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.15 -42.14 94.07 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.148 0.579 . . . . 15.0 111.011 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 66' ' ' VAL . 95.9 t -59.68 -44.78 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-O 121.625 0.726 . . . . 15.0 109.974 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 26' ' ' THR . 4.1 ttmp? -63.7 -36.11 82.78 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.592 -1.186 . . . . 15.0 111.089 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -92.67 -1.99 56.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.605 1.162 . . . . 15.0 111.245 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -99.71 -39.9 8.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.376 0.67 . . . . 15.0 109.782 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 55' ' ' ALA . 52.8 mt -82.12 -8.64 59.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.412 -0.813 . . . . 15.0 112.225 -175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.9 -31.62 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 109.241 -0.651 . . . . 15.0 109.241 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -71.98 -43.76 64.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.04 0.936 . . . . 15.0 109.334 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.91 -37.95 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.097 -0.956 . . . . 15.0 110.4 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -46.1 90.66 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.339 0.656 . . . . 15.0 110.853 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -69.58 -34.97 74.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.616 0.366 . . . . 15.0 111.698 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.28 -53.01 59.61 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.893 0.877 . . . . 15.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 t -86.85 2.19 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.718 0.807 . . . . 15.0 110.645 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 74.26 9.44 4.49 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.764 1.625 . . . . 15.0 112.695 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mt -58.31 -27.73 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.155 1.382 . . . . 15.0 111.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.58 -32.54 74.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.564 0.746 . . . . 15.0 111.122 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.32 -33.68 64.39 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.668 0.605 . . . . 15.0 111.852 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.5 -18.18 42.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.368 0.667 . . . . 15.0 110.766 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.8 ttt85 -70.58 108.34 4.3 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.518 0.727 . . . . 15.0 109.059 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -91.0 -2.81 57.64 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.278 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -7.87 79.39 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-O 119.548 -0.585 . . . . 15.0 113.859 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -65.82 -48.66 70.92 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.289 0.636 . . . . 15.0 110.768 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.08 121.79 80.98 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.474 -0.935 . . . . 15.0 108.474 174.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.68 131.68 45.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.882 2.388 . . . . 15.0 112.25 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.7 tpt -63.23 -32.6 74.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.308 1.043 . . . . 15.0 111.602 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.3 p30 -57.97 -38.8 76.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.587 0.755 . . . . 15.0 112.765 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.44 -51.93 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.085 0.954 . . . . 15.0 110.429 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.495 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 29.6 m -72.39 -19.34 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.754 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -74.18 -58.42 3.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.043 0.537 . . . . 15.0 110.983 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.551 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.7 pt20 -73.31 -34.71 65.86 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.878 -173.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.1 mtt180 -96.51 -70.38 0.72 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.072 0.549 . . . . 15.0 111.091 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 91.8 m-85 -72.29 -18.89 61.76 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.473 0.709 . . . . 15.0 112.177 -169.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.27 23.4 15.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.526 -0.597 . . . . 15.0 112.704 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.08 -21.82 66.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.088 0.955 . . . . 15.0 111.882 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.8 p -62.56 -32.44 73.41 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.563 0.745 . . . . 15.0 111.32 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 78.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.173 0.989 . . . . 15.0 109.692 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -108.07 -48.18 3.42 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.184 -0.673 . . . . 15.0 109.184 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -56.72 -45.34 81.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.677 1.191 . . . . 15.0 111.576 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.53 -34.1 77.45 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.85 -1.068 . . . . 15.0 111.206 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 28' ' ' VAL . 42.5 t -80.18 -63.64 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.24 -44.58 83.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.962 0.905 . . . . 15.0 112.773 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.48 -37.4 94.73 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.542 0.526 . . . . 15.0 112.606 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.35 -33.5 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.984 0.914 . . . . 15.0 111.122 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 70.4 mt -70.06 -32.5 70.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.955 0.502 . . . . 15.0 110.432 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.5 mtm -63.14 -37.64 88.01 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 123.413 0.445 . . . . 15.0 110.455 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 -55.6 5.81 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.488 0.715 . . . . 15.0 110.799 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -67.92 -37.15 81.3 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.117 0.567 . . . . 15.0 112.425 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -75.47 -30.02 59.78 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 117.875 0.307 . . . . 15.0 111.026 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -64.31 -54.54 31.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.073 0.549 . . . . 15.0 110.666 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.6 -35.13 71.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 123.74 0.65 . . . . 15.0 110.618 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.71 -47.66 82.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.63 0.772 . . . . 15.0 110.611 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.2 -56.46 20.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.929 -1.032 . . . . 15.0 111.325 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.559 HD12 ' HD3' ' A' ' 86' ' ' PRO . 21.4 pt -64.88 -31.86 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.914 0.709 . . . . 15.0 112.914 -170.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.87 -49.23 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.798 0.439 . . . . 15.0 110.519 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -72.12 -29.71 64.34 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 116.641 -0.254 . . . . 15.0 111.053 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -87.3 1.34 53.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.514 0.726 . . . . 15.0 111.57 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 66.96 12.99 9.29 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.86 1.264 . . . . 15.0 112.942 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 70.4 mt -87.06 122.1 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.919 0.888 . . . . 15.0 108.727 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -117.9 117.27 35.66 Favored Pre-proline 0 N--CA 1.481 1.075 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.559 ' HD3' HD12 ' A' ' 79' ' ' ILE . 72.9 Cg_endo -71.6 152.71 59.76 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 15.0 113.383 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.67 52.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.099 -1.41 . . . . 15.0 107.218 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 304' ' ' ALA . . . -162.23 146.2 11.69 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.031 -1.44 . . . . 15.0 110.002 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -58.57 108.26 1.25 Allowed Pre-proline 0 N--CA 1.48 1.062 0 CA-C-N 117.415 0.607 . . . . 15.0 109.859 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 11.3 Cg_exo -69.16 109.8 2.28 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.439 2.093 . . . . 15.0 111.802 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 47.4 m -69.89 92.39 0.7 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.775 0.83 . . . . 15.0 109.971 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -73.43 104.71 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.92 103.56 3.45 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.021 -1.103 . . . . 15.0 108.021 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 104.24 1.32 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.076 1.851 . . . . 15.0 109.848 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.59 176.75 38.42 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.764 -0.653 . . . . 15.0 113.166 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.8 116.81 20.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.212 0.53 . . . . 15.0 110.07 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -102.01 98.78 8.94 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.783 -1.191 . . . . 15.0 107.783 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.7 mttt -77.84 136.47 38.09 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.769 -1.197 . . . . 15.0 107.769 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.01 106.94 2.51 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.394 -0.595 . . . . 15.0 109.394 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.64 10.46 40.78 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 116.238 -0.437 . . . . 15.0 112.693 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 38.3 mt-10 -134.71 -179.75 5.79 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.996 1.318 . . . . 15.0 109.221 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -81.04 173.71 12.32 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.597 0.759 . . . . 15.0 111.76 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -115.27 92.34 3.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 15.0 108.723 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -92.55 96.08 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.847 0.859 . . . . 15.0 109.228 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -108.98 178.23 4.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.43 0.692 . . . . 15.0 109.604 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.6 m -139.49 150.12 44.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.86 0.864 . . . . 15.0 109.284 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.97 117.22 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -98.07 136.91 37.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.401 1.08 . . . . 15.0 109.366 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -167.58 165.74 14.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.509 0.723 . . . . 15.0 109.823 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.89 174.67 5.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.306 0.643 . . . . 15.0 109.379 170.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.16 -166.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.161 0.984 . . . . 15.0 109.174 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 114.4 58.5 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 122.853 0.461 . . . . 15.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.03 112.47 3.26 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.681 2.254 . . . . 15.0 111.787 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.39 96.42 0.88 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.611 0.764 . . . . 15.0 109.421 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.97 134.38 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.054 0.941 . . . . 15.0 110.992 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.8 110.53 22.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.48 0.712 . . . . 15.0 109.379 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.64 ' HB3' HD21 ' A' ' 120' ' ' LEU . 94.1 mt -75.08 128.85 36.49 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -124.6 112.47 16.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.627 0.771 . . . . 15.0 109.784 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 61.0 67.1 2.28 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 124.469 1.106 . . . . 15.0 113.536 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 117' ' ' LEU . 38.5 mt -66.33 -25.15 66.69 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.59 0.356 . . . . 15.0 110.547 175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 414' ' ' LYS . 2.8 mp0 -71.82 -35.99 70.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.084 0.953 . . . . 15.0 110.75 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.29 -22.09 63.83 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.538 0.735 . . . . 15.0 111.548 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.34 127.43 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.951 0.9 . . . . 15.0 109.991 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 38.2 mt-10 -108.47 110.14 21.58 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.835 0.854 . . . . 15.0 109.778 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HB ' HG12 ' A' ' 417' ' ' VAL . 37.9 t -119.82 165.06 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.789 1.236 . . . . 15.0 107.853 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.04 149.01 32.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.625 -0.88 . . . . 15.0 108.625 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HE2' HD11 ' A' ' 129' ' ' ILE . 83.4 tttt -116.64 85.51 16.97 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.917 -1.142 . . . . 15.0 107.917 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.42 102.01 1.38 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.2 1.933 . . . . 15.0 111.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.496 HD11 ' HE2' ' A' ' 127' ' ' LYS . 41.1 mm -73.95 86.98 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.852 -1.166 . . . . 15.0 107.852 171.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.728 HG22 HG23 ' A' ' 422' ' ' THR . 28.7 t -107.27 148.37 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.08 -0.964 . . . . 15.0 110.502 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.12 165.17 37.06 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.246 1.018 . . . . 15.0 109.696 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG11 ' SD ' ' A' ' 274' ' ' MET . 2.8 t -96.77 88.54 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.777 -0.823 . . . . 15.0 108.777 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 69.8 p -77.21 -175.94 3.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.032 0.933 . . . . 15.0 110.352 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.99 -55.12 34.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.53 0.732 . . . . 15.0 111.366 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.05 66.97 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.977 0.798 . . . . 15.0 111.799 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -79.03 -45.33 20.39 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.362 0.665 . . . . 15.0 110.889 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.64 -54.94 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.204 0.602 . . . . 15.0 109.434 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.77 -48.04 82.44 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.731 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.96 99.09 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.91 0.757 . . . . 15.0 113.379 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.2 tpt -68.51 -50.86 48.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.599 0.759 . . . . 15.0 111.038 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.26 -38.33 68.4 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.024 0.53 . . . . 15.0 111.817 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 t70 -68.05 -39.17 83.09 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.45 -0.796 . . . . 15.0 110.571 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 71.1 m -61.97 -39.82 93.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.186 0.594 . . . . 15.0 110.128 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 140' ' ' MET . 83.4 mt -63.48 -38.26 90.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.166 0.587 . . . . 15.0 110.06 176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HB3' ' HD2' ' A' ' 246' ' ' PRO . 63.7 mtm180 -64.59 -34.41 78.2 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.223 173.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 142' ' ' ASP . 87.1 mttt -67.85 -35.94 79.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.513 0.325 . . . . 15.0 110.885 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 143' ' ' THR . 92.8 mt-30 -70.47 -33.32 71.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.859 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -103.59 29.47 5.7 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.848 . . . . 15.0 111.241 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.88 24.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.276 0.843 . . . . 15.0 113.276 -171.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -96.05 136.24 36.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.46 1.104 . . . . 15.0 110.306 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -81.78 111.82 18.36 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.225 0.61 . . . . 15.0 110.238 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -125.81 113.04 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 15.0 110.406 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 44.7 mt-10 -65.04 119.37 10.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.385 0.674 . . . . 15.0 111.063 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 47.0 pttt -123.78 -179.57 4.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.385 1.074 . . . . 15.0 110.009 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -165.58 154.12 11.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.916 0.887 . . . . 15.0 108.827 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 123.27 -38.75 2.39 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.436 -0.666 . . . . 15.0 111.436 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.02 123.68 7.28 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.608 0.363 . . . . 15.0 110.786 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 206' ' ' LYS . 40.5 t -85.43 131.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.491 -0.929 . . . . 15.0 108.491 171.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -121.85 -177.63 3.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.149 0.979 . . . . 15.0 109.72 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -81.43 -9.23 59.77 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.505 0.722 . . . . 15.0 111.893 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -97.62 19.33 13.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.958 0.903 . . . . 15.0 111.718 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.8 m-20 -94.11 158.78 15.45 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.102 0.953 . . . . 15.0 112.301 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 6.5 tmm_? -120.85 91.53 3.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.068 -2.197 . . . . 15.0 105.068 165.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 166' ' ' ILE . 28.4 t -90.22 148.75 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.392 1.077 . . . . 15.0 110.791 -174.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 41.0 m -126.19 121.63 33.33 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 107.759 -1.2 . . . . 15.0 107.759 171.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.611 HG22 HD23 ' A' ' 237' ' ' LEU . 36.3 pt -128.95 174.08 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.577 0.751 . . . . 15.0 111.914 -172.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -118.49 116.57 26.95 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.163 -1.792 . . . . 15.0 106.163 158.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.562 ' HE1' HG23 ' B' ' 387' ' ' ILE . 11.6 p90 -107.88 140.99 40.16 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 234' ' ' ALA . 1.5 t -137.28 113.65 10.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.923 -1.14 . . . . 15.0 107.923 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -101.25 154.79 19.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 116.131 -0.486 . . . . 15.0 113.072 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 p -136.88 104.17 5.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.741 0.816 . . . . 15.0 109.206 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 231' ' ' ALA . 52.9 t -77.39 112.95 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.141 -0.936 . . . . 15.0 109.271 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.9 t70 64.44 25.34 13.32 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 124.703 1.252 . . . . 15.0 110.573 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.47 21.15 52.56 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.04 -0.982 . . . . 15.0 114.524 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.12 150.43 49.98 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.02 0.91 . . . . 15.0 110.911 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -78.97 81.44 5.24 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.996 -1.113 . . . . 15.0 107.996 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.538 ' H ' ' HD1' ' A' ' 177' ' ' PHE . 1.1 p90 -59.48 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 112.712 -2.04 . . . . 15.0 112.387 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.46 ' HG2' ' HD2' ' A' ' 177' ' ' PHE . 12.0 mm-40 -101.0 176.52 5.23 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.574 1.55 . . . . 15.0 109.231 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -74.61 60.68 2.45 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.081 -0.808 . . . . 15.0 111.081 165.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -99.97 83.42 0.56 Allowed Glycine 0 C--N 1.344 0.985 0 C-N-CA 123.335 0.493 . . . . 15.0 111.985 -174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -148.39 165.22 31.75 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.909 0.883 . . . . 15.0 109.399 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.52 94.94 1.52 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.855 -0.611 . . . . 15.0 109.855 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 128.69 37.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.631 -1.168 . . . . 15.0 109.335 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 65.25 33.28 9.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.073 0.949 . . . . 15.0 111.145 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.01 127.65 32.38 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 122.784 0.434 . . . . 15.0 109.945 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.6 t -95.83 95.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.624 0.77 . . . . 15.0 110.263 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.603 HD22 ' HE3' ' A' ' 194' ' ' MET . 36.7 tp -86.79 90.08 8.18 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.433 0.635 . . . . 15.0 110.285 170.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.461 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . . . -83.27 89.72 7.03 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.811 -1.181 . . . . 15.0 107.811 169.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 46.7 mtp -57.07 137.48 55.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.321 0.648 . . . . 15.0 111.83 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 124.41 -28.87 5.18 Favored Glycine 0 N--CA 1.47 0.95 0 N-CA-C 112.077 -0.409 . . . . 15.0 112.077 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.461 ' NE2' ' HB3' ' A' ' 188' ' ' ALA . 10.4 pt20 -98.98 158.72 15.46 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.296 0.639 . . . . 15.0 110.553 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.98 66.32 2.8 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.986 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -107.7 10.63 28.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.54 0.736 . . . . 15.0 110.859 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.603 ' HE3' HD22 ' A' ' 187' ' ' LEU . 24.6 mmt -129.7 149.13 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.944 0.898 . . . . 15.0 110.583 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 23.8 pt -95.34 141.31 23.04 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.946 -1.025 . . . . 15.0 108.711 167.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.43 120.99 7.68 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.383 2.722 . . . . 15.0 112.918 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.89 -34.03 3.38 Favored Glycine 0 N--CA 1.467 0.76 0 CA-C-N 116.231 -0.44 . . . . 15.0 112.107 -176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 213' ' ' ILE . 5.4 t80 -78.07 -57.05 4.0 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.097 0.559 . . . . 15.0 110.233 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -19.93 65.47 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.953 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.669 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 21.2 m-20 -58.16 -41.15 83.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.426 0.69 . . . . 15.0 110.815 170.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.628 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -67.71 -30.51 74.7 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.15 -0.932 . . . . 15.0 112.92 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 187' ' ' LEU . 39.1 mm -75.99 -52.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.982 0.513 . . . . 15.0 110.346 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 55.8 pttt -80.16 20.19 0.68 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.053 0.941 . . . . 15.0 113.365 -167.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.48 31.22 2.15 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.367 -0.693 . . . . 15.0 111.367 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -146.99 -161.73 1.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.342 1.057 . . . . 15.0 109.695 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.424 ' HA ' HG23 ' A' ' 158' ' ' VAL . 9.9 ptpp? -148.89 168.75 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.189 0.596 . . . . 15.0 109.671 172.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -65.4 148.64 51.37 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 117.987 0.358 . . . . 15.0 110.626 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.75 -45.63 1.28 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.804 -0.634 . . . . 15.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.92 122.95 28.93 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.471 0.653 . . . . 15.0 110.375 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -99.43 135.95 40.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.19 0.996 . . . . 15.0 110.11 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -144.46 173.03 12.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.033 0.933 . . . . 15.0 109.172 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 58.7 m -129.79 116.81 19.28 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.89 -0.781 . . . . 15.0 108.89 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.628 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.1 pt -92.32 170.58 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.029 0.932 . . . . 15.0 110.071 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.93 124.6 33.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.379 0.672 . . . . 15.0 109.441 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.01 163.64 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.586 -1.264 . . . . 15.0 107.586 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 28.3 m -129.83 140.13 51.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.723 0.809 . . . . 15.0 109.38 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -82.84 143.11 45.92 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 122.977 0.511 . . . . 15.0 110.549 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.63 155.51 1.43 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 124.295 3.33 . . . . 15.0 115.587 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -70.29 -25.79 63.5 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.176 -0.92 . . . . 15.0 110.406 172.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.29 -13.13 35.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.277 1.031 . . . . 15.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -55.67 140.98 39.64 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 123.259 0.623 . . . . 15.0 111.275 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -46.84 -67.61 0.27 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 125.178 1.549 . . . . 15.0 112.806 -171.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.69 125.57 28.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.063 0.545 . . . . 15.0 110.45 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.18 -31.94 62.88 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.6 0.76 . . . . 15.0 111.587 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 229' ' ' LYS . 27.8 p-10 -64.23 -17.2 63.34 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.447 0.699 . . . . 15.0 111.416 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.824 HD11 ' HA ' ' B' ' 388' ' ' VAL . 28.8 mt -100.01 -39.31 8.2 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.172 0.989 . . . . 15.0 110.601 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -46.63 113.58 0.67 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.136 1.774 . . . . 15.0 112.813 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.65 -18.93 27.32 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.608 0.567 . . . . 15.0 114.253 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 98.4 mttt -84.17 154.28 23.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.619 0.768 . . . . 15.0 112.453 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.44 23.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.363 1.065 . . . . 15.0 110.638 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 172' ' ' VAL . . . -90.23 135.67 33.53 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.215 1.006 . . . . 15.0 111.067 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.74 100.85 11.26 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.479 ' HE1' HG21 ' B' ' 387' ' ' ILE . 90.6 m-85 -96.53 107.74 20.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.555 0.342 . . . . 15.0 110.563 -176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 169' ' ' THR . . . -77.23 102.68 6.77 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.078 -0.712 . . . . 15.0 109.078 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.52 134.38 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.865 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -115.99 100.44 7.97 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.033 -1.099 . . . . 15.0 108.033 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 166' ' ' ILE . 95.0 mt -74.08 110.15 8.14 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.874 -0.787 . . . . 15.0 108.874 175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -108.96 -33.37 6.94 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.096 0.474 . . . . 15.0 110.142 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.694 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 72.4 mmtt -133.28 122.99 24.69 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.108 0.963 . . . . 15.0 109.498 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 207' ' ' ALA . 97.5 t -114.97 87.44 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 106.872 -1.529 . . . . 15.0 106.872 169.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 163' ' ' ARG . 44.7 mt-10 -93.77 169.18 10.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.62 -0.881 . . . . 15.0 108.62 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 32.2 tt0 -134.42 122.84 23.1 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -74.1 83.99 1.81 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.132 -1.432 . . . . 15.0 107.132 167.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 127.17 31.6 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.752 -1.567 . . . . 15.0 110.746 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.38 115.0 9.36 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.389 1.076 . . . . 15.0 109.247 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 78.7 Cg_endo -75.52 -176.56 3.02 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.047 2.498 . . . . 15.0 112.407 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.96 142.53 56.42 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.001 -1.0 . . . . 15.0 110.964 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 24.4 tp -107.1 23.04 15.06 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.104 -1.073 . . . . 15.0 108.104 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 29.8 p -71.56 176.7 4.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.509 1.124 . . . . 15.0 111.216 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -38.05 -59.49 0.84 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.944 1.698 . . . . 15.0 114.573 -166.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.28 -22.82 65.63 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.001 0.741 . . . . 15.0 113.001 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.31 -50.21 6.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.095 0.558 . . . . 15.0 109.786 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.609 HG13 HD22 ' A' ' 266' ' ' LEU . 15.6 tt -65.36 -27.29 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.012 0.525 . . . . 15.0 111.841 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -22.65 42.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.022 0.378 . . . . 15.0 112.022 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -62.81 -22.15 66.42 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.052 0.941 . . . . 15.0 111.568 -169.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -39.95 90.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.185 0.994 . . . . 15.0 110.857 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 150.1 26.5 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 O-C-N 123.416 0.447 . . . . 15.0 113.452 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.11 143.56 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 117.558 0.679 . . . . 15.0 109.185 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -69.65 -57.2 5.45 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.386 0.674 . . . . 15.0 111.135 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -91.54 -38.3 12.59 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.745 0.418 . . . . 15.0 110.51 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.17 32.43 5.27 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.147 -0.479 . . . . 15.0 112.645 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.7 p -78.65 145.64 34.51 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.392 0.596 . . . . 15.0 109.738 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 253' ' ' ILE . 44.7 t -58.16 -41.59 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.127 0.971 . . . . 15.0 111.126 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -54.22 -34.66 61.16 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.853 0.861 . . . . 15.0 111.858 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.88 -25.36 58.2 Favored Glycine 0 C--N 1.356 1.687 0 N-CA-C 111.366 -0.694 . . . . 15.0 111.366 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.609 HD22 HG13 ' A' ' 253' ' ' ILE . 54.7 tp -75.97 -28.46 57.9 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.44 -45.88 78.33 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.071 -0.714 . . . . 15.0 109.071 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.99 82.05 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.307 -1.315 . . . . 15.0 110.419 173.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -68.13 -45.55 73.3 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.222 0.951 . . . . 15.0 111.855 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.04 -22.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 122.506 0.322 . . . . 15.0 110.649 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -68.47 -53.14 25.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.948 -0.39 . . . . 15.0 109.948 169.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -77.43 -2.18 33.98 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 112.537 0.569 . . . . 15.0 112.537 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.85 -59.37 1.75 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.271 0.628 . . . . 15.0 110.39 167.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.485 ' SD ' HG11 ' A' ' 132' ' ' VAL . 64.2 mtt -74.23 -38.0 63.65 Favored 'General case' 0 C--O 1.201 -1.493 0 CA-C-O 118.045 -0.979 . . . . 15.0 112.055 -169.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -71.2 -37.81 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 120.044 1.293 . . . . 15.0 109.804 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.486 ' NH2' ' HA ' ' A' ' 378' ' ' TYR . 5.8 tpp180 -56.58 -40.36 75.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.714 0.805 . . . . 15.0 110.939 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.12 -60.38 2.36 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.891 -0.595 . . . . 15.0 110.581 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 130' ' ' VAL . 39.8 tp -64.24 -60.47 3.16 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 125.174 1.39 . . . . 15.0 112.775 -171.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -63.06 -32.53 73.92 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.03 0.443 . . . . 15.0 110.756 -172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 48.1 t -69.82 -38.53 76.6 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.075 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.65 98.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.067 0.547 . . . . 15.0 110.734 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 1.9 mp -61.45 -51.52 71.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 O-C-N 123.593 0.558 . . . . 15.0 109.558 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.4 HH22 ' HG3' ' A' ' 409' ' ' GLU . 12.5 tpt180 -57.5 -52.23 66.24 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 123.639 0.587 . . . . 15.0 111.35 -175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -69.24 -28.7 66.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.922 0.889 . . . . 15.0 111.456 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -64.22 -57.62 8.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.814 0.445 . . . . 15.0 110.084 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 50.1 t -63.51 -35.84 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.677 0.791 . . . . 15.0 110.534 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 408' ' ' VAL . 86.6 tttt -64.05 -48.74 75.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.931 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 85.9 p -67.69 -31.1 70.83 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.182 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -70.25 -35.98 74.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.09 0.556 . . . . 15.0 110.701 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -52.43 57.76 Favored 'General case' 0 C--N 1.352 0.675 0 O-C-N 123.446 0.467 . . . . 15.0 109.929 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 HG22 ' A' ' 347' ' ' VAL . 34.0 mm -61.78 -50.25 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.847 0.717 . . . . 15.0 111.486 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.45 -35.34 80.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.802 -0.635 . . . . 15.0 109.707 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.41 -40.57 96.43 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.009 0.818 . . . . 15.0 112.474 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 350' ' ' LEU . 45.7 mt -60.76 -46.33 90.89 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.18 0.992 . . . . 15.0 111.109 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 291' ' ' ILE . 41.4 t -64.2 -48.23 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.696 0.76 . . . . 15.0 109.784 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -66.37 -24.07 66.43 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.028 -0.987 . . . . 15.0 110.685 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.09 53.25 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.859 0.863 . . . . 15.0 112.473 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.38 149.39 10.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 -169.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.41 136.37 47.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.776 -0.647 . . . . 15.0 110.314 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 346' ' ' VAL . 4.8 tp -117.8 115.91 50.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.001 0.92 . . . . 15.0 109.228 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.82 141.76 35.93 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.469 HG12 HD11 ' A' ' 307' ' ' ILE . 24.7 t -126.93 115.33 22.14 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.747 0.819 . . . . 15.0 109.633 -165.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.02 141.13 16.37 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.275 2.65 . . . . 15.0 112.974 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.497 ' HB3' ' HA2' ' A' ' 88' ' ' GLY . . . -64.55 -33.65 76.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.267 1.21 . . . . 15.0 114.267 -166.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.63 65.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.753 0.421 . . . . 15.0 111.552 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 345' ' ' VAL . 14.5 mt -88.16 -29.83 20.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.417 -0.811 . . . . 15.0 110.271 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.469 HD11 HG12 ' A' ' 302' ' ' VAL . 2.2 mp -59.39 -51.63 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 167.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.82 -57.21 11.75 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 114.438 -1.255 . . . . 15.0 110.342 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 313' ' ' VAL . 32.3 t -60.77 -56.32 22.63 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.401 1.063 . . . . 15.0 111.848 -173.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.78 -45.47 78.35 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 111.744 0.275 . . . . 15.0 111.744 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 46.7 mt -64.83 -37.02 79.12 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 N-CA-C 109.803 -0.443 . . . . 15.0 109.803 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 8.2 t70 -57.59 -46.68 83.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.694 0.797 . . . . 15.0 110.934 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' B' ' 471' ' ' LYS . 96.3 t -55.55 -52.0 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 123.837 0.711 . . . . 15.0 110.573 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 341' ' ' ALA . 84.1 mt -70.57 -21.96 62.63 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.803 -1.09 . . . . 15.0 112.3 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 329' ' ' ALA . 49.8 mtm180 -83.4 -27.89 29.28 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.125 0.57 . . . . 15.0 110.783 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 64.5 mtt180 -70.46 -42.66 71.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 172.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.18 -51.55 69.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.088 0.955 . . . . 15.0 110.502 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.46 31.11 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 115.499 -0.773 . . . . 15.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.29 74.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 123.965 0.791 . . . . 15.0 111.476 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -59.48 -36.04 75.26 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.2 0.6 . . . . 15.0 110.789 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -87.51 -19.76 27.47 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.52 0.728 . . . . 15.0 110.45 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -86.81 -5.84 58.99 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.826 1.25 . . . . 15.0 110.508 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.83 61.65 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.035 -0.53 . . . . 15.0 113.308 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.95 17.36 74.95 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 122.613 -0.345 . . . . 15.0 113.246 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.443 HD22 HD13 ' B' ' 408' ' ' LEU . 53.9 t30 -70.55 159.56 34.09 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 122.887 0.475 . . . . 15.0 109.771 174.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 76.82 -55.5 0.56 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.236 1.815 . . . . 15.0 111.354 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.494 ' HE3' ' HA2' ' B' ' 417' ' ' GLY . 48.6 mttm 65.39 21.03 11.88 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.128 1.371 . . . . 15.0 110.937 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -97.79 15.25 24.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.781 1.632 . . . . 15.0 110.083 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -50.72 -19.87 1.08 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 126.013 1.725 . . . . 15.0 114.692 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 59.1 tp -49.77 -34.96 20.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.931 0.893 . . . . 15.0 111.601 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.7 -29.3 68.52 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.937 1.695 . . . . 15.0 113.04 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 337' ' ' PHE . 53.1 mt -43.76 123.26 3.84 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 123.853 0.861 . . . . 15.0 112.556 -171.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 53.5 Cg_exo -43.03 127.8 5.15 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 124.995 3.797 . . . . 15.0 115.189 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -52.91 -48.42 67.26 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.655 1.182 . . . . 15.0 112.076 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.52 -18.79 4.75 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.332 1.053 . . . . 15.0 113.447 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 86.1 mt -74.8 -38.02 62.22 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.224 0.465 . . . . 15.0 110.878 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 332' ' ' LEU . 41.9 m-85 -120.03 -51.94 2.21 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.095 0.558 . . . . 15.0 112.241 -168.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -47.53 -40.21 18.24 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.987 1.315 . . . . 15.0 113.301 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.56 -34.9 59.92 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.279 1.032 . . . . 15.0 112.469 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -104.22 -30.78 9.95 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.154 0.982 . . . . 15.0 111.126 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.559 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -76.49 -60.63 2.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.249 1.02 . . . . 15.0 110.971 -173.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.439 ' HG3' HG11 ' A' ' 302' ' ' VAL . 88.3 tttt -62.32 -25.03 67.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.428 -0.805 . . . . 15.0 109.792 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 347' ' ' VAL . 29.5 ttt85 -71.69 -35.09 70.14 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 118.421 -0.8 . . . . 15.0 110.719 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -57.36 -43.16 83.3 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 119.243 0.929 . . . . 15.0 109.306 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 306' ' ' LEU . 41.3 t -60.73 -49.8 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 114.265 -1.334 . . . . 15.0 110.704 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.432 HG13 HG21 ' A' ' 300' ' ' ILE . 68.2 t -59.59 -48.95 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.611 0.764 . . . . 15.0 111.058 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 291' ' ' ILE . 71.6 t -52.64 -43.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.138 0.975 . . . . 15.0 110.267 173.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -70.36 -37.87 70.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 15.0 113.854 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.88 -47.2 54.45 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.267 0.627 . . . . 15.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HB3' HD13 ' A' ' 294' ' ' LEU . 76.9 mt -62.38 -57.88 9.7 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 123.998 0.811 . . . . 15.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 355' ' ' ILE . 53.2 mt -65.65 -34.45 78.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.125 0.57 . . . . 15.0 112.216 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.5 99.0 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.696 -0.562 . . . . 15.0 111.696 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.25 -37.42 85.46 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.072 -0.564 . . . . 15.0 110.687 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 350' ' ' LEU . 62.5 t -63.49 -36.28 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-N 117.956 0.343 . . . . 15.0 110.786 176.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 360' ' ' LEU . 97.1 mt -64.0 -44.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.367 0.667 . . . . 15.0 109.807 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -66.23 -56.4 11.46 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.488 -0.324 . . . . 15.0 111.361 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 77.0 m -54.48 -42.65 70.96 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.982 1.313 . . . . 15.0 111.985 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -101.19 14.65 31.31 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.155 0.582 . . . . 15.0 111.547 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 48.65 33.56 4.32 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 125.729 1.612 . . . . 15.0 114.205 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 355' ' ' ILE . 65.9 mt -72.42 157.04 38.38 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.087 0.955 . . . . 15.0 113.055 -172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 152.68 40.17 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.967 0.907 . . . . 15.0 110.415 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.69 111.62 17.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.477 0.711 . . . . 15.0 109.556 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 15.2 t70 -107.55 137.39 45.67 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.327 0.651 . . . . 15.0 110.884 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -64.48 -31.76 73.1 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.739 0.815 . . . . 15.0 113.03 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -66.08 -32.74 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 363' ' ' ASP . 10.7 tpp180 -71.75 -44.99 63.13 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 371' ' ' ILE . 94.1 t -55.56 -60.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 124.111 0.882 . . . . 15.0 109.819 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -59.48 -35.83 74.85 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.161 0.913 . . . . 15.0 111.897 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.62 -55.7 27.41 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.902 0.751 . . . . 15.0 111.816 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.04 -42.97 81.45 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.641 0.776 . . . . 15.0 111.014 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 398' ' ' MET . 51.2 mm -51.22 -60.22 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.467 1.104 . . . . 15.0 110.461 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.54 -42.87 95.45 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.755 0.659 . . . . 15.0 112.14 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.59 -44.89 93.21 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 124.017 0.823 . . . . 15.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -77.09 -35.45 56.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 119.658 -0.211 . . . . 15.0 110.668 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 378' ' ' TYR . . . -69.19 -27.09 65.2 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.482 0.713 . . . . 15.0 111.798 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.6 t -65.78 -19.64 65.96 Favored 'General case' 0 CA--C 1.558 1.264 0 O-C-N 123.916 0.76 . . . . 15.0 110.908 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -95.75 3.03 54.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.972 0.909 . . . . 15.0 111.933 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.486 ' HA ' ' NH2' ' A' ' 276' ' ' ARG . 2.8 m-85 -88.74 177.57 6.69 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.065 0.546 . . . . 15.0 109.686 172.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.29 -47.22 62.15 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.173 -0.921 . . . . 15.0 109.359 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.37 122.31 13.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.379 1.072 . . . . 15.0 109.233 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -70.69 -40.28 4.0 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.708 2.272 . . . . 15.0 114.178 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -54.32 -47.79 72.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.359 0.874 . . . . 15.0 113.359 -167.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.93 -24.68 66.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.236 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.07 -45.79 29.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 123.859 0.864 . . . . 15.0 109.164 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.04 -47.04 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.053 0.541 . . . . 15.0 109.57 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.66 -39.93 80.43 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.142 0.577 . . . . 15.0 112.36 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -63.4 -36.65 84.44 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.527 0.731 . . . . 15.0 111.08 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.453 ' HA ' HD23 ' A' ' 394' ' ' LEU . 34.8 m-85 -73.84 -62.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.922 -0.581 . . . . 15.0 110.599 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.2 p -57.6 -32.17 66.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.32 17.42 11.29 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 15.0 111.98 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.637 HD21 HG22 ' B' ' 435' ' ' THR . 56.7 t-20 -139.84 106.14 5.27 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.35 -0.982 . . . . 15.0 108.35 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -65.83 -41.2 92.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.998 0.519 . . . . 15.0 111.345 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.67 -41.97 96.13 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 123.932 0.77 . . . . 15.0 110.517 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 388' ' ' TYR . 22.5 tp -72.14 -38.92 69.12 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.691 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 93.0 mmm -66.26 -30.76 71.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.92 0.488 . . . . 15.0 110.69 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.9 -39.96 69.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.285 1.034 . . . . 15.0 109.852 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -75.43 -21.58 58.05 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.208 -0.905 . . . . 15.0 110.916 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 371' ' ' ILE . 5.8 tpt -87.69 -20.07 26.79 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.586 0.217 . . . . 15.0 111.586 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.57 -36.89 57.33 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 167.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -52.02 -61.59 2.17 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.736 -1.12 . . . . 15.0 110.343 168.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 398' ' ' MET . 9.8 p -66.32 -27.47 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 118.154 0.434 . . . . 15.0 111.685 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -58.73 -58.01 10.46 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.033 0.533 . . . . 15.0 110.355 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 24.3 tp -77.76 -23.32 49.27 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.76 -1.109 . . . . 15.0 111.582 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.52 -51.66 33.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.99 0.516 . . . . 15.0 109.625 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.28 -35.8 82.03 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.8 -0.636 . . . . 15.0 111.176 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -69.85 -33.55 72.42 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.012 0.525 . . . . 15.0 111.205 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.97 93.02 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.84 0.456 . . . . 15.0 110.303 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.5 t -58.12 -53.6 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.815 -0.63 . . . . 15.0 109.752 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.4 ' HG3' HH22 ' A' ' 283' ' ' ARG . 43.6 mt-10 -60.38 -25.6 66.01 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.987 0.915 . . . . 15.0 112.908 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.94 -30.59 62.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.783 0.433 . . . . 15.0 111.317 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 294' ' ' LEU . 43.5 t -70.67 -43.27 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 108.077 -1.082 . . . . 15.0 108.077 172.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 83.4 mt -65.23 -40.7 94.42 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.362 1.039 . . . . 15.0 111.57 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.35 -23.16 67.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.836 0.854 . . . . 15.0 111.564 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 24.4 mtpp -98.96 -27.42 13.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 15.0 111.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.966 0.907 . . . . 15.0 111.348 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 92.8 mttt -69.93 83.51 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.692 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 125' ' ' VAL . 5.0 m -93.8 91.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.033 0.921 . . . . 15.0 109.487 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.7 t -70.72 95.2 1.09 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.513 -1.221 . . . . 15.0 109.188 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 131.81 40.59 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 115.055 -0.975 . . . . 15.0 110.505 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -146.86 145.43 29.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.27 135.12 33.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.728 HG23 HG22 ' A' ' 130' ' ' VAL . 4.5 t -159.86 174.03 15.06 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.495 0.497 . . . . 15.0 110.657 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.5 p -100.61 175.34 5.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.475 1.11 . . . . 15.0 111.948 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.454 ' HD2' HD22 ' A' ' 278' ' ' LEU . 38.4 t80 -52.71 -28.06 20.33 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.578 1.551 . . . . 15.0 111.691 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.661 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 23.2 m-80 -65.12 -15.61 62.59 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.775 1.23 . . . . 15.0 112.945 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' A' ' 427' ' ' LEU . 23.4 tp10 -60.7 -37.21 80.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.582 1.153 . . . . 15.0 111.414 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 426' ' ' GLU . 4.8 mp -109.23 -77.85 0.59 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.435 -0.165 . . . . 15.0 111.192 -174.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -68.35 -50.54 52.56 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.838 0.455 . . . . 15.0 112.1 -171.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 15.9 m120 -82.84 47.88 1.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -174.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -102.09 76.02 1.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.18 -38.71 11.42 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.574 0.75 . . . . 15.0 109.437 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.017 0.927 . . . . 15.0 109.482 -176.241 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 78.4 t . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.35 120.5 13.95 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.599 HD23 ' H ' ' B' ' 367' ' ' LEU . 1.1 pt? -94.46 -70.42 0.71 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -161.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.473 ' H ' ' HG ' ' B' ' 367' ' ' LEU . 7.2 t70 -79.93 -81.22 0.12 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.014 0.825 . . . . 0.0 109.243 -169.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' B' ' 370' ' ' ALA . 1.7 pm0 -104.26 -73.19 0.68 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 160.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' B' ' 369' ' ' GLU . . . -107.25 -85.19 0.51 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 119.197 0.908 . . . . 0.0 110.426 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.582 HG13 ' H ' ' B' ' 372' ' ' GLN . 1.7 p -110.71 -78.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.582 ' H ' HG13 ' B' ' 371' ' ' VAL . 8.4 tt0 -95.13 -78.89 0.44 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.562 ' HB3' ' O ' ' B' ' 377' ' ' PHE . 26.1 tpt180 -104.83 -84.0 0.5 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 163.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' B' ' 378' ' ' ALA . . . -105.67 -78.73 0.57 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.952 0.797 . . . . 0.0 111.834 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.48 HD13 ' H ' ' B' ' 375' ' ' LEU 0.292 0.0 OUTLIER -111.65 -58.28 2.14 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.212 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.475 ' H ' HD22 ' B' ' 375' ' ' LEU . 4.8 tm-20 -102.43 -82.58 0.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' B' ' 373' ' ' ARG . 3.0 m-85 -98.73 -87.91 0.33 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 161.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' B' ' 374' ' ' ALA . . . -91.56 -84.92 0.25 Allowed 'General case' 0 C--N 1.358 0.946 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -107.48 -85.66 0.51 Allowed 'General case' 0 C--O 1.242 0.71 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 166.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.492 ' HG3' ' HA ' ' B' ' 393' ' ' ALA . 40.2 tptt 176.0 80.55 0.0 OUTLIER 'General case' 0 C--N 1.35 0.595 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -73.27 -69.52 0.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.72 -167.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 74.73 -87.98 0.74 Allowed Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.367 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -100.82 134.93 43.06 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.387 0.675 . . . . 0.0 111.233 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 55.1 m -144.99 -73.74 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 166.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.515 HD13 ' SD ' ' A' ' 194' ' ' MET . 2.3 pt? -142.88 147.8 35.95 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 157.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.6 91.78 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -164.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 168' ' ' PHE . 0.1 OUTLIER -146.37 87.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 156.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.824 ' HA ' HD11 ' A' ' 226' ' ' LEU . 9.8 p -152.5 154.69 7.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.406 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 97.8 m -64.08 128.12 34.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 160.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -41.5 112.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.17 1.388 . . . . 0.0 112.82 -167.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -149.02 146.14 27.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.358 0.663 . . . . 0.0 110.137 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -152.21 137.94 17.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.272 1.029 . . . . 0.0 109.782 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' B' ' 380' ' ' LYS . . . -77.61 148.41 35.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.113 0.965 . . . . 0.0 111.733 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -91.05 4.06 53.12 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.859 0.864 . . . . 0.0 111.101 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -54.46 107.86 0.32 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.145 0.978 . . . . 0.0 111.264 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 39.3 m 70.44 178.61 0.25 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.126 1.516 . . . . 0.0 112.373 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 64.34 -87.44 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.06 1.344 . . . . 0.0 110.516 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.523 HG13 ' H ' ' B' ' 399' ' ' VAL . 11.4 pt 32.71 -83.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 126.136 1.774 . . . . 0.0 114.128 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.523 ' H ' HG13 ' B' ' 398' ' ' ILE . 2.6 p -60.87 108.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.456 0.702 . . . . 0.0 109.234 171.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 63.23 91.39 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -164.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.57 -25.68 26.47 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.538 2.825 . . . . 0.0 113.961 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -125.04 -78.17 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 54.6 m -157.23 -42.27 0.07 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 63.93 -168.44 0.2 Allowed 'General case' 0 C--N 1.36 1.035 0 CA-C-N 113.875 -1.511 . . . . 0.0 111.045 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -74.59 113.64 26.15 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.791 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.13 149.01 74.71 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.927 2.418 . . . . 0.0 112.703 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -66.48 -20.69 70.0 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.717 0.635 . . . . 0.0 113.574 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.443 HD13 HD22 ' A' ' 325' ' ' ASN . 98.3 mt -99.3 27.39 5.21 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.82 0.848 . . . . 0.0 110.157 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 54.2 p 65.72 -60.36 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 126.759 2.024 . . . . 0.0 112.152 -171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.52 -167.07 1.35 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.496 1.119 . . . . 0.0 109.571 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.39 -17.53 60.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.539 0.735 . . . . 0.0 111.321 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 25.9 tp 72.53 159.18 0.21 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.732 1.613 . . . . 0.0 111.521 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.26 -74.94 0.09 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.348 0.659 . . . . 0.0 110.321 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 48.3 m -162.19 -60.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.951 0.9 . . . . 0.0 109.054 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.05 94.1 0.07 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.947 1.299 . . . . 0.0 110.591 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -54.19 -57.96 9.18 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.189 1.796 . . . . 0.0 113.355 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . 0.494 ' HA2' ' HE3' ' A' ' 327' ' ' LYS . . . -168.1 -64.98 0.03 OUTLIER Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.044 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 59.04 -150.22 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.934 0.894 . . . . 0.0 111.147 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.488 HG13 ' H ' ' B' ' 420' ' ' MET 0.281 7.2 p 47.58 -78.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 126.762 2.025 . . . . 0.0 114.948 177.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.488 ' H ' HG13 ' B' ' 419' ' ' VAL . 12.5 tmm? -156.38 106.82 2.38 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 422' ' ' MET . 0.5 OUTLIER 59.91 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.38 1.872 . . . . 0.0 112.948 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.41 ' H ' HG22 ' B' ' 421' ' ' VAL . 13.5 ttt 63.69 33.48 13.0 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.999 1.32 . . . . 0.0 111.286 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -4.43 41.85 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.511 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -104.8 120.16 40.72 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 168.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.42 58.86 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.536 0.522 . . . . 0.0 112.823 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' B' ' 429' ' ' GLU . 65.7 t30 59.7 20.73 9.43 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.889 1.276 . . . . 0.0 111.31 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 65.5 p -78.42 173.35 12.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.64 0.776 . . . . 0.0 111.335 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 63.94 8.0 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.925 1.29 . . . . 0.0 112.379 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' B' ' 432' ' ' GLN . 3.5 tm-20 -70.0 -32.14 70.17 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.47 1.108 . . . . 0.0 110.027 -171.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -55.5 -40.14 71.37 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.453 1.101 . . . . 0.0 110.905 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 22.7 t -101.13 -7.5 23.11 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.204 -169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.42 ' HG2' ' HA ' ' B' ' 429' ' ' GLU . 29.4 mm-40 -56.92 -56.01 27.16 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.2 0.455 . . . . 0.0 110.995 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.31 111.85 20.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -88.14 48.95 1.71 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.742 0.817 . . . . 0.0 111.414 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.637 HG22 HD21 ' A' ' 391' ' ' ASN . 19.8 m -66.71 -24.72 66.28 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.15 0.98 . . . . 0.0 110.998 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -137.44 -179.19 16.63 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 38.6 t 62.1 -90.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.863 1.265 . . . . 0.0 111.915 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 61.21 36.48 17.94 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.152 0.981 . . . . 0.0 110.022 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 99.0 mt 64.2 18.33 11.21 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.179 1.392 . . . . 0.0 112.337 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.673 ' HG3' HG12 ' B' ' 441' ' ' ILE . 35.3 ptt180 -151.9 -159.81 1.07 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.665 1.186 . . . . 0.0 108.175 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.673 HG12 ' HG3' ' B' ' 440' ' ' ARG . 34.0 mm 68.55 110.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.78 0.832 . . . . 0.0 112.066 168.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.73 92.47 1.2 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -142.93 167.3 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.63 0.728 . . . . 0.0 112.183 -169.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . 0.482 ' HB3' HD11 ' B' ' 470' ' ' LEU . 97.3 m-85 -121.3 169.77 10.26 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.306 174.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -125.46 156.2 19.16 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -89.52 156.08 5.33 Favored 'Trans proline' 0 CA--C 1.555 1.57 0 C-N-CA 122.569 2.179 . . . . 0.0 113.109 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -137.58 75.88 1.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 62.86 21.27 12.73 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.997 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -83.88 -34.65 24.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.332 0.653 . . . . 0.0 111.719 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.89 4.17 2.78 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.683 0.793 . . . . 0.0 112.21 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.15 -19.73 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 123.485 0.714 . . . . 0.0 110.759 168.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 14.0 p -62.46 -35.83 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.562 1.145 . . . . 0.0 110.928 173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.4 -73.63 2.01 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.004 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -168.86 -34.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.461 1.504 . . . . 0.0 107.237 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 72.4 p 57.83 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.946 2.098 . . . . 0.0 112.219 -172.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.6 138.28 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.336 1.454 . . . . 0.0 111.953 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 73.25 -19.15 0.34 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 124.635 1.174 . . . . 0.0 113.038 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 35.2 p -65.84 -59.28 4.03 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.511 1.124 . . . . 0.0 111.802 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -173.52 -63.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.764 1.226 . . . . 0.0 107.752 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.76 126.35 47.31 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -66.28 -72.45 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.23 0.612 . . . . 0.0 109.561 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -166.69 -128.96 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.342 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' B' ' 464' ' ' MET . 53.3 m 79.62 152.33 0.12 Allowed 'General case' 0 C--N 1.366 1.326 0 C-N-CA 124.597 1.159 . . . . 0.0 110.413 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' B' ' 463' ' ' THR . 2.7 ptp 75.35 -47.95 0.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.248 2.619 . . . . 0.0 111.242 -173.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 70.72 -30.38 0.2 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.908 1.683 . . . . 0.0 112.943 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.36 -11.51 4.39 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 124.491 1.116 . . . . 0.0 112.649 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.37 -19.56 56.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.437 1.095 . . . . 0.0 112.37 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 16.3 mt -152.96 -2.73 0.23 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.017 0.927 . . . . 0.0 112.662 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.95 97.67 0.14 Allowed Glycine 0 C--N 1.355 1.609 0 N-CA-C 115.115 0.806 . . . . 0.0 115.115 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' B' ' 444' ' ' TYR . 51.7 tp -106.96 152.33 24.1 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.592 ' HA ' HG11 ' A' ' 313' ' ' VAL . 3.5 tmmm? . . . . . 0 C--O 1.249 1.031 0 N-CA-C 107.711 -1.218 . . . . 12.06 107.711 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.135 -0.691 . . . . 15.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.37 116.09 16.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.763 . . . . 15.0 109.039 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.68 161.57 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.053 0.454 . . . . 15.0 111.224 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 16' ' ' THR . 9.4 p -152.92 103.45 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.111 -0.95 . . . . 15.0 109.137 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.79 107.3 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 121.646 0.736 . . . . 15.0 110.233 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.2 100.54 10.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.323 1.049 . . . . 15.0 109.375 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.5 m -69.19 97.66 0.94 Allowed 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.676 -0.861 . . . . 15.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.7 p -75.6 -61.35 1.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.912 0.885 . . . . 15.0 111.402 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -149.46 103.99 3.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.663 -0.495 . . . . 15.0 109.663 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.02 -108.02 1.95 Allowed Glycine 0 C--N 1.353 1.521 0 O-C-N 124.018 0.824 . . . . 15.0 113.644 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.26 -29.64 61.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 15.0 110.682 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 119.35 12.41 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 124.164 0.915 . . . . 15.0 112.968 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HD2' HG11 ' A' ' 111' ' ' VAL . 64.6 mtt85 -133.39 118.95 19.04 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.527 1.131 . . . . 15.0 109.515 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 37.5 ttm180 -89.94 96.74 10.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.001 1.32 . . . . 15.0 110.248 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG11 ' HB1' ' A' ' 78' ' ' ALA . 41.0 t -89.11 88.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.558 -0.905 . . . . 15.0 108.558 173.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 31.5 m -77.65 114.26 16.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.087 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.3 mt -105.08 112.95 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.752 0.821 . . . . 15.0 109.19 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 87.3 m -94.62 105.07 17.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.547 0.739 . . . . 15.0 109.885 174.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 23' ' ' SER . 60.8 mt -91.47 101.25 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.9 0.88 . . . . 15.0 109.53 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.8 173.6 9.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.151 0.58 . . . . 15.0 111.365 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.12 59.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.385 1.474 . . . . 15.0 113.798 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.11 -32.34 73.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.64 0.776 . . . . 15.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 19' ' ' ILE . 50.1 m -92.03 -29.62 16.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.991 0.516 . . . . 15.0 111.473 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.7 mt -59.49 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.575 -0.898 . . . . 15.0 108.575 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.72 78.88 5.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.947 0.879 . . . . 15.0 109.374 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.4 m -158.72 -55.99 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.612 -1.995 . . . . 15.0 105.612 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.97 70.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.331 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 66' ' ' VAL . 89.1 t -58.29 -62.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 123.945 0.778 . . . . 15.0 110.125 173.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -63.51 -39.83 95.46 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.736 -1.12 . . . . 15.0 111.86 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.3 m -68.66 -25.34 64.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.622 -0.717 . . . . 15.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -80.57 -43.25 20.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.7 0.286 . . . . 15.0 110.239 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.771 HD21 HG11 ' A' ' 62' ' ' VAL . 68.4 mt -74.15 -18.74 60.74 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.928 0.714 . . . . 15.0 112.928 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 p -76.71 -31.98 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 171.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -67.89 -49.03 64.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.342 0.657 . . . . 15.0 109.517 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.5 -33.64 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.288 1.035 . . . . 15.0 110.538 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.5 -54.12 50.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.994 0.518 . . . . 15.0 110.908 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.65 -42.54 86.49 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.291 0.636 . . . . 15.0 111.641 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -66.88 -51.84 50.59 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.643 1.177 . . . . 15.0 111.52 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -90.84 2.71 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.515 0.726 . . . . 15.0 110.407 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 71.11 17.28 6.14 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.265 1.426 . . . . 15.0 112.736 173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 48.3 mt -66.57 -25.09 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.55 1.14 . . . . 15.0 110.771 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 -33.47 73.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.945 0.898 . . . . 15.0 111.201 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.91 -30.55 74.33 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.861 0.725 . . . . 15.0 112.855 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.5 m-85 -80.51 -24.79 39.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.358 0.663 . . . . 15.0 110.444 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -71.31 105.38 3.47 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.73 -0.668 . . . . 15.0 109.983 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.77 6.54 45.44 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.151 0.981 . . . . 15.0 110.774 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.56 21.79 68.56 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.211 0.319 . . . . 15.0 112.588 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -69.02 -49.06 61.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.087 0.955 . . . . 15.0 110.092 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.01 127.84 30.02 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 115.0 -1.0 . . . . 15.0 108.644 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.67 144.91 51.23 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.202 2.601 . . . . 15.0 113.337 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.58 -29.02 68.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.865 0.866 . . . . 15.0 112.351 -170.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -67.35 -38.94 85.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.648 0.379 . . . . 15.0 110.85 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.742 HG23 ' HD2' ' A' ' 57' ' ' ARG . 61.4 mt -73.28 -32.61 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.959 0.904 . . . . 15.0 111.202 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 15.8 m -75.3 -20.1 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.922 -0.486 . . . . 15.0 111.358 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -86.9 -62.97 1.39 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.255 0.622 . . . . 15.0 111.438 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.82 -41.49 26.3 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.742 ' HD2' HG23 ' A' ' 53' ' ' ILE . 95.2 mtt180 -86.78 -63.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.814 0.446 . . . . 15.0 110.648 -173.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' ' HA ' ' A' ' 54' ' ' VAL . 40.3 m-85 -75.73 -21.57 57.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.092 0.557 . . . . 15.0 111.803 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.38 25.51 12.61 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.432 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.55 -28.41 69.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.354 0.662 . . . . 15.0 112.581 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 m -77.45 -8.13 57.27 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.617 0.767 . . . . 15.0 112.61 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.771 HG11 HD21 ' A' ' 32' ' ' LEU . 2.7 p -119.36 86.58 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 122.537 1.16 . . . . 15.0 109.814 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 4.5 mmp_? -115.66 -47.98 2.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.567 -1.197 . . . . 15.0 108.959 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.88 -50.0 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.996 1.318 . . . . 15.0 111.993 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.03 -35.61 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.991 0.916 . . . . 15.0 111.151 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 28' ' ' VAL . 96.3 t -66.79 -38.28 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 114.813 -1.085 . . . . 15.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 HD21 ' CZ ' ' A' ' 97' ' ' TYR . 57.8 mt -62.0 -27.56 68.95 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.595 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.01 86.74 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.567 0.542 . . . . 15.0 112.507 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.68 -47.54 83.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.733 0.813 . . . . 15.0 110.943 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.94 -57.38 13.04 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.377 -1.283 . . . . 15.0 111.547 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 71.6 mtm -69.98 -30.49 67.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.5 0.72 . . . . 15.0 112.288 -174.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 t -68.62 -51.31 43.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.002 0.521 . . . . 15.0 111.06 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.692 -0.686 . . . . 15.0 110.456 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.03 -26.45 64.04 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.538 0.524 . . . . 15.0 112.153 -171.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -63.05 -59.31 4.97 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.469 0.308 . . . . 15.0 110.517 173.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.86 -25.61 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.936 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.87 -58.32 7.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.289 0.636 . . . . 15.0 109.384 171.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HB1' HG11 ' A' ' 15' ' ' VAL . . . -59.74 -53.87 52.98 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.052 -0.976 . . . . 15.0 112.077 -171.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.451 HD12 ' HG3' ' A' ' 86' ' ' PRO . 30.1 pt -58.79 -35.11 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.792 0.664 . . . . 15.0 112.792 -172.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.6 -42.35 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.086 0.554 . . . . 15.0 111.028 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -73.74 -31.9 63.59 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.242 0.217 . . . . 15.0 111.226 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -79.09 -0.96 33.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.683 0.793 . . . . 15.0 110.951 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 67.58 12.34 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.134 1.373 . . . . 15.0 112.432 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -78.26 118.69 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.653 0.781 . . . . 15.0 109.349 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -87.86 96.67 0.64 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HG3' HD12 ' A' ' 79' ' ' ILE . 55.2 Cg_endo -87.3 145.79 7.26 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.086 2.524 . . . . 15.0 114.164 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.3 46.98 0.82 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.945 0.898 . . . . 15.0 109.079 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 110' ' ' GLU . . . -144.24 153.68 25.22 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.443 -0.798 . . . . 15.0 112.088 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 113.0 12.65 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.798 0.839 . . . . 15.0 109.785 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.26 106.97 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.953 1.769 . . . . 15.0 111.334 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -88.27 92.8 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.934 -0.765 . . . . 15.0 108.934 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -74.76 111.73 10.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.18 0.592 . . . . 15.0 109.508 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.38 93.62 27.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.173 0.989 . . . . 15.0 108.797 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.69 91.65 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.911 2.407 . . . . 15.0 111.951 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.24 -27.15 70.16 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.456 -0.793 . . . . 15.0 113.121 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB2' ' HE3' ' A' ' 98' ' ' LYS . 14.7 pt-20 -165.47 161.58 18.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.503 0.721 . . . . 15.0 110.456 172.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 13.8 t80 -157.22 108.35 2.33 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.685 -1.228 . . . . 15.0 107.685 168.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -125.7 130.01 50.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.163 0.985 . . . . 15.0 108.423 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 tp -67.16 104.8 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.693 0.621 . . . . 15.0 109.484 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.74 12.24 44.47 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.602 -0.554 . . . . 15.0 113.467 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.0 mt-10 -130.09 -97.43 0.35 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 118.738 -0.649 . . . . 15.0 109.841 172.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -140.93 160.05 40.9 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.274 0.943 . . . . 15.0 112.105 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -131.8 74.5 1.59 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.437 1.495 . . . . 15.0 107.058 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.481 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 43.1 m -80.66 124.54 29.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.8 -1.091 . . . . 15.0 109.319 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -143.82 129.54 19.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.921 0.488 . . . . 15.0 109.871 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 70.2 m -84.89 120.02 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.172 0.989 . . . . 15.0 110.423 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.7 94.3 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.364 -0.976 . . . . 15.0 108.364 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -99.27 113.37 25.61 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.41 0.684 . . . . 15.0 110.505 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -142.66 162.74 34.69 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.205 0.602 . . . . 15.0 110.504 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 36.1 mt-10 -85.41 167.33 15.62 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.192 -0.913 . . . . 15.0 110.116 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 13' ' ' ARG . 33.5 m -127.67 170.09 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.484 0.714 . . . . 15.0 110.726 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -75.22 113.49 25.99 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.532 -0.914 . . . . 15.0 108.532 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.35 161.84 19.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.064 1.843 . . . . 15.0 110.848 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -70.27 111.51 5.93 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.171 -0.677 . . . . 15.0 109.171 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 300' ' ' ILE . 4.8 p -71.1 124.83 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.862 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.33 122.8 43.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.48 -0.782 . . . . 15.0 110.79 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 91.3 mt -93.71 133.77 36.73 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.597 -0.89 . . . . 15.0 108.597 163.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -137.82 112.53 8.9 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.552 0.741 . . . . 15.0 109.063 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.96 63.79 4.32 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.747 0.654 . . . . 15.0 114.239 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 29.2 mt -70.79 -30.6 67.1 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.144 0.497 . . . . 15.0 110.346 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -72.3 -23.04 61.11 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.654 1.182 . . . . 15.0 111.212 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.8 43.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.232 0.613 . . . . 15.0 111.503 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.412 HG23 ' HA3' ' A' ' 293' ' ' GLY . 67.6 mt -65.79 123.59 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.717 0.807 . . . . 15.0 109.982 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -105.89 109.57 21.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.052 0.541 . . . . 15.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 289' ' ' GLN . 59.1 t -109.02 154.02 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.866 1.266 . . . . 15.0 107.714 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 286' ' ' VAL . 42.7 tt0 -103.36 142.66 33.83 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 119.24 0.927 . . . . 15.0 109.973 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 417' ' ' VAL . 82.5 tttt -123.56 87.36 52.23 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.941 0.897 . . . . 15.0 109.083 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 282' ' ' ILE . 6.7 Cg_exo -72.66 97.5 0.89 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.884 1.723 . . . . 15.0 111.554 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.549 HD11 ' HE2' ' A' ' 127' ' ' LYS . 40.2 mm -69.25 92.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.768 -1.197 . . . . 15.0 107.768 166.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 427' ' ' LEU . 37.5 t -116.04 142.55 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.487 -0.779 . . . . 15.0 110.128 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.39 159.23 32.36 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.242 -1.345 . . . . 15.0 108.578 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.93 86.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' VAL . 43.6 p -64.4 174.89 1.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.701 0.8 . . . . 15.0 110.317 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.73 -33.02 72.28 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 120.95 0.405 . . . . 15.0 110.853 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.41 83.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.281 -0.872 . . . . 15.0 110.979 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 424' ' ' PHE . 69.2 m-20 -74.59 -41.64 60.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.884 0.474 . . . . 15.0 111.195 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 133' ' ' THR . 82.4 t -61.79 -61.03 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.769 0 N-CA-C 108.411 -0.959 . . . . 15.0 108.411 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.65 -33.84 73.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.856 0.722 . . . . 15.0 111.359 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.53 Favored Glycine 0 N--CA 1.478 1.476 0 O-C-N 123.62 0.575 . . . . 15.0 113.676 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.411 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 12.1 tpt -68.57 -46.36 69.6 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.069 0.548 . . . . 15.0 110.082 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 78.4 mt -58.07 -31.96 67.57 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.14 0.576 . . . . 15.0 111.748 172.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.56 -41.48 72.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.34 1.056 . . . . 15.0 110.216 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 86.0 m -58.2 -44.09 87.91 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.07 0.856 . . . . 15.0 109.71 173.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 141' ' ' LEU . 89.9 mt -63.65 -40.93 98.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.918 0.887 . . . . 15.0 111.208 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 39.0 mtm-85 -64.51 -31.5 72.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.325 0.65 . . . . 15.0 110.157 176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.2 mttt -87.32 -15.9 36.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.235 0.614 . . . . 15.0 112.443 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 143' ' ' THR . 97.5 mt-30 -78.17 -30.42 49.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.642 -0.503 . . . . 15.0 109.642 167.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.45 36.54 2.78 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.102 0.961 . . . . 15.0 110.538 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -76.19 152.82 36.52 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.629 0.974 . . . . 15.0 113.629 -172.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.5 m -81.75 122.18 27.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.616 -1.175 . . . . 15.0 110.027 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 26.5 m95 -80.8 125.28 29.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.752 -0.833 . . . . 15.0 108.752 173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 152' ' ' LYS . 28.9 ttpt -158.83 128.32 5.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.914 -0.773 . . . . 15.0 108.914 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.629 ' HG2' ' HG2' ' A' ' 241' ' ' GLU . 43.4 mt-10 -77.26 134.39 38.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.885 0.374 . . . . 15.0 111.184 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 34.0 pttt -120.74 179.99 4.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.574 1.15 . . . . 15.0 109.816 169.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -142.92 152.91 42.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.566 0.746 . . . . 15.0 109.296 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -49.77 0.88 Allowed Glycine 0 N--CA 1.465 0.581 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.339 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.63 160.71 43.17 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.356 0.578 . . . . 15.0 111.417 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.5 t -116.79 134.39 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.347 1.059 . . . . 15.0 108.821 173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -107.21 -179.58 3.97 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.31 1.044 . . . . 15.0 109.878 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.4 1.67 28.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.407 0.891 . . . . 15.0 113.407 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.27 40.83 3.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.227 0.537 . . . . 15.0 110.349 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -122.27 -170.52 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.045 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.771 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 15.2 mtm180 -119.94 124.07 45.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 171.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.61 100.11 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.784 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 12.5 m -83.31 110.02 17.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.13 -1.063 . . . . 15.0 108.13 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 237' ' ' LEU . 33.6 pt -132.79 164.48 35.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.288 1.035 . . . . 15.0 110.4 -172.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -111.47 126.69 55.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.526 -1.657 . . . . 15.0 106.526 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -135.85 150.01 49.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.52 0.676 . . . . 15.0 111.281 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.1 t -139.16 123.78 18.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.147 -1.427 . . . . 15.0 107.147 165.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -113.53 166.66 12.17 Favored Glycine 0 C--O 1.241 0.585 0 CA-C-N 115.97 -0.559 . . . . 15.0 113.065 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -145.1 134.93 23.6 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.308 0.643 . . . . 15.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 226' ' ' LEU . 61.6 t -118.54 137.89 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 171.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 29.2 t70 68.66 16.35 9.01 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.982 0.896 . . . . 15.0 110.889 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.77 1.98 76.21 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 115.781 -0.645 . . . . 15.0 113.946 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -136.98 163.12 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.509 0.724 . . . . 15.0 110.654 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.24 165.5 22.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.23 0.612 . . . . 15.0 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.83 -159.78 0.97 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.405 1.082 . . . . 15.0 110.186 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -58.72 118.28 5.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.459 0.703 . . . . 15.0 111.635 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.461 ' HA3' ' HB ' ' B' ' 386' ' ' VAL . . . 85.15 -57.12 4.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.941 -1.027 . . . . 15.0 111.827 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.12 -60.37 4.78 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.384 -0.286 . . . . 15.0 112.384 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -116.36 150.92 36.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.611 0.764 . . . . 15.0 111.801 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -153.91 93.1 1.61 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.801 -1.09 . . . . 15.0 108.87 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.2 m -73.69 137.94 44.39 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.682 -1.144 . . . . 15.0 110.172 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' B' ' 380' ' ' LYS . 2.9 m-20 60.67 29.21 18.85 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.703 0.801 . . . . 15.0 113.018 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.84 132.77 49.48 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.144 0.577 . . . . 15.0 110.292 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.8 t -97.96 113.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.641 -0.874 . . . . 15.0 108.641 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 202' ' ' ILE . 12.5 tp -97.54 89.0 4.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.692 0.397 . . . . 15.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.22 86.36 1.08 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 15.0 109.543 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 203' ' ' LYS . 0.8 OUTLIER -51.78 132.09 31.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.012 0.925 . . . . 15.0 110.878 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.0 49.78 1.86 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.213 -0.755 . . . . 15.0 111.213 -168.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.7 150.43 48.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.628 0.771 . . . . 15.0 111.082 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.36 56.32 3.91 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.589 -0.732 . . . . 15.0 113.046 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -136.7 1.89 2.6 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.95 0.9 . . . . 15.0 109.672 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 187' ' ' LEU . 33.1 mmt -94.09 154.25 17.71 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.87 0.868 . . . . 15.0 111.107 -173.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.76 143.3 46.1 Favored Pre-proline 0 C--O 1.248 0.991 0 CA-C-N 114.887 -1.051 . . . . 15.0 108.438 172.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.65 109.79 0.47 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.796 2.331 . . . . 15.0 111.226 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 134.01 -44.26 1.2 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.798 -178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 202' ' ' ILE . 86.4 t80 -73.09 -62.25 1.53 Allowed 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -59.39 -32.93 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.259 -1.337 . . . . 15.0 111.984 -176.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.546 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 14.8 t70 -71.02 -31.94 68.57 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.665 0.786 . . . . 15.0 110.835 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -5.53 89.21 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.836 0.71 . . . . 15.0 113.134 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 187' ' ' LEU . 31.6 mm -104.54 -51.07 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.399 0.68 . . . . 15.0 110.947 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 200' ' ' ASP . 58.5 pttt -76.88 6.35 6.34 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.475 1.11 . . . . 15.0 113.817 -163.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -131.87 27.32 3.69 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.507 -1.037 . . . . 15.0 110.507 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -125.08 -161.6 1.04 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.357 1.063 . . . . 15.0 110.361 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -154.85 153.28 30.9 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.516 0.727 . . . . 15.0 110.894 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 240' ' ' VAL . . . -69.81 120.25 15.27 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.886 0.474 . . . . 15.0 111.392 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.69 -35.04 2.2 Favored Glycine 0 C--N 1.334 0.455 0 O-C-N 124.237 0.961 . . . . 15.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.72 126.21 32.66 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.442 -0.577 . . . . 15.0 109.442 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.0 123.82 48.73 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.08 -1.082 . . . . 15.0 108.08 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -145.08 178.04 8.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.333 1.053 . . . . 15.0 110.612 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.2 m -130.93 130.97 44.15 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.529 -1.286 . . . . 15.0 107.529 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 39.1 pt -104.06 160.48 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.378 0.671 . . . . 15.0 109.942 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.11 106.05 13.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 15.0 109.549 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.41 166.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.416 -1.327 . . . . 15.0 107.416 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 65.9 m -147.02 135.33 21.73 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.053 -1.092 . . . . 15.0 108.053 172.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.536 ' HZ ' HD11 ' B' ' 387' ' ' ILE . 95.5 m-85 -86.23 142.39 35.73 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 109.874 -0.417 . . . . 15.0 109.874 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.3 154.49 46.37 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.493 2.129 . . . . 15.0 111.834 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.14 -17.64 60.37 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.061 167.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.56 -24.5 61.93 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.294 1.438 . . . . 15.0 111.235 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.467 ' HE2' ' HB3' ' A' ' 223' ' ' ALA . 79.7 t80 -61.96 147.0 48.36 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.029 0.931 . . . . 15.0 111.238 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -71.12 -61.74 1.65 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.769 0.828 . . . . 15.0 113.109 -166.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.467 ' HB3' ' HE2' ' A' ' 221' ' ' TYR . . . -63.98 113.94 3.8 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.011 0.524 . . . . 15.0 110.356 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 227' ' ' LYS . 42.7 tt0 -65.02 -36.66 85.11 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.819 0.848 . . . . 15.0 112.652 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -64.46 -27.89 69.3 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.079 0.551 . . . . 15.0 111.429 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.558 ' HA ' HG11 ' A' ' 172' ' ' VAL . 81.7 mt -90.33 -40.51 12.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.848 0.859 . . . . 15.0 110.315 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 224' ' ' GLU . 14.6 ttmm -47.89 128.62 13.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.631 1.972 . . . . 15.0 113.001 -171.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.9 -31.44 3.66 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.379 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -98.04 163.73 12.64 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.636 0.774 . . . . 15.0 112.123 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -88.75 144.58 26.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.895 -1.048 . . . . 15.0 111.522 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -117.98 108.38 15.2 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.178 0.991 . . . . 15.0 109.837 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.12 101.04 12.52 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.24 0.616 . . . . 15.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -96.18 120.47 36.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.878 0.871 . . . . 15.0 109.752 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.24 98.55 9.45 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.96 -0.756 . . . . 15.0 108.96 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.1 mm -88.26 133.6 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.081 0.952 . . . . 15.0 110.611 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.81 95.15 4.71 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.456 -1.313 . . . . 15.0 107.456 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.551 ' HA ' HG22 ' A' ' 166' ' ' ILE . 0.4 OUTLIER -78.06 97.36 5.38 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 -173.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -96.58 -38.63 9.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.633 0.373 . . . . 15.0 111.475 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.784 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 74.4 mmtt -131.63 148.73 52.63 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.095 0.558 . . . . 15.0 110.775 -176.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 207' ' ' ALA . 21.2 t -121.44 99.0 6.5 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 165.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 34.1 mt-10 -83.14 169.23 16.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.277 -1.009 . . . . 15.0 108.277 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 38.9 tt0 -140.24 139.76 35.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.725 0.41 . . . . 15.0 110.278 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.468 HH12 ' HD3' ' A' ' 146' ' ' LYS . 26.3 ptt85 -98.97 83.89 2.98 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.083 -1.08 . . . . 15.0 108.083 164.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.1 154.36 31.37 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.829 -1.078 . . . . 15.0 109.681 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.404 HD21 ' HE3' ' A' ' 146' ' ' LYS . 97.5 mt -59.12 133.25 87.57 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 122.715 0.406 . . . . 15.0 110.022 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 145' ' ' ARG . 95.5 Cg_endo -77.71 -179.23 5.24 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.642 2.228 . . . . 15.0 111.351 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.489 ' HB3' HG23 ' A' ' 249' ' ' THR . 47.1 mt-10 -70.56 116.73 11.22 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.516 -0.765 . . . . 15.0 108.964 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 27.8 tp -85.82 43.81 1.07 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.046 0.927 . . . . 15.0 108.992 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.489 HG23 ' HB3' ' A' ' 247' ' ' GLU . 25.5 p -76.23 166.65 23.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.054 1.342 . . . . 15.0 110.174 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.6 -45.74 13.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.701 1.2 . . . . 15.0 113.063 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.01 -31.85 71.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.545 0.738 . . . . 15.0 112.592 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -81.57 -49.77 10.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.048 0.539 . . . . 15.0 110.379 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.689 HG13 HD22 ' A' ' 266' ' ' LEU . 12.8 tt -65.16 -29.54 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 122.974 0.51 . . . . 15.0 111.249 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 18.0 ptmt -78.58 -17.12 56.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 111.944 0.35 . . . . 15.0 111.944 174.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -70.14 -19.32 63.22 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.113 0.565 . . . . 15.0 110.675 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -71.43 -17.86 62.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.251 0.62 . . . . 15.0 111.152 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 146.05 -24.44 1.76 Allowed Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.417 -0.657 . . . . 15.0 113.184 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 10.8 t -54.91 144.46 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.185 0.994 . . . . 15.0 111.394 -172.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.79 -46.96 50.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.563 0.745 . . . . 15.0 111.001 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -106.22 -43.82 4.71 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.545 0.738 . . . . 15.0 110.587 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 112.35 24.85 4.9 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.892 -0.393 . . . . 15.0 113.1 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.1 p -71.96 144.3 48.94 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 117.471 0.635 . . . . 15.0 109.776 172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 253' ' ' ILE . 60.9 t -59.37 -48.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.219 0.608 . . . . 15.0 110.165 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -58.71 -25.11 62.57 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.506 1.123 . . . . 15.0 112.237 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.29 -27.68 54.8 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.077 -0.809 . . . . 15.0 111.077 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.689 HD22 HG13 ' A' ' 253' ' ' ILE . 60.6 tp -76.28 -30.09 57.66 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.009 -0.737 . . . . 15.0 109.009 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.442 ' HA ' HG22 ' A' ' 270' ' ' VAL . 73.5 mtp180 -67.48 -37.41 82.83 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 175.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.61 93.82 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.76 . . . . 15.0 110.892 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -66.72 -40.83 88.55 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.349 -0.841 . . . . 15.0 111.314 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 267' ' ' ARG . 19.3 m -81.56 -19.62 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.592 0.357 . . . . 15.0 110.512 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt85 -59.79 -66.16 0.56 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.71 -0.848 . . . . 15.0 108.71 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -59.28 -44.17 92.49 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.483 0.49 . . . . 15.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -74.06 -42.06 60.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.26 -13.28 55.58 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.532 0.605 . . . . 15.0 111.432 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.89 -47.01 49.59 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.096 0.862 . . . . 15.0 108.707 162.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.588 ' HB2' ' HB1' ' A' ' 377' ' ' ALA . 74.8 ttt180 -60.41 -27.51 67.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.489 1.516 . . . . 15.0 111.904 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -91.78 -59.72 2.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.826 0.45 . . . . 15.0 110.199 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.426 HD11 HG11 ' A' ' 130' ' ' VAL . 62.7 tp -67.85 -57.58 6.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.358 0.503 . . . . 15.0 112.358 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.74 -27.66 67.79 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.196 0.31 . . . . 15.0 110.185 -172.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 43.3 t -66.63 -50.1 64.11 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.519 -0.764 . . . . 15.0 109.82 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.82 -38.41 88.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.786 0.834 . . . . 15.0 111.94 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' A' ' 130' ' ' VAL . 89.7 mt -64.14 -50.32 77.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 C-N-CA 123.947 0.899 . . . . 15.0 108.823 175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.369 0.668 . . . . 15.0 110.776 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -68.52 -45.53 71.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.992 -0.744 . . . . 15.0 108.992 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -57.69 -54.85 42.18 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.04 0.838 . . . . 15.0 110.599 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 282' ' ' ILE . 59.1 t -60.63 -52.96 55.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.113 -0.949 . . . . 15.0 110.725 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.29 -39.84 93.07 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.539 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 94.6 p -64.3 -43.83 93.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 119.47 -0.3 . . . . 15.0 110.588 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.441 ' HB2' HG13 ' A' ' 125' ' ' VAL . 57.0 mt-30 -68.01 -33.88 75.44 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.96 0.788 . . . . 15.0 111.832 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.4 -55.1 27.11 Favored 'General case' 0 C--N 1.35 0.597 0 O-C-N 123.511 0.507 . . . . 15.0 109.865 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 295' ' ' VAL . 25.7 mm -61.65 -44.03 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.067 0.947 . . . . 15.0 111.774 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.24 -48.0 80.06 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.382 0.61 . . . . 15.0 109.491 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.8 -40.85 99.74 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 114.038 -1.437 . . . . 15.0 112.246 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.518 ' HB3' HD13 ' A' ' 350' ' ' LEU . 18.8 mt -55.7 -60.14 3.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.237 1.015 . . . . 15.0 110.987 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 291' ' ' ILE . 40.6 t -56.07 -51.45 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 124.039 0.837 . . . . 15.0 109.638 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -64.27 -26.84 68.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.638 0.775 . . . . 15.0 112.138 -176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -76.67 -24.77 53.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.564 0.579 . . . . 15.0 112.564 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.0 164.62 29.77 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 113.516 0.932 . . . . 15.0 113.516 -168.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -105.6 133.66 49.98 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.036 -0.984 . . . . 15.0 109.835 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.1 tp -155.77 116.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.695 0.798 . . . . 15.0 108.96 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.36 94.76 9.87 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.614 -0.884 . . . . 15.0 108.614 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.694 HG21 HG22 ' A' ' 346' ' ' VAL . 19.0 t -79.93 127.33 77.64 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 114.466 -1.243 . . . . 15.0 110.513 -168.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.77 124.11 12.29 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.138 2.559 . . . . 15.0 112.896 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.75 -20.05 54.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.142 1.377 . . . . 15.0 114.196 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.17 94.7 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.947 0.499 . . . . 15.0 111.588 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.74 -35.39 80.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.635 0.774 . . . . 15.0 110.86 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 304' ' ' ALA . 2.7 mp -65.78 -53.28 40.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.501 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.22 -33.52 74.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.461 0.704 . . . . 15.0 111.14 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 39.6 t -58.07 -58.39 8.62 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 124.027 0.829 . . . . 15.0 110.607 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.414 ' HA ' HG23 ' A' ' 313' ' ' VAL . 17.4 mm-40 -77.02 -18.96 57.81 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.1 -42.84 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 167.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.736 ' HA ' ' HD2' ' A' ' 315' ' ' ARG . 15.1 t70 -59.04 -39.25 81.41 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 123.958 0.786 . . . . 15.0 111.349 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' B' ' 447' ' ' HIS . 23.4 t -58.33 -51.85 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 121.19 0.519 . . . . 15.0 110.819 172.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 341' ' ' ALA . 76.0 mt -68.71 -21.39 64.41 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.46 -0.791 . . . . 15.0 112.093 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.736 ' HD2' ' HA ' ' A' ' 312' ' ' ASP . 77.0 mtt180 -69.97 -44.82 68.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.168 0.987 . . . . 15.0 108.86 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -66.8 -35.62 80.48 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.815 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -62.13 -41.2 98.03 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.436 0.695 . . . . 15.0 110.996 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.26 -46.87 78.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.083 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.86 70.82 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.148 0.979 . . . . 15.0 111.839 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -59.86 -43.41 94.69 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.968 0.907 . . . . 15.0 109.882 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -83.81 -16.69 43.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.569 0.748 . . . . 15.0 110.099 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -82.06 10.24 7.0 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.706 1.202 . . . . 15.0 110.353 171.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.22 46.25 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.061 -0.518 . . . . 15.0 113.85 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 66.81 2.57 17.45 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 114.107 0.403 . . . . 15.0 114.107 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.05 158.57 19.19 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 124.437 1.095 . . . . 15.0 109.79 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.626 ' HB3' ' HG2' ' A' ' 328' ' ' GLN . 34.6 mm-40 80.8 -53.06 0.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.789 1.636 . . . . 15.0 112.547 173.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm 58.4 28.52 16.93 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.469 1.107 . . . . 15.0 110.764 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.626 ' HG2' ' HB3' ' A' ' 326' ' ' GLU . 81.2 mm-40 -87.3 11.77 13.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.573 1.149 . . . . 15.0 109.968 174.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 315' ' ' ARG . . . -40.17 -45.95 2.12 Favored 'General case' 0 C--N 1.363 1.183 0 C-N-CA 126.823 2.049 . . . . 15.0 113.498 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -58.54 -18.06 26.52 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.871 0.869 . . . . 15.0 112.895 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -98.55 -11.43 22.21 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.623 0.769 . . . . 15.0 112.174 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 315' ' ' ARG . 92.8 mt -55.59 131.78 71.45 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 123.244 0.618 . . . . 15.0 111.024 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.413 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 77.6 Cg_exo -52.24 125.26 16.96 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.142 3.228 . . . . 15.0 114.501 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -51.82 -44.23 63.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.703 1.201 . . . . 15.0 112.416 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -60.35 -18.91 53.26 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.739 0.816 . . . . 15.0 113.114 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 84.8 mt -69.5 -32.68 71.7 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.997 0.427 . . . . 15.0 110.468 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.89 -17.3 12.05 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.237 1.015 . . . . 15.0 111.238 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -49.95 -46.8 52.62 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.435 1.894 . . . . 15.0 113.213 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.46 -60.74 2.7 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 124.794 1.309 . . . . 15.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.7 pt20 -80.87 -32.4 34.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.757 -0.656 . . . . 15.0 111.387 -177.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 314' ' ' LEU . . . -60.71 -61.85 2.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 15.0 110.844 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -55.4 -41.41 72.65 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.113 0.883 . . . . 15.0 109.869 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt-85 -59.42 -36.1 75.25 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.113 0.883 . . . . 15.0 110.909 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 70.3 mtt-85 -76.22 -29.4 57.57 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.807 0.443 . . . . 15.0 110.34 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.53 -37.95 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 302' ' ' VAL . 43.1 t -67.59 -34.42 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.564 HG13 HD12 ' A' ' 351' ' ' LEU . 41.2 t -56.97 -50.22 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.553 0.741 . . . . 15.0 109.216 167.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.13 80.27 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.255 -0.884 . . . . 15.0 113.912 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.47 -58.61 3.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.124 0.57 . . . . 15.0 111.528 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.518 HD13 ' HB3' ' A' ' 294' ' ' LEU . 89.9 mt -60.29 -53.52 56.63 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.919 0.888 . . . . 15.0 110.872 -176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.564 HD12 HG13 ' A' ' 347' ' ' VAL . 44.8 mt -68.38 -30.72 69.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -59.47 -38.62 93.8 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.504 0.502 . . . . 15.0 112.478 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.43 -42.34 83.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.956 -0.622 . . . . 15.0 110.387 174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.7 -34.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.115 0.566 . . . . 15.0 111.146 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.0 mt -66.73 -49.68 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.819 0.848 . . . . 15.0 110.057 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -60.15 -54.36 46.81 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 116.064 -0.517 . . . . 15.0 110.988 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 89.4 m -61.22 -43.99 97.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.196 0.999 . . . . 15.0 111.72 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -91.9 12.61 21.06 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.066 0.546 . . . . 15.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 47.38 30.9 1.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.312 1.845 . . . . 15.0 114.181 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.532 HD22 HE21 ' A' ' 406' ' ' GLN . 73.7 mt -66.72 158.1 31.06 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.339 1.056 . . . . 15.0 113.032 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.9 167.27 27.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.856 -1.52 . . . . 15.0 107.799 170.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.0 90.99 0.09 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.701 -0.481 . . . . 15.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.74 131.29 45.97 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.254 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -51.71 -41.98 61.91 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.699 1.249 . . . . 15.0 112.12 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.5 -19.69 49.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.582 -0.735 . . . . 15.0 111.643 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -86.23 -35.0 20.28 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 110.025 -0.361 . . . . 15.0 110.025 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.78 -52.47 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 108.268 -1.012 . . . . 15.0 108.268 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -51.06 -45.24 61.32 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.66 1.184 . . . . 15.0 111.381 172.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.75 5.88 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.851 1.344 . . . . 15.0 112.155 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 402' ' ' ALA . 66.6 mt -55.73 -52.27 64.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.394 0.678 . . . . 15.0 111.675 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.533 HD11 ' HG2' ' A' ' 398' ' ' MET . 39.9 mm -50.55 -57.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 124.387 1.054 . . . . 15.0 111.417 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.36 -36.57 60.95 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.467 0.48 . . . . 15.0 111.781 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -51.04 71.08 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.279 0.561 . . . . 15.0 110.266 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.634 ' SD ' ' HB3' ' B' ' 442' ' ' ALA . 54.6 ttp -67.18 -44.08 80.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.224 1.409 . . . . 15.0 111.016 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -70.56 -44.78 66.72 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.68 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.4 m -69.5 -16.97 63.56 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.801 0.334 . . . . 15.0 111.458 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 276' ' ' ARG . . . -74.2 -29.33 61.69 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.513 0.725 . . . . 15.0 110.31 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.425 ' HB3' ' HG3' ' B' ' 440' ' ' ARG . 20.8 m-85 -87.61 -168.6 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.773 0.829 . . . . 15.0 111.178 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -70.87 -66.22 0.64 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.122 0.969 . . . . 15.0 110.822 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.16 108.29 48.33 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 109.106 -0.702 . . . . 15.0 109.106 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.599 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 24.6 Cg_endo -63.08 -40.29 34.58 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.553 2.169 . . . . 15.0 113.953 174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -57.39 -51.71 68.33 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.907 0.883 . . . . 15.0 113.041 -161.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.755 ' HB3' HH12 ' B' ' 440' ' ' ARG . 31.3 tt0 -70.11 -20.07 63.2 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 68.4 t -76.44 -45.29 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.172 -0.677 . . . . 15.0 109.172 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.8 mp -51.51 -52.58 19.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.04 -32.07 73.33 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.188 -0.915 . . . . 15.0 112.647 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -64.78 -50.66 65.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.088 0.555 . . . . 15.0 109.771 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -72.41 -50.92 22.9 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.518 0.511 . . . . 15.0 111.437 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.5 p -62.07 -28.05 69.33 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.695 0.628 . . . . 15.0 112.695 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.46 17.08 23.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.589 0.755 . . . . 15.0 111.034 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 395' ' ' MET . 50.5 t-20 -137.26 93.58 2.84 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.776 -1.194 . . . . 15.0 107.776 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -58.57 -33.81 70.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.258 1.023 . . . . 15.0 112.204 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.82 -63.46 1.15 Allowed 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.269 0.98 . . . . 15.0 110.243 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.87 -18.33 58.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.307 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 391' ' ' ASN . 0.0 OUTLIER -67.03 -48.85 67.07 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.544 -0.91 . . . . 15.0 108.544 177.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.62 -34.32 73.9 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 114.962 -1.017 . . . . 15.0 110.695 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.54 -45.12 95.03 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.463 0.649 . . . . 15.0 110.201 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.533 ' HG2' HD11 ' A' ' 371' ' ' ILE . 32.6 tpp -66.92 -30.99 71.29 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.111 -0.95 . . . . 15.0 110.855 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -71.95 -32.72 67.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.154 0.582 . . . . 15.0 111.205 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -51.49 61.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 398' ' ' MET . 10.0 p -72.63 -20.35 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.377 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 370' ' ' LEU . . . -70.12 -43.62 70.64 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.899 0.479 . . . . 15.0 110.412 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.97 -26.59 59.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.228 -0.896 . . . . 15.0 110.721 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 408' ' ' VAL . 73.2 tt0 -60.63 -51.29 70.03 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 109.69 -0.485 . . . . 15.0 109.69 170.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -56.35 -49.2 75.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.074 0.949 . . . . 15.0 111.017 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.532 HE21 HD22 ' A' ' 360' ' ' LEU . 53.4 tt0 -64.8 -36.36 84.07 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.752 1.221 . . . . 15.0 111.614 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.39 66.92 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.02 -0.536 . . . . 15.0 111.063 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 404' ' ' GLU . 68.8 t -55.18 -54.18 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.925 -0.768 . . . . 15.0 108.925 168.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 412' ' ' LEU . 44.6 mt-10 -61.21 -30.7 70.59 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.635 1.174 . . . . 15.0 112.425 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.55 73.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.992 0.517 . . . . 15.0 111.342 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.27 -31.56 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.061 -0.718 . . . . 15.0 109.061 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 409' ' ' GLU . 91.6 mt -67.45 -35.3 78.94 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 15.0 110.864 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.13 -17.43 63.46 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.298 0.639 . . . . 15.0 111.978 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -109.58 -26.26 10.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.575 1.15 . . . . 15.0 112.076 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.94 158.38 16.31 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.919 0.888 . . . . 15.0 110.875 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -73.41 84.78 1.47 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.306 0.642 . . . . 15.0 109.751 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 127' ' ' LYS . 21.2 t -86.8 94.78 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.59 -0.892 . . . . 15.0 108.59 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 3.9 t -68.92 94.5 0.63 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 122.429 1.109 . . . . 15.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -76.25 130.82 38.75 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.027 -1.442 . . . . 15.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -133.69 136.87 44.98 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.759 0.824 . . . . 15.0 108.905 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -98.72 127.82 44.78 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.287 -0.635 . . . . 15.0 109.287 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.469 HG21 ' HG2' ' A' ' 426' ' ' GLU . 9.7 t -160.89 176.61 11.25 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 122.78 0.432 . . . . 15.0 111.724 -173.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 33.6 p -92.96 165.92 12.63 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 111.488 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 136' ' ' ASP . 56.7 t80 -58.6 -28.96 66.09 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.715 1.206 . . . . 15.0 111.228 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 429' ' ' ASN . 0.9 OUTLIER -65.24 -6.84 10.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.03 0.932 . . . . 15.0 113.387 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.497 ' HB3' HD12 ' A' ' 427' ' ' LEU . 12.6 tp10 -74.22 -41.49 61.29 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.033 0.933 . . . . 15.0 112.106 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.642 HD11 HG21 ' A' ' 130' ' ' VAL . 5.3 mp -89.54 -68.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.035 0.534 . . . . 15.0 111.031 -170.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 428' ' ' MET . 1.2 mpt? -74.36 -49.62 21.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.847 0.459 . . . . 15.0 110.668 -175.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 425' ' ' ASN . 1.7 m-20 -79.38 31.57 0.23 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -170.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -43.19 99.29 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.297 0.57 . . . . 15.0 109.754 172.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -98.99 40.49 1.2 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.12 0.968 . . . . 15.0 110.796 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.744 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.65 61.54 1.51 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.698 1.237 . . . . 0.0 109.103 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.11 14.77 30.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.322 -1.763 . . . . 0.0 111.725 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -46.22 -49.09 17.55 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.383 1.873 . . . . 0.0 114.131 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.68 -88.82 0.24 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -167.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -114.48 -75.21 0.59 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 109.694 169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.24 -84.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.962 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -104.55 -78.45 0.56 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -102.62 -69.98 0.77 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -103.99 -73.61 0.67 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.067 0.547 . . . . 0.0 109.672 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.61 -75.96 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.697 ' HB3' ' HG2' ' B' ' 381' ' ' GLU . 32.5 tt0 -103.07 -75.79 0.6 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.541 0.736 . . . . 0.0 109.483 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -102.58 -85.09 0.45 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.15 0.58 . . . . 0.0 112.264 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -103.29 -84.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -166.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.64 -69.24 0.86 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.665 0.386 . . . . 0.0 111.446 -164.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -141.49 111.58 6.77 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.696 0.76 . . . . 0.0 109.518 177.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' B' ' 376' ' ' GLU . 6.4 mp0 -105.73 147.99 27.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.271 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.64 -138.71 25.34 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.047 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -165.62 -87.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 117.186 0.493 . . . . 0.0 110.504 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 23.7 m 53.41 98.29 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 125.559 1.544 . . . . 0.0 114.524 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.63 108.78 19.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 165.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.461 ' HB ' ' HA3' ' A' ' 179' ' ' GLY . 24.0 m -71.91 95.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.668 0.747 . . . . 0.0 111.051 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.536 HD11 ' HZ ' ' A' ' 217' ' ' PHE . 13.5 tt -155.82 162.64 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.62 0.768 . . . . 0.0 108.97 165.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 10.6 t -56.81 109.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 22.6 m -74.09 99.11 3.26 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.346 0.658 . . . . 0.0 110.91 -173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -89.45 170.25 10.69 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.481 174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.5 170.81 14.97 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.633 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -151.82 -154.08 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.592 -169.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.87 177.77 0.53 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.015 0.926 . . . . 0.0 113.194 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -55.74 -39.88 71.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.748 1.219 . . . . 0.0 112.351 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.65 -71.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.208 1.403 . . . . 0.0 111.67 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 48.8 m 66.86 -178.1 0.2 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.069 1.348 . . . . 0.0 111.686 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.645 HE22 HG12 ' B' ' 399' ' ' VAL . 0.9 OUTLIER 47.89 -172.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.124 1.769 . . . . 0.0 113.162 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 29.1 pt -133.94 118.38 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 110.91 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.645 HG12 HE22 ' B' ' 397' ' ' GLN . 9.4 p -157.54 116.85 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 124.137 0.975 . . . . 0.0 108.692 170.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -167.18 101.55 0.63 Allowed Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 124.288 1.035 . . . . 0.0 108.302 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.98 -67.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.509 2.139 . . . . 0.0 111.631 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -173.95 -69.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 23.2 m 68.49 -75.81 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.474 1.51 . . . . 0.0 112.92 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.07 115.16 19.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 0.0 110.309 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . 55.95 82.4 0.24 Allowed Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.605 1.162 . . . . 0.0 110.746 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -52.72 94.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.754 2.969 . . . . 0.0 114.02 -170.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -86.33 -83.43 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.391 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 4.8 tt 60.42 -83.58 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.359 1.464 . . . . 0.0 110.514 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 23.7 p 40.46 83.62 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 125.974 1.71 . . . . 0.0 112.997 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.62 147.8 52.78 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -174.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -103.57 138.03 40.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.85 -33.9 57.86 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.337 0.655 . . . . 0.0 109.934 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 31.7 t30 66.65 103.54 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.902 1.376 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 11.3 t -73.16 -24.8 60.62 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.358 0.663 . . . . 0.0 111.731 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' B' ' 417' ' ' GLY . 57.0 tttm -87.32 150.05 24.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.0 -21.57 61.54 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.629 0.372 . . . . 0.0 110.614 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . 0.45 ' H ' ' HG2' ' B' ' 415' ' ' LYS . . . -75.57 -154.23 4.57 Favored Glycine 0 C--N 1.357 1.734 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.392 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 69.29 -67.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 125.236 1.414 . . . . 0.0 110.721 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.15 157.1 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 C-N-CA 124.384 1.073 . . . . 0.0 109.97 168.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 42.7 mtm 81.35 -32.92 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 126.122 1.769 . . . . 0.0 112.308 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 59.6 t 64.12 -81.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 111.082 -174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.63 138.99 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 66.5 p -158.18 -171.52 3.53 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.756 0.823 . . . . 0.0 110.212 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 65.6 t80 66.32 93.5 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.809 1.244 . . . . 0.0 110.263 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.32 130.52 6.23 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.549 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -94.0 -86.0 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.567 0.747 . . . . 0.0 109.792 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.1 t -116.4 -86.49 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.868 0.467 . . . . 0.0 111.667 -168.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 66.62 9.06 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.241 1.02 . . . . 0.0 110.785 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -93.27 -61.34 1.59 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.738 -173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.57 -83.09 0.16 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.882 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 9.0 p -111.61 -78.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.46 0.704 . . . . 0.0 109.995 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -104.58 -46.37 4.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.281 0.633 . . . . 0.0 111.926 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.13 169.09 19.42 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.247 0.619 . . . . 0.0 109.838 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -143.29 -61.16 0.42 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.146 0.978 . . . . 0.0 108.676 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 6.6 t -164.77 4.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.527 0.731 . . . . 0.0 110.677 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -68.99 -5.62 48.22 Favored Glycine 0 C--N 1.359 1.853 0 C-N-CA 123.751 0.691 . . . . 0.0 114.805 -168.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . 0.505 ' HA ' ' HB ' ' B' ' 441' ' ' ILE . 10.7 p -53.22 -58.96 5.26 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.746 0.818 . . . . 0.0 110.564 166.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 44.57 -84.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.934 1.694 . . . . 0.0 113.729 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.4 -57.41 0.95 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.472 1.109 . . . . 0.0 109.553 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.755 HH12 ' HB3' ' A' ' 383' ' ' GLU . 28.0 ttp85 -86.76 -8.43 57.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.428 0.691 . . . . 0.0 112.469 -165.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' B' ' 437' ' ' SER . 31.1 mm -117.03 125.21 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . 0.634 ' HB3' ' SD ' ' A' ' 374' ' ' MET . . . -105.95 -147.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 70.75 165.98 0.29 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.345 1.058 . . . . 0.0 111.609 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.06 136.4 10.98 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.155 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -75.91 140.97 26.6 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.148 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.28 94.94 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.437 2.092 . . . . 0.0 109.437 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . 0.503 ' HA ' HG22 ' A' ' 313' ' ' VAL . 3.6 t60 72.34 -71.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.921 1.688 . . . . 0.0 112.402 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -139.89 -151.96 0.39 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.782 0.833 . . . . 0.0 109.29 -171.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -56.23 114.49 1.99 Allowed 'General case' 0 C--N 1.354 0.778 0 C-N-CA 123.499 0.72 . . . . 0.0 110.797 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.88 142.28 56.14 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 0.0 110.608 -174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 48.1 t -75.57 -26.28 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.011 0.924 . . . . 0.0 110.411 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 73.2 t 67.63 -72.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.546 1.538 . . . . 0.0 112.131 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -89.08 119.17 5.37 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 120.026 -0.319 . . . . 0.0 112.585 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.552 HD23 HG21 ' B' ' 463' ' ' THR . 43.9 tp -148.92 128.81 13.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 5.6 t -138.79 161.55 36.94 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.196 0.998 . . . . 0.0 109.454 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.54 135.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.956 1.302 . . . . 0.0 112.189 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 60.74 17.87 8.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.891 1.277 . . . . 0.0 111.987 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 14.2 m -138.71 85.03 2.05 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -94.4 24.83 4.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.099 1.36 . . . . 0.0 113.188 -162.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.425 ' H ' HD13 ' B' ' 460' ' ' LEU . 0.0 OUTLIER -105.19 30.49 5.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.58 0.752 . . . . 0.0 110.271 174.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 64.78 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.144 1.378 . . . . 0.0 111.681 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -89.78 116.28 27.76 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.552 HG21 HD23 ' B' ' 454' ' ' LEU . 27.9 m -68.62 106.49 2.62 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.406 175.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -89.34 131.62 35.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -86.48 25.96 1.15 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.633 0.773 . . . . 0.0 112.285 -165.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.09 -41.79 90.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.425 0.69 . . . . 0.0 109.271 166.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.42 32.82 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.033 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.23 -86.38 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.629 0.772 . . . . 0.0 111.0 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 71.43 -84.32 0.44 Allowed Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.901 -172.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 58.73 79.23 0.22 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.021 1.328 . . . . 0.0 111.463 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.064 -1.087 . . . . 12.06 108.064 177.062 . . . . . . . . 0 0 . 1 stop_ save_